Psyllid ID: psy5603

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-----
Protein Sequence
MTSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccccccccHHccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHcccccccccccccccccccccccEEEEEccccEEEEEEEccccccccccccccHHcccHHHHHHHHHHHHHHccccccccccccccccccEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccEEcccHHHHHHHHHHHHHHHHcccccccHHHHHHHEccccccccccccHHHHHHHHHHcccccccccccccEEEEEccccccccccHEEEEEEEEEHHHccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccccHHHHHccccccccEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEcccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccHHHHHEccccccccHcHccHHHEccccccccEEEEEEEcccccccHHHHccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHcccc
Coil and Loop (DISEMBL)
mtsesiitedieiRHLKQYVVHELGIILNERDDWKKIMSIVtvdcdplkplkysakDIKIVERagkrnfpergctdifldewgtsgrrrprLSDLIMFLKKAELHQAARYVEVdvlkkpespgdntEAAEWLQEVIQQEEANNKTEYIGELIAFTfcdleratdgfnrkpyprrgnklgegqfgtVYYGKLKNGMEIAVKTLennanysssnsdnteaaMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRlarvnntppldsnkrYSIALGVAEALHYLHslskpiihrdvksanvlldenfvpklgdfgivkmsetsnmktmytenltgtrpymppeamhcqistktdvFSYGVILLELLtgmkpiddnnTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVfekdkrasMRDIVDLLSKSVNN
Flexible Loop (DISEMBL)
mtsesiitedieirhlkqYVVHELGIILNERDDWKKIMSivtvdcdplkplkysakdikiveragkrnfpergctdifldewgtsgrrrPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDgfnrkpyprrgnklgegqfGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDenfvpklgdfgivkmsetsnmkTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Low Complexity Region (SEG)
MtsesiitedieiRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEnnanysssnsdnTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Disordered region (IsUnstruct)
*****IITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVL**************WLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTL***************AAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET*NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR*****I**********
Disordered Region (DISOPRED)
******I**DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARY******************************************AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVK*****************AAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS***
Disordered Region (DISEMBL)
MTSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK*********AAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Disordered Region (DISPRO)
*****IITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVL********************************GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD*L******
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	455	2.2.26 [Sep-21-2011]
Q1RMT8	461	Interleukin-1 receptor-as	yes	N/A	0.621	0.613	0.364	1e-48
Q9NWZ3	460	Interleukin-1 receptor-as	yes	N/A	0.914	0.904	0.286	6e-48
Q8R4K2	459	Interleukin-1 receptor-as	yes	N/A	0.791	0.784	0.303	2e-45
Q0WVM4	634	Probable LRR receptor-lik	yes	N/A	0.610	0.438	0.378	2e-43
Q8VYT3	648	Probable LRR receptor-lik	no	N/A	0.628	0.441	0.368	2e-41
Q93ZS4	632	Protein NSP-INTERACTING K	no	N/A	0.617	0.444	0.357	3e-41
C0LGU5	614	Probable LRR receptor-lik	no	N/A	0.643	0.477	0.358	6e-41
Q94F62	615	BRASSINOSTEROID INSENSITI	no	N/A	0.619	0.458	0.368	4e-40
C0LGT1	613	Probable LRR receptor-lik	no	N/A	0.617	0.458	0.366	6e-40
Q9SKG5	620	Somatic embryogenesis rec	no	N/A	0.619	0.454	0.380	7e-40

>sp|Q1RMT8|IRAK4_BOVIN Interleukin-1 receptor-associated kinase 4 OS=Bos taurus GN=IRAK4 PE=2 SV=1

 Score =  194 bits (492), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 180/302 (59%), Gaps = 19/302 (6%)

Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L    + S+  
Sbjct: 168 SFSFFELKDVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-RTVAVKKLAAMVDISTEE 226

Query: 213 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 271
                        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct: 227 LKQQ---------FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 277

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
           ++ TPPL  N R  IA G A  L YLH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct: 278 LDGTPPLSWNMRCKIAQGAANGLSYLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 335

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN-- 389
            SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct: 336 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 394

Query: 390 --TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
              +     + ++E  + + +D++  + + T +ET+ S+   +C   +K+KR  ++ +  
Sbjct: 395 QLLLDIKEEIEDEEKTIEDYVDRKMNDIDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 453

Query: 448 LL 449
           LL
Sbjct: 454 LL 455

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.
Bos taurus (taxid: 9913)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9NWZ3|IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1

 Score =  192 bits (487), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 138/481 (28%), Positives = 240/481 (49%), Gaps = 65/481 (13%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           IT    +R L   ++ +L   ++ ++ WKK+   +       +  ++  +  + + + GK
Sbjct: 5   ITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGK 64

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNT 126
               E       L +WGT+      + DL+  L + E    A  +  D + K  +   + 
Sbjct: 65  SPTSE------LLFDWGTTNCT---VGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSK 115

Query: 127 EAAEWLQEVI-----------------------QQEEANNKTEYIGE--LIAFTFCDLER 161
           EA    Q+ +                             NK+  + +    +F+F +L+ 
Sbjct: 116 EAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKN 175

Query: 162 ATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMI 221
            T+ F+ +P    GNK+GEG FG VY G + N   +AVK L               AAM+
Sbjct: 176 VTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL---------------AAMV 219

Query: 222 PILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNN 274
            I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ ++ 
Sbjct: 220 DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 279

Query: 275 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
           TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DFG+ + SE
Sbjct: 280 TPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASE 337

Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN----T 390
               +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++      
Sbjct: 338 KF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 396

Query: 391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  ++ +  LL 
Sbjct: 397 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPDIKKVQQLLQ 455

Query: 451 K 451
           +
Sbjct: 456 E 456

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8R4K2|IRAK4_MOUSE Interleukin-1 receptor-associated kinase 4 OS=Mus musculus GN=Irak4 PE=1 SV=1

 Score =  184 bits (466), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 124/408 (30%), Positives = 206/408 (50%), Gaps = 48/408 (11%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +       +  ++  +  + + + GK
Sbjct: 5   LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGK 64

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNT 126
                  C  +F  +WGT+      + DL+  L + EL   A  +  D + +        
Sbjct: 65  ----SPTCELLF--DWGTTNCT---VGDLVDLLVQIELFAPATLLLPDAVPQTVKSLPPR 115

Query: 127 EAAEWLQEVIQQEEANN-------KTEYIGE------------------LIAFTFCDLER 161
           EAA   Q     +E +        K E+  E                    +F+F +L+ 
Sbjct: 116 EAATVAQTHGPCQEKDRTSVMPMPKLEHSCEPPDSSSPDNRSVESSDTRFHSFSFHELKS 175

Query: 162 ATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMI 221
            T+ F+ +P    GN++GEG FG VY G + N + +AVK L      S+           
Sbjct: 176 ITNNFDEQPASAGGNRMGEGGFGVVYKGCVNNTI-VAVKKLGAMVEISTEELKQQ----- 229

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDS 280
               F+ E++ ++ C+H NL+ LLG  ++  N C+VY YM NGSL DRL+ ++ TPPL  
Sbjct: 230 ----FDQEIKVMATCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSCLDGTPPLSW 285

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           + R  +A G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ + S     +T
Sbjct: 286 HTRCKVAQGTANGIRFLHENHH--IHRDIKSANILLDKDFTAKISDFGLARAS-ARLAQT 342

Query: 341 MYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN 388
           + T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N
Sbjct: 343 VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDEN 390

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  177 bits (448), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 118/312 (37%), Positives = 169/312 (54%), Gaps = 34/312 (10%)

Query: 148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 207
           +G L +FTF +L  ATDGF+ K        LG G FG VY GK  +G  +AVK L++  N
Sbjct: 281 LGNLRSFTFRELHVATDGFSSKSI------LGAGGFGNVYRGKFGDGTVVAVKRLKD-VN 333

Query: 208 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLY 266
            +S NS            F  E++ +S   H NLLRL+G C ++    +VY YM NGS+ 
Sbjct: 334 GTSGNSQ-----------FRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVA 382

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKLG 325
            RL      P LD N R  IA+G A  L YLH    P IIHRDVK+AN+LLDE F   +G
Sbjct: 383 SRL---KAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVG 439

Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM-- 382
           DFG+ K+   ++  +  T  + GT  ++ PE +   Q S KTDVF +G++LLEL+TGM  
Sbjct: 440 DFGLAKL--LNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRA 497

Query: 383 ----KPIDDNNTILYYYLVVEQEVPVREVLDKEAG-EWNETHVETLISIVFEKCCVFEKD 437
               K +     +L +   + +E+ V E++D+E G  ++   V  ++ +    C  F   
Sbjct: 498 LEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVAL-LCTQFLPA 556

Query: 438 KRASMRDIVDLL 449
            R  M ++V +L
Sbjct: 557 HRPKMSEVVQML 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  170 bits (430), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 119/323 (36%), Positives = 178/323 (55%), Gaps = 37/323 (11%)

Query: 137 QQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGME 196
           +QEE     + +G L +FTF +L   TDGF+ K      N LG G FG VY GKL +G  
Sbjct: 277 KQEEG---LQGLGNLRSFTFRELHVYTDGFSSK------NILGAGGFGNVYRGKLGDGTM 327

Query: 197 IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCI 255
           +AVK L++  N +S +S            F  E++ +S   H NLLRL+G C  +    +
Sbjct: 328 VAVKRLKD-INGTSGDSQ-----------FRMELEMISLAVHKNLLRLIGYCATSGERLL 375

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANV 314
           VY YM NGS+  +L    + P LD N R  IA+G A  L YLH    P IIHRDVK+AN+
Sbjct: 376 VYPYMPNGSVASKL---KSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANI 432

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGV 373
           LLDE F   +GDFG+ K+   ++  +  T  + GT  ++ PE +   Q S KTDVF +G+
Sbjct: 433 LLDECFEAVVGDFGLAKL--LNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 490

Query: 374 ILLELLTGMKPIDDNNTI------LYYYLVVEQEVPVREVLDKEAG-EWNETHVETLISI 426
           +LLEL+TG++ ++   T+      L +   + +E+ V E+LD+E G  +++  V  ++ +
Sbjct: 491 LLLELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQV 550

Query: 427 VFEKCCVFEKDKRASMRDIVDLL 449
               C  +    R  M ++V +L
Sbjct: 551 AL-LCTQYLPAHRPKMSEVVLML 572

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  170 bits (430), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 112/313 (35%), Positives = 171/313 (54%), Gaps = 32/313 (10%)

Query: 148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 207
           +G L  +TF +L  AT+ FN K      N LG G +G VY G L +G  +AVK L++  N
Sbjct: 283 LGHLKRYTFKELRSATNHFNSK------NILGRGGYGIVYKGHLNDGTLVAVKRLKD-CN 335

Query: 208 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLY 266
            +              + F+ EV+T+S   H NLLRL G C+ N    +VY YM NGS+ 
Sbjct: 336 IAGGE-----------VQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVA 384

Query: 267 DRLA-RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKL 324
            RL   +   P LD ++R  IA+G A  L YLH    P IIHRDVK+AN+LLDE+F   +
Sbjct: 385 SRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVV 444

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK 383
           GDFG+ K+ +  +  +  T  + GT  ++ PE +   Q S KTDVF +G++LLEL+TG K
Sbjct: 445 GDFGLAKLLD--HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502

Query: 384 PID------DNNTILYYYLVVEQEVPVREVLDKEAGE-WNETHVETLISIVFEKCCVFEK 436
            +D          +L +   + QE  +++++DK+  + ++   +E ++ +    C  F  
Sbjct: 503 ALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVAL-LCTQFNP 561

Query: 437 DKRASMRDIVDLL 449
             R  M +++ +L
Sbjct: 562 SHRPKMSEVMKML 574

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  169 bits (427), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 120/335 (35%), Positives = 175/335 (52%), Gaps = 42/335 (12%)

Query: 131 WLQEVIQQEEANNKTEY-IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYG 189
           W +  + +       E+ IG L  F+F +++ AT  F+ K      N LG+G FG VY G
Sbjct: 264 WHRSRLSRSHVQQDYEFEIGHLKRFSFREIQTATSNFSPK------NILGQGGFGMVYKG 317

Query: 190 KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI----LLFENEVQTLSQCKHVNLLRLL 245
            L NG  +AVK L++                 PI    + F+ EV+ +    H NLLRL 
Sbjct: 318 YLPNGTVVAVKRLKD-----------------PIYTGEVQFQTEVEMIGLAVHRNLLRLF 360

Query: 246 GLCNNIM-NCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP 303
           G C       +VY YM NGS+ DRL       P LD N+R SIALG A  L YLH    P
Sbjct: 361 GFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNP 420

Query: 304 -IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q 361
            IIHRDVK+AN+LLDE+F   +GDFG+ K+ +  +  +  T  + GT  ++ PE +   Q
Sbjct: 421 KIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRD--SHVTTAVRGTIGHIAPEYLSTGQ 478

Query: 362 ISTKTDVFSYGVILLELLTGMKPIDDNN------TILYYYLVVEQEVPVREVLDKE-AGE 414
            S KTDVF +GV++LEL+TG K ID  N       IL +   ++ E    E++D++  GE
Sbjct: 479 SSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGE 538

Query: 415 WNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
           +++  +E ++ +    C     + R  M  ++ +L
Sbjct: 539 FDDLVLEEVVELAL-LCTQPHPNLRPRMSQVLKVL 572

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  166 bits (419), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 116/315 (36%), Positives = 165/315 (52%), Gaps = 33/315 (10%)

Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 206
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 270 HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEER 323

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 265
                            L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 324 TQGGE------------LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 371

Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 372 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 431

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +  T  T  + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 432 VGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 489

Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 490 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 548

Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 549 SPMERPKMSEVVRML 563

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1

 Score =  165 bits (418), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 115/314 (36%), Positives = 166/314 (52%), Gaps = 33/314 (10%)

Query: 148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 207
            G+L  F + +L+ ATD F+ K      N LG+G FG VY G L +  ++AVK L    +
Sbjct: 272 FGQLKRFAWRELQLATDNFSEK------NVLGQGGFGKVYKGVLPDNTKVAVKRL---TD 322

Query: 208 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLY 266
           + S   D           F+ EV+ +S   H NLLRL+G C       +VY +M N SL 
Sbjct: 323 FESPGGDAA---------FQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLA 373

Query: 267 DRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKL 324
            RL  +    P LD   R  IALG A    YLH    P IIHRDVK+ANVLLDE+F   +
Sbjct: 374 HRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 433

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK 383
           GDFG+ K+ +    +T  T  + GT  ++ PE +   + S +TDVF YG++LLEL+TG +
Sbjct: 434 GDFGLAKLVDVR--RTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 491

Query: 384 PID-------DNNTILYYYLVVEQEVPVREVLDKEA-GEWNETHVETLISIVFEKCCVFE 435
            ID       D+  +L +   +E+E  +  ++DK   GE+ +  VE +I +    C    
Sbjct: 492 AIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVAL-LCTQGS 550

Query: 436 KDKRASMRDIVDLL 449
            + R  M ++V +L
Sbjct: 551 PEDRPVMSEVVRML 564

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  165 bits (418), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 120/315 (38%), Positives = 164/315 (52%), Gaps = 33/315 (10%)

Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 206
           ++G+L  FT  +L  ATD F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 275 HLGQLKRFTLRELLVATDNFSNK------NVLGRGGFGKVYKGRLADGNLVAVKRLKEER 328

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 265
                            L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 329 TKGGE------------LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 376

Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPK 323
              L  R    P LD  KR  IALG A  L YLH    + IIHRDVK+AN+LLDE F   
Sbjct: 377 ASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAV 436

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+   ++  +  T  + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 437 VGDFGLAKLMNYND--SHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 494

Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           K         DD+  +L +   V +E  +  ++D E  G++ ET VE LI +    C   
Sbjct: 495 KAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMAL-LCTQS 553

Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 554 SAMERPKMSEVVRML 568

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
242009174	485	serine-threonine protein kinase, plant-t	0.927	0.870	0.361	2e-76
321474115	490	hypothetical protein DAPPUDRAFT_314397 [	0.916	0.851	0.338	3e-59
442747537	454	Putative serine/threonine protein kinase	0.894	0.896	0.345	4e-55
269993241	474	interleukin-1 receptor-associated kinase	0.945	0.907	0.327	5e-54
348512857	461	PREDICTED: interleukin-1 receptor-associ	0.945	0.932	0.327	7e-54
241598587	454	cyclin T-dependent kinase CDK9, putative	0.885	0.887	0.344	1e-53
291239163	598	PREDICTED: hypothetical protein [Saccogl	0.648	0.493	0.395	3e-53
384402280	467	interleukin-1 receptor-associated kinase	0.905	0.882	0.327	4e-53
326911443	419	PREDICTED: interleukin-1 receptor-associ	0.668	0.725	0.361	6e-52
269993243	525	interleukin-1 receptor-associated kinase	0.938	0.813	0.322	7e-52

>gi|242009174|ref|XP_002425367.1| serine-threonine protein kinase, plant-type, putative [Pediculus humanus corporis] gi|212509152|gb|EEB12629.1| serine-threonine protein kinase, plant-type, putative [Pediculus humanus corporis]

 Score =  293 bits (749), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 177/490 (36%), Positives = 267/490 (54%), Gaps = 68/490 (13%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPL-KYSAKDIKIVERAG 65
           + E+ EIR L    +++LG IL+  + W+K+M+++  D +    + KY+ + IK+++ AG
Sbjct: 1   MNENTEIRKLPAAAIYKLGQILDTENAWQKVMAMIPSDPNDFNSVAKYTPQHIKLIQTAG 60

Query: 66  KRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLK--KPESPG 123
           ++    + CT+I  DEWGTSG  RP L+ L+  L KA+ ++AA +V V++LK   PE P 
Sbjct: 61  EKQ--NKSCTEILFDEWGTSGEVRPNLNTLLQILIKAQFYRAAEFVAVELLKGEPPERPL 118

Query: 124 DNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPR---------- 173
               A   L  + Q  ++N ++   G++I   +  LE+ T+ FN  P  +          
Sbjct: 119 VGPAAPVKLPSLTQDLDSNFQS---GDVIHIPYSTLEQVTNNFNETPLKKCIHGDGVVHF 175

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQT 232
            G+KLG G FGTVY+G+L+NG ++AVK L   N N  +               FENE++ 
Sbjct: 176 TGHKLGSGAFGTVYFGELENGKQVAVKKLHMTNINLKNQ--------------FENEIKV 221

Query: 233 LSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTP--------------- 276
           LS+ +HVNL+ L+G  C+   NC++YE+M NGSL D+L     +P               
Sbjct: 222 LSEYRHVNLVPLIGFSCDTDDNCLIYEFMSNGSLLDKLQIKIGSPSVCNSLDANKVLNGM 281

Query: 277 --------------PLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFV 321
                         PL   KR  IAL V E +++LH+  K P+IHRD+KSAN+LLD    
Sbjct: 282 VSNCGSPSAILTDKPLGWMKRIEIALDVCEGINFLHNSKKFPLIHRDIKSANILLDHRLT 341

Query: 322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
            KLGDFG+VK+        M T  + GT  YM PEA    +S K DVFSYGV+LLELLTG
Sbjct: 342 GKLGDFGLVKIKPNLTESKMLTSTVFGTSAYMAPEAFRGDVSVKMDVFSYGVVLLELLTG 401

Query: 382 MKPIDDNNTILYYYLVVEQEV--PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR 439
           + P D+N         VE  V   +  +LDK+AG WN    + + ++   + C+ EK  R
Sbjct: 402 LPPYDENREGCDLVTYVEDAVDDSIEFLLDKKAGFWNSEIAQKIFTL--SQSCLEEKKTR 459

Query: 440 ASMRDIVDLL 449
             ++++++ L
Sbjct: 460 PLIKNVLETL 469

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|321474115|gb|EFX85081.1| hypothetical protein DAPPUDRAFT_314397 [Daphnia pulex]

 Score =  235 bits (600), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 160/472 (33%), Positives = 241/472 (51%), Gaps = 55/472 (11%)

Query: 24  LGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWG 83
           L  +L+  + WK +M  +      ++  K+S++ + ++E   KR   ++   DI +DEWG
Sbjct: 9   LSSMLDTNNSWKIVMGAIPELNGDVETKKFSSEHVGLIEEEAKRQ--KKSAFDILIDEWG 66

Query: 84  TSGRRRPRLSDLIMFLKKAELHQAARYVEVDVL------KKPESPGDN----TEAAEWLQ 133
           TSG++RP + +L+  L + EL+QAA Y+  D+L      +    P  N    TE   +LQ
Sbjct: 67  TSGKQRPTVCELVKLLAELELYQAADYLSTDLLGEGPVERPANGPSANVPSSTEDINFLQ 126

Query: 134 EV---IQQEEANNKTEYIGE--------------------LIAFTFCDLERATDGFNRKP 170
                IQ        E+I                      L   ++ DLE  T+ F+  P
Sbjct: 127 TTSHSIQAAILEATNEHINPRFFEKKMPFSPPEVDKFDTTLPHLSYADLEYLTNDFDLNP 186

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-------NGMEIAVK---TLENNANYSSSNSDNTEAAM 220
              +G KLG G FGTV+ G LK        G+EI  K   +L++       ++   +  +
Sbjct: 187 V-SQGRKLGAGAFGTVFLGILKENPQLDDRGIEIYKKMKLSLQHKVAVKRLHNQKVDVDI 245

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLD 279
               LF  EV+T+SQ  H NLL LL    +  +C +VY ++ NGSL  RLA    +PPL 
Sbjct: 246 DTNRLFRTEVETMSQYVHENLLALLAFSADGPDCCLVYSFIPNGSLEARLACEGASPPLQ 305

Query: 280 SNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-- 336
            N+R  +A GV++AL +LH+  ++P++HRDVKSANVLLD N   KLGDFG++++  +   
Sbjct: 306 WNQRLDVAHGVSKALIHLHTGGAQPLVHRDVKSANVLLDHNMKAKLGDFGLIRIGASGRG 365

Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPID---DNNTILY 393
           +    +T N+ GT  YM PEA    IS K D FS+GVI+LELLTG+ P D   D N ++ 
Sbjct: 366 SKSVAFTSNVLGTSAYMAPEAFRGDISVKLDTFSFGVIILELLTGLPPYDEERDGNDLIS 425

Query: 394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +      E+   ++LD +     E     L SI     C+ EK +R  M  +
Sbjct: 426 HVDSALDEIEFIQLLDPKISPLPEDMASALHSIAL--SCIQEKKRRPLMTQV 475

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|442747537|gb|JAA65928.1| Putative serine/threonine protein kinase [Ixodes ricinus]

 Score =  221 bits (564), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 159/460 (34%), Positives = 238/460 (51%), Gaps = 53/460 (11%)

Query: 3   SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVE 62
           +ES++T D E+R L       L  +L+  D WKKI+ ++T    P + L ++A    ++E
Sbjct: 14  AESVVTADTELRFLPGRARSLLVNLLDAGDGWKKILYLITHPDHPDRKL-FNADHAWVLE 72

Query: 63  RAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESP 122
                N   R  TD  L  W T+GR RP++ DL+  LK+AE ++AA  +  DVL++    
Sbjct: 73  -----NETRRSRTDEILKSWSTTGRNRPKIRDLLCLLKEAEQYRAASIITTDVLQEDPVD 127

Query: 123 GDNTEAAEWL-----------QEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPY 171
            D+    E L           Q V       N TE   + +   +  L RAT  F+    
Sbjct: 128 EDDESVQELLYQLDMEPSAPPQSVADSTPDVNSTES-SDALEIPYAVLVRATRNFH---- 182

Query: 172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                K+GEG FG VY G L +G  +AVK L+                      F +EV+
Sbjct: 183 ----TKVGEGAFGIVYKGTLPDGTTVAVKGLKETFPNK----------------FLSEVE 222

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L +  H NLL L+G+ N+  + CIVY++M  GSL   LAR N+ PP+   KR SI   V
Sbjct: 223 LLRRLSHPNLLPLVGVANDSRHCCIVYKFMEYGSLQSCLARENDAPPMYWEKRISILTEV 282

Query: 291 AEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           A A+++LH+ +  P+IHRDVKSANVLLDE++  KLGDFG+ ++   +   T  TE + GT
Sbjct: 283 AAAINFLHTRTPDPLIHRDVKSANVLLDEHWSAKLGDFGLTRV--LAGNATAVTE-IVGT 339

Query: 350 RPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI----DDNNTILYYYLVVEQEVPVR 405
             YM PEA    +S K D +S+GV+++E+LT + P+      +   +  YL  E    + 
Sbjct: 340 TVYMAPEAFRGVVSPKMDTYSFGVVIMEILTAL-PLYISSRGHARDILSYLSEEHPDDIV 398

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             LD+ AGEWN  ++   +  + E C   +K +R +M+ +
Sbjct: 399 PALDESAGEWN-VNLARKVHELAESCVDPDKRRRPTMQPV 437

Source: Ixodes ricinus

Species: Ixodes ricinus

Genus: Ixodes

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|269993241|emb|CBI63173.1| interleukin-1 receptor-associated kinase 4 [Oncorhynchus mykiss] gi|269993247|emb|CBI63176.1| interleukin-1 receptor-associated kinase 4 [Oncorhynchus mykiss]

 Score =  218 bits (555), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 156/477 (32%), Positives = 248/477 (51%), Gaps = 47/477 (9%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           IT    IR+L   V  +L  +L+ +D WK ++ ++     P    +YS + ++  E    
Sbjct: 5   ITSATFIRNLNYGVRRKLSDLLDPQDSWKDVIVLIH---KPTGEPRYSQQHLRRFEAVVL 61

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIM---FLKKAE--LHQAARYVEVDVLKKPES 121
           +    R  T   L++WGTS      L D++M    +  A   L  A       V + P+S
Sbjct: 62  QG---RSPTMELLNDWGTSNCTVGELVDILMSHRLMAAASIILPYAINNPRPAVPQPPDS 118

Query: 122 PGD-----NTEAAEW----LQEVIQQEEANNKTEYIGE---------LIAFTFCDLERAT 163
           P D     N++AA       +E  +++   + T    E          +  +F +L++ T
Sbjct: 119 PRDKEMVGNSDAATRPLGRTEEQTKEQPPPDSTSEPQEDPEPNGTAGFLRLSFHELKKIT 178

Query: 164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
             F+ +P    G++LGEG FGTVY G L NG  +AVK L +  + S              
Sbjct: 179 GHFDERPVSEGGSRLGEGGFGTVYKG-LINGKPVAVKKLHSMEDISLEELS--------- 228

Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
           + F  EVQTL   KH NL+ ++G   +  + C+VY YM NGSL DRLA ++ +PPL  ++
Sbjct: 229 VQFIQEVQTLMVLKHENLVDMVGFSRDGHHPCLVYAYMSNGSLLDRLACLDGSPPLSWHR 288

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
           R  IA+G A  L YLHS     +HRDVKS N+LLDE  VPK+ DFG+ + S T +  T+ 
Sbjct: 289 RCLIAVGTARGLDYLHSNHH--VHRDVKSGNILLDELLVPKISDFGLTRASATRSSATVM 346

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY----LVV 398
           TE + GT  YM  EA+  +I+ K+D++S+GV+LLE+L+G+ P+D+N    +       + 
Sbjct: 347 TERIVGTTAYMANEALRGEITPKSDIYSFGVVLLEILSGLPPVDENRDPKFLMEMKDEID 406

Query: 399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
           E+E+ + + +DK+  +W+   VE    +  + C   +K+KR  M +++  L   V +
Sbjct: 407 EEEMALEDFVDKKMTDWDLPLVERTYFLASD-CLSDKKNKRPLMEEVLTELEDVVKS 462

Source: Oncorhynchus mykiss

Species: Oncorhynchus mykiss

Genus: Oncorhynchus

Family: Salmonidae

Order: Salmoniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|348512857|ref|XP_003443959.1| PREDICTED: interleukin-1 receptor-associated kinase 4-like [Oreochromis niloticus]

 Score =  218 bits (554), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 155/473 (32%), Positives = 241/473 (50%), Gaps = 43/473 (9%)

Query: 4   ESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVER 63
           +S +T    IR+L   +  +L   L+ +D WK+++  +     P    +YS   ++  E 
Sbjct: 2   DSSVTSATYIRNLGYCLRRKLSDFLDPQDRWKEVLVDIQ---KPSGEPRYSQLHVRRFEG 58

Query: 64  AGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV--EVDVLKKPES 121
              +    R  T   L++WGT+   +  + +L+  LK  EL  AA  +  E   L+   +
Sbjct: 59  LVAQG---RSPTMELLNDWGTT---KSTVGELVDILKSHELLAAANVLLPESSPLETQLT 112

Query: 122 P--GDNTEAAEWLQE---------VIQQEEANNKTEYIGE-LIAFTFCDLERATDGFNRK 169
           P    +T +   L+E         V+Q       TE I     +F + DL R T  F+ +
Sbjct: 113 PLKTRSTASTRLLEERDVQQPVTTVLQLRTPEENTEPIHTGFSSFLYSDLMRITGNFDDR 172

Query: 170 PYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
                G+++GEG FGTVY G L +   +AVK L    +       +          F  E
Sbjct: 173 STSAGGSRIGEGGFGTVYKGLLDDK-PVAVKKLNPVDDMPLDKLQDQ---------FNQE 222

Query: 230 VQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +QTL   KH NL+ ++G  C+    C+VY +M NGSL DRLA    +PPL  + R  IA 
Sbjct: 223 IQTLKVLKHENLVDMVGFSCDEQHLCLVYAFMANGSLLDRLACFEGSPPLSWHHRCLIAE 282

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           G A+ L YLHS     +HRDVKSAN+LLDE FV K+ DFG+ + S      TM TE + G
Sbjct: 283 GTAKGLEYLHSNHH--VHRDVKSANILLDEQFVAKISDFGLTRASAKRTSTTMMTERIVG 340

Query: 349 TRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV------EQEV 402
           TR YM PEA+  +I+ K+DVFS+GV+LLE+L+G+ P+D+N    +   +       ++E+
Sbjct: 341 TRAYMAPEALRGEITPKSDVFSFGVVLLEILSGLPPVDENREPQFLMEMRYDIDDEDEEL 400

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            + + +DK+  +W  + VE++ S+    C    K++R  +R +   +   V N
Sbjct: 401 TLEDFVDKKMKDWELSQVESIYSLAC-NCLHDRKNRRPVIRQVYAEIHGVVKN 452

Source: Oreochromis niloticus

Species: Oreochromis niloticus

Genus: Oreochromis

Family: Cichlidae

Order: Perciformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|241598587|ref|XP_002404763.1| cyclin T-dependent kinase CDK9, putative [Ixodes scapularis] gi|215500483|gb|EEC09977.1| cyclin T-dependent kinase CDK9, putative [Ixodes scapularis]

 Score =  217 bits (552), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 160/464 (34%), Positives = 242/464 (52%), Gaps = 61/464 (13%)

Query: 3   SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVE 62
           +ES++T D E+R L       L  +L+  D WKKI+ ++T      + L ++A    ++E
Sbjct: 14  AESVVTADTELRFLPGRARSLLVNLLDAGDGWKKILYLITHPDHSDRKL-FNADHAWVLE 72

Query: 63  RAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESP 122
                N   R  TD  L  W T+GR RP++ DL+  LK+AE ++AA  +  DVL+  E+P
Sbjct: 73  -----NETRRSRTDEILKSWSTTGRNRPKIRDLLCLLKEAEQYRAASIIATDVLQ--EAP 125

Query: 123 GDNTEAAEWLQEVIQQEEAN---------------NKTEYIGELIAFTFCDLERATDGFN 167
            D  E  E +QE++ Q +                 N TE   + +   +  L RAT  F+
Sbjct: 126 VD--EGDESVQELLSQLDMEPSAPPQSVTDSTPDVNSTES-SDALEIPYAVLVRATRNFH 182

Query: 168 RKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
                    K+GEG FG VY G L +G  +AVK L+                      F 
Sbjct: 183 --------TKVGEGAFGIVYKGTLPDGTTVAVKCLKETFPNK----------------FL 218

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           +EV+ L + +H NLL L+G+ N+  + CIVY++M  GSL   LAR N+  P+   KR SI
Sbjct: 219 SEVELLRRLRHPNLLPLVGVANDSRHCCIVYKFMEYGSLQSCLARENDVAPMYWEKRISI 278

Query: 287 ALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
              VA A+++LH+ +  P+IHRDVKSANVLLDE++  KLGDFG+ ++   +   T  TE 
Sbjct: 279 LTEVAAAINFLHTRTPDPLIHRDVKSANVLLDEHWSAKLGDFGLTRV--LAGNATAVTE- 335

Query: 346 LTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI----DDNNTILYYYLVVEQE 401
           + GT  YM PEA    +S K D +S+GV+++E+LT + P+      +   +  YL  E  
Sbjct: 336 IVGTTVYMAPEAFRGVVSPKMDTYSFGVVIMEILTAL-PLYISSRGHARDILSYLSEEHP 394

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             +   LD+ AGEWN   +   +  + E C   +K +R +M+ +
Sbjct: 395 DDIVPALDESAGEWN-VDLARKVHELAESCIDPDKRRRPTMQPV 437

Source: Ixodes scapularis

Species: Ixodes scapularis

Genus: Ixodes

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|291239163|ref|XP_002739502.1| PREDICTED: hypothetical protein [Saccoglossus kowalevskii]

 Score =  215 bits (548), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 134/339 (39%), Positives = 178/339 (52%), Gaps = 44/339 (12%)

Query: 120 ESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLG 179
           E  G   E    LQEV   +E              ++ DL   TDGFN       GN +G
Sbjct: 286 EHSGKTAEIRMTLQEVAPDKE-------------LSYTDLSHMTDGFNISKQEDGGNFIG 332

Query: 180 EGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL-----LFENEVQTLS 234
           EG FG V+ G   NG ++A+K L+                  P+L      F+NE++TL 
Sbjct: 333 EGAFGIVFLGNASNGNKLAIKKLK--------------VGDTPLLSRITEQFKNEIKTLF 378

Query: 235 QCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +CKHVNL+ LLG    CN++  C+VYEYMCNGSL DRL    NTPPL    R SI+  VA
Sbjct: 379 RCKHVNLVPLLGYSCDCNHL--CLVYEYMCNGSLQDRLMCNGNTPPLSWTTRVSISKDVA 436

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLHS  + +IHRD+KSANVLLDENFV K+GDFG+++           T  + GT P
Sbjct: 437 KGITYLHS--ENLIHRDIKSANVLLDENFVAKVGDFGLIRPGPEIGHSITRTSTVFGTSP 494

Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE----V 407
           YMP EA    I+ K D +SYGV+LLE++TG+   D++         VE E    E    +
Sbjct: 495 YMPKEAFSGTITPKQDTYSYGVVLLEIMTGLPVFDESRKSCDLCSHVEDECDADEDFISI 554

Query: 408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           +D    +WNE  +  L  I   KC    + KR  M +I+
Sbjct: 555 VDSNMNDWNEESITELYLIAL-KCLEHTRKKRPFMAEIL 592

Source: Saccoglossus kowalevskii

Species: Saccoglossus kowalevskii

Genus: Saccoglossus

Family: Harrimaniidae

Class: Enteropneusta

Phylum: Hemichordata

Superkingdom: Eukaryota

>gi|384402280|gb|AFH88675.1| interleukin-1 receptor-associated kinase 4 [Trachidermus fasciatus]

 Score =  215 bits (548), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 151/461 (32%), Positives = 232/461 (50%), Gaps = 49/461 (10%)

Query: 13  IRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPER 72
           +R L   V   L   L+ +D W+++++ +     P   L+YS   ++  E    +    +
Sbjct: 11  VRSLSYSVRRRLSYFLDPQDRWREVIASIR---KPSGELRYSQLHVRRFEGLVAQG---K 64

Query: 73  GCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV-----EVDVLKKPESPGDNTE 127
             T   L +WGTS      + +L+  L+  +L  AA  +      V    +P SP   T 
Sbjct: 65  SPTLELLVDWGTSNST---VGELVDILRSHKLLAAASVLLPEEEAVPPETQPTSPAVETN 121

Query: 128 A---AEWLQE----------VIQQEEANNKTE--YIGELIAFTFCDLERATDGFNRKPYP 172
           +      L+E          V+Q +     +E  Y   + +F + +L   T  F+ +P  
Sbjct: 122 SLLSTRLLEETGTRPPLELAVLQPQIPTESSEPGYTDSISSFFYNELMEITGNFDDRPVS 181

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
             G +LGEG FGTVY G L N   +AVK L    + S              + F  EVQT
Sbjct: 182 DGGRRLGEGGFGTVYKGLL-NDKPVAVKKLNPMDDISLDELR---------VQFNQEVQT 231

Query: 233 LSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L   KH NL+ ++G  C+    C+VY  M NGSL DRLA +  +PPL   +R  IA G A
Sbjct: 232 LKVLKHENLVDMVGFSCDGQHPCLVYALMVNGSLLDRLACLEGSPPLSWRQRSLIAEGTA 291

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             L YLHS     +HRDVKSAN+LLDE FV K+ DFG+ + S      TM TE + GTR 
Sbjct: 292 RGLEYLHSNHH--VHRDVKSANILLDETFVAKISDFGLTRASAKRTSTTMMTERIVGTRA 349

Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV------EQEVPVR 405
           YM PEA+  +I+ ++DVFS+GV+LLE+L+G+ P  +N    +   +       ++E+ + 
Sbjct: 350 YMAPEALRGEITPRSDVFSFGVVLLEILSGLPPAAENREPQFLMEMRHDIDDEDEELTLE 409

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           + LDK  G+W+ + VE++ S+    C    K++R  ++ ++
Sbjct: 410 DFLDKTMGDWDLSQVESVYSLAC-NCLHDRKNRRPVIKQVL 449

Source: Trachidermus fasciatus

Species: Trachidermus fasciatus

Genus: Trachidermus

Family: Cottidae

Order: Scorpaeniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|326911443|ref|XP_003202068.1| PREDICTED: interleukin-1 receptor-associated kinase 4-like [Meleagris gallopavo]

 Score =  211 bits (537), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 117/324 (36%), Positives = 192/324 (59%), Gaps = 20/324 (6%)

Query: 125 NTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFG 184
           NTE    +   + +E ++ ++    +   F F DLE  T+ F+ +P    GNKLGEG FG
Sbjct: 100 NTEKQPSVPPCLSEENSSTQSSNT-DFHNFCFRDLENVTNNFDERPESAGGNKLGEGGFG 158

Query: 185 TVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL 244
            V+ G + NG  +AVK L    + S+ +             F+ E++ +++CKH NL+ L
Sbjct: 159 IVFKGYI-NGRNVAVKKLAAVVDVSAQDLKQQ---------FDQEIEIMAKCKHENLVEL 208

Query: 245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP 303
           LG  ++    C+VYEYM NGSL DRLA ++ TPP+  N R  IA G A  +++LH  +  
Sbjct: 209 LGFSSDGAQPCLVYEYMPNGSLLDRLACLDGTPPISWNTRCEIAQGTASGINFLHDNNH- 267

Query: 304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS 363
            IHRD+KSAN+LL + +VPK+ DFG+ + S T   +T+ T+ + GT  YM PEA+  +I+
Sbjct: 268 -IHRDIKSANILLTDKYVPKISDFGLARASVTFT-RTIMTDRVVGTAAYMAPEALRGEIT 325

Query: 364 TKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV----EQEVPVREVLDKEAGEWNETH 419
            K+D+FS+GV+LLE++TG+ P+D+N        +     ++E  V + +D +  +W+ T 
Sbjct: 326 PKSDIFSFGVVLLEVITGLPPVDENREPQLLLSIKDEIEDEEATVEDYVDVKMSDWDATS 385

Query: 420 VETLISIVFEKCCVFEKDKRASMR 443
           V  + S+  ++C   +K++R +++
Sbjct: 386 VHKMYSLA-DRCLNEKKNRRPNIQ 408

Source: Meleagris gallopavo

Species: Meleagris gallopavo

Genus: Meleagris

Family: Phasianidae

Order: Galliformes

Class: Aves

Phylum: Chordata

Superkingdom: Eukaryota

>gi|269993243|emb|CBI63174.1| interleukin-1 receptor-associated kinase 4 [Coregonus maraena] gi|302353978|emb|CBI63179.2| interleukin-1 receptor-associated kinase 4 [Coregonus maraena]

 Score =  211 bits (536), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 155/480 (32%), Positives = 238/480 (49%), Gaps = 53/480 (11%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           IT    IR L   V  +L   L+ +D WK +  IV++   P    +YS + ++  E    
Sbjct: 5   ITSATFIRKLNYGVRRKLSDFLDPQDSWKYV--IVSIH-KPTGEPRYSQQHLRRFEAVVL 61

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKP------- 119
           +    R  T   L++WGTS      L D++M      L  AA  +  D +  P       
Sbjct: 62  QG---RSPTMELLNDWGTSNSTVGELVDILM---SHRLMAAASILLPDAINNPRPAVPQP 115

Query: 120 -ESP------GDNTEAAEWLQEVIQQEEANNKTEYIGE------------LIAFTFCDLE 160
            +SP      G+N  A   L     Q +     +   E             +  +F +L+
Sbjct: 116 SDSPRDKEMIGNNDAATRPLGRTEAQTKEQPPPDSTSEPQEDQDPNDTAGFLRLSFHELK 175

Query: 161 RATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM 220
           + T  F+ +P    G++LGEG FGTVY G L N   +AVK L +  + S           
Sbjct: 176 KITGNFDERPVGDGGSRLGEGGFGTVYKG-LINDKPVAVKKLHSMEDISLKELS------ 228

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLD 279
              + F  EVQTL   KH NL+ ++G   +  + C+VY YM NGSL DRLA ++ +PPL 
Sbjct: 229 ---VQFIQEVQTLMVLKHENLVDMVGFSRDGHHPCLVYAYMSNGSLLDRLACLDGSPPLS 285

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++R  IA+G A  L YLHS     +HRDVKS N+LL+E  VPK+ DFG+ + S T +  
Sbjct: 286 WHRRCLIAVGTARGLDYLHSNHH--VHRDVKSGNILLNELLVPKISDFGLTRASATRSSS 343

Query: 340 TMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY---- 395
           T+ TE + GT  YM  EA+  +I+ K+D++S+GV+LLE+L+G+ P+D+N    +      
Sbjct: 344 TVMTERIVGTTAYMANEALRGEITPKSDIYSFGVVLLEILSGLPPVDENRDPKFLMEMKD 403

Query: 396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            + E+E+ + + +DK    W+   VE     +   C   +K+KR  M +++  L   V +
Sbjct: 404 EIDEEEMALEDFVDKRMTYWDLPLVEKTY-FLPSDCLTDKKNKRPRMEEVLTELEDVVKS 462

Source: Coregonus maraena

Species: Coregonus maraena

Genus: Coregonus

Family: Salmonidae

Order: Salmoniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
UNIPROTKB|E1C1A7	464	IRAK4 "Uncharacterized protein	0.738	0.724	0.351	1.4e-58
UNIPROTKB|Q1RMT8	461	IRAK4 "Interleukin-1 receptor-	0.626	0.618	0.371	2e-51
UNIPROTKB|A9QT42	460	IRAK4 "Uncharacterized protein	0.626	0.619	0.375	2e-49
RGD|1305303	461	Irak4 "interleukin-1 receptor-	0.628	0.620	0.354	2.6e-49
ZFIN|ZDB-GENE-040426-738	483	irak4 "interleukin-1 receptor-	0.621	0.585	0.338	1.6e-47
UNIPROTKB|Q9NWZ3	460	IRAK4 "Interleukin-1 receptor-	0.626	0.619	0.365	1.6e-47
UNIPROTKB|E2RDL0	460	IRAK4 "Uncharacterized protein	0.621	0.615	0.364	4.2e-47
MGI|MGI:2182474	459	Irak4 "interleukin-1 receptor-	0.626	0.620	0.351	9.1e-45
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.564	0.245	0.380	1.6e-42
TAIR|locus:2046728	708	AT2G23450 [Arabidopsis thalian	0.560	0.360	0.348	2e-42

UNIPROTKB|E1C1A7 IRAK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 546 (197.3 bits), Expect = 1.4e-58, Sum P(2) = 1.4e-58
 Identities = 126/358 (35%), Positives = 201/358 (56%)

Query:    99 LKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCD 158
             L   E  Q  +  EV  +K   S   NTE        + QE ++ ++    +   F F D
Sbjct:   121 LPVCEKQQPIQEKEVTSVKPVLS--QNTEKQPSAPPCLSQEISSTQSSNT-DFHNFWFHD 177

Query:   159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEA 218
             LE  T+ F+ +P    GNKLGEG FG V+ G + NG  +AVK L                
Sbjct:   178 LESVTNNFDERPESAGGNKLGEGGFGIVFKGYI-NGRNVAVKKLAAVVDVSAQDLKQQ-- 234

Query:   219 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPP 277
                    F+ E++ +++CKH NL+ LLG  ++    C+VYEYM NGSL DRLA ++ TPP
Sbjct:   235 -------FDQEIEIMAKCKHENLVELLGFSSDGAQPCLVYEYMPNGSLLDRLACLDGTPP 287

Query:   278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
             +  N R  IA G A  +++LH  +   IHRD+KSAN+LL + +VPK+ DFG+ + S T  
Sbjct:   288 ISWNTRCEIAQGTANGINFLHDNNH--IHRDIKSANILLTDTYVPKISDFGLARASVTFT 345

Query:   338 MKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYY 395
              +T+ T+ + GT  YM PEA+  +I+ K+D+FS+GV+LLE++TG+ P+D+N    +L   
Sbjct:   346 -RTIMTDRVVGTAAYMAPEALRGEITPKSDIFSFGVVLLEVITGLPPVDENREPQLLLSI 404

Query:   396 L--VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                + ++E  + + +D +  +W+ T V  + S+  ++C   +K++R +M+ +   L +
Sbjct:   405 KDEIEDEEATIEDYVDVKMSDWDATSVHKMYSLA-DQCLNEKKNRRPNMKMVQQYLQE 461

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

UNIPROTKB|Q1RMT8 IRAK4 "Interleukin-1 receptor-associated kinase 4" [Bos taurus (taxid:9913)]

 Score = 507 (183.5 bits), Expect = 2.0e-51, Sum P(2) = 2.0e-51
 Identities = 113/304 (37%), Positives = 181/304 (59%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   168 SFSFFELKDVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-RTVAVKKL------AAMV 220

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   221 DISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 277

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  N R  IA G A  L YLH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   278 LDGTPPLSWNMRCKIAQGAANGLSYLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 335

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   336 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 394

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +D++  + + T +ET+ S+   +C   +K+KR  ++ +  
Sbjct:   395 QLLLDIKEEIEDEEKTIEDYVDRKMNDIDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 453

Query:   448 LLSK 451
             LL +
Sbjct:   454 LLEE 457

GO:0005737 "cytoplasm" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0045087 "innate immune response" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

UNIPROTKB|A9QT42 IRAK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 515 (186.3 bits), Expect = 2.0e-49, P = 2.0e-49
 Identities = 114/304 (37%), Positives = 181/304 (59%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F FC+L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFAFCELKDVTNNFDERPVSIGGNKMGEGGFGVVYKGYVNN-RAVAVKKL------AAVV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ L++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DISTEELKQQ---FDQEIKVLAKCQHENLVELLGFSSDGDDLCLVYVYMSNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             +++TPPL    R  IA G A  L +LH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   277 LDDTPPLSWYMRCKIAQGAANGLSFLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +DK+  + + T +ET+ S+   +C   +K+KR  ++ +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDKKMNDTDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 452

Query:   448 LLSK 451
             LL +
Sbjct:   453 LLQE 456

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

RGD|1305303 Irak4 "interleukin-1 receptor-associated kinase 4" [Rattus norvegicus (taxid:10116)]

 Score = 479 (173.7 bits), Expect = 2.6e-49, Sum P(2) = 2.6e-49
 Identities = 108/305 (35%), Positives = 177/305 (58%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GN++GEG FG VY G + N   +AVK L          
Sbjct:   169 SFSFYELKSITNDFDERPVSIGGNRMGEGGFGVVYKGCVNN-TTVAVKKL------GAMV 221

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLG  ++  N C+VY YM NGSL DRL+ 
Sbjct:   222 EISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSC 278

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  IA G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ +
Sbjct:   279 LDGTPPLSWHMRCKIARGAANGIRFLHENHH--IHRDIKSANILLDQDFTAKISDFGLAR 336

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              S     +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N   
Sbjct:   337 AS-AKLAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDENREP 395

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + +  D++  + +   VE + S+   +C   +K++R  +  +  
Sbjct:   396 QLLLDIKEEIEDKEKTIEDCTDEKMSDADPASVEAMYSVA-SQCLHEKKNRRPDIAKVQQ 454

Query:   448 LLSKS 452
             LL ++
Sbjct:   455 LLQET 459

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA;ISO

GO:0003674 "molecular_function" evidence=ND

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005149 "interleukin-1 receptor binding" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007254 "JNK cascade" evidence=IMP

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IMP

ZFIN|ZDB-GENE-040426-738 irak4 "interleukin-1 receptor-associated kinase 4" [Danio rerio (taxid:7955)]

 Score = 453 (164.5 bits), Expect = 1.6e-47, Sum P(2) = 1.6e-47
 Identities = 102/301 (33%), Positives = 167/301 (55%)

Query:   154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXX 213
             F+  +L   T  ++ +P    G +LG G FG V+ G++ +   +AVK L           
Sbjct:   186 FSLHELTAMTQHWDERPLSDGGCRLGSGGFGVVFRGRMGD-KHVAVKKLNPLDGSSYEDL 244

Query:   214 XXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARV 272
                         F  E+QTL    H N+LR+LG  C+    C+V+E M NGSL +RLA  
Sbjct:   245 RKQ---------FNQEIQTLRSLSHENVLRVLGCSCSGPPLCVVFELMVNGSLLERLACA 295

Query:   273 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
              +TP L    R  I +G A  L YLH+ +   IHRDVKSAN+LLDE FV K+ DFG+ + 
Sbjct:   296 EHTPALTWRNRCWITVGAARGLSYLHTHAH--IHRDVKSANILLDEGFVAKISDFGLTRS 353

Query:   333 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN-NTI 391
             +   ++ T+ TE + GT  YM PEA+  +I+ K+DVFS+GV+LLE+L+G+ P+D++ +  
Sbjct:   354 AAAGSLMTLQTERIVGTTAYMAPEALRGEITAKSDVFSFGVVLLEVLSGLPPVDESRDPA 413

Query:   392 LYYYL---VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL 448
             L   +   + ++++ + +  D+   +W    ++ +      +C   +K+KR ++  ++ +
Sbjct:   414 LLLEMKDDLDDEDLSLLDFTDRRMQDWRTEELQIMYEAA-SQCLCQKKNKRPAIAQVLSV 472

Query:   449 L 449
             L
Sbjct:   473 L 473

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0009617 "response to bacterium" evidence=IDA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IDA

UNIPROTKB|Q9NWZ3 IRAK4 "Interleukin-1 receptor-associated kinase 4" [Homo sapiens (taxid:9606)]

 Score = 497 (180.0 bits), Expect = 1.6e-47, P = 1.6e-47
 Identities = 111/304 (36%), Positives = 180/304 (59%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL------AAMV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DITTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +DK+  + + T VE + S+   +C   +K+KR  ++ +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPDIKKVQQ 452

Query:   448 LLSK 451
             LL +
Sbjct:   453 LLQE 456

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0007254 "JNK cascade" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0004672 "protein kinase activity" evidence=EXP

GO:0004674 "protein serine/threonine kinase activity" evidence=EXP;TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005886 "plasma membrane" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0010008 "endosome membrane" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|E2RDL0 IRAK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
 Identities = 110/302 (36%), Positives = 178/302 (58%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFSFYELKNVTNNFDERPISLGGNKMGEGGFGVVYKGYVNN-KTVAVKKL------AAMV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  IA G A  + +LH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHMRCKIAQGAANGISFLHENHH--IHRDIKSANILLDEDFTAKVSDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +D +  + + T +ET+ S+   +C   +K+KR  +  +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDPKMNDTDPTSIETMYSVA-SQCLHEKKNKRPDIEKVQQ 452

Query:   448 LL 449
             LL
Sbjct:   453 LL 454

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

MGI|MGI:2182474 Irak4 "interleukin-1 receptor-associated kinase 4" [Mus musculus (taxid:10090)]

 Score = 471 (170.9 bits), Expect = 9.1e-45, P = 9.1e-45
 Identities = 107/304 (35%), Positives = 175/304 (57%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GN++GEG FG VY G + N + +AVK L          
Sbjct:   167 SFSFHELKSITNNFDEQPASAGGNRMGEGGFGVVYKGCVNNTI-VAVKKL------GAMV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ ++ C+H NL+ LLG  ++  N C+VY YM NGSL DRL+ 
Sbjct:   220 EISTEELKQQ---FDQEIKVMATCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  +A G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHTRCKVAQGTANGIRFLHENHH--IHRDIKSANILLDKDFTAKISDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              S     +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N   
Sbjct:   335 ASARL-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDENREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + +  D++  + +   VE + S    +C   +K++R  +  +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYTDEKMSDADPASVEAMYSAA-SQCLHEKKNRRPDIAKVQQ 452

Query:   448 LLSK 451
             LL +
Sbjct:   453 LLQE 456

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007254 "JNK cascade" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IDA

GO:0045087 "innate immune response" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=ISO

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 384 (140.2 bits), Expect = 1.6e-42, Sum P(2) = 1.6e-42
 Identities = 108/284 (38%), Positives = 149/284 (52%)

Query:   176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
             NKLGEG FG VY G L +G E+AVK L                       F  E+  +S 
Sbjct:   714 NKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQ-------------FVAEIIAISS 760

Query:   236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
               H NL++L G C       +VYEY+ NGSL D+    + +  LD + RY I LGVA  L
Sbjct:   761 VLHRNLVKLYGCCFEGDHRLLVYEYLPNGSL-DQALFGDKSLHLDWSTRYEICLGVARGL 819

Query:   295 HYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
              YLH   S  IIHRDVK++N+LLD   VPK+ DFG+ K+ +  + KT  +  + GT  Y+
Sbjct:   820 VYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYD--DKKTHISTRVAGTIGYL 877

Query:   354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV------EQEVPVRE 406
              PE AM   ++ KTDV+++GV+ LEL++G K  D+N      YL+       E+   V E
Sbjct:   878 APEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDV-E 936

Query:   407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
             ++D E  E+N   V+ +I I    C       R  M  +V +LS
Sbjct:   937 LIDDELSEYNMEEVKRMIGIAL-LCTQSSYALRPPMSRVVAMLS 979

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)]

 Score = 376 (137.4 bits), Expect = 2.0e-42, Sum P(2) = 2.0e-42
 Identities = 101/290 (34%), Positives = 157/290 (54%)

Query:   177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
             KLG G +GTVY GKL+N   +A+K L              +  M       NE++ LS  
Sbjct:   353 KLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESL------DQVM-------NEIKLLSSV 399

Query:   237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
              H NL+RLLG C    +  +VYEYM NG+L + L R   +  L    R ++A   A+A+ 
Sbjct:   400 SHPNLVRLLGCCIEQGDPVLVYEYMPNGTLSEHLQRDRGSG-LPWTLRLTVATQTAKAIA 458

Query:   296 YLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPY 352
             YLHS ++ PI HRD+KS N+LLD +F  K+ DFG+ +  M+E+S++ T       GT  Y
Sbjct:   459 YLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQ----GTPGY 514

Query:   353 MPPEAMHC-QISTKTDVFSYGVILLELLTGMKPID---DNNTILYYYLVVEQ-------E 401
             + P+   C  +S K+DV+S+GV+L E++TG+K +D    +  I    L V++       E
Sbjct:   515 LDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDE 574

Query:   402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             + +  +LD +   W  + + T+  + F +C  F  D R +M ++ D L +
Sbjct:   575 I-IDPILDLDLDAWTLSSIHTVAELAF-RCLAFHSDMRPTMTEVADELEQ 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9NWZ3	IRAK4_HUMAN	2, ., 7, ., 1, 1, ., 1	0.2869	0.9142	0.9043	yes	N/A
Q8R4K2	IRAK4_MOUSE	2, ., 7, ., 1, 1, ., 1	0.3039	0.7912	0.7843	yes	N/A
Q1RMT8	IRAK4_BOVIN	2, ., 7, ., 1, 1, ., 1	0.3642	0.6219	0.6138	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	455
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-36
cd08308	125	cd08308, Death_Tube, Death domain of Tube	3e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-29
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-09
cd08309	95	cd08309, Death_IRAK, Death domain of Interleukin-1	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	0.001
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.002
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  169 bits (432), Expect = 7e-50
 Identities = 88/296 (29%), Positives = 134/296 (45%), Gaps = 58/296 (19%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
             G KLGEG FG VY G LK        ++AVKTL+  A+      +  E        F 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-----EEEREE-------FL 49

Query: 228 NEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E   + +  H N++RLLG+C       IV EYM  G L D L    +   L       +
Sbjct: 50  EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQM 107

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           AL +A+ + YL S  K  +HRD+ + N L+ EN V K+ DFG   +S        Y +  
Sbjct: 108 ALQIAKGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRG 162

Query: 347 TGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
            G  P  +M PE+    + ++K+DV+S+GV+L E+ T G +P        Y        +
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--------Y------PGM 208

Query: 403 PVREVLDK-EAGE--------WNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
              EVL+  E G          +E  +  L+     +C  ++ + R +  ++V+ L
Sbjct: 209 SNEEVLELLEDGYRLPRPENCPDE--LYELML----QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  166 bits (422), Expect = 2e-48
 Identities = 88/287 (30%), Positives = 135/287 (47%), Gaps = 44/287 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           G KLGEG FG VY G LK       +E+AVKTL+ +A+               I  F  E
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS------------EQQIEEFLRE 51

Query: 230 VQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            + + +  H N+++LLG+C     +M  IV EYM  G L D L R N    L  +   S 
Sbjct: 52  ARIMRKLDHPNIVKLLGVCTEEEPLM--IVMEYMPGGDLLDYL-RKNRPKELSLSDLLSF 108

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +     +   +    L
Sbjct: 109 ALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 347 TGTRPY--MPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
               P   M PE+    + ++K+DV+S+GV+L E+ T G +P        Y  +   +  
Sbjct: 167 ----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--------YPGMSNAE-- 212

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
            V E L K        +    +  +  +C   + + R +  ++V++L
Sbjct: 213 -VLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (422), Expect = 2e-48
 Identities = 88/287 (30%), Positives = 134/287 (46%), Gaps = 45/287 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           G KLGEG FG VY GKLK       +E+AVKTL+ +A         +E     I  F  E
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA---------SEQQ---IEEFLRE 51

Query: 230 VQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            + + +  H N+++LLG+C     +   IV EYM  G L   L    N P L  +   S 
Sbjct: 52  ARIMRKLDHPNVVKLLGVCTEEEPLY--IVMEYMEGGDLLSYL--RKNRPKLSLSDLLSF 107

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +     +        L
Sbjct: 108 ALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL 165

Query: 347 TGTRPY--MPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
               P   M PE+    + ++K+DV+S+GV+L E+ T G +P        Y  +  E+  
Sbjct: 166 ----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--------YPGMSNEE-- 211

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
            V E L          +    +  +  +C   + + R +  ++V++L
Sbjct: 212 -VLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (411), Expect = 9e-47
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 49/292 (16%)

Query: 176 NKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            KLGEG FG VY GKLK       E+AVKTL+ +A    S  +  +        F  E +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKD--------FLKEAR 48

Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL------ARVNNTPPLDSNKRY 284
            + +  H N++RLLG+C       +V EYM  G L D L              L      
Sbjct: 49  VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           S A+ +A+ + YL S  K  +HRD+ + N L+ E+ V K+ DFG   +S        Y +
Sbjct: 109 SFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRK 163

Query: 345 NLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
              G  P  +M PE++   I ++K+DV+S+GV+L E+ T G  P        Y       
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------Y------P 209

Query: 401 EVPVREVLDK-EAGEWNE--THVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
            +   EVL+    G       +    +  +   C   + + R +  ++V+ L
Sbjct: 210 GLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (400), Expect = 9e-46
 Identities = 71/206 (34%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LGEG FGTVY  + K  G ++A+K ++   + S                   E++ L + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE------------LLREIEILKKL 48

Query: 237 KHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L G+  +     +V EY   GSL D L    N   L  ++   I L + E L 
Sbjct: 49  NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLE 106

Query: 296 YLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
           YLHS    IIHRD+K  N+LLD  N   KL DFG+ K+  +          + GT  YM 
Sbjct: 107 YLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK---TIVGTPAYMA 161

Query: 355 PEAMHCQ--ISTKTDVFSYGVILLEL 378
           PE +  +   S K+D++S GVIL EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (401), Expect = 2e-45
 Identities = 93/283 (32%), Positives = 131/283 (46%), Gaps = 38/283 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               KLG G FGTVY  K K  G  +AVK L       S  S   + A         E++
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKIL----KKRSEKSKKDQTAR-------REIR 50

Query: 232 TLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L +  H N++RL+      +++   +V EY   G L+D L+R     PL  ++   IAL
Sbjct: 51  ILRRLSHPNIVRLIDAFEDKDHL--YLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIAL 105

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L YLHS    IIHRD+K  N+LLDEN V K+ DFG+ K    S+  ++ T    G
Sbjct: 106 QILRGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTT--FVG 160

Query: 349 TRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           T  YM PE          K DV+S GVIL ELLTG  P    N +       +Q   +R 
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL-------DQLQLIRR 213

Query: 407 VLDKEA-GEWNETH--VETLISIVFEKCCVFEKDKRASMRDIV 446
           +L      +  +     E    ++ +KC   +  KR +  +I+
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLI-KKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  150 bits (381), Expect = 2e-42
 Identities = 73/279 (26%), Positives = 115/279 (41%), Gaps = 38/279 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               KLGEG FG VY  + K  G  +A+K ++                         E++
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER------------ILREIK 49

Query: 232 TLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L + KH N++RL  +    + +   +V EY   G L+D L        L  ++      
Sbjct: 50  ILKKLKHPNIVRLYDVFEDEDKL--YLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLR 104

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 347
            +  AL YLHS    I+HRD+K  N+LLDE+   KL DFG+ + +     + T       
Sbjct: 105 QILSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF-----V 157

Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GT  YM PE +  +      D++S GVIL ELLTG  P   ++ +L  +  + +      
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP----- 212

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                              ++  K  V + +KR +  + 
Sbjct: 213 --KPPFPPPEWDISPEAKDLI-RKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  134 bits (341), Expect = 1e-36
 Identities = 81/280 (28%), Positives = 122/280 (43%), Gaps = 43/280 (15%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            RG  LG G FG+VY    K  G  +AVK++E     S  + +  EA        E E++
Sbjct: 3   TRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEA-------LEREIR 51

Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSN--KRYSI 286
            LS  +H N++R  G   +       I  EY+  GSL   L +      L     ++Y+ 
Sbjct: 52  ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTR 108

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              + E L YLHS    I+HRD+K AN+L+D + V KL DFG  K           T ++
Sbjct: 109 Q--ILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG-DIETGEGTGSV 163

Query: 347 TGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKP---IDDNNTILYYYLVVEQEV 402
            GT  +M PE +  +      D++S G  ++E+ TG  P   + +    LY      +  
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP 223

Query: 403 PVREVLDKEAGEWNETHVETLISIVF-EKCCVFEKDKRAS 441
            + E L +EA +             F  KC   +  KR +
Sbjct: 224 EIPEHLSEEAKD-------------FLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  133 bits (336), Expect = 5e-36
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 28/236 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               K+G+G FG VY  +  + G E+A+K +       S            I+   NE+Q
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVI----KLESKEKKE------KII---NEIQ 49

Query: 232 TLSQCKHVNLLRLLG--LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L +CKH N+++  G  L  + +   IV E+   GSL D L +  N    +S   Y +  
Sbjct: 50  ILKKCKHPNIVKYYGSYLKKDELW--IVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCK 105

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + L YLHS    IIHRD+K+AN+LL  +   KL DFG+          T     + G
Sbjct: 106 ELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDTKARNTMVG 159

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           T  +M PE ++ +    K D++S G+  +EL  G  P  +   +   + +     P
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP 215

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|176724 cd08308, Death_Tube, Death domain of Tube

 Score =  124 bits (312), Expect = 3e-34
 Identities = 53/122 (43%), Positives = 72/122 (59%), Gaps = 5/122 (4%)

Query: 10  DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPL-KPLKYSAKDIKIVERAGKRN 68
           D EIR L    ++ L  IL+  D WKK+M+I+  D D      KY+A+  K++E+A  + 
Sbjct: 1   DTEIRKLPPADLYRLVNILDINDGWKKLMAIIPSDDDDFNNLAKYNAEHFKLIEQAANK- 59

Query: 69  FPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNT 126
              R C++I LDEWGTSG+ RP L  L+  L KAEL +AA YV VD+LK+  P  P    
Sbjct: 60  -QRRSCSEILLDEWGTSGKVRPTLGVLLQLLVKAELFRAADYVAVDILKEEPPARPVVGP 118

Query: 127 EA 128
            A
Sbjct: 119 AA 120

Death domains (DDs) similar to the DD in the protein Tube from Drosophila melanogaster. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in mediating innate immune response to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Some members of this subfamily contain a C-terminal kinase domain, like Pelle, in addition to the DD. Tube has no counterpart in vertebrates. It contains an N-terminal DD and a C-terminal region with five copies of the Tube repeat, an 8-amino acid motif. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes. Length = 125

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (310), Expect = 3e-32
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 34/225 (15%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G+G FG VY  +   +G    +K +    + S+ +    E A+       NEV+ L 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI----DLSNMSEKEREDAL-------NEVKILK 54

Query: 235 QCKHVNLLRLLGLCNNIMN----CIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALG 289
           +  H N+++      +       CIV EY   G L  ++  +     P    +     + 
Sbjct: 55  KLNHPNIIKY---YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM-KTMYTENLT 347
           +  AL YLHS  + I+HRD+K  N+ L  N + KLGDFGI K +S T ++ KT+      
Sbjct: 112 LCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-----V 164

Query: 348 GTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  Y+ PE   CQ    + K+D++S G +L EL T   P +  N
Sbjct: 165 GTPYYLSPEL--CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (294), Expect = 3e-29
 Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 27/285 (9%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLGEG FG VY  + +    +A+K L       S            +  F  E+Q L+
Sbjct: 5   LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKE----------VERFLREIQILA 52

Query: 235 QCKH-VNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              H  N+++L     +     +V EY+  GSL D L ++    PL  ++   I   +  
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLT---G 348
           AL YLH  SK IIHRD+K  N+LLD +  V KL DFG+ K+       +      +   G
Sbjct: 113 ALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 349 TRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EV 402
           T  YM PE +        S+ +D++S G+ L ELLTG+ P +           ++   E+
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
           P   +    +    E   +    ++ +K    +   R S    + 
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (288), Expect = 4e-29
 Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 35/275 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R   LG+G  G VY  + K  G   A+K +     +   + +  +  +        E++
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-----HVDGDEEFRKQLL-------RELK 51

Query: 232 TLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           TL  C+   +++  G         IV EYM  GSL D L +V   P         IA  +
Sbjct: 52  TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQI 108

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            + L YLH+    IIHRD+K +N+L++     K+ DFGI K+ E +  +        GT 
Sbjct: 109 LKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN---TFVGTV 164

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            YM PE +  +  S   D++S G+ LLE   G  P        ++ L       ++ + D
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-------MQAICD 217

Query: 410 KEAGEWNETHV-ETLISIVFEKCCVFEKD--KRAS 441
                             +    C+ +KD  KR S
Sbjct: 218 GPPPSLPAEEFSPEFRDFI--SACL-QKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (283), Expect = 3e-28
 Identities = 74/249 (29%), Positives = 125/249 (50%), Gaps = 50/249 (20%)

Query: 178 LGEGQFGTVYYGKL--KNGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LGEG FG VY G+L   N       +A+KTL+ NA                   F  E +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE------------FRQEAE 60

Query: 232 TLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTP-------------- 276
            +S  +H N++ LLG+C      C+++EY+ +G L++ L  V N+P              
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL--VRNSPHSDVGAESGDETVK 118

Query: 277 -PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
             LD +    IA+ +A  + YL S     +HRD+ + N L+ E    K+ DFG+ +   +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 336 SNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY 393
           ++   + +++L   R +MPPEA ++ + +T++D++S+GV+L E+ + G++P         
Sbjct: 177 ADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP--------- 226

Query: 394 YYLVVEQEV 402
           YY    QEV
Sbjct: 227 YYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 1e-27
 Identities = 74/235 (31%), Positives = 117/235 (49%), Gaps = 28/235 (11%)

Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ +G G FG VY G  L+ G  +A+K +              E A+  I+    E+  L
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLE--------KIKEEALKSIM---QEIDLL 53

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALGVA 291
              KH N+++ +G      +  I+ EY  NGSL   + +    P  L +   Y +  G  
Sbjct: 54  KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG-- 111

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
             L YLH   + +IHRD+K+AN+L  ++ V KL DFG+  K+++ S        ++ GT 
Sbjct: 112 --LAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----DASVVGT- 162

Query: 351 PY-MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           PY M PE +     ST +D++S G  ++ELLTG  P  D N +   + +V+ + P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 41/216 (18%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G      ++AVKTL+                M P    + E Q + + 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLK-------------PGTMSPEAFLQ-EAQIMKKL 58

Query: 237 KHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPP---LDSNKRYSIALGV 290
           +H  L++L  +C+    I   IV EYM  GSL D L     +     L   +   +A  +
Sbjct: 59  RHDKLVQLYAVCSEEEPIY--IVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQI 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           AE + YL S  +  IHRD+ + N+L+ EN V K+ DFG+ ++ E       YT    G +
Sbjct: 113 AEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE----YTAR-EGAK 165

Query: 351 PYMP-----PEAMHC-QISTKTDVFSYGVILLELLT 380
              P     PEA +  + + K+DV+S+G++L E++T
Sbjct: 166 --FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (272), Expect = 6e-27
 Identities = 76/235 (32%), Positives = 109/235 (46%), Gaps = 36/235 (15%)

Query: 174 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           RGNK+G G FG VY    L  G  +AVK +           DN       I    +E++ 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ--------DNDPKT---IKEIADEMKV 52

Query: 233 LSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L   KH NL++  G+  +     I  EY C+G   + L            + Y++ L   
Sbjct: 53  LELLKHPNLVKYYGVEVHREKVYIFMEY-CSGGTLEELLEHGRILDEHVIRVYTLQL--L 109

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
           E L YLHS    I+HRD+K AN+ LD N V KLGDFG  VK+   +       ++L GT 
Sbjct: 110 EGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 351 PYMPPEAMHCQISTKT---------DVFSYGVILLELLTGMKP---IDDNNTILY 393
            YM PE     + T           D++S G ++LE+ TG +P   +D+   I++
Sbjct: 168 AYMAPE-----VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 7e-27
 Identities = 69/289 (23%), Positives = 133/289 (46%), Gaps = 41/289 (14%)

Query: 173 RRGNKLGEGQFGTVYYG-----KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
            +   LG G FGTVY G       K  + +A+K L    +  ++     EA ++      
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVM------ 63

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
                 +   H +++RLLG+C +    ++ + M  G L D +   N+   + S    +  
Sbjct: 64  ------ASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWC 115

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ + YL    K ++HRD+ + NVL+      K+ DFG+ K+ +    +        
Sbjct: 116 VQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 348 GTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 405
             + +M  E++  +I T K+DV+SYGV + EL+T G KP +               +P  
Sbjct: 174 PIK-WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG--------------IPAV 218

Query: 406 EVLD--KEAGEWNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           E+ D  ++     +  + T+ + +V  KC + + + R + +++++  SK
Sbjct: 219 EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 1e-26
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 36/211 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +G+G+FG V  G  + G ++AVK L++++  + +              F  E   ++
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA--------------FLAEASVMT 55

Query: 235 QCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
             +H NL++LLG+    N +   IV EYM  GSL D L R      +   ++   AL V 
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLY--IVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVC 112

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           E + YL    K  +HRD+ + NVL+ E+ V K+ DFG+ K +          +     + 
Sbjct: 113 EGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS---------QGQDSGKL 161

Query: 351 --PYMPPEAM-HCQISTKTDVFSYGVILLEL 378
              +  PEA+   + STK+DV+S+G++L E+
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (268), Expect = 3e-26
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 176 NKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
            +LGEG FG V   +        G ++AVK+L ++      +             FE E+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD------------FEREI 57

Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L    H N+++  G+C         ++ EY+ +GSL D L R  +   ++  +    +
Sbjct: 58  EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFS 115

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  IHRD+ + N+L++   + K+ DFG+ K+      K  Y     
Sbjct: 116 SQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEP 171

Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S+ +DV+S+GV L EL T
Sbjct: 172 GESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 9e-26
 Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 18/216 (8%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEV 230
           RRG  LG+G FG VY    +  G E+AVK +  +  +  +    N           E E+
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA---------LECEI 55

Query: 231 QTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           Q L   +H  +++  G L ++    I  EYM  GS+ D+L        L           
Sbjct: 56  QLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQ 112

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T        +++TGT
Sbjct: 113 ILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170

Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
             +M PE +  +    K DV+S G  ++E+LT   P
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (262), Expect = 1e-25
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 39/217 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG G FG V+ G  KN + +A+K L+++              ++    F+ EVQ L 
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-------------LLKQQDFQKEVQALK 57

Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLA----RVNNTPPLDSNKRYSIALG 289
           + +H +L+ L  +C+      I+ E M  GSL   L     +V     L       +A  
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQ 112

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE-----TSNMKTMYTE 344
           VAE + YL    +  IHRD+ + N+L+ E+ V K+ DFG+ ++ +     +S+ K  Y  
Sbjct: 113 VAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK- 169

Query: 345 NLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
                  +  PEA  H   STK+DV+S+G++L E+ T
Sbjct: 170 -------WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  103 bits (258), Expect = 5e-25
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 41/279 (14%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG +G+VY     + G  +A+K +           D  E           E+  L Q
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQE--------IIKEISILKQ 54

Query: 236 CKHVNLLRLLG---LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           C    +++  G      ++   IV EY   GS+ D +   N T  L   +  +I     +
Sbjct: 55  CDSPYIVKYYGSYFKNTDLW--IVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLK 110

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L YLHS     IHRD+K+ N+LL+E    KL DFG+      +  K      + GT  +
Sbjct: 111 GLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---RNTVIGTPFW 165

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           M PE       + K D++S G+  +E+  G  P  D + +   +++  +  P     +K 
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW 225

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           + E+N+      +     KC V + ++R S    + LL 
Sbjct: 226 SPEFND-----FVK----KCLVKDPEERPS---AIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 6e-25
 Identities = 69/226 (30%), Positives = 113/226 (50%), Gaps = 20/226 (8%)

Query: 174 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G  +G+G +G VY    +  G  +AVK +E  A   +   D+ +  M+  L   +E++T
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPA-TIAGRHDSRQKDMVKAL--RSEIET 61

Query: 233 LSQCKHVNLLRLLGL--CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           L    H+N+++ LG       ++ I  EY+  GS+     R       +          V
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLS-IFLEYVPGGSI-GSCLR--TYGRFEEQLVRFFTEQV 117

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET--SNMKTMYTENLTG 348
            E L YLHS  K I+HRD+K+ N+L+D + + K+ DFGI K S+    N + M   ++ G
Sbjct: 118 LEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM---SMQG 172

Query: 349 TRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
           +  +M PE +H      S K D++S G ++LE+  G +P  D   I
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  102 bits (255), Expect = 1e-24
 Identities = 68/215 (31%), Positives = 111/215 (51%), Gaps = 27/215 (12%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+ +               + +  F  E   + 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 57

Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 116

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 117 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIK 170

Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 4e-24
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 28/214 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V+ GK +  +++A+K +              E AM      E E + + 
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIR-------------EGAMSEDDFIE-EAKVMM 54

Query: 235 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +  H NL++L G+C       IV EYM NG L + L        L +     +   V EA
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEA 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR--- 350
           + YL   S   IHRD+ + N L+ E+ V K+ DFG+ +      +   YT +  GT+   
Sbjct: 113 MEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSS-QGTKFPV 165

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLTGMK 383
            + PPE   + + S+K+DV+S+GV++ E+ +  K
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 6e-24
 Identities = 73/218 (33%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R+G  LG G FG+VY G  L +G   AVK +    + +       EA    +   E E+ 
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEV----SLADDGQTGQEA----VKQLEQEIA 54

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALG 289
            LS+ +H N+++ LG      N  I  E +  GSL   L +  + P P+       I LG
Sbjct: 55  LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG 114

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTG 348
               L YLH   +  +HRD+K AN+L+D N V KL DFG+ K + E S  K+       G
Sbjct: 115 ----LEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF-----KG 163

Query: 349 TRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKP 384
           +  +M PE +  Q       D++S G  +LE+ TG  P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.4 bits (248), Expect = 9e-24
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLG+G +G+VY  K L +    A+K      +  S +    E A+       NE++ L+ 
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALK----EVDLGSMSQKEREDAV-------NEIRILAS 55

Query: 236 CKHVNLLR-----LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALG 289
             H N++      L G   N + CIV EY   G L   +++       +   + + I + 
Sbjct: 56  VNHPNIISYKEAFLDG---NKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L  LH     I+HRD+KSAN+LL  N + K+GD GI K+     +K    +   GT
Sbjct: 112 LLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKTQIGT 164

Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
             YM PE    +  S K+D++S G +L E+ T   P
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 24/219 (10%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           NK+G+G FG V+    K +    A+K +    + S  N    E A+       +E + L+
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQI----DLSKMNRREREEAI-------DEARVLA 54

Query: 235 QCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +     ++R      +     IV EY  NG L+  L ++    PL  ++ +   + +   
Sbjct: 55  KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L +LHS  K I+HRD+KS N+ LD     K+GD G+ K+   +   T +   + GT  Y+
Sbjct: 114 LAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYL 168

Query: 354 PPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE   C+    + K+DV++ GV+L E  TG  P D NN
Sbjct: 169 SPEL--CEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 55/237 (23%)

Query: 178 LGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LGEG FG V+ G+  +         +AVKTL+     ++SN    +        FE E +
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE----TASNDARKD--------FEREAE 60

Query: 232 TLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSL------YDRLARVNNTP----- 276
            L+  +H N+++  G+C      IM   V+EYM +G L      +   A    +P     
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDPPIM---VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L  ++   IA+ +A  + YL S     +HRD+ + N L+  + V K+GDFG   MS   
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFG---MS--- 169

Query: 337 NMKTMYTEN---LTGTR--P--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
             + +YT +   + G    P  +MPPE+ M+ + +T++DV+S+GV+L E+ T G +P
Sbjct: 170 --RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 68/214 (31%), Positives = 90/214 (42%), Gaps = 24/214 (11%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +G+G FG VY     +    +A+K +            + E A   I   + E+Q LSQ
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVI------------DLEEAEDEIEDIQQEIQFLSQ 55

Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           C+   + +  G         I+ EY   GS  D L        LD      I   V   L
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGL 111

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH   K  IHRD+K+AN+LL E    KL DFG V    TS M    T    GT  +M 
Sbjct: 112 EYLHEEGK--IHRDIKAANILLSEEGDVKLADFG-VSGQLTSTMSKRNT--FVGTPFWMA 166

Query: 355 PEA-MHCQISTKTDVFSYGVILLELLTGMKPIDD 387
           PE         K D++S G+  +EL  G  P+ D
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G      ++A+K+L+             + +M P   F  E   + Q 
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLK-------------QGSMSP-EAFLAEANLMKQL 58

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +      L  NK   +A  +AE + +
Sbjct: 59  QHPRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    K  IHRD+++AN+L+ E    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 118 IER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 171

Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 41/272 (15%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G VY    +  G E+A+K +            N E  +       NE+  +  
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKM-------RLRKQNKELII-------NEILIMKD 71

Query: 236 CKHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           CKH N++        + + +  V EYM  GSL D +   N     +    Y +   V + 
Sbjct: 72  CKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAY-VCREVLQG 128

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENLTGTRP 351
           L YLHS  + +IHRD+KS N+LL ++   KL DFG       E S   ++      GT P
Sbjct: 129 LEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-----VGT-P 180

Query: 352 Y-MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
           Y M PE +  +    K D++S G++ +E+  G  P      +   +L+  + +P      
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL---- 236

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           K   +W+    + L      KC V + +KR S
Sbjct: 237 KNPEKWSPEFKDFL-----NKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 4e-22
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 37/216 (17%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL--FENEVQTLS 234
           K+G+G FG VY G LK   E+AVKT  +               + P L   F  E + L 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRST--------------LPPDLKRKFLQEAEILK 47

Query: 235 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           Q  H N+++L+G+C     I   IV E +  GSL   L +  N   L   K   ++L  A
Sbjct: 48  QYDHPNIVKLIGVCVQKQPIY--IVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAA 103

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             + YL   SK  IHRD+ + N L+ EN V K+ DFG+ +  E      +YT  ++    
Sbjct: 104 AGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG----IYT--VSDGLK 155

Query: 352 YMP-----PEAM-HCQISTKTDVFSYGVILLELLTG 381
            +P     PEA+ + + ++++DV+SYG++L E  + 
Sbjct: 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 5e-22
 Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 23/220 (10%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G  LG+G +GTVY G    G  IAVK +E      +SN    E     +   + EV  L
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVE----LDTSNVLAAEKEYEKL---QEEVDLL 56

Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALG 289
              KHVN+++ LG C  +N ++ I  E++  GS+   L R    P      +Y+  I  G
Sbjct: 57  KSLKHVNIVQYLGTCLDDNTIS-IFMEFVPGGSISSILNRFGPLPEP-VFCKYTKQILDG 114

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK---MSETSNMKTMYTENL 346
           VA    YLH  +  ++HRD+K  NV+L  N + KL DFG  +           +   +++
Sbjct: 115 VA----YLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 347 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            GT  +M PE ++      K+D++S G  + E+ TG  P+
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 42/224 (18%)

Query: 178 LGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LG+G FG VY G  K          +A+KT+  NA    S  +  E        F NE  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIE--------FLNEAS 61

Query: 232 TLSQ--CKHVNLLRLLGLC---NNIMNCIVYEYMCNGSL--YDRLAR-----VNNTPPLD 279
            + +  C HV  +RLLG+       +  +V E M  G L  Y R  R          P  
Sbjct: 62  VMKEFNCHHV--VRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             K   +A  +A+ + YL +  K  +HRD+ + N ++ E+   K+GDFG   M+      
Sbjct: 118 LQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFG---MTRDIYET 172

Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +TK+DV+S+GV+L E+ T
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 21/215 (9%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +G G    VY    L N  ++A+K +    +     +   E           EVQ +S
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELR--------KEVQAMS 54

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           QC H N+++     +  + +  +V  Y+  GSL D +        LD     ++   V +
Sbjct: 55  QCNHPNVVKYYTSFVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN-LTGTRP 351
            L YLHS  +  IHRD+K+ N+LL E+   K+ DFG+         +T        GT  
Sbjct: 114 GLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171

Query: 352 YMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKP 384
           +M PE M        K D++S+G+  +EL TG  P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 32/206 (15%)

Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++N+A   +               F  E   ++Q +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 57

Query: 238 HVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL + +   +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 117 YLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 166

Query: 354 PPEAM-HCQISTKTDVFSYGVILLEL 378
            PEA+   + STK+DV+S+G++L E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +G+G FGTV   + K+ G  +  K +    +Y   N    E   +      +EV  L 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEI----DYG--NMTEKEKQQLV-----SEVNILR 54

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYM--CNGSLYDRLARV-----NNTPPLDSNKRYSIA 287
           + KH N++R      +  N  +Y  M  C G   D LA++          ++    + I 
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGG--D-LAQLIQKCKKERKYIEEEFIWRIL 111

Query: 288 LGVAEALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             +  AL+  H+ S P   ++HRD+K AN+ LD N   KLGDFG+ K+       + + +
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAK 168

Query: 345 NLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
              GT  YM PE + H     K+D++S G ++ EL     P
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 17/223 (7%)

Query: 174 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G  +G G FG+VY G    +G  +AVK +E  +   S++S + + +M+  L    E+  
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPS--VSASSKDRKRSMLDAL--AREIAL 59

Query: 233 LSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           L + +H N+++ LG  L  + +N I  EY+  GS+    A +NN    +     +    +
Sbjct: 60  LKELQHENIVQYLGSSLDADHLN-IFLEYVPGGSV---AALLNNYGAFEETLVRNFVRQI 115

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN---LT 347
            + L+YLH+  + IIHRD+K AN+L+D     K+ DFGI K  E +++ T        L 
Sbjct: 116 LKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 348 GTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNN 389
           G+  +M PE +     T K D++S G +++E+LTG  P  D  
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 68/222 (30%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           ++LGEG  G+V   +LK  GM  A+KT+          +D        IL    E++   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTI---------TTDPNPDLQKQIL---RELEINK 54

Query: 235 QCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSL---YDRL----ARVNNTPPLDSNKRY 284
            CK   +++  G   +  +    I  EY   GSL   Y ++     R+            
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------ 108

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            IA  V + L YLHS  + IIHRD+K +N+LL      KL DFG+      S   T    
Sbjct: 109 KIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT---- 162

Query: 345 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
             TGT  YM PE +  +  S  +DV+S G+ LLE+     P 
Sbjct: 163 -FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 88/307 (28%), Positives = 141/307 (45%), Gaps = 64/307 (20%)

Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V     YG  K+   M++AVK L+      +++S   EA M
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-----PTAHSSEREALM 86

Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTP 276
                  +E++ +S    H N++ LLG C     I+  ++ EY C G L + L R     
Sbjct: 87  -------SELKIMSHLGNHENIVNLLGACTIGGPIL--VITEYCCYGDLLNFLRR-KRES 136

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 334
            L      S +  VA+ + +L S  K  IHRD+ + NVLL    + K+ DFG+ +  M++
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194

Query: 335 TSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT-------GMKP 384
            SN    Y        P  +M PE++ +C  + ++DV+SYG++L E+ +       GM P
Sbjct: 195 -SN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM-P 248

Query: 385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRD 444
           +D      +Y L+ E        + +        H    I  + + C   +  KR + + 
Sbjct: 249 VDSK----FYKLIKEGYR-----MAQPE------HAPAEIYDIMKTCWDADPLKRPTFKQ 293

Query: 445 IVDLLSK 451
           IV L+ K
Sbjct: 294 IVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 5e-21
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++     S S  +           F  E + + + 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDE-----------FIEEAKVMMKL 56

Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G+C       IV EYM NG L + L           ++   +   V E + 
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMA 114

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL S  K  IHRD+ + N L+D+    K+ DFG+ +      +   YT ++    P  + 
Sbjct: 115 YLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 168

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID 386
           PPE +   + S+K+DV+++GV++ E+ + G  P +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.2 bits (226), Expect = 7e-21
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 35/216 (16%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +GEG+FG V  G+   G ++AVK ++          D T  A      F  E   ++
Sbjct: 11  GEIIGEGEFGAVLQGEYT-GQKVAVKNIK---------CDVTAQA------FLEETAVMT 54

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           +  H NL+RLLG+  +    IV E M  G+L + L R      +   +    +L VAE +
Sbjct: 55  KLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGM 113

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS----ETSNMKTMYTENLTGTR 350
            YL S  K ++HRD+ + N+L+ E+ V K+ DFG+ ++     + S +   +T       
Sbjct: 114 EYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT------- 164

Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
               PEA+ H + S+K+DV+SYGV+L E+ + G  P
Sbjct: 165 ---APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 68/216 (31%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +LG G  G V     +  G  +AVKT+           +      I       E+  L 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIR-------LEINEAIQKQIL-----RELDILH 54

Query: 235 QCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +C    ++   G      +I  C+  EYM  GSL   L  V    P     +  IA+ V 
Sbjct: 55  KCNSPYIVGFYGAFYNNGDISICM--EYMDGGSLDKILKEVQGRIPERILGK--IAVAVL 110

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + L YLH   K IIHRDVK +N+L++     KL DFG+      S  KT       GT  
Sbjct: 111 KGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSS 164

Query: 352 YMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPID 386
           YM PE +     S K+D++S G+ L+EL TG  P  
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 38/276 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++    +A+K +    +YS   S+     +I       EV+ L Q
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKM----SYSGKQSNEKWQDII------KEVRFLQQ 71

Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N +   G         +V EY C GS  D L    +  PL   +  +I  G  + L
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEV--HKKPLQEVEIAAICHGALQGL 128

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS  +  IHRD+K+ N+LL E    KL DFG   +   +N       +  GT  +M 
Sbjct: 129 AYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMA 179

Query: 355 PE---AM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE   AM   Q   K DV+S G+  +EL     P+ + N +   Y + + + P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----- 234

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            + +W++     +     + C       R S  +++
Sbjct: 235 SSNDWSDYFRNFV-----DSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 22/209 (10%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++GEG  G V+  K  + G  +A+K +              E  +    L   E++ L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALR---------RLEGGIPNQAL--REIKALQA 55

Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           C+H  +++LL +  +     +V EYM    L + L       P    K Y   L   + +
Sbjct: 56  CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRML--LKGV 112

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+H+    I+HRD+K AN+L+  + V K+ DFG+ ++      +    +    TR Y  
Sbjct: 113 AYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ--VATRWYRA 168

Query: 355 PEAMHCQ--ISTKTDVFSYGVILLELLTG 381
           PE ++         D+++ G I  ELL G
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 33/220 (15%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++GEG +G VY  +  K G  +A+K +           +N E    PI     E++ L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI---------RMEN-EKEGFPITAIR-EIKLLQ 53

Query: 235 QCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYD--RLARVNNTPPLDSNKRYSIA 287
           + +H N++RL  +       +I   +V+EYM     +D   L         +S  +    
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSIY--MVFEYMD----HDLTGLLDSPEVKFTESQIK-CYM 106

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + E L YLHS    I+HRD+K +N+L++ + V KL DFG+ +   T      YT N  
Sbjct: 107 KQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYT-NRV 162

Query: 348 GTRPYMPPEA-MHC-QISTKTDVFSYGVILLELLTGMKPI 385
            T  Y PPE  +   +   + D++S G IL EL  G KPI
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 31/219 (14%)

Query: 176 NKLGEGQFGTVYYG--KLKNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            +LG G FG+V  G   +K+G E+  AVKTL+             +   +       E  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI------AAGKKEFL------REAS 48

Query: 232 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            ++Q  H  ++RL+G+C      +V E    G L   L +    P  D  +   +A  VA
Sbjct: 49  VMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVA 105

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             + YL   SK  +HRD+ + NVLL + +   K+ DFG   MS      + Y    T  R
Sbjct: 106 MGMAYLE--SKHFVHRDLAARNVLLVNRHQA-KISDFG---MSRALGAGSDYYRATTAGR 159

Query: 351 -P---YMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
            P   Y P    + + S+K+DV+SYGV L E  + G KP
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 32/218 (14%)

Query: 178 LGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+L    K  +++A+KTL+  A  S     +          F  E   +
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGSSDKQRLD----------FLTEASIM 59

Query: 234 SQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++RL G+      +M  I+ EYM NGSL   L    N       +   +  G+
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVM--IITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGI 115

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E S     YT    G  
Sbjct: 116 ASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTK-GGKI 170

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P  +  PEA+ + + ++ +DV+S+G+++ E+++ G +P
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 177 KLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+         SD     M     F  E   
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK---------SDKLSDIMDD---FLKEAAI 49

Query: 233 LSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           +    H NL+RL G  L + +M  +V E    GSL DRL R +       +     A+ +
Sbjct: 50  MHSLDHENLIRLYGVVLTHPLM--MVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQI 106

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT--ENLTG 348
           A  + YL S  K  IHRD+ + N+LL  +   K+GDFG+  M      +  Y   E+L  
Sbjct: 107 ANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGL--MRALPQNEDHYVMEEHLKV 162

Query: 349 TRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
              +  PE++     S  +DV+ +GV L E+ T G +P
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 23/217 (10%)

Query: 181 GQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV 239
           G +G V+  K K+  +I A+K +   A+    N  +        +L E ++  LSQ +  
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQ-------VLTERDI--LSQAQSP 53

Query: 240 NLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH 298
            +++L           +V EY+  G L   L  V +    +   R  IA  +  AL YLH
Sbjct: 54  YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLD--EDVARIYIA-EIVLALEYLH 110

Query: 299 SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN-----LTGTRPYM 353
           S    IIHRD+K  N+L+D N   KL DFG+ K+        +  +      + GT  Y+
Sbjct: 111 SNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNN 389
            PE +  Q  +KT D +S G IL E L G+ P     
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 28/223 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
               ++G GQFG V+ G      ++A+KT+   A    S  D           F  E Q 
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEED-----------FIEEAQV 52

Query: 233 LSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           + +  H  L++L G+C      C+V+E+M +G L D L                + L V 
Sbjct: 53  MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVC 110

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           E + YL S +  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+ 
Sbjct: 111 EGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSS-TGTKF 163

Query: 351 --PYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
              +  PE     + S+K+DV+S+GV++ E+ +  K   +N +
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 5e-20
 Identities = 70/249 (28%), Positives = 104/249 (41%), Gaps = 43/249 (17%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K+  ++ A+K L+             E           E   LS+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK-----KKKIIKRKEVEHT-----LTERNILSRI 50

Query: 237 KHVNLLRL---------LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            H  +++L         L         +V EY   G L+  L++       +  + Y   
Sbjct: 51  NHPFIVKLHYAFQTEEKL--------YLVLEYAPGGELFSHLSKEGRFSE-ERARFY--- 98

Query: 288 LGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
              AE   AL YLHSL   II+RD+K  N+LLD +   KL DFG+ K   +   +T  T 
Sbjct: 99  --AAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NT- 152

Query: 345 NLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              GT  Y+ PE  +        D +S GV+L E+LTG  P    +    Y  +++  + 
Sbjct: 153 -FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211

Query: 404 VREVLDKEA 412
             E L  EA
Sbjct: 212 FPEFLSPEA 220

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.5 bits (219), Expect = 8e-20
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 32/211 (15%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G      ++AVKTL+                M P    E E Q + + 
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLK-------------PGTMSPESFLE-EAQIMKKL 58

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKRYSIALGVAE 292
           +H  L++L  + +     IV EYM  GSL D L     R    P L       +A  VA 
Sbjct: 59  RHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAA 113

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y+  ++   IHRD++SAN+L+ +  V K+ DFG+ ++ E +     YT       P 
Sbjct: 114 GMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE----YTARQGAKFPI 167

Query: 353 ---MPPEAMHCQISTKTDVFSYGVILLELLT 380
               P  A++ + + K+DV+S+G++L EL+T
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 31/211 (14%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G   N   +AVKTL+          D  +        F  E Q + + 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLK------PGTMDPKD--------FLAEAQIMKKL 58

Query: 237 KHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +H  L++L  +C     I   IV E M  GSL + L        L   +   +A  VA  
Sbjct: 59  RHPKLIQLYAVCTLEEPIY--IVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASG 115

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR--- 350
           + YL + +   IHRD+ + NVL+ EN + K+ DFG+ ++      + +Y E   G +   
Sbjct: 116 MAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVI----KEDIY-EAREGAKFPI 168

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLT 380
            +  PEA ++ + S K+DV+S+G++L E++T
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 66/266 (24%), Positives = 103/266 (38%), Gaps = 50/266 (18%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTL-------ENNANYSSSNSDNTEAAMIPILLF 226
           G  +GEG F TV   K K    E A+K L       E    Y            I     
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY----------VKI----- 50

Query: 227 ENEVQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
             E + L++   H  +++L     +  N   V EY  NG L   + +  +     +  R+
Sbjct: 51  --EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT--RF 106

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------------ 332
             A  +  AL YLHS    IIHRD+K  N+LLD++   K+ DFG  K+            
Sbjct: 107 YAAE-ILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163

Query: 333 -----SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPID 386
                            +  GT  Y+ PE +        +D+++ G I+ ++LTG  P  
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEA 412
            +N  L +  +++ E         +A
Sbjct: 224 GSNEYLTFQKILKLEYSFPPNFPPDA 249

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 18/217 (8%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R G  LG+G FG VY       G E+AVK ++ +   S   S    A        E E+Q
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPE-SPETSKEVNA-------LECEIQ 56

Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L    H  +++  G   + M     I  E+M  GS+ D+L        L  N       
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTR 113

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  +     +++TG
Sbjct: 114 QILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           T  +M PE +  +    K D++S G  ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 41/230 (17%)

Query: 175 GNKLGEGQFGTVYYG------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LGEG FG V                +AVK L+++A         TE  +   L+ E 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---------TEKDLSD-LVSEM 66

Query: 229 EVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY--- 284
           E+  +   KH N++ LLG+C       +V EY  +G+L D L R    P   ++      
Sbjct: 67  EMMKMIG-KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRP 124

Query: 285 -----------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
                      S A  VA  + +L S  K  IHRD+ + NVL+ E+ V K+ DFG   ++
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFG---LA 179

Query: 334 ETSNMKTMYTENLTGTRPY--MPPEAMHCQIST-KTDVFSYGVILLELLT 380
              +    Y +   G  P   M PEA+  ++ T ++DV+S+GV+L E+ T
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 62/267 (23%)

Query: 171 YPRRG----NKLGEGQFGTVYYGK---LKNGME---IAVKTLENNANYSSSNSDNTEAAM 220
           YPR        +G+G FG V+  +   L        +AVK L+  A      S + +A  
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------SADMQAD- 54

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVN----- 273
                F+ E   +++  H N+++LLG+C     M C+++EYM  G L + L   +     
Sbjct: 55  -----FQREAALMAEFDHPNIVKLLGVCAVGKPM-CLLFEYMAYGDLNEFLRHRSPRAQC 108

Query: 274 --------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
                         N  PL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN
Sbjct: 109 SLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGEN 166

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILL 376
            V K+ DFG   +S        Y  +     P  +MPPE++ + + +T++DV++YGV+L 
Sbjct: 167 MVVKIADFG---LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223

Query: 377 ELLT-GMKPIDDNNTILYYYLVVEQEV 402
           E+ + GM+P         YY +  +EV
Sbjct: 224 EIFSYGMQP---------YYGMAHEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.7 bits (214), Expect = 3e-19
 Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 18/217 (8%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           RRG  LG+G FG VY    +  G E+A K ++ +   S   S    A        E E+Q
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE-SPETSKEVSA-------LECEIQ 56

Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H  +++  G   +       I  EYM  GS+ D+L +          ++Y+   
Sbjct: 57  LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQ- 114

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  M      ++TG
Sbjct: 115 -ILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           T  +M PE +  +    K DV+S G  ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 41/230 (17%)

Query: 177 KLGEGQFGTVYYGKLKNGME---------------IAVKTLENNANYSSSNSDNTEAAMI 221
           KLGEGQFG V+  + +   E               +AVK L  +   ++ N         
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND-------- 63

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL---------YDRLAR 271
               F  E++ +S+ K+ N++RLLG+C ++   C++ EYM NG L               
Sbjct: 64  ----FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            NN P +       +A+ +A  + YL SL+   +HRD+ + N L+  ++  K+ DFG+ +
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSR 177

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT 380
              + +   +    +   R +M  E++   + +T +DV+++GV L E+ T
Sbjct: 178 NLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.5 bits (214), Expect = 4e-19
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 29/218 (13%)

Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+  + Y+     +          F +E   +
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLK--SGYTEKQRRD----------FLSEASIM 59

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNT--PPLDSNKRYSIALGV 290
            Q  H N++ L G+        I+ E+M NG+L D   R N+     +   +   +  G+
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVI---QLVGMLRGI 115

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT +L G  
Sbjct: 116 AAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 34/226 (15%)

Query: 178 LGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           LG G FG VY G   +        + +AVKTL   A    ++ +  E        F  E 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKE--------FLKEA 50

Query: 231 QTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL--YDRLARVNNTPP--LDSNKRYS 285
             +S   H N+++LLG+C  N    I+ E M  G L  Y R ARV    P  L   +   
Sbjct: 51  HLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKT 340
           I L VA+   YL  +    IHRD+ + N L+ E     + V K+GDFG+ +    S+   
Sbjct: 111 ICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 341 MYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
              E L   R +M PE+ +  + +T++DV+S+GV++ E+LT G +P
Sbjct: 169 KEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 85.6 bits (212), Expect = 7e-19
 Identities = 72/225 (32%), Positives = 113/225 (50%), Gaps = 31/225 (13%)

Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G+G FG VY+G L   +G +I  AVK+L       +  +D  E        F  E   +
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-------NRITDLEEVEQ-----FLKEGIIM 50

Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 51  KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVA 108

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTR 350
           + + YL   SK  +HRD+ + N +LDE+F  K+ DFG   ++     K  Y+  N TG +
Sbjct: 109 KGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAK 163

Query: 351 ---PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNT 390
               +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D ++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 45/233 (19%)

Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+          + +E+A      F+ E 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----------EASESAR---QDFQREA 58

Query: 231 QTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP---------- 276
           + L+  +H +++R  G+C      +M   V+EYM +G L +R  R +             
Sbjct: 59  ELLTVLQHQHIVRFYGVCTEGRPLLM---VFEYMRHGDL-NRFLRSHGPDAKILAGGEDV 114

Query: 277 ---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
               L   +  +IA  +A  + YL SL    +HRD+ + N L+ +  V K+GDFG+ +  
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +++   +    +   R +MPPE+ ++ + +T++D++S+GV+L E+ T G +P
Sbjct: 173 YSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 57/249 (22%)

Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEI-----------------AVKTLENNANY 208
           F R+P      KLGEGQFG V+  +     +                  AVK L  +A+ 
Sbjct: 2   FPRQPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 209 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD 267
           ++               F  EV+ LS+    N+ RLLG+C  +   C++ EYM NG L  
Sbjct: 61  NARED------------FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 268 RLAR--------VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
            L +          N+  L  +    +A  +A  + YL SL+   +HRD+ + N L+ +N
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKN 166

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTEN---LTGTRP----YMPPEAMH-CQISTKTDVFSY 371
           +  K+ DFG   MS     + +Y+ +   + G  P    +M  E++   + +TK+DV+++
Sbjct: 167 YTIKIADFG---MS-----RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 372 GVILLELLT 380
           GV L E+LT
Sbjct: 219 GVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   K+K+     A+K ++          +  +   I      +E + L +C
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-----VETGQQEHI-----FSEKEILEEC 50

Query: 237 KHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            H  +++L     +     +Y   EY   G L+  L         +   R+ IA  V  A
Sbjct: 51  NHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLA 105

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
             YLH+    II+RD+K  N+LLD N   KL DFG  K  ++   KT +T    GT  Y+
Sbjct: 106 FEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KT-WT--FCGTPEYV 159

Query: 354 PPEAMHCQISTK-----TDVFSYGVILLELLTGMKP 384
            PE     I  K      D +S G++L ELLTG  P
Sbjct: 160 APE----IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 74/226 (32%), Positives = 107/226 (47%), Gaps = 45/226 (19%)

Query: 178 LGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +GEG FG V    +K     M  A+K L+    ++S N             F  E++ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE---FASENDHRD---------FAGELEVL- 56

Query: 235 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C N     I  EY   G+L D  R +RV  T P           
Sbjct: 57  -CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + NVL+ EN   K+ DFG+ +  E   
Sbjct: 116 LTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173

Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +TK+DV+S+GV+L E+++
Sbjct: 174 KKTM------GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 34/225 (15%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
                LG G FG VY G  +        +++AVKTL        S S+  E+       F
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL------PESCSEQDESD------F 56

Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRL----ARVNNTPPLDSN 281
             E   +S+  H N++RL+G+    +   I+ E M  G L   L     R      L   
Sbjct: 57  LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 338
                A  VA+   YL       IHRD+ + N LL       V K+ DFG   M+     
Sbjct: 117 DLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFG---MARDIYR 171

Query: 339 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            + Y +      P  +MPPEA    I ++KTDV+S+GV+L E+ +
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 24/207 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G      ++A+KTL+                M+P    + E Q + + 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLK-------------PGTMMPEAFLQ-EAQIMKKL 58

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+ L  + +     IV E+M  GSL D L +  +   L   +   +A  +A+ + Y
Sbjct: 59  RHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY---M 353
           +  ++   IHRD+++AN+L+ +N V K+ DFG+ ++ E +     YT       P     
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE----YTARQGAKFPIKWTA 171

Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT 380
           P  A++ + + K+DV+S+G++L EL+T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 36/229 (15%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G  GTV   K + +G   AVK ++     S ++ +  +A          EV  L  C
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQA----------EVCCLLNC 88

Query: 237 KHVNLLRLLGLC-------------NNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNK 282
              ++++    C             N +M  +V +Y   G L   + +R         ++
Sbjct: 89  DFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTM 341
              + + V  A+H++HS  K +IHRD+KSAN+LL  N + KLGDFG  KM + T +    
Sbjct: 145 AGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202

Query: 342 YTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            T    GT  Y+ PE       S K D+FS GV+L ELLT  +P D  N
Sbjct: 203 RT--FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +   
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKTL 58

Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+RL  +        I+ EYM  GSL D L + +    +   K    +  +AE + 
Sbjct: 59  QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  + 
Sbjct: 118 YIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWT 171

Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT 380
            PEA++    + K+DV+S+G++L E++T
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 24/207 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+         + + EA       F  E Q + + 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTMSPEA-------FLQEAQVMKKL 58

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 59  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY---M 353
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P     
Sbjct: 118 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 171

Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT 380
           P  A++ + + K+DV+S+G++L EL T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 3e-18
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 28/219 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDN--TEAAMIPILLFENE 229
            +  KLGEG +G VY  +  K G  +A+K +  +      N +      A+        E
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTAL-------RE 48

Query: 230 VQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +  L + KH N+++LL + +      +V+EY C+  L   L       PL  N   SI  
Sbjct: 49  ISLLKELKHPNIVKLLDVIHTERKLYLVFEY-CDMDLKKYLD--KRPGPLSPNLIKSIMY 105

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L Y H  S  I+HRD+K  N+L++ + V KL DFG+ + +    ++T YT  +  
Sbjct: 106 QLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRT-YTHEVV- 160

Query: 349 TRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
           T  Y  PE  +  +  ST  D++S G I  E++TG KP+
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.1 bits (209), Expect = 4e-18
 Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 24/238 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   + K   +  A+K L           ++            NE + L   
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL----------NEKRILQSI 58

Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+ L G   +  N  +V EY+  G L+  L R +   P    + Y  A  V  AL 
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLALE 115

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL   I++RD+K  N+LLD +   K+ DFG  K  +    +T YT  L GT  Y+ P
Sbjct: 116 YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RT-YT--LCGTPEYLAP 167

Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           E +  +   K  D ++ G+++ E+L G  P  D+N I  Y  ++E +V        +A
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDA 225

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 66/233 (28%), Positives = 118/233 (50%), Gaps = 44/233 (18%)

Query: 177 KLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGEG FG V+  +       K+ M +AVK L++    ++               F+ E 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKD------------FQREA 58

Query: 231 QTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLY--------DRLARVNNTP-- 276
           + L+  +H ++++  G+C +    IM   V+EYM +G L         D +  V+  P  
Sbjct: 59  ELLTNLQHEHIVKFYGVCGDGDPLIM---VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 277 ---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
               L  ++   IA  +A  + YL   S+  +HRD+ + N L+  N + K+GDFG+ +  
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173

Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +++   +    +   R +MPPE+ M+ + +T++DV+S+GVIL E+ T G +P
Sbjct: 174 YSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 45/226 (19%)

Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++  A    S  D+ +        F  E++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRD--------FAGELEVL- 61

Query: 235 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 62  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178

Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 179 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.6 bits (206), Expect = 6e-18
 Identities = 67/227 (29%), Positives = 114/227 (50%), Gaps = 35/227 (15%)

Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       + +AVKTL++        SDN          F  E 
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-------SDNARKD------FHREA 58

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTPP--LD 279
           + L+  +H ++++  G+C      I V+EYM +G L         D +       P  L 
Sbjct: 59  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG+ +   +++  
Sbjct: 119 QSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +    +   R +MPPE+ M+ + +T++DV+S GV+L E+ T G +P
Sbjct: 177 RVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 70/237 (29%), Positives = 102/237 (43%), Gaps = 54/237 (22%)

Query: 174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G KLGEG +  VY  + K  G  +A+K ++      + +  N  A          E++ 
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL--------REIKL 55

Query: 233 LSQCKHVNLLRLL---GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           L + KH N++ LL   G  +NI   +V+E+M      D    + +          SI L 
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNI--NLVFEFM----ETDLEKVIKDK---------SIVLT 100

Query: 290 VAE----------ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            A+           L YLHS    I+HRD+K  N+L+  + V KL DFG+ +   + N K
Sbjct: 101 PADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Query: 340 TMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLEL------LTGMKPID 386
              T  +  TR Y  PE    A H       D++S G I  EL      L G   ID
Sbjct: 159 --MTHQVV-TRWYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.1 bits (205), Expect = 9e-18
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 33/225 (14%)

Query: 169 KPYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTL--ENNANYSSSNSDNTEAAMI 221
           K + +R   LGEG FG V   +        G ++AVK+L  E+  N+ +           
Sbjct: 3   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---------- 52

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPL 278
                + E++ L    H N+++  G+C         ++ E++ +GSL + L R  N   L
Sbjct: 53  ----LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL 108

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 109 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-- 162

Query: 339 KTMYTENLTGTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           K  YT       P   Y P   +  +    +DV+S+GV L ELLT
Sbjct: 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 73/248 (29%), Positives = 116/248 (46%), Gaps = 33/248 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++N   +A+K +    +YS   S+     +I       EV+ L +
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKM----SYSGKQSNEKWQDII------KEVRFLQK 71

Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N ++  G         +V EY C GS  D L    +  PL   +  ++  G  + L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 128

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M 
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------XFVGTPYWMA 179

Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 234

Query: 411 EAGEWNET 418
           ++G W+E 
Sbjct: 235 QSGHWSEY 242

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 67/250 (26%), Positives = 120/250 (48%), Gaps = 50/250 (20%)

Query: 177 KLGEGQFGTVYYGKLK-NGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +LGE  FG +Y G L   GM+    +A+KTL++  N                  F+ E  
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE------------FQQEAS 59

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-------------- 276
            +++  H N++ LLG+       C+++EY+  G L++ L  +  +P              
Sbjct: 60  LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDEDGTV 117

Query: 277 --PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
              LD      IA+ +A  + YL S     +H+D+ + N+L+ E    K+ D G+ +   
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 335 TSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL 392
           +++   +  ++L   R +MPPEA M+ + S+ +D++S+GV+L E+ + G++P        
Sbjct: 176 SADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-------- 226

Query: 393 YYYLVVEQEV 402
            YY    QEV
Sbjct: 227 -YYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 72/285 (25%), Positives = 135/285 (47%), Gaps = 42/285 (14%)

Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V+ G LK      + +A+KTL+    Y+     +          F +E   +
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLK--PGYTEKQRQD----------FLSEASIM 60

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        I+ EYM NG+L D+  R ++     S +   +  G+A 
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLR-DHDGEFSSYQLVGMLRGIAA 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  ++   +HRD+ + N+L++ N   K+ DFG+ ++ E     T  T    G  P 
Sbjct: 119 GMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG--GKIPI 174

Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV--PVRE 406
            +  PEA+ + + ++ +DV+S+G+++ E+++ G +P         Y+ +   EV   + +
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP---------YWDMSNHEVMKAIND 225

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                A         + +  +  +C   ++ +R    DIV+LL K
Sbjct: 226 GFRLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 52/244 (21%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNGME------------------IAVKTLENNANY 208
           +PR+      KLGEGQFG V+  + + GME                  +AVK L  +AN 
Sbjct: 2   FPRKRLTFKEKLGEGQFGEVHLCEAE-GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60

Query: 209 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD 267
           ++ N             F  E++ +S+ K  N++RLL +C  +   C++ EYM NG L  
Sbjct: 61  NARND------------FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 268 RLARVN-NTPPLDSNKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
            L+R         ++           +A  +A  + YL SL+   +HRD+ + N L+ +N
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKN 166

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHC-QISTKTDVFSYGVILL 376
           +  K+ DFG   MS        Y        P  +M  E++   + +T +DV+++GV L 
Sbjct: 167 YTIKIADFG---MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223

Query: 377 ELLT 380
           E+LT
Sbjct: 224 EILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R G  LG G FG VY       G E+AVK +  + + S   S    A        E E+Q
Sbjct: 5   RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD-SQETSKEVNA-------LECEIQ 56

Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H  +++  G   +       I  EYM  GS+ D+L +       +  +RY+   
Sbjct: 57  LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQ- 114

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  M     +++TG
Sbjct: 115 -ILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           T  +M PE +  +    K DV+S    ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 175 GNKLGEGQFGTVYYG--KLKNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  +GEGQFG VY G        +I  AVKT +N  +         E        F  E 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-----PSVRE-------KFLQEA 58

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
             + Q  H ++++L+G+       IV E    G L   L     +  L S   YS  L  
Sbjct: 59  YIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL-- 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E  +    Y +   G  
Sbjct: 117 STALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES----YYKASKGKL 170

Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)

Query: 178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG VY  + K  G+  A K ++  +       +  E  M+       E+  LS+C
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES------EEELEDFMV-------EIDILSEC 59

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNG----SLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           KH N++ L           +    C+G    S+   L R      L   +   +   + E
Sbjct: 60  KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLE 114

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRP 351
           AL++LHS    +IHRD+K+ N+LL  +   KL DFG+       N  T+   +   GT  
Sbjct: 115 ALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPY 168

Query: 352 YMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTI 391
           +M PE + C+         K D++S G+ L+EL     P  + N +
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 17/229 (7%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G +LG G F + Y  + +K G  +AVK +    N SS   +  EA          E++ 
Sbjct: 4   KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALR-------KEIRL 56

Query: 233 LSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +++  H +++R+LG  C +    +  E+M  GS+   L   +           +    + 
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLL 113

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG-IVKMSETSNMKTMYTENLTGT 349
             L YLH     IIHRDVK AN+L+D      ++ DFG   +++        +   L GT
Sbjct: 114 RGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 350 RPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
             +M PE +  +   ++ DV+S G +++E+ T   P +      +  L+
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 42/281 (14%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R  K+G+G  GTVY    +  G E+A+K +    N                 L  NE+ 
Sbjct: 22  TRFEKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKE---------LIINEIL 68

Query: 232 TLSQCKHVNLLRLLG---LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            + + KH N++  L    + + +   +V EY+  GSL D    V     +D  +  ++  
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELW--VVMEYLAGGSLTD----VVTETCMDEGQIAAVCR 122

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENL 346
              +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   TM     
Sbjct: 123 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----- 175

Query: 347 TGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  +M PE +       K D++S G++ +E++ G  P  + N +   YL+     P  
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-- 233

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           E+ + E        +  +      +C   + +KR S ++++
Sbjct: 234 ELQNPEK-------LSAIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 40/225 (17%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
            ++G G +G VY  + +  G  +A+K   LE   ++                  + E+  
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI---------------IQQEISM 53

Query: 233 LSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           L +C+H N++   G  L  + +  IV EY   GSL D + +V   P         IA   
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKL-WIVMEYCGGGSLQD-IYQVTRGPL----SELQIAYVC 107

Query: 291 AEAL---HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENL 346
            E L    YLH   K  IHRD+K AN+LL E+   KL DFG+  +++ T   +     + 
Sbjct: 108 RETLKGLAYLHETGK--IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK----SF 161

Query: 347 TGTRPYMPPEA----MHCQISTKTDVFSYGVILLELLTGMKPIDD 387
            GT  +M PE            K D+++ G+  +EL     P+ D
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 80/302 (26%), Positives = 128/302 (42%), Gaps = 36/302 (11%)

Query: 169 KPYPRRGNKLGEGQFGTV--YYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           K Y ++   LGEG FG V  Y     N   G  +AVKTL+           NT       
Sbjct: 3   KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-----RECGQQNTSG----- 52

Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI---VYEYMCNGSLYDRLARVNNTPPLDS 280
             ++ E+  L    H N+++  G C+         + EY+  GSL D L +      L+ 
Sbjct: 53  --WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNL 106

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +    A  + E + YLHS  +  IHRD+ + NVLLD + + K+GDFG+ K     +   
Sbjct: 107 AQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164

Query: 341 MYTENLTGTRP---YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
              E+  G  P   Y        + S  +DV+S+GV L ELLT               + 
Sbjct: 165 RVRED--GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG 222

Query: 398 VEQ----EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV 453
            +Q     V + E+L++        +    + I+ + C   E   R + R ++ +L K +
Sbjct: 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL-KEM 281

Query: 454 NN 455
           ++
Sbjct: 282 HH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 43/232 (18%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG FG VY   ++K G  +A+K +  +           E    PI     E++ L +
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMH----------NEKDGFPITALR-EIKILKK 63

Query: 236 CKHVNLLRLLGL-------CNNIMNCI--VYEYMC---NGSLYDRLARVNNTPPLDSNKR 283
            KH N++ L+ +              +  V  YM    +G L +    V  T        
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKC-- 119

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY- 342
               L + E ++YLH     I+HRD+K+AN+L+D   + K+ DFG+ +  +         
Sbjct: 120 --YMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 343 ----TENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
               T   T    TR Y PPE +    + +T  D++  G +  E+ T  +PI
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 70/234 (29%), Positives = 102/234 (43%), Gaps = 24/234 (10%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G+G FG VY G      E+ A+K ++             E A   I   + E+  LS
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIID------------LEEAEDEIEDIQQEITVLS 57

Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + R  G         I+ EY+  GS  D L       PL+     +I   + + 
Sbjct: 58  QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 168

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +       K D++S G+  +EL  G  P  D + +   +L+ +   P  E
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE 222

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 44/106 (41%), Positives = 63/106 (59%), Gaps = 10/106 (9%)

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           IA+ + +AL YLHS    +IHRDVK +NVL++ N   KL DFGI      S  KT+    
Sbjct: 108 IAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID--- 163

Query: 346 LTGTRPYMPPEAMHCQIST-----KTDVFSYGVILLELLTGMKPID 386
             G +PYM PE ++ +++      K+DV+S G+ ++EL TG  P D
Sbjct: 164 -AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 23/218 (10%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           K+GEG FG +Y  K K+  E  V       + +       EA+       + EV  L++ 
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVI---KEIDLTKMPVKEKEAS-------KKEVILLAKM 56

Query: 237 KHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH N++        N    IV EY C+G   D + R+N    +  ++   ++  V  +L 
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEY-CDGG--DLMKRINRQRGVLFSEDQILSWFVQISLG 113

Query: 296 YLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             H   + I+HRD+KS N+ L +N  V KLGDFGI +     N          GT  Y+ 
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLS 170

Query: 355 PEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE   CQ    + KTD++S G +L EL T   P + NN
Sbjct: 171 PEI--CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 73/249 (29%), Positives = 112/249 (44%), Gaps = 33/249 (13%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +++G G FG VY+    +  E+ AVK +    +YS   ++     +I       EV+ L 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKM----SYSGKQTNEKWQDII------KEVKFLQ 76

Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q KH N +   G         +V EY C GS  D L    +  PL   +  +I  G  + 
Sbjct: 77  QLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQG 133

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS +   IHRD+K+ N+LL E    KL DFG    S  +N       +  GT  +M
Sbjct: 134 LAYLHSHNM--IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-------SFVGTPYWM 184

Query: 354 PPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + + P      
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---- 240

Query: 410 KEAGEWNET 418
            ++ EW ++
Sbjct: 241 -QSNEWTDS 248

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 71/226 (31%), Positives = 111/226 (49%), Gaps = 45/226 (19%)

Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++    Y+S +             F  E++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRD---------FAGELEVL- 49

Query: 235 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 50  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 166

Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 167 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 26/232 (11%)

Query: 176 NKLGEGQFGTVYYGKLKNGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            ++G+G FG V+ G + N  +  +A+K ++             E A   I   + E+  L
Sbjct: 10  ERIGKGSFGEVFKG-IDNRTQQVVAIKIID------------LEEAEDEIEDIQQEITVL 56

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           SQC    + +  G         I+ EY+  GS  D L       P D  +  ++   + +
Sbjct: 57  SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILK 112

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +
Sbjct: 113 GLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFW 167

Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           M PE +      +K D++S G+  +EL  G  P  D + +   +L+ +   P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP 219

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 31/218 (14%)

Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+  A Y+     +          F +E   +
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLK--AGYTEKQRRD----------FLSEASIM 59

Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G+      +M  IV EYM NGSL D   R ++       +   +  G+
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVM--IVTEYMENGSL-DAFLRKHDGQ-FTVIQLVGMLRGI 115

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  
Sbjct: 116 ASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKI 171

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 26/234 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++             E A   I   + E+  LS
Sbjct: 11  KIGKGSFGEVFKG-IDNRTQKVVAIKIID------------LEEAEDEIEDIQQEITVLS 57

Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 168

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE 222

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +GEG +G V   + K  G  +A+K  +         S++ E      L    EV+ L Q
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKE--------SEDDEDVKKTAL---REVKVLRQ 56

Query: 236 CKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            +H N++ L         +   +V+EY    +L + L       P D+ + Y   L   +
Sbjct: 57  LRHENIVNLKEAFRRKGRLY--LVFEY-VERTLLELLEASPGGLPPDAVRSYIWQL--LQ 111

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+ Y HS    IIHRD+K  N+L+ E+ V KL DFG  + +  +   +  T+ +  TR Y
Sbjct: 112 AIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVA-TRWY 167

Query: 353 MPPEAMHCQIS--TKTDVFSYGVILLELLTG 381
             PE +    +     DV++ G I+ ELL G
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 26/218 (11%)

Query: 178 LGEGQFG-TVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG    Y + ++   +  K + N    S     +   A+       NE+  LS  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEV-NLTRLSEKERRD---AL-------NEIVILSLL 56

Query: 237 KHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           +H N++      + +N +  I  EY   G+LYD++ R       +          +  A+
Sbjct: 57  QHPNIIAYYNHFMDDNTL-LIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAV 114

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+H     I+HRD+K+ N+ L +  + KLGDFGI K+      +    E + GT  YM 
Sbjct: 115 SYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSMAETVVGTPYYMS 169

Query: 355 PEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE   CQ    + K+D+++ G +L ELLT  +  D  N
Sbjct: 170 PEL--CQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.0 bits (194), Expect = 3e-16
 Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 33/247 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++    +A+K +    +YS   S+     +I       EV+ L +
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKM----SYSGKQSNEKWQDII------KEVKFLQR 81

Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            KH N +   G         +V EY C GS  D L    +  PL   +  +I  G  + L
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQGL 138

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRD+K+ N+LL E    KL DFG   ++  +N       +  GT  +M 
Sbjct: 139 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-------SFVGTPYWMA 189

Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----- 244

Query: 411 EAGEWNE 417
           ++ EW++
Sbjct: 245 QSNEWSD 251

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 72/233 (30%), Positives = 100/233 (42%), Gaps = 45/233 (19%)

Query: 178 LGEGQFGTVYYGKL---KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +G G FGTV   K+    +G  +AVK +        S  D  E     +L+  + V   S
Sbjct: 12  IGRGAFGTVN--KMLHKPSGTIMAVKRI-------RSTVDEKE--QKRLLMDLDVVMRSS 60

Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYM------CNGSLYDRLARVNNTPPLDSNKRYSIA 287
            C    +++  G      +C I  E M          +Y+ L  V     +       IA
Sbjct: 61  DC--PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV-----IPEEILGKIA 113

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           +   +AL+YL    K IIHRDVK +N+LLD N   KL DFGI      S  KT       
Sbjct: 114 VATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----A 168

Query: 348 GTRPYMPPEAMHCQIST--------KTDVFSYGVILLELLTGMKPIDDNNTIL 392
           G RPYM PE    +I          ++DV+S G+ L E+ TG  P    N++ 
Sbjct: 169 GCRPYMAPE----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 72/253 (28%), Positives = 111/253 (43%), Gaps = 36/253 (14%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +LG+G FG VY  K K  G   A K +E      + + +  E  M+       E++ L+ 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMV-------EIEILAT 65

Query: 236 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGVA 291
           C H  +++LLG         +    C G   D     L R    P +       I   + 
Sbjct: 66  CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----ICRQML 120

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTR 350
           EAL YLHS    IIHRD+K+ NVLL  +   KL DFG+       N+KT+   ++  GT 
Sbjct: 121 EALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTP 174

Query: 351 PYMPPEAMHCQI------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            +M PE + C+         K D++S G+ L+E+     P  + N +     + + E P 
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 405 REVLDKEAGEWNE 417
                K + E+ +
Sbjct: 235 LSQPSKWSMEFRD 247

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 73/243 (30%), Positives = 110/243 (45%), Gaps = 60/243 (24%)

Query: 177 KLGEGQFGTVYYGKLKNGME-----------------IAVKTLENNANYSSSNSDNTEAA 219
           KLGEGQFG V+  ++ N  +                 +AVK L  +AN ++ N       
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND------ 65

Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL---------YDRL 269
                 F  EV+ LS+ K  N++RLLG+C +    C++ EYM NG L          D+ 
Sbjct: 66  ------FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119

Query: 270 ARVNNTPPLDS-------NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 322
              N+  P          +    +AL +A  + YL SL+   +HRD+ + N L+ EN   
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTI 177

Query: 323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HC----QISTKTDVFSYGVILL 376
           K+ DFG   MS        Y   + G R  +P   M   C    + +T +DV+++GV L 
Sbjct: 178 KIADFG---MSRNLYAGDYY--RIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231

Query: 377 ELL 379
           E+L
Sbjct: 232 EIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ GK +  +++A+K +   A                   F  E + + + 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED--------------FIEEAKVMMKL 56

Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G+C       IV E+M NG L + L +      L  +   S+   V E + 
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGME 114

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL   S   IHRD+ + N L+    V K+ DFG+ +      +   YT +     P  + 
Sbjct: 115 YLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWS 168

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
           PPE  +  + S+K+DV+S+GV++ E+ T
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)

Query: 178 LGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LG G+FG V+  K K   E      + VK L+       +  +N ++       F  E+ 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ------KTKDENLQSE------FRRELD 60

Query: 232 TLSQCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRL------ARVNNTPPLDSNKRY 284
              +  H N++RLLGLC     + ++ EY   G L   L            PPL + ++ 
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           ++   +A  + +L +     +HRD+ + N L+             VK+S  S  K +Y  
Sbjct: 121 ALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR--------EVKVSLLSLSKDVYNS 170

Query: 345 ------NLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
                 N      ++ PEA+     STK+DV+S+GV++ E+ T
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 8e-16
 Identities = 60/231 (25%), Positives = 90/231 (38%), Gaps = 45/231 (19%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ- 235
           +GEG +G VY  +  K G  +A+K ++          D  E         + E   L + 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIE-------DEEEEI-------KEEYNILRKY 59

Query: 236 CKHVNLLRLLG--LCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--- 285
             H N+    G  +  N         +V E    GS+ D    V         KR     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL---VKGL--RKKGKRLKEEW 114

Query: 286 ---IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
              I       L YLH     +IHRD+K  N+LL +N   KL DFG+    +++  +   
Sbjct: 115 IAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR--- 169

Query: 343 TENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDD 387
                GT  +M PE + C          ++DV+S G+  +EL  G  P+ D
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 37/96 (38%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +  AL YLHS  K IIHRD+K  N+LLDE     + DF I        + T      +GT
Sbjct: 109 IVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST----SGT 162

Query: 350 RPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKP 384
             YM PE +  Q  +   D +S GV   E L G +P
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 34/216 (15%)

Query: 178 LGEGQFGTV---YYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           LG+G FG+V    Y  L++  G  +AVK L+++   +    D           FE E++ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-----------FEREIEI 58

Query: 233 LSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           L   +H N+++  G+C      N+   +V EY+  GSL D L    +   LD  K    A
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLR--LVMEYLPYGSLRDYL--QKHRERLDHRKLLLYA 114

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  K  +HRD+ + N+L++     K+GDFG+ K+      K  Y     
Sbjct: 115 SQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD--KEYYKVREP 170

Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 31/215 (14%)

Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---FENEVQTLS 234
           LG+G FG V+ G LK+   +AVKT + +               +P  L   F +E + L 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKED---------------LPQELKIKFLSEARILK 47

Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q  H N+++L+G+C       IV E +  G     L +  +   L + +    AL  A  
Sbjct: 48  QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAG 105

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +  +      +Y+ +     P  
Sbjct: 106 MAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG----IYSSSGLKQIPIK 159

Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PEA+ + + S+++DV+SYG++L E  + G+ P
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP 194

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  +    G  +A+K +                          E++ L +
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKI------KLRFESEGIPKTA-----LREIKLLKE 54

Query: 236 CKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             H N+++LL +     ++   +V+E+M +  LY  +        L  +   S    + +
Sbjct: 55  LNHPNIIKLLDVFRHKGDLY--LVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQ 109

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L + HS    I+HRD+K  N+L++   V KL DFG+ +   +      YT  +  TR Y
Sbjct: 110 GLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVV-TRWY 164

Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTG 381
             PE +      ST  D++S G I  ELL+ 
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 34/241 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +R   +G G +G VY GK +  G  +A+K +       + ++ + + + I     + EV 
Sbjct: 4   QRLELIGRGAYGAVYRGKHVPTGRVVALKII-------NLDTPDDDVSDI-----QREVA 51

Query: 232 TLSQCKHV---NLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            LSQ +     N+ +  G         I+ EY   GS+   L +     P+   ++Y I+
Sbjct: 52  LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAG---PIA--EKY-IS 104

Query: 288 LGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           + + E   AL Y+H     +IHRD+K+AN+L+      KL DFG+  +   ++ K     
Sbjct: 105 VIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK---RS 159

Query: 345 NLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
              GT  +M PE +       TK D++S G+ + E+ TG  P  D +      L+ + + 
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP 219

Query: 403 P 403
           P
Sbjct: 220 P 220

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 58

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 59  QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 116

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  + 
Sbjct: 117 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 170

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLT 380
            PEA+     + K+DV+S+G++L+E++T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 66/290 (22%), Positives = 142/290 (48%), Gaps = 43/290 (14%)

Query: 173 RRGNKLGEGQFGTVYYG-------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
           R+   LG G FGTV+ G        +K  + +A+KT+++ +   +               
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIK--IPVAIKTIQDRSGRQTFQE------------ 55

Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
             + +  +    H  ++RLLG+C      +V +    GSL D + +  +   LD  +  +
Sbjct: 56  ITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLN 113

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             + +A+ ++YL      ++HR++ + N+LL  + + ++ DFG+  +    + K  Y+E+
Sbjct: 114 WCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 346 LTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 403
            T  + +M  E++     T ++DV+SYGV + E+++ G +P         Y  +   EVP
Sbjct: 172 KTPIK-WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP---------YAGMRPHEVP 221

Query: 404 VREVLDKEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             ++L+K  GE   +  + T+ + +V  KC + +++ R + +++ +  ++
Sbjct: 222 --DLLEK--GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 47/142 (33%), Positives = 78/142 (54%), Gaps = 12/142 (8%)

Query: 249 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD 308
           NNI  C+  E+M  GSL DR+ +     P++   +  IA+ V E L YL+++ + I+HRD
Sbjct: 76  NNI--CMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR-IMHRD 129

Query: 309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTD 367
           +K +N+L++     KL DFG+     +  +     +   GT  YM PE +   + + K+D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 368 VFSYGVILLELLTGMKPIDDNN 389
           V+S G+ ++EL  G  P   +N
Sbjct: 185 VWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 75/239 (31%), Positives = 114/239 (47%), Gaps = 45/239 (18%)

Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKNGME----IAVKTLENNANYSSSNSDNTEA 218
           +PR     G  LGEG FG V     YG  K+  +    +AVK L++NA      +D   A
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA------TDKDLA 62

Query: 219 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTP 276
            +I     E E+  L   KH N++ LLG+C       ++ EY   G+L + L AR    P
Sbjct: 63  DLIS----EMELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP 117

Query: 277 ------------PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 324
                        L      S A  VA  + YL S  +  IHRD+ + NVL+ E+ V K+
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKI 175

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            DFG+ +     +    Y +   G  P  +M PEA+  ++ T ++DV+S+G+++ E+ T
Sbjct: 176 ADFGLARGVHDID---YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 45/219 (20%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE-------- 227
           K+G+GQF  VY    L +G  +A+K ++                     +FE        
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQ---------------------IFEMMDAKARQ 47

Query: 228 ---NEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLAR--VNNTPPLDS 280
               E+  L Q  H N+++ L   + NN +N IV E    G L  R+ +        +  
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELN-IVLELADAGDL-SRMIKHFKKQKRLIPE 105

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
              +   + +  AL ++HS  K I+HRD+K ANV +    V KLGD G+ +   +   KT
Sbjct: 106 RTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KT 160

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLEL 378
               +L GT  YM PE +H    + K+D++S G +L E+
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTL-ENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           LG+G +G VY  + L   + IA+K + E ++ Y                L E E+   S 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-------------LHE-EIALHSY 61

Query: 236 CKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--VA 291
            KH N+++ LG    N     I  E +  GSL   L   +   PL  N++  I     + 
Sbjct: 62  LKHRNIVQYLGSDSENGFFK-IFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQIL 118

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TGT 
Sbjct: 119 EGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFTGTL 173

Query: 351 PYMPPEAMHCQI---STKTDVFSYGVILLELLTGMKP 384
            YM PE +           D++S G  ++E+ TG  P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 41/288 (14%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A+K +                     
Sbjct: 15  GDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE------------ 61

Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 62  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 115

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 339
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   
Sbjct: 116 QIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 340 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 174 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Query: 399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
               P  +         N   +  +      +C   + D+R S ++++
Sbjct: 229 TNGTPELQ---------NPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 177 KLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +LG+G FG+VY  + K   E+ A+K +     + S      E  M        EV++L +
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM--KKKFYS-----WEECMN-----LREVKSLRK 53

Query: 236 CK-HVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
              H N+++L  +     N     V+EYM  G+LY  L +     P   +   SI   + 
Sbjct: 54  LNEHPNIVKLKEVF--RENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQIL 109

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + L ++H       HRD+K  N+L+    V K+ DFG+ +  E  +    YT+ +  TR 
Sbjct: 110 QGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPP-YTDYV-STRW 163

Query: 352 YMPPEA-MHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           Y  PE  +     S+  D+++ G I+ EL T ++P+
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.8 bits (181), Expect = 7e-15
 Identities = 72/244 (29%), Positives = 107/244 (43%), Gaps = 44/244 (18%)

Query: 177 KLGEGQFGTVYYGK---------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +LG+G FGTVY  K         LK   EI V  L  N    +    N EA         
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEA--------- 53

Query: 228 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-- 284
              Q LS+  H  +++           CI+ EY     L  +L  + +T    S  +   
Sbjct: 54  ---QLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110

Query: 285 ---SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMKT 340
               + LGV    HY+H   + I+HRD+K+ N+ L  N + K+GDFG+ ++   S ++ T
Sbjct: 111 WFIQLLLGV----HYMHQ--RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT 163

Query: 341 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
                 TGT  YM PEA+ H    +K+D++S G IL E+       +  N +     +VE
Sbjct: 164 ----TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Query: 400 QEVP 403
              P
Sbjct: 220 GPTP 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G  G VY  +  K G  +AVK +       + N +        IL+  + V     C
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM-----RRTGNKEE----NKRILMDLDVVLKSHDC 73

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYM-CNGSLYDRLA-RVNNTPPLDSNKRYSIALGVAEAL 294
            ++  ++  G    I +  V+  M    +  D+L  R+    P+  +    + + + +AL
Sbjct: 74  PYI--VKCYGYF--ITDSDVFICMELMSTCLDKLLKRIQG--PIPEDILGKMTVAIVKAL 127

Query: 295 HYL---HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           HYL   H     +IHRDVK +N+LLD +   KL DFGI      S  KT       G   
Sbjct: 128 HYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----RSAGCAA 179

Query: 352 YMPPEAMHCQIST-----KTDVFSYGVILLELLTGMKPIDDNNT 390
           YM PE +           + DV+S G+ L+EL TG  P  +  T
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 41/231 (17%)

Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+++A     +   +E  M+ ++  
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 77

Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSL--YDRLAR---------VNN 274
                     KH N++ LLG C       ++ EY   G+L  Y R  R         +  
Sbjct: 78  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    VA  + YL   S+  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR- 185

Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 186 -DVNNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 36/221 (16%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           N++GEG +G VY  +     EI A+K +  +           E   IPI     E+  L 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMD----------NERDGIPISSLR-EITLLL 61

Query: 235 QCKHVNLLRLLGLC-----NNIMNCIVYEYMCN---GSLYDRLARVNNTPPLDSNKRYSI 286
             +H N++ L  +      ++I   +V EY C     SL D     N   P   ++   +
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIF--LVMEY-CEQDLASLLD-----NMPTPFSESQVKCL 113

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
            L +   L YLH     IIHRD+K +N+LL +    K+ DFG+ +           T  +
Sbjct: 114 MLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLART--YGLPAKPMTPKV 169

Query: 347 TGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
             T  Y  PE +  C   T   D+++ G IL ELL   KP+
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 66/240 (27%), Positives = 116/240 (48%), Gaps = 34/240 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           G  LGEG+FG+V  G+L      +++AVKT++      S   D           F +E  
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-----------FLSEAV 52

Query: 232 TLSQCKHVNLLRLLGLC-NNIMN------CIVYEYMCNGSLYDRL--ARVNNTPP-LDSN 281
            + +  H N++RL+G+C   + +       ++  +M +G L+  L  +R+ + P  L + 
Sbjct: 53  CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
                   +A  + YL S  K  IHRD+ + N +L+EN    + DFG+ K     +    
Sbjct: 113 MLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD---Y 167

Query: 342 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDD-NNTILYYYL 396
           Y +      P  ++  E++  ++ +TK+DV+S+GV + E+ T G  P     N+ +Y YL
Sbjct: 168 YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 43/232 (18%)

Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V           K    + +AVK L+++A     +   +E  M+ ++  
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI-- 74

Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSN---- 281
                     KH N++ LLG C       ++ EY   G+L + L R    P +D +    
Sbjct: 75  ---------GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTC 124

Query: 282 ----------KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
                        S A  VA  + YL   S+  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 332 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
             +  N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV+L E+ T
Sbjct: 183 --DVHNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 35/239 (14%)

Query: 169 KPYPRRGNKLGEGQFGTVY-YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI-LLF 226
           + Y ++G  LGEG +G V        G  +A+K ++     +    D     M  I    
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 227 ENEVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
             E++ +++ KH N++ L+ +        +V + M      D L +V     +D   R +
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA----SD-LKKV-----VDRKIRLT 117

Query: 286 ------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-------VKM 332
                 I L +   L+ LH      +HRD+  AN+ ++   + K+ DFG+          
Sbjct: 118 ESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 333 SETSNMKTMY-TENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
              S  +TM   E +T    T  Y  PE +    +     D++S G I  ELLTG KP+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233

Length = 335

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.1 bits (176), Expect = 5e-14
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62

Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 116

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172

Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 232 GTPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 43/232 (18%)

Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+++A     +   +E  M+ ++  
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 80

Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLD------ 279
                     KH N++ LLG C       ++ EY   G+L + L R    P ++      
Sbjct: 81  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPT 130

Query: 280 --------SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
                        S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Query: 332 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
                +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 189 ---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 22/239 (9%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+       E + L+  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDV---VIQDDDVECTMV-------EKRVLALQ 57

Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   ++ +  V EY+  G L   + +V         +    A  ++  L
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGL 114

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +LH   + II+RD+K  NV+LD     K+ DFG   M +   +  + T    GT  Y+ 
Sbjct: 115 FFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMVDGVTTRTFCGTPDYIA 169

Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D ++YGV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 35/217 (16%)

Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+GEG  G V        G ++AVK ++                    LLF NEV  + 
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRE------------LLF-NEVVIMR 71

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +
Sbjct: 72  DYQHPNIVEMYSSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLK 126

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    ++L GT  +
Sbjct: 127 ALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSK-EVPRRKSLVGTPYW 181

Query: 353 MPPEAMHCQIS-----TKTDVFSYGVILLELLTGMKP 384
           M PE     IS     T+ D++S G++++E++ G  P
Sbjct: 182 MAPEV----ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.1 bits (177), Expect = 7e-14
 Identities = 71/239 (29%), Positives = 105/239 (43%), Gaps = 22/239 (9%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+     E  V  L   
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVII---QDDDVECTMV-----EKRVLALPGK 59

Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 60  PP--FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGL 114

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +LHS  K II+RD+K  NV+LD     K+ DFG   M + +      T    GT  Y+ 
Sbjct: 115 FFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCGTPDYIA 169

Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D +++GV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 29/212 (13%)

Query: 177 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G V+  K +N   G  +A+K       +  S  D     +  I L   E++ L
Sbjct: 8   KIGEGSYGVVF--KCRNRETGQIVAIK------KFVESEDD---PVIKKIAL--REIRML 54

Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            Q KH NL+ L+ +      ++ +V+EY C+ ++ + L +  N   +  +    I     
Sbjct: 55  KQLKHPNLVNLIEVFRRKRKLH-LVFEY-CDHTVLNELEK--NPRGVPEHLIKKIIWQTL 110

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           +A+++ H  +   IHRDVK  N+L+ +    KL DFG  ++   +     YT+    TR 
Sbjct: 111 QAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTD-YVATRW 165

Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTG 381
           Y  PE +    Q     DV++ G +  ELLTG
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 80/286 (27%), Positives = 137/286 (47%), Gaps = 45/286 (15%)

Query: 178 LGEGQFGTVYYGK-LKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           LG G FGTVY G  + +G    + +A+K L  N    +S   N E     IL   +E   
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKE-----IL---DEAYV 62

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++      + RLLG+C      +V + M  G L D +    N   + S    +  + +A+
Sbjct: 63  MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAK 120

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +   ++HRD+ + NVL+      K+ DFG+ ++ +    +T Y  +  G  P 
Sbjct: 121 GMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID--ETEYHAD-GGKVPI 175

Query: 352 -YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M  E+ +H + + ++DV+SYGV + EL+T G KP D               +P RE+ 
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------IPAREIP 221

Query: 409 D-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           D  E GE   +  + T+ + ++  KC + + + R   R++VD  S+
Sbjct: 222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.1 bits (174), Expect = 8e-14
 Identities = 73/290 (25%), Positives = 132/290 (45%), Gaps = 50/290 (17%)

Query: 178 LGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           LG G+FG +  G L    K  + +A+ TL    +                  F  E  TL
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG------------FLAEALTL 60

Query: 234 SQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++RL G+    N +M  IV EYM NG+L   L +  +   L + +   +  G+
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMM--IVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGL 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  +    +H+ + +  VL++ + V K+  F  +   +    + +YT  ++G  
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYT-TMSGKS 170

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE 406
           P  +  PEA+ +   S+ +DV+S+G+++ E+++ G +P         Y+ +  Q+V ++ 
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP---------YWDMSGQDV-IKA 220

Query: 407 VLDK---EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV 453
           V D     A       +  L+   ++K    E+ +R     I  +LSK V
Sbjct: 221 VEDGFRLPAPRNCPNLLHQLMLDCWQK----ERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 76/287 (26%), Positives = 134/287 (46%), Gaps = 37/287 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +R   LG G FGTVY G  +  G  + +       N ++    N E        F +E  
Sbjct: 10  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--------FMDEAL 61

Query: 232 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            ++   H +L+RLLG+C +    +V + M +G L D +    +   + S    +  + +A
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIA 119

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  G  P
Sbjct: 120 KGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-GGKMP 174

Query: 352 --YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV 407
             +M  E +H  + + ++DV+SYGV + EL+T G KP D               +P RE+
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IPTREI 220

Query: 408 LD-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            D  E GE   +  + T+ + +V  KC + + D R   +++    S+
Sbjct: 221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 40/224 (17%)

Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+            N  A+M   + F NE 
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV------------NEAASMRERIEFLNEA 60

Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRL----ARVNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L   L      + N P   P   
Sbjct: 61  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 119 KKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 173

Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 174 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 66/249 (26%), Positives = 111/249 (44%), Gaps = 28/249 (11%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +LG+G FG VY  + K  G+  A K ++      + + +  E  M+       E+  L+ 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVID------TKSEEELEDYMV-------EIDILAS 58

Query: 236 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           C H N+++LL       N  +    C G   D +  +    PL   +   +     EAL+
Sbjct: 59  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLTEPQIRVVCKQTLEALN 117

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRPYMP 354
           YLH     IIHRD+K+ N+L   +   KL DFG+       N +T+   ++  GT  +M 
Sbjct: 118 YLHE--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMA 171

Query: 355 PEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
           PE + C+ S       K DV+S G+ L+E+     P  + N +     + + E P     
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP 231

Query: 409 DKEAGEWNE 417
            + + E+ +
Sbjct: 232 SRWSSEFKD 240

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 61/248 (24%), Positives = 114/248 (45%), Gaps = 49/248 (19%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LGEG+FG+V  G+L       +++AVKT++    ++ S  +           F +E 
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-DIHTYSEIEE----------FLSEA 52

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNC-------IVYEYMCNGSL-----YDRLARVNNTPPL 278
             +    H N+++L+G+C    +        ++  +M +G L     Y RL  +    PL
Sbjct: 53  ACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL 112

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
            +  ++   + +A  + YL +  +  IHRD+ + N +L E+    + DFG+         
Sbjct: 113 QTLLKF--MVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGL--------S 160

Query: 339 KTMYTENL--TGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLT-GMKPIDD-N 388
           K +Y+ +    G    MP + +  +       ++K+DV+++GV + E+ T G  P     
Sbjct: 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220

Query: 389 NTILYYYL 396
           N  +Y YL
Sbjct: 221 NHEIYDYL 228

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 36/222 (16%)

Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+    N S+S  +  E       L E  V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV----NESASLRERIE------FLNEASV 62

Query: 231 QTLSQCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLARV---NNT--PPLDSNK 282
                C HV  +RLLG+ +      +V E M +G L  Y R  R    NN   PP    +
Sbjct: 63  MKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTM 341
              +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET      
Sbjct: 121 MIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD----Y 174

Query: 342 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 41/288 (14%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           G  +K Y R   K+G+G  GTV+    +  G E+A+K +                     
Sbjct: 15  GDPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE------------ 61

Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 62  -LIINEILVMKELKNPNIVNFLDSFLVGDEL-FVVMEYLAGGSLTD----VVTETCMDEA 115

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 339
           +  ++     +AL +LH+    +IHRD+KS NVLL  +   KL DFG       E S   
Sbjct: 116 QIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 340 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 174 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Query: 399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
               P  +         N   +  +      +C   + +KR S ++++
Sbjct: 229 TNGTPELQ---------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 48/237 (20%)

Query: 175 GNKLGEGQFGTVYYG-----KLKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LGEG+FG V        K + G   +AVK L+ NA+ S              LL  +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD----------LL--S 52

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL--YDRLAR-----------VNN 274
           E   L Q  H ++++L G C+      ++ EY   GSL  + R +R             N
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 275 TPPLDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
           +  LD+    ++ +G        ++  + YL  +   ++HRD+ + NVL+ E    K+ D
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISD 170

Query: 327 FGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           FG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L E++T
Sbjct: 171 FG---LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
            I  E+M  GSL   L +    P     K   I++ V   L YL    K I+HRDVK +N
Sbjct: 75  SICMEHMDGGSLDQVLKKAGRIPENILGK---ISIAVLRGLTYLREKHK-IMHRDVKPSN 130

Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYG 372
           +L++     KL DFG+      S   +       GTR YM PE +     + ++D++S G
Sbjct: 131 ILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYTVQSDIWSLG 185

Query: 373 VILLELLTGMKPI 385
           + L+E+  G  PI
Sbjct: 186 LSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 39/217 (17%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           N +  G+ G  Y GK +KNGM+  VK + +       NS       IP     +E+  + 
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIND------VNS-------IP----SSEIADMG 738

Query: 235 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +H N+++L+GLC +     +++EY+   +L + L        L   +R  IA+G+A+A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792

Query: 294 LHYLHSLSKP-IIHRDVKSANVLLDENFVPKL--GDFGIVKMSETSNMKTMYTENLTGTR 350
           L +LH    P ++  ++    +++D    P L     G++       + +          
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS---------- 842

Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPID 386
            Y+ PE      I+ K+D++ +G+IL+ELLTG  P D
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 41/96 (42%), Positives = 58/96 (60%), Gaps = 6/96 (6%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +A AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S     K     +  GT
Sbjct: 107 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGT 161

Query: 350 RPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKP 384
             YM PE ++ +  T++ D +S+GV++ E+LTG  P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 21/230 (9%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G +G V   + + +G +  +K L    N  +++    +AA       E E Q LSQ 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKL----NLRNASRRERKAA-------EQEAQLLSQL 56

Query: 237 KHVNLL--RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++  R      + +  IV  +   G LY +L +      L  N+     + +A AL
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMAL 115

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH   K I+HRD+K+ NV L    + K+GD GI ++ E           L GT  YM 
Sbjct: 116 QYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---DMASTLIGTPYYMS 170

Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           PE    +  + K+DV++ G  + E+ T     +  +     Y ++E ++P
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 35/215 (16%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+GEG F  V   +  K G   A+K ++ +  + S    N             E+Q L 
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNNL----------REIQALR 52

Query: 235 QCK-HVNLLRLLG-LCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           +   H N+LRL+  L +     +  V+E M + +LY+ L +     PL   +  S    +
Sbjct: 53  RLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYE-LIK-GRKRPLPEKRVKSYMYQL 109

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            ++L ++H     I HRD+K  N+L+ ++ + KL DFG  +       K  YTE ++ TR
Sbjct: 110 LKSLDHMHR--NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYIS-TR 162

Query: 351 PYMPPEAMHCQIST-----KTDVFSYGVILLELLT 380
            Y  PE   C ++      K D+++ G +  E+L+
Sbjct: 163 WYRAPE---CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 26/241 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+       E + L+  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDV---VIQDDDVECTMV-------EKRVLALS 57

Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEA 293
                L  L  C   M+ +  V EY+  G L  ++ +V     P        IA+G    
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM-KTMYTENLTGTRPY 352
           L +LHS  K II+RD+K  NV+LD     K+ DFG+ K     NM   + T+   GT  Y
Sbjct: 114 LFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDY 167

Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           + PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KE
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227

Query: 412 A 412
           A
Sbjct: 228 A 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 70/240 (29%), Positives = 104/240 (43%), Gaps = 24/240 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK   E+ AVK L+ +        D+ E  M        E + L+  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDV---ILQDDDVECTM-------TEKRVLALA 52

Query: 237 KHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C    +    V EY  NG   D +  +  +   D  +    A  +   L
Sbjct: 53  GKHPFLTQLHSCFQTKDRLFFVMEY-VNGG--DLMFHIQRSGRFDEPRARFYAAEIVLGL 109

Query: 295 HYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
            +LH   + II+RD+K  NVLLD E  + K+ DFG+ K      +    T    GT  Y+
Sbjct: 110 QFLHE--RGIIYRDLKLDNVLLDSEGHI-KIADFGMCKEGILGGVT---TSTFCGTPDYI 163

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +  Q      D ++ GV+L E+L G  P + ++    +  ++E EV     L KEA
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEA 223

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 71/239 (29%), Positives = 106/239 (44%), Gaps = 22/239 (9%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK +G   AVK L+ +        D+ E  M      E  + +L+  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVIL---QDDDVECTMT-----EKRILSLA-R 53

Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            H  L +L   C    + +  V E++  G L   +  +  +   D  +    A  +  AL
Sbjct: 54  NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSAL 109

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +LH   K II+RD+K  NVLLD     KL DFG+ K     N KT  T    GT  Y+ 
Sbjct: 110 MFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKT--TSTFCGTPDYIA 164

Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +         D ++ GV+L E+L G  P +  N    +  ++  EV     L ++A
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDA 223

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 64/225 (28%), Positives = 88/225 (39%), Gaps = 28/225 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG G FG V   K K  G   A+K L+           +             E   L
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ----------EKSIL 72

Query: 234 SQCKH---VNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +  H   VN++      +      + E++  G L+  L R     P D  K Y     +
Sbjct: 73  MELSHPFIVNMMC--SFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAE--L 127

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             A  YLHS  K II+RD+K  N+LLD     K+ DFG  K           T  L GT 
Sbjct: 128 VLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTP 179

Query: 351 PYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 394
            Y+ PE +  +   K  D ++ GV+L E + G  P  D+     Y
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224

Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  +LK      A+K L+ +        D+ E  M+     E  V +L+  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DDVECTMV-----EKRVLSLAW- 53

Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L        N   V EY+  G L   +  + +    D  +    A  +   L 
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQ 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +LHS  K I++RD+K  N+LLD +   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 111 FLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAP 165

Query: 356 EAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           E +  Q  +T  D +S+GV+L E+L G  P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 28/219 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK 237
           +G G FG V+  + K   ++ +              D   AA       +NE Q L    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAA-------QNECQVLKLLS 57

Query: 238 HVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           H N++      N + +    IV EY   G+L + + +  N+  LD +      + +  AL
Sbjct: 58  HPNIIEYYE--NFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLAL 114

Query: 295 HYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           H++H+  K I+HRD+K+ N+LLD++  V K+GDFGI K    S+    YT  + GT  Y+
Sbjct: 115 HHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYT--VVGTPCYI 168

Query: 354 PPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE   C+    + K+D+++ G +L EL +  +  +  N
Sbjct: 169 SPEL--CEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.8 bits (164), Expect = 4e-12
 Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 63/235 (26%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +G V      + G ++A+K + N                    +F++ +      
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN--------------------VFDDLID----A 43

Query: 237 KHV----NLLRLLGLCNNIMNC----------------IVYEYMCNGSLYDRLARVNNTP 276
           K +     LLR L    NI+                  IV E M      D L +V  +P
Sbjct: 44  KRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELM----ETD-LHKVIKSP 97

Query: 277 -PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            PL  +        +   L YLHS +  +IHRD+K +N+L++ N   K+ DFG+ +  + 
Sbjct: 98  QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 336 SNMKTMYTENLTG---TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
              +      LT    TR Y  PE +    + +   D++S G I  ELLT  KP+
Sbjct: 156 DEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           ++G G +G VY    L  G   AVK   LE   ++S               L + E+  +
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---------------LIQQEIFMV 60

Query: 234 SQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            +CKH N++   G  L    +  I  EY   GSL D     + T PL   +   +     
Sbjct: 61  KECKHCNIVAYFGSYLSREKL-WICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETL 116

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
           + L YLHS  K  +HRD+K AN+LL +N   KL DFG+  K++ T   +    ++  GT 
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR----KSFIGTP 170

Query: 351 PYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDD 387
            +M PE    +     +   D+++ G+  +EL     P+ D
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 70/227 (30%), Positives = 101/227 (44%), Gaps = 34/227 (14%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ- 235
           +G+G FG V   + K   +  AVK L+  A                IL  + E   +S+ 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKA----------------ILKKKEEKHIMSER 46

Query: 236 ---CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
               K+V    L+GL  +         V +Y+  G L+  L R      L+   R+  A 
Sbjct: 47  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF--LEPRARF-YAA 103

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +A AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N     T    G
Sbjct: 104 EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCG 158

Query: 349 TRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 394
           T  Y+ PE +H Q   +T D +  G +L E+L G+ P    NT   Y
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 27/212 (12%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V   + K +G ++AVK ++                    LLF NEV  +  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRE------------LLF-NEVVIMRD 74

Query: 236 CKHVNLLRLL--GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L    +  ++ E++  G+L D +++      L+  +  ++   V +A
Sbjct: 75  YQHQNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQA 129

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  + +IHRD+KS ++LL  +   KL DFG          K    ++L GT  +M
Sbjct: 130 LCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWM 184

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +      T+ D++S G++++E++ G  P
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 177 KLGEGQFGTV---YYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FGTV    Y   K+   +AVK L+N+ N         + A+   LL E  V  +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN---------DPALKDELLREANV--M 50

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++R++G+C      +V E    G L   L +  +   +       +   V+  
Sbjct: 51  QQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMG 107

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP- 351
           + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N    Y     G  P 
Sbjct: 108 MKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPV 162

Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PE M + + S+K+DV+S+GV++ E  + G KP
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 68/212 (32%), Positives = 94/212 (44%), Gaps = 33/212 (15%)

Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G  GTVY    L     +AVK +           D T      I+   +E++ L +C
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP---------LDITVELQKQIM---SELEILYKC 56

Query: 237 KHVNLLRLLG---LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
               ++   G   + N I  C   E+M  GSL D   ++    P     R  IA+ V + 
Sbjct: 57  DSPYIIGFYGAFFVENRISICT--EFMDGGSL-DVYRKI----PEHVLGR--IAVAVVKG 107

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YL SL   I+HRDVK +N+L++     KL DFG+      S  KT       GT  YM
Sbjct: 108 LTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY-----VGTNAYM 160

Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLTGMKP 384
            PE +   Q    +DV+S G+  +EL  G  P
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 36/212 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---FENEVQT 232
           ++G G FG V+ G+L+ +   +AVK+                   +P  L   F  E + 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRET---------------LPPDLKAKFLQEARI 46

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           L Q  H N++RL+G+C       +   +  G  +    R    P L   +   +    A 
Sbjct: 47  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAA 105

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE------TSNMKTMYTENL 346
            + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E      T  MK +  +  
Sbjct: 106 GMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-- 161

Query: 347 TGTRPYMPPEAM-HCQISTKTDVFSYGVILLE 377
                +  PEA+ + + S+++DV+S+G++L E
Sbjct: 162 -----WTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 74/298 (24%), Positives = 119/298 (39%), Gaps = 53/298 (17%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEIA---VKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +++G G FG V  G+   GM  A   VK L  +A                 LLF  EVQ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ------------LLFLQEVQP 48

Query: 233 LSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL--YDRLARVNNTPPLDSNKRYSIALG 289
             +  H N+L+ LG C  +I   +V E+   G L  Y R  R         +    +A  
Sbjct: 49  YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE 108

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           VA  L +LH      IH D+   N  L  +   K+GD+G+            Y    T  
Sbjct: 109 VASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYI--TKD 160

Query: 350 RPYMP-----PEAMH--------CQISTKTDVFSYGVILLELLT-GMKPIDD-NNTILYY 394
              +P     PE +            + K++++S GV + EL T   +P  D ++  +  
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220

Query: 395 YLVVEQEV--PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
            +V EQ++  P  ++  K +  W E        + F   C  + + R +  ++ +LL+
Sbjct: 221 QVVREQDIKLPKPQLDLKYSDRWYEV-------MQF---CWLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 37/230 (16%)

Query: 177 KLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGE +FG VY G L      +    +A+KTL++ A                   F++E 
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE------------FKHEA 59

Query: 231 QTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-----PLDSNKRY 284
              S+ +H N++ LLG+        +++ Y  +  L++ L  V  +P       D +K  
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL--VMRSPHSDVGSTDDDKTV 117

Query: 285 SIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
              L  A+ +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +    +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 31/242 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIA---VKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           ++G G +G VY  +  N  E+A   V  LE   +++               + + E+  +
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA---------------VVQQEIIMM 60

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             CKH N++   G         I  E+   GSL D     + T PL  ++   ++    +
Sbjct: 61  KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQ 117

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L+YLHS  K  +HRD+K AN+LL +N   KL DFG+      +  K    ++  GT  +
Sbjct: 118 GLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYW 172

Query: 353 MPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
           M PE    +     +   D+++ G+  +EL     P+ D + +   +L+ +      ++ 
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232

Query: 409 DK 410
           DK
Sbjct: 233 DK 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 34/233 (14%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAV--KTLENNANYSSSNSDNTEAAMIPILLFENEV 230
            +  K+G+G FG V+  + K   +I    K L  N           E   I  L    E+
Sbjct: 15  EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---------KEGFPITAL---REI 62

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNC---------IVYEYMCNGSLYDRLARVNNTPPLDSN 281
           + L   KH N++ L+ +C               +V+E+ C   L   L+  N    L   
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLSEI 121

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK- 339
           K+  +   +   L+Y+H  +K I+HRD+K+AN+L+ ++ + KL DFG+ +  S + N K 
Sbjct: 122 KK--VMKMLLNGLYYIHR-NK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 340 TMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
             YT N   T  Y PPE +          D++  G I+ E+ T   PI   NT
Sbjct: 178 NRYT-NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 40/136 (29%), Positives = 60/136 (44%), Gaps = 13/136 (9%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
            +V EY+ NG     L +     P D  K+Y     V   +  LH   + IIHRD+K  N
Sbjct: 73  YLVMEYL-NGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ--RGIIHRDIKPEN 127

Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYG 372
           +L+D+    KL DFG+ +    +       +   GT  Y+ PE +      K +D +S G
Sbjct: 128 LLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAPETILGVGDDKMSDWWSLG 180

Query: 373 VILLELLTGMKPIDDN 388
            ++ E L G  P    
Sbjct: 181 CVIFEFLFGYPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 45/225 (20%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE--------- 227
           K+G GQF  VY                     ++   D    A+  + +FE         
Sbjct: 9   KIGRGQFSEVYR--------------------ATCLLDRKPVALKKVQIFEMMDAKARQD 48

Query: 228 --NEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK- 282
              E+  L Q  H N+++ L   + +N +N IV E    G L   +        L   + 
Sbjct: 49  CVKEIDLLKQLNHPNVIKYLDSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERT 107

Query: 283 --RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +Y + L    A+ ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT
Sbjct: 108 VWKYFVQL--CSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KT 160

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
               +L GT  YM PE +H    + K+D++S G +L E+     P
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 25/236 (10%)

Query: 178 LGEGQFGTVYYGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           LG G FG V     KN     +A+K  E +        D+  +          E + L+ 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS----------ERKILNY 87

Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H   + L G   +     +V E++  G  +  L R N   P D    Y  A  +    
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFY--AAQIVLIF 144

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YL SL+  I++RD+K  N+LLD++   K+ DFG  K+ +T       T  L GT  Y+ 
Sbjct: 145 EYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTLCGTPEYIA 196

Query: 355 PEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
           PE  ++       D ++ G+ + E+L G  P   N  +L Y  ++E  +   + LD
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252

Length = 340

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V     K+ G ++AVK ++                    LLF NEV  +  
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 75

Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V  A
Sbjct: 76  YHHENVVDMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRA 130

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLH+  + +IHRD+KS ++LL  +   KL DFG          K    ++L GT  +M
Sbjct: 131 LSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWM 185

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +      T+ D++S G++++E++ G  P
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 27/225 (12%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           K+G GQF  VY    L +G+ +A+K ++  +   + + +D  +           E+  L 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-----------EIDLLK 57

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK---RYSIALG 289
           Q  H N+++     + +N +N IV E    G L   +        L   K   +Y + L 
Sbjct: 58  QLNHPNVIKYYASFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL- 115

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
              AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT    +L GT
Sbjct: 116 -CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGT 169

Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILY 393
             YM PE +H    + K+D++S G +L E+     P   +   LY
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 67/247 (27%), Positives = 103/247 (41%), Gaps = 39/247 (15%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   + ++   I A+KT+      S S   +T        L E  V     C
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT--------LAERTVLAQVNC 52

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR------YSIALGV 290
             +  L+             + +     LY  LA +N        +R             
Sbjct: 53  PFIVPLK-------------FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99

Query: 291 AE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK-TMYTENL 346
           AE   AL  LH  +  +I+RD+K  N+LLD      L DFG+ K+    NMK    T   
Sbjct: 100 AELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKL----NMKDDDKTNTF 153

Query: 347 TGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  Y+ PE +     TK  D ++ GV+L E+LTG+ P  D N    Y  ++++ +   
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213

Query: 406 EVLDKEA 412
           +  D++A
Sbjct: 214 DGFDRDA 220

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 34/217 (15%)

Query: 180 EGQFGTVYYGKLKNGM-----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           EG FG ++YG L +       E+ VKT++++A            + I + L   E   L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA------------SEIQVTLLLQESCLLY 63

Query: 235 QCKHVNLLRLLGLCNNIMNC--IVYEYMCNGSLYD-----RLARVNNTPPLDSNKRYSIA 287
              H N+L +L +C        ++Y YM  G+L       RL   NN   L + +   +A
Sbjct: 64  GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENL 346
           + +A  + YLH     +IH+D+ + N ++DE    K+ D  + +     +   +   EN 
Sbjct: 124 IQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN- 180

Query: 347 TGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 380
              RP  +M  E++ + + S+ +DV+S+GV+L EL+T
Sbjct: 181 ---RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 75/286 (26%), Positives = 134/286 (46%), Gaps = 45/286 (15%)

Query: 178 LGEGQFGTVYYG-------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           LG G FGTVY G       K+K  + +A+K L      ++S   N E     IL   +E 
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVK--IPVAIKELRE----ATSPKANKE-----IL---DEA 60

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
             ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +
Sbjct: 61  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 118

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+   ++ K  + E      
Sbjct: 119 AKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GADEKEYHAEGGKVPI 175

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M  E+ +H   + ++DV+SYGV + EL+T G KP D               +P  E+ 
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEIS 221

Query: 409 D-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
              E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 20/215 (9%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK   E+ A+K L+ +        D+ +  M      E  +  L+  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL---QDDDVDCTMT-----EKRILALAA- 53

Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH  L  L            V EY+  G L  ++ R       D  +    A  V  AL 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK---FDEPRSRFYAAEVTLALM 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +LH     +I+RD+K  N+LLD     KL DFG   M +   +  + T    GT  Y+ P
Sbjct: 111 FLHR--HGVIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCGTPDYIAP 165

Query: 356 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           E +         D ++ GV++ E++ G  P + +N
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)

Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 109

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 110 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 163

Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 81/329 (24%), Positives = 126/329 (38%), Gaps = 101/329 (30%)

Query: 134 EVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY- 187
           ++I+  E NN          +TF D  +    +N K  +PR     G  LG G FG V  
Sbjct: 9   KIIEAAEGNN----------YTFIDPTQLP--YNEKWEFPRDNLQFGKTLGAGAFGKVVE 56

Query: 188 -----YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF------ENEVQTLSQC 236
                 GK  N + +AVK L+     +S+++D  EA M  + +       +N V  L  C
Sbjct: 57  ATAFGLGKEDNVLRVAVKMLK-----ASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111

Query: 237 KH----------------VNLLR-----LLGLCNNIM----NCIVYEYMCNGSLYDR--- 268
            H                +N LR      L     +         Y+ +     Y R   
Sbjct: 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDS 171

Query: 269 ----------------------------LARVNNTPPLDSNKRYSIALGVAEALHYLHSL 300
                                            ++ PLD +     +  VA+ + +L S 
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS- 230

Query: 301 SKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEA 357
            K  IHRDV + NVLL +  V K+ DFG+ + +   SN    Y        P  +M PE+
Sbjct: 231 -KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YVVKGNARLPVKWMAPES 285

Query: 358 M-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  C  + ++DV+SYG++L E+ + G  P
Sbjct: 286 IFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 177 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +G G +G VY  K KNG    E A+K  +            T  +         E+  L
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFK------GDKEQYTGISQSAC----REIALL 56

Query: 234 SQCKHVNLLRLLGLC-NNIMNCI--VYEYMCNGSLYDRLA-----RVNNTPPLDSNKRYS 285
            + KH N++ L+ +   +    +  +++Y    + +D        R      +  +   S
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNMKTM 341
           +   +   +HYLHS    ++HRD+K AN+L+     E  V K+GD G+ ++   + +K +
Sbjct: 113 LLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN-APLKPL 169

Query: 342 YTEN-LTGTRPYMPPE----AMHCQISTKT-DVFSYGVILLELLTGMKPI 385
              + +  T  Y  PE    A H    TK  D+++ G I  ELLT ++PI
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT-LEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 24/212 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK   E  A+K L+ +        D+ E  M+     E  V  L+  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMV-----ERRVLALAW- 53

Query: 237 KHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +H  L  L   C          V EY+  G L   +  + ++   D  +    A  +   
Sbjct: 54  EHPFLTHLF--CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICG 108

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L +LH   K II+RD+K  NVLLD++   K+ DFG+ K +     K        GT  Y+
Sbjct: 109 LQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPDYI 163

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKP 384
            PE +  Q   ++ D +S+GV+L E+L G  P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 60/295 (20%)

Query: 178 LGEGQFGTVYYGKLKN---------GMEIAV--KTLENNANYSSSNSDNTEAAMIPILLF 226
           LG+G F  +Y G L+          G E++V  K L ++   S +              F
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--------------F 48

Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
                 +SQ  H +L++L G+C    N +V EY+  G L   L R  N   L   K   +
Sbjct: 49  FETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSL-HWKLD-V 106

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVP--KLGDFGIVKMSETSNMK 339
           A  +A ALHYL    K ++H +V   N+L+     +E +VP  KL D GI        + 
Sbjct: 107 AKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-------PIT 157

Query: 340 TMYTENLTGTRPYMPPEAM---HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY 395
            +  E      P++ PE +      ++   D +S+G  LLE+ + G +P+          
Sbjct: 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST-------L 210

Query: 396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
              E+E   ++       +  E  +  LI+    +C  ++  KR S R I+  L+
Sbjct: 211 SSSEKERFYQDQHRLPMPDCAE--LANLIN----QCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 41/223 (18%)

Query: 177 KLGEGQFGTVYYG--KL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FG V  G  K+ K  +++A+K L+N       N  +    M+       E + +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE------NEKSVRDEMM------REAEIM 49

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAE 292
            Q  +  ++R++G+C      +V E    G L   L          S K+  I +  V E
Sbjct: 50  HQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL----------SGKKDEITVSNVVE 99

Query: 293 ALH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            +H       YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + Y   
Sbjct: 100 LMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD--SYYKAR 155

Query: 346 LTGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
             G  P  +  PE ++  + S+++DV+SYG+ + E  + G KP
Sbjct: 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 7e-11
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 15/166 (9%)

Query: 226 FENEVQTLSQCKHVNLLRLL--GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           F  E    ++  H N++ LL  G     +   V+EY+   +L + LA     P  ++ + 
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGR- 83

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKM----SETS 336
             + L V +AL   H+  + I+HRD+K  N+++         K+ DFGI  +     +  
Sbjct: 84  --LMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139

Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTG 381
                 T  + GT  Y  PE +  +  T  +D++++G+I LE LTG
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 38/240 (15%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   K K +G   AVK L+  A                 +L + E + +   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----------------ILKKKEQKHIMAE 45

Query: 237 KHVNLLR------LLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           ++V LL+      L+GL  +         V +Y+  G L+  L R  + P  +   R+  
Sbjct: 46  RNV-LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP--EPRARF-Y 101

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           A  +A AL YLHSL+  II+RD+K  N+LLD      L DFG+ K     + KT  T   
Sbjct: 102 AAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT--TSTF 156

Query: 347 TGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  Y+ PE +  Q   +T D +  G +L E+L G+ P    +T   Y  ++ + + ++
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 42/224 (18%)

Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           R N++G G  GTVY    +  G   A+K +  N         + +     I     E++ 
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---------HEDTVRRQIC---REIEI 125

Query: 233 LSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           L    H N+++    C+++ +      ++ E+M  GSL      + +   L       +A
Sbjct: 126 LRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGT--HIADEQFLAD-----VA 174

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             +   + YLH   + I+HRD+K +N+L++     K+ DFG+ ++      +TM   N +
Sbjct: 175 RQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMDPCNSS 228

Query: 348 -GTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKP 384
            GT  YM PE ++  ++         D++S GV +LE   G  P
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 26/213 (12%)

Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSS-SNSDNTEAAMIPILLFENEVQ 231
           +  K+GEG FG     K K +G +  +K +    N S  S  +  E+          EV 
Sbjct: 4   KVKKIGEGSFGKAILVKSKEDGKQYVIKEI----NISKMSPKEREES--------RKEVA 51

Query: 232 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            LS  KH N+++         N  IV +Y   G LY    ++N    +   +   +   V
Sbjct: 52  VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLY---KKINAQRGVLFPEDQILDWFV 108

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              L   H   + I+HRD+KS N+ L ++   KLGDFGI ++   S ++   T    GT 
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELART--CIGTP 165

Query: 351 PYMPPEAMHCQ---ISTKTDVFSYGVILLELLT 380
            Y+ PE   C+    + K+D+++ G +L E+ T
Sbjct: 166 YYLSPEI--CENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 57/289 (19%)

Query: 178 LGEGQFGTVYYGKLKN--------GMEIAVKTLEN-NANYSSSNSDNTEAAMIPILLFEN 228
           LG+G F  ++ G  +           E+ +K L+  + NYS S     EAA +       
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESF---FEAASM------- 52

Query: 229 EVQTLSQCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
               +SQ  H +L+   G+C     +IM   V EY+  GSL   L +  N   +  + + 
Sbjct: 53  ----MSQLSHKHLVLNYGVCVCGDESIM---VQEYVKFGSLDTYLKKNKNLINI--SWKL 103

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMKTMYT 343
            +A  +A ALH+L    K + H +V + NVLL      K G+   +K+S+   ++  +  
Sbjct: 104 EVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161

Query: 344 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGM-KPI---DDNNTILYYYLV 397
           E L    P++PPE +     +S   D +S+G  L E+ +G  KP+   D    + +Y   
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-- 219

Query: 398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              ++P        A +W E      ++ +  +C  +E D R S R I+
Sbjct: 220 DRHQLP--------APKWTE------LANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 24/240 (10%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+     +     +T        L EN V  L   
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 52

Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 109

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYL 163

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 223

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 65/244 (26%), Positives = 118/244 (48%), Gaps = 39/244 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LG+G+FG+V   +LK    +  ++AVK L+ +   SS            I  F  E 
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-----------IEEFLREA 52

Query: 231 QTLSQCKHVNLLRLLGLCNNI-------MNCIVYEYMCNGSLYDRL--ARVNNTP---PL 278
             + +  H N+++L+G+           +  ++  +M +G L+  L  +R+   P   PL
Sbjct: 53  ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
            +  R+ I   +A  + YL S  K  IHRD+ + N +L+EN    + DFG+ K   + + 
Sbjct: 113 QTLVRFMI--DIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD- 167

Query: 339 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDD-NNTILY 393
              Y +      P  ++  E++   + +T +DV+++GV + E++T G  P     N+ +Y
Sbjct: 168 --YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225

Query: 394 YYLV 397
            YL+
Sbjct: 226 NYLI 229

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKT-LENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +GEG +G V   K K  G  +A+K  LE     S  +    + AM        E++ L 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLE-----SEDDKMVKKIAM-------REIRMLK 55

Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q +H NL+ L+ +        +V+E++ + ++ D L +  N   LD ++       +   
Sbjct: 56  QLRHENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDLEKYPNG--LDESRVRKYLFQILRG 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + + HS    IIHRD+K  N+L+ ++ V KL DFG  +         +YT+    TR Y 
Sbjct: 113 IEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTD-YVATRWYR 167

Query: 354 PPEAMHCQIS--TKTDVFSYGVILLELLTG 381
            PE +          D+++ G ++ E+LTG
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 11/159 (6%)

Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L      P     K   ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 109

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 110 IAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 163

Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+EL  G  PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 40/218 (18%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY G+ +  G  +A+K +  +A       + T +  I       E+  + +
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAE------EGTPSTAI------REISLMKE 54

Query: 236 CKHVNLLRL---LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            KH N++RL   +   N +M  +V+EYM +  L   +        LD N   S    + +
Sbjct: 55  LKHENIVRLHDVIHTENKLM--LVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-----VKMSETSN-MKTMY---T 343
            + + H     ++HRD+K  N+L+++    KL DFG+     + ++  SN + T++    
Sbjct: 112 GIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169

Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
           + L G+R Y          ST  D++S G I+ E++TG
Sbjct: 170 DVLLGSRTY----------STSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPY 352
           L Y+HS +  +IHRD+K +N+L++E+   ++GDFG+ + +S +      +      TR Y
Sbjct: 120 LKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 353 MPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
             PE +    + +T  D++S G I  E+L G + +
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLENNANYSSSNSDNTEAAMIP----ILLFENEVQT 232
           LG+G FG V   +LK   E  AVK L+ +        D+ E  M+      L +EN   T
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DDVECTMVEKRVLALAWENPFLT 59

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              C       L           V E++  G L   +  + +    D  +    A  +  
Sbjct: 60  HLYCTFQTKEHLF---------FVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVC 107

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN----LTG 348
            L +LHS  K II+RD+K  NV+LD +   K+ DFG+ K       + ++ +N      G
Sbjct: 108 GLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCG 158

Query: 349 TRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI--DDNNTIL 392
           T  Y+ PE +   + +   D +S+GV+L E+L G  P   DD + + 
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 19/172 (11%)

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL---ARVNNTPPLDSNKR 283
           NE + L +  H  ++RL    ++     ++ EY+  G L+  L    R +N+  L     
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----- 104

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
              A  +  AL YLHS    I++RD+K  N+LLD+    KL DFG  K  +  +     T
Sbjct: 105 -FYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDR----T 155

Query: 344 ENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYY 394
             L GT  Y+ PE +  +   K  D ++ G+++ E+L G  P  D+N    Y
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 46/136 (33%), Positives = 64/136 (47%), Gaps = 16/136 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ +Y+  G L+  L +  +    +S  R  IA  V  AL +LH L   II+RD+K  N+
Sbjct: 82  LILDYVNGGELFTHLYQREHFT--ESEVRVYIAEIVL-ALDHLHQLG--IIYRDIKLENI 136

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM------HCQISTKTDV 368
           LLD      L DFG+ K       +  Y+    GT  YM PE +      H       D 
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIRGGSGGH---DKAVDW 191

Query: 369 FSYGVILLELLTGMKP 384
           +S GV+  ELLTG  P
Sbjct: 192 WSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 34/238 (14%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   K K +G   AVK L+     +     +  A    +L            
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL------------ 50

Query: 237 KHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           K+V    L+GL  +         V +++  G L+  L R  + P  +   R+  A  +A 
Sbjct: 51  KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARFYAA-EIAS 107

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK----MSETSNMKTMYTENLTG 348
           AL YLHS++  I++RD+K  N+LLD      L DFG+ K     S+T       T    G
Sbjct: 108 ALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-------TTTFCG 158

Query: 349 TRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           T  Y+ PE +  Q    T D +  G +L E+L G+ P    +    Y  ++ + + +R
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 25/240 (10%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L      +     +T            E + L   
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT----------ESRVLQNT 52

Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +  + Y     +  AL 
Sbjct: 53  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAE--IVSALE 109

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 110 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 162

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 41/119 (34%), Positives = 59/119 (49%), Gaps = 12/119 (10%)

Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            D    V+ + PL   +  +I   + EAL YLH   + IIHRDVK+ N+ LDE     LG
Sbjct: 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLG 227

Query: 326 DFGIV-KMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELL 379
           DFG   K+    +    Y    +GT     PE +    +C    KTD++S G++L E+ 
Sbjct: 228 DFGAACKLDAHPDTPQCY--GWSGTLETNSPELLALDPYC---AKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 23/230 (10%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL 224
           GF +     + +KLGEG + TVY G+         K  +N         ++ E A    +
Sbjct: 1   GFGKLETYIKLDKLGEGTYATVYKGR--------SKLTDNLVALKEIRLEHEEGAPCTAI 52

Query: 225 LFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
               EV  L   KH N++ L  + +   +  +V+EY+ +  L   L    N+  + + K 
Sbjct: 53  ---REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL 108

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
           +   L     L+Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T   
Sbjct: 109 FLFQL--LRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTY 161

Query: 344 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
            N   T  Y PP+ +      ST+ D++  G I  E+ TG +P+   +T+
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTV 210

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 40/220 (18%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
             ++GEG +GTVY  + L  G  +A+K +             +E  +    L E  + + 
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKV---------RVPLSEEGIPLSTLREIALLKQ 54

Query: 233 LSQCKHVNLLRLLGLCNNIMNC------IVYEYMCNGSLYDRLARVNNTPP--LDSNKRY 284
           L   +H N++RLL +C+           +V+E+  +  L   L++    P   L      
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKC---PKPGLPPETIK 110

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMK 339
            +   +   + +LHS    I+HRD+K  N+L+  +   K+ DFG+ +     M+ TS + 
Sbjct: 111 DLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168

Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLEL 378
           T++         Y  PE  +    +T  D++S G I  EL
Sbjct: 169 TLW---------YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           E++ L   +H N++    L +  ++ +   Y     L   L R+  + PL+         
Sbjct: 59  ELKLLKHLRHENII---SLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY 115

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L Y+HS    ++HRD+K +N+L++EN   K+ DFG+ ++ +   M T Y      
Sbjct: 116 QILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQD-PQM-TGYVS---- 167

Query: 349 TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
           TR Y  PE M    +   + D++S G I  E+L G KP+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 52/234 (22%), Positives = 104/234 (44%), Gaps = 24/234 (10%)

Query: 223 ILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPP 277
           I + ENE++ L +    N+L++ G   +I++      ++ EY   G L + L   +    
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKD 118

Query: 278 LDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           L    +  +A+   + L+ L+   +KP  ++++ S + L+ EN+  K+   G+ K+  + 
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176

Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
             K +   N      Y     +  + + K D++S GV+L E+ TG  P ++  T   Y L
Sbjct: 177 PFKNV---NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233

Query: 397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           ++          +K             I  + E C   +  KR ++++I+  LS
Sbjct: 234 II----------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +K+ G  +AVK ++                    LLF NEV  +  
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 73

Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 74  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKA 128

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L  LH+  + +IHRD+KS ++LL  +   KL DFG        + +    ++L GT  +M
Sbjct: 129 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ---VSKEVPRRKSLVGTPYWM 183

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +       + D++S G++++E++ G  P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.9 bits (147), Expect = 6e-10
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 14/170 (8%)

Query: 226 FENEVQTLSQCKHVNLLR----LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            ENE+  L +  H N+L+    L    N  M    Y++     +YD      + P L   
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +   I   +  A+ Y+H   K +IHRD+K  N+ L+ +    LGDFG     E       
Sbjct: 270 RA--IMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325

Query: 342 Y--TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKPIDDN 388
           Y     +    P +     +C+I   TD++S G+ILL++L+    PI D 
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEI---TDIWSCGLILLDMLSHDFCPIGDG 372

Length = 501

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   K K +G   AVK L+          ++  A        E  V  L   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMA--------ERNV-LLKNL 53

Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH  L+ L            V +Y+  G L+  L R      L+   R+  A  VA A+ 
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCF--LEPRARF-YAAEVASAIG 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHSL+  II+RD+K  N+LLD      L DFG+ K  +          T    GT  Y+
Sbjct: 111 YLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-----TSTFCGTPEYL 163

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKP 384
            PE +  +   +T D +  G +L E+L G+ P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 15/153 (9%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    K Y+    V  AL  +HS+   +IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAE--VVLALDAIHSMG--LIHRDVKPDNM 173

Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM ET     +  +   GT  Y+ PE +  Q        + D 
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           +S GV L E+L G  P   ++ +  Y  +++ +
Sbjct: 231 WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 23/219 (10%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +KLGEG + TV+ G+         K  EN         ++ E A    +    EV  L  
Sbjct: 11  DKLGEGTYATVFKGR--------SKLTENLVALKEIRLEHEEGAPCTAI---REVSLLKN 59

Query: 236 CKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            KH N++ L  + +      +V+EY+ +  L   L    N   + + K +   L     L
Sbjct: 60  LKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQL--LRGL 116

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y H   + I+HRD+K  N+L++E    KL DFG+ +     ++ T    N   T  Y P
Sbjct: 117 SYCHK--RKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRP 171

Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
           P+ +    + ST  D++  G IL E+ TG +P+   +T+
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTV 209

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 177 KLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G+G +G V+  K K+  EI A+K +            +    +  +     E   L+ 
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRM----------KKSLLFKLNEVRHVLTERDILTT 57

Query: 236 CKHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLARVNNTPPLDSNK-RYSIALGVA 291
            K   L++LL    +     +Y   EY+  G   D    +NN   L  +  R+ +A    
Sbjct: 58  TKSEWLVKLLYAFQDDEY--LYLAMEYVPGG---DFRTLLNNLGVLSEDHARFYMAEMF- 111

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           EA+  LH L    IHRD+K  N L+D +   KL DFG+ K   T      Y  ++ G+  
Sbjct: 112 EAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSPD 163

Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNT 390
           YM PE +  +    T D +S G +L E L G  P   +  
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 13/162 (8%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C V EY+  G L+  L+R       D  + Y     +  AL YLHS    I++RD+K  N
Sbjct: 71  CFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAE--IVSALDYLHS--GKIVYRDLKLEN 125

Query: 314 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 370
           ++LD++   K+ DFG+ K  +++ + MKT       GT  Y+ PE +         D + 
Sbjct: 126 LMLDKDGHIKITDFGLCKEGITDAATMKT-----FCGTPEYLAPEVLEDNDYGRAVDWWG 180

Query: 371 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            GV++ E++ G  P  + +    + L++ +++     L  +A
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 6/160 (3%)

Query: 228 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYS 285
           +E+  L+ C H  +++      ++    ++ EY   G L  ++  R+    P    +   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   +  AL  +HS  + ++HRD+KSAN+ L    + KLGDFG  K   + ++      +
Sbjct: 174 LFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-SDSVSLDVASS 230

Query: 346 LTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP 384
             GT  Y+ PE     + S K D++S GVIL ELLT  +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 39/221 (17%)

Query: 177 KLGEGQFGTVYYGKLKNGMEI-AVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +GTV+  K +   EI A+K   L+++     S++               E+  L
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-------------LREICLL 53

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + KH N++RL   L ++    +V+EY C+  L       N     D     S    + +
Sbjct: 54  KELKHKNIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDI--DPEIVKSFMFQLLK 110

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK------MSETSNMKTMYTENL 346
            L + HS    ++HRD+K  N+L+++N   KL DFG+ +         ++ + T++    
Sbjct: 111 GLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW---- 164

Query: 347 TGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPI 385
                Y PP+ +      ST  D++S G I  EL    +P+
Sbjct: 165 -----YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 16/94 (17%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++         + +TG   T
Sbjct: 130 GLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD---------DEMTGYVAT 178

Query: 350 RPYMPPEAMHCQIS-TKT-DVFSYGVILLELLTG 381
           R Y  PE M   +   +T D++S G I+ ELLTG
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   +  A+K L+     +     +T        L E+ V  L   
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--------LTESRV--LQNT 52

Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALG 109

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHS    +++RD+K  N++LD++   K+ DFG+ K    S+  TM T    GT  Y+ P
Sbjct: 110 YLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT--FCGTPEYLAP 164

Query: 356 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           E +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|176725 cd08309, Death_IRAK, Death domain of Interleukin-1 Receptor-Associated Kinases

 Score = 54.7 bits (132), Expect = 1e-09
 Identities = 26/102 (25%), Positives = 47/102 (46%), Gaps = 11/102 (10%)

Query: 12  EIRHLKQYVVHELGIILNER--DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNF 69
            IR L   V+  L  +L+      W+++ S++      L   +Y   D++ +E   +R  
Sbjct: 2   YIRQLPYSVLARLCKVLDPLELKGWRQLASLIP---KGLGGPRYDLTDVRQIESMKQRG- 57

Query: 70  PERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV 111
             R  T   L +WGT   +   + DL+  L + EL++AA  +
Sbjct: 58  --RSPTRELLWDWGT---QNATVQDLVQVLVQLELYRAADLL 94

Death Domains (DDs) found in Interleukin-1 (IL-1) Receptor-Associated Kinases (IRAK1-4) and similar proteins. IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. All four types are involved in signal transduction involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinase pathways. IRAK1 and IRAK4 are active kinases while IRAK2 and IRAK-M (also called IRAK3) are inactive. In general, IRAKs are expressed ubiquitously, except for IRAK-M which is detected only in macrophages. The insect homologs, Pelle and Tube, are important components of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in the innate immune response. Most members have an N-terminal DD followed by a kinase domain. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes. Length = 95

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 2e-09
 Identities = 40/116 (34%), Positives = 60/116 (51%), Gaps = 18/116 (15%)

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------ 332
           D +KRY I   + +AL Y+HS    +IHRD+K +N+LL+ +   KL DFG+ +       
Sbjct: 106 DVHKRY-IMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162

Query: 333 SETSNMKTMYTENLTGTRPYMPPE---AMHCQISTKTDVFSYGVILLELLTGMKPI 385
           +  + + T Y      TR Y  PE         +   D++S G IL E+L G KP+
Sbjct: 163 NPENPVLTDYVA----TRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 15/136 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDIPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 173

Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDV 368
           LLD++   KL DFG  +KM        +  +   GT  Y+ PE +           + D 
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 369 FSYGVILLELLTGMKP 384
           +S GV L E+L G  P
Sbjct: 231 WSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 50/147 (34%), Positives = 69/147 (46%), Gaps = 24/147 (16%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---ALHYLHSLSKPIIHRDVK 310
           C+V EY+  G     L  +    P+D  + Y      AE   AL YLH+    I+HRD+K
Sbjct: 77  CMVMEYVEGGDCATLLKNIG-ALPVDMARMY-----FAETVLALEYLHNYG--IVHRDLK 128

Query: 311 SANVLLDENFVPKLGDFGIVK---MSETSNMKTMYTENLT---------GTRPYMPPEAM 358
             N+L+      KL DFG+ K   MS T+N+   + E  T         GT  Y+ PE +
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188

Query: 359 HCQISTK-TDVFSYGVILLELLTGMKP 384
             Q   K  D ++ G+IL E L G  P
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE-NEVQTLS 234
           K+GEG +G VY  +    G  +A+K          +  +  E  + P  L E + +Q LS
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALK---------KTRLEMDEEGIPPTALREISLLQMLS 58

Query: 235 QCKH-VNLLRLLGLCNN---IMNCIVYEYMCNG--SLYDRLARVNNTP-PLDSNKR--YS 285
           +  + V LL +  +          +V+EY+ +      D   R    P P  + K   Y 
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTE 344
           +  GVA    + H     ++HRD+K  N+L+D +  + K+ D G+ + + +  +K+ YT 
Sbjct: 119 LLKGVA----HCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKS-YTH 170

Query: 345 NLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 381
            +  T  Y  PE +      ST  D++S G I  E+   
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 12/132 (9%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
            IV EYM        LA V    PL           +   L Y+HS +  ++HRD+K AN
Sbjct: 92  YIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN 144

Query: 314 VLLD-ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKT-DVF 369
           V ++ E+ V K+GDFG+ + +    + K   +E L  T+ Y  P   +     TK  D++
Sbjct: 145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMW 203

Query: 370 SYGVILLELLTG 381
           + G I  E+LTG
Sbjct: 204 AAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 42/218 (19%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  +    G  +A+K +  +          TE   +P      E+  L +
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 55

Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSL--YDRLARVNNTP-PLDSNKRYSIALGVA 291
             H N+++LL + +      +V+E++ +  L  +   + ++  P PL  +  + +  G+A
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 342
               + HS    ++HRD+K  N+L++     KL DFG+ +       + T  + T++   
Sbjct: 115 ----FCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT 380
            E L G + Y          ST  D++S G I  E++T
Sbjct: 169 PEILLGCKYY----------STAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           N++ EG +G VY  + K   EI A+K L+             E    PI     E+  L 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKME----------KEKEGFPITSLR-EINILL 59

Query: 235 QCKHVNLLRL----LGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           + +H N++ +    +G   + I   +V EY+ +  L   +       P   ++   + L 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIY--MVMEYVEH-DLKSLME--TMKQPFLQSEVKCLMLQ 114

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   + +LH     I+HRD+K++N+LL+   + K+ DFG+ +    S +K  YT+ +  T
Sbjct: 115 LLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKP-YTQLVV-T 169

Query: 350 RPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
             Y  PE +    + ST  D++S G I  ELLT  KP+
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 36/98 (36%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LH     II+RD+K  N+LLD     KL DFG+ K S         T    GT  Y
Sbjct: 112 ALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTIEY 166

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           M PE  M        D +S G ++ ++LTG  P    N
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 10/132 (7%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V +YM  G L+  L +       +   ++ IA  V  AL +LH     I++RD+K  N+
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFS--EDRAKFYIAELVL-ALEHLHKYD--IVYRDLKPENI 127

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 372
           LLD      L DFG+ K + T N KT  T    GT  Y+ PE +      +   D +S G
Sbjct: 128 LLDATGHIALCDFGLSKANLTDN-KT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184

Query: 373 VILLELLTGMKP 384
           V++ E+  G  P
Sbjct: 185 VLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 35/241 (14%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +G VY G+ +K G   A+K +           D TE     I L  N ++  S  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM-----------DVTEDEEEEIKLEINMLKKYSH- 71

Query: 237 KHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
            H N+    G         ++    +V E+   GS+ D L +      L  +    I   
Sbjct: 72  -HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICRE 129

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTG 348
           +   L +LH+    +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     G
Sbjct: 130 ILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IG 183

Query: 349 TRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           T  +M PE + C          ++D++S G+  +E+  G  P+ D + +   +L+     
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243

Query: 403 P 403
           P
Sbjct: 244 P 244

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 34/223 (15%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY GK K NG  +A+K +       +  +   EA+++  L           
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL----------- 60

Query: 236 CKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIALGVAE 292
            KH N++ L  + +      +V+EY     ++  L +  +  P  L           +  
Sbjct: 61  -KHANIVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+H   + I+HRD+K  N+L+ +    KL DFG+ +     ++ +    N   T  Y
Sbjct: 115 GLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWY 169

Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLT------GMKPIDD 387
            PP+ +    + ST  D++  G I +E++       GMK I D
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 27/232 (11%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL 224
           GF +     +  KLGEG + TV+ G+         K  EN         ++ E A    +
Sbjct: 1   GFGKMETYIKLEKLGEGTYATVFKGR--------SKLTENLVALKEIRLEHEEGAPCTAI 52

Query: 225 LFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNK- 282
               EV  L   KH N++ L  + +   +  +V+EY+ +  L   +    N   + + K 
Sbjct: 53  ---REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI 108

Query: 283 -RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
             Y I  G+A    Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T 
Sbjct: 109 FLYQILRGLA----YCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTK 159

Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
              N   T  Y PP+ +    + ST+ D++  G I  E+ +G +P+   +T+
Sbjct: 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTV 210

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 10/95 (10%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLTGTRPY 352
           L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ +  SE  +  T Y      TR Y
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWY 174

Query: 353 MPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
             PE +    + +T  DV+S G I  ELL G KP+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 34/225 (15%)

Query: 178 LGEGQFGTVY-YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G +G VY     K+G   AVK L+       S+ D    A   IL      Q+L   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNIL------QSLPN- 77

Query: 237 KHVNLLRLLGLCNNIMNCI------VYEYMCNGSLYDRLAR--VNNTPPLDSNKRYSIAL 288
            H N+++  G+       +      V E +CNG     L +  +     LD      I  
Sbjct: 78  -HPNVVKFYGMFYKADKLVGGQLWLVLE-LCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           G    L +LH+    IIHRDVK  N+LL      KL DFG+     ++ ++   +    G
Sbjct: 136 GALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VG 190

Query: 349 TRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDD 387
           T  +M PE + C+         + DV+S G+  +EL  G  P+ D
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 16/158 (10%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EY+  G L   + R    P  + + R+  A  +  AL++LH   + II+RD+K  NV
Sbjct: 73  LVIEYVNGGDLMFHMQRQRKLP--EEHARF-YAAEICIALNFLHE--RGIIYRDLKLDNV 127

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD +   KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 128 LLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184

Query: 374 ILLELLTGMKPID------DNNTILYYYLVVEQEVPVR 405
           ++ E++ G  P D      D NT  Y + V+  E P+R
Sbjct: 185 LMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H   K ++HRD+KS N+ L +N   KLGDFG  ++  +      Y     GT  Y+PPE 
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYVGTPYYVPPEI 171

Query: 358 M-HCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
             +   + K+D++S G IL EL T   P   N+
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSN-KRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           +V EY   G L   L R  +    D +  ++ +A  +  A+H +H +    +HRD+K  N
Sbjct: 78  LVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLA-ELVLAIHSVHQMG--YVHRDIKPEN 132

Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-------HCQISTKT 366
           VL+D     KL DFG    +  +  K + ++   GT  Y+ PE +             + 
Sbjct: 133 VLIDRTGHIKLADFG--SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190

Query: 367 DVFSYGVILLELLTGMKPIDDNNTILYY 394
           D +S GVI  E++ G  P  +  +   Y
Sbjct: 191 DWWSLGVIAYEMIYGRSPFHEGTSAKTY 218

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 11/162 (6%)

Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E   L    H +++R+   L +  + C+V  +  +  LY  L     + PL  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLT--KRSRPLPIDQALIIE 163

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + E L YLH+    IIHRDVK+ N+ +++     +GD G  +    +         L 
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA 217

Query: 348 GTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDN 388
           GT     PE +   + ++K D++S G++L E+L     I ++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Length = 357

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 73/244 (29%), Positives = 104/244 (42%), Gaps = 31/244 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   + K   E+ A+K L+     +    D  E+ M    +FE    T +  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---DEVESLMCEKRIFE----TANSE 59

Query: 237 KHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           +H  L+ L   C    +  C V EY   G L   +     + P      Y  A  V   L
Sbjct: 60  RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--RAVFY--AACVVLGL 114

Query: 295 HYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRP 351
            YLH     I++RD+K  N+LLD E FV K+ DFG+ K  M          T    GT  
Sbjct: 115 QYLHE--NKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDR-----TSTFCGTPE 166

Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVREVL 408
           ++ PE +     T+  D +  GV++ E+L G  P   DD   +  +  +V  EV     L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FDSIVNDEVRYPRFL 224

Query: 409 DKEA 412
            +EA
Sbjct: 225 SREA 228

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 37/242 (15%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ- 235
           +G G +G VY G+ +K G   A+K ++          D  E         + E+  L + 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD-------VTGDEEEE-------IKQEINMLKKY 59

Query: 236 CKHVNLLRLLG--LCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             H N+    G  +  N         +V E+   GS+ D +         +    Y I  
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICR 118

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLT 347
            +   L +LH     +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     
Sbjct: 119 EILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----I 172

Query: 348 GTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           GT  +M PE + C  +       K+D++S G+  +E+  G  P+ D + +   +L+    
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232

Query: 402 VP 403
            P
Sbjct: 233 AP 234

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LH L   I++RD+K  N+LLD      L DFG+ K   +   +  Y+    GT  Y
Sbjct: 117 ALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEY 172

Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKP 384
           M PE +  +       D +S G+++ ELLTG  P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 7/96 (7%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS-ETSNMKTMYTENLTGTRP 351
            L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ +++    +     TE    TR 
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE-YVATRW 174

Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
           Y  PE M      +   D++S G IL E+L+  +P+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           V E++  G L   + R    P  + + R+  A  ++ AL++LH   + II+RD+K  NVL
Sbjct: 74  VIEFVSGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNFLHE--RGIIYRDLKLDNVL 128

Query: 316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVI 374
           LD     KL D+G   M +        T    GT  Y+ PE +  +      D ++ GV+
Sbjct: 129 LDAEGHIKLTDYG---MCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185

Query: 375 LLELLTGMKPID--------DNNTILYYYLVVEQEVPVR 405
           + E++ G  P D        D NT  Y + V+  E  +R
Sbjct: 186 MFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQIR 223

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY G  + NG  +A+K +          S  TE   +P      E   L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVI----------SMKTEEG-VPFTAIR-EASLLKG 59

Query: 236 CKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIAL 288
            KH N++    L ++I++       V+EYM     +  LA+     P  L          
Sbjct: 60  LKHANIV----LLHDIIHTKETLTFVFEYM-----HTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L Y+H   + I+HRD+K  N+L+      KL DFG+ + +++   +T  +E +  
Sbjct: 111 QLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-- 165

Query: 349 TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 381
           T  Y PP+ +      S+  D++  G I +E+L G
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 30/235 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   K+K+   I A+K L        +  +  + A       E  V     C
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKIL--------NKWEMLKRAETACFREERNVLVNGDC 60

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---A 293
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y     +AE   A
Sbjct: 61  QWITTLHYAFQDENYLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLA 114

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPY 352
           +H +H L    +HRD+K  NVLLD N   +L DFG  +KM++     T+ +    GT  Y
Sbjct: 115 IHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---TVQSSVAVGTPDY 169

Query: 353 MPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +        +   + D +S GV + E+L G  P    + +  Y  ++  E
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 45/134 (33%), Positives = 62/134 (46%), Gaps = 13/134 (9%)

Query: 258 EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD 317
           EYM  GSL    A    T  +  +    I   V + L +L      IIHRDVK  NVL++
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVN 137

Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFS 370
            N   KL DFG+      S  KT    N+ G + YM PE +           + ++DV+S
Sbjct: 138 GNGQVKLCDFGVSGNLVASLAKT----NI-GCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192

Query: 371 YGVILLELLTGMKP 384
            G+ +LE+  G  P
Sbjct: 193 LGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENN-ANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +G G FG V+     ++G  +A+K + N   N  S      E  M            L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKM------------LCF 55

Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNK----RYSIALG 289
            KH N+L  L  L    ++     Y+    +   L ++  +P PL S+      Y I  G
Sbjct: 56  FKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
               L YLHS    I+HRD+K  N+L++ N V K+ DFG+ ++ E    K M  E +  T
Sbjct: 116 ----LKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--T 167

Query: 350 RPYMPPE----AMHCQISTKTDVFSYGVILLELLTG 381
           + Y  PE    + H   ++  D++S G I  ELL  
Sbjct: 168 QYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 43/229 (18%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQT 232
            ++GEG +G VY  + K+ G  +A+K   L+N            E    PI     E++ 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDN------------EKEGFPITAIR-EIKI 59

Query: 233 LSQCKHVNLLRLLGLCNNIMNC-----------IVYEYMCN---GSLYDRLARVNNTPPL 278
           L Q  H N++ L  +  +  +            +V+EYM +   G L   L   +     
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE---- 115

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
           D  K  S    + E L+Y H   K  +HRD+K +N+LL+     KL DFG+ ++   S  
Sbjct: 116 DHIK--SFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEE 170

Query: 339 KTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
              YT N   T  Y PPE +    +     DV+S G IL EL T  KPI
Sbjct: 171 SRPYT-NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAEALHYLHSLSKPIIHRDVKSAN 313
           ++ +Y+  G L+  L++          +   I  G +  AL +LH L   II+RD+K  N
Sbjct: 82  LILDYINGGELFTHLSQRERF----KEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLEN 135

Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFS 370
           +LLD N    L DFG+ K      ++  Y  +  GT  YM P+ +           D +S
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193

Query: 371 YGVILLELLTGMKP 384
            GV++ ELLTG  P
Sbjct: 194 MGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 52/234 (22%)

Query: 177 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           ++G G FG V  G++ +G    ++ VK L  +A+                + F  E Q  
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ------------MKFLEEAQPY 49

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL--YDRLARV--NNTPPLDSNKR--YSI 286
              +H NLL+ LG C  +    +V E+   G L  Y R  R     TP   + +R    I
Sbjct: 50  RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN- 345
           ALG+      LH      IH D+   N LL  +   K+GD+G+      S+ K  Y E+ 
Sbjct: 110 ALGL------LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL------SHNK--YKEDY 155

Query: 346 -LTGTRPYMP-----PE---AMHCQI-----STKTDVFSYGVILLELLT-GMKP 384
            +T  + ++P     PE    +H  +     + +++V+S GV + EL   G +P
Sbjct: 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 18/168 (10%)

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NVL
Sbjct: 74  VIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNVL 128

Query: 316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVI 374
           LD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV+
Sbjct: 129 LDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185

Query: 375 LLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           + E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 186 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENN-ANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +GEG +G V   + K   EI A+K  +++  N     +   E  M+  L  EN V+    
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 236 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            +    L L           V+EY+   ++ + L  + N  P +  + Y   L   +A+H
Sbjct: 69  FRRRGKLYL-----------VFEYV-EKNMLELLEEMPNGVPPEKVRSYIYQL--IKAIH 114

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMP 354
           + H     I+HRD+K  N+L+  N V KL DFG  + +SE SN    YTE    TR Y  
Sbjct: 115 WCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTE-YVATRWYRS 169

Query: 355 PE-AMHCQISTKTDVFSYGVILLELLTG 381
           PE  +        D++S G IL EL  G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 48/158 (30%), Positives = 67/158 (42%), Gaps = 34/158 (21%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + L R +  P  +   R+ IA  V  AL  +H L    IHRD+K  N+
Sbjct: 78  LVMEYMPGGDLMNLLIRKDVFP--EETARFYIAELVL-ALDSVHKLG--FIHRDIKPDNI 132

Query: 315 LLDENFVPKLGDFGI-------------------------VKMSETSNMKTMYTENLT-G 348
           L+D +   KL DFG+                         V +    + +     N T G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192

Query: 349 TRPYMPPEAMHCQIS--TKTDVFSYGVILLELLTGMKP 384
           T  Y+ PE +        + D +S GVIL E+L G  P
Sbjct: 193 TPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 37/139 (26%), Positives = 59/139 (42%), Gaps = 10/139 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  V   P     +    A  +   L +LH     I++RD+K  N
Sbjct: 69  CLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPEN 125

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSY 371
           VLLD++   ++ D G+ V++     +K        GT  YM PE +  ++     D F+ 
Sbjct: 126 VLLDDHGNVRISDLGLAVELKGGKKIKGR-----AGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 372 GVILLELLTGMKPIDDNNT 390
           G  L E++ G  P      
Sbjct: 181 GCTLYEMIAGRSPFRQRKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 46/136 (33%), Positives = 68/136 (50%), Gaps = 15/136 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 173

Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 369 FSYGVILLELLTGMKP 384
           +S GV L E+L G  P
Sbjct: 231 WSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   KLKN  ++ A+K L        +  +  + A       E +V      
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKIL--------NKWEMLKRAETACFREERDVLVNGDN 60

Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 61  QWITTLHYAFQDENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  N+L+D N   +L DFG  +K+ E     T+ +    GT  Y+ 
Sbjct: 120 QLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---TVQSSVAVGTPDYIS 171

Query: 355 PEAMHCQISTK------TDVFSYGVILLELLTGMKP 384
           PE +      K       D +S GV + E+L G  P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G VY G+ K  G  +A+K   LE+            E   +P      E+  L
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES------------EEEGVPSTAIR-EISLL 53

Query: 234 SQCKHVNLLRLLGLCNNIMN----CIVYEYMCNGSLYDRLARVNNTPP---LDSNKRYSI 286
            + +H N++ L  +   +M      +++E++      D    +++ P    +D+    S 
Sbjct: 54  KELQHPNIVCLQDV---LMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSY 106

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              + + + + HS  + ++HRD+K  N+L+D   V KL DFG+ +         +YT  +
Sbjct: 107 LYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEV 162

Query: 347 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLT 380
             T  Y  PE +    + ST  D++S G I  E+ T
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 16/103 (15%)

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNMKT 340
           S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG    I K  +      
Sbjct: 177 SYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------ 228

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            Y        P  +M PE++  ++ +T++DV+S+GV+L E+ +
Sbjct: 229 -YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 48/230 (20%)

Query: 177 KLGEGQFGTV---YYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG+G +G V      +      +A+K + N                    +F  ++   
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITN--------------------VFSKKILAK 46

Query: 234 SQCKHVNLLRLLGLCNNIMNC----IVYEYMCNGS-LYDRLARVNNTPPLDSNKR----- 283
              + + LLR      NI       IV+    N   LY+ L   +    + S +      
Sbjct: 47  RALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH 106

Query: 284 -----YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 337
                Y I  G    L Y+HS +  ++HRD+K  N+L++ +   K+ DFG+ +  SE   
Sbjct: 107 FQSFIYQILCG----LKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160

Query: 338 MKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
               +      TR Y  PE M      +   DV+S G IL ELL G KP+
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 53/228 (23%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G VY  +    G  +A+K   LE       +  +   +  I       E+  L
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLE-------TEDEGVPSTAI------REISLL 52

Query: 234 SQCKHVNLLRLLGLCNNIMNC-----IVYEY--MCNGSLYDRLARVNNTPPLDSNKRYSI 286
            +  H N++RLL    ++++      +V+E+  +      D        PPL  +  Y +
Sbjct: 53  KELNHPNIVRLL----DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKT 340
             G+A    Y HS    ++HRD+K  N+L+D     KL DFG+ +       + T  + T
Sbjct: 109 LQGIA----YCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT 162

Query: 341 MY---TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           ++    E L G+R Y          ST  D++S G I  E++   +P+
Sbjct: 163 LWYRAPEILLGSRQY----------STPVDIWSIGCIFAEMVNR-RPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 17/136 (12%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TR 350
           L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         + +TG   TR
Sbjct: 131 LKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD---------DEMTGYVATR 179

Query: 351 PYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVREV 407
            Y  PE M      +   D++S G I+ ELL G      N+ I     ++E    P  EV
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 408 LDKEAGEWNETHVETL 423
           L K + E    ++++L
Sbjct: 240 LKKISSEHARKYIQSL 255

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 68/242 (28%), Positives = 98/242 (40%), Gaps = 43/242 (17%)

Query: 158 DLERATDG-FNRKPYP--RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNS 213
           D E+  D   NR P    + GN +G G FG VY    +    ++A+K +  +  Y +   
Sbjct: 51  DEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--- 107

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC---------NNIMNCIVYEYMCNG- 263
                          E+  +    H+N++ L              NI   +V E++    
Sbjct: 108 --------------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV 153

Query: 264 -SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FV 321
                  AR N+  PL   K YS  L    AL Y+HS  K I HRD+K  N+L+D N   
Sbjct: 154 HKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIHS--KFICHRDLKPQNLLIDPNTHT 209

Query: 322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
            KL DFG  K          Y      +R Y  PE M      +T  D++S G I+ E++
Sbjct: 210 LKLCDFGSAKNLLAGQRSVSY----ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Query: 380 TG 381
            G
Sbjct: 266 LG 267

Length = 440

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 10/107 (9%)

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETS 336
           LD+    S +  VA+ + +L   SK  IHRD+ + N+LL    + K+ DFG+ + +   S
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 337 NMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 380
           N    Y        P  +M PE++ +C  + ++DV+SYG++L E+ +
Sbjct: 269 N----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y+H+ +  + HRD+K  N+L + +   K+ DFG+ +++       ++  +   TR Y
Sbjct: 115 ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 353 MPPEAMHCQISTKT---DVFSYGVILLELLTGMKPI 385
             PE      S  T   D++S G I  E+LTG KP+
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 20/140 (14%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---ALHYLHSLSKPIIHRDVKS 311
           +V +Y   G L   L++  +  P D  + Y     +AE   A+  +H L    +HRD+K 
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQLG--YVHRDIKP 130

Query: 312 ANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QIST 364
            NVLLD+N   +L DFG  +++       T+ +    GT  Y+ PE +        +   
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADG---TVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187

Query: 365 KTDVFSYGVILLELLTGMKP 384
           + D +S GV + E+L G  P
Sbjct: 188 ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 10/136 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  V     L+  +    +  +   + +LHS+   I++RD+K  N
Sbjct: 69  CLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPEN 125

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSY 371
           VLLD+    +L D G+ V++ +             GT  YM PE +  +  S   D F+ 
Sbjct: 126 VLLDDQGNCRLSDLGLAVELKDGKT-----ITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 372 GVILLELLTGMKPIDD 387
           G  + E++ G  P  D
Sbjct: 181 GCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 29/171 (16%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      T
Sbjct: 129 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VAT 180

Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELLTG       + I    L++     P  E
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240

Query: 407 VLDKEAGEWNETHVETLISI------------------VFEKCCVFEKDKR 439
           +L K + E    ++++L  +                  + EK  V + DKR
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 60/232 (25%)

Query: 177 KLGEGQFGTVYYGKLKNGME-IAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G VY  + +   E IA+K   LE             E   +P      E+  L
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQ------------EDEGVPSTAIR-EISLL 55

Query: 234 SQCKHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKR----- 283
            + +H N++RL     ++++      +V+EY+      D    ++++P    N R     
Sbjct: 56  KEMQHGNIVRL----QDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTY 107

Query: 284 -YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKM------SET 335
            Y I  G+A    Y HS    ++HRD+K  N+L+D      KL DFG+ +       + T
Sbjct: 108 LYQILRGIA----YCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 336 SNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
             + T++         Y  PE +      ST  D++S G I  E++   KP+
Sbjct: 162 HEVVTLW---------YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 44/164 (26%), Positives = 63/164 (38%), Gaps = 28/164 (17%)

Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVY-EYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           E   L    H ++++L G    N   C++   Y  +  LY  LA   N    D     +I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI---LAI 187

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY---- 342
              V  A+ YLH     IIHRD+K+ N+ ++      LGDFG        N    Y    
Sbjct: 188 ERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 343 -----TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
                   L    PY P            D++S G++L E+ T 
Sbjct: 246 TIATNAPELLARDPYGP----------AVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY G+ K  G  +A+K +              E A    +    E   L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---------EGAPFTAI---REASLLKD 59

Query: 236 CKHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            KH N++ L    ++I++      +V+EY+ +  L   +        + + + +   L  
Sbjct: 60  LKHANIVTL----HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL-- 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              L Y H   + ++HRD+K  N+L+ E    KL DFG+ + +++   KT   E +  T 
Sbjct: 113 LRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV--TL 167

Query: 351 PYMPPEAM--HCQISTKTDVFSYGVILLELLTGM 382
            Y PP+ +    + ST  D++  G I  E+ TG 
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 18/139 (12%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ +Y+ +G L+D L        L   +   I   + EAL+ LH     IIH D+K  NV
Sbjct: 86  LIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENV 140

Query: 315 LLDENFVP-KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM---HCQISTKTDVFS 370
           L D       L D+G+ K+  T    + Y     GT  Y  PE +   +  +S   D ++
Sbjct: 141 LYDRAKDRIYLCDYGLCKIIGT---PSCY----DGTLDYFSPEKIKGHNYDVS--FDWWA 191

Query: 371 YGVILLELLTGMKPIDDNN 389
            GV+  ELLTG  P  ++ 
Sbjct: 192 VGVLTYELLTGKHPFKEDE 210

Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
            R   +N +P L        +  VA  + +L   SK  +HRD+ + NVL+ E  + K+ D
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICD 282

Query: 327 FGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 380
           FG+ + +   SN    Y    +   P  +M PE++ +   +T +DV+S+G++L E+ T
Sbjct: 283 FGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 12/113 (10%)

Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPI-----DDNNTILYYYLVVEQEVP 403
           +   ++  +  D FS G +L +LL G  P       D + I    L +  E+P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 32/226 (14%)

Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +             T    +P+     EV  L 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ----------TGEEGMPLSTIR-EVAVLR 56

Query: 235 QCK---HVNLLRLLGLCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
             +   H N++RL  +C            +V+E++ +  L   L +V   P + +     
Sbjct: 57  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKD 114

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++        M   +
Sbjct: 115 MMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTS 168

Query: 346 LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           +  T  Y  PE  +    +T  D++S G I  E+    KP+   ++
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 25/241 (10%)

Query: 178 LGEGQFGTVYYGKLKNGME--IAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           LG G FG VY  + KN  +  +A+K +  +N  +     +  ++         + V  ++
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS-------IGDIVSEVT 60

Query: 235 ----QCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR-YSIAL 288
               Q +H N++R       N    IV + +    L +    +       + +R ++I +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLT 347
            +  AL YLH   K I+HRD+   N++L E+    + DFG+ K     S + ++      
Sbjct: 121 QMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV-----V 174

Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVR 405
           GT  Y  PE +  +    K DV+++G IL ++ T   P    N +     +VE    P+ 
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234

Query: 406 E 406
           E
Sbjct: 235 E 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 29/118 (24%), Positives = 55/118 (46%), Gaps = 25/118 (21%)

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--- 341
           +I  G    L+YLH      IHR++K++++L+  +        G+V +S  S++ ++   
Sbjct: 105 NILFGALRGLNYLHQ--NGYIHRNIKASHILISGD--------GLVSLSGLSHLYSLVRN 154

Query: 342 ---------YTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDD 387
                    + +  T   P++ PE +   +     K+D++S G+   EL TG  P  D
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 9/134 (6%)

Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G L   +  V+   P     +       +   L +LH   + II+RD+K  
Sbjct: 69  CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPE 126

Query: 313 NVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFS 370
           NVLLD +   ++ D G+ V++ +  +     T+   GT  +M PE +   +     D F+
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQSK----TKGYAGTPGFMAPELLQGEEYDFSVDYFA 182

Query: 371 YGVILLELLTGMKP 384
            GV L E++    P
Sbjct: 183 LGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 12/113 (10%)

Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 358 MH--CQISTKTDVFSYGVILLELLTGMKPI-----DDNNTILYYYLVVEQEVP 403
           +       +  D FS G +L +LL G  P       D + I    L V  E+P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 55/290 (18%)

Query: 178 LGEGQFGTVY-YGKLKNGMEIAVKTL----------ENNANYSSSNSDNTEAAMIPILLF 226
           +G+G +G V+     KNG + AVK L          E   N   + SD+        + +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           + +V+   Q     L  +L LCN             GS+ D +        L   +R   
Sbjct: 86  KKDVKNGDQ-----LWLVLELCNG------------GSVTDLVKGF-----LKRGERMEE 123

Query: 286 --IALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
             IA  + EAL  L  L     IHRDVK  N+LL      KL DFG+     ++ ++   
Sbjct: 124 PIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183

Query: 343 TENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
           +    GT  +M PE + C+         + DV+S G+  +EL  G  P+ D + +   + 
Sbjct: 184 S---VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240

Query: 397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           +     P     +  + E+N+            KC   + +KR ++ D++
Sbjct: 241 IPRNPPPTLHQPELWSNEFND---------FIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 9/99 (9%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           VA  + +L   S+  IHRD+ + N+LL EN V K+ DFG+ +          Y    +  
Sbjct: 183 VARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGSAR 237

Query: 350 RP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            P  +M PE++  ++ +T++DV+S+GV+L E+ + G  P
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 51/240 (21%), Positives = 86/240 (35%), Gaps = 61/240 (25%)

Query: 177 KLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +G+       V+  K K     +AVK        +  +    +     + L + E+ T 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVK------KINLDSCSKED-----LKLLQQEIITS 53

Query: 234 SQCKHVNLLRLLGLCNNIMNC--------IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            Q +H N+          +          +V   M  GS  D L         +     +
Sbjct: 54  RQLQHPNI-------LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELA 102

Query: 286 IAL---GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM- 341
           IA     V  AL Y+HS  K  IHR VK++++LL  +        G V +S      +M 
Sbjct: 103 IAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGD--------GKVVLSGLRYSVSMI 152

Query: 342 -----------YTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDD 387
                      + ++     P++ PE +   +     K+D++S G+   EL  G  P  D
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 26/212 (12%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSS-SNSDNTEAAMIPILLFENEVQTLS 234
           ++G G +GTVY  +   +G  +A+K++    N      S   E A++         + L 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALL---------KRLE 57

Query: 235 QCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
              H N++RL+ +C            +V+E++ +  L   L +V   P L +     +  
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVP-PPGLPAETIKDLMR 115

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
                L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    +  
Sbjct: 116 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVV 169

Query: 349 TRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
           T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV----TRYY 188

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           VA+ + +L   S+  IHRD+ + N+LL EN V K+ DFG+ +          Y       
Sbjct: 188 VAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDAR 242

Query: 350 RP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            P  +M PE +  ++ + ++DV+S+GV+L E+ + G  P
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 43/222 (19%)

Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN----EVQT 232
           +G G +GTV      + G ++A+K L     Y    S+          LF      E++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-----YRPFQSE----------LFAKRAYRELRL 67

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           L   KH N++ LL +    ++   +   Y+    +   L ++     L  ++   +   +
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG-- 348
            + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++          +TG  
Sbjct: 128 LKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---------MTGYV 176

Query: 349 -TRPYMPPEA----MHCQISTKTDVFSYGVILLELLTGMKPI 385
            TR Y  PE     MH   +   D++S G I+ E+LTG KP+
Sbjct: 177 VTRWYRAPEVILNWMH--YTQTVDIWSVGCIMAEMLTG-KPL 215

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 33/227 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G K+G G +G VY  K K+G        +++ +Y+    + T  +M        E+  L 
Sbjct: 6   GCKVGRGTYGHVYKAKRKDG--------KDDRDYALKQIEGTGISMSAC----REIALLR 53

Query: 235 QCKHVNLLRLLGLCNNIMN---CIVYEY----MCNGSLYDRLARVNNTP-PLDSNKRYSI 286
           + KH N++ L  +  +  +    ++++Y    + +   + R ++ N  P  L      S+
Sbjct: 54  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNMKTMY 342
              + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G  ++  +       
Sbjct: 114 LYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 343 TENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 385
            + +  T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 172 LDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 183

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTG 381
             PE  +        D++S G I+ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 39/226 (17%)

Query: 178 LGEGQFGTVYYGKL--KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---------- 225
           LG+G    +Y G+L  + G E     +E+       N++  E  ++  +L          
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 226 FENEVQTLSQCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           F      +SQ  H++L  + G+C     NIM   V E++ +G L   L +     P+   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIM---VEEFVEHGPLDVCLRKEKGRVPVAW- 118

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVP--KLGDFGIVKMSE 334
            + ++A  +A AL YL    K ++H +V + N+LL      E   P  KL D G+     
Sbjct: 119 -KITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV----- 170

Query: 335 TSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLEL 378
             +   +  E      P++ PE +     +ST  D +S+G  LLE+
Sbjct: 171 --SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 49/214 (22%)

Query: 263 GSLYDRLARVNNTPP--------------LDSNKRYSIALGVAEALHYLHSLSKPIIHRD 308
            S YDR A    +                L +    S    VA  + +L   SK  +HRD
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRD 262

Query: 309 VKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-ST 364
           + + NVLL +  + K+ DFG+ + +   SN    Y    +   P  +M PE++   + +T
Sbjct: 263 LAARNVLLAQGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 365 KTDVFSYGVILLELLT-GMKP-----IDDN--NTILYYYLVVEQEVPVREVLDKEAGEWN 416
            +DV+SYG++L E+ + G  P     +D    N I   Y + + +   +EV D     WN
Sbjct: 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWN 378

Query: 417 ETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
                             E +KR S   + D++ 
Sbjct: 379 S-----------------EPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 20/95 (21%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TR 350
           L Y+HS    IIHRD+K  N+ ++E+   K+ DFG+ + ++           +TG   TR
Sbjct: 130 LKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAE---------MTGYVVTR 178

Query: 351 PYMPPEA----MHCQISTKTDVFSYGVILLELLTG 381
            Y  PE     MH   +   D++S G I+ E+LTG
Sbjct: 179 WYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 18/112 (16%)

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-------- 336
           SI   +   + Y+HS  K ++HRD+K  N+LL       + D+G     +          
Sbjct: 117 SIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 337 -NMKTMYTENLT------GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT 380
            + + +   ++T      GT  YM PE  +    S  TD+++ GVIL ++LT
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 5e-05
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 33/231 (14%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +   G K+G G +G VY  K K+G        ++   Y+    + T  +M        E+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDG--------KDEKEYALKQIEGTGISMSAC----REI 49

Query: 231 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEY----MCNGSLYDRLARVNNTP-PLDSNK 282
             L + KH N++ L  +    ++    ++++Y    + +   + R ++ N  P  L  + 
Sbjct: 50  ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNM 338
             S+   + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G  ++  +   
Sbjct: 110 VKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 339 KTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 385
                + +  T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 16/156 (10%)

Query: 228 NEVQTLSQCKHVNLLRLLGL-CNNIMNCIVY-EYMCNGSLYDRL-ARVNNTPPLDSNKRY 284
           +E + L +  H  +L LL +     + C+V  +Y  +  LY  L AR+    PL   +  
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR---PLGLAQVT 263

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGIVKMSETSNMKTMY 342
           ++A  +  A+ Y+H   + IIHRD+K+ NVL++  E+    LGDFG    +  S     +
Sbjct: 264 AVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFH 319

Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLE 377
              + GT     PE +     T + D++S G+++ E
Sbjct: 320 Y-GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 184

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++         + I  +  V+EQ   P  E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 55/248 (22%)

Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           K+G G+FG V+  K K   E      I+ + L+             E + + I     EV
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-----------EKSQLVI-----EV 63

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLARVNNT-PPLDSNKRYSI 286
             + + KH N++R +    N  N  +Y   E+   G L   + +       ++ +    I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 287 ALGVAEALHYLHSLS-----KPIIHRDVKSANVLLDENF-----------------VPKL 324
              +  AL Y H+L      + ++HRD+K  N+ L                     + K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTG 381
           GDFG+ K     +M      +  GT  Y  PE +  +  +   K+D+++ G I+ EL +G
Sbjct: 184 GDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 382 MKPIDDNN 389
             P    N
Sbjct: 240 KTPFHKAN 247

Length = 1021

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 36/133 (27%), Positives = 62/133 (46%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  + N P  +  +    A  +   L  LH   +  ++RD+K  N
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPEN 132

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 371
           +LLD+    ++ D G+ VK+ E  +++        GT  YM PE ++ Q  T   D +  
Sbjct: 133 ILLDDYGHIRISDLGLAVKIPEGESIR-----GRVGTVGYMAPEVLNNQRYTLSPDYWGL 187

Query: 372 GVILLELLTGMKP 384
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 19/167 (11%)

Query: 181 GQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH- 238
           G FG VY G+ KN  ++ AVK ++         +D     M+  +  E +   LS+    
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKK--------ADMINKNMVHQVQAERDALALSKSPFI 66

Query: 239 VNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH 298
           V+L   L   NN+   +V EY+  G +   L          + K  S    VA AL YLH
Sbjct: 67  VHLYYSLQSANNVY--LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS---EVALALDYLH 121

Query: 299 SLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNMKTMYT 343
                IIHRD+K  N+L+      KL DFG+  V ++   NM  + T
Sbjct: 122 RHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILT 166

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 43/177 (24%), Positives = 68/177 (38%), Gaps = 52/177 (29%)

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           V +Y+  G +   L R+      +   R+ IA  +  A+  +H +    IHRD+K  N+L
Sbjct: 79  VMDYIPGGDMMSLLIRLGIFE--EDLARFYIA-ELTCAIESVHKMG--FIHRDIKPDNIL 133

Query: 316 LDENFVPKLGDFGIV---------------------------KMSETSN--MKTMYTEN- 345
           +D +   KL DFG+                            + SE     +K +     
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193

Query: 346 ----------LTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDN 388
                     L GT  Y+ PE +    + Q+    D +S GVIL E+L G  P   +
Sbjct: 194 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL---CDWWSVGVILYEMLVGQPPFLAD 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 41/165 (24%), Positives = 59/165 (35%), Gaps = 51/165 (30%)

Query: 290 VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           +AE   A+  +H L    IHRD+K  N+LLD     KL DFG+    + S+    Y   L
Sbjct: 107 IAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY-RIL 163

Query: 347 TGTRP------------------------------------YMPPEA-MHCQISTKTDVF 369
           +   P                                    Y+ PE  +    + + D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 370 SYGVILLELLTGMKPIDDNNTILYY--------YLVVEQEVPVRE 406
           S GVI+ E+L G  P   +N    Y         L    EVP+  
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSP 268

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 37/113 (32%), Positives = 52/113 (46%), Gaps = 24/113 (21%)

Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V     YG  K+   M +AVK L+      S++    EA M
Sbjct: 32  FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK-----PSAHLTEREALM 86

Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR 271
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R
Sbjct: 87  -------SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRR 132

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRP 351
            L  LH   + I++RD+K  N+LLD++   ++ D G+ V + E   +K        GT  
Sbjct: 114 GLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----GRVGTVG 166

Query: 352 YMPPEAMHCQIST-KTDVFSYGVILLELLTGMKP 384
           YM PE +  +  T   D ++ G +L E++ G  P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  + N P  D  +    A  +   L  LH   + I++RD+K  N
Sbjct: 76  CLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPEN 132

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 371
           +LLD+    ++ D G+ V++ E   ++        GT  YM PE +  +  T   D +  
Sbjct: 133 ILLDDYGHIRISDLGLAVEIPEGETIR-----GRVGTVGYMAPEVVKNERYTFSPDWWGL 187

Query: 372 GVILLELLTGMKP 384
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  + N P  D  +    A  +   L  L    + I++RD+K  N
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPEN 132

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 371
           +LLD+    ++ D G+ V++ E   ++        GT  YM PE ++ +  T   D +  
Sbjct: 133 ILLDDRGHIRISDLGLAVQIPEGETVR-----GRVGTVGYMAPEVINNEKYTFSPDWWGL 187

Query: 372 GVILLELLTGMKP 384
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 43/156 (27%), Positives = 59/156 (37%), Gaps = 45/156 (28%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT----- 347
           A+  +H L    IHRD+K  N+LLD     KL DFG+    + ++ +T +  NLT     
Sbjct: 113 AIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH-RTEFYRNLTHNPPS 169

Query: 348 ----------------------------GTRPYMPPEA-MHCQISTKTDVFSYGVILLEL 378
                                       GT  Y+ PE  M    +   D +S GVI+ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 379 LTGMKPIDDNNTILYY--------YLVVEQEVPVRE 406
           L G  P         Y         LV   EVP+ E
Sbjct: 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISE 265

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 63/249 (25%), Positives = 92/249 (36%), Gaps = 66/249 (26%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPI-----LLFENEV 230
            LG+G  G V+  +LK  G   A+K L+                MI       +L E E+
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-------------MIKRNKVKRVLTEQEI 54

Query: 231 QTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIAL 288
             L+   H  L  L          C+V +Y   G L+  L R        +  + Y    
Sbjct: 55  --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY---- 108

Query: 289 GVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE----------- 334
             AE   AL YLH L   I++RD+K  N+LL E+    L DF + K S+           
Sbjct: 109 -AAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 335 --TSNMKTMYTENLT-------------GTRPYMPPE----AMHCQISTKTDVFSYGVIL 375
             +         + T             GT  Y+ PE      H    +  D ++ G++L
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILL 222

Query: 376 LELLTGMKP 384
            E+L G  P
Sbjct: 223 YEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 33/143 (23%), Positives = 65/143 (45%), Gaps = 16/143 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA---LGVAEALHYLHSLSKPIIHRDVKS 311
           +V  +M  GS  D +     T  +D     +IA    GV +AL Y+H +    +HR VK+
Sbjct: 76  VVTSFMAYGSAKDLIC----THFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKA 129

Query: 312 ANVLLDEN---FVPKL-GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS---T 364
           +++L+  +   ++  L  +  ++   +   +   + +      P++ PE +   +     
Sbjct: 130 SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189

Query: 365 KTDVFSYGVILLELLTGMKPIDD 387
           K+D++S G+   EL  G  P  D
Sbjct: 190 KSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	455
KOG1187|consensus	361		100.0
KOG0575|consensus	592		100.0
KOG0192|consensus	362		100.0
KOG0615|consensus	475		100.0
KOG0581|consensus	364		100.0
KOG0595|consensus	429		100.0
KOG0598|consensus	357		100.0
KOG0197|consensus	468		100.0
KOG0591|consensus	375		100.0
KOG0592|consensus	604		100.0
KOG0593|consensus	396		100.0
KOG0616|consensus	355		100.0
KOG0198|consensus	313		100.0
KOG0583|consensus	370		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578|consensus	550		100.0
KOG0193|consensus	678		100.0
KOG0582|consensus	516		100.0
KOG0588|consensus	786		100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0661|consensus	538		100.0
KOG0659|consensus	318		100.0
KOG0605|consensus	550		100.0
KOG4721|consensus	904		100.0
KOG0600|consensus	560		100.0
KOG0585|consensus	576		100.0
KOG0597|consensus	808		100.0
KOG0694|consensus	694		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580|consensus	281		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG1026|consensus	774		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0611|consensus	668		100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0194|consensus	474		100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0201|consensus	467		100.0
KOG0663|consensus	419		100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG2345|consensus	302		100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG1095|consensus	1025		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0589|consensus	426		100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0610|consensus	459		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0032|consensus	382		100.0
KOG0599|consensus	411		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0660|consensus	359		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG1989|consensus	738		100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0594|consensus	323		100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0658|consensus	364		100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0196|consensus	996		100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0577|consensus	948		100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0690|consensus	516		100.0
KOG4250|consensus	732		100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0574|consensus	502		100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0033|consensus	355		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG1094|consensus	807		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0584|consensus	632		100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0579|consensus	1187		100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4279|consensus	1226		100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4257|consensus	974		100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4717|consensus	864		100.0
KOG4278|consensus	1157		100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0199|consensus	1039		100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0586|consensus	596		100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0667|consensus	586		100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4645|consensus	1509		100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0983|consensus	391		100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0596|consensus	677		100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653|consensus	534		100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0696|consensus	683		100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0986|consensus	591		100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG2052|consensus	513		100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1006|consensus	361		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0612|consensus	1317		100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0614|consensus	732		100.0
KOG0666|consensus	438		100.0
KOG0607|consensus	463		100.0
KOG1035|consensus	1351		100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1025|consensus	1177		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0604|consensus	400		100.0
KOG1151|consensus	775		100.0
KOG0200|consensus	609		100.0
KOG4236|consensus	888		100.0
KOG0669|consensus	376		100.0
KOG0662|consensus	292		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0603|consensus	612		100.0
KOG0587|consensus	953		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0671|consensus	415		99.98
cd08308	125	Death_Tube Death domain of Tube. Death domains (DD	99.98
KOG0695|consensus	593		99.98
KOG0608|consensus	1034		99.98
KOG1027|consensus	903		99.97
KOG0984|consensus	282		99.97
KOG0576|consensus	829		99.97
KOG1024|consensus	563		99.97
KOG1152|consensus	772		99.97
KOG0664|consensus	449		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
cd08793	100	Death_IRAK4 Death domain of Interleukin-1 Receptor	99.96
KOG0670|consensus	752		99.96
KOG0668|consensus	338		99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665|consensus	369		99.96
KOG1345|consensus	378		99.95
KOG1290|consensus	590		99.95
KOG1167|consensus	418		99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
cd08307	97	Death_Pelle Death domain of the protein kinase Pel	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164|consensus	322		99.92
KOG1165|consensus	449		99.91
cd08309	95	Death_IRAK Death domain of Interleukin-1 Receptor-	99.91
cd08795	88	Death_IRAK2 Death domain of Interleukin 1 Receptor	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
cd08796	89	Death_IRAK-M Death domain of Interleukin 1 Recepto	99.9
KOG1163|consensus	341		99.9
KOG0195|consensus	448		99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG0590|consensus	601		99.89
PF14786	137	Death_2: Tube Death domain; PDB: 1D2Z_B.	99.88
KOG1240|consensus	1431		99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG0603|consensus	612		99.85
cd08794	84	Death_IRAK1 Death domain of Interleukin 1 Receptor	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1023|consensus	484		99.82
smart00090	237	RIO RIO-like kinase.	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
KOG1166|consensus	974		99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG4158|consensus	598		99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0606|consensus	1205		99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG1033|consensus	516		99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0590|consensus	601		99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG1266|consensus	458		99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG0601|consensus	524		99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
cd08781	83	Death_UNC5-like Death domain found in Uncoordinate	99.33
KOG3087|consensus	229		99.28
COG4248	637	Uncharacterized protein with protein kinase and he	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
cd08783	97	Death_MALT1 Death domain similar to that found in	99.23
KOG0606|consensus	1205		99.19
KOG1243|consensus	690		99.17
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.1
cd08782	82	Death_DAPK1 Death domain found in death-associated	99.07
KOG0601|consensus	524		99.03
cd08312	79	Death_MyD88 Death domain of Myeloid Differentation	99.0
KOG3741|consensus	655		99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
PRK09902	216	hypothetical protein; Provisional	98.81
cd08799	84	Death_UNC5C Death domain found in Uncoordinated-5C	98.75
cd08310	72	Death_NFkB-like Death domain of Nuclear Factor-Kap	98.74
KOG2137|consensus	700		98.73
cd08802	84	Death_UNC5B Death domain found in Uncoordinated-5B	98.7
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.69
cd08800	84	Death_UNC5A Death domain found in Uncoordinated-5A	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.47
KOG1235|consensus	538		98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.4
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
cd08801	98	Death_UNC5D Death domain found in Uncoordinated-5D	98.28
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.28
PF01636	239	APH: Phosphotransferase enzyme family This family	98.26
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.2
PLN02876	822	acyl-CoA dehydrogenase	98.1
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.09
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.06
smart00005	88	DEATH DEATH domain, found in proteins involved in	97.91
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.88
KOG0576|consensus	829		97.83
PRK10593	297	hypothetical protein; Provisional	97.83
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
PF00531	83	Death: Death domain; InterPro: IPR000488 The death	97.76
KOG2268|consensus	465		97.72
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.71
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.68
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.62
PRK05231	319	homoserine kinase; Provisional	97.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.55
cd08797	76	Death_NFkB1_p105 Death domain of the Nuclear Facto	97.54
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.47
cd01670	79	Death Death Domain: a protein-protein interaction	97.46
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.43
cd08798	76	Death_NFkB2_p100 Death domain of the Nuclear Facto	97.37
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.33

>KOG1187|consensus

Probab=100.00  E-value=7.7e-54  Score=425.64  Aligned_cols=281  Identities=40%  Similarity=0.632  Sum_probs=231.5

Q ss_pred             cceeeeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHH
Q psy5603         150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE  229 (455)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  229 (455)
                      ....|++.+|..||++|+..      ++||+|+||.||+|...+|+.||||++.......             ...|.+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~------~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-------------~~eF~~E  121 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSES------NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-------------EREFLNE  121 (361)
T ss_pred             CcceeeHHHHHHHHhCCchh------cceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-------------hhHHHHH
Confidence            56789999999999999998      9999999999999999988999999886443210             1239999


Q ss_pred             HHHHhhCCccceeeecccccC-c-eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeee
Q psy5603         230 VQTLSQCKHVNLLRLLGLCNN-I-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIH  306 (455)
Q Consensus       230 ~~~l~~l~h~niv~l~~~~~~-~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~~~iiH  306 (455)
                      +.++.+++|||+|+++|||.+ + ..+||||||++|||.++|...... +++|.+|++||.++|+||+|||+. ..+|||
T Consensus       122 i~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiH  200 (361)
T KOG1187|consen  122 VEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIH  200 (361)
T ss_pred             HHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEec
Confidence            999999999999999999998 5 489999999999999999986544 899999999999999999999996 347999


Q ss_pred             cCCCCCcEEEcCCCceEEeeccccccccc-CCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCC
Q psy5603         307 RDVKSANVLLDENFVPKLGDFGIVKMSET-SNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       307 ~Dikp~NILl~~~~~~kl~DFGla~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p  384 (455)
                      |||||+|||||+++.+||+|||+|+..+. ..  ...+.. .||.+|+|||+. .|..+.|+|||||||+|+|++||+.|
T Consensus       201 rDiKssNILLD~~~~aKlsDFGLa~~~~~~~~--~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~  277 (361)
T KOG1187|consen  201 RDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT--SVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA  277 (361)
T ss_pred             CCCCHHHeeECCCCCEEccCccCcccCCcccc--ceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence            99999999999999999999999976654 22  111111 899999999966 57899999999999999999999999


Q ss_pred             CCCCc----chhhHH-Hhhhcccchhhccchhcc--CCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         385 IDDNN----TILYYY-LVVEQEVPVREVLDKEAG--EWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       385 ~~~~~----~~~~~~-~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .+...    .....+ ........+.+++|+.+.  ..........+..+...|+..+|+.||+|.||++.|+.+.
T Consensus       278 ~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  278 VDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             cCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            98643    112222 223344588999999974  3332223333555677899999999999999999997765

>KOG0575|consensus

Probab=100.00  E-value=9.1e-49  Score=390.78  Aligned_cols=248  Identities=28%  Similarity=0.417  Sum_probs=214.7

Q ss_pred             CCCcCCCccCcCCCeEEEEEEE-cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++++.||+|||++||.+++ .+|..||+|++.+....+...          .....+||+|-+++.|||||++++++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~----------reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQ----------REKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcch----------HHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            4578889999999999999998 679999999998765543322          45588999999999999999999999


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...|+|.|+|.+++|..++.+   ..+++++.++.++.||+.||.|||+  ++|||||||..|++|+++.++||+||
T Consensus        88 EDs~nVYivLELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEeccc
Confidence            99 888999999999999999885   4579999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |||........   ...+++|||.|+|||++. .+.+..+||||+|||+|.||.|++||...+....+..+...+-.++.
T Consensus       163 GLAt~le~~~E---rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~  239 (592)
T KOG0575|consen  163 GLATQLEYDGE---RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS  239 (592)
T ss_pred             ceeeeecCccc---ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc
Confidence            99988765432   244689999999999764 46789999999999999999999999988766666666554444443


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                  .++...++||.++|..+|.+|||+++|+.
T Consensus       240 ------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  240 ------------HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                        34455889999999999999999999975

>KOG0192|consensus

Probab=100.00  E-value=3e-48  Score=383.33  Aligned_cols=251  Identities=34%  Similarity=0.533  Sum_probs=205.7

Q ss_pred             CccCcCCCeEEEEEEEcCCcE-EEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc--e
Q psy5603         176 NKLGEGQFGTVYYGKLKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--M  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  252 (455)
                      +.||+|+||+||+|.++ |+. ||||++........           ....|.+|+.+|++++|||||+++|+|.+.  .
T Consensus        47 ~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~-----------~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDE-----------SRKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             hhcccCCceeEEEEEeC-CceeEEEEEecchhcChH-----------HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            56999999999999998 566 99999975432111           055699999999999999999999999884  5


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-eeecCCCCCcEEEcCCC-ceEEeecccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENF-VPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~-iiH~Dikp~NILl~~~~-~~kl~DFGla  330 (455)
                      .++|||||++|+|.+++... ....+++..++.++.+||+|+.|||+  .+ ||||||||+|||++.++ ++||+|||++
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            89999999999999999874 34579999999999999999999999  77 99999999999999998 9999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +......   .......||..|||||++.+   .++.|+|||||||++|||+||..||.+.................   
T Consensus       192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp---  265 (362)
T KOG0192|consen  192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP---  265 (362)
T ss_pred             eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC---
Confidence            8765432   11223689999999998875   48999999999999999999999999887533333322211110   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                             .-+..++..+..|+.+||..||.+||++.+++..|+.+..
T Consensus       266 -------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  266 -------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                   1111245558888899999999999999999999987753

>KOG0615|consensus

Probab=100.00  E-value=3.3e-49  Score=376.64  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=207.3

Q ss_pred             CCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         168 RKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       168 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ...+|.+.+.||+|+||.|-+|..+ +|+.||||++++..........      .......+|+++|++++|||||++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~------~~~~~v~~EieILkkL~HP~IV~~~d  243 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAI------AKTRDVQNEIEILKKLSHPNIVRIKD  243 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccc------cchhhhHHHHHHHHhcCCCCEEEEee
Confidence            3456788899999999999999876 5999999999876543322100      01222579999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---Cce
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVP  322 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---~~~  322 (455)
                      ++.. +..|+||||+.||.|.+++...   ..+.+..-..++.|++.|+.|||+  +||+||||||+|||+..+   ..+
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEE
Confidence            9988 7779999999999999999874   458888889999999999999999  899999999999999765   789


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccCC---CC-cccchHHHHHHHHHHHcCCCCCCCCcchh-hHHHh
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---IS-TKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLV  397 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~-~~sDv~SlGvvl~elltG~~p~~~~~~~~-~~~~~  397 (455)
                      ||+|||+|++.+...    ...+.+||+.|.|||++.++   ++ .++|+||+|||||-+|+|.+||.+..... ....+
T Consensus       319 KItDFGlAK~~g~~s----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI  394 (475)
T KOG0615|consen  319 KITDFGLAKVSGEGS----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI  394 (475)
T ss_pred             Eecccchhhccccce----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH
Confidence            999999999876432    34578999999999977442   33 38999999999999999999999876433 33222


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+...+        ++.....++....+||.+||..||++||+++|+++
T Consensus       395 ~~G~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  395 LKGRYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hcCcccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2222111        22334567788999999999999999999999976

>KOG0581|consensus

Probab=100.00  E-value=1.6e-48  Score=369.36  Aligned_cols=241  Identities=29%  Similarity=0.395  Sum_probs=199.2

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c-e
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I-M  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~-~  252 (455)
                      +.||+|..|+||++.++ +++.+|+|++.....            ....+++.+|++++++++|||||.+||.|.. . .
T Consensus        85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~------------~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNID------------PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             hhcccCCCcEEEEEEEcCCCeEEEEEeecccCC------------HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            78999999999999988 478899999953321            1226779999999999999999999997655 6 4


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+++||||.+|||.+.+...   ..+++....+|+.++++||.|||+. ++||||||||+|||++..|.+||||||.+..
T Consensus       153 isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            99999999999999999874   4599999999999999999999953 7899999999999999999999999999886


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcc-----hhhHHHhhhcccchhh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT-----ILYYYLVVEQEVPVRE  406 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~-----~~~~~~~~~~~~~~~~  406 (455)
                      ....     ...++.||..|||||.+.+ .++.++||||||++++|+++|+.||.....     ......+..+      
T Consensus       229 lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~------  297 (364)
T KOG0581|consen  229 LVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE------  297 (364)
T ss_pred             hhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC------
Confidence            6543     3457899999999997765 689999999999999999999999987521     1111111111      


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          .....+...++..+++||.+||.+||.+||+++|+++
T Consensus       298 ----ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  298 ----PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ----CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                1112222246677999999999999999999999875

>KOG0595|consensus

Probab=100.00  E-value=8e-47  Score=360.73  Aligned_cols=205  Identities=32%  Similarity=0.511  Sum_probs=177.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      -|...+.||+|+||+||+|+++ ++..||||.+.++...           ....+-+..|+++|+.++|||||.+++++.
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-----------~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~   79 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-----------KKLVELLLSEIKILKELKHPNIVRLLDCIE   79 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-----------HHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence            3455688999999999999987 4899999999765321           112444789999999999999999999988


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC------Cce
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN------FVP  322 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~------~~~  322 (455)
                      + +..|||||||.||+|.++++..+   .+++..+..++.|+|.||++||+  ++||||||||+||||+..      -.+
T Consensus        80 ~~~~i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~L  154 (429)
T KOG0595|consen   80 DDDFIYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVL  154 (429)
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceE
Confidence            7 88999999999999999999854   59999999999999999999999  899999999999999765      568


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      ||+|||+||......    ...+.+|++-|||||++ ..+|+.|+|+||+|+|||+|++|.+||+.........
T Consensus       155 KIADFGfAR~L~~~~----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~  224 (429)
T KOG0595|consen  155 KIADFGFARFLQPGS----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL  224 (429)
T ss_pred             EecccchhhhCCchh----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            999999999887543    35678999999999976 7789999999999999999999999999887544433

>KOG0598|consensus

Probab=100.00  E-value=3.3e-47  Score=360.32  Aligned_cols=237  Identities=27%  Similarity=0.364  Sum_probs=201.7

Q ss_pred             CCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +.+.||+|+||+||.++.++ ++.+|+|++++.......          .......|..||.+++||.||+++-.+++ +
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~----------e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~   98 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK----------EVRHTKAERNILSKIKHPFIVKLIYSFQTEE   98 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh----------hHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence            34999999999999999774 889999999876653321          14557889999999999999999988887 8


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+|++|+.||.|...|.+.+   .+++..+..++.+|+.||.|||+  +|||||||||+|||||.+|+++|+|||+|+
T Consensus        99 kLylVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccch
Confidence            9999999999999999999854   59999999999999999999999  899999999999999999999999999999


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc-cchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~d  409 (455)
                      .......   .+.+++||+.|||||++ ..+++..+|+||+||++|||++|.+||...+...+...+..+. ...+.++ 
T Consensus       174 ~~~~~~~---~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~l-  249 (357)
T KOG0598|consen  174 EDLKDGD---ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYL-  249 (357)
T ss_pred             hcccCCC---ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccC-
Confidence            6554432   24568999999999965 5578999999999999999999999999988777776666554 2222223 


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCC
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                                 +...++++.+++..+|++|.
T Consensus       250 -----------s~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  250 -----------SEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----------CHHHHHHHHHHhccCHHHhc
Confidence                       33478889999999999995

>KOG0197|consensus

Probab=100.00  E-value=1.2e-46  Score=371.76  Aligned_cols=249  Identities=29%  Similarity=0.456  Sum_probs=208.5

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      +.||+|-||.||.|.++....||||.++....              ....|.+|+++|++++|+|||+++|+|.. +.+|
T Consensus       212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--------------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--------------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             HHhcCCccceEEEEEEcCCCcccceEEecccc--------------ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            78999999999999999777999999986532              13459999999999999999999999988 5589


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ||||||+.|||.++|... .+..+...+.+.++.|||+|++||++  +++|||||-..||||++++.+||+|||+||...
T Consensus       278 IVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccC
Confidence            999999999999999973 35679999999999999999999999  889999999999999999999999999999554


Q ss_pred             cCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         335 TSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      .+....  .....-...|.|||++ .+.++.|||||||||+||||+| |+.||.+.........+..           ..
T Consensus       355 d~~Y~~--~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-----------Gy  421 (468)
T KOG0197|consen  355 DDEYTA--SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-----------GY  421 (468)
T ss_pred             CCceee--cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-----------cC
Confidence            433211  1222334469999965 6789999999999999999999 9999998875444333332           22


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      +-..+..|+..+.+++..||..+|++|||+..+...|+++..
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            223455677788899999999999999999999999988754

>KOG0591|consensus

Probab=100.00  E-value=4.3e-47  Score=346.00  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=206.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc-ccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~  250 (455)
                      ++.++||+|+||+||++... +|..||.|.++-...       +    ....+....|+.+|++++|||||++++. +.+
T Consensus        22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-------d----~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-------D----AKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-------c----HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            45589999999999999864 689999999873221       1    1225668899999999999999999993 333


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC--CCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSL--SKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~--~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                        ...++|||||.+|+|.+.+..... +..+++..+++++.|+++||.++|+.  ..-|+||||||+||+|+.+|.+||+
T Consensus        91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence              347899999999999999875433 56799999999999999999999983  3349999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||++++....   +..+...+|||.||+||.+ ..+++.+|||||+||++|||+.-++||.+.+-.....++...+.  
T Consensus       171 DfGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~--  245 (375)
T KOG0591|consen  171 DFGLGRFLSSK---TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY--  245 (375)
T ss_pred             cchhHhHhcch---hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--
Confidence            99999987654   2345678999999999965 55789999999999999999999999999876655555554321  


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                              .+.+...++..+..+|..|+..||+.||+...++..+
T Consensus       246 --------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  246 --------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             --------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                    1233456777899999999999999999965555444

>KOG0592|consensus

Probab=100.00  E-value=2.2e-45  Score=361.11  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=209.8

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ..++.||+|+|++||+|+.+ +++.||||++.+.-.....+          .+....|-.+|.+| .||.|++|+-.+.|
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K----------vkYV~~Ek~~l~~L~~hPgivkLy~TFQD  145 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK----------VKYVTREKEALTQLSGHPGIVKLYFTFQD  145 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc----------cchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence            34588999999999999976 48999999998765543332          33467788899999 89999999998888


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ..+|+|+||+++|+|.++|.+.+   .+++.....++.+|+.||+|||+  .|||||||||+|||||+++++||+|||.
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccc
Confidence             88999999999999999999854   59999999999999999999999  8999999999999999999999999999


Q ss_pred             ccccccCCcc------e----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         330 VKMSETSNMK------T----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       330 a~~~~~~~~~------~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      |+........      .    .....++||..|.+||++.. ..++.+|+|+||||||.|+.|.+||.+.+++.....+.
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~  300 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ  300 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence            9876543221      1    11145899999999998765 56889999999999999999999999999988888877


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .-...+++.+            +..+.+||.+.|..||++|++..++.+
T Consensus       301 ~l~y~fp~~f------------p~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  301 ALDYEFPEGF------------PEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HhcccCCCCC------------CHHHHHHHHHHHccCccccccHHHHhh
Confidence            6544444333            345889999999999999999988754

>KOG0593|consensus

Probab=100.00  E-value=1.9e-45  Score=338.25  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=201.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+...++|+|+||.||+++.++ |+.||||++....+           .....+-..+|++.|++++|||+|.++++|..
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-----------d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr   72 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-----------DPVVKKIALREIRMLKQLKHENLVNLIEVFRR   72 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-----------cHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence            4555889999999999999875 99999999964322           12234557899999999999999999998887


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...+||+|||.. ++.+-|....  ..++...+.+++.|++.|+.|+|+  +++|||||||+|||++.+|.+||||||+
T Consensus        73 krklhLVFE~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   73 KRKLHLVFEYCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             cceeEEEeeecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchh
Confidence             888999999965 4555555533  358899999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cc----
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QE----  401 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~----  401 (455)
                      ||......   ...+..+.|..|.|||.+.|  +|+..+||||+||++.||++|.+.|.+.++....+.+..  ++    
T Consensus       148 AR~L~~pg---d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr  224 (396)
T KOG0593|consen  148 ARTLSAPG---DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR  224 (396)
T ss_pred             hHhhcCCc---chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence            99776321   11235688999999997755  689999999999999999999999998875443333322  11    


Q ss_pred             -------------cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 -------------VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 -------------~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                   ..+++.-+...-+..-..++..+-+|+..|+..||.+|++.++++.
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                         1112222221111112345668889999999999999999999864

>KOG0616|consensus

Probab=100.00  E-value=6e-45  Score=334.31  Aligned_cols=231  Identities=30%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ..||.|+||.|.+++.+. |..+|+|++.+...          ......+...+|..+|+.+.||+++++++.+.+ +..
T Consensus        50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v----------VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV----------VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             eeeccCccceEEEEEEccCCceeehhhcCHHHH----------HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            889999999999999874 78899999975432          122235567889999999999999999998887 899


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||.+||.|..+|++.   .++++..++.++.||+.||+|||+  .+|++||+||+|||||.+|.+||+|||+|+..
T Consensus       120 ymvmeyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEEEeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            9999999999999999984   469999999999999999999999  78999999999999999999999999999875


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ...      +.+.+|||.|+|||++ ...++.++|+|||||++|||+.|.+||...+....+.++.+.+..++.++++. 
T Consensus       195 ~~r------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~-  267 (355)
T KOG0616|consen  195 SGR------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSD-  267 (355)
T ss_pred             cCc------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHH-
Confidence            432      4568999999999966 45678899999999999999999999999999888888888888887776654 


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCC
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKR  439 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~R  439 (455)
                                 +++||.+.++.|-.+|
T Consensus       268 -----------~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  268 -----------AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----------HHHHHHHHHhhhhHhh
Confidence                       7888889999987777

>KOG0198|consensus

Probab=100.00  E-value=6.3e-45  Score=349.80  Aligned_cols=250  Identities=30%  Similarity=0.439  Sum_probs=198.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +..++.||+|+||.||++...+ |...|||.+......           .  .+.+.+|+.+|++++|||||+++|....
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-----------~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~   85 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-----------T--SESLEREIRILSRLNHPNIVQYYGSSSS   85 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccch-----------h--HHHHHHHHHHHHhCCCCCEEeeCCcccc
Confidence            3456899999999999999874 889999998644110           0  4458899999999999999999997433


Q ss_pred             -c--eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CCceEEee
Q psy5603         251 -I--MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGD  326 (455)
Q Consensus       251 -~--~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~D  326 (455)
                       .  .+++.|||+++|||.+++.+.++  .++++.+..++.||+.||.|||+  +||||+||||+|||++. ++.+||+|
T Consensus        86 ~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaD  161 (313)
T KOG0198|consen   86 RENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLAD  161 (313)
T ss_pred             ccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEecc
Confidence             3  68999999999999999998653  69999999999999999999999  89999999999999999 79999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCC--CcccchHHHHHHHHHHHcCCCCCCCC-cchhhHHHhhhcccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN-NTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~sDv~SlGvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~  403 (455)
                      ||++...............+.||+.|||||+...+.  ..++|||||||++.||+||.+||... ........+.... .
T Consensus       162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~  240 (313)
T KOG0198|consen  162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-S  240 (313)
T ss_pred             CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-C
Confidence            999886654111222234679999999999776433  34999999999999999999999873 2222222221111 1


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      .+        .+ +..++...++||.+|+..+|++|||+.++++.
T Consensus       241 ~P--------~i-p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  241 LP--------EI-PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             CC--------CC-CcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            11        11 22356678999999999999999999999874

>KOG0583|consensus

Probab=100.00  E-value=6.3e-44  Score=355.43  Aligned_cols=249  Identities=30%  Similarity=0.451  Sum_probs=206.5

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeeccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGL  247 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  247 (455)
                      ..|++++.||+|+||.|+.|... ++..||||++......... .       .....+.+|+.++++++ ||||++++.+
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~-------~~~~~i~rEi~~~~~~~~HpnI~~l~ev   88 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-Q-------KLDELIKREISILRRLRSHPNIIRLLEV   88 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-c-------ccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence            34677899999999999999875 5899999977654221111 0       11334668999999999 9999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-CceEEe
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLG  325 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~  325 (455)
                      ... ...++||||+.||+|.+++..   ..++.+..+..++.|++.|++|||+  +||+||||||+|||+|.+ +.+||+
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEe
Confidence            877 779999999999999999998   3468999999999999999999999  899999999999999999 999999


Q ss_pred             ecccccccc-cCCcceeeeccCCCCCCCCCcccccCC--C-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc
Q psy5603         326 DFGIVKMSE-TSNMKTMYTENLTGTRPYMPPEAMHCQ--I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       326 DFGla~~~~-~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      |||++.... ...    .....+||+.|+|||++.+.  | ..++||||+||+||.|++|..||+..+.......+....
T Consensus       164 DFG~s~~~~~~~~----~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~  239 (370)
T KOG0583|consen  164 DFGLSAISPGEDG----LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE  239 (370)
T ss_pred             ccccccccCCCCC----cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence            999999774 221    23467999999999988764  4 468999999999999999999999977655555555555


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      ..++..+.           +..+..|+.+||..+|.+|+++.+++
T Consensus       240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            55555542           33478889999999999999999997

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-43  Score=350.01  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++.++||+|+||.||+|.+.      +++.||||+++....      .      .....+.+|+.++.++ +||||+++
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~niv~~   76 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT------A------SEHKALMSELKILIHIGNHLNVVNL   76 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc------h------HHHHHHHHHHHHHHHhccCcceeeE
Confidence            466799999999999999742      246799999864321      0      0134588999999999 89999999


Q ss_pred             cccccC--ceeEEEEEeccCCCHHHHHhhcCC------------------------------------------------
Q psy5603         245 LGLCNN--IMNCIVYEYMCNGSLYDRLARVNN------------------------------------------------  274 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------  274 (455)
                      +++|..  ...++||||+++|+|.+++.....                                                
T Consensus        77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (338)
T cd05102          77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS  156 (338)
T ss_pred             EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence            998765  457899999999999999975321                                                


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeee
Q psy5603         275 -----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT  343 (455)
Q Consensus       275 -----------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  343 (455)
                                 ..++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~  233 (338)
T cd05102         157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRK  233 (338)
T ss_pred             cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcc
Confidence                       1358889999999999999999999  8999999999999999999999999999986533221 1112


Q ss_pred             ccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHH
Q psy5603         344 ENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVE  421 (455)
Q Consensus       344 ~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  421 (455)
                      ....++..|+|||++ ...++.++|||||||++|||++ |..||...................          ..+..++
T Consensus       234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~  303 (338)
T cd05102         234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM----------RAPENAT  303 (338)
T ss_pred             cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC----------CCCCCCC
Confidence            234567889999965 4467999999999999999997 999998754322111111111000          0112234


Q ss_pred             HHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         422 TLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       422 ~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+.+++.+||..||++||++.++++.|++++.
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            458889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578|consensus

Probab=100.00  E-value=2.4e-43  Score=349.34  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=215.2

Q ss_pred             HHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh
Q psy5603         157 CDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  235 (455)
Q Consensus       157 ~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  235 (455)
                      ..+......-+...+|..-.+||+|+.|.||.+... +++.||||++.......             ...+.+|+.+|+.
T Consensus       260 ~~l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-------------keLilnEi~Vm~~  326 (550)
T KOG0578|consen  260 AKLKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-------------KELLLNEILVMRD  326 (550)
T ss_pred             HHhheeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-------------hhhhHHHHHHHHh
Confidence            344455556666677777799999999999999865 47889999997544311             3347899999999


Q ss_pred             CCccceeeecccc-cCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       236 l~h~niv~l~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .+|+|||.++..+ ..+..+.|||||.||+|.|.+..    ..+++.++..|+.+++.||+|||.  +||+|||||++||
T Consensus       327 ~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnI  400 (550)
T KOG0578|consen  327 LHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNI  400 (550)
T ss_pred             ccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHh--cceeeecccccee
Confidence            9999999999954 45889999999999999998875    359999999999999999999999  8999999999999


Q ss_pred             EEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhh
Q psy5603         315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      |++.+|.+||+|||+|........   .....+||+.|||||+. ...|++++||||||++++||+-|.+||-..+...-
T Consensus       401 LL~~~g~vKltDFGFcaqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA  477 (550)
T KOG0578|consen  401 LLTMDGSVKLTDFGFCAQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  477 (550)
T ss_pred             EeccCCcEEEeeeeeeeccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH
Confidence            999999999999999887654432   34568999999999966 45799999999999999999999999998776555


Q ss_pred             HHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.+.....+         ....+..++..+++|+.+||..|+.+||++.|+++
T Consensus       478 lyLIa~ng~P---------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  478 LYLIATNGTP---------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHhhcCCC---------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            5554432211         11223466778999999999999999999999986

>KOG0193|consensus

Probab=100.00  E-value=6.3e-44  Score=354.73  Aligned_cols=257  Identities=29%  Similarity=0.502  Sum_probs=208.6

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      .++.+||+|.||+||+|+|.  ..||||+++......           ...+.|.+|+..+++-+|.||+-+.|||....
T Consensus       395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~-----------~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTP-----------EQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             hccceeccccccceeecccc--cceEEEEEecCCCCH-----------HHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            46789999999999999996  479999998654421           13677999999999999999999999999977


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      +.+|..+|.|-||+.+|+-.+  ..+...+.+.|+.||+.|+.|||.  ++|||||||+.||+|.+++.+||+|||++..
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             eeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccceee
Confidence            799999999999999998765  368999999999999999999999  9999999999999999999999999999876


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ...-. .........|...|||||++..    .++..|||||||||+|||+||..||.....+...+.+-.+... ++..
T Consensus       538 k~~w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~-pd~s  615 (678)
T KOG0193|consen  538 KTRWS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM-PDLS  615 (678)
T ss_pred             eeeec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC-ccch
Confidence            54332 1122345678889999997643    4789999999999999999999999955443332222211111 0110


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                            .....+++.+++|+..|+..++++||.+.+|+..|+.++.
T Consensus       616 ------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  616 ------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                  1123567779999999999999999999999999988764

>KOG0582|consensus

Probab=100.00  E-value=5.6e-43  Score=336.99  Aligned_cols=260  Identities=23%  Similarity=0.323  Sum_probs=205.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++...||.|..++||+|... .+..||||++.-....            .....+.+|++.++.++||||++++..|.
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~------------~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN------------NDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh------------hhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            3567789999999999999875 4799999999754331            11556889999999999999999998655


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ..+++||+||.+||+.+.+...-. ..+++..+..|++++++||.|||.  +|.||||||+.||||+.+|.+||+|||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCce
Confidence            4 899999999999999999987543 459999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeee-ccCCCCCCCCCccccc---CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         329 IVKMSETSNMKTMYT-ENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~-~~~~gt~~Y~aPE~~~---~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      .+-............ ..+.||+.|||||++.   .+|+.|+|||||||+..||.+|+.||.......+......+..+.
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~  251 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT  251 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence            865544433222222 6789999999999852   368999999999999999999999999876544333333222221


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..  ...............++.+|+.|+..||.+|||++++++
T Consensus       252 ~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11  111111112344557889999999999999999999875

>KOG0588|consensus

Probab=100.00  E-value=3.8e-43  Score=351.91  Aligned_cols=245  Identities=28%  Similarity=0.426  Sum_probs=209.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++-||.|+.|.|-+|++. +|+.+|||++.+........          ...+.+|+-+|+-+.||||+.+|+.+.+
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~----------~~~IerEIviMkLi~HpnVl~LydVwe~   83 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQ----------PAGIEREIVIMKLIEHPNVLRLYDVWEN   83 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeecccccccccc----------ccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence            578899999999999999975 69999999998764333222          2347789999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       .++|+|.||++||.|+++|.+   .+++++..+.+++.||+.|+.|+|.  .+|+|||+||+|+|||.++.+||+|||+
T Consensus        84 ~~~lylvlEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGM  158 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGM  158 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccce
Confidence             899999999999999999998   4569999999999999999999999  7899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccCC-C-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      |..-..+..    -.+.||++.|.|||++.|. | +.++||||+|||||.||||+.||++++......++..+...++.+
T Consensus       159 AsLe~~gkl----LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~  234 (786)
T KOG0588|consen  159 ASLEVPGKL----LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSN  234 (786)
T ss_pred             eecccCCcc----ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCc
Confidence            987554432    3456999999999988775 3 569999999999999999999999877555555555555544444


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                  ++...++||.+|+..||.+|.++.||++
T Consensus       235 ------------Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  235 ------------ISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ------------CCHHHHHHHHHHhccCccccccHHHHhh
Confidence                        4445899999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-42  Score=334.47  Aligned_cols=262  Identities=20%  Similarity=0.327  Sum_probs=205.6

Q ss_pred             CcceeeeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHH
Q psy5603         149 GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN  228 (455)
Q Consensus       149 ~~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (455)
                      .++..+++.++..     ...      ..||+|++|.||+|.++ |+.||||+++....      .    .......|.+
T Consensus        10 ~~~~~i~~~~i~~-----~~~------~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~------~----~~~~~~~~~~   67 (283)
T PHA02988         10 NDIKCIESDDIDK-----YTS------VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHK------G----HKVLIDITEN   67 (283)
T ss_pred             CcceecCHHHcCC-----CCC------eEEeeCCceEEEEEEEC-CEEEEEEecccccc------c----cHHHHHHHHH
Confidence            3455667776622     111      67999999999999995 79999999864321      0    0111456889


Q ss_pred             HHHHHhhCCccceeeecccccC-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         229 EVQTLSQCKHVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       229 E~~~l~~l~h~niv~l~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      |+.++++++||||++++|++.+     ...++||||+++|+|.+++...   ..+++.....++.+++.||.|||+. .+
T Consensus        68 E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~-~~  143 (283)
T PHA02988         68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKY-TN  143 (283)
T ss_pred             HHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhc-CC
Confidence            9999999999999999997754     3568999999999999999863   3689999999999999999999973 26


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc---CCCCcccchHHHHHHHHHHHc
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~sDv~SlGvvl~ellt  380 (455)
                      ++||||||+|||+++++.+||+|||+++......      ....||..|+|||++.   +.++.++|||||||++|||+|
T Consensus       144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~  217 (283)
T PHA02988        144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT  217 (283)
T ss_pred             CCCCcCChhhEEECCCCcEEEcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence            8899999999999999999999999987543321      2346899999999775   367899999999999999999


Q ss_pred             CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         381 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       381 G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      |..||...........+........          .+..++..+.+++.+||..||++||+++++++.|+++
T Consensus       218 g~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        218 GKIPFENLTTKEIYDLIINKNNSLK----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCC----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            9999987664333322221111110          0113455689999999999999999999999999875

>KOG0661|consensus

Probab=100.00  E-value=8.4e-44  Score=345.04  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  248 (455)
                      +|.+.++||.|+||.||+|+.+ +|..||||+++.+....+            .-.=.+|++.|+++. ||||+++.+.+
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e------------e~~nLREvksL~kln~hpniikL~Evi   78 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE------------ECMNLREVKSLRKLNPHPNIIKLKEVI   78 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH------------HHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence            3455689999999999999976 488999999986543211            122468999999998 99999999987


Q ss_pred             cC-c-eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         249 NN-I-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 ~~-~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .+ . .+++||||| ..+|++++...  ..++++..+..|+.||+.||+|+|.  +|+.|||+||+|||+..+..+||+|
T Consensus        79 ~d~~~~L~fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   79 RDNDRILYFVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             hccCceEeeeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecc
Confidence            76 4 789999999 68999999876  4589999999999999999999999  8999999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccc--cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--ccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEV  402 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~  402 (455)
                      ||+||........+    ..+.|..|.|||++  .+.|+.++|+||+|||++|+.+-++.|.+.+.....+++..  +..
T Consensus       154 FGLARev~SkpPYT----eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  154 FGLAREVRSKPPYT----EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP  229 (538)
T ss_pred             cccccccccCCCcc----hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence            99999877654332    45789999999955  45678999999999999999999999998886554444433  111


Q ss_pred             c---------hhhccchhccCCCh-------hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 P---------VREVLDKEAGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~---------~~~~~d~~~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .         +...+.-......+       ..++....+||.+||..||.+||++.|.++
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            1         00111111111111       125566778999999999999999999886

>KOG0659|consensus

Probab=100.00  E-value=2.7e-42  Score=312.54  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=200.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |...++||+|.||.||+|++. +|+.||||+++.......-           .....+|++.|+.++|+||+.+++.+..
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-----------~~talREIK~Lqel~h~nIi~LiD~F~~   72 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-----------NRTALREIKLLQELKHPNIIELIDVFPH   72 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-----------cHHHHHHHHHHHHccCcchhhhhhhccC
Confidence            455689999999999999975 5899999999865321111           2337799999999999999999998887


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +...||+||| ..+|+..+...  ...++..++..++.++++||+|||+  +.|+||||||.|+|++.+|.+||+|||+
T Consensus        73 ~~~l~lVfEfm-~tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   73 KSNLSLVFEFM-PTDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             CCceEEEEEec-cccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccc
Confidence             8889999999 47899988764  4589999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccc---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVP---  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~---  403 (455)
                      |+.........   ...+-|..|.|||.+.|  .|+..+|+||.|||+.||+-|.+-|.+.++......+.. -..+   
T Consensus       148 Ar~f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~  224 (318)
T KOG0659|consen  148 ARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD  224 (318)
T ss_pred             hhccCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence            99887654322   22378999999996644  589999999999999999999988888764333222222 0101   


Q ss_pred             -------hhhccchhccCC-----ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -------VREVLDKEAGEW-----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -------~~~~~d~~~~~~-----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ++++..-..-+.     --..++...-+|+.+++..||.+|+++.|+++
T Consensus       225 ~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  225 QWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence                   122221111000     01233445678999999999999999999876

>KOG0605|consensus

Probab=100.00  E-value=1.5e-42  Score=341.29  Aligned_cols=245  Identities=21%  Similarity=0.288  Sum_probs=197.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++...||+|+||.||+|+.++ |..+|+|++++..-....          .+.....|-.+|....+|+||++|-.+++ 
T Consensus       144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~----------Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKN----------QVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhh----------hHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            455999999999999999774 899999999876442221          24557889999999999999999998888 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ..+||||||++||++..+|.+   ...|++..+..++.+++.||..||+  .|+|||||||+|+|||..|++||+|||||
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeecccccc
Confidence            899999999999999999998   4579999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccC---------------------Cccee----e-------------------eccCCCCCCCCCcccccC-CCCcc
Q psy5603         331 KMSETS---------------------NMKTM----Y-------------------TENLTGTRPYMPPEAMHC-QISTK  365 (455)
Q Consensus       331 ~~~~~~---------------------~~~~~----~-------------------~~~~~gt~~Y~aPE~~~~-~~~~~  365 (455)
                      .-....                     .....    .                   ....+|||.|||||++.+ +++..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            422110                     00000    0                   012589999999997755 67899


Q ss_pred             cchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC
Q psy5603         366 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS  441 (455)
Q Consensus       366 sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs  441 (455)
                      +|+||||||+||||.|.+||...+....+..+......+...        ....++....+||.+||. ||++|..
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP--------EEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999999999999888887776633222111        112233567888888888 9999965

>KOG4721|consensus

Probab=100.00  E-value=2.6e-43  Score=346.63  Aligned_cols=235  Identities=30%  Similarity=0.512  Sum_probs=197.6

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      +-||.|+.|.||+|+++ ++.||||+++.-                    -..+|+-|++|+||||+.+.|+|.. ..+|
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~el--------------------kETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL--------------------KETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhh--------------------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            56999999999999998 599999998521                    2368899999999999999999988 8999


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ||||||+.|-|...|..   ..+++......+..+||.|+.|||.  +.|||||||+-||||..+..+||+|||-++...
T Consensus       189 IiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             EeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            99999999999999987   4578899999999999999999999  789999999999999999999999999888655


Q ss_pred             cCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhcc
Q psy5603         335 TSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  413 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  413 (455)
                      ...  +  .-.+.||.+|||||++.. ..+.|+|||||||||||||||..||.+.+.....+-+          -...+.
T Consensus       264 ~~S--T--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----------GsNsL~  329 (904)
T KOG4721|consen  264 DKS--T--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----------GSNSLH  329 (904)
T ss_pred             hhh--h--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec----------cCCccc
Confidence            432  2  335899999999998765 4689999999999999999999999876643222211          111122


Q ss_pred             CCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         414 EWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ...+..++.-++-|+++||.-.|.+||++.+++..|+
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            2234556667888999999999999999999998875

>KOG0600|consensus

Probab=100.00  E-value=1.8e-42  Score=338.08  Aligned_cols=257  Identities=24%  Similarity=0.356  Sum_probs=196.7

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +...+||+|+||.||+|++. +|+.||+|+++.+......           .....+||.||+++.||||++|.+...+ 
T Consensus       120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-----------~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-----------PITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-----------hHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            34488999999999999975 5899999999865431111           2336789999999999999999995433 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        +..|+|+|||+ -+|.-++...  ...+++.++..++.|++.||.|+|+  +||+|||||.+|||||.+|.+||+|||
T Consensus       189 ~~~siYlVFeYMd-hDL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMD-HDLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             CCceEEEEEeccc-chhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEecccc
Confidence              68899999995 5777776642  3469999999999999999999999  899999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~  405 (455)
                      ||++........ .+ ..+-|..|.|||++.|  .|++++|+||.||||.||++|++.|.+.....-...+.. -..+-.
T Consensus       264 LAr~y~~~~~~~-~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  264 LARFYTPSGSAP-YT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             ceeeccCCCCcc-cc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            999876554222 23 3467999999997765  589999999999999999999999999885544444433 111111


Q ss_pred             hccc---------hhcc-CCC------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLD---------KEAG-EWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d---------~~~~-~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++..         .+.. ...      ....+...-+|+..+|..||.+|.|+.++++
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1111         0000 000      0122334556899999999999999999875

>KOG0585|consensus

Probab=100.00  E-value=2e-42  Score=335.07  Aligned_cols=262  Identities=22%  Similarity=0.319  Sum_probs=206.7

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCC-chhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNS-DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      -|++...||+|.||.|-+|... +++.||||++.+......... .......+.++...+|+.||++|+|||||+|+.+.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            3567799999999999999976 489999999976543222111 11112234567799999999999999999999988


Q ss_pred             cC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         249 NN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       249 ~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      .+   ...|+|+|||..|.+..   +....+.+++.++++++.++..||.|||.  +|||||||||+|+||+++|++||+
T Consensus       178 DDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             cCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCCCcEEee
Confidence            66   67899999999998743   22223349999999999999999999999  899999999999999999999999


Q ss_pred             ecccccccccCCcc--eeeeccCCCCCCCCCcccccCC-----CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         326 DFGIVKMSETSNMK--TMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       326 DFGla~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~-----~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      |||.+.........  ...-....|||+|+|||...++     .+.+.||||+||+||.|+.|+.||.+......+.++.
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            99998866333211  1122447999999999966442     2558899999999999999999999988877777777


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +....++..-          .+...+++||.++|.+||++|.+..+|..
T Consensus       333 n~pL~fP~~p----------e~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  333 NDPLEFPENP----------EINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             cCcccCCCcc----------cccHHHHHHHHHHhhcChhheeehhhhee
Confidence            6554444321          24456899999999999999999988754

>KOG0597|consensus

Probab=100.00  E-value=1.1e-42  Score=342.34  Aligned_cols=243  Identities=27%  Similarity=0.408  Sum_probs=203.6

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      .+.+.||+|+||+||||+.| +.+.||+|.+.+....           ...++.+.+|++|+++++|||||.+++.+.. 
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-----------~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~   73 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-----------EKELKNLRQEVRILRSLKHPNIVEMLESFETS   73 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-----------hHHHHHHHHHHHHHHhcCCcchhhHHHhhccc
Confidence            34478999999999999987 4788999999654331           1125668999999999999999999998888 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .+.|+|.||+.| +|..+|...   ..++++++..|+.+++.||.|||+  .+|+|||+||.|||++..|.+|+||||+|
T Consensus        74 ~~~~vVte~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~A  147 (808)
T KOG0597|consen   74 AHLWVVTEYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLA  147 (808)
T ss_pred             ceEEEEehhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhh
Confidence            889999999976 999999874   459999999999999999999999  78999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +....+   +...+.+.|||-|||||+..+ .++..+|.||+||++||+.+|++||...........+..+...      
T Consensus       148 r~m~~~---t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~------  218 (808)
T KOG0597|consen  148 RAMSTN---TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK------  218 (808)
T ss_pred             hhcccC---ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC------
Confidence            977653   344567899999999997655 5788999999999999999999999977644443333322222      


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ++..++..+.+|+...+.+||.+|.++.+++.
T Consensus       219 ------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 ------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                  12356677899999999999999999998864

>KOG0694|consensus

Probab=100.00  E-value=1.7e-42  Score=349.61  Aligned_cols=238  Identities=25%  Similarity=0.349  Sum_probs=200.6

Q ss_pred             CCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  250 (455)
                      +.+.||+|+||+|+++..++ ++.+|||++++......+.          ......|..|+... +||.++.++..++. 
T Consensus       372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~----------Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE----------VESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc----------HHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            44899999999999999884 7889999999887654432          44567788877666 69999999999988 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .+.|+||||+.||++..+.+    ...+++..+..++..++.||+|||+  +||||||||.+|||||.+|++||+|||++
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecccccc
Confidence            89999999999999544433    3469999999999999999999999  89999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +..-...   ..+++++||+.|||||++.+ .|+.++|+|||||+|||||.|+.||.+++.......+...+..++..+ 
T Consensus       516 Ke~m~~g---~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~l-  591 (694)
T KOG0694|consen  516 KEGMGQG---DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL-  591 (694)
T ss_pred             cccCCCC---CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcc-
Confidence            8654332   24678999999999997755 689999999999999999999999999998877777766555554443 


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                 +.....++.+++..+|++|.-+
T Consensus       592 -----------s~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  592 -----------SKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----------cHHHHHHHHHHhccCcccccCC
Confidence                       3346677889999999999766

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.5e-42  Score=338.25  Aligned_cols=242  Identities=23%  Similarity=0.359  Sum_probs=194.1

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||||+++......          ......+.+|+.++++++||||+++++++.+ ...
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   70 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA----------KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL   70 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE
Confidence            36999999999999976 58899999997532210          1113457889999999999999999998776 788


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++..   ...+++.++..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          71 CFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            999999999999999876   3468999999999999999999999  88999999999999999999999999998753


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......||+.|+|||++.+ .++.++|||||||++|||+||..||...+.......+......++       
T Consensus       146 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p-------  215 (323)
T cd05571         146 ISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-------  215 (323)
T ss_pred             ccCC---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence            2221   11234679999999997654 578999999999999999999999987654333332222222221       


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           ..++..+.+||.+||..||++||     ++.++++
T Consensus       216 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 -----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                 12344578899999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-42  Score=332.49  Aligned_cols=243  Identities=26%  Similarity=0.385  Sum_probs=196.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +++.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   72 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR----------LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD   72 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh----------hHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc
Confidence            455689999999999999987 48899999986432100          0114458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+  +|++||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          73 QRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCc
Confidence             7889999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.....      .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......++.  
T Consensus       148 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--  219 (291)
T cd05612         148 AKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--  219 (291)
T ss_pred             chhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc--
Confidence            8765332      123579999999997654 5788999999999999999999999877644433333322222211  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                ..+..+.+||.+|+..||.+||+     +.++++
T Consensus       220 ----------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         220 ----------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ----------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                      12345888999999999999995     777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-42  Score=339.95  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=195.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||+++......          ......+.+|+.++++++||||+++++++.+
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK----------MKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh----------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            455689999999999999986 47899999997532111          1114558899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~  164 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGF  164 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccC
Confidence             8889999999999999999863   458999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......      ....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.........+......++.. 
T Consensus       165 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~-  237 (329)
T PTZ00263        165 AKKVPDRT------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW-  237 (329)
T ss_pred             ceEcCCCc------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC-
Confidence            87653321      23579999999997654 57889999999999999999999998766443333332222222211 


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIV  446 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl  446 (455)
                                 ++..+.+||.+||..||++||+     +++++
T Consensus       238 -----------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        238 -----------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             -----------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence                       2345788999999999999996     56665

>KOG0580|consensus

Probab=100.00  E-value=2e-42  Score=309.12  Aligned_cols=245  Identities=26%  Similarity=0.419  Sum_probs=207.5

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++++.||+|-||.||+|+.+ ++..||+|++.+......          -...++.+|++|-+.++||||+++|+++.+ 
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~----------~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKT----------QVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHh----------cchhhhhheeEeecccCCccHHhhhhheecc
Confidence            45699999999999999976 477899999986553221          124668999999999999999999999888 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...||++||.++|+|...|.... ...+++.....++.|+|.|+.|+|.  +++|||||||+|+|++..+..||+|||-+
T Consensus        95 ~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            88899999999999999998543 4568999999999999999999999  89999999999999999999999999988


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ...+.+.     ....+||..|+|||...+ ..+..+|+|++|++.||++.|.+||........+..+..-...++.   
T Consensus       172 V~~p~~k-----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~---  243 (281)
T KOG0580|consen  172 VHAPSNK-----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS---  243 (281)
T ss_pred             eecCCCC-----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc---
Confidence            7665332     345799999999997766 5688999999999999999999999988866666655543333332   


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .++...++||.+|+..+|.+|.+..||++
T Consensus       244 ---------~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  244 ---------TISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ---------ccChhHHHHHHHHhccCccccccHHHHhh
Confidence                     34455889999999999999999999876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-42  Score=335.77  Aligned_cols=238  Identities=23%  Similarity=0.300  Sum_probs=190.0

Q ss_pred             cCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||+|.++ +++.||+|+++......          ......+.+|+.++.+++||||+++++++.+ ...|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   70 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS----------RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYL   70 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEE
Confidence            799999999999986 47889999986432111          1114557889999999999999999998776 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        71 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          71 VLAFINGGELFHHLQRE---GRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            99999999999999763   458999999999999999999999  8899999999999999999999999999875432


Q ss_pred             CCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccC
Q psy5603         336 SNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ..   .......||+.|+|||++.+ .++.++|||||||++|||+||..||...........+......++         
T Consensus       146 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---------  213 (312)
T cd05585         146 DD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP---------  213 (312)
T ss_pred             CC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC---------
Confidence            21   12345679999999997644 578899999999999999999999987654333332222221111         


Q ss_pred             CChhHHHHHHHHHHHhhhccCcCCCCCHHHH
Q psy5603         415 WNETHVETLISIVFEKCCVFEKDKRASMRDI  445 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RPs~~ev  445 (455)
                         ..++..+.+||.+||..||++||+...+
T Consensus       214 ---~~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         214 ---DGFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             ---CcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence               2234558899999999999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-41  Score=343.33  Aligned_cols=257  Identities=27%  Similarity=0.463  Sum_probs=197.2

Q ss_pred             CcCCCccCcCCCeEEEEEEE------cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      +++++.||+|+||.||+|++      .++..||||+++.....     .       ....+.+|+.++..+ +||||+++
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-----~-------~~~~~~~Ei~il~~l~~HpnIv~l  104 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-----T-------EREALMSELKVLSYLGNHINIVNL  104 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-----H-------HHHHHHHHHHHHHHhcCCcceeee
Confidence            34568999999999999974      23568999998643210     1       134588999999999 89999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------------------------------------------
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------------------  274 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------  274 (455)
                      +++|.+ ...++||||+++|+|.+++.....                                                 
T Consensus       105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (375)
T cd05104         105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD  184 (375)
T ss_pred             eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence            998877 788999999999999999865321                                                 


Q ss_pred             -----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         275 -----------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       275 -----------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                                             ..++++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~  262 (375)
T cd05104         185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLAR  262 (375)
T ss_pred             cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccce
Confidence                                   1257889999999999999999999  889999999999999999999999999988


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......... ......++..|+|||.+ .+.++.++|||||||++|||++ |..||..................      
T Consensus       263 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------  335 (375)
T cd05104         263 DIRNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR------  335 (375)
T ss_pred             eccCccccc-ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc------
Confidence            654332111 12233456789999966 4467899999999999999998 99999765432211111111100      


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          ...+...+..+.+|+.+||..||++||++.+|++.|++.+
T Consensus       336 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         336 ----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence                0011122445889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-41  Score=330.77  Aligned_cols=262  Identities=28%  Similarity=0.382  Sum_probs=196.7

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-----------------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      .|++.++||+|+||.||+|.+++                 +..||+|.+.....      .      .....|.+|+.++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l   73 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN------K------NARNDFLKEVKIL   73 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC------H------HHHHHHHHHHHHH
Confidence            35667899999999999998642                 33699999864321      1      1145688999999


Q ss_pred             hhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHH
Q psy5603         234 SQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVN----------------NTPPLDSNKRYSIALGVAEALHY  296 (455)
Q Consensus       234 ~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~gl~~  296 (455)
                      .+++||||+++++++.+ ...|+||||+++|+|.+++....                ....+++..++.++.|++.||.|
T Consensus        74 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  153 (304)
T cd05096          74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY  153 (304)
T ss_pred             hhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            99999999999998877 78899999999999999986532                12357889999999999999999


Q ss_pred             HHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHH
Q psy5603         297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVIL  375 (455)
Q Consensus       297 LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl  375 (455)
                      ||+  .+|+||||||+|||++.++.+||+|||+++....... ........++..|+|||.+ .+.++.++||||||+++
T Consensus       154 lH~--~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         154 LSS--LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL  230 (304)
T ss_pred             HHH--CCccccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence            999  8899999999999999999999999999876543321 1123345668899999965 55789999999999999


Q ss_pred             HHHHc--CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         376 LELLT--GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       376 ~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      |||++  +..||...............   ..... .......+..++..+.+++.+|+..+|++||++.+|.+.|++
T Consensus       231 ~el~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         231 WEILMLCKEQPYGELTDEQVIENAGEF---FRDQG-RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHHHccCCCCCCcCCHHHHHHHHHHH---hhhcc-ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            99987  66788765432211111100   00000 000000112344568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-41  Score=333.32  Aligned_cols=242  Identities=23%  Similarity=0.367  Sum_probs=193.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||+|+++......          ......+.+|++++++++||||+++++++.. ...
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~   70 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA----------KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   70 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE
Confidence            36999999999999976 48999999997543211          1114457889999999999999999997766 788


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          71 CFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            9999999999999988763   468999999999999999999999  88999999999999999999999999998753


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......||+.|+|||.+. +.++.++|||||||++|||++|..||...+.......+......++       
T Consensus       146 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p-------  215 (323)
T cd05595         146 ISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP-------  215 (323)
T ss_pred             cCCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-------
Confidence            2221   1123467999999999764 4678999999999999999999999987654333322222222221       


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           ..++..+.++|.+||..||++||     ++.++++
T Consensus       216 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 -----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                 12344578899999999999998     7877764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-41  Score=334.95  Aligned_cols=242  Identities=24%  Similarity=0.377  Sum_probs=193.4

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||||++.......          ......+.+|++++++++||||+++++++.+ ...
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   70 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA----------KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL   70 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE
Confidence            36999999999999976 48899999997543211          1114568889999999999999999998776 788


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++..   ...+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~Ey~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          71 CFVMEYVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             EEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            999999999999998876   3468999999999999999999999  88999999999999999999999999998753


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......||+.|+|||.+. ..++.++|||||||++|||++|..||...+.......+......++       
T Consensus       146 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p-------  215 (328)
T cd05593         146 ITDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP-------  215 (328)
T ss_pred             CCcc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC-------
Confidence            3221   1123467999999999764 4678999999999999999999999987654332222221222111       


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           ..++..+.+||.+||..||++||     ++.++++
T Consensus       216 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         216 -----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence                 12344578899999999999997     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG1026|consensus

Probab=100.00  E-value=2.9e-42  Score=356.30  Aligned_cols=253  Identities=29%  Similarity=0.474  Sum_probs=208.6

Q ss_pred             CCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         175 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+.||+|+||+||+|+..      +.+.||||.++..+..            ...+.|++|++.+..++|||||+++|.|
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~------------~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN------------QARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH------------HHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            377999999999999853      2467999999865431            1256699999999999999999999999


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      .+ +.+|+|+|||..|+|.++|.....           .++|+..+.+.||.|||.|+.||-+  +.+|||||-..|+||
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLV  636 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhcee
Confidence            88 777999999999999999975321           2348999999999999999999999  789999999999999


Q ss_pred             cCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcc-cccCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhH
Q psy5603         317 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY  394 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~  394 (455)
                      +++..+||+|||++|.....+..... ..-.-..+||||| ++.+++|++||||||||||||++| |+.||.+....++.
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            99999999999999987765543311 1122345799999 778999999999999999999999 99999988765554


Q ss_pred             HHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..+..+..           -..++.++..+..|+..||+..|++||+++||-.+|+...
T Consensus       716 e~i~~g~l-----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  716 ECIRAGQL-----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHcCCc-----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            44433221           1124566777889999999999999999999999998753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-41  Score=326.94  Aligned_cols=250  Identities=20%  Similarity=0.258  Sum_probs=193.9

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||+|+||.||+|.+. +|+.||||.+........          .....+.+|+.++++++|+||+++++++.+ 
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~   72 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKRILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh----------hhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence            44588999999999999875 589999999865432110          012347889999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          73 DALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             CeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            78899999999999998886533 3468999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......    ......||..|+|||++. ..++.++|||||||++|||++|..||..................      
T Consensus       150 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------  219 (285)
T cd05631         150 VQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE------  219 (285)
T ss_pred             EEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc------
Confidence            7653322    123457999999999764 46889999999999999999999999876532111111100000      


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      ..  ......++..+.+|+.+||..||++||+     ++++++
T Consensus       220 ~~--~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 DQ--EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cc--ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            00  0011224456888999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-41  Score=337.20  Aligned_cols=242  Identities=24%  Similarity=0.361  Sum_probs=195.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcC--CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .+.+.||+|+||.||+|.+++  +..||+|++.......          ......+.+|+.+++.++||||+++++++.+
T Consensus        33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK----------QKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh----------hhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            445889999999999998653  3689999986432211          1113458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCC
Confidence             7889999999999999999863   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.....      .....||+.|+|||++.+ .++.++|||||||++|||++|.+||...+.......+......++.  
T Consensus       178 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--  249 (340)
T PTZ00426        178 AKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK--  249 (340)
T ss_pred             CeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--
Confidence            8765321      224579999999997654 5788999999999999999999999887654444433322222221  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                .++..+.++|.+|+..+|++|+     +++++++
T Consensus       250 ----------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        250 ----------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ----------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                      1234478899999999999995     7888765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.8e-41  Score=321.11  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=198.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +++.+.||+|+||.||+|.++    .+..||+|.++....      .      .....|.+|+.++.+++||||++++++
T Consensus         7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~iv~~~~~   74 (266)
T cd05064           7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS------D------KQRRGFLAEALTLGQFDHSNIVRLEGV   74 (266)
T ss_pred             eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC------H------HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            355689999999999999864    256899999864321      1      113458899999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.. ...|+||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+  ++++||||||+|||++.++.+|++|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          75 ITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             EecCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECC
Confidence            766 78899999999999999987643  368999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||.+........  .......++..|+|||.+ .+.++.++|||||||++||+++ |..||............... ...
T Consensus       151 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~  227 (266)
T cd05064         151 FRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRL  227 (266)
T ss_pred             Ccccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCC
Confidence            998765432211  111223456789999965 4567899999999999999875 99999876543322222111 000


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                                ..+..++..+.+++.+||..+|.+||++.++.+.|.+++
T Consensus       228 ----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         228 ----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence                      012234556888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.4e-41  Score=338.30  Aligned_cols=256  Identities=28%  Similarity=0.469  Sum_probs=197.4

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeec
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      ++++.||+|+||.||+|.+.      ++..||||+++....      .+      ....+.+|+.+++.+ +|+||++++
T Consensus        41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~------~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH------TD------EREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC------HH------HHHHHHHHHHHHHhhccCCceeeEe
Confidence            45589999999999999853      235799999964322      10      134588999999999 899999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC--------------------------------------------------
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN--------------------------------------------------  274 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------  274 (455)
                      ++|.. ...|+||||+++|+|.+++.....                                                  
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            98877 788999999999999999864211                                                  


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCC
Q psy5603         275 -----------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN  337 (455)
Q Consensus       275 -----------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  337 (455)
                                       ..++++.+++.++.|++.||.|||+  ++++||||||+|||+++++.+||+|||+++......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~  266 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS  266 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence                             1357889999999999999999999  889999999999999999999999999987654332


Q ss_pred             cceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhccCC
Q psy5603         338 MKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEW  415 (455)
Q Consensus       338 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  415 (455)
                      .. .......++..|+|||++ .+.++.++|||||||++|||++ |..||..................          ..
T Consensus       267 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~----------~~  335 (374)
T cd05106         267 NY-VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ----------MS  335 (374)
T ss_pred             ce-eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC----------cc
Confidence            11 112233456789999965 4568999999999999999997 99999865432211111111100          00


Q ss_pred             ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         416 NETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       416 ~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .+...+..+.+++.+|+..+|++||++.+|++.|++++
T Consensus       336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            01123455888999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=334.09  Aligned_cols=251  Identities=23%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. ++.||||+++......          ......+.+|++++.+++||||+++++++.+
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~   72 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK----------LNEVRHVLTERDILTTTKSEWLVKLLYAFQD   72 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh----------hhHHHHHHHHHHHHHhCCCCCCccEEEEEEc
Confidence            4566899999999999999874 7899999997542210          1114558899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++..   ...+++.++..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          73 DEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcC
Confidence             788999999999999999976   3468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++....      ......||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......+.   
T Consensus       148 a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  218 (333)
T cd05600         148 SKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---  218 (333)
T ss_pred             Cccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---
Confidence            875433      1234689999999997644 678899999999999999999999987664333222221111100   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ......+...++..+.++|.+|+..+|.+||++.++++
T Consensus       219 -~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         219 -RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             -CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence             00000001234556788999999988999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.5e-41  Score=324.44  Aligned_cols=258  Identities=20%  Similarity=0.237  Sum_probs=194.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+++ +++.||||+++......           .....+.+|++++++++||||+++++++..
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-----------EVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-----------cchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            556689999999999999987 47889999997542211           113457889999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||++++++..+...   ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence             888999999998877655433   2468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccch--
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV--  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~--  404 (455)
                      ++.......  .......||+.|+|||++. ..++.++|+|||||++|||++|.+||...+.......+..  ...+.  
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd07848         147 ARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ  224 (287)
T ss_pred             ccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence            886543221  1123457899999999664 4678899999999999999999999987653221111111  00000  


Q ss_pred             ----------hhccchhccC------CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 ----------REVLDKEAGE------WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ----------~~~~d~~~~~------~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                .....+....      .....++..+.+|+.+|+..||++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                      0000000000      001124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.8e-41  Score=332.86  Aligned_cols=259  Identities=19%  Similarity=0.337  Sum_probs=192.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|.++ +|..||||++.......    .       ....+.+|+.++++++||||+++++++..
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   70 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV----S-------DATRILREIKLLRLLRHPDIVEIKHIMLP   70 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc----h-------hHHHHHHHHHHHHhCCCCCEeeecceEec
Confidence            566789999999999999976 48999999986432110    0       13457899999999999999999997632


Q ss_pred             ------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         251 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       251 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                            ...|+||||+ +++|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        71 ~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL  144 (338)
T cd07859          71 PSRREFKDIYVVFELM-ESDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKI  144 (338)
T ss_pred             cCCCCCceEEEEEecC-CCCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEE
Confidence                  2479999999 5799998876   3468999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCccccc---CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      +|||+++................||+.|+|||++.   ..++.++|||||||++|||+||.+||.............. .
T Consensus       145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~  224 (338)
T cd07859         145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL  224 (338)
T ss_pred             ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            99999986543222222223467999999999764   3578899999999999999999999987653211111100 0


Q ss_pred             ccchh------------hccch----hccCCC--hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVR------------EVLDK----EAGEWN--ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~------------~~~d~----~~~~~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+..            ..+..    ......  ...++..+.+++.+||..+|++||++.++++
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000            00000    000000  0123345778999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.7e-41  Score=324.40  Aligned_cols=260  Identities=23%  Similarity=0.307  Sum_probs=195.6

Q ss_pred             CCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         168 RKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       168 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ....|++.++||+|+||.||+|..+ ++..||+|+++.......            ...+.+|+.++++++||||+++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~   70 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA------------PCTAIREVSLLKNLKHANIVTLHD   70 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc------------chhHHHHHHHHHhCCCCCEeeEEE
Confidence            3445677799999999999999976 478999999864321100            223678999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...++||||+. |+|.+++....  ..+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+
T Consensus        71 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~  145 (288)
T cd07871          71 IIHTERCLTLVFEYLD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLA  145 (288)
T ss_pred             EEcCCCeEEEEEeCCC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEC
Confidence            8776 77899999996 59999887543  357899999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-ccc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~  402 (455)
                      |||+++......   .......||+.|+|||.+.+  .++.++|||||||++|||+||.+||...+.......+.. ...
T Consensus       146 DfG~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  222 (288)
T cd07871         146 DFGLARAKSVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT  222 (288)
T ss_pred             cCcceeeccCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999987543321   11234578999999997643  478899999999999999999999987653322221111 000


Q ss_pred             chh----h---------ccchhcc--CC--ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVR----E---------VLDKEAG--EW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~----~---------~~d~~~~--~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..    .         ...+...  .+  ....++....+||.+|+..||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000    0         0000000  00  00123456788999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0611|consensus

Probab=100.00  E-value=1.9e-41  Score=322.10  Aligned_cols=248  Identities=24%  Similarity=0.416  Sum_probs=205.7

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEE-cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      .-+|++.+.||+|+||.|-+|.. +.|+.||||.++++.....      +    ....+.+|++|++.++||||+.+|.+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde------q----DlvhIRREIeIMSsLNHPhII~IyEV  121 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE------Q----DLVHIRREIEIMSSLNHPHIIQIYEV  121 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH------H----HHHHHHHHHHHHhhcCCCceeehhhh
Confidence            34456668999999999999986 5699999999987655221      1    14558899999999999999999999


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      |.+ +...+||||..+|.|+|++...+   .+++.....++.||..|+.|+|.  ++++|||||.+|||||.++.+||+|
T Consensus       122 FENkdKIvivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  122 FENKDKIVIVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             hcCCceEEEEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeec
Confidence            988 88899999999999999999844   59999999999999999999999  7899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCC--CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||++........    -.+++|++-|.+||+.+|..  .+.+|.|||||+||.|..|..||++.+...+...+..+.   
T Consensus       197 FGLSNly~~~kf----LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga---  269 (668)
T KOG0611|consen  197 FGLSNLYADKKF----LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA---  269 (668)
T ss_pred             cchhhhhccccH----HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc---
Confidence            999987765542    35689999999999988864  679999999999999999999999987544443333211   


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                        +        .+..-+....-||..||..+|++|.++.+|...
T Consensus       270 --Y--------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 --Y--------REPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             --c--------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence              1        111112235556889999999999999998753

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.1e-41  Score=330.88  Aligned_cols=243  Identities=23%  Similarity=0.311  Sum_probs=191.8

Q ss_pred             CccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         176 NKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||++...    +++.||||+++.......         ......+.+|+.++++++||||+++++++.. 
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~   72 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN---------QKDTAHTKAERNILEAVKHPFIVDLIYAFQTG   72 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh---------hhhHHHHHHHHHHHHhCCCCchhceeeEEecC
Confidence            67999999999999863    478899999975322110         1113457889999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          73 GKLYLILEYLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             CeEEEEEeCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            788999999999999999976   3468899999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +......   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......++.   
T Consensus       148 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~---  221 (323)
T cd05584         148 KESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP---  221 (323)
T ss_pred             eecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence            7543222   11234579999999997654 5788999999999999999999999876643322222222211111   


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               .++..+.++|.+|+..+|++||     ++.++++
T Consensus       222 ---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         222 ---------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                     2334578899999999999999     7777754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-40  Score=315.12  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=196.8

Q ss_pred             ccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCcee
Q psy5603         177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      .||+|+||.||+|.++   ++..||+|+++.....           ......+.+|+.+++++.||||+++++++.+...
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   70 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-----------PALKDELLREANVMQQLDNPYIVRMIGICEAESW   70 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-----------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCc
Confidence            5899999999999753   4688999998643210           0124568899999999999999999999888888


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++++||||||+||++++++.+||+|||+++..
T Consensus        71 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          71 MLVMELAELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            9999999999999999763   358999999999999999999999  88999999999999999999999999998865


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............++..|+|||.+. +.++.++|+|||||++|||++ |..||...........+.....  ..     
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~-----  218 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--ME-----  218 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--CC-----
Confidence            44332111122234567899999664 457889999999999999998 9999987654332222221110  00     


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                          .+..++..+.++|.+||..+|++||++.+|.+.|++.
T Consensus       219 ----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 ----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                1112445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0194|consensus

Probab=100.00  E-value=2.1e-41  Score=339.51  Aligned_cols=253  Identities=30%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             CCccCcCCCeEEEEEEEcC--C--cE-EEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         175 GNKLGEGQFGTVYYGKLKN--G--ME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~--~--~~-vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      +++||+|+||.||+|+++.  +  .. ||||..+....          .....+..|.+|.+++++++|||||++||++.
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~----------~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE----------LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeeccccc----------ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            4889999999999999763  2  23 89999874221          12334778999999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ..+++|||+|.||+|.++|....+  .++..++..++.++|.||+|||+  +++|||||-..|+|++.++.+||+|||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCccc
Confidence            7 777899999999999999998543  59999999999999999999999  899999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++........   ...-.-...|+|||.+ .+.++.++|||||||++||+++ |..||.+.........+.....+.  
T Consensus       308 Ls~~~~~~~~~---~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~--  382 (474)
T KOG0194|consen  308 LSRAGSQYVMK---KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM--  382 (474)
T ss_pred             cccCCcceeec---cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC--
Confidence            98865421111   1111334679999965 5578999999999999999999 899999987654444442221111  


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              ..+...+..+..++.+||..+|++||+|.++.+.|+.+.+
T Consensus       383 --------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  383 --------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             --------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                    1112345567788889999999999999999999988754

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-40  Score=327.13  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=197.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-Cc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +..+.||+|+||.||+|.+.. +.    .||||+++....            ......+.+|+.+++.++||||++++|+
T Consensus        10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~niv~~~g~   77 (316)
T cd05108          10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------------PKANKEILDEAYVMASVDNPHVCRLLGI   77 (316)
T ss_pred             eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC------------HHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            445899999999999998742 33    489999863211            0113458899999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      |.....++|++|+++|+|.+++....  ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~Df  153 (316)
T cd05108          78 CLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDF  153 (316)
T ss_pred             EcCCCceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccc
Confidence            98878899999999999999998643  358899999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++........ .......++..|+|||.+ ...++.++|||||||++|||++ |..||.+............. ...+
T Consensus       154 G~a~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~  231 (316)
T cd05108         154 GLAKLLGADEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP  231 (316)
T ss_pred             cccccccCCCcc-eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCCC
Confidence            999876543211 112223456789999965 4567899999999999999998 99999876533322221111 1100


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                .+..++..+.+++.+|+..+|.+||++.+++..|.++.+
T Consensus       232 ----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         232 ----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                      011123347788999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0201|consensus

Probab=100.00  E-value=3.3e-42  Score=331.43  Aligned_cols=242  Identities=27%  Similarity=0.388  Sum_probs=199.6

Q ss_pred             CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      ..+||+|.||.||+|.+. +++.||+|++.....            ...+...++|+.++.+|+++||.++|+.+.. ..
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~------------~deIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA------------EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhc------------chhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            378999999999999986 478999999965432            1125558899999999999999999996655 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+++||||.||++.+.|..   +..+.+..+..|+.+++.|+.|||.  ++.+|||||++|||+..+|.+|++|||.+-.
T Consensus        86 LwiiMey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeee
Confidence            8999999999999999986   4456888999999999999999999  8899999999999999999999999999876


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   ....+++||+-|||||++.+ .|+.|+||||||++.+||++|.+|+.+..+......+.....       +.
T Consensus       161 l~~~~---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P-------P~  230 (467)
T KOG0201|consen  161 LTNTV---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP-------PR  230 (467)
T ss_pred             eechh---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC-------Cc
Confidence            55433   22367899999999997765 789999999999999999999999998765332222221111       11


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +    ...++..+++|+..|+..+|+.||++.++++
T Consensus       231 L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  231 L----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             c----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1    1245566999999999999999999999986

>KOG0663|consensus

Probab=100.00  E-value=4.2e-41  Score=313.39  Aligned_cols=255  Identities=24%  Similarity=0.296  Sum_probs=196.3

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC--
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ..++|++|+||.||+|+++ +++.||+|+++.+....          -+++. ..+||.+|.+++|||||.+-.+...  
T Consensus        80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~----------GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE----------GFPIT-SLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             HHhhcccCcceeEEEeccCCcceeEEeeecccccccC----------CCcch-hHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            3389999999999999987 47899999998654311          12233 5799999999999999999885433  


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+|||||. -+|...+....  .++...++..+..|+++|++|||.  +.|+|||||++|+|+...|.+||+|||+
T Consensus       149 ~d~iy~VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  149 MDKIYIVMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             cceeeeeHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccch
Confidence             67899999995 68888887754  479999999999999999999999  7899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccc---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVP---  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~---  403 (455)
                      ||..+....  . .+..+-|..|.|||++.|  .+++++|+||+|||+.||+++.+-|.+.........+.. -..+   
T Consensus       224 AR~ygsp~k--~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  224 AREYGSPLK--P-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             hhhhcCCcc--c-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            998776521  1 234577999999997755  589999999999999999999999998874333333222 0000   


Q ss_pred             -hhhcc--------------chhc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -VREVL--------------DKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -~~~~~--------------d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .+.+.              -..+ +.+........-.+|+..++..||.+|.|+.+.++
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             01000              0000 11111124456778999999999999999998764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-40  Score=328.74  Aligned_cols=237  Identities=27%  Similarity=0.347  Sum_probs=189.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++ +++.||||++........          .....+..|..++..+ +||||+++++++.+ ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   70 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD----------DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR   70 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc----------cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE
Confidence            36999999999999986 478999999875322111          1134577888888876 69999999998777 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~iv~Ey~~~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          71 LFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             EEEEEcCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            89999999999999998763   468999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+......++.     
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----  217 (320)
T cd05590         146 GIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT-----  217 (320)
T ss_pred             cCcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-----
Confidence            33221   12344679999999997654 5788999999999999999999999877644433333222222111     


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                             .++..+.++|.+|+..||++||++
T Consensus       218 -------~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         218 -------WLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -------CCCHHHHHHHHHHcccCHHHCCCC
Confidence                   234457889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.8e-40  Score=314.92  Aligned_cols=255  Identities=26%  Similarity=0.363  Sum_probs=203.1

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      ..|++.++||+|+||.||+|.++++..||+|+++....              ....|.+|++++++++||||+++++++.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--------------~~~~~~~E~~~l~~l~~~~i~~~~~~~~   71 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--------------SPEAFLQEAQVMKKLRHEKLVQLYAVVS   71 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--------------CHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence            34677799999999999999987667899999864221              1235889999999999999999999887


Q ss_pred             CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      +...++||||+++|+|.+++.... ...+++..+..++.+++.||.|||+  .+++||||||+||++++++.+||+|||.
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~  148 (262)
T cd05071          72 EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGL  148 (262)
T ss_pred             CCCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCc
Confidence            777899999999999999997532 3457999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........  ......++..|+|||.. .+.++.++|+||||+++|||+| |..||................ ..   
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~---  222 (262)
T cd05071         149 ARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM---  222 (262)
T ss_pred             eeeccccccc--cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CC---
Confidence            8765433211  12234567789999965 4568899999999999999999 898997665332222221110 00   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                             .....++..+.+++.+|+..+|++||++.++++.|++.++
T Consensus       223 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~~  262 (262)
T cd05071         223 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  262 (262)
T ss_pred             -------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhcC
Confidence                   0012344567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.7e-40  Score=326.84  Aligned_cols=255  Identities=25%  Similarity=0.328  Sum_probs=196.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.++ ++..||+|.+.....            ......+.+|++++++++||||+++++++.+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK------------PAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC------------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            455689999999999999987 478899999864311            0114568999999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence             7889999999999999999763   3589999999999999999999982 3599999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc----cc-
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE----VP-  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~----~~-  403 (455)
                      +.......     .....||+.|+|||.+.+ .++.++|||||||++|||+||+.||...+............    .. 
T Consensus       151 ~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (331)
T cd06649         151 SGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE  225 (331)
T ss_pred             cccccccc-----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCC
Confidence            87553321     234579999999997654 57889999999999999999999997655322211110000    00 


Q ss_pred             ---------------------------hhhccc----hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 ---------------------------VREVLD----KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ---------------------------~~~~~d----~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                                 ..+..+    ......+...++..+.+||.+||..||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                       000000    00011112235567899999999999999999999976

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-40  Score=326.74  Aligned_cols=241  Identities=25%  Similarity=0.350  Sum_probs=188.3

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh-CCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++. ++.||||+++.......          .....+..|..++.. .+||||+++++++.. ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~   70 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED----------DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence            369999999999999864 78899999975432111          012335567777765 489999999998766 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          71 LFFVMEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            89999999999999998763   468999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+......++      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~------  216 (316)
T cd05592         146 NMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP------  216 (316)
T ss_pred             CCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            43322   12345679999999997654 578899999999999999999999987664333332222111111      


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHH-HHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                            ..++..+.+|+.+||..+|++||++. +++
T Consensus       217 ------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 ------RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                  12344578899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.7e-40  Score=314.26  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=200.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++.++||+|+||.||+|..++++.||+|.+.....              ....+.+|+.++++++|+||+++++++.+ 
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--------------SVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             eEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--------------hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            356689999999999999988788899999753211              13458899999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++.... ...+++..++.++.+++.||+|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccc
Confidence            77899999999999999997643 3468999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......++..|+|||.+. +.++.++|||||||++|+|+| |..||............... ...+   
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~---  224 (261)
T cd05072         151 RVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP---  224 (261)
T ss_pred             eecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCC---
Confidence            86543321  1122345677899999654 467889999999999999998 99999876533322222211 1100   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                             ....++..+.+++.+||..+|++||+++++.+.|+++
T Consensus       225 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 -------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                   0112344578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-40  Score=328.18  Aligned_cols=242  Identities=25%  Similarity=0.342  Sum_probs=191.7

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|+++. ++.||||+++.......          .....+..|.+++..+ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~   70 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD----------DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR   70 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe
Confidence            369999999999999864 78999999975422111          1134577888988866 79999999998877 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          71 LFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            89999999999999998763   458999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||+||..||...+.......+.......+.     
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~-----  217 (321)
T cd05591         146 GILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV-----  217 (321)
T ss_pred             cccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence            43222   11234679999999997654 6788999999999999999999999877644433333222211111     


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCC-------CHHHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRA-------SMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-------s~~evl~  447 (455)
                             .++..+.++|.+|+..+|++||       ++.++++
T Consensus       218 -------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         218 -------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                   1334578899999999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.5e-40  Score=316.59  Aligned_cols=255  Identities=22%  Similarity=0.411  Sum_probs=198.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-Cc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.+.||+|+||.||+|.+.. +.    .|++|++.....            ......+..|+.+++++.||||++++++
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~------------~~~~~~~~~~~~~l~~l~h~~iv~~~~~   77 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG------------RQTFQEITDHMLAMGSLDHAYIVRLLGI   77 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc------------hHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence            445889999999999999753 44    467777642211            0113457788999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.....++++||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Df  153 (279)
T cd05111          78 CPGASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADF  153 (279)
T ss_pred             ECCCccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCC
Confidence            88877889999999999999997643  368999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++...... .........|+..|+|||.+ .+.++.++|||||||++||++| |..||.+................ .
T Consensus       154 g~~~~~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~  231 (279)
T cd05111         154 GVADLLYPDD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL-A  231 (279)
T ss_pred             ccceeccCCC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C
Confidence            9998654332 11122345677889999966 4568899999999999999998 99999876543322222211111 0


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                                .+..++..+.+++.+|+..+|++||++.|+++.|..+.+|
T Consensus       232 ----------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         232 ----------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                      0111233467788999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.7e-41  Score=330.85  Aligned_cols=243  Identities=24%  Similarity=0.361  Sum_probs=192.6

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||+|+++......          ......+.+|++++..++||||+++++++.. ...
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~----------~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~   70 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA----------KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL   70 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE
Confidence            36999999999999975 58899999997542211          1113457789999999999999999997766 788


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+. +||+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~E~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          71 CFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999999998876   34689999999999999999999962 47999999999999999999999999998754


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      .....   ......||+.|+|||++. +.++.++|||||||++|||+||..||...........+......++.      
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~------  217 (325)
T cd05594         147 IKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR------  217 (325)
T ss_pred             CCCCc---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC------
Confidence            32211   123457999999999764 46789999999999999999999999876543333332222222221      


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                            .++..+.++|.+||..||++|+     ++.++++
T Consensus       218 ------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         218 ------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                  2334578899999999999996     8888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.1e-40  Score=334.91  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=199.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l  244 (455)
                      ++++++||+|+||.||+|++..      +..||||+++....      .      ...+.|.+|+++++++. ||||+++
T Consensus        39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~------~------~~~~~~~~Ei~~l~~l~~HpnIv~l  106 (400)
T cd05105          39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR------S------SEKQALMSELKIMTHLGPHLNIVNL  106 (400)
T ss_pred             eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC------h------HHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            4566999999999999998631      34699999864321      0      01345899999999996 9999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------------------------------------------
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------------------  274 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------  274 (455)
                      ++++.+ ...|+|||||++|+|.+++.....                                                 
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence            999877 788999999999999998865310                                                 


Q ss_pred             --------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCC
Q psy5603         275 --------------------------------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       275 --------------------------------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dik  310 (455)
                                                                  ...+++..++.++.|++.||.|||+  .+++|||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dik  264 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLA  264 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCC
Confidence                                                        1347888999999999999999999  889999999


Q ss_pred             CCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCC
Q psy5603         311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDN  388 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~  388 (455)
                      |+|||++.++.+||+|||+++........ .......++..|+|||.+ .+.++.++|||||||++|||++ |..||...
T Consensus       265 p~Nill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         265 ARNVLLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             hHhEEEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            99999999999999999998865432211 112334677889999965 4467899999999999999997 99999765


Q ss_pred             cchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         389 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................          ..+..++..+.+++.+||..+|++||++.+|.+.|++++.
T Consensus       344 ~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         344 IVDSTFYNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             chhHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            4322211111111110          0112345568889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-40  Score=323.86  Aligned_cols=258  Identities=23%  Similarity=0.318  Sum_probs=192.6

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.++||+|+||.||+|..+ +++.||||+++......            ....+.+|+.++++++||||+++++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~   72 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG------------TPFTAIREASLLKGLKHANIVLLHDII   72 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc------------cchhHHHHHHHHhhCCCCCcCeEEEEE
Confidence            34566799999999999999986 58899999986432110            022367899999999999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...|+||||+ +++|.+++....  ..++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        73 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          73 HTKETLTLVFEYV-HTDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             ecCCeEEEEEECC-CcCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCC
Confidence            77 7889999999 578888886532  358899999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH-h-hh-ccc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL-V-VE-QEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~-~-~~-~~~  402 (455)
                      |+++......   .......||+.|+|||++.+  .++.++|||||||++|||++|..||.+......... . .. ...
T Consensus       148 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  224 (303)
T cd07869         148 GLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP  224 (303)
T ss_pred             CcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCC
Confidence            9987543221   11234578999999997643  468899999999999999999999987543211111 0 00 000


Q ss_pred             c---------hhhccchhc---------cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 P---------VREVLDKEA---------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~---------~~~~~d~~~---------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .         .........         ..+........+.+|+.+|+..||++|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0         000000000         00111112345778999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.9e-40  Score=316.88  Aligned_cols=254  Identities=28%  Similarity=0.483  Sum_probs=200.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++.+.||+|+||.||+|....      ...||+|.++....      .      .....|.+|+.++.+++||||+++++
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~------~------~~~~~~~~ei~~l~~l~h~~i~~~~~   75 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE------P------KVQQEFRQEAELMSDLQHPNIVCLLG   75 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC------H------HHHHHHHHHHHHHHhcCCcccceEEE
Confidence            345889999999999998753      25799999863321      0      11345889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~  312 (455)
                      ++.+ ...|++|||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  ++++||||||+
T Consensus        76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~  153 (283)
T cd05048          76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAAR  153 (283)
T ss_pred             EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccc
Confidence            8876 778999999999999999976421             1458899999999999999999999  88999999999


Q ss_pred             cEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcc
Q psy5603         313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      ||++++++.+||+|||+++....... ........+++.|+|||.+ .+.++.++|||||||++|||++ |..||.+...
T Consensus       154 Nil~~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         154 NCLVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             eEEEcCCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999876543221 1122344678899999955 4578999999999999999998 9999987654


Q ss_pred             hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ......+....  ..         ..+..++..+.+|+.+|+..+|.+||++.+|++.|+++
T Consensus       233 ~~~~~~i~~~~--~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 QEVIEMIRSRQ--LL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHHHcCC--cC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            33322222111  00         11223456688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-40  Score=328.05  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=189.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHH---HhhCCccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT---LSQCKHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.++ +++.||||+++.......          .....+.+|+.+   +++++||||+++++++
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR----------DEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            45688999999999999976 488999999975421111          012345556554   4677899999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...|+||||+++|+|..++..    ..+++..+..++.|++.||.|||+  +|++||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcc
Confidence            77 788999999999999988764    359999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++......   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...........+.......+ 
T Consensus       146 g~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p-  221 (324)
T cd05589         146 GLCKEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP-  221 (324)
T ss_pred             cCCccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-
Confidence            9987532221   12345689999999996644 578899999999999999999999987664333322222211111 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                 ..++..+.++|.+||..||.+||+     +.++++
T Consensus       222 -----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         222 -----------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                       123445788999999999999994     555543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.6e-40  Score=312.49  Aligned_cols=247  Identities=25%  Similarity=0.416  Sum_probs=195.5

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.+.||+|+||.||+|.++++..+|+|.+.....              ....|.+|+.++++++||||+++++++.+ .
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--------------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCc--------------cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            34478999999999999998777899998753321              13348899999999999999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||||+++|+|.+++....  ..+++..+..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCcc
Confidence            8899999999999999987533  358999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+. ..++.++|+||||+++|||++ |..||...+.......+.......     
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-----  221 (256)
T cd05114         149 YVLDDEYT--SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-----  221 (256)
T ss_pred             ccCCCcee--ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-----
Confidence            65432211  112334567899999764 467889999999999999999 999998766433322222111100     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                            .+...+..+.+++.+||..+|++||++.++++.|.
T Consensus       222 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 ------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  01112345788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.9e-40  Score=325.82  Aligned_cols=242  Identities=27%  Similarity=0.376  Sum_probs=192.0

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++. ++.||||+++.......          .....+..|.+++..+ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~   70 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD----------DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR   70 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence            369999999999999864 78999999975432111          1134577888998887 79999999998776 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||++||+|.+++...   ..+++.++..++.|++.||.|||+  .+++||||||+|||+++++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          71 LFFVMEYVNGGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             EEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            89999999999999998763   369999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|+|||||++|+|++|..||...........+......++      
T Consensus       146 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~------  216 (318)
T cd05570         146 GILGG---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP------  216 (318)
T ss_pred             cCcCC---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            32221   11234579999999997654 678899999999999999999999987654333322222211111      


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCH-----HHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASM-----RDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~-----~evl~  447 (455)
                            ..++..+.+||.+||..||++||++     .++++
T Consensus       217 ------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 ------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                  1234558889999999999999999     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.4e-40  Score=318.36  Aligned_cols=257  Identities=23%  Similarity=0.348  Sum_probs=190.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc--CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC---Cccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|.+.  +++.||||+++........           ...+.+|+.+++.+   +||||+++++
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~hpniv~~~~   71 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----------PLSTIREVAVLRHLETFEHPNVVRLFD   71 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-----------hHHHHHHHHHHHhhcccCCCCcceEEE
Confidence            566789999999999999873  3678999998754321110           12355676666655   7999999999


Q ss_pred             ccc------CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         247 LCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       247 ~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      ++.      ....++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  ++++||||||+|||++.++
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~  147 (290)
T cd07862          72 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG  147 (290)
T ss_pred             EEecccCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCC
Confidence            763      256799999995 69999987643 2458999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||+++......    ......||+.|+|||.+ ...++.++|||||||++|||++|.+||...........+..
T Consensus       148 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~  223 (290)
T cd07862         148 QIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  223 (290)
T ss_pred             CEEEccccceEeccCCc----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence            99999999987654321    23345799999999966 44678899999999999999999999987764322222211


Q ss_pred             -cccchhh-----------ccchhccCCC---hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QEVPVRE-----------VLDKEAGEWN---ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~-----------~~d~~~~~~~---~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+...           .+........   ...++..+.+|+.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence             0000000           0000000000   0124566789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.6e-40  Score=325.95  Aligned_cols=241  Identities=25%  Similarity=0.299  Sum_probs=189.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcc-ceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV-NLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.++. ++.||||+++......          ......+..|.+++..+.|+ +|+.+++++.
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ----------DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            3456899999999999999874 6789999997543211          11144578899999999765 5778888776


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+||||+++|+|.+++...   ..+++.++..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecC
Confidence            6 7889999999999999998763   458999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||+||..||...........+......++. 
T Consensus       147 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~-  222 (324)
T cd05587         147 MCKENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK-  222 (324)
T ss_pred             cceecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence            987432221   11234579999999997654 5788999999999999999999999877654433333322222211 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                 .++..+.+++.+||..+|.+|++.
T Consensus       223 -----------~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         223 -----------SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence                       233457788999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-39  Score=310.78  Aligned_cols=250  Identities=27%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||.||+|.++++..||+|.++....      .        ...|.+|+.++++++|+|++++++++.+.
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~--------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   73 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------S--------PESFLEEAQIMKKLRHDKLVQLYAVVSEE   73 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCC------C--------HHHHHHHHHHHHhcCCCceEEEEeEECCC
Confidence            455689999999999999988778899999864321      0        23488999999999999999999988777


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++.+++.++.+++.||.|||+  ++++||||||+||++++++.++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          74 PIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeee
Confidence            8899999999999999987633 3458999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+ .+.++.++|+||||+++|||++ |.+||............... ...     
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~-----  222 (260)
T cd05070         151 LIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRM-----  222 (260)
T ss_pred             eccCcccc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCC-----
Confidence            65432211  12233456789999965 4567889999999999999999 99999765533222222111 000     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                           ..+...+..+.+++.+|+..+|.+||++.++.+.|++
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 0112334568899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.1e-40  Score=324.48  Aligned_cols=241  Identities=25%  Similarity=0.333  Sum_probs=188.7

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh-CCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++ +|+.||+|+++.......          .....+..|..++.. .+||||+++++++.+ ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   70 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID----------DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc----------chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE
Confidence            36999999999999987 478999999975432111          013346678888875 489999999998777 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+.+|+|.+++...   ..+++.++..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          71 LFFVMEFLNGGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEECCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            89999999999999998763   468999999999999999999999  8899999999999999999999999999874


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++.     
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-----  217 (316)
T cd05620         146 NVFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR-----  217 (316)
T ss_pred             cccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----
Confidence            32211   11335679999999997654 6788999999999999999999999876543322222211111111     


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHH-HHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                             .++..+.++|.+||..||++||++. ++.
T Consensus       218 -------~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 -------WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                   1334578899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-39  Score=311.95  Aligned_cols=250  Identities=28%  Similarity=0.463  Sum_probs=198.6

Q ss_pred             CCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +.++||+|+||.||+|.++. ++.||+|.+.....              ....+.+|++++++++||||+++++++.. .
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052          10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             EeeecCCcccceEEEEEEecCCceEEEEEecCCch--------------HHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            34789999999999999764 78999999853211              13458899999999999999999998776 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+  ++++||||||+||++++++.+||+|||+++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          76 PFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            8899999999999999987543 3468999999999999999999999  889999999999999999999999999988


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......++..|+|||.+. ..++.++|||||||++|||++ |..||............... ...     
T Consensus       153 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-----  224 (263)
T cd05052         153 LMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRM-----  224 (263)
T ss_pred             cccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCC-----
Confidence            6543221  1112234466899999664 467889999999999999998 99999876543322222111 000     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                           ..+..++..+.+++.+|+..+|++||++.++++.|+.++
T Consensus       225 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         225 -----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                 011224456888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=332.60  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||+++......          ......+.+|++++..++||||+++++++.+
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK----------RNQIAHVRAERDILADADSPWIVKLYYSFQD   72 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh----------ccHHHHHHHHHHHHHhcCCCCccchhhheec
Confidence            456689999999999999987 58999999997542211          1124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++++|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          73 EEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             CCeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCC
Confidence             7889999999999999999874   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCc--------------------------ceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCC
Q psy5603         330 VKMSETSNM--------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       330 a~~~~~~~~--------------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~  382 (455)
                      ++.......                          .........||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  227 (350)
T cd05573         148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF  227 (350)
T ss_pred             CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence            876543320                          0011234579999999997654 5789999999999999999999


Q ss_pred             CCCCCCcchhhHHHhhh--cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC-HHHHHH
Q psy5603         383 KPIDDNNTILYYYLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVD  447 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~  447 (455)
                      .||...........+..  ....++.          ...++..+.+||.+|+. +|.+||+ +.++++
T Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         228 PPFYSDTLQETYNKIINWKESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCCCCCHHHHHHHHhccCCcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            99987764333332222  1111110          11144568888998886 9999999 999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-39  Score=310.73  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=199.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++..+||+|+||.||+|.++.+..||+|.+.....              ....+.+|+.++++++|+|++++++++...
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   73 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--------------MPEAFLQEAQIMKKLRHDKLVPLYAVVSEE   73 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--------------cHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            566689999999999999987767899998754321              124488999999999999999999988777


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++..+..++.+++.||.|||+  .+++|+||||+||++++++.++|+|||+++
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccce
Confidence            8899999999999999997643 3458999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||... +..+.++|+||||+++|||+| |..||.+............. ...     
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-----  222 (260)
T cd05069         151 LIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRM-----  222 (260)
T ss_pred             EccCCccc--ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC-----
Confidence            65433211  112335677899999654 567889999999999999999 99999876533222222111 000     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                           ..+...+..+.+++.+||..+|++||++++|.+.|++
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 0112345568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-40  Score=334.19  Aligned_cols=253  Identities=23%  Similarity=0.255  Sum_probs=190.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.++ +++.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~----------~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN----------RNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            455689999999999999876 47899999997532211          1114568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence             8889999999999999999863   458999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcc--------------------------------------------eeeeccCCCCCCCCCccccc-CCCCc
Q psy5603         330 VKMSETSNMK--------------------------------------------TMYTENLTGTRPYMPPEAMH-CQIST  364 (455)
Q Consensus       330 a~~~~~~~~~--------------------------------------------~~~~~~~~gt~~Y~aPE~~~-~~~~~  364 (455)
                      ++........                                            ........||+.|+|||++. ..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            7533110000                                            00112357999999999664 45789


Q ss_pred             ccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhcc--CcCCCCCH
Q psy5603         365 KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVF--EKDKRASM  442 (455)
Q Consensus       365 ~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~--dp~~RPs~  442 (455)
                      ++|||||||++|||+||..||...........+......+.        ......++..+.+||.++|..  ++..||++
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH--------IPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC--------CCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            99999999999999999999987654332222221111100        000112334567778775544  45669999


Q ss_pred             HHHHH
Q psy5603         443 RDIVD  447 (455)
Q Consensus       443 ~evl~  447 (455)
                      .++++
T Consensus       300 ~~~l~  304 (381)
T cd05626         300 DDIKA  304 (381)
T ss_pred             HHHhc
Confidence            99975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-40  Score=328.01  Aligned_cols=238  Identities=24%  Similarity=0.332  Sum_probs=190.3

Q ss_pred             CccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         176 NKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||++...    +|+.||+|++......           ......+.+|++++++++||||+++++++.+ 
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-----------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTE   70 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence            57999999999998752    4789999999753221           0113447789999999999999999998776 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        71 ~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  145 (318)
T cd05582          71 GKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS  145 (318)
T ss_pred             CEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCC
Confidence            788999999999999999976   3468999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +......   .......||+.|+|||.+.+ .++.++|||||||++|||+||..||...........+......++    
T Consensus       146 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----  218 (318)
T cd05582         146 KESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----  218 (318)
T ss_pred             cccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence            7654321   11234689999999997654 578899999999999999999999987654333222222222211    


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRD  444 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e  444 (455)
                              ..++..+.+||.+||..||++||++.+
T Consensus       219 --------~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 --------QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                    123445788999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG2345|consensus

Probab=100.00  E-value=1.2e-40  Score=299.19  Aligned_cols=262  Identities=23%  Similarity=0.312  Sum_probs=204.5

Q ss_pred             CCCcCCCccCcCCCeEEEEEEE-cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+|++.++||+|||+-||+++. .++..||+|++.....      ++       +....+|++.-++++|||++++++++
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~------~~-------~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ------ED-------IEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccch------HH-------HHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            4678889999999999999984 3578999999965431      11       45588999999999999999999976


Q ss_pred             cC------ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         249 NN------IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~------~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..      ...|++++|+..|||.+.+....- +..+++.+.+.|+.++++||++||+...++.||||||+|||+.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            33      357999999999999999876543 45799999999999999999999996556999999999999999999


Q ss_pred             eEEeecccccccccCCcceee------eccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcch
Q psy5603         322 PKLGDFGIVKMSETSNMKTMY------TENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      ++|.|||.++...-.-.....      -..-..|..|.|||.+.-    ..++++|||||||+||+|+.|..||+..-+ 
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-  246 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-  246 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-
Confidence            999999998755432111000      012356899999998854    368899999999999999999999974211 


Q ss_pred             hhHHHhhhcccchh-hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         392 LYYYLVVEQEVPVR-EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       392 ~~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                              ....+. .+......-+...-+++.+.++|..|++.||.+||++.+++..+++++
T Consensus       247 --------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 --------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                    111111 111222222333346777899999999999999999999999998875

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.3e-40  Score=323.67  Aligned_cols=241  Identities=27%  Similarity=0.360  Sum_probs=188.8

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh-CCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++. ++.||||+++.......          .....+..|..++.. ++||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~   70 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN   70 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc----------chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE
Confidence            369999999999999864 78899999975432111          012346677888876 499999999998877 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++...   ..+++.++..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          71 LFFVMEYLNGGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            89999999999999999763   468999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++      
T Consensus       146 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~------  216 (316)
T cd05619         146 NMLGDA---KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP------  216 (316)
T ss_pred             CCCCCC---ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            332211   1234579999999997654 578999999999999999999999987654332222221111111      


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHH-HHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                            ..++..+.++|.+|+..+|++||++. ++.
T Consensus       217 ------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 ------RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                  12334578899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.3e-40  Score=328.28  Aligned_cols=248  Identities=22%  Similarity=0.282  Sum_probs=191.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||++...    +++.||+|++.......         .......+..|+.++.++ +|+||+++++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ---------KAKTVEHTRTERNVLEHVRQSPFLVTLHY   72 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh---------hhhHHHHHHHHHHHHHhccCCCCcccEEE
Confidence            456689999999999999863    47899999996532211         011134578899999999 5899999998


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.. ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        73 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~  147 (332)
T cd05614          73 AFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLT  147 (332)
T ss_pred             EEecCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEe
Confidence            7766 7889999999999999999763   458999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcch----hhHHHhhh
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVE  399 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~  399 (455)
                      |||+++........  ......||+.|+|||++.+  .++.++|||||||++|||+||..||......    ........
T Consensus       148 DfG~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  225 (332)
T cd05614         148 DFGLSKEFLSEEKE--RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK  225 (332)
T ss_pred             eCcCCccccccCCC--ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc
Confidence            99998754332211  1234679999999997754  3678999999999999999999999754321    11111111


Q ss_pred             cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      ....+            +..++..+.+++.+|+..||++||     ++.++++
T Consensus       226 ~~~~~------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 CDPPF------------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCC------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111            122345588899999999999999     6667654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-39  Score=310.38  Aligned_cols=250  Identities=21%  Similarity=0.365  Sum_probs=194.8

Q ss_pred             ccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCcee
Q psy5603         177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      .||+|+||.||+|.+.   .+..||+|++.....      .      .....|.+|+.++++++||||+++++++.....
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   69 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE------K------SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL   69 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC------h------HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCe
Confidence            3899999999999864   245799999864321      0      113458899999999999999999999887888


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++..
T Consensus        70 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          70 MLVMEMASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             EEEEEeCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccc
Confidence            9999999999999998753  2368999999999999999999999  88999999999999999999999999998755


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............++..|+|||.+. ..++.++|||||||++||+++ |..||................. .       
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~-------  217 (257)
T cd05115         146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-L-------  217 (257)
T ss_pred             cCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C-------
Confidence            43321111112223457899999664 467889999999999999996 9999987654332222211110 0       


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                         ..+..++..+.+++.+||..+|++||++.+|.+.|+.+.
T Consensus       218 ---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         218 ---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence               011123455778999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8e-40  Score=316.71  Aligned_cols=265  Identities=27%  Similarity=0.378  Sum_probs=198.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEE-----cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      ++++.+.||+|+||+||++..     .++..||+|.++....      .      .....|.+|++++++++||||++++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~i~~~~   72 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG------Q------QNTSGWKKEINILKTLYHENIVKYK   72 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC------h------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            346678999999999988753     2467899999864321      0      0134588999999999999999999


Q ss_pred             ccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         246 GLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++..   ...++||||+++++|.+++..    ..+++.+++.++.|++.||.|||+  ++++||||||+||++++++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~  146 (283)
T cd05080          73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLV  146 (283)
T ss_pred             EEEecCCCceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcE
Confidence            97654   357899999999999999875    248999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      ||+|||+++................++..|+|||.+. +..+.++||||||+++|||+||..|+..............  
T Consensus       147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  226 (283)
T cd05080         147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG  226 (283)
T ss_pred             EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence            9999999886543321111122234566799999654 5678999999999999999999999875442211111000  


Q ss_pred             --cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         400 --QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       400 --~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ....+.+..+.......+..++..+.+++.+|+..+|++||++++|++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         227 QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence              001111111111111112345567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=310.84  Aligned_cols=250  Identities=28%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.+.||+|+||.||+|.+++++.||+|.++....              ....+.+|+.++++++||||+++++++.. .
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05068           9 QLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--------------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE   74 (261)
T ss_pred             eeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--------------cHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence            45589999999999999987778899999864321              03448899999999999999999998776 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||||+++++|.+++.... ...+++..+..++.+++.||.|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  151 (261)
T cd05068          75 PIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLAR  151 (261)
T ss_pred             CeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence            7899999999999999997643 3468999999999999999999999  889999999999999999999999999988


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+. ..++.++|+||||+++|||+| |..||............... ...     
T Consensus       152 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-----  223 (261)
T cd05068         152 VIKEDIYE--AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRM-----  223 (261)
T ss_pred             EccCCccc--ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCC-----
Confidence            76532211  111223345799999764 467889999999999999999 99999876533222222111 110     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ..+..++..+.+++.+|+..+|++||++.++.+.|+++
T Consensus       224 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 -----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                 01112345588899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=331.94  Aligned_cols=252  Identities=22%  Similarity=0.319  Sum_probs=193.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.++ +|+.||||++.......          ......+.+|+.++..++||||+++++++.+
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE----------KEQVAHVRAERDILAEADNPWVVKLYYSFQD   72 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence            455689999999999999986 48899999997432110          1113457889999999999999999998777


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  147 (364)
T cd05599          73 ENYLYLIMEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGL  147 (364)
T ss_pred             CCeEEEEECCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeeccc
Confidence             8889999999999999999863   469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcce-----------------------------------eeeccCCCCCCCCCcccc-cCCCCcccchHHHHH
Q psy5603         330 VKMSETSNMKT-----------------------------------MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGV  373 (455)
Q Consensus       330 a~~~~~~~~~~-----------------------------------~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGv  373 (455)
                      +..........                                   .......||+.|+|||++ ...++.++|||||||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  227 (364)
T cd05599         148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV  227 (364)
T ss_pred             ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence            87543211000                                   001124699999999966 446789999999999


Q ss_pred             HHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC---HHHHHH
Q psy5603         374 ILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---MRDIVD  447 (455)
Q Consensus       374 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---~~evl~  447 (455)
                      ++|||++|..||...........+......+.        ......++..+.+||.+|+. +|.+|++   +.++++
T Consensus       228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQ--------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC--------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999999999987764333222221111110        00011234457788888885 8999997   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.5e-40  Score=325.08  Aligned_cols=240  Identities=25%  Similarity=0.316  Sum_probs=189.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|..+. ++.||||+++......          ......+..|..++..+ +|++|+.+++++.+
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~   72 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ----------DDDVECTMVEKRVLALSGKPPFLTQLHSCFQT   72 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhccCCCeEeeEEEEEec
Confidence            455899999999999999874 7899999997543211          11134466788888777 58899999988776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++...   ..+++.++..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~  147 (323)
T cd05616          73 MDRLYFVMEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCC
Confidence             7889999999999999998763   358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......||+.|+|||++. +.++.++|||||||++|||+||..||...+.......+......++   
T Consensus       148 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p---  221 (323)
T cd05616         148 CKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP---  221 (323)
T ss_pred             ceecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            87543221   1233568999999999664 4678999999999999999999999987764443333332222111   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                               ..++..+.+++.+|+..+|.+|++.
T Consensus       222 ---------~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 ---------KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence                     1234457889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.4e-40  Score=328.84  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=190.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|..+ +++.||||+++.....          .......+.+|+.++.+++|+||+++++.+.+
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~   72 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML----------EKEQVGHIRAERDILVEADSLWVVKMFYSFQD   72 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH----------HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            345589999999999999876 4789999999643211          01123557889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   .++++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGl  147 (363)
T cd05628          73 KLNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGL  147 (363)
T ss_pred             CCeEEEEEcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccC
Confidence             7889999999999999999863   469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcc--------------------------------eeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHH
Q psy5603         330 VKMSETSNMK--------------------------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILL  376 (455)
Q Consensus       330 a~~~~~~~~~--------------------------------~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~  376 (455)
                      ++........                                ........||+.|+|||++. ..++.++|||||||++|
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~  227 (363)
T cd05628         148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (363)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence            8754321100                                00012357999999999764 46789999999999999


Q ss_pred             HHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhcc-C-cCCCCCHHHHHH
Q psy5603         377 ELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVF-E-KDKRASMRDIVD  447 (455)
Q Consensus       377 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~-d-p~~RPs~~evl~  447 (455)
                      ||++|..||...........+......+.  +.+      ...++..+.++|.++|.. . +..||++.|+++
T Consensus       228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         228 EMLIGYPPFCSETPQETYKKVMNWKETLI--FPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHcCcCccc--CCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            99999999987664433333322111110  000      011233466667665542 2 445799999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=308.97  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=196.8

Q ss_pred             CccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      ++||+|+||.||+|.+..    +..||+|.+......            .....+.+|+++++++.||||+++++++...
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA------------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE   68 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC
Confidence            369999999999998642    268999998643321            1145588999999999999999999998888


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~  143 (257)
T cd05060          69 PLMLVMELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSR  143 (257)
T ss_pred             ceEEEEEeCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccc
Confidence            889999999999999999863   368999999999999999999999  889999999999999999999999999988


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ................++..|+|||.+. +.++.++|+|||||++|||++ |.+||...+.......+.... ..     
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~-----  217 (257)
T cd05060         144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RL-----  217 (257)
T ss_pred             eeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cC-----
Confidence            6544322111112223456899999654 467889999999999999998 999998765432222221111 00     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                           ..+..++..+.+++.+||..+|++||++.+|++.|+++.
T Consensus       218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                 011223456888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-40  Score=315.47  Aligned_cols=248  Identities=33%  Similarity=0.500  Sum_probs=189.5

Q ss_pred             CCccCcCCCeEEEEEEEc-----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         175 GNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .+.||.|.||.||+|.++     .+..|+||.++....      .      .....|.+|++.+++++||||++++|++.
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~------~------~~~~~~~~e~~~l~~l~h~ni~~~~g~~~   71 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS------E------EEEEEFLNEIQILRKLRHPNIVKLYGFCI   71 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS------H------HHHHHHHHHHHHHHTHSBTTBE-EEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc------c------ccceeeeeccccccccccccccccccccc
Confidence            468999999999999987     257899999954211      0      11456899999999999999999999988


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...++|+||+++|+|.++|.... ...+++.++..|+.|++.||.|||+  ++++||||+++||+++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   72 ENEPLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             SSSSEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccccccccccccccc-ccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            6 67899999999999999999852 3569999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++...... .........+...|+|||.+. ..++.++||||||+++|||+| |..||...+............ .   
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-~---  223 (259)
T PF07714_consen  149 LSRPISEKS-KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-R---  223 (259)
T ss_dssp             TGEETTTSS-SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-E---
T ss_pred             ccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-c---
Confidence            988763222 112223445677899999764 457899999999999999999 789998765433222222111 1   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                             ...+..++..+.+++.+||..+|++||++.++++.|
T Consensus       224 -------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 -------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                   011122344578899999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=310.42  Aligned_cols=253  Identities=27%  Similarity=0.436  Sum_probs=198.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.++.    ...||||.++....      .      .....|.+|+.++++++||||+++++++
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (266)
T cd05033           7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS------D------KQRLDFLTEASIMGQFDHPNIIRLEGVV   74 (266)
T ss_pred             eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC------h------HHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence            345899999999999999752    35799999864321      1      1134588999999999999999999987


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+||++++++.++|+||
T Consensus        75 ~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          75 TKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             ecCCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECcc
Confidence            66 78899999999999999997643  368999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++...... .........++..|+|||.+. ..++.++||||||+++|+|++ |..||............... ...+
T Consensus       151 g~~~~~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~  228 (266)
T cd05033         151 GLSRRLEDSE-ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLP  228 (266)
T ss_pred             chhhcccccc-cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence            9998765222 111122334567899999664 467889999999999999998 99999765533222222111 0000


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                                .+..++..+.+++.+|+..+|++||++.+|++.|++++
T Consensus       229 ----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         229 ----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                      01123455889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.1e-40  Score=332.31  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=194.6

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||.||++..+ +++.||+|++........          .....+.+|+.+++.++||||+++++++.+ 
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR----------SDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            34489999999999999986 478999999964321110          113447789999999999999999998777 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++||+|.+++..    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            788999999999999998865    247889999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +.......  .......||+.|+|||++.+     .++.++|||||||++|||++|..||...........+......+.
T Consensus       190 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  267 (370)
T cd05596         190 MKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT  267 (370)
T ss_pred             eeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC
Confidence            76543221  11234679999999997643     367899999999999999999999987764433333222111100


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCC--CCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                              ......++..+.+||.+|+..+|++  ||++.++++
T Consensus       268 --------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         268 --------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             --------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                    0011124566888999999988887  999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.4e-39  Score=309.35  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||.||+|..++++.||+|.+.....              ....|.+|+.++++++|+||+++++++.+.
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   73 (260)
T cd05067           8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--------------SPEAFLAEANLMKQLQHPRLVRLYAVVTQE   73 (260)
T ss_pred             ceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--------------cHHHHHHHHHHHHhcCCcCeeeEEEEEccC
Confidence            456689999999999999988889999999863321              134588999999999999999999988778


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+.+++|.+++.... ...+++.++..++.|++.||.|||+  .+++||||||+||++++++.++|+|||++.
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCccee
Confidence            8899999999999999987643 3468999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+. +.++.++|+||||+++||+++ |.+||............... ...     
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-----  222 (260)
T cd05067         151 LIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRM-----  222 (260)
T ss_pred             ecCCCCcc--cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCC-----
Confidence            65432211  122345677899999664 457889999999999999999 99999866533222211111 000     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ..+...+..+.+++.+|+..+|++||+++++.+.|+++
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 -----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                 00112344588899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.9e-40  Score=326.81  Aligned_cols=259  Identities=25%  Similarity=0.380  Sum_probs=198.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .|++.+.||+|+||.||+|.+.      +++.||+|+++....      .      .....+..|+.++.++ +|+||++
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~------~------~~~~~~~~E~~~~~~l~~h~niv~   75 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT------A------SEYKALMTELKILIHIGHHLNVVN   75 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC------H------HHHHHHHHHHHHHHhhccCcchhh
Confidence            4567799999999999999743      247899999864221      1      0134577899999999 8999999


Q ss_pred             ecccccC--ceeEEEEEeccCCCHHHHHhhcCC-----------------------------------------------
Q psy5603         244 LLGLCNN--IMNCIVYEYMCNGSLYDRLARVNN-----------------------------------------------  274 (455)
Q Consensus       244 l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------  274 (455)
                      ++++|..  ...++++||+++++|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            9997754  567899999999999999864321                                               


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeee
Q psy5603         275 -----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT  343 (455)
Q Consensus       275 -----------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  343 (455)
                                 ..++++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++....... ....
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~  232 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRK  232 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhc
Confidence                       1268999999999999999999999  8899999999999999999999999999986543221 1122


Q ss_pred             ccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHH
Q psy5603         344 ENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVE  421 (455)
Q Consensus       344 ~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  421 (455)
                      ....++..|+|||++ ...++.++|||||||++|||++ |..||..................          ...+....
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~  302 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR----------MRAPEYAT  302 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC----------CCCCccCC
Confidence            344667889999955 5568999999999999999998 99999764322111111111100          00111233


Q ss_pred             HHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         422 TLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       422 ~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+.+++.+||+.+|++||++.+|++.|++++.
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            457888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-40  Score=326.08  Aligned_cols=238  Identities=27%  Similarity=0.375  Sum_probs=186.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH-HHhhCCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||+||+|.++ +|+.||||++........          .....+..|.. +++.++||||+++++.+.+ ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~   70 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK   70 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE
Confidence            36999999999999986 589999999965322110          01233445554 4678999999999997766 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          71 LYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            8999999999999999876   3468999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+......+.      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------  216 (323)
T cd05575         146 GIEHS---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK------  216 (323)
T ss_pred             cccCC---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            32221   12335679999999997644 578899999999999999999999987654333333222211111      


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                            ...+..+.++|.+|+..+|++||++.
T Consensus       217 ------~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 ------PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                  12244578899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.2e-40  Score=324.54  Aligned_cols=241  Identities=24%  Similarity=0.345  Sum_probs=187.8

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++ +++.||||+++......          ......+..|..++.++ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~----------~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~   70 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND----------DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR   70 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE
Confidence            36999999999999986 47899999997542211          11144578899999988 79999999998876 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          71 LFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            89999999999999988763   469999999999999999999999  8899999999999999999999999999874


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch---------hhHHHhhhccc
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---------LYYYLVVEQEV  402 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~---------~~~~~~~~~~~  402 (455)
                      .....   .......||+.|+|||++.+ .++.++|+|||||++|||+||..||+.....         .....+.....
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (329)
T cd05588         146 GIRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI  222 (329)
T ss_pred             cccCC---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC
Confidence            32211   11334689999999997654 5788999999999999999999999743210         01111111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC------HHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS------MRDIV  446 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs------~~evl  446 (455)
                      .++            ..++..+.++|.+||..||.+||+      +.+++
T Consensus       223 ~~p------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         223 RIP------------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             CCC------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            111            123445788999999999999997      55664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG1095|consensus

Probab=100.00  E-value=2.6e-40  Score=353.19  Aligned_cols=255  Identities=29%  Similarity=0.440  Sum_probs=206.3

Q ss_pred             CCCccCcCCCeEEEEEEEcC--Cc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN--GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ....||+|.||.||.|...+  |.    .||||.++....            ......|.+|..+|++++|||||+++|+
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~------------~~~~~~Fl~Ea~~m~~f~HpNiv~liGv  763 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS------------EQEVSDFLKEALLMSKFDHPNIVSLIGV  763 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC------------HHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence            45789999999999999763  33    489999875432            1125669999999999999999999999


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      |.+ ..+++++|||+||+|..+|+....    ...++....+.++.+||+|+.||++  +++|||||-..|+||+....+
T Consensus       764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcE
Confidence            988 788999999999999999987521    3468999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhc
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  400 (455)
                      ||+|||+||.....+.... .....-...|||||.+ .+.++.|||||||||++||++| |..||.+.+..........+
T Consensus       842 KIaDFGlArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g  920 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRK-HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG  920 (1025)
T ss_pred             EEcccchhHhhhhchheec-cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence            9999999996655543321 1111223469999976 4789999999999999999999 99999988754433322221


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      . .          -.++..++..+.+++.+||..+|++||++..+++++..+++
T Consensus       921 g-R----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  921 G-R----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             C-c----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            1 1          12234566667799999999999999999999999988764

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-40  Score=332.55  Aligned_cols=250  Identities=20%  Similarity=0.285  Sum_probs=189.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||++.+. +++.||||+..                   ...+.+|++++++++||||+++++++.
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------------------~~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------------------RGGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------------------hhhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            4667799999999999999986 47899999753                   122678999999999999999999776


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...|+|+|++ +++|..++...   ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       154 ~~~~~~lv~e~~-~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        154 YNKFTCLILPRY-KTDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             ECCeeEEEEecC-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCC
Confidence            6 7889999998 57898888763   358999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcc--------hhhHHHhhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT--------ILYYYLVVE  399 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~--------~~~~~~~~~  399 (455)
                      +++.......  .......||+.|+|||++.+ .++.++|||||||++|||+||..||.....        .........
T Consensus       228 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        228 AACFPVDINA--NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             cccccccccc--cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence            9875432211  11234689999999997644 678999999999999999999988764321        000000000


Q ss_pred             -cccc----------hhhcc-------chhcc---CCC-hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QEVP----------VREVL-------DKEAG---EWN-ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~----------~~~~~-------d~~~~---~~~-~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+          +....       .....   .|. ...++..+.+||.+|+..||++|||+.|+++
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000          00000       00000   000 1134556888999999999999999999985

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-39  Score=313.80  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=197.4

Q ss_pred             CCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +.+.||+|+||.||+|...+      +..||||.++....      .      .....|.+|++++++++|+||++++++
T Consensus         9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~l~~l~~~~i~~~~~~   76 (280)
T cd05049           9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS------N------DARKDFEREAELLTNFQHENIVKFYGV   76 (280)
T ss_pred             HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC------H------HHHHHHHHHHHHHHhcCCCCchheeeE
Confidence            34889999999999998642      47899999864321      1      013568999999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEE
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +.. ...++||||+++++|.+++...+.           ...+++.++..++.|++.|+.|||+  ++++||||||+||+
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nil  154 (280)
T cd05049          77 CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCL  154 (280)
T ss_pred             EecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEE
Confidence            877 788999999999999999975421           3458899999999999999999999  88999999999999


Q ss_pred             EcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhh
Q psy5603         316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                      ++.++.+||+|||+++........ .......++..|+|||++. +.++.++|||||||++|||++ |..||........
T Consensus       155 i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~  233 (280)
T cd05049         155 VGYDLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV  233 (280)
T ss_pred             EcCCCeEEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999998754332211 1122345678899999664 467889999999999999999 9999977654332


Q ss_pred             HHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .........           ...+..++..+.+++.+||..+|++||++.||++.|++
T Consensus       234 ~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 IECITQGRL-----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            222211110           01112344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-39  Score=322.73  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=194.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++.++ ++..+|+|.++....      .      .....+.+|++++++++||||+++++++.+
T Consensus         7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK------P------AIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC------H------HHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            455699999999999999987 478899998864321      0      113458899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||+++|+|.+++..   ...+++..+..++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence             888999999999999999976   34589999999999999999999972 3699999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccc---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP---  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~---  403 (455)
                      +.......     .....||..|+|||.+.+ .++.++|+|||||++|||++|..||..............  ....   
T Consensus       151 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (333)
T cd06650         151 SGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES  225 (333)
T ss_pred             chhhhhhc-----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence            87543221     234579999999997654 578899999999999999999999986543222111100  0000   


Q ss_pred             -------------------------hhhccch----hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -------------------------VREVLDK----EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -------------------------~~~~~d~----~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                               .....+.    .....+....+..+.+|+.+||..||++||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                     0000000    0001111123456889999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=338.97  Aligned_cols=249  Identities=21%  Similarity=0.286  Sum_probs=195.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC--CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      |.+.+.||+|+||.||+|....  +..||+|.+.....      .       ....+.+|+.+++.++||||+++++++.
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~------~-------~~~~~~~E~~~l~~l~Hpniv~~~~~~~  135 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE------R-------QAAYARSELHCLAACDHFGIVKHFDDFK  135 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH------H-------HHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            4566899999999999998653  56788887642211      1       1345778999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      . +..|+||||++||+|.+++... ....++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       136 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeC
Confidence            6 8889999999999999988642 224578999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++...... .........||+.|+|||++.+ .++.++|||||||++|||+||..||..................   
T Consensus       214 gla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---  289 (478)
T PTZ00267        214 GFSKQYSDSV-SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---  289 (478)
T ss_pred             cCceecCCcc-ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence            9998654322 1112345679999999997644 5788999999999999999999999876543322222211110   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         +     .+..++..+.++|.+||..+|++||++.+++.
T Consensus       290 ---~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 ---P-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---C-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               0     01123445888999999999999999999864

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.7e-40  Score=323.95  Aligned_cols=237  Identities=24%  Similarity=0.344  Sum_probs=184.4

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|..+ +++.||+|+++......          ......+.+|+.++.++ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   70 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND----------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   70 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc----------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE
Confidence            36999999999999986 47899999997542211          01134577899888776 89999999998766 88


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          71 LFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            89999999999999988763   469999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch---------hhHHHhhhccc
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---------LYYYLVVEQEV  402 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~---------~~~~~~~~~~~  402 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||......         .....+.....
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~  222 (329)
T cd05618         146 GLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI  222 (329)
T ss_pred             ccCCC---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC
Confidence            32221   11234689999999997654 5788999999999999999999999632210         01111111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      .+            +..++..+.++|.+||..||++||+.
T Consensus       223 ~~------------p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RI------------PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CC------------CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            11            11234457889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-39  Score=309.25  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=191.8

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||+|.++ +++.||+|.+.....      .      .....|.+|++++++++||||+++++++.. ...
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   68 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP------P------DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI   68 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC------H------HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe
Confidence            36999999999999986 588999998753211      0      113458899999999999999999998877 778


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+++..
T Consensus        69 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  144 (252)
T cd05084          69 YIVMELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREE  144 (252)
T ss_pred             EEEEeeccCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCccc
Confidence            9999999999999998753  2468999999999999999999999  88999999999999999999999999998754


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..... ........++..|+|||.+ .+.++.++|+|||||++|||++ |..||............... ..        
T Consensus       145 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~--------  214 (252)
T cd05084         145 EDGVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VR--------  214 (252)
T ss_pred             ccccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CC--------
Confidence            32211 1111112234569999965 4467889999999999999998 99999765432221111110 00        


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                        ...+..++..+.+++.+|+..+|++||++.+|++.|++
T Consensus       215 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         215 --LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             --CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence              01112234568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-39  Score=308.03  Aligned_cols=254  Identities=29%  Similarity=0.393  Sum_probs=197.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||.||+|... ++..||+|.+........        .......+.+|++++++++||||+++++++.+
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPE--------TKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchh--------hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            345599999999999999875 489999999864432111        01114568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||+
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence             8889999999999999998763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++................|+..|+|||.+.+ .++.++||||||+++|||++|..||..................     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  225 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-----  225 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-----
Confidence            8754332211111134568889999997654 5788999999999999999999999765432222111111100     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                           ...+..++..+.+++.+||..+|++||++.++++.
T Consensus       226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 00112344558889999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.4e-39  Score=310.06  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=195.2

Q ss_pred             CCCccCcCCCeEEEEEEEcC-Cc--EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +++.||+|+||.||+|.+.. +.  .||+|.++....      .     ......|.+|++++++++|+||+++++++..
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------T-----RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQ   71 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------C-----HHHHHHHHHHHHHHHhCCCCCcceEEEEEcc
Confidence            45889999999999999864 32  589998864321      0     0114568899999999999999999997632


Q ss_pred             -------ceeEEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         251 -------IMNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       251 -------~~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                             ...++|+||+++|+|.+++....   ....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~  149 (272)
T cd05075          72 TVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENM  149 (272)
T ss_pred             CCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCC
Confidence                   24589999999999999874321   13458999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~  398 (455)
                      .+||+|||+++........ .......+++.|+|||.+. ..++.++|||||||++|||++ |..||.............
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  228 (272)
T cd05075         150 NVCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR  228 (272)
T ss_pred             CEEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999998865433211 1112335677899999664 457899999999999999999 899997655332222222


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .... .          .....++..+.+++.+||..+|.+||++.++++.|++++
T Consensus       229 ~~~~-~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         229 QGNR-L----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             cCCC-C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            1110 0          011223455889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.7e-39  Score=308.64  Aligned_cols=247  Identities=25%  Similarity=0.422  Sum_probs=195.5

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.+.||+|+||.||+|.++++..||||.+.....              ....|.+|+.++++++||||+++++++.. .
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--------------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--------------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            45588999999999999987667799999864321              12348899999999999999999998876 6


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+.+|+|.+++....  ..+++.+++.++.|++.||+|||+  .+++|+||||+||+++.++.+||+|||.++
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccce
Confidence            7799999999999999987643  268999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......++..|+|||.+. +.++.++|+|||||++|||+| |..||..................      
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------  220 (256)
T cd05113         149 YVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------  220 (256)
T ss_pred             ecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC------
Confidence            6543321  1112234567899999764 467889999999999999999 99999766533222222211110      


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                           ..+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       221 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 -----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 011122455788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.2e-40  Score=331.15  Aligned_cols=252  Identities=22%  Similarity=0.273  Sum_probs=190.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|... +++.||||++......          .......+.+|+.++++++||||+++++.+.+
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~----------~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL----------LRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh----------hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            455689999999999999976 4789999998643210          01124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++.+.   ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCC
Confidence             7889999999999999999763   358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCc--------------------------------------------ceeeeccCCCCCCCCCccccc-CCCCc
Q psy5603         330 VKMSETSNM--------------------------------------------KTMYTENLTGTRPYMPPEAMH-CQIST  364 (455)
Q Consensus       330 a~~~~~~~~--------------------------------------------~~~~~~~~~gt~~Y~aPE~~~-~~~~~  364 (455)
                      ++.......                                            .........||+.|+|||++. ..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            753210000                                            000112357999999999664 46889


Q ss_pred             ccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC---
Q psy5603         365 KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---  441 (455)
Q Consensus       365 ~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---  441 (455)
                      ++|||||||++|||++|.+||...+.......+.......        .......++....++|.++| .+|++|++   
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL--------HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc--------CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            9999999999999999999998765433222222111110        00011223445677777776 58999987   


Q ss_pred             HHHHHH
Q psy5603         442 MRDIVD  447 (455)
Q Consensus       442 ~~evl~  447 (455)
                      +.++++
T Consensus       299 ~~ei~~  304 (382)
T cd05625         299 ADEIKA  304 (382)
T ss_pred             HHHHhc
Confidence            777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.8e-40  Score=322.94  Aligned_cols=242  Identities=27%  Similarity=0.350  Sum_probs=187.4

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHH-HHHhhCCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++. ++.||+|++........          .....+..|. .+++.++||||+++++++.+ +.
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~   70 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK----------KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK   70 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh----------hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe
Confidence            369999999999999874 67899999974321100          0122234444 45678999999999998766 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          71 LYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            89999999999999999763   358889999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|.+||...+.......+......+.      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~------  216 (325)
T cd05602         146 NIEHN---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK------  216 (325)
T ss_pred             cccCC---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC------
Confidence            33221   12345679999999997654 578899999999999999999999987664433333322211111      


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..++..+.++|.+|+..+|.+||++.+.+.
T Consensus       217 ------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         217 ------PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             ------CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence                  123455888999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.9e-39  Score=312.17  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=197.5

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.++||+|+||+||+|.+. +|.    .||+|+++....      .      .....+.+|+.+++.+.||||++++++
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~------~------~~~~~~~~e~~~l~~~~~~~i~~~~~~   77 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS------P------KANKEILDEAYVMAGVGSPYVCRLLGI   77 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC------H------HHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            44589999999999999864 343    489999864321      0      113458899999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.....+++++|+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+|||+++++.+||+||
T Consensus        78 ~~~~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          78 CLTSTVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             EcCCCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCC
Confidence            98877889999999999999987532  368999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++....... ........++..|+|||.. .+.++.++|||||||++|||++ |..||................ ...
T Consensus       154 G~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~  231 (279)
T cd05109         154 GLARLLDIDET-EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLP  231 (279)
T ss_pred             Cceeecccccc-eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCC
Confidence            99886643321 1111223456789999965 4568899999999999999998 999998665332222222111 000


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                .+..++..+.+++.+||..||++||++.++++.|+++..
T Consensus       232 ----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         232 ----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                      011233457888999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-39  Score=310.16  Aligned_cols=258  Identities=22%  Similarity=0.314  Sum_probs=201.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +++.||||.++......          ......+.+|++++++++||||+++++++.+
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD----------AKARQDCVKEIDLLKQLNHPNVIKYLDSFIE   73 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC----------HHHHHHHHHHHHHHHhCCCcceeeeeeeEEE
Confidence            455689999999999999976 58999999886432111          0114558899999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       +..++|+||+++|+|.+++..... ...+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccc
Confidence             788999999999999998864322 3468999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|++.|+|||.+. ...+.++|+||||+++|||++|..||...................   
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---  225 (267)
T cd08228         152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY---  225 (267)
T ss_pred             cceeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC---
Confidence            9886543221   123457889999999664 467889999999999999999999997654221111111011000   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ...+....+..+.+++.+||..+|.+||++.+|++.|+++
T Consensus       226 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 -----PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -----CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                 1111234456688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0589|consensus

Probab=100.00  E-value=1.9e-40  Score=326.72  Aligned_cols=250  Identities=21%  Similarity=0.279  Sum_probs=209.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|+..+.+|+|+||.+++++.+ +++.|++|++.........           .....+|+.++++++|||||.+.+.+.
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-----------r~~A~~E~~lis~~~hP~iv~y~ds~~   73 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-----------RRSAIQEMDLLSKLLHPNIVEYKDSFE   73 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-----------hHHHHHHHHHHHhccCCCeeeeccchh
Confidence            3566799999999999999876 4789999999765542221           234789999999999999999999776


Q ss_pred             C-ce-eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         250 N-IM-NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~-~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      . +. .|+||+||.||+|.+.+.+.. +.-+++..++.++.|++.|+.|||+  +.|+|||||++||++..++.+||+||
T Consensus        74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   74 EDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             cCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecch
Confidence            5 66 899999999999999998876 4679999999999999999999998  78999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+|+......   .......||+.||+||++.+ .|+.|+|||||||++|||++-+++|...+.......+....     
T Consensus       151 GlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----  222 (426)
T KOG0589|consen  151 GLAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----  222 (426)
T ss_pred             hhhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----
Confidence            9999876543   23567899999999998876 57999999999999999999999999887554444443221     


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                       .++     -+..++..++.+|..|+..+|..||++.+++..
T Consensus       223 -~~P-----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSP-----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCC-----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             111     123456668999999999999999999999875

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=326.45  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=186.1

Q ss_pred             CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .++||+|+||.||+|.++ +++.||||++.....      .      .....+.+|++++++++|+||+++++++.+ +.
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  146 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE------D------TVRRQICREIEILRDVNHPNVVKCHDMFDHNGE  146 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc------H------HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence            378999999999999976 489999999854321      0      113558899999999999999999998877 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+.+|+|.+.       ...++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.
T Consensus       147 ~~lv~e~~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT-------HIADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             EEEEEecCCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence            8999999999998653       235678888999999999999999  8899999999999999999999999999886


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-----C-CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-----Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~-~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ......   ......||..|+|||.+..     . .+.++|||||||++|||++|..||..................   
T Consensus       218 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---  291 (353)
T PLN00034        218 LAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS---  291 (353)
T ss_pred             cccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc---
Confidence            543211   1234579999999997632     2 345899999999999999999999854322211111100000   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ........++..+.+||.+||..+|++||++.|+++
T Consensus       292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000011234456889999999999999999999986

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-39  Score=313.16  Aligned_cols=255  Identities=26%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+.+.||+|+||.||++...      ++..+|+|.+.....             .....+.+|++++++++||||+++++
T Consensus         8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~   74 (288)
T cd05093           8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-------------NARKDFHREAELLTNLQHEHIVKFYG   74 (288)
T ss_pred             eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-------------HHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            34588999999999999852      245689998853211             11445889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEE
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVN----------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      ++.. ...++||||+++++|.+++....          ....+++.+++.++.|++.||.|||+  +|++||||||+||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nil  152 (288)
T cd05093          75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCL  152 (288)
T ss_pred             EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEE
Confidence            8877 88899999999999999997532          12358999999999999999999999  88999999999999


Q ss_pred             EcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhh
Q psy5603         316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                      +++++.+||+|||+++....... ........++..|+|||.+. ..++.++|+|||||++|||+| |.+||........
T Consensus       153 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~  231 (288)
T cd05093         153 VGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  231 (288)
T ss_pred             EccCCcEEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999875543221 11123345678899999765 457889999999999999999 9999987654332


Q ss_pred             HHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...+......  .    .     ....+..+.+++.+|+..+|.+||++.+|.+.|+++.+
T Consensus       232 ~~~i~~~~~~--~----~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         232 IECITQGRVL--Q----R-----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHHcCCcC--C----C-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2222211100  0    0     11233458889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-39  Score=312.51  Aligned_cols=254  Identities=24%  Similarity=0.416  Sum_probs=195.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.++      .+..||||++.....      .      .....|.+|+.+++.++||||++++
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~------~------~~~~~~~~e~~~l~~l~~~~iv~~~   75 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS------M------RERIEFLNEASVMKEFNCHHVVRLL   75 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC------H------HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            345589999999999999764      246799998753211      0      0134588999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++.+ ...++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+  .+++||||||+||+++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~  153 (277)
T cd05062          76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVA  153 (277)
T ss_pred             EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEc
Confidence            98876 788999999999999999875332       2346888999999999999999999  8899999999999999


Q ss_pred             CCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHH
Q psy5603         318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      +++.+||+|||+++......... ......++..|+|||.+. +.++.++|||||||++|||++ |..||..........
T Consensus       154 ~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~  232 (277)
T cd05062         154 EDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR  232 (277)
T ss_pred             CCCCEEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999987554332111 112235678899999764 467899999999999999999 789997665332222


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ......  ...         .+..++..+.+++.+||..+|++||++.++++.|++
T Consensus       233 ~~~~~~--~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVMEGG--LLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHcCC--cCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            221111  000         112234568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-40  Score=330.20  Aligned_cols=252  Identities=20%  Similarity=0.277  Sum_probs=191.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++..+ +++.||||++......          .......+.+|++++++++||||+++++++.+
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~   72 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF----------KKDQLAHVKAERDVLAESDSPWVVSLYYSFQD   72 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH----------HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            455689999999999999876 5889999998643211          11124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGl  147 (377)
T cd05629          73 AQYLYLIMEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGL  147 (377)
T ss_pred             CCeeEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccc
Confidence             7889999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcc----------e----------------------------------eeeccCCCCCCCCCccccc-CCCCc
Q psy5603         330 VKMSETSNMK----------T----------------------------------MYTENLTGTRPYMPPEAMH-CQIST  364 (455)
Q Consensus       330 a~~~~~~~~~----------~----------------------------------~~~~~~~gt~~Y~aPE~~~-~~~~~  364 (455)
                      ++........          .                                  .......||+.|+|||++. ..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  227 (377)
T cd05629         148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ  227 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence            8632110000          0                                  0001246999999999664 46789


Q ss_pred             ccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCC---CCC
Q psy5603         365 KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK---RAS  441 (455)
Q Consensus       365 ~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~---RPs  441 (455)
                      ++|||||||++|||+||.+||...........+......+        .......++..+.+||.+|+. +|.+   |++
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL--------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999999999998765433322222111000        000111234568888999887 6555   569


Q ss_pred             HHHHHH
Q psy5603         442 MRDIVD  447 (455)
Q Consensus       442 ~~evl~  447 (455)
                      +.++++
T Consensus       299 ~~~~l~  304 (377)
T cd05629         299 AHEIKS  304 (377)
T ss_pred             HHHHhc
Confidence            988875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.9e-39  Score=312.80  Aligned_cols=247  Identities=21%  Similarity=0.278  Sum_probs=189.8

Q ss_pred             cCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||+||++.++ +++.||+|++.......          ......+..|++++++++|+||+++.+++.. ...|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l   70 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK----------RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCL   70 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh----------hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEE
Confidence            799999999999976 57899999986432110          0113457889999999999999999997766 78899


Q ss_pred             EEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++....
T Consensus        71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            999999999998875432 24579999999999999999999999  889999999999999999999999999987654


Q ss_pred             cCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhcc
Q psy5603         335 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  413 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  413 (455)
                      ....   ......||+.|+|||++. +.++.++|+|||||++|||++|..||...............      ...... 
T Consensus       149 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~------~~~~~~-  218 (280)
T cd05608         149 DGQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR------ILNDSV-  218 (280)
T ss_pred             CCCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh------hcccCC-
Confidence            3221   123457999999999664 46788999999999999999999999865422111111000      000000 


Q ss_pred             CCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         414 EWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                       ..+..++..+.+++.+||..+|++||     +++++++
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 -TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence             00123455688899999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-40  Score=330.29  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=192.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++..+. ++.||+|++.......          ......+.+|+.+++.++||||+++++++.+
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK----------RSDSAFFWEERDIMAFANSPWVVQLFCAFQD  114 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            3455899999999999999874 7889999986432111          0113457889999999999999999998777


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++..    ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence             788999999999999999865    248899999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      +........  .......||+.|+|||++.+     .++.++|+|||||++|||++|..||...........+......+
T Consensus       189 a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  266 (370)
T cd05621         189 CMKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL  266 (370)
T ss_pred             ceecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence            886543221  11235689999999997643     26789999999999999999999998766433322222111110


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCC--CCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                      .        ......++..+++++.+|+..++++  |+++.++++
T Consensus       267 ~--------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         267 N--------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             C--------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            0        0011234566788888888755543  899999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.9e-39  Score=317.12  Aligned_cols=197  Identities=24%  Similarity=0.374  Sum_probs=159.0

Q ss_pred             CCccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         175 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++||+|+||.||+|..+   +++.||+|.+.....               ...+.+|+.++++++||||+++++++.. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---------------SMSACREIALLRELKHPNVISLQKVFLSH   70 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---------------cHHHHHHHHHHHhcCCCCCcceeeeEecC
Confidence            478999999999999865   357899999864321               1236789999999999999999997633 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE----cC
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  318 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl----~~  318 (455)
                        ...|+||||+ +++|.+++....      ....+++..+..++.|++.||.|||+  ++|+||||||+|||+    +.
T Consensus        71 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~  147 (317)
T cd07868          71 ADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  147 (317)
T ss_pred             CCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCC
Confidence              5678999998 568888875422      12358999999999999999999999  889999999999999    46


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCc
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~  389 (455)
                      ++.+||+|||+++................||+.|+|||++.+  .++.++||||+||++|||++|.+||....
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            689999999999865433221122345688999999997654  46889999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0610|consensus

Probab=100.00  E-value=1.1e-39  Score=312.05  Aligned_cols=248  Identities=25%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ++||.|.-|+||++..++ +..+|+|++.+.....          .....+.+.|-+||+.+.||.++.||+.+.. ...
T Consensus        83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~----------rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS----------RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh----------hhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            789999999999999885 5889999997654422          2225668889999999999999999998877 888


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+|||||+||+|..+++++. +..+++..+..++.+++.||+|||-  .|||+|||||+||||-++|++.|+||.|+...
T Consensus       153 cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999999888765 4679999999999999999999999  78999999999999999999999999886322


Q ss_pred             ccC----------------------------------C-------------------cceeeeccCCCCCCCCCcccccC
Q psy5603         334 ETS----------------------------------N-------------------MKTMYTENLTGTRPYMPPEAMHC  360 (455)
Q Consensus       334 ~~~----------------------------------~-------------------~~~~~~~~~~gt~~Y~aPE~~~~  360 (455)
                      ...                                  .                   ........++||-.|+|||++.|
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            110                                  0                   00011234689999999998876


Q ss_pred             -CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCC
Q psy5603         361 -QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR  439 (455)
Q Consensus       361 -~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~R  439 (455)
                       +-+.++|+|+|||++||||.|..||.+.+.......+..++..+++.          ..++...++||.+.|.+||++|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~----------~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE----------PEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC----------CcchhHHHHHHHHHhccChhhh
Confidence             56889999999999999999999999988766666655544443322          2456679999999999999999


Q ss_pred             CC----HHHHH
Q psy5603         440 AS----MRDIV  446 (455)
Q Consensus       440 Ps----~~evl  446 (455)
                      ..    ++||.
T Consensus       380 lg~~rGA~eIK  390 (459)
T KOG0610|consen  380 LGSKRGAAEIK  390 (459)
T ss_pred             hccccchHHhh
Confidence            87    66653

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.1e-40  Score=336.32  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=188.0

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|+++++||+|+||.||+|... +++.||||++....                 ....+|+.++++++||||+++++++
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----------------~~~~~Ei~il~~l~h~niv~l~~~~  128 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------------QYKNRELLIMKNLNHINIIFLKDYY  128 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----------------chHHHHHHHHHhcCCCCCcceeeeE
Confidence            44677799999999999999986 47899999885321                 1145799999999999999998864


Q ss_pred             cC---------ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         249 NN---------IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       249 ~~---------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ..         ...++||||++ ++|.+++... .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.
T Consensus       129 ~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~  205 (440)
T PTZ00036        129 YTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDP  205 (440)
T ss_pred             eecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcC
Confidence            21         24578999996 5777776532 224579999999999999999999999  88999999999999996


Q ss_pred             CC-ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         319 NF-VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       319 ~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      ++ .+||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||+||.+||.+........
T Consensus       206 ~~~~vkL~DFGla~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  281 (440)
T PTZ00036        206 NTHTLKLCDFGSAKNLLAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV  281 (440)
T ss_pred             CCCceeeeccccchhccCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            64 799999999986543221    224578999999997644  57899999999999999999999998765322211


Q ss_pred             Hhhh--cccch---------------hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVE--QEVPV---------------REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~--~~~~~---------------~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+..  .....               +...........+...+..+.+||.+||..+|.+||++.|+++
T Consensus       282 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            1111  11000               0000000000011123456889999999999999999999874

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=337.84  Aligned_cols=252  Identities=27%  Similarity=0.335  Sum_probs=197.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.+. +|+.||||++......           ......+.+|+.++..++|+|++++...+.
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-----------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-----------EADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-----------HHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            3456699999999999999875 5899999998654221           011455889999999999999999887543


Q ss_pred             C---------ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         250 N---------IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       250 ~---------~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      .         ...++||||+++|+|.+++.... ...++++..+..++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCC
Confidence            2         13579999999999999987533 24579999999999999999999999  889999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++....... ........||+.|+|||++.+ .++.++|||||||++|||++|..||.............
T Consensus       180 ~~vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~  258 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL  258 (496)
T ss_pred             CCEEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            9999999999886543221 112345689999999997654 57899999999999999999999998765433222221


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....      +     .+..++..+.+++.+||..+|.+||++.++++
T Consensus       259 ~~~~~------~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        259 AGRYD------P-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             cCCCC------C-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            11100      0     01223456888999999999999999999876

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.3e-39  Score=312.39  Aligned_cols=253  Identities=25%  Similarity=0.433  Sum_probs=195.8

Q ss_pred             cCCCccCcCCCeEEEEEEEc-----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.+.||+|+||.||+|...     .+..||+|.+.....      .      .....|.+|+.++++++||||++++++
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~------~------~~~~~~~~E~~~l~~l~h~niv~~~~~   75 (283)
T cd05090           8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN------P------QQWGEFQQEASLMAELHHPNIVCLLGV   75 (283)
T ss_pred             eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC------H------HHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence            45588999999999999852     357899999864221      0      113458899999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNN--------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~  312 (455)
                      +.. ...|+||||+++++|.+++.....              ...+++.++..++.+++.||.|||+  ++++||||||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~  153 (283)
T cd05090          76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAAR  153 (283)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccc
Confidence            766 788999999999999999864221              2347899999999999999999999  88999999999


Q ss_pred             cEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcc
Q psy5603         313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      |||+++++.+||+|||+++....... ........++..|+|||.+. +.++.++|+|||||++|||++ |..||.+...
T Consensus       154 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05090         154 NILIGEQLHVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN  232 (283)
T ss_pred             eEEEcCCCcEEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999886543321 11223445677899999664 567889999999999999999 9999977553


Q ss_pred             hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ...........  ...         .+..++..+.+++.+|+..+|.+||++.+|.+.|..
T Consensus       233 ~~~~~~~~~~~--~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQ--LLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCC--cCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            22222111111  000         111234457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.7e-40  Score=325.78  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=196.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||++..+ +|+.||||+++......          ......+.+|+.+++.++|+||+++++++.+
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~   72 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA----------QETVSFFEEERDILSISNSPWIPQLQYAFQD   72 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            445689999999999999976 48899999997542210          1124558899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~  148 (330)
T cd05601          73 KDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGS  148 (330)
T ss_pred             CCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCC
Confidence             78899999999999999998742  369999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +.........  ......||+.|+|||++.       ..++.++|||||||++|||++|..||...........+.....
T Consensus       149 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~  226 (330)
T cd05601         149 AARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR  226 (330)
T ss_pred             CeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence            9865433211  223457999999999764       3467899999999999999999999987654333222221110


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+ .+       .....++..+.+||.+|+. +|.+||++.++++
T Consensus       227 ~~-~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 FL-KF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cc-CC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00 00       0011244557888988887 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.2e-39  Score=313.15  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=199.5

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+.+.||+|+||.||+|...      ++..+++|.+.....             .....+.+|++++++++|+||+++++
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~   74 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-------------AARKDFQREAELLTNLQHEHIVKFYG   74 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-------------HHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            34488999999999999853      245689998753221             11345889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~  312 (455)
                      ++.+ ...++||||+++++|.+++.....             ...+++..++.++.|++.||.|||+  ++++||||||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~  152 (291)
T cd05094          75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATR  152 (291)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcc
Confidence            8877 788999999999999999975321             2348999999999999999999999  88999999999


Q ss_pred             cEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcc
Q psy5603         313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      ||+++.++.++|+|||++........ ........|+..|+|||.+. ..++.++|||||||++|||+| |..||.....
T Consensus       153 Nil~~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         153 NCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             eEEEccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999876543321 11123456788999999654 467889999999999999999 9999977654


Q ss_pred             hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...........  ...         .....+..+.+++.+|+..+|++||++.+|++.|+++.+
T Consensus       232 ~~~~~~~~~~~--~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         232 TEVIECITQGR--VLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHHHHhCCC--CCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            33222221111  000         011234558899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-39  Score=308.22  Aligned_cols=256  Identities=21%  Similarity=0.368  Sum_probs=196.7

Q ss_pred             cCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+++.||+|+||.||+|.+..    +..||||+++.....           ......+.+|+..++.++||||+++++++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   70 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-----------YSEIEEFLSEAACMKDFDHPNVMKLIGVC   70 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-----------HHHHHHHHHHHHHHHhCCCCCeeeEEeee
Confidence            456899999999999998752    367999998643220           01134589999999999999999999976


Q ss_pred             cC-c------eeEEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         249 NN-I------MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      .. .      ..++|+||+++|+|..++....   ....+++..+..++.|++.||.|||+  .+++||||||+||++++
T Consensus        71 ~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~  148 (273)
T cd05035          71 FEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLRE  148 (273)
T ss_pred             ccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECC
Confidence            54 3      3689999999999999885532   12468999999999999999999999  88999999999999999


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHH
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++......... ......++..|+|||.+. ..++.++|||||||++|||++ |..||...........
T Consensus       149 ~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~  227 (273)
T cd05035         149 DMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY  227 (273)
T ss_pred             CCeEEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999988654432111 112234567899999764 457889999999999999999 9999976653322222


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..... ..          ..+..++..+.+++.+||..+|++||++.+|++.|++++
T Consensus       228 ~~~~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         228 LRHGN-RL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             HHcCC-CC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            11110 00          001223455888899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=306.45  Aligned_cols=246  Identities=27%  Similarity=0.444  Sum_probs=194.3

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.+.||+|+||.||+|.++++..+|+|.+.....      .        ...|.+|+.++++++||||+++++++.. .
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------S--------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCC------C--------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            45588999999999999988777899999853221      0        2347889999999999999999998777 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||||+++++|.+++....  ..+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccce
Confidence            7899999999999999997643  268999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+. +.++.++|+||||+++|||+| |..||...+........... ...     
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~-----  220 (256)
T cd05059         149 YVLDDQYT--SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRL-----  220 (256)
T ss_pred             eccccccc--ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcC-----
Confidence            65432211  111223455799999664 567889999999999999999 89999765533222221111 000     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                           ..+..++..+.+++.+|+..+|++||++.++++.|
T Consensus       221 -----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 -----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 01122455688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0032|consensus

Probab=100.00  E-value=2.4e-39  Score=322.53  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=210.8

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLG  246 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  246 (455)
                      ...|++++.||+|.||.||++..+. |+.+|+|.+.+.......          ....+.+|+.+|+++. |||||.+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~----------~~~~v~~Ev~il~~l~~hpniv~l~~  103 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE----------DREDVRREVAILQQLSGHPNIVQLKD  103 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc----------cHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3457778999999999999999885 999999999876542221          1345889999999998 999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC----CCc
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----NFV  321 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~----~~~  321 (455)
                      .+.+ ...++|||++.||.|.+++...    .+++..+..++.|++.|++|||+  .|++||||||+|+|+..    ++.
T Consensus       104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  104 AFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             EEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCc
Confidence            8887 8889999999999999999885    29999999999999999999999  88999999999999953    358


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +|++|||++.......    ....++||+.|+|||++. ..++..+|+||+||++|.|++|.+||.+.........+...
T Consensus       178 ik~~DFGla~~~~~~~----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~  253 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKPGE----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG  253 (382)
T ss_pred             EEEeeCCCceEccCCc----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC
Confidence            9999999999876522    245679999999999886 57899999999999999999999999998866555544433


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...        ......+.++..++++|..++..||.+|+++.++++
T Consensus       254 ~~~--------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  254 DFD--------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCC--------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            321        111223456778999999999999999999999986

>KOG0599|consensus

Probab=100.00  E-value=3.1e-40  Score=299.88  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=209.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||.|..+.|-++..+ +|..+|+|++...+.......     .......-.+|+.||+++ .||||+++.+++.. ..
T Consensus        23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~-----~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET-----PYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             HHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-----HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            88999999999998876 588999999976544332221     222345567899999998 79999999998877 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++|+|.|+.|.|+|+|..   .-.+++....+|+.|+..|+.|||.  ++||||||||+|||+|++..+||+|||++..
T Consensus        98 ~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccceeec
Confidence            8999999999999999987   4569999999999999999999999  8899999999999999999999999999987


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ......    -...+|||+|+|||.+..       +|+..+|.||+||++|.+|.|.+||....+..+...+..+...+.
T Consensus       173 l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  173 LEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             cCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            765542    346799999999997743       477899999999999999999999998888777777766543321


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              .....+++...++||.+|+..||.+|.|++|++.
T Consensus       249 --------speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  249 --------SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             --------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                    1223567778999999999999999999999875

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.7e-39  Score=317.37  Aligned_cols=262  Identities=22%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.++||+|+||.||+|+++ +++.||+|+++.......            ...+.+|+.++++++||||+++
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~   69 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTL   69 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc------------chhHHHHHHHHHhCCCCCcceE
Confidence            445556777899999999999999986 478899999864332110            2236789999999999999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.. ...|+||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+|
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~k  144 (309)
T cd07872          70 HDIVHTDKSLTLVFEYLD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELK  144 (309)
T ss_pred             EEEEeeCCeEEEEEeCCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEE
Confidence            998766 78899999996 58888886543  358899999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||+++.......   ......+|+.|+|||.+.+  .++.++|||||||++|||+||.+||...+.......... .
T Consensus       145 l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  221 (309)
T cd07872         145 LADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL  221 (309)
T ss_pred             ECccccceecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            999999875433221   1223468999999997643  468899999999999999999999987653222211111 0


Q ss_pred             ccch----hhc------cchhccCC-------ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPV----REV------LDKEAGEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~----~~~------~d~~~~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.    +..      .+......       ....++..+.+||.+|+..||++||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000    000      00000000       00124556789999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.8e-39  Score=313.26  Aligned_cols=256  Identities=26%  Similarity=0.354  Sum_probs=197.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++.+.||+|+||.||+|....      ...+|+|.+.....      .      .....+.+|+.+++.++||||+++++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~   70 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS------S------SELRDLLSEFNLLKQVNHPHVIKLYG   70 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC------H------HHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            456899999999999998641      35688888853321      0      11355889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVN---------------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~i  304 (455)
                      .+.. ...++|+||+.+|+|.+++....                     ...++++..++.++.|++.||.|||+  .++
T Consensus        71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i  148 (290)
T cd05045          71 ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKL  148 (290)
T ss_pred             EEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCe
Confidence            8766 78899999999999999986421                     12358899999999999999999999  889


Q ss_pred             eecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CC
Q psy5603         305 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GM  382 (455)
Q Consensus       305 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~  382 (455)
                      +||||||+|||+++++.+||+|||+++........ .......++..|+|||.+ ...++.++||||||+++|||+| |.
T Consensus       149 vH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~  227 (290)
T cd05045         149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG  227 (290)
T ss_pred             ehhhhhhheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence            99999999999999999999999998765332211 112234567789999965 4457889999999999999999 99


Q ss_pred             CCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .||.+............. ..          ...+..++..+.+++.+|+..+|++||++.++++.|++++.
T Consensus       228 ~p~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         228 NPYPGIAPERLFNLLKTG-YR----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCCCCCHHHHHHHHhCC-CC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            999776533322222110 00          00112234457889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-39  Score=322.35  Aligned_cols=241  Identities=25%  Similarity=0.346  Sum_probs=187.0

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH-HHhhCCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|..+ +|+.||||++.......          ......+..|.. +++.++||||+++++++.. ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~   70 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN----------RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK   70 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE
Confidence            36999999999999976 58899999996542211          011233555554 4677999999999997766 88


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++..   ..++++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          71 LYFVLDFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             EEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            8999999999999998876   3468999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+..............+.      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~------  216 (325)
T cd05604         146 GIAQS---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR------  216 (325)
T ss_pred             CCCCC---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC------
Confidence            32221   11235679999999997654 578899999999999999999999987664333332222211111      


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                            ...+..+.++|.+|+..+|++||++.+.+
T Consensus       217 ------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 ------PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ------CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                  11334477889999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-39  Score=312.75  Aligned_cols=265  Identities=25%  Similarity=0.373  Sum_probs=196.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .+++.+.||+|+||.||+|..+     ++..||+|+++....      .       ....|.+|++++++++||||++++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~~   71 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------E-------HLRDFEREIEILKSLQHDNIVKYK   71 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------H-------HHHHHHHHHHHHHhCCCCCeeEEE
Confidence            3456689999999999999743     478899999864321      1       134588999999999999999999


Q ss_pred             ccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         246 GLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++..   ...++|+||+++|+|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+||++++++.+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~  147 (284)
T cd05081          72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRV  147 (284)
T ss_pred             EEEccCCCCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeE
Confidence            96533   46789999999999999987532  358999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ||+|||+++................++..|+|||.+. +.++.++|+|||||++|||++|..|+................
T Consensus       148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd05081         148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ  227 (284)
T ss_pred             EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc
Confidence            9999999987644321111112223445699999664 457889999999999999999987765432211100000000


Q ss_pred             --c---chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         402 --V---PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       402 --~---~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                        .   .+.+.+...........++..+.+|+.+||..+|++|||+.+|++.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              0   00011111111112234456688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=313.91  Aligned_cols=251  Identities=21%  Similarity=0.281  Sum_probs=194.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++... +++.||||++.......          ......+.+|+.++++++||||+++++.+.+
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK----------RKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh----------hhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            455689999999999999975 48899999986432210          0113447789999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence             78899999999999999886533 3468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.......    .....||..|+|||++. ..++.++|||||||++|||++|..||...............   +    
T Consensus       149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---~----  217 (285)
T cd05605         149 AVEIPEGET----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---V----  217 (285)
T ss_pred             ceecCCCCc----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---h----
Confidence            876543221    12357899999999664 46788999999999999999999999875432111111100   0    


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      ...... .+..++..+.+|+.+|+..||.+||     +++++++
T Consensus       218 ~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         218 KEDQEE-YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hhcccc-cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            000000 1123455688899999999999999     7878754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-39  Score=312.83  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=197.3

Q ss_pred             cCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++.+.||+|+||.||+|.+.+      +..||||+++....      .      .....|.+|+.+++.++||||+++++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~~~~l~h~~iv~~~~   75 (283)
T cd05091           8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE------G------PLREEFKHEAMMRSRLQHPNIVCLLG   75 (283)
T ss_pred             HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC------H------HHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            344789999999999998642      47899999864321      0      11345889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~  312 (455)
                      ++.+ ...+++++|+++++|.+++....             ....+++..+..++.|++.||.|||+  ++++||||||+
T Consensus        76 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~  153 (283)
T cd05091          76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATR  153 (283)
T ss_pred             EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchh
Confidence            8877 77899999999999999985321             12358889999999999999999999  88999999999


Q ss_pred             cEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcc
Q psy5603         313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      ||++++++.+||+|||+++....... ........+++.|+|||.+ .+.++.++|||||||++|||+| |..||.+...
T Consensus       154 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         154 NVLVFDKLNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             heEecCCCceEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999886543321 1112344567899999965 5678899999999999999998 8889877654


Q ss_pred             hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ......+.....  .         ..+..++..+.+++.+|++.+|.+||++++|+..|+.
T Consensus       233 ~~~~~~i~~~~~--~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 QDVIEMIRNRQV--L---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHHcCCc--C---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            322222211110  0         0112345668889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.8e-39  Score=307.42  Aligned_cols=252  Identities=26%  Similarity=0.438  Sum_probs=196.3

Q ss_pred             CCccCcCCCeEEEEEEEcC-C---cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         175 GNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .+.||+|+||.||+|..+. +   ..+|+|.++....      .      .....+.+|++++++++|||++++++++.+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT------E------KQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC------H------HHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            3889999999999999753 3   3689998854321      0      113458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++....  ..+++.++..++.+++.||+|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCcc
Confidence             78899999999999999987633  468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +..................+..|+|||.+. +.++.++|||||||++|||++ |..||...........+.. ....+  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~--  230 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLP--  230 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCC--
Confidence            876543322111112223355799999664 467889999999999999998 9999976654322222211 11111  


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                              ....++..+.+++.+|+..+|++||++.+|++.|++++
T Consensus       231 --------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         231 --------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             --------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                    11123455788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0660|consensus

Probab=100.00  E-value=4e-40  Score=311.00  Aligned_cols=263  Identities=24%  Similarity=0.383  Sum_probs=200.0

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |....+|...+.||+|+||.|..+.++ +|+.||||++.....           .....++-.+|+++|+.++|+||+.+
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~-----------~~~~akRtlRElklLr~~~HeNIi~l   86 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE-----------NQIDAKRTLRELKLLRHLRHENIIGL   86 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh-----------chHHHHHHHHHHHHHHHhcCCCcceE
Confidence            333344444588999999999999986 589999999863322           12235668899999999999999999


Q ss_pred             ccccc-----C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         245 LGLCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       245 ~~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ++...     . ...|+|+|+| +.+|...+..   ...++......++.|+++||.|+|+  .+++|||+||+|+|++.
T Consensus        87 ~di~~p~~~~~f~DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~  160 (359)
T KOG0660|consen   87 LDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNA  160 (359)
T ss_pred             EeecccccccccceeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeecc
Confidence            88542     2 5779999999 6788888886   3459999999999999999999999  78999999999999999


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc--cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      +...||+|||+||..... .....-+..+.|..|.|||++  ...++.+.||||.|||+.||++|++-|.+.+...-...
T Consensus       161 ~c~lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l  239 (359)
T KOG0660|consen  161 DCDLKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL  239 (359)
T ss_pred             CCCEEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH
Confidence            999999999999987644 122223456889999999954  33689999999999999999999999998874322222


Q ss_pred             hhh--cccc-----------hhhccchhccCCCh-------hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         397 VVE--QEVP-----------VREVLDKEAGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~--~~~~-----------~~~~~d~~~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..  +..+           ...++.... ..+.       ..+.....+|+.+||..||.+|+|++|.++
T Consensus       240 I~~~lGtP~~e~l~~i~s~~ar~yi~slp-~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  240 ILELLGTPSEEDLQKIRSEKARPYIKSLP-QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHhcCCCCHHHHHHhccHHHHHHHHhCC-CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            211  1000           111111111 1110       234456778999999999999999999875

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.9e-40  Score=329.40  Aligned_cols=252  Identities=21%  Similarity=0.270  Sum_probs=191.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +++.||||++.......          ......+.+|+.++++++||||+++++.+.+
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM----------RNQAAHVKAERDILAEADNEWVVKLYYSFQD   72 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh----------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            566799999999999999976 48899999986432100          1114558899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          73 KDNLYFVMDYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence             8889999999999999999763   458999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCc----------------------------------------ceeeeccCCCCCCCCCcccccC-CCCcccch
Q psy5603         330 VKMSETSNM----------------------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDV  368 (455)
Q Consensus       330 a~~~~~~~~----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv  368 (455)
                      +........                                        .........||+.|+|||++.+ .++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            753210000                                        0001123579999999997644 57889999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC---CHHHH
Q psy5603         369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA---SMRDI  445 (455)
Q Consensus       369 ~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP---s~~ev  445 (455)
                      |||||++|||++|..||...........+........        ......++..+.++|.+|| .+|.+|+   ++.++
T Consensus       228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH--------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc--------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            9999999999999999987764332222211111100        0001123445677787765 5999999   78887


Q ss_pred             HH
Q psy5603         446 VD  447 (455)
Q Consensus       446 l~  447 (455)
                      ++
T Consensus       299 l~  300 (376)
T cd05598         299 KA  300 (376)
T ss_pred             hC
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.6e-39  Score=319.32  Aligned_cols=238  Identities=26%  Similarity=0.327  Sum_probs=185.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH-HHhhCCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|+++ +++.||+|++.......          ......+..|.. +++.++||||+++++++.+ ..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~   70 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK----------KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK   70 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH----------hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE
Confidence            36999999999999986 47899999986432210          011233445554 5788999999999998766 88


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+.+..   ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          71 LYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             EEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            8999999999999998876   3458899999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+......++      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~------  216 (321)
T cd05603         146 GVEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP------  216 (321)
T ss_pred             CCCCC---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC------
Confidence            32221   12345679999999997644 578899999999999999999999987764333333222211111      


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                            ...+..+.++|.+|+..+|.+||+..
T Consensus       217 ------~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 ------GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                  12234578889999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.2e-39  Score=307.50  Aligned_cols=250  Identities=29%  Similarity=0.425  Sum_probs=199.7

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.++||.|+||.||+|.++++..+|+|.+.....      .       ....+.+|+.+++.++||||+++++++.+ .
T Consensus         9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (261)
T cd05148           9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL------L-------KQQDFQKEVQALKRLRHKHLISLFAVCSVGE   75 (261)
T ss_pred             HHhhhhccCCCccEEEeEecCCCcEEEEeccccch------h-------hHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence            34588999999999999998889999999864321      0       13458899999999999999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++.++..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~  152 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLAR  152 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchh
Confidence            7899999999999999998644 3468999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......   ......++..|+|||.+ .+.++.++|+||||+++|+|++ |..||................ .      
T Consensus       153 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~------  222 (261)
T cd05148         153 LIKEDVY---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-R------  222 (261)
T ss_pred             hcCCccc---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-c------
Confidence            6543211   12234567789999965 4467889999999999999998 899997765332222221110 0      


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                          ...+..++..+.+++.+||..+|.+||++.++.+.|+.+
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                011123345578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG1989|consensus

Probab=100.00  E-value=1.4e-39  Score=337.78  Aligned_cols=254  Identities=24%  Similarity=0.309  Sum_probs=200.7

Q ss_pred             cCCCccCcCCCeEEEEEEEcCC-cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccc-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLC-N  249 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~  249 (455)
                      ++.+.|.+|||+.||+|.+..+ ..||+|++-...             +.......+|+++|++|. |+|||.+++.+ .
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d-------------e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND-------------EEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC-------------HHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            4568999999999999998765 999999985431             122566889999999996 99999999922 1


Q ss_pred             -----C--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 -----N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 -----~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                           .  -+.+|+||||.||+|.|++...... .|++.++++|+.++++|+.+||....+|||||||-+||||+.+|..
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~  185 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY  185 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence                 1  2457899999999999999865543 4999999999999999999999987789999999999999999999


Q ss_pred             EEeecccccccccCCcce----eeec--cCCCCCCCCCcccc---cC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchh
Q psy5603         323 KLGDFGIVKMSETSNMKT----MYTE--NLTGTRPYMPPEAM---HC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL  392 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~----~~~~--~~~gt~~Y~aPE~~---~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~  392 (455)
                      ||||||.|.-.-......    ....  ...-|+.|+|||++   .+ .+++|+|||||||+||-|+....||++.....
T Consensus       186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la  265 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA  265 (738)
T ss_pred             EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence            999999876332221000    0000  12468999999965   33 47999999999999999999999999774321


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                    +++......+...++..+.+||..||..+|.+||++.+|+..+-++.+
T Consensus       266 --------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 --------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                          112222222235677889999999999999999999999999987753

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-39  Score=320.00  Aligned_cols=259  Identities=24%  Similarity=0.357  Sum_probs=196.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEE------cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .|++.+.||+|+||.||+|.+      .+++.||||+++.....     .       ....+.+|+.++.++ +||||++
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~~h~niv~   75 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-----S-------EHRALMSELKILIHIGHHLNVVN   75 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-----H-------HHHHHHHHHHHHHhccCCccHhh
Confidence            456779999999999999974      23678999999643210     1       134588899999999 6899999


Q ss_pred             ecccccC--ceeEEEEEeccCCCHHHHHhhcCC-----------------------------------------------
Q psy5603         244 LLGLCNN--IMNCIVYEYMCNGSLYDRLARVNN-----------------------------------------------  274 (455)
Q Consensus       244 l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------  274 (455)
                      +++++..  ...++||||+++|+|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (343)
T cd05103          76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE  155 (343)
T ss_pred             hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence            9997755  567899999999999999865321                                               


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCC
Q psy5603         275 -----------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN  337 (455)
Q Consensus       275 -----------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  337 (455)
                                       ...+++.++..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~  233 (343)
T cd05103         156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP  233 (343)
T ss_pred             CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence                             1247888999999999999999999  889999999999999999999999999987653322


Q ss_pred             cceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhccCC
Q psy5603         338 MKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEW  415 (455)
Q Consensus       338 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  415 (455)
                      . ........++..|+|||.+ ...++.++||||||+++|+|++ |..||...................      ..   
T Consensus       234 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~---  303 (343)
T cd05103         234 D-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------RA---  303 (343)
T ss_pred             c-hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC------CC---
Confidence            1 1112234567789999965 4567899999999999999997 999997654221111111111000      00   


Q ss_pred             ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         416 NETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       416 ~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                       +...+..+.+++..|+..+|++||++.+|++.|++++.
T Consensus       304 -~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         304 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             01122346788889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.6e-39  Score=307.68  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.++.    +..+|+|.++....      .      .....|.+|+.++++++||||++++++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT------E------KQRRDFLSEASIMGQFDHPNIIHLEGV   73 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC------H------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3456899999999999998742    33789999854221      1      013568899999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...|+||||+++++|.+++....  ..+++.+++.++.|++.||.|||+  .+++||||||+|||++.++.++|+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~d  149 (267)
T cd05066          74 VTKSKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSD  149 (267)
T ss_pred             EecCCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCC
Confidence            766 78899999999999999997643  368999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++................++..|+|||.+. +.++.++|+||||+++||+++ |..||............... ...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~  228 (267)
T cd05066         150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRL  228 (267)
T ss_pred             CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcC
Confidence            999886654322111122233456899999765 467899999999999999887 99999876533222222111 111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +          ....++..+.+++.+|+..+|.+||++.++++.|++++
T Consensus       229 ~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         229 P----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             C----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            0          01123445788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.1e-39  Score=318.19  Aligned_cols=237  Identities=24%  Similarity=0.334  Sum_probs=185.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|..+ +++.||+|+++......          ......+.+|+.++.++ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   70 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD----------DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR   70 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE
Confidence            36999999999999976 47899999997542211          11145578899999888 69999999998776 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          71 LFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            89999999999999988763   369999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcch-------hhHHHhhhcccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-------LYYYLVVEQEVPV  404 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-------~~~~~~~~~~~~~  404 (455)
                      .....   .......||+.|+|||++. ..++.++|||||||++|||++|..||......       ............+
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (327)
T cd05617         146 GLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI  222 (327)
T ss_pred             ccCCC---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC
Confidence            32211   1123468999999999764 46788999999999999999999999643210       1111111111111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      +            ..++..+.+++.+||..||++|+++
T Consensus       223 p------------~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 P------------RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             C------------CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1            1233447888999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-39  Score=312.95  Aligned_cols=267  Identities=25%  Similarity=0.443  Sum_probs=198.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      +|++.+.||+|+||.||++.+.     ++..||+|.++....      .      .....+.+|++++++++||||++++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~   72 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG------G------NHIADLKKEIEILRNLYHENIVKYK   72 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc------H------HHHHHHHHHHHHHHhCCCCCeeeee
Confidence            4566689999999999999742     478899999864321      0      0134588999999999999999999


Q ss_pred             ccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         246 GLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++.+   ...++||||++|++|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~  148 (284)
T cd05079          73 GICTEDGGNGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQV  148 (284)
T ss_pred             eEEecCCCCceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCE
Confidence            97755   45689999999999999987532  358999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH-hhhc
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL-VVEQ  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~-~~~~  400 (455)
                      ||+|||+++................|+..|+|||.+ .+.++.++|||||||++|||+|+..|............ ....
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd05079         149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG  228 (284)
T ss_pred             EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence            999999988654432221222345677889999965 44678899999999999999998876543211110000 0000


Q ss_pred             ccchh---hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         401 EVPVR---EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       401 ~~~~~---~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .....   ..+........+..++..+.+|+.+||..+|++||++.++++.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             cccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            00000   000000011112234567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.8e-39  Score=304.72  Aligned_cols=245  Identities=29%  Similarity=0.439  Sum_probs=194.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc-C
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-N  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~  250 (455)
                      +++.+.||+|+||.||+|..+ |..||+|.++....               ...|.+|+.++++++|+|++++++++. +
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   71 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch---------------HHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence            345589999999999999886 78899999853211               345889999999999999999999653 3


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++.... ...+++..++.++.+++.||+|||+  ++++||||||+||++++++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~  148 (256)
T cd05082          72 KGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGL  148 (256)
T ss_pred             CCceEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCcc
Confidence             67899999999999999987643 3458999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++......      ....++..|+|||++.+ .++.++|||||||++|||++ |..||................ .    
T Consensus       149 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~----  217 (256)
T cd05082         149 TKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-K----  217 (256)
T ss_pred             ceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-C----
Confidence            87543221      22345667999996644 57889999999999999998 999997654322222221110 0    


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                            ......++..+.+++.+||..+|++||++.++++.|+++
T Consensus       218 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 ------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  001123445688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.8e-39  Score=308.82  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|..+ ++..||||.+......      +    ......+.+|+.+++.++||||+++++++.+ 
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~------~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM------D----AKARADCIKEIDLLKQLNHPNVIKYYASFIED   74 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh------h----HHHHHHHHHHHHHHHHccCCchhhhhheeEeC
Confidence            44588999999999999975 5899999988643210      0    1113568899999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      ...++||||+++++|.+++..... ...+++.+++.++.+++.||.|||+  ++++|+||||+||+++.++.++|+|||+
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~  152 (267)
T cd08229          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchh
Confidence            788999999999999998875322 4568999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||.................      
T Consensus       153 ~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  223 (267)
T cd08229         153 GRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC------  223 (267)
T ss_pred             hhccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC------
Confidence            876543221   123457899999999664 4578899999999999999999999976542211111100000      


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        .....+....+..+.+++.+|+..+|++||++.+|++.++++.
T Consensus       224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              0011122345667899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.3e-39  Score=309.41  Aligned_cols=249  Identities=25%  Similarity=0.355  Sum_probs=194.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +++.||+|++.....      ..       ...+.+|+.++++++||||+++++++..
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~-------~~~~~~e~~~l~~~~h~~ii~~~~~~~~   77 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG------DD-------FSLIQQEIFMVKECKHCNIVAYFGSYLS   77 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc------ch-------HHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence            456699999999999999975 578999999864321      11       2347889999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++..   ..++++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~  152 (267)
T cd06646          78 REKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGV  152 (267)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCcc
Confidence             788999999999999999875   3468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ++......   .......|+..|+|||.+.    +.++.++|+|||||++|||++|..||....................
T Consensus       153 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  229 (267)
T cd06646         153 AAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP  229 (267)
T ss_pred             ceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC
Confidence            87653221   1123457889999999663    3467899999999999999999999975542211111111100000


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                           ..  .....++..+.+++.+||..+|++||+++++++.
T Consensus       230 -----~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         230 -----KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             -----CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                 00  0112344568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.4e-39  Score=318.86  Aligned_cols=239  Identities=24%  Similarity=0.317  Sum_probs=187.8

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-  250 (455)
                      ..+.||+|+||.||+|..+ +|+.||||++.......          ......+..|..++..+. |++|+++++++.+ 
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (323)
T cd05615           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ----------DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV   73 (323)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhccCCCchhheeeEEecC
Confidence            3488999999999999976 48899999997532211          111345778889988886 5677788887766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++||+|.+++...   ..+++.++..++.|++.||.|||+  +|++||||||+|||++.++.+||+|||++
T Consensus        74 ~~~~lv~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          74 DRLYFVMEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccc
Confidence            7889999999999999998763   469999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +......   .......||+.|+|||++.+ .++.++|+|||||++|||+||..||...........+......++.   
T Consensus       149 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~---  222 (323)
T cd05615         149 KEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK---  222 (323)
T ss_pred             cccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---
Confidence            7543221   12334679999999997644 5788999999999999999999999877644333333222211111   


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                               .++..+.+++.+||..+|.+|++.
T Consensus       223 ---------~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         223 ---------SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---------cCCHHHHHHHHHHcccCHhhCCCC
Confidence                     233457888999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.1e-39  Score=312.07  Aligned_cols=246  Identities=22%  Similarity=0.296  Sum_probs=188.5

Q ss_pred             cCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||++..+ +|+.||+|++........          .....+..|++++++++||||+++++++.+ ...|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~----------~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~l   70 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK----------SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCL   70 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc----------hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEE
Confidence            799999999999976 489999999864322110          012335679999999999999999987766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||++|++|.+++.... ..++++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          71 VMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             EEecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            999999999999886543 3458999999999999999999999  8899999999999999999999999999876543


Q ss_pred             CCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccC
Q psy5603         336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ...    .....||..|+|||++. +.++.++|+|||||++|||++|..||...............      ...... .
T Consensus       148 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~------~~~~~~-~  216 (277)
T cd05607         148 GKT----ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR------TLEDEV-K  216 (277)
T ss_pred             Cce----eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH------hhcccc-c
Confidence            221    22357899999999664 45788999999999999999999999764321111111000      000000 0


Q ss_pred             CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         415 WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....++..+.+|+.+||..||++||++.|+++
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            111234556889999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.7e-38  Score=301.39  Aligned_cols=245  Identities=27%  Similarity=0.429  Sum_probs=193.4

Q ss_pred             ccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      .||+|+||.||+|..+++..||+|.++....      .      .....|.+|++++++++||||+++++++.. ...++
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   69 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP------Q------ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI   69 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCC------H------HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence            6899999999999988788999999864321      1      113458899999999999999999998877 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++++|.+++....  ..+++..+..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||+++....
T Consensus        70 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          70 VMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             EEECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            999999999999987543  358999999999999999999999  8899999999999999999999999999875432


Q ss_pred             CCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhcc
Q psy5603         336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  413 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  413 (455)
                      ...  .......++..|+|||.+. +.++.++||||||+++|++++ |..||............... ...         
T Consensus       146 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~---------  213 (250)
T cd05085         146 GIY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRM---------  213 (250)
T ss_pred             ccc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCC---------
Confidence            211  1111224466799999664 467889999999999999999 99999876543222222111 000         


Q ss_pred             CCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         414 EWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                       ..+..++..+.+++.+|+..+|++||++.++++.|.
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 -SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence             001123456888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-38  Score=304.99  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=192.0

Q ss_pred             CccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||+|.+.+    +..||+|.+.....            ......+.+|+.+++.++||||+++++++.. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD------------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS   68 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC------------HHHHHHHHHHHHHHccCCCCCcceEEEEeecC
Confidence            368999999999998642    35799998743211            0114558899999999999999999997643 


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++|+|.+++....  ..+++..++.++.|++.||.|||+  .+++||||||+|||+++++.+||+|||+
T Consensus        69 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          69 EGSPLVVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccc
Confidence             56799999999999999997643  246788889999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcce-eeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         330 VKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++......... .......++..|+|||.+ ...++.++|||||||++|||++ |.+||................ ..  
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~--  221 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RL--  221 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CC--
Confidence            87554322111 111234567789999965 4567889999999999999999 566776554322221111110 00  


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                              ..+..++..+.+++.+||..+|++||++.+|++.|++++.+
T Consensus       222 --------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~~  262 (262)
T cd05058         222 --------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST  262 (262)
T ss_pred             --------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhcC
Confidence                    00112334588899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.2e-39  Score=324.85  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=197.1

Q ss_pred             CCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecc
Q psy5603         174 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLG  246 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  246 (455)
                      ++++||+|+||.||+|++.      .+..||||+++.....     .       ....+.+|+.++.++. ||||+++++
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-----~-------~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-----S-------EKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-----h-------HHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            4488999999999999864      2468999999643210     0       1345889999999997 999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCC---------------------------------------------------
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------------------------------------  274 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------  274 (455)
                      ++.. ...++|+||+++|+|.+++.....                                                   
T Consensus       109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence            8877 788999999999999999975321                                                   


Q ss_pred             --------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCC
Q psy5603         275 --------------------------------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       275 --------------------------------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dik  310 (455)
                                                                  ...+++..+..++.|++.||.|||+  ++++|||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlk  266 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLA  266 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCC
Confidence                                                        1347888899999999999999999  889999999


Q ss_pred             CCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCC
Q psy5603         311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDN  388 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~  388 (455)
                      |+|||+++++.+||+|||+++......... ......++..|+|||.+. +.++.++|||||||++|||++ |..||...
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999988643322111 112345788899999654 457889999999999999998 89999765


Q ss_pred             cchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         389 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ................          ..+..++..+.+++.+|+..+|.+||++++|++.|++++
T Consensus       346 ~~~~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         346 PMNEQFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CchHHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            4322211111111110          011224456889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-39  Score=311.87  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=195.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC---------------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN---------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  235 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  235 (455)
                      .|++.++||+|+||.||++...+               ...||+|+++....      .      .....|.+|++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~ei~~l~~   73 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT------K------TARNDFLKEIKIMSR   73 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC------H------HHHHHHHHHHHHHHh
Confidence            45677999999999999987642               23589999864321      0      113458899999999


Q ss_pred             CCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5603         236 CKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVN---------NTPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       236 l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~ii  305 (455)
                      ++|+|++++++++.. ...++||||+++++|.+++....         ....+++..++.++.+++.||+|||+  .+++
T Consensus        74 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~  151 (295)
T cd05097          74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFV  151 (295)
T ss_pred             CCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCee
Confidence            999999999998876 88899999999999999986532         12347899999999999999999999  8899


Q ss_pred             ecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc--CC
Q psy5603         306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT--GM  382 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt--G~  382 (455)
                      ||||||+||+++.++.+||+|||+++....... ........++..|+|||.+ .+.++.++|+|||||++|+|++  |.
T Consensus       152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~  230 (295)
T cd05097         152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE  230 (295)
T ss_pred             ccccChhhEEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999876543321 1112334567789999955 5578999999999999999998  67


Q ss_pred             CCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .||...............    ............+...+..+.+|+.+|+..+|++||++.+|++.|++
T Consensus       231 ~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         231 QPYSLLSDEQVIENTGEF----FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             CCCcccChHHHHHHHHHh----hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            788765432211111100    00000000000011234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.4e-39  Score=311.82  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=198.4

Q ss_pred             cCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeec
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      ++.+.||+|+||.||+|....      ...||+|.+.....      .      .....+.+|+.++.++ +|+||++++
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT------E------KDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC------H------HHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            344889999999999998742      36789999864311      0      0134588999999999 899999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCC
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARV-------------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  311 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp  311 (455)
                      +++.. +..+++|||+++|+|.+++...             .....+++..++.++.|++.||.|||+  ++|+||||||
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp  160 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAA  160 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccce
Confidence            98777 7889999999999999999653             123568999999999999999999999  8899999999


Q ss_pred             CcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCc
Q psy5603         312 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN  389 (455)
Q Consensus       312 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~  389 (455)
                      +||+++.++.+||+|||+++......... ......++..|+|||.+ ...++.++|||||||++|||++ |..||....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eeEEEcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            99999999999999999998654432111 11223456789999965 4467899999999999999998 999998665


Q ss_pred             chhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         390 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ............ ..          ..+..++..+.+|+.+|+..+|++||++.++++.|++++.
T Consensus       240 ~~~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~  293 (293)
T cd05053         240 VEELFKLLKEGY-RM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT  293 (293)
T ss_pred             HHHHHHHHHcCC-cC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence            333222221111 00          0011234457889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.2e-39  Score=314.04  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=197.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC--------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Ccccee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |.+++.||+|+||.||++.+..        +..||+|.++....     ..       ....+.+|+.++.++ +||||+
T Consensus        20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-----~~-------~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098          20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-----EK-------DLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-----hH-------HHHHHHHHHHHHHHhcCCCCEe
Confidence            3566899999999999997531        24699999864311     01       134588899999999 799999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      ++++++.. ...++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+  .|++|||
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~d  165 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRD  165 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCccccc
Confidence            99998877 788999999999999999976431             1358999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+||++++++.+||+|||+++........ .......++..|+|||.+. +.++.++|+|||||++|||++ |..||.
T Consensus       166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         166 LAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             ccHHheEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999998755432111 1112223457899999664 457889999999999999998 889997


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ............... ..          ..+..++..+.+++.+|+..+|++||++.+|++.|++++.
T Consensus       245 ~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         245 GVPVEELFKLLKEGH-RM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             cCCHHHHHHHHHcCC-CC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            655322222221110 00          0112334568889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-38  Score=306.70  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=187.8

Q ss_pred             ccCcCCCeEEEEEEEcC---CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         177 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .||+|+||.||+|.+.+   +..+|+|.++....      .      .....|.+|+.++++++||||+++++++.+ ..
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   69 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS------V------QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP   69 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC------h------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC
Confidence            58999999999998653   45789998864321      0      013458889999999999999999998877 77


Q ss_pred             eEEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .++||||+++|+|.+++.....  ...+++..+..++.|++.|+.|||+  .+++|+||||+||+++.++.+||+|||++
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCcccc
Confidence            8999999999999999975332  2356778888999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC--------CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHH-hhhc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL-VVEQ  400 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~-~~~~  400 (455)
                      +....... ........|+..|+|||++.+        .++.++|+||||+++|||++ |..||........... ....
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05087         148 HNKYKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ  226 (269)
T ss_pred             ccccCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc
Confidence            75433221 111234567889999997643        24779999999999999996 9999976553222111 1111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ...   ..++..    ....+..+.+++.+|+ .+|++||++.+|+..|+
T Consensus       227 ~~~---~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLK---LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCC---CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111   111111    1122344777888787 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.4e-39  Score=305.94  Aligned_cols=255  Identities=26%  Similarity=0.406  Sum_probs=198.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++++.||+|+||.||+|...+++.+|||.++.......       ........+.+|++++++++|+||+++++++.+ 
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVL-------AAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD   74 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchh-------hHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence            456789999999999999987789999999875432111       011124568899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||+++++|.+++.+.   .++++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            7889999999999999999763   358999999999999999999999  78999999999999999999999999998


Q ss_pred             cccccCCc---ceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         331 KMSETSNM---KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ........   .........|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+.......+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR  229 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence            76532211   1112234578999999997654 5688999999999999999999999865533222222111111111


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .+..++..+.++|.+||..+|.+||++.++++
T Consensus       230 ---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 ---------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     11224455788999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.7e-39  Score=324.56  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=192.2

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||++.++ +++.||+|++.......          ......+.+|+.+++.++||||+++++.+.+ 
T Consensus        46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~----------~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK----------RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            44589999999999999987 47899999986432110          1113447889999999999999999998776 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++||+|.+++..    ..++...+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            788999999999999999865    248899999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +.......  .......||+.|+|||++.+     .++.++|||||||++|||++|..||...+.......+......+.
T Consensus       190 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         190 MKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             eEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence            86543221  11235679999999997643     267899999999999999999999987764433333322111110


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCC--CCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                       +       .....++..+.++|.+|+..++.+  ||++.++++
T Consensus       268 -~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         268 -F-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             -C-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence             0       011234566888899999744433  788888876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-38  Score=304.20  Aligned_cols=259  Identities=24%  Similarity=0.338  Sum_probs=202.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|... +|+.||+|.++........          ....+.+|++++++++|+|++++++++.+
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----------~~~~~~~ei~~l~~~~~~~i~~~~~~~~~   73 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK----------ARQDCLKEIDLLKQLDHPNVIKYLASFIE   73 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh----------hHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            345589999999999999987 6899999998643221110          13458899999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++||||+++|+|.+++.... ....+++.+++.++.+++.||.|||+  .|++||||||+||+++.++.++|+|||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccc
Confidence             78899999999999999986532 24568999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++.......   ......|+..|+|||.+. ..++.++|+|||||++|+|++|..||.................     
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----  223 (267)
T cd08224         152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-----  223 (267)
T ss_pred             eeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC-----
Confidence            9876543221   123356889999999654 4578899999999999999999999976542211111100000     


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                         .....+....+..+.++|.+||..+|++||++.+|++.|+++.
T Consensus       224 ---~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 ---DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence               0011112245566889999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-38  Score=308.15  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=200.4

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.+.||+|+||.||+|.+.+     +..||+|++.....            ......+.+|+.++++++||||++++++
T Consensus         9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni~~~~~~   76 (280)
T cd05043           9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS------------EIQVTLLLQESCLLYGLSHQNILPILHV   76 (280)
T ss_pred             EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC------------HHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            455899999999999999865     67899998753211            1114558899999999999999999997


Q ss_pred             ccC--ceeEEEEEeccCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         248 CNN--IMNCIVYEYMCNGSLYDRLARVNNT-----PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       248 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +..  ...+++++|+++++|.+++......     ..+++.+++.++.|++.||.|||+  .+++||||||+||++++++
T Consensus        77 ~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~  154 (280)
T cd05043          77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEEL  154 (280)
T ss_pred             EecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCC
Confidence            655  6778999999999999998764322     568999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~  398 (455)
                      .+||+|||+++........ .......++..|+|||.+. ..++.++||||||+++||+++ |..||...+.........
T Consensus       155 ~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  233 (280)
T cd05043         155 QVKITDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK  233 (280)
T ss_pred             cEEECCCCCcccccCCceE-EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            9999999998755332211 1122345677899999664 457889999999999999999 999998765433222221


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      . ...+.          ....++..+.+++.+|+..+|++||++.+|++.|+++.+
T Consensus       234 ~-~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 D-GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             c-CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1 11110          011234457889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-38  Score=311.69  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=197.7

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeec
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      ++.+.||+|+||.||+|.+.      .+..||||.++....      .      .....+.+|+.+++++ +||||++++
T Consensus        38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH------S------SEREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC------h------HHHHHHHHHHHHHHhccCCCCcceEE
Confidence            34589999999999999752      245799999864321      0      0134588999999999 799999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      +++.. +..++||||+++|+|.+++.... ...+++.++..++.+++.||.|||+  ++++|+||||+|||++.++.+||
T Consensus       106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         106 GACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEE
Confidence            98876 78899999999999999997633 2348999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+++....... ........++..|+|||.+ .+.++.++|||||||++|||+| |..||.................
T Consensus       183 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~  261 (302)
T cd05055         183 CDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY  261 (302)
T ss_pred             CCCcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence            99999876543321 1122334567889999965 4567889999999999999998 9999976553222111111110


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..          ..+...+..+.+++.+|+..+|++||++.+|++.|++++
T Consensus       262 ~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         262 RM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             cC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            00          011123445888999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-38  Score=309.38  Aligned_cols=256  Identities=24%  Similarity=0.427  Sum_probs=196.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.++||+|+||.||+|..++      +..||+|.++....      .      .....+.+|+.++++++||||++++
T Consensus         8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~e~~~l~~l~~~~i~~~~   75 (288)
T cd05061           8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS------L------RERIEFLNEASVMKGFTCHHVVRLL   75 (288)
T ss_pred             ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC------H------HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            3455899999999999997542      45799998753221      0      0123478899999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++.+ ...|+||||+++|+|.+++.....       .+.+++..+..++.|++.||.|||+  ++++||||||+||+++
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~  153 (288)
T cd05061          76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVA  153 (288)
T ss_pred             EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEc
Confidence            98766 778999999999999999975321       3456788899999999999999999  8899999999999999


Q ss_pred             CCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHH
Q psy5603         318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++......... ......++..|+|||.+ .+.++.++|+|||||++|||++ |..||..........
T Consensus       154 ~~~~~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~  232 (288)
T cd05061         154 HDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK  232 (288)
T ss_pred             CCCcEEECcCCcccccccccccc-ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999988654322111 11223457789999965 4567899999999999999999 888997655332222


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .......  ..         .+...+..+.+++.+|+..+|++||++.++++.|++.+
T Consensus       233 ~~~~~~~--~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         233 FVMDGGY--LD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHcCCC--CC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111100  00         01123456889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-38  Score=303.91  Aligned_cols=251  Identities=26%  Similarity=0.377  Sum_probs=198.1

Q ss_pred             CccCcCCCeEEEEEEEcC--C--cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         176 NKLGEGQFGTVYYGKLKN--G--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      +.||+|+||.||+|.+.+  +  ..||||.+......            .....|.+|++++++++||||+++++++.+.
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLTH   68 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH------------HHHHHHHHHHHHHhhcCCCCccceeEEEcCC
Confidence            368999999999998753  2  36899998654321            1245689999999999999999999987777


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++|+||+++++|.+++..... ..+++..++.++.|++.||+|||+  ++++||||||+||+++.++.+||+|||+++
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~  145 (257)
T cd05040          69 PLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMR  145 (257)
T ss_pred             eEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccc
Confidence            88999999999999999987442 468999999999999999999999  889999999999999999999999999988


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ................++..|+|||.+. ..++.++|||||||++|||++ |..||...+...............     
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----  220 (257)
T cd05040         146 ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----  220 (257)
T ss_pred             cccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-----
Confidence            7654322111223456788999999764 467889999999999999999 999997665433322222111000     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                           ..+...+..+.+++.+|+..+|++||++.++++.|.+
T Consensus       221 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         221 -----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             -----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence                 0011234568889999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9e-39  Score=314.30  Aligned_cols=197  Identities=25%  Similarity=0.367  Sum_probs=158.6

Q ss_pred             CCccCcCCCeEEEEEEEcC---CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         175 GNKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.+||+|+||.||+|..++   +..||+|.+.....               ...+.+|+.++++++||||+++++++.. 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---------------SMSACREIALLRELKHPNVIALQKVFLSH   70 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---------------cHHHHHHHHHHHhCCCCCeeeEEEEEecc
Confidence            4789999999999999753   57899999864321               2237789999999999999999997632 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE----cC
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  318 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl----~~  318 (455)
                        ...|+|+||+. ++|.+++....      ....+++..+..++.|++.||.|||+  ++|+||||||+|||+    +.
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~  147 (317)
T cd07867          71 SDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  147 (317)
T ss_pred             CCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCC
Confidence              56789999985 68888775321      12358899999999999999999999  889999999999999    56


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCc
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~  389 (455)
                      ++.+||+|||+++................||+.|+|||.+.+  .++.++|||||||++|||+||.+||....
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            789999999999876543222222334678999999997654  46889999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-39  Score=307.74  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=197.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++.+.||+|+||.||+|.++.      +..||+|.+.....      .      .....+.+|+.+++.++||||+++++
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~------~------~~~~~~~~e~~~l~~~~~~~i~~~~~   76 (277)
T cd05032           9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS------M------RERIEFLNEASVMKEFNCHHVVRLLG   76 (277)
T ss_pred             eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC------H------HHHHHHHHHHHHHHhCCCCceeEEEE
Confidence            455889999999999998752      36799999853211      0      11345889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ++.+ ...++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||+  .+++||||||+||+++.
T Consensus        77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~  154 (277)
T cd05032          77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAE  154 (277)
T ss_pred             EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcC
Confidence            8776 788999999999999999975332       2347899999999999999999999  88999999999999999


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHH
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++........ .......++..|+|||.+ .+.++.++|||||||++||++| |..||...+.......
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  233 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF  233 (277)
T ss_pred             CCCEEECCcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence            999999999998765433211 112334577889999965 4567889999999999999998 9999976654332222


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .....  ...         .+..++..+.+++.+||..+|++||++.++++.|++
T Consensus       234 ~~~~~--~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         234 VIDGG--HLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HhcCC--CCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            21110  000         011234568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-38  Score=304.45  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             cCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+.+.||+|+||.||+|.+.+    ...||||.......      .      .....|.+|+.+++++.||||+++++++
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~------~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~   76 (270)
T cd05056           9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS------P------SVREKFLQEAYIMRQFDHPHIVKLIGVI   76 (270)
T ss_pred             eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC------H------HHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence            345889999999999998753    24689998864321      0      1134588999999999999999999999


Q ss_pred             cCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         249 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       249 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      .+...++||||+++|+|.+++....  ..+++.+++.++.+++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          77 TENPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             cCCCcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCc
Confidence            8888899999999999999997632  358999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++........  ......++..|+|||.+. ..++.++||||||+++||+++ |..||................ ... 
T Consensus       153 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~-  228 (270)
T cd05056         153 LSRYLEDESYY--KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLP-  228 (270)
T ss_pred             eeeecccccce--ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cCC-
Confidence            98865443211  122334556899999664 457889999999999999996 999998765432222221111 110 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               .+..++..+.+++.+|+..+|.+||++.++++.|+++.+
T Consensus       229 ---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         229 ---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     112334568889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-38  Score=311.61  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=198.0

Q ss_pred             cCCCccCcCCCeEEEEEEEc--------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceee
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .+++.||+|+||.||+|...        ++..||+|.+.....            ......+.+|+.+++.+ +||||++
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~------------~~~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101          18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT------------EKDLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc------------hHHHHHHHHHHHHHHhhccCCCchh
Confidence            45588999999999999742        235799999853211            01134588999999999 8999999


Q ss_pred             ecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         244 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      +++++.. ...++||||+++|+|.+++.....             ...+++.++..++.|++.||.|||+  +|++||||
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dl  163 (304)
T cd05101          86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDL  163 (304)
T ss_pred             eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeeccc
Confidence            9998877 778999999999999999976421             2357889999999999999999999  88999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCC
Q psy5603         310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+||+++.++.+||+|||+++........ .......++..|+|||++. ..++.++||||||+++|||++ |..||..
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999998865432211 1122345677899999664 457889999999999999998 8888876


Q ss_pred             CcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .............. ..          ..+..++..+.+++.+|+..+|++||++.+|++.|++++.
T Consensus       243 ~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         243 IPVEELFKLLKEGH-RM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             CCHHHHHHHHHcCC-cC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            65333222221111 00          0112345568889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=305.07  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=199.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-Cc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.+.||+|+||.||+|.++. |.    .||+|.+.....            ......+.+|+.++++++||||++++++
T Consensus        10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   77 (279)
T cd05057          10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS------------PKANKEILDEAYVMASVDHPHVVRLLGI   77 (279)
T ss_pred             EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC------------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            455899999999999998753 32    589998754321            1114558899999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.....++|+||+++|+|.+++....  ..+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~df  153 (279)
T cd05057          78 CLSSQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDF  153 (279)
T ss_pred             EecCceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCC
Confidence            88888899999999999999997643  358999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++....... ........++..|+|||.+ .+.++.++|+||||+++||+++ |..||................ .. 
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-  230 (279)
T cd05057         154 GLAKLLDVDEK-EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL-  230 (279)
T ss_pred             cccccccCccc-ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC-
Confidence            99986553321 1111223346689999966 4567889999999999999999 999998765433222222111 00 


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ..+...+..+.+++.+||..+|+.||++.++++.|+++.+
T Consensus       231 ---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 ---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     0011122347788999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.3e-39  Score=345.28  Aligned_cols=262  Identities=21%  Similarity=0.258  Sum_probs=198.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||.||+|.+. +|+.||||+++......          ......|.+|++++++++||||+++++++.
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~----------e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN----------PLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC----------HHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            3566799999999999999986 48899999986432110          112456899999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      + +..|+||||++||+|.+++.....        ...+++..++.++.|++.||+|||+  +||+||||||+|||++.++
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg  150 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFG  150 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCC
Confidence            7 788999999999999999864211        2346678889999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcc---------------eeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCC
Q psy5603         321 VPKLGDFGIVKMSETSNMK---------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~---------------~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p  384 (455)
                      .+||+|||+++........               ........||+.|+|||.+. ..++.++|||||||++|||+||..|
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            9999999999865211100               01112357999999999664 4678899999999999999999999


Q ss_pred             CCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-CHHHHHHHHHhhh
Q psy5603         385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSV  453 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~  453 (455)
                      |..............        .++. ...+...++..+.+++.+|+..||++|| ++.++.+.|+..+
T Consensus       231 F~~~~~~ki~~~~~i--------~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        231 YRRKKGRKISYRDVI--------LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             CCCcchhhhhhhhhc--------cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            976442211111000        0000 0011123455688899999999999995 6777777777654

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-38  Score=310.22  Aligned_cols=254  Identities=28%  Similarity=0.404  Sum_probs=194.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-Cc--EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.+++ +.  .+++|.++....      .      .....|.+|++++.++ +||||++++++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~------~------~~~~~~~~E~~~l~~l~~hp~iv~~~~~   71 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS------E------NDHRDFAGELEVLCKLGHHPNIINLLGA   71 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC------H------HHHHHHHHHHHHHHhhcCCCchhheEEE
Confidence            3455899999999999998763 33  478888753211      0      0134588999999999 79999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCc
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~N  313 (455)
                      +.+ ...++|+||+++++|.+++.....             ...+++..++.++.|++.||.|||+  ++++||||||+|
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~N  149 (297)
T cd05089          72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARN  149 (297)
T ss_pred             EccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcce
Confidence            877 778999999999999999975321             1358899999999999999999999  889999999999


Q ss_pred             EEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcch
Q psy5603         314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTI  391 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~  391 (455)
                      ||+++++.+||+|||++.......    .......+..|+|||.+. ..++.++|||||||++|||++ |..||......
T Consensus       150 ill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~  225 (297)
T cd05089         150 VLVGENLASKIADFGLSRGEEVYV----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA  225 (297)
T ss_pred             EEECCCCeEEECCcCCCcccccee----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999986422110    111123345799999664 457889999999999999998 99999876543


Q ss_pred             hhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ......... ..          ...+..++..+.+++.+|+..+|.+||++.++++.|++++.
T Consensus       226 ~~~~~~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         226 ELYEKLPQG-YR----------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHHHHHhcC-CC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            322221111 00          00112244568889999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0594|consensus

Probab=100.00  E-value=1.3e-38  Score=301.63  Aligned_cols=256  Identities=24%  Similarity=0.317  Sum_probs=195.5

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc-eeeecccccC-c-
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-LLRLLGLCNN-I-  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~-~-  251 (455)
                      ++||+|+||+||+|+.+ +|+.||+|+++-......           .-....+|+.++++++|+| ||.+++++.+ . 
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-----------~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-----------VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-----------CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            67999999999999976 588999999986544211           0122578999999999999 9999998765 4 


Q ss_pred             -----eeEEEEEeccCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         252 -----MNCIVYEYMCNGSLYDRLARVNNT-PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       252 -----~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                           ..++|+||+ .-+|..++...... ..++...+..++.|+++||.|||+  ++|+||||||+|||++++|.+||+
T Consensus        86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeee
Confidence                 678999999 68999999875421 357778999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--c-
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--Q-  400 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~-  400 (455)
                      |||+|+.......   ....-++|..|.|||++.|  .+++.+|+||+||+++||+++++-|.+......-..+..  + 
T Consensus       163 DFGlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  163 DFGLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             ccchHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            9999996553321   1234578999999997655  488999999999999999999999998875333333222  1 


Q ss_pred             --ccchhhc---cch--hccCCC-hhHHH-------HHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         401 --EVPVREV---LDK--EAGEWN-ETHVE-------TLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       401 --~~~~~~~---~d~--~~~~~~-~~~~~-------~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                        +...+..   -+-  ....|. +..+.       ....+++.+|+..+|.+|.|++..++.
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              1111111   011  112222 11111       357789999999999999999998764

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-38  Score=302.73  Aligned_cols=252  Identities=23%  Similarity=0.391  Sum_probs=199.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .+++.++||+|+||.||+|.++++..+|+|.+.....              ....|.+|++++++++|+||+++++++.+
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--------------SVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCChh--------------HHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            4566799999999999999987778899998863211              13458899999999999999999998877


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...+++|||+++++|.+++.... ...+++..++.++.+++.||.|||+  .+++|+||||+||+++.++.+||+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcce
Confidence            77899999999999999997643 3468899999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ........  .......++..|+|||.+. +.++.++|+|||||++|+++| |..||...+........... ....   
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~---  223 (260)
T cd05073         150 RVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP---  223 (260)
T ss_pred             eeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCC---
Confidence            76543221  1122335667899999664 457889999999999999999 99999876533222222111 0100   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                             .....+..+.+++.+|+..+|++||++.++.+.|+++
T Consensus       224 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         224 -------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             -------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                   0112344588899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-39  Score=316.74  Aligned_cols=253  Identities=22%  Similarity=0.279  Sum_probs=191.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++..+ +++.||||++......          .......|.+|+.++..++|+||+++++++.+
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML----------KRAETACFREERDVLVNGDRRWITNLHYAFQD   72 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh----------hhhhHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence            456689999999999999976 4889999999642211          01124558889999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++....  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~  148 (331)
T cd05597          73 ENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGS  148 (331)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCc
Confidence             78899999999999999997632  358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +........  .......||+.|+|||++.      +.++.++|||||||++|||++|..||...........+......
T Consensus       149 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~  226 (331)
T cd05597         149 CLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH  226 (331)
T ss_pred             eeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc
Confidence            875443221  1122347999999999764      24678999999999999999999999876543332222211111


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccC--cCCCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFE--KDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~d--p~~RPs~~evl~  447 (455)
                      ..  +..     ....++..+++++.+|+..+  +..||++.++++
T Consensus       227 ~~--~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         227 FQ--FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             cc--CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            00  000     01124455777888877554  334789988865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.2e-39  Score=322.27  Aligned_cols=256  Identities=25%  Similarity=0.347  Sum_probs=192.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.+. +|+.||||++.....      .     ......+.+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------N-----LVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------c-----hHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            34589999999999999975 589999999853211      0     1113458899999999999999999998765 


Q ss_pred             c-----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         251 I-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       251 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      .     ..|+|+||+. ++|.+.+..   ...+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEec
Confidence            3     6799999995 688888765   3469999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QE  401 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~  401 (455)
                      |||+++........  ......+|+.|+|||.+.+  .++.++|||||||++|||++|+.||...+.......+..  +.
T Consensus       146 Dfg~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~  223 (372)
T cd07853         146 DFGLARVEEPDESK--HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT  223 (372)
T ss_pred             cccceeecccCccc--cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999865433211  1223468999999997654  368899999999999999999999987663322221111  11


Q ss_pred             cchhh----------ccchhccCC--------ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVRE----------VLDKEAGEW--------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~----------~~d~~~~~~--------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....          .+.......        .....+..+.+||.+|+..||++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            01000          000000000        00122456788999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0658|consensus

Probab=100.00  E-value=6.6e-40  Score=310.07  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=188.0

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC---c
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---I  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~  251 (455)
                      +++|.|+||.||+|...+ +..||||++-.+...                 -.+|+++|+.+.|||||++.-++..   .
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----------------knrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----------------KNRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----------------CcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            889999999999999764 689999998654331                 2369999999999999999876532   2


Q ss_pred             ---eeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-CceEEee
Q psy5603         252 ---MNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGD  326 (455)
Q Consensus       252 ---~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~D  326 (455)
                         ..++|||||+ .+|.+.++... .+..++.-.+.-+..||.+||.|||+  .||+||||||.|+|+|.+ |.+||||
T Consensus        93 d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicD  169 (364)
T KOG0658|consen   93 DEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICD  169 (364)
T ss_pred             chhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEecc
Confidence               3468999995 78998887421 13467888888999999999999999  889999999999999976 9999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--ccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEV  402 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~  402 (455)
                      ||.|+....+....    ...-|.-|.|||.+.|  .|+.+.||||.|||+.||+-|++-|.+.+.......+..  +..
T Consensus       170 FGSAK~L~~~epni----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  170 FGSAKVLVKGEPNI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP  245 (364)
T ss_pred             CCcceeeccCCCce----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence            99999877655322    2356888999996644  689999999999999999999999998763222221111  111


Q ss_pred             chh----------hccchhc--cCC---ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVR----------EVLDKEA--GEW---NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~----------~~~d~~~--~~~---~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .-.          +.-.+..  ..|   .....+....+|+.+++..+|.+|.++.|++.
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            111          1111111  111   22344556778999999999999999998874

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-38  Score=300.02  Aligned_cols=246  Identities=25%  Similarity=0.353  Sum_probs=196.6

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +.+.||+|+||.||+|..+ +++.||+|.+......           ......+.+|++++++++||||+++++++.+ .
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-----------RREREEAIDEARVLAKLDSSYIIRYYESFLDKG   72 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-----------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCC
Confidence            4488999999999999986 4889999998643221           1114558899999999999999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||||+++++|.+++.... ...+++..++.++.+++.||.|||+  .+++||||||+||+++.++.++|+|||+++
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~  149 (256)
T cd08529          73 KLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAK  149 (256)
T ss_pred             EEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccce
Confidence            8899999999999999998642 3568999999999999999999999  889999999999999999999999999988


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      .......   ......|+..|+|||++. +.++.++|+||||+++|+|++|..||................  ..     
T Consensus       150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-----  219 (256)
T cd08529         150 LLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FP-----  219 (256)
T ss_pred             eccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC-----
Confidence            6543321   123457889999999664 457889999999999999999999998766332222211111  00     


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         . ....++..+.+++.+|+..+|++||++.++++
T Consensus       220 ---~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         220 ---P-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ---C-CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence               0 11134456888999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-38  Score=309.12  Aligned_cols=260  Identities=27%  Similarity=0.353  Sum_probs=198.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-----------------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      .|++.+.||+|+||.||+|.+..                 +..||+|.+......            .....+.+|++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------------~~~~~~~~e~~~l   73 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD------------NAREDFLKEVKIL   73 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH------------HHHHHHHHHHHHH
Confidence            34667999999999999998642                 245899998643221            1145688999999


Q ss_pred             hhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy5603         234 SQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       234 ~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~i  304 (455)
                      ++++||||+++++++.. ...++|+||+++++|.+++.....        ...+++..++.++.|++.||.|||+  +++
T Consensus        74 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i  151 (296)
T cd05051          74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNF  151 (296)
T ss_pred             HhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCc
Confidence            99999999999998877 788999999999999999976431        2368999999999999999999999  889


Q ss_pred             eecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc--C
Q psy5603         305 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT--G  381 (455)
Q Consensus       305 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt--G  381 (455)
                      +||||||+||+++.++.++|+|||+++....... ........++..|+|||.+. +.++.++|||||||++|||++  |
T Consensus       152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             cccccchhceeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence            9999999999999999999999999876543321 11223456778899999654 478999999999999999998  7


Q ss_pred             CCCCCCCcchhhHHHhhhc--ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         382 MKPIDDNNTILYYYLVVEQ--EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ..||...............  ........      ..+..++..+.+++.+||..+|++||++.+|++.|++
T Consensus       231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         231 EQPYEHLTDQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             CCCCCCcChHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            7888765432222211110  00000000      0111234568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.1e-38  Score=304.75  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=193.2

Q ss_pred             CCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +.+.||+|+||.||+|.+.+      +..||+|.+.....      .      .....|.+|+.++++++|+||++++++
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~------~------~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (277)
T cd05036          10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS------E------QDESDFLMEALIMSKFNHQNIVRLIGV   77 (277)
T ss_pred             eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC------H------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            44899999999999998853      46789998753221      1      113458899999999999999999997


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC--
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF--  320 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~--  320 (455)
                      +.+ ...++||||+++++|.+++.....    ...+++.+++.++.|++.||+|||+  ++++||||||+||+++.++  
T Consensus        78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCC
Confidence            766 778999999999999999976432    2358999999999999999999999  8899999999999998765  


Q ss_pred             -ceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHh
Q psy5603         321 -VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  397 (455)
Q Consensus       321 -~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~  397 (455)
                       .+||+|||+++........ .......++..|+|||.+ .+.++.++|||||||++|||++ |..||............
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~  234 (277)
T cd05036         156 RVAKIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV  234 (277)
T ss_pred             cceEeccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             6999999998865332211 111223445679999965 4568999999999999999997 99999876533222222


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .... ..          ..+..++..+.+++.+|+..+|++||++.+|++.|++
T Consensus       235 ~~~~-~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         235 TGGG-RL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HcCC-cC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            1110 00          0012234567889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-39  Score=324.96  Aligned_cols=251  Identities=21%  Similarity=0.294  Sum_probs=190.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||++..+ +++.||||+++......          ......+.+|+.++.+++||||+++++.+.+
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   72 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE----------KEQVAHIRAERDILVEADGAWVVKMFYSFQD   72 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh----------hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            345589999999999999986 48899999997432111          1124558889999999999999999998777


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          73 KRNLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             CCEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccC
Confidence             7889999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcc--------------------------------eeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHH
Q psy5603         330 VKMSETSNMK--------------------------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILL  376 (455)
Q Consensus       330 a~~~~~~~~~--------------------------------~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~  376 (455)
                      ++........                                ........||+.|+|||++. ..++.++|||||||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily  227 (360)
T cd05627         148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence            8744221100                                00012357999999999764 46788999999999999


Q ss_pred             HHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC---HHHHH
Q psy5603         377 ELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---MRDIV  446 (455)
Q Consensus       377 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---~~evl  446 (455)
                      ||+||.+||...........+......+.  +.      +...++..+.+||.++| .+|++|++   +.+++
T Consensus       228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~~--~p------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         228 EMLIGYPPFCSETPQETYRKVMNWKETLV--FP------PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             ecccCCCCCCCCCHHHHHHHHHcCCCcee--cC------CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence            99999999987765443333322111100  00      00113445777888877 49999985   45554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-38  Score=319.87  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=189.7

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||++.+. +|..||||++......           ......+.+|+.+++.++||||+++++++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~   89 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-----------QTHAKRAYRELVLLKCVNHKNIISLLNVF   89 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-----------hhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            34566699999999999999976 4889999998643210           01134577899999999999999999976


Q ss_pred             cC-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..       ...|+||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~  161 (359)
T cd07876          90 TPQKSLEEFQDVYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  161 (359)
T ss_pred             ccCCCccccceeEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCC
Confidence            43       24689999995 567666643     47889999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +||+|||+++......    ......||+.|+|||.+.+ .++.++|||||||++|+|+||..||...+.......... 
T Consensus       162 ~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~  237 (359)
T cd07876         162 LKILDFGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ  237 (359)
T ss_pred             EEEecCCCccccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999987543321    1234578999999997654 678899999999999999999999987653221111110 


Q ss_pred             cccch-----------hhccchhc-----------cCC-------ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QEVPV-----------REVLDKEA-----------GEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~-----------~~~~d~~~-----------~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+.           ..+.....           ..|       .....+..+.+||.+|+..||++||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000           00000000           000       00112356789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.8e-39  Score=306.32  Aligned_cols=251  Identities=32%  Similarity=0.463  Sum_probs=194.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||+||++.... ++.||+|++.....      .     ........+|+.++++++||||+++++++.+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~------~-----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~   69 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI------E-----EEEREENIREIKILRRLRHPNIVQILDVFQD   69 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH------H-----HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc------c-----ccccchhhhhhhccccccccccccccccccc
Confidence            4567899999999999999875 67899999975432      1     1112223459999999999999999998866


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.+++|.+++..   ...+++..++.++.|++.||.+||+  .+++|+||||+||+++.++.++|+|||.
T Consensus        70 ~~~~~~v~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~  144 (260)
T PF00069_consen   70 DNYLYIVMEYCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGS  144 (260)
T ss_dssp             SSEEEEEEEEETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred             cccccccccccccccccccccc---ccccccccccccccccccccccccc--cccccccccccccccccccccccccccc
Confidence             888999999999999999984   3468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchhh
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~  406 (455)
                      +......   ........+|..|+|||+..  ...+.++|+||+|+++|+|++|..||.............. .......
T Consensus       145 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  221 (260)
T PF00069_consen  145 SVKLSEN---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS  221 (260)
T ss_dssp             TEESTST---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH
T ss_pred             ccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc
Confidence            8754111   11234568899999999765  5678999999999999999999999998732111111111 1101100


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..      .........+.++|.+||..+|++||++.++++
T Consensus       222 ~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 SS------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HT------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cc------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      001111256888999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-38  Score=302.80  Aligned_cols=251  Identities=29%  Similarity=0.432  Sum_probs=191.3

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.++.||+|+||.||+|... ++..||+|++.........        ......+.+|+.++++++||||+++++++.+ 
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET--------SKEVSALECEIQLLKNLQHERIVQYYGCLRDR   76 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh--------HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence            44589999999999999976 4889999998654321110        1124558899999999999999999997643 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...++++||+++++|.+++...   ..+++...+.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCC
Confidence              5678999999999999999763   358999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++................|+..|+|||.+.+ .++.++|+|||||++|||++|..||................ .    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~----  226 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-T----  226 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-C----
Confidence            98754322111111233568899999997654 57889999999999999999999998654322211111110 0    


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .+    ..+..+...+++++ +||..+|++||++++|++
T Consensus       227 -~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 -NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             00    01123445577788 577789999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-38  Score=299.47  Aligned_cols=249  Identities=30%  Similarity=0.468  Sum_probs=199.2

Q ss_pred             CccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||+|....    +..||+|.++......            ....+.+|++.+..++|+||+++++++.+ 
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   68 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE------------ERKDFLKEARVMKKLGHPNVVRLLGVCTEE   68 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh------------HHHHHHHHHHHHhhcCCCChheeeeeecCC
Confidence            369999999999999863    6789999986543211            14568899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNN------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      ...++||||+++++|.+++.....      ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||
T Consensus        69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l  146 (262)
T cd00192          69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKI  146 (262)
T ss_pred             CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEE
Confidence            788999999999999999987521      2579999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||.++....... ........++..|+|||.+. ..++.++||||||+++|||++ |..||................ 
T Consensus       147 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-  224 (262)
T cd00192         147 SDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-  224 (262)
T ss_pred             cccccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-
Confidence            99999987654331 11233456788999999664 467889999999999999999 699998775333222221100 


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      .          ...+..++..+.+++.+|+..+|++||++.++++.|+
T Consensus       225 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 R----------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C----------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0          0011223556888999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4e-38  Score=301.77  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=197.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.++..||+|+||.||+|.+. +++.||+|.+..........    .........+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSK----DRKRSMLDALAREIALLKELQHENIVQYLGSSLD   77 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchh----HHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence            456689999999999999875 47899999986543321111    1111224568899999999999999999998777


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++||||+|+||++++++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          78 ADHLNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             CCccEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCC
Confidence             7889999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcce---eeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         330 VKMSETSNMKT---MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~---~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ++.........   .......|+..|+|||.+. +.++.++|+|||||++|+|++|..||...............     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----  227 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-----  227 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-----
Confidence            88665321111   1112356889999999664 46788999999999999999999999875432221111110     


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ..+    ..+..++..+.++|.+||..+|++||++.++++
T Consensus       228 --~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 --ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              000    011234456888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-38  Score=303.90  Aligned_cols=244  Identities=29%  Similarity=0.447  Sum_probs=195.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.+.||+|+||.||+|... ++.||+|.++....               ...+.+|+.++++++|||++++++++...
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~-~~~~~iK~~~~~~~---------------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT---------------AQAFLEETAVMTKLHHKNLVRLLGVILHN   71 (254)
T ss_pred             ceeeeeeccCCCCceEecccC-CCceEEEeecCcch---------------HHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            345689999999999999864 78899999853211               34588999999999999999999988887


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+  .|++||||||+||+++.++.+||+|||+++
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccce
Confidence            7899999999999999997643 3458999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......      .....+..|+|||.+. +.++.++|+|||||++|||++ |.+||............... ..      
T Consensus       149 ~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~------  215 (254)
T cd05083         149 VGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YR------  215 (254)
T ss_pred             eccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CC------
Confidence            543211      1224456799999664 567889999999999999998 99999876543322222111 00      


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                          ......++..+.+++.+||..+|++||+++++++.|++
T Consensus       216 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 ----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                00112344567889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-38  Score=315.82  Aligned_cols=253  Identities=21%  Similarity=0.263  Sum_probs=193.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++..+. ++.||+|++.+...          ........+..|+.++..++|+||+++++++.+
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM----------LKRAETACFREERDVLVNGDNQWITTLHYAFQD   72 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH----------HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence            4556899999999999999874 67899999864211          011113457889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~  148 (332)
T cd05623          73 ENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGS  148 (332)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecch
Confidence             78899999999999999997643  368999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +.......  ........||+.|+|||++.      +.++.++|||||||++|||++|..||...........+......
T Consensus       149 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~  226 (332)
T cd05623         149 CLKLMEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER  226 (332)
T ss_pred             heecccCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc
Confidence            87543222  11233457999999999764      34688999999999999999999999876644433333221111


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcC--CCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKD--KRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~--~RPs~~evl~  447 (455)
                      ..  +     ......++..+.+|+.+|+..+++  .|+++.++++
T Consensus       227 ~~--~-----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         227 FQ--F-----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             cc--C-----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            10  0     001123455678888888866544  3688888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.8e-38  Score=306.44  Aligned_cols=257  Identities=22%  Similarity=0.289  Sum_probs=188.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC---Cccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.++ +++.||+|.++........           ...+.+|+++++++   +||||++++++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~h~ni~~~~~~   70 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-----------PLSTVREVALLKRLEAFDHPNIVRLMDV   70 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-----------chHHHHHHHHHHHhhhcCCCCeeeeeee
Confidence            456689999999999999987 4889999998754321110           12255677766655   79999999997


Q ss_pred             ccC------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         248 CNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +..      ...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  ++++||||||+|||++.++.
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~  146 (288)
T cd07863          71 CATSRTDRETKVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQ  146 (288)
T ss_pred             eccccCCCCceEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence            643      34689999996 58988887643 2458999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +||+|||+++......    ......||..|+|||++ ...++.++|||||||++|||++|.+||...........+.. 
T Consensus       147 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  222 (288)
T cd07863         147 VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL  222 (288)
T ss_pred             EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence            9999999988654322    12345789999999966 44678999999999999999999999976653221111111 


Q ss_pred             -cc---cchhh-------ccchhccCC---ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QE---VPVRE-------VLDKEAGEW---NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~---~~~~~-------~~d~~~~~~---~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ..   ...+.       ...+.....   ....++..+.++|.+||..||++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00   00000       000000000   00134556889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-38  Score=303.01  Aligned_cols=248  Identities=27%  Similarity=0.449  Sum_probs=190.5

Q ss_pred             ccCcCCCeEEEEEEEcC-Cc--EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-c
Q psy5603         177 KLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  251 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  251 (455)
                      .||+|+||.||+|.+++ +.  .+|+|.++....      .      .....+.+|++++.++ +||||+++++++.. +
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   69 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------K------DDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   69 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC------H------HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC
Confidence            58999999999999864 33  468888753211      0      1134588999999999 89999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ..++||||+++|+|.+++....             ....+++.++..++.|++.||+|||+  .+++||||||+||++++
T Consensus        70 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~  147 (270)
T cd05047          70 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGE  147 (270)
T ss_pred             CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcC
Confidence            7899999999999999997532             12358899999999999999999999  88999999999999999


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHH
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++......    .......+..|+|||.+. ..++.++|+|||||++|||++ |..||...........
T Consensus       148 ~~~~kl~dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~  223 (270)
T cd05047         148 NYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  223 (270)
T ss_pred             CCeEEECCCCCccccchhh----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence            9999999999976322110    111223456799999664 457889999999999999997 9999976543222221


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .... ...    +      .+..++..+.+++.+|+..+|.+||++.+++..|++++
T Consensus       224 ~~~~-~~~----~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LPQG-YRL----E------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HhCC-CCC----C------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1110 000    0      01123345788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=300.30  Aligned_cols=251  Identities=28%  Similarity=0.422  Sum_probs=198.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++.+.||+|+||.||+|.++++..||||.+.....              ....+.+|+.++++++|+||+++++++.+ 
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--------------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE   73 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--------------CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence            345689999999999999988778899999864321              13458899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++.... ...+++..+..++.+++.|+.|||+  ++++|+||||+||+++.++.+||+|||++
T Consensus        74 ~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          74 EPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             CceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccc
Confidence            78899999999999999997643 3468999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........  ......++..|+|||.+. +.++.++|+||||+++|+++| |+.||.+............. ...    
T Consensus       151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~----  223 (261)
T cd05034         151 RLIEDDEYT--AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRM----  223 (261)
T ss_pred             eeccchhhh--hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC----
Confidence            765432111  112234567899999664 467889999999999999999 99999766533222222111 000    


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                            ..+...+..+.+++.+|+..+|.+||+++++.+.|+++
T Consensus       224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         224 ------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence                  00112244588899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=318.34  Aligned_cols=241  Identities=23%  Similarity=0.286  Sum_probs=186.7

Q ss_pred             cCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC---CccceeeecccccC-ce
Q psy5603         178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~  252 (455)
                      ||+|+||+||+|.++ +++.||||++.......          ......+..|..++.++   .||||+++++.+.+ ..
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~   70 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA----------KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD   70 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh----------hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe
Confidence            799999999999986 48899999986432110          01133455677777665   69999999997766 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++..   ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          71 LYLVTDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             EEEEEcCCCCChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            8999999999999999876   3458999999999999999999999  8899999999999999999999999999875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      .....   .......||+.|+|||++.+  .++.++|||||||++|||+||..||...........+......++     
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----  217 (330)
T cd05586         146 NLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-----  217 (330)
T ss_pred             CCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence            43221   11235679999999997644  368899999999999999999999987664433333322221111     


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCC----HHHHHH
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRAS----MRDIVD  447 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs----~~evl~  447 (455)
                            ...++..+.++|.+||..+|++||+    +.++++
T Consensus       218 ------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 ------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                  1123455788999999999999984    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-38  Score=305.30  Aligned_cols=252  Identities=25%  Similarity=0.422  Sum_probs=195.0

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ....+||+|+||.||++...      ++..+|+|.+.....      .       ....|.+|++++++++|+||+++++
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~~~~~   74 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------S-------ARQDFQREAELLTVLQHQHIVRFYG   74 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------H-------HHHHHHHHHHHHhcCCCCCCceEEE
Confidence            34588999999999999742      256789998753211      1       1346899999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCc
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNN------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~N  313 (455)
                      ++.+ ...++|+||+++++|.+++.....            ...+++..++.++.|++.||+|||+  .+++||||||+|
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~n  152 (280)
T cd05092          75 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRN  152 (280)
T ss_pred             EEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhh
Confidence            8877 778999999999999999976431            1358999999999999999999999  889999999999


Q ss_pred             EEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcch
Q psy5603         314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTI  391 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~  391 (455)
                      ||+++++.+||+|||+++....... ........+++.|+|||.+. ..++.++|||||||++|||++ |.+||......
T Consensus       153 il~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         153 CLVGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             EEEcCCCCEEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            9999999999999999875443221 11122334578899999654 467899999999999999998 99999765533


Q ss_pred             hhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .......... ..          ..+..++..+.+++.+||..+|++||++.+|++.|+.
T Consensus       232 ~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         232 EAIECITQGR-EL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHHcCc-cC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            2222221111 00          0111234458899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0196|consensus

Probab=100.00  E-value=1.9e-40  Score=337.13  Aligned_cols=276  Identities=25%  Similarity=0.402  Sum_probs=228.6

Q ss_pred             ceeeeHHHHHHHhcCCCCCCC---CcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhH
Q psy5603         151 LIAFTFCDLERATDGFNRKPY---PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPI  223 (455)
Q Consensus       151 ~~~~~~~~l~~~t~~f~~~~~---~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~  223 (455)
                      +.-++|+|-.++...|..+-.   -.+.+.||.|.||.||+|+++-    ...||||.++....            +...
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt------------ekqr  674 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT------------EKQR  674 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc------------HHHH
Confidence            566889999899888876522   2678999999999999999863    35699999975432            1124


Q ss_pred             HHHHHHHHHHhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q psy5603         224 LLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK  302 (455)
Q Consensus       224 ~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~  302 (455)
                      ..|+.|..||.++.||||++|.|.... ....+|.|||+||+|..+|+..++  .+++.|...++++|+.|++||-+  .
T Consensus       675 rdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsd--m  750 (996)
T KOG0196|consen  675 RDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSD--M  750 (996)
T ss_pred             hhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhh--c
Confidence            559999999999999999999998777 666789999999999999998764  59999999999999999999999  7


Q ss_pred             CeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCC--CCCCCCcccc-cCCCCcccchHHHHHHHHHHH
Q psy5603         303 PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG--TRPYMPPEAM-HCQISTKTDVFSYGVILLELL  379 (455)
Q Consensus       303 ~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ell  379 (455)
                      ++|||||-..|||++.+..+|++|||++|+..++....  .+..-|  ...|.|||++ ..+++.+|||||||||+||.+
T Consensus       751 ~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~--ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVm  828 (996)
T KOG0196|consen  751 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  828 (996)
T ss_pred             CchhhhhhhhheeeccceEEEeccccceeecccCCCcc--ccccCCccceeecChhHhhhcccCchhhccccceEEEEec
Confidence            89999999999999999999999999999876654221  222233  3569999965 568999999999999999998


Q ss_pred             c-CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       380 t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                      + |..||.+.........++.           ..+..++.+++..+.+|+..||++|..+||.+.+++..|++++.|
T Consensus       829 SyGERPYWdmSNQdVIkaIe~-----------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  829 SYGERPYWDMSNQDVIKAIEQ-----------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ccCCCcccccchHHHHHHHHh-----------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            8 9999998875544443332           223345667888899999999999999999999999999999876

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-38  Score=304.47  Aligned_cols=246  Identities=23%  Similarity=0.364  Sum_probs=192.1

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +.+.||+|+||.||+|.+. +++.||+|.++....      .       ....+.+|+.+++.++||||+++++++.+ .
T Consensus        13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~-------~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645          13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG------E-------DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch------h-------HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            4478999999999999875 488999999864321      1       12347789999999999999999998766 8


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++|+||+++++|.+++...   ..+++.+++.++.|++.||.|||+  .|++|+||||+||+++.++.+||+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeee
Confidence            889999999999999998763   468999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ......   .......|+..|+|||.+    .+.++.++|+|||||++|+|++|..||......................
T Consensus       155 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd06645         155 QITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL  231 (267)
T ss_pred             EccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcc
Confidence            553221   112345799999999975    3357889999999999999999999997654322211111111111100


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+       ...++..+.+++.+|+..+|++||++.+|++
T Consensus       232 ~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KD-------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc-------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00       0123345788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.5e-38  Score=306.09  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=193.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ ++..||||+++......           .....+.+|+.++++++||||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-----------GVPSTAIREISLLKELQHPNIVCLQDVLMQ   70 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-----------CchHHHHHHHHHHHhcCCCCEeeeEEEEee
Confidence            345588999999999999986 48899999986432211           012447789999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++ ++|.+++........+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          71 ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccc
Confidence             78899999996 6898988765544679999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--ccc---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEV---  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~---  402 (455)
                      +.......   .......+++.|+|||.+.+  .++.++|+|||||++|+|+||.+||..............  ...   
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd07861         148 ARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED  224 (285)
T ss_pred             eeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            87543321   11223467889999997644  368899999999999999999999987653221111110  000   


Q ss_pred             ------chhhccchhccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 ------PVREVLDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ------~~~~~~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..... ......+.       ...++..+.++|.+||..||.+||++.+|++
T Consensus       225 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         225 VWPGVTSLPDY-KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhcchhhHHH-HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  00000 00000000       1124456778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-38  Score=302.43  Aligned_cols=255  Identities=26%  Similarity=0.443  Sum_probs=197.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-C---cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +++.+.||+|+||.||+|.++. +   ..||||.+.....            ......|..|+.++++++||||++++++
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni~~~~~~   73 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT------------EKQRRDFLSEASIMGQFDHPNIIHLEGV   73 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC------------HHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            4566899999999999999763 3   3699999864311            1114568999999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+++++|.+++....  ..+++.+++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~d  149 (269)
T cd05065          74 VTKSRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSD  149 (269)
T ss_pred             ECCCCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECC
Confidence            877 77799999999999999987643  358999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCC--CCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTG--TRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      ||+++................|  +..|+|||.+. +.++.++|||||||++||+++ |..||...........+.. ..
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-~~  228 (269)
T cd05065         150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DY  228 (269)
T ss_pred             CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CC
Confidence            9998765433221111111222  45799999664 467889999999999999987 9999987654322222211 11


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..+          .+..++..+.+++.+|+..+|.+||++.+|+..|++++
T Consensus       229 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         229 RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            110          01223455788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-38  Score=306.99  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=191.9

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||+|+||+||+|.+. +++.||+|.+.......          ......+.+|++++++++|+||+++++++.. 
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK----------RKGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh----------hhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            34478999999999999986 48899999986432210          0113447789999999999999999987665 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..|+||||+++++|.+++.... ..++++..+..++.|++.||.|||+  ++|+||||||+||++++++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            78899999999999998886543 3469999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........    .....|+..|+|||.+ ...++.++|+|||||++|||++|..||......................  
T Consensus       150 ~~~~~~~~----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--  223 (285)
T cd05632         150 VKIPEGES----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV--  223 (285)
T ss_pred             eecCCCCc----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--
Confidence            75432211    1235799999999966 4467889999999999999999999998765332211111100000000  


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                            ....++..+.+|+.+|+..+|++||+     +.+++.
T Consensus       224 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 ------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                  01123445788999999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-38  Score=303.43  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=184.6

Q ss_pred             ccCcCCCeEEEEEEEcC---CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         177 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .||+|+||.||+|...+   ...+|+|.+.....      .      .....|.+|+.+++.++||||+++++.+.+ ..
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~   69 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT------P------DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP   69 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCC------h------HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc
Confidence            59999999999997643   34678887643211      0      113458899999999999999999998877 77


Q ss_pred             eEEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .++||||+++|+|.+++.....  ....++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccc
Confidence            8999999999999999976443  2335678889999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc--------CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhH-HHhhhc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY-YLVVEQ  400 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~-~~~~~~  400 (455)
                      +........ .......++..|+|||++.        ...+.++|||||||++|||++ |..||......... ......
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05042         148 LEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ  226 (269)
T ss_pred             cccccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence            754332211 1123345677899999753        235779999999999999999 88898766532211 111111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ...+.   .+.    ....++..+.+++..|+ .||++||++++|++.|.
T Consensus       227 ~~~~~---~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLP---KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCC---CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111   111    11223445666676666 69999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3e-38  Score=306.44  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=195.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++.+.||+|+||.||+|.++      ++..||+|.+.....      .      .....|.+|+.++++++||||+++++
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~------~------~~~~~~~~ei~~l~~l~h~~iv~~~~   75 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------A------DMQADFQREAALMAEFDHPNIVKLLG   75 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC------H------HHHHHHHHHHHHHHhcCCCchheEEE
Confidence            45589999999999999864      367899999864321      0      11345889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVN-------------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIH  306 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH  306 (455)
                      ++.+ ...|+|+||+++|+|.+++....                   ....+++.+++.++.|++.||.|||+  ++++|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H  153 (288)
T cd05050          76 VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVH  153 (288)
T ss_pred             EEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeec
Confidence            8877 77899999999999999997431                   12357899999999999999999999  88999


Q ss_pred             cCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCC
Q psy5603         307 RDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP  384 (455)
Q Consensus       307 ~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p  384 (455)
                      |||||+||+++.++.++|+|||+++........ .......++..|+|||.+ .+.++.++|||||||++|||++ |..|
T Consensus       154 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p  232 (288)
T cd05050         154 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP  232 (288)
T ss_pred             ccccHhheEecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998754322111 111223456779999965 4568899999999999999998 8889


Q ss_pred             CCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      |.+...............  .        . .+..++..+.+++.+|+..+|.+||++.|+++.|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~--~--------~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         233 YYGMAHEEVIYYVRDGNV--L--------S-CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCHHHHHHHHhcCCC--C--------C-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            876553322222211110  0        0 011234558889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.2e-38  Score=309.06  Aligned_cols=253  Identities=26%  Similarity=0.434  Sum_probs=193.3

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCc--EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.++ ++.  .+|+|.++....            ......+.+|+.++.++ +||||+++++++
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~------------~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~   77 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------------KDDHRDFAGELEVLCKLGHHPNIINLLGAC   77 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC------------HHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            34488999999999999975 344  457777642211            01135588899999999 899999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .. ..+++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+  +|++||||||+||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Ni  155 (303)
T cd05088          78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNI  155 (303)
T ss_pred             CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheE
Confidence            77 788999999999999999975421             2368999999999999999999999  8899999999999


Q ss_pred             EEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHc-CCCCCCCCcchh
Q psy5603         315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~  392 (455)
                      |++.++.+||+|||+++......    ......++..|+|||.+.+ .++.++|||||||++|||+| |..||.......
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  231 (303)
T cd05088         156 LVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  231 (303)
T ss_pred             EecCCCcEEeCccccCcccchhh----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence            99999999999999986322111    1112234667999996644 56889999999999999998 999997655332


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....... .....          .+..++..+.+++.+|+..+|++||++.+++..|++++.
T Consensus       232 ~~~~~~~-~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         232 LYEKLPQ-GYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHHHhc-CCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2221110 00000          011234457889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-38  Score=307.05  Aligned_cols=250  Identities=21%  Similarity=0.280  Sum_probs=192.8

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||+|+||.||++.++ +++.||||.+........          .....+.+|+.++++++|+|++++++.+.+ 
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGESMALNEKQILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch----------HHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence            34588999999999999986 478999999865322110          012347789999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++|++|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||++
T Consensus        73 ~~~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          73 DALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            88899999999999999886533 2468999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........    .....||..|+|||++. +.++.++|+|||||++|+|++|..||....................    
T Consensus       150 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~----  221 (285)
T cd05630         150 VHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----  221 (285)
T ss_pred             eecCCCcc----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh----
Confidence            76443221    12347999999999664 4678999999999999999999999986542211111100000000    


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                          ......++..+.+|+.+||..||++||+     +.|+++
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                0011223445788999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-38  Score=308.24  Aligned_cols=254  Identities=27%  Similarity=0.431  Sum_probs=195.8

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +..+.||+|+||.||+|.+. +|.    .||+|.+.....      .      .....+.+|+.++++++||||++++++
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~~~~l~h~niv~~~~~   77 (303)
T cd05110          10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG------P------KANVEFMDEALIMASMDHPHLVRLLGV   77 (303)
T ss_pred             eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC------H------HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            34488999999999999875 343    578888753221      0      112358899999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.....+++++|+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          78 CLSPTIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             EcCCCceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEccc
Confidence            88777789999999999999987642  358999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++....... ........++..|+|||.+. ..++.++|||||||++|||++ |..||.+.............. .+ 
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-  230 (303)
T cd05110         154 GLARLLEGDEK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RL-  230 (303)
T ss_pred             cccccccCccc-ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CC-
Confidence            99986543221 11122345677899999664 467889999999999999998 999997654322222221111 00 


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ..+..++..+.+++..||..+|++||++.++++.|+++.+
T Consensus       231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     0011123347788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-38  Score=301.01  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=196.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.++ ++..||+|.++.....     .       ....+.+|+.++++++|+||+++++.+.+
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   69 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-----S-------AVEDSRKEAVLLAKMKHPNIVAFKESFEA   69 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-----H-------HHHHHHHHHHHHHhCCCCCcceEEEEEEE
Confidence            355689999999999999986 4889999998643210     0       13457889999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++++|+||||+||++++++.++|+|||+
T Consensus        70 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          70 DGHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCc
Confidence             88899999999999999887533 3468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......|++.|+|||++.+ ..+.++|+||||+++|+|++|..||...+..............  .  
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~--  219 (255)
T cd08219         147 ARLLTSPG---AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--P--  219 (255)
T ss_pred             ceeecccc---cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--C--
Confidence            87654322   11234578999999997654 5788999999999999999999999876532222222111100  0  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                             .+..++..+.+++.+||..+|++||++.+++.+
T Consensus       220 -------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 -------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   012234458889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.8e-38  Score=307.94  Aligned_cols=262  Identities=23%  Similarity=0.340  Sum_probs=196.2

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.++||+|+||.||+|.++ +++.||+|.++.......            ...+.+|+.++++++||||+++
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~nI~~~   69 (301)
T cd07873           2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTL   69 (301)
T ss_pred             CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc------------hhHHHHHHHHHHhcCCCCcceE
Confidence            333445677799999999999999986 478999999864332110            2236789999999999999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.. ...|+||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+|
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~k  144 (301)
T cd07873          70 HDIIHTEKSLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELK  144 (301)
T ss_pred             EEEEecCCeEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEE
Confidence            998876 78899999996 69999887643  368899999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||++........   ......+++.|+|||.+.+  .++.++|||||||++|||+||.+||...+.......... .
T Consensus       145 l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~  221 (301)
T cd07873         145 LADFGLARAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL  221 (301)
T ss_pred             ECcCcchhccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            999999875433211   1223467889999997644  467899999999999999999999987653222111111 0


Q ss_pred             ccc----hhhccch------hccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVP----VREVLDK------EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~----~~~~~d~------~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+    .....+.      ......       ...++..+.+||.+|+..||.+||+++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000    0000000      000000       1124556889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.8e-38  Score=307.20  Aligned_cols=259  Identities=26%  Similarity=0.354  Sum_probs=194.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-----------------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHh
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS  234 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  234 (455)
                      |++.++||+|+||.||++...+                 +..||+|+++....      .      .....|.+|+.+++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~------~------~~~~~~~~E~~~l~   74 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN------K------NARNDFLKEIKIMS   74 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC------H------HHHHHHHHHHHHHH
Confidence            4566899999999999986431                 34689999864321      0      11345889999999


Q ss_pred             hCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5603         235 QCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       235 ~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~ii  305 (455)
                      +++|+||+++++++.. ...|+||||+++|+|.+++.....        ...+++.++..++.|++.||.|||+  .+++
T Consensus        75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~  152 (296)
T cd05095          75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFV  152 (296)
T ss_pred             hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCee
Confidence            9999999999998876 788999999999999999976431        1247788999999999999999999  8899


Q ss_pred             ecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccc-ccCCCCcccchHHHHHHHHHHHc--CC
Q psy5603         306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT--GM  382 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~-~~~~~~~~sDv~SlGvvl~ellt--G~  382 (455)
                      ||||||+|||++.++.++|+|||+++........ .......++..|+|||. ..+.++.++|+|||||++|||+|  |.
T Consensus       153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~  231 (296)
T cd05095         153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE  231 (296)
T ss_pred             cccCChheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence            9999999999999999999999998755332211 11223345678999994 45678999999999999999998  77


Q ss_pred             CCCCCCcchhhHHHhhh--cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         383 KPIDDNNTILYYYLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .||..............  .........      ..+..++..+.+|+.+||..+|++||++.+|++.|++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         232 QPYSQLSDEQVIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CCccccChHHHHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            88876543222111100  000000000      0112234568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-38  Score=297.69  Aligned_cols=246  Identities=28%  Similarity=0.466  Sum_probs=197.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++.+.||.|+||.||+|... |+.||||.+.....              ..+.+.+|+.++++++|+||+++++++.+ 
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--------------AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             ccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--------------HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            345589999999999999987 78999999864321              14568899999999999999999998775 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++++|.+++..... ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccc
Confidence            788999999999999999976432 368999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......      ....++..|+|||.+ .+.++.++|+||||+++||+++ |..||................ ..    
T Consensus       150 ~~~~~~~------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~----  218 (256)
T cd05039         150 KEASQGQ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM----  218 (256)
T ss_pred             ccccccc------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC----
Confidence            8653221      123446679999965 4567889999999999999997 999997665332222111110 00    


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                            ..+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus       219 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 ------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                  00112345688899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-38  Score=313.22  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=189.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++......           ......+.+|+.++++++||||+++++++.
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-----------LIHARRTYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-----------hHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence            3556699999999999999875 4789999998643210           111345778999999999999999998764


Q ss_pred             C-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...|++++++ +++|.+++..    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          85 PATSIENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             ccccccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCE
Confidence            2       3458899987 8899888764    358999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|+|++|..||...+.......... 
T Consensus       158 kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07878         158 RILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV  231 (343)
T ss_pred             EEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            99999998864332      224578999999997654  478899999999999999999999987653222111111 


Q ss_pred             cccchhhccch-----------hccCCCh-------hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QEVPVREVLDK-----------EAGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~-----------~~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+..+....           .....+.       ......+.+||.+||..||++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00010000000           0000000       012334678999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.4e-38  Score=299.51  Aligned_cols=252  Identities=28%  Similarity=0.380  Sum_probs=192.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||.||+|.++ ++..||||.+.........        ......+.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET--------SKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc--------HHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            345689999999999999976 4889999998643221110        1124568899999999999999999997754


Q ss_pred             ---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++||||+++++|.+++...   ..+++.....++.|++.||.|||+  .+++|+||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Df  150 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDF  150 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcC
Confidence               3578999999999999998763   358899999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++................|+..|+|||.+. ..++.++|+|||||++|||++|..||................     
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----  225 (265)
T cd06652         151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-----  225 (265)
T ss_pred             ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-----
Confidence            99875432211111123356899999999664 457889999999999999999999997654222111111000     


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          . ....+......+.++|.+|+ .+|++||++++|++
T Consensus       226 ----~-~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~  260 (265)
T cd06652         226 ----T-NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR  260 (265)
T ss_pred             ----C-CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence                0 01112334556778888888 48999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-38  Score=328.07  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=182.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC------ccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK------HVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l  244 (455)
                      |++.++||+|+||+||+|.+. +++.||||+++....      .        ...+..|++++..++      |.+++.+
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~--------~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------Y--------TRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------h--------HHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            456689999999999999976 478899999863211      0        122445666666554      4568888


Q ss_pred             cccccC--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC--
Q psy5603         245 LGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF--  320 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~--  320 (455)
                      ++++..  ...|+||+++ |++|.+++...   .++++..+..|+.|++.||.|||+. .|||||||||+|||++.++  
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcc
Confidence            887755  5789999988 88999988763   4699999999999999999999971 3899999999999998765  


Q ss_pred             --------------ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCC
Q psy5603         321 --------------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       321 --------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~  385 (455)
                                    .+||+|||++......      .....||+.|+|||++.+ .++.++|||||||++|||+||++||
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCccc------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                          4999999987543211      234689999999997644 6889999999999999999999999


Q ss_pred             CCCcchhhHHHhhhcccchh-------------hccch----------h-----c--cCCChhHHHHHHHHHHHhhhccC
Q psy5603         386 DDNNTILYYYLVVEQEVPVR-------------EVLDK----------E-----A--GEWNETHVETLISIVFEKCCVFE  435 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~-------------~~~d~----------~-----~--~~~~~~~~~~~l~~Li~~~l~~d  435 (455)
                      ...+.......+......++             ++++.          .     .  ...........+.+||.+||..|
T Consensus       346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            87664322222111000000             00000          0     0  00000111345779999999999


Q ss_pred             cCCCCCHHHHHH
Q psy5603         436 KDKRASMRDIVD  447 (455)
Q Consensus       436 p~~RPs~~evl~  447 (455)
                      |++||+++|+++
T Consensus       426 P~~R~ta~e~L~  437 (467)
T PTZ00284        426 RQKRLNARQMTT  437 (467)
T ss_pred             hhhCCCHHHHhc
Confidence            999999999986

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.6e-38  Score=308.26  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=195.5

Q ss_pred             cCCCccCcCCCeEEEEEEEc--------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceee
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .++++||+|+||.||+|...        .+..||+|.++....      .      .....+.+|+.+++++ +||||++
T Consensus        15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv~   82 (314)
T cd05099          15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT------D------KDLADLISEMELMKLIGKHKNIIN   82 (314)
T ss_pred             eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC------h------HHHHHHHHHHHHHHhccCCCCeee
Confidence            34589999999999999752        245689999863221      0      0134588899999999 6999999


Q ss_pred             ecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         244 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      +++++.+ ...|+||||+++|+|.+++.....             ...+++.++..++.|++.||.|||+  +|++||||
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dl  160 (314)
T cd05099          83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDL  160 (314)
T ss_pred             EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccc
Confidence            9998877 778999999999999999976321             2458999999999999999999999  89999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q psy5603         310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+|||+++++.+||+|||+++......... ......++..|+|||.+ .+.++.++|||||||++|||++ |..||..
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         161 AARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             cceeEEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998654322111 11222445679999965 4467889999999999999999 8999976


Q ss_pred             CcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .............. ..          ..+..++..+.+++.+|+..+|++||++.++++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~-~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         240 IPVEELFKLLREGH-RM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             CCHHHHHHHHHcCC-CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            55332222221110 00          001223445778999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-38  Score=314.92  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=192.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+++.+ +++.||+|++......          .......+.+|..++..++|+||+.+++++.+
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~   72 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML----------KRAETACFREERNVLVNGDCQWITTLHYAFQD   72 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH----------hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            456689999999999999986 4788999998642210          01123457889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++....  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~  148 (331)
T cd05624          73 ENYLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGS  148 (331)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccc
Confidence             78899999999999999997643  368999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc--
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE--  401 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--  401 (455)
                      ++.......  .......||+.|+|||++.      +.++.++|+|||||++|||++|..||...+.......+....  
T Consensus       149 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~  226 (331)
T cd05624         149 CLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER  226 (331)
T ss_pred             eeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc
Confidence            876543321  1223457999999999765      346889999999999999999999998765433322222111  


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCC--CCCHHHHHH
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                      ..++..+         ..++..+.+++.+|+..++++  |++++++++
T Consensus       227 ~~~p~~~---------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 FQFPSHI---------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ccCCCcc---------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            1111111         123455778888888765443  567777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=327.70  Aligned_cols=251  Identities=21%  Similarity=0.293  Sum_probs=188.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|.+.. ++.||||...                   ...+.+|++++++++|+|||++++++..
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------------------~~~~~~E~~iL~~L~HpnIv~l~~~~~~  231 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------------------YASSVHEARLLRRLSHPAVLALLDVRVV  231 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------------------ccCHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            4566899999999999999874 7889999642                   1126689999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||+++ .++|.+++....  .++++.+++.|+.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       232 ~~~~~lv~e~~-~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        232 GGLTCLVLPKY-RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             CCEEEEEEEcc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCC
Confidence             7889999999 578988886532  369999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcc--------hhhHHHhhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT--------ILYYYLVVEQ  400 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~--------~~~~~~~~~~  400 (455)
                      ++....... ........||..|+|||++.+ .++.++|||||||++|||++|..|+.....        ......+...
T Consensus       307 a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        307 ACFARGSWS-TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             ceecccccc-cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            986543221 112234679999999997654 578899999999999999998876543221        1111111111


Q ss_pred             ccc---hhhccc----------------hhc--cCCCh-hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVP---VREVLD----------------KEA--GEWNE-THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~---~~~~~d----------------~~~--~~~~~-~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   +.....                +..  ..|.. ......+.+||.+||..||++||++.|+++
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            100   000000                000  00110 122346788999999999999999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.9e-38  Score=307.84  Aligned_cols=256  Identities=24%  Similarity=0.309  Sum_probs=194.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++.+. ++..||+|.++....      .      .....+.+|++++++++||||+++++++.+
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   70 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK------P------AIRNQIIRELKVLHECNSPYIVGFYGAFYS   70 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC------H------HHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            345589999999999999976 478899998864321      0      113458899999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||+++++|.+++...   .++++..+..++.|++.||.|||+. .+++||||||+|||++.++.+||+|||+
T Consensus        71 ~~~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          71 DGEISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             CCEEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCC
Confidence             8889999999999999999763   4689999999999999999999972 3799999999999999999999999998


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch----
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV----  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----  404 (455)
                      +.......     .....|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...+...............    
T Consensus       147 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  221 (308)
T cd06615         147 SGQLIDSM-----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE  221 (308)
T ss_pred             cccccccc-----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence            86543221     234578999999997654 57889999999999999999999997654222211111100000    


Q ss_pred             ------------------hhccchh----ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         405 ------------------REVLDKE----AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       405 ------------------~~~~d~~----~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                                        .+..+..    ....+...++..+.+++.+|+..+|++||++.+|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              0000000    0011112245568899999999999999999999763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-38  Score=297.90  Aligned_cols=248  Identities=29%  Similarity=0.411  Sum_probs=195.0

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      ++||+|+||.||++.+++++.||+|++......            .....+.+|+++++++.|+||+++++++.+ ...+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   68 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP------------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY   68 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH------------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeE
Confidence            369999999999999876899999988643220            113458999999999999999999998877 7889


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      +||||+.+++|.+++....  ..+++..+..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||+++...
T Consensus        69 ~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          69 IVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9999999999999997643  368899999999999999999999  889999999999999999999999999987554


Q ss_pred             cCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         335 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ... .........++..|+|||.+. +.++.++|+|||||++|||+| |..||............... .          
T Consensus       145 ~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~----------  212 (251)
T cd05041         145 GGI-YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-Y----------  212 (251)
T ss_pred             CCc-ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-C----------
Confidence            221 111112223466799999664 467889999999999999999 89999766533222222111 0          


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ....+...+..+.+++.+|+..+|++||++.+|++.|+.
T Consensus       213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            011122345568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-38  Score=321.77  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=189.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      |++.+.||+|+||.||++...   .+..||||.+....                  .+.+|++++++++||||+++++++
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------------------~~~~E~~il~~l~h~~iv~~~~~~  155 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------------------TPGREIDILKTISHRAIINLIHAY  155 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------------------cHHHHHHHHHhcCCCCccceeeeE
Confidence            567799999999999999764   25789999875321                  156899999999999999999977


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .. ...|+|||++ +++|.+++..   ..++++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus       156 ~~~~~~~lv~e~~-~~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~Df  229 (392)
T PHA03207        156 RWKSTVCMVMPKY-KCDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDF  229 (392)
T ss_pred             eeCCEEEEEehhc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccC
Confidence            66 7889999998 5789888854   3569999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch----hhHHHhhh-cc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVE-QE  401 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~-~~  401 (455)
                      |+++....... ........||+.|+|||++.+ .++.++|||||||++|||++|..||.+....    ........ ..
T Consensus       230 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~  308 (392)
T PHA03207        230 GAACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV  308 (392)
T ss_pred             ccccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence            99876543321 112235689999999997754 5788999999999999999999999765421    11110000 00


Q ss_pred             cc--hhh------------ccchhccCCC------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VP--VRE------------VLDKEAGEWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~--~~~------------~~d~~~~~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+  +..            +.......+.      ....+..+.++|.+||..+|++||++.+++.
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            00  000            0000000000      0123445778999999999999999999875

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.6e-38  Score=303.36  Aligned_cols=250  Identities=30%  Similarity=0.443  Sum_probs=193.3

Q ss_pred             CccCcCCCeEEEEEEEcC-------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         176 NKLGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      +.||+|+||.||+|+.++       +..||||.+.....      .      .....|.+|+.++++++||||+++++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT------D------QEKKEFLKEAHLMSNFNHPNIVKLLGVC   68 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc------h------hhHHHHHHHHHHHHhcCCCCeeeEeeee
Confidence            359999999999998753       25789998854321      0      0134588999999999999999999987


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC---
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVN----NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---  320 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~---  320 (455)
                      .+ ...++||||+++++|.+++....    ....+++.+++.++.|++.||.|||+  .+++|+||||+||+++.++   
T Consensus        69 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~  146 (269)
T cd05044          69 LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDA  146 (269)
T ss_pred             cCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCC
Confidence            76 78899999999999999997532    12458899999999999999999999  8899999999999999887   


Q ss_pred             --ceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHH
Q psy5603         321 --VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       321 --~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                        .++|+|||+++........ .......++..|+|||.+ .+.++.++|||||||++|||+| |..||...+.......
T Consensus       147 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~  225 (269)
T cd05044         147 DRVVKIGDFGLARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH  225 (269)
T ss_pred             CcceEECCccccccccccccc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence              8999999998755432211 111233567889999965 4567899999999999999998 9999976553322221


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ..... .          ...+..++..+.+++.+||..+|.+||++.+|++.|++
T Consensus       226 ~~~~~-~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         226 VTAGG-R----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HhcCC-c----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11110 0          01112345668899999999999999999999998864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.8e-38  Score=311.39  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=197.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC--------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Ccccee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |++++.||+|+||.||+|.+..        +..||+|.++....      .      .....+.+|+++++++ +||||+
T Consensus        14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv   81 (334)
T cd05100          14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT------D------KDLSDLVSEMEMMKMIGKHKNII   81 (334)
T ss_pred             eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC------H------HHHHHHHHHHHHHHhhcCCCCee
Confidence            4567899999999999997531        23689998864221      0      1145688999999999 899999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      ++++++.. ...++|+||+++|+|.+++.....             ...+++.+++.++.|++.||.|||+  +|++|||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~d  159 (334)
T cd05100          82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRD  159 (334)
T ss_pred             eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccc
Confidence            99998877 778999999999999999975321             2358899999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++........ .......++..|+|||++ ...++.++|||||||++|||++ |..||.
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         160 LAARNVLVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             cccceEEEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999999998765432211 112223456779999966 4467889999999999999998 899998


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ............... .. .         .+..++..+.+++.+|+..+|++||++.++++.|++++.
T Consensus       239 ~~~~~~~~~~~~~~~-~~-~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         239 GIPVEELFKLLKEGH-RM-D---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             CCCHHHHHHHHHcCC-CC-C---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            765333222221110 00 0         011233457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.6e-38  Score=297.58  Aligned_cols=247  Identities=25%  Similarity=0.433  Sum_probs=194.3

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.+.||+|+||.||+|.+.++..+|+|.+.....              ....|.+|++++++++|||++++++++.. .
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--------------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--------------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            34488999999999999987778999999863321              02348899999999999999999998776 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||||+++++|.+++....  .++++..+..++.+++.|+.|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCccee
Confidence            8899999999999999987643  358899999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+. +.++.++|+||||+++|||++ |..||................ .      
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------  219 (256)
T cd05112         149 FVLDDQYT--SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-R------  219 (256)
T ss_pred             ecccCccc--ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-C------
Confidence            65432211  112234567899999664 567889999999999999998 999998655332222211110 0      


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                          ...+...+..+.+++.+|+..+|++||++.+|++.|.
T Consensus       220 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         220 ----LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                0011112355888999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.8e-38  Score=311.06  Aligned_cols=258  Identities=19%  Similarity=0.241  Sum_probs=191.0

Q ss_pred             CCCccCcC--CCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         174 RGNKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       174 ~~~~LG~G--~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +.++||+|  +||+||++..+ +|+.||||++......           ......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~   70 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-----------NEMVTFLQGELHVSKLFNHPNIVPYRATFIA   70 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-----------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE
Confidence            34789999  78999999876 5899999998643220           1113457789999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.++++|||.
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227          71 DNELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             CCEEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccch
Confidence             78899999999999999986533 2358999999999999999999999  8899999999999999999999999986


Q ss_pred             ccccccCCcc----eeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         330 VKMSETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +.........    ........++..|+|||++.+   .++.++|||||||++|||++|..||...............  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--  225 (327)
T cd08227         148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG--  225 (327)
T ss_pred             hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC--
Confidence            5432211100    011123357788999997753   4788999999999999999999999865422211111100  


Q ss_pred             chhhccc-------------------hhc-----------------cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         403 PVREVLD-------------------KEA-----------------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       403 ~~~~~~d-------------------~~~-----------------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      .++..++                   ...                 .......++..+.+|+.+|+..||++|||+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell  305 (327)
T cd08227         226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL  305 (327)
T ss_pred             CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence            0000000                   000                 0001123455788999999999999999999997


Q ss_pred             H
Q psy5603         447 D  447 (455)
Q Consensus       447 ~  447 (455)
                      +
T Consensus       306 ~  306 (327)
T cd08227         306 N  306 (327)
T ss_pred             c
Confidence            6

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.4e-38  Score=301.33  Aligned_cols=254  Identities=28%  Similarity=0.359  Sum_probs=195.1

Q ss_pred             HHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC
Q psy5603         159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK  237 (455)
Q Consensus       159 l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  237 (455)
                      ++.+++++...      ..||+|+||.||+|.+. ++..||+|.+.....      .       ....+.+|+.++++++
T Consensus         3 ~~~~~~~~~~~------~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~   63 (268)
T cd06624           3 YEYEYDENGER------VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS------R-------YVQPLHEEIALHSYLK   63 (268)
T ss_pred             cccccccCCce------EEEecCCceEEEEeEecCCCcEEEEEEecCCCH------H-------HHHHHHHHHHHHHhcC
Confidence            44556677666      78999999999999976 477899998864321      1       1345889999999999


Q ss_pred             ccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         238 HVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPL--DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       238 h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      |+||+++++++.. ...++|+||+++++|.+++....  .++  ++..+..++.|++.||.|||+  ++|+||||||+||
T Consensus        64 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~ni  139 (268)
T cd06624          64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNV  139 (268)
T ss_pred             CCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHE
Confidence            9999999998877 78899999999999999997643  234  888999999999999999999  8899999999999


Q ss_pred             EEcC-CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcc
Q psy5603         315 LLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       315 Ll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~  390 (455)
                      +++. ++.++|+|||++........   ......|+..|+|||.+.+   .++.++|+||||+++|+|++|..||.....
T Consensus       140 l~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~  216 (268)
T cd06624         140 LVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE  216 (268)
T ss_pred             EEcCCCCeEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9986 67999999999875533221   1223468899999997643   267899999999999999999999976542


Q ss_pred             hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......... ...        ....-+..+...+.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         217 PQAAMFKVG-MFK--------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhhHhhhh-hhc--------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            111110000 000        000011234455788999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.1e-38  Score=303.83  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=198.1

Q ss_pred             cCCCCCCCCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcccee
Q psy5603         164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL  242 (455)
Q Consensus       164 ~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  242 (455)
                      .++.....|++.++||.|+||.||+|.++. +..||+|.+.....      .       ....+.+|+++++.++||||+
T Consensus         6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~   72 (292)
T cd06644           6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------E-------ELEDYMVEIEILATCNHPYIV   72 (292)
T ss_pred             cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH------H-------HHHHHHHHHHHHHhCCCCcEe
Confidence            345555667888999999999999999864 78999999864211      1       145588899999999999999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++.+.. ...|+||||+++++|..++....  ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~  148 (292)
T cd06644          73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGD  148 (292)
T ss_pred             eeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCC
Confidence            99997655 78899999999999988876533  358999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +||+|||++.......   .......|+..|+|||.+.      ..++.++|+|||||++|||++|.+||...+......
T Consensus       149 ~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  225 (292)
T cd06644         149 IKLADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL  225 (292)
T ss_pred             EEEccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH
Confidence            9999999876533221   1123456889999999763      235779999999999999999999997655322221


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......  +..       ..+..++..+.+++.+||..+|++||++.++++
T Consensus       226 ~~~~~~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         226 KIAKSEP--PTL-------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHhcCCC--ccC-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111110  000       011233445788999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.4e-38  Score=316.82  Aligned_cols=254  Identities=22%  Similarity=0.267  Sum_probs=190.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. .++.||||++.......           .....+.+|+.+++.++||||+++++++.
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~   93 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-----------THAKRAYRELVLMKCVNHKNIIGLLNVFT   93 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-----------hhHHHHHHHHHHHHhcCCCCccccceeec
Confidence            3556699999999999999976 47899999986432110           11345778999999999999999998654


Q ss_pred             C-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...|+||||+. ++|.+.+..     .+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875          94 PQKSLEEFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             ccccccccCeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcE
Confidence            3       34699999995 578777753     47899999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      ||+|||+++......    ......||..|+|||++.+ .++.++|||||||++|||++|..||...+.......... -
T Consensus       166 kL~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  241 (364)
T cd07875         166 KILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL  241 (364)
T ss_pred             EEEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999998654322    1234578999999997644 678899999999999999999999987663322222111 0


Q ss_pred             ccchhh-----------ccchhc---------------cCCC---hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVRE-----------VLDKEA---------------GEWN---ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~-----------~~d~~~---------------~~~~---~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.++           ......               ..+.   .......+.+||.+|+..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000           000000               0000   0112345788999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.5e-38  Score=303.04  Aligned_cols=245  Identities=24%  Similarity=0.389  Sum_probs=190.8

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|... +++.||+|++.....      .        ...+.+|+.++.++ +|+||+++++++..
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~--------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   74 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------E--------EEEIKQEINMLKKYSHHRNIATYYGAFIK   74 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------c--------HHHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence            34488999999999999976 478899999864321      1        23477899999998 79999999997753


Q ss_pred             -------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         251 -------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                             ...|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+  ++++|+||||+||++++++.+|
T Consensus        75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~  151 (272)
T cd06637          75 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVK  151 (272)
T ss_pred             cCCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEE
Confidence                   35789999999999999987633 3468999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      |+|||+++......   .......|+..|+|||++.      ..++.++|+|||||++|||++|..||............
T Consensus       152 l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~  228 (272)
T cd06637         152 LVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  228 (272)
T ss_pred             EccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            99999987543221   1123467899999999763      24677999999999999999999999765432222111


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...  ..        .......++..+.+|+.+||..+|.+||++.++++
T Consensus       229 ~~~--~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRN--PA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcC--CC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            110  00        01111223456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-37  Score=296.80  Aligned_cols=248  Identities=26%  Similarity=0.343  Sum_probs=195.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++..+. ++.||+|++......           ......+.+|++++++++|+|++++++.+..
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-----------RRERKAAEQEAQLLSQLKHPNIVAYRESWEG   70 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-----------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecC
Confidence            4567899999999999999764 788999998643221           0113458899999999999999999987653


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...|+||||+++++|.+++.... ..++++.++..++.+++.||.+||+  .+++||||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          71 EDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             CCCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEeccc
Confidence              46789999999999999997633 3468999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|++.|+|||... +.++.++|+||||+++|+|++|..||...+.............  .  
T Consensus       148 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~--  220 (257)
T cd08223         148 IARVLENQCD---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--P--  220 (257)
T ss_pred             ceEEecccCC---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--C--
Confidence            9876543221   223457899999999664 4578899999999999999999999986653322222111111  0  


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ..+..++..+.+++.+|+..+|++||++.++++
T Consensus       221 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 -------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   011234556889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.1e-38  Score=300.16  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=184.4

Q ss_pred             ccCcCCCeEEEEEEEcCCc---EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         177 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .||+|+||.||+|...++.   .+++|.+.....      .      .....|.+|+.+++.++||||+++++.+.+ ..
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   69 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS------S------KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP   69 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC------h------HHHHHHHHHHHHHhccCCcchhheEEEecCCCc
Confidence            5999999999999865433   456666543211      0      014568999999999999999999998877 77


Q ss_pred             eEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .|+||||+++|+|.+++..... ...++...+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~  147 (268)
T cd05086          70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGP  147 (268)
T ss_pred             cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEeccccccc
Confidence            8999999999999999976432 3456778888999999999999999  889999999999999999999999999876


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccccC--------CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      ...... .........|+..|+|||++..        ..+.++|||||||++|||++ |..||..............+. 
T Consensus       148 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-  225 (268)
T cd05086         148 SRYKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ-  225 (268)
T ss_pred             ccCcch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc-
Confidence            432221 1111234578899999997632        24678999999999999997 677887655322222111111 


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                       .....++...    ......+.+++..|+ .+|++||++.+|++.|-
T Consensus       226 -~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         226 -QVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -ccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             1111122111    113344666787777 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0577|consensus

Probab=100.00  E-value=1.9e-39  Score=320.65  Aligned_cols=239  Identities=27%  Similarity=0.425  Sum_probs=198.9

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||.|+||.||-+++. +...||||++.-...      ...+.    .+.+..|+..|.+++|||++.+-|++.. ...
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGK------Qs~EK----WqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEK----WQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeecccccc------ccHHH----HHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            67999999999999975 578899999854322      22222    4458889999999999999999998766 667


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      +|||||| -||-.|++.-..  .|+.+..+..|+.+.+.||+|||+  ++.||||||..||||.+.|.+||+|||.|...
T Consensus       102 WLVMEYC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            8999999 688888887653  489999999999999999999999  88999999999999999999999999988765


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccc----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhh-HHHhhhcccchhhcc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILY-YYLVVEQEVPVREVL  408 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~  408 (455)
                      ..       ...++|||.|||||++    .|.|+-++|||||||+-.||.-.++|+..++...- +....++...+    
T Consensus       177 ~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL----  245 (948)
T KOG0577|consen  177 AP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----  245 (948)
T ss_pred             Cc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC----
Confidence            43       3468999999999965    57899999999999999999999999998875433 33333332222    


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             +...++..+.+|+..||..-|..|||..+++.
T Consensus       246 -------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 -------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                   24467788999999999999999999998865

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.9e-38  Score=303.50  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=193.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+.. +..+|+|.+.....      .       ....+.+|+++++.++||||+++++++..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~ii~~~~~~~~   73 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------E-------ELEDYMVEIDILASCDHPNIVKLLDAFYY   73 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH------H-------HHHHHHHHHHHHHHCCCCCeeeEEEEEee
Confidence            4555889999999999999874 67889998853211      1       14458899999999999999999997766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|..++....  .++++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        74 ~~~~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~  149 (282)
T cd06643          74 ENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGV  149 (282)
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccc
Confidence             78899999999999998876532  468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +.......   .......||..|+|||++.      ..++.++|+|||||++|||++|.+||..................
T Consensus       150 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~  226 (282)
T cd06643         150 SAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP  226 (282)
T ss_pred             cccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC
Confidence            87543221   1123457899999999763      23577999999999999999999999865533222222111100


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ..       ..+..++..+.++|.+||..+|.+||++.++++
T Consensus       227 --~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         227 --TL-------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00       011224456889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.9e-38  Score=300.18  Aligned_cols=237  Identities=24%  Similarity=0.392  Sum_probs=183.1

Q ss_pred             ccCcCCCeEEEEEEEcC-------------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceee
Q psy5603         177 KLGEGQFGTVYYGKLKN-------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      .||+|+||.||+|+...             ...||+|.+.....      .       ....|..|+.+++.++||||++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~-------~~~~~~~~~~~l~~l~hp~iv~   68 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR------D-------ISLAFFETASMMRQVSHKHIVL   68 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh------h-------HHHHHHHHHHHHHhCCCCCEee
Confidence            58999999999998532             23588888753211      1       1345888999999999999999


Q ss_pred             ecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc-
Q psy5603         244 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-  321 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~-  321 (455)
                      +++++.+ ...++||||+++|+|..++....  .++++..++.++.|++.||+|||+  ++|+||||||+|||++.++. 
T Consensus        69 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~  144 (262)
T cd05077          69 LYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGID  144 (262)
T ss_pred             EEEEEecCCCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCcc
Confidence            9998877 77899999999999988876532  468999999999999999999999  88999999999999987664 


Q ss_pred             ------eEEeecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHH-cCCCCCCCCcchh
Q psy5603         322 ------PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL-TGMKPIDDNNTIL  392 (455)
Q Consensus       322 ------~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~ell-tG~~p~~~~~~~~  392 (455)
                            ++++|||++......       ....|+..|+|||.+.  ..++.++|||||||++|||+ +|..||.......
T Consensus       145 ~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~  217 (262)
T cd05077         145 GECGPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE  217 (262)
T ss_pred             CCCCceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence                  899999987644321       2346888999999764  35788999999999999998 5888887654222


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ..... ......          .  ......+.+|+.+||..||++||++.++++.|+
T Consensus       218 ~~~~~-~~~~~~----------~--~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         218 KERFY-EGQCML----------V--TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHHH-hcCccC----------C--CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            11111 010000          0  011245788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0690|consensus

Probab=100.00  E-value=1.9e-39  Score=301.04  Aligned_cols=235  Identities=26%  Similarity=0.396  Sum_probs=197.8

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ++||+|.||.|-+++-+ +++.+|+|++++.......          ....-..|-++|.+++||.+..+--.++. ...
T Consensus       174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd----------EVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD----------EVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             HHhcCCccceEEEEeecccCceeehhhhhhhheeehH----------HhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            88999999999999876 5899999999877653221          13335679999999999998887655555 899


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||..||.|+-.|.+.   ..+++.....+...|+.||.|||+  ++||+||||.+|+|||++|++||.|||+|+..
T Consensus       244 CFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999999999874   359999999999999999999999  88999999999999999999999999999854


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      -...   ..+..++|||.|+|||++.. .+..++|+|.+|||+|||++|+.||...+.......+..++..++..+.+. 
T Consensus       319 I~~g---~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~e-  394 (516)
T KOG0690|consen  319 IKYG---DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPE-  394 (516)
T ss_pred             cccc---ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHH-
Confidence            4322   23567999999999998854 688999999999999999999999999887666666666666666555443 


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCC
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                                 .+.|+...+..||++|.
T Consensus       395 -----------AktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  395 -----------AKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -----------HHHHHHHHhhcChHhhc
Confidence                       67788899999999994

>KOG4250|consensus

Probab=100.00  E-value=7.5e-39  Score=324.09  Aligned_cols=265  Identities=25%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ...+.||+||||.||+|+.+ +|+.||||.++.....            .......+|++++++++|+|||++++.-.+ 
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~------------r~~e~~~~EieilkKLnh~NIVk~f~iee~~   83 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL------------RPRERWCREIEILKKLNHPNIVKLFDIEETK   83 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhccc------------chHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence            34478999999999999965 6999999999865421            124568899999999999999999986554 


Q ss_pred             ------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc--C--CC
Q psy5603         251 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--E--NF  320 (455)
Q Consensus       251 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~--~--~~  320 (455)
                            ....+|||||+||||...|.+-++...|++.+.+.++..+..||.|||+  +||+||||||.||++-  +  .-
T Consensus        84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~  161 (732)
T KOG4250|consen   84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQS  161 (732)
T ss_pred             ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCce
Confidence                  3468999999999999999988888889999999999999999999999  8899999999999993  2  33


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcch----hhH
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYY  394 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~----~~~  394 (455)
                      ..||+|||.|+....+..    ...+.||..|++||++.  +.++.-+|.|||||++|+++||..||......    ...
T Consensus       162 IyKLtDfG~Arel~d~s~----~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~  237 (732)
T KOG4250|consen  162 IYKLTDFGAARELDDNSL----FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM  237 (732)
T ss_pred             EEeeecccccccCCCCCe----eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence            689999999998776542    34679999999999775  56788999999999999999999999866532    122


Q ss_pred             HHhhh-cccchhhccchhc-------cCC--C---hhHHHHHHHHHHHhhhccCcCCCC--CHHHHHHHHHhhhcC
Q psy5603         395 YLVVE-QEVPVREVLDKEA-------GEW--N---ETHVETLISIVFEKCCVFEKDKRA--SMRDIVDLLSKSVNN  455 (455)
Q Consensus       395 ~~~~~-~~~~~~~~~d~~~-------~~~--~---~~~~~~~l~~Li~~~l~~dp~~RP--s~~evl~~L~~~~~~  455 (455)
                      +.+.. ....+.-...+..       ...  +   .......+...++.++..+|++|-  ...++...+.+|+++
T Consensus       238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            22211 1111110111000       000  1   123344566778899999999999  888888888888753

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-37  Score=304.51  Aligned_cols=246  Identities=27%  Similarity=0.437  Sum_probs=195.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|... ++..||+|.+.....      .       ....+.+|+.+++.++|+||+++++++.
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~------~-------~~~~~~~e~~~l~~~~h~~v~~~~~~~~   87 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ------P-------KKELIINEILVMRENKNPNIVNYLDSYL   87 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc------c-------hHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4556688999999999999875 478999999864322      1       0344889999999999999999999776


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...|+||||+++++|.+++..    ..+++.++..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          88 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             eCCEEEEeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccc
Confidence            6 788999999999999999864    358999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|++.|+|||.+.+ ..+.++|+|||||++|+|++|..||.................+  . 
T Consensus       162 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~-  235 (296)
T cd06654         162 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--E-  235 (296)
T ss_pred             cchhcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC--C-
Confidence            9875433211   1233578999999996644 5788999999999999999999999866532211111111100  0 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ...+..+...+.+++.+||..+|++||++.++++
T Consensus       236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 ------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                  0012234566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-38  Score=317.19  Aligned_cols=254  Identities=22%  Similarity=0.264  Sum_probs=189.4

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||++.+. .++.||||++......           ......+.+|+.+++.++||||+++++++.
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   86 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-----------QTHAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-----------hHHHHHHHHHHHHHHHhCCCchhceeeeee
Confidence            3455689999999999999876 4789999998643210           011345778999999999999999999764


Q ss_pred             C-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...|+||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~  158 (355)
T cd07874          87 PQKSLEEFQDVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             ccccccccceeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCE
Confidence            3       34689999995 567777653     48899999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      ||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......... -
T Consensus       159 kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (355)
T cd07874         159 KILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_pred             EEeeCcccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999998654321    1234578999999997654 578899999999999999999999987653221111110 0


Q ss_pred             ccc-----------hhhccc---------------hhc---cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVP-----------VREVLD---------------KEA---GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~-----------~~~~~d---------------~~~---~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+           ...+.+               ...   ...........+.+||.+|+..||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            000           000000               000   00001123456789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0574|consensus

Probab=100.00  E-value=3.2e-40  Score=303.23  Aligned_cols=241  Identities=24%  Similarity=0.419  Sum_probs=200.3

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc-cccCcee
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG-LCNNIMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~  253 (455)
                      .+||+|+||.||++.++. |..||||++....+               .+.+..|+.|+.+|..|++|++|| |+....+
T Consensus        39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---------------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---------------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHhcCCcchHHHHHHHhccCcEEEEEecCccch---------------HHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            789999999999999874 89999999975543               566889999999999999999999 5566999


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++|||||..||..|.++..  ..++++..+..++...+.||+|||.  ..-||||||..||||+.+|.+||+|||.|-..
T Consensus       104 WIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~--~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHD--LKKIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             EeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHH--HHHHHhhcccccEEEcccchhhhhhccccchh
Confidence            9999999999999998764  4589999999999999999999999  45799999999999999999999999987644


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ...   -...+.+.||+-|||||++.. +|+.++||||||++..||..|++||.+.....-...+-  ..+.+       
T Consensus       180 TDT---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--T~PPP-------  247 (502)
T KOG0574|consen  180 TDT---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--TKPPP-------  247 (502)
T ss_pred             hhh---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--CCCCC-------
Confidence            332   123467899999999997754 78999999999999999999999998765322111111  11111       


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .-..+..++..+.+++++||...|++|.++.++++
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            12235677888999999999999999999999876

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-37  Score=296.34  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=196.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||+|..+ ++..||+|.+........        .......+.+|++++++++|+||+++++++.+
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT--------GQEAVKQLEQEIALLSKLQHPNIVQYLGTERE   73 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc--------chHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence            445688999999999999987 689999999865332111        01124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          74 EDNLYIFLELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCcc
Confidence             7889999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-C-CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~-~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +.......    ......|+..|+|||.+.. . ++.++|+||||+++|+|++|..||............... ..... 
T Consensus       149 ~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-  222 (258)
T cd06632         149 AKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-KELPP-  222 (258)
T ss_pred             ceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-ccCCC-
Confidence            87654322    1234578999999996543 4 788999999999999999999999876532222211110 01100 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              .+..++..+.+++.+||..+|.+||++.+++.
T Consensus       223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                    01223455788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0033|consensus

Probab=100.00  E-value=3.7e-40  Score=295.22  Aligned_cols=248  Identities=24%  Similarity=0.383  Sum_probs=200.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|.|+.||++... +|+.+|+|.+........           ..+.+.+|+.|.+.++||||+++......
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-----------~~e~l~rEarIC~~LqHP~IvrL~~ti~~   81 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-----------DFQKLEREARICRKLQHPNIVRLHDSIQE   81 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-----------cHHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence            344478999999999999765 589999999875543222           14558899999999999999999996655


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc---CCCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~D  326 (455)
                       +..|+|+|+|.|++|..-+-..   ...++..+...+.||+.+|.|+|.  ++|||||+||.|+||.   ...-+||+|
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~  156 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLAD  156 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecc
Confidence             8999999999999997666542   357888999999999999999999  8899999999999994   445799999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|.......    ..-...|||.|||||++. ..++..+||||.|||||-||.|.+||.+.++...+..+.....++.
T Consensus       157 FGvAi~l~~g~----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~  232 (355)
T KOG0033|consen  157 FGLAIEVNDGE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP  232 (355)
T ss_pred             cceEEEeCCcc----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC
Confidence            99998776332    133578999999999765 4688999999999999999999999999776666655544332221


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ...|  +.+....++|+.+||..||.+|.|+.|.++
T Consensus       233 ------~~~w--~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 ------SPEW--DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ------Cccc--CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                  1122  345566899999999999999999999864

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.2e-38  Score=297.54  Aligned_cols=237  Identities=27%  Similarity=0.413  Sum_probs=186.0

Q ss_pred             CccCcCCCeEEEEEEEcCCc-----------EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         176 NKLGEGQFGTVYYGKLKNGM-----------EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      +.||+|+||.||+|.+.+..           .|++|.+.....              ....|.+|+.++++++||||+++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~   66 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--------------DSLAFFETASLMSQLSHKHLVKL   66 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--------------hHHHHHHHHHHHHcCCCcchhhe
Confidence            36999999999999986422           477887653221              03458899999999999999999


Q ss_pred             cccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC----
Q psy5603         245 LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----  320 (455)
Q Consensus       245 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~----  320 (455)
                      ++++.....++||||+++|+|.+++.....  .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++    
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~  142 (259)
T cd05037          67 YGVCVRDENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEG  142 (259)
T ss_pred             eeEEecCCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccC
Confidence            998876778999999999999999987432  68999999999999999999999  8899999999999999888    


Q ss_pred             ---ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhh
Q psy5603         321 ---VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       321 ---~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                         .+||+|||++.....       .....++..|+|||++.+   .++.++|+|||||++|||++ |..||...+....
T Consensus       143 ~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~  215 (259)
T cd05037         143 YVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK  215 (259)
T ss_pred             CceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence               899999999875433       123457788999997754   47889999999999999999 6888876542211


Q ss_pred             HHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ..... .....+         .+   ....+.+++.+|+..+|.+||++.+|++.|+
T Consensus       216 ~~~~~-~~~~~~---------~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ERFYQ-DQHRLP---------MP---DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHh-cCCCCC---------CC---CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11111 000000         00   0145788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-38  Score=304.56  Aligned_cols=255  Identities=24%  Similarity=0.313  Sum_probs=195.0

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||+||++.+. +|+.||+|++.....            ......+.+|+++++.++||||+++++++.+ 
T Consensus         8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK------------SSVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc------------chHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            44588999999999999976 478999999864321            0114568899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++..   ..++++..+..++.+++.||.|||+. ++++||||||+||++++++.++|+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            888999999999999998876   34689999999999999999999962 47999999999999999999999999987


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-ccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~  408 (455)
                      .......     .....|+..|+|||.+ .+.++.++|+|||||++|+++||..||............... ...+....
T Consensus       152 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         152 GELINSI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             cchhhhc-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            6542221     2345789999999965 456788999999999999999999999865431000000000 00000111


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      .......+...++..+.+|+.+|+..+|.+||++.||++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111111222355668899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1094|consensus

Probab=100.00  E-value=1.4e-38  Score=314.46  Aligned_cols=262  Identities=27%  Similarity=0.369  Sum_probs=207.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .++++||+|-||.|.++...++..||||+++..+..            .....|..|+++|.+|+||||++++|.|.. +
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~------------~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK------------NARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccch------------hHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            467999999999999999987799999999865431            125669999999999999999999999976 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .+|+|+|||++|+|.+++....- +.+.-....+|+.||+.|++||.+  -++|||||.+.|+|+|.++++||+|||++|
T Consensus       609 PicmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCccccc
Confidence            88999999999999999988542 224556677899999999999999  679999999999999999999999999999


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcc-cccCCCCcccchHHHHHHHHHHHc--CCCCCCCCcchhhHHHhhh-cccchhhc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT--GMKPIDDNNTILYYYLVVE-QEVPVREV  407 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~~~~~~sDv~SlGvvl~ellt--G~~p~~~~~~~~~~~~~~~-~~~~~~~~  407 (455)
                      -....+... .....+-...|||+| ++.|+++++||+|+||+++||+++  ...||.............. -...-...
T Consensus       686 ~lysg~yy~-vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~  764 (807)
T KOG1094|consen  686 NLYSGDYYR-VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV  764 (807)
T ss_pred             ccccCCcee-eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce
Confidence            665544322 122344567899999 778999999999999999999876  8889987654333222211 01111111


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                           -...+.-++..+.+++..||..+.++||+++++...|.+...|
T Consensus       765 -----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~~~  807 (807)
T KOG1094|consen  765 -----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDALN  807 (807)
T ss_pred             -----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhccC
Confidence                 1122334555566888899999999999999999999876553

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.1e-38  Score=303.99  Aligned_cols=242  Identities=28%  Similarity=0.373  Sum_probs=194.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.+. +++.||+|++.......          ......+.+|+++++++.||||+++++++.+
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK----------LKQVEHVLNEKRILQSIRHPFLVNLYGSFQD   72 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence            455689999999999999986 47899999986432211          1114558899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++++|.+++...   ..++...+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+
T Consensus        73 ~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~  147 (290)
T cd05580          73 DSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGF  147 (290)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence             7889999999999999999874   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......      .....|++.|+|||.+. +..+.++|+||||+++|+|++|..||..................++.  
T Consensus       148 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  219 (290)
T cd05580         148 AKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--  219 (290)
T ss_pred             ccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--
Confidence            8765433      23457899999999654 45688999999999999999999999876633222222222212111  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIV  446 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl  446 (455)
                                ..+..+.++|.+|+..+|.+|+     ++++++
T Consensus       220 ----------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         220 ----------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ----------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                      1234578899999999999998     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.3e-38  Score=301.67  Aligned_cols=237  Identities=25%  Similarity=0.393  Sum_probs=182.3

Q ss_pred             ccCcCCCeEEEEEEEcC-------------------------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH
Q psy5603         177 KLGEGQFGTVYYGKLKN-------------------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ  231 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  231 (455)
                      +||+|+||.||+|....                         ...||+|++.....             .....|.+|+.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-------------~~~~~~~~~~~   68 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-------------DIALAFFETAS   68 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-------------HHHHHHHHHHH
Confidence            69999999999997521                         13588888753211             11345888999


Q ss_pred             HHhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCC
Q psy5603         232 TLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       232 ~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dik  310 (455)
                      ++++++||||+++++++.+ ...++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+  ++|+|||||
T Consensus        69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlk  144 (274)
T cd05076          69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLED--KNLVHGNVC  144 (274)
T ss_pred             HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCC
Confidence            9999999999999999877 78899999999999999886532  368899999999999999999999  889999999


Q ss_pred             CCcEEEcCCC-------ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHH-c
Q psy5603         311 SANVLLDENF-------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELL-T  380 (455)
Q Consensus       311 p~NILl~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~ell-t  380 (455)
                      |+|||+++.+       .+|++|||++......       ....++..|+|||.+.+  .++.++|+|||||++||++ +
T Consensus       145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             cccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999997654       4899999987543221       12357888999997643  4788999999999999994 7


Q ss_pred             CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         381 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       381 G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      |..||............. .....+.            .....+.+++.+||..+|.+||++.+|++.|+
T Consensus       218 g~~p~~~~~~~~~~~~~~-~~~~~~~------------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         218 GEVPLKERTPSEKERFYE-KKHRLPE------------PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CCCCccccChHHHHHHHH-hccCCCC------------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            999998665322211111 1111110            01224778899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5e-38  Score=303.73  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=188.0

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.+. +++.||+|.+.....      .      .....+.+|++++++++||||+++++++.. 
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT------V------ELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC------h------HHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            45588999999999999875 578999999864311      0      013458899999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|..+.       .+++..+..++.|++.||.|||+  .+++|+||||+|||++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             CEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            7889999999999996542       37888999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......     .....||..|+|||.+. ..++.++|+||||+++|+|++|..||..............   ......+
T Consensus       143 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~  214 (279)
T cd06619         143 TQLVNSI-----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ---LLQCIVD  214 (279)
T ss_pred             eeccccc-----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH---HHHHHhc
Confidence            7543321     23458999999999664 4578899999999999999999999975331110000000   0000000


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......+....+..+.+++.+|+..+|++||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00111112223445788999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-37  Score=301.91  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=194.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.++ ++..||+|.++....      .      .....+.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD------E------SKFNQIIMELDILHKAVSPYIVDFYGAFFI   70 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC------H------HHHHHHHHHHHHHHhcCCCcHHhhhhheec
Confidence            455689999999999999987 589999999864211      0      013458899999999999999999997766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|..++........+++..+..++.+++.||.|||+. .+++||||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence             88899999999999999887643334689999999999999999999962 4799999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccCC-------CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +.......     .....|+..|+|||.+.+.       ++.++|+|||||++|+|++|..||..............   
T Consensus       150 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---  221 (286)
T cd06622         150 SGNLVASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA---  221 (286)
T ss_pred             cccccCCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH---
Confidence            87543221     2334688899999976432       47799999999999999999999976543221111110   


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ..+...... +..++..+.++|.+|+..+|.+||++.++++
T Consensus       222 ----~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         222 ----IVDGDPPTL-PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----HhhcCCCCC-CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                000000011 1225566888999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-37  Score=298.54  Aligned_cols=261  Identities=26%  Similarity=0.434  Sum_probs=197.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... +|+.||+|.++...........   ........+.+|+.++++++|||++++++++..
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   79 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS---RQKDMVKALRSEIETLKDLDHLNIVQYLGFETT   79 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccch---HHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence            445689999999999999875 4889999998643221111100   111224568889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++...   .++++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence             7889999999999999999864   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++...... .........|+..|+|||.+..   .++.++|+||||+++|++++|..||................  ...
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~  231 (272)
T cd06629         155 SKKSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--SAP  231 (272)
T ss_pred             cccccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--cCC
Confidence            87643321 1111234578899999997643   26889999999999999999999997654322221111110  000


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+...    ....++..+.+++.+||..+|.+||++.+|++
T Consensus       232 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 PIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00110    11234566888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-37  Score=301.21  Aligned_cols=257  Identities=22%  Similarity=0.331  Sum_probs=194.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++...||+|+||.||+|.++ +|+.||+|++........           ..+.+.+|+.++++++|||++++++++..
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV-----------IKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc-----------ccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            455689999999999999987 488999999864322110           12347899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|..++..   ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECcccc
Confidence             788999999999888877654   3358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchh-
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR-  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~-  405 (455)
                      +........   ......++..|+|||.+.+  .++.++|+||||+++|||++|.+||.+............ ...... 
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07847         147 ARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR  223 (286)
T ss_pred             ceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            886543321   1223467889999997643  468899999999999999999999987653222211111 000000 


Q ss_pred             --hccc----------hhccCC-C----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 --EVLD----------KEAGEW-N----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 --~~~d----------~~~~~~-~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ...+          +..... +    ...++..+.+|+.+|+..+|++||++.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              0000          000000 0    1123556889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-37  Score=301.60  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=197.3

Q ss_pred             eHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH
Q psy5603         155 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       155 ~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      .+..+..++++|...      +.||+|+||.||+|.++ +++.||+|++.....      .        ...+.+|+.++
T Consensus         9 ~~~~~~~~~~~~~~~------~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------~--------~~~~~~e~~~l   68 (286)
T cd06638           9 IFDSFPDPSDTWEII------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------I--------DEEIEAEYNIL   68 (286)
T ss_pred             EeecCCCcccceeee------eeeccCCCcEEEEEEECCCCceeEEEeeccccc------h--------HHHHHHHHHHH
Confidence            344555566666544      89999999999999986 478999998753211      0        23477899999


Q ss_pred             hhC-Cccceeeeccccc-----C-ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5603         234 SQC-KHVNLLRLLGLCN-----N-IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       234 ~~l-~h~niv~l~~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~ii  305 (455)
                      +++ +||||+++++++.     + ...++||||+++++|.+++... .....+++..+..++.|++.||.|||+  .+++
T Consensus        69 ~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~  146 (286)
T cd06638          69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTI  146 (286)
T ss_pred             HHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCcc
Confidence            999 6999999999762     2 5679999999999999987642 224568999999999999999999999  8899


Q ss_pred             ecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHH
Q psy5603         306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELL  379 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~ell  379 (455)
                      ||||||+||+++.++.+||+|||+++.......   ......|++.|+|||++.      ..++.++|||||||++|||+
T Consensus       147 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~  223 (286)
T cd06638         147 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG  223 (286)
T ss_pred             ccCCCHHhEEECCCCCEEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence            999999999999999999999999876543221   123357899999999763      23678999999999999999


Q ss_pred             cCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         380 TGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       380 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      +|..||...............  .....       ..+..++..+.+++.+||..+|++||++.++++.
T Consensus       224 ~g~~p~~~~~~~~~~~~~~~~--~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         224 DGDPPLADLHPMRALFKIPRN--PPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCCCCCCCchhHHHhhcccc--CCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            999999865432211111100  00000       0111234458889999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=298.26  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=195.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|.+. +++.||+|.+......     .       ....+.+|+++++.++|+||+++++++.+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-----D-------EIEDIQQEIQFLSQCRSPYITKYYGSFLK   70 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc-----h-------HHHHHHHHHHHHHHcCCCCeeeeeEEEEE
Confidence            445588999999999999976 4889999998643210     1       13457899999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|+||+++++|.+++...    ++++..+..++.|++.|+.|||+  ++++||||+|+||++++++.++|+|||+
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          71 GSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             CCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccccc
Confidence             7889999999999999998752    78999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......|+..|+|||.+. ..++.++|+||||+++|+|+||..||...+.......+....  .+.  
T Consensus       145 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~--  217 (274)
T cd06609         145 SGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPS--  217 (274)
T ss_pred             ceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CCC--
Confidence            88765432   1123457889999999664 457899999999999999999999998665332222111110  000  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            .....++..+.+++.+||..+|++||++.++++
T Consensus       218 ------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 ------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                  001114455888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-38  Score=314.60  Aligned_cols=186  Identities=25%  Similarity=0.378  Sum_probs=156.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+. +..||+|+....                   ....|+.++++++||||+++++++..
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------------------~~~~E~~~l~~l~h~~iv~~~~~~~~  128 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------------------TTLIEAMLLQNVNHPSVIRMKDTLVS  128 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence            4566999999999999999874 678999974321                   13468999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|+||+ .++|.+++...  ..++++..+..|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       129 ~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        129 GAITCMVLPHY-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             CCeeEEEEEcc-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCcc
Confidence             7789999999 57888888653  3468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCC
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~  385 (455)
                      ++......    ......||..|+|||++. ..++.++|||||||++|||+++..|+
T Consensus       204 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        204 AQFPVVAP----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccCc----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            87543221    123457999999999764 46789999999999999999855554

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.5e-38  Score=300.47  Aligned_cols=237  Identities=27%  Similarity=0.377  Sum_probs=183.2

Q ss_pred             ccCcCCCeEEEEEEEcC--------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         177 KLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .||+|+||.||+|..+.        ...||+|.+.....             .....+.+|+.+++.+.||||+++++++
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~~~h~~iv~~~~~~   68 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-------------NYSESFFEAASMMSQLSHKHLVLNYGVC   68 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhH-------------HHHHHHHHHHHHHHhCCCCChhheeeEE
Confidence            59999999999998642        23478888743211             1134588899999999999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc------
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV------  321 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~------  321 (455)
                      .. ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.      
T Consensus        69 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~  144 (258)
T cd05078          69 VCGDESIMVQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNP  144 (258)
T ss_pred             EeCCCcEEEEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCC
Confidence            76 78899999999999999997643  368999999999999999999999  88999999999999987765      


Q ss_pred             --eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCC-CCCCCCcchhhHHH
Q psy5603         322 --PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGM-KPIDDNNTILYYYL  396 (455)
Q Consensus       322 --~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~-~p~~~~~~~~~~~~  396 (455)
                        ++++|||++.....       .....++..|+|||.+.+  .++.++|||||||++|||++|. +|+...........
T Consensus       145 ~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~  217 (258)
T cd05078         145 PFIKLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF  217 (258)
T ss_pred             ceEEecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH
Confidence              58999998764332       223568889999997754  4688999999999999999984 66654433221111


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                       ......++            ......+.+++.+||..+|++||+++++++.|+
T Consensus       218 -~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 -YEDRHQLP------------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -HHccccCC------------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             11111111            112234788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-37  Score=296.37  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=198.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||+||+|... ++..+|+|++.......            ....+.+|+++++.++|+||+++++.+..
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT------------SVDELRKEVQAMSQCNHPNVVKYYTSFVV   70 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch------------HHHHHHHHHHHHHhcCCCCEEEEEEEEee
Confidence            456689999999999999975 47889999986432210            14568899999999999999999997766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+|++++++|.+++........+++..+..++.|++.||.|||+  .|++||||||+||++++++.++|+|||+
T Consensus        71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccch
Confidence             7889999999999999999764333468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcce-eeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         330 VKMSETSNMKT-MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +.......... .......|+..|+|||.+..  ..+.++|+|||||++|+|++|..||..................   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  225 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP---  225 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC---
Confidence            87665433211 11234578999999996643  4788999999999999999999999866533222211111100   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   .......++..+.+++.+|+..+|++||++.++++
T Consensus       226 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLE---TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcC---CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000   00011245566889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-37  Score=302.07  Aligned_cols=257  Identities=25%  Similarity=0.365  Sum_probs=200.3

Q ss_pred             HHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC
Q psy5603         159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK  237 (455)
Q Consensus       159 l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  237 (455)
                      +.+..+..+....|...+.||+|+||.||+|... +++.||+|++.......          ......+.+|+.+++.++
T Consensus         4 ~~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~----------~~~~~~~~~Ei~~l~~l~   73 (307)
T cd06607           4 IAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS----------NEKWQDIIKEVRFLQQLR   73 (307)
T ss_pred             HHHhhcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc----------HHHHHHHHHHHHHHHhCC
Confidence            4444555556666777799999999999999976 48899999986432211          011345889999999999


Q ss_pred             ccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE
Q psy5603         238 HVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       238 h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      ||||+++++++.+ ...++|+||+. |+|.+.+....  .++++..+..++.|++.||.|||+  .+++||||+|+||++
T Consensus        74 h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~  148 (307)
T cd06607          74 HPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILL  148 (307)
T ss_pred             CCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEE
Confidence            9999999998877 78899999996 67877776432  368999999999999999999999  889999999999999


Q ss_pred             cCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcchh
Q psy5603         317 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL  392 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~  392 (455)
                      +.++.+||+|||++......       ....|+..|+|||.+.    +.++.++||||||+++|||+||..||...+...
T Consensus       149 ~~~~~~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~  221 (307)
T cd06607         149 TEPGTVKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS  221 (307)
T ss_pred             CCCCCEEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence            99999999999988754322       2346888999999652    457889999999999999999999998765332


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........          ........++..+.++|.+||..+|++||++.+|+.
T Consensus       222 ~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         222 ALYHIAQND----------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             HHHHHhcCC----------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            222111111          011112234556899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-37  Score=294.58  Aligned_cols=245  Identities=27%  Similarity=0.415  Sum_probs=195.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+. +..||+|.+.....               ...+.+|++++++++||||+++++++.+
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~   69 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---------------LQEIIKEISILKQCDSPYIVKYYGSYFK   69 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---------------HHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence            4555899999999999999875 78999999853211               3458999999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+++||+++++|.+++....  ..+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+
T Consensus        70 ~~~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~  145 (256)
T cd06612          70 NTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV  145 (256)
T ss_pred             CCcEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEccccc
Confidence             78899999999999999987533  468999999999999999999999  7899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||...............  ...   
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---  217 (256)
T cd06612         146 SGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--PPP---  217 (256)
T ss_pred             chhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--CCC---
Confidence            876543321   1234568899999997644 5788999999999999999999999865432211111100  000   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ....+..++..+.+++.+||..+|++||++.+|++
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 ----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ----CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                00112234556888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.9e-37  Score=298.54  Aligned_cols=253  Identities=24%  Similarity=0.382  Sum_probs=195.7

Q ss_pred             cCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++...||+|+||.||+|+.+.      .+.||+|.+.....            ......+.+|++++++++|+||+++++
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~   75 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD------------ENLQSEFRRELDMFRKLSHKNVVRLLG   75 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc------------hHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence            344889999999999998642      45789998753211            011455889999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNT------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++.+ ...|+||||+++|+|.+++......      .++++..+..++.|++.||+|||+  .+++||||||+||+++.+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~  153 (275)
T cd05046          76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQ  153 (275)
T ss_pred             EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCC
Confidence            8877 7889999999999999999764422      268999999999999999999999  889999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~  397 (455)
                      +.++|+|||++........  .......++..|+|||.+ .+..+.++||||||+++|+|++ |..||............
T Consensus       154 ~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         154 REVKVSLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             CcEEEcccccccccCcccc--cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            9999999999875432221  112234567789999965 4567889999999999999999 88899765433222222


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ........          ....++..+.+++.+||..+|.+||++.+++..|.+
T Consensus       232 ~~~~~~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 QAGKLELP----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HcCCcCCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11111110          112344568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0584|consensus

Probab=100.00  E-value=9e-39  Score=319.85  Aligned_cols=245  Identities=25%  Similarity=0.397  Sum_probs=197.6

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +....||+|+|-+||+|.+. +|-.||-=.++.....         ......++|..|+.+|+.|+||||+++|.++.+ 
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~---------q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT---------QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhh---------cChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            44578999999999999986 3777764333221111         111125789999999999999999999998866 


Q ss_pred             c--eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CCceEEeec
Q psy5603         251 I--MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDF  327 (455)
Q Consensus       251 ~--~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DF  327 (455)
                      .  ..-+|.|.+..|+|..|+.+.+   ..+...+..|++||++||.|||+...+|||||||.+||+|+. .|.+||+|+
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecch
Confidence            3  4568999999999999999855   488899999999999999999998889999999999999974 599999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcch-hhHHHhhh--cccch
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVE--QEVPV  404 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~--~~~~~  404 (455)
                      |||.......     ...+.|||.|||||++...|+..+||||||+.++||.|+..||.+.... ..+.++..  .+..+
T Consensus       191 GLAtl~r~s~-----aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl  265 (632)
T KOG0584|consen  191 GLATLLRKSH-----AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL  265 (632)
T ss_pred             hHHHHhhccc-----cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence            9998766543     2347999999999999989999999999999999999999999988743 44433332  22223


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+-|+.            ++++|.+|+.. .+.||++.|+++
T Consensus       266 ~kV~dPe------------vr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  266 SKVKDPE------------VREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hccCCHH------------HHHHHHHHhcC-chhccCHHHHhh
Confidence            3333333            78889999999 999999999875

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-37  Score=295.48  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=198.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||.|+||.||.+... ++..|++|++.......           .....+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   70 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-----------KERRDALNEIVILSLLQHPNIIAYYNHFMD   70 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-----------hHHHHHHHHHHHHHhCCCCCeeEEEeEEec
Confidence            455689999999999999865 47899999986432211           113458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++.... ...+++.++..++.|++.||.|||+  .+++||||+|+||++++++.+||+|||+
T Consensus        71 ~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          71 DNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcc
Confidence             78899999999999999997643 3468999999999999999999999  7899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|++.|+|||.+.+ ..+.++|+||||+++|||++|..||...........+......  .  
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~--  220 (256)
T cd08221         148 SKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--P--  220 (256)
T ss_pred             eEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--C--
Confidence            876543321   2234578999999996644 5788999999999999999999999875543322222211110  0  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                             ....++..+.+++.+||..+|.+||++.++++.
T Consensus       221 -------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 -------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                   012344568889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=293.42  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=196.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|... +++.+|+|.+......             ....+.+|++++++++||||+++++++.+
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-------------DFEIIQQEISMLKECRHPNIVAYFGSYLR   71 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-------------hHHHHHHHHHHHHhCCCCChhceEEEEEe
Confidence            455689999999999999976 4788999998643210             14558899999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|++|||+++++|.+++....  .++++.++..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          72 RDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECcccc
Confidence             78899999999999999887632  468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +.......   .......|+..|+|||.+.+    .++.++|+||||+++|||+||.+||....................
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~  224 (262)
T cd06613         148 SAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP  224 (262)
T ss_pred             chhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc
Confidence            87544321   11234578889999997643    578899999999999999999999987653322222211111110


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .       ......++..+.+++.+|+..+|.+||++.+|+.
T Consensus       225 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0       1112345566889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=336.34  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=192.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+.. +..||+|.+......           ......|..|+.++.+++|||||++++++.
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-----------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-----------EREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-----------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            35667999999999999999874 678999998643221           011455889999999999999999999764


Q ss_pred             C---ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCeeecCCCCCcEEEcC--
Q psy5603         250 N---IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLS-----KPIIHRDVKSANVLLDE--  318 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~-----~~iiH~Dikp~NILl~~--  318 (455)
                      +   ...|+||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+..     ++||||||||+||||+.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            3   56799999999999999987532 2356999999999999999999999842     35999999999999964  


Q ss_pred             ---------------CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHc
Q psy5603         319 ---------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       319 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~ellt  380 (455)
                                     .+.+||+|||++.......    ......||+.|+|||++.+   .++.++||||||||||||+|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT  238 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS  238 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence                           3458999999987654322    1234579999999997633   47889999999999999999


Q ss_pred             CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         381 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       381 G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      |..||..................           .+....+..+.+||..||..+|.+||++.+++.
T Consensus       239 Gk~PF~~~~~~~qli~~lk~~p~-----------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        239 GKTPFHKANNFSQLISELKRGPD-----------LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCCcCCcHHHHHHHHhcCCC-----------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99999865532211111111111           111123445888999999999999999999984

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-37  Score=299.93  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=190.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|..||+|+++.......           ....+.+|++++++++||||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~-----------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   70 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-----------VPSSALREICLLKELKHKNIVRLYDVLHS   70 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc-----------CccchhHHHHHHHhcCCCCeeeHHHHhcc
Confidence            455688999999999999986 488999999865322111           02337789999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+. ++|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          71 DKKLTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             CCceEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccch
Confidence             78899999996 68888876532  368999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhH-HHhhh--cccc-
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY-YLVVE--QEVP-  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~-~~~~~--~~~~-  403 (455)
                      ++.......   ......++..|+|||.+.+  .++.++|||||||++|||+||..|+......... ..+..  .... 
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07839         146 ARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  222 (284)
T ss_pred             hhccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            875433211   1223467889999997644  3588999999999999999998886543321111 11100  0000 


Q ss_pred             -----hhhccchhc-cCCC--------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -----VREVLDKEA-GEWN--------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -----~~~~~d~~~-~~~~--------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           +....+... ....        ...++..+.++|.+||..||.+|||++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                 000000000 0000        1124566788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0579|consensus

Probab=100.00  E-value=7.9e-39  Score=318.01  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=206.6

Q ss_pred             hcCCCCCCCCcCCCccCcCCCeEEEEEEEcCC-cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce
Q psy5603         163 TDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       163 t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      ..+.++..+|++...||.|+||.||+|..++. -..|-|++.....             .....|.-|++||..|.||+|
T Consensus        25 ~rdlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse-------------EELEDylVEIeILa~CdHP~i   91 (1187)
T KOG0579|consen   25 YRDLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE-------------EELEDYLVEIEILAECDHPVI   91 (1187)
T ss_pred             hccCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch-------------hHHhhhhhhhhhhhcCCChHH
Confidence            44566666777888999999999999998753 3346777753321             114558899999999999999


Q ss_pred             eeecc-cccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         242 LRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       242 v~l~~-~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      |++++ ||.++.++++.|||.||-....+-..++  +|.+.++..++++++.||.|||+  ++|||||||..|||++-+|
T Consensus        92 vkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldG  167 (1187)
T KOG0579|consen   92 VKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDG  167 (1187)
T ss_pred             HHHHHHHhccCceEEEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecC
Confidence            99999 6677899999999999999888877654  79999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhH
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYY  394 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~  394 (455)
                      .++|+|||.+-....   .......+.|||.|||||+..      ..|+.++|||||||+|.||..+.+|-...+...+.
T Consensus       168 dirLADFGVSAKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl  244 (1187)
T KOG0579|consen  168 DIRLADFGVSAKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  244 (1187)
T ss_pred             cEeeecccccccchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH
Confidence            999999997643221   112345789999999999653      24788999999999999999999998877655544


Q ss_pred             HHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+...+.+  .       ...+..++..+.+++..||..+|..||+++++++
T Consensus       245 lKiaKSePP--T-------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  245 LKIAKSEPP--T-------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHhhcCCC--c-------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            444432211  1       2334567788999999999999999999999875

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=300.07  Aligned_cols=247  Identities=26%  Similarity=0.406  Sum_probs=195.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|.++ ++..||+|.+.....      .       ....|.+|++++++++||||+++++++..
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE------E-------ELEDFMVEIDILSECKHPNIVGLYEAYFY   73 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH------H-------HHHHHHHHHHHHHhCCCCceeEEEEEEec
Confidence            456689999999999999986 478999999863211      1       13458899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++++|.+++....  .++++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~  149 (280)
T cd06611          74 ENKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGV  149 (280)
T ss_pred             CCeEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCcc
Confidence             78899999999999999987643  369999999999999999999999  8899999999999999999999999998


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +........   ......||..|+|||.+.      ..++.++|+||||+++|||++|..||...+.............+
T Consensus       150 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  226 (280)
T cd06611         150 SAKNKSTLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP  226 (280)
T ss_pred             chhhccccc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC
Confidence            765433221   123457899999999753      23577999999999999999999999876543322222111100


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        . +      ..+..++..+.+++.+|+..+|.+||++.++++
T Consensus       227 --~-~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         227 --T-L------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             --C-c------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence              0 0      011234456888999999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-37  Score=299.41  Aligned_cols=257  Identities=21%  Similarity=0.312  Sum_probs=192.0

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||+|+||.||+|+++ +|+.||||+++.......           ....+.+|++++++++||||+++++++.+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-----------VPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc-----------cchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            44588999999999999986 488999999864432111           12348899999999999999999998777 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccch
Confidence            78899999995 68998887643 3468999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-C-CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchhhc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~-~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~  407 (455)
                      ........   ......++..|+|||.+.+ . ++.++|+||||+++|||+||..||.............. ...+....
T Consensus       148 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd07860         148 RAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV  224 (284)
T ss_pred             hhcccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            75543211   1223457889999997644 3 57899999999999999999999987653222111111 10000000


Q ss_pred             c---c------hhccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 L---D------KEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~---d------~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .   .      .....+.       ...++..+.++|.+|+..||.+||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0   0      0000000       0123445778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-37  Score=301.80  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=198.4

Q ss_pred             eeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHH
Q psy5603         154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  232 (455)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  232 (455)
                      ++..++..++++|...      +.||+|+||.||++..+ +++.+|+|.+.....              ....+.+|+.+
T Consensus        12 ~~~~~~~~~~~~y~~~------~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--------------~~~~~~~e~~~   71 (291)
T cd06639          12 LGLESLGDPTDTWEII------ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--------------VDEEIEAEYNI   71 (291)
T ss_pred             hhcccCCCCCCCeEEE------EEeecCCCeEEEEEEECCCCCEEEEEEeccccc--------------HHHHHHHHHHH
Confidence            3445555566666554      89999999999999986 488999999853211              12347789999


Q ss_pred             HhhC-CccceeeecccccC------ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy5603         233 LSQC-KHVNLLRLLGLCNN------IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       233 l~~l-~h~niv~l~~~~~~------~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~i  304 (455)
                      +.++ +|||++++++++..      ...++|+||+++++|.+++.... ....+++..++.++.|++.||.|||+  .++
T Consensus        72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i  149 (291)
T cd06639          72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRI  149 (291)
T ss_pred             HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCe
Confidence            9998 89999999997743      35799999999999999886422 23568999999999999999999999  889


Q ss_pred             eecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC------CCCcccchHHHHHHHHHH
Q psy5603         305 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLEL  378 (455)
Q Consensus       305 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~sDv~SlGvvl~el  378 (455)
                      +||||||+||+++.++.+||+|||+++.......   ......|+..|+|||.+..      .++.++|+|||||++|||
T Consensus       150 vH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el  226 (291)
T cd06639         150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL  226 (291)
T ss_pred             eccCCCHHHEEEcCCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence            9999999999999999999999999876543221   1233578899999997643      257899999999999999


Q ss_pred             HcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         379 LTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       379 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++|.+||...............  ......       .+..+...+.++|.+||..+|++||++.++++
T Consensus       227 ~~g~~p~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         227 GDGDPPLFDMHPVKTLFKIPRN--PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hhCCCCCCCCcHHHHHHHHhcC--CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            9999999876532221111111  111111       11223456889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3e-37  Score=296.15  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcC--CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh-CCccceeeeccccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCN  249 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~  249 (455)
                      .+.+.||+|+||.||+|.++.  ++.+|+|.+...........   .........+.+|+.++.+ ++||||+++++++.
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~---~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   79 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDK---RERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL   79 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccccc---ccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence            445889999999999999864  67899999865432211100   0111224557789988865 79999999999776


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      + +..++||||+++++|.+++... .....+++..++.++.|++.||.|||+. .+++||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecc
Confidence            6 8889999999999999988542 2245689999999999999999999952 57999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |++.......    ......|+..|+|||.+. +.++.++|+||||+++|||++|.+||..................   
T Consensus       159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  231 (269)
T cd08528         159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE---  231 (269)
T ss_pred             cceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC---
Confidence            9988654332    223457899999999664 45788999999999999999999999766533222222111100   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                             ......++..+.+++.+||..||++||++.||..++++
T Consensus       232 -------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         232 -------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             -------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                   00111234558889999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.7e-37  Score=299.24  Aligned_cols=246  Identities=27%  Similarity=0.434  Sum_probs=195.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||.|+||.||+|.+. +++.||+|.+.....      .       ....+.+|+.+++.++||||+++++++.
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ------P-------KKELIINEILVMKELKNPNIVNFLDSFL   86 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC------c-------hHHHHHHHHHHHHhcCCCceeeeeeeEe
Confidence            3556689999999999999875 588999999864221      1       1344789999999999999999999876


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++|+||+++++|.+++..    ..+++.++..++.+++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg  160 (296)
T cd06655          87 VGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFG  160 (296)
T ss_pred             cCceEEEEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCc
Confidence            6 788999999999999998864    358999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|+..|+|||.+. ..++.++|+|||||++|+|++|..||...+.............+  . 
T Consensus       161 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~--~-  234 (296)
T cd06655         161 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--E-  234 (296)
T ss_pred             cchhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc--c-
Confidence            9875443221   123457899999999664 45788999999999999999999999876543222111111100  0 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ...+..++..+.++|.+||..+|++||++.+++.
T Consensus       235 ------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 ------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                  0011234556888999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-37  Score=300.88  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=193.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|.++ +++.||+|++.......           .....+.+|++++++++||||+++++++.+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-----------MVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-----------hhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            455689999999999999986 48899999986432211           013447889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|+||+.+++|..+...   ...+++.+++.++.|++.||.|||+  .+++||||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeee
Confidence             788999999999988887664   2358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV---  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---  404 (455)
                      +........   ......|+..|+|||.+.+  .++.++||||||+++|||++|.+||..................+   
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07846         147 ARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR  223 (286)
T ss_pred             eeeccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence            876543221   1223568899999997643  46789999999999999999999997655322211111100000   


Q ss_pred             -hhccc----------hhccC-----CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 -REVLD----------KEAGE-----WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 -~~~~d----------~~~~~-----~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ....+          +....     .....++..+.+|+.+|+..+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             00000          00000     001134566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-37  Score=299.65  Aligned_cols=265  Identities=24%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      +++.+.||+|+||.||+|.+.     ++..||||.+......            .....|.+|+++++++.|+||+++++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~------------~~~~~~~~ei~~l~~l~~~~i~~~~~   73 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE------------QHRSDFEREIEILRTLDHENIVKYKG   73 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch------------HHHHHHHHHHHHHHhCCCCChheEEe
Confidence            345588999999999999864     3678999998643221            11456999999999999999999999


Q ss_pred             cccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         247 LCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       247 ~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++..   ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  .+++||||||+||+++.++.++
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          74 VCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVK  149 (284)
T ss_pred             eeecCCCCceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEE
Confidence            7754   46799999999999999997643  258999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cc
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      |+|||++.................++..|+|||.+ ...++.++|+||||+++|||+||..|+.............. ..
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  229 (284)
T cd05038         150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ  229 (284)
T ss_pred             EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence            99999998765332211112223456679999965 45678899999999999999999999865432111000000 00


Q ss_pred             cc---hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         402 VP---VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       402 ~~---~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ..   +...+........+..++..+.+++.+||..+|++||++.+|+++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00   0000011111111123345688899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.2e-37  Score=298.32  Aligned_cols=258  Identities=23%  Similarity=0.317  Sum_probs=195.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||++.......           .....+.+|+.++++++||||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-----------GIPNQALREIKALQACQHPYVVKLLDVFPH   70 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-----------hhhHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            456789999999999999986 58899999987543211           013458899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+ +++|.+++....  .++++.+++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          71 GSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             CCeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence             7889999999 999999987643  469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccc--
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP--  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~--  403 (455)
                      +........  .......|+..|+|||.+.+  .++.++||||||+++|||+||.+||..............  ....  
T Consensus       146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07832         146 ARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE  223 (286)
T ss_pred             cccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence            886544321  11234578999999997643  358899999999999999999888876553222111111  0000  


Q ss_pred             -hhhcc---c------hhcc--CCC--hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -VREVL---D------KEAG--EWN--ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -~~~~~---d------~~~~--~~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .+++.   +      ....  .+.  ....+..+.++|.+|+..+|++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             00000   0      0000  000  0123467888999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-37  Score=297.38  Aligned_cols=244  Identities=25%  Similarity=0.411  Sum_probs=194.9

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ...++||.|+||.||+|.++ ++..||||.+.....            ......+.+|+++++++.||||+++++++.+ 
T Consensus         7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (277)
T cd06640           7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG   74 (277)
T ss_pred             hhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            34488999999999999986 478999999863321            0114568899999999999999999998777 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++|+|.+++..    .++++.++..++.+++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          75 TKLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccc
Confidence            788999999999999998864    358999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......   .......++..|+|||.+.+ ..+.++|+|||||++|||+||..||................        
T Consensus       149 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------  217 (277)
T cd06640         149 GQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--------  217 (277)
T ss_pred             eeccCCc---cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--------
Confidence            7654322   11234568889999997644 57889999999999999999999998665332221111100        


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                         .......++..+.+++.+|+..+|++||++.+++..
T Consensus       218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 ---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence               011123455668899999999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4279|consensus

Probab=100.00  E-value=1.9e-38  Score=318.18  Aligned_cols=243  Identities=27%  Similarity=0.390  Sum_probs=196.4

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      -.||+|+||+||-|++.+ ...+|||.+..+..      ..       .+-+..|+..-++++|.|||+++|.+.+ ++.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds------r~-------~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~  647 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS------RE-------VQPLHEEIALHSTLRHKNIVRYLGSVSENGFF  647 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc------hh-------hccHHHHHHHHHHHhhHhHHHHhhccCCCCeE
Confidence            469999999999999875 45679999865432      11       2337789999999999999999998766 777


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc-CCCceEEeecccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPL--DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIV  330 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla  330 (455)
                      -+.||-++||||.++|...=  +|+  ++...-.+..||++||.|||+  +.|||||||-+|||++ -.|.+||+|||-+
T Consensus       648 kIFMEqVPGGSLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTs  723 (1226)
T KOG4279|consen  648 KIFMEQVPGGSLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTS  723 (1226)
T ss_pred             EEEeecCCCCcHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccc
Confidence            89999999999999998743  466  888999999999999999999  7799999999999996 6799999999988


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-C--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-C--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +....-   ...++++.||..|||||++. |  +|+.++|||||||++.||.||++||.+.....-......       +
T Consensus       724 KRLAgi---nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-------m  793 (1226)
T KOG4279|consen  724 KRLAGI---NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-------M  793 (1226)
T ss_pred             hhhccC---CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-------c
Confidence            765543   34578899999999999874 3  578899999999999999999999987663221111100       0


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  +..+.-+..++...+.+|.+|+..+|.+||++++++.
T Consensus       794 y--KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 Y--KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             e--ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            0  1112234667788999999999999999999999874

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.9e-37  Score=301.40  Aligned_cols=245  Identities=27%  Similarity=0.437  Sum_probs=193.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... +++.||+|.+.....      ..       ...+.+|+.+++.++|+||+++++++..
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~-------~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ------PK-------KELIINEILVMRENKNPNIVNYLDSYLV   87 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc------ch-------HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            445589999999999999975 589999999864321      11       3447889999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++++|.+++..    ..+++.++..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~  161 (297)
T cd06656          88 GDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGF  161 (297)
T ss_pred             CCEEEEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCcc
Confidence             788999999999999999864    358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|++.|+|||.+. ..++.++|+|||||++|++++|..||...+.............+     
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----  233 (297)
T cd06656         162 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-----  233 (297)
T ss_pred             ceEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-----
Confidence            876433221   123357889999999664 45788999999999999999999999765432111111100000     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ....+...+..+.+++.+||..+|++||++.++++
T Consensus       234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 ----ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00112334566888999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.8e-37  Score=300.06  Aligned_cols=260  Identities=24%  Similarity=0.329  Sum_probs=195.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|.++ +++.||||++..........        .....+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD--------GINFTALREIKLLQELKHPNIIGLLDVFGH   73 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccc--------hhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence            345588999999999999976 48899999997544321111        113446789999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+ +|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        74 ~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          74 KSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             CCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEcccee
Confidence             7889999999 999999997633  369999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-ccc---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVP---  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~---  403 (455)
                      ++.......   ......++..|+|||.+.+  .++.++|+|||||++|||++|.+||............... ..+   
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (298)
T cd07841         149 ARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE  225 (298)
T ss_pred             eeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence            876544321   1223456888999997643  4688999999999999999998888765532211111110 000   


Q ss_pred             -------hhhccchhc-cCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -------VREVLDKEA-GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -------~~~~~d~~~-~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ......... ...+    ....+..+.++|.+||..+|++||++.+|++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                   000000000 0000    1223566888999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4257|consensus

Probab=100.00  E-value=6.5e-38  Score=311.43  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=205.4

Q ss_pred             cCCCccCcCCCeEEEEEEEcC---C--cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN---G--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...++||+|-||.||+|.+.+   |  -.||||+.+.+...     ++       .+.|.+|.-++++++||||++++|.
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-----d~-------tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-----DD-------TEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-----hh-------HHHHHHHHHHHHhCCCcchhheeee
Confidence            346889999999999998642   2  35899998754331     11       4559999999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      |.+...++|||.++-|.|..+|....  ..++......++.||+.||.|||+  +.+|||||-..|||+...-.+||+||
T Consensus       460 ~~e~P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  460 CVEQPMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             eeccceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeeccc
Confidence            99999999999999999999998754  368899999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |++|.........  .+...-...|||||.+ ..+++++||||-|||.+||+|. |..||.+-........+++      
T Consensus       536 GLSR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn------  607 (974)
T KOG4257|consen  536 GLSRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN------  607 (974)
T ss_pred             chhhhccccchhh--ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC------
Confidence            9999887765432  2222234469999955 4589999999999999999998 9999987653322222222      


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                           .-+...++.|+..+..|+.+||..+|.+||.++++...|++++
T Consensus       608 -----GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  608 -----GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             -----CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                 1122234456666778999999999999999999999998875

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-37  Score=294.97  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=195.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+.++.||+|+||.||+|... +++.||+|++........   .    .......+.+|+.++++++|+||+++++++.+
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~---~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSS---E----QEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCch---h----HHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            345589999999999999874 588999999864332111   0    01124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC-ceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG  328 (455)
                       +..++|+||+++++|.+++..   ..++++..+..++.|++.||.|||+  +|++|+||||+||+++.++ .+||+|||
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence             788999999999999999976   3468999999999999999999999  8899999999999998776 69999999


Q ss_pred             cccccccCCcc-eeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMK-TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++......... ........||..|+|||.+. ..++.++|+||+|+++|+|++|..||................     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----  224 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-----  224 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh-----
Confidence            98765433211 11123457899999999664 457889999999999999999999997544211111111000     


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ........+...+..+.+++.+|+..+|.+||++.++++
T Consensus       225 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 --SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              000001112235566888999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=302.96  Aligned_cols=253  Identities=26%  Similarity=0.351  Sum_probs=196.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.... ++.||+|.+.......          ......+.+|++++++++|+||+++++.+.+
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK----------RNKVKRVLTEQEILATLDHPFLPTLYASFQT   72 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch----------HHHHHHHHHHHHHHHhCCCCCchhheeeeec
Confidence            3455899999999999999864 8999999997543211          0114558899999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          73 ETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             CCEEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecch
Confidence             78899999999999999987532 3568999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcce--------------------------eeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCC
Q psy5603         330 VKMSETSNMKT--------------------------MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       330 a~~~~~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~  382 (455)
                      +..........                          .......||..|+|||.+. ..++.++||||||+++|+|++|.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            87543221100                          0112357899999999664 45788999999999999999999


Q ss_pred             CCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC----HHHHHH
Q psy5603         383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS----MRDIVD  447 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs----~~evl~  447 (455)
                      .||...+................          .....+..+.+++.+|+..+|++||+    +.+++.
T Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         230 TPFKGSNRDETFSNILKKEVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCCchHHHHHHHhcCCccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            99987664332222221111111          11125567899999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.6e-37  Score=292.00  Aligned_cols=249  Identities=25%  Similarity=0.360  Sum_probs=196.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||++... ++..||+|.+......           ......+.+|++++++++||||+++++++..
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-----------EKEKQQLVSEVNILRELKHPNIVRYYDRIID   70 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-----------HHHHHHHHHHHHHHHhcCCCccceeeeeeec
Confidence            445688999999999999875 4789999998643221           1114558889999999999999999996642


Q ss_pred             ---ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCeeecCCCCCcEEEcCCCc
Q psy5603         251 ---IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLH-----SLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH-----~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                         ...+++|||+++++|.+++..... ..++++..++.++.+++.||.|||     +  .+++|+||||+||+++.++.
T Consensus        71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--~~i~h~dl~p~nili~~~~~  148 (265)
T cd08217          71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG--NTVLHRDLKPANIFLDANNN  148 (265)
T ss_pred             CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc--CcceecCCCHHHEEEecCCC
Confidence               567899999999999999976422 457999999999999999999999     6  78999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||++........   ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+...
T Consensus       149 ~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  225 (265)
T cd08217         149 VKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG  225 (265)
T ss_pred             EEEecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC
Confidence            99999999887654321   123457899999999764 45788999999999999999999999876532222221111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ...         ..+...+..+.+++.+|+..+|++||++.+|++
T Consensus       226 --~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 --KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             --CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence              100         111234556889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-37  Score=299.77  Aligned_cols=241  Identities=28%  Similarity=0.426  Sum_probs=191.5

Q ss_pred             CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .+.||+|+||.||+|.+. ++..||+|.+.....      .      .....+.+|++++++++||||+++++++.+ ..
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA------E------DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK   76 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc------h------HHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence            377999999999999876 478899998853321      0      114568899999999999999999998776 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++++|.+++..    .++++..+..++.+++.|+.|||+  ++++|+||+|+||++++++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEcccccccc
Confidence            8999999999999998864    358999999999999999999999  8899999999999999999999999999876


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......|+..|+|||.+.+ .++.++|+|||||++|||+||..||................       .  
T Consensus       151 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~--  218 (277)
T cd06642         151 LTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-------P--  218 (277)
T ss_pred             ccCcc---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-------C--
Confidence            54322   11233568899999997644 57889999999999999999999997554322211111000       0  


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ......++..+.+++.+|+..+|.+||++.+|++
T Consensus       219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         219 --PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              0011234456888999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.1e-37  Score=302.14  Aligned_cols=255  Identities=20%  Similarity=0.269  Sum_probs=195.4

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||++..+. ++.||+|.+......          .......+.+|+++++.++||||+++++.+.. 
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI----------LRNQIQQVFVERDILTFAENPFVVSMFCSFETK   73 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh----------hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC
Confidence            445899999999999999874 789999998643210          01113457899999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++|++|.+++...   .++++..+..++.+++.||.|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~  148 (305)
T cd05609          74 RHLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLS  148 (305)
T ss_pred             CEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCc
Confidence            7789999999999999999763   468999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcc------------eeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         331 KMSETSNMK------------TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       331 ~~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +........            ........|+..|+|||.+ ...++.++|+|||||++|||++|..||.+..........
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~  228 (305)
T cd05609         149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  228 (305)
T ss_pred             cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            742211100            0111234678899999965 456789999999999999999999999866533222222


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .......+         .....++..+.++|.+|+..+|++||+..++.+.|+.
T Consensus       229 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 ISDDIEWP---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HhcccCCC---------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            21111110         0011244558899999999999999997777666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.9e-37  Score=299.80  Aligned_cols=244  Identities=26%  Similarity=0.414  Sum_probs=192.0

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +....||+|+||.||+|... +++.||+|.+.....      .       ....+.+|+.++..++||||+++++++.. 
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   90 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ------Q-------RRELLFNEVVIMRDYQHQNVVEMYKSYLVG   90 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc------c-------hHHHHHHHHHHHHhCCCCchhhhhhheeeC
Confidence            33478999999999999876 488999999854321      0       13447889999999999999999997766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+|+||+++++|.+++..    ..+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        91 ~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~  164 (297)
T cd06659          91 EELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFC  164 (297)
T ss_pred             CeEEEEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhH
Confidence            788999999999999987754    358999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......   .......|+..|+|||.+.+ .++.++|+|||||++|||++|..||..................  ..  
T Consensus       165 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~--  237 (297)
T cd06659         165 AQISKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP--KL--  237 (297)
T ss_pred             hhccccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--Cc--
Confidence            7543321   11234578999999997644 6788999999999999999999999865533222221111100  00  


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .     ....++..+.++|.+|+..+|++||++.++++
T Consensus       238 ~-----~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         238 K-----NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             c-----ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0     01123445788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.3e-37  Score=297.29  Aligned_cols=257  Identities=24%  Similarity=0.363  Sum_probs=195.6

Q ss_pred             eHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH
Q psy5603         155 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       155 ~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      ++.++......|.      +.+.||+|+||.||+|.+. +++.||+|.+.....              ....+..|+.++
T Consensus         7 ~~~~~~~~~~~~~------~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--------------~~~~~~~e~~~l   66 (282)
T cd06636           7 DLSALRDPAGIFE------LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--------------EEEEIKLEINML   66 (282)
T ss_pred             hhhhhcChhhhhh------hheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--------------HHHHHHHHHHHH
Confidence            3444444444443      3489999999999999985 478999999753211              133478899999


Q ss_pred             hhC-Cccceeeeccccc-------CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5603         234 SQC-KHVNLLRLLGLCN-------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       234 ~~l-~h~niv~l~~~~~-------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~ii  305 (455)
                      +++ +|+||+++++++.       ....|++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+  .+++
T Consensus        67 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~iv  143 (282)
T cd06636          67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA--HKVI  143 (282)
T ss_pred             HHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcc
Confidence            998 6999999999773       256799999999999999987643 3458899999999999999999999  8899


Q ss_pred             ecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHH
Q psy5603         306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELL  379 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~ell  379 (455)
                      |+||||+||++++++.++|+|||++.......   .......|+..|+|||.+.      ..++.++|+|||||++|||+
T Consensus       144 H~dl~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~  220 (282)
T cd06636         144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA  220 (282)
T ss_pred             cCCCCHHHEEECCCCCEEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH
Confidence            99999999999999999999999987543221   1123457899999999653      24677999999999999999


Q ss_pred             cCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         380 TGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       380 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +|..||...............  .        ........++..+.++|.+||..+|.+||++.|+++
T Consensus       221 ~g~~p~~~~~~~~~~~~~~~~--~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         221 EGAPPLCDMHPMRALFLIPRN--P--------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hCCCCccccCHHhhhhhHhhC--C--------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            999999765432111111100  0        011112234556889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4717|consensus

Probab=100.00  E-value=8.5e-38  Score=304.72  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|-|..|-+|++- +|..||||++.+....           ......+.+|++.++-++|||||++|.+...
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-----------~~st~hlfqEVRCMKLVQHpNiVRLYEViDT   88 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-----------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT   88 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-----------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence            445588999999999999864 5999999999765431           2224557899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc-CCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl~DFG  328 (455)
                       ..+|||+|.-.+|+|+|++.+++.  .+++....+++.||+.||.|+|+  ..+|||||||+||.+. +-|-+||.|||
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeecc
Confidence             788999999999999999988764  59999999999999999999999  6799999999999885 56899999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CC-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++..+.....    -...+|+.+|-|||++.| .| .+++||||||||||.|.+|++||...+.....-.+         
T Consensus       165 FSNkf~PG~k----L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------  231 (864)
T KOG4717|consen  165 FSNKFQPGKK----LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------  231 (864)
T ss_pred             ccccCCCcch----hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------
Confidence            9876554432    346799999999997766 45 46899999999999999999999876644332222         


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       +|-+  ..-+..++...++||..||..||++|.+.+++..
T Consensus       232 -mDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  232 -MDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -hccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             2222  1224567777899999999999999999999864

>KOG4278|consensus

Probab=100.00  E-value=5.9e-38  Score=311.30  Aligned_cols=250  Identities=28%  Similarity=0.480  Sum_probs=207.6

Q ss_pred             CCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .++||-|.||.||.|.|+. .-.||||.++.+.              +....|+.|..+++.++|||+|+++|+|.. ..
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--------------MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhhcc--------------hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            4889999999999999985 5789999997532              336779999999999999999999999987 67


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|||.|||+.|+|.++|++..+ ..++....+.++.||+.|+.||..  +++|||||-..|.|+.++..+||+||||+|+
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            7999999999999999987654 457788889999999999999999  8999999999999999999999999999998


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ...+....  .....-...|.|||-+ ...++.|||||+|||+|||+.| |..||.+.+...++...+.           
T Consensus       415 MtgDTYTA--HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-----------  481 (1157)
T KOG4278|consen  415 MTGDTYTA--HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-----------  481 (1157)
T ss_pred             hcCCceec--ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-----------
Confidence            76543211  1222334579999954 5578999999999999999999 9999998875554444332           


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+-..+..|+.-+..|+..||+..|.+||+++|+-+.|+.++.
T Consensus       482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            11112234556667888999999999999999999999988764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-36  Score=292.48  Aligned_cols=255  Identities=23%  Similarity=0.352  Sum_probs=193.3

Q ss_pred             cCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.++    ++..||||++......           ......+.+|++++++++||||+++++++
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   70 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-----------SSDIEEFLREAACMKEFDHPNVIKLIGVS   70 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-----------hHHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence            45588999999999999864    3678999998643211           01145588999999999999999999976


Q ss_pred             cC-c------eeEEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         249 NN-I------MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      .. .      ..+++++|+.+|+|.+++....   ....+++..++.++.|++.||+|||+  .+|+||||||+||+++.
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~  148 (273)
T cd05074          71 LRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNE  148 (273)
T ss_pred             ccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcC
Confidence            43 1      2378899999999998875322   12357899999999999999999999  88999999999999999


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHH
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++........ .......++..|++||.+. +.++.++|||||||++|||++ |.+||...+.......
T Consensus       149 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~  227 (273)
T cd05074         149 NMTVCVADFGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY  227 (273)
T ss_pred             CCCEEECcccccccccCCcce-ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH
Confidence            999999999998865432211 1112334567899999664 457889999999999999999 8999976654322221


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ..... ...          .....+..+.+++.+||..+|++||++.++++.|+++
T Consensus       228 ~~~~~-~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 LIKGN-RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHcCC-cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111 000          0012334588899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=295.75  Aligned_cols=245  Identities=27%  Similarity=0.400  Sum_probs=193.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC---ccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~  247 (455)
                      |+..+.||+|+||.||+|.+. +++.||+|.++.....     .       ....+.+|+.++++++   |||+++++++
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~~~~~~~vi~~~~~   70 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-----D-------DVSDIQREVALLSQLRQSQPPNITKYYGS   70 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-----h-------hHHHHHHHHHHHHHhccCCCCCeeeEeee
Confidence            445588999999999999975 5889999998643210     0       1345788999999986   9999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...|+||||+++++|.+++..    .++++..++.++.+++.||.|||+  .+++||||+|+||+++.++.++|+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06917          71 YLKGPRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCD  144 (277)
T ss_pred             eeeCCEEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEcc
Confidence            776 788999999999999998864    268999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||++........   ......|+..|+|||.+.+  .++.++|+|||||++|+|++|..||...............    
T Consensus       145 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~----  217 (277)
T cd06917         145 FGVAALLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS----  217 (277)
T ss_pred             CCceeecCCCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC----
Confidence            999876654321   1234578999999997643  3588999999999999999999999865432211111100    


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..........+..+.+++.+|+..+|++||++.++++
T Consensus       218 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 ------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                  0011111124456888999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-36  Score=290.89  Aligned_cols=251  Identities=29%  Similarity=0.437  Sum_probs=195.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... +++.||+|.++.....           ......+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~   70 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-----------PKTIKEIADEMKVLELLKHPNLVKYYGVEVH   70 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-----------hHHHHHHHHHHHHHHhCCCCChhheeeeEec
Confidence            456689999999999999875 5789999998754321           1114568999999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++..   ...+++..+..++.+++.||.|||+  .+++|+||+|+||++++++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          71 REKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             CCEEEEEEecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccccc
Confidence             788999999999999999876   3458899999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceee-eccCCCCCCCCCcccccC-C---CCcccchHHHHHHHHHHHcCCCCCCCCcchh-hHHHhhhcccc
Q psy5603         330 VKMSETSNMKTMY-TENLTGTRPYMPPEAMHC-Q---ISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~-~---~~~~sDv~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~  403 (455)
                      +............ .....++..|+|||.+.+ .   .+.++||||||+++|++++|..||...+... .......... 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  224 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-  224 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCC-
Confidence            8876543322111 223578899999997654 3   6789999999999999999999997653211 1111111000 


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            +...  ....++..+.++|.+||..+|.+||++.+++.
T Consensus       225 ------~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 ------PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ------CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  0000  01123455778999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-36  Score=289.72  Aligned_cols=248  Identities=32%  Similarity=0.504  Sum_probs=195.5

Q ss_pred             CCCccCcCCCeEEEEEEEcC-----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      +.+.||.|+||.||++.+..     +..||+|+++......            ....+.+|+..+.+++|+||+++++++
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~~   70 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ------------QIEEFLREARIMRKLDHPNIVKLLGVC   70 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH------------HHHHHHHHHHHHHhcCCCchheEEEEE
Confidence            45789999999999999864     3789999986432200            145688999999999999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ +..+++|||+++++|.+++..... ..+++.++..++.|++.||+|||+  .+++||||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       71 TEEEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             cCCCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEccc
Confidence            77 888999999999999999876332 128999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++.........  .....++..|+|||.+ .+.++.++|+||||+++|+|++ |.+||.................   
T Consensus       148 g~~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---  222 (258)
T smart00219      148 GLSRDLYDDDYYK--KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---  222 (258)
T ss_pred             CCceecccccccc--cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---
Confidence            9988765442211  1123477899999966 4467889999999999999998 8899887553333222221110   


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                              ...+...+..+.+++.+|+..+|++||++.++++.|
T Consensus       223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    011112445688899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.1e-37  Score=291.70  Aligned_cols=248  Identities=23%  Similarity=0.338  Sum_probs=195.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++... +|+.||+|++.......           .....+.+|+.++++++||||+++++++.+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-----------KEREESRKEVAVLSNMKHPNIVQYQESFEE   70 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-----------HHHHHHHHHHHHHHhCCCCCeeeeEeeecC
Confidence            455689999999999999876 47899999986432210           013458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++.... ...+++.+++.++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          71 NGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccc
Confidence             78899999999999999887533 2357899999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|++.|+|||.+. +..+.++|+|||||++++|++|..||...+.......+.....+     
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-----  219 (256)
T cd08218         148 ARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-----  219 (256)
T ss_pred             eeecCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-----
Confidence            876543221   122346889999999764 45788999999999999999999999866533222222111110     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..+...+..+.++|.+|+..+|.+||++.+|++
T Consensus       220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 ------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                  011223455888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0199|consensus

Probab=100.00  E-value=5.9e-38  Score=315.19  Aligned_cols=247  Identities=26%  Similarity=0.386  Sum_probs=206.6

Q ss_pred             CccCcCCCeEEEEEEEcC--Cc--EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         176 NKLGEGQFGTVYYGKLKN--GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      ++||+|+||.|++|.|+.  |+  .||||.++......            ....|.+|+.+|.+++|+|++++||...+.
T Consensus       116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~------------~mddflrEas~M~~L~H~hliRLyGvVl~q  183 (1039)
T KOG0199|consen  116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA------------IMDDFLREASHMLKLQHPHLIRLYGVVLDQ  183 (1039)
T ss_pred             HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch------------hHHHHHHHHHHHHhccCcceeEEeeeeccc
Confidence            789999999999999974  44  57999998654422            134599999999999999999999999988


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ...+|+|.++.|||.++|+. .....|.....+.++.|||.|++||.+  +++|||||-..|+||...-.+||+||||.|
T Consensus       184 p~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeeccccee
Confidence            88899999999999999998 446789999999999999999999999  899999999999999999999999999999


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ....++..-.+.....-...|+|||.+ .+.++.+||||+|||++|||+| |..||.+.+...+...+..          
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~----------  330 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA----------  330 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc----------
Confidence            887665433334444455679999954 6789999999999999999999 9999999876555444432          


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                       ......+..+++.+.+++..||.++|.+||++..+.+.
T Consensus       331 -~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  331 -GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence             22222344577778999999999999999999998643

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=295.84  Aligned_cols=258  Identities=23%  Similarity=0.320  Sum_probs=190.4

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|..+ +++.||||.+........            ...+.+|++++++++|+||+++++++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA------------PFTAIREASLLKDLKHANIVTLHDII   72 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC------------chhHHHHHHHHhhCCCcceeeEEEEE
Confidence            34566799999999999999986 478999999865332110            12367899999999999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...|+||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+||
T Consensus        73 ~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          73 HTKKTLTLVFEYLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             ecCCeEEEEEecCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECcc
Confidence            77 78899999997 59999887643  368999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchh-hHHHhhh-cccc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVE-QEVP  403 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~-~~~~  403 (455)
                      |+++.......   ......++..|+|||.+.+  .++.++||||||+++|+|++|..||....... ....... -..+
T Consensus       148 g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07844         148 GLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP  224 (291)
T ss_pred             ccccccCCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC
Confidence            99875432211   1122356888999997643  46889999999999999999999997654111 1000000 0000


Q ss_pred             hhh----------ccchhccCCCh-------hHHH--HHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VRE----------VLDKEAGEWNE-------THVE--TLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~----------~~d~~~~~~~~-------~~~~--~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...          ...........       ....  ..+.+++.+||..+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000          00000000000       0111  45678999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.3e-36  Score=297.80  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=192.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +...+.||+|+||.||+|.+. ++..||+|++........          .....+.+|++++++++|||++++++++.+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN----------EKWQDIIKEVKFLQRIKHPNSIEYKGCYLR   96 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch----------HHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            344488999999999999975 478999999864322110          113458889999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+. |+|.+.+...  ..++++.++..++.+++.||.|||+  ++++||||+|+||+++.++.+||+|||+
T Consensus        97 ~~~~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635          97 EHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCC
Confidence             77899999996 5888877543  3468999999999999999999999  8899999999999999999999999998


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccc----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +.....       .....|+..|+|||.+    .+..+.++|+|||||++|||++|..||.................   
T Consensus       172 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---  241 (317)
T cd06635         172 ASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---  241 (317)
T ss_pred             ccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC---
Confidence            765432       2235788999999965    24578899999999999999999999977543322222211110   


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                             .......++..+.+++.+|+..+|.+||++.++++.+
T Consensus       242 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         242 -------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                   1111223455688999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0586|consensus

Probab=100.00  E-value=1.3e-37  Score=311.22  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=205.9

Q ss_pred             CCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         167 NRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       167 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .....|.+...||+|.|+.|.+|++. ++..||||.+.+.....           ...+.+.+|+++++.++|||||+++
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-----------~~~~k~~rev~imk~l~HPnIvkl~  121 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-----------SKRQKLGREVDIMKSLNHPNIVKLF  121 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-----------HHHHHHHHHHHHHHhcCCcceeeee
Confidence            33455677799999999999999976 58999999997654311           1245588999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      .+... ..+|+||||+.+|.+++++...+   ...+..+..++.|+.+|++|||+  ++|||||||.+||||+.+..+||
T Consensus       122 ~v~~t~~~lylV~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikI  196 (596)
T KOG0586|consen  122 SVIETEATLYLVMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKI  196 (596)
T ss_pred             eeeeecceeEEEEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceee
Confidence            98876 89999999999999999999854   46678899999999999999999  89999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccCC--CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||++.+.....    ....++|++.|.|||++.|.  .++++|+||+|++||.|+.|..||++...............
T Consensus       197 aDfgfS~~~~~~~----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~  272 (596)
T KOG0586|consen  197 ADFGFSTFFDYGL----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY  272 (596)
T ss_pred             eccccceeecccc----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee
Confidence            9999998876443    24568999999999999774  36799999999999999999999998774433333333344


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .++.++.            ....++|.+++..+|.+|++++++.+
T Consensus       273 rIp~~ms------------~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  273 RIPFYMS------------CDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             cccceee------------chhHHHHHHhhccCccccCCHHHhhh
Confidence            4443333            23677788999999999999999864

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.1e-37  Score=297.27  Aligned_cols=247  Identities=27%  Similarity=0.332  Sum_probs=186.9

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHH-HhhCCccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||+|+++.....     ..       ...+..|+.+ ++..+||||+++++++..
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~-------~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-----QE-------QKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-----HH-------HHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            44588999999999999986 4899999998643210     00       2235556665 566789999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCCcEEEcCCCceEEeec
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                       ...|+||||++ |+|.+++... .....+++..++.++.|++.||.|||+  + +++||||||+||+++.++.+||+||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeec
Confidence             78899999995 7888887653 224579999999999999999999998  6 8999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+++......    ......|+..|+|||.+.+     .++.++|+|||||++|+|++|..||.................
T Consensus       149 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  224 (283)
T cd06617         149 GISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP  224 (283)
T ss_pred             cccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC
Confidence            9987653321    1223568899999997643     357899999999999999999999975432111111000100


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .         ...+...++..+.++|.+||..+|.+||++.++++
T Consensus       225 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 S---------PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0         01112234556888999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0667|consensus

Probab=100.00  E-value=2.1e-37  Score=312.53  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=196.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-c-----cceee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-H-----VNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~  243 (455)
                      .|++.+.||+|+||.|.+|.+. +++.||||+++.....              ..+-..|+.+|..++ |     -|+|+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--------------~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr  252 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--------------LRQAQIEIRILELLNKHDPDDKYNIVR  252 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--------------HHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence            4577899999999999999876 5899999999865431              344667999999997 4     39999


Q ss_pred             ecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC--C
Q psy5603         244 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--F  320 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~--~  320 (455)
                      +++++.. .+.|||+|.+ ..+|.++|.... ..+++...+..|+.||+.||.+||+  .+|||+||||+||||.+-  .
T Consensus       253 m~d~F~fr~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  253 MLDYFYFRNHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             eeeccccccceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcC
Confidence            9998876 9999999999 789999998654 4569999999999999999999999  789999999999999643  4


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||++.+......      ....+.-|.|||++ ...++.+.|+||||||++||++|.+.|.+.+.......+.+
T Consensus       329 ~vKVIDFGSSc~~~q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e  402 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE  402 (586)
T ss_pred             ceeEEecccccccCCcce------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence            899999999987654321      34667889999966 45789999999999999999999999988874433333221


Q ss_pred             -cccch----------hhccch--------------------------------hccC-----CC---hhHHHHHHHHHH
Q psy5603         400 -QEVPV----------REVLDK--------------------------------EAGE-----WN---ETHVETLISIVF  428 (455)
Q Consensus       400 -~~~~~----------~~~~d~--------------------------------~~~~-----~~---~~~~~~~l~~Li  428 (455)
                       -..+.          ..+++.                                ...+     +.   .......+.++|
T Consensus       403 ~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dfl  482 (586)
T KOG0667|consen  403 VLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFL  482 (586)
T ss_pred             HhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHH
Confidence             11110          011111                                0000     00   113345688999


Q ss_pred             HhhhccCcCCCCCHHHHHH
Q psy5603         429 EKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       429 ~~~l~~dp~~RPs~~evl~  447 (455)
                      ++|+..||.+|+|..+.++
T Consensus       483 k~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  483 KRCLEWDPAERITPAQALN  501 (586)
T ss_pred             HHHhccCchhcCCHHHHhc
Confidence            9999999999999999875

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-36  Score=288.25  Aligned_cols=246  Identities=24%  Similarity=0.358  Sum_probs=194.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||++... ++..+|||.+.......           .....+.+|++++++++||||+++++.+..
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-----------DERLAAQNECQVLKLLSHPNIIEYYENFLE   70 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-----------HHHHHHHHHHHHHhhCCCCchhheeeeEec
Confidence            445589999999999999875 47889999986432210           114568899999999999999999997665


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-CceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~DFG  328 (455)
                       ...++||||+++++|.+++.... ...+++..+..++.+++.||.|||+  ++++||||||+||+++++ +.+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          71 DKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCC
Confidence             78899999999999999997643 3458999999999999999999999  889999999999999855 568999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-ccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~  406 (455)
                      ++.......    ......|+..|+|||.+.+ ..+.++|+||||+++|+|++|..||...+........... ..++  
T Consensus       148 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--  221 (256)
T cd08220         148 ISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI--  221 (256)
T ss_pred             CceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC--
Confidence            988654332    1223578899999997654 5688999999999999999999999876533222222111 1111  


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                +..++..+.+++.+|+..+|.+||++.+++.
T Consensus       222 ----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ----------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                      1123445888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-36  Score=294.21  Aligned_cols=257  Identities=24%  Similarity=0.326  Sum_probs=194.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||.|++|.||+|+++ +|..||||+++......            ....+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   69 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG------------TPSTAIREISLMKELKHENIVRLHDVIHT   69 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc------------chHHHHHHHHHHHhhcCCCEeeeeeeEee
Confidence            345589999999999999986 48899999987543210            12346789999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||++ ++|.+++.......++++.++..++.|++.||.|||+  .+++||||||+||++++++.++|+|||+
T Consensus        70 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~  146 (284)
T cd07836          70 ENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGL  146 (284)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecch
Confidence             78899999997 5898888765544579999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccch--
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPV--  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~--  404 (455)
                      ++.......   ......++..|+|||.+.+  .++.++|+|||||++|+|++|..||.............. ...+.  
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07836         147 ARAFGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES  223 (284)
T ss_pred             hhhhcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence            875433211   1123467889999997644  357899999999999999999999987653222111111 00000  


Q ss_pred             --------hhccc-------hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 --------REVLD-------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 --------~~~~d-------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              .....       ...... ...++..+.+++.+|+..+|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         224 TWPGISQLPEYKPTFPRYPPQDLQQL-FPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hHHHHhcCchhcccccCCChHHHHHH-hhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    00000       000000 1123566889999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=293.69  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=193.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|..+ +++.||+|++.....              ....+.+|+.+++++ .|+||+++++++.
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--------------EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--------------hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            455599999999999999986 478899999864321              134588999999999 7999999999875


Q ss_pred             C-------ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         250 N-------IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +       ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCe
Confidence            4       34799999999999999987533 13578999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +||+|||++.......   .......|+..|+|||.+.+      .++.++|||||||++|+|++|..||..........
T Consensus       152 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  228 (275)
T cd06608         152 VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF  228 (275)
T ss_pred             EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH
Confidence            9999999987654322   11234578999999997632      35778999999999999999999997544222111


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....  ....       ......++..+.+++.+|+..||++||++.++++
T Consensus       229 ~~~~~--~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 KIPRN--PPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             Hhhcc--CCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11110  1111       1112235567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=304.53  Aligned_cols=259  Identities=23%  Similarity=0.364  Sum_probs=191.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||.||+|.++ +|+.||||++.....      .      .....+.+|+.++++++||||+++++++.
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~   73 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------Q------TFCQRTLREIKILRRFKHENIIGILDIIR   73 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc------c------hhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence            4566799999999999999876 488999999853211      0      01344778999999999999999998654


Q ss_pred             C------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         250 N------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      .      ...|+|+||+. ++|.+.+..    .++++..+..++.|++.||.|||+  .+++||||||+||+++.++.+|
T Consensus        74 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~k  146 (336)
T cd07849          74 PPSFESFNDVYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLK  146 (336)
T ss_pred             cccccccceEEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEE
Confidence            3      34689999995 588877754    368999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      |+|||+++................||..|+|||.+.  ..++.++|||||||++|+|++|++||...+..........  
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~  226 (336)
T cd07849         147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL  226 (336)
T ss_pred             ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            999999876543322222223457899999999653  3578899999999999999999999976542211111100  


Q ss_pred             cccc---hhhccchhc------------cCCC--hhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         400 QEVP---VREVLDKEA------------GEWN--ETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       400 ~~~~---~~~~~d~~~------------~~~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      ....   .....+...            ..+.  ....+..+.+++.+||..+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000   000000000            0000  01234557899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=294.25  Aligned_cols=256  Identities=23%  Similarity=0.321  Sum_probs=192.4

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||.|++|.||+|.++ +|+.||||++........           ....+.+|++++++++|||++++++++.+ 
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~   70 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-----------VPSTAIREISLLKELNHPNIVRLLDVVHSE   70 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc-----------chhHHHHHHHHHHhcCCCCccCHhheeccC
Confidence            45588999999999999976 589999999875432111           02347789999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+ +++|.+++..... ..+++..++.++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~iv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          71 NKLYLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             CeEEEEEecc-CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence            7889999999 5799999876432 368999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-ccch---
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPV---  404 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~---  404 (455)
                      +.......   ......++..|+|||.+.+  .++.++|+||||+++|+|++|.+||............... ..+.   
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd07835         147 RAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV  223 (283)
T ss_pred             cccCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence            75432211   1123356889999997644  3588999999999999999999999876532221111110 0000   


Q ss_pred             -------hhccc-------hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 -------REVLD-------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 -------~~~~d-------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ++...       ..... ....++..+.++|.+|+..+|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         224 WPGVTSLPDYKPTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhchhhhhhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                   00000       00000 01223456788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.4e-37  Score=295.10  Aligned_cols=242  Identities=22%  Similarity=0.275  Sum_probs=182.8

Q ss_pred             ccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH---HHhhCCccceeeecccccC-c
Q psy5603         177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ---TLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .||+|+||.||++... +++.||+|.+..........          ...+.+|..   ++...+||||+.+++++.. +
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----------ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD   70 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH----------HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC
Confidence            4899999999999986 47899999987543211110          122334443   3344579999999987765 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|.+++...   ..+++.++..++.|++.||.|||+  .+++||||||+|||+++++.++|+|||++.
T Consensus        71 ~~~lv~e~~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          71 KLCFILDLMNGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             eEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            889999999999999998763   469999999999999999999999  889999999999999999999999999986


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-C-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......     .....||..|+|||.+. + .++.++|+|||||++|||++|..||.............. ....     
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~-----  214 (279)
T cd05633         146 DFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTV-----  214 (279)
T ss_pred             eccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcC-----
Confidence            543221     12347899999999764 3 468899999999999999999999976542211111100 0000     


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                         ....+..++..+.++|.+|+..||.+||     +++++++
T Consensus       215 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         215 ---NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ---CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence               0011123455688899999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=289.37  Aligned_cols=252  Identities=29%  Similarity=0.395  Sum_probs=193.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||.||+|.+. ++..||+|.+.........        ......+.+|++++++++|+||+++++++.+
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET--------SKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh--------hHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            456699999999999999975 4889999988543211110        1124568899999999999999999998754


Q ss_pred             ---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++|+||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~df  150 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDF  150 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcc
Confidence               4578999999999999998763   358899999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++................|+..|+|||.+.+ ..+.++|+|||||++|+|++|..||...............  +.  
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--  226 (264)
T cd06653         151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PT--  226 (264)
T ss_pred             ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC--CC--
Confidence            998865332111111234578999999997654 5788999999999999999999999865432211111100  00  


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ....+..+...+.+++.+||. +|.+||+..+++.
T Consensus       227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                  011123455668899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.9e-37  Score=291.09  Aligned_cols=248  Identities=27%  Similarity=0.363  Sum_probs=193.8

Q ss_pred             cCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||++.+.. |+.||+|.+.......          ......+.+|++++++++||||+++++.+.. ...|+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   70 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR----------KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYL   70 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh----------hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEE
Confidence            6999999999999874 8999999986432211          1124568899999999999999999997766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      |+||+++++|.+++.+..   .+++..+..++.|++.||.|||+  .+++||||+|+||++++++.++|+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          71 VMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            999999999999998743   68999999999999999999999  8899999999999999999999999999876543


Q ss_pred             CCcc-----eeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         336 SNMK-----TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       336 ~~~~-----~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ....     ........++..|+|||.. ....+.++|+||||+++|++++|..||...................+..  
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  223 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--  223 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--
Confidence            3210     1122345788899999965 4457889999999999999999999998766433322222111111110  


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                              ...+..+.+++.+|+..+|.+||++..+.+.|+
T Consensus       224 --------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         224 --------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             --------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                    012456788999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=295.28  Aligned_cols=258  Identities=25%  Similarity=0.312  Sum_probs=193.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||+++......           .....+.+|++++++++|+||+++++++.+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE-----------DVKKTALREVKVLRQLRHENIVNLKEAFRR   71 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc-----------cchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence            456689999999999999987 47899999986432211           113458899999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||++++.+..+...   ...+++.++..++.+++.||.|||+  .+++|+||+|+||++++++.+||+|||+
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~  146 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGF  146 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeec
Confidence             788999999988777665544   2358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccc--
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP--  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~--  403 (455)
                      +........  .......++..|+|||++.+  .++.++|+||||+++|+|++|.+||..............  ....  
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T cd07833         147 ARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS  224 (288)
T ss_pred             ccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            887654332  11234578899999996643  467899999999999999999999986543221111100  0000  


Q ss_pred             ---------------hhhccchh-ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 ---------------VREVLDKE-AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ---------------~~~~~d~~-~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                     .....+.. .....+..++..+.+||.+|+..+|++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                           00000000 000111223567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-36  Score=294.30  Aligned_cols=257  Identities=22%  Similarity=0.286  Sum_probs=189.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|... +|..||+|.+.......            ....+.+|+.++++++|+||+++++++.
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~e~~~l~~l~h~ni~~~~~~~~   73 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG------------VPFTAIREASLLKGLKHANIVLLHDIIH   73 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC------------CcHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3455689999999999999875 48899999986443211            0223678999999999999999999877


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+|+||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||
T Consensus        74 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          74 TKETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             cCCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccc
Confidence            7 78899999995 78877765432  357888999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc--ccc-
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EVP-  403 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~-  403 (455)
                      +++.......   ......++..|+|||.+.+  .++.++|+|||||++|||+||..||...............  ..+ 
T Consensus       149 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07870         149 LARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT  225 (291)
T ss_pred             cccccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCC
Confidence            9875433211   1223467899999997754  4688999999999999999999999865532111110000  000 


Q ss_pred             ---------hhhccchhc---------cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 ---------VREVLDKEA---------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ---------~~~~~d~~~---------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .+.......         ..+........+.+++.+|+..||++|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                     000000000         00000011345778999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.2e-37  Score=297.54  Aligned_cols=241  Identities=25%  Similarity=0.400  Sum_probs=190.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ..||+|+||.||++... ++..||||++.....             .....+.+|+.+++.++|+||+++++.+.. +..
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-------------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchH-------------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            67999999999999875 478999999853211             113458899999999999999999997766 888


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++..    ..+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            999999999999998854    358999999999999999999999  88999999999999999999999999998754


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      .....   ......|+..|+|||.+.+ .++.++|+||||+++|||++|..||...............       .....
T Consensus       169 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~  238 (292)
T cd06658         169 SKEVP---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-------LPPRV  238 (292)
T ss_pred             ccccc---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------CCCcc
Confidence            33221   1223568999999997644 6788999999999999999999999865533221111110       00000


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ......+..+.+++.+|+..+|++||++.++++
T Consensus       239 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         239 --KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             --ccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              001123456888999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-36  Score=295.21  Aligned_cols=252  Identities=29%  Similarity=0.355  Sum_probs=192.0

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC--
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ..++||.|++|.||+|.++ +++.||+|.+......            .....+.+|++++++++||||+++++++.+  
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   72 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP------------DLQKQILRELEINKSCKSPYIVKYYGAFLDES   72 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch------------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence            3488999999999999986 4789999998643210            113458899999999999999999997744  


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...|+||||+++++|.+++.... ....++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeecc
Confidence             46799999999999999876422 24568999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcc---hhhHHHhhhcccch
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~---~~~~~~~~~~~~~~  404 (455)
                      ++.......     .....++..|+|||.+. +.++.++|+|||||++|+|++|..||.....   ..............
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd06621         151 VSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN  225 (287)
T ss_pred             ccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc
Confidence            987543321     12346788999999654 4678899999999999999999999986632   00000000011011


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....+..   .....++..+.+++.+|+..+|.+||++.|+++
T Consensus       226 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 PELKDEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhhccCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1110000   001234566889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-36  Score=289.52  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=190.9

Q ss_pred             cCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||.|+||.||+|+++. ++.||+|++........          .....+.+|++++++++||||+++++++.+ ...|+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   70 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET----------GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYM   70 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh----------hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEE
Confidence            6999999999999864 78999999865432110          113568899999999999999999998766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      |+||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          71 LMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             EEecCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            99999999999999763   358999999999999999999999  8899999999999999999999999999886644


Q ss_pred             CCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcc--hhhHHHhhhcccchhhccchhc
Q psy5603         336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ..    ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||.....  .............         
T Consensus       146 ~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  212 (262)
T cd05572         146 GQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK---------  212 (262)
T ss_pred             cc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC---------
Confidence            32    123457889999999664 4678899999999999999999999987652  2221111100000         


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      .. .+...+..+.++|.+|+..+|++||+     ++|+++
T Consensus       213 ~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LE-FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CC-CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            00 11122456888999999999999999     677765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.6e-36  Score=291.75  Aligned_cols=242  Identities=21%  Similarity=0.272  Sum_probs=182.9

Q ss_pred             ccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHH---HHHHhhCCccceeeecccccC-c
Q psy5603         177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE---VQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .||+|+||.||+|... +++.||+|.+..........          ...+..|   ++.++...||||+.+++++.+ .
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----------ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   70 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh----------HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            4899999999999875 47899999987543211100          1113333   344555689999999997766 8


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||||++||+|.+++..   ..++++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.
T Consensus        71 ~~~~v~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          71 KLSFILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             EEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            88999999999999998875   3469999999999999999999999  889999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-C-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......     .....|+..|+|||.+. + .++.++|+|||||++|||++|..||................     ...
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~  215 (278)
T cd05606         146 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TMA  215 (278)
T ss_pred             ccCccC-----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----ccC
Confidence            543221     22347999999999764 3 47889999999999999999999998763211111100000     000


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                         ..+ +...+..+.+++.+|+..+|.+||     ++.++++
T Consensus       216 ---~~~-~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 ---VEL-PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---CCC-CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               001 112345688899999999999999     8989875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4645|consensus

Probab=100.00  E-value=1e-38  Score=339.53  Aligned_cols=248  Identities=28%  Similarity=0.395  Sum_probs=199.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +..+.+||.|.||.||.|... +|...|+|-++.....           ........+|+.++..++|||+|++||+-..
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-----------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-----------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-----------cccCcchHHHHHHHHhccCccccccCceeec
Confidence            345699999999999999864 5888999988654332           1113447889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..+|.||||.+|+|.+.+..   +.-.++.....+..|++.|+.|||+  +|||||||||+||+|+.+|.+|++|||.
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccc
Confidence             788899999999999999886   3346777777889999999999999  8999999999999999999999999999


Q ss_pred             ccccccCC-cceeeeccCCCCCCCCCcccccCC----CCcccchHHHHHHHHHHHcCCCCCCCCcc--hhhHHHhhhccc
Q psy5603         330 VKMSETSN-MKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~sDv~SlGvvl~elltG~~p~~~~~~--~~~~~~~~~~~~  402 (455)
                      |....... ..........||+.|||||++.|.    -.-+.||||+|||++||+||+.||...+.  ..++.+......
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence            98776542 111222467899999999988653    34589999999999999999999987763  234443333333


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++++            .++..-.++|..|+..||++|.++.|+++
T Consensus      1461 q~P~------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 QIPE------------RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CCch------------hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            3332            36667889999999999999999888765

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-36  Score=291.64  Aligned_cols=244  Identities=27%  Similarity=0.427  Sum_probs=193.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..++||+|+||.||+|.++ ++..||||.+.....            ......+.+|+.++++++||||+++++++.+
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   73 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA------------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   73 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc------------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe
Confidence            344588999999999999875 478999998753211            0113458899999999999999999998777


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++..    .++++..+..++.+++.|+.|||+  .+++|+||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~  147 (277)
T cd06641          74 DTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGV  147 (277)
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeeccc
Confidence             788999999999999998864    358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......   .......|+..|+|||.+. ...+.++|+|||||++|+|++|..||...........+.....  .   
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~---  219 (277)
T cd06641         148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP--P---  219 (277)
T ss_pred             ceecccch---hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC--C---
Confidence            87554321   1123357888999999764 4578899999999999999999999976553322222211110  0   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            .....++..+.+++.+|+..+|.+||++.++++
T Consensus       220 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         220 ------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  001123455788899999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.1e-37  Score=291.36  Aligned_cols=247  Identities=25%  Similarity=0.279  Sum_probs=195.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|.++ +++.||+|.+........          .....+.+|++++++++||||+++++++.+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK----------GSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch----------hHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            455689999999999999986 489999999975432110          114568899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|+||+.|++|.+++...   .++++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence             7889999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......    ......|+..|+|||.+.+ ..+.++|+||||+++|+|++|..||...+..............     
T Consensus       147 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  217 (258)
T cd05578         147 ATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA-----  217 (258)
T ss_pred             ccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc-----
Confidence            87654332    1234578899999996644 5688999999999999999999999876632111111111000     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCH--HHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASM--RDIV  446 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~--~evl  446 (455)
                          ....+..++..+.++|.+|+..+|.+||+.  ++++
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 ----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                001112234668889999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-36  Score=295.11  Aligned_cols=256  Identities=22%  Similarity=0.287  Sum_probs=191.7

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||.|+||.||+|.++ +++.||+|.++.......           ....+.+|+.++.+++||||+++++++.+ 
T Consensus         8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   76 (293)
T cd07843           8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----------FPITSLREINILLKLQHPNIVTVKEVVVGS   76 (293)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc-----------chhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence            34488999999999999987 478999999975432110           12346789999999999999999997643 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...|+||||+. ++|.+++....  ..+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          77 NLDKIYMVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             CCCcEEEEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecC
Confidence              67899999996 59999887643  368999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccc--
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVP--  403 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~--  403 (455)
                      +++.......   ......+++.|+|||.+.+  ..+.++|+||||+++|||++|.+||.............. ...+  
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         152 LAREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             ceeeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            9886554321   1123467889999997654  358899999999999999999999986653221111110 0000  


Q ss_pred             ----------------hhhccchhc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 ----------------VREVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ----------------~~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                      ......... ..++...++..+.++|.+|+..+|++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                            000000000 01111113566889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.9e-36  Score=294.61  Aligned_cols=259  Identities=20%  Similarity=0.276  Sum_probs=190.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.+. +++.||||+++.......           ....+.+|+.+++++. ||||+++++++.
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-----------IPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-----------CchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            345589999999999999986 488999999865322110           1234788999999995 699999999775


Q ss_pred             C-ce-----eEEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CC
Q psy5603         250 N-IM-----NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NF  320 (455)
Q Consensus       250 ~-~~-----~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~  320 (455)
                      . ..     .|+||||+++ +|.+++.....  ..++++..++.++.|++.||.|||+  ++++||||||+||+++. ++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~  148 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKG  148 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCC
Confidence            5 33     6899999975 89888865432  3468999999999999999999999  88999999999999998 89


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      .+||+|||+++.......   ......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.............
T Consensus       149 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  225 (295)
T cd07837         149 LLKIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF  225 (295)
T ss_pred             eEEEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            999999999875433211   1123357888999996643  46889999999999999999999998765332222211


Q ss_pred             hc-ccchhhcc----chh----ccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 EQ-EVPVREVL----DKE----AGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~-~~~~~~~~----d~~----~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ..+.....    ...    ...+.       ...++..+.++|.+|+..+|.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            10 00000000    000    00000       0124556888999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=299.12  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=190.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC---CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      |++.++||+|+||.||+|.++.   +..||+|.+.........          ....+.+|+.++++++||||+++++++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG----------ISQSACREIALLRELKHENVVSLVEVF   71 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC----------ccHHHHHHHHHHHhcCCCCccceEEEE
Confidence            3455889999999999999854   689999999764321111          123477899999999999999999977


Q ss_pred             cC---ceeEEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC----C
Q psy5603         249 NN---IMNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----N  319 (455)
Q Consensus       249 ~~---~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~----~  319 (455)
                      .+   ...|+||||+. ++|.+.+.....  ..++++..++.++.|++.||.|||+  .+++||||||+||+++.    +
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          72 LEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             eCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCcc
Confidence            54   46799999996 577777754322  2378999999999999999999999  88999999999999999    9


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhh----
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILY----  393 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~----  393 (455)
                      +.+||+|||+++................+|..|+|||.+.+  .++.++|+|||||++|+|++|.+||........    
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            99999999998865443221222334578999999996644  468899999999999999999999986543210    


Q ss_pred             H-----HHhhh--cccc---------hhhccc---hhc-cCCC--------hh--HHHHHHHHHHHhhhccCcCCCCCHH
Q psy5603         394 Y-----YLVVE--QEVP---------VREVLD---KEA-GEWN--------ET--HVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       394 ~-----~~~~~--~~~~---------~~~~~d---~~~-~~~~--------~~--~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                      .     .....  ....         .++...   ... ...+        ..  ..+..+.+++.+||..+|++||++.
T Consensus       229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence            0     00000  0000         000000   000 0000        00  2334577899999999999999999


Q ss_pred             HHHH
Q psy5603         444 DIVD  447 (455)
Q Consensus       444 evl~  447 (455)
                      |+++
T Consensus       309 eil~  312 (316)
T cd07842         309 EALE  312 (316)
T ss_pred             HHhc
Confidence            9875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0983|consensus

Probab=100.00  E-value=5.5e-37  Score=278.82  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=189.0

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      ..||.|+.|.|++++.+. |...|||.+.......            ..++++..+.++.... +|+||+++||+.. ..
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke------------e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE------------ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccCCHH------------HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            569999999999999874 7889999997543311            1455777888877764 8999999998866 66


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..+.||.| ..-+..+|.+..  .++++..+-++...+..||.||.+ .++|||||+||+|||+|+.|.+|+||||++-.
T Consensus       166 V~IcMelM-s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  166 VFICMELM-STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHH-HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccce
Confidence            77888888 334444454433  479999999999999999999987 47899999999999999999999999999876


Q ss_pred             cccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH-hhhcccchhhc
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL-VVEQEVPVREV  407 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~  407 (455)
                      ...+..    .+...|-+.|||||.+.    ..|+.++|||||||+|+||.||+.||.+.+....... +.+++.   ..
T Consensus       242 lvdSkA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---P~  314 (391)
T KOG0983|consen  242 LVDSKA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---PL  314 (391)
T ss_pred             eecccc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---CC
Confidence            654432    34568999999999763    3578899999999999999999999998774433322 222221   22


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++...+      .+..+.+|+..||..|+.+||...++++
T Consensus       315 L~~~~g------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  315 LPGHMG------FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCcccC------cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            222222      4556899999999999999999988765

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3e-36  Score=294.98  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=188.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|..+ +++.||||++........           ....+.+|++++++++||||+++++++..
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-----------FPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-----------chhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            345589999999999999986 488999999864322110           02236689999999999999999997754


Q ss_pred             -c--------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         251 -I--------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 -~--------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                       .        ..++||||+. ++|.+.+....  ..+++.+++.++.|++.||.|||+  ++++|+||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGI  157 (310)
T ss_pred             ccccccCCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCc
Confidence             2        3489999995 58888876532  368999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcc-eeeeccCCCCCCCCCcccccCC--CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         322 PKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~--~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +||+|||++......... ........++..|+|||.+.+.  ++.++|+||||+++|||+||.+||.............
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999998765433211 1112345678899999976443  5789999999999999999999998765321111111


Q ss_pred             h--cccc---hhhc-----cch---------hc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 E--QEVP---VREV-----LDK---------EA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~--~~~~---~~~~-----~d~---------~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  ...+   .+..     .+.         .. ...........+.++|.+||..+|.+||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            1  0000   0000     000         00 00000011234678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=288.53  Aligned_cols=244  Identities=20%  Similarity=0.302  Sum_probs=186.5

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH-hhCCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-SQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|... +|+.||||++.......          ......+..|..++ ...+|+|++++++++.. ..
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   71 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA----------KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY   71 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH----------HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe
Confidence            56999999999999985 47899999986432100          00022244555444 45589999999998876 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+|+||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+++.
T Consensus        72 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          72 LYLVMEYLNGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             EEEEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            89999999999999999763   468999999999999999999999  8899999999999999999999999998875


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ...       .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||.....................     
T Consensus       147 ~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  214 (260)
T cd05611         147 GLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE-----  214 (260)
T ss_pred             ccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC-----
Confidence            432       224568899999997654 4688999999999999999999999876543332222211111100     


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                         .....++..+.+++.+|+..+|++||++.++.+.|
T Consensus       215 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         215 ---EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ---cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence               01113455688999999999999999876665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.1e-36  Score=290.84  Aligned_cols=245  Identities=22%  Similarity=0.281  Sum_probs=187.7

Q ss_pred             cCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||+||++..+ +|+.||+|.+........          .....+.+|++++++++||||+++++.+.. +..|+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   70 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR----------KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCL   70 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh----------hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEE
Confidence            699999999999876 488999999864321100          113447789999999999999999987766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++++|.+++..... ..+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          71 VMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             EEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            9999999999999976442 468999999999999999999999  8899999999999999999999999999876543


Q ss_pred             CCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccC
Q psy5603         336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ..    ......|+..|+|||.+. +.++.++|+|||||++|+|++|..||..................       .. .
T Consensus       148 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~-~  215 (277)
T cd05577         148 GK----KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------MA-V  215 (277)
T ss_pred             CC----ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-------cc-c
Confidence            21    122346788999999664 45788999999999999999999999765431111111110000       00 0


Q ss_pred             CChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         415 WNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      ..+...+..+.++|.+||..+|.+||     ++.++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            01112345578899999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.5e-36  Score=295.13  Aligned_cols=257  Identities=23%  Similarity=0.319  Sum_probs=191.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||+|+++........           ...+.+|+.++++++|+||+++++++.+
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-----------PISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-----------cchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            345589999999999999986 4899999998754321110           1235679999999999999999997754


Q ss_pred             ---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++||||+. ++|.+++....  ..+++.++..++.|++.||.|||+  .+++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          78 KHLDSIFLVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             CCCCeEEEEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcc
Confidence               45799999995 58888887533  468999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccch
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPV  404 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~  404 (455)
                      |++........   ......++..|+|||.+.+  .++.++|+|||||++|||++|.+||...+.......... ...+.
T Consensus       153 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07845         153 GLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN  229 (309)
T ss_pred             ceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99886543321   1122345788999997643  468899999999999999999999987664333222221 00000


Q ss_pred             hhcc------------chhccCCC-----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVL------------DKEAGEWN-----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~------------d~~~~~~~-----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....            ........     ....+..+.++|.+|+..||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000            00000000     0113456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.1e-36  Score=300.19  Aligned_cols=259  Identities=20%  Similarity=0.325  Sum_probs=193.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +|..||+|++........           ....+.+|+.++++++||||+++++++..
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   75 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-----------LAKRTLRELKILRHFKHDNIIAIRDILRP   75 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc-----------chHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence            345589999999999999976 489999999864322110           13457789999999999999999986632


Q ss_pred             -----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         251 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       251 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                           ...++||||+. ++|.+++..   ...+++..+..++.|++.||.|||+  ++++||||||+||++++++.+||+
T Consensus        76 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          76 PGADFKDVYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             cCCCCceEEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEec
Confidence                 46789999994 689998875   3459999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcc-eeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cc
Q psy5603         326 DFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       326 DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      |||++......... ........|+..|+|||.+.+  .++.++|||||||++|||++|.+||...+.......... ..
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g  229 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG  229 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence            99998765432211 111234578999999997643  478899999999999999999999987653222111111 11


Q ss_pred             cchhh------------ccchhc--cCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVRE------------VLDKEA--GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~------------~~d~~~--~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+...            ..+...  ...+    ....+..+.++|.+||..+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11101            110000  0000    0123566899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0596|consensus

Probab=100.00  E-value=4.9e-37  Score=302.33  Aligned_cols=248  Identities=23%  Similarity=0.254  Sum_probs=192.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      .|++.++||+||-+.||++...+.+.||+|++.....      +     ......|.+|+..|.++ .|.+||.+++|-.
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~------D-----~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA------D-----NQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc------C-----HHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            3577899999999999999987778899988753322      1     22367799999999999 5999999999976


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . +.+|+||||= ..+|..+|..... ....| .+..+..|++.++.++|.  +||||.||||+|+|+- .|.+||+|||
T Consensus       431 ~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlV-kG~LKLIDFG  504 (677)
T KOG0596|consen  431 TDGYLYMVMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLV-KGRLKLIDFG  504 (677)
T ss_pred             cCceEEEEeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEE-eeeEEeeeec
Confidence            6 8899999975 6799999987554 23334 888999999999999999  8899999999999985 4699999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC------------CCCcccchHHHHHHHHHHHcCCCCCCCCc-chhhHH
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYY  395 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~~~~sDv~SlGvvl~elltG~~p~~~~~-~~~~~~  395 (455)
                      +|....... ........+||+.||+||++..            +.+.+|||||||||||+|+.|++||.... ......
T Consensus       505 IA~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~  583 (677)
T KOG0596|consen  505 IANAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH  583 (677)
T ss_pred             hhcccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH
Confidence            998776553 3445567799999999997731            15679999999999999999999998654 222222


Q ss_pred             Hhhhccc--chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVEQEV--PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~--~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.....  .+++.        ++   ...+.+++++||..||++||++.++++
T Consensus       584 aI~~P~~~Iefp~~--------~~---~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  584 AITDPNHEIEFPDI--------PE---NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hhcCCCccccccCC--------CC---chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            2211111  11111        11   111778899999999999999999985

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.8e-36  Score=288.94  Aligned_cols=254  Identities=22%  Similarity=0.315  Sum_probs=188.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |++.++||+|+||.||+|..+ +++.||+|+++.......            .....+|+.++.++. |+|++++++++.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~------------~~~~~~e~~~l~~l~~h~~i~~~~~~~~   68 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE------------QVNNLREIQALRRLSPHPNILRLIEVLF   68 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch------------hhhHHHHHHHHhhcCCCCCccceEEEEe
Confidence            345688999999999999976 478999999865322100            112457888998885 999999999765


Q ss_pred             C---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +   +..++|+||+. |+|.+.+....  ..+++..++.++.|++.||.|||+  .+++||||||+||+++. +.+||+|
T Consensus        69 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~d  142 (282)
T cd07831          69 DRKTGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLAD  142 (282)
T ss_pred             cCCCCcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEe
Confidence            4   57799999996 68888876532  368999999999999999999999  88999999999999999 9999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccc-c-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-H-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~  403 (455)
                      ||+++.......    .....++..|+|||.+ . +..+.++|+|||||++|||++|.+||...+.......... ....
T Consensus       143 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07831         143 FGSCRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP  218 (282)
T ss_pred             cccccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCC
Confidence            999876543221    1234688999999955 3 3468899999999999999999999987653222111111 0000


Q ss_pred             hhh---ccchh-cc--CCC----------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VRE---VLDKE-AG--EWN----------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~---~~d~~-~~--~~~----------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   ..... ..  .++          ...++..+.++|.+||..+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000   00000 00  000          1234577899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.2e-36  Score=290.18  Aligned_cols=241  Identities=25%  Similarity=0.409  Sum_probs=191.2

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||+|..+ +++.||+|++.....      .       ....+.+|+.++++++||||+++++++.. ...
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------~-------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ------Q-------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccch------h-------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence            78999999999999975 578999998853211      0       13447899999999999999999997766 888


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+|+||+++++|.+++..    .++++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||++...
T Consensus        92 ~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            999999999999999876    358999999999999999999999  88999999999999999999999999987754


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      .....   ......|+..|+|||.+.+ .++.++|+|||||++|||++|..||...+.............+  ..     
T Consensus       166 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~-----  235 (285)
T cd06648         166 SKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP--KL-----  235 (285)
T ss_pred             ccCCc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCC--CC-----
Confidence            43211   1233568999999997644 5788999999999999999999999876543222222111100  00     


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  ....++..+.+++.+||..+|++||++.++++
T Consensus       236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             c--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            0  01123456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.9e-36  Score=295.36  Aligned_cols=258  Identities=18%  Similarity=0.276  Sum_probs=189.6

Q ss_pred             CccCcC--CCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         176 NKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       176 ~~LG~G--~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ..||+|  +||+||++.+. +|+.||||++.....      ..     ...+.+.+|+.+++.++||||+++++++.. .
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~------~~-----~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   72 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC------TE-----EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS   72 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC------CH-----HHHHHHHHHHHHHHhCCCCCcceEeeeEecCC
Confidence            456777  99999999986 589999999864321      10     114568899999999999999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+|+||+.+++|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++++||+.+.
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            8899999999999999987643 2358999999999999999999999  889999999999999999999999998654


Q ss_pred             ccccCCcce----eeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         332 MSETSNMKT----MYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       332 ~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      .........    .......++..|+|||++.+   .++.++|||||||++|||++|..||...................
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd08226         150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS  229 (328)
T ss_pred             hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC
Confidence            332211100    00112245677999997754   36789999999999999999999998765322211111000000


Q ss_pred             h-----------------------------------hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 R-----------------------------------EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~-----------------------------------~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +                                   ...+..........++..+.+|+.+||..||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0                                   000000111112345667889999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.6e-36  Score=286.18  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=193.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|..+. |..||+|.+.......           .....+.+|++++++++|+||+++++.+.+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~   70 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-----------KEKEASKKEVILLAKMKHPNIVTFFASFQE   70 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-----------hhhHHHHHHHHHHHhCCCCChhhhhheecc
Confidence            3455889999999999999874 7889999986532110           013457899999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC-ceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG  328 (455)
                       ...++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+  .+++|+||||+||++++++ .+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          71 NGRLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccc
Confidence             78899999999999999997643 3468999999999999999999999  8899999999999999886 56999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      .+........   ......|+..|+|||.+. +.++.++|+||||+++|||++|..||................  .   
T Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---  219 (257)
T cd08225         148 IARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY--F---  219 (257)
T ss_pred             cchhccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--C---
Confidence            9876543221   122346899999999664 467889999999999999999999998655322222111111  0   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ..     .....+..+.+++.+||..+|++||++.++++
T Consensus       220 -~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 -AP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -CC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             00     01123445888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.2e-36  Score=289.17  Aligned_cols=247  Identities=28%  Similarity=0.382  Sum_probs=193.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||+|+||.||++.++ +++.||+|.+......            .....+.+|++++++++||||+++++++.. 
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE------------AIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh------------HHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            34478999999999999987 4789999998654220            114558899999999999999999998766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||+++++|.+++....  .++++..+..++.|++.||.|||+. .+++||||||+||+++.++.++|+|||.+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            88899999999999999988642  4789999999999999999999982 46999999999999999999999999988


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcc---hhhHHHhhhcccchhh
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~  406 (455)
                      .......     .....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.   ........        
T Consensus       149 ~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------  215 (265)
T cd06605         149 GQLVNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY--------  215 (265)
T ss_pred             hhhHHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH--------
Confidence            7553221     112678899999996644 578899999999999999999999976531   11111100        


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........+...++..+.++|.+|+..+|++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         216 IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            00000011111125556889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-36  Score=291.80  Aligned_cols=248  Identities=26%  Similarity=0.317  Sum_probs=186.2

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||++.+. +++.||+|++......            .....+.+|+.++.++. |+||+++++++.. ..
T Consensus        10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~   77 (288)
T cd06616          10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD   77 (288)
T ss_pred             HHhCCCCceEEEEEEECCCCCEEEEEEehhccCh------------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence            67999999999999986 4789999998643221            11455889999999996 9999999997766 77


Q ss_pred             eEEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .+++|||+. ++|.++....  .....+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||++
T Consensus        78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            789999985 5665543211  1135699999999999999999999972 38999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +.......    .....|+..|+|||.+.+    .++.++|||||||++|||++|..||................ ..+ 
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~-  229 (288)
T cd06616         156 GQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPP-  229 (288)
T ss_pred             HHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CCC-
Confidence            76543221    123468999999997654    37889999999999999999999997654211111100000 000 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          .........++..+.+|+.+|+..+|.+||++.+|++
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         230 ----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             ----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0111111235566889999999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.8e-36  Score=291.65  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=192.4

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|... +++.||+|.+.....      .       ....+.+|+.++++++||||+++++++.. 
T Consensus        22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   88 (293)
T cd06647          22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ------P-------KKELIINEILVMRENKHPNIVNYLDSYLVG   88 (293)
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc------h-------HHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence            44588999999999999875 478899999853211      0       13458899999999999999999998866 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||+++++|.+++..    ..+++..+..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~  162 (293)
T cd06647          89 DELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (293)
T ss_pred             CcEEEEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcce
Confidence            788999999999999999875    247899999999999999999999  88999999999999999999999999988


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........   ......|++.|+|||.+ .+.++.++|+||||+++|++++|..||...+............        
T Consensus       163 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~--------  231 (293)
T cd06647         163 AQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--------  231 (293)
T ss_pred             eccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC--------
Confidence            75443221   12345788999999965 4467889999999999999999999998654321111110000        


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .........++..+.+++.+||..+|.+||++.+++.
T Consensus       232 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         232 -TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0001112234556889999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6e-36  Score=292.06  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=189.9

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||||+++.......           ....+.+|++++++++||||+++++++.+ 
T Consensus        10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-----------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~   78 (302)
T cd07864          10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-----------FPITAIREIKILRQLNHRNIVNLKEIVTDK   78 (302)
T ss_pred             heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-----------chHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence            34489999999999999987 478999999875432111           12347789999999999999999997755 


Q ss_pred             c----------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         251 I----------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       251 ~----------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .          ..|+|+||+++ +|.+.+...  ...+++.++..++.|++.||+|||+  .+|+||||||+||++++++
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~  153 (302)
T cd07864          79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             chhhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCC
Confidence            2          67999999975 777777653  3468999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      .+||+|||++..........  .....++..|+|||.+.+  ..+.++|||||||++|||++|++||.............
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~  231 (302)
T cd07864         154 QIKLADFGLARLYNSEESRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS  231 (302)
T ss_pred             cEEeCcccccccccCCcccc--cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999987654432111  122356788999996643  36889999999999999999999998665322211111


Q ss_pred             h--cccc---hhhcc--------chhcc---C--CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 E--QEVP---VREVL--------DKEAG---E--WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~--~~~~---~~~~~--------d~~~~---~--~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  ....   .+...        +....   .  .....++..+.+++.+||..+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1  0000   00000        00000   0  001123566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-35  Score=280.12  Aligned_cols=246  Identities=28%  Similarity=0.420  Sum_probs=196.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |...+.||+|+||.||++.+. ++..|++|++.....             .....+.+|+.++++++|+|++++++++..
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   68 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-------------EKKEKIINEIQILKKCKHPNIVKYYGSYLK   68 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-------------hHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            345588999999999999986 578999999965322             014558899999999999999999997766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++++||+++++|.+++....  .++++..+..++.+++.||.+||+  .+++||||+|+||++++++.++|+|||.
T Consensus        69 ~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~  144 (253)
T cd05122          69 KDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGL  144 (253)
T ss_pred             CCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeeccc
Confidence             78899999999999999987642  468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........    .....|+..|+|||.+. +..+.++|+||||+++|+|++|..||...+..........  .......
T Consensus       145 ~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~  218 (253)
T cd05122         145 SAQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGLR  218 (253)
T ss_pred             ccccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCcC
Confidence            876554321    23457889999999664 4568899999999999999999999987642221111111  1111111


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .       ...++..+.++|.+|+..+|++||++.++++
T Consensus       219 ~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 N-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             c-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0       1112456888999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.2e-35  Score=292.12  Aligned_cols=240  Identities=28%  Similarity=0.398  Sum_probs=188.8

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||+|+.. +++.||+|++.......          ......+.+|++++++++|||++++++++.+ ...
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT----------NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc----------hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            77999999999999975 47899999986432211          0113457889999999999999999998877 778


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+. |+|.+.+....  .++++.++..++.|++.||.|||+  .|++||||+|+||+++.++.+||+|||++...
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            99999995 68888776533  468999999999999999999999  88999999999999999999999999987643


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ..       .....|+..|+|||.+.    +.++.++|+|||||++|+|++|..||...+.............  +.   
T Consensus       172 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~---  239 (313)
T cd06633         172 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PT---  239 (313)
T ss_pred             CC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CC---
Confidence            21       22457899999999763    4578899999999999999999999987653322222211111  00   


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           .....++..+.+++.+||..+|.+||++.+++.
T Consensus       240 -----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         240 -----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 111123345888999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.4e-36  Score=299.61  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=190.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|... +|+.||||++......     .      .....+.+|+.++++++||||+++++++.
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   85 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-----V------THAKRAYRELVLMKLVNHKNIIGLLNVFT   85 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-----h------hHHHHHHHHHHHHHhcCCCCCcceeeeec
Confidence            3455589999999999999976 5889999998532210     0      01344778999999999999999998764


Q ss_pred             C-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...|+||||+. ++|.+.+..     .++...+..++.|++.||.|||+  .|++||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          86 PQKSLEEFQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             cCCCccccCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCE
Confidence            3       24699999995 688888764     28899999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      ||+|||+++......    ......||..|+|||.+. ..++.++|||||||++|+|++|..||...+.......... -
T Consensus       158 kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  233 (353)
T cd07850         158 KILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL  233 (353)
T ss_pred             EEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            999999988654322    122346889999999654 4678999999999999999999999986653222111111 0


Q ss_pred             ccc--------------------------hhhccchhc----cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVP--------------------------VREVLDKEA----GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~--------------------------~~~~~d~~~----~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+                          +.+......    ........+..+.++|.+|+..||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000                          000000000    00001234556789999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.1e-36  Score=289.35  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=190.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||++...    +|..||+|++........         ......+.+|+.++.++ +|+||+++++
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK---------AKTTEHTRTERQVLEHIRQSPFLVTLHY   72 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc---------chHHHHHHHHHHHHHhcccCCChhceee
Confidence            345689999999999999863    578999999864322111         11134578899999999 5899999998


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      .+.. ...|+|+||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~  147 (290)
T cd05613          73 AFQTDTKLHLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLT  147 (290)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEe
Confidence            7766 7779999999999999999863   468899999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++........  ......|+..|+|||.+.+   ..+.++||||||+++|+|++|..||...............  
T Consensus       148 dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--  223 (290)
T cd05613         148 DFGLSKEFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR--  223 (290)
T ss_pred             eCccceeccccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH--
Confidence            99998765432211  1234578999999997643   3578999999999999999999999754321110000000  


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           +....... +..++..+.+++.+|+..+|.+||     ++.+++.
T Consensus       224 -----~~~~~~~~-~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         224 -----ILKSEPPY-PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----hhccCCCC-CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                 00000001 122455688899999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=334.41  Aligned_cols=248  Identities=23%  Similarity=0.415  Sum_probs=189.5

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||+|.++ ++..||||+++....                 ....|++++++++|||||+++++|.+ ...
T Consensus       696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----------------IPSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             cEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----------------ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            78999999999999975 589999999853211                 02346888999999999999999877 778


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      |+||||+++|+|.+++..      ++|..+..|+.|++.|++|||.. ..+|+||||||+||+++.++.+++. ||....
T Consensus       759 ~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            999999999999999963      89999999999999999999943 2689999999999999999988876 665443


Q ss_pred             cccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcc---hhhHHHh-hhcccchhhc
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLV-VEQEVPVREV  407 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~---~~~~~~~-~~~~~~~~~~  407 (455)
                      ...       .....||+.|+|||++. +.++.++|||||||++|||+||+.||+....   ....+.. ..........
T Consensus       832 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (968)
T PLN00113        832 LCT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW  904 (968)
T ss_pred             ccc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe
Confidence            221       11236889999999764 4689999999999999999999999964321   1111111 1112223334


Q ss_pred             cchhccCC--ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         408 LDKEAGEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      +|+.....  ........+.+++.+|+..+|++||+|.||++.|+++..
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            44433211  112233456678889999999999999999999998764

>KOG3653|consensus

Probab=100.00  E-value=1.3e-36  Score=294.94  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=196.8

Q ss_pred             CCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh--CCccceeeecccccC--
Q psy5603         175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCNN--  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~--  250 (455)
                      ...||+|.||.||+|.+. ++.||||++...                ..+.|++|-.|.+-  ++|+||++++++-..  
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----------------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----------------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHH----------------HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            377999999999999998 599999998532                14568888888765  589999999997644  


Q ss_pred             ---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCeeecCCCCCcEEEcCCC
Q psy5603         251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-------SKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-------~~~iiH~Dikp~NILl~~~~  320 (455)
                         ..++||++|.+.|||.++|..    ..++|....+|+..+++||+|||+.       ..+|+|||||+.||||..++
T Consensus       278 ~~~~eywLVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  278 ADRMEYWLVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             ccccceeEEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence               378999999999999999986    3589999999999999999999972       35699999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCC-------cccchHHHHHHHHHHHcCCCCCCC--Ccch
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPIDD--NNTI  391 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-------~~sDv~SlGvvl~elltG~~p~~~--~~~~  391 (455)
                      .+.|+|||+|......... ..+-.-+||.+|||||++.|..+       .+.||||+|.|||||++....++.  ...+
T Consensus       354 TccIaDFGLAl~~~p~~~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y  432 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY  432 (534)
T ss_pred             cEEeeccceeEEecCCCCC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence            9999999999877654322 22334699999999999977432       268999999999999997766642  1122


Q ss_pred             hhHHHhhhcccc-h--------hhccchhc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         392 LYYYLVVEQEVP-V--------REVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       392 ~~~~~~~~~~~~-~--------~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..-+..+.+..+ +        .+-..+.. ..|......+.+.+.+..||.+||+-|.|+.=|.+++.++.
T Consensus       433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            221211111111 1        11111111 23334455678899999999999999999999988887654

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.4e-36  Score=285.03  Aligned_cols=249  Identities=28%  Similarity=0.384  Sum_probs=195.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|++|.||+|..+. ++.||||++......            .....+.+|+.++.+++|+|++++++++.. 
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE------------EFRKQLLRELKTLRSCESPYVVKCYGAFYKE   71 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence            345899999999999999874 899999998653221            114558999999999999999999998777 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||+++++|.+++...   .++++..++.++.|++.|+.|||+. .+++||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccc
Confidence            7889999999999999999863   5699999999999999999999982 35999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .........   .....++..|+|||.+. +.++.++|+||||+++|+|+||..||..............       ...
T Consensus       148 ~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-------~~~  217 (264)
T cd06623         148 KVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-------ICD  217 (264)
T ss_pred             eecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-------Hhc
Confidence            765433211   12456889999999664 4568899999999999999999999987642111111110       000


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......+...++..+.++|.+||..+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            01111111124566889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.7e-36  Score=288.29  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=195.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |.+.+.||+|+||.||+|..+ ++..||+|++........          .....+.+|+++++++. ||||+++++++.
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~   72 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE----------KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ   72 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch----------HHHHHHHHHHHHHHhcccCCCchhHHHHhc
Confidence            455688999999999999986 589999999865322110          11345788999999998 999999999876


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+++++|.+++...   ..+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          73 DEENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             CCceEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCc
Confidence            6 7889999999999999999873   369999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcc-----------------eeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcc
Q psy5603         329 IVKMSETSNMK-----------------TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       329 la~~~~~~~~~-----------------~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~  390 (455)
                      ++.........                 ........|+..|+|||.+ ....+.++|+||||++++++++|..||.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  227 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE  227 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            98765433211                 0122345688999999965 44578899999999999999999999987763


Q ss_pred             hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH----HHHHH
Q psy5603         391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM----RDIVD  447 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~----~evl~  447 (455)
                      .............++            ..++..+.++|.+|+..+|.+||++    .++++
T Consensus       228 ~~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 YLTFQKILKLEYSFP------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHHHhcCCCCC------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            322222211111111            1234558889999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-35  Score=294.41  Aligned_cols=259  Identities=25%  Similarity=0.339  Sum_probs=196.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|.... +..||||++.......           ...+.+.+|+.+++.++|+||+++++++..
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL-----------IDAKRILREIKLLRHLRHENIIGLLDILRP   70 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc-----------hhhhhHHHHHHHHHhcCCcchhhhhhhhcc
Confidence            4566899999999999999864 8899999986532100           113458899999999999999999998766


Q ss_pred             -c-----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         251 -I-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       251 -~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                       .     ..|+||+|+. ++|.+++..   ..++++..++.++.+++.||.|||+  +|++||||||+||+++.++.++|
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L  144 (330)
T cd07834          71 PSPEDFNDVYIVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKI  144 (330)
T ss_pred             cCcccccceEEEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEE
Confidence             3     6799999996 589888876   3379999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      +|||++.................+|..|+|||.+.+  .++.++|+||||+++|+|++|.+||...........+.. ..
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  224 (330)
T cd07834         145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG  224 (330)
T ss_pred             cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence            999998876543211112234568899999997644  468899999999999999999999987764332222211 01


Q ss_pred             cchhh------------ccchhc----cCCC--hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVRE------------VLDKEA----GEWN--ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~------------~~d~~~----~~~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+..+            .+....    ..+.  ....+..+.++|.+||..+|.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            00000            000000    0000  0123456788999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-35  Score=285.66  Aligned_cols=246  Identities=27%  Similarity=0.416  Sum_probs=195.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||+|.++ ++..||+|++.....              ....+.+|++.+++++|+|++++++++..
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--------------NKELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--------------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            445589999999999999987 578999999864321              13458899999999999999999997766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++....  ..+++..+..++.+++.||.|||+  .|++|+||+|+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccch
Confidence             88899999999999999998743  369999999999999999999999  8899999999999999999999999998


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+....  ...  
T Consensus       163 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--  235 (286)
T cd06614         163 AAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG--IPP--  235 (286)
T ss_pred             hhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCC--
Confidence            765433211   123346888999999664 457889999999999999999999998665432222211111  000  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ......++..+.++|.+|+..+|.+||++.++++
T Consensus       236 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 -----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -----CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 0111224556889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-35  Score=291.21  Aligned_cols=259  Identities=20%  Similarity=0.205  Sum_probs=190.0

Q ss_pred             CCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +++.+|.|+++.||++.. +++.||||+++.....           ......+.+|++++++++|+||+++++++.+ ..
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   73 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-----------KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE   73 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccc-----------hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence            445566667776776665 4899999999753210           0114568999999999999999999997766 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||.+..
T Consensus        74 ~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~  150 (314)
T cd08216          74 LYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVS  150 (314)
T ss_pred             EEEEEeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCcccee
Confidence            899999999999999997643 2358899999999999999999999  8899999999999999999999999998865


Q ss_pred             cccCCcc----eeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc---
Q psy5603         333 SETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV---  402 (455)
Q Consensus       333 ~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~---  402 (455)
                      .......    ........++..|+|||++.+   .++.++|+|||||++|||++|..||.................   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (314)
T cd08216         151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL  230 (314)
T ss_pred             eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence            4322111    111234567888999997754   468899999999999999999999986543221111100000   


Q ss_pred             ----chhh-----------ccchhc----cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 ----PVRE-----------VLDKEA----GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ----~~~~-----------~~d~~~----~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ..+.           ..+...    ...........+.+++.+||..+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                0000           000000    01112234556788999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=286.52  Aligned_cols=254  Identities=23%  Similarity=0.356  Sum_probs=191.6

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  250 (455)
                      .+.+.||+|+||.||+|...+ ++.||||++.......    .        .....+|+..+.+++ |+|++++++++.+
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~--------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   69 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW----E--------ECMNLREVKSLRKLNEHPNIVKLKEVFRE   69 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch----h--------HHHHHHHHHHHHhccCCCCchhHHHHhhc
Confidence            455889999999999999864 7889999986432210    0        123557899999999 9999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+ +|+|.+.+.... ...+++.++..++.|++.||.|||+  ++++|+||+|+||++++++.++|+|||+
T Consensus        70 ~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~  145 (283)
T cd07830          70 NDELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGL  145 (283)
T ss_pred             CCcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeeccc
Confidence             7889999999 899999887644 2468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccc---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVP---  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~---  403 (455)
                      +........    .....|+..|+|||.+.  ..++.++|+||||++++||++|.+||.............. ...+   
T Consensus       146 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (283)
T cd07830         146 AREIRSRPP----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ  221 (283)
T ss_pred             ceeccCCCC----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence            876543221    12346888999999763  3468899999999999999999999976653322222111 0000   


Q ss_pred             -------hhhccchh--------ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -------VREVLDKE--------AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -------~~~~~d~~--------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             .....+..        .....+ .....+.++|.+||..+|++||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         222 DWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                   00000000        000000 11355888999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=286.62  Aligned_cols=257  Identities=25%  Similarity=0.347  Sum_probs=191.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|...+ ++.||+|++.......    .       ....+.+|++++++++|+|++++++++.+ 
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~----~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE----G-------FPITAIREIKLLQKLRHPNIVRLKEIVTSK   70 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc----c-------chHHHHHHHHHHHhccCCCeeeheeeEecC
Confidence            455889999999999999874 7899999997653100    0       12347889999999999999999997754 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        +..++|+||++ ++|.+++....  ..+++.+++.++.|++.||.|||+  .+++|+||||+||++++++.+||+|||
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          71 GKGSIYMVFEYMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             CCCcEEEEecccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEcccc
Confidence              47899999996 58988887532  468999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccc-
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP-  403 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~-  403 (455)
                      ++.........  ......++..|+|||.+.+  .++.++||||||+++|||+||..||..............  .... 
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07840         146 LARPYTKRNSA--DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD  223 (287)
T ss_pred             ceeeccCCCcc--cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            98866543211  1223467888999996543  468899999999999999999999987663222111111  0000 


Q ss_pred             --hhhccc--------------hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 --VREVLD--------------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 --~~~~~d--------------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        .....+              ..........++..+.+++.+|+..+|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              000000              00000000112456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.7e-36  Score=289.99  Aligned_cols=256  Identities=22%  Similarity=0.236  Sum_probs=193.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||++...    +++.||||+++......         .......+.+|++++.++ +||||+++++
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~---------~~~~~~~~~~E~~~l~~~~~~~~i~~~~~   72 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ---------KAKTAEHTRTERQVLEAVRRCPFLVTLHY   72 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh---------hhhHHHHHHHHHHHHHhccCCcchhhhhe
Confidence            345588999999999999853    46889999986432210         011234588999999999 5999999998


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      .+.. ...|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+++||||||.||+++.++.++|+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~  147 (288)
T cd05583          73 AFQTDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLT  147 (288)
T ss_pred             eeecCCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEE
Confidence            7666 7889999999999999998763   358999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccCC---CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++.......  .......|+..|+|||.+.+.   .+.++|+||||+++|||++|..||...............  
T Consensus       148 dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--  223 (288)
T cd05583         148 DFGLSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR--  223 (288)
T ss_pred             ECccccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH--
Confidence            9999876543321  112345789999999976443   578999999999999999999999644321111110000  


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                          .....  ...+..++..+.+++.+|+..+|++||++.+|.+.|+.
T Consensus       224 ----~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         224 ----ILKSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----HHccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                00000  00112234557889999999999999999888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.6e-36  Score=290.48  Aligned_cols=258  Identities=21%  Similarity=0.297  Sum_probs=189.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||+|++.......           .....+.+|++++++++||||+++++++.+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-----------GVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-----------cchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            445589999999999999986 58899999986432210           012347889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DFG  328 (455)
                       ...|+||||++ ++|.+.+.... ...+++..+..++.|++.||+|||+  ++++||||||+||+++. ++.+||+|||
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccc
Confidence             88899999995 68888876533 2346888999999999999999999  88999999999999985 5679999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~  405 (455)
                      ++.......   .......|++.|+|||.+.+  .++.++|||||||++|+|+||.+||.............. ...+..
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  225 (294)
T PLN00009        149 LARAFGIPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE  225 (294)
T ss_pred             cccccCCCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            987543321   11123467889999997644  468899999999999999999999987653222221111 001111


Q ss_pred             hccc---------hhccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLD---------KEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d---------~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+         .....+.       ....+..+.+++.+|+..+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000         0000000       1123445788999999999999999999875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=288.79  Aligned_cols=266  Identities=15%  Similarity=0.132  Sum_probs=180.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhh-hhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTE-AAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.++||+|+||.||+|.+.+    +..+|+|+.......   ...+.. ...........+...+..+.|+|+++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~---~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc---hhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            35677999999999999999764    345566654322110   000000 0000111233444556678999999999


Q ss_pred             ccccCc-----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         246 GLCNNI-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       246 ~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +.+...     ..+++++++ ..++.+.+...   ...++..+..++.|++.||.|||+  ++++||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCC
Confidence            865432     336777776 45777766542   246788899999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcc----eeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch-hhH
Q psy5603         321 VPKLGDFGIVKMSETSNMK----TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYY  394 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~  394 (455)
                      .++|+|||+++........    ........||+.|+|||+..+ .++.++|||||||++|||++|..||...... ...
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999865432211    011233579999999997654 5789999999999999999999999876321 111


Q ss_pred             HHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ......  -+........   ....++..+.+++..|+..+|++||++.++.+.|+
T Consensus       244 ~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCD--FIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHH--HHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            110000  0001111110   11223566889999999999999999999998763

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-35  Score=291.08  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=188.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|.++ +++.||||++.........           ...+.+|++++++++||||+++++++.+
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-----------PITALREIKILKKLKHPNVVPLIDMAVE   78 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-----------chhHHHHHHHHHhcCCCCccchhhheec
Confidence            455689999999999999986 4789999998654321111           1236789999999999999999986533


Q ss_pred             ---------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         251 ---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                               ...++|++|+. ++|...+...  ...+++.++..++.|++.||.|||+  ++++||||||+||++++++.
T Consensus        79 ~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          79 RPDKSKRKRGSVYMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGI  153 (311)
T ss_pred             ccccccccCceEEEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence                     24689999995 5777777643  3469999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcce--------eeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcch
Q psy5603         322 PKLGDFGIVKMSETSNMKT--------MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~--------~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      +||+|||+++.........        .......|++.|+|||.+.+  .++.++|||||||++|||++|.+||.+....
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~  233 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI  233 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999987654322111        11123467889999996643  4688999999999999999999999876532


Q ss_pred             hhHHHhhh--cccc---------hhhccchhc-cCCCh------hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         392 LYYYLVVE--QEVP---------VREVLDKEA-GEWNE------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       392 ~~~~~~~~--~~~~---------~~~~~d~~~-~~~~~------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ........  ....         +....+... ...+.      ......+.++|.+||..+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            21111111  0000         000000000 00000      112245778999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=285.82  Aligned_cols=256  Identities=23%  Similarity=0.309  Sum_probs=194.5

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|++|.||+|... +++.+|+|++.......           .....+.+|++++++++|+||+++++++.+ 
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-----------GIPKTALREIKLLKELNHPNIIKLLDVFRHK   70 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-----------hhHHHHHHHHHHHHHhcCCCcchHHHhhccC
Confidence            44578999999999999976 58899999986543211           113457889999999999999999998776 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||++ ++|.+.+....  .++++.+++.++.+++.||.|||+  .+++|+||||+||+++.++.+||+|||.+
T Consensus        71 ~~~~~v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          71 GDLYLVFEFMD-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             CCEEEEEeccC-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence            78899999996 58888887643  478999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchh--
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR--  405 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~--  405 (455)
                      ....... .  ......++..|+|||.+.+  ..+.++|+||||+++|+|+||+.||...+.......... ......  
T Consensus       146 ~~~~~~~-~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd05118         146 RSFGSPV-R--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV  222 (283)
T ss_pred             EecCCCc-c--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence            7665432 1  1223468889999996643  468899999999999999999999977663322222111 000000  


Q ss_pred             --hccc---------hhccCC----ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 --EVLD---------KEAGEW----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 --~~~d---------~~~~~~----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ...+         +.....    ....++..+.++|.+|+..+|.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              0000         000000    01235667889999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0696|consensus

Probab=100.00  E-value=1.3e-36  Score=289.81  Aligned_cols=235  Identities=28%  Similarity=0.372  Sum_probs=193.7

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      ..||+|+||.|-+|..++ ...+|||+++++........   +.       -..|-++|.-. +-|.++.+...++. +.
T Consensus       355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv---ec-------tm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV---EC-------TMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             EEeccCccceeeeecccCcchhhhhhhhccceeeecCcc---cc-------eehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            889999999999999874 56799999998876544322   12       23466677665 45788888888888 89


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      +|+||||+.||+|...++..+   .+-++.+..++.+||-||-|||+  +|||+||||.+|||||.+|++||+|||+++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999999998754   48888999999999999999999  9999999999999999999999999999986


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .-...   ..+.+++||+.|+|||++ ...|+.++|+|||||+||||+.|++||++.+.......+.+....+++.+...
T Consensus       500 ni~~~---~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkE  576 (683)
T KOG0696|consen  500 NIFDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKE  576 (683)
T ss_pred             cccCC---cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHH
Confidence            54432   235678999999999965 44678899999999999999999999999998888877776666665554443


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCC
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                                  ...+....+...|.+|.
T Consensus       577 ------------Av~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  577 ------------AVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ------------HHHHHHHHhhcCCcccc
Confidence                        45556777888888884

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=279.72  Aligned_cols=246  Identities=26%  Similarity=0.415  Sum_probs=196.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|++|.||+|..+ +++.||+|.+......           ......+.+|++++++++|||++++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-----------EEALKSIMQEIDLLKNLKHPNIVKYIGSIET   70 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-----------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEe
Confidence            455689999999999999876 4789999999754321           0114568999999999999999999998766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+.+++|.+++...   .++++..+..++.|++.||.|||+  .|++||||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          71 SDSLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEecccc
Confidence             7889999999999999998763   469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.........   .....|+..|+|||...+ ..+.++|+||||+++|+|++|..||.................  .   
T Consensus       146 ~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~---  217 (254)
T cd06627         146 ATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH--P---  217 (254)
T ss_pred             ceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC--C---
Confidence            8866543211   234578889999996543 467899999999999999999999986553222221111100  0   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..+..++..+.+++.+||..+|++||++.+++.
T Consensus       218 ------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 ------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                  011223456888999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986|consensus

Probab=100.00  E-value=4.5e-37  Score=296.21  Aligned_cols=242  Identities=24%  Similarity=0.306  Sum_probs=192.1

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ++||+||||.||-+..+ +|+.||.|++.++.....          .......+|-++|.++..+.||.+--.+.. +.+
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr----------~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR----------KGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHh----------hhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            88999999999998876 599999999976544211          113447889999999999999998766666 899


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+|+..|.||+|.-+|...+. +.+++..+..++.+|+.||++||+  ..||+||+||+|||||+.|+++|+|+|||...
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceEEec
Confidence            999999999999999887663 789999999999999999999999  88999999999999999999999999999987


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ......    ...+||.+|||||++ .+.|+...|+|||||+||||+.|+.||...........+...  .   .-++  
T Consensus       338 ~~g~~~----~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr--~---~~~~--  406 (591)
T KOG0986|consen  338 PEGKPI----RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR--T---LEDP--  406 (591)
T ss_pred             CCCCcc----ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH--H---hcch--
Confidence            765432    234899999999976 456889999999999999999999999865532222111100  0   0000  


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      ..+ ++..+...+++....|..||++|...
T Consensus       407 ~ey-~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  407 EEY-SDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hhc-ccccCHHHHHHHHHHHccCHHHhccC
Confidence            011 13455567888889999999998643

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.7e-35  Score=290.48  Aligned_cols=241  Identities=28%  Similarity=0.422  Sum_probs=189.0

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||+|..+ ++..||+|.+.......    .      .....+.+|+++++.++|+|++++++++.+ ...
T Consensus        21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----N------EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC----h------HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            78999999999999986 47889999986422111    0      113457889999999999999999998776 778


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+. |+|.+.+...  ..++++.++..++.|++.|+.|||+  .+++||||||+||+++.++.+||+|||++...
T Consensus        91 ~lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            99999996 6888877543  2468999999999999999999999  88999999999999999999999999988754


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ...       ....|+..|+|||.+.    +..+.++|||||||++|+|++|..||.................       
T Consensus       166 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------  231 (308)
T cd06634         166 APA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------  231 (308)
T ss_pred             cCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-------
Confidence            321       2356889999999653    3578899999999999999999999976543222221111110       


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                         .......++..+.++|.+|+..+|++||++.+|++.
T Consensus       232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence               011122455668899999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-35  Score=295.47  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=191.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... +++.||||.+........           ....+.+|+.+++.++|+||+++++++..
T Consensus         7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   75 (337)
T cd07858           7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-----------DAKRTLREIKLLRHLDHENVIAIKDIMPP   75 (337)
T ss_pred             eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-----------hhHHHHHHHHHHHhcCCCCccchHHheec
Confidence            556689999999999999976 488999999864321110           12346789999999999999999997644


Q ss_pred             ------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         251 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       251 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                            ...|+|+||+. ++|.+++..   ..++++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          76 PHREAFNDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             ccccccCcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEE
Confidence                  24699999995 789888875   3469999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--c
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--Q  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~  400 (455)
                      +|||+++......   .......|+..|+|||.+.  ..++.++|+|||||++|+|++|.+||...+.......+..  +
T Consensus       150 ~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  226 (337)
T cd07858         150 CDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG  226 (337)
T ss_pred             CcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            9999988654321   1123346888999999653  3578899999999999999999999976542211111110  0


Q ss_pred             ccc-----------hhhccc-------hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         401 EVP-----------VREVLD-------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       401 ~~~-----------~~~~~d-------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      ...           ....+.       ..... ....++..+.++|.+||..+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000           000000       00000 012345667899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-35  Score=295.02  Aligned_cols=256  Identities=25%  Similarity=0.339  Sum_probs=190.2

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||||++........           ....+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852          10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-----------DAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-----------hhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            44588999999999999986 478999999854221100           123467899999999 99999999997753


Q ss_pred             ---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...|+||||+. ++|.+++...    .+++..+..++.|++.||.|||+  .||+||||||+||+++.++.+||+||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~  151 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADF  151 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeec
Confidence               35799999996 6999888752    68899999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcc--eeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-ccc
Q psy5603         328 GIVKMSETSNMK--TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~  402 (455)
                      |++.........  ........||..|+|||.+.+  ..+.++|+||||+++|+|+||+.||.............. ...
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~  231 (337)
T cd07852         152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP  231 (337)
T ss_pred             cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            998865433211  112234578999999996633  468899999999999999999999976543221111111 000


Q ss_pred             ch------------hhccchh-------ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PV------------REVLDKE-------AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~------------~~~~d~~-------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..            ...++..       .... ...++..+.++|.+|+..+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             CCHHHHHHHHhhhHHHhhhhcccccccchhhh-ccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence            00            0000000       0000 0114556888999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.9e-36  Score=290.17  Aligned_cols=246  Identities=26%  Similarity=0.370  Sum_probs=185.5

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.++. ++.||||.++.....     .       ....+..|+.++.+. .||||+++++++.+
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~-------~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-----E-------ENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-----H-------HHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            445899999999999999875 889999998643210     0       133466677777666 49999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+ +++|.+.+....  .++++..+..++.+++.||+|||+. .+++||||+|+||++++++.+||+|||+
T Consensus        86 ~~~~~~v~e~~-~~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          86 DSDVFICMELM-STCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             CCeEEEEeecc-CcCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECcccc
Confidence             7889999998 557877766533  3799999999999999999999962 4799999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccCC-----CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      +........    .....|+..|+|||.+.+.     ++.++|+||||+++|+|++|..||.................  
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--  235 (296)
T cd06618         162 SGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--  235 (296)
T ss_pred             chhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--
Confidence            875533221    1234678899999977533     68899999999999999999999976432211111110100  


Q ss_pred             hhccchhccCCC-hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWN-ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~-~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ....+ ...++..+.+|+.+||..+|++||++.++++
T Consensus       236 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         236 -------PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             -------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00000 0123455888999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-35  Score=279.86  Aligned_cols=247  Identities=25%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++..+ ++..+|+|++......           ......+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-----------QKEREDAVNEIRILASVNHPNIISYKEAFLD   70 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-----------HHHHHHHHHHHHHHHhCCCCCchhhhhhhcc
Confidence            345588999999999999876 5789999998643321           1113457889999999999999999997666


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++|+||+++++|.+++..... ...+++..++.++.+++.||.|||+  .|++|+||+|+||+++.++.+||+|||
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeecc
Confidence             888999999999999998865322 3568999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......     .....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+...........  ...  
T Consensus       149 ~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--  219 (256)
T cd08530         149 ISKVLKKNM-----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYP--  219 (256)
T ss_pred             chhhhccCC-----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCC--
Confidence            988765431     223468889999996644 5678999999999999999999999876533222221111  110  


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            . .+...+..+.+++.+||..+|++||++.++++
T Consensus       220 ------~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 ------P-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ------C-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0 11234556889999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.9e-35  Score=279.13  Aligned_cols=249  Identities=29%  Similarity=0.410  Sum_probs=196.6

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ...+.||+|++|.||+|..+ +++.|++|++......           ......+.+|+.++++++||||+++++.+.+ 
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-----------EEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-----------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            34588999999999999987 5889999998654321           1124568899999999999999999997755 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...++|+||+++++|.+++...   ..+++..+..++.+++.||.|||+  .+++||||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccc
Confidence              4678999999999999999873   379999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      .+......... .......++..|+|||.+.+ ..+.++|+||||+++|+|++|..||...............       
T Consensus       147 ~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------  218 (260)
T cd06606         147 CAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-------  218 (260)
T ss_pred             cEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-------
Confidence            98876554321 11234578899999997654 4788999999999999999999999876521111111000       


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        .......+...+..+.+++.+|+..+|++||++.+++.
T Consensus       219 --~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 --SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             --cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence              00001111233566899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.8e-35  Score=288.06  Aligned_cols=241  Identities=24%  Similarity=0.390  Sum_probs=189.4

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      .+||+|+||.||+|..+ ++..||||++.....             .....+.+|+.++++++|+||+++++++.. ...
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   92 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-------------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL   92 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-------------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence            67999999999999886 588999998743211             013458899999999999999999997766 888


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++..    ..+++..+..++.|++.|++|||+  .|++||||||+||++++++.++|+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            999999999999998753    358999999999999999999999  88999999999999999999999999987754


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......|+..|+|||.+. ..++.++|+||||+++|+|++|..||............... .  ...+.   
T Consensus       167 ~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~--~~~~~---  237 (292)
T cd06657         167 SKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-L--PPKLK---  237 (292)
T ss_pred             cccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-C--CcccC---
Confidence            3321   1123356889999999664 46788999999999999999999999865433221111110 0  00000   


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         ....++..+.+++.+|+..+|.+||++.++++
T Consensus       238 ---~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ---CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence               01123345778899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=278.02  Aligned_cols=237  Identities=27%  Similarity=0.353  Sum_probs=189.4

Q ss_pred             cCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||++... +++.||+|.+........          .....+..|++++++++||||+++++.+.+ ...|+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   70 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR----------KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYL   70 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch----------HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEE
Confidence            699999999999986 388999999875432111          114458899999999999999999998766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          71 VLEYAPGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            99999999999999863   358999999999999999999999  8899999999999999999999999999876544


Q ss_pred             CCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccC
Q psy5603         336 SNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ..   .......|+..|+|||...+ ..+.++|+||||+++|++++|..||...+..............++.        
T Consensus       146 ~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  214 (250)
T cd05123         146 EG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE--------  214 (250)
T ss_pred             CC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC--------
Confidence            32   11334578899999996644 5688999999999999999999999766542222222211111111        


Q ss_pred             CChhHHHHHHHHHHHhhhccCcCCCCCHHH
Q psy5603         415 WNETHVETLISIVFEKCCVFEKDKRASMRD  444 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e  444 (455)
                          ..+..+.+++.+|+..+|++||++.+
T Consensus       215 ----~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 ----FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ----CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                12445788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.8e-35  Score=292.16  Aligned_cols=268  Identities=20%  Similarity=0.245  Sum_probs=192.2

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhh-hhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEA-AMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.+.||+|+||.||+|.++ +++.||||+++............... .......+.+|++++++++|+||+++++++.. 
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4578999999999999976 48999999986543321110000000 00001246789999999999999999998766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+. |+|.+++..   ...+++.....++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEEECCccce
Confidence            78899999996 699998876   3458999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCc-----------ceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         331 KMSETSNM-----------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       331 ~~~~~~~~-----------~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +.......           .........++..|+|||.+.+  .++.++|+|||||++|||+||.+||...+.......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            76542110           0011122356888999997654  3688999999999999999999999876643222221


Q ss_pred             hh-cccchhhcc------------chh-ccCC--ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VE-QEVPVREVL------------DKE-AGEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~-~~~~~~~~~------------d~~-~~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ...+....+            ... ....  .....+..+.++|.+||..+|.+||++.+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11 000000000            000 0000  00122455788999999999999999999975

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.4e-35  Score=280.95  Aligned_cols=232  Identities=24%  Similarity=0.300  Sum_probs=177.2

Q ss_pred             cCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh-CCccceeeecccccC-ceeE
Q psy5603         178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~~~  254 (455)
                      ||+|+||.||++..+ ++..+|+|.+......                  ..|+..... .+||||+++++.+.. ...|
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------------------~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------------------AIEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------------------hhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            599999999999976 4788999998643210                  012222211 279999999997766 8889


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC-ceEEeeccccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVKMS  333 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~  333 (455)
                      +||||+++++|.+++...   .++++.++..++.|++.||.|||+  .+++||||||+||+++.++ .++|+|||+++..
T Consensus        86 iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999763   379999999999999999999999  8899999999999999998 9999999998754


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ...       ....|+..|+|||++.+ .++.++|+||||+++|||++|..||................      .... 
T Consensus       161 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~-  226 (267)
T PHA03390        161 GTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR------QQKK-  226 (267)
T ss_pred             CCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh------hccc-
Confidence            322       23468999999997644 67889999999999999999999998554222111110000      0000 


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCC-HHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~  447 (455)
                       .......+..+.++|.+||+.+|.+||+ ++++++
T Consensus       227 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 -LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             0111235566889999999999999995 688764

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.9e-35  Score=277.72  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=197.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.+. ++..||+|++......           ......+.+|+++++.++|||++++++.+..
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~   70 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-----------EKEREDALNEVKILKKLNHPNIIKYYESFEE   70 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-----------hHHHHHHHHHHHHHHhcCCCChhheEEEEec
Confidence            345588999999999999986 4789999998643321           1114558899999999999999999997766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++|+||+++++|.+++.... ...++++..+..++.+++.||.|||+  .+++|+||+|+||++++++.++|+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCcc
Confidence             78899999999999999997642 13579999999999999999999999  789999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......   .......|++.|+|||.+ ...++.++|+||+|+++++|++|..||...+............  ..  
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--  221 (258)
T cd08215         149 ISKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YP--  221 (258)
T ss_pred             ceeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--CC--
Confidence            987654432   123345789999999965 4457889999999999999999999998765322222211110  00  


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            .. +..++..+.+++.+||..+|.+||++.++++
T Consensus       222 ------~~-~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         222 ------PI-PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ------CC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  00 1134456888999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=282.86  Aligned_cols=256  Identities=23%  Similarity=0.301  Sum_probs=189.2

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC---Cccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.++. ++.||+|+++.......           ....+.+|+.+++++   .|||++++++++
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   70 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-----------IPLSTLREIALLKQLESFEHPNIVRLLDVC   70 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-----------hhhhHHHHHHHHHHhhccCCCCcceEEEEE
Confidence            455889999999999999874 89999999975432110           022355677776655   699999999987


Q ss_pred             cC-ce-----eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         249 NN-IM-----NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       249 ~~-~~-----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .+ ..     .+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~  146 (287)
T cd07838          71 HGPRTDRELKLTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQV  146 (287)
T ss_pred             eeccCCCCceeEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCE
Confidence            66 44     799999996 589998876432 358999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-  400 (455)
                      ||+|||++........    .....++..|+|||.+. ..++.++|+|||||++|||++|.+||...........+... 
T Consensus       147 ~l~dfg~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07838         147 KIADFGLARIYSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI  222 (287)
T ss_pred             EEeccCcceeccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence            9999999876543321    12345788999999664 45788999999999999999999999876533222221110 


Q ss_pred             cc--c--h-------hhccchhccCCC---hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EV--P--V-------REVLDKEAGEWN---ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~--~--~-------~~~~d~~~~~~~---~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..  .  .       ............   .......+.++|.+||..||.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00  0  0       000000000000   1234566788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4e-35  Score=292.09  Aligned_cols=257  Identities=22%  Similarity=0.307  Sum_probs=188.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||.|+||.||+|..+ +|+.||+|++.....      .       ....+.+|++++++++||||+++++++.
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~------~-------~~~~~~~Ei~~l~~l~h~~i~~~~~~~~   72 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP------Q-------SVKHALREIKIIRRLDHDNIVKVYEVLG   72 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC------c-------hHHHHHHHHHHHHhcCCCcchhhHhhhc
Confidence            4566799999999999999986 488999999864322      1       1345788999999999999999997654


Q ss_pred             C---------------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         250 N---------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       250 ~---------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .               ...|+||||+. ++|.+++..    ..+++..+..++.|++.||.|||+  .|++||||||+||
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Ni  145 (342)
T cd07854          73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANV  145 (342)
T ss_pred             ccccccccccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHE
Confidence            3               24689999996 689888753    358999999999999999999999  8899999999999


Q ss_pred             EEc-CCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcch
Q psy5603         315 LLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       315 Ll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      +++ +++.+||+|||+++................|+..|+|||.+.+  .++.++|||||||++|+|++|..||......
T Consensus       146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~  225 (342)
T cd07854         146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL  225 (342)
T ss_pred             EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            997 5568999999998765332111111233468889999996532  4678999999999999999999999876532


Q ss_pred             hhHHHhhhc-ccc-----------hhhccc--hhccCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         392 LYYYLVVEQ-EVP-----------VREVLD--KEAGEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       392 ~~~~~~~~~-~~~-----------~~~~~d--~~~~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......... ...           ......  ......+    ....+..+.+|+.+||..||++||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            222211110 000           000000  0000000    0123456788999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-35  Score=293.65  Aligned_cols=265  Identities=23%  Similarity=0.333  Sum_probs=191.2

Q ss_pred             HHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHh
Q psy5603         156 FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS  234 (455)
Q Consensus       156 ~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  234 (455)
                      ..|+..++..+..  .|.+.+.||+|+||.||+|.+. +|+.||||++.......           .....+.+|+.+++
T Consensus         3 ~~~~~~~~~~~~~--~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~e~~~l~   69 (342)
T cd07879           3 REEVNKTVWELPE--RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-----------IFAKRAYRELTLLK   69 (342)
T ss_pred             hhhhhhhhhcccc--ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-----------cchhHHHHHHHHHH
Confidence            3445444433322  2455689999999999999975 58999999986432100           01334788999999


Q ss_pred             hCCccceeeecccccC-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5603         235 QCKHVNLLRLLGLCNN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHR  307 (455)
Q Consensus       235 ~l~h~niv~l~~~~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~  307 (455)
                      +++||||+++++++..       ...|+|++|+. .+|..++.     ..+++..+..++.|++.||.|||+  ++++||
T Consensus        70 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~  141 (342)
T cd07879          70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS--AGIIHR  141 (342)
T ss_pred             hcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccC
Confidence            9999999999997653       24589999995 47766542     258999999999999999999999  889999


Q ss_pred             CCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCC
Q psy5603         308 DVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       308 Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~  385 (455)
                      ||||+||+++.++.+||+|||+++.....      .....||..|+|||.+.+  .++.++|+|||||++|||++|+.||
T Consensus       142 dlkp~NIll~~~~~~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf  215 (342)
T cd07879         142 DLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             CCCHHHEEECCCCCEEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999998754321      123467889999997644  4688999999999999999999999


Q ss_pred             CCCcchhhHHHhhh-cccchhhccc---h--------hccCCCh-------hHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         386 DDNNTILYYYLVVE-QEVPVREVLD---K--------EAGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       386 ~~~~~~~~~~~~~~-~~~~~~~~~d---~--------~~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      ...+.......... ...+.+.+.+   .        .....+.       ...+..+.+||.+||..||++||++.+++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l  295 (342)
T cd07879         216 KGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL  295 (342)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            87653221111111 0001000000   0        0000000       12344577899999999999999999998


Q ss_pred             H
Q psy5603         447 D  447 (455)
Q Consensus       447 ~  447 (455)
                      .
T Consensus       296 ~  296 (342)
T cd07879         296 E  296 (342)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.9e-36  Score=310.97  Aligned_cols=272  Identities=20%  Similarity=0.262  Sum_probs=181.4

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC--CcEEEEEEeecccCcCCCCC----chhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNS----DNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      .|++.++||+|+||+||++..+.  +..+++|.+...........    ............+.+|+.++++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            46777999999999999997653  23333332211110000000    0000011124568899999999999999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++.+ ...|+|++++ +++|.+++....-  .......++..|+.|++.||.|||+  ++||||||||+|||++.++.
T Consensus       229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence            998877 7788999998 5678777654221  2233466778899999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCC-CCCCcch---hhHHH
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKP-IDDNNTI---LYYYL  396 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p-~~~~~~~---~~~~~  396 (455)
                      +||+|||+++.......  .......||..|+|||++.+ .++.++|||||||++|||++|..+ +......   .....
T Consensus       306 vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        306 IVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             EEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            99999999986543321  12234689999999997644 678999999999999999998754 4333211   11111


Q ss_pred             hhhcccc----------hhhccchhc----cC-----CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         397 VVEQEVP----------VREVLDKEA----GE-----WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~----------~~~~~d~~~----~~-----~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +......          +.++++...    ..     ......+..+.++|.+||..||++||++.|++.
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1000000          001111000    00     000112334667899999999999999999986

>KOG2052|consensus

Probab=100.00  E-value=1.5e-35  Score=285.58  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=197.7

Q ss_pred             CCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh--CCccceeeeccccc--
Q psy5603         174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCN--  249 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~--  249 (455)
                      +.+.||+|.||.||+|.|+ |..||||++....                ...+.+|.+|...  ++|+||+.+++.-.  
T Consensus       215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----------------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----------------ERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             EEEEecCccccceeecccc-CCceEEEEecccc----------------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            4578999999999999998 8999999996432                2347788888765  59999999998532  


Q ss_pred             -C--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeeecCCCCCcEEEcCCC
Q psy5603         250 -N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       250 -~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~------~~~iiH~Dikp~NILl~~~~  320 (455)
                       +  .+.+||.+|.+.|||+|+|.+    ..++....++++..+|.||+|||..      ...|.|||||+.|||+.++|
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence             2  477999999999999999997    3699999999999999999999952      24599999999999999999


Q ss_pred             ceEEeecccccccccCCc-ceeeeccCCCCCCCCCcccccCCC-------CcccchHHHHHHHHHHHcC----------C
Q psy5603         321 VPKLGDFGIVKMSETSNM-KTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTG----------M  382 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~-------~~~sDv~SlGvvl~elltG----------~  382 (455)
                      .+.|+|+|||........ -....+..+||..|||||++....       ...+||||||.|+||++..          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            999999999876554421 112235568999999999986542       2368999999999999752          4


Q ss_pred             CCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +||.+.-+.........+..-+...-......|....+...+.++++.||..+|.-|-++=.+-+.|.++.
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            56664432111111111111111111122256777788888999999999999999999999988888775

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6e-35  Score=278.77  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=191.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||++.+.. +..+++|.++......... .       ....+..|+.++++++||||+++++++.+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-N-------ETVQANQEAQLLSKLDHPAIVKFHASFLE   73 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc-c-------hHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence            5566899999999999998764 4456677765432211111 1       12346789999999999999999998776


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...|+||||+++++|.+++.... ....+++.+++.++.|++.||.|||+  .+++|+||||+||+++. +.+||+|||
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g  150 (260)
T cd08222          74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFG  150 (260)
T ss_pred             CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccC
Confidence             78899999999999999886532 24579999999999999999999999  88999999999999975 579999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......|+..|+|||.+. ..++.++|+||||+++|+|++|..||................  .+  
T Consensus       151 ~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~--  223 (260)
T cd08222         151 VSRLLMGSC---DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--TP--  223 (260)
T ss_pred             ceeecCCCc---ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CC--
Confidence            987654322   1223457889999999664 457889999999999999999999997654322221111111  00  


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ..+..++..+.++|.+||..+|++||++.++++
T Consensus       224 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 -------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   012344566888999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006|consensus

Probab=100.00  E-value=4.4e-37  Score=278.52  Aligned_cols=262  Identities=29%  Similarity=0.350  Sum_probs=194.2

Q ss_pred             cceeeeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHH
Q psy5603         150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN  228 (455)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (455)
                      ....|+-.+|...             ..||.|+||+|++-.++ .|+..|||+++....            ....+++..
T Consensus        57 ~~~~F~~~~Lqdl-------------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~------------~keq~rll~  111 (361)
T KOG1006|consen   57 HLHTFTSDNLQDL-------------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI------------EKEQKRLLM  111 (361)
T ss_pred             cccccccchHHHH-------------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc------------hHHHHHHHH
Confidence            4555666666554             67999999999999887 489999999976543            111456888


Q ss_pred             HHHHHhh-CCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy5603         229 EVQTLSQ-CKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       229 E~~~l~~-l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~i  304 (455)
                      |.+...+ -+.||||++||.+.. +..++.||.| .-||..+....  .....+++...-.|+..+..||.||-+. ..|
T Consensus       112 e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lki  189 (361)
T KOG1006|consen  112 EHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKI  189 (361)
T ss_pred             HHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhh
Confidence            8887544 478999999997655 8888999999 46665443221  1134689999999999999999999874 579


Q ss_pred             eecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc---CCCCcccchHHHHHHHHHHHcC
Q psy5603         305 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       305 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~sDv~SlGvvl~elltG  381 (455)
                      |||||||+|||||..|.+||||||++-....+-.    .+.-.|-.+|||||.+.   .+++.+|||||||++|||+.||
T Consensus       190 IHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG  265 (361)
T KOG1006|consen  190 IHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG  265 (361)
T ss_pred             hhccCChhheEEecCCCEeeecccchHhHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence            9999999999999999999999999875544321    23447889999999663   2488899999999999999999


Q ss_pred             CCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..||.+.+.............+..-..+..     ....+..+..+|..|+.+|.+.||...++.+
T Consensus       266 ~fPyr~w~svfeql~~Vv~gdpp~l~~~~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  266 NFPYRKWDSVFEQLCQVVIGDPPILLFDKE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CCCcchHHHHHHHHHHHHcCCCCeecCccc-----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            999998775332222222111111111111     1123445778899999999999999998865

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-35  Score=292.61  Aligned_cols=251  Identities=23%  Similarity=0.367  Sum_probs=188.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... ++..||||++.....      .     ......+.+|++++++++||||+++++++..
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------S-----ELFAKRAYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------c-----hHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence            455689999999999999875 588999999854221      0     0113457899999999999999999997654


Q ss_pred             -c------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         251 -I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 -~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                       .      ..|+||+|+ +++|.+++..    .++++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             CccccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEE
Confidence             2      358999998 7899888763    358999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-  400 (455)
                      |+|||+++.....      .....+++.|+|||.+.+  .++.++|+|||||++|++++|..||...+........... 
T Consensus       159 l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07880         159 ILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT  232 (343)
T ss_pred             EeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998754322      123467899999997643  4788999999999999999999999876532222111110 


Q ss_pred             ccchh------------hccchhccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVR------------EVLDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~------------~~~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....            .+... .....       ...++..+.++|.+|+..||++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKK-LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHh-ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000            00000 00000       0123445788999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0612|consensus

Probab=100.00  E-value=2.2e-36  Score=318.15  Aligned_cols=245  Identities=24%  Similarity=0.335  Sum_probs=198.4

Q ss_pred             CCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +.+.||+|+||.|..++++. ++.||.|++++-.-...          .....|..|-.+|.....+-|+.+.-.+.+ .
T Consensus        79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr----------~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR----------AETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc----------hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34899999999999999874 78899999975322111          114458889999999999999999888877 8


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ++|+||+||+||+|..++.+.+   ++++..+..++..|+.||.-||+  .|+|||||||+|||||..|++||+|||.|-
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCcEeeccchhHH
Confidence            8999999999999999998854   69999999999999999999999  789999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc--ccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EVP  403 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~  403 (455)
                      ....+.  +...+..+|||.|++||++.      |.|+..+|+||+||++||||.|..||........+-.+..-  ...
T Consensus       224 km~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  224 KMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             hcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence            665443  33456789999999999872      45788999999999999999999999998877777666552  222


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC---HHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---MRDIV  446 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---~~evl  446 (455)
                      +++          ...++...++||. .+.-+|.+|..   +.++-
T Consensus       302 FP~----------~~~VSeeakdLI~-~ll~~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  302 FPD----------ETDVSEEAKDLIE-ALLCDREVRLGRNGIEDIK  336 (1317)
T ss_pred             CCc----------ccccCHHHHHHHH-HHhcChhhhcccccHHHHH
Confidence            221          2335666888886 44556777766   66553

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.7e-35  Score=290.73  Aligned_cols=252  Identities=22%  Similarity=0.348  Sum_probs=188.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +++.||||++.......           .....+.+|++++++++||||+++++++..
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-----------VLAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-----------chhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            344599999999999999876 58899999986432110           013447789999999999999999997644


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...|+|+||+ +++|.+++..    .++++.....++.|++.||.|||+  .+++||||||+||++++++.+||+|||
T Consensus        81 ~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          81 PLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             CCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCccc
Confidence              5678999998 6789888763    357888999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~  405 (455)
                      +++.....      .....++..|+|||.+.+  .++.++|+|||||++|+|+||.+||.............. -..+..
T Consensus       154 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  227 (328)
T cd07856         154 LARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD  227 (328)
T ss_pred             cccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            98753221      123467889999997643  578899999999999999999999977653221111111 000000


Q ss_pred             h------------ccchhc--cCCCh----hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 E------------VLDKEA--GEWNE----THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~------------~~d~~~--~~~~~----~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +            ++....  ...+.    ..++..+.++|.+||..+|++||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0            000000  00000    123456888999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-35  Score=291.24  Aligned_cols=260  Identities=25%  Similarity=0.360  Sum_probs=190.1

Q ss_pred             HHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC
Q psy5603         158 DLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       158 ~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      ++..++++|.      +.+.||+|+||.||+|... +++.||+|++......           ......+.+|+.+++++
T Consensus        11 ~~~~~~~~y~------~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~Ei~~l~~l   73 (345)
T cd07877          11 TIWEVPERYQ------NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-----------IIHAKRTYRELRLLKHM   73 (345)
T ss_pred             HHhhccCceE------EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-----------hHHHHHHHHHHHHHHHc
Confidence            4444555554      4489999999999999865 5889999998643210           01134577899999999


Q ss_pred             CccceeeecccccC-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         237 KHVNLLRLLGLCNN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       237 ~h~niv~l~~~~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      +||||+++++++..       ...|++++++ +++|.+++..    ..+++..+..++.|++.||+|||+  .+++||||
T Consensus        74 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dl  146 (345)
T cd07877          74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDL  146 (345)
T ss_pred             CCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCC
Confidence            99999999987643       2357777776 8899888764    258999999999999999999999  88999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCC
Q psy5603         310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~  387 (455)
                      ||+||+++.++.+||+|||+++.....      .....||..|+|||.+.+  .++.++|||||||++|||++|..||..
T Consensus       147 kp~NIll~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         147 KPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             ChHHEEEcCCCCEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999998754321      223578899999996644  468899999999999999999999976


Q ss_pred             CcchhhHHHhhh-cccchhhcc---------------chhccC-CC--hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         388 NNTILYYYLVVE-QEVPVREVL---------------DKEAGE-WN--ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       388 ~~~~~~~~~~~~-~~~~~~~~~---------------d~~~~~-~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.......... .........               ...... +.  ....+..+.++|.+|+..+|.+||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            553221111111 000000000               000000 00  0012445788999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-35  Score=293.38  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=189.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++...||+|+||.||+|.+. ++..||||++......           ......+.+|+.++++++|||++++++++..
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-----------AIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-----------hhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            455689999999999999986 4789999998543110           0013447789999999999999999986654


Q ss_pred             -ce------eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         251 -IM------NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 -~~------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                       ..      .|+|+||+ +++|.+++..    .++++..+..++.|++.||.|||+  .|++||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEE
Confidence             33      78999998 7799998874    368999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||++......      .....++..|+|||.+.+  .++.++|||||||++||++||..||...........+.. .
T Consensus       159 L~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~  232 (343)
T cd07851         159 ILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV  232 (343)
T ss_pred             Ecccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence            9999998765332      223467889999996643  468899999999999999999999986653322222111 0


Q ss_pred             ccchhhccc------------hhc----cCCC--hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLD------------KEA----GEWN--ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d------------~~~----~~~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+...+..            ...    ..+.  ....+..+.++|.+||..+|++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            101000000            000    0000  0112556889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=279.58  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=192.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +....||+|+||.||+|+... ++.||+|++....... .          ....+.+|+.++++++|+|++++++++.+ 
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   70 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-G----------IPSTALREISLLKELKHPNIVKLLDVIHTE   70 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccc-c----------ccHHHHHHHHHHHhcCCCCHHHHHhhhhcC
Confidence            344789999999999999874 8999999997543110 0          12347789999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||++ ++|.+++....  ..+++..+..++.+++.||.|||+  .+++||||+|+||++++++.+||+|||++
T Consensus        71 ~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          71 RKLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             CceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcc
Confidence            78899999997 69999998642  369999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-C-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccchh--
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR--  405 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~--  405 (455)
                      +.......   ......++..|+|||.+. . .++.++|+|||||++||+++|.+||.............. ...+..  
T Consensus       146 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07829         146 RAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES  222 (282)
T ss_pred             cccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence            76543221   122335677899999653 3 578899999999999999999999987653322211111 000000  


Q ss_pred             -----hc--cchhccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 -----EV--LDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 -----~~--~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ..  .+.....+.       ....+..+.++|.+||..+|++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                 00  000000000       0122456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.2e-35  Score=288.22  Aligned_cols=259  Identities=23%  Similarity=0.293  Sum_probs=187.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC---CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||++....   +..||||++.......           ...+.+.+|+.+++++ .||||++++++
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~h~~iv~~~~~   70 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK-----------ILAKRALRELKLLRHFRGHKNITCLYDM   70 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc-----------hhHHHHHHHHHHHHHhcCCCChheeeee
Confidence            3455889999999999999763   6789999986332110           1134578899999999 59999999985


Q ss_pred             cc----C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         248 CN----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       248 ~~----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +.    . ...+++++|+ +++|.+++..   ..++++..+..++.|++.||.|||+  +|++||||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~  144 (332)
T cd07857          71 DIVFPGNFNELYLYEELM-EADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCEL  144 (332)
T ss_pred             eeeccccCCcEEEEEecc-cCCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCE
Confidence            32    2 3457888887 5799998865   3468999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcc-eeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         323 KLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      ||+|||+++........ ........||..|+|||.+.+  .++.++|+|||||++|+|++|.+||...+..........
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~  224 (332)
T cd07857         145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ  224 (332)
T ss_pred             EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence            99999998765432211 111234678999999996543  468899999999999999999999986552211111110


Q ss_pred             -cccchhhc---------------cchhc-cC--CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QEVPVREV---------------LDKEA-GE--WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~---------------~d~~~-~~--~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       -..+..+.               ..... ..  ......+..+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             00000000               00000 00  000112456888999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0614|consensus

Probab=100.00  E-value=3.3e-36  Score=293.43  Aligned_cols=239  Identities=26%  Similarity=0.363  Sum_probs=199.7

Q ss_pred             CCCccCcCCCeEEEEEEEcCCc-EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLKNGM-EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +...||-||||.|=++..++.. .+|+|.+++...-...          .......|-.||..++.|.||++|..+.+ .
T Consensus       424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtk----------QqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTK----------QQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchh----------HHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            3467999999999999887522 3899999876542221          13457789999999999999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|++||-|-||.|...|+..   ..++......++..+++|+.|||+  +|||+|||||+|.+||.+|.+||.|||+|+
T Consensus       494 yvYmLmEaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHH
Confidence            889999999999999999984   459999999999999999999999  999999999999999999999999999999


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcc-cccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ......    .+.+++||+.|.||| +++.+.+.++|.||||+++||||||.+||.+.++...+..+..+-..+      
T Consensus       569 ki~~g~----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------  638 (732)
T KOG0614|consen  569 KIGSGR----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------  638 (732)
T ss_pred             HhccCC----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------
Confidence            887654    366799999999999 567778999999999999999999999999999877777765421111      


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCC
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRAS  441 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs  441 (455)
                         .+ +..+.....+||.+.|..+|..|..
T Consensus       639 ---~~-Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 ---EF-PRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hc-ccccchhHHHHHHHHHhcCcHhhhc
Confidence               11 1334555788899999999999865

>KOG0666|consensus

Probab=100.00  E-value=1e-35  Score=274.86  Aligned_cols=203  Identities=24%  Similarity=0.337  Sum_probs=164.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++..+||+|+||.||+|..++     .+.+|||+++...+...-           .....+|+..++.++||||+.+..
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-----------S~SAcREiaL~REl~h~nvi~Lv~   94 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-----------SMSACREIALLRELKHPNVISLVK   94 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-----------CHHHHHHHHHHHHhcCCcchhHHH
Confidence            4556889999999999996542     236899999765442111           234779999999999999999998


Q ss_pred             ccc--CceeEEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---
Q psy5603         247 LCN--NIMNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---  319 (455)
Q Consensus       247 ~~~--~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---  319 (455)
                      ++.  +...++++||.+ -+|.+.++-...  ...++...+.+|+.||+.|+.|||+  +-|+||||||+|||+..+   
T Consensus        95 Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgpe  171 (438)
T KOG0666|consen   95 VFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPE  171 (438)
T ss_pred             HHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCc
Confidence            654  478899999995 578888754332  4568899999999999999999999  679999999999999776   


Q ss_pred             -CceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCC
Q psy5603         320 -FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       320 -~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~  388 (455)
                       |.+||+|||++|.....-..-.....++-|..|.|||++.|  .++.+.|+||+|||+.||||-.+-|.+.
T Consensus       172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence             99999999999987654322223355678999999997655  5889999999999999999999988754

>KOG0607|consensus

Probab=100.00  E-value=9e-35  Score=269.43  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             eeeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEE-EcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH
Q psy5603         153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ  231 (455)
Q Consensus       153 ~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  231 (455)
                      .=.+.|+-+.|.           +.||+|+++.|-.+. ..+|..||||++.+...             ....+..+|++
T Consensus        72 ~g~F~d~YkLt~-----------e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-------------HsR~RvfREVe  127 (463)
T KOG0607|consen   72 SGKFEDMYKLTS-----------ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-------------HSRSRVFREVE  127 (463)
T ss_pred             cchHHHHHHhHH-----------HHhcCccceeeeeeeeeccchhhhhhhhhcCCc-------------hHHHHHHHHHH
Confidence            345677777775           669999999999886 45789999999965422             11455789999


Q ss_pred             HHhhC-CccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         232 TLSQC-KHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       232 ~l~~l-~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      ++.+| .|+||+.+++|+.+ ...|||||-|.||+|..++...   ..+++..+..++..|+.||.|||.  +||.|||+
T Consensus       128 ~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDl  202 (463)
T KOG0607|consen  128 TFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHT--KGIAHRDL  202 (463)
T ss_pred             HHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhh--cCcccccC
Confidence            99999 59999999999988 7889999999999999999884   459999999999999999999999  99999999


Q ss_pred             CCCcEEEcCC---CceEEeecccccccccCCc----ceeeeccCCCCCCCCCcccc---cC---CCCcccchHHHHHHHH
Q psy5603         310 KSANVLLDEN---FVPKLGDFGIVKMSETSNM----KTMYTENLTGTRPYMPPEAM---HC---QISTKTDVFSYGVILL  376 (455)
Q Consensus       310 kp~NILl~~~---~~~kl~DFGla~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~---~~---~~~~~sDv~SlGvvl~  376 (455)
                      ||+|||-...   .-+|||||.+..-......    .+..-.+.+|+..|||||+.   .+   .|+.+.|.||||||||
T Consensus       203 KPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlY  282 (463)
T KOG0607|consen  203 KPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILY  282 (463)
T ss_pred             CccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHH
Confidence            9999999644   3689999987643222111    11222457899999999954   33   3678999999999999


Q ss_pred             HHHcCCCCCCCCcc---------------hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC
Q psy5603         377 ELLTGMKPIDDNNT---------------ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS  441 (455)
Q Consensus       377 elltG~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs  441 (455)
                      -||+|.+||.++-.               ......++++...+        .+.....++...++|+...+..++.+|.+
T Consensus       283 ImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeF--------PdkdWahIS~eakdlisnLlvrda~~rls  354 (463)
T KOG0607|consen  283 IMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEF--------PDKDWAHISSEAKDLISNLLVRDAKQRLS  354 (463)
T ss_pred             HHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcC--------ChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence            99999999987531               11111122111111        11223567888999999999999999999


Q ss_pred             HHHHHH
Q psy5603         442 MRDIVD  447 (455)
Q Consensus       442 ~~evl~  447 (455)
                      +.+|++
T Consensus       355 a~~vln  360 (463)
T KOG0607|consen  355 AAQVLN  360 (463)
T ss_pred             hhhccC
Confidence            998875

>KOG1035|consensus

Probab=100.00  E-value=2.8e-35  Score=312.03  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=185.6

Q ss_pred             eeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHH
Q psy5603         154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  232 (455)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  232 (455)
                      +......+...+|.+.      ..||+||||.||+++.+ +|+.||||++.....            ........+|+..
T Consensus       469 ~~~r~~SRY~~DFEEL------~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s------------~~~~skI~rEVk~  530 (1351)
T KOG1035|consen  469 PLQRQFSRYLNDFEEL------ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKAS------------DKLYSKILREVKL  530 (1351)
T ss_pred             ccccchhhHhhhhHHH------HHhcCCCCceEEEEeecccchhhhhhhccCchH------------HHHHHHHHHHHHH
Confidence            3344445666777666      89999999999999977 799999999975541            1113447889999


Q ss_pred             HhhCCccceeeeccccc---------------------------------------------------------------
Q psy5603         233 LSQCKHVNLLRLLGLCN---------------------------------------------------------------  249 (455)
Q Consensus       233 l~~l~h~niv~l~~~~~---------------------------------------------------------------  249 (455)
                      +++++|||||+++..+.                                                               
T Consensus       531 LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~  610 (1351)
T KOG1035|consen  531 LARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKA  610 (1351)
T ss_pred             HhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccc
Confidence            99999999999862110                                                               


Q ss_pred             -------------------------------------------------C--------ceeEEEEEeccCCCHHHHHhhc
Q psy5603         250 -------------------------------------------------N--------IMNCIVYEYMCNGSLYDRLARV  272 (455)
Q Consensus       250 -------------------------------------------------~--------~~~~lV~e~~~~gsL~~~l~~~  272 (455)
                                                                       +        ...|+=||||+..+|.+++.+.
T Consensus       611 ~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N  690 (1351)
T KOG1035|consen  611 SYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN  690 (1351)
T ss_pred             cccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc
Confidence                                                             0        1135678999888888877763


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc----c----------CCc
Q psy5603         273 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE----T----------SNM  338 (455)
Q Consensus       273 ~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~----~----------~~~  338 (455)
                      ...  -.....++++.+|+.||.|+|+  +|||||||||.||+||+++.+||+|||+|....    .          ...
T Consensus       691 ~~~--~~~d~~wrLFreIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g  766 (1351)
T KOG1035|consen  691 HFN--SQRDEAWRLFREILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAG  766 (1351)
T ss_pred             ccc--hhhHHHHHHHHHHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccC
Confidence            211  1467889999999999999999  889999999999999999999999999998721    0          000


Q ss_pred             -ceeeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcch-hhHHHhhhcccch-hhccchh
Q psy5603         339 -KTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPV-REVLDKE  411 (455)
Q Consensus       339 -~~~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~-~~~~d~~  411 (455)
                       .....+..+||.-|+|||++.+    .++.|+|+||||||++||+.   ||.....- ...........+. ..+.++.
T Consensus       767 ~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~  843 (1351)
T KOG1035|consen  767 SNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPE  843 (1351)
T ss_pred             CCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccccccc
Confidence             1112345789999999998854    47889999999999999994   56544311 1111111111111 1222222


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        + .-..+|.+++.+||.+|||+.|+++
T Consensus       844 ~--------~-~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  844 H--------P-EEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             c--------h-HHHHHHHHHhcCCCccCCCHHHHhh
Confidence            2        1 1344688999999999999999975

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.5e-34  Score=309.23  Aligned_cols=145  Identities=29%  Similarity=0.340  Sum_probs=125.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.++||+|+||.||+|.+. +++.||||+++......          ......+.+|+.++..++||||+++++++..
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   75 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN----------KNMVHQVQAERDALALSKSPFIVHLYYSLQS   75 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC----------HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE
Confidence            456689999999999999987 48899999996532210          1114568899999999999999999987766


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.|++|.+++...   ..+++..++.|+.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~lVmEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          76 ANNVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence             7889999999999999999763   358899999999999999999999  7899999999999999999999999999


Q ss_pred             cc
Q psy5603         330 VK  331 (455)
Q Consensus       330 a~  331 (455)
                      ++
T Consensus       151 s~  152 (669)
T cd05610         151 SK  152 (669)
T ss_pred             Cc
Confidence            86

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1025|consensus

Probab=100.00  E-value=4.9e-35  Score=298.72  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=203.1

Q ss_pred             CCccCcCCCeEEEEEEEc-C----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         175 GNKLGEGQFGTVYYGKLK-N----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .++||+|+||+||+|.|- .    .-+||||++......+.            ...+..|+-+|.+++|||+++++|+|.
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~------------s~e~LdeAl~masldHpnl~RLLgvc~  768 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA------------SIELLDEALRMASLDHPNLLRLLGVCM  768 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh------------hHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence            488999999999999873 2    35789999875543211            345899999999999999999999999


Q ss_pred             CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      ....-||.+||++|+|.|+++..+  .++-....+.|..|||+|+.|||.  +.++||||-..|||+..-..+||.|||+
T Consensus       769 ~s~~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  769 LSTLQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             cchHHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecch
Confidence            988889999999999999998754  478889999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++....... ........-.+.|||-|.+ ...++.+||||||||++||++| |..||++...........         
T Consensus       845 a~ll~~d~~-ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle---------  914 (1177)
T KOG1025|consen  845 AKLLAPDEK-EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE---------  914 (1177)
T ss_pred             hhccCcccc-cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh---------
Confidence            997765542 2222233334568888844 5678999999999999999999 999999887543332222         


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                        ..-+...+.-++-.+..++.+||..|++.||+++++...+.+..++
T Consensus       915 --~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  915 --KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             --ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence              2212223334455566678899999999999999999999887653

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5e-34  Score=269.31  Aligned_cols=218  Identities=20%  Similarity=0.216  Sum_probs=172.1

Q ss_pred             CCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEEEEE
Q psy5603         181 GQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYE  258 (455)
Q Consensus       181 G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e  258 (455)
                      |.||.||++.++ +++.||+|+++....                  +.+|...+....||||+++++++.+ ...|+|||
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   65 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------------------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQ   65 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------------------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEe
Confidence            899999999986 488999999864321                  3345555566679999999998776 78899999


Q ss_pred             eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCc
Q psy5603         259 YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM  338 (455)
Q Consensus       259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  338 (455)
                      |++||+|.+++...   .++++..+..++.|++.||.|||+  ++++||||||+||+++.++.++++|||++......  
T Consensus        66 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--  138 (237)
T cd05576          66 HAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--  138 (237)
T ss_pred             cCCCCCHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhccccc--
Confidence            99999999999763   358999999999999999999999  88999999999999999999999999987654332  


Q ss_pred             ceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCCh
Q psy5603         339 KTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE  417 (455)
Q Consensus       339 ~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  417 (455)
                          .....++..|+|||... +.++.++|+||+|+++|||++|..|+.........    .....+            +
T Consensus       139 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~----~~~~~~------------~  198 (237)
T cd05576         139 ----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----HTTLNI------------P  198 (237)
T ss_pred             ----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc----ccccCC------------c
Confidence                12335677899999764 45788999999999999999999887643211000    000001            1


Q ss_pred             hHHHHHHHHHHHhhhccCcCCCCCHH
Q psy5603         418 THVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       418 ~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                      ..++..+.++|.+|+..||++||++.
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            12345578899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604|consensus

Probab=100.00  E-value=1e-34  Score=267.18  Aligned_cols=239  Identities=25%  Similarity=0.302  Sum_probs=190.9

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC---
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  250 (455)
                      .+||-|--|.|-.+..+ +++.+|+|++..                  .....+|++.=-.. .|||||.+++++.+   
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D------------------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD------------------SPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhc------------------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            78999999999999877 588999999852                  12266788765444 69999999997654   


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc---CCCceEEe
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~  325 (455)
                        ..+.+|||+|.||.|+.++..++ ..++++.++..|+.||..|+.|||+  .+|.||||||+|+|..   .|..+||+
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcceEec
Confidence              45568999999999999999865 4679999999999999999999999  7899999999999995   45689999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch----hhHHHhhhc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVEQ  400 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~~  400 (455)
                      |||+|+......    .-.+.+-|+.|.|||++.. +++...|+||+||++|-||+|.+||..+...    -+...+..+
T Consensus       207 DfGFAK~t~~~~----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g  282 (400)
T KOG0604|consen  207 DFGFAKETQEPG----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG  282 (400)
T ss_pred             ccccccccCCCc----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence            999998655322    1235688999999998854 5788889999999999999999999876531    111111111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+        .....+++++..+++|+++|..+|.+|.++.++++
T Consensus       283 qy~F--------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  283 QYEF--------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CccC--------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1111        11123678889999999999999999999999875

>KOG1151|consensus

Probab=100.00  E-value=3.9e-35  Score=281.77  Aligned_cols=281  Identities=26%  Similarity=0.346  Sum_probs=210.3

Q ss_pred             ceeeeHHHHHHHhcC----CCCCC----CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhh
Q psy5603         151 LIAFTFCDLERATDG----FNRKP----YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMI  221 (455)
Q Consensus       151 ~~~~~~~~l~~~t~~----f~~~~----~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~  221 (455)
                      +...-..||.++.+.    |..-|    +|-..++||+|||+.||++.+- ..+.||||+-.......+.+.      ..
T Consensus       436 vrnlHiRELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKK------eN  509 (775)
T KOG1151|consen  436 VRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKK------EN  509 (775)
T ss_pred             HHHHHHHHHHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhh------hh
Confidence            344555666666543    43333    2456788999999999999975 367899998765443322211      11


Q ss_pred             hHHHHHHHHHHHhhCCccceeeecccc-cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q psy5603         222 PILLFENEVQTLSQCKHVNLLRLLGLC-NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS  299 (455)
Q Consensus       222 ~~~~~~~E~~~l~~l~h~niv~l~~~~-~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~  299 (455)
                      -.+...+|..|-+.+.||.||++|+|+ .+ ...|-|+|||+|.+|.-+|..   ...+++..+..|+.||+.||.||.+
T Consensus       510 YhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNE  586 (775)
T KOG1151|consen  510 YHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNE  586 (775)
T ss_pred             HHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhc
Confidence            245578899999999999999999976 34 788999999999999999987   3468999999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEEc---CCCceEEeecccccccccCCcc----eeeeccCCCCCCCCCcccc-cC----CCCcccc
Q psy5603         300 LSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMK----TMYTENLTGTRPYMPPEAM-HC----QISTKTD  367 (455)
Q Consensus       300 ~~~~iiH~Dikp~NILl~---~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~-~~----~~~~~sD  367 (455)
                      ...+|||-||||.||||-   ..|.+||.|||+++........    -..++...||..|+|||.| .+    +.+.|+|
T Consensus       587 ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVD  666 (775)
T KOG1151|consen  587 IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVD  666 (775)
T ss_pred             cCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccccee
Confidence            878999999999999994   4589999999999987665432    2346778999999999954 33    4688999


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         368 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       368 v~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      |||+|||+|.++.|+.||..+-..... .   ++..+....  .....+...++...+++|.+||+...++|....++.
T Consensus       667 VWSvGVIFyQClYGrKPFGhnqsQQdI-L---qeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  667 VWSVGVIFYQCLYGRKPFGHNQSQQDI-L---QENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             eEeeehhhhhhhccCCCCCCchhHHHH-H---hhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            999999999999999999876421111 0   011111110  011122345566788899999999999999887764

>KOG0200|consensus

Probab=100.00  E-value=7.9e-34  Score=301.38  Aligned_cols=253  Identities=29%  Similarity=0.457  Sum_probs=199.7

Q ss_pred             CCCccCcCCCeEEEEEEEcC--------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      +.+.||+|.||.|++|..+.        ...||||.++.....            .....+..|+++++.+ .|+||+.+
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~------------~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS------------SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCc------------HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            44689999999999998531        357999999765442            1145699999999998 69999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcC---C--C--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCC
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVN---N--T--------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---~--~--------~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dik  310 (455)
                      +|+|.. +..++|.||+..|+|.++|....   .  .        ..++....+.++.|||.|++||++  .++|||||-
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLA  445 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLA  445 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhh
Confidence            999988 88899999999999999998765   0  1        248999999999999999999999  889999999


Q ss_pred             CCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCC--CCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~--Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      ..|||+.++..+||+|||+|+..........  ..-.|+.+  |||||.+. ..++.+||||||||+||||+| |..||.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999999999997655443221  12233343  99999664 478999999999999999999 999998


Q ss_pred             CCc-chhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         387 DNN-TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       387 ~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +.. ......           .+........+..+...+.+++..||+.+|++||++.++.+.|+..+
T Consensus       524 ~~~~~~~l~~-----------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  524 GIPPTEELLE-----------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCCcHHHHHH-----------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            743 111111           11111112223344556778999999999999999999999998865

>KOG4236|consensus

Probab=100.00  E-value=9.8e-35  Score=283.99  Aligned_cols=242  Identities=26%  Similarity=0.341  Sum_probs=191.0

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|.||+||-|.++ +|+.||||++.+...... .          ..++.+|+.||.+++||.||.+--.|.. +..
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-q----------esqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-Q----------ESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCc-h----------HHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            68999999999999875 699999999975443111 1          3458899999999999999999988888 788


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---CceEEeecccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIV  330 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~DFGla  330 (455)
                      +.|||-+.|.=|+-.|...  .+.+++..-..++.||+.||.|||-  ++|+|+||||+||||...   -.+||||||+|
T Consensus       639 FVVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  639 FVVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             EEEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccce
Confidence            9999999554444444443  3479999999999999999999999  899999999999999643   47999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      |+.+....    ...++||++|+|||++. .+++...|+||.||++|--|+|..||.+....-  ..+++..     ++ 
T Consensus       715 RiIgEksF----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAa-----FM-  782 (888)
T KOG4236|consen  715 RIIGEKSF----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAA-----FM-  782 (888)
T ss_pred             eecchhhh----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccc-----cc-
Confidence            99876542    45689999999999764 567888899999999999999999998764321  1111111     11 


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                        ....+...++...-+||...|+..-++|-+++.-+
T Consensus       783 --yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  783 --YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             --cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence              12223356677788889999999988998887654

>KOG0669|consensus

Probab=100.00  E-value=2.2e-35  Score=265.61  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=189.6

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +...+||+|.||.||+|+.++ |+.||+|++-.....          .-.++. ..+|+++|..++|+|++.+++.|.. 
T Consensus        20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK----------eGfpit-alreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK----------EGFPIT-ALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc----------cCCcHH-HHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            334789999999999999764 788999876432221          111122 5689999999999999999987732 


Q ss_pred             --------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         251 --------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       251 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                              ...|+|+.+|+ -+|.-+|...  ...++...+.+++.+++.||.|+|+  ..|+|||+|++|+|++.+|.+
T Consensus        89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cCCcccccceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceE
Confidence                    34689999995 5788877653  2468999999999999999999999  779999999999999999999


Q ss_pred             EEeecccccccccCCcce-eeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         323 KLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      ||+|||++|......... ......+-|..|++||.+.|  .++++.|+|+.|||+.||.||.+-+.++........+..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            999999998665443211 11233456999999996655  589999999999999999999999998874333222211


Q ss_pred             --c-----------ccchhhccchh-ccCCChhHH---------HHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 --Q-----------EVPVREVLDKE-AGEWNETHV---------ETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 --~-----------~~~~~~~~d~~-~~~~~~~~~---------~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        +           +.++-+.+... ++......+         .....+|+.+++..||.+|+.++++++
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence              0           01111111111 111111111         124567899999999999999999875

>KOG0662|consensus

Probab=100.00  E-value=1.9e-33  Score=241.40  Aligned_cols=254  Identities=23%  Similarity=0.300  Sum_probs=191.7

Q ss_pred             CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc-cCce
Q psy5603         175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~  252 (455)
                      .++||+|.||+||+|+.+ +++.||+|.++-+.....-           -....+|+-+++.++|.|||++++.. .+..
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegv-----------pssalreicllkelkhknivrl~dvlhsdkk   75 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-----------PSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-----------cHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence            378999999999999866 4788999999865432111           23378999999999999999999965 4588


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..+|+||| ..+|..+.....  +.++...+..++.|+++||.|+|+  +++.|||+||.|+|++.+|..|++|||+++.
T Consensus        76 ltlvfe~c-dqdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   76 LTLVFEFC-DQDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             eEEeHHHh-hHHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhh
Confidence            89999999 578888777654  368999999999999999999999  8899999999999999999999999999997


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhh--c---c---
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVE--Q---E---  401 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~--~---~---  401 (455)
                      .+...   ...+.-+-|..|.||.++.|  -+++..|+||.||++.|+.. |++.|.+.+.......+..  +   +   
T Consensus       151 fgipv---rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w  227 (292)
T KOG0662|consen  151 FGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW  227 (292)
T ss_pred             cCCce---EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence            76532   12334467899999997655  37889999999999999998 8888887763322222221  1   1   


Q ss_pred             cchhhccchhc-cCCCh--------hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVREVLDKEA-GEWNE--------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~-~~~~~--------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+...-|-.+ ..++.        ......-++|+.+.+.-+|.+|.++++.++
T Consensus       228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11112222111 11111        122233567888999999999999988764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.8e-33  Score=292.13  Aligned_cols=256  Identities=20%  Similarity=0.215  Sum_probs=163.3

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEcC-----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      ..|++.++||+|+||.||+|.+.+     +..||||++.....               ...+.++  .+.+..+.++..+
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---------------~e~~~~e--~l~~~~~~~~~~~  194 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---------------VEIWMNE--RVRRACPNSCADF  194 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---------------hHHHHHH--HHHhhchhhHHHH
Confidence            345677999999999999999863     58899999753211               0001111  1112222222222


Q ss_pred             ccc-------ccCceeEEEEEeccCCCHHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHcC
Q psy5603         245 LGL-------CNNIMNCIVYEYMCNGSLYDRLARVNN-----------------TPPLDSNKRYSIALGVAEALHYLHSL  300 (455)
Q Consensus       245 ~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~i~~gl~~LH~~  300 (455)
                      +..       ..+...++||||+.+++|.+++.....                 ........+..++.|++.||.|||+ 
T Consensus       195 ~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-  273 (566)
T PLN03225        195 VYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-  273 (566)
T ss_pred             HHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-
Confidence            221       122678999999999999999875321                 0111234566899999999999999 


Q ss_pred             CCCeeecCCCCCcEEEcC-CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-------------------
Q psy5603         301 SKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-------------------  360 (455)
Q Consensus       301 ~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------------------  360 (455)
                       ++|+||||||+|||++. ++.+||+|||+++......  ........||+.|+|||.+..                   
T Consensus       274 -~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~  350 (566)
T PLN03225        274 -TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV  350 (566)
T ss_pred             -CCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccch
Confidence             88999999999999985 6899999999997553322  112345689999999995421                   


Q ss_pred             ----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh---hccchhccC-----CC-hhHHHHHHHHH
Q psy5603         361 ----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR---EVLDKEAGE-----WN-ETHVETLISIV  427 (455)
Q Consensus       361 ----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~d~~~~~-----~~-~~~~~~~l~~L  427 (455)
                          .++.++|||||||+||||+++..|++...... ............   .........     +. .+.......+|
T Consensus       351 l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dL  429 (566)
T PLN03225        351 LWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWEL  429 (566)
T ss_pred             hccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHH
Confidence                12345699999999999999877655331111 111111111111   111111000     00 00112234579


Q ss_pred             HHhhhccCcCCCCCHHHHHH
Q psy5603         428 FEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       428 i~~~l~~dp~~RPs~~evl~  447 (455)
                      |.+|+..||++|||++++++
T Consensus       430 i~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHHccCCcccCCCHHHHhC
Confidence            99999999999999999976

>KOG0603|consensus

Probab=100.00  E-value=1.9e-33  Score=282.79  Aligned_cols=234  Identities=24%  Similarity=0.288  Sum_probs=188.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      -|+....+|.|+||.|-.+.+. +++..+||++.....      +           -.+|+.++... .||||+++.+.+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~-----------~~~e~~~~~~~~~h~niv~~~~v~  385 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------D-----------NQDEIPISLLVRDHPNIVKSHDVY  385 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc------c-----------cccccchhhhhcCCCcceeeccee
Confidence            3566778999999999999876 478899999975522      1           23577676666 799999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE-cCCCceEEee
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGD  326 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl-~~~~~~kl~D  326 (455)
                      .+ .+.++|||.+.|+-|.+.+....    .....+..|+.+|+.|+.|||+  +|+|||||||+|||+ +..++++|+|
T Consensus       386 ~~~~~~~~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrlty  459 (612)
T KOG0603|consen  386 EDGKEIYLVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTY  459 (612)
T ss_pred             cCCceeeeeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEE
Confidence            88 88899999999999999887633    2337788899999999999999  899999999999999 6999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch-hhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~  404 (455)
                      ||.++......      ...+-|..|.|||++.. .++.++||||||++||+||+|+.||...... .....+  ....+
T Consensus       460 FG~a~~~~~~~------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i--~~~~~  531 (612)
T KOG0603|consen  460 FGFWSELERSC------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI--QMPKF  531 (612)
T ss_pred             echhhhCchhh------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh--cCCcc
Confidence            99988765542      12366888999997754 6899999999999999999999999876543 111111  11111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                  ...++...++||.+||+.||.+||++.++..
T Consensus       532 ------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  532 ------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                        1456777999999999999999999999853

>KOG0587|consensus

Probab=100.00  E-value=5e-33  Score=286.87  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=201.0

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  247 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      +.+++...||.|.+|.||+++.+ +++.+|||+.......              ......|..+++.. .|||++.++|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--------------deEiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--------------EEEIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--------------cHHHHHHHHHHHhccCCCCcceEEEE
Confidence            34466799999999999999865 5888999998654331              12256688888776 79999999996


Q ss_pred             c------cCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         248 C------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +      .+++++||||||.|||..|++.... +..+.|..+..|+.++++|+.+||.  ..+||||||-.|||++.++.
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCc
Confidence            5      3378899999999999999998766 6789999999999999999999999  77999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +||+|||++.-....   .....+..||+.|||||++..      .++..+|+||||++..||.-|.+|+.+........
T Consensus       162 VKLvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF  238 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF  238 (953)
T ss_pred             EEEeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence            999999987654332   233566799999999998743      35668999999999999999999998876543333


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+..  .+.+       ....+..+.+.+.++|..|+..|..+||++.++++
T Consensus       239 ~IpR--NPPP-------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 LIPR--NPPP-------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cCCC--CCCc-------cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            3221  1111       22234577888999999999999999999998865

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.5e-32  Score=252.31  Aligned_cols=236  Identities=30%  Similarity=0.455  Sum_probs=186.7

Q ss_pred             CCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEEEEEe
Q psy5603         182 QFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEY  259 (455)
Q Consensus       182 ~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~  259 (455)
                      +||.||+|.... |+.||+|++........            ...+.+|++.+++++|+|++++++++.. ...++++||
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   68 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK------------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEY   68 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH------------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeC
Confidence            689999999874 89999999865432100            3458899999999999999999998877 788999999


Q ss_pred             ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcc
Q psy5603         260 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK  339 (455)
Q Consensus       260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  339 (455)
                      +.+++|.+++....   .+++..++.++.+++.++.+||+  .+++|+||+|.||+++.++.++|+|||.+.......  
T Consensus        69 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--  141 (244)
T smart00220       69 CDGGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--  141 (244)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--
Confidence            99999999987633   38999999999999999999999  789999999999999999999999999988665432  


Q ss_pred             eeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCc-chhhHHHhhhcccchhhccchhccCCCh
Q psy5603         340 TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYYLVVEQEVPVREVLDKEAGEWNE  417 (455)
Q Consensus       340 ~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~  417 (455)
                        ......|+..|+|||.+. ..++.++|+||||++++++++|..||.... ..................         .
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~  210 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP---------E  210 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc---------c
Confidence              123457888999999654 567889999999999999999999998733 222111111111110000         0


Q ss_pred             hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         418 THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       418 ~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..++..+.+++.+|+..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            003455788999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.2e-31  Score=276.13  Aligned_cols=272  Identities=18%  Similarity=0.120  Sum_probs=175.1

Q ss_pred             CcCCCccCcCCCeEEEEEEE-----------------cCCcEEEEEEeecccCcCCCCCch-hhhhhhhHHHHHHHHHHH
Q psy5603         172 PRRGNKLGEGQFGTVYYGKL-----------------KNGMEIAVKTLENNANYSSSNSDN-TEAAMIPILLFENEVQTL  233 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l  233 (455)
                      |++.++||+|+||.||+|.+                 ..++.||||+++............ ..........+..|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            34559999999999999964                 125679999986432210000000 000000112345677788


Q ss_pred             hhCCccce-----eeeccccc---------CceeEEEEEeccCCCHHHHHhhcCC---------------------CCCC
Q psy5603         234 SQCKHVNL-----LRLLGLCN---------NIMNCIVYEYMCNGSLYDRLARVNN---------------------TPPL  278 (455)
Q Consensus       234 ~~l~h~ni-----v~l~~~~~---------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l  278 (455)
                      .+++|.++     ++++++|.         .+..++||||+++++|.+++....+                     ...+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            88876654     66677653         2467999999999999999875321                     1234


Q ss_pred             CHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc
Q psy5603         279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM  358 (455)
Q Consensus       279 ~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  358 (455)
                      ++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++........  ......+|+.|+|||.+
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCcceeChhhh
Confidence            678899999999999999999  88999999999999999999999999998754332111  11223458899999965


Q ss_pred             cCC-----------------------CCcccchHHHHHHHHHHHcCCC-CCCCCcchhhHHHhhhccc-chhhccchhcc
Q psy5603         359 HCQ-----------------------ISTKTDVFSYGVILLELLTGMK-PIDDNNTILYYYLVVEQEV-PVREVLDKEAG  413 (455)
Q Consensus       359 ~~~-----------------------~~~~sDv~SlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~  413 (455)
                      ...                       ...+.|+||+||++|+|++|.. ||................. ....+......
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            321                       1124799999999999999875 7754321111000000000 00000000000


Q ss_pred             CCChhHHHHHHHHHHHhhhccCc---CCCCCHHHHHH
Q psy5603         414 EWNETHVETLISIVFEKCCVFEK---DKRASMRDIVD  447 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp---~~RPs~~evl~  447 (455)
                      ....+..+....+|+.+++..+|   .+|+|++|+++
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            01122345668888999999764   68999999875

>KOG0671|consensus

Probab=99.98  E-value=1.3e-32  Score=261.03  Aligned_cols=254  Identities=21%  Similarity=0.320  Sum_probs=190.5

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc--c----ce
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH--V----NL  241 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----ni  241 (455)
                      .+.|.+...+|+|+||.|-.+.+.. +..||||+++.-..+              .....-|++++.++.+  |    -+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY--------------reAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY--------------REAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH--------------hhHHHHHHHHHHHHHhcCCCCceEE
Confidence            3556777999999999999998764 688999999743221              3345678999999832  2    35


Q ss_pred             eeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC--
Q psy5603         242 LRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--  318 (455)
Q Consensus       242 v~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~--  318 (455)
                      |.+.+++.- ++.|+|+|.+ |-|+.++|.... -.+++..++..++.|+++++.|||+  .+++|-||||+|||+-.  
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSE  229 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccc
Confidence            666676765 8999999999 779999998744 4679999999999999999999999  77999999999999921  


Q ss_pred             ------------------CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHH
Q psy5603         319 ------------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL  379 (455)
Q Consensus       319 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~ell  379 (455)
                                        +..+||+|||.|++.....      +.++.|..|.|||++.| +++..+||||+||||+|+.
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely  303 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY  303 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence                              3468999999998754432      45788999999996655 8999999999999999999


Q ss_pred             cCCCCCCCCcchh---hHHHhhhcccch--------hhccchhccC------------------------CChhHHHHHH
Q psy5603         380 TGMKPIDDNNTIL---YYYLVVEQEVPV--------REVLDKEAGE------------------------WNETHVETLI  424 (455)
Q Consensus       380 tG~~p~~~~~~~~---~~~~~~~~~~~~--------~~~~d~~~~~------------------------~~~~~~~~~l  424 (455)
                      ||...|...+...   +...+. ++.+.        .+++...--.                        ...+.....+
T Consensus       304 tG~~LFqtHen~EHLaMMerIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  304 TGETLFQTHENLEHLAMMERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             ccceecccCCcHHHHHHHHHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            9999998876222   111111 11110        0010000000                        0112333458


Q ss_pred             HHHHHhhhccCcCCCCCHHHHHH
Q psy5603         425 SIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       425 ~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+|+.+||..||.+|+|+.|++.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhc
Confidence            88999999999999999999875

>cd08308 Death_Tube Death domain of Tube

Probab=99.98  E-value=8.2e-33  Score=225.03  Aligned_cols=116  Identities=45%  Similarity=0.727  Sum_probs=106.8

Q ss_pred             CceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCC-CCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCC
Q psy5603          10 DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDP-LKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        10 ~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~-~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      +||||+||++++++||++||++++|++||+.|++++|+ ++.+||++.|++.||++++|  +|+|||++||++|||+|+.
T Consensus         1 ~TeIR~Lp~~~~~~L~~iLD~~d~Wk~L~~~Ip~~~~~~~~~~~Y~~~hv~~ie~~~~~--~grSpte~LL~eWGT~g~~   78 (125)
T cd08308           1 DTEIRKLPPADLYRLVNILDINDGWKKLMAIIPSDDDDFNNLAKYNAEHFKLIEQAANK--QRRSCSEILLDEWGTSGKV   78 (125)
T ss_pred             CcchhcCCHHHHHHHHHHcCccccHHHHHHhcCCcccccccccccCHHHHHHHHHHHHh--cCCChHHHHHHHHhhcCCC
Confidence            59999999999999999999999999999999999886 78899999999999999987  8999999999999999888


Q ss_pred             CCCHHHHHHHHHhccccccccccccccccC--CCCCCCCch
Q psy5603          89 RPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTE  127 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~  127 (455)
                      +|||++|+++|.+++|++||+++.++.++.  |..|..+++
T Consensus        79 r~Tv~~L~~LL~k~~L~~Aa~~la~d~l~~~~~~rp~~gp~  119 (125)
T cd08308          79 RPTLGVLLQLLVKAELFRAADYVAVDILKEEPPARPVVGPA  119 (125)
T ss_pred             CCcHHHHHHHHHHhhHHHHHHHHHHHHhcCCCCCCCCCCcc
Confidence            899999999999999999999999999876  444444443

Death domains (DDs) similar to the DD in the protein Tube from Drosophila melanogaster. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in mediating innate immune response to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Some members of this subfamily contain a C-terminal kinase domain, like Pelle, in addition to the DD. Tube has no counterpart in vertebrates. It contains an N-terminal DD and a C-terminal region with five copies of the Tube repeat, an 8-amino acid motif. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (D

>KOG0695|consensus

Probab=99.98  E-value=4.2e-32  Score=253.05  Aligned_cols=237  Identities=24%  Similarity=0.340  Sum_probs=189.2

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  250 (455)
                      +...||+|+|..|-+++++ +.+.||+|++++........          +.-.+.|-.+..+- +||.+|-+..++.. 
T Consensus       254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded----------idwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED----------IDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc----------chhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            4489999999999999976 46789999998765422221          22255666666554 79999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|.||++||+|.-.++++.   .++++.+..+...|..||.|||+  +|||+||||.+|+|+|..|++||.|+|++
T Consensus       324 srlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchh
Confidence            88899999999999988888754   49999999999999999999999  89999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCc--------chhhHHHhhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN--------TILYYYLVVEQE  401 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~--------~~~~~~~~~~~~  401 (455)
                      +..-...   ..+++++||+.|+|||++.| .+...+|+|++||+++||+.|+.||+-..        ......++.+..
T Consensus       399 ke~l~~g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq  475 (593)
T KOG0695|consen  399 KEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ  475 (593)
T ss_pred             hcCCCCC---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence            8654332   33678999999999998877 58899999999999999999999997321        233344444455


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                      ..++..+.-+            ...+++.-+++||+.|.
T Consensus       476 iriprslsvk------------as~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 IRIPRSLSVK------------ASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ccccceeehh------------hHHHHHHhhcCCcHHhc
Confidence            5555444433            33447788889999884

>KOG0608|consensus

Probab=99.98  E-value=2e-32  Score=272.71  Aligned_cols=207  Identities=24%  Similarity=0.336  Sum_probs=167.9

Q ss_pred             CCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ..+.||-|+||.|.++...+ ...||.|.+++.......          .......|-.||..-..+-||+||-.+.+ +
T Consensus       633 kik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rn----------QvaHVKAERDILAEADn~WVVrLyySFQDkd  702 (1034)
T KOG0608|consen  633 KIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRN----------QVAHVKAERDILAEADNEWVVRLYYSFQDKD  702 (1034)
T ss_pred             EEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhh----------hhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence            34789999999999998543 567899999865432211          13346778999999999999999988877 8


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .+|+||+|++||++..+|-+   .+.+++..+..++.++..|+++.|.  .|+|||||||+|||||.+|++||.|||||.
T Consensus       703 nLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCceeeeeccccc
Confidence            99999999999999999987   4469999999999999999999999  789999999999999999999999999984


Q ss_pred             cccc---------CCcc------------------------------eeeeccCCCCCCCCCcccc-cCCCCcccchHHH
Q psy5603         332 MSET---------SNMK------------------------------TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSY  371 (455)
Q Consensus       332 ~~~~---------~~~~------------------------------~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~Sl  371 (455)
                      -+.-         ....                              ....-..+||+.|+|||++ ..+++...|+||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            2211         0000                              0001124799999999965 5678999999999


Q ss_pred             HHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         372 GVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       372 Gvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      |||||||+.|++||-........+
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCccee
Confidence            999999999999998877544333

>KOG1027|consensus

Probab=99.97  E-value=9.4e-33  Score=283.62  Aligned_cols=241  Identities=24%  Similarity=0.322  Sum_probs=183.6

Q ss_pred             CccCcCCCeE-EEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGT-VYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.+|.|+-|+ ||+|... |+.||||++-...                .....+|+..|... +|||||++++.-.+ ++
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----------------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF  577 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----------------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQF  577 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHh----------------HHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence            6789998887 6999997 7999999984221                23467899999888 69999999998777 88


Q ss_pred             eEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-----CCceEEee
Q psy5603         253 NCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGD  326 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-----~~~~kl~D  326 (455)
                      .|+..|.| ..||.+++... ...........+.+..|++.||++||+  -+||||||||.||||+.     ...++|+|
T Consensus       578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecc
Confidence            89999988 79999999874 111111214457789999999999999  67999999999999975     25899999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++........-...+...||.+|+|||++.. .-+.++||||+|||+|+.++ |.+||.+.-...  ..+......+
T Consensus       655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L  732 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTL  732 (903)
T ss_pred             cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccce
Confidence            9999987765533334577899999999997755 44668999999999999999 599998653211  1111111111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+     .  +..++  +..+||.+|++.+|..||++.+|+.
T Consensus       733 ~~L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VHL-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eee-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            111     0  11111  6889999999999999999999964

>KOG0984|consensus

Probab=99.97  E-value=8e-32  Score=236.22  Aligned_cols=197  Identities=27%  Similarity=0.358  Sum_probs=160.1

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc-Cce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-~~~  252 (455)
                      ..||+|++|.|-+-++. +|+..|+|.++.....     .       ..++..+|+.+..++ .+|.+|.+||... +..
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-----q-------~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-----Q-------EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcCh-----H-------HHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            67999999999887765 5899999999755431     1       145578899998877 6899999999554 488


Q ss_pred             eEEEEEeccCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .++.||.| .-||..+... ...+..+++...-+|+..+..||.|||+. ..+||||+||+|||++.+|.+||||||++-
T Consensus       120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999999 4677655432 12256789999999999999999999984 469999999999999999999999999987


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccccC-----CCCcccchHHHHHHHHHHHcCCCCCCCCcc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~sDv~SlGvvl~elltG~~p~~~~~~  390 (455)
                      ...++-..    +.-.|-..|||||.+..     +|+.+|||||||+++.||.+++.||+....
T Consensus       198 ~L~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            76554322    22367889999997643     478899999999999999999999998764

>KOG0576|consensus

Probab=99.97  E-value=9.5e-32  Score=269.92  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             CCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         167 NRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       167 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      +..+.|+...++|.|++|.|||++++ .+...|||+++-...      ++       ....++|+-+++.|+||||+.++
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~------dd-------~~~iqqei~~~~dc~h~nivay~   78 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG------DD-------FSGIQQEIGMLRDCRHPNIVAYF   78 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC------cc-------ccccccceeeeecCCCcChHHHH
Confidence            45566778899999999999999987 488999999976543      21       33367899999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      |.+.. ...+++||||.||||.+.-+-   ..++++.++..+++..+.|++|||+  .|-+|||||-+|||+++.|.+|+
T Consensus        79 gsylr~dklwicMEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvkl  153 (829)
T KOG0576|consen   79 GSYLRRDKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKL  153 (829)
T ss_pred             hhhhhhcCcEEEEEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceee
Confidence            96655 888999999999999998765   6789999999999999999999999  78999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccc----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      .|||.+-.....-   .....+.||+.|||||+-    .|++...+|+|++|+...|+---++|.....+....+..-..
T Consensus       154 aDfgvsaqitati---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS  230 (829)
T KOG0576|consen  154 ADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS  230 (829)
T ss_pred             cccCchhhhhhhh---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc
Confidence            9999865443221   223467999999999954    567899999999999999999999887655433222222111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....+..       ..+..+...+.+|++.++..+|++||+++.++.
T Consensus       231 ~~qpp~l-------kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 GFQPPTL-------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCCcc-------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1111122       223456677999999999999999999987653

>KOG1024|consensus

Probab=99.97  E-value=8.8e-31  Score=248.69  Aligned_cols=254  Identities=25%  Similarity=0.342  Sum_probs=203.3

Q ss_pred             cCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      +....+-+|.||.||+|.|.+      .+.|-||.++..+            .++....+.+|--.+..+.|||++++.+
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A------------S~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA------------SQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc------------cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            445789999999999996642      3557788876433            2344677899999999999999999999


Q ss_pred             cccC--ceeEEEEEeccCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         247 LCNN--IMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       247 ~~~~--~~~~lV~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      .+.+  ..++.+|.++.-|+|..+|.-.     .....++-.+...++.|++.|+.|||+  +++||.||-..|.++|+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceehhh
Confidence            7755  7788999999999999999722     223457778899999999999999999  889999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~  397 (455)
                      ..+||+|=.++|..-..+. ......-.....||+||.+ ...++.++|+|||||++|||+| |+.||.+.++.++....
T Consensus       433 LqVkltDsaLSRDLFP~DY-hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDY-HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             eeEEeccchhccccCcccc-cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            9999999999886544332 1112222335579999966 5578999999999999999999 99999998877665544


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ..+           .+.-.+..++..+..++++||...|++||+.+|+..-|.+.
T Consensus       512 kdG-----------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 KDG-----------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             hcc-----------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            322           12233456777888899999999999999999999888764

>KOG1152|consensus

Probab=99.97  E-value=3.6e-31  Score=261.89  Aligned_cols=200  Identities=25%  Similarity=0.390  Sum_probs=167.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC---ccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~  248 (455)
                      ...+.+|+|+||.|++|.++. ...|+||.+.+.....+....+..     .-..-.|++||..++   |+||+++++++
T Consensus       564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrk-----LGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRK-----LGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccc-----cCccchhHHHHHHhhhcCccchhhhhhee
Confidence            455889999999999999874 678999999876654433332221     122456999999997   99999999999


Q ss_pred             cC-ceeEEEEEecc-CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         249 NN-IMNCIVYEYMC-NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 ~~-~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .+ +.+||++|-.. |-+|++++..   .+.+++..+..|+.|++.|+++||+  .||||||||-+||.++.+|.+||+|
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEee
Confidence            88 78889998764 4589999987   5679999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCC--CCcccchHHHHHHHHHHHcCCCCCCC
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~sDv~SlGvvl~elltG~~p~~~  387 (455)
                      ||.+.......     ...++||..|.|||++.|.  ....-|||++|++||.+.....||.+
T Consensus       714 fgsaa~~ksgp-----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  714 FGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccchhhhcCCC-----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99987765443     3457999999999999875  36688999999999999999999864

>KOG0664|consensus

Probab=99.97  E-value=9.8e-32  Score=244.51  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=186.2

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC----
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN----  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  250 (455)
                      +-||-|+||.||-+++. +|+.||+|++..-.           ......+.+.+|++.|..++|.|++..++...-    
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-----------q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-----------QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHH-----------HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            78999999999999875 69999999985322           122335678899999999999999998886533    


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        .+.|.|.|.| ..+|...+-.   ..+++.+.+.-++.||++||.|||+  .+|.||||||.|+|++.|..+||||||
T Consensus       128 fFqEiYV~TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  128 FFQELYVLTELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHHHHHHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEecccc
Confidence              3457778888 4567666654   4579999999999999999999999  789999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccch
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~  404 (455)
                      ++|......... ++ .-+-|..|.|||++.|  .++.++||||.||++.|++..+..|...+.......+..  +....
T Consensus       202 LARvee~d~~~h-MT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  202 LARTWDQRDRLN-MT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             cccccchhhhhh-hH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence            999776554322 22 2245788999997755  589999999999999999999999987764332222211  11111


Q ss_pred             h-----------hccchhc---------cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 R-----------EVLDKEA---------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~-----------~~~d~~~---------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +           .++....         ....+.........++.+++..||++|.+.++.+.
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            0           1111000         11111223334455677899999999999887754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.6e-29  Score=227.24  Aligned_cols=209  Identities=36%  Similarity=0.558  Sum_probs=177.8

Q ss_pred             cCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEE
Q psy5603         178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|++|.||++...+ ++.+++|++.......            ....+.+|++.++.+.|++++++++++.. ...++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~   68 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL   68 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEE
Confidence            6999999999999864 7899999987543211            13568999999999999999999998877 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CCceEEeecccccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSE  334 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~  334 (455)
                      ++|++.+++|.+++....  ..+++..+..++.++++++.+||+  .+++|+||+|.||+++. ++.++|+|||.+....
T Consensus        69 ~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~  144 (215)
T cd00180          69 VMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT  144 (215)
T ss_pred             EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence            999999999999988642  368999999999999999999999  78999999999999999 8999999999987655


Q ss_pred             cCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhc
Q psy5603         335 TSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   ......+...|++||.+..  ..+.++|+||+|++++++                                  
T Consensus       145 ~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         145 SDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             CCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            4321   1233567888999997755  567899999999999999                                  


Q ss_pred             cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                               ..+.+++..|+..+|++||++.++++.
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                     236778999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd08793 Death_IRAK4 Death domain of Interleukin-1 Receptor-Associated Kinase 4

Probab=99.96  E-value=2.9e-30  Score=201.46  Aligned_cols=98  Identities=23%  Similarity=0.359  Sum_probs=93.4

Q ss_pred             ceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCC
Q psy5603          11 IEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRP   90 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~   90 (455)
                      ||||.||++++++||++|||+++|+++|+.|++++|   +++|++.|||.||++++   +|+|||++||++||++   |+
T Consensus         1 t~ir~L~~~vrkkL~~~LDp~~~W~~LA~~i~~~~~---~~~y~~~ei~~ie~~~~---~g~SPT~~LL~dWgt~---N~   71 (100)
T cd08793           1 TYVRNLNYGLLRQLSDFLDPQEGWKKIAVAIKKPSG---DPRYSQFHIRRFEALVQ---QGKSPTCELLFDWGTT---NC   71 (100)
T ss_pred             ChHHHcCHHHHHHHHHHhCCcccHHHHHHHHhcccC---CCCCCHHHHHHHHHHHH---cCCChHHHHHHHHccC---CC
Confidence            799999999999999999999999999999999988   89999999999999988   5999999999999997   99


Q ss_pred             CHHHHHHHHHhcccccccccccccccc
Q psy5603          91 RLSDLIMFLKKAELHQAARYVEVDVLK  117 (455)
Q Consensus        91 ~~~~l~~~l~~~~l~~~~~~~~~~~~~  117 (455)
                      ||++|+++|.+.++++||+++.|++.+
T Consensus        72 TV~~L~~lL~k~~l~~am~~l~p~~~~   98 (100)
T cd08793          72 TVGDLVDLLIQNEFFAPASLLLPDAVP   98 (100)
T ss_pred             cHHHHHHHHHHcccHHHHHHHCCCccc
Confidence            999999999999999999999887653

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinases. IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK4 is an active kinase that is also involved in T-cell receptor signaling pathways, implying that it may function in acquired immunity and not just in innate immunity. It is known as the master IRAK member because its absence strongly impairs TLR- and IL-1-mediated signaling and innate immune defenses, while the absence of other IRAK proteins only shows slight effects. IRAK4-deficient patients have impaired inflammatory responses and recurrent life-threatening infections. DDs are protein-protein int

>KOG0670|consensus

Probab=99.96  E-value=6.3e-30  Score=250.24  Aligned_cols=254  Identities=23%  Similarity=0.307  Sum_probs=194.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc------cceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH------VNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l  244 (455)
                      |++....|+|-||+|.+|.+.. |..||||+++....              --+.=+.|++||++|..      -|++++
T Consensus       434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--------------M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--------------MHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             eEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--------------HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            4566778999999999999864 78999999975321              02224679999999953      388888


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-Cce
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVP  322 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-~~~  322 (455)
                      +..|.. .++|||+|-+ ..+|.+.|...+....|....+..++.|+..||..|-.  -||+|.||||+|||+++. ..+
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCccee
Confidence            886655 9999999988 68999999998888889999999999999999999999  679999999999999864 689


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      ||||||.|.+...+...+.     .-+.-|.|||++.| .|+...|+||.||+||||.||+..|.+.....+......  
T Consensus       577 KLCDfGSA~~~~eneitPY-----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  577 KLCDFGSASFASENEITPY-----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeccCccccccccccccHH-----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            9999999988877664332     33456999996655 689999999999999999999999988763322222111  


Q ss_pred             cccc-----------------------------------hhhccch------hc-c--CCC--hhHHHHHHHHHHHhhhc
Q psy5603         400 QEVP-----------------------------------VREVLDK------EA-G--EWN--ETHVETLISIVFEKCCV  433 (455)
Q Consensus       400 ~~~~-----------------------------------~~~~~d~------~~-~--~~~--~~~~~~~l~~Li~~~l~  433 (455)
                      +..+                                   +..++.+      .+ +  ..+  .......+.+|+.+|+.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            1111                                   0001111      00 0  011  23455678899999999


Q ss_pred             cCcCCCCCHHHHHH
Q psy5603         434 FEKDKRASMRDIVD  447 (455)
Q Consensus       434 ~dp~~RPs~~evl~  447 (455)
                      .||.+|.+..+.+.
T Consensus       732 LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  732 LDPEKRITVNQALK  745 (752)
T ss_pred             cChhhcCCHHHHhc
Confidence            99999999998864

>KOG0668|consensus

Probab=99.96  E-value=4.1e-29  Score=222.31  Aligned_cols=258  Identities=19%  Similarity=0.305  Sum_probs=193.0

Q ss_pred             HhcCCCCCCCCcCCCccCcCCCeEEEEEEE-cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-cc
Q psy5603         162 ATDGFNRKPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HV  239 (455)
Q Consensus       162 ~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~  239 (455)
                      .+-.|....-|++.+++|+|-++.||.|.. .++..++||++++-                ..+.+.+|+.||..++ ||
T Consensus        30 ~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----------------kkkKIkREikIL~nL~gg~   93 (338)
T KOG0668|consen   30 LVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----------------KKKKIKREIKILQNLRGGP   93 (338)
T ss_pred             eeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----------------HHHHHHHHHHHHHhccCCC
Confidence            455566666778889999999999999984 35789999999742                1455889999999997 99


Q ss_pred             ceeeecccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE
Q psy5603         240 NLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       240 niv~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      ||+++++...+   ..+.||+||..+.+...+..      .++.-.+..++.+++.||.|+|+  .||+|||+||.|+++
T Consensus        94 NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen   94 NIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMI  165 (338)
T ss_pred             CeeehhhhhcCccccCchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeee
Confidence            99999998766   56789999999888877654      37888899999999999999999  889999999999999


Q ss_pred             cC-CCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcc--h
Q psy5603         317 DE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNT--I  391 (455)
Q Consensus       317 ~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~--~  391 (455)
                      |. .-.++|+|+|+|.+.......    +..+.+..|.-||++-  ..++...|+|||||+|..|+..+-||.....  +
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D  241 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD  241 (338)
T ss_pred             chhhceeeeeecchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence            95 458999999999987655422    2335667788999663  3578899999999999999999999865431  1


Q ss_pred             -hhHHHhhhcc---------------cchhhccchhc-cCC-------ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         392 -LYYYLVVEQE---------------VPVREVLDKEA-GEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       392 -~~~~~~~~~~---------------~~~~~~~d~~~-~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       +.......+.               ..+..++.... ..|       ....+....-+|+.+.+..|-.+|+|++|.+.
T Consensus       242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             1111100010               01111111111 111       11233356778999999999999999999764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1e-27  Score=222.71  Aligned_cols=197  Identities=35%  Similarity=0.532  Sum_probs=165.7

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      .+.+.||+|++|.||+|...+ ++.+|+|.+......            .....+.+|++.+.+++|+|++++++++.. 
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~   69 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE------------KQREEFLREIRILKKLKHPNIVKLYGVFEDP   69 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch------------HHHHHHHHHHHHHHhCCCCChhhheeeeecC
Confidence            345889999999999999875 789999998754321            014568899999999999999999998776 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++++||+.+++|.+++.....  .+++..+..++.+++.++.+||+  .+++|+||+|.||+++.++.++|+|||++
T Consensus        70 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       70 EPLYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             CceEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence            788999999999999999986332  28899999999999999999999  78999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-c-CCCCcccchHHHHHHHHHHHcCCCCCCC
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-H-CQISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~-~~~~~~sDv~SlGvvl~elltG~~p~~~  387 (455)
                      ........  .......++..|++||.+ . ..++.++|+||||++++||++|+.||..
T Consensus       146 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      146 RFIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eEecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            87654320  012345678889999976 2 3467799999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665|consensus

Probab=99.96  E-value=6.5e-29  Score=231.04  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=187.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      +|.-...+|.|.- .|--+.+. .+++||+|++.......           ...++..+|...+..+.|+||++++.++.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~-----------~~akra~rel~l~~~v~~~nii~l~n~ft   85 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ-----------THAKRAYRELKLMKCVNHKNIISLLNVFT   85 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC-----------ccchhhhhhhhhhhhhcccceeeeeeccC
Confidence            3334477899988 56666543 47999999986542211           11455789999999999999999999763


Q ss_pred             C-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      -       ...|+|||+| .++|.+.+..     .++-..+..|..|++.|++|||+  .+|+||||||+||++..+..+
T Consensus        86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~l  157 (369)
T KOG0665|consen   86 PQKTLEEFQEVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTL  157 (369)
T ss_pred             ccccHHHHHhHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhhe
Confidence            2       3558999999 6889888773     36778899999999999999999  789999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-c
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      ||.|||+|+.....    ...+..+.|..|.|||++ ..++.+.+||||+||++.||++|..-|.+.+...-+.++.. -
T Consensus       158 Ki~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l  233 (369)
T KOG0665|consen  158 KILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL  233 (369)
T ss_pred             eeccchhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence            99999999865433    223456889999999965 44688899999999999999999999987764333333222 1


Q ss_pred             ccc--------------------------hhhccchhc---cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVP--------------------------VREVLDKEA---GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~--------------------------~~~~~d~~~---~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.+                          +.+.+....   ....+..-....++|+.+||-.+|++|.+++++++
T Consensus       234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            111                          011110000   00001123456888999999999999999999875

>KOG1345|consensus

Probab=99.95  E-value=1.8e-28  Score=223.28  Aligned_cols=241  Identities=20%  Similarity=0.328  Sum_probs=177.2

Q ss_pred             CCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecc-cccC
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG-LCNN  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~  250 (455)
                      +.+.||+|.||.+-+++++. .+.+++|.+....              .....|.+|...--.+ .|.||+..|+ .+..
T Consensus        28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--------------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--------------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             HHHHhcccceeeEEeeeccCCceEEEeeccCcch--------------hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            44899999999999999884 6789999986432              2256699999876666 6899999998 4555


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc--CCCceEEeec
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDF  327 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~--~~~~~kl~DF  327 (455)
                       +.+.+++||++.|+|..-+..    ..+-+.....++.|++.||.|+|+  +++||||||.+|||+-  +...+|||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeec
Confidence             778899999999999887764    347888899999999999999999  9999999999999994  3458999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc----CC--CCcccchHHHHHHHHHHHcCCCCCCCCcch-hhHHH---h
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL---V  397 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~--~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~~~---~  397 (455)
                      |+.+..+...      ...--+..|.|||...    +.  ..+.+|+|.|||++|.++||.+||...... ..+..   .
T Consensus       168 G~t~k~g~tV------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w  241 (378)
T KOG1345|consen  168 GLTRKVGTTV------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW  241 (378)
T ss_pred             ccccccCcee------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH
Confidence            9987544321      1223456799999542    22  467899999999999999999999854311 11111   1


Q ss_pred             hh-cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         398 VE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       398 ~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                      .. ....+++.+    ..+     +.-+..++++-+..++++|-.+.++.+.-
T Consensus       242 ~~rk~~~~P~~F----~~f-----s~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  242 LKRKNPALPKKF----NPF-----SEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             hcccCccCchhh----ccc-----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            11 111122222    122     22245567788999999997777665544

>KOG1290|consensus

Probab=99.95  E-value=7.4e-27  Score=227.68  Aligned_cols=129  Identities=28%  Similarity=0.332  Sum_probs=107.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-----c---cce
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----H---VNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~ni  241 (455)
                      +|-+.++||-|-|++||++-+.. .+.||+|+.+...-              -.+....||++|++++     |   ..|
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--------------YtEaAlDEIklL~~v~~~Dp~~~~~~~V  144 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--------------YTEAALDEIKLLQQVREGDPNDPGKKCV  144 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--------------HHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence            56778999999999999998763 67899999974322              1344678999999874     2   379


Q ss_pred             eeeccccc----C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE
Q psy5603         242 LRLLGLCN----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       242 v~l~~~~~----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      |+|+++|.    + .+.|+|+|++ |.+|..++..... ..++...+..|+.|++.||.|||+- -||||-||||+|||+
T Consensus       145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence            99999773    2 6789999999 8899999987553 5689999999999999999999985 479999999999999

>KOG1167|consensus

Probab=99.95  E-value=8.8e-28  Score=231.17  Aligned_cols=253  Identities=24%  Similarity=0.281  Sum_probs=186.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |...++||+|+|++||++++.+    .+.||+|.+.....               -....+|++.|..+ .+.||+++.+
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---------------p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---------------PSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---------------chHHHHHHHHHHHhccchhhhcchh
Confidence            4555999999999999998643    57899999865432               23488999999999 5999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CCceEE
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKL  324 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl  324 (455)
                      +... +..++|+||++...-.+++..      ++...+..++..++.||.++|.  +|||||||||+|+|.+. .+.-.|
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceE
Confidence            8766 889999999999999998875      7789999999999999999999  89999999999999984 578899


Q ss_pred             eecccccccccCC---------------------------------c--------ceeeeccCCCCCCCCCccccc--CC
Q psy5603         325 GDFGIVKMSETSN---------------------------------M--------KTMYTENLTGTRPYMPPEAMH--CQ  361 (455)
Q Consensus       325 ~DFGla~~~~~~~---------------------------------~--------~~~~~~~~~gt~~Y~aPE~~~--~~  361 (455)
                      +|||+|.......                                 .        .........||++|.|||++.  +.
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            9999986110000                                 0        000011247999999999764  35


Q ss_pred             CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH--------------hhh-cc------cc----------hhhccch
Q psy5603         362 ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL--------------VVE-QE------VP----------VREVLDK  410 (455)
Q Consensus       362 ~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~--------------~~~-~~------~~----------~~~~~d~  410 (455)
                      -++++||||.|||++.+++++.||.....+.....              ... +.      ..          +....-.
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            68899999999999999999999975431111000              000 00      00          0001000


Q ss_pred             hcc---------CCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         411 EAG---------EWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       411 ~~~---------~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...         ....+..+..+.+|+.+|+..||.+|.++++.++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            000         0112334457888999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=5.7e-27  Score=257.83  Aligned_cols=197  Identities=17%  Similarity=0.145  Sum_probs=134.6

Q ss_pred             HhhCCc-cceeeecccc-------cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         233 LSQCKH-VNLLRLLGLC-------NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       233 l~~l~h-~niv~l~~~~-------~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      .+.++| +||+.+++++       .. ...++++||+ +++|.++|...  ..++++.+++.++.||+.||.|||+  +|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~g  100 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHS--QG  100 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHh--CC
Confidence            345556 5888888866       12 3446678877 77999999753  2469999999999999999999999  88


Q ss_pred             eeecCCCCCcEEEcCC-------------------CceEEeecccccccccCCc-------------ceeeeccCCCCCC
Q psy5603         304 IIHRDVKSANVLLDEN-------------------FVPKLGDFGIVKMSETSNM-------------KTMYTENLTGTRP  351 (455)
Q Consensus       304 iiH~Dikp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~-------------~~~~~~~~~gt~~  351 (455)
                      |+||||||+||||+..                   +.+||+|||+++.......             .........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999654                   4455666666543211000             0000112468999


Q ss_pred             CCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHh
Q psy5603         352 YMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEK  430 (455)
Q Consensus       352 Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~  430 (455)
                      |+|||++ ...++.++|||||||+||||++|.+|+..........  ....      +.+..    .... ....+++.+
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~--~~~~------~~~~~----~~~~-~~~~~~~~~  247 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSL--RHRV------LPPQI----LLNW-PKEASFCLW  247 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHH--HHhh------cChhh----hhcC-HHHHHHHHH
Confidence            9999965 4568999999999999999999998876432211110  0000      00100    0001 123456778


Q ss_pred             hhccCcCCCCCHHHHHH
Q psy5603         431 CCVFEKDKRASMRDIVD  447 (455)
Q Consensus       431 ~l~~dp~~RPs~~evl~  447 (455)
                      ||..+|.+||++.|+++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.2e-25  Score=201.91  Aligned_cols=166  Identities=22%  Similarity=0.274  Sum_probs=124.5

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceee
Q psy5603         263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY  342 (455)
Q Consensus       263 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  342 (455)
                      |||.+++...+  .++++.+++.|+.|++.||.|||+  ++      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccc------
Confidence            78999997643  369999999999999999999999  55      999999999999999  9998765432      


Q ss_pred             eccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH-HhhhcccchhhccchhccCCChhHH
Q psy5603         343 TENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY-LVVEQEVPVREVLDKEAGEWNETHV  420 (455)
Q Consensus       343 ~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~d~~~~~~~~~~~  420 (455)
                        ...||+.|+|||++. +.++.++|||||||++|||+||..||.......... .........    +.. .......+
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~  135 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD----DPR-DRSNLESV  135 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC----Ccc-ccccHHHH
Confidence              126899999999764 467889999999999999999999997654221111 111110000    000 00112233


Q ss_pred             HH--HHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         421 ET--LISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       421 ~~--~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..  .+.+++.+|+..+|++||++.++++.+..+.
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            33  5889999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd08307 Death_Pelle Death domain of the protein kinase Pelle

Probab=99.93  E-value=2e-26  Score=181.44  Aligned_cols=88  Identities=22%  Similarity=0.426  Sum_probs=84.0

Q ss_pred             ceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCC
Q psy5603          11 IEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRP   90 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~   90 (455)
                      ||||+||++++++||++||++++|++||+.|+         +|++.||+.||+++.   +|+|||++||++||++   |+
T Consensus         1 ~yIr~Lp~~~~~~Lc~lLD~~~~W~~LA~~i~---------~ys~~~v~~i~~~~~---~g~SPt~eLL~~WG~~---n~   65 (97)
T cd08307           1 MYIYDIPFTERKQLCALLDTDNVWEELAFVMM---------GYSNDDVEGIQRCCL---RGRSPTEELLDIWGNK---NH   65 (97)
T ss_pred             CCcccCCHHHHHHHHHHhCCcCcHHHHHHHHh---------cCCHHHHHHHHHHHc---CCCChHHHHHHHHhhc---CC
Confidence            69999999999999999999999999999997         899999999999987   5999999999999998   99


Q ss_pred             CHHHHHHHHHhcccccccccccc
Q psy5603          91 RLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        91 ~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                      ||++|+++|.+.++++||+++.+
T Consensus        66 Tv~~L~~~L~k~kl~~Am~ilk~   88 (97)
T cd08307          66 TITELFVLLYREKLFRAMRIIKD   88 (97)
T ss_pred             CHHHHHHHHHHhchHHHHHHHHH
Confidence            99999999999999999998754

Death domain (DD) of the protein kinase Pelle from Drosophila melanogaster and simlar proteins. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and in mediating innate immune responses to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Pelle also functions in photoreceptor axon targeting. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=3.8e-25  Score=218.99  Aligned_cols=167  Identities=18%  Similarity=0.133  Sum_probs=124.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc--CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      |.+++.||+|+||+||+|.++  +++.||||++........   .     ......|.+|++++++++|+|+++.+..  
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~---~-----~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS---K-----PLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc---c-----HHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            345599999999999999875  467789998752211000   0     0114558999999999999999863322  


Q ss_pred             CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC-CCCcEEEcCCCceEEeecc
Q psy5603         250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV-KSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di-kp~NILl~~~~~~kl~DFG  328 (455)
                      .+..|+||||++|++|.. +..      ..   ...++.+++.||.|||+  +||+|||| ||+|||++.++.+||+|||
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            245799999999999963 211      11   14678899999999999  89999999 9999999999999999999


Q ss_pred             cccccccCCccee-----eeccCCCCCCCCCcccccC
Q psy5603         329 IVKMSETSNMKTM-----YTENLTGTRPYMPPEAMHC  360 (455)
Q Consensus       329 la~~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~  360 (455)
                      +|+..........     ......+++.|+|||.+..
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9987654321111     1135678999999998753

>KOG1164|consensus

Probab=99.92  E-value=1.5e-23  Score=207.08  Aligned_cols=259  Identities=24%  Similarity=0.281  Sum_probs=183.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCC--cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc----cceeee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH----VNLLRL  244 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l  244 (455)
                      .|.+.++||+|+||.||.|.....  ..+|+|...........             .+..|..++..+..    +++..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-------------~l~~E~~vl~~l~~~~~~~~~~~~   85 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-------------VLKIEIQVLKKLEKKNGPSHFPKL   85 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-------------cchhHHHHHHHHhhhcCCCCCCEE
Confidence            356779999999999999998653  47888887654321111             26678888887762    577777


Q ss_pred             cccc-cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---
Q psy5603         245 LGLC-NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---  319 (455)
Q Consensus       245 ~~~~-~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---  319 (455)
                      ++.. .. ...++||+.+ |.||.++..... ...++..+++.|+.|++.+|++||+  .|++||||||+|++++..   
T Consensus        86 ~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~  161 (322)
T KOG1164|consen   86 LDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRS  161 (322)
T ss_pred             EEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCc
Confidence            7766 34 6789999988 999999876544 4579999999999999999999999  889999999999999865   


Q ss_pred             --CceEEeeccccc--ccccCCc---ceee--eccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCc
Q psy5603         320 --FVPKLGDFGIVK--MSETSNM---KTMY--TENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       320 --~~~kl~DFGla~--~~~~~~~---~~~~--~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~  389 (455)
                        ..+.|.|||+++  .......   ....  ...+.||..|.++.+..+ ..+.+.|+||++.++.|++.|..||....
T Consensus       162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence              469999999998  3222211   1111  234679999999996544 67899999999999999999999997654


Q ss_pred             chhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         390 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..........  ......... ...    ..+..+..+...+-..+...+|....+...|++..
T Consensus       242 ~~~~~~~~~~--~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  242 MTDLKSKFEK--DPRKLLTDR-FGD----LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             ccchHHHHHH--Hhhhhcccc-ccC----CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            2211111111  000011110 111    12223444444444477999999999999887664

>KOG1165|consensus

Probab=99.91  E-value=1.3e-23  Score=196.60  Aligned_cols=257  Identities=21%  Similarity=0.315  Sum_probs=187.2

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEE-cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      .+.|+++++||+|+||..|.|+. -++..||||.-..++.               .-++..|....+.| ..++|...|-
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---------------APQLrdEYr~YKlL~g~~GIP~vYY   91 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---------------APQLRDEYRTYKLLGGTEGIPQVYY   91 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC---------------cchHHHHHHHHHHHcCCCCCCceee
Confidence            35678999999999999999984 3589999998654332               22367788888777 4688888877


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-----C
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-----F  320 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-----~  320 (455)
                      |-.+ .+..||+|.+ |.||+|+..-.++  .++...++.+|.|++.-++|+|+  +.+|.|||||+|+||+.-     .
T Consensus        92 FGqeG~~NiLVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n  166 (449)
T KOG1165|consen   92 FGQEGKYNILVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDAN  166 (449)
T ss_pred             eccccchhhhhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCc
Confidence            7766 5678999998 8999998876544  69999999999999999999999  889999999999999743     4


Q ss_pred             ceEEeecccccccccCCcceee----eccCCCCCCCCCcc-cccCCCCcccchHHHHHHHHHHHcCCCCCCCCcc---hh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMY----TENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT---IL  392 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~----~~~~~gt~~Y~aPE-~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~---~~  392 (455)
                      .+.|+|||+|+...+.......    .....||..||+-- .+...-+.+-|.-|+|-|++..|-|..||.+...   ..
T Consensus       167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~  246 (449)
T KOG1165|consen  167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE  246 (449)
T ss_pred             eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence            7899999999987766543322    23468999999988 4544678899999999999999999999998762   23


Q ss_pred             hHHHhhh--cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         393 YYYLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .+.++-+  ...++.++..    . .+.+....+.  ..+-|.+  ..-|..+-+...+.++++
T Consensus       247 kYeKIGe~Kr~T~i~~Lc~----g-~P~efa~Yl~--yvR~L~F--~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  247 KYEKIGETKRSTPIEVLCE----G-FPEEFATYLR--YVRRLDF--FETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             HHHHhccccccCCHHHHHh----c-CHHHHHHHHH--HHHhcCc--ccCCCHHHHHHHHHHHHH
Confidence            3333322  1112222211    1 2233333444  3344443  445677666666665553

>cd08309 Death_IRAK Death domain of Interleukin-1 Receptor-Associated Kinases

Probab=99.91  E-value=1.1e-24  Score=173.64  Aligned_cols=92  Identities=27%  Similarity=0.459  Sum_probs=88.2

Q ss_pred             ceeeecCHHHHHHhhhhcCC--cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCC
Q psy5603          11 IEIRHLKQYVVHELGIILNE--RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~--~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      ||||+||++++++||.+||+  +++|++||+.|+++.|   .+||++.||+.||..++|   |+|||++||++||++   
T Consensus         1 ~~i~~Lp~~~~~~L~~~LD~~~~~~W~~LA~~i~~~~~---~~~~~~~~i~~~e~~~~~---g~SPt~~LL~~W~~~---   71 (95)
T cd08309           1 TYIRQLPYSVLARLCKVLDPLELKGWRQLASLIPKGLG---GPRYDLTDVRQIESMKQR---GRSPTRELLWDWGTQ---   71 (95)
T ss_pred             CcceeCCHHHHHHHHHHhCCcccCChHHHHHHhccccc---cCCcCHHHHHHHHHHhhc---CCChHHHHHHHHHhc---
Confidence            79999999999999999999  9999999999999988   889999999999999884   999999999999998   


Q ss_pred             CCCHHHHHHHHHhcccccccccc
Q psy5603          89 RPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      |+||++|+++|.+.++++|++++
T Consensus        72 ~~Tv~~L~~~L~~~~l~~A~~~i   94 (95)
T cd08309          72 NATVQDLVQVLVQLELYRAADLL   94 (95)
T ss_pred             CCCHHHHHHHHHHcccHHHHHHh
Confidence            99999999999999999999875

Death Domains (DDs) found in Interleukin-1 (IL-1) Receptor-Associated Kinases (IRAK1-4) and similar proteins. IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. All four types are involved in signal transduction involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinase pathways. IRAK1 and IRAK4 are active kinases while IRAK2 and IRAK-M (also called IRAK3) are inactive. In general, IRAKs are expressed ubiquitously, except for IRAK-M which is detected only in macrophages. The insect homologs, Pelle and Tube, are important components of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in the innate immune response. Most members have an N-terminal DD followed by a kinase domain. In general, DDs are protein-protein interaction domains found in a variety of domain a

>cd08795 Death_IRAK2 Death domain of Interleukin 1 Receptor Associated Kinase-2

Probab=99.91  E-value=1e-24  Score=166.53  Aligned_cols=86  Identities=16%  Similarity=0.263  Sum_probs=76.9

Q ss_pred             eeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCC
Q psy5603          12 EIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        12 ~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      |||.||++|+++||++||++++|+.++.+.+--+        +|+|+|.||++++   +|+|||+|||++||++   |+|
T Consensus         2 ~iy~lP~~v~~~lc~~lDsl~~w~~~~~a~~~~~--------~q~~vr~ie~~~~---~G~SpT~eLL~~Wg~~---N~T   67 (88)
T cd08795           2 YVYQLPAWVLDDFCRNMDALSDWDWMRFASYVIT--------DQTQLRKIKSMEW---TGVSITRELMWWWGMR---LAT   67 (88)
T ss_pred             chhhCCHHHHHHHHHHHcccchHHHHHHHHHhcc--------cHHHHHHHHHHHH---cCCChHHHHHHHHHcC---CCC
Confidence            8999999999999999999999997766554111        2889999999988   5999999999999998   999


Q ss_pred             HHHHHHHHHhcccccccccc
Q psy5603          92 LSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~~~~  111 (455)
                      |++|+++|.+.+++||++++
T Consensus        68 V~~L~~lL~~~~l~rA~~ii   87 (88)
T cd08795          68 VQQLVDLLQRLELYRAAQII   87 (88)
T ss_pred             HHHHHHHHHHCccHHHHHHh
Confidence            99999999999999999865

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors (TLRs), nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK2 is an essential component of several signaling pathways, including NF-kappaB and the IL-1 signaling pathways. It is an inactive kinase that participates in septic shock mediated by TLR4 and TLR9. It plays a redundant role with IRAK1 in early NF-kB and MAPK responses, and remains present at later stages whereas IRAK1 disappears. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-as

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=9.5e-23  Score=197.73  Aligned_cols=257  Identities=31%  Similarity=0.462  Sum_probs=191.7

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcc-ceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV-NLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~-  250 (455)
                      ++...||.|+||.||++.+.  ..+|+|.+........          .....|.+|+.++..+.|+ +++++++++.. 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   70 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS----------KEVERFLREIQILASLNHPPNIVKLYDFFQDE   70 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch----------hHHHHHHHHHHHHHHccCCcceeeEEEEEecC
Confidence            45578999999999999986  7899999976544221          1245689999999999988 79999998766 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC-ceEEeeccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGI  329 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGl  329 (455)
                      ...+++++++.++++.+.+........++......++.|++.++.|+|+  .+++|||+||+||+++..+ .++++|||+
T Consensus        71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~  148 (384)
T COG0515          71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGL  148 (384)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence            4569999999999999766652211268999999999999999999999  7899999999999999998 799999999


Q ss_pred             ccccccCCcce---eeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcc----hhhHHHhh
Q psy5603         330 VKMSETSNMKT---MYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNT----ILYYYLVV  398 (455)
Q Consensus       330 a~~~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~----~~~~~~~~  398 (455)
                      ++.........   .......||..|+|||.+.+    ..+..+|+||+|++++++++|..||.....    ........
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  228 (384)
T COG0515         149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL  228 (384)
T ss_pred             ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence            88554433211   12356789999999997654    567899999999999999999999776653    11111111


Q ss_pred             hcccc-hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 EQEVP-VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~~~~-~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....+ ..........    ......+.+++..++..+|..|.+..+...
T Consensus       229 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         229 ELPTPSLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             hcCCcccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            11111 1000000000    122345777888999999999999887654

>cd08796 Death_IRAK-M Death domain of Interleukin 1 Receptor Associated Kinase-M

Probab=99.90  E-value=2.8e-24  Score=165.87  Aligned_cols=85  Identities=14%  Similarity=0.246  Sum_probs=78.9

Q ss_pred             ceeeecCHHHHHHhhhhcCCcc---hHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCC
Q psy5603          11 IEIRHLKQYVVHELGIILNERD---DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~---~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      |.+|.||++|+++||++||+++   +|++||+.|+.+          +.|+|.||++++   +|+|||+|||++||++  
T Consensus         1 ~~ly~lP~~v~~~lc~~LDs~~~~~~W~~lA~~i~~~----------~~~vr~ie~~~~---~G~SPT~eLL~~Wg~~--   65 (89)
T cd08796           1 TLLFDLPPVLLGSLCALLDSGVGGLGWRTLAERLSSS----------WLEVRHIEKYVV---QGKSGTRELLWSWAQK--   65 (89)
T ss_pred             CchhhCCHHHHHHHHHHhcCCCccccHHHHHHHHhcc----------HHHHHHHHHHHH---cCCCcHHHHHHHHHcc--
Confidence            4689999999999999999877   999999999832          889999999988   5999999999999998  


Q ss_pred             CCCCHHHHHHHHHhcccccccccc
Q psy5603          88 RRPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                       |+||++|+++|.+.++++|++++
T Consensus        66 -n~TV~eL~~~L~~~~l~rA~~li   88 (89)
T cd08796          66 -NKTVGDLLQVLDEMGHARAISLF   88 (89)
T ss_pred             -CCCHHHHHHHHHHcCcHHHHHhh
Confidence             99999999999999999999865

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase M (IRAK-M). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors(TLRs), nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK-M, also called IRAK-3, is an inactive kinase present only in macrophages in an inducible manner. It is a negative regulator of TLR signaling and it contributes to the attenuation of NF-kB activation. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitme

>KOG1163|consensus

Probab=99.90  E-value=3.4e-23  Score=186.00  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=181.7

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc-cceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~  248 (455)
                      -|++.++||.|+||.+|.|..- +|..||||.-+..+..+               ++.-|..+...+++ ..|..+.-|.
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp---------------qL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP---------------QLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc---------------chhHHHHHHHHhccCCCCchhhhhc
Confidence            3567799999999999999854 59999999986554422               26678888888875 4566666666


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKL  324 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl  324 (455)
                      .+ ....+||+.+ |.||++++.-..+  .++..+++-++-|++.-++|+|.  +++|||||||+|.|.+-   ...+.+
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEE
Confidence            66 6778999998 8999998875433  58999999999999999999999  89999999999999963   457899


Q ss_pred             eecccccccccCCccee----eeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch---hhHHH
Q psy5603         325 GDFGIVKMSETSNMKTM----YTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYYYL  396 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~---~~~~~  396 (455)
                      +|||+++...+......    ......||..|.+--+..| .-+.+.|+-|+|.||....-|..||.+....   ..+..
T Consensus       156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence            99999987665433221    1245689999988775544 4577899999999999999999999987633   33333


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHH
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      +.+.....+  +..-...     .+..+...+.-|=...-++-|...-+-+.+.
T Consensus       236 I~EkK~s~~--ie~LC~G-----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  236 ISEKKMSTP--IEVLCKG-----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHHhhcCCC--HHHHhCC-----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            333222111  1111111     2233444455565555666666655544443

>KOG0195|consensus

Probab=99.90  E-value=3.7e-24  Score=195.14  Aligned_cols=247  Identities=25%  Similarity=0.365  Sum_probs=188.1

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      .+|.+...|..|+|+|. |..+++|+++........           ...|..|.-.|+-+.||||++++|.|.. ..+.
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~ri-----------srdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARI-----------SRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhccCCCccccccccc-Ccchhhhhhhhhhcchhh-----------cchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            56899999999999997 677888988755432221           2238889999999999999999999988 7889


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ++..||+-|||+..|+... +-..+-.++.+++..+++|++|||+...-|----+.+..+++|++..++|+= +-++++-
T Consensus       264 ~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfsf  341 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF  341 (448)
T ss_pred             EeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceeee
Confidence            9999999999999999755 3457788999999999999999999853344447899999999999888752 2222211


Q ss_pred             cCCcceeeeccCCCCCCCCCcccccCCC----CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         335 TSNMKTMYTENLTGTRPYMPPEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      .       .....-.++||+||.+....    -.++|+|||+++|||+.|...||.+.....--.++..+....      
T Consensus       342 q-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv------  408 (448)
T KOG0195|consen  342 Q-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV------  408 (448)
T ss_pred             e-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc------
Confidence            1       11224578899999876543    237899999999999999999998876543333332222111      


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          .-+..++.....|+.-|.+.||.+||.++.|+-.|++++
T Consensus       409 ----~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 ----HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                112234455777888999999999999999999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=8.7e-23  Score=185.84  Aligned_cols=152  Identities=16%  Similarity=0.163  Sum_probs=111.2

Q ss_pred             CCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCC------Cc-------hhhhhhhhHHHHHHHHHHHhhCCccce
Q psy5603         175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN------SD-------NTEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~------~~-------~~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      ...||+|+||.||+|...+|+.||||+++.........      ..       ......+......+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            36799999999999998789999999998653211110      00       000001112234569999999988776


Q ss_pred             eeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeeecCCCCCcEEEcCCC
Q psy5603         242 LRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL-HSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       242 v~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~L-H~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .....+.. ...++||||++|+++......   ..+++......++.|++.+|.++ |+  .||+||||||+|||++ ++
T Consensus        82 ~~p~~~~~-~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILL-KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEe-cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE-CC
Confidence            43333222 234899999998877655333   23688999999999999999999 68  7899999999999998 47


Q ss_pred             ceEEeeccccccc
Q psy5603         321 VPKLGDFGIVKMS  333 (455)
Q Consensus       321 ~~kl~DFGla~~~  333 (455)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590|consensus

Probab=99.89  E-value=1.5e-23  Score=220.63  Aligned_cols=258  Identities=20%  Similarity=0.258  Sum_probs=184.5

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ..+..+|.|++|.|+...... ...++.|..+.. .....  .....    ...+..|+-+-..+.|||++..+....+ 
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~--s~~~~----~~~i~sE~~i~~~l~h~~~~e~l~~~~~~  393 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTE--SERKY----NYNITSEFCIGSSLSHPNIIETLDIVQEI  393 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcc--cHHHH----hhhhhhheeecccccCCchhhhHHHHhhc
Confidence            456889999999888776532 444555554321 10000  11111    1226678888899999999998886665 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ....-+||||++ +|..++...   ..++...+..++.|++.|+.|+|+  .||.|||+|++|+++..+|.+||+|||.+
T Consensus       394 ~~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  394 DGILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             ccchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCcc
Confidence            444445999999 999999873   358888999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcc-eeeeccCCCCCCCCCcccccC-CCCc-ccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         331 KMSETSNMK-TMYTENLTGTRPYMPPEAMHC-QIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~~-~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ......... ......++|+.+|+|||++.+ .+.+ ..||||.|+++..|.+|+.||.........+.........   
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~---  544 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQR---  544 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccc---
Confidence            876554322 244567899999999997755 5655 6799999999999999999997654321111000000000   


Q ss_pred             cchhccCCC-hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWN-ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~-~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ....+.+. ....+..-+.+|.++++.+|.+|.++.+|++
T Consensus       545 -~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 -NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             00001111 2344555677899999999999999999975

>PF14786 Death_2: Tube Death domain; PDB: 1D2Z_B

Probab=99.88  E-value=1.3e-23  Score=170.71  Aligned_cols=118  Identities=44%  Similarity=0.791  Sum_probs=90.8

Q ss_pred             CCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCC----C-----CCcchHHHHHHHHhcccCCCCCCchHHH
Q psy5603           8 TEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLK----P-----LKYSAKDIKIVERAGKRNFPERGCTDIF   78 (455)
Q Consensus         8 ~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~----~-----~~~~~~~~~~~e~~~~~~~~~~s~t~~l   78 (455)
                      +.+|+||+||++.+.+|+.|||.+  |++||+.||+..|+..    +     +||+.+|++.||..++| .+++|||+.|
T Consensus         2 ~r~tEiRkl~~~~~~~L~~ILd~~--WrklM~~IPk~l~d~~~~~~~~~~~~~KYt~~hi~~Ie~~a~r-~~~~s~s~il   78 (137)
T PF14786_consen    2 TRNTEIRKLPPSDLYRLASILDIN--WRKLMSIIPKKLGDVQQPSGSGLYPIPKYTSQHISLIEEAAER-LQNRSCSEIL   78 (137)
T ss_dssp             -TTSBGGGS-HHHHHHHHHHHHGG--HHHHHHH-BSS---HHHHHSTT-HHHBSS-HHHHHHHHHHHHH-STTS-HHHHH
T ss_pred             CccchhhcCCHHHHHHHHHHhchh--HHHHHHHccccccccccccccccccccccchhHHHHHHHHHHh-ccCCcHHHHH
Confidence            678999999999999999999987  9999999999864322    2     59999999999999963 2899999999


Q ss_pred             HHhhhcCCCC--CCCHHHHHHHHHhccccccccccccccccC--CCCCCCCchh
Q psy5603          79 LDEWGTSGRR--RPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTEA  128 (455)
Q Consensus        79 l~~w~~~~~~--~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~  128 (455)
                      |++|||+|+.  ++||++|+++|.+++++|||+++..+.++.  |++|..++.+
T Consensus        79 ldEWgTSGr~~eRPTl~~Ll~LLvkael~rAADyva~~~Lke~~p~RP~~GPaA  132 (137)
T PF14786_consen   79 LDEWGTSGRKNERPTLGHLLQLLVKAELFRAADYVAVDILKEEPPARPDDGPAA  132 (137)
T ss_dssp             HHHHHT-SSTTTS-BHHHHHHHHHHTT-HHHHHHHHHHTT--------SSSTTS
T ss_pred             HHHhhccCcccCCCcHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Confidence            9999999987  999999999999999999999999888876  4556555554

>KOG1240|consensus

Probab=99.88  E-value=2.9e-23  Score=219.04  Aligned_cols=243  Identities=23%  Similarity=0.298  Sum_probs=175.0

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHH--HhhCCccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT--LSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||++.|=+|.+|++++|. |+||++-+......            ...|.++++-  ....+|||++++.-.-.. ..
T Consensus        29 ~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~s------------L~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kA   95 (1431)
T KOG1240|consen   29 ENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTIS------------LRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKA   95 (1431)
T ss_pred             cccCchhhhhhhhccCCCce-EEEEEEeccCCCCC------------chHHHHHHHHHHHHhhcCCcccchHHHHHhhHH
Confidence            77999999999999998765 99999865543221            2224443333  445689999998876554 56


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+|-+|. .-+|+|+|..   .+-+...+...|+.|++.||.-+|+  .||+|||||.+|||++.-+.+.|+||...+.
T Consensus        96 AylvRqyv-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYV-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHH-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCC
Confidence            67888888 5799999986   5678889999999999999999999  8899999999999999999999999987664


Q ss_pred             cccCCcce----eeeccCCCCCCCCCcccccC------------CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHH
Q psy5603         333 SETSNMKT----MYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       333 ~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~------------~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .......+    .+..+..--..|+|||.|..            ..+++.||||+|||++||++ |++||.-.. ... +
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-L~a-Y  247 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-LLA-Y  247 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-HHh-H
Confidence            43332222    11122233346999996621            14678999999999999999 788886321 111 1


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      ... +......++.. +..       ..++++|..|++.||.+|.+++++++.
T Consensus       248 r~~-~~~~~e~~Le~-Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  248 RSG-NADDPEQLLEK-IED-------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hcc-CccCHHHHHHh-CcC-------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111 01111111111 110       027888999999999999999999876

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.6e-21  Score=176.38  Aligned_cols=154  Identities=16%  Similarity=0.199  Sum_probs=112.7

Q ss_pred             CCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCc---------h----hhhhhhhHHHHHHHHHHHhhCCccce
Q psy5603         175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD---------N----TEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~---------~----~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      ...||+|+||.||+|.+.+|+.||||+++...........         .    ..........+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3679999999999999878999999999875321100000         0    00001112335689999999999987


Q ss_pred             eeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         242 LRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       242 v~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .....+... ..++||||++|+++......   ..+++......++.+++.++.++|+. .||+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec-CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE-CCC
Confidence            544333222 34899999998865443222   23578889999999999999999972 4699999999999999 889


Q ss_pred             eEEeecccccccc
Q psy5603         322 PKLGDFGIVKMSE  334 (455)
Q Consensus       322 ~kl~DFGla~~~~  334 (455)
                      ++|+|||+++...
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.3e-21  Score=177.27  Aligned_cols=190  Identities=18%  Similarity=0.177  Sum_probs=140.7

Q ss_pred             CCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccCcee
Q psy5603         175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNNIMN  253 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  253 (455)
                      ...|++|+||+||.+.. .+.+++.+.+........         ......|.+|+++|+++. |+++.+++++   ...
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~---------~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~   73 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLR---------GVAWWLARREALALRQLDGLPRTPRLLHW---DGR   73 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhh---------hHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCE
Confidence            47899999999998876 478888887754322100         111235889999999995 5788888876   346


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC-CCCcEEEcCCCceEEeecccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV-KSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di-kp~NILl~~~~~~kl~DFGla~~  332 (455)
                      +++|+|+.|.+|.+.+..          ....++.+++.+|.++|+  +||+|||| ||+|||++.++.++|+|||++..
T Consensus        74 ~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            899999999999754321          113577899999999999  88999999 79999999999999999999985


Q ss_pred             cccCCcc------e----eeeccCCCCCCCCCcccc--cCCCC-cccchHHHHHHHHHHHcCCCCCCCCc
Q psy5603         333 SETSNMK------T----MYTENLTGTRPYMPPEAM--HCQIS-TKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       333 ~~~~~~~------~----~~~~~~~gt~~Y~aPE~~--~~~~~-~~sDv~SlGvvl~elltG~~p~~~~~  389 (455)
                      .......      .    ..+-....++.|+.|+..  ....+ ...++++-|.-+|.++|+..+..+++
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            5433210      0    001112367888888843  33444 57899999999999999998877654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.4e-21  Score=180.78  Aligned_cols=176  Identities=12%  Similarity=0.104  Sum_probs=127.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.+.||.|+||.||+... ++..+|||.++.........    ......-..+.+|++.+.++.|++|..+..++..
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~----~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERF----LKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHH----HHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            456779999999999999766 46789999997554311100    0000011226899999999999999998876432


Q ss_pred             ---------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         251 ---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                               ...++||||++|.+|.+...       ++.    ....+++.++..+|+  .|++|||+||+||+++++| 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeCCC-
Confidence                     24789999999999988632       232    245699999999999  8899999999999999998 


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHH
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELL  379 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~ell  379 (455)
                      ++|+|||..+.........    .      |    ++...+..++|+||||+++.-..
T Consensus       173 i~liDfg~~~~~~e~~a~d----~------~----vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD----R------I----DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHH----H------H----HHHhHhcccccccceeEeehHHH
Confidence            9999999776443211000    0      0    12233557899999999876554

>KOG0603|consensus

Probab=99.85  E-value=2.3e-22  Score=203.08  Aligned_cols=225  Identities=24%  Similarity=0.301  Sum_probs=177.8

Q ss_pred             cCcCCCeEEEEEEE----cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-c
Q psy5603         178 LGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  251 (455)
Q Consensus       178 LG~G~fg~Vy~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~  251 (455)
                      +|+|+||.|+++..    +.|.-+|.|++++........           .....|-.++..++ ||.+|++.-.+.. .
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-----------~~t~~er~il~~~~~~~f~v~lhyafqt~~   70 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-----------THTKQERIILAFVHNTPFLVKLHYAFQTDG   70 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-----------cccccHHHHHhhccCCCceeeeeeeecccc
Confidence            79999999997652    237789999998765432221           12456788888886 9999999876655 8


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..+++++|..||.|..++..   ...+.......+...++-++.++|+  .+++|||+|++||+++.+|++++.|||+++
T Consensus        71 kl~l~ld~~rgg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   71 KLYLILDFLRGGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSK  145 (612)
T ss_pred             chhHhhhhcccchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhh
Confidence            88999999999999998876   3457788888889999999999999  789999999999999999999999999998


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .......       .+||..|||||++. .....+|.||||++.+||+||..||..    .....+...+..        
T Consensus       146 e~v~~~~-------~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~--------  205 (612)
T KOG0603|consen  146 EAVKEKI-------ACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE--------  205 (612)
T ss_pred             HhHhhhh-------cccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC--------
Confidence            7654431       18999999999887 667789999999999999999999987    222222211222        


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                          .+......+++++..++..+|.+|.-.
T Consensus       206 ----~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 ----MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ----CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                234556668888888888899888644

>cd08794 Death_IRAK1 Death domain of Interleukin 1 Receptor Associated Kinase-1

Probab=99.85  E-value=1.6e-21  Score=143.16  Aligned_cols=81  Identities=19%  Similarity=0.390  Sum_probs=75.3

Q ss_pred             ceeeecCHHHHHHhhhhcCC--cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCC
Q psy5603          11 IEIRHLKQYVVHELGIILNE--RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~--~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      .|+|+||++|+.+||.+||+  +.+|.+||+.|.+|          |+++|.+|+       ++|+|.||+|.||++   
T Consensus         1 ~~Ly~lP~~vm~~fc~~MDsls~~dW~~fAS~ii~d----------qtelR~~E~-------~~s~T~elmw~W~~R---   60 (84)
T cd08794           1 RFLYELPPSVMWRFCLVMDSLSDLDWTRFASEIIKD----------QTELRLLEQ-------SGRRTDWVMWRWENR---   60 (84)
T ss_pred             CccccCCHHHHHHHHHHHcccccccHHHHHHHHhcc----------HHHHHHHHH-------cCCcHHHHHHHHHhc---
Confidence            38999999999999999999  67899999999998          999999992       448999999999998   


Q ss_pred             CCCHHHHHHHHHhcccccccccc
Q psy5603          89 RPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      |+||++|+++|.+.+++||++++
T Consensus        61 n~tV~~Ll~iL~~L~l~RA~~ii   83 (84)
T cd08794          61 NGRVGELLDILERLQLLRARDVI   83 (84)
T ss_pred             ccHHHHHHHHHHHhhhhhhhhhh
Confidence            99999999999999999999865

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK1 is an active kinase and also plays adaptor functions. It binds to the MyD88-IRAK4 complex via its DD, which facilitates its phosphorylation by IRAK4, activating it for further auto-phosphorylation. Hyper-phosphorylated IRAK1 forms a cytosolic complex with TRAF6, leading to the activation of NF-kB and MAPK pathways. IRAK1 is involved in autoimmunity and may be associated with lupus pathogenesis. DDs are protein-protein interaction domains found in a variety of domain architectures.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=6.5e-21  Score=181.44  Aligned_cols=232  Identities=22%  Similarity=0.283  Sum_probs=147.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc----------cc-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH----------VN-  240 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~n-  240 (455)
                      ..+..||.|+|+.||.+++.. |+.+|||++......          .....+.+.+|.-....+.+          -. 
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~----------~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~   84 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA----------SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT----------HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEeccccc----------chHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence            345789999999999999974 899999998765421          11124556666655444322          11 


Q ss_pred             -----eeeecc---cc---cC-c-----eeEEEEEeccCCCHHHHHhh---cCC-CCCCCHHHHHHHHHHHHHHHHHHHc
Q psy5603         241 -----LLRLLG---LC---NN-I-----MNCIVYEYMCNGSLYDRLAR---VNN-TPPLDSNKRYSIALGVAEALHYLHS  299 (455)
Q Consensus       241 -----iv~l~~---~~---~~-~-----~~~lV~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~gl~~LH~  299 (455)
                           ++++-+   +.   .+ .     ..+++|+-+ .++|.+.+..   ... ..++....++.+..|+++.+++||+
T Consensus        85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~  163 (288)
T PF14531_consen   85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS  163 (288)
T ss_dssp             ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence                 122211   11   11 1     236788877 6888887542   111 1234556677888999999999999


Q ss_pred             CCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC---------CCCcccchHH
Q psy5603         300 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---------QISTKTDVFS  370 (455)
Q Consensus       300 ~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~~~sDv~S  370 (455)
                        .|++|+||+|+|++++++|.++|+||+.....+...     .. ...+..|.|||....         .++.+.|.|+
T Consensus       164 --~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~  235 (288)
T PF14531_consen  164 --YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ  235 (288)
T ss_dssp             --TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred             --cceEecccceeeEEEcCCCCEEEcChHHHeecCcee-----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence              889999999999999999999999999776543321     11 244577999995522         2577899999


Q ss_pred             HHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCC
Q psy5603         371 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR  439 (455)
Q Consensus       371 lGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~R  439 (455)
                      ||+++|.|.+|..||..........         .     ......  .+++.++.||.++|..+|++|
T Consensus       236 LG~~ly~lWC~~lPf~~~~~~~~~~---------~-----~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  236 LGITLYSLWCGRLPFGLSSPEADPE---------W-----DFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHSS-STCCCGGGSTSG---------G-----GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHccCCCCCCCcccccc---------c-----cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence            9999999999999998664221100         0     122222  678889999999999999987

>KOG1023|consensus

Probab=99.82  E-value=3.9e-20  Score=186.77  Aligned_cols=211  Identities=27%  Similarity=0.404  Sum_probs=157.1

Q ss_pred             HhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe-eecCCC
Q psy5603         233 LSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI-IHRDVK  310 (455)
Q Consensus       233 l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~i-iH~Dik  310 (455)
                      |+.+.|.|+.+++|.+.+ ...+.|.+||..|||.|.+...  ...+++-....++..++.||.|||+  .+| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            457899999999999887 7888999999999999999873  3468999999999999999999999  444 999999


Q ss_pred             CCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCC--------CCcccchHHHHHHHHHHHcCC
Q psy5603         311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--------ISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~~~sDv~SlGvvl~elltG~  382 (455)
                      +.|.++|..+.+||+|||+........... ......-..-|.|||.+.+.        .+.+.|+||||++++|+++..
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPE-AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             cccceeeeeEEEEechhhhccccccccccc-ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999987664311000 01111233458999987553        466899999999999999999


Q ss_pred             CCCCCCcchh----hHHHhhh-cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         383 KPIDDNNTIL----YYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       383 ~p~~~~~~~~----~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .||+......    ....+.. ....+...+..      .......+..+++.||..+|.+||++++|-..++.+.+
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhh------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9998754211    1111111 11111111110      11233357778999999999999999999988877654

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1.1e-19  Score=171.20  Aligned_cols=157  Identities=15%  Similarity=0.155  Sum_probs=113.8

Q ss_pred             CCCCcCCCccCcCCCeEEEEEE--EcCCcEEEEEEeecccCcCCCCC------c-----hhhhhhhhHHHHHHHHHHHhh
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGK--LKNGMEIAVKTLENNANYSSSNS------D-----NTEAAMIPILLFENEVQTLSQ  235 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~--~~~~~~vAvK~~~~~~~~~~~~~------~-----~~~~~~~~~~~~~~E~~~l~~  235 (455)
                      ...|.+.+.||+|+||.||+|.  ..+|+.||||+++..........      .     ...........+..|+.++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3455677999999999999998  45689999999975432110000      0     000001112346789999999


Q ss_pred             CCccc--eeeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-eeecCCCCC
Q psy5603         236 CKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSA  312 (455)
Q Consensus       236 l~h~n--iv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~-iiH~Dikp~  312 (455)
                      +.+.+  +.+++++   ...++||||+.|++|......   ..++.......++.|++.++++||+  .| ++||||||+
T Consensus       107 L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp~  178 (237)
T smart00090      107 LYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSEY  178 (237)
T ss_pred             HHhcCCCCCeeeEe---cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCChh
Confidence            97532  3333432   345899999999888765432   2346667778999999999999999  88 999999999


Q ss_pred             cEEEcCCCceEEeecccccccc
Q psy5603         313 NVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ||+++ ++.++|+|||.+....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999877543

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=5.7e-19  Score=162.53  Aligned_cols=132  Identities=14%  Similarity=0.232  Sum_probs=100.6

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-----CccceeeecccccC
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-----KHVNLLRLLGLCNN  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~  250 (455)
                      ..||+|+||.||.  +......+||++......             ....+.+|+.+++++     .||||++++|++.+
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~-------------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG-------------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCeEEEEEeccccc-------------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            7899999999996  433233479988653210             134488999999999     57999999998866


Q ss_pred             c----eeE-EEEEe--ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCeeecCCCCCcEEEcC----
Q psy5603         251 I----MNC-IVYEY--MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL-HYLHSLSKPIIHRDVKSANVLLDE----  318 (455)
Q Consensus       251 ~----~~~-lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl-~~LH~~~~~iiH~Dikp~NILl~~----  318 (455)
                      +    ..+ +|+||  +.+|+|.+++...    .+++.  ..++.+++.++ +|||+  ++|+||||||+|||++.    
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~  144 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISES  144 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCC
Confidence            3    223 78999  5579999999652    35555  35678888887 99999  88999999999999974    


Q ss_pred             CCceEEee-cccc
Q psy5603         319 NFVPKLGD-FGIV  330 (455)
Q Consensus       319 ~~~~kl~D-FGla  330 (455)
                      ++.++|+| ||..
T Consensus       145 ~~~~~LiDg~G~~  157 (210)
T PRK10345        145 EVIPVVCDNIGES  157 (210)
T ss_pred             CCcEEEEECCCCc
Confidence            34899999 4543

>KOG1166|consensus

Probab=99.79  E-value=6.1e-19  Score=189.79  Aligned_cols=188  Identities=22%  Similarity=0.232  Sum_probs=146.6

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce----eeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL----LRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni----v~l~~~~  248 (455)
                      .+.+.||+|+||.||+|...+|+.||+|+-+......                |+--.+++.||+ +-+    .++...+
T Consensus       701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----------------fYI~~q~~~RLk-~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----------------FYICLQVMERLK-PQMLPSIMHISSAH  763 (974)
T ss_pred             EEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----------------eeehHHHHHhhc-hhhhcchHHHHHHH
Confidence            4568899999999999998889999999986554321                333455566666 333    3333322


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc-------CCC
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-------ENF  320 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~-------~~~  320 (455)
                      .- +.-+||++|.+-|||.+++..   ...++|..++.++.|+++-+.+||.  .+||||||||+|.||.       ++.
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCccc
Confidence            22 444799999999999999984   5579999999999999999999999  7899999999999993       345


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCC-CCcccchHHHHHHHHHHHcCCC
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMK  383 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~sDv~SlGvvl~elltG~~  383 (455)
                      .++|+|||-+.....-...+ .....++|-.+-.+|+..|+ +++.+|.|.|+.+++-||.|..
T Consensus       839 ~l~lIDfG~siDm~lfp~~~-~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGT-KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCCc-EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            78999999876544332221 23456788999999988775 7999999999999999999853

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=7.1e-19  Score=161.40  Aligned_cols=149  Identities=17%  Similarity=0.182  Sum_probs=109.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhh---------hhhhhHHHHHHHHHHHhhCCccc--
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTE---------AAMIPILLFENEVQTLSQCKHVN--  240 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~n--  240 (455)
                      |.+.+.||+|+||.||+|..++|+.||||+++..............         ........+..|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            4455889999999999999888999999998754311110000000         00111234678999999998774  


Q ss_pred             eeeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         241 LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       241 iv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +...++   ....++||||++|++|......         .....++.+++.++.++|+  .|++||||||+||++++++
T Consensus        97 v~~~~~---~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~Nill~~~~  162 (198)
T cd05144          97 VPKPID---WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK--HGIIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCceee---cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH--CCCCcCCCCcccEEEcCCC
Confidence            333333   3456899999999999765321         2356788999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccc
Q psy5603         321 VPKLGDFGIVKMSE  334 (455)
Q Consensus       321 ~~kl~DFGla~~~~  334 (455)
                      .++|+|||++....
T Consensus       163 ~~~liDfg~~~~~~  176 (198)
T cd05144         163 KIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEEECCccccCC
Confidence            99999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.6e-18  Score=160.46  Aligned_cols=141  Identities=19%  Similarity=0.218  Sum_probs=112.9

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      +.||+|++|.||+|.+. |..|+||+........     ...........+.+|+.++..+.|+++.....++.+ ...+
T Consensus         2 ~~l~~G~~~~vy~~~~~-~~~~~vK~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-GIKAVIKWRIPKRYRH-----PELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI   75 (211)
T ss_pred             cccccCceEEEEEEeeC-CCceEEEEeCCcCCcC-----hHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence            57999999999999984 7889999875332111     111112234568899999999999988776665544 6778


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      +||||++|++|.+.+...      .. .+..++.+++.+|.++|+  .+++|||++|+|||++ ++.++|+|||.++.
T Consensus        76 lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999998652      12 888999999999999999  8899999999999999 78999999998765

>KOG4158|consensus

Probab=99.78  E-value=1.7e-18  Score=165.86  Aligned_cols=196  Identities=21%  Similarity=0.248  Sum_probs=138.2

Q ss_pred             CccceeeecccccC----------------------------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q psy5603         237 KHVNLLRLLGLCNN----------------------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL  288 (455)
Q Consensus       237 ~h~niv~l~~~~~~----------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  288 (455)
                      +|||||++++++.+                            ...|+||.-+ ..+|.+++...    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence            69999999875522                            2347888877 57899998763    356667778899


Q ss_pred             HHHHHHHHHHcCCCCeeecCCCCCcEEE--cCCC--ceEEeecccccccccCCcce---eeeccCCCCCCCCCcccccCC
Q psy5603         289 GVAEALHYLHSLSKPIIHRDVKSANVLL--DENF--VPKLGDFGIVKMSETSNMKT---MYTENLTGTRPYMPPEAMHCQ  361 (455)
Q Consensus       289 ~i~~gl~~LH~~~~~iiH~Dikp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~  361 (455)
                      |+++|+.|||+  +|+.|||+|++|||+  |+++  ...|+|||.|-.-.......   ...-..-|...-||||++...
T Consensus       349 QlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  349 QLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999  899999999999999  4444  56799999865332211111   111234577889999987543


Q ss_pred             C-------CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhcc
Q psy5603         362 I-------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVF  434 (455)
Q Consensus       362 ~-------~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~  434 (455)
                      .       ..|+|.|+.|.+.||+++...||........+.... .+..++.         -++.++..+++|+...+..
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y-qe~qLPa---------lp~~vpp~~rqlV~~lL~r  496 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY-QESQLPA---------LPSRVPPVARQLVFDLLKR  496 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-hhhhCCC---------CcccCChHHHHHHHHHhcC
Confidence            2       348999999999999999999999855332221111 1111111         1234555688889999999


Q ss_pred             CcCCCCCHHHHHHHH
Q psy5603         435 EKDKRASMRDIVDLL  449 (455)
Q Consensus       435 dp~~RPs~~evl~~L  449 (455)
                      ||++|++..=..+.|
T Consensus       497 ~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  497 DPSKRVSPNIAANVL  511 (598)
T ss_pred             CccccCCccHHHhHH
Confidence            999999876554444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=3.2e-18  Score=156.95  Aligned_cols=137  Identities=20%  Similarity=0.247  Sum_probs=106.0

Q ss_pred             ccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc-CceeEE
Q psy5603         177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCI  255 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~l  255 (455)
                      .||+|+||.||+|.+. |..|++|+........     ..-........+.+|++++..++|+++.....++. ....++
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRH-----PELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTI   74 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcC-----chHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEE
Confidence            3899999999999975 6899999965432111     00111223456889999999999887544433333 356689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ||||++|++|.+.+....   .       .++.+++.+|.+||+  .+++|||++|.||+++ ++.++++|||+++.
T Consensus        75 v~e~~~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGN---D-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEECCccHHHHHhhcH---H-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999876421   1       789999999999999  8899999999999999 88999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=5.7e-18  Score=178.38  Aligned_cols=141  Identities=21%  Similarity=0.224  Sum_probs=110.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ...+.||+|+||.||+|.+. +..+++|+...... ..    ...........+.+|++++.+++|++++....++.+ .
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~-~~----~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGY-RH----PELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             CccceeccCCcEEEEEEeec-CccceeEEEecccc-cc----hhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34589999999999999986 45566665432211 00    000112224568899999999999999887666555 6


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||++|++|.+++.           ....++.+++.+|.+||+  .+++||||||+|||+ .++.++|+|||+++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            6789999999999999875           346789999999999999  889999999999999 67899999999987


Q ss_pred             cc
Q psy5603         332 MS  333 (455)
Q Consensus       332 ~~  333 (455)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG0606|consensus

Probab=99.74  E-value=3.3e-18  Score=181.12  Aligned_cols=202  Identities=24%  Similarity=0.352  Sum_probs=138.7

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  254 (455)
                      +.|..|++|.||..+++. .+++|+ ++++...                 ...+   ++.....|.+|            
T Consensus        89 klisngAygavylvrh~~trqrfa~-kiNkq~l-----------------ilRn---ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   89 KLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----------------ILRN---ILTFAGNPFVV------------  135 (1205)
T ss_pred             EeeccCCCCceeeeeccccccchhh-cccccch-----------------hhhc---cccccCCccee------------
Confidence            899999999999999874 678898 4432211                 0111   23333334333            


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                              |+-.+.+..   .++++...        +.+++|||+  .||+|||+||+|.+|..-|++|+.|||+++...
T Consensus       136 --------gDc~tllk~---~g~lPvdm--------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 --------GDCATLLKN---IGPLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             --------chhhhhccc---CCCCcchh--------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                    444555554   23344433        788999999  889999999999999999999999999987543


Q ss_pred             cCCcc------------eeeeccCCCCCCCCCccc-ccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc
Q psy5603         335 TSNMK------------TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       335 ~~~~~------------~~~~~~~~gt~~Y~aPE~-~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      .....            ......++||+.|.|||+ +..+|...+|+|++|+|+||.+-|..||.+.......-......
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            22110            111235699999999995 56689999999999999999999999999987544333322221


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                      ...++- |.        ......++++.++|..+|..|-
T Consensus       275 i~wpE~-de--------a~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  275 IEWPEE-DE--------ALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cccccc-Cc--------CCCHHHHHHHHHHHHhChHhhc
Confidence            111111 11        1233477888888999988883

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=1.9e-16  Score=149.42  Aligned_cols=147  Identities=18%  Similarity=0.160  Sum_probs=107.1

Q ss_pred             CccC-cCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce--eeecccccC--
Q psy5603         176 NKLG-EGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGLCNN--  250 (455)
Q Consensus       176 ~~LG-~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~--  250 (455)
                      ..|| .||.|+||.+... +..++||.+........-..............+.+|+.++.++.|++|  +..+++...  
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5688 9999999999886 688999998643210000000000011224568899999999998875  556665322  


Q ss_pred             c---eeEEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         251 I---MNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       251 ~---~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .   ..++|+|+++| .+|.+++..    .+++..    .+.+++.+|.+||+  .||+||||||+|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2   23599999997 699888764    235544    35789999999999  8899999999999999999999999


Q ss_pred             ccccccc
Q psy5603         327 FGIVKMS  333 (455)
Q Consensus       327 FGla~~~  333 (455)
                      ||.++..
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9987754

>KOG1033|consensus

Probab=99.69  E-value=7.1e-18  Score=167.67  Aligned_cols=172  Identities=24%  Similarity=0.340  Sum_probs=126.7

Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+.|++|...+|.++|.+.......++...+.++.|++.|+.|     ++.+|+|+||.||....+..+||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence            468999999999999999876666678899999999999999999     479999999999999999999999999977


Q ss_pred             ccccCCc---ceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         332 MSETSNM---KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       332 ~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      .......   .....+...||..||+||.+.| .++.++||||||++|+|+++ =..++....             .+.+
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-------------t~~d  471 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-------------TLTD  471 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-------------hhhh
Confidence            5544331   0112345689999999997664 78999999999999999997 222222111             0111


Q ss_pred             ccchhccCCChh---HHHHHHHHHHHhhhccCcCCCCCHHHH
Q psy5603         407 VLDKEAGEWNET---HVETLISIVFEKCCVFEKDKRASMRDI  445 (455)
Q Consensus       407 ~~d~~~~~~~~~---~~~~~l~~Li~~~l~~dp~~RPs~~ev  445 (455)
                      +   +-+.+++.   +.+. -..|+.+++...|.+||++.++
T Consensus       472 ~---r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  472 I---RDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             h---hcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence            1   11112211   1111 2246889999999999955544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=2.6e-16  Score=142.78  Aligned_cols=150  Identities=19%  Similarity=0.218  Sum_probs=99.7

Q ss_pred             CCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchh-----------hhhhhhHHHHHHHHHHHhhCCccc--e
Q psy5603         175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNT-----------EAAMIPILLFENEVQTLSQCKHVN--L  241 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~n--i  241 (455)
                      ++.||+|+||.||+|.+.+++.||||+++.............           ............|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            478999999999999988789999999875432111110000           000001111245666666664432  3


Q ss_pred             eeecccccCceeEEEEEeccCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         242 LRLLGLCNNIMNCIVYEYMCNGSLYD-RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       242 v~l~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .+.+++   ...++||||++|+++.. .+....    .. .....++.+++.++.++|.. .+|+||||||+||+++ ++
T Consensus        82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec---CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE-CC
Confidence            333332   34589999999965432 122110    11 66788999999999999973 4699999999999999 89


Q ss_pred             ceEEeecccccccc
Q psy5603         321 VPKLGDFGIVKMSE  334 (455)
Q Consensus       321 ~~kl~DFGla~~~~  334 (455)
                      .++|+|||.++...
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=9.7e-16  Score=132.75  Aligned_cols=132  Identities=20%  Similarity=0.234  Sum_probs=109.0

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc--cceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH--VNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-~~  252 (455)
                      +.||+|.++.||++...+ ..++||.......               ...+.+|+.++..++|  .++.+++++... +.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~   67 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---------------GADREREVAILQLLARKGLPVPKVLASGESDGW   67 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc---------------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc
Confidence            679999999999999874 7899999754321               1238889999999976  488888887765 67


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-KPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .++++||+.|+++..+          +......++.+++.++.+||... .+++|||++|+||++++.+.++++|||.++
T Consensus        68 ~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          68 SYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             cEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            8999999988877543          45677788999999999999852 469999999999999999999999999877


Q ss_pred             cc
Q psy5603         332 MS  333 (455)
Q Consensus       332 ~~  333 (455)
                      ..
T Consensus       138 ~~  139 (155)
T cd05120         138 YG  139 (155)
T ss_pred             CC
Confidence            53

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590|consensus

Probab=99.64  E-value=3.2e-17  Score=172.86  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=180.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcC--CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeeccccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCN  249 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      ++.+.||+|+|+.|-......  ...+|+|.+..... ..   .       .......|..+-+.+. |+|++.+++...
T Consensus        23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~-~~---~-------~~~~i~~e~~~~~~~s~h~n~~~~~~~~~   91 (601)
T KOG0590|consen   23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK-SE---D-------SSEHIDTETDIQKKLSKHSNTVHMIEPSS   91 (601)
T ss_pred             cccccccccccchhhhhhhcCCCcceeeccCCCCCCC-cc---c-------hhhhcCccccccccccccccccccCCccC
Confidence            444679999999998877532  34567776654331 00   0       0222445777777776 999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCeeecCCCCCcEEEcCCC-ceEEee
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKSANVLLDENF-VPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH-~~~~~iiH~Dikp~NILl~~~~-~~kl~D  326 (455)
                      + ...+++.+|..|+++.+.+... .....+....-.++.|+..++.|+| .  .++.|+||||+|.+++..+ ..+++|
T Consensus        92 ~~~~~~~~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~d  168 (601)
T KOG0590|consen   92 SPRSYLLSLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIAD  168 (601)
T ss_pred             CCcccccccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCC
Confidence            7 7888999999999999988321 1224566677789999999999999 7  7899999999999999999 999999


Q ss_pred             cccccccccCCcceeeeccCCC-CCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTG-TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      ||+|................+| ++.|+|||.+.+  ...+..|+||.|+++.-+++|..|++........+....+.. 
T Consensus       169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-  247 (601)
T KOG0590|consen  169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-  247 (601)
T ss_pred             chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-
Confidence            9999877662222233345678 999999997766  346788999999999999999999987653221111110000 


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                            ......+.........+++.+++..+|..|.+..++.
T Consensus       248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence                  0001111223333455667788888899999887763

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=2.1e-14  Score=146.97  Aligned_cols=152  Identities=20%  Similarity=0.183  Sum_probs=101.8

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCC--------------------C-Cchh------hhhhhhHHHHHH
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSS--------------------N-SDNT------EAAMIPILLFEN  228 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~--------------------~-~~~~------~~~~~~~~~~~~  228 (455)
                      +.||+|++|.||+|++++|+.||||+.++.....-.                    . .+..      .........|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998754211000                    0 0000      000001123566


Q ss_pred             HHHHHhhCC----ccceeeecccccC--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHcCC
Q psy5603         229 EVQTLSQCK----HVNLLRLLGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE-ALHYLHSLS  301 (455)
Q Consensus       229 E~~~l~~l~----h~niv~l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-gl~~LH~~~  301 (455)
                      |...+.+++    |.+-+.+-..+.+  ...++||||++|++|.+.......  ..   .+..++..++. .+..+|.  
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~--  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR--  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh--
Confidence            666666652    3333333333322  456899999999999887654211  12   23456666666 4678898  


Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      .|++|+|+||.||++++++.++++|||++....
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            789999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266|consensus

Probab=99.45  E-value=2.1e-13  Score=128.36  Aligned_cols=202  Identities=20%  Similarity=0.247  Sum_probs=139.1

Q ss_pred             HHHhhCCccceeeecccccCc------eeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         231 QTLSQCKHVNLLRLLGLCNNI------MNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       231 ~~l~~l~h~niv~l~~~~~~~------~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      .-|-++.|.|||++..|+.+.      ...++.|||..|+|.++|++... ...+......+|+.||+.||.|||+...+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            345567899999999988652      34789999999999999987543 45678888899999999999999999889


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccc-cCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcC
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSE-TSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~-~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG  381 (455)
                      |+|+++..+-|++..+|-+||+----..... ........++...|.++|.+||.= ..+.+.++|||+||...+||.-|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999999985311100000 000011122344677889999953 34567799999999999999887


Q ss_pred             CCCCCCC-cchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         382 MKPIDDN-NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       382 ~~p~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..--... ........+...-..+..-+               -+.++.+|+...|+.||+|.+++-
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~len~l---------------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIGLENGL---------------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCcceeehhhhhhhheeeccCcc---------------ccCcCcccccCCCCCCcchhhhhc
Confidence            6543222 12221111111100111111               123478999999999999998753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=3.9e-13  Score=119.71  Aligned_cols=128  Identities=20%  Similarity=0.209  Sum_probs=95.1

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCceeEE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI  255 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l  255 (455)
                      +.|+.|.++.||+++.. +..|++|........              ...+..|+.++..+.+.++++-+-.+.....++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--------------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~l   68 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--------------LINRENEAENSKLAAEAGIGPKLYYFDPETGVL   68 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--------------ccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeE
Confidence            56899999999999986 788999997543210              112678899998887666554332233344589


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-----eeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-----IIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~-----iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ||||++|.++.+.  .      .   ....++.+++++|..||+  .+     ++|||++|.||+++ ++.++++|||.+
T Consensus        69 v~e~i~G~~l~~~--~------~---~~~~~~~~l~~~l~~LH~--~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          69 ITEFIEGSELLTE--D------F---SDPENLEKIAKLLKKLHS--SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             EEEecCCCccccc--c------c---cCHHHHHHHHHHHHHHhC--CCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            9999999888643  0      1   112456789999999999  44     59999999999999 678999999987


Q ss_pred             cc
Q psy5603         331 KM  332 (455)
Q Consensus       331 ~~  332 (455)
                      ..
T Consensus       135 ~~  136 (170)
T cd05151         135 GM  136 (170)
T ss_pred             cC
Confidence            64

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.43  E-value=2.7e-13  Score=137.62  Aligned_cols=246  Identities=20%  Similarity=0.191  Sum_probs=172.4

Q ss_pred             CccCc--CCCeEEEEEEE--c-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         176 NKLGE--GQFGTVYYGKL--K-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       176 ~~LG~--G~fg~Vy~~~~--~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      ..+|.  |.+|.||.+..  . ++..+|+|+-+........           ...-.+|+..-+++ .|+|.++.+..+.
T Consensus       120 ~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-----------~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  120 SRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-----------SKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-----------cccccchhhcccccCccccccccCcccc
Confidence            67999  99999999987  3 4788999985433221111           11134566666666 4899999888887


Q ss_pred             CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCeeecCCCCCcEEEcCC-CceEE
Q psy5603         250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE----ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKL  324 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----gl~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl  324 (455)
                      +....+++..+++.+|..+.....  ..++....+.+..+...    |+.++|+  .+++|-|+||+||+...+ ...++
T Consensus       189 ~~~~lfiqtE~~~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELCGESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cCCcceeeeccccchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccceeec
Confidence            754444555555889988877643  34777888888888888    9999999  889999999999999999 89999


Q ss_pred             eecccccccccCCcceee--eccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         325 GDFGIVKMSETSNMKTMY--TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+.............  .-...|...|++||...+-++..+|+||+|.|..+..+|..+........+..... .. 
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~~-  342 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-GY-  342 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-cc-
Confidence            999998877765532211  12336778899999999999999999999999999999887765442111111100 00 


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...++.+..         ...+...+.+++..+|..|++...+..
T Consensus       343 ip~e~~~~~---------s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  343 IPLEFCEGG---------SSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CchhhhcCc---------chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            001111111         111333588899999999998876643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=4.8e-13  Score=138.80  Aligned_cols=151  Identities=20%  Similarity=0.208  Sum_probs=93.6

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCc--------------------CCCCC-c------hhhhhhhhHHHHH
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANY--------------------SSSNS-D------NTEAAMIPILLFE  227 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~--------------------~~~~~-~------~~~~~~~~~~~~~  227 (455)
                      +.||+|++|.||+|++++ |+.||||+.++....                    ..... +      +..........|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999987 999999999865210                    00000 0      0000011112355


Q ss_pred             HHHHHHhhCC----ccceeeecccccC--ceeEEEEEeccCCCHHHH--HhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH
Q psy5603         228 NEVQTLSQCK----HVNLLRLLGLCNN--IMNCIVYEYMCNGSLYDR--LARVNN-TPPLDSNKRYSIALGVAEALHYLH  298 (455)
Q Consensus       228 ~E~~~l~~l~----h~niv~l~~~~~~--~~~~lV~e~~~~gsL~~~--l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH  298 (455)
                      +|...+.+++    +.+.+.+-..+.+  ...++||||+.|+++.+.  +...+. ...+....+..++.|+       .
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            5555555542    4444443333332  456899999999999874  222110 0123333333334443       3


Q ss_pred             cCCCCeeecCCCCCcEEEcCCC----ceEEeeccccccccc
Q psy5603         299 SLSKPIIHRDVKSANVLLDENF----VPKLGDFGIVKMSET  335 (455)
Q Consensus       299 ~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGla~~~~~  335 (455)
                      .  .|++|+|+||.||+++.+|    .++++|||++.....
T Consensus       278 ~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 R--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             h--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4  6899999999999999888    999999999876543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=1.5e-11  Score=111.61  Aligned_cols=148  Identities=14%  Similarity=0.181  Sum_probs=100.3

Q ss_pred             CccCcCCCeEEEEEEEcC-------CcEEEEEEeecccCcCCCCCc----hhh-----hhhhhHHHH----HHHHHHHhh
Q psy5603         176 NKLGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSD----NTE-----AAMIPILLF----ENEVQTLSQ  235 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~----~~~-----~~~~~~~~~----~~E~~~l~~  235 (455)
                      ..||.|--+.||.|...+       +..+|||+.+.....-.....    +..     ........+    .+|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            579999999999997542       478999998754321100000    000     001112233    389999999


Q ss_pred             CCc--cceeeecccccCceeEEEEEeccCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeeecCCCC
Q psy5603         236 CKH--VNLLRLLGLCNNIMNCIVYEYMCNGSLYD-RLARVNNTPPLDSNKRYSIALGVAEALHYL-HSLSKPIIHRDVKS  311 (455)
Q Consensus       236 l~h--~niv~l~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~gl~~L-H~~~~~iiH~Dikp  311 (455)
                      +..  -++...+.+   ...++||||+.+..+.. .+..    ..++..+...+..+++.+|..| |+  .|+|||||++
T Consensus        83 l~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHh--CCeecCCCCH
Confidence            854  344444443   45689999997654422 2322    2355566778889999999998 88  7899999999


Q ss_pred             CcEEEcCCCceEEeeccccccc
Q psy5603         312 ANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       312 ~NILl~~~~~~kl~DFGla~~~  333 (455)
                      .|||++ ++.+.|+|||.+...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999977644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd08781 Death_UNC5-like Death domain found in Uncoordinated-5 homolog family

Probab=99.33  E-value=3.5e-12  Score=98.88  Aligned_cols=78  Identities=22%  Similarity=0.377  Sum_probs=66.9

Q ss_pred             cCHHHHHHhhhhcCCc----chHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCC
Q psy5603          16 LKQYVVHELGIILNER----DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~~----~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      ||++++++||.+||+.    ++|+.+|..+.-+           ..|+.|+       .+.|||..||+.|.+++..++|
T Consensus         1 lp~~~r~~Lc~~LD~~~~~g~dWr~LA~~Lgl~-----------~~i~~~~-------~~~SPT~~LL~~We~~~~~~~t   62 (83)
T cd08781           1 LPYSIRQKLCSSLDPPNPRGNDWRLLAKKLSVD-----------RYLNYFA-------TKPSPTGVILDLWEARHRDDGA   62 (83)
T ss_pred             CCHHHHHHHHHHcCCCCCCCCCHHHHHHHhCcH-----------HHHHHHc-------CCCChHHHHHHHHHhcCCCcch
Confidence            7999999999999986    7999999997622           2455555       4789999999999988777899


Q ss_pred             HHHHHHHHHhcccccccccc
Q psy5603          92 LSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~~~~  111 (455)
                      |++|+.+|.+.+...|++++
T Consensus        63 v~~L~~~L~~mgr~da~~ll   82 (83)
T cd08781          63 LNDLAQILEEMGRTDAVNLL   82 (83)
T ss_pred             HHHHHHHHHHcCcHHHHHHh
Confidence            99999999999998888654

Death Domain (DD) found in Uncoordinated-5 (UNC-5) homolog family, which includes Unc5A, B, C and D in vertebrates. UNC5 proteins are receptors for secreted netrins (netrin-1, -3 and -4) that are involved in diverse processes like axonal guidance, neuronal migration, blood vessel patterning, and apoptosis. They are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit

>KOG3087|consensus

Probab=99.28  E-value=6.4e-11  Score=103.73  Aligned_cols=150  Identities=19%  Similarity=0.247  Sum_probs=110.0

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      ..|-+|+-+.|+++.+. |+...||.-..+.     .....-.......+-.+|.+.+.+|+--.|.-..=++.+ ...+
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~-----YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~   86 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKR-----YRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ   86 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeeccccc-----ccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence            67999999999999997 7888888654322     112233345567778899999999976555333233333 6678


Q ss_pred             EEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC---ceEEeecccc
Q psy5603         255 IVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIV  330 (455)
Q Consensus       255 lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~DFGla  330 (455)
                      ++|||++| .++.+++...... +........++..|-+.+.-||.  .++|||||..+||+|..++   .+.++|||++
T Consensus        87 i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   87 IYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecch
Confidence            99999977 3778888765432 23333337889999999999999  7899999999999996554   4589999998


Q ss_pred             cccc
Q psy5603         331 KMSE  334 (455)
Q Consensus       331 ~~~~  334 (455)
                      ..+.
T Consensus       164 ~~s~  167 (229)
T KOG3087|consen  164 SVSR  167 (229)
T ss_pred             hccc
Confidence            7654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.27  E-value=3e-10  Score=110.80  Aligned_cols=255  Identities=16%  Similarity=0.146  Sum_probs=163.4

Q ss_pred             CCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceee--------e
Q psy5603         174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR--------L  244 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l  244 (455)
                      .+..||+|+-+.+|..--- +.. +-|+++....-               . -.+-+..|.+. .||-+-.        +
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa---------------~-~aqk~a~la~~p~~p~~~~rvaWPqa~L   76 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPA---------------A-QAQKVAELAATPDAPLLNYRVAWPQATL   76 (637)
T ss_pred             CCccccCCccceeeecchh-hch-hheeecCCCch---------------H-HHHHHHHhccCCCCcchhhhhcccHHHh
Confidence            3578999999999964321 223 44777643220               0 11122233333 4553322        2


Q ss_pred             cccccCceeEEEEEeccCC-CHHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         245 LGLCNNIMNCIVYEYMCNG-SLYDRLA---RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       245 ~~~~~~~~~~lV~e~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +|--.....-++|+.++|. ...+++.   +....+...|...++.+..++.+.+-||.  +|.+-||++++|+|+++++
T Consensus        77 ~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~  154 (637)
T COG4248          77 HGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDS  154 (637)
T ss_pred             hCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCc
Confidence            2222223356788888765 2333332   22335778999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-C-----CCCcccchHHHHHHHHHHHcC-CCCCCCCcch--
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-----QISTKTDVFSYGVILLELLTG-MKPIDDNNTI--  391 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-----~~~~~sDv~SlGvvl~elltG-~~p~~~~~~~--  391 (455)
                      .+.|.|-.........    ......+|.+.|.+||.-+ +     .-+..+|-|.|||+++++|.| ++||.+.-..  
T Consensus       155 ~V~LVdsDsfqi~~ng----~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~  230 (637)
T COG4248         155 KVVLVDSDSFQINANG----TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD  230 (637)
T ss_pred             eEEEEcccceeeccCC----ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence            9999985433322111    1234568999999999543 2     246789999999999999985 9999875311  


Q ss_pred             ---hhHHHhhhccc----chhhccchhccCCChhHHHHHHHHHHHhhhccC--cCCCCCHHHHHHHHHhh
Q psy5603         392 ---LYYYLVVEQEV----PVREVLDKEAGEWNETHVETLISIVFEKCCVFE--KDKRASMRDIVDLLSKS  452 (455)
Q Consensus       392 ---~~~~~~~~~~~----~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~d--p~~RPs~~evl~~L~~~  452 (455)
                         .....+.....    .-..-..+-.+.|+-.-.+..++.|+.+|+...  +.-||+.+.++..|..+
T Consensus       231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence               00001110000    001111223355666667777888888999887  77899999988877654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=5.9e-11  Score=110.17  Aligned_cols=142  Identities=24%  Similarity=0.326  Sum_probs=107.4

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcc--ceeeecccccC---
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV--NLLRLLGLCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---  250 (455)
                      +.||.|.++.||+++..+|..+++|.........            ....+.+|++++..+++.  ++.+++.+...   
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~------------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~   71 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP------------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV   71 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCc------------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc
Confidence            5689999999999998766899999975432210            023378899999998763  45666776655   


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-----------------------------  300 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-----------------------------  300 (455)
                       +..++||||++|.++.+.+..    ..++..++..++.+++.+|..||+.                             
T Consensus        72 ~~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (223)
T cd05154          72 LGTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD  147 (223)
T ss_pred             cCCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence             256899999999988775431    2467778888888888888888852                             


Q ss_pred             -------------------------CCCeeecCCCCCcEEEcC--CCceEEeeccccccc
Q psy5603         301 -------------------------SKPIIHRDVKSANVLLDE--NFVPKLGDFGIVKMS  333 (455)
Q Consensus       301 -------------------------~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~  333 (455)
                                               ...++|||++|.||+++.  ++.+.|+||+.+...
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                                     134799999999999998  677899999977643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.3e-10  Score=102.29  Aligned_cols=140  Identities=20%  Similarity=0.254  Sum_probs=101.4

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      ..+++|+-+.+|.+.+. |.++++|.-- ...+..    ..-+......+-.+|..++.+++--.|.-.+=|..+ ....
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri-~K~YR~----p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERI-PKRYRH----PELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL   75 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeec-CcccCC----hHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence            45899999999999886 4566666533 222222    222334445667789999998865444332223333 5557


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q psy5603         255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ++|||.+|..|.+.+...          ...++..+-.-+.-||.  .||+||||.++||++...+ +.++|||++.+..
T Consensus        76 I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          76 IVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             EEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999999999999988862          25667778888899999  7899999999999998765 9999999987543

>cd08783 Death_MALT1 Death domain similar to that found in Mucosa-associated lymphoid tissue-lymphoma-translocation gene 1

Probab=99.23  E-value=3.1e-11  Score=92.41  Aligned_cols=91  Identities=18%  Similarity=0.280  Sum_probs=76.5

Q ss_pred             eecCHHHHHHhhhhcCCc---chHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCC
Q psy5603          14 RHLKQYVVHELGIILNER---DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRP   90 (455)
Q Consensus        14 ~~l~~~~~~~l~~~ld~~---~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~   90 (455)
                      -.|+..++++||.+||..   -+|+++|..+-..  ..|  |++..++.+|--.+--  +|.|||..||+.|+.+   ++
T Consensus         2 ~~L~e~~l~~L~~lLD~~~~~~gWr~LAe~lg~~--~~f--r~S~~el~~cslkvl~--p~gSPsk~LL~~~~~r---g~   72 (97)
T cd08783           2 NRLREPLLRRLSELLDRAADGKGWRKLAELAGSR--GRF--RLSCLDLEQCSLKVLE--PEGSPSRSLLKLLGER---GC   72 (97)
T ss_pred             CcccHHHHHHHHHHHhCCCccCCHHHHHHHHccC--Ccc--ccCHHHHHHHHHHHhc--CCCCchHHHHHHHHHc---CC
Confidence            458889999999999975   6899999998754  233  7899999666444332  8999999999999998   89


Q ss_pred             CHHHHHHHHHhcccccccccccc
Q psy5603          91 RLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        91 ~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                      ||.+|+++|....+.+|.+++.+
T Consensus        73 Tv~~Ll~~L~~Mgh~eAl~lL~~   95 (97)
T cd08783          73 TVTELSEFLQAMEHTEALQLLSP   95 (97)
T ss_pred             cHHHHHHHHHHhhhHHHHHHhcC
Confidence            99999999999999999987653

Death domain (DD) similar to that found in Malt1 (mucosa-associated lymphoid tissue-lymphoma-translocation gene 1). Malt1, together with Bcl10 (B-cell lymphoma 10), are the integral components of the CBM signalosome. They associate with CARD9 to form M-CBM (CBM complex in myeloid immune cells) and with CARMA1 to form L-CBM (CBM complex in lymphoid immune cells), to mediate activation of NF-kB and MAPK by ITAM-coupled receptors expressed on immune cells. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins

>KOG0606|consensus

Probab=99.19  E-value=1.3e-11  Score=131.69  Aligned_cols=246  Identities=18%  Similarity=0.207  Sum_probs=163.1

Q ss_pred             CCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc-cCc
Q psy5603         174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNI  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~  251 (455)
                      +.+-+-+|.||.++.+.-.. |...++|............          ......+-.++-..++|-++...--+ ...
T Consensus       808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~----------~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs  877 (1205)
T KOG0606|consen  808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND----------YESIRSKSNILITPRSPAVVRSFPSFPCRS  877 (1205)
T ss_pred             ecccccCCCCcccccCCccccccccchhhhccchhhcccc----------ccccCCccCccccCCCCceecccCCCCCCC
Confidence            44678899999999876442 4444555543222111000          01111222222223456666544432 336


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..+||++|+.|++|...|+..   ++.+.......+..+..++++||.  ..++|+|++|.|+|...+|..++.|||...
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCcccccc
Confidence            678999999999999999873   456777777788889999999999  669999999999999999999999998433


Q ss_pred             ccccC---------------------Ccc-e------eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCC
Q psy5603         332 MSETS---------------------NMK-T------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       332 ~~~~~---------------------~~~-~------~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~  382 (455)
                      ..+..                     ... .      .....+.||+.|++||...+ .....+|+|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            22110                     000 0      00123579999999996544 5688899999999999999999


Q ss_pred             CCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHH
Q psy5603         383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                      +||...........+.....+.+         ..+.......++++...+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~~f~ni~~~~~~~p---------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWP---------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhhhccccCCCCCC---------CCccccChhhhhhhhhhhccCchhccCcc
Confidence            99998775544433332222211         11233444577788888889999887665

>KOG1243|consensus

Probab=99.17  E-value=4e-10  Score=115.90  Aligned_cols=167  Identities=22%  Similarity=0.279  Sum_probs=121.9

Q ss_pred             EEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ceeEEEEEeccCCCHH
Q psy5603         189 GKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLY  266 (455)
Q Consensus       189 ~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~  266 (455)
                      |..+ ++.+|.|...+....      .       ......+-++.|+.++||||++++..... +..|+|.|-+  ..|.
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~------~-------~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~   95 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNG------E-------VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLE   95 (690)
T ss_pred             cceeccCCceEEEEEeCCCc------h-------hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHH
Confidence            4433 478898888864322      0       12336677889999999999999997766 8899999988  5677


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccC
Q psy5603         267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL  346 (455)
Q Consensus       267 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  346 (455)
                      .++..      +....+..-+.||+.||.|||.- .+++|++|.-+.|+++..|..||++|-++.........   ....
T Consensus        96 ~~lk~------l~~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~---~~~~  165 (690)
T KOG1243|consen   96 TVLKE------LGKEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP---AKSL  165 (690)
T ss_pred             HHHHH------hHHHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc---cccc
Confidence            77776      34667777899999999999863 57999999999999999999999999887654332210   0001


Q ss_pred             CCCCCCCCcccccCCCCcccchHHHHHHHHHHHcC
Q psy5603         347 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       347 ~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG  381 (455)
                      .---.|..|+... .-....|.|-|||+++|++.|
T Consensus       166 ~~~~s~~~P~~~~-~s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  166 YLIESFDDPEEID-PSEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhcccChhhcC-ccccchhhhhHHHHHHHHhCc
Confidence            1111255555431 111356999999999999999

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.10  E-value=9.3e-10  Score=99.41  Aligned_cols=139  Identities=21%  Similarity=0.205  Sum_probs=86.5

Q ss_pred             EEEEEEEcCCcEEEEEEeecccCcC----------CCCC---chhhhhhhhHHHHHHHHHHHhhCCccc--eeeeccccc
Q psy5603         185 TVYYGKLKNGMEIAVKTLENNANYS----------SSNS---DNTEAAMIPILLFENEVQTLSQCKHVN--LLRLLGLCN  249 (455)
Q Consensus       185 ~Vy~~~~~~~~~vAvK~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~  249 (455)
                      .||.|...+|..+|||..+.....-          ....   ..............+|.+.|.++..-+  +.+.+.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899998888999999987542110          0000   001112333456788999999997653  4445443  


Q ss_pred             CceeEEEEEecc--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         250 NIMNCIVYEYMC--NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY-LHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       250 ~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~-LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                       ...++||||+.  |..+..+...     .++......++.+++..+.. +|+  .|++|||+.+.|||++++ .+.|+|
T Consensus        79 -~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   79 -NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             -ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEEE--
T ss_pred             -eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEEEEe
Confidence             34589999998  6555443332     12234456677888885555 578  789999999999999988 999999


Q ss_pred             cccccccc
Q psy5603         327 FGIVKMSE  334 (455)
Q Consensus       327 FGla~~~~  334 (455)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99876544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd08782 Death_DAPK1 Death domain found in death-associated protein kinase 1

Probab=99.07  E-value=3.2e-10  Score=87.32  Aligned_cols=76  Identities=21%  Similarity=0.298  Sum_probs=59.6

Q ss_pred             HHHHhhhhcCCcc----hHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHH
Q psy5603          20 VVHELGIILNERD----DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDL   95 (455)
Q Consensus        20 ~~~~l~~~ld~~~----~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l   95 (455)
                      ++++||.+|||.+    +|+.+|..+--.          ... ..++...+   +|.|||+.||+.|++++  .+||++|
T Consensus         2 ~R~~L~~lLdpp~~~g~DW~~LA~~Lg~~----------~~~-~~~~~~~~---~~~sPT~~LL~~W~~~~--~~tvg~L   65 (82)
T cd08782           2 TRRKLSRLLDPPDPMGRDWCLLAVNLGLT----------DLV-PQLDTNSS---SLPSPTDALLQEWATAP--PSTIGTL   65 (82)
T ss_pred             HHHHHHHHcCCCCCCCCCHHHHHHHcCCh----------hhH-HHHHhcCC---CCCCcHHHHHHHHhcCC--cccHHHH
Confidence            6899999999976    999999997632          223 33333323   47999999999999983  3999999


Q ss_pred             HHHHHhcccccccccc
Q psy5603          96 IMFLKKAELHQAARYV  111 (455)
Q Consensus        96 ~~~l~~~~l~~~~~~~  111 (455)
                      +++|.+.+...+++++
T Consensus        66 ~~~L~~~gR~Da~~~l   81 (82)
T cd08782          66 IDKLRELGREDAADVL   81 (82)
T ss_pred             HHHHHHcCcHHHHHHh
Confidence            9999999887777643

Death domain (DD) found in death-associated protein kinase 1 (DAPK1). DAPK1 is composed of several functional domains, including a kinase domain, a CaM regulatory domain, ankyrin repeats, a cytoskeletal binding domain and a C-terminal DD. It plays important roles in a diverse range of signal transduction pathways including apoptosis, growth factor signalling, and autophagy. Loss of DAPK1 expression, usually because of DNA methylation, is implicated in many tumor types. DAPK1 is highly abundant in the brain and has also been associated with neurodegeneration. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as ad

>KOG0601|consensus

Probab=99.03  E-value=2.5e-10  Score=116.25  Aligned_cols=236  Identities=22%  Similarity=0.263  Sum_probs=159.0

Q ss_pred             CccCcCCCeEEEEEEEc--CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecccc-cCc
Q psy5603         176 NKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC-NNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-~~~  251 (455)
                      ..||.|.|+.||....+  ++..|++|.+.........           ...-..|+.+...+ -|.+++..+..+ ...
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-----------di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-----------DIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHh-----------hhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            88999999999988744  4788999988654332111           11134566666655 578888877644 447


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-CceEEeecccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIV  330 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla  330 (455)
                      ..|+=-|||.++++...+..   ...+....++++..+++.++.++|+  ..++|+|+||+||++..+ +..+++|||..
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhccccccc
Confidence            77788899999999887754   3357888899999999999999999  889999999999999876 88899999986


Q ss_pred             cccccCCcceeeeccCCCCCCCC-CcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYM-PPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~-aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      .......      ....+.-.+. .+|++..  .+..+.|+||||..+.|.++|.+--.......   .+..+..+    
T Consensus       415 t~~~~~~------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~~~p----  481 (524)
T KOG0601|consen  415 TRLAFSS------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSGDTP----  481 (524)
T ss_pred             cccceec------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeeccccc----
Confidence            5322111      1122333344 2454322  35679999999999999999865433221110   00000000    


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                         .    . ......++.+...+...++..||.+.++...
T Consensus       482 ---~----~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  482 ---N----L-PGLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             ---C----C-CchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence               0    0 1111445666778888889999988776543

>cd08312 Death_MyD88 Death domain of Myeloid Differentation primary response protein MyD88

Probab=99.00  E-value=9.8e-10  Score=84.43  Aligned_cols=68  Identities=24%  Similarity=0.444  Sum_probs=58.9

Q ss_pred             HHHHhhhhcCCc----chHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHH
Q psy5603          20 VVHELGIILNER----DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDL   95 (455)
Q Consensus        20 ~~~~l~~~ld~~----~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l   95 (455)
                      ++++||.+||+.    ++|+.||..+          .|+..+|+.||       ...|||+.||..|++++. ++||+.|
T Consensus         1 ~R~~L~~~Ldp~~~~g~DWr~LA~~L----------g~~~~~I~~f~-------~~~sPt~~lL~~W~~r~~-~atv~~L   62 (79)
T cd08312           1 VRRRLSLFLNPPRVVAADWTALAEEM----------GFEYLEIRNFE-------TKPSPTEKVLEDWETRPD-GATVGNL   62 (79)
T ss_pred             CHHHHHHHcCCCCCcccCHHHHHHHc----------CCCHHHHHHHc-------cCCChHHHHHHHHHhcCC-CCcHHHH
Confidence            579999999996    8999999975          56788999998       356999999999999855 6999999


Q ss_pred             HHHHHhcccc
Q psy5603          96 IMFLKKAELH  105 (455)
Q Consensus        96 ~~~l~~~~l~  105 (455)
                      +++|...+-.
T Consensus        63 ~~~L~~~~R~   72 (79)
T cd08312          63 LELLEKLERR   72 (79)
T ss_pred             HHHHHHcChH
Confidence            9999987653

Death Domain (DD) of Myeloid Differentiation primary response protein 88 (MyD88). MyD88 is an adaptor protein involved in interleukin-1 receptor (IL-1R)- and Toll-like receptor (TLR)-induced activation of nuclear factor-kappaB (NF-kB) and mitogen activated protein kinase pathways that lead to the induction of proinflammatory cytokines. It is a key component in the signaling pathway of pathogen recognition in the innate immune system. MyD88 contains an N-terminal DD and a C-terminal Toll/IL-1 Receptor (TIR) homology domain that mediates interaction with TLRs and IL-1R. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and

>KOG3741|consensus

Probab=99.00  E-value=2.2e-08  Score=100.38  Aligned_cols=168  Identities=18%  Similarity=0.287  Sum_probs=125.7

Q ss_pred             CeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc-----CceeEEE
Q psy5603         183 FGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-----NIMNCIV  256 (455)
Q Consensus       183 fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~lV  256 (455)
                      -.+.|++..+ +|..|++|+++........+             -..-+++++++.|+|||++.+++.     +...++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-------------~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slvlv  355 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK-------------DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLV  355 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCccc-------------chHHHHHHHHhccCceeehhhhhhhhccCcceEEEE
Confidence            4567899865 69999999996554433322             223578899999999999988553     3567999


Q ss_pred             EEeccCC-CHHHHHhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         257 YEYMCNG-SLYDRLARV------------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       257 ~e~~~~g-sL~~~l~~~------------~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      |+|+++. +|.++....            ..+...++...|.++.|+..||.++|+  .|+.-+-|.+.+||++.+-.++
T Consensus       356 YDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIr  433 (655)
T KOG3741|consen  356 YDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIR  433 (655)
T ss_pred             EecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEE
Confidence            9999865 787765321            113457789999999999999999999  7898899999999999998999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCC
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p  384 (455)
                      |+..|.......+..                 |-+  .--.+-|.=.||.+++.|.||..-
T Consensus       434 iS~C~i~Dvl~~d~~-----------------~~l--e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  434 ISGCGIMDVLQEDPT-----------------EPL--ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             EecccceeeecCCCC-----------------cch--hHHhhhhHHHHHHHHHHHhhcccc
Confidence            988876654433220                 101  112367888999999999999543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=7.4e-09  Score=99.02  Aligned_cols=151  Identities=18%  Similarity=0.132  Sum_probs=101.1

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce--eeecccccC---
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGLCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~---  250 (455)
                      +.+-+.....|+++... |+.|.||...........+.--  ....+...+.+|...+.+|...+|  .+.+++...   
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~--~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~  104 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLL--SLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN  104 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhc--ccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence            33444444557787775 7899999874332100000000  000122347889999888854333  233333321   


Q ss_pred             ---ceeEEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-------C
Q psy5603         251 ---IMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-------N  319 (455)
Q Consensus       251 ---~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-------~  319 (455)
                         ...++|+|++++. +|.+++.... ..+.+...+..++.+++..+.-||.  .||+|||+++.|||++.       +
T Consensus       105 ~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        105 PATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             CccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCC
Confidence               2457999999886 8999886422 2345677788999999999999999  88999999999999975       4


Q ss_pred             CceEEeecccccc
Q psy5603         320 FVPKLGDFGIVKM  332 (455)
Q Consensus       320 ~~~kl~DFGla~~  332 (455)
                      +.+.++||+.++.
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.95  E-value=5.7e-09  Score=97.28  Aligned_cols=148  Identities=21%  Similarity=0.195  Sum_probs=100.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchh--------hhh-hhhHHHHHHHHHHHhhCCcc--c
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNT--------EAA-MIPILLFENEVQTLSQCKHV--N  240 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~E~~~l~~l~h~--n  240 (455)
                      ..++..||.|--|.||.|....|.++|||.-+....+-.......        ..| .......++|.++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            356689999999999999998899999998654322111100000        011 33456678899999998544  4


Q ss_pred             eeeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         241 LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       241 iv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +.+.++   -+.+++||||..|-.|...-        ++....-.++..|+.-+.-+-.  .|+||||+.+-||+++++|
T Consensus       173 VP~P~~---~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~--~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIA---WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR--RGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCccc---cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH--cCccccCCchheEEEecCC
Confidence            444433   35668999999886664421        1233334445555555554445  6899999999999999999


Q ss_pred             ceEEeecccccc
Q psy5603         321 VPKLGDFGIVKM  332 (455)
Q Consensus       321 ~~kl~DFGla~~  332 (455)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999985543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=6.5e-08  Score=89.22  Aligned_cols=107  Identities=19%  Similarity=0.226  Sum_probs=82.4

Q ss_pred             HHHHHHHHHHHhhCCccc--eeeecccccC-----ceeEEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q psy5603         223 ILLFENEVQTLSQCKHVN--LLRLLGLCNN-----IMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEAL  294 (455)
Q Consensus       223 ~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl  294 (455)
                      .....+|...+.+|..-.  +.+.+++...     ...++|+|++++. +|.+++.....   ++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            445778888887775332  3334443322     2347999999885 89998886332   66778889999999999


Q ss_pred             HHHHcCCCCeeecCCCCCcEEEcCCC---ceEEeecccccccc
Q psy5603         295 HYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSE  334 (455)
Q Consensus       295 ~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~DFGla~~~~  334 (455)
                      .-||.  .||+|+|+++.|||++.++   .+.++||+.++...
T Consensus       132 ~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999  8899999999999999887   89999999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1e-07  Score=86.86  Aligned_cols=143  Identities=15%  Similarity=0.109  Sum_probs=103.8

Q ss_pred             cCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc--eeeeccccc---C--
Q psy5603         178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN--LLRLLGLCN---N--  250 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~---~--  250 (455)
                      -|+||-+.|++.... |..+-+|+-......+-..       ......|.+|+..+.++...+  +.+.. ++.   .  
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~-------P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRY-------PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccC-------CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence            478999999998876 5678899875222111110       113456999999999985433  33333 332   1  


Q ss_pred             -ceeEEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc--eEEee
Q psy5603         251 -IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--PKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~--~kl~D  326 (455)
                       -.-+||+|-+.| -||.+++.... ..+.+..++..++.+++..+.-||+  .|+.|+|+.+.||+++.++.  ++++|
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEE
Confidence             234789998854 48988886532 2356888889999999999999999  88999999999999986666  99999


Q ss_pred             cccccc
Q psy5603         327 FGIVKM  332 (455)
Q Consensus       327 FGla~~  332 (455)
                      |--++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            986553

>cd08799 Death_UNC5C Death domain found in Uncoordinated-5C

Probab=98.75  E-value=3.8e-08  Score=75.51  Aligned_cols=75  Identities=19%  Similarity=0.333  Sum_probs=60.5

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCC
Q psy5603          16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      +|+.++++||.+||+    .++|+.+|..+--+       +    .+..|+       ...|||..||+.|-.++...+|
T Consensus         1 ~p~~~R~kLc~lLd~p~~~g~DWr~LAekLgl~-------~----~l~~f~-------~~~SPT~~LLd~WEar~~~~~t   62 (84)
T cd08799           1 IPLSIRQKLCGSLDAPQTRGNDWRMLAHKLNLD-------R----YLNYFA-------TKSSPTGVILDLWEAQHFPDGN   62 (84)
T ss_pred             CChHHHHHHHHHcCCCCCCCCCHHHHHHHcCCH-------H----HHHHHH-------cCCChHHHHHHHHHhccCCCCc
Confidence            699999999999997    35899999986532       2    344555       4689999999999987656899


Q ss_pred             HHHHHHHHHhccccccc
Q psy5603          92 LSDLIMFLKKAELHQAA  108 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~  108 (455)
                      |+.|+.+|.+.....|.
T Consensus        63 v~~L~~~L~emgR~d~~   79 (84)
T cd08799          63 LSRLAAVLEEMGRHETV   79 (84)
T ss_pred             HHHHHHHHHHcCCccch
Confidence            99999999988764443

Death Domain (DD) found in Uncoordinated-5C (UNC5C). UNC5C is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a role in axonal guidance, angiogenesis, and apoptosis. UNC5C plays a critical role in the development of spinal accesory motor neurons. Methylation of the UNC5C gene is associated with early stages of colorectal carcinogenesis. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN.

>cd08310 Death_NFkB-like Death domain of Nuclear Factor-KappaB precursor proteins

Probab=98.74  E-value=2.2e-08  Score=75.19  Aligned_cols=71  Identities=15%  Similarity=0.262  Sum_probs=59.5

Q ss_pred             HHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHH
Q psy5603          20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      .+++||.+||+..+|+.+|..+          .|+ ..|..|+       ...|||..||+.|..+   ++||++|+++|
T Consensus         1 ~r~~L~~lLd~~~dWr~LA~~L----------~~~-~~i~~~~-------~~~sPt~~LL~~we~~---~~tv~~L~~~L   59 (72)
T cd08310           1 TRERLCKLLDDGCDWRELAQLL----------DLG-HLVNFIR-------LSPSPTKMLLDYFEMQ---GGTLERLRDAL   59 (72)
T ss_pred             CHHHHHHHhCCCCCHHHHHHHc----------CcH-HHHHHHh-------cCCCHHHHHHHHHHhC---CCCHHHHHHHH
Confidence            3789999999999999999985          333 3477777       5789999999999998   59999999999


Q ss_pred             Hhcccccccccc
Q psy5603         100 KKAELHQAARYV  111 (455)
Q Consensus       100 ~~~~l~~~~~~~  111 (455)
                      .+.....|+.++
T Consensus        60 ~~mgr~dav~~l   71 (72)
T cd08310          60 EVLGETEAVELI   71 (72)
T ss_pred             HHcCcHHHHHhc
Confidence            999887777643

Death Domain (DD) of Nuclear Factor-KappaB (NF-kB) precursor proteins. The NF-kB family of transcription factors play a central role in cardiovascular growth, stress response, and inflammation by controlling the expression of a network of different genes. There are five NF-kB proteins, all containing an N-terminal REL Homology Domain (RHD). Two of these, NF-kB1 and NF-kB2 are produced from the processing of the precursor proteins p105 and p100, respectively. In addition to RHD, p105 and p100 contain ANK repeats and a C-terminal DD. NF-kBs are regulated by the Inhibitor of NF-kB (IkB) Kinase (IKK) complex through classical and non-canonical pathways, which differ in the IKK subunits involved and downstream targets. IKKs facilitate the release of NF-kB dimers from an inactive state, allowing them to migrate to the nucleus where they regulate gene transcription. The precursor proteins p105 and p100 function

>KOG2137|consensus

Probab=98.73  E-value=4.1e-09  Score=108.97  Aligned_cols=150  Identities=17%  Similarity=0.252  Sum_probs=100.8

Q ss_pred             HHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcce------eeeccCCCCCCCCCcccccC-C
Q psy5603         289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT------MYTENLTGTRPYMPPEAMHC-Q  361 (455)
Q Consensus       289 ~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~-~  361 (455)
                      +++.|+.|+|+. .++||++|.|++|.++.++..||+.|+++..........      .......-...|.|||++.+ .
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            445999999985 579999999999999999999999999876544321111      11112234567999996654 4


Q ss_pred             CCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC
Q psy5603         362 ISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       362 ~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                      .+.++|+||+||++|.+.. |+.-+...+....+..... ....       ....-...++..+++-+.+++..++..||
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-~~~~-------~~~~~s~~~p~el~~~l~k~l~~~~~~rp  257 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-LLNA-------GAFGYSNNLPSELRESLKKLLNGDSAVRP  257 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-cccc-------ccccccccCcHHHHHHHHHHhcCCcccCc
Confidence            5789999999999999994 5555555443322222111 1010       00011134566677778899999999999


Q ss_pred             CHHHHHH
Q psy5603         441 SMRDIVD  447 (455)
Q Consensus       441 s~~evl~  447 (455)
                      ++.++..
T Consensus       258 ~~~~l~~  264 (700)
T KOG2137|consen  258 TLDLLLS  264 (700)
T ss_pred             chhhhhc
Confidence            8877643

>cd08802 Death_UNC5B Death domain found in Uncoordinated-5B

Probab=98.70  E-value=6.2e-08  Score=74.19  Aligned_cols=75  Identities=15%  Similarity=0.301  Sum_probs=60.9

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCC
Q psy5603          16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      ||+.++++||..||+    .++|+.||..+--+       +    .+..||       ...|||..||+.|-.+++..++
T Consensus         1 ~p~~vR~kLc~~Ld~p~~~g~DW~~LAekL~ld-------~----yl~~f~-------~~psPT~~LLd~WE~~~~~~~~   62 (84)
T cd08802           1 IPLSIRQKICNSLDAPNSRGNDWRLLAQKLSMD-------R----YLNYFA-------TKASPTGVILDLWEARHQDDGD   62 (84)
T ss_pred             CChhHHHHHHHHhCCCCCCCCcHHHHHHHcCch-------h----HHHHHH-------cCCCcHHHHHHHHHhcCCCccc
Confidence            699999999999997    47899999986532       2    334555       3569999999999998767899


Q ss_pred             HHHHHHHHHhccccccc
Q psy5603          92 LSDLIMFLKKAELHQAA  108 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~  108 (455)
                      |++|+++|.+.....+.
T Consensus        63 v~~L~~~L~~mgR~D~~   79 (84)
T cd08802          63 LNSLASALEEMGKSEML   79 (84)
T ss_pred             HHHHHHHHHHcCcchHH
Confidence            99999999988765443

Death Domain (DD) found in Uncoordinated-5B (UNC5B). UNC5B is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a role in axonal guidance, angiogenesis, and apoptosis. UNC5B signaling is involved in the netrin-1-induced proliferation and migration of renal proximal tubular cells. It is also required for vascular patterning during embryonic development, and its activation inhibits sprouting angiogenesis. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activatio

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.69  E-value=8.8e-08  Score=99.15  Aligned_cols=163  Identities=20%  Similarity=0.200  Sum_probs=99.8

Q ss_pred             HHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcC-------------------CC-C-Cchh-
Q psy5603         159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYS-------------------SS-N-SDNT-  216 (455)
Q Consensus       159 l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~-------------------~~-~-~~~~-  216 (455)
                      +.+....|++.       -|+.++-|.||+|++++|+.||||+.++.....                   .. . .+-. 
T Consensus       121 iee~F~eF~~~-------PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~  193 (517)
T COG0661         121 IEELFSEFEPE-------PIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE  193 (517)
T ss_pred             HHHHHHHcCCC-------chhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHH
Confidence            44556677764       599999999999999999999999987653210                   00 0 0000 


Q ss_pred             -----hhhhhhHHHHHHHHHHHhhCC----ccceeeecccccC--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHH
Q psy5603         217 -----EAAMIPILLFENEVQTLSQCK----HVNLLRLLGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS  285 (455)
Q Consensus       217 -----~~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~  285 (455)
                           .........+.+|...+.+++    ...-+.+-..+.+  ....++|||+.|-.+.+...-..  ..++..   .
T Consensus       194 vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~  268 (517)
T COG0661         194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---E  268 (517)
T ss_pred             HHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---H
Confidence                 000111122445555554442    2222233333322  56689999999999988743322  124422   2


Q ss_pred             HHHHHHHH-HHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q psy5603         286 IALGVAEA-LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       286 i~~~i~~g-l~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ++..++++ +..+-.  .|++|.|.+|.||+++.+|.+.+.|||+......
T Consensus       269 ia~~~~~~f~~q~~~--dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         269 LAELLVRAFLRQLLR--DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHHHHHHHh--cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            33323222 222222  5799999999999999999999999999875543

>cd08800 Death_UNC5A Death domain found in Uncoordinated-5A

Probab=98.51  E-value=4.5e-07  Score=69.02  Aligned_cols=75  Identities=13%  Similarity=0.279  Sum_probs=61.9

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCC
Q psy5603          16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      +|+.++++||..||+    .++|+.+|...--+           ..+..|+       .-.|||..||+.|.++++..+|
T Consensus         1 ip~~iR~kLc~lLD~p~~~G~DWr~LA~kL~ld-----------~~~~~f~-------~~pSPT~~LLd~WEa~~~~~g~   62 (84)
T cd08800           1 IPFLIRQKIISSLDAPCPNGADWRLLAQKLKLD-----------SHLSFFA-------SKSSPTAVILNLWEAQHFPNGN   62 (84)
T ss_pred             CChHHHHHHHHHcCCCCCCCCcHHHHHHHcCCc-----------cHHHHHH-------cCCChHHHHHHHHHhccCCCCc
Confidence            689999999999997    68999999987644           2455555       3569999999999998888999


Q ss_pred             HHHHHHHHHhccccccc
Q psy5603          92 LSDLIMFLKKAELHQAA  108 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~  108 (455)
                      |++|...|....-..|+
T Consensus        63 l~~L~~~l~emGR~da~   79 (84)
T cd08800          63 LNQLAAVVAEIGKQDAM   79 (84)
T ss_pred             HHHHHHHHHHhCchHHH
Confidence            99999999887655444

Death Domain (DD) found in Uncoordinated-5A (UNC5A). UNC5A is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a critical role in neuronal development and differentiation, as well as axon-guidance. It also plays a role in regulating apoptosis in non-neuronal cells as a downstream target of p53. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathway

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.47  E-value=2.2e-06  Score=80.23  Aligned_cols=138  Identities=15%  Similarity=0.160  Sum_probs=80.7

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce--eeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-~~  252 (455)
                      ..||+|..+.||+.  . +..+++|.......               .....+|.++++.+..-.+  .+.+++..+ +.
T Consensus         7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~~~---------------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~   68 (226)
T TIGR02172         7 TQTGEGGNGESYTH--K-TGKWMLKLYNPGFD---------------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGR   68 (226)
T ss_pred             eeecCCCCcceeEe--c-CCCEEEEeCCCCCC---------------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe
Confidence            56899999999984  2 45678888753221               2235789999888764433  445666554 55


Q ss_pred             eEEEEEeccCCC-HH--------------HHHhh----cCCC--CCCCHHHHHH-HHH----------HHHH-HHHHHHc
Q psy5603         253 NCIVYEYMCNGS-LY--------------DRLAR----VNNT--PPLDSNKRYS-IAL----------GVAE-ALHYLHS  299 (455)
Q Consensus       253 ~~lV~e~~~~gs-L~--------------~~l~~----~~~~--~~l~~~~~~~-i~~----------~i~~-gl~~LH~  299 (455)
                      ..+||+++.|.+ +.              ..+..    ....  +......... +..          .+.. ...+|.+
T Consensus        69 ~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~  148 (226)
T TIGR02172        69 LGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE  148 (226)
T ss_pred             eeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh
Confidence            678999998863 21              11111    0100  1111111110 000          0111 1222222


Q ss_pred             --CCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         300 --LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       300 --~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                        ....++|||+.|.||++++++ +.|+||+.+..
T Consensus       149 ~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       149 VPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence              224579999999999999988 99999997654

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235|consensus

Probab=98.43  E-value=1.6e-06  Score=89.67  Aligned_cols=163  Identities=17%  Similarity=0.179  Sum_probs=96.6

Q ss_pred             HHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCC-------------------CCC-----ch
Q psy5603         160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSS-------------------SNS-----DN  215 (455)
Q Consensus       160 ~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~-------------------~~~-----~~  215 (455)
                      +.+...|++       +-||.-+.|.||+|+.++|+.||||+-++.-....                   ...     ++
T Consensus       158 e~if~~f~~-------~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE  230 (538)
T KOG1235|consen  158 EDIFSEFDE-------EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDE  230 (538)
T ss_pred             HHHHHhcCc-------chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHH
Confidence            344556665       46999999999999999999999999765422100                   000     00


Q ss_pred             hhhhhhhHHHHHHHHHHHhh----CCccce---eeecccccC--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHH
Q psy5603         216 TEAAMIPILLFENEVQTLSQ----CKHVNL---LRLLGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI  286 (455)
Q Consensus       216 ~~~~~~~~~~~~~E~~~l~~----l~h~ni---v~l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i  286 (455)
                      .....-....|.+|.+-..+    ++|-+.   |.+-.++.+  ....|+||||.|..+.|.-.-...  .++...+..-
T Consensus       231 ~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~  308 (538)
T KOG1235|consen  231 IAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNK  308 (538)
T ss_pred             HHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHH
Confidence            00000111235555554433    345551   112233322  466899999999988765332211  2444443333


Q ss_pred             HHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC----CCceEEeeccccccccc
Q psy5603         287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----NFVPKLGDFGIVKMSET  335 (455)
Q Consensus       287 ~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~----~~~~kl~DFGla~~~~~  335 (455)
                      +.++..-.- ++   .|++|+|-+|.||++..    ++.+.+.|||+......
T Consensus       309 l~~~~~~qI-f~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  309 LVEAYLEQI-FK---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHHHH-Hh---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            333222111 22   57999999999999984    67999999999775543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.40  E-value=2.2e-06  Score=79.48  Aligned_cols=168  Identities=18%  Similarity=0.220  Sum_probs=98.5

Q ss_pred             eeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCC-----c------hhhhhhhh
Q psy5603         154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS-----D------NTEAAMIP  222 (455)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~-----~------~~~~~~~~  222 (455)
                      .+...|....+   ...+......|++|--+.||+|...++..||||+++..........     +      .....+..
T Consensus        35 ~t~~~l~~L~~---rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          35 RTLETLRRLLS---RGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             HHHHHHHHHhc---CCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            34444444433   3333355567899999999999987789999999975533211100     0      00000000


Q ss_pred             HHHHHHHHHHHhhCCcc--ceeeecccccCceeEEEEEeccCCCH-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q psy5603         223 ILLFENEVQTLSQCKHV--NLLRLLGLCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS  299 (455)
Q Consensus       223 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~  299 (455)
                      ..=...|+.-|+++...  .+.+-+++   ....|||||+....+ .-.|..    .++.......+..++++.+.-|-.
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~---~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAF---RNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceee---cCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHH
Confidence            11123355555555322  22222222   234799999954311 111111    123333567777888888877665


Q ss_pred             CCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         300 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       300 ~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      . .++||+||..-|||+. ++.+.|+|||-|...
T Consensus       185 ~-a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         185 E-AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             h-cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            2 4699999999999999 889999999976543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=2.8e-06  Score=74.59  Aligned_cols=131  Identities=20%  Similarity=0.177  Sum_probs=92.2

Q ss_pred             CCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceee-ecccccCce
Q psy5603         174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR-LLGLCNNIM  252 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  252 (455)
                      +...|++|++|.||+|.+. |..+|+|+-+.++.               ...+..|.++|..+.-.++-+ +|.|..+  
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~---------------r~~l~kEakiLeil~g~~~~p~vy~yg~~--   87 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP---------------RRNLEKEAKILEILAGEGVTPEVYFYGED--   87 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcc---------------hhhHHHHHHHHHHhhhcCCCceEEEechh--
Confidence            3478999999999999998 57999999765443               444889999999887766655 3333333  


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCC-CCcEEEcCCCceEEeeccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK-SANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dik-p~NILl~~~~~~kl~DFGla~  331 (455)
                       .+.|||+.|-+|.+.-..      .+..+.    ..++..-.-|-.  .||-|+.|. |...+|-.++.+.|+||..|+
T Consensus        88 -~i~me~i~G~~L~~~~~~------~~rk~l----~~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          88 -FIRMEYIDGRPLGKLEIG------GDRKHL----LRVLEKAYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             -hhhhhhhcCcchhhhhhc------ccHHHH----HHHHHHHHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence             345999998888776542      122333    344444444555  679999986 666666666699999999887


Q ss_pred             cccc
Q psy5603         332 MSET  335 (455)
Q Consensus       332 ~~~~  335 (455)
                      +...
T Consensus       155 ~k~~  158 (201)
T COG2112         155 FKKK  158 (201)
T ss_pred             hccC
Confidence            5443

>cd08801 Death_UNC5D Death domain found in Uncoordinated-5D

Probab=98.28  E-value=3.6e-06  Score=64.33  Aligned_cols=71  Identities=11%  Similarity=0.300  Sum_probs=60.0

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCC
Q psy5603          16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      +|+.++++||..||+    .++|+.||-.+.-+           ..|.-|.       ...|||.-+|+-|.++++.+.+
T Consensus         1 iP~~iRqklC~~LD~p~~kg~DWR~LA~kL~iD-----------Ryl~yFa-------tk~SPT~viLdLWEa~~~~~g~   62 (98)
T cd08801           1 IPYSIRQRICATFDTPNAKGKDWQMLAQKNSID-----------RNLSYFA-------TQSSPSAVILSLWEARHQHDGD   62 (98)
T ss_pred             CchhHHHHHHHHcCCCCCCCccHHHHHHHhcch-----------hHHHHHh-------cCCChHHHHHHHHHHhcCCCCC
Confidence            699999999999998    68999999987654           2455554       3689999999999999999999


Q ss_pred             HHHHHHHHHhccc
Q psy5603          92 LSDLIMFLKKAEL  104 (455)
Q Consensus        92 ~~~l~~~l~~~~l  104 (455)
                      +..|..+|....-
T Consensus        63 L~~La~aleeiGr   75 (98)
T cd08801          63 LDSLACALEEIGR   75 (98)
T ss_pred             HHHHHHHHHHhCc
Confidence            9999988876653

Death Domain (DD) found in Uncoordinated-5D (UNC5D). UNC5D is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a role in axonal guidance, angiogenesis, and apoptosis. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.28  E-value=5.1e-06  Score=76.18  Aligned_cols=137  Identities=14%  Similarity=0.120  Sum_probs=83.3

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcc---ceeeecccc----
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV---NLLRLLGLC----  248 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~----  248 (455)
                      +.+-......|.+-..+ |+.+++|..+.........    -.....-....+++..+.+++..   ...+++-+.    
T Consensus        37 kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~----~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~  111 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEID-GKKYILKEPREENRRPERR----FKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI  111 (229)
T ss_pred             EeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHH----HHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence            55666667777777665 6899999986543210000    00000001123344444444322   222222211    


Q ss_pred             --cCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         249 --NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                        .....++||||++|..|.+...       ++.    .++..+..++.-||+  .|+.|||.+|+|+++.+++ ++++|
T Consensus       112 ~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  112 FRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             ccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH--cCCccCCCCcCcEEEECCc-EEEEE
Confidence              1134468999999998876533       222    245667788999999  8899999999999999655 89999


Q ss_pred             ccccc
Q psy5603         327 FGIVK  331 (455)
Q Consensus       327 FGla~  331 (455)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.26  E-value=5.5e-06  Score=77.10  Aligned_cols=141  Identities=22%  Similarity=0.208  Sum_probs=80.9

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc--eeeecccccC---
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN--LLRLLGLCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~---  250 (455)
                      +.|+.|..+.||+....+ ..+++|.....               .....+.+|..++..+....  +.+++.++..   
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---------------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~   66 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---------------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF   66 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---------------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---------------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc
Confidence            468999999999999886 69999997532               01344667888877775333  3445543211   


Q ss_pred             -ceeEEEEEeccCCCHHH----------------HHh---hc-CCCCCCCHHH---------HHHH------------HH
Q psy5603         251 -IMNCIVYEYMCNGSLYD----------------RLA---RV-NNTPPLDSNK---------RYSI------------AL  288 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~  288 (455)
                       ...+++|++++|.++..                .+.   .. ....++....         ....            ..
T Consensus        67 ~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (239)
T PF01636_consen   67 NGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLE  146 (239)
T ss_dssp             TSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHH
T ss_pred             cccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhH
Confidence             34689999999998877                111   11 0111111111         0000            11


Q ss_pred             HHHH-HHHHHHc-----CCCCeeecCCCCCcEEEc-CCCceEEeecccccc
Q psy5603         289 GVAE-ALHYLHS-----LSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKM  332 (455)
Q Consensus       289 ~i~~-gl~~LH~-----~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~  332 (455)
                      .+.. .+..+++     ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  147 ELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2222 3333332     235699999999999999 666668999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.20  E-value=1.7e-05  Score=74.97  Aligned_cols=139  Identities=17%  Similarity=0.154  Sum_probs=80.1

Q ss_pred             ccCcCCC-eEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-cee
Q psy5603         177 KLGEGQF-GTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       177 ~LG~G~f-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~  253 (455)
                      .|..|.. ..||+.... +..+.||......                .....+|+++++.+. +--+.+++++... +..
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   67 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP----------------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRA   67 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc----------------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCcc
Confidence            3555555 889999765 4778888875321                011556888877763 3334455665544 567


Q ss_pred             EEEEEeccCCCHHHHH-------------------hhcCC-CCCCCHH--HHHHHHH--------------------HHH
Q psy5603         254 CIVYEYMCNGSLYDRL-------------------ARVNN-TPPLDSN--KRYSIAL--------------------GVA  291 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------~i~  291 (455)
                      ++||++++|.+|....                   +.... ..++...  .......                    .+.
T Consensus        68 ~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (244)
T cd05150          68 WLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAE  147 (244)
T ss_pred             EEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHH
Confidence            8999999998876432                   11100 0011100  0000000                    011


Q ss_pred             HHHHHHHc-----CCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         292 EALHYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       292 ~gl~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..+..|-.     ....++|||+.|.|||+++++...|+||+.+..
T Consensus       148 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         148 ELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11222211     113489999999999999988888999997653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.10  E-value=3.1e-05  Score=86.11  Aligned_cols=78  Identities=18%  Similarity=0.301  Sum_probs=54.8

Q ss_pred             CccCcCCCeEEEEEEEcCC---cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccce--eeeccccc
Q psy5603         176 NKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNL--LRLLGLCN  249 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~  249 (455)
                      ..|+.|.+..+|+....++   ..+++|+........            ....+.+|.++++.+. |.++  .+++.+|.
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~------------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~  111 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ------------SAHAVEREYQVLRALGEHTDVPVPKVYCLCT  111 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc------------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEec
Confidence            6789999999999887643   467888764322100            0224778999999985 6654  66777776


Q ss_pred             C----ceeEEEEEeccCCCH
Q psy5603         250 N----IMNCIVYEYMCNGSL  265 (455)
Q Consensus       250 ~----~~~~lV~e~~~~gsL  265 (455)
                      +    +..|+||||++|..+
T Consensus       112 d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876        112 DASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CCCcCCCceEEEEecCCccc
Confidence            5    467899999988653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.09  E-value=1.2e-05  Score=72.82  Aligned_cols=105  Identities=27%  Similarity=0.225  Sum_probs=81.4

Q ss_pred             HHHHHHHHhhCCc-cceeeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCC
Q psy5603         226 FENEVQTLSQCKH-VNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKP  303 (455)
Q Consensus       226 ~~~E~~~l~~l~h-~niv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~~~  303 (455)
                      ..+|.-++..+.+ +++.+++|+|.+   .+|.||...+++...-......-..+|..|.+|+.++++.+.+|+.. ...
T Consensus         6 ~~~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    6 QNNEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             hccHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            3568888888876 699999999965   67999998776643210000112368999999999999999999975 234


Q ss_pred             eeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      +.-.|++++|+-++++|.+|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            788899999999999999999999865543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.06  E-value=3.5e-05  Score=72.45  Aligned_cols=31  Identities=23%  Similarity=0.427  Sum_probs=26.1

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++|||+.+.|||+++++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3489999999999999776667999997653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>smart00005 DEATH DEATH domain, found in proteins involved in cell death (apoptosis)

Probab=97.91  E-value=1.8e-05  Score=62.29  Aligned_cols=81  Identities=19%  Similarity=0.300  Sum_probs=67.1

Q ss_pred             HHHHHhhhhcCC--cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHH
Q psy5603          19 YVVHELGIILNE--RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLI   96 (455)
Q Consensus        19 ~~~~~l~~~ld~--~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~   96 (455)
                      ..+.+|+.++|.  ..+|++||..+.          ++..+|+.|+....+  ...+|+.++|..|.+++..++||..|+
T Consensus         3 ~~~~~~~~l~~~~~g~~W~~la~~Lg----------~~~~~i~~i~~~~~~--~~~~~~~~lL~~W~~~~g~~at~~~L~   70 (88)
T smart00005        3 LTREKLAKLLDHPLGLDWRELARKLG----------LSEADIDQIRTEAPR--DLAEQSVQLLRLWEQREGKNATLGTLL   70 (88)
T ss_pred             hHHHHHHHHHcCccchHHHHHHHHcC----------CCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHccchhhHHHHHH
Confidence            456778888874  799999998754          447899999988754  467999999999999877789999999


Q ss_pred             HHHHhcccccccccc
Q psy5603          97 MFLKKAELHQAARYV  111 (455)
Q Consensus        97 ~~l~~~~l~~~~~~~  111 (455)
                      ..|.+..+..+++.+
T Consensus        71 ~aL~~~~~~d~a~~i   85 (88)
T smart00005       71 EALRKMGRDDAVELL   85 (88)
T ss_pred             HHHHHcChHHHHHHH
Confidence            999999887777643

Alpha-helical domain present in a variety of proteins with apoptotic functions. Some (but not all) of these domains form homotypic and heterotypic dimers.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.88  E-value=0.00015  Score=65.83  Aligned_cols=131  Identities=24%  Similarity=0.269  Sum_probs=86.5

Q ss_pred             CccCcCCC-eEEEEEEEcCCcEEEEEEeecccCcCCCCC---c---hh--hhhhhhHHHHHHHHHHHhhCC---ccce--
Q psy5603         176 NKLGEGQF-GTVYYGKLKNGMEIAVKTLENNANYSSSNS---D---NT--EAAMIPILLFENEVQTLSQCK---HVNL--  241 (455)
Q Consensus       176 ~~LG~G~f-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~---~---~~--~~~~~~~~~~~~E~~~l~~l~---h~ni--  241 (455)
                      +.||.|.- |.||++... |+.+|+|.++.-........   .   ..  .....-..-|..|.+...+++   +.++  
T Consensus        43 efLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~A  121 (207)
T PF13095_consen   43 EFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWA  121 (207)
T ss_pred             eecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceE
Confidence            78999999 999999997 78999999432111111100   0   00  000112335889999988875   4455  


Q ss_pred             eeecccc--c-C----------------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q psy5603         242 LRLLGLC--N-N----------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK  302 (455)
Q Consensus       242 v~l~~~~--~-~----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~  302 (455)
                      |+++||.  . +                ....+|.||.+...            .++    .+-+.++.+-+..+|.  .
T Consensus       122 vkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~~k--~  183 (207)
T PF13095_consen  122 VKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKILHK--L  183 (207)
T ss_pred             EEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHHHH--C
Confidence            8888864  1 0                11247778776543            122    2235677888999999  7


Q ss_pred             CeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         303 PIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       303 ~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ||+-+|+++.|..     .-||+|||.+
T Consensus       184 gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  184 GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CeeeccCcccccc-----CCEEEecccC
Confidence            8999999999987     3489999854

>KOG0576|consensus

Probab=97.83  E-value=3.8e-06  Score=86.65  Aligned_cols=181  Identities=19%  Similarity=0.146  Sum_probs=124.1

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc-eeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-LLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~-~~~  253 (455)
                      +-+++|+++.++|.+..-.+....+.+...                  ....-+++.|.+++||| .+..++-+.. ...
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~------------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~  309 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL  309 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc------------------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence            557999999999976432233335554321                  11445889999999999 5555554444 666


Q ss_pred             EEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         254 CIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++++++.++ |-.......  -..+..-+...+...-+++++++|+  ..-+|+|    ||+..+ +..|..||+....
T Consensus       310 ~i~~~i~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             chhhhhhcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccc--ccccCcc----cccccc-cccccccccCCcc
Confidence            8899999877 222111110  1123344556677788899999999  3358888    777665 6889999997664


Q ss_pred             cccCCcceeeeccCCCCCCCCCccc-ccCCCCcccchHHHHHHHHHHHcCCCCCCC
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~-~~~~~~~~sDv~SlGvvl~elltG~~p~~~  387 (455)
                      .....    ......+|+.++|||+ ..+.+....|.||+|+-..++.-|.+|-..
T Consensus       381 L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  381 LTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cCccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            43321    3456789999999994 556678899999999988888888877654

>PRK10593 hypothetical protein; Provisional

Probab=97.83  E-value=0.0003  Score=68.70  Aligned_cols=74  Identities=12%  Similarity=0.095  Sum_probs=52.1

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc---cceeeecccccC--
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH---VNLLRLLGLCNN--  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~--  250 (455)
                      +.||+|..+.||+....++ .+.+|..+....               ...|.+|...++.+.-   ..+.+++++|..  
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~---------------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARSFST---------------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEeccccc---------------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            5699999999999876544 567777432111               1238889999888743   356667766532  


Q ss_pred             --ceeEEEEEeccCCCH
Q psy5603         251 --IMNCIVYEYMCNGSL  265 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL  265 (455)
                        +..++|||++.|+++
T Consensus        84 ~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         84 SPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCCCeEEEEeccCCEec
Confidence              557999999998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.00026  Score=66.37  Aligned_cols=73  Identities=16%  Similarity=0.169  Sum_probs=46.8

Q ss_pred             CccCcCCCeEEEEEEEcC--CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceee-ecccccCce
Q psy5603         176 NKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR-LLGLCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  252 (455)
                      +.|..|-...+|+....+  +..|++|........   . .          .-.+|+.+++.+...++++ +++.+.   
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~-~----------d~~~E~~~~~~l~~~gl~P~v~~~~~---   66 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---I-I----------DRERELRIHKLLSKHGLAPKLYATFQ---   66 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---e-e----------cHHHHHHHHHHHHhCCCCCeEEEEeC---
Confidence            467888899999998763  578999976532110   0 0          1246888888775444433 333322   


Q ss_pred             eEEEEEeccCCCH
Q psy5603         253 NCIVYEYMCNGSL  265 (455)
Q Consensus       253 ~~lV~e~~~~gsL  265 (455)
                      ..+||||++|.++
T Consensus        67 ~~~l~e~i~G~~l   79 (235)
T cd05157          67 NGLIYEFIPGRTL   79 (235)
T ss_pred             CcEEEEeeCCCcC
Confidence            2479999998776

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF00531 Death: Death domain; InterPro: IPR000488 The death domain (DD) is a homotypic protein interaction module composed of a bundle of six alpha-helices

Probab=97.76  E-value=1.7e-05  Score=61.68  Aligned_cols=76  Identities=21%  Similarity=0.309  Sum_probs=61.7

Q ss_pred             Hhhhhc--CCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy5603          23 ELGIIL--NERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLK  100 (455)
Q Consensus        23 ~l~~~l--d~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~  100 (455)
                      +|++++  +..++|+.||..+          .++..+|+.|+....   ...+||.++|..|..+...++||..|+..|.
T Consensus         2 ~l~~~l~~~~~~~Wk~La~~L----------g~~~~~i~~i~~~~~---~~~~~~~~~L~~W~~~~~~~at~~~L~~aL~   68 (83)
T PF00531_consen    2 KLFDLLAEDLGSDWKRLARKL----------GLSESEIENIEEENP---DLREQTYEMLQRWRQREGPNATVDQLIQALR   68 (83)
T ss_dssp             HHHHHHHHSHSTCHHHHHHHT----------TS-HHHHHHHHHHST---SHHHHHHHHHHHHHHHHGSTSSHHHHHHHHH
T ss_pred             hHHHHHhhcchhhHHHHHHHh----------CcCHHHHHHHHHhCC---ChHHHHHHHHHHHHHhcCCCCcHHHHHHHHH
Confidence            577777  5589999999875          456789999997543   2569999999999877556899999999999


Q ss_pred             hcccccccccc
Q psy5603         101 KAELHQAARYV  111 (455)
Q Consensus       101 ~~~l~~~~~~~  111 (455)
                      +.+...+++.+
T Consensus        69 ~~~~~d~~~~i   79 (83)
T PF00531_consen   69 DIGRNDLAEKI   79 (83)
T ss_dssp             HTTHHHHHHHH
T ss_pred             HCCcHHHHHHH
Confidence            99998887654

DD is related in sequence and structure to the death effector domain (DED, see IPR001875 from INTERPRO) and the caspase recruitment domain (CARD, see IPR001315 from INTERPRO), which work in similar pathways and show similar interaction properties []. DD bind each other forming oligomers. Mammals have numerous and diverse DD-containing proteins []. Within these proteins, the DD domains can be found in combination with other domains, including: CARDs, DEDs, ankyrin repeats (IPR002110 from INTERPRO), caspase-like folds, kinase domains, leucine zippers (IPR002158 from INTERPRO), leucine-rich repeats (LRR) (IPR001611 from INTERPRO), TIR domains (IPR000157 from INTERPRO), and ZU5 domains (IPR000906 from INTERPRO) []. Some DD-containing proteins are involved in the regulation of apoptosis and inflammation through their activation of caspases and NF-kappaB, which typically involves interactions with TNF (tumour necrosis factor) cytokine receptors [, ]. In humans, eight of the over 30 known TNF receptors contain DD in their cytoplasmic tails; several of these TNF receptors use caspase activation as a signalling mechanism. The DD mediates self-association of these receptors, thus giving the signal to downstream events that lead to apoptosis. Other DD-containing proteins, such as ankyrin, MyD88 and pelle, are probably not directly involved in cell death signalling. DD-containing proteins also have links to innate immunity, communicating with Toll family receptors through bipartite adapter proteins such as MyD88 [].; GO: 0005515 protein binding, 0007165 signal transduction; PDB: 3OQ9_L 3EZQ_F 1E41_A 1E3Y_A 2GF5_A 2OF5_L 3EWV_E 3G5B_A 3MOP_L 2A9I_A ....

>KOG2268|consensus

Probab=97.72  E-value=2.8e-05  Score=74.61  Aligned_cols=150  Identities=14%  Similarity=0.135  Sum_probs=97.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCc--------hhhhh-hhhHHHHHHHHHHHhhCCccce
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD--------NTEAA-MIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      ++.+++.||-|--+.||.+.+.+|++.++|.-+-...+-.....        ....| ........+|...|+.+.....
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            44677999999999999999998999999974322111000000        00011 1234456778888888743111


Q ss_pred             eeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         242 LRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       242 v~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                       ++-..+....+|+|||++.|-.|.+.-+-      .+.++   +...+..-|.-|.+  +|+||||.+-=||++++++.
T Consensus       173 -pVPkpiD~~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~--~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  173 -PVPKPIDHNRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLAN--HGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             -CCCCcccccceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHH--cCceecccchheeEEecCCC
Confidence             11122333667999999988888654221      22222   34444455566667  89999999999999999999


Q ss_pred             eEEeecccccc
Q psy5603         322 PKLGDFGIVKM  332 (455)
Q Consensus       322 ~kl~DFGla~~  332 (455)
                      ++++||.-+..
T Consensus       241 i~vIDFPQmvS  251 (465)
T KOG2268|consen  241 IVVIDFPQMVS  251 (465)
T ss_pred             EEEeechHhhc
Confidence            99999986543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.71  E-value=0.00064  Score=68.66  Aligned_cols=82  Identities=13%  Similarity=0.118  Sum_probs=53.5

Q ss_pred             CccCcCCCeEEEEEEEcCC-cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC---ccceeeecccccCc
Q psy5603         176 NKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGLCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  251 (455)
                      +.||.|.+..||++...+| +.|+||.-........      +.+.....++..|.+.|..+.   -.++.+++.+.. .
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g------~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~  104 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVG------ESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-E  104 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCccccccc------ccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-C
Confidence            5699999999999998766 4899998542211100      011222455777888887763   234555666533 5


Q ss_pred             eeEEEEEeccCCC
Q psy5603         252 MNCIVYEYMCNGS  264 (455)
Q Consensus       252 ~~~lV~e~~~~gs  264 (455)
                      ..++||||+++..
T Consensus       105 ~~~lVME~L~~~~  117 (401)
T PRK09550        105 LAVTVMEDLSDHK  117 (401)
T ss_pred             CCEEEEecCCCcc
Confidence            5689999998754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.68  E-value=0.00028  Score=67.18  Aligned_cols=138  Identities=15%  Similarity=0.130  Sum_probs=77.4

Q ss_pred             ccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceee-ecccccCceeEE
Q psy5603         177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR-LLGLCNNIMNCI  255 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~l  255 (455)
                      .+..|-.+.+|+.... +..+++|.........  .           ....+|..+++.+....+.+ ++....   .++
T Consensus         3 ~~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~--~-----------~~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~   65 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHP-GISFVWRPQSPVCKAL--G-----------VDRQREYQILQALSALGLAPKPILVNE---HWL   65 (256)
T ss_pred             cCCCcCcCCeEEEEeC-CccEEEeeCCcccccc--c-----------CcHHHHHHHHHHHHhcCCCCceEEEeC---CEE
Confidence            3667888899998754 6788998754321100  0           01467888888875443432 333322   368


Q ss_pred             EEEeccCCCHHH--------------HHhhcCC----CCCCCHHHH-HHHHHHH---------HHHHHHHHcC------C
Q psy5603         256 VYEYMCNGSLYD--------------RLARVNN----TPPLDSNKR-YSIALGV---------AEALHYLHSL------S  301 (455)
Q Consensus       256 V~e~~~~gsL~~--------------~l~~~~~----~~~l~~~~~-~~i~~~i---------~~gl~~LH~~------~  301 (455)
                      ||+|++|..+..              .+.+...    ..+++.... ..+..++         ...+..+-..      .
T Consensus        66 v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (256)
T TIGR02721        66 LVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLP  145 (256)
T ss_pred             EEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCC
Confidence            999999876532              1111111    112222111 1111111         1112222111      1


Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++|+|+.|.||++++++ +.|+||..+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            3489999999999999887 78999987654

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.62  E-value=0.0011  Score=60.38  Aligned_cols=138  Identities=16%  Similarity=0.165  Sum_probs=88.3

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhh----hhhhhHHHHHHHHHHHhhCC------ccceeeec
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTE----AAMIPILLFENEVQTLSQCK------HVNLLRLL  245 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~------h~niv~l~  245 (455)
                      ..||+|+.-.||.-  .+.....||+.+... .........-    .......++.+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDR-GERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEcccc-ccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            67999999999974  335678999997665 1111000000    00011234566666655554      78899999


Q ss_pred             ccccC-ceeEEEEEecc------CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         246 GLCNN-IMNCIVYEYMC------NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~------~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      |+..+ ...-+|+|.+.      .-+|.+++..    ..++. ..   ...+-.-..||-+  .+|+.+|++|.||++..
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~---~~~L~~f~~~l~~--~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-EL---RQALDEFKRYLLD--HHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HH---HHHHHHHHHHHHH--cCCeecCCCcccEEEEe
Confidence            98777 66678888764      3368888854    23555 33   3334444566666  67999999999999953


Q ss_pred             C--C--ceEEee
Q psy5603         319 N--F--VPKLGD  326 (455)
Q Consensus       319 ~--~--~~kl~D  326 (455)
                      .  +  .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            3  2  577888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK05231 homoserine kinase; Provisional

Probab=97.59  E-value=0.0018  Score=63.69  Aligned_cols=32  Identities=25%  Similarity=0.347  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         301 SKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       301 ~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++||+|++|.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            35799999999999999776668999997754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.55  E-value=0.0016  Score=63.74  Aligned_cols=161  Identities=14%  Similarity=0.073  Sum_probs=86.1

Q ss_pred             eHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHh
Q psy5603         155 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS  234 (455)
Q Consensus       155 ~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  234 (455)
                      +..+|......|... .......++.|.-..+|+....+ ..+++|+.+....               ......|++++.
T Consensus         8 ~~~~l~~~l~~y~~~-~~~~i~~~~~G~~n~~y~v~t~~-~~~vLK~~~~~~~---------------~~~i~~e~~~l~   70 (307)
T TIGR00938         8 SDEEMSSFLDGYDLG-ELLSLKGIAEGVENSNYLLTTDV-GRYILTLYEKRVK---------------AEELPFFLALTT   70 (307)
T ss_pred             CHHHHHHHHHhcCCC-CceeccccCCccccceEEEEeCC-CcEEEEEecCCCC---------------HHHHHHHHHHHH
Confidence            334555554444321 12223667888888999987654 4688898653211               111334555555


Q ss_pred             hCCcc--ceeeecccc-------cCceeEEEEEeccCCCHH-----------HH---HhhcCCC--CC-------CCHHH
Q psy5603         235 QCKHV--NLLRLLGLC-------NNIMNCIVYEYMCNGSLY-----------DR---LARVNNT--PP-------LDSNK  282 (455)
Q Consensus       235 ~l~h~--niv~l~~~~-------~~~~~~lV~e~~~~gsL~-----------~~---l~~~~~~--~~-------l~~~~  282 (455)
                      .+...  .+.+++...       .++..++|++|++|.++.           ..   ++.....  .+       ..|..
T Consensus        71 ~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~  150 (307)
T TIGR00938        71 HLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHI  150 (307)
T ss_pred             HHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHH
Confidence            55321  133333211       125668999999885532           11   1111110  00       11111


Q ss_pred             HH------------HHHHHHHHHHHHHHc-----CCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         283 RY------------SIALGVAEALHYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       283 ~~------------~i~~~i~~gl~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..            .....+...+.++..     ...+++|+|+++.||++++++...|+||+.+..
T Consensus       151 ~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       151 LAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            00            001123334555532     236799999999999999988788999997653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd08797 Death_NFkB1_p105 Death domain of the Nuclear Factor-KappaB1 precursor protein p105

Probab=97.54  E-value=0.00024  Score=53.27  Aligned_cols=71  Identities=15%  Similarity=0.255  Sum_probs=55.7

Q ss_pred             HHHHhhhhcCCc---chHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHH
Q psy5603          20 VVHELGIILNER---DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLI   96 (455)
Q Consensus        20 ~~~~l~~~ld~~---~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~   96 (455)
                      |+.+||..||+.   -.|+.+|...--+           ..+-.|+       .--|||..||+-|-..   ..+|.+|+
T Consensus         1 ~rqkLc~~Ld~p~~~g~Wr~LA~kL~l~-----------~l~~~f~-------~~pSPt~~LLd~~E~~---~G~l~~L~   59 (76)
T cd08797           1 VKQQLYKLLESPDPDKNWETLAQKLGLG-----------ILNNAFR-------LSPSPSKTLLDNYEVS---GGTVRELL   59 (76)
T ss_pred             ChhHHHHHhCCCCCCCCHHHHHHHHCch-----------hHHHHHh-------CCCCcHHHHHHHHhcC---CCCHHHHH
Confidence            578999999953   3599999986533           2333343       4679999999999987   68999999


Q ss_pred             HHHHhcccccccccc
Q psy5603          97 MFLKKAELHQAARYV  111 (455)
Q Consensus        97 ~~l~~~~l~~~~~~~  111 (455)
                      ..|.......+.+++
T Consensus        60 ~aL~~mG~~eav~~L   74 (76)
T cd08797          60 AALKRMGYTEAIEVI   74 (76)
T ss_pred             HHHHHhCcHHHHHHH
Confidence            999999887777654

Death Domain (DD) of the Nuclear Factor-KappaB1 (NF-kB1) precursor protein p105. The NF-kB family of transcription factors play a central role in cardiovascular growth, stress response, and inflammation by controlling the expression of a network of different genes. There are five NF-kB proteins, all containing an N-terminal REL Homology Domain (RHD). NF-kB1 (or p50) is produced from the processing of the precursor protein p105, which contains ANK repeats and a C-terminal DD in addition to the RHD. It is regulated by the classical (or canonical) NF-kB pathway. In the cytosol, p50 forms an inactive complex with RelA (or p65) and the Inhibitor of NF-kB (IkB). Activation is triggered by the phosphorylation and degradation of IkB, resulting in the active DNA-binding p50-RelA dimer to migrate to the nucleus. The classical pathway regulates the majority of genes activated by NF-kB including those encod

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.47  E-value=0.0017  Score=63.22  Aligned_cols=140  Identities=16%  Similarity=0.119  Sum_probs=80.8

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc--eeeecccc-----
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN--LLRLLGLC-----  248 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~-----  248 (455)
                      ..|..|....+|+.... +..+++|+... ..               ......|+.++..+.+.+  +.+++...     
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~-~~---------------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~   82 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK-VS---------------AEELPFFLALLDHLAERGLPVPRPIADRDGEYL   82 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC-CC---------------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEe
Confidence            56888888899998765 45789998753 11               112445666666664322  33443321     


Q ss_pred             --cCceeEEEEEeccCCCHHH-----------HH---hhcCC--C------CCCCHHHHH----------HHHHHHHHHH
Q psy5603         249 --NNIMNCIVYEYMCNGSLYD-----------RL---ARVNN--T------PPLDSNKRY----------SIALGVAEAL  294 (455)
Q Consensus       249 --~~~~~~lV~e~~~~gsL~~-----------~l---~~~~~--~------~~l~~~~~~----------~i~~~i~~gl  294 (455)
                        .++..++|++|++|.++..           .|   +....  .      ....|....          .....+..++
T Consensus        83 ~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  162 (296)
T cd05153          83 SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADEL  162 (296)
T ss_pred             eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHH
Confidence              1245578999999877521           11   11100  0      011221111          0111223344


Q ss_pred             HHHHc-----CCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         295 HYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       295 ~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++.+     ...+++|||+.|.|||+++++.+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         163 ARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            44442     224699999999999999988889999997654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd01670 Death Death Domain: a protein-protein interaction domain

Probab=97.46  E-value=0.0002  Score=54.99  Aligned_cols=69  Identities=22%  Similarity=0.332  Sum_probs=58.6

Q ss_pred             HHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy5603          21 VHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLK  100 (455)
Q Consensus        21 ~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~  100 (455)
                      +..+|+.|.  ++|++||-.+.          ++..+|+.|+....   ...+|+.++|..|..+....+|+..|+..|.
T Consensus         2 ~~~ia~~lg--~~W~~la~~Lg----------l~~~~I~~i~~~~~---~~~~~~~~mL~~W~~~~~~~at~~~L~~aL~   66 (79)
T cd01670           2 LDKLAKKLG--KDWKKLARKLG----------LSDGEIDQIEEDNP---RVREQAYQLLLKWEEREGDNATVGNLIEALR   66 (79)
T ss_pred             HHHHHHHHh--hHHHHHHHHhC----------CCHHHHHHHHHhCC---CHHHHHHHHHHHHHhccCcCcHHHHHHHHHH
Confidence            467888888  99999998754          45789999997754   3679999999999988767899999999999


Q ss_pred             hccc
Q psy5603         101 KAEL  104 (455)
Q Consensus       101 ~~~l  104 (455)
                      +..+
T Consensus        67 ~~~~   70 (79)
T cd01670          67 EIGR   70 (79)
T ss_pred             HcCH
Confidence            9887

Death Domains (DDs) are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. Structural analysis of DD-DD complexes show that the domains interact with each other in many different ways. DD-containing proteins serve as adaptors in signaling pathways and they can recruit other proteins into signaling complexes. In mammals, they are prominent components of the programmed cell death (apoptosis) pathway and are found in a number of other signaling pathways. In invertebrates, they are involved in transcriptional regulation of zygotic patterning genes in insect embryogenesis, and are components of the ToII/NF-kappaB pathway, a conserved innate immune pathway in a

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.43  E-value=0.00081  Score=64.87  Aligned_cols=31  Identities=26%  Similarity=0.460  Sum_probs=25.4

Q ss_pred             CeeecCCCCCcEEEcCCCc-eEEeeccccccc
Q psy5603         303 PIIHRDVKSANVLLDENFV-PKLGDFGIVKMS  333 (455)
Q Consensus       303 ~iiH~Dikp~NILl~~~~~-~kl~DFGla~~~  333 (455)
                      .++|+|++|.|||+++++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 469999976643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd08798 Death_NFkB2_p100 Death domain of the Nuclear Factor-KappaB2 precursor protein p100

Probab=97.37  E-value=0.00051  Score=51.48  Aligned_cols=70  Identities=17%  Similarity=0.319  Sum_probs=55.3

Q ss_pred             HHHhhhhcCC---cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHH
Q psy5603          21 VHELGIILNE---RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIM   97 (455)
Q Consensus        21 ~~~l~~~ld~---~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~   97 (455)
                      +++||..||.   +.+|+.+|...--+           ..+-.|+       .--|||..||+-|-.+   ..+|.+|+.
T Consensus         2 ~qkLc~~Ld~p~~g~dW~~LA~kL~l~-----------~l~~~f~-------~~~SPt~~LLd~yE~~---~G~l~~L~~   60 (76)
T cd08798           2 LQRLEQLLNDTQTDVPWMELAERLGLQ-----------SLVDTYK-------PTQSPPGSLLRSYELA---GGPLQGLIE   60 (76)
T ss_pred             HHHHHHHhcCCCCCCCHHHHHHHHCcc-----------hHHHHHh-------CCCCchHHHHHHhhcc---CCCHHHHHH
Confidence            6799999994   56899999986532           2344444       3569999999999988   679999999


Q ss_pred             HHHhcccccccccc
Q psy5603          98 FLKKAELHQAARYV  111 (455)
Q Consensus        98 ~l~~~~l~~~~~~~  111 (455)
                      .|.......+.+++
T Consensus        61 aL~~mG~~eav~~l   74 (76)
T cd08798          61 ALQDMGLREGVRLL   74 (76)
T ss_pred             HHHHhChHHHHHHh
Confidence            99998887777643

Death Domain (DD) of the Nuclear Factor-KappaB2 (NF-kB2) precursor protein p100. The NF-kB family of transcription factors play a central role in cardiovascular growth, stress response, and inflammation by controlling the expression of a network of different genes. There are five NF-kB proteins, all containing an N-terminal REL Homology Domain (RHD). NF-kB2 (or p52) is produced from the processing of the precursor protein p100, which contains ANK repeats and a C-terminal DD in addition to the RHD. It is regulated by the non-canonical NF-kB pathway. The p100 precursor is cytosolic and interacts with RelB. Upon phosphorylation by IKKalpha, p100 is processed to its 52kDa active, DNA binding form and the p52/RelB complex is translocated into the nucleus. The non-canonical pathway plays a role in adaptive immunity and lymphorganogenesis. In general, DDs are protein-protein interaction domains found i

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.33  E-value=0.0013  Score=64.22  Aligned_cols=74  Identities=19%  Similarity=0.294  Sum_probs=46.1

Q ss_pred             CccCcCCCeEEEEEEEcC-------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcccee-eeccc
Q psy5603         176 NKLGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL-RLLGL  247 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~  247 (455)
                      +.|..|-...||+....+       ++.+++|........              .....+|.+++..+....+. +++++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--------------~~~r~~E~~~~~~l~~~g~~P~~~~~   69 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--------------LIDRERELVVFARLSERNLGPKLYGI   69 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--------------eechHHHHHHHHHHHhCCCCCceEEE
Confidence            456677777999988654       478999997543211              11145677777777543333 34444


Q ss_pred             ccCceeEEEEEeccCCCHH
Q psy5603         248 CNNIMNCIVYEYMCNGSLY  266 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~  266 (455)
                      +.+   .+|++|++|.++.
T Consensus        70 ~~~---~~v~e~i~G~~l~   85 (302)
T cd05156          70 FPN---GRIEEFIPSRTLT   85 (302)
T ss_pred             eCC---CchhheeCCCcCC
Confidence            432   3589999887764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	455
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-48
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-48
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-48
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-45
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-40
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-29
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-26
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-25
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-24
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-24
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-24
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-24
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-24
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-24
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-24
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-10
1d2z_B	153	Three-Dimensional Structure Of A Complex Between Th		4e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-05
3soa_A	444	Full-Length Human Camkii Length = 444		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-05

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 110/310 (35%), Positives = 181/310 (58%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 62
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL
Sbjct: 63  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 175
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 176 DFGLARASEKF-AQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 293
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 294 IKKVQQLLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  189 bits (479), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 110/310 (35%), Positives = 181/310 (58%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 62
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL
Sbjct: 63  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 175
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 176 DFGLARASEKF-AQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 293
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 294 IKKVQQLLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  188 bits (477), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 110/310 (35%), Positives = 179/310 (57%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 56
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL
Sbjct: 57  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 112 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 169
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE      M    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 170 DFGLARASEKFAQXVMXXR-IVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 228
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  
Sbjct: 229 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 287
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 288 IKKVQQLLQE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 175/310 (56%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK GEG FG VY G + N   +AVK L          
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKL---------- 53
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++  ++C+H NL+ LLG  ++  + C+VY Y  NGSL
Sbjct: 54  -----AAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 109 LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 166
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE    + +    + GT  Y  PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 167 DFGLARASEKF-AQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 225
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE   S+   +C   +K+KR  
Sbjct: 226 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVA-SQCLHEKKNKRPD 284
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 285 IKKVQQLLQE 294

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 115/315 (36%), Positives = 164/315 (52%), Gaps = 33/315 (10%)
Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXX 206
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 21  HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLK--- 71
Query: 207 XXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 265
                     E      L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 72  ---------EERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 123 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 182
Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +        + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 183 VGDFGLAKLMDYKDXHVXXA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 241 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 299
Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 300 SPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  161 bits (407), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 114/315 (36%), Positives = 162/315 (51%), Gaps = 33/315 (10%)
Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXX 206
           ++G+L  F+  +L+ A+D F  K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 13  HLGQLKRFSLRELQVASDNFXNK------NILGRGGFGKVYKGRLADGXLVAVKRLK--- 63
Query: 207 XXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 265
                     E      L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 64  ---------EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +        + G   ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 175 VGDFGLAKLMDYKDXHVXXA--VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 291
Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 292 SPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 90/233 (38%), Positives = 129/233 (55%), Gaps = 25/233 (10%)
Query: 156 FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXX 215
             DLE AT+ F+ K        +G G FG VY G L++G ++A+K               
Sbjct: 31  LVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALK-------------RR 71
Query: 216 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVN- 273
           T  +   I  FE E++TLS C+H +L+ L+G C+     I +Y+YM NG+L   L   + 
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 274 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K  
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
            T   +T     + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I
Sbjct: 190 -TELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/233 (38%), Positives = 129/233 (55%), Gaps = 25/233 (10%)
Query: 156 FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXX 215
             DLE AT+ F+ K        +G G FG VY G L++G ++A+K               
Sbjct: 31  LVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALK-------------RR 71
Query: 216 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVN- 273
           T  +   I  FE E++TLS C+H +L+ L+G C+     I +Y+YM NG+L   L   + 
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 274 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K  
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
            T   +T     + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I
Sbjct: 190 -TELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 35/279 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+G G FGTV+  +  +G ++AVK L                       F  EV  + + 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-----------FLREVAIMKRL 91
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ ++
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH+ + PI+HRD+KS N+L+D+ +  K+ DFG+ ++  +     + ++   GT  +M P
Sbjct: 152 YLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX---FLXSKXAAGTPEWMAP 208
Query: 356 EAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVPVREVLDK 410
           E +  + S  K+DV+S+GVIL EL T  +P  + N       V  +    E+P       
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------- 261
Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                   ++   ++ + E C   E  KR S   I+DLL
Sbjct: 262 -------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 35/279 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+G G FGTV+  +  +G ++AVK L                       F  EV  + + 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-----------FLREVAIMKRL 91
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ ++
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH+ + PI+HR++KS N+L+D+ +  K+ DFG+ ++  ++ +    +++  GT  +M P
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS---SKSAAGTPEWMAP 208
Query: 356 EAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVPVREVLDK 410
           E +  + S  K+DV+S+GVIL EL T  +P  + N       V  +    E+P       
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------- 261
Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                   ++   ++ + E C   E  KR S   I+DLL
Sbjct: 262 -------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 40  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 86
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 87  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 145 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 201
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 247

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 41  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 87
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 202
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 248

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 15  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 61
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 62  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 120 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 176
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 174
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 18  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 64
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 122
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 123 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 179
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 225

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 18  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 64
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 122
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 123 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 179
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 41  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 87
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 201
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 248

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 33  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 79
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 80  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 137
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 138 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 193
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 240

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 174
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 173
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 17  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 63
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 64  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 121
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 122 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 178
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 75
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 75
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 111/224 (49%), Gaps = 25/224 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           ++G G FGTVY GK     ++AVK L+             +        F NEV  L + 
Sbjct: 43  RIGSGSFGTVYKGKWHG--DVAVKILKV-----------VDPTPEQFQAFRNEVAVLRKT 89
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +HVN+L  +G        IV ++    SLY  L  V  T      +   IA   A+ + Y
Sbjct: 90  RHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHL-HVQETK-FQMFQLIDIARQTAQGMDY 147
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           LH+  K IIHRD+KS N+ L E    K+GDFG+  +    +  +   E  TG+  +M PE
Sbjct: 148 LHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-GSQQVEQPTGSVLWMAPE 204
Query: 357 AMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
            +  Q     S ++DV+SYG++L EL+TG  P   I++ + I++
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 41/279 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G G FG V   K +   ++A+K +E                      F  E++ LS+  
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---------------FIVELRQLSRVN 60
Query: 238 HVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL 297
           H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ + YL
Sbjct: 61  HPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 298 HSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           HS+  K +IHRD+K  N+LL     V K+ DFG        +++T  T N  G+  +M P
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNN-KGSAAWMAP 173
Query: 356 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ---EVPVREVLDKE 411
           E       S K DVFS+G+IL E++T  KP D+     +  +         P+ + L K 
Sbjct: 174 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 233
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
                   +E+L++    +C   +  +R SM +IV +++
Sbjct: 234 --------IESLMT----RCWSKDPSQRPSMEEIVKIMT 260

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 41/279 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G G FG V   K +   ++A+K +E                      F  E++ LS+  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---------------FIVELRQLSRVN 59
Query: 238 HVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL 297
           H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ + YL
Sbjct: 60  HPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 298 HSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           HS+  K +IHRD+K  N+LL     V K+ DFG        +++T  T N  G+  +M P
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNN-KGSAAWMAP 172
Query: 356 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ---EVPVREVLDKE 411
           E       S K DVFS+G+IL E++T  KP D+     +  +         P+ + L K 
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
                   +E+L++    +C   +  +R SM +IV +++
Sbjct: 233 --------IESLMT----RCWSKDPSQRPSMEEIVKIMT 259

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 115/219 (52%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLKNGME----IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK   +    +A+KTL+            +EA++            +
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI------------M 69
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q +H N++RL G+  N M   I+ E+M NG+L D   R+N+       +   +  G+A 
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQ-FTVIQLVGMLRGIAS 127
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++    YT +L G  P 
Sbjct: 128 GMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPI 185
Query: 352 -YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+   + ++ +D +SYG+++ E+++ G +P  D
Sbjct: 186 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 71  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 183
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 71
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 72  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 131 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 184
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 178
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 75
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 76  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 135 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 188
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 60
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 61  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 120 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 173
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + +    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVL---------FKTQLEKAGVEHQL-RREVEIQ 66
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELAN 123
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL  N   K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT-----LCGTLDY 176
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L GM P + + 
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + +    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVL---------FKTQLEKAGVEHQL-RREVEIQ 66
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELAN 123
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL  N   K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-----LCGTLDY 176
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L GM P + + 
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 66
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 67  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 126 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 181
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 75  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 134 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 189
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 180
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 67
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 68  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 127 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 182
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 74  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 132
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 133 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 188
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 189 AINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 71
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 72  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 131 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 186
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 180
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 177 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 234
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              H N+++L GL +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 295 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
            Y+ + + PI+HRD++S N+    LDEN     K+ DFG      TS         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG------TSQQSVHSVSGLLGN 189
Query: 350 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 387
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G +Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQFG VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 177 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 234
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              H N+++L GL +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 295 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
            Y+ + + PI+HRD++S N+    LDEN     K+ DFG+ + S  S         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGN 189
Query: 350 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 387
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L+GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTT-----LSGTLDY 173
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++A+KTL+                M P    E E Q + + 
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLK-------------PGTMSPESFLE-EAQIMKKL 61
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKRYSIALGVAE 292
           KH  L++L  + +     IV EYM  GSL D L     R    P L       +A  VA 
Sbjct: 62  KHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAA 116
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y+  ++   IHRD++SAN+L+    + K+ DFG+ ++ E  N  T         +  
Sbjct: 117 GMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKWT 173
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLT 380
            P  A++ + + K+DV+S+G++L EL+T
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 63
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 64  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 123 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 176
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 79
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 136
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 137 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 189
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 388
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 61
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 62  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHR++++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 121 IEE--RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 174
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + KN   I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 60
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 61  RHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 120 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEA 176
Query: 357 AMHCQISTKTDVFSYGVILLELLT 380
           A++ + + K+DV+S+G++L EL T
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 83
Query: 235 QCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       IV EYM  G+L D L R  N   + +     +A  ++ A
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQISSA 142
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN V K+ DFG+ ++         YT +     P  
Sbjct: 143 MEYLEK--KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT----YTAHAGAKFPIK 196
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ +   S K+DV+++GV+L E+ T GM P
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 88
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 145
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 146 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 198
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 388
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 77
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 136
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 137 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 190
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 61
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 118
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 119 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 171
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 179
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-----LCGTLDY 173
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 61
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 62  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 121 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 174
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 319
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 320 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 379 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 432
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 66
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 123
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 176
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKI 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 179
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 65
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 124
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 125 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 181
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 68
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 127
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 128 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 181
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 88
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 145
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S       ++L GT  Y
Sbjct: 146 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RDDLCGTLDY 198
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 388
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G +Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LXGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  +    K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 59
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 60  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 119 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 172
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 173 PEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S       ++L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RDDLCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 114/219 (52%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLKNGME----IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK   +    +A+KTL+            +EA++            +
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI------------M 71
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q +H N++RL G+  N M   I+ E+M NG+L D   R+N+       +   +  G+A 
Sbjct: 72  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQ-FTVIQLVGMLRGIAS 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++     T +L G  P 
Sbjct: 130 GMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 352 -YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+   + ++ +D +SYG+++ E+++ G +P  D
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 226

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 185
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 59
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 116
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 117 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 169
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEA 186
Query: 357 AMHCQISTKTDVFSYGVILLELLT 380
           A++ + + K+DV+S+G++L EL T
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 84
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 142
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 143 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKL 198
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTA 178
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 65
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 124
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT       P  
Sbjct: 125 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAPAGAKFPIK 178
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 173
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT       P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAPAGAKFPIK 179
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+ +AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 67
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   ++  +A  + Y
Sbjct: 68  RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 127 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 180
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQ G V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTA--REGAKFPIKWTAPE 180
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 177 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 234
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              H N+++L GL +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 295 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
            Y+ + + PI+HRD++S N+    LDEN     K+ DF + + S  S         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS------VSGLLGN 189
Query: 350 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 387
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 83
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 141
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 142 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 197
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 80
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 138
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 139 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 194
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 64
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 121
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 122 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 174
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 64
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 121
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S   T     L GT  Y
Sbjct: 122 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT-----LCGTLDY 174
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 144 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 84
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 142
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 143 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 198
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 144 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 82
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 140
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 141 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 196
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTX-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----ELCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 77
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 78  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 135
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 136 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 191
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 104
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 105 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 162
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 163 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 218
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 263

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  G L D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 103
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 104 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 161
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 162 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 217
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 262

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +   
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKTL 65
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+RL  +        I+ EYM  GSL D L + +    +   K    +  +AE + 
Sbjct: 66  QHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 124
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  + 
Sbjct: 125 YIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWT 178
Query: 354 PPEAMHCQIST-KTDVFSYGVILLELLT 380
            PEA++    T K+DV+S+G++L E++T
Sbjct: 179 APEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  G L D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 67
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L  + +     IV EYM  GSL D L +      L   +   ++  +A  + Y
Sbjct: 68  RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 127 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPEA 183
Query: 357 AMHCQISTKTDVFSYGVILLELLT 380
           A++ + + K+DV+S+G++L EL T
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 59
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 118 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 171
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGNMSP-EAFLQEAQVMKKL 237
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGVAE 292
           +H  L++L  + +     IV EYM  GSL D     + +    P L       +A  +A 
Sbjct: 238 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-----VDMAAQIAS 292
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P 
Sbjct: 293 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNE----YTARQGAKFPI 346
Query: 352 -YMPPE-AMHCQISTKTDVFSYGVILLELLT 380
            +  PE A++ + + K+DV+S+G++L EL T
Sbjct: 347 KWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 55
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 113
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 114 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 167
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++             E +M      E E + +   
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMNL 61
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+ 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAME 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  + 
Sbjct: 120 YLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 173
Query: 354 PPEA-MHCQISTKTDVFSYGVILLELLT 380
           PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++             E +M      E E + +   
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMNL 76
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+ 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAME 134
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  + 
Sbjct: 135 YLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 188
Query: 354 PPEA-MHCQISTKTDVFSYGVILLELLT 380
           PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 66
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 124
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 125 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 178
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 39/230 (16%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 71
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 276
           + L+  +H +++R  G+C      + V+EYM +G L +R  R +                
Sbjct: 72  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 130
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 131 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 188
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 189 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 39/230 (16%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 65
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 276
           + L+  +H +++R  G+C      + V+EYM +G L +R  R +                
Sbjct: 66  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 124
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 125 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 182
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 183 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 83
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 141
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 142 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 197
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 86
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 145 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 200
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 144 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 72
Query: 238 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++          TG  P  + 
Sbjct: 132 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWT 181
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 63
Query: 238 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 123 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+     STK+DV+S+G++L E+ +
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 144 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 39/230 (16%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 94
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 276
           + L+  +H +++R  G+C      + V+EYM +G L +R  R +                
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 153
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 212 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 271
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 330
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 331 MEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 384
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--------------TMEVEEFLKEAAVMK 310
Query: 235 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 311 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 369
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 370 MEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 423
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 458

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 57
Query: 238 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++          TG  P  + 
Sbjct: 117 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWT 166
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 90
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 91  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 148
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 149 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 204
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 249

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 86
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 145 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVH--NKTGAKL 200
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 60
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT +     P  +
Sbjct: 119 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSRGSKFPVRW 172
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 244
Query: 238 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++          TG  P  + 
Sbjct: 304 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWT 353
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 30/210 (14%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++             E +M      E E + +   
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMNL 76
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+ 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAME 134
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM----SETSNMKTMYTENLTGTRP 351
           YL   SK  +HRD+ + N L+++  V K+ DFG+ +      ETS++ + +         
Sbjct: 135 YLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR------ 186
Query: 352 YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           + PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 144
Query: 234 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 202
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 203 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 258
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 109/247 (44%), Gaps = 33/247 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++N   +A+K +                          EV+ L +
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQK 71
Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N ++  G         +V EY C GS  D L    +  PL   +  ++  G  + L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 128
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M 
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMA 179
Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 234
Query: 411 EAGEWNE 417
           ++G W+E
Sbjct: 235 QSGHWSE 241

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 109/247 (44%), Gaps = 33/247 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++N   +A+K +                          EV+ L +
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQK 110
Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N ++  G         +V EY C GS  D L    +  PL   +  ++  G  + L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 167
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M 
Sbjct: 168 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMA 218
Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 273
Query: 411 EAGEWNE 417
           ++G W+E
Sbjct: 274 QSGHWSE 280

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +   
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKTL 64
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+RL  +        I+ E+M  GSL D L + +    +   K    +  +AE + 
Sbjct: 65  QHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  + 
Sbjct: 124 YIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWT 177
Query: 354 PPEAMHCQIST-KTDVFSYGVILLELLT 380
            PEA++    T K++V+S+G++L E++T
Sbjct: 178 APEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +++G+G FG VY G   +  E+ A+K ++                       + E+  LS
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI------------QQEITVLS 72
Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + R  G    +    I+ EY+  GS  D L       PL+     +I   + + 
Sbjct: 73  QCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKG 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 129 LDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 183
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +       K D++S G+  +EL  G  P  D + +   +L+ +   P  E
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE 237

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 46/260 (17%)
Query: 171 YPRRG----NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           YPR        +GEG FG V+  +    +     T+              +A       F
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD------F 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRL---------------- 269
           + E   +++  + N+++LLG+C      C+++EYM  G L + L                
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 270 ---ARVNNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 324
              ARV++   PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 215
Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GM 382
            DFG+ +   +++       +    R +MPPE++ + + +T++DV++YGV+L E+ + G+
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 383 KPIDDNNTILYYYLVVEQEV 402
           +P         YY +  +EV
Sbjct: 275 QP---------YYGMAHEEV 285

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 58
Query: 236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL   S  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 117 AYLEEAS--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 169
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 38/230 (16%)
Query: 177 KLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +       K+ M +AVK L+                      F+ E 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-------------FQREA 68
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTP----- 276
           + L+  +H ++++  G+C +    I V+EYM +G L         D +  V+  P     
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L  ++   IA  +A  + YL   S+  +HRD+ + N L+  N + K+GDFG+ +   ++
Sbjct: 129 ELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ M+ + +T++DV+S+GVIL E+ T G +P
Sbjct: 187 DYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V  GK K   ++AVK ++             E +M     F+ E QT+ +
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIK-------------EGSMSEDEFFQ-EAQTMMK 59
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++  G+C+      IV EY+ NG L + L   ++   L+ ++   +   V E +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            +L   S   IHRD+ + N L+D +   K+ DFG+ +      +   Y  ++    P  +
Sbjct: 118 AFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKW 171
Query: 353 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID 386
             PE  H  + S+K+DV+++G+++ E+ + G  P D
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 14  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 60
Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 116
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 171
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 225

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 29  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 75
Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 76  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 131
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 132 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 186
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 240

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 14  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 60
Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 116
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 171
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       + +AVKTL+                      F  E 
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-------------FHREA 66
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTPP--LD 279
           + L+  +H ++++  G+C      I V+EYM +G L         D +      PP  L 
Sbjct: 67  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELT 126
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG+ +   +++  
Sbjct: 127 QSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +    +   R +MPPE+ M+ + +T++DV+S GV+L E+ T G +P
Sbjct: 185 RVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G LK      + +A+KTL+            +EA++            +
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI------------M 88
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L G+        I+ E+M NGSL D   R N+       +   +  G+A 
Sbjct: 89  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQ-FTVIQLVGMLRGIAA 146
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT  L G  P 
Sbjct: 147 GMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 204
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 205 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 61
Query: 236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 62  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 120 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 172
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 67
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 68  QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 125
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  + 
Sbjct: 126 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 179
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT 380
            PEA++    + K+DV+S+G++L+E++T
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 240
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 241 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 298
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  + 
Sbjct: 299 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 352
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA++    + K+DV+S+G++L+E++T
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 34  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 80
Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 81  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 136
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 137 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 191
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 245

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G G FG VY      G E+AVK                            E +  +  K
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIEN---------VRQEAKLFAMLK 64
Query: 238 HVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           H N++ L G+C    N C+V E+   G L +R+      PP   +   + A+ +A  ++Y
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPP---DILVNWAVQIARGMNY 120
Query: 297 LHSLS-KPIIHRDVKSANVLLDE--------NFVPKLGDFGIVK-MSETSNMKTMYTENL 346
           LH  +  PIIHRD+KS+N+L+ +        N + K+ DFG+ +    T+ M        
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA------ 174
Query: 347 TGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            G   +M PE +   + +K +DV+SYGV+L ELLTG  P    + +   Y V        
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-------- 226
Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
             ++K A     T  E    ++ E C   +   R S  +I+D L+
Sbjct: 227 -AMNKLALPIPSTCPEPFAKLM-EDCWNPDPHSRPSFTNILDQLT 269

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 58
Query: 236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 117 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 169
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 56
Query: 236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 114
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 115 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 167
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 133/286 (46%), Gaps = 35/286 (12%)
Query: 174 RGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           R   +G G+FG VY G LK       + +A+KTL+            TE   +  L    
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---------TEKQRVDFL---G 95
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E   + Q  H N++RL G+ +      I+ EYM NG+L D+  R  +       +   + 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGE-FSVLQLVGML 153
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
            G+A  + YL +++   +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T    
Sbjct: 154 RGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 348 GTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 405
               +  PEA+ + + ++ +DV+S+G+++ E++T G +P         Y+ +   E  V 
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------YWELSNHE--VM 260
Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           + ++            + I  +  +C   E+ +R    DIV +L K
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT++             E +M      E E + + +
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIK-------------EGSMSEDDFIE-EAEVMMK 78
Query: 236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 79  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 136
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 137 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 189
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 190 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 229

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 59
Query: 236 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G+C      C+V E+M +G L D L          +     + L V E +
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 118 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 170
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K N   +A+K L                          E++  
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----------LRREIEIQ 69
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LR+    ++     ++ E+   G LY  L +       D  +  +    +A+
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELAD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           ALHY H   + +IHRD+K  N+L+      K+ DFG      + +  ++    + GT  Y
Sbjct: 127 ALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVHAPSLRRRXMCGTLDY 179
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 386
           +PPE +  +    K D++  GV+  E L GM P D
Sbjct: 180 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 234
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 235 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 292
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++     +K            +  P
Sbjct: 293 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK------------WTAP 338
Query: 356 EAMHC-QISTKTDVFSYGVILLELLT 380
           EA++    + K+DV+S+G++L+E++T
Sbjct: 339 EAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG G FG V+  + + NG   A+K L+            T           +E   LS  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----------DERLMLSIV 63
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  ++R+ G   +     ++ +Y+  G L+  L R +   P    K Y  A  V  AL 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFY--AAEVCLALE 120
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHS  K II+RD+K  N+LLD+N   K+ DFG  K           T  L GT  Y+ P
Sbjct: 121 YLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYXLCGTPDYIAP 172
Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           E +  +   K+ D +S+G+++ E+L G  P  D+NT+  Y  ++  E+
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 69
Query: 235 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 70  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 186
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 187 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 79
Query: 235 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 80  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 197 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G LK      + +A+KTL+            +EA++            +
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI------------M 62
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L G+        I+ E+M NGSL D   R N+       +   +  G+A 
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQ-FTVIQLVGMLRGIAA 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  ++   +HR + + N+L++ N V K+ DFG+ +  E       YT  L G  P 
Sbjct: 121 GMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 217

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 30  RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDI------------QQEITVLS 76
Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G         I+ EY+  GS  D L       P D  +  ++   + + 
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKG 132
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 133 LDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 187
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            PE +      +K D++S G+  +EL  G  P  D + +   +L+ +   P 
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT 239

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 41/288 (14%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D +        +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETC----MDEG 116
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 339
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 340 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 175 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
               P  +         N   +  +      +C   + +KR S ++++
Sbjct: 230 TNGTPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 124/259 (47%), Gaps = 45/259 (17%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARVNNTPPLDSNKRYSIA---LGVAEALHYLHSL--------SKPIIHRD 308
            C G L + L R +    L+++  ++IA   L   + LH+   +        SK  IHRD
Sbjct: 132 CCYGDLLNFLRRKSRV--LETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 309 VKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKT 366
           V + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 367 DVFSYGVILLELLT-GMKP 384
           DV+SYG++L E+ + G+ P
Sbjct: 248 DVWSYGILLWEIFSLGLNP 266

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 121/259 (46%), Gaps = 45/259 (17%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS-----------LSKPIIHRD 308
            C G L + L R +    L+++  ++IA   A     LH             SK  IHRD
Sbjct: 132 CCYGDLLNFLRRKSRV--LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 309 VKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKT 366
           V + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 367 DVFSYGVILLELLT-GMKP 384
           DV+SYG++L E+ + G+ P
Sbjct: 248 DVWSYGILLWEIFSLGLNP 266

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y  R  K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 17  GDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 63
Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D +        +D  
Sbjct: 64  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETC----MDEG 117
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 118 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 173
Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 174 -RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 232
Query: 401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 233 GTPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 169 KPYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K + +R   LGEG FG V   +        G ++AVK+L+             E+    I
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------------PESGGNHI 67
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
              + E++ L    H N+++  G+C     N I   ++ E++ +GSL + L +  N   L
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKINL 125
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 126 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 339 KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT 380
                ++      +  PE  M  +    +DV+S+GV L ELLT
Sbjct: 182 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G  G V YG+L+      + +A+K L+            +EA++            +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI------------M 104
Query: 234 SQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+     +  IV EYM NGSL D   R ++       +   +  GV  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQ-FTIMQLVGMLRGVGA 162
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E        T        +
Sbjct: 163 GMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRW 220
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G  G V YG+L+      + +A+K L+            +EA++            +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI------------M 104
Query: 234 SQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+     +  IV EYM NGSL D   R ++       +   +  GV  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQ-FTIMQLVGMLRGVGA 162
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E  +    YT    G  P 
Sbjct: 163 GMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTT-GGKIPI 218
Query: 352 -YMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 84
Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G+   C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 140
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 141 GSGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 169 KPYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K + +R   LGEG FG V   +        G ++AVK+L+             E+    I
Sbjct: 8   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------------PESGGNHI 55
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
              + E++ L    H N+++  G+C     N I   ++ E++ +GSL + L +  N   L
Sbjct: 56  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKINL 113
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 114 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 169
Query: 339 KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT 380
                ++      +  PE  M  +    +DV+S+GV L ELLT
Sbjct: 170 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 71
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 130 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 185
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 98
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 156
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 157 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 214
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 215 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 41/255 (16%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARV-------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
            C G L + L R         +  PL+       +  VA+ + +L   SK  IHRDV + 
Sbjct: 132 CCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAAR 189
Query: 313 NVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 370
           NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++DV+S
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247
Query: 371 YGVILLELLT-GMKP 384
           YG++L E+ + G+ P
Sbjct: 248 YGILLWEIFSLGLNP 262

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 88
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 146
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 147 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 202
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 41/288 (14%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y  R  K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 17  GDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 63
Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D +        +D  
Sbjct: 64  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETC----MDEG 117
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 339
           +  ++     +AL +LHS    +IHR++KS N+LL  +   KL DFG       E S   
Sbjct: 118 QIAAVCRECLQALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 340 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 176 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230
Query: 399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
               P  +         N   +  +      +C   + +KR S ++++
Sbjct: 231 TNGTPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G+FG VY  + K N   +A+K L                          E++  S  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----------LRREIEIQSHL 71
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N+LR+    ++     ++ E+   G LY  L +       D  +  +    +A+ALH
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 128
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   + +IHRD+K  N+L+      K+ DFG      + +  ++    + GT  Y+PP
Sbjct: 129 YCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVHAPSLRRRXMCGTLDYLPP 181
Query: 356 EAMHCQI-STKTDVFSYGVILLELLTGMKPID 386
           E +  +    K D++  GV+  E L GM P D
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D +        +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETC----MDEG 116
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 173 -RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 232 GTPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 224 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D +        +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETC----MDEG 116
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 173 -RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 232 GTPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 69
Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G+   C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 125
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 126 GSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 222

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 41/255 (16%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 18  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 75
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 76  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 123
Query: 260 MCNGSLYDRLARV-------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
            C G L + L R         +  PL+       +  VA+ + +L   SK  IHRDV + 
Sbjct: 124 CCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAAR 181
Query: 313 NVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 370
           NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++DV+S
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWS 239
Query: 371 YGVILLELLT-GMKP 384
           YG++L E+ + G+ P
Sbjct: 240 YGILLWEIFSLGLNP 254

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 63
Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G+   C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 119
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 120 GSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 76
Query: 235 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 77  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHR++ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQ--KQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYV 193
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 194 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  GK +  G ++AVK L                ++  +     E+Q L
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR----------SLDVVGKIRREIQNL 70
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H ++++L  + +   +  +V EY+  G L+D + +      LD  +   +   +  
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILS 127
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y H     ++HRD+K  NVLLD +   K+ DFG+  M         +     G+  Y
Sbjct: 128 GVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRXSCGSPNY 181
Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 390
             PE +  ++    + D++S GVIL  LL G  P DD++ 
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  G+ +  G ++AVK L                ++  +   + E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNL 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H ++++L  + +   +  +V EY+  G L+D + +      +++ + +   L   +
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
             H        ++HRD+K  NVLLD +   K+ DFG+  M         +  +  G+  Y
Sbjct: 126 YCH-----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRDSCGSPNY 176
Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 390
             PE +  ++    + D++S GVIL  LL G  P DD + 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           GN LG+G F  VY  + +  G+E+A+K ++             +A M+  +  +NEV+  
Sbjct: 16  GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--------KAGMVQRV--QNEVKIH 65
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q KH ++L L     +     +   MC+    +R  + N   P   N+       +   
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQIITG 124
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YLHS    I+HRD+  +N+LL  N   K+ DFG+    +  + K  YT  L GT  Y+
Sbjct: 125 MLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT--LCGTPNYI 179
Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPID 386
            PE A       ++DV+S G +   LL G  P D
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  G+ +  G ++AVK L                ++  +   + E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNL 65
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H ++++L  + +   +  +V EY+  G L+D + +      +++ + +   L   +
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
             H        ++HRD+K  NVLLD +   K+ DFG+  M         +     G+  Y
Sbjct: 126 YCH-----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNY 176
Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 390
             PE +  ++    + D++S GVIL  LL G  P DD + 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 74
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 64
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 65  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    ++   
Sbjct: 123 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 181 KGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 73
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 74  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    ++   
Sbjct: 132 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 190 KGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 228 NEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSN 281
            E+Q +SQC H N++             +V + +  GS+ D +  +     + +  LD +
Sbjct: 62  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN--MK 339
              +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T     +
Sbjct: 122 TIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 340 TMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
               +   GT  +M PE M  Q+     K D++S+G+  +EL TG  P      +    L
Sbjct: 180 NKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 397 VVEQEVPVRE--VLDKEAGEWNETHVETLISIVFEK 430
            ++ + P  E  V DKE  +        +IS+  +K
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 274

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 228 NEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSN 281
            E+Q +SQC H N++             +V + +  GS+ D +  +     + +  LD +
Sbjct: 57  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 116
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN--MK 339
              +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T     +
Sbjct: 117 TIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 340 TMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
               +   GT  +M PE M  Q+     K D++S+G+  +EL TG  P      +    L
Sbjct: 175 NKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 233
Query: 397 VVEQEVPVRE--VLDKEAGEWNETHVETLISIVFEK 430
            ++ + P  E  V DKE  +        +IS+  +K
Sbjct: 234 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 269

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 68
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 46/226 (20%)
Query: 178 LGEGQFGTVYYG----KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G+G FG VY+G    + +N ++ A+K+L             TE   +   L E  +  +
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------TEMQQVEAFLREGLL--M 76
Query: 234 SQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L L+G  L    +  ++  YMC+G L   +      P +      S  L VA
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVA 134
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-----------VKMSETSNMKT 340
             + YL    +  +HRD+ + N +LDE+F  K+ DFG+           V+    + +  
Sbjct: 135 RGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 341 MYT--ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
            +T  E+L   R            +TK+DV+S+GV+L ELLT   P
Sbjct: 193 KWTALESLQTYR-----------FTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 74
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 68
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 62
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + +H N++ L  +  N  + + + E +  G L+D LA       L  ++       + +
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILD 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 120 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 173
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 69
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + +H N++ L  +  N  + + + E +  G L+D LA   +   L  ++       + +
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 127 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 70
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 71  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 129 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 183
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 184 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 120/263 (45%), Gaps = 51/263 (19%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARVNNTPP---------------LDSNKRYSIALGVAEALHYLHSLSKPI 304
            C G L + L R    PP               L S      +  VA+ + +L   SK  
Sbjct: 132 CCYGDLLNFLRR--KRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNC 187
Query: 305 IHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQI 362
           IHRDV + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  
Sbjct: 188 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVY 245
Query: 363 STKTDVFSYGVILLELLT-GMKP 384
           + ++DV+SYG++L E+ + G+ P
Sbjct: 246 TVQSDVWSYGILLWEIFSLGLNP 268

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 73
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 74  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 132 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 186
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 187 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 69
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYD-----RLARVNNT--PPLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L       R A  NN    P   
Sbjct: 70  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 128 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 182
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 183 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 159 GMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 214
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 72
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 73  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 131 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 185
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 186 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG G FG V+  + ++ G+E  +KT+              + + +P+   E E++ L  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTIN------------KDRSQVPMEQIEAEIEVLKS 76
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEA 293
             H N++++  +  +  N  IV E    G L +R+         L       +   +  A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDEN--FVP-KLGDFGIVKMSETSNMKTMYTENLTGTR 350
           L Y HS  + ++H+D+K  N+L  +     P K+ DFG+ ++ ++    T    N  GT 
Sbjct: 137 LAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST----NAAGTA 190
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            YM PE     ++ K D++S GV++  LLTG  P 
Sbjct: 191 LYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 66
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 67  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 125 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 179
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 180 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 31  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREE-------IEREVNIL 83
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + +H N++ L  +  N  + + + E +  G L+D LA       L  ++       + +
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILD 140
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 141 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFG 194
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 195 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 79
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYD-----RLARVNNT--PPLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L       R A  NN    P   
Sbjct: 80  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 192
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 72
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 73  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 131 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 185
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 186 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 93/182 (51%), Gaps = 13/182 (7%)
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           FE EV   SQ  H N++ ++ + +   +C  +V EY+   +L +    + +  PL  +  
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDV-DEEDDCYYLVMEYIEGPTLSEY---IESHGPLSVDTA 113
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMY 342
            +    + + + + H +   I+HRD+K  N+L+D N   K+ DFGI K +SETS  +   
Sbjct: 114 INFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--- 168
Query: 343 TENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           T ++ GT  Y  PE    + + + TD++S G++L E+L G  P +    +      ++  
Sbjct: 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228
Query: 402 VP 403
           VP
Sbjct: 229 VP 230

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 442
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  L YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 503 A--LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 554
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 71
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 130 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 185
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 79
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 80  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 192
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G+        IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 130/287 (45%), Gaps = 38/287 (13%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD------------FLGEASIM 77
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L G+        IV EYM NGSL   L +  N       +   +  G++ 
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKK--NDGQFTVIQLVGMLRGISA 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 136 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193
Query: 353 MPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
             PEA+   + ++ +DV+SYG+++ E+++ G +P         Y+ +  Q+V ++ V   
Sbjct: 194 TAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP---------YWEMTNQDV-IKAV--- 240
Query: 411 EAGEWNETHVETLISI--VFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
           E G    + ++   ++  +   C   E++ R    +IV++L K + N
Sbjct: 241 EEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           ++G+G++G V+ GK + G ++AVK               TE A       E E+      
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVF-----------FTTEEAS---WFRETEIYQTVLM 88
Query: 237 KHVNLLRLL-----GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +H N+L  +     G  +     ++ +Y  NGSLYD L     +  LD+     +A    
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSV 144
Query: 292 EALHYLHS-----LSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTE 344
             L +LH+       KP I HRD+KS N+L+ +N    + D G+ VK    +N   +   
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 345 NLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLEL 378
              GT+ YMPPE +       H Q     D++S+G+IL E+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 101
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 102 SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 160 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 214
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 215 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 79
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 80  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 128
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 129 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 187 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--AREPPGLEYSYNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 59
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 117
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 118 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 171
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 83
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 84  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 132
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 133 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 191 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 75
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 76  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYCYNP 124
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 183 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 82
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 83  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 131
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 132 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 190 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTR---PYMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +N T  R    +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID--YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 26/252 (10%)
Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           E  T   N + +     +LG+G FG VY  + K    +A   +              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV-----IDTKSEEELEDY 81
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 279
           M+       E+  L+ C H N+++LL       N  +    C G   D +  +    PL 
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLT 133
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+       N +
Sbjct: 134 ESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTR 187
Query: 340 TMY-TENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTIL 392
           T+   ++  GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N + 
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 247
Query: 393 YYYLVVEQEVPV 404
               + + E P 
Sbjct: 248 VLLKIAKSEPPT 259

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 65
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 66  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 123
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 124 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 177
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 225

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 137/291 (47%), Gaps = 46/291 (15%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+             EA++            +
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI------------M 98
Query: 234 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G+      +M  IV E+M NG+L D   R ++       +   +  G+
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVM--IVIEFMENGAL-DAFLRKHDGQ-FTVIQLVGMLRGI 154
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + + +YT    G  
Sbjct: 155 AAGMRYLADMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYT-TTGGKI 210
Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD--NNTILYYYLVVEQEVPV 404
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D  N  ++     +E+   +
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK---AIEEGYRL 267
Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
              +D  AG          +  +   C   E+ +R     IV +L K + N
Sbjct: 268 PAPMDCPAG----------LHQLMLDCWQKERAERPKFEQIVGILDKMIRN 308

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 68
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 69  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 126
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 127 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 184
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 64
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 65  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 122
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 123 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 176
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 224

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 104/251 (41%), Gaps = 24/251 (9%)
Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           E  T   N + +     +LG+G FG VY  + K    +A   +              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV-----IDTKSEEELEDY 81
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 279
           M+       E+  L+ C H N+++LL       N  +    C G   D +  +    PL 
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLT 133
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +   
Sbjct: 134 ESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKNTRX 188
Query: 340 TMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILY 393
               ++  GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N +  
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 248
Query: 394 YYLVVEQEVPV 404
              + + E P 
Sbjct: 249 LLKIAKSEPPT 259

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 67
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 125
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 126 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 179
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDD--NNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 66
Query: 231 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 67  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N  + E+F  K+GDFG+ + + ET    
Sbjct: 125 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD--- 179
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 180 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYCYNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  +     
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKVKEP 176
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET+   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA--- 184
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 90
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 91  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 148
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 149 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 202
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 250

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 231
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 232 TLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+L+      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVP 403
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 103/251 (41%), Gaps = 24/251 (9%)
Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           E  T   N + +     +LG+G FG VY  + K    +A   +              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV-----IDTKSEEELEDY 81
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 279
           M+       E+  L+ C H N+++LL       N  +    C G   D +  +    PL 
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLT 133
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +   
Sbjct: 134 ESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKNTRX 188
Query: 340 TMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILY 393
               +   GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N +  
Sbjct: 189 IQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 248
Query: 394 YYLVVEQEVPV 404
              + + E P 
Sbjct: 249 LLKIAKSEPPT 259

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 36  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 90
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 91  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 143
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 144 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 201
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 202 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 258 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 307
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 308 RPTFKQIVQLIEKQIS 323

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V ++ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMRIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S         L    
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK- 177
Query: 351 PYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
            +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 178 -WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 131
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 132 ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA--RRPPGLEYSYNP 180
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 239 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 86
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 87  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 194
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 195 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 184
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
            +LG+G FG VY  K K  G   A K +E                      +  E++ L+
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-------------YIVEIEILA 71
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGV 290
            C H  +++LLG   +     +    C G   D     L R    P +    R  +    
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---- 127
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGT 349
            EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT
Sbjct: 128 -EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGT 180
Query: 350 RPYMPPEAMHCQI------STKTDVFSYGVILLEL 378
             +M PE + C+         K D++S G+ L+E+
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 38  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 92
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 93  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 145
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 146 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 203
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 204 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 260 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 309
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 310 RPTFKQIVQLIEKQIS 325

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 89
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 90  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 140
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 141 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 197
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 65
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 123
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 124 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 179
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
            +LG+G FG VY  K K  G   A K +E                      +  E++ L+
Sbjct: 17  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-------------YIVEIEILA 63
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGV 290
            C H  +++LLG   +     +    C G   D     L R    P +    R  +    
Sbjct: 64  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---- 119
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGT 349
            EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT
Sbjct: 120 -EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGT 172
Query: 350 RPYMPPEAMHCQI------STKTDVFSYGVILLEL 378
             +M PE + C+         K D++S G+ L+E+
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 143
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 144 ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 251
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 252 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 61
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 62  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 119
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 120 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 175
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 84
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 85  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLTARNVLVTENNVMKIADFGLAR- 192
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 193 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 442
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  L YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +   G  
Sbjct: 503 A--LAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKASKGKL 554
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 68
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 69  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 126
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 127 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 182
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 231
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 232 TLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVP 403
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEFSFNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +     T      + +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 RDIHHIDXXKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 67
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 68  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 125
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 126 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 181
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 70
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 71  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 128
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 129 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 183
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 184 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 60
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 61  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 118
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 119 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 174
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 66
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 67  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 124
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 125 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 180
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 97
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 98  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 208
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 209 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 314
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 315 RPTFKQIVQLIEKQIS 330

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 74
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 75  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 185
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 186 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 291
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 292 RPTFKQIVQLIEKQIS 307

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 69
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 70  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 127
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 128 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 183
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 97
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 98  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 208
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 209 ICDFGLARHIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 314
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 315 RPTFKQIVQLIEKQIS 330

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 64
Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K      
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 122
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHR++ + N+L++     K+GDFG+ K+      K  Y     G
Sbjct: 123 QICKGMEYLGT--KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD--KEYYKVKEPG 178
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 179 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 176
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 93
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 94  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 151
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 152 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 207
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 29/240 (12%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 231
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 232 TLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVP 403
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   D  +++ Y + V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQH-VREDPIP 238

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 176
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           +R   LG G FGTVY G       I V   E                    + F +E   
Sbjct: 18  KRVKVLGSGAFGTVYKG-------IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 70
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   H +L+RLLG+C +    +V + M +G L + +    +   + S    +  + +A+
Sbjct: 71  MASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  G  P 
Sbjct: 129 GMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-GGKMPI 183
Query: 352 -YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M  E +H  + + ++DV+SYGV + EL+T G KP D               +P RE+ 
Sbjct: 184 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IPTREIP 229
Query: 409 D-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
           D  E GE   +  + T+ + +V  KC + + D R   +++    S+   +
Sbjct: 230 DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 279

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 173 RRGNKLGEGQFGTVYYG-KLKNG----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           +R   LG G FGTVY G  +  G    + +A+K L                       F 
Sbjct: 41  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE------------FM 88
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   H +L+RLLG+C +    +V + M +G L + +    +   + S    +  
Sbjct: 89  DEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWC 146
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  
Sbjct: 147 VQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-G 201
Query: 348 GTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 403
           G  P  +M  E +H  + + ++DV+SYGV + EL+T G KP D               +P
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IP 247
Query: 404 VREVLD-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            RE+ D  E GE   +  + T+ + +V  KC + + D R   +++    S+   +
Sbjct: 248 TREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 302

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 120/268 (44%), Gaps = 54/268 (20%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 11  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 68
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 69  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 116
Query: 260 MCNGSLYDRLARV--------------------NNTPPLDSNKRYSIALGVAEALHYLHS 299
            C G L + L R                      +  PL+       +  VA+ + +L  
Sbjct: 117 CCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL-- 174
Query: 300 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAM 358
            SK  IHRDV + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++
Sbjct: 175 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESI 232
Query: 359 H-CQISTKTDVFSYGVILLELLT-GMKP 384
             C  + ++DV+SYG++L E+ + G+ P
Sbjct: 233 FDCVYTVQSDVWSYGILLWEIFSLGLNP 260

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 81
Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K      
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 139
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   G
Sbjct: 140 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--PG 195
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLGEG +G+VY    K  G  +A+K +              E+ +  I+    E+  + Q
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVP------------VESDLQEII---KEISIMQQ 80
Query: 236 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           C   ++++  G    N    IV EY   GS+ D +   N T  L  ++  +I     + L
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH + K  IHRD+K+ N+LL+     KL DFG+         K      + GT  +M 
Sbjct: 139 EYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK---RNXVIGTPFWMA 193
Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
           PE +     +   D++S G+  +E+  G  P  D + +   +++
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 23/228 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L                          E++  
Sbjct: 28  GRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ----------LRREIEIQ 77
Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +   H N+LRL     +     ++ EY   G LY  L +       D  +  +I   +A+
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELAD 134
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y H   K +IHRD+K  N+LL      K+ DFG    + +   KTM      GT  Y
Sbjct: 135 ALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTM-----CGTLDY 187
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
           +PPE +  ++ + K D++  GV+  ELL G  P +  +    Y  +V+
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVK 235

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 81
Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K      
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 139
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   G
Sbjct: 140 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--PG 195
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++  Y   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G  +G+G+FG VY+G+     E+A++ ++                   +  F+ EV    
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQ-----------LKAFKREVMAYR 84
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           Q +H N++  +G C +  +  +   +C G     + R +    LD NK   IA  + + +
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGM 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET--SNMKTMYTENLTGTRPY 352
            YLH  +K I+H+D+KS NV  D   V  + DFG+  +S    +  +        G   +
Sbjct: 144 GYLH--AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 353 MPPEAMH----------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           + PE +              S  +DVF+ G I  EL     P                E 
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----------EA 250
Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            + ++        ++  +   IS +   C  FE+++R +   ++D+L K
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + ++K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 113
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 114 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 339 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 396
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
Query: 397 VVEQEVP 403
           V E  +P
Sbjct: 232 VREDPIP 238

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 65
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G+C +       ++ EY+  GSL D L    +   +D  K     
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDHIKLLQYT 123
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 124 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 179
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+     +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNIDXX-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +              E+ +        EVQ L Q 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLL-------REVQLLKQL 89
Query: 237 KHVNLLRLLGLCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 146
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 147 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 198
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 199 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 27/243 (11%)
Query: 170 PYPRR--------GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           P PR+        G  LGEG F TV   + L    E A+K LE             +   
Sbjct: 1   PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENK 52
Query: 221 IPILLFENEVQTLSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 279
           +P +  E +V  +S+  H   ++L     ++        Y  NG L   + ++ +    +
Sbjct: 53  VPYVTRERDV--MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--E 108
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
           +  R+  A  +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K
Sbjct: 109 TCTRFYTA-EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESK 164
Query: 340 TMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
                   GT  Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  ++
Sbjct: 165 QARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 224
Query: 399 EQE 401
           + E
Sbjct: 225 KLE 227

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+     +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNIDXX-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 27/243 (11%)
Query: 170 PYPRR--------GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           P PR+        G  LGEG F TV   + L    E A+K LE             +   
Sbjct: 2   PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENK 53
Query: 221 IPILLFENEVQTLSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 279
           +P +  E +V  +S+  H   ++L     ++        Y  NG L   + ++ +    +
Sbjct: 54  VPYVTRERDV--MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--E 109
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
           +  R+  A  +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K
Sbjct: 110 TCTRFYTA-EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESK 165
Query: 340 TMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
                   GT  Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  ++
Sbjct: 166 QARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 225
Query: 399 EQE 401
           + E
Sbjct: 226 KLE 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++  Y   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 99/177 (55%), Gaps = 17/177 (9%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ +++  G L+ RL++       + + ++ +A  +A AL +LHSL   II+RD+K  N+
Sbjct: 104 LILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENI 158
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 373
           LLDE    KL DFG+ K S   + K  Y+    GT  YM PE ++ +  T++ D +S+GV
Sbjct: 159 LLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGV 215
Query: 374 ILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEK 430
           ++ E+LTG  P    +      ++++ ++ + + L  EA        ++L+ ++F++
Sbjct: 216 LMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA--------QSLLRMLFKR 264

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 99/177 (55%), Gaps = 17/177 (9%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ +++  G L+ RL++       + + ++ +A  +A AL +LHSL   II+RD+K  N+
Sbjct: 103 LILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENI 157
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 373
           LLDE    KL DFG+ K S   + K  Y+    GT  YM PE ++ +  T++ D +S+GV
Sbjct: 158 LLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGV 214
Query: 374 ILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEK 430
           ++ E+LTG  P    +      ++++ ++ + + L  EA        ++L+ ++F++
Sbjct: 215 LMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA--------QSLLRMLFKR 263

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 113
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 114 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 339 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 396
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
Query: 397 VVEQEVP 403
           V E  +P
Sbjct: 232 VREDPIP 238

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 83
Query: 237 KHVNLLRLLGLCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 141 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 192
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 135/287 (47%), Gaps = 29/287 (10%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R+   LG G FGTV+ G       + +   E             ++         + +  
Sbjct: 34  RKLKVLGSGVFGTVHKG-------VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 86
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H +++RLLGLC      +V +Y+  GSL D + +      L      +  + +A+
Sbjct: 87  IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAK 144
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y+E  T  + +
Sbjct: 145 GMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-W 201
Query: 353 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           M  E++H  + + ++DV+SYGV + EL+T G +P         Y  +   EVP  ++L+K
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP---------YAGLRLAEVP--DLLEK 250
Query: 411 EAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
             GE   +  + T+ + +V  KC + +++ R + +++ +  ++   +
Sbjct: 251 --GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 295

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 101/178 (56%), Gaps = 19/178 (10%)
Query: 255 IVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           ++ +++  G L+ RL++ V  T   + + ++ +A  +A AL +LHSL   II+RD+K  N
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFT---EEDVKFYLA-ELALALDHLHSLG--IIYRDLKPEN 156
Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYG 372
           +LLDE    KL DFG+ K S   + K  Y+    GT  YM PE ++ +  T++ D +S+G
Sbjct: 157 ILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 373 VILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEK 430
           V++ E+LTG  P    +      ++++ ++ + + L  EA        ++L+ ++F++
Sbjct: 214 VLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA--------QSLLRMLFKR 263

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 130
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 131 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 339 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 396
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 248
Query: 397 VVEQEVP 403
           V E  +P
Sbjct: 249 VREDPIP 255

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 87
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 144
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 201
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 251

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 21/231 (9%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 91
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVY--EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           S+  H   ++L   C      + +   Y  NG L   + ++ +    ++  R+  A  + 
Sbjct: 92  SRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIV 147
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 204
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 255

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 62
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 176
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 184
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 135/287 (47%), Gaps = 29/287 (10%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R+   LG G FGTV+ G       + +   E             ++         + +  
Sbjct: 16  RKLKVLGSGVFGTVHKG-------VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H +++RLLGLC      +V +Y+  GSL D + +      L      +  + +A+
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAK 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y+E  T  + +
Sbjct: 127 GMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-W 183
Query: 353 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           M  E++H  + + ++DV+SYGV + EL+T G +P         Y  +   EVP  ++L+K
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP---------YAGLRLAEVP--DLLEK 232
Query: 411 EAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
             GE   +  + T+ + +V  KC + +++ R + +++ +  ++   +
Sbjct: 233 --GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 12  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 61
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 118
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 175
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 72
Query: 231 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 73  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 130
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 131 QEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 185
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 186 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V   + K +G ++AVK ++                    LLF NEV  +  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE------------LLF-NEVVIMRD 98
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L    +  ++ E++  G+L D +++V     L+  +  ++   V +A
Sbjct: 99  YQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQA 153
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLH+  + +IHRD+KS ++LL  +   KL DFG          K    + L GT  +M
Sbjct: 154 LAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKXLVGTPYWM 208
Query: 354 PPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +   + +T+ D++S G++++E++ G  P   ++ +            ++ + D   
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----------AMKRLRDSPP 258
Query: 413 GEWNETH-VETLISIVFEKCCVFEKDKRASMRDIVD 447
            +   +H V  ++    E+  V +  +RA+ ++++D
Sbjct: 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 106
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 163
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 164 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 215
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 216 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 83
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 140
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 197
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 247

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 19  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 68
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 182
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 232

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 107
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 164
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 165 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 216
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 217 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 55
Query: 238 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 111
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 397 V 397
           V
Sbjct: 232 V 232

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 73  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 117
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 118 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 174
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANAFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDK-----------TQLNPTSLQKLFREVRIMKIL 71
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 128
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 129 YCHQ--KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAP 182
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 56
Query: 238 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 57  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 112
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 232
Query: 397 V 397
           V
Sbjct: 233 V 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 87
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 144
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 201
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 251

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 61
Query: 238 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 62  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 117
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 237
Query: 397 V 397
           V
Sbjct: 238 V 238

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 58
Query: 238 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 59  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 114
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 174
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 234
Query: 397 V 397
           V
Sbjct: 235 V 235

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V++ M  G L+D L        L   +  SI   + EA+ +LH+    I+HRD+K  N+
Sbjct: 177 LVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENI 231
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-------STKTD 367
           LLD+N   +L DFG     E           L GT  Y+ PE + C +         + D
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 368 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE--THVETLIS 425
           +++ GVIL  LL G  P      IL   +++E +          + EW++  + V+ LIS
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF------SSPEWDDRSSTVKDLIS 341
Query: 426 IVFE 429
            + +
Sbjct: 342 RLLQ 345

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 83
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 140
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 197
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 247

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 66
Query: 232 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G+C +       ++ E++  GSL + L +  +   +D  K      
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKERIDHIKLLQYTS 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   G
Sbjct: 125 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--PG 180
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 89
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 90  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 146
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 203
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 253

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 94
Query: 238 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 150
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 397 V 397
           V
Sbjct: 271 V 271

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 255 IVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           ++ +++  G L+ RL++ V  T   + + ++ +A  +A  L +LHSL   II+RD+K  N
Sbjct: 107 LILDFLRGGDLFTRLSKEVMFT---EEDVKFYLA-ELALGLDHLHSLG--IIYRDLKPEN 160
Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 372
           +LLDE    KL DFG+ K +   + K  Y+    GT  YM PE ++ Q  S   D +SYG
Sbjct: 161 ILLDEEGHIKLTDFGLSKEA-IDHEKKAYS--FCGTVEYMAPEVVNRQGHSHSADWWSYG 217
Query: 373 VILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           V++ E+LTG  P    +      L+++ ++ + + L  EA
Sbjct: 218 VLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEA 257

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 21/238 (8%)
Query: 161 RATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           R   G+N     R   K+G GQF  VY    L +G+ +A+K ++              A 
Sbjct: 23  RPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK----ARAD 78
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 277
            I       E+  L Q  H N+++     + +N +N IV E    G L   +        
Sbjct: 79  CI------KEIDLLKQLNHPNVIKYYASFIEDNELN-IVLELADAGDLSRMIKHFKKQKR 131
Query: 278 LDSNKR-YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           L   +  +   + +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   + 
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS- 188
Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILY 393
             KT    +L GT  YM PE +H    + K+D++S G +L E+     P   +   LY
Sbjct: 189 --KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G L +G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQS--------------WFRETEIYNTVLLR 60
Query: 238 HVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +       N      ++  Y  +GSLYD L R    P L      S A G+A 
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAH 120
Query: 293 ALHY--LHSLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLTG 348
            LH     +  KP I HRD KS NVL+  N    + D G+  M S+ S+   +      G
Sbjct: 121 -LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVG 179
Query: 349 TRPYMPPEAMHCQISTK-------TDVFSYGVILLEL 378
           T+ YM PE +  QI T        TD++++G++L E+
Sbjct: 180 TKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 128/317 (40%), Gaps = 65/317 (20%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKNG--MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG  K G  +++AVK L+            +E  M
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYD------------ 267
           +  L             H N++ LLG C  +    +++EY C G L +            
Sbjct: 102 MTQL-----------GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 268 --------RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
                   RL    +   L        A  VA+ + +L    K  +HRD+ + NVL+   
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHG 208
Query: 320 FVPKLGDFGIVK--MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVI 374
            V K+ DFG+ +  MS+++     Y        P  +M PE++   I T K+DV+SYG++
Sbjct: 209 KVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 375 LLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCV 433
           L E+ + G+ P         +Y +++    + +            +    I I+ + C  
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF----------YATEEIYIIMQSCWA 313
Query: 434 FEKDKRASMRDIVDLLS 450
           F+  KR S  ++   L 
Sbjct: 314 FDSRKRPSFPNLTSFLG 330

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 81
Query: 238 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 82  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 137
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 197
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 198 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 257
Query: 397 V 397
           V
Sbjct: 258 V 258

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 177 KLGEGQFGTVYYGKL---KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G     K  +++A+K L+            TE  M        E Q +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMM-------REAQIM 64
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++RL+G+C      +V E    G L+  L       P+ +         VAE 
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---------VAEL 115
Query: 294 LH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           LH       YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT   
Sbjct: 116 LHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARS 171
Query: 347 TGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
            G  P  +  PE ++  + S+++DV+SYGV + E L+ G KP
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+A+K ++            T+     +     EV+ +   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDK-----------TQLNPTSLQKLFREVRIMKIL 68
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        ++ EY   G ++D L         ++  ++     +  A+ 
Sbjct: 69  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQ 125
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYM 353
           Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   G+ PY 
Sbjct: 126 YCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDTFCGSPPYA 177
Query: 354 PPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
            PE    +     + DV+S GVIL  L++G  P D  N
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V     K   E+ A+K L+             E  M+       E + L+  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDD---VECTMV-------EKRVLALL 76
Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   ++ +  V EY+  G L   + +V         +    A  ++  L
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISIGL 133
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +LH   + II+RD+K  NV+LD     K+ DFG   M +   M  + T    GT  Y+ 
Sbjct: 134 FFLHK--RGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMMDGVTTREFCGTPDYIA 188
Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D ++YGV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 247

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 92/219 (42%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 83
Query: 237 KHVNLLRLLGLCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+ +L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y H     I+HRD+K  N+LL     D N   ++ DFG+    E S       ++  GT 
Sbjct: 141 YXHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKK----XKDKIGTA 192
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 171 YPRRGNK--LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           Y   G++  LG+G +G VY G+ L N + IA+K +                         
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-------------LH 53
Query: 228 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E+      KH N+++ LG    N    I  E +  GSL   L R    P  D+ +    
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGF 112
Query: 287 -ALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTE 344
               + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE
Sbjct: 113 YTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTE 167
Query: 345 NLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
             TGT  YM PE +           D++S G  ++E+ TG  P        +Y L   Q 
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--------FYELGEPQA 219
Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              +  + K   E  E+      + +  KC   + DKRA   D++
Sbjct: 220 AMFKVGMFKVHPEIPESMSAEAKAFIL-KCFEPDPDKRACANDLL 263

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 171 YPRRGNK--LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           Y   G++  LG+G +G VY G+ L N + IA+K +                         
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-------------LH 67
Query: 228 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E+      KH N+++ LG    N    I  E +  GSL   L R    P  D+ +    
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGF 126
Query: 287 -ALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTE 344
               + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE
Sbjct: 127 YTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTE 181
Query: 345 NLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
             TGT  YM PE +           D++S G  ++E+ TG  P        +Y L   Q 
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--------FYELGEPQA 233
Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              +  + K   E  E+      + +  KC   + DKRA   D++
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFIL-KCFEPDPDKRACANDLL 277

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AV+ ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 63
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIVSAVQ 120
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 121 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 174
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G  PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 59
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 117 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPIL--LFENEVQT 232
            K+GEG +G V+  + ++ G  +A+K                E+   P++  +   E++ 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF-------------LESEDDPVIKKIALREIRM 55
Query: 233 LSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L Q KH NL+ LL +        +V+EY C+ ++   L R     P    K  SI     
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVK--SITWQTL 112
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           +A+++ H  +   IHRDVK  N+L+ ++ V KL DFG  ++       + Y ++   TR 
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP---SDYYDDEVATRW 167
Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
           Y  PE +    Q     DV++ G +  ELL+G+      + +   YL+
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AV+ ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 59
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 117 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 168 RKPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIP 222
            K Y ++   LGEG FG V    Y    +G    +AVK L+             +A    
Sbjct: 29  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK------------ADAGPQH 76
Query: 223 ILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLD 279
              ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    + 
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IG 132
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             +    A  + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ K     +  
Sbjct: 133 LAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEX 190
Query: 340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
               E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMKTMYT- 343
           I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 344 -------ENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL 379
                      GT+ YM PE +H    S K D+FS G+IL ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 113/231 (48%), Gaps = 28/231 (12%)
Query: 226 FENEVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           F  EV+ +   +H N+L+ +G+   +  +N I  EY+  G+L   +  +++  P   ++R
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT-EYIKGGTLRGIIKSMDSQYPW--SQR 110
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-----SETSNM 338
            S A  +A  + YLHS++  IIHRD+ S N L+ EN    + DFG+ ++     ++   +
Sbjct: 111 VSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 339 KTMYTEN------LTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
           +++   +      + G   +M PE ++ +    K DVFS+G++L E++  +    D    
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD---- 224
Query: 392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM 442
            Y    ++  + VR  LD+    +   +       +  +CC  + +KR S 
Sbjct: 225 -YLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSF 270

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F T    + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTTVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V +Y+  G L+  L R      L+   R+  A  +A AL YLHSL+  I++RD+K  N+
Sbjct: 116 FVLDYINGGELFYHLQRERCF--LEPRARF-YAAEIASALGYLHSLN--IVYRDLKPENI 170
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 373
           LLD      L DFG+ K +   N     T    GT  Y+ PE +H Q   +T D +  G 
Sbjct: 171 LLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 374 ILLELLTGMKPIDDNNTILYY 394
           +L E+L G+ P    NT   Y
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMY 248

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M++     + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MAQDIYRASYYR 201
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 129
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 130 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 183
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GTR YM PE +     S ++D++S G+ L+E+  G  PI   +  +  +          E
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIF----------E 233
Query: 407 VLDKEAGEWNETHVETLISIVFE----KCCVFEKDKRASMRDIV 446
           +LD    E        + S+ F+    KC +    +RA ++ ++
Sbjct: 234 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  + K   +  A+K L+             E  M+     E  V +L+  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMV-----EKRVLSLA-W 76
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  +        N   V EY+  G L   +  + +    D ++    A  +   L 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 134 FLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGTPDYIAP 188
Query: 356 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           E +  Q  +   D +S+GV+L E+L G  P 
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+A+K ++            T+     +     EV+ +   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDK-----------TQLNPTSLQKLFREVRIMKIL 71
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        ++ EY   G ++D L         ++  ++     +  A+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQ 128
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYM 353
           Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   G  PY 
Sbjct: 129 YCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDAFCGAPPYA 180
Query: 354 PPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
            PE    +     + DV+S GVIL  L++G  P D  N
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG  G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  + K   +  A+K L+             E  M+     E  V +L+  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMV-----EKRVLSLA-W 75
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  +        N   V EY+  G L   +  + +    D ++    A  +   L 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 133 FLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTPDYIAP 187
Query: 356 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           E +  Q  +   D +S+GV+L E+L G  P 
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 201
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 114
Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 115 --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 173 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 227
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIXKVL 70
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G  PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 72  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 119
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 177
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 178 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 375 LLELLT 380
           L E+ +
Sbjct: 235 LWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 201
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 72  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 119
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 177
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 178 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 375 LLELLT 380
           L E+ +
Sbjct: 235 LWEIFS 240

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 137
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 138 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 191
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 29  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 88
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 89  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 137 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 194
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 195 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 251
Query: 375 LLELLT 380
           L E+ +
Sbjct: 252 LWEIFS 257

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 87  YSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 192
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 193 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 375 LLELLT 380
           L E+ +
Sbjct: 250 LWEIFS 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 87  CSEQDELDFLMEALII------------SKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 192
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 193 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 375 LLELLT 380
           L E+ +
Sbjct: 250 LWEIFS 255

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMKTMYT- 343
           I + +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 169 IFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 344 -------ENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL 379
                      GT+ YM PE +H    S K D+FS G+IL ELL
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 94
Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 95  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 153 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 207
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 210
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 211 PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 266
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 354
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+ 
Sbjct: 267 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYLA 320
Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 379

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 4   YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 63
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 64  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 111
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 112 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 169
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 170 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 226
Query: 375 LLELLT 380
           L E+ +
Sbjct: 227 LWEIFS 232

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 207
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 208 PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 263
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 354
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+ 
Sbjct: 264 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYLA 317
Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 67
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +AE
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAE 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 126 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 182
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 228
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 229 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 276

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 118/243 (48%), Gaps = 38/243 (15%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  LGEG+FG+V  G LK      +++AVKT++              ++   I  F +E 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK-----------LDNSSQREIEEFLSEA 87
Query: 231 QTLSQCKHVNLLRLLGLCNNIMN------CIVYEYMCNGSLYDRL--ARVNNTP---PLD 279
             +    H N++RLLG+C  + +       ++  +M  G L+  L  +R+   P   PL 
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
           +  ++ +   +A  + YL   ++  +HRD+ + N +L ++    + DFG+ K   + +  
Sbjct: 148 TLLKFMV--DIALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-- 201
Query: 340 TMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDD-NNTILYY 394
             Y +      P  ++  E++  ++ T K+DV+++GV + E+ T GM P     N  +Y 
Sbjct: 202 -YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 395 YLV 397
           YL+
Sbjct: 261 YLL 263

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 87  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 134
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 192
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 193 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 375 LLELLT 380
           L E+ +
Sbjct: 250 LWEIFS 255

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 134/291 (46%), Gaps = 45/291 (15%)
Query: 173 RRGNKLGEGQFGTVYYG-KLKNG----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           R+   LG G FGTVY G  + +G    + +A+K L             +  A   IL   
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---------SPKANKEIL--- 67
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++      + RLLG+C      +V + M  G L D +    N   L S    +  
Sbjct: 68  DEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVR--ENRGRLGSQDLLNWC 125
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ + YL  +   ++HRD+ + NVL+      K+ DFG+ ++ +    +T Y  +  
Sbjct: 126 MQIAKGMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID--ETEYHAD-G 180
Query: 348 GTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 403
           G  P  +M  E+ +  + + ++DV+SYGV + EL+T G KP D               +P
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------IP 226
Query: 404 VREVLD-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            RE+ D  E GE   +  + T+ + ++  KC + + + R   R++V   S+
Sbjct: 227 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSR 277

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEGQF TVY  + KN  +I A+K ++              A          E++ L + 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL--------REIKLLQEL 69
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N++ LL    +  N  +V+++M        +   +N+  L  +   +  L   + L 
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH     I+HRD+K  N+LLDEN V KL DFG+ K   + N    Y   +  TR Y  P
Sbjct: 127 YLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYXHQVV-TRWYRAP 181
Query: 356 EAMHC--QISTKTDVFSYGVILLELL 379
           E +          D+++ G IL ELL
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG G+F  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 80
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 138
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 139 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 195
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 241
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 242 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 289

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 172
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 173 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 226
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLAR-VNNTPPLDSNKR 283
           +EV  L + KH N++R      +  N  +Y   EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 284 YSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N  T
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDT 170
Query: 341 MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            + +   GT  YM PE M+    + K+D++S G +L EL   M P 
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 169 KPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---------- 56
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 280
             ++ E++ L    H ++++  G C +       +V EY+  GSL D L R      +  
Sbjct: 57  --WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 110
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +    A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +   
Sbjct: 111 AQLLLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 168
Query: 341 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
              E+      +  PE +  C+    +DV+S+GV L ELLT
Sbjct: 169 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 30  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 89
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 90  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 138 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 195
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+        Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 196 PGRVAKIGDFG---MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 252
Query: 375 LLELLT 380
           L E+ +
Sbjct: 253 LWEIFS 258

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 169 KPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---------- 57
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 280
             ++ E++ L    H ++++  G C +       +V EY+  GSL D L R      +  
Sbjct: 58  --WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 111
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +    A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +   
Sbjct: 112 AQLLLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 169
Query: 341 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
              E+      +  PE +  C+    +DV+S+GV L ELLT
Sbjct: 170 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 53  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 112
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G+   ++   I+ E M  G 
Sbjct: 113 CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 218
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+        Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 219 PGRVAKIGDFG---MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275
Query: 375 LLELLT 380
           L E+ +
Sbjct: 276 LWEIFS 281

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 57  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 114
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 115 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 168
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 169 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 71
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAK 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 130 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 186
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 232
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 74
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 133 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 189
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 235
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLAR-VNNTPPLDSNKR 283
           +EV  L + KH N++R      +  N  +Y   EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 284 YSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N  T
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDT 170
Query: 341 MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            + +   GT  YM PE M+    + K+D++S G +L EL   M P 
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 71
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 130 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 186
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 232
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 81/174 (46%), Gaps = 25/174 (14%)
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSL--YDRLARVNNTPPLDSNK 282
           F+NE+Q ++  K+   L   G+  N     I+YEYM N S+  +D    V     LD N 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-----LDKNY 144
Query: 283 RYSIAL--------GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
              I +         V  +  Y+H+  K I HRDVK +N+L+D+N   KL DFG     E
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFG-----E 198
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPI 385
           +  M     +   GT  +MPPE    + S    K D++S G+ L  +   + P 
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 64  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 121
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 122 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 175
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 176 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 230

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 30/274 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G ++G G FG V+ G+L+ +   +AVK+                        F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK------------FLQEARIL 166
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  H N++RL+G+C       +   +  G  +    R      L       +    A  
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAG 225
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E   +             + 
Sbjct: 226 MEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWT 282
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
            PEA+ + + S+++DV+S+G++L E  + G  P        Y  L  +Q    RE ++K 
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASP--------YPNLSNQQ---TREFVEKG 331
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                       +  + E+C  +E  +R S   I
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++           N
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GN 233
Query: 282 KRYSIA------LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK- 331
           KR   A        +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K 
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDD 387
           + ETS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  +
Sbjct: 292 LGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 388 NNT 390
           + T
Sbjct: 347 HRT 349

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +R  KLG G +G V   K K  G E A+K ++            T  +    LL  +EV 
Sbjct: 7   QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSV--------TTTSNSGALL--DEVA 56
Query: 232 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L Q  H N+++L     +  N  +V E    G L+D +        +D+     I   V
Sbjct: 57  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQV 113
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSN-MKTMYTENL 346
                YLH  +  I+HRD+K  N+LL+    + + K+ DFG+    E    MK    E L
Sbjct: 114 LSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK----ERL 167
Query: 347 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 168 -GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 15/173 (8%)
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L  +  +  +  +V + +  G L+DR+         D++   +
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---T 124
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A++YLH +   I+HRD+K  N+L    DE     + DFG+ KM    ++ +  
Sbjct: 125 LIRQVLDAVYYLHRMG--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS-- 180
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI-DDNNTILY 393
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D+N++ L+
Sbjct: 181 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLF 231

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 41/223 (18%)
Query: 177 KLGEGQFGTVYYGKL---KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G     K  +++A+K L+            TE  M        E Q +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMM-------REAQIM 390
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAE 292
            Q  +  ++RL+G+C      +V E    G L+  L            KR  I +  VAE
Sbjct: 391 HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV----------GKREEIPVSNVAE 440
Query: 293 ALH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            LH       YL    K  +HR++ + NVLL      K+ DFG+ K     +  + YT  
Sbjct: 441 LLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTAR 496
Query: 346 LTGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
             G  P  +  PE ++  + S+++DV+SYGV + E L+ G KP
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V     K+ G ++AVK ++                    LLF NEV  +  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 98
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V  A
Sbjct: 99  YHHDNVVDMYSSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRA 153
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLH+  + +IHRD+KS ++LL  +   KL DFG          K    + L GT  +M
Sbjct: 154 LSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKXLVGTPYWM 208
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +      T+ D++S G++++E++ G  P
Sbjct: 209 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 95
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 153
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 154 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 210
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 256
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 257 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 304

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 112/233 (48%), Gaps = 35/233 (15%)
Query: 173 RRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL- 225
           R   +LGE +FG VY G L      +    +A+KTL+             + A  P+   
Sbjct: 29  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-------------DKAEGPLREE 75
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRL---ARVNNTPPLDSN 281
           F +E    ++ +H N++ LLG+        +++ Y  +G L++ L   +  ++    D +
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 282 KRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
           +    AL   + +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +  
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
             ++   +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 196 YAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++           N
Sbjct: 197 PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GN 247
Query: 282 KRYSIA------LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK- 331
           KR   A        +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K 
Sbjct: 248 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 305
Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDD 387
           + ETS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  +
Sbjct: 306 LGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
Query: 388 NNT 390
           + T
Sbjct: 361 HRT 363

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 76
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 134
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 135 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 191
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 237
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 238 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 285

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +R  KLG G +G V   K K  G E A+K ++               A++      +EV 
Sbjct: 24  QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTS----NSGALL------DEVA 73
Query: 232 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L Q  H N+++L     +  N  +V E    G L+D +        +D+     I   V
Sbjct: 74  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQV 130
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                YLH  +  I+HRD+K  N+LL+    + + K+ DFG+    E         +   
Sbjct: 131 LSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK----MKERL 184
Query: 348 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 185 GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG G F  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 111/229 (48%), Gaps = 35/229 (15%)
Query: 177 KLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENE 229
           +LGE +FG VY G L      +    +A+KTL+             + A  P+   F +E
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-------------DKAEGPLREEFRHE 62
Query: 230 VQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRL---ARVNNTPPLDSNKRYS 285
               ++ +H N++ LLG+        +++ Y  +G L++ L   +  ++    D ++   
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 286 IALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
            AL   + +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +    ++
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
              +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 183 YYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 64
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 123 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 179
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 225
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 30/274 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G ++G G FG V+ G+L+ +   +AVK+                        F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK------------FLQEARIL 166
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  H N++RL+G+C       +   +  G  +    R      L       +    A  
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAG 225
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E   +             + 
Sbjct: 226 MEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWT 282
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
            PEA+ + + S+++DV+S+G++L E  + G  P        Y  L  +Q    RE ++K 
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASP--------YPNLSNQQ---TREFVEKG 331
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                       +  + E+C  +E  +R S   I
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 65
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 122
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 123 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 175
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+             E  M+       E + L+  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMV-------EKRVLALP 398
Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 455
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +L S  K II+RD+K  NV+LD     K+ DFG+ K    +    + T+   GT  Y+ 
Sbjct: 456 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIA 510
Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KEA
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 170 PYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           PY  R   LGEG FG V      K   ++A+K +                     +  E 
Sbjct: 10  PYIIR-ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMH----------MRVER 58
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           E+  L   +H ++++L  +     + ++      G L+D +         D  +R+    
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-DEGRRF--FQ 115
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +  A+ Y H     I+HRD+K  N+LLD+N   K+ DFG+  +    N    + +   G
Sbjct: 116 QIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCG 169
Query: 349 TRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDD 387
           +  Y  PE ++ ++    + DV+S G++L  +L G  P DD
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 30/237 (12%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 236 CKHVNLLRLLGLCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            KH N++ L+ +C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 130
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 28/236 (11%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 236 CKHVNLLRLLGLCNNIMN----CIVYEYM----CNGSLYDRLARVNNTPPLDSNKRYSIA 287
            KH N++ L+ +C    +    C    Y+    C   L   L+ V     L   KR  + 
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VM 131
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENL 346
             +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N 
Sbjct: 132 QMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 347 TGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 190 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/319 (23%), Positives = 128/319 (40%), Gaps = 46/319 (14%)
Query: 138 QEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGME 196
           QEE N + + I EL         +A    N   + +   ++G G F TVY G   +  +E
Sbjct: 1   QEERNQQQDDIEELET-------KAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVE 53
Query: 197 IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN--- 253
           +A   L+                      F+ E + L   +H N++R      + +    
Sbjct: 54  VAWCELQDRKLTKSERQR-----------FKEEAEXLKGLQHPNIVRFYDSWESTVKGKK 102
Query: 254 CIVY--EYMCNGSLYDRLAR--VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 309
           CIV   E   +G+L   L R  V     L S  R      + + L +LH+ + PIIHRD+
Sbjct: 103 CIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ-----ILKGLQFLHTRTPPIIHRDL 157
Query: 310 KSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDV 368
           K  N+ +       K+GD G+  +   S     + + + GT  +  PE    +     DV
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFXAPEXYEEKYDESVDV 212
Query: 369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVF 428
           +++G   LE  T   P  +       Y  V   V        +   +++  +  +  I+ 
Sbjct: 213 YAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGV--------KPASFDKVAIPEVKEII- 263
Query: 429 EKCCVFEKDKRASMRDIVD 447
           E C    KD+R S++D+++
Sbjct: 264 EGCIRQNKDERYSIKDLLN 282

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EYM  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+             E  M+       E + L+  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMV-------EKRVLALP 77
Query: 237 KHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   M+    V EY+  G L   + +V              A  +A  L
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +L S  K II+RD+K  NV+LD     K+ DFG+ K +    +    T+   GT  Y+ 
Sbjct: 135 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIA 189
Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KEA
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EYM  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 30/237 (12%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 236 CKHVNLLRLLGLCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            KH N++ L+ +C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 130
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 168 RKPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIP 222
            K Y ++   LGEG FG V    Y    +G    +AVK L+                   
Sbjct: 12  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG--------- 62
Query: 223 ILLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLD 279
              ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    + 
Sbjct: 63  ---WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IG 115
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             +    A  + E + YLHS  +  IHR++ + NVLLD + + K+GDFG+ K     +  
Sbjct: 116 LAQLLLFAQQICEGMAYLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 173
Query: 340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
               E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 174 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L      P     K   ++
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 121 IAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 174
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+EL  G  PI
Sbjct: 175 GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 58/112 (51%), Gaps = 10/112 (8%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           I L   +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT     
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----R 184
Query: 346 LTGTRPYMPPEAMHCQIS-----TKTDVFSYGVILLELLTGMKPIDDNNTIL 392
             G RPYM PE +    S      ++DV+S G+ L EL TG  P    N++ 
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 30/237 (12%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 72
Query: 236 CKHVNLLRLLGLCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            KH N++ L+ +C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 130 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 243

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 84/195 (43%), Gaps = 26/195 (13%)
Query: 227 ENEVQTLSQCKHVNLLRLLGL-----CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           E EV +L   KH N+L+ +G        ++   ++  +   GSL D L        +  N
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWN 121
Query: 282 KRYSIALGVAEALHYLH-------SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKMS 333
           +   IA  +A  L YLH          KP I HRD+KS NVLL  N    + DFG+    
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVF------SYGVILLELLTGMKPIDD 387
           E        T    GTR YM PE +   I+ + D F      + G++L EL +     D 
Sbjct: 182 EAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD- 239
Query: 388 NNTILYYYLVVEQEV 402
              +  Y L  E+E+
Sbjct: 240 -GPVDEYMLPFEEEI 253

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 34/224 (15%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +  V     L+NG E AVK +E             +A      +F  EV+TL QC
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIE------------KQAGHSRSRVF-REVETLYQC 67
Query: 237 K-HVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + + N+L L+    ++    +V+E +  GS+   LA +      +  +   +   VA AL
Sbjct: 68  QGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAAL 124
Query: 295 HYLHSLSKPIIHRDVKSANVLLD--ENFVP-KLGDFGIVKMSETSNMKT-MYTENLT--- 347
            +LH+  K I HRD+K  N+L +  E   P K+ DF +    + +N  T + T  LT   
Sbjct: 125 DFLHT--KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 348 GTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKPI 385
           G+  YM PE +       T      D++S GV+L  +L+G  P 
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 113
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +         
Sbjct: 114 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDEMANEFV 167
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP 384
           GTR YM PE +     S ++D++S G+ L+E+  G  P
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 178 LGEGQFGTVYYG-KLKNG--MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG G FGTVY G  +  G  ++I V  +E            +  A   IL   +E   ++
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT-------SPKANKEIL---DEAYVMA 106
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+ +
Sbjct: 107 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGM 164
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
           +YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +M 
Sbjct: 165 NYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWMA 221
Query: 355 PEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD-KE 411
            E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+    E
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSILE 267
Query: 412 AGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 268 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 313

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 32  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 81
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 138
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+DE    ++ DFG  K  +        T  L GT  
Sbjct: 139 LTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR------TWXLCGTPE 190
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 242

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    K Y+    V  AL  +HS+   +IHRDVK  N+
Sbjct: 152 MVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAE--VVLALDAIHSMG--LIHRDVKPDNM 205
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM ET     ++ +   GT  Y+ PE +  Q        + D 
Sbjct: 206 LLDKHGHLKLADFGTCMKMDETG---MVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 262
Query: 369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           +S GV L E+L G  P   ++ +  Y  +++ +
Sbjct: 263 WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 295

>pdb|1D2Z|B Chain B, Three-Dimensional Structure Of A Complex Between The Death Domains Of Pelle And Tube Length = 153

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 19/134 (14%)
Query: 14  RHLKQYVVHELGIILNERDDWKKIMSIVTVDCD------------PL---KPLKYSAKDI 58
           R ++   ++ L  IL+E   W+K+MSI+    D            P    K  KY+A+D+
Sbjct: 12  RRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGFKYTAQDV 71
Query: 59  KIVERAGKRNFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAARYVEVDVL 116
             ++ A  R  P++  + + +DEW TSG+   RP +  L+  L +AEL  AA +V +D L
Sbjct: 72  FQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVALDFL 131
Query: 117 KK--PESPGDNTEA 128
            +  P  P D   A
Sbjct: 132 NESTPARPVDGPGA 145

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 74
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 133 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 189
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 235
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 67
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 68  PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 123
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 354
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+ 
Sbjct: 124 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYLA 177
Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 236

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 68
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 69  PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 354
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+ 
Sbjct: 125 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYLA 178
Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 237

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 178 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 63
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
               H ++++L+G+       I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 64  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 122 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 177
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 385
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 107/246 (43%), Gaps = 36/246 (14%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ-TLSQ 235
           LG+G FG V   ++K  G   AVK L+                   ++L +++V+ T+++
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKD-----------------VILQDDDVECTMTE 73
Query: 236 CKHVNLLRLLGLCNNIMNCI--------VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            + ++L R       +  C         V E++  G L   +  +  +   D  +    A
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYA 130
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             +  AL +LH   K II+RD+K  NVLLD     KL DFG+ K    + + T       
Sbjct: 131 AEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFC 185
Query: 348 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GT  Y+ PE +   +     D ++ GV+L E+L G  P +  N    +  ++  EV    
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245
Query: 407 VLDKEA 412
            L ++A
Sbjct: 246 WLHEDA 251

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 172
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  + +      T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA------TWTLCGTPE 224
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 69
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 70  PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 125
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 354
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+ 
Sbjct: 126 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYLA 179
Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 238

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 168 RKPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIP 222
            K Y ++   LGEG FG V    Y    +G    +AVK L+                   
Sbjct: 12  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG--------- 62
Query: 223 ILLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLD 279
              ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    + 
Sbjct: 63  ---WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IG 115
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             +    A  + E + YLH+  +  IHR++ + NVLLD + + K+GDFG+ K     +  
Sbjct: 116 LAQLLLFAQQICEGMAYLHA--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 173
Query: 340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
               E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 174 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLAR-VNNTPPLDSNKR 283
           +EV  L + KH N++R      +  N  +Y   EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 284 YSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDE 170
Query: 341 MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            + +   GT  YM PE M+    + K+D++S G +L EL   M P 
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 108/243 (44%), Gaps = 54/243 (22%)
Query: 178 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVMLLA 57
Query: 235 QCKHVNLLRLLGLCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 280
              H  ++R         N               I  EY  NG+LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
             R  +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++ 
Sbjct: 118 YWR--LFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 340 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL----TGMK 383
            + ++NL           GT  Y+  E +      + K D++S G+I  E++    TGM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 384 PID 386
            ++
Sbjct: 234 RVN 236

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 14/218 (6%)
Query: 177 KLGEGQFGTVYYGKLKNGM-EIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG G +G V   K KNG  E A+K ++             +          NE+  L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++L  +  +     +V E+   G L++++    N    D     +I   +   +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGI 159
Query: 295 HYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            YLH  +  I+HRD+K  N+LL+        K+ DFG+         K     +  GT  
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS----KDYKLRDRLGTAY 213
Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           Y+ PE +  + + K DV+S GVI+  LL G  P    N
Sbjct: 214 YIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLAGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 178 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 79
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
               H ++++L+G+       I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 80  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 137
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 138 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 193
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 385
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 178 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 67
Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
               H ++++L+G+       I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 126 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 181
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 385
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 67
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 124
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 125 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 177
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 237

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +R  KLG G +G V   + K   +E A+K +              E           EV 
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-----------EVA 88
Query: 232 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L    H N+++L     +  N  +V E    G L+D +        +D+     I   V
Sbjct: 89  VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQV 145
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
              + YLH  +  I+HRD+K  N+LL+   ++ + K+ DFG+  + E  N K M  E L 
Sbjct: 146 LSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKM-KERL- 199
Query: 348 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 200 GTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLXGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 60
Query: 238 HVNLLRLLG-----LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +        ++    ++  Y   GSLYD L        LD+     I L +A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIAS 116
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   +    
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 346 LTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 382
             GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 60
Query: 238 HVNLLRLLG-----LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +        ++    ++  Y   GSLYD L        LD+     I L +A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIAS 116
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   +    
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 346 LTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 382
             GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 40  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 89
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 146
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 147 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 198
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 199 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 250

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L      +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKV 255

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 72/136 (52%), Gaps = 12/136 (8%)
Query: 286 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K+ DFGI      S  KT+   
Sbjct: 158 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID-- 213
Query: 345 NLTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              G +PYM PE ++ ++     S K+D++S G+ ++EL     P D   T       V 
Sbjct: 214 --AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 400 QEVPVREVLDKEAGEW 415
           +E   +   DK + E+
Sbjct: 272 EEPSPQLPADKFSAEF 287

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 172
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 224
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 31/178 (17%)
Query: 229 EVQTLSQC--KHVNLLRLLGLCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 275
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 334
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 122 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPI 385
              +++     + GT  Y+ PE + C ++        + D++S GVI+  LL G  P 
Sbjct: 177 GEKLRS-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K +    E AVK +                          EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----------REVELLKKL 78
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +  +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           Y+H  +  I+HRD+K  N+LL+   ++   K+ DFG+     T   +    ++  GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKDRIGTAYY 189
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           + PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 31  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 80
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 137
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 138 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPE 189
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 190 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 241

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K +    E AVK +                          EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----------REVELLKKL 78
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +  +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           Y+H  +  I+HRD+K  N+LL+   ++   K+ DFG+     T   +    ++  GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKDRIGTAYY 189
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           + PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 89
Query: 238 HVNLLRLLG-----LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +        ++    ++  Y   GSLYD L        LD+     I L +A 
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIAS 145
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   +    
Sbjct: 146 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 205
Query: 346 LTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 382
             GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 206 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 73  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 129
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 130 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 185
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 186 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 230

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 72  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 128
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 129 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 184
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 185 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 229

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 74  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 130
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 131 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 186
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 187 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 231

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 180
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 181 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 180
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 181 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 112 SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 168
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 169 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 224
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 225 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 82  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 138
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 139 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 194
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 195 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 239

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 67  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 123
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 124 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 179
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 180 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 224

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K +    E AVK +                    IL    EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS--------TIL---REVELLKKL 78
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  +  +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP 351
           Y+H     I+HRD+K  N+LL+   ++   K+ DFG+     + + MK     +  GT  
Sbjct: 136 YMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-----DRIGTAY 188
Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           Y+ PE +      K DV+S GVIL  LL+G  P 
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 229 EVQTLSQC--KHVNLLRLLGLCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 275
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 49  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 108
Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 334
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 109 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 163
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPI 385
              ++      + GT  Y+ PE + C ++        + D++S GVI+  LL G  P 
Sbjct: 164 GEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 66  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 122
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 123 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 178
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 179 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 118 SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 174
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 175 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 230
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 231 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 229 EVQTLSQC--KHVNLLRLLGLCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 275
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 334
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 122 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPI 385
              ++      + GT  Y+ PE + C ++        + D++S GVI+  LL G  P 
Sbjct: 177 GEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG+ K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 96/242 (39%), Gaps = 42/242 (17%)
Query: 181 GQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVN 240
           G+FG V+  +L N   +AVK                          E E+ +    KH N
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS--------------EREIFSTPGMKHEN 70
Query: 241 LLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           LL+ +       N      ++  +   GSL D L    N   +  N+   +A  ++  L 
Sbjct: 71  LLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK--GNI--ITWNELCHVAETMSRGLS 126
Query: 296 YLHS--------LSKP-IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           YLH           KP I HRD KS NVLL  +    L DFG+    E        T   
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGK-PPGDTHGQ 185
Query: 347 TGTRPYMPPEAMHCQISTKTDVF------SYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
            GTR YM PE +   I+ + D F      + G++L EL++  K  D    +  Y L  E+
Sbjct: 186 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD--GPVDEYMLPFEE 243
Query: 401 EV 402
           E+
Sbjct: 244 EI 245

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 52/245 (21%)
Query: 171 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+              A+ 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK------------ENASP 67
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 277
             +    +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 278 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                      LD     ++ +G        +++ + YL  +   ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE 185
Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 375
               K+ DFG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L
Sbjct: 186 GRKMKISDFG---LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 376 LELLT 380
            E++T
Sbjct: 243 WEIVT 247

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ ++  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 48/243 (19%)
Query: 171 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+              A+ 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK------------ENASP 67
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 277
             +    +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 278 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                      LD     ++ +G        +++ + YL  +S  ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILVAE 185
Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLE 377
               K+ DFG+ +     +     ++     + +M  E++   I +T++DV+S+GV+L E
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 378 LLT 380
           ++T
Sbjct: 245 IVT 247

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 204
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 205 YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 259
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L  LH+    +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 260 LSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 314
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +       + D++S G++++E++ G  P
Sbjct: 315 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 87
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 196
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 87
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 196
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 82
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 83  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 137
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 138 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 192
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +       + D++S G++++E++ G  P
Sbjct: 193 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG G + TVY G  K  G+ +A+K ++            T +  I       E+  + +
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG------TPSTAI------REISLMKE 59
Query: 236 CKHVNLLRLLGLCNNIMN-CIVYEYMCNG-SLYDRLARVNNTP-PLDSNKRYSIALGVAE 292
            KH N++RL  + +      +V+E+M N    Y     V NTP  L+ N        + +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM---------SETSNMKTMYT 343
            L + H     I+HRD+K  N+L+++    KLGDFG+ +          SE   +     
Sbjct: 120 GLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           + L G+R Y          ST  D++S G IL E++TG KP+
Sbjct: 178 DVLMGSRTY----------STSIDIWSCGCILAEMITG-KPL 208

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 84
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 85  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 139
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 140 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 194
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +       + D++S G++++E++ G  P
Sbjct: 195 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 172
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 224
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 73
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 74  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 129 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 183
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +       + D++S G++++E++ G  P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 70
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 130 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 180
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 181 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 61
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 121 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 171
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 172 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 71
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 131 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 182 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 65
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 125 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 175
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 176 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 24/228 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   K K  G   A+K L+            T           NE +     
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRIQQAV 99
Query: 237 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
               L++L     +N    +V EY   G ++  L R+      + + R+  A  +     
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFE 156
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  Y+ P
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPEYLAP 208
Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           E +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 112 SQCPHI--VRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQA-FTEREASEIXK 168
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 169 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 224
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D +S GVI   LL G  P   N+ +
Sbjct: 225 YTPY--YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL 269

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 77
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 78  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 132
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 133 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 187
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +       + D++S G++++E++ G  P
Sbjct: 188 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L +L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 127
Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 128 YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 182
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 183 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 237
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            PE +       + D++S G++++E++ G  P
Sbjct: 238 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L +L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ P  +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L +L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 62
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 63  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 121 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 176
Query: 348 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            ENE+  L + KH N++ L  +  +  +  +V + +  G L+DR+         D++   
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--- 109
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 341
            +   V  A+ YLH     I+HRD+K  N+L    +EN    + DFG+ KM +   M T 
Sbjct: 110 LVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI 385
                 GT  Y+ PE +  +  +K  D +S GVI   LL G  P 
Sbjct: 168 -----CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 54/243 (22%)
Query: 178 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVMLLA 57
Query: 235 QCKHVNLLRLLGLCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 280
              H  ++R         N               I  EY  N +LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
             R  +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++ 
Sbjct: 118 YWR--LFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 340 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL----TGMK 383
            + ++NL           GT  Y+  E +      + K D++S G+I  E++    TGM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 384 PID 386
            ++
Sbjct: 234 RVN 236

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    ++ DFG+ K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 229 EVQTLSQCKHVNLLR-------LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           E+Q + +  H N++        L  L  N +  +  EY   G L   L +  N   L   
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 338
              ++   ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K  +   +
Sbjct: 123 PIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 339 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDN 388
            T +     GT  Y+ PE +  +  T T D +S+G +  E +TG +P   N
Sbjct: 181 CTEFV----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 63
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 64  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 121
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 122 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 177
Query: 348 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 229 EVQTLSQCKHVNLLR-------LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           E+Q + +  H N++        L  L  N +  +  EY   G L   L +  N   L   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 338
              ++   ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K  +   +
Sbjct: 122 PIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 339 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDN 388
            T +     GT  Y+ PE +  +  T T D +S+G +  E +TG +P   N
Sbjct: 180 CTEFV----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  K   G  +A+K +              E   IP      E+  L + 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----------AEDEGIPSTAI-REISLLKEL 76
Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKR---YSIALGVA 291
            H N++ L+ + ++   C+  V+E+M       ++   N T   DS  +   Y +  GVA
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 342
                 H     I+HRD+K  N+L++ +   KL DFG+ +       S T  + T++   
Sbjct: 134 ------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            + L G++ Y          ST  D++S G I  E++TG KP+
Sbjct: 188 PDVLMGSKKY----------STSVDIWSIGCIFAEMITG-KPL 219

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 75
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 133
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 134 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 189
Query: 348 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 66  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 122
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K + + N  T     
Sbjct: 123 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----E 176
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
              T  Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   K+KN   I A+K L              + A       E +V     C
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEML--------KRAETACFREERDVLVNGDC 133
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 134 QWITALHYAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  NVLLD N   +L DFG  +KM++   +++       GT  Y+ 
Sbjct: 193 QLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VGTPDYIS 244
Query: 355 PEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           PE +        +   + D +S GV + E+L G  P    + +  Y  ++  E
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 297

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  K   G  +A+K +              E   IP      E+  L + 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----------AEDEGIPSTAI-REISLLKEL 76
Query: 237 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKR---YSIALGVA 291
            H N++ L+ + ++   C+  V+E+M       ++   N T   DS  +   Y +  GVA
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 342
                 H     I+HRD+K  N+L++ +   KL DFG+ +       S T  + T++   
Sbjct: 134 ------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            + L G++ Y          ST  D++S G I  E++TG KP+
Sbjct: 188 PDVLMGSKKY----------STSVDIWSIGCIFAEMITG-KPL 219

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLGEG + TVY GK K     +A+K +              E A    +    EV  L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---------EGAPCTAI---REVSLLK 55
Query: 235 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             KH N++ L  + +   +  +V+EY+ +  L   L    N   + + K +   L     
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL--LRG 112
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T   +N   T  Y 
Sbjct: 113 LAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYR 167
Query: 354 PPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
           PP+ +      ST+ D++  G I  E+ TG +P+   +T+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTV 206

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   K+KN   I A+K L              + A       E +V     C
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEML--------KRAETACFREERDVLVNGDC 149
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 150 QWITALHYAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  NVLLD N   +L DFG  +KM++   +++       GT  Y+ 
Sbjct: 209 QLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VGTPDYIS 260
Query: 355 PEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           PE +        +   + D +S GV + E+L G  P    + +  Y  ++  E
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 313

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 108/243 (44%), Gaps = 48/243 (19%)
Query: 171 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+              A+ 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK------------ENASP 67
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 277
             +    +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 278 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                      LD     ++ +G        +++ + YL  +   ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE 185
Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLE 377
               K+ DFG+ +     +     ++     + +M  E++   I +T++DV+S+GV+L E
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 378 LLT 380
           ++T
Sbjct: 245 IVT 247

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 59
Query: 231 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 60  QILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 117
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+        +  E   
Sbjct: 118 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQ 175
Query: 348 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
               +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 176 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 13  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 72
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 73  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 117
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 118 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 168
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228
Query: 400 QEV 402
           Q V
Sbjct: 229 QRV 231

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
            + PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 12  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 71
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 72  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 116
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 117 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 167
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 168 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 227
Query: 400 QEV 402
           Q V
Sbjct: 228 QRV 230

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           + + + +AL+YL      +IHRDVK +N+LLDE    KL DFGI         K    + 
Sbjct: 129 MTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DR 183
Query: 346 LTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
             G   YM PE +     TK       DV+S G+ L+EL TG  P  +  T       V 
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243
Query: 400 QEVP 403
           QE P
Sbjct: 244 QEEP 247

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 13  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 72
Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S      ++RLL       +  ++ E M    + D    +     L      S    V E
Sbjct: 73  S-----GVIRLLDWFERPDSFVLILERM--EPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K     +  GTR Y
Sbjct: 126 AVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDTVYTDFDGTRVY 179
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
            PPE +  H        V+S G++L +++ G  P + +  I+   +   Q V
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 400 QEV 402
           Q V
Sbjct: 230 QRV 232

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 28  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 87
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 88  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 132
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 133 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 183
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 400 QEV 402
           Q V
Sbjct: 244 QRV 246

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNXG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224
Query: 400 QEV 402
           Q V
Sbjct: 225 QRV 227

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 55/251 (21%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G VY G+ +K G   A+K ++                       E E++     
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------------------EEEIK----- 68
Query: 237 KHVNLLRLLGLCNNIMN-----------------CIVYEYMCNGSLYDRLARVNNTPPLD 279
           + +N+L+      NI                    +V E+   GS+ D +         +
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNM 338
               Y I   +   L +LH     +IHRD+K  NVLL EN   KL DFG+  ++  T   
Sbjct: 129 EWIAY-ICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 339 KTMYTENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
           +  +     GT  +M PE + C          K+D++S G+  +E+  G  P+ D + + 
Sbjct: 186 RNTF----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 393 YYYLVVEQEVP 403
             +L+     P
Sbjct: 242 ALFLIPRNPAP 252

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 28  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 87
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 88  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 132
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 133 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 183
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 400 QEV 402
           Q V
Sbjct: 244 QRV 246

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 400 QEV 402
           Q V
Sbjct: 245 QRV 247

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 400 QEV 402
           Q V
Sbjct: 245 QRV 247

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 400 QEV 402
           Q V
Sbjct: 245 QRV 247

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 400 QEV 402
           Q V
Sbjct: 230 QRV 232

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224
Query: 400 QEV 402
           Q V
Sbjct: 225 QRV 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V      + G + AVK ++            T +  +     + E       
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKF--------TSSPGLSTEDLKREASICHML 83
Query: 237 KHVNLLRLL-GLCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKRYSIALG----- 289
           KH +++ LL    ++ M  +V+E+M    L ++ + R       D+   YS A+      
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMR 137
Query: 290 -VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMSETSNMKTMYTE 344
            + EAL Y H     IIHRDVK  NVLL   EN  P KLGDFG+ +++ E+     +   
Sbjct: 138 QILEALRYCHD--NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG----LVAG 191
Query: 345 NLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI 385
              GT  +M PE +  +   K  DV+  GVIL  LL+G  P 
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 400 QEV 402
           Q V
Sbjct: 230 QRV 232

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 108 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 152
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 153 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 203
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263
Query: 400 QEV 402
           Q V
Sbjct: 264 QRV 266

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 19/217 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +GTV+  K +   EI    L+            + A          E+  L + 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIV--ALKRVRLDDDDEGVPSSAL--------REICLLKEL 58
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           KH N++RL  + ++     +    C+  L       N    LD     S    + + L +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGF 116
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
            HS  + ++HRD+K  N+L++ N   KL DFG+ +      ++    E +T    Y PP+
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYSAEVVTLW--YRPPD 171
Query: 357 AMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
            +      ST  D++S G I  EL    +P+   N +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDV 208

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 36  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 95
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 96  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 140
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 141 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 191
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 192 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 251
Query: 400 QEV 402
           Q V
Sbjct: 252 QRV 254

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +  +  L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 56  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 115
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 116 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 160
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 161 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 211
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 400 QEV 402
           Q V
Sbjct: 272 QRV 274

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 61  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 120
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 121 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 165
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 166 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 216
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 217 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276
Query: 400 QEV 402
           Q V
Sbjct: 277 QRV 279

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 176 NKLGEGQFGTVYYG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           + LG G FG V+    K KN  E+ VK ++             +   + +     E+  L
Sbjct: 30  SPLGSGAFGFVWTAVDKEKN-KEVVVKFIKKEKVLEDCWIEDPKLGKVTL-----EIAIL 83
Query: 234 SQCKHVNLLRLLGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           S+ +H N++++L +  N      ++ ++   GS  D  A ++  P LD      I   + 
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKH---GSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            A+ YL    K IIHRD+K  N+++ E+F  KL DFG     E    K  YT    GT  
Sbjct: 141 SAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYT--FCGTIE 194
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPI 385
           Y  PE +        + +++S GV L  L+    P 
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 89
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 201
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 309

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 224
Query: 400 QEV 402
           Q V
Sbjct: 225 QRV 227

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 56  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 115
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 116 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 160
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 161 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 211
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 400 QEV 402
           Q V
Sbjct: 272 QRV 274

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 184
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 310

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 310

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 89
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 201
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 309

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 152
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 153 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 209
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV 398
           ++ E++ G  P D        D NT  Y + V+
Sbjct: 210 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 242

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 310

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 137
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 138 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 194
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 195 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 243

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           R G  LG+G FGTV+ G +L + +++A+K +             +    + + L     +
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL---WK 90
Query: 232 TLSQCKHVNLLRLLGL--CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +   H  ++RLL           ++   +    L+D    +    PL           
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDY---ITEKGPLGEGPSRCFFGQ 147
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           V  A+ + HS  + ++HRD+K  N+L+D      KL DFG    S        YT +  G
Sbjct: 148 VVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYT-DFDG 200
Query: 349 TRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
           TR Y PPE  + H   +    V+S G++L +++ G  P + +  IL
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL 246

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 47/290 (16%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 409
           PE    AMH   +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 191 PEIMLNAMH--YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 410 KEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 43/290 (14%)
Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           + +G G +G+V      K G+ +AVK L                ++I       E++ L 
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLK 96
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +  
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y
Sbjct: 157 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWY 208
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 409
             PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 410 KEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 269 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 318

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 77
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 189
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 249
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 297

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 43/290 (14%)
Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           + +G G +G+V      K G+ +AVK L                ++I       E++ L 
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLK 99
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +  
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y
Sbjct: 160 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWY 211
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 409
             PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 271
Query: 410 KEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 272 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 321

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 76
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 188
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 248
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 296

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 75
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 187
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 295

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           IA+ + +AL +LHS    +IHRDVK +NVL++     K+ DFGI         K +    
Sbjct: 114 IAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169
Query: 346 LTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             G +PYM PE ++ ++     S K+D++S G+ ++EL     P D   T       V +
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228
Query: 401 EVPVREVLDKEAGEW 415
           E   +   DK + E+
Sbjct: 229 EPSPQLPADKFSAEF 243

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 141
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 198
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 97
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 209
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 270 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 317

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 75
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 187
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 295

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  D  K +
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 285 -------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
                    +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +      
Sbjct: 141 LTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR---DIY 195
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 112/257 (43%), Gaps = 35/257 (13%)
Query: 178 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 82
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL +     +   +   Y+    +   L  +  +  L       +   +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLR 142
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 143 GLKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQAD---------EEMTGYVAT 191
Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 407 VLDKEAGEWNETHVETL 423
           VL K + E   T++++L
Sbjct: 252 VLAKISSEHARTYIQSL 268

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAEALHYLHSLSKPIIHRDVKSAN 313
           ++ +Y+  G L+  L++        +     I +G +  AL +LH L   II+RD+K  N
Sbjct: 136 LILDYINGGELFTHLSQRERF----TEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLEN 189
Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFS 370
           +LLD N    L DFG+ K       +  Y  +  GT  YM P+ +    S      D +S
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAY--DFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 371 YGVILLELLTGMKPI 385
            GV++ ELLTG  P 
Sbjct: 248 LGVLMYELLTGASPF 262

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 178 LGEGQFGTVYY-GKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG G+FG V+   +   G+++A K ++                M      +NE+  ++Q 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTR-------------GMKDKEEVKNEISVMNQL 143
Query: 237 KHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            H NL++L       N+I+  +V EY+  G L+DR+  ++ +  L           + E 
Sbjct: 144 DHANLIQLYDAFESKNDIV--LVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEG 199
Query: 294 LHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSE-TSNMKTMYTENLTGT 349
           + ++H +   I+H D+K  N+L    D   + K+ DFG+ +  +    +K  +     GT
Sbjct: 200 IRHMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF-----GT 251
Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP-IDDNNT 390
             ++ PE ++   +S  TD++S GVI   LL+G+ P + DN+ 
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 13/142 (9%)
Query: 260 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
           +C G L + L ++ +  PL  +    I      A+ ++H    PIIHRD+K  N+LL   
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174
Query: 320 FVPKLGDFGIVKM-------SETSNMKTMYTENLT-GTRP-YMPPEAM----HCQISTKT 366
              KL DFG           S ++  + +  E +T  T P Y  PE +    +  I  K 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 367 DVFSYGVILLELLTGMKPIDDN 388
           D+++ G IL  L     P +D 
Sbjct: 235 DIWALGCILYLLCFRQHPFEDG 256

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 119/291 (40%), Gaps = 49/291 (16%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TRP 351
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++         + +TG   TR 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD---------DEMTGXVATRW 187
Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVL 408
           Y  PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 409 DKEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
            K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 282 KRYSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
           K  ++ L + E   AL YL +  + IIHRD+K  N+LLDE+    + DF I  M      
Sbjct: 113 KEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 339 KTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP 384
            T     + GT+PYM PE    +     S   D +S GV   ELL G +P
Sbjct: 171 IT----TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 151 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 204
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 369 FSYGVILLELLTGMKPI 385
           +S GV L E+L G  P 
Sbjct: 262 WSVGVFLYEMLVGDTPF 278

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  D  K +
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 285 -------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
                    +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +      
Sbjct: 141 LTLEHLICYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLAR---DIY 195
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 174 RGNKLGEGQFG-TVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R  K+GEG FG  +     ++G +  +K +                          EV  
Sbjct: 28  RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-----------RREVAV 76
Query: 233 LSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L+  KH N+++       N    IV +Y   G L+ R+           ++     + + 
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQIC 135
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            AL ++H   + I+HRD+KS N+ L ++   +LGDFGI ++    N          GT  
Sbjct: 136 LALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPY 190
Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLT 380
           Y+ PE    +  + K+D+++ G +L EL T
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           + + + Y+HS  K +IHRD+K +N+ L +    K+GDFG+V   +    +T       GT
Sbjct: 145 ITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS----KGT 198
Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELL 379
             YM PE +  Q    + D+++ G+IL ELL
Sbjct: 199 LRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 4/105 (3%)
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           P+      S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG+ +     
Sbjct: 195 PITMEDLISYSFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 251
Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           N   +   +      +M PE++  +I STK+DV+SYGV+L E+ +
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 146 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 199
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 369 FSYGVILLELLTGMKPI 385
           +S GV L E+L G  P 
Sbjct: 257 WSVGVFLYEMLVGDTPF 273

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KL E   G ++ G+ + G +I VK L+                      F  E   L   
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLRIF 64
Query: 237 KHVNLLRLLGLCNNI---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            H N+L +LG C +       ++  +M  GSLY+ L    N   +D ++    AL +A  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARG 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + +LH+L   I    + S +V++DE+   ++     VK S  S  + MY         ++
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARIS-MADVKFSFQSPGR-MYAPA------WV 175
Query: 354 PPEAMHCQIS----TKTDVFSYGVILLELLTGMKPIDD 387
            PEA+  +         D++S+ V+L EL+T   P  D
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           + +G G +G+V     +K+G++IAVK L                ++I       E++ L 
Sbjct: 57  SPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQ-----------SIIHAKRTYRELRLLK 105
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +  
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 165
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y
Sbjct: 166 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWY 217
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTG 381
             PE M      +   D++S G I+ ELLTG
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 151 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 204
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 369 FSYGVILLELLTGMKPI 385
           +S GV L E+L G  P 
Sbjct: 262 WSVGVFLYEMLVGDTPF 278

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 88
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 148
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 200
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 260
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 308

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 35/257 (13%)
Query: 178 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 74
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL +     +   +   Y+    +   L  +     L       +   +  
Sbjct: 75  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 134
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 135 GLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD---------EEMTGYVAT 183
Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 243
Query: 407 VLDKEAGEWNETHVETL 423
           VL K + E   T++++L
Sbjct: 244 VLAKISSEHARTYIQSL 260

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ EY+  G L+ +L R      ++    + +A  ++ AL +LH   K II+RD+K  N+
Sbjct: 98  LILEYLSGGELFMQLEREGIF--MEDTACFYLA-EISMALGHLHQ--KGIIYRDLKPENI 152
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGV 373
           +L+     KL DFG+ K S         T    GT  YM PE  M    +   D +S G 
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 374 ILLELLTGMKPIDDNN 389
           ++ ++LTG  P    N
Sbjct: 210 LMYDMLTGAPPFTGEN 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 97
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 209
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 270 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 317

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 101
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MXGYVATRWYRA 213
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 321

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 98
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 210
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 318

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 16/169 (9%)
Query: 225 LFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           +   E+  L +  H N+++L  +        +V E +  G L+DR+         D+   
Sbjct: 94  IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA 153
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMK 339
               L   EA+ YLH     I+HRD+K  N LL     P    K+ DFG+ K+ E     
Sbjct: 154 VKQIL---EAVAYLHE--NGIVHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVE----H 203
Query: 340 TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDD 387
            +  + + GT  Y  PE +  C    + D++S G+I   LL G +P  D
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 86
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP--PLDSNK 282
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  P D  K
Sbjct: 87  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 283 RY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +    
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLAR-DIX 199
Query: 336 SNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
            +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V+  K + +G    +K ++             E A       E EV+ L++ 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN----------NEKA-------EREVKALAKL 61
Query: 237 KHVNLLRLLGLCNNI---------------MNCIVYEY-MCNGSLYDRLARVNNTPPLDS 280
            HVN++   G  +                   C+  +   C+    ++         LD 
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
                +   + + + Y+HS  K +I+RD+K +N+ L +    K+GDFG+V    TS    
Sbjct: 122 VLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLV----TSLKND 175
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELL 379
                  GT  YM PE +  Q    + D+++ G+IL ELL
Sbjct: 176 GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 35/257 (13%)
Query: 178 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 82
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL +     +   +   Y+    +   L  +     L       +   +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 142
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 143 GLKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQAD---------EEMTGYVAT 191
Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 407 VLDKEAGEWNETHVETL 423
           VL K + E   T++++L
Sbjct: 252 VLAKISSEHARTYIQSL 268

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E++ L Q +H NL+ LL +C       +V+E++ + ++ D L    N   LD        
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNG--LDYQVVQKYL 130
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             +   + + HS +  IIHRD+K  N+L+ ++ V KL DFG  +   T        ++  
Sbjct: 131 FQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR---TLAAPGEVYDDEV 185
Query: 348 GTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG--MKPIDDNNTILYYYLV 397
            TR Y  PE +    +     DV++ G ++ E+  G  + P D +   LY+ ++
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D+G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 19/217 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +GTV+  K +   EI    L+            + A          E+  L + 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIV--ALKRVRLDDDDEGVPSSAL--------REICLLKEL 58
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           KH N++RL  + ++     +    C+  L       N    LD     S    + + L +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGF 116
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
            HS  + ++HRD+K  N+L++ N   KL +FG+ +      ++    E +T    Y PP+
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLW--YRPPD 171
Query: 357 AMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
            +      ST  D++S G I  EL    +P+   N +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ EY+  G L+ +L R      ++    + +A  ++ AL +LH   K II+RD+K  N+
Sbjct: 98  LILEYLSGGELFMQLEREGIF--MEDTACFYLA-EISMALGHLHQ--KGIIYRDLKPENI 152
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGV 373
           +L+     KL DFG+ K S         T    GT  YM PE  M    +   D +S G 
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDG---TVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 374 ILLELLTGMKPIDDNN 389
           ++ ++LTG  P    N
Sbjct: 210 LMYDMLTGAPPFTGEN 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 50/232 (21%)
Query: 178 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVXLLA 57
Query: 235 QCKHVNLLRLLGLCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 280
              H  ++R         N               I  EY  N +LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD- 116
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMK 339
            + + +   + EAL Y+HS  + IIHR++K  N+ +DE+   K+GDFG+ K    S ++ 
Sbjct: 117 -EYWRLFRQILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 340 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL 379
            + ++NL           GT  Y+  E +      + K D +S G+I  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 186
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNK 282
           +L + E+  L+  +H N+L L     ++   + ++E++    +++R+    NT   + N+
Sbjct: 46  VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNE 101
Query: 283 R--YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           R   S    V EAL +LHS    I H D++  N++       +     I++  +   +K 
Sbjct: 102 REIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQ---TRRSSTIKIIEFGQARQLKP 156
Query: 341 MYTENLTGTRP--YMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
                L  T P  Y P    H  +ST TD++S G ++  LL+G+ P
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   KLKN  ++ A+K L              + A       E +V      
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEML--------KRAETACFREERDVLVNGDS 133
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           K +  L      +N +  +V +Y   G L   L++  +  P +  + Y   + +A +++H
Sbjct: 134 KWITTLHYAFQDDNNLY-LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  N+L+D N   +L DFG  +K+ E   +++       GT  Y+ 
Sbjct: 193 QLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA---VGTPDYIS 244
Query: 355 PEAMHCQISTK------TDVFSYGVILLELLTGMKPI 385
           PE +      K       D +S GV + E+L G  P 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 188
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 85
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP---PLDSN 281
               +    H+N++ LLG C      +M  + +    N S Y R  R    P   P D  
Sbjct: 86  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLY 141
Query: 282 KRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
           K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +   
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DI 198
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
             +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 18/165 (10%)
Query: 238 HVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPP-LDSNKRYSIALGVA 291
           H N+LRL+  C           ++  +   G+L++ + R+ +    L  ++   + LG+ 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS---ETSNMKTMYTENLTG 348
             L  +H+  K   HRD+K  N+LL +   P L D G +  +      + + +  ++   
Sbjct: 145 RGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 349 TR---PYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPID 386
            R    Y  PE      HC I  +TDV+S G +L  ++ G  P D
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTL------------ 73
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 98
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MXGXVATRWYRA 210
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 318

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 197
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 39/220 (17%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFEN--EVQTLS 234
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 341
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
            TE +  TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MTEXV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 75  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 131 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 188
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+  FG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 196
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 197 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LHS  + ++H DVK AN+ L      KLGDFG++    T+       E   G   Y
Sbjct: 169 ALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA----GEVQEGDPRY 222
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMK 383
           M PE +     T  DVFS G+ +LE+   M+
Sbjct: 223 MAPELLQGSYGTAADVFSLGLTILEVACNME 253

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 86
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 87  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL 142
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 143 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 198
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 199 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 79  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 134
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 135 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 192
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 73
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 74
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 75  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 130
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 131 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 74
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 75  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 130
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 131 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 67
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 68  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 123
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 124 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 29  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 75
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 76  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 131
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 132 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 20  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 66
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 67  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 122
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 123 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 73
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 75  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 131 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 73  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 128
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 129 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 121
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 122 ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 233
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 234 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 67
Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 68  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 123
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 124 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 197
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 198 IYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 39/220 (17%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFEN--EVQTLS 234
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 341
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
            TE    TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MTE-YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 113/244 (46%), Gaps = 39/244 (15%)
Query: 175 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  LG+G+FG+V   +LK    + +++AVK L+               A   I  F  E 
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-----------ASSDIEEFLREA 76
Query: 231 QTLSQCKHVNLLRLLGLCNNI-------MNCIVYEYMCNGSLYDRL--ARVNNTP---PL 278
             + +  H ++ +L+G+           +  ++  +M +G L+  L  +R+   P   PL
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
            +  R+ +   +A  + YL S  +  IHRD+ + N +L E+    + DFG+ +   + + 
Sbjct: 137 QTLVRFMV--DIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD- 191
Query: 339 KTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDD-NNTILY 393
              Y +      P  ++  E++   + T  +DV+++GV + E++T G  P     N  +Y
Sbjct: 192 --YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 394 YYLV 397
            YL+
Sbjct: 250 NYLI 253

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 91  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 146
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 147 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 204
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 91  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI 146
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 147 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V E M  G L D++ R          +  ++   + + + YLH+  + ++HRD+K +N+
Sbjct: 93  VVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNI 147
Query: 315 L-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTKT 366
           L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q      
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLERQGYDAAC 201
Query: 367 DVFSYGVILLELLTGMKPI 385
           D++S GV+L  +LTG  P 
Sbjct: 202 DIWSLGVLLYTMLTGYTPF 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           + E+      +H N++R   +     +  I+ EY   G LY+R+    N      ++   
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDEARF 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYT 343
               +   + Y HS+   I HRD+K  N LLD +  P+L   DFG  K    S++     
Sbjct: 121 FFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQP 174
Query: 344 ENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
           ++  GT  Y+ PE +  Q       DV+S GV L  +L G  P +D
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 350 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 62
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 120
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 175
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 350 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 188
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 350 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 SFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 293
             H N+++LL + +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 116 LAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 170
Query: 354 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
            PE  + C+  ST  D++S G I  E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 187
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 188 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 187
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 188 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 61
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             H N+++LL + +      +V+E++     +  D  A      PL  +  + +  G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
              + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y
Sbjct: 121 ---FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--Y 172
Query: 353 MPPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
             PE  + C+  ST  D++S G I  E++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 118 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 60
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 293
             H N+++LL + +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 117
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 118 LAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 172
Query: 354 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
            PE  + C+  ST  D++S G I  E++T
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 39/220 (17%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFEN--EVQTLS 234
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 235 QCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 341
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
             E    TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MVE-FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 83/160 (51%), Gaps = 6/160 (3%)
Query: 229 EVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L + +H N++ +  +   + +  +   Y+    +   L ++  +  L ++      
Sbjct: 91  EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFL 150
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             +   L Y+HS +  ++HRD+K +N+L++     K+ DFG+ ++++  +  T +     
Sbjct: 151 YQILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 348 GTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
            TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 137 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 191
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPID 386
           Y+ PE + C+   S + D++S G IL  LL G  P +
Sbjct: 192 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 65
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 123
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 178
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 12/136 (8%)
Query: 286 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K  DFGI         K +   
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-- 196
Query: 345 NLTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              G +PY  PE ++ ++     S K+D++S G+  +EL     P D   T       V 
Sbjct: 197 --AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV 254
Query: 400 QEVPVREVLDKEAGEW 415
           +E   +   DK + E+
Sbjct: 255 EEPSPQLPADKFSAEF 270

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 293
             H N+++LL + +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 119 LAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 173
Query: 354 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
            PE  + C+  ST  D++S G I  E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 57
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             H N+++LL + +      +V+E++     +  D  A      PL  +  + +  G+A 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA- 116
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
              + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y
Sbjct: 117 ---FCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWY 168
Query: 353 MPPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
             PE  + C+  ST  D++S G I  E++T
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 207
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN 388
           Y+ PE + C+   S + D++S G IL  LL G  P + +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 111/268 (41%), Gaps = 57/268 (21%)
Query: 179 GEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE----VQTL 233
           G+G FGTV  GK K+ GM +A+K +                  I    F N     +Q L
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV------------------IQDPRFRNRELQIMQDL 73
Query: 234 SQCKHVNLLRLLGLC--------NNIMNCIVYEYM------CNGSLYDRLARVNNTPPLD 279
           +   H N+++L             +I   +V EY+      C  + Y R       PP  
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV----APPPI 129
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNM 338
             K +   L    ++  LH  S  + HRD+K  NVL++E +   KL DFG  K    S  
Sbjct: 130 LIKVFLFQL--IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 339 KTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYY 394
              Y      +R Y  PE +  +   +T  D++S G I  E++ G +PI   DN+    +
Sbjct: 188 NVAY----ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSAGQLH 242
Query: 395 YLVVEQEVPVREVLDKEAGEWNETHVET 422
            +V     P REVL K     N +H + 
Sbjct: 243 EIVRVLGCPSREVLRK----LNPSHTDV 266

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           Y H++   + HRD+K  N LLD +  P  K+ DFG  K S   +      ++  GT  Y+
Sbjct: 130 YAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ----PKSAVGTPAYI 183
Query: 354 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 62
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 120
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 175
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 83/181 (45%), Gaps = 25/181 (13%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKR 283
            + E       KH +++ LL    ++ M  +V+E+M    L ++ + R       D+   
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFV 128
Query: 284 YSIALG------VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMS 333
           YS A+       + EAL Y H     IIHRDVK   VLL   EN  P KLG FG+ +++ 
Sbjct: 129 YSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTIL 392
           E+     +      GT  +M PE +  +   K  DV+  GVIL  LL+G  P       L
Sbjct: 187 ESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 242
Query: 393 Y 393
           +
Sbjct: 243 F 243

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKR 283
            + E       KH +++ LL    ++ M  +V+E+M    L ++ + R       D+   
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFV 126
Query: 284 YSIALG------VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMS 333
           YS A+       + EAL Y H     IIHRDVK   VLL   EN  P KLG FG+ +++ 
Sbjct: 127 YSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI 385
           E+     +      GT  +M PE +  +   K  DV+  GVIL  LL+G  P 
Sbjct: 185 ESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 76
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 77  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 131
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 132 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 76
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 77  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 131
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 132 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 131 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIA 185
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 245
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 246 SLIQKMLQT 254

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V    KL  G E A K +                A I  LL           
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL----------- 60
Query: 237 KHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH N++RL   +     + +V++ +  G L++ +         D++      L   EA+ 
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL---EAVL 117
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           + H +   ++HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  Y
Sbjct: 118 HCHQMG--VVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPGY 172
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           + PE +  +   K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLY 215

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 131 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIA 185
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 245
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 246 SLIQKMLQT 254

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DF + +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 66
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 67  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 121
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 122 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 135 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIA 189
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 190 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 249
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 250 SLIQKMLQT 258

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 56
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 57  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 111
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 112 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    + L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPN 207
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN 388
           Y+ PE + C+   S + D++S G IL  LL G  P + +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEAMHCQ--ISTKTDVFSYGVILLELLT 380
           PE +      ST  D++S G I  E++T
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 61  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 115
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 116 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 54
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 55  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 109
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 110 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 21  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 74
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 75  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 129
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 130 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 322
           G+L + LAR             S    V EA+ + H+    ++HRD+K  N+L+D N   
Sbjct: 152 GALQEELAR-------------SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN--- 193
Query: 323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLT 380
             G+  ++     + +K     +  GTR Y PPE +  H        V+S G++L +++ 
Sbjct: 194 -RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252
Query: 381 GMKPIDDNNTILYYYLVVEQEV 402
           G  P + +  I+   +   Q V
Sbjct: 253 GDIPFEHDEEIIRGQVFFRQRV 274

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRP 351
            L Y+HS    +IHRD+K +N+L++EN   K+GDFG+ +   TS  +  Y       TR 
Sbjct: 171 GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 352 YMPPEAMHC--QISTKTDVFSYGVILLELLT 380
           Y  PE M    + +   D++S G I  E+L 
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 65
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 123
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 178
Query: 355 PEAMHCQ--ISTKTDVFSYGVILLELLT 380
           PE +      ST  D++S G I  E++T
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 60
Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 61  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 115
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 116 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRP 351
            L Y+HS    +IHRD+K +N+L++EN   K+GDFG+ +   TS  +  Y       TR 
Sbjct: 170 GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 352 YMPPEAMHC--QISTKTDVFSYGVILLELLT 380
           Y  PE M    + +   D++S G I  E+L 
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    + L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPN 207
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN 388
           Y+ PE + C+   S + D++S G IL  LL G  P + +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTIR-EISILKEL 57
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 285
           KH N+++L  + +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 346 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 381
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 IV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 82
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 83  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 143 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 195
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 196 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 235

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 361
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 306 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 360
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 361
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 361
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 53/111 (47%), Gaps = 11/111 (9%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLGDFGIVKMSETSNMKTMYTENLT 347
           +  ALHYLH+  + I HRD+K  N L   N  F  KL DFG+ K     N    Y     
Sbjct: 177 IFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 348 GTRPY-MPPEAMHC---QISTKTDVFSYGVILLELLTGMKP---IDDNNTI 391
              PY + PE ++        K D +S GV+L  LL G  P   ++D +TI
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           F+ E++ +    H N++RL     +N    +V E    G L++R+         D+ +  
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-- 110
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGIVKMSETSNMKTM 341
            I   V  A+ Y H L+  + HRD+K  N L   D    P KL DFG+    +   M  M
Sbjct: 111 -IMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 165
Query: 342 YTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            T+   GT  Y+ P+ +      + D +S GV++  LL G  P 
Sbjct: 166 RTK--VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTIR-EISILKEL 57
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 285
           KH N+++L  + +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 346 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 381
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 VV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTIR-EISILKEL 57
Query: 237 KHVNLLRLLGLCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 285
           KH N+++L  + +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 346 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 381
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 VV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           F+ E++ +    H N++RL     +N    +V E    G L++R+         D+ +  
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-- 127
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGIVKMSETSNMKTM 341
            I   V  A+ Y H L+  + HRD+K  N L   D    P KL DFG+    +   M  M
Sbjct: 128 -IMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 182
Query: 342 YTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            T+   GT  Y+ P+ +      + D +S GV++  LL G  P 
Sbjct: 183 RTK--VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 16/173 (9%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPL 278
           PI     E+  L +  H N+++L+ + ++       +V+E +  G + +    V    PL
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME----VPTLKPL 134
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
             ++       + + + YLH   + IIHRD+K +N+L+ E+   K+ DFG+    + S+ 
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD- 191
Query: 339 KTMYTENLTGTRPYMPPEAMHCQ---ISTKT-DVFSYGVILLELLTGMKPIDD 387
                 N  GT  +M PE++       S K  DV++ GV L   + G  P  D
Sbjct: 192 --ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG G FGTV  G  +      +K +              + A+   LL E  V  + Q 
Sbjct: 376 ELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELLAEANV--MQQL 427
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
            +  ++R++G+C      +V E    G L   L +  N    D N    +   V+  + Y
Sbjct: 428 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGMKY 484
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPP 355
           L   +   +HRD+ + NVLL      K+ DFG+ K +    N     T      + Y P 
Sbjct: 485 LEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 356 EAMHCQISTKTDVFSYGVILLELLT-GMKP 384
              + + S+K+DV+S+GV++ E  + G KP
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG G FGTV  G  +      +K +              + A+   LL E  V  + Q 
Sbjct: 377 ELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELLAEANV--MQQL 428
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
            +  ++R++G+C      +V E    G L   L +  N    D N    +   V+  + Y
Sbjct: 429 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGMKY 485
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPP 355
           L   +   +HRD+ + NVLL      K+ DFG+ K +    N     T      + Y P 
Sbjct: 486 LEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 356 EAMHCQISTKTDVFSYGVILLELLT-GMKP 384
              + + S+K+DV+S+GV++ E  + G KP
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 97
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 98  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 158 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 210
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 211 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 250

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           I+ E M  G L+ R+    +       +   I   +  A+ +LHS +  I HRDVK  N+
Sbjct: 84  IIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 140
Query: 315 LL---DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQISTKT-DVF 369
           L    +++ V KL DFG  K +  + ++T  YT        Y+ PE +  +   K+ D++
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY------YVAPEVLGPEKYDKSCDMW 194
Query: 370 SYGVILLELLTGMKPIDDNN 389
           S GVI+  LL G  P   N 
Sbjct: 195 SLGVIMYILLCGFPPFYSNT 214

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 129 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 183
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDN 388
           PE +  +  S + DV+S G I+  LL G  P + +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 61
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           I+ E M  G L+ R+    +       +   I   +  A+ +LHS +  I HRDVK  N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 159
Query: 315 LL---DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQISTKT-DVF 369
           L    +++ V KL DFG  K +  + ++T  YT        Y+ PE +  +   K+ D++
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY------YVAPEVLGPEKYDKSCDMW 213
Query: 370 SYGVILLELLTGMKPIDDNN 389
           S GVI+  LL G  P   N 
Sbjct: 214 SLGVIMYILLCGFPPFYSNT 233

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG+G +G V+     + G  +AVK +                 MI   L  +E      
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE------ 69
Query: 236 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
              VNLL +L   N+    +V++YM   +    + R N   P+  +K+Y +   + + + 
Sbjct: 70  -NIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV--HKQY-VVYQLIKVIK 123
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYTEN----- 345
           YLHS    ++HRD+K +N+LL+     K+ DFG+ +        T+N+     EN     
Sbjct: 124 YLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 346 --------LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                      TR Y  PE +    + +   D++S G IL E+L G KPI
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 235 QCKHVNLLRLLGLCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +H N++RL  +C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 343
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 344 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 395
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 396 LVVEQEVPVREVLDKEAGEWNETH-VETLISIVFE-------KCCVFEKDKRAS 441
           L  E++ P    L ++A        +E  ++ + E       KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 103
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 164 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 216
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 217 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 74
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 75  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 135 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 187
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 188 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 227

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 226 FENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           F      +S+  H +L+   G+C     N +V E++  GSL   L +  N   ++   + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKL 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            +A  +A A+H+L      +IH +V + N+LL      K G+   +K+S+     T+  +
Sbjct: 117 EVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 345 NLTGTR-PYMPPEAMHC--QISTKTDVFSYGVILLELLTG----MKPIDDNNTILYYYLV 397
           ++   R P++PPE +     ++  TD +S+G  L E+ +G    +  +D    + +Y   
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            +   P       +A E         ++ +   C  +E D R S R I+
Sbjct: 235 HQLPAP-------KAAE---------LANLINNCMDYEPDHRPSFRAII 267

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 153 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 207
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 267
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 268 SLIQKMLQT 276

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 235 QCKHVNLLRLLGLCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +H N++RL  +C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 343
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 344 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 395
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 396 LVVEQEVPVREVLDKEAGEWNETH-VETLISIVFE-------KCCVFEKDKRAS 441
           L  E++ P    L ++A        +E  ++ + E       KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 107
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 108 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 168 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 220
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 221 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 260

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 105
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 106 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 166 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 218
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 219 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 258

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 235 QCKHVNLLRLLGLCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +H N++RL  +C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 343
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 344 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 395
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 396 LVVEQEVPVREVLDKEAGEWNETH-VETLISIVFE-------KCCVFEKDKRAS 441
           L  E++ P    L ++A        +E  ++ + E       KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 155 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 209
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 269
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 270 SLIQKMLQT 278

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 226 FENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           F      +S+  H +L+   G+C     N +V E++  GSL   L +  N   ++   + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKL 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            +A  +A A+H+L      +IH +V + N+LL      K G+   +K+S+     T+  +
Sbjct: 117 EVAKQLAWAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 345 NLTGTR-PYMPPEAMHC--QISTKTDVFSYGVILLELLTG----MKPIDDNNTILYYYLV 397
           ++   R P++PPE +     ++  TD +S+G  L E+ +G    +  +D    + +Y   
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            +   P       +A E         ++ +   C  +E D R S R I+
Sbjct: 235 HQLPAP-------KAAE---------LANLINNCMDYEPDHRPSFRAII 267

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 41/218 (18%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQC 236
           +G G FG V+  KL    E+A+K +                       F+N E+Q +   
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------------FKNRELQIMRIV 89
Query: 237 KHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRYSI 286
           KH N++ L           + +   +V EY+   ++Y      A++  T P+   K Y  
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS+   I HRD+K  N+LLD  + V KL DFG  K+            +
Sbjct: 149 QL--LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----S 200
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTG 381
              +R Y  PE +      +T  D++S G ++ EL+ G
Sbjct: 201 XICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 237 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAEAL 294
           +H N++ L  + ++  +  +V E M  G L D++ R        S +  S  L  + + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTV 134
Query: 295 HYLHSLSKPIIHRDVKSANVL-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLT 347
            YLHS  + ++HRD+K +N+L +DE+  P   ++ DFG  K     N   M   YT N  
Sbjct: 135 EYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN-- 190
Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
               ++ PE +  Q      D++S G++L  +L G  P 
Sbjct: 191 ----FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E              AA +     + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKI---------AANV-----KREIINHRSL 72
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 353
           Y H++   + HRD+K  N LLD +  P+L   DFG  K    S++     ++  GT  Y+
Sbjct: 130 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYI 183
Query: 354 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+  +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+  +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 60
Query: 236 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 117
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 118 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 171
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +     +K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 215

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 61
Query: 236 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 119 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 172
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +     +K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAEALHYLHSLSKPIIHRDVKSAN 313
           +V E M  G L D++ R        S +  S  L  + + + YLHS  + ++HRD+K +N
Sbjct: 98  LVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTVEYLHS--QGVVHRDLKPSN 151
Query: 314 VL-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTK 365
           +L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q     
Sbjct: 152 ILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLKRQGYDEG 205
Query: 366 TDVFSYGVILLELLTGMKPIDDN 388
            D++S G++L  +L G  P  + 
Sbjct: 206 CDIWSLGILLYTMLAGYTPFANG 228

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRL---------------LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDS 280
             H N++RL               L L  + +   VY       +    +R   T P+  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYR------VARHYSRAKQTLPVIY 123
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMK 339
            K Y   L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++
Sbjct: 124 VKLYMYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VR 175
Query: 340 TMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
                +   +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S GVI+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 229 EVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+QT+S  +H  L+ L     ++    ++YE+M  G L++++A  +N    D    Y   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--M 261
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGI-VKMSETSNMKTMYTE 344
             V + L ++H  +   +H D+K  N++         KL DFG+   +    ++K     
Sbjct: 262 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--- 316
Query: 345 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
             TGT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 317 --TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S GVI+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 229 EVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           E+QT+S  +H  L+ L      +N M  ++YE+M  G L++++A  +N    D    Y  
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEM-VMIYEFMSGGELFEKVADEHNKMSEDEAVEY-- 154
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGI-VKMSETSNMKTMYT 343
              V + L ++H  +   +H D+K  N++         KL DFG+   +    ++K    
Sbjct: 155 MRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-- 210
Query: 344 ENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
              TGT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 211 ---TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 227 ENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYM--CNGSLYDRLARVNNTPPLDSNKRY 284
           + E+Q L + +H N+++L+ +  N     +Y  M  C   + + L  V         KR+
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-------PEKRF 106
Query: 285 SIALG------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 337
            +         + + L YLHS  + I+H+D+K  N+LL      K+   G+ + +   + 
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 338 MKTMYTENLTGTRPYMPPE---AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
             T  T    G+  + PPE    +      K D++S GV L  + TG+ P + +N
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 61
Query: 236 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 119 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 172
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 389
           Y+ PE +     +K  D+++ GVIL  LL G  P  D +
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 148
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 149 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 209 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 261
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 262 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 301

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 37/166 (22%)
Query: 234 SQCKHVNLLRLLGLCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET+  K      
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTGEK------ 174
Query: 346 LTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
                                D++S GVI+  LL G  P   N+ +
Sbjct: 175 ----------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 29/216 (13%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 71
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 128
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 353
           Y H++   + HRD+K  N LLD +  P+L   DFG  K    S++     ++  GT  Y+
Sbjct: 129 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYI 182
Query: 354 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 157
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 158 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 213
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 385
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 181
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 100/241 (41%), Gaps = 37/241 (15%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG G FG V+  + K  G + AVK +                    + +F  E   L  
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------------------LEVFRAE--ELMA 138
Query: 236 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  +   R++ L   +       I  E +  GSL  +L +     P D    Y   LG A
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY---LGQA 194
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFG-IVKMSETSNMKTMYTEN-LT 347
            E L YLHS  + I+H DVK+ NVLL  +     L DFG  V +      K++ T + + 
Sbjct: 195 LEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GT  +M PE  +      K DV+S   ++L +L G  P            +  +  PVRE
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVRE 312
Query: 407 V 407
           +
Sbjct: 313 I 313

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 77
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 78  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 138 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 189
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 230

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 228 NEVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E++ L   +H N++ LL +   +  ++     Y+    +   L ++     L  ++   
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 132
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++     +    
Sbjct: 133 LVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV--- 187
Query: 346 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 381
              TR Y  PE +    + +   D++S G I+ E++TG
Sbjct: 188 ---TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 70
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 131 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 223

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 88
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 89  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 149 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 200
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 181
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 129
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 130 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVK 185
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 385
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY----VVTRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +    +   D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQ 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 73
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 74  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 134 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 185
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 81
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 142 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 193
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 81
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 142 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 193
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 16/119 (13%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 108 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 163
Query: 338 MKTMYTENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
             ++  ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 164 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 16/119 (13%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 104 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 159
Query: 338 MKTMYTENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
             ++  ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 160 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 54  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 110
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 111 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 166
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 385
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 157
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 158 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 213
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 385
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 84
Query: 236 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL   +     + +V++ +  G L++ +         D++      L   E++
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESI 141
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 142 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 195
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +     +K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 103
Query: 236 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 164 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 215
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 216 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E E +     KH N++RL   +     + ++++ +  G L++ +         D++   
Sbjct: 68  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 127
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSETSNMKTM 341
              L   EA+ + H +   ++HRD+K  N+LL         KL DFG+    E       
Sbjct: 128 QQIL---EAVLHCHQMG--VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 182
Query: 342 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 183 ---GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 233

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 192
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 136 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPY----VVTRYY 189
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 238

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRL---------------LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDS 280
             H N++RL               L L  + +   VY       +    +R   T P+  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYR------VARHYSRAKQTLPVIY 123
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMK 339
            K Y   L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++
Sbjct: 124 VKLYMYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VR 175
Query: 340 TMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
                +   +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 129
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +   +  
Sbjct: 130 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDXXXVVK 185
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 385
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 28/218 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KL E   G ++ G+ + G +I VK L+                      F  E   L   
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLRIF 64
Query: 237 KHVNLLRLLGLCNNI---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            H N+L +LG C +       ++  +   GSLY+ L    N   +D ++    AL  A  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFV-VDQSQAVKFALDXARG 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
             +LH+L   I    + S +V +DE+   ++     VK S  S  +            ++
Sbjct: 124 XAFLHTLEPLIPRHALNSRSVXIDEDXTARISX-ADVKFSFQSPGRXYAPA-------WV 175
Query: 354 PPEAMHCQIST----KTDVFSYGVILLELLTGMKPIDD 387
            PEA+  +         D +S+ V+L EL+T   P  D
Sbjct: 176 APEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFAD 213

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 99/241 (41%), Gaps = 37/241 (15%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG G FG V+  + K  G + AVK +                    + +F  E   L  
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------------------LEVFRAE--ELMA 119
Query: 236 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  +   R++ L   +       I  E +  GSL  +L +     P D    Y   LG A
Sbjct: 120 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY---LGQA 175
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFG-IVKMSETSNMKTMYTEN-LT 347
            E L YLHS  + I+H DVK+ NVLL  +     L DFG  V +      K + T + + 
Sbjct: 176 LEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GT  +M PE  +      K DV+S   ++L +L G  P            +  +  PVRE
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVRE 293
Query: 407 V 407
           +
Sbjct: 294 I 294

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E E +     KH N++RL   +     + +V++ +  G L++ +         D++   
Sbjct: 77  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH-- 134
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTM 341
                + E+++++H     I+HRD+K  N+LL    +    KL DFG+    +       
Sbjct: 135 -CIHQILESVNHIHQ--HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 342 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 192 ---GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLY 242

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           RR  KLGEG +G VY          A+ T+              E   +P      EV  
Sbjct: 37  RRITKLGEGTYGEVYK---------AIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSL 86
Query: 233 LSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L + +H N++ L  + + N    +++EY  N    D    ++  P +      S    + 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 292 EALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             +++ HS  +  +HRD+K  N+LL      E  V K+GDFG+ +       +  +T  +
Sbjct: 143 NGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198
Query: 347 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
             T  Y PPE +      ST  D++S   I  E+L
Sbjct: 199 I-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V+E M  GS+   + +  +   L+++    +   VA AL +LH+  K I HRD+K  N+
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHN--KGIAHRDLKPENI 142
Query: 315 LLDE-NFVP--KLGDFGI---VKMS-ETSNMKTMYTENLTGTRPYMPPEAMHC------Q 361
           L +  N V   K+ DFG+   +K++ + S + T       G+  YM PE +         
Sbjct: 143 LCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 362 ISTKTDVFSYGVILLELLTGMKPI 385
              + D++S GVIL  LL+G  P 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V    K+  G E A K +                A I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL---------- 60
Query: 236 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            KH N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 61  -KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESV 116
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           ++ H     I+HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  
Sbjct: 117 NHCHL--NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPG 171
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLY 215

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 117
Query: 236 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  ++  R++ L   +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 118 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 173
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFGIVKMSETSNM-KTMYTEN-LT 347
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 174 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V    K+  G E A K +                A I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL---------- 60
Query: 236 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            KH N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 61  -KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESV 116
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           ++ H     I+HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  
Sbjct: 117 NHCHL--NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPG 171
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLY 215

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V E    G L D++ R          +  ++   + + + YLH+  + ++HRD+K +N+
Sbjct: 93  VVTELXKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNI 147
Query: 315 L-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTKT 366
           L +DE+  P   ++ DFG  K     N       YT N      ++ PE +  Q      
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTAN------FVAPEVLERQGYDAAC 201
Query: 367 DVFSYGVILLELLTGMKPI 385
           D++S GV+L   LTG  P 
Sbjct: 202 DIWSLGVLLYTXLTGYTPF 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 236 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 287
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M  + + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALDPVV 172
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 86/179 (48%), Gaps = 14/179 (7%)
Query: 227 ENEVQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           + E+  L  C+ H N+++L  + ++ ++  +V E +  G L++R+ +  +    +++   
Sbjct: 53  QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--- 109
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 341
            I   +  A+ ++H +   ++HRD+K  N+L    ++N   K+ DFG  ++    N    
Sbjct: 110 YIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL- 166
Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
             +    T  Y  PE ++        D++S GVIL  +L+G  P   ++  L     VE
Sbjct: 167 --KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 353
           Y H++   + HRD+K  N LLD +  P+L    FG  K    S++     ++  GT  Y+
Sbjct: 130 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK----SSVLHSQPKDTVGTPAYI 183
Query: 354 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 12/131 (9%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           IV EYM        LA V    PL           +   L Y+HS +  ++HRD+K AN+
Sbjct: 99  IVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANL 151
Query: 315 LLD-ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFS 370
            ++ E+ V K+GDFG+ + M    + K   +E L  T+ Y  P  +      +   D+++
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 371 YGVILLELLTG 381
            G I  E+LTG
Sbjct: 211 AGCIFAEMLTG 221

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EY   G L   L++     P +  + Y     +  A+  +H L    +HRD+K  N+
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE--IVMAIDSVHRLG--YVHRDIKPDNI 193
Query: 315 LLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTK 365
           LLD     +L DFG  +K+     ++++      GT  Y+ PE +              +
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVA---VGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 366 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
            D ++ GV   E+  G  P   ++T   Y  +V
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 119
Query: 236 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  ++  R++ L   +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 120 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 175
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFGIVKMSETSNM-KTMYTEN-LT 347
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 176 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 103
Query: 236 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  ++  R++ L   +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 159
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFGIVKMSETSNM-KTMYTEN-LT 347
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 160 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 18/144 (12%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V+E M  GS+   + +  +   L+++    +   VA AL +LH+  K I HRD+K  N+
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHN--KGIAHRDLKPENI 142
Query: 315 LLDE-NFVP--KLGDF----GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------Q 361
           L +  N V   K+ DF    GI    + S + T       G+  YM PE +         
Sbjct: 143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 362 ISTKTDVFSYGVILLELLTGMKPI 385
              + D++S GVIL  LL+G  P 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 236 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 287
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALAPVV 172
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 25/213 (11%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G +GTVY  +   +G  +A+K++                     LL     + L  
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL-----RRLEA 70
Query: 236 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 287
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 126
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++       T     L 
Sbjct: 127 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
               Y  PE  +    +T  D++S G I  E+ 
Sbjct: 185 ----YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 353
           Y H++   + HRD+K  N LLD +  P+L    FG  K    S++     ++  GT  Y+
Sbjct: 130 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK----SSVLHSQPKSTVGTPAYI 183
Query: 354 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E E +     KH N++RL   +     + ++++ +  G L++ +         D++   
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSETSNMKTM 341
              L   EA+ + H +   ++HR++K  N+LL         KL DFG+    E       
Sbjct: 117 QQIL---EAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 342 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 ---GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNT 390
           M T Y      TR Y  PE  +        D++S G I+ E      L  G   ID  N 
Sbjct: 181 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 391 IL 392
           ++
Sbjct: 237 VI 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 173
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNT 390
           M T Y      TR Y  PE  +        D++S G I+ E      L  G   ID  N 
Sbjct: 174 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 391 IL 392
           ++
Sbjct: 230 VI 231

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 33/171 (19%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
           M T Y      TR Y  PE  +        D++S G I+ E++         + IL+   
Sbjct: 181 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--------RHKILF--- 225
Query: 397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
                 P R+ +D    +WN+     +I  +   C  F K  + ++R+ V+
Sbjct: 226 ------PGRDYID----QWNK-----VIEQLGTPCPEFMKKLQPTVRNYVE 261

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 17/173 (9%)
Query: 227 ENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           +NE+  ++Q  H  L+ L     +     ++ E++  G L+DR+A  +    +   +  +
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVIN 153
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIV-KMSETSNMKTMY 342
                 E L ++H  S  I+H D+K  N++ +       K+ DFG+  K++    +K   
Sbjct: 154 YMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT- 210
Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI---DDNNTI 391
               T T  +  PE +  + +   TD+++ GV+   LL+G+ P    DD  T+
Sbjct: 211 ----TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M   +      TR Y
Sbjct: 140 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV----TRYY 193
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 253

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 236 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 287
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALFPVV 172
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 50/238 (21%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI-LLFENEVQTLSQC 236
           LG G  GTV +     G  +AVK +              + A++ I LL E++       
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESD------- 84
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYM--CNGSLYDRLARVN-NTPPLDSNKRY---SIALGV 290
            H N++R    C+   +  +Y  +  CN +L D +   N +   L   K Y   S+   +
Sbjct: 85  DHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKMSETSN 337
           A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K  ++  
Sbjct: 143 ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG- 199
Query: 338 MKTMYTENL---TGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  +  NL   +GT  +  PE +      +++   D+FS G +   +L+ G  P  D
Sbjct: 200 -QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 50/238 (21%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI-LLFENEVQTLSQC 236
           LG G  GTV +     G  +AVK +              + A++ I LL E++       
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESD------- 84
Query: 237 KHVNLLRLLGLCNNIMNCIVYEYM--CNGSLYDRLARVN-NTPPLDSNKRY---SIALGV 290
            H N++R    C+   +  +Y  +  CN +L D +   N +   L   K Y   S+   +
Sbjct: 85  DHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKMSETSN 337
           A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K  ++  
Sbjct: 143 ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG- 199
Query: 338 MKTMYTENL---TGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  +  NL   +GT  +  PE +      +++   D+FS G +   +L+ G  P  D
Sbjct: 200 -QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y    
Sbjct: 197 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKG 251
Query: 347 TGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 252 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y    
Sbjct: 204 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKG 258
Query: 347 TGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 259 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 300

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y    
Sbjct: 206 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKG 260
Query: 347 TGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 261 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 302

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 26/149 (17%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+++E +   SLY+ + R N N   ++  K Y I   + +AL+YL  +S  + H D+K  
Sbjct: 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE--ILKALNYLRKMS--LTHTDLKPE 166
Query: 313 NVLLDENF-------VPKLGDFGIVKMSET------------SNMKTMYTENLTGTRPYM 353
           N+LLD+ +       V ++ D   +++  T            +  K+ Y  ++  TR Y 
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR 226
Query: 354 PPEA-MHCQISTKTDVFSYGVILLELLTG 381
            PE  ++      +D++S+G +L EL TG
Sbjct: 227 APEVILNLGWDVSSDMWSFGCVLAELYTG 255

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 192
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----VVTRYY 184
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	455
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-91
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-82
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-78
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-67
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-60
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-59
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-50
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-48
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-30
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-26
1d2z_B	153	Death domain of tube; six-helix bundle, linear arr	2e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-21
1wh4_A	127	IRAK4, interleukin-1 receptor-associated kinase 4;	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-20
2a9i_A	113	IRAK-4, interleukin-1 receptor-associated kinase-4	2e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-13
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-08
1d2z_A	108	Death domain of pelle; six-helix bundle, linear ar	2e-07

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  279 bits (715), Expect = 2e-91
 Identities = 107/307 (34%), Positives = 178/307 (57%), Gaps = 19/307 (6%)

Query: 149 GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANY 208
               +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L    + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68

Query: 209 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD 267
           ++      +        F+ E++ +++C+H NL+ LLG   +    C+VY YM NGSL D
Sbjct: 69  TTEELKQ-Q--------FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 268 RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 327
           RL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DF
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDF 177

Query: 328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDD 387
           G+ + SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D+
Sbjct: 178 GLARASEKFA-QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 388 N----NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR 443
           +      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  ++
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS-QCLHEKKNKRPDIK 295

Query: 444 DIVDLLS 450
            +  LL 
Sbjct: 296 KVQQLLQ 302

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  256 bits (656), Expect = 2e-82
 Identities = 114/315 (36%), Positives = 162/315 (51%), Gaps = 33/315 (10%)

Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 206
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 13  HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEE- 65

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 265
               +     +        F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 66  ---RTQGGELQ--------FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114

Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +  T  T  + GT  ++ PE     + S KTDVF YGV+LLEL+TG 
Sbjct: 175 VGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232

Query: 383 KPIDDNNTIL--YYYLV-----VEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +  D           L+     + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 291

Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 292 SPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  244 bits (625), Expect = 8e-78
 Identities = 98/305 (32%), Positives = 149/305 (48%), Gaps = 32/305 (10%)

Query: 154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 213
               DLE AT+ F+ K        +G G FG VY G L++G ++A+K          S+ 
Sbjct: 29  VPLVDLEEATNNFDHK------FLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----SSQ 77

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRL-AR 271
              E        FE E++TLS C+H +L+ L+G C+      ++Y+YM NG+L   L   
Sbjct: 78  GIEE--------FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
              T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 332 MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
                + +T  +  + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I  +  
Sbjct: 188 KGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 391 ILYYYLV-----VEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVFEKDKRASMRD 444
                L            + +++D   A +     +         KC     + R SM D
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTA-VKCLALSSEDRPSMGD 305

Query: 445 IVDLL 449
           ++  L
Sbjct: 306 VLWKL 310

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  217 bits (555), Expect = 1e-67
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 31/279 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             K+G G FGTV+  +   G ++AVK L                       F  EV  + 
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVKILME-----QDFHAERVNE------FLREVAIMK 89

Query: 235 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           ++YLH+ + PI+HR++KS N+L+D+ +  K+ DFG+ ++  ++ + +    +  GT  +M
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK---SAAGTPEWM 206

Query: 354 PPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV--PVREVLDK 410
            PE +  + S  K+DV+S+GVIL EL T  +P  + N       V  +     +   L+ 
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
           +        V  +I    E C   E  KR S   I+DLL
Sbjct: 267 Q--------VAAII----EGCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  208 bits (532), Expect = 2e-64
 Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 44/290 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             ++G+G FG V+ G+L  +   +A+K+L    +   +              F+ EV  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE------FQREVFIM 77

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           S   H N+++L GL +N    +V E++  G LY RL   +   P+  + +  + L +A  
Sbjct: 78  SNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALG 134

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           + Y+ + + PI+HRD++S N+ L           K+ DFG+ +     ++  +      G
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGL-----LG 188

Query: 349 TRPYMPPEAM---HCQISTKTDVFSYGVILLELLTGMKPIDD--NNTILYYYLVVEQ--- 400
              +M PE +       + K D +S+ +IL  +LTG  P D+     I +  ++ E+   
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248

Query: 401 -EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
             +P          E     +  +I    E C   +  KR     IV  L
Sbjct: 249 PTIP----------EDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKEL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (527), Expect = 1e-63
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 45/285 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G G FG V   K +   ++A+K +          S++   A      F  E++ LS
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQI---------ESESERKA------FIVELRQLS 56

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           +  H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ +
Sbjct: 57  RVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 295 HYLHSLS-KPIIHRDVKSANVLLDENF-VPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            YLHS+  K +IHRD+K  N+LL     V K+ DFG     +T     M      G+  +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNN--KGSAAW 169

Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILY-YYLVVEQ----EVPVRE 406
           M PE       + K DVFS+G+IL E++T  KP D+     +     V       +    
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI--- 226

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                  +     +E+L+     +C   +  +R SM +IV +++ 
Sbjct: 227 -------KNLPKPIESLM----TRCWSKDPSQRPSMEEIVKIMTH 260

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (509), Expect = 4e-61
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 28/279 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L       ++ +     A      F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLN-----VTAPTPQQLQA------FKNEVGVLR 75

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+       +    + +  +G+  +M 
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL-SGSILWMA 190

Query: 355 PEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +  Q     S ++DV+++G++L EL+TG  P  + N       +V +          
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG--SLSPDLS 248

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
           +        ++ L+     +C   ++D+R S   I+  +
Sbjct: 249 KVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (505), Expect = 1e-60
 Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 46/288 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KL E   G ++ G+ + G +I VK L+     +  + D           F  E   L 
Sbjct: 15  LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLR 62

Query: 235 QCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
              H N+L +LG C +       ++  +M  GSLY+ L        +D ++    AL +A
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMA 121

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             + +LH+L   I    + S +V++DE+   ++       +  +                
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD---VKFSFQSPGR-----MYAPA 173

Query: 352 YMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVP 403
           ++ PEA+            D++S+ V+L EL+T   P  D + +     V  +     +P
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                          HV  L+    + C   +  KR     IV +L K
Sbjct: 234 ----------PGISPHVSKLM----KICMNEDPAKRPKFDMIVPILEK 267

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (505), Expect = 4e-60
 Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 41/290 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +G+G+FG VY+G+     E+A++ +    +    N D  +A       F+ EV    
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLI----DIERDNEDQLKA-------FKREVMAYR 84

Query: 235 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q +H N++  +G C +  +  I+       +LY  +   +    LD NK   IA  + + 
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKG 142

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNMKTMYTENLTGTRP 351
           + YLH+  K I+H+D+KS NV  D   V  + DFG+  +     +  +        G   
Sbjct: 143 MGYLHA--KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 352 YMPPEAMHCQI----------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           ++ PE +              S  +DVF+ G I  EL     P          + +    
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            P            ++  +   IS +   C  FE+++R +   ++D+L K
Sbjct: 260 KP----------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  198 bits (504), Expect = 6e-60
 Identities = 73/329 (22%), Positives = 121/329 (36%), Gaps = 58/329 (17%)

Query: 154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 213
               +L   +         +       G+FG V+  +L     +AVK        S    
Sbjct: 14  LGTENLYFQSMPL------QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS---- 62

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDR 268
                        E EV +L   KH N+L+ +G      +      ++  +   GSL D 
Sbjct: 63  ----------WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112

Query: 269 LARVNNTPPLDSNKRYSIALGVAEALHYLHS-------LSKP-IIHRDVKSANVLLDENF 320
           L        +  N+   IA  +A  L YLH          KP I HRD+KS NVLL  N 
Sbjct: 113 LKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168

Query: 321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVI 374
              + DFG+    E +      T    GTR YM PE +   I+       + D+++ G++
Sbjct: 169 TACIADFGLALKFE-AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 375 LLELLTGMKPIDDNNT--ILYYYLVVEQEVPVRE----VLDKEA-----GEWNETHVETL 423
           L EL +     D      +L +   + Q   + +    V+ K+        W +     +
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287

Query: 424 ISIVFEKCCVFEK-DKRASMRDIVDLLSK 451
           +    E+ C     + R S   + + +++
Sbjct: 288 LCETIEE-CWDHDAEARLSAGCVGERITQ 315

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  194 bits (495), Expect = 4e-59
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G G FG VY      G E+AVK   ++ +   S +         I     E +  +
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQT---------IENVRQEAKLFA 61

Query: 235 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             KH N++ L G+C    N C+V E+   G L   L+       +  +   + A+ +A  
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARG 117

Query: 294 LHYLHSL-SKPIIHRDVKSANVLLDE--------NFVPKLGDFGIVKMSETSNMKTMYTE 344
           ++YLH     PIIHRD+KS+N+L+ +        N + K+ DFG+ +    +   +    
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA--- 174

Query: 345 NLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--- 400
              G   +M PE +   + +  +DV+SYGV+L ELLTG  P    + +   Y V      
Sbjct: 175 --AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232

Query: 401 -EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             +P                   L+    E C   +   R S  +I+D L+ 
Sbjct: 233 LPIP----------STCPEPFAKLM----EDCWNPDPHSRPSFTNILDQLTT 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  187 bits (477), Expect = 4e-56
 Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 46/294 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G FG       +  G  + +K L     +                 F  EV+ +
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRT----------FLKEVKVM 61

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H N+L+ +G+         + EY+  G+L   +   +       ++R S A  +A 
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIAS 119

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL------ 346
            + YLHS    IIHRD+ S N L+ EN    + DFG+ ++      +     +L      
Sbjct: 120 GMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177

Query: 347 -----TGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 G   +M PE ++ +    K DVFS+G++L E++  +              +   
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------DPDYLPRT 229

Query: 401 E---VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               + VR  LD+            +      +CC  + +KR S   +   L  
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWLET 279

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  177 bits (452), Expect = 2e-52
 Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G++G V+ G    G  +AVK          S+ D            E E+    
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIF--------SSRDEKSW------FRETELYNTV 57

Query: 235 QCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +       +      ++  Y   GSLYD L        LD+     I L 
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLS 113

Query: 290 VAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 342
           +A  L +LH           I HRD+KS N+L+ +N    + D G+ V  S+++N   + 
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173

Query: 343 TENLTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGMKPIDDNNT--ILY 393
                GT+ YM PE +   I         + D++++G++L E+   M            +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

Query: 394 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           Y +V      E   + V   +        W      T ++ + ++C       R +   I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

Query: 446 VDLLSK 451
              L+K
Sbjct: 294 KKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (449), Expect = 1e-51
 Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             ++G+G++G V+ GK + G ++AVK        S                 E E+    
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS--------------WFRETEIYQTV 86

Query: 235 QCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +              ++ +Y  NGSLYD L     +  LD+     +A  
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYS 142

Query: 290 VAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 342
               L +LH+          I HRD+KS N+L+ +N    + D G+ VK    +N   + 
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 343 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILY 393
                GT+ YMPPE +       H Q     D++S+G+IL E+              + Y
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 394 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + LV      E     V  K+        W+       +  +  +C       R +   +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 446 VDLLSK 451
              L+K
Sbjct: 323 KKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  172 bits (438), Expect = 5e-50
 Identities = 70/306 (22%), Positives = 124/306 (40%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G+FG V+ GK + G E+AVK          S+ +            E E+    
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIF--------SSREERSW------FREAEIYQTV 91

Query: 235 QCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +   N          +V +Y  +GSL+D L    N   +       +AL 
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALS 147

Query: 290 VAEALHYLHS-----LSKP-IIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 342
            A  L +LH        KP I HRD+KS N+L+ +N    + D G+ V+    ++   + 
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 343 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKP--IDDNNTILY 393
             +  GT+ YM PE +       H +   + D+++ G++  E+        I ++  + Y
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 394 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           Y LV      E   + V +++        W       +++ +  +C       R +   I
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

Query: 446 VDLLSK 451
              LS+
Sbjct: 328 KKTLSQ 333

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  168 bits (428), Expect = 1e-48
 Identities = 64/342 (18%), Positives = 118/342 (34%), Gaps = 69/342 (20%)

Query: 152 IAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSS 211
           +     +     D        +    +G G++G VY G L +   +AVK        +  
Sbjct: 1   MEAAASEPSLDLDNL------KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-- 51

Query: 212 NSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN------CIVYEYMCNGSL 265
                        + E  +  +   +H N+ R +     +         +V EY  NGSL
Sbjct: 52  ------------FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSL 99

Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS------LSKP-IIHRDVKSANVLLDE 318
              L+        D      +A  V   L YLH+        KP I HRD+ S NVL+  
Sbjct: 100 XKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155

Query: 319 NFVPKLGDFGIVKM-----SETSNMKTMYTENLTGTRPYMPPEAMHCQIST--------K 365
           +    + DFG+              +     +  GT  YM PE +   ++         +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215

Query: 366 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP--------VREVLDK------- 410
            D+++ G+I  E+      +    ++  Y +  + EV            V  +       
Sbjct: 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP 275

Query: 411 EAGEWNETHVETLISIVFEKCCVFEK-DKRASMRDIVDLLSK 451
           EA + N   V +L   +  + C  +  + R + +   + +++
Sbjct: 276 EAWKENSLAVRSLKETI--EDCWDQDAEARLTAQXAEERMAE 315

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  157 bits (400), Expect = 4e-44
 Identities = 71/288 (24%), Positives = 112/288 (38%), Gaps = 46/288 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G ++G G FG V+ G+L+ +   +AVK+             + +A       F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL------PPDLKAK------FLQEARIL 166

Query: 234 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++RL+G+C     I   IV E +  G     L        L       +    
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIY--IVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDA 222

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL S  K  IHRD+ + N L+ E  V K+ DFG   MS                 
Sbjct: 223 AAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFG---MSREEADGVYAASGGLRQV 277

Query: 351 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE 406
           P     PEA++    S+++DV+S+G++L E  + G  P        Y        +  ++
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP--------Y------PNLSNQQ 323

Query: 407 VLDK-EAGEWNE--THVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             +  E G            +  + E+C  +E  +R S   I   L  
Sbjct: 324 TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  149 bits (377), Expect = 2e-41
 Identities = 61/255 (23%), Positives = 110/255 (43%), Gaps = 32/255 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +  ++LG+G FG+V   +        G  +AVK L+++        D           F+
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRD-----------FQ 72

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E+Q L       +++  G+          +V EY+ +G L D L R  +   LD+++  
Sbjct: 73  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLL 130

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             +  + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y  
Sbjct: 131 LYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVV 186

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
              G  P  +  PE+      S ++DV+S+GV+L EL T   K    +   L        
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246

Query: 401 EVPVREVLDK-EAGE 414
              +  +L+  E G+
Sbjct: 247 VPALSRLLELLEEGQ 261

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  145 bits (368), Expect = 2e-40
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V+ G      ++AVK+L+  +    S              F  E   + 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDA-----------FLAEANLMK 63

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           Q +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE +
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGM 122

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E       YT       P   
Sbjct: 123 AFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKW 176

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA++    + K+DV+S+G++L E++T G  P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  145 bits (368), Expect = 2e-40
 Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 43/285 (15%)

Query: 171 YPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           + +   ++G G F TVY G   +  +E+A   L++     S               F+ E
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-----------RQRFKEE 75

Query: 230 VQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            + L   +H N++R      + +       +V E M +G+L   L R      +   + +
Sbjct: 76  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSW 134

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 343
                + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S  K +  
Sbjct: 135 --CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-- 190

Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
               GT  +M PE    +     DV+++G+ +LE+ T   P  +       Y  V   V 
Sbjct: 191 ---IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 404 ---VREVLDKEAGEWNETHVETLISIVF-EKCCVFEKDKRASMRD 444
                +V   E  E               E C    KD+R S++D
Sbjct: 248 PASFDKVAIPEVKE-------------IIEGCIRQNKDERYSIKD 279

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  145 bits (367), Expect = 4e-40
 Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 31/255 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +R   LGEG FG V   +        G ++AVK+L+  +  +                 +
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD------------LK 71

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E++ L    H N+++  G+C         ++ E++ +GSL + L +  N   ++  ++ 
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQL 129

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             A+ + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   K  YT 
Sbjct: 130 KYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTV 185

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
                 P  +  PE  M  +    +DV+S+GV L ELLT            L        
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245

Query: 401 EVPVREVLDK-EAGE 414
           ++ V  +++  + G+
Sbjct: 246 QMTVTRLVNTLKEGK 260

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  143 bits (363), Expect = 1e-39
 Identities = 59/256 (23%), Positives = 112/256 (43%), Gaps = 33/256 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +   +LG+G FG+V   +        G  +AVK L+              +    +  FE
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------------HSTEEHLRDFE 59

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E++ L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K  
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLL 117

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
                + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  +  
Sbjct: 118 QYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKV 173

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-- 399
              G  P  +  PE+    + S  +DV+S+GV+L EL T ++            +  +  
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233

Query: 400 QEVPVREVLDK-EAGE 414
            ++ V  +++  +   
Sbjct: 234 GQMIVFHLIELLKNNG 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  143 bits (363), Expect = 2e-39
 Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 34/228 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LG+G+FG+V   +LK      +++AVK L+ +   SS   +           F  E 
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-----------FLREA 76

Query: 231 QTLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSL--YDRLARVNNTP-PLDS 280
             + +  H ++ +L+G+           +  ++  +M +G L  +   +R+   P  L  
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
                  + +A  + YL S  +  IHRD+ + N +L E+    + DFG   +S       
Sbjct: 137 QTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFG---LSRKIYSGD 191

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +      P  ++  E++   + +  +DV+++GV + E++T G  P
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  143 bits (362), Expect = 3e-39
 Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 33/255 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LGEG FG V            G  +AVK L+ +A     +             ++
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG------------WK 81

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E+  L    H ++++  G C +       +V EY+  GSL D L R      +   +  
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLL 137

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             A  + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ K          Y  
Sbjct: 138 LFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRV 193

Query: 345 NLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
              G  P  +  PE +   +    +DV+S+GV L ELLT            L    + + 
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253

Query: 401 EVPVREVLDK-EAGE 414
           ++ V  + +  E GE
Sbjct: 254 QMTVLRLTELLERGE 268

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  143 bits (363), Expect = 3e-39
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 45/253 (17%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LG G FGTVY G      E     +A+K L       +S   N E          
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKE--------IL 65

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWC 123

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+            +  
Sbjct: 124 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAE 177

Query: 348 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
           G +    +M  E++  +I + ++DV+SYGV + EL+T G KP        Y        +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------Y------DGI 223

Query: 403 PVREVLDK-EAGE 414
           P  E+    E GE
Sbjct: 224 PASEISSILEKGE 236

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (361), Expect = 4e-39
 Identities = 60/256 (23%), Positives = 112/256 (43%), Gaps = 33/256 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +   +LG+G FG+V   +        G  +AVK L+              +    +  FE
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------------HSTEEHLRDFE 90

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E++ L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K  
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLL 148

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
                + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  Y  
Sbjct: 149 QYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEYYKV 204

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-- 399
              G  P  +  PE+    + S  +DV+S+GV+L EL T ++            +  +  
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264

Query: 400 QEVPVREVLDK-EAGE 414
            ++ V  +++  +   
Sbjct: 265 GQMIVFHLIELLKNNG 280

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  141 bits (357), Expect = 6e-39
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V YGK +   ++A+K ++  +    S  +           F  E + + 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDE-----------FIEEAKVMM 74

Query: 235 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
              H  L++L G+C     I   I+ EYM NG L + L R        + +   +   V 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIF--IITEYMANGCLLNYL-R-EMRHRFQTQQLLEMCKDVC 130

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           EA+ YL   SK  +HRD+ + N L+++  V K+ DFG+ +          YT ++    P
Sbjct: 131 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFP 184

Query: 352 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
               PPE +     S+K+D++++GV++ E+ + G  P
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (355), Expect = 8e-39
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             ++G GQFG V+ G   N  ++A+KT+   A    S  D           F  E + + 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEED-----------FIEEAEVMM 58

Query: 235 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +  H  L++L G+C     I   +V E+M +G L D L R        +     + L V 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPIC--LVTEFMEHGCLSDYL-R-TQRGLFAAETLLGMCLDVC 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           E + YL      +IHRD+ + N L+ EN V K+ DFG+ +          YT +     P
Sbjct: 115 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFP 168

Query: 352 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                PE       S+K+DV+S+GV++ E+ + G  P
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  140 bits (355), Expect = 9e-39
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V  GK K   ++AVK ++  +    S  +           F  E QT+ 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDE-----------FFQEAQTMM 58

Query: 235 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +  H  L++  G+C+    I   IV EY+ NG L + L   ++   L+ ++   +   V 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIY--IVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVC 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           E + +L   S   IHRD+ + N L+D +   K+ DFG+ +          Y  ++    P
Sbjct: 115 EGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVGTKFP 168

Query: 352 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                PE  H    S+K+DV+++G+++ E+ + G  P
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (365), Expect = 1e-38
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG GQFG V+        ++AVKT+            +          F  E   + 
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM---------KPGSMSVEA-----FLAEANVMK 238

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             +H  L++L  +       I+ E+M  GSL D L + +        K    +  +AE +
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGM 297

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P   
Sbjct: 298 AFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKW 351

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA++    + K+DV+S+G++L+E++T G  P
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (354), Expect = 2e-38
 Identities = 74/237 (31%), Positives = 112/237 (47%), Gaps = 43/237 (18%)

Query: 162 ATDGFNRKPY--PRR----GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDN 215
           A D F R  +    +       +G+G+FG V  G  + G ++AVK +          +D 
Sbjct: 7   AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDA 56

Query: 216 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLAR 271
           T  A      F  E   ++Q +H NL++LLG+       +   IV EYM  GSL D L R
Sbjct: 57  TAQA------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYL-R 107

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
                 L  +     +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG   
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG--- 162

Query: 332 MSETSNMKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           ++     K   +   TG  P     PEA+  +  STK+DV+S+G++L E+ + G  P
Sbjct: 163 LT-----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  140 bits (354), Expect = 2e-38
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 24/220 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           R   KLG+G FG V  G+        + +AVK L    +  S      +        F  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL--KPDVLSQPEAMDD--------FIR 70

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           EV  +    H NL+RL G+       +V E    GSL DRL    +            A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAV 128

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            VAE + YL   SK  IHRD+ + N+LL    + K+GDFG+++    ++    Y      
Sbjct: 129 QVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHR 184

Query: 349 TRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             P+    PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  139 bits (353), Expect = 3e-38
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 28/218 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              LGEG FG VY G   N     + +AVKT     + +  N +           F +E 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEK----------FMSEA 64

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
             +    H ++++L+G+       I+ E    G L   L    N   L        +L +
Sbjct: 65  VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQI 122

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            +A+ YL   S   +HRD+   N+L+      KLGDFG+ +  E  +    Y +      
Sbjct: 123 CKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRL 176

Query: 351 P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P  +M PE+++ +  +T +DV+ + V + E+L+ G +P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (354), Expect = 3e-38
 Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 27/217 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +R ++LG G +G V+  + K +G   AVK              +    +        EV 
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS----MSPFRGPKDRARKL-------AEVG 108

Query: 232 TLSQ-CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +  +  +H   +RL        I+  +  E  C  SL            L   + +    
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGIL-YLQTEL-CGPSLQQHCEAWGA--SLPEAQVWGYLR 164

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 347
               AL +LHS  + ++H DVK AN+ L      KLGDFG++  +      +        
Sbjct: 165 DTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-----E 217

Query: 348 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
           G   YM PE +     T  DVFS G+ +LE+   M+ 
Sbjct: 218 GDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  140 bits (354), Expect = 3e-38
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 33/227 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LGEG+FG+V  G LK      +++AVKT++ +   +SS  +  E        F +E 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD---NSSQREIEE--------FLSEA 87

Query: 231 QTLSQCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSL--YDRLARVNNTP-PLDSN 281
             +    H N++RLLG+C            ++  +M  G L  Y   +R+   P  +   
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
                 + +A  + YL +  +  +HRD+ + N +L ++    + DFG   +S+       
Sbjct: 148 TLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFG---LSKKIYSGDY 202

Query: 342 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           Y +      P  ++  E++  ++ ++K+DV+++GV + E+ T GM P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  139 bits (353), Expect = 3e-38
 Identities = 70/222 (31%), Positives = 104/222 (46%), Gaps = 31/222 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G FG VY+G L +     +  AVK+L           + ++        F  E 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQ--------FLTEG 77

Query: 231 QTLSQCKHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +    H N+L LLG+C        +V  YM +G L + + R N T            L
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-R-NETHNPTVKDLIGFGL 135

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLT 347
            VA+ + YL S  K  +HRD+ + N +LDE F  K+ DFG   ++     K  Y   N T
Sbjct: 136 QVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKT 190

Query: 348 GTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           G + P  +M  E++  Q  +TK+DV+S+GV+L EL+T G  P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  139 bits (352), Expect = 3e-38
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT       S S  +           F  E 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREK----------FLQEA 67

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L   L        LD       A  +
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQL 125

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 126 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 179

Query: 351 P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P  +M PE+++ +  ++ +DV+ +GV + E+L  G+KP
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (355), Expect = 3e-38
 Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 45/253 (17%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           R+   LG G FGTV+ G      E     + +K +E+ +    S                
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQA-----------VT 63

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + +  +    H +++RLLGLC      +V +Y+  GSL D +    +   L      +  
Sbjct: 64  DHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWG 121

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y    +
Sbjct: 122 VQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----S 175

Query: 348 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
             +    +M  E++H    + ++DV+SYGV + EL+T G +P        Y        +
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--------Y------AGL 221

Query: 403 PVREVLDK-EAGE 414
            + EV D  E GE
Sbjct: 222 RLAEVPDLLEKGE 234

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 4e-38
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 33/225 (14%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
                +G+G FG VY+G+  +     ++ A+K+L          +            F  
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA------------FLR 71

Query: 229 EVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           E   +    H N+L L+G+      +  ++  YMC+G L   +   +           S 
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISF 129

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
            L VA  + YL    +  +HRD+ + N +LDE+F  K+ DFG+ +          Y    
Sbjct: 130 GLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE----YYSVQ 183

Query: 347 TGTR---P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                  P  +   E++     +TK+DV+S+GV+L ELLT G  P
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  144 bits (364), Expect = 5e-38
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG+G FG V+ G       +A+KTL       S  +            F  E Q + 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEA------------FLQEAQVMK 317

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  +
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGM 376

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P   
Sbjct: 377 AYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKW 430

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA      + K+DV+S+G++L EL T G  P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (351), Expect = 5e-38
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +KLG GQ+G VY G  K   + +AVKTL+ +        +           F  E   +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEE-----------FLKEAAVM 63

Query: 234 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            + KH NL++LLG+C         I+ E+M  G+L D L R  N   + +     +A  +
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQI 120

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     
Sbjct: 121 SSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKF 174

Query: 351 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P     PE++     S K+DV+++GV+L E+ T GM P
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  139 bits (353), Expect = 6e-38
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 33/222 (14%)

Query: 175 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G  G V YG+L+      + +A+K L   A Y+     +          F +E 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRD----------FLSEA 101

Query: 231 QTLSQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
             + Q  H N++RL G+       M  IV EYM NGSL   L    +       +   + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAM--IVTEYMENGSLDTFLR--THDGQFTIMQLVGML 157

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
            GV   + YL       +HRD+ + NVL+D N V K+ DFG   +S             T
Sbjct: 158 RGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFG---LSRVLEDDPDAAYTTT 212

Query: 348 GTR-PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           G + P     PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  142 bits (360), Expect = 7e-38
 Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 37/218 (16%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G+FG V  G  + G ++AVK +          +D T  A      F  E   ++
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQA------FLAEASVMT 241

Query: 235 QCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           Q +H NL++LLG+       +   IV EYM  GSL D L R      L  +     +L V
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDV 298

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            EA+ YL       +HRD+ + NVL+ E+ V K+ DFG   ++     K   +   TG  
Sbjct: 299 CEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG---LT-----KEASSTQDTGKL 348

Query: 351 PY--MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P     PEA+   + STK+DV+S+G++L E+ + G  P
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (350), Expect = 1e-37
 Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 33/240 (13%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
           + K Y     KLGEG F  V   + L +G   A+K +            + E A      
Sbjct: 27  DNKHY-LFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL------CHEQQDREEAQ----- 74

Query: 226 FENEVQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRL-ARVNNTPPLD 279
              E        H N+LRL+  C           ++  +   G+L++ +    +    L 
Sbjct: 75  --READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE---TS 336
            ++   + LG+   L  +H+  K   HRD+K  N+LL +   P L D G +  +      
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 337 NMKTMYTENL---TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           + + +  ++      T  Y  PE      HC I  +TDV+S G +L  ++ G  P D   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  141 bits (357), Expect = 1e-37
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG+G FG V+ G       +A+KTL       S  +            F  E Q + 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEA------------FLQEAQVMK 234

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  +
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGM 293

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P   
Sbjct: 294 AYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKW 347

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA      + K+DV+S+G++L EL T G  P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (353), Expect = 2e-37
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 29/221 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G FG VY+G L +     +  AVK+L           + ++        F  E 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQ--------FLTEG 141

Query: 231 QTLSQCKHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +    H N+L LLG+C        +V  YM +G L + + R N T            L
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-R-NETHNPTVKDLIGFGL 199

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ +        +++ +  TG
Sbjct: 200 QVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK--TG 255

Query: 349 TR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            + P  +M  E++  Q  +TK+DV+S+GV+L EL+T G  P
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  138 bits (350), Expect = 2e-37
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 34/223 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
              +G G+FG VY G LK       + +A+KTL   A Y+     +          F  E
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVD----------FLGE 96

Query: 230 VQTLSQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
              + Q  H N++RL G+ +    +M  I+ EYM NG+L   L            +   +
Sbjct: 97  AGIMGQFSHHNIIRLEGVISKYKPMM--IITEYMENGALDKFLR--EKDGEFSVLQLVGM 152

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             G+A  + YL +     +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T   
Sbjct: 153 LRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-- 208

Query: 347 TGTR-PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            G + P     PEA+  +  ++ +DV+S+G+++ E++T G +P
Sbjct: 209 -GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  136 bits (345), Expect = 4e-37
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 25/215 (11%)

Query: 177 KLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G  +     +++A+K L+     + +                 E Q +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE------------MMREAQIM 64

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++RL+G+C      +V E    G L+  L        +  +    +   V+  
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMG 122

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY- 352
           + YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT    G  P  
Sbjct: 123 MKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLK 178

Query: 353 -MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
              PE ++ +  S+++DV+SYGV + E L+ G KP
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  136 bits (345), Expect = 4e-37
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 25/215 (11%)

Query: 177 KLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FGTV  G  +       +AVK L+N AN  +   +              E   +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-----------LLAEANVM 72

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++R++G+C      +V E    G L   L        +       +   V+  
Sbjct: 73  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMG 129

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY- 352
           + YL       +HRD+ + NVLL      K+ DFG+ K          Y     G  P  
Sbjct: 130 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVK 185

Query: 353 -MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
              PE ++    S+K+DV+S+GV++ E  + G KP
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (355), Expect = 5e-37
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +KLG GQ+G VY G  K   + +AVKTL+ +        +           F  E   +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEE-----------FLKEAAVM 270

Query: 234 SQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            + KH NL++LLG+C         I+ E+M  G+L D L R  N   + +     +A  +
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQI 327

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + A+ YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     
Sbjct: 328 SSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKF 381

Query: 351 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P     PE++     S K+DV+++GV+L E+ T GM P
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  134 bits (339), Expect = 3e-36
 Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 41/234 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LGE +FG VY G L           +A+KTL++ A                   F +
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA------EGPLREE------FRH 61

Query: 229 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL-------------ARVNN 274
           E    ++ +H N++ LLG+   +    +++ Y  +G L++ L                  
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 275 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
              L+      +   +A  + YL S    ++H+D+ + NVL+ +    K+ D G   +  
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLG---LFR 176

Query: 335 TSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                  Y        P  +M PEA+     S  +D++SYGV+L E+ + G++P
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (339), Expect = 3e-36
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 48/243 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
             RR      +LGEG FG V+  +  N       M +AVK L+             +  +
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-------------DPTL 58

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL-------------Y 266
                F+ E + L+  +H ++++  G+C +     +V+EYM +G L              
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                      L  ++   IA  +A  + YL S     +HRD+ + N L+  N + K+GD
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGD 176

Query: 327 FGIVKMSETSNMKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-G 381
           FG+ +   +++    Y      T  P  +MPPE++  +  +T++DV+S+GVIL E+ T G
Sbjct: 177 FGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232

Query: 382 MKP 384
            +P
Sbjct: 233 KQP 235

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (341), Expect = 3e-36
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 45/253 (17%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LG G FGTVY G      E     +A+K L       +S   N E          
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKE--------IL 65

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWC 123

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+            +  
Sbjct: 124 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAE 177

Query: 348 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
           G +    +M  E++  +I + ++DV+SYGV + EL+T G KP        Y        +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------Y------DGI 223

Query: 403 PVREVLDK-EAGE 414
           P  E+    E GE
Sbjct: 224 PASEISSILEKGE 236

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  133 bits (337), Expect = 4e-36
 Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 45/240 (18%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +    +G G FG V+  K   +G    +K +     Y++  +             E EV+
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKA-------------EREVK 56

Query: 232 TLSQCKHVNLLRLLG-----------------LCNNIMNCIVYEYMCNGSLYDRLARVNN 274
            L++  HVN++   G                         I  E+   G+L   + +   
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 275 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MS 333
              LD      +   + + + Y+HS  K +I+RD+K +N+ L +    K+GDFG+V  + 
Sbjct: 117 EK-LDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
                         GT  YM PE +  Q    + D+++ G+IL ELL       + +   
Sbjct: 174 NDGKRTRS-----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (337), Expect = 9e-36
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 35/228 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LG+G FG VY G  K          +A+KT+   A    S  +  E        F N
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIE--------FLN 77

Query: 229 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD-------RLARVNNTPPLDS 280
           E   + +    +++RLLG+        ++ E M  G L          +A      P   
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG   M+       
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFG---MTRDIYETD 192

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T   +P
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (340), Expect = 1e-35
 Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 38/247 (15%)

Query: 154 FTFCDLERATDGFNRKPYPRR----GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENN 205
            TF D  +    F ++            +G G+FG V  G+LK      + +A+KTL   
Sbjct: 26  HTFEDPTQTVHEFAKE-LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--K 82

Query: 206 ANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---IMNCIVYEYMCN 262
             Y+     +          F  E   + Q  H N++RL G+      +M  IV EYM N
Sbjct: 83  VGYTEKQRRD----------FLGEASIMGQFDHPNIIRLEGVVTKSKPVM--IVTEYMEN 130

Query: 263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 322
           GSL   L    +       +   +  G+A  + YL  +    +HRD+ + N+L++ N V 
Sbjct: 131 GSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVC 186

Query: 323 KLGDFGIVKMSETSNMKTMYTENLTGTR-PY--MPPEAMHCQI-STKTDVFSYGVILLEL 378
           K+ DFG   +               G + P     PEA+  +  ++ +DV+SYG++L E+
Sbjct: 187 KVSDFG---LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

Query: 379 LT-GMKP 384
           ++ G +P
Sbjct: 244 MSYGERP 250

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  138 bits (349), Expect = 2e-35
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 28/220 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             G  +GEGQFG V+ G   +     M +A+KT       S S  +           F  
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREK----------FLQ 440

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           E  T+ Q  H ++++L+G+       I+ E    G L   L        LD       A 
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAY 498

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G
Sbjct: 499 QLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKG 552

Query: 349 TRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             P  +M PE+++ +  ++ +DV+ +GV + E+L  G+KP
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  131 bits (332), Expect = 3e-35
 Identities = 62/255 (24%), Positives = 100/255 (39%), Gaps = 40/255 (15%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG G FG V+  K K +    A+K +       +      +           EV+
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKV--------MREVK 55

Query: 232 TLSQCKHVNLLRLLG-------------LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
            L++ +H  ++R                    +   I  +     +L D +         
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 337
           + +    I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +   
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 338 MKTMYTENLT--------GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDN 388
            +T+ T            GT+ YM PE +H    S K D+FS G+IL ELL         
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQM 231

Query: 389 NTILYYYLVVEQEVP 403
             +     V   + P
Sbjct: 232 ERVRTLTDVRNLKFP 246

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  132 bits (334), Expect = 3e-35
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 41/233 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LGEG FG V+  +  N       M +AVK L+             EA+      F+ 
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQR 92

Query: 229 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL------------ARVNNT 275
           E + L+  +H +++R  G+C       +V+EYM +G L   L                  
Sbjct: 93  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152

Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG   MS  
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFG---MSRD 207

Query: 336 SNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                 Y        P  +MPPE++  +  +T++DV+S+GV+L E+ T G +P
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (332), Expect = 6e-35
 Identities = 68/232 (29%), Positives = 111/232 (47%), Gaps = 42/232 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            + +GEG FG V   ++K     M+ A+K ++  A    S  D+ +        F  E++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRD--------FAGELE 77

Query: 232 TLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD--RLARVNNTPPLDSNKRY--- 284
            L +   H N++ LLG C +     +  EY  +G+L D  R +RV  T P  +       
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137

Query: 285 --------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
                     A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E  
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV- 194

Query: 337 NMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                Y +   G  P  +M  E+++  + +T +DV+SYGV+L E+++ G  P
Sbjct: 195 -----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (331), Expect = 1e-34
 Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 36/240 (15%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R    L EG F  VY  + + +G E A+K L       S+  +   A          EV 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRL------LSNEEEKNRAI-------IQEVC 77

Query: 232 TLSQCK-HVNLLRLLG--------LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            + +   H N+++                   ++   +C G L + L ++ +  PL  + 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-------KMSET 335
              I      A+ ++H    PIIHRD+K  N+LL      KL DFG           S +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197

Query: 336 SNMKTMYTENLT--GTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +  + +  E +T   T  Y  PE      +  I  K D+++ G IL  L     P +D  
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (341), Expect = 1e-34
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPI 223
            R        +LG G FG+V  G  +     +++A+K L+      +  +D  E      
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEE------ 382

Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
                E Q + Q  +  ++RL+G+C      +V E    G L+  L        +  +  
Sbjct: 383 --MMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNV 438

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
             +   V+  + YL    K  +HR++ + NVLL      K+ DFG+ K     +  + YT
Sbjct: 439 AELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYT 494

Query: 344 ENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
               G  P     PE ++ +  S+++DV+SYGV + E L+ G KP
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (323), Expect = 4e-34
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 23/236 (9%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +G G +G     +   +G  +  K L    +Y S      +  +       +EV  L +
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQMLV-------SEVNLLRE 61

Query: 236 CKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVA 291
            KH N++R      +  N    IV EY   G L   + +       LD      +   + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 292 EALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++       T + +   G
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKTFVG 178

Query: 349 TRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           T  YM PE M+    + K+D++S G +L EL   M P    +       + E +  
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  128 bits (324), Expect = 4e-34
 Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 46/231 (19%)

Query: 175 GNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
              LG+G F  ++ G  +           E+ +K L+             +A       F
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-------------KAHRNYSESF 59

Query: 227 ENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
                 +S+  H +L+   G+C     N +V E++  GSL   L +  N   ++   +  
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLE 117

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLD--------ENFVPKLGDFGIVKMSETSN 337
           +A  +A A+H+L      +IH +V + N+LL              KL D G   +S    
Sbjct: 118 VAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---IS---- 168

Query: 338 MKTMYTENLTGTR-PYMPPEA-MHCQI-STKTDVFSYGVILLELLT-GMKP 384
             T+  +++   R P++PPE   + +  +  TD +S+G  L E+ + G KP
Sbjct: 169 -ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  129 bits (327), Expect = 4e-34
 Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 26/237 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R  K+GEG FG     K  ++G +  +K +    N S  +S   E +         EV 
Sbjct: 27  VRLQKIGEGSFGKAILVKSTEDGRQYVIKEI----NISRMSSKEREESR-------REVA 75

Query: 232 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
            L+  KH N+++       N  +  IV +Y   G L+ R+           ++     + 
Sbjct: 76  VLANMKHPNIVQYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQ 133

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM-KTMYTENLT 347
           +  AL ++H   + I+HRD+KS N+ L ++   +LGDFGI + ++ T  + +        
Sbjct: 134 ICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-----I 186

Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           GT  Y+ PE    +  + K+D+++ G +L EL T     +  +       ++    P
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  128 bits (325), Expect = 5e-34
 Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 35/228 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
              LG G FG VY G++         +++AVKTL        S  D  +        F  
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELD--------FLM 82

Query: 229 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKR 283
           E   +S+  H N++R +G+   ++   I+ E M  G L         R +    L     
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 340
             +A  +A    YL       IHRD+ + N LL       V K+GDFG+ +    ++   
Sbjct: 143 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--- 197

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +      P  +MPPEA    I ++KTD +S+GV+L E+ + G  P
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  127 bits (322), Expect = 1e-33
 Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 47/244 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V                +AVK L+  A    ++S++     
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRA--- 76

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYD--RLARVNNT 275
                  +E++ L     H+N++ LLG C        ++ E+   G+L    R  R    
Sbjct: 77  -----LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131

Query: 276 P-----------PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 324
           P            L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKI 189

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT- 380
            DFG   ++        Y        P  +M PE +  ++ + ++DV+S+GV+L E+ + 
Sbjct: 190 CDFG---LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

Query: 381 GMKP 384
           G  P
Sbjct: 247 GASP 250

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  127 bits (322), Expect = 2e-33
 Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 54/246 (21%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V              +++AVK L++ A       +      
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEA--- 95

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL--------- 269
                  +E++ +S   +H N++ LLG C +     ++ EY C G L + L         
Sbjct: 96  -----LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150

Query: 270 --ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 327
             A         +      +  VA+ + +L S  K  IHRDV + NVLL    V K+GDF
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDF 208

Query: 328 G----IVKMSETSNMKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELL 379
           G    I        M           R P  +M PE++   + + ++DV+SYG++L E+ 
Sbjct: 209 GLARDI--------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

Query: 380 T-GMKP 384
           + G+ P
Sbjct: 261 SLGLNP 266

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (320), Expect = 2e-33
 Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 48/245 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V              M +AVK L+ +A+ +   +       
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA------- 72

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL--------- 269
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L         
Sbjct: 73  -----LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 270 ------ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
                    ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 185

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT 380
           + DFG   ++      + Y        P   M PE++   + + ++DV+SYG+ L EL +
Sbjct: 186 ICDFG---LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

Query: 381 -GMKP 384
            G  P
Sbjct: 243 LGSSP 247

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  126 bits (319), Expect = 2e-33
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 25/219 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R   K+G GQF  VY    L +G+ +A+K ++    +   ++      +        E+ 
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI---FDLMDAKARADCI-------KEID 84

Query: 232 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIAL 288
            L Q  H N+++     + +N +  IV E    G L   +         +     +   +
Sbjct: 85  LLKQLNHPNVIKYYASFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENL 346
            +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   S+T+   ++     
Sbjct: 144 QLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL----- 196

Query: 347 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
            GT  YM PE +H    + K+D++S G +L E+     P
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (320), Expect = 3e-33
 Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 44/278 (15%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               ++G G FG V+  K  + G + AVK +                  + +     E+ 
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-----------------LEVFR-VEELV 102

Query: 232 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +      ++ L G       +N I  E +  GSL   + ++     L  ++       
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVN-IFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQ 158

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVK-MSETSNMKTMYTEN-L 346
             E L YLH+  + I+H DVK+ NVLL  +     L DFG    +      K++ T + +
Sbjct: 159 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 347 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  +M PE +  +    K D++S   ++L +L G  P            +  +  P+R
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR 276

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKD--KRAS 441
           E+    A    +            +     K+   RAS
Sbjct: 277 EIPPSCAPLTAQ----------AIQEG-LRKEPVHRAS 303

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (321), Expect = 4e-33
 Identities = 66/228 (28%), Positives = 97/228 (42%), Gaps = 35/228 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
              LG G FG VY G++         +++AVKTL        S  D  +        F  
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELD--------FLM 123

Query: 229 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKR 283
           E   +S+  H N++R +G+   ++   I+ E M  G L   L     R +    L     
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 340
             +A  +A    YL       IHRD+ + N LL       V K+GDFG   M+       
Sbjct: 184 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAG 238

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +      P  +MPPEA    I ++KTD +S+GV+L E+ + G  P
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (315), Expect = 5e-33
 Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 39/276 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  +  ++   +A+K L       +                  EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR----------REVEIQ 63

Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           S  +H N+LRL G       +   ++ EY   G++Y  L +++     D  +  +    +
Sbjct: 64  SHLRHPNILRLYGYFHDATRVY--LILEYAPLGTVYRELQKLS---KFDEQRTATYITEL 118

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S    +      GT 
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL-----CGTL 171

Query: 351 PYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            Y+PPE         K D++S GV+  E L G  P + N     Y  +   E    + + 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + A          LIS    +       +R  +R++
Sbjct: 232 EGA--------RDLIS----RLLKHNPSQRPMLREV 255

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  125 bits (315), Expect = 7e-33
 Identities = 46/243 (18%), Positives = 89/243 (36%), Gaps = 47/243 (19%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               K+G G+FG+V+   K  +G   A+K          + S + + A+        EV 
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRS----KKPLAGSVDEQNAL-------REVY 62

Query: 232 TLSQ-CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIA 287
             +   +H +++R       ++ M  I  EY   GSL D ++            +   + 
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHM-LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-------------------KLGDFG 328
           L V   L Y+HS    ++H D+K +N+ +    +P                   K+GD G
Sbjct: 122 LQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS--TKTDVFSYGVILLELLTGMKPID 386
            V     S+ +        G   ++  E +    +   K D+F+  + ++          
Sbjct: 180 HVTR--ISSPQVE-----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232

Query: 387 DNN 389
           + +
Sbjct: 233 NGD 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  127 bits (319), Expect = 7e-33
 Identities = 35/301 (11%), Positives = 89/301 (29%), Gaps = 39/301 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSD--NTEAAMIPILLFENE 229
           +    L  G    V+  + ++   + A+K     A  S S  +  +        LL E+ 
Sbjct: 65  KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124

Query: 230 VQTLSQCKHVNLLRLLGLCN--------------NIMN-CIVYEYMCNGSLYDRLARVNN 274
            +   + + +     + + +               + N  ++     +  L    + ++ 
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDF 183

Query: 275 TP----PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                        + +   +      L S    ++H      N+ +  +    LGD   +
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 387
                +          +    Y P E ++      +   + +  G+ +  +     P   
Sbjct: 242 W-KVGTRGPAS-----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 388 -NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
               I   +      VP  + L   +       V+TLI     +   F++ +R    + +
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG----RFLNFDRRRRLLPLEAM 351

Query: 447 D 447
           +
Sbjct: 352 E 352

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (317), Expect = 8e-33
 Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKL--------KNGMEIAVKTLENNANYSSSNSDNTEA 218
           +PR     G  LGEG FG V   +         K  + +AVK L+++A    +  D ++ 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSD- 86

Query: 219 AMIPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL----------- 265
                    +E++ +    KH N++ LLG C  +    ++ EY   G+L           
Sbjct: 87  -------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139

Query: 266 --YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
             Y           +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           + DFG   ++   N    Y +   G  P  +M PEA+  ++ + ++DV+S+GV++ E+ T
Sbjct: 198 IADFG---LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

Query: 381 -GMKP 384
            G  P
Sbjct: 255 LGGSP 259

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  124 bits (314), Expect = 1e-32
 Identities = 65/299 (21%), Positives = 119/299 (39%), Gaps = 54/299 (18%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 26  KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 73

Query: 227 ENEVQTLSQCKHVNL--LRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            NE+  L++ +  +   +RL         I   +V E   N  L   L +      +D  
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 127

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 128 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSV 183

Query: 342 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 386
             ++  GT  YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +  + L+  +    E+   ++ +K+  +        ++      C   +  +R S+ ++
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEKDLQD--------VLK----CCLKRDPKQRISIPEL 290

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (314), Expect = 2e-32
 Identities = 66/250 (26%), Positives = 108/250 (43%), Gaps = 53/250 (21%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR+    G  LGEG+FG V      +         +AVK L+ NA    S S+  +   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRD--- 72

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD--RLARVNNTPP 277
                  +E   L Q  H ++++L G C  +    ++ EY   GSL    R +R      
Sbjct: 73  -----LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 278 LDSNKRY-------------------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 318
           L S                       S A  +++ + YL      ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAARNILVAE 185

Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 375
               K+ DFG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L
Sbjct: 186 GRKMKISDFG---LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

Query: 376 LELLT-GMKP 384
            E++T G  P
Sbjct: 243 WEIVTLGGNP 252

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (315), Expect = 2e-32
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 24/236 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLE----NNANYSSSNSDNTEAAMIPILLFENEV 230
              L +G+F  +   + K+    A+K  E          + ++++  +       F+NE+
Sbjct: 36  IRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 231 QTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARV-------NNTPPLDSNK 282
           Q ++  K+   L   G+  N     I+YEYM N S+                  P+   K
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  V  +  Y+H+  K I HRDVK +N+L+D+N   KL DFG  +      +K   
Sbjct: 155 CI--IKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS- 210

Query: 343 TENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYY 395
                GT  +MPPE    + S    K D++S G+ L  +   + P     +++  +
Sbjct: 211 ----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (316), Expect = 2e-32
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 58/250 (23%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKL--------KNGMEIAVKTLENNANYSSSNSDNTEA 218
           +PR     G  LGEG FG V   +         K  + +AVK L+++A    +  D ++ 
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSD- 132

Query: 219 AMIPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD--RLARVNN 274
                    +E++ +    KH N++ LLG C  +    ++ EY   G+L +  R  R   
Sbjct: 133 -------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185

Query: 275 T-----------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
                         +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 243

Query: 324 LGDFGIVKMSETSNMKTMYTENL----TGTR-P--YMPPEAMHCQI-STKTDVFSYGVIL 375
           + DFG   ++     + +   +     T  R P  +M PEA+  ++ + ++DV+S+GV++
Sbjct: 244 IADFG---LA-----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295

Query: 376 LELLT-GMKP 384
            E+ T G  P
Sbjct: 296 WEIFTLGGSP 305

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  124 bits (313), Expect = 3e-32
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 63/255 (24%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
           YPR        +GEG FG V+  +            +AVK L+  A      S + +A  
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------SADMQAD- 96

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL-------------- 265
                F+ E   +++  + N+++LLG+C      C+++EYM  G L              
Sbjct: 97  -----FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 266 -------YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                            PPL   ++  IA  VA  + YL       +HRD+ + N L+ E
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE 209

Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTEN--LTGTR---P--YMPPEAMHCQI-STKTDVFS 370
           N V K+ DFG   +S     + +Y+ +          P  +MPPE++     +T++DV++
Sbjct: 210 NMVVKIADFG---LS-----RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261

Query: 371 YGVILLELLT-GMKP 384
           YGV+L E+ + G++P
Sbjct: 262 YGVVLWEIFSYGLQP 276

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (315), Expect = 3e-32
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 44/237 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V   +             ++AVK L+++A    +  D ++         
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSD--------L 121

Query: 227 ENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL-------------YDRLAR 271
            +E++ +    KH N++ LLG C  +    ++ EY   G+L             Y     
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG   
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFG--- 236

Query: 332 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           ++   +    Y +   G  P  +M PEA+  +I + ++DV+S+GV+L E+ T G  P
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  123 bits (311), Expect = 6e-32
 Identities = 65/299 (21%), Positives = 119/299 (39%), Gaps = 54/299 (18%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 7   KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 54

Query: 227 ENEVQTLSQCKHVNL--LRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            NE+  L++ +  +   +RL         I   +V E   N  L   L +      +D  
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 108

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 109 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSV 164

Query: 342 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 386
             ++  GT  YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +  + L+  +    E+   ++ +K+         + ++      C   +  +R S+ ++
Sbjct: 225 NQISKLHAIIDPNHEIEFPDIPEKDL--------QDVLK----CCLKRDPKQRISIPEL 271

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (311), Expect = 1e-31
 Identities = 43/224 (19%), Positives = 86/224 (38%), Gaps = 27/224 (12%)

Query: 173 RRGNKLGEGQ--FGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
                +G+G     TV   +    G  + V+ +         N +     M+  L    E
Sbjct: 28  ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI---------NLEACSNEMVTFLQ--GE 76

Query: 230 VQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +       H N++      + +N +  +V  +M  GS  D L   +    ++      I 
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNEL-WVVTSFMAYGSAKD-LICTHFMDGMNELAIAYIL 134

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNMKTMYT 343
            GV +AL Y+H +    +HR VK++++L+  +    L        ++   +   +   + 
Sbjct: 135 QGVLKALDYIHHMGY--VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 344 ENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKP 384
           +      P++ PE +   +     K+D++S G+   EL  G  P
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  121 bits (306), Expect = 1e-31
 Identities = 57/250 (22%), Positives = 90/250 (36%), Gaps = 54/250 (21%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   +   +    A+K +           +             +EV  L
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKI-------RHTEEKLSTI-------LSEVMLL 56

Query: 234 SQCKHVNLLRLLGLCNNIMN--------------CIVYEYMCNGSLYDRLARVNNTPPLD 279
           +   H  ++R         N               I  EY  NG+LYD +   N      
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQ 114

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++ + +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K    S   
Sbjct: 115 RDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 340 TMYTENLT-----------GTRPYMPPEAMHCQIS------TKTDVFSYGVILLELLTGM 382
                              GT  Y+  E     +        K D++S G+I  E++   
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATE----VLDGTGHYNEKIDMYSLGIIFFEMIYPF 228

Query: 383 KPIDDNNTIL 392
               +   IL
Sbjct: 229 STGMERVNIL 238

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (311), Expect = 1e-31
 Identities = 64/299 (21%), Positives = 118/299 (39%), Gaps = 54/299 (18%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 54  KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 101

Query: 227 ENEVQTLSQCKHVNL--LRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            NE+  L++ +  +   +RL         I   +V E   N  L   L +      +D  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 155

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 156 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSV 211

Query: 342 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 386
             ++  G   YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +  + L+  +    E+   ++ +K+         + ++      C   +  +R S+ ++
Sbjct: 272 NQISKLHAIIDPNHEIEFPDIPEKDL--------QDVLK----CCLKRDPKQRISIPEL 318

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (308), Expect = 2e-31
 Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 61/268 (22%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V              +++AVK L+  A     +S+      
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREA--- 94

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD----------- 267
                  +E++ ++Q   H N++ LLG C  +    +++EY C G L +           
Sbjct: 95  -----LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 268 ---------RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                    RL    +   L        A  VA+ + +L    K  +HRD+ + NVL+  
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTH 207

Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 375
             V K+ DFG   ++      + Y        P  +M PE++   I + K+DV+SYG++L
Sbjct: 208 GKVVKICDFG---LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

Query: 376 LELLT-GMKPIDDNNTILYYYLVVEQEV 402
            E+ + G+ P        Y  + V+   
Sbjct: 265 WEIFSLGVNP--------YPGIPVDANF 284

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  119 bits (301), Expect = 7e-31
 Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 26/219 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG+G +G VY G+ L N + IA+K +         +S  ++           E+ 
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQP-------LHEEIA 71

Query: 232 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
                KH N+++ LG    N  +  I  E +  GSL   L         +          
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TG
Sbjct: 131 ILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTG 185

Query: 349 TRPYMPPEAMHCQI---STKTDVFSYGVILLELLTGMKP 384
           T  YM PE +           D++S G  ++E+ TG  P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  121 bits (305), Expect = 7e-31
 Identities = 34/310 (10%), Positives = 86/310 (27%), Gaps = 61/310 (19%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN--- 228
            RG  LG+            + G    V          S+     +  ++ + L      
Sbjct: 76  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135

Query: 229 ------------EVQTLSQCKHVNLLRLLGLCNN--IMNCIVYEYMCNGSLYDRL----A 270
                           +   +   ++R+     +  +++          +L        +
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195

Query: 271 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
             +    L  + R  + L V   L  LH     ++H  ++  +++LD+     L  F  +
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQI------------STKTDVFSYGVILLEL 378
                  +        + +R + PPE    +             +   D ++ G+++  +
Sbjct: 254 VRDGARVV-------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 379 LTGMKPIDDNNTILYYYLVVEQEVPV-REVLDKEAGEWNETHVETLISIVFEKCCVFEKD 437
                PI  +  +     +      + + V               L+         + K+
Sbjct: 307 WCADLPITKDAALGGSEWIFRSCKNIPQPVRA-------------LLE----GFLRYPKE 349

Query: 438 KRASMRDIVD 447
            R      ++
Sbjct: 350 DRLLPLQAME 359

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (306), Expect = 8e-31
 Identities = 36/275 (13%), Positives = 78/275 (28%), Gaps = 46/275 (16%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            RG  LG+            + G    V          S+     +  ++ + L      
Sbjct: 81  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 232 TLSQCKHVNLLRLLGLCNN-----------------IMNCIVYEYMCNGSLYDRL----A 270
                 H+  +    L  +                 +++          +L        +
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 271 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
             +    L  + R  + L V   L  LH     ++H  ++  +++LD+     L  F  +
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-----------STKTDVFSYGVILLELL 379
                S +           R + PPE    ++           +   D ++ G+ +  + 
Sbjct: 259 VRDGASAV-------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 380 TGMKPIDDNNTILYYYLVVEQEV----PVREVLDK 410
               P  D+  +     +         PVR +L+ 
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (306), Expect = 1e-30
 Identities = 45/222 (20%), Positives = 82/222 (36%), Gaps = 32/222 (14%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             + LG G  GT+ Y  + +  ++AVK +           +    A       + EVQ L
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRDVAVKRI---------LPECFSFA-------DREVQLL 71

Query: 234 SQC-KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            +  +H N++R      +     I  E  C  +L + +            +  ++     
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATLQEYV--EQKDFAHLGLEPITLLQQTT 128

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKTMYTENL 346
             L +LHSL+  I+HRD+K  N+L+            + DFG+ K              +
Sbjct: 129 SGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 347 TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKP 384
            GT  ++ PE          +   D+FS G +   +++    
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (307), Expect = 2e-30
 Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 28/227 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             KLG G +G V   K K    E A+K ++ +       SD+ +          NE+  L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N+++L  +  +     +V E+   G L++++          +  ++       I
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---------INRHKFDECDAANI 151

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              +   + YLH  +  I+HRD+K  N+LL   +     K+ DFG+    S+   ++   
Sbjct: 152 MKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR- 208

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +  + + K DV+S GVI+  LL G  P    N
Sbjct: 209 ----LGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  117 bits (296), Expect = 3e-30
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 35/229 (15%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  +  +N   +A+K L  +                       E++  
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR----------REIEIQ 68

Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           S  +H N+LR+         I   ++ E+   G LY  L +        S   +     +
Sbjct: 69  SHLRHPNILRMYNYFHDRKRI--YLMLEFAPRGELYKELQKHGRFDEQRS-ATF--MEEL 123

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A+ALHY H   + +IHRD+K  N+L+      K+ DFG    + +   +TM      GT 
Sbjct: 124 ADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM-----CGTL 176

Query: 351 PYMPPEAMHCQISTKT-----DVFSYGVILLELLTGMKPIDDNNTILYY 394
            Y+PPE     I  KT     D++  GV+  E L GM P D  +    +
Sbjct: 177 DYLPPEM----IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (297), Expect = 8e-30
 Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 37/283 (13%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           ++LG G  G V+    K +G+ +A K +         + +   A    I+    E+Q L 
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQII---RELQVLH 86

Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +C    ++   G   ++    I  E+M  GSL   L +      +       +++ V + 
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKG 143

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YL    K I+HRDVK +N+L++     KL DFG+      S   +       GTR YM
Sbjct: 144 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYM 197

Query: 354 PPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +     S ++D++S G+ L+E+  G  PI   +                  L    
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-------------AKELELMFGC 244

Query: 413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
               +            +              I +LL   VN 
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (305), Expect = 9e-30
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 32/242 (13%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V        G ++A+K           +  N E        +  E+Q +
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCR-----QELSPKNRER-------WCLEIQIM 66

Query: 234 SQCKHVNLLRLL-------GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            +  H N++           L  N +  +  EY   G L   L +  N   L      ++
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVK-MSETSNMKTMY 342
              ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K + +        
Sbjct: 127 LSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +   D +S+G +  E +TG +P   N   + ++  V ++
Sbjct: 185 -----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239

Query: 402 VP 403
             
Sbjct: 240 SN 241

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (294), Expect = 1e-29
 Identities = 72/283 (25%), Positives = 113/283 (39%), Gaps = 44/283 (15%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LS 234
           ++G G +G+V     K +G  +AVK +          S   E     +L    ++   + 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI---------RSTVDEKEQKQLL---MDLDVVMR 76

Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY--SIALGVA 291
                 +++  G L       I  E M + S       V +       +     I L   
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATV 135

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT       G RP
Sbjct: 136 KALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----RDAGCRP 190

Query: 352 YMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYY-YLVVEQEVPVR 405
           YM PE +           ++DV+S G+ L EL TG  P    N++      VV+ + P  
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP-- 248

Query: 406 EVLDKEAGEWNETHVETLISIVF----EKCCVFEKDKRASMRD 444
           ++ + E  E+         S  F      C   ++ KR   ++
Sbjct: 249 QLSNSEEREF---------SPSFINFVNLCLTKDESKRPKYKE 282

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (293), Expect = 1e-29
 Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 37/234 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG+G    V+ G+ K  G   A+K   N      S     +       +   E + L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVD-------VQMREFEVL 61

Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +  H N+++L  +          ++ E+   GSLY  L   +N   L  ++   +   V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y   
Sbjct: 122 VGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 346 LTGTRPYMPPE---------AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
             GT  Y+ P+             +     D++S GV      TG  P      
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (292), Expect = 2e-29
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 32/232 (13%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
           NR  Y      +G G    V          ++A+K +            N E     +  
Sbjct: 13  NRDDY-ELQEVIGSGATAVVQAAYCAPKKEKVAIKRI------------NLEKCQTSMDE 59

Query: 226 FENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYD-----RLARVNNTPPL 278
              E+Q +SQC H N++      +  + +  +V + +  GS+ D          + +  L
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSN 337
           D +   +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+   ++   +
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 338 MKTMYTEN-LTGTRPY-MPPEAMHCQIS---TKTDVFSYGVILLELLTGMKP 384
           +          GT P  M PE M  Q+     K D++S+G+  +EL TG  P
Sbjct: 177 ITRNKVRKTFVGT-PCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAP 226

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  113 bits (286), Expect = 8e-29
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +LG G +G V   +   +G  +AVK +    N          +     LL + ++ ++ 
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----------SQEQKRLLMDLDI-SMR 61

Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALGVAE 292
                  +   G L       I  E M + SL     +V +    +  +    IA+ + +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LHS    +IHRDVK +NVL++     K+ DFGI         K +      G +PY
Sbjct: 121 ALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKPY 175

Query: 353 MPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTIL 392
           M PE ++ ++     S K+D++S G+ ++EL     P D   T  
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  117 bits (294), Expect = 1e-28
 Identities = 66/227 (29%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   K K  G E AVK +        ++ ++             EVQ L
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES----------LLREVQLL 80

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            Q  H N+++L     +     +V E    G L+D +          S KR+S      I
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---------SRKRFSEVDAARI 131

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + Y+H     I+HRD+K  N+LL    ++   ++ DFG+      +  MK   
Sbjct: 132 IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK- 188

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 189 ----IGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (290), Expect = 1e-28
 Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 37/234 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG+G    V+ G+ K  G   A+K   N      S     +       +   E + L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVD-------VQMREFEVL 61

Query: 234 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +  H N+++L  +          ++ E+   GSLY  L   +N   L  ++   +   V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y   
Sbjct: 122 VGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 346 LTGTRPYMPPE---------AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
             GT  Y+ P+             +     D++S GV      TG  P      
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (285), Expect = 1e-28
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +LG+G FG VY  K  + G   A K +E  +       +  E        +  E++ L+
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELE-------DYIVEIEILA 71

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            C H  +++LLG    +  +  I+ E+   G++   +  ++    L   +   +   + E
Sbjct: 72  TCDHPYIVKLLGAYYHDGKL-WIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLE 128

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTR 350
           AL++LHS     IHRD+K+ NVL+      +L DFG+  K  +T     +       GT 
Sbjct: 129 ALNFLHSKRI--IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGT- 180

Query: 351 PY-MPPEAMHCQIS------TKTDVFSYGVILLELLTGMKP 384
           PY M PE + C+         K D++S G+ L+E+     P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  116 bits (293), Expect = 2e-28
 Identities = 62/227 (27%), Positives = 94/227 (41%), Gaps = 39/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             KLG G +G V   + K   +E A+K +   +  +SSNS               EV  L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-----------LLEEVAVL 90

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N+++L     +  N  +V E    G L+D +             +++      I
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---------HRMKFNEVDAAVI 141

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + YLH  +  I+HRD+K  N+LL   +++ + K+ DFG+         MK   
Sbjct: 142 IKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER- 198

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +  +   K DV+S GVIL  LL G  P     
Sbjct: 199 ----LGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT 241

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  112 bits (282), Expect = 2e-28
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 34/227 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + GN LG+G F  VY  + +  G+E+A+K ++  A Y +                +NEV+
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----------VQNEVK 63

Query: 232 TLSQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
              Q KH ++L L       N +   +V E   NG +   L   N   P   N+      
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVY--LVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH 119

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG--IVKMSETSNMKTMYTENL 346
            +   + YLHS    I+HRD+  +N+LL  N   K+ DFG             T+     
Sbjct: 120 QIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL----- 172

Query: 347 TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            GT  Y+ PE    + H     ++DV+S G +   LL G  P D + 
Sbjct: 173 CGTPNYISPEIATRSAH---GLESDVWSLGCMFYTLLIGRPPFDTDT 216

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (281), Expect = 7e-28
 Identities = 56/225 (24%), Positives = 85/225 (37%), Gaps = 29/225 (12%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-S 234
           ++G G  G V+  + +  G  IAVK +              +     IL    ++  +  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQM---------RRSGNKEENKRIL---MDLDVVLK 79

Query: 235 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
                 +++  G    N    I  E M          R+    P+       + + + +A
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKA 136

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L+YL      +IHRDVK +N+LLDE    KL DFGI         K        G   YM
Sbjct: 137 LYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCAAYM 191

Query: 354 PPEAMHCQI------STKTDVFSYGVILLELLTGMKPIDDNNTIL 392
            PE +            + DV+S G+ L+EL TG  P  +  T  
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 7e-28
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 36/227 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             KLG G FG V+  + + +G+E  +KT+            N + + +P+   E E++ L
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTI------------NKDRSQVPMEQIEAEIEVL 74

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N++++  +  +  N  IV E    G L +R+            K  S      +
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA-----RGKALSEGYVAEL 129

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              +  AL Y HS    ++H+D+K  N+L      +   K+ DFG+        +     
Sbjct: 130 MKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA- 186

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  YM PE     ++ K D++S GV++  LLTG  P    +
Sbjct: 187 ----AGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  111 bits (280), Expect = 7e-28
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 32/215 (14%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+ G   +    +A+K +    +   +  +        I   + E+  LSQ
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKII----DLEEAEDE--------IEDIQQEITVLSQ 76

Query: 236 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           C    + +  G  L +  +  I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 77  CDSPYVTKYYGSYLKDTKL-WIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 131

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMK-TMYTENLTGTRP 351
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+  ++++T   + T       GT P
Sbjct: 132 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-----VGT-P 183

Query: 352 Y-MPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           + M PE +      +K D++S G+  +EL  G  P
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  113 bits (284), Expect = 1e-27
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 36/231 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G  G V     +    ++A++ +        S  +   A  +     E E++ L
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV-----ETEIEIL 194

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IA 287
            +  H  ++++    +     IV E M  G L+D++           NKR          
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYF 245

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYT 343
             +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG    + ETS M+T+  
Sbjct: 246 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 301

Query: 344 ENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
               GT  Y+ PE          +   D +S GVIL   L+G  P  ++ T
Sbjct: 302 ---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (280), Expect = 1e-27
 Identities = 59/273 (21%), Positives = 96/273 (35%), Gaps = 59/273 (21%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV----- 230
            +G G FG V+  K K +    A+K +       +      E   +  L     V     
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 231 -------------------------------QTLSQCKHVNLLRLLGLCNNIMN------ 253
                                             +    +  +      N +        
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 254 ----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 309
                I  +     +L D + R  +    +      I + +AEA+ +LHS  K ++HRD+
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDL 190

Query: 310 KSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT--------GTRPYMPPEAMHC 360
           K +N+    + V K+GDFG+V  M +    +T+ T            GT+ YM PE +H 
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 361 QI-STKTDVFSYGVILLELLTGMKPIDDNNTIL 392
              S K D+FS G+IL ELL       +   I+
Sbjct: 251 NNYSHKVDIFSLGLILFELLYSFSTQMERVRII 283

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  113 bits (285), Expect = 2e-27
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   K +    E AVK +   +  +   S               EV+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----------ILREVELL 75

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            +  H N+++L  +  +  +  IV E    G L+D +            KR+S      I
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---------KRKRFSEHDAARI 126

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + MK   
Sbjct: 127 IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR- 183

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 184 ----IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (276), Expect = 4e-27
 Identities = 55/251 (21%), Positives = 87/251 (34%), Gaps = 48/251 (19%)

Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEA 218
           E   D  +R+ Y  RG  LG+G F   +           A K +  +        +    
Sbjct: 32  EVLVDPRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--- 87

Query: 219 AMIPILLFENEVQTLSQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNT 275
                     E+       H +++   G     + +   +V E     SL +   R    
Sbjct: 88  -------MSMEISIHRSLAHQHVVGFHGFFEDNDFV--FVVLELCRRRSLLELHKR---- 134

Query: 276 PPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI 329
                 K  +          +     YLH     +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGL 187

Query: 330 --VKMSETSNMKTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMK 383
                 +    K +      GT  Y+ PE      H   S + DV+S G I+  LL G  
Sbjct: 188 ATKVEYDGERKKVL-----CGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKP 239

Query: 384 PIDDNNTILYY 394
           P + +     Y
Sbjct: 240 PFETSCLKETY 250

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (280), Expect = 5e-27
 Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 52/247 (21%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              LG G  GTV +     G  +AVK +           D  + A         E++ L+
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIA-------LMEIKLLT 63

Query: 235 QCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV-- 290
           +   H N++R            I  E  CN +L D +   N +      ++    + +  
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122

Query: 291 --AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKM--- 332
             A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K    
Sbjct: 123 QIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 333 SETSNMKTMYTENLTGTRPYMPPE--------AMHCQISTKTDVFSYGVILLELLT-GMK 383
            ++S    +     +GT  +  PE            +++   D+FS G +   +L+ G  
Sbjct: 181 GQSSFRTNLNN--PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 384 PIDDNNT 390
           P  D  +
Sbjct: 239 PFGDKYS 245

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  108 bits (273), Expect = 5e-27
 Identities = 56/248 (22%), Positives = 87/248 (35%), Gaps = 48/248 (19%)

Query: 163 TDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMI 221
            D  +R+ Y  RG  LG+G F   +           A K +      S     +    M 
Sbjct: 9   VDPRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKM- 62

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
                  E+       H +++   G     + +   +V E     SL +   R       
Sbjct: 63  -----SMEISIHRSLAHQHVVGFHGFFEDNDFV--FVVLELCRRRSLLELHKR------- 108

Query: 279 DSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--V 330
              K  +          +     YLH     +IHRD+K  N+ L+E+   K+GDFG+   
Sbjct: 109 --RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPID 386
              +    K +      GT  Y+ PE      H   S + DV+S G I+  LL G  P +
Sbjct: 165 VEYDGERKKVL-----CGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFE 216

Query: 387 DNNTILYY 394
            +     Y
Sbjct: 217 TSCLKETY 224

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (271), Expect = 8e-27
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   K +    E AVK +   +  +   S               EV+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----------ILREVELL 75

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            +  H N+++L  +  +  +  IV E    G L+D +            KR+S      I
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---------KRKRFSEHDAARI 126

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + MK   
Sbjct: 127 IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR- 183

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 184 ----IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (269), Expect = 1e-26
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 41/227 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            N +G G +G V     K   +  A K +           ++ +        F+ E++ +
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDR-------FKQEIEIM 60

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N++RL     +  +  +V E    G L++R+            + +       I
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV---------HKRVFRESDAARI 111

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V  A+ Y H L+  + HRD+K  N L      +   KL DFG+  +      M+T  
Sbjct: 112 MKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK- 168

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ P+ +      + D +S GV++  LL G  P     
Sbjct: 169 ----VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPT 211

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  108 bits (271), Expect = 2e-26
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G G FG VY+ + ++N   +A+K +  +           + +         EV+ L 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYS----------GKQSNEKWQDIIKEVRFLQ 109

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + +H N ++  G  L  +    +V EY C GS  D L    +  PL   +  ++  G  +
Sbjct: 110 KLRHPNTIQYRGCYLREHTA-WLVMEY-CLGSASDLL--EVHKKPLQEVEIAAVTHGALQ 165

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L YLHS +   IHRDVK+ N+LL E  + KLGDFG    S  +   +       GT PY
Sbjct: 166 GLAYLHSHNM--IHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANSF-----VGT-PY 215

Query: 353 -MPPEAMHCQIST----KTDVFSYGVILLELLTGMKP 384
            M PE +          K DV+S G+  +EL     P
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>1d2z_B Death domain of tube; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 Length = 153

 Score =  103 bits (257), Expect = 2e-26
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 17/133 (12%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIV---------------TVDCDPLKPL 51
            + + E+R ++   ++ L  IL+E   W+K+MSI+                   +  K  
Sbjct: 5   YSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGF 64

Query: 52  KYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAAR 109
           KY+A+D+  ++ A  R  P++  + + +DEW TSG+   RP +  L+  L +AEL  AA 
Sbjct: 65  KYTAQDVFQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAAD 124

Query: 110 YVEVDVLKKPESP 122
           +V +D L +    
Sbjct: 125 FVALDFLNESTPA 137

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (270), Expect = 3e-26
 Identities = 57/262 (21%), Positives = 85/262 (32%), Gaps = 59/262 (22%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G+G +G V            A+K +  N     +  D            + EV+ +
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI--------KTEVRLM 82

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--- 289
            +  H N+ RL  +  +    C+V E    G L D+L    +                  
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 290 ----------------------------------VAEALHYLHSLSKPIIHRDVKSANVL 315
                                             +  ALHYLH+    I HRD+K  N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFL 200

Query: 316 L--DENFVPKLGDFG---IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTD 367
              +++F  KL DFG               M T    GT  ++ PE ++        K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT--KAGTPYFVAPEVLNTTNESYGPKCD 258

Query: 368 VFSYGVILLELLTGMKPIDDNN 389
            +S GV+L  LL G  P    N
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVN 280

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  110 bits (276), Expect = 5e-26
 Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 37/217 (17%)

Query: 177 KLGEGQFGTVYYGK--LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +  G  G +Y       NG  + +K L         +S + EA  +       E Q L+
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGL--------VHSGDAEAQAM----AMAERQFLA 134

Query: 235 QCKHVNLLRLL------GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +  H +++++           + +  IV EY+   SL     +      L   +  +  L
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLL 189

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 347
            +  AL YLHS    +++ D+K  N++L E  + KL D G V  ++    +         
Sbjct: 190 EILPALSYLHS--IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL--------Y 238

Query: 348 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
           GT  +  PE +    +  TD+++ G  L  L   +  
Sbjct: 239 GTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  106 bits (267), Expect = 5e-26
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            KLGEG +G+VY     + G  +A+K +   ++                     E+  + 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE---------------IIKEISIMQ 79

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           QC   ++++  G    N  +  IV EY   GS+ D +   N    L  ++  +I     +
Sbjct: 80  QCDSPHVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLK 136

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSET-SNMKTMYTENLTGTR 350
            L YLH + K  IHRD+K+ N+LL+     KL DFG+  ++++T +   T+      GT 
Sbjct: 137 GLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-----IGT- 188

Query: 351 PY-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           P+ M PE       +   D++S G+  +E+  G  P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (267), Expect = 6e-26
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 36/231 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G  G V     +    ++A+K +        S  +   A  +     E E++ L
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV-----ETEIEIL 69

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IA 287
            +  H  ++++    +     IV E M  G L+D++           NKR          
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYF 120

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYT 343
             +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG    + ETS M+T+  
Sbjct: 121 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176

Query: 344 ENLTGTRPYMPPEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNT 390
               GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 177 ---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 7e-26
 Identities = 62/226 (27%), Positives = 92/226 (40%), Gaps = 41/226 (18%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +G G +G VY G+ +K G   A+K ++          D  E         + E+  L +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-------GDEEE-------EIKQEINMLKK 76

Query: 236 -CKHVNLLRLLG--LCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
              H N+    G  +  N         +V E+   GS+ D L +      L       I 
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYIC 135

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTEN 345
             +   L +LH      IHRD+K  NVLL EN   KL DFG+  ++  T     T     
Sbjct: 136 REILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---- 189

Query: 346 LTGTRPY-MPPEAMHCQIS------TKTDVFSYGVILLELLTGMKP 384
             GT PY M PE + C  +       K+D++S G+  +E+  G  P
Sbjct: 190 -IGT-PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (266), Expect = 8e-26
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 33/216 (15%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+GEG  G V   +   +G ++AVK ++             E       L  NEV  + 
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLR------KQQRRE-------LLFNEVVIMR 97

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             +H N++ +    L    +  ++ E++  G+L D +++V     L+  +  ++   V +
Sbjct: 98  DYQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQ 152

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTR 350
           AL YLH+     IHRD+KS ++LL  +   KL DFG   ++S+     K++      GT 
Sbjct: 153 ALAYLHAQGV--IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-----VGT- 204

Query: 351 PY-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           PY M PE       +T+ D++S G++++E++ G  P
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (264), Expect = 1e-25
 Identities = 63/246 (25%), Positives = 95/246 (38%), Gaps = 39/246 (15%)

Query: 161 RATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAA 219
            +T GF    Y      LG G    V     K    E AVK ++     S S  +  E  
Sbjct: 10  HSTHGFYEN-Y-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67

Query: 220 MIPILLFENEVQTLSQ-CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 277
                    EV  L +   H N+++L           +V++ M  G L+D L        
Sbjct: 68  E----ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT------- 116

Query: 278 LDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-V 330
                  S      I   + E +  LH L+  I+HRD+K  N+LLD++   KL DFG   
Sbjct: 117 --EKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 172

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-------DVFSYGVILLELLTGMK 383
           ++     ++      + GT  Y+ PE + C ++          D++S GVI+  LL G  
Sbjct: 173 QLDPGEKLRE-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

Query: 384 PIDDNN 389
           P     
Sbjct: 228 PFWHRK 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (263), Expect = 1e-25
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 33/216 (15%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+G+G  GTVY    +  G E+A++ +              E       L  NE+  + 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ------QQPKKE-------LIINEILVMR 72

Query: 235 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + K+ N++  L   L  + +  +V EY+  GSL D +        +D  +  ++     +
Sbjct: 73  ENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQ 127

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTR 350
           AL +LHS     IHRD+KS N+LL  +   KL DFG   +++   S   TM      GT 
Sbjct: 128 ALEFLHSNQV--IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-----VGT- 179

Query: 351 PY-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           PY M PE         K D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (260), Expect = 3e-25
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 37/229 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++     SS    + E         E EV  L
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 62

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++ L  +  N  +  ++ E +  G L+D LA           +  +       
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---------EKESLTEDEATQF 113

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTM 341
              + + +HYLHS    I H D+K  N++L +  VP    KL DFGI  K+   +  K +
Sbjct: 114 LKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P     
Sbjct: 172 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (260), Expect = 6e-25
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 25/223 (11%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G+E A K ++   + +S    + E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L  +  N  +  ++ E +  G L+D LA+  +    ++         + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQILD 126

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTMYTENLT 347
            ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K ++     
Sbjct: 127 GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----- 179

Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (259), Expect = 1e-24
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 22/227 (9%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G+G F  V     +  G + AVK + + A ++SS   +TE         + E    
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTED-------LKREASIC 80

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVA 291
              KH +++ LL   ++     +V+E+M    L   +  R +                + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYTENLT 347
           EAL Y H  +  IIHRDVK   VLL   + +   KLG FG+ +++ E+            
Sbjct: 141 EALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGG--RV 194

Query: 348 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILY 393
           GT  +M PE +  +      DV+  GVIL  LL+G  P       L+
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  104 bits (260), Expect = 1e-24
 Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 40/289 (13%)

Query: 118 KPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNK 177
             + P  +       +++   +    +  Y   +          A   F +K Y    + 
Sbjct: 44  LRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK-Y-DPKDV 101

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G    V     +  G E AVK +E  A   S                  E   L Q 
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT-----RRETHILRQV 156

Query: 237 K-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IAL 288
             H +++ L+    +     +V++ M  G L+D L               S      I  
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---------EKVALSEKETRSIMR 207

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLT 347
            + EA+ +LH+ +  I+HRD+K  N+LLD+N   +L DFG    +     ++      L 
Sbjct: 208 SLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-----LC 260

Query: 348 GTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  Y+ PE + C +         + D+++ GVIL  LL G  P     
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  100 bits (252), Expect = 3e-24
 Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 40/228 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG+G F  V     K  G+E A K +    N    ++ + +         E E +  
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQK-------LEREARIC 59

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++RL           +V++ +  G L++ +          + + YS       
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---------AREFYSEADASHC 110

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++       
Sbjct: 111 IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF- 167

Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +     S   D+++ GVIL  LL G  P  D +
Sbjct: 168 ----AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (253), Expect = 4e-24
 Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 60/302 (19%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLE-------------NNANYSSSNSDNTEAAM 220
            +++G+G +G V       +    A+K L                   +           
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 221 IPILLFENEVQTLSQCKHVNLLRL---LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 277
            PI     E+  L +  H N+++L   L   N     +V+E +  G + +         P
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KP 133

Query: 278 LDSNK--RY--SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
           L  ++   Y   +  G+     YLH     IIHRD+K +N+L+ E+   K+ DFG   +S
Sbjct: 134 LSEDQARFYFQDLIKGI----EYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFG---VS 184

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDD 387
                      N  GT  +M PE+     + K       DV++ GV L   + G  P  D
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPES--LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

Query: 388 NNTILYYYLVVEQEV--PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKD--KRASMR 443
              +  +  +  Q +  P +  + ++         + LI+       + +K+   R  + 
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDL--------KDLIT------RMLDKNPESRIVVP 288

Query: 444 DI 445
           +I
Sbjct: 289 EI 290

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 4e-24
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G++ A K ++     SS    + E         E EV  L
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-------IEREVSIL 68

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++ L  +  N  +  ++ E +  G L+D LA           +  +       
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---------EKESLTEEEATEF 119

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGI-VKMSETSNMKTM 341
              +   ++YLHSL   I H D+K  N++L          K+ DFG+  K+   +  K +
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177

Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 178 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  101 bits (254), Expect = 5e-24
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 37/229 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G+E A K ++   + +S      E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-------IEREVSIL 69

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            Q  H N++ L  +  N  +  ++ E +  G L+D LA           +  S       
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---------QKESLSEEEATSF 120

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTM 341
              + + ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K +
Sbjct: 121 IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178

Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 179 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  100 bits (251), Expect = 5e-24
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 22/232 (9%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLG G   TVY  +     +++A+K +           +  E     +  FE EV   SQ
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAI--FIPPR----EKEET----LKRFEREVHNSSQ 67

Query: 236 CKHVNLLRLL--GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             H N++ ++     ++    +V EY+   +L + +       PL  +   +    + + 
Sbjct: 68  LSHQNIVSMIDVDEEDDC-YYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDG 123

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + + H     I+HRD+K  N+L+D N   K+ DFGI K    +++    T ++ GT  Y 
Sbjct: 124 IKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--TQTNHVLGTVQYF 179

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            PE A        TD++S G++L E+L G  P +    +      ++  VP 
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 41/227 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G F  V+  K +  G   A+K ++ +    +    +           ENE+  L
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSS----------LENEIAVL 60

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + KH N++ L  +  +  +  +V + +  G L+DR+              Y+      +
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---------ERGVYTEKDASLV 111

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
              V  A+ YLH     I+HRD+K  N+L    +EN    + DFG+ KM +   M T   
Sbjct: 112 IQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-- 167

Query: 344 ENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
               GT  Y+ PE +  +  S   D +S GVI   LL G  P  +  
Sbjct: 168 ---CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 57/251 (22%), Positives = 97/251 (38%), Gaps = 59/251 (23%)

Query: 166 FNRKPYPRRGN----------KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSD 214
             + P P++             LG G  G V     +  G + A+K L ++         
Sbjct: 15  LFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------- 66

Query: 215 NTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDR 268
                         EV    Q     +++ +L +  N+ +      I+ E M  G L+ R
Sbjct: 67  ----------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116

Query: 269 LARVNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DEN 319
           +           ++ ++      I   +  A+ +LHS +  I HRDVK  N+L    +++
Sbjct: 117 IQER-------GDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKD 167

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLEL 378
            V KL DFG  K +  + ++T        T  Y+ PE +  +      D++S GVI+  L
Sbjct: 168 AVLKLTDFGFAKETTQNALQTP-----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222

Query: 379 LTGMKPIDDNN 389
           L G  P   N 
Sbjct: 223 LCGFPPFYSNT 233

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 40/228 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG+G F  V     K  G+E A K +      ++      +   +     E E +  
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKII------NTKKLSARDFQKL-----EREARIC 82

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++RL           +V++ +  G L++ +            + YS       
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---------EFYSEADASHC 133

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++       
Sbjct: 134 IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF- 190

Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +     S   D+++ GVIL  LL G  P  D +
Sbjct: 191 ----AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 46/227 (20%), Positives = 89/227 (39%), Gaps = 41/227 (18%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G+FG V+      +      K +          +D            + E+  L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVL--------VKKEISIL 55

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
           +  +H N+L L     ++    +++E++    +++R+          S    +       
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI--------NTSAFELNEREIVSY 107

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNMKTMYT 343
              V EAL +LHS +  I H D++  N++     +   K+ +FG   ++    N + ++ 
Sbjct: 108 VHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF- 164

Query: 344 ENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                   Y  PE   H  +ST TD++S G ++  LL+G+ P     
Sbjct: 165 ----TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG G    V+  + L++  ++AVK L   A+ +     +        L F  E Q  
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLA----RDPSF----YLRFRREAQNA 66

Query: 234 SQCKHVNLLRLL--GLCNNIMNCIVY---EYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +   H  ++ +   G        + Y   EY+   +L D +       P+   +   +  
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIA 123

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
              +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  + G
Sbjct: 124 DACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 349 TRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           T  Y+ PE A    +  ++DV+S G +L E+LTG  P
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 42/229 (18%)

Query: 174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +   LG G+FG V+  +    G+++A K +       +    + E         +NE+  
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKII------KTRGMKDKEE-------VKNEISV 139

Query: 233 LSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------ 285
           ++Q  H NL++L     +  +  +V EY+  G L+DR+        +D +   +      
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--------IDESYNLTELDTIL 191

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTM 341
               + E + ++H +   I+H D+K  N+L    D   + K+ DFG+  +      +K  
Sbjct: 192 FMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVN 248

Query: 342 YTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE   +  +S  TD++S GVI   LL+G+ P   +N
Sbjct: 249 F-----GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 39/233 (16%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           Y     +LG G+F  V     K  G E A K L           D             +E
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFL----KKRRRGQDCRAE-------ILHE 78

Query: 230 VQTLSQCKHV-NLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-- 285
           +  L   K    ++ L  +  N     ++ EY   G ++            +  +  S  
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP-------ELAEMVSEN 131

Query: 286 ----IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSN 337
               +   + E ++YLH  +  I+H D+K  N+LL         K+ DFG+  K+     
Sbjct: 132 DVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

Query: 338 MKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           ++ +      GT  Y+ PE ++   I+T TD+++ G+I   LLT   P    +
Sbjct: 190 LREI-----MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 99.1 bits (247), Expect = 2e-22
 Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 42/228 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V+    +  G   A K +       + +  + E           E+QT+
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFV------MTPHESDKET-------VRKEIQTM 208

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
           S  +H  L+ L     +     ++YE+M  G L++++         D + + S       
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--------ADEHNKMSEDEAVEY 260

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V + L ++H  +   +H D+K  N++      N + KL DFG+   +    ++K   
Sbjct: 261 MRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTT 317

Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 318 -----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 40/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V+    K  G     K +      ++    +           +NE+  +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYT-------VKNEISIM 102

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
           +Q  H  L+ L     +     ++ E++  G L+DR+           + + S       
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--------AAEDYKMSEAEVINY 154

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNMKTMYT 343
                E L ++H  S  I+H D+K  N++    +    K+ DFG+  K++    +K    
Sbjct: 155 MRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT- 211

Query: 344 ENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
                T  +  PE +  + +   TD+++ GV+   LL+G+ P    +
Sbjct: 212 ----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 12/153 (7%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +    +    L   L R     PL   +  +I   +  AL   H+      HRDVK  N+
Sbjct: 111 VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENI 165

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGV 373
           L+  +    L DFGI   +    + T    N  GT  YM PE       + + D+++   
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKL-TQ-LGNTVGTLYYMAPERFSESHATYRADIYALTC 223

Query: 374 ILLELLTGMKPID-DNNTILYYYLVVEQEVPVR 405
           +L E LTG  P   D  +++  ++    +   R
Sbjct: 224 VLYECLTGSPPYQGDQLSVMGAHI---NQAIPR 253

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 95.4 bits (237), Expect = 9e-22
 Identities = 61/287 (21%), Positives = 93/287 (32%), Gaps = 72/287 (25%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAA-MIPILLFE 227
           G  LG G FG V                +AVK L+  A +S   +  +E   +I I    
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 228 NEVQTLSQC--------------KHVNLLRLLGLCNNIMNCIV-----------YEYMCN 262
           N V  L  C              K  NL   L    N                 Y     
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 263 GSLYDRLARVNNTPPLDSNKRY----------------------------SIALGVAEAL 294
             L  RL  + ++    S+                                 +  VA+ +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            +L S  +  IHRD+ + N+LL E  V K+ DFG   ++        Y        P   
Sbjct: 207 EFLAS--RKCIHRDLAARNILLSEKNVVKICDFG---LARDIYKDPDYVRKGDARLPLKW 261

Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP---IDDNNTILYY 394
           M PE +     + ++DV+S+GV+L E+ + G  P   +  +      
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 41/243 (16%), Positives = 70/243 (28%), Gaps = 39/243 (16%)

Query: 175 GNKLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
            + LGEG F  VY          KN  +  +K  +              A      +   
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-------------PANPWEFYIGTQ 116

Query: 229 EVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTP--PLDSNKRYS 285
            ++ L        ++          + +V E    G+L + +    NTP   +      S
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----------KLGDFGI-VKMS 333
            A+ +   +  +H     IIH D+K  N +L   F+             L D G  + M 
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTIL 392
                          T  +   E +  +    + D F     +  +L G      N    
Sbjct: 235 LFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 393 YYY 395
              
Sbjct: 293 CKP 295

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 41/229 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG+G F  V        G E A   +      +  +              E E +  
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-----------LEREARIC 64

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
              KH N++RL    +   +  ++++ +  G L++ +          + + YS       
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---------AREYYSEADASHC 115

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKM--SETSNMKTM 341
              + EA+ + H +   ++HR++K  N+LL    +    KL DFG+      E       
Sbjct: 116 IQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173

Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
                 GT  Y+ PE +         D+++ GVIL  LL G  P  D +
Sbjct: 174 A-----GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           Y      LG G  G V     K    + A+K L++                        E
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------------------KARRE 104

Query: 230 VQTLSQC-KHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDR-LARVNNTPPLDSNK 282
           V+   +  +  +++R++ +  N+        IV E +  G L+ R   R         ++
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--------GDQ 156

Query: 283 RYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMS 333
            ++      I   + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K +
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214

Query: 334 ETSN-MKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
            + N + T        T  Y+ PE +  +      D++S GVI+  LL G  P   N+
Sbjct: 215 TSHNSLTTP-----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>1wh4_A IRAK4, interleukin-1 receptor-associated kinase 4; death domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: a.77.1.2 Length = 127

 Score = 88.2 bits (218), Expect = 3e-21
 Identities = 24/116 (20%), Positives = 48/116 (41%), Gaps = 9/116 (7%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +     P    +Y+   I+  E   +
Sbjct: 12  LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIK---KPSGDDRYNQFHIRRFEALLQ 68

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESP 122
                +  T   L +WGT+      + DL+  L + EL   A  +  D + +    
Sbjct: 69  TG---KSPTCELLFDWGTTN---CTVGDLVDLLVQIELFAPATLLLPDAVPQTVKS 118

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 21/224 (9%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG G FG V+     +   E+ VK ++          ++ +   + +     E+  L
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-----EIAIL 83

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGS-LYDRLARVNNTPPLDSNKRYSIALGVA 291
           S+ +H N++++L    N     +V E   +G  L+  + R    P LD      I   + 
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLV 140

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
            A+ YL    K IIHRD+K  N+++ E+F  KL DFG    +       T       GT 
Sbjct: 141 SAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----GTI 193

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
            Y  PE +        + +++S GV L  L+    P  +    +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV 237

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 43/232 (18%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
              +   LGEG F        K +    AVK +          S   EA        + E
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----------SKRMEANT------QKE 55

Query: 230 VQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-- 285
           +  L  C+ H N+++L  + ++ ++  +V E +  G L++R+ +          K +S  
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK---------KKHFSET 106

Query: 286 ----IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNM 338
               I   +  A+ ++H +   ++HRD+K  N+L    ++N   K+ DFG  ++    N 
Sbjct: 107 EASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163

Query: 339 KTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           + + T     T  Y  PE ++        D++S GVIL  +L+G  P   ++
Sbjct: 164 QPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 25/241 (10%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LGEG F TV   +      E A+K LE       +                 E   +S+ 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR----------ERDVMSRL 87

Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE--- 292
            H   ++L     +         Y  NG L   + ++  +      + Y+     AE   
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYT-----AEIVS 141

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH     IIHRD+K  N+LL+E+   ++ DFG  K+    + K     +  GT  Y
Sbjct: 142 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGTAQY 198

Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           + PE +  + + K+ D+++ G I+ +L+ G+ P    N  L +  +++ E    E    +
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258

Query: 412 A 412
           A
Sbjct: 259 A 259

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.3 bits (230), Expect = 5e-21
 Identities = 62/253 (24%), Positives = 98/253 (38%), Gaps = 49/253 (19%)

Query: 162 ATDGFN---RKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 217
           +TD F+      Y  + + LGEG    V          E AVK +E    +  S      
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR----- 56

Query: 218 AAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNT 275
                      EV+ L QC+ H N+L L+          +V+E M  GS+   + +    
Sbjct: 57  --------VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---- 104

Query: 276 PPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD 326
                 + ++      +   VA AL +LH+    I HRD+K  N+L    ++    K+ D
Sbjct: 105 -----RRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICD 157

Query: 327 FGI-VKMSETSNMKTMYTENLT---GTRPYMPPEAMHCQISTKT------DVFSYGVILL 376
           F +   +    +   + T  L    G+  YM PE +       +      D++S GVIL 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

Query: 377 ELLTGMKPIDDNN 389
            LL+G  P     
Sbjct: 218 ILLSGYPPFVGRC 230

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 43/279 (15%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G  + + + +A+K +E +         N     +P+     EV  L
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPM-----EVVLL 100

Query: 234 SQCKHV--NLLRLLGLC-NNIMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALG 289
            +       ++RLL          ++ E       L+D +        L      S    
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQ 157

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVKMSETSNMKTMYTENLTG 348
           V EA+ + H+    ++HRD+K  N+L+D N    KL DFG   + + +           G
Sbjct: 158 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-----FDG 210

Query: 349 TRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           TR Y PPE +           V+S G++L +++ G  P + +  I+        +V  R+
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------RGQVFFRQ 264

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            +  E         + LI      C       R +  +I
Sbjct: 265 RVSSEC--------QHLIR----WCLALRPSDRPTFEEI 291

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 45/281 (16%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G FGTV+ G  L + +++A+K +  N     S   ++     P+     EV  L
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSV--TCPL-----EVALL 88

Query: 234 SQC----KHVNLLRLLGLC-NNIMNCIVYEYMCNGS-LYDRLARVNNTPPLDSNKRYSIA 287
            +      H  ++RLL          +V E       L+D +        L         
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFF 145

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             V  A+ + HS  + ++HRD+K  N+L+D      KL DFG   +              
Sbjct: 146 GQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-----F 198

Query: 347 TGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            GTR Y PPE +      +    V+S G++L +++ G  P + +  IL      E E+  
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------EAELHF 252

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
              +  +           LI     +C   +   R S+ +I
Sbjct: 253 PAHVSPDC--------CALIR----RCLAPKPSSRPSLEEI 281

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 44/226 (19%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            ++LG G    VY  K K      A+K L+   +                     E+  L
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---------------VRTEIGVL 102

Query: 234 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            +  H N+++L  +        +V E +  G L+DR+              YS       
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV---------EKGYYSERDAADA 153

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              + EA+ YLH     I+HRD+K  N+L      +   K+ DFG+   +     MKT+ 
Sbjct: 154 VKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV- 210

Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDD 387
                GT  Y  PE +       + D++S G+I   LL G +P  D
Sbjct: 211 ----CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 35/234 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ LGEG +G V      +     AVK L+        N +            + E+Q L
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN---------VKKEIQLL 60

Query: 234 SQCKHVNLLRL---LGLCNNIMNCIVYEYMCNGS--LYDRLARVNNTPPLDSNKRYSIAL 288
            + +H N+++L   L         +V EY   G   + D +       P+     Y   L
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQL 118

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT- 347
              + L YLHS    I+H+D+K  N+LL      K+   G+      +     +  + T 
Sbjct: 119 --IDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGV------AEALHPFAADDTC 168

Query: 348 ----GTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDDNNTILYY 394
               G+  + PPE  +   +    K D++S GV L  + TG+ P + +N    +
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF 222

>2a9i_A IRAK-4, interleukin-1 receptor-associated kinase-4; hexahelical bundle, transferase; 1.70A {Mus musculus} PDB: 3mop_G Length = 113

 Score = 85.5 bits (211), Expect = 2e-20
 Identities = 24/113 (21%), Positives = 46/113 (40%), Gaps = 9/113 (7%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +     P    +Y+   I+  E   +
Sbjct: 5   LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIK---KPSGDDRYNQFHIRRFEALLQ 61

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKP 119
                   T   L +WGT       + DL+  L + EL   A  +  D + + 
Sbjct: 62  TG---LSPTCELLFDWGT---TNCTVGDLVDLLVQIELFAPATLLLPDAVPQT 108

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 38/276 (13%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G+G F  V   + +  G E+A+K ++       +  + T    +       EV+ +
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDK------TQLNPTSLQKL-----FREVRIM 68

Query: 234 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
               H N+++L  +        ++ EY   G ++D L         ++         +  
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVS 125

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRP 351
           A+ Y H     I+HRD+K+ N+LLD +   K+ DFG   + +    +         G  P
Sbjct: 126 AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-----FCGAPP 178

Query: 352 YMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
           Y  PE    +     + DV+S GVIL  L++G  P D  N       V+  +  +   + 
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            +         E L+     +  V    KR ++  I
Sbjct: 239 TDC--------ENLLK----RFLVLNPIKRGTLEQI 262

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 45/224 (20%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G G +        K   ME AVK +        S  D TE           E++ L
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTE-----------EIEIL 69

Query: 234 SQC-KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------ 285
            +  +H N++ L  + ++     +V E M  G L D++ R          K +S      
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---------KFFSEREASA 120

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVP-KLGDFGIVKMSETSNMKTM 341
           +   + + + YLH+    ++HRD+K +N+L      N    ++ DFG  K     N   +
Sbjct: 121 VLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLL 177

Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKP 384
            T     T  ++ PE +  Q      D++S GV+L  +LTG  P
Sbjct: 178 MT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 41/280 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LGEG +G V           +AVK ++         +             + E+   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN------------IKKEICIN 59

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGV 290
               H N+++  G      +  +  EY   G L+DR+      P  D+ + +   +A   
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YLH +   I HRD+K  N+LLDE    K+ DFG+  +    N +      + GT 
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTL 171

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQE--VPVR 405
           PY+ PE +  +   +   DV+S G++L  +L G  P D  +++   Y    E++  +   
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + +D             L+     K  V     R ++ DI
Sbjct: 232 KKIDSAP--------LALLH----KILVENPSARITIPDI 259

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 71/284 (25%), Positives = 116/284 (40%), Gaps = 53/284 (18%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  G+    G ++AVK L      S       +           E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK----------REIQNL 65

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--- 289
              +H ++++L   +       +V EY+  G L+D + +         + R         
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---------HGRVEEMEARRL 116

Query: 290 ---VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
              +  A+ Y H     ++HRD+K  NVLLD +   K+ DFG+   MS+   ++T     
Sbjct: 117 FQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----- 169

Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-- 401
             G+  Y  PE +  +     + D++S GVIL  LL G  P DD +    +  +      
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY 229

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +P          E+    V TL+          +  KRA+++DI
Sbjct: 230 IP----------EYLNRSVATLLM----HMLQVDPLKRATIKDI 259

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 73/280 (26%), Positives = 116/280 (41%), Gaps = 45/280 (16%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  GK    G ++AVK L      S                   E+Q L
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR----------REIQNL 70

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-IALGVA 291
              +H ++++L   +       +V EY+  G L+D + +       +S + +  I  GV 
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV- 129

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL--T-- 347
               Y H     ++HRD+K  NVLLD +   K+ DFG+      SNM  M       T  
Sbjct: 130 ---DYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGL------SNM--MSDGEFLRTSC 176

Query: 348 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           G+  Y  PE +  +     + D++S GVIL  LL G  P DD++    +  + +      
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP 236

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + L+            +L+          +  KRA+++DI
Sbjct: 237 QYLNPSV--------ISLLK----HMLQVDPMKRATIKDI 264

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 33/238 (13%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LGEG +G V           +AVK ++         +             + E+   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN------------IKKEICIN 59

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGV 290
               H N+++  G      +  +  EY   G L+DR+      P  D+ + +   +A   
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT--- 347
              + YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +    L    
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMC 168

Query: 348 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQEV 402
           GT PY+ PE +  +   +   DV+S G++L  +L G  P D  +++   Y    E++ 
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 35/223 (15%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQTL 233
           KLG G F TV+  K + N   +A+K +  +  Y       TEAA   I +L   N+    
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNT 78

Query: 234 SQCK--HVNLLRLLG---LCNNIMN--CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYS 285
            +      ++L+LL              +V+E +   +L   + +  +   PL   K+ S
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP------KLGDFGIVKMSETSNMK 339
             L     L Y+H     IIH D+K  NVL++    P      K+ D G    +     +
Sbjct: 138 KQL--LLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLG----NACWYDE 190

Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
                    TR Y  PE  +        D++S   ++ EL+TG
Sbjct: 191 HYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 59/241 (24%), Positives = 86/241 (35%), Gaps = 59/241 (24%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G G FG     +       +AVK +E  A    +               + E+   
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--------------VQREIINH 70

Query: 234 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H N++R   +        I+ EY   G LY+R+             R        E
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN---------AGR----FSEDE 117

Query: 293 A----------LHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNM-K 339
           A          + Y HS+   I HRD+K  N LLD +  P  K+ DFG  K S   +  K
Sbjct: 118 ARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175

Query: 340 TMYTENLTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDDNNTILY 393
           +       GT  Y+ PE     +  +       DV+S GV L  +L G  P +D      
Sbjct: 176 S-----TVGTPAYIAPEV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

Query: 394 Y 394
           Y
Sbjct: 227 Y 227

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 64/277 (23%), Positives = 113/277 (40%), Gaps = 40/277 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LGEG FG V      K   ++A+K +       S      E           E+  L
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----------REISYL 63

Query: 234 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-IALGVA 291
              +H ++++L   +       +V EY   G L+D +         +  + +  I   + 
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAI- 121

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
               Y H     I+HRD+K  N+LLD+N   K+ DFG+   M++ + +KT       G+ 
Sbjct: 122 ---EYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-----SCGSP 171

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
            Y  PE ++ +     + DV+S G++L  +L G  P DD      +  V      + + L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
              A        ++LI     +  V +  +R ++++I
Sbjct: 232 SPGA--------QSLIR----RMIVADPMQRITIQEI 256

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 83.9 bits (208), Expect = 9e-18
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 45/243 (18%)

Query: 160 ERATDGFNRKPYPRR---GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNT 216
             A+DG   +           +G G FG V+  KL    E+A+K +  +  +        
Sbjct: 27  VLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------- 78

Query: 217 EAAMIPILLFEN-EVQTLSQCKHVNLLRLL-------GLCNNIMNCIVYEYMCNGSLY-- 266
                     +N E+Q +   KH N++ L           + +   +V EY+   ++Y  
Sbjct: 79  ----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRA 127

Query: 267 -DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKL 324
               A++  T P+   K Y   L    +L Y+HS+   I HRD+K  N+LLD    V KL
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQL--LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKL 183

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGM 382
            DFG  K+         Y      +R Y  PE +      +T  D++S G ++ EL+ G 
Sbjct: 184 IDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG- 238

Query: 383 KPI 385
           +P+
Sbjct: 239 QPL 241

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 58/256 (22%), Positives = 95/256 (37%), Gaps = 52/256 (20%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   +  +  ++ A+K +        +   N             E+Q +   
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF----------KELQIMQGL 72

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           +H   VNL         +          +V + +  G L   L + N     ++ K +  
Sbjct: 73  EHPFLVNLWYSFQDEEDM---------FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLF-- 120

Query: 287 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
              + E   AL YL +    IIHRD+K  N+LLDE+    + DF I           + T
Sbjct: 121 ---ICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT 173

Query: 344 ENLTGTRPYMPPEAMHCQIS---TKT-DVFSYGVILLELLTGMKP---IDDNNTILYYYL 396
             + GT+PYM PE    +     +   D +S GV   ELL G +P       ++    + 
Sbjct: 174 --MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231

Query: 397 VVEQEVPVREVLDKEA 412
                V       +E 
Sbjct: 232 FETTVVTYPSAWSQEM 247

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +  K+GEG +G V+  +    G  +A+K                  +  +I  +    E+
Sbjct: 7   KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------------DDPVIKKIALR-EI 53

Query: 231 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L Q KH NL+ LL +      +   +V+EY  + ++   L R     P    K  +  
Sbjct: 54  RMLKQLKHPNLVNLLEVFRRKRRLH--LVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
               +A+++ H      IHRDVK  N+L+ ++ V KL DFG  ++  T      Y + + 
Sbjct: 111 T--LQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDY-YDDEVA 164

Query: 348 GTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
            TR Y  PE  +         DV++ G +  ELL+G  P+
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL 202

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 71/366 (19%), Positives = 120/366 (32%), Gaps = 63/366 (17%)

Query: 78  FLD-----EWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWL 132
           FLD     E     +R+    +L               V   ++       +     +  
Sbjct: 83  FLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLF 142

Query: 133 QEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNK---------LGEGQF 183
           QE+ +        EY+       + D          K   R+            LG+G F
Sbjct: 143 QELTRLT-----HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197

Query: 184 GTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH---V 239
           G V   +++   ++ A K LE               A+       NE Q L +      V
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKR---IKKRKGEAMAL-------NEKQILEKVNSRFVV 247

Query: 240 NLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +L         L         C+V   M  G L   +  +      ++   +  A  +  
Sbjct: 248 SLAYAYETKDAL---------CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICC 297

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP 351
            L  LH     I++RD+K  N+LLD++   ++ D G+   + E   +K        GT  
Sbjct: 298 GLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-----VGTVG 350

Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILY----YYLVVEQEVPVRE 406
           YM PE +  +  T + D ++ G +L E++ G  P       +       LV E      E
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410

Query: 407 VLDKEA 412
               +A
Sbjct: 411 RFSPQA 416

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 56/248 (22%), Positives = 89/248 (35%), Gaps = 48/248 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   KLKN  ++ A+K L        + +             E +V  L   
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE--------ERDV--LVNG 131

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
                  L         L          +V +Y   G L   L++  +  P +  + Y  
Sbjct: 132 DSKWITTLHYAFQDDNNL---------YLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-- 180

Query: 287 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
              +AE   A+  +H L    +HRD+K  N+L+D N   +L DFG               
Sbjct: 181 ---LAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 344 ENLTGTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
               GT  Y+ PE +      K       D +S GV + E+L G  P    + +  Y  +
Sbjct: 236 --AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

Query: 398 VEQEVPVR 405
           +  +   +
Sbjct: 294 MNHKERFQ 301

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 67/249 (26%), Positives = 105/249 (42%), Gaps = 42/249 (16%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K      A+K L+     +     +T          EN V  L   
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT--------ENRV--LQNS 205

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           +H     L        RL         C V EY   G L+  L+R       D  + Y  
Sbjct: 206 RHPFLTALKYSFQTHDRL---------CFVMEYANGGELFFHLSRER-VFSEDRARFY-- 253

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTE 344
              +  AL YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT    
Sbjct: 254 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--- 309

Query: 345 NLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              GT  Y+ PE +      +  D +  GV++ E++ G  P  + +    + L++ +E+ 
Sbjct: 310 --CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367

Query: 404 VREVLDKEA 412
               L  EA
Sbjct: 368 FPRTLGPEA 376

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 24/238 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   K K      A+K L+          ++T           NE + L   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----------LNEKRILQAV 98

Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
               L++L     +  N  +V EY+  G ++  L R+      + + R+  A  +     
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARFYAA-QIVLTFE 155

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +       +T  L GT   + P
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT--LCGTPEALAP 207

Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           E +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V        + 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 49/254 (19%)

Query: 150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNA 206
           + +   FC        +       +  K+G+G FG V+  +  K G ++A+K   +EN  
Sbjct: 6   DSVECPFC---DEVSKY------EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-- 54

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-------NNIMNCI--VY 257
                     E    PI     E++ L   KH N++ L+ +C       N     I  V+
Sbjct: 55  ----------EKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103

Query: 258 EYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           ++      +D LA +  N       ++   +   +   L+Y+H     I+HRD+K+ANVL
Sbjct: 104 DFCE----HD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVL 156

Query: 316 LDENFVPKLGDFGIVKM--SETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSY 371
           +  + V KL DFG+ +      ++    YT N   T  Y PPE +          D++  
Sbjct: 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYT-NRVVTLWYRPPELLLGERDYGPPIDLWGA 215

Query: 372 GVILLELLTGMKPI 385
           G I+ E+ T   PI
Sbjct: 216 GCIMAEMWTR-SPI 228

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 46/230 (20%), Positives = 85/230 (36%), Gaps = 46/230 (20%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN-------- 228
            +  G +G V  G    G+ +A+K + N  +   + +           +  +        
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN-----------ILSDSFLCKRVL 77

Query: 229 -EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYMCNGSLYDRLARVNNTPP 277
            E++ L+   H N+L L     +I             +V E M   +   ++        
Sbjct: 78  REIRLLNHFHHPNILGLR----DIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVI 131

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
              + +Y     +   LH LH     ++HRD+   N+LL +N    + DF + +      
Sbjct: 132 SPQHIQY-FMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 338 MKTMYTENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
            KT Y       R Y  PE +   +  TK  D++S G ++ E+    K +
Sbjct: 189 NKTHY----VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 79.6 bits (197), Expect = 9e-17
 Identities = 54/248 (21%), Positives = 87/248 (35%), Gaps = 70/248 (28%)

Query: 159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 217
           L+   +      Y      LG G  G V     K    + A+K L++             
Sbjct: 8   LQIKKNAIIDD-YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------- 55

Query: 218 AAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDR-LA 270
                      EV+   +  +  +++R++ +  N+        IV E +  G L+ R   
Sbjct: 56  -------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 108

Query: 271 RVNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFV 321
           R         ++ ++      I   + EA+ YLHS++  I HRDVK  N+L      N +
Sbjct: 109 R--------GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 158

Query: 322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
            KL DFG                           E    +     D++S GVI+  LL G
Sbjct: 159 LKLTDFGFA------------------------KETTGEKYDKSCDMWSLGVIMYILLCG 194

Query: 382 MKPIDDNN 389
             P   N+
Sbjct: 195 YPPFYSNH 202

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 39/223 (17%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFENE 229
           +  K+GEG +G VY  K   G  +A+K   L+             E   IP   +    E
Sbjct: 25  KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA------------EDEGIPSTAI---RE 69

Query: 230 VQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRY 284
           +  L +  H N++ L+ +      +   +V+E+M      D L +V   N   L  ++  
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLT--LVFEFM----EKD-LKKVLDENKTGLQDSQIK 122

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
                +   + + H     I+HRD+K  N+L++ +   KL DFG+ +      +++ YT 
Sbjct: 123 IYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRS-YT- 177

Query: 345 NLTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
           +   T  Y  P+  M  +  ST  D++S G I  E++TG KP+
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 51/250 (20%), Positives = 79/250 (31%), Gaps = 50/250 (20%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G F  V   K+K   ++ A+K +                        E +V  L   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE--------ERDV--LVNG 118

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
                  L         L          +V EY   G L   L++     P +  + Y  
Sbjct: 119 DRRWITQLHFAFQDENYL---------YLVMEYYVGGDLLTLLSKFGERIPAEMARFY-- 167

Query: 287 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
              +AE   A+  +H L    +HRD+K  N+LLD     +L DFG               
Sbjct: 168 ---LAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222

Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVF--------SYGVILLELLTGMKPIDDNNTILYYY 395
               GT  Y+ PE +                   + GV   E+  G  P   ++T   Y 
Sbjct: 223 --AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280

Query: 396 LVVEQEVPVR 405
            +V  +  + 
Sbjct: 281 KIVHYKEHLS 290

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 44/231 (19%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPI------- 223
              ++G G +GTVY  +   +G  +A+K+  + N                +PI       
Sbjct: 13  PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---------GGGGGGGLPISTVREVA 63

Query: 224 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNC------IVYEYMCNGSLYD--RLARVNNT 275
           LL     + L   +H N++RL+ +C            +V+E++      D          
Sbjct: 64  LL-----RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----DQDLRTYLDKAPP 114

Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
           P L +     +       L +LH+    I+HRD+K  N+L+      KL DFG+ ++  +
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIY-S 171

Query: 336 SNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
             M    T  +  T  Y  PE  +    +T  D++S G I  E+    KP+
Sbjct: 172 YQMA--LT-PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 228
           + + LGEGQF TVY  +       +A+K   L + +              I    L    
Sbjct: 14  KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---------INRTAL---R 61

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYS 285
           E++ L +  H N++ LL    +  N  +V+++M      D L  +  +N+  L  +   +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM----ETD-LEVIIKDNSLVLTPSHIKA 116

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L   + L YLH     I+HRD+K  N+LLDEN V KL DFG+ K S  S  +  YT +
Sbjct: 117 YMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRA-YT-H 171

Query: 346 LTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
              TR Y  PE     ++     D+++ G IL ELL    P 
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 43/224 (19%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN-EVQTLS 234
            +G G FG VY  KL  +G  +A+K +  +  +                  +N E+Q + 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------------KNRELQIMR 102

Query: 235 QCKHVNLLRLL-------GLCNNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRY 284
           +  H N++RL           + +   +V +Y+   ++Y      +R   T P+   K Y
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLY 161

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYT 343
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 162 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 344 ENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 218 C----SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 32/220 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
               +GEG +G V   +    G  +A+K     +            +  M+  +    E+
Sbjct: 29  NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------------DDKMVKKIAMR-EI 75

Query: 231 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L Q +H NL+ LL +C         +V+E++ + ++ D L    N       ++Y   
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWY--LVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ 132

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           +     + + H  S  IIHRD+K  N+L+ ++ V KL DFG  +    +  +  Y  +  
Sbjct: 133 I--INGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEV-YD-DEV 185

Query: 348 GTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
            TR Y  PE  +         DV++ G ++ E+  G +P+
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL 224

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 32/222 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +  KLG G + TVY G     G+ +A+K   L++     S+       A+        E+
Sbjct: 9   QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-------AI-------REI 54

Query: 231 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCN--GSLYDRLARVNNTPPLDSNKRYS 285
             + + KH N++RL  +    N +   +V+E+M N      D     N    L+ N    
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
               + + L + H     I+HRD+K  N+L+++    KLGDFG+ +      + T ++ +
Sbjct: 113 FQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNT-FS-S 167

Query: 346 LTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
              T  Y  P+  M  +  ST  D++S G IL E++TG KP+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 39/224 (17%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 228
           +  K+GEG +GTV+  K  +    +A+K   L++            +   +P   L    
Sbjct: 6   KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------------DDEGVPSSAL---R 50

Query: 229 EVQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKR 283
           E+  L + KH N++RL  +      +   +V+E+       D L +   +    LD    
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLT--LVFEFC----DQD-LKKYFDSCNGDLDPEIV 103

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + + L + HS  + ++HRD+K  N+L++ N   KL +FG+ +      ++  Y+
Sbjct: 104 KSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRC-YS 159

Query: 344 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                T  Y PP+ +      ST  D++S G I  EL    +P+
Sbjct: 160 -AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 49/252 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K      A+K L      +     +T          E+ V  L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT--------ESRV--LQNT 62

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           +H     L        RL         C V EY   G L+  L+R       +  + Y  
Sbjct: 63  RHPFLTALKYAFQTHDRL---------CFVMEYANGGELFFHLSRER-VFTEERARFYGA 112

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK--MSETSNMKTM 341
            I      AL YLHS  + +++RD+K  N++LD++  + K+ DFG+ K  +S+ + MKT 
Sbjct: 113 EIVS----ALEYLHS--RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTF 165

Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 GT  Y+ PE +      +  D +  GV++ E++ G  P  + +    + L++ +
Sbjct: 166 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

Query: 401 EVPVREVLDKEA 412
           E+     L  EA
Sbjct: 221 EIRFPRTLSPEA 232

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 37/224 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
             G+G FGTV  GK K  GM +A+K +  +  +      N E            +Q L+ 
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-----NRELQ---------IMQDLAV 75

Query: 236 CKHVNLLRLL--------GLCNNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRY 284
             H N+++L             +I   +V EY+   +L+       R    PP    K +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 343
              L    ++  LH  S  + HRD+K  NVL++  +   KL DFG  K    S     Y 
Sbjct: 135 LFQL--IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY- 191

Query: 344 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                +R Y  PE +  +   +T  D++S G I  E++ G +PI
Sbjct: 192 ---ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 35/221 (15%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPI--LLFENE 229
              K+GEG +G VY  +   G   A+K   LE             E   IP   +    E
Sbjct: 6   GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK------------EDEGIPSTTI---RE 50

Query: 230 VQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSI 286
           +  L + KH N+++L  + +      +V+E++      D L ++       L+S    S 
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHL----DQD-LKKLLDVCEGGLESVTAKSF 105

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
            L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +      ++  YT + 
Sbjct: 106 LLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRK-YT-HE 160

Query: 347 TGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
             T  Y  P+  M  +  ST  D++S G I  E++ G  P+
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 58/259 (22%), Positives = 96/259 (37%), Gaps = 55/259 (21%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V+  ++K   ++ A K L              + AM        E + L++ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKR---LKKRKGYQGAM-------VEKKILAKV 242

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR--- 283
                V+L         L         C+V   M  G +   +  V+   P     R   
Sbjct: 243 HSRFIVSLAYAFETKTDL---------CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293

Query: 284 YSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNM 338
           Y+     A+    L +LH  +  II+RD+K  NVLLD++   ++ D G+     +  +  
Sbjct: 294 YT-----AQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

Query: 339 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILY---- 393
           K        GT  +M PE +  +    + D F+ GV L E++    P       +     
Sbjct: 347 KGY-----AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401

Query: 394 YYLVVEQEVPVREVLDKEA 412
              V+EQ V   +     +
Sbjct: 402 KQRVLEQAVTYPDKFSPAS 420

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 24/221 (10%), Positives = 49/221 (22%), Gaps = 58/221 (26%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
             G       +         ++A+  ++           +            +    LS+
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVD-----PQGVLPDDVLQE-----TLSRTLRLSR 87

Query: 236 CKHVNLLRLL------GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
                + R+L               +V E++  GSL +                      
Sbjct: 88  IDKPGVARVLDVVHTRAGG-----LVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQS 137

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +A A    H     +       + V +  +    L                         
Sbjct: 138 LAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA--------------------- 174

Query: 350 RPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
              MP        + + D+   G  L  LL    P+ +   
Sbjct: 175 --TMPDA------NPQDDIRGIGASLYALLVNRWPLPEAGV 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 44/228 (19%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 228
           R  KLGEG +G VY          +A+K   LE+            E   +P   +    
Sbjct: 38  RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH------------EEEGVPGTAI---R 82

Query: 229 EVQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRY 284
           EV  L + +H N++ L  +    + +   +++EY       D L +  +  P +      
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLH--LIFEYA----END-LKKYMDKNPDVSMRVIK 135

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDFGIVKMSETSNMK 339
           S    +   +++ HS  +  +HRD+K  N+LL  +        K+GDFG+ +      ++
Sbjct: 136 SFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIR 192

Query: 340 TMYTENLTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
             +T +   T  Y PPE  +  +  ST  D++S   I  E+L    P+
Sbjct: 193 Q-FT-HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 45/237 (18%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +   G K+G G +G VY  K K   +  + A+K +E     S S                
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSAC-------------- 66

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCN--GSLYDRL---ARVNNTPPLD 279
            E+  L + KH N++ L  +  +  +    ++++Y  +    +               L 
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSET 335
                S+   + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G  ++   
Sbjct: 127 RGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-N 183

Query: 336 SNMKTMYTENLTG---TRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 385
           S +K +   +L     T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 184 SPLKPLA--DLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 235

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 29/226 (12%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQTLS 234
           +G+G FG V      K    +A+K + N   +          A   I IL    +    +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-------HRQAAEEIRILEHLRKQDKDN 157

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
               +++L      N+I  C+ +E + + +LY+ L + N             A  + + L
Sbjct: 158 TMNVIHMLENFTFRNHI--CMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
             LH     IIH D+K  N+LL +      K+ DFG    S     + +YT     +R Y
Sbjct: 214 DALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG----SSCYEHQRVYTY--IQSRFY 265

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI---DDNNTILYY 394
             PE  +  +     D++S G IL ELLTG  P+   +D    L  
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLAC 310

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 37/222 (16%)

Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
           + +KLGEG + TVY GK K     +A+K   LE+      +       A+        EV
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-------AI-------REV 51

Query: 231 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYS 285
             L   KH N++ L  +     ++   +V+EY+      D L +   +    ++ +    
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLT--LVFEYL----DKD-LKQYLDDCGNIINMHNVKL 104

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
               +   L Y H   + ++HRD+K  N+L++E    KL DFG+ +   +   KT Y  N
Sbjct: 105 FLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKT-YD-N 159

Query: 346 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
              T  Y PP+ +      ST+ D++  G I  E+ TG +P+
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 28/240 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V+  + ++     A+K L+          ++T           +E   LS  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----------DERLMLSIV 63

Query: 237 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGVAEA 293
            H  ++R+ G   +     ++ +Y+  G L+  L +    P     K Y+  + L    A
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVAKFYAAEVCL----A 118

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS    II+RD+K  N+LLD+N   K+ DFG  K          YT  L GT  Y+
Sbjct: 119 LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT--LCGTPDYI 170

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +  +   K+ D +S+G+++ E+L G  P  D+NT+  Y  ++  E+      +++ 
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 230

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 52/230 (22%), Positives = 94/230 (40%), Gaps = 48/230 (20%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEI-AVK--TLENNANYSSSNSDNTEAAMIPI-------L 224
            ++GEG +G V+  + LKNG    A+K   ++                 +P+       +
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------------GEEGMPLSTIREVAV 64

Query: 225 LFENEVQTLSQCKHVNLLRLLGLCNNIMNC------IVYEYMCNGSLYD--RLARVNNTP 276
           L       L   +H N++RL  +C            +V+E++      D          P
Sbjct: 65  LRH-----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----DQDLTTYLDKVPEP 115

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            + +     +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++  + 
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SF 172

Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
            M    T ++  T  Y  PE  +    +T  D++S G I  E+    KP+
Sbjct: 173 QMA--LT-SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.1 bits (183), Expect = 8e-15
 Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 49/254 (19%)

Query: 178 LGEGQFGTVY---YGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           LG+G +G V+        N  +I A+K L         N+ +T          E  +  L
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKA-----ERNI--L 75

Query: 234 SQCKH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
            + KH   V+L+       +L          ++ EY+  G L+ +L R       D+   
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKL---------YLILEYLSGGELFMQLEREGIFM-EDTACF 125

Query: 284 YS--IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMK 339
           Y   I++    AL +LH     II+RD+K  N++L+     KL DFG+ K  + + +   
Sbjct: 126 YLAEISM----ALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 340 TMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
           T       GT  YM PE +      +  D +S G ++ ++LTG  P    N       ++
Sbjct: 180 TF-----CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234

Query: 399 EQEVPVREVLDKEA 412
           + ++ +   L +EA
Sbjct: 235 KCKLNLPPYLTQEA 248

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 42/249 (16%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+ +      + + T          E  V  L   
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--------EKRVLALP-G 399

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           K      L        RL           V EY+  G L   + +V           Y  
Sbjct: 400 KPPFLTQLHSCFQTMDRL---------YFVMEYVNGGDLMYHIQQVGRFK-EPHAVFY-- 447

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTE 344
           A  +A  L +L S  K II+RD+K  NV+LD     K+ DFG+ K  + +    KT    
Sbjct: 448 AAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--- 502

Query: 345 NLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              GT  Y+ PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V 
Sbjct: 503 --CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 560

Query: 404 VREVLDKEA 412
             + + KEA
Sbjct: 561 YPKSMSKEA 569

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 232
           + +G+G FG V           +A+K ++N   +          A   + +L   N+  T
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-------LNQAQIEVRLLELMNKHDT 112

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             +   V+L R     N++  C+V+E M + +LYD L R  N   +  N     A  +  
Sbjct: 113 EMKYYIVHLKRHFMFRNHL--CLVFE-MLSYNLYDLL-RNTNFRGVSLNLTRKFAQQMCT 168

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTR 350
           AL +L +    IIH D+K  N+LL        K+ DFG    S     + +Y      +R
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQ--YIQSR 222

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
            Y  PE  +        D++S G IL+E+ TG
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 39/238 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSS----------------------SNS 213
            LG G FG V       +G   A+K +  +  Y +                      +  
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLY---DRLA 270
           D       P           +   + +   ++    N    ++ EY+   +L+       
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFI 132

Query: 271 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGI 329
           R   + P++    Y   L    A+ ++HSL   I HRD+K  N+L++ ++   KL DFG 
Sbjct: 133 RSGRSIPMNLISIYIYQL--FRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
            K    S     Y      +R Y  PE M    + +   D++S G +  EL+ G KP+
Sbjct: 189 AKKLIPSEPSVAY----ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KPL 241

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 42/249 (16%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   + K      AVK L+  A        +  +        E  V   +  
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS--------ERNVLLKN-V 96

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           KH   V L        +L           V +Y+  G L+  L R          + Y+ 
Sbjct: 97  KHPFLVGLHFSFQTADKL---------YFVLDYINGGELFYHLQRER-CFLEPRARFYAA 146

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            IA     AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N  T  T 
Sbjct: 147 EIAS----ALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT-ST- 198

Query: 345 NLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              GT  Y+ PE +H Q   +T D +  G +L E+L G+ P    NT   Y  ++ + + 
Sbjct: 199 -FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 257

Query: 404 VREVLDKEA 412
           ++  +   A
Sbjct: 258 LKPNITNSA 266

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 23/166 (13%)

Query: 229 EVQTLSQCKHVNLLRLLGL---CNNIMNC----IVYEYM-CNGSLYDRLARVNNTPPLDS 280
           E+  +    H N++ LL +     ++       IV E M  N      L +V        
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQMELDHE 127

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
              Y +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T
Sbjct: 128 RMSY-LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

Query: 341 MYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI 385
            Y      TR Y  PE +      +  D++S G I+ E++ G   +
Sbjct: 185 PY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 69/258 (26%), Positives = 115/258 (44%), Gaps = 59/258 (22%)

Query: 178 LGEGQFGTVY---YGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT- 232
           LG+G FG V+        +  ++ A+K L+                    L   + V+T 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-----------------TLKVRDRVRTK 74

Query: 233 -----LSQCKH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 277
                L +  H   V L        +L          ++ +++  G L+ RL++      
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKL---------YLILDFLRGGDLFTRLSKEVMFT- 124

Query: 278 LDSNKRYS--IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            +  K Y   +AL    AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S  
Sbjct: 125 EEDVKFYLAELAL----ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178

Query: 336 SNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 394
              K  Y+    GT  YM PE ++ +  T++ D +S+GV++ E+LTG  P    +     
Sbjct: 179 HEKKA-YS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

Query: 395 YLVVEQEVPVREVLDKEA 412
            ++++ ++ + + L  EA
Sbjct: 236 TMILKAKLGMPQFLSPEA 253

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 44/250 (17%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  + K   +  A+K L+ +      + + T          E  V +L+  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV--------EKRVLSLA-W 75

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           +H    ++         L           V EY+  G L   +   +    L     Y+ 
Sbjct: 76  EHPFLTHMFCTFQTKENL---------FFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAA 125

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYT 343
            I L     L +LHS    I++RD+K  N+LLD++  + K+ DFG+ K +   + KT  T
Sbjct: 126 EIIL----GLQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKT-NT 177

Query: 344 ENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
               GT  Y+ PE +  Q    + D +S+GV+L E+L G  P    +    ++ +     
Sbjct: 178 --FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

Query: 403 PVREVLDKEA 412
                L+KEA
Sbjct: 236 FYPRWLEKEA 245

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 68/252 (26%), Positives = 104/252 (41%), Gaps = 48/252 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+ +      + + T          E  V  L   
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--------EKRVLALP-G 78

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           K      L        RL           V EY+  G L   + +V           Y+ 
Sbjct: 79  KPPFLTQLHSCFQTMDRL---------YFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYAA 128

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK--MSETSNMKTM 341
            IA+     L +L S    II+RD+K  NV+LD    + K+ DFG+ K  + +    KT 
Sbjct: 129 EIAI----GLFFLQSKG--IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTF 181

Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 GT  Y+ PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E 
Sbjct: 182 -----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

Query: 401 EVPVREVLDKEA 412
            V   + + KEA
Sbjct: 237 NVAYPKSMSKEA 248

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 60/250 (24%), Positives = 94/250 (37%), Gaps = 55/250 (22%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   + K+  ++ A+K L        S+S             E ++  ++  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE--------ERDI--MAFA 126

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
                V L         L          +V EYM  G L + +          SN     
Sbjct: 127 NSPWVVQLFYAFQDDRYL---------YMVMEYMPGGDLVNLM----------SNYDVPE 167

Query: 287 ALG---VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
                  AE   AL  +HS+    IHRDVK  N+LLD++   KL DFG     + +    
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGM 223

Query: 341 MYTENLTGTRPYMPPEAMHCQISTKT-----DVFSYGVILLELLTGMKPIDDNNTILYYY 395
           +  +   GT  Y+ PE +  Q          D +S GV L E+L G  P   ++ +  Y 
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 283

Query: 396 LVVEQEVPVR 405
            ++  +  + 
Sbjct: 284 KIMNHKNSLT 293

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.4 bits (180), Expect = 5e-14
 Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 15/164 (9%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
             + + M  G L+  L++       D   R+  A  +   L ++H+    +++RD+K AN
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEADM--RFYAA-EIILGLEHMHNRF--VVYRDLKPAN 322

Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS-TKT-DVFSY 371
           +LLDE+   ++ D G+                  GT  YM PE +   ++   + D FS 
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSL 377

Query: 372 GVILLELLTGMKPIDDNNTI---LYYYLVVEQEVPVREVLDKEA 412
           G +L +LL G  P   + T        + +   V + +    E 
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 64/252 (25%), Positives = 101/252 (40%), Gaps = 48/252 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   ++K   ++ AVK L+ +      + + T          E  + +L++ 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT--------EKRILSLAR- 81

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            H     L        RL           V E++  G L   + +          + Y+ 
Sbjct: 82  NHPFLTQLFCCFQTPDRL---------FFVMEFVNGGDLMFHIQKSR-RFDEARARFYA- 130

Query: 287 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTM 341
               AE   AL +LH     II+RD+K  NVLLD     KL DFG+ K  +       T 
Sbjct: 131 ----AEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184

Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 GT  Y+ PE +   +     D ++ GV+L E+L G  P +  N    +  ++  
Sbjct: 185 -----CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

Query: 401 EVPVREVLDKEA 412
           EV     L ++A
Sbjct: 240 EVVYPTWLHEDA 251

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 23/166 (13%)

Query: 229 EVQTLSQCKHVNLLRLLGL---CNNIMNC----IVYEYM-CNGSLYDRLARVNNTPPLDS 280
           E+  +    H N++ LL +      +       +V E M  N      L +V        
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN------LCQVIQMELDHE 164

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
              Y +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T
Sbjct: 165 RMSY-LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221

Query: 341 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI 385
            Y      TR Y  PE +         D++S G I+ E++   K +
Sbjct: 222 PY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 64/234 (27%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------ 228
             +G G +G+V      ++G ++A+K L                       F++      
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------------------PFQSEIFAKR 69

Query: 229 ---EVQTLSQCKHVNLLRLLGLCNNIMNC-----------IVYEYM-CNGSLYDRLARVN 273
              E+  L   +H N++ LL    ++              +V  +M  +      L ++ 
Sbjct: 70  AYRELLLLKHMQHENVIGLL----DVFTPASSLRNFYDFYLVMPFMQTD------LQKIM 119

Query: 274 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
                +   +Y +   + + L Y+HS    ++HRD+K  N+ ++E+   K+ DFG+ +  
Sbjct: 120 GLKFSEEKIQY-LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR-- 174

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                 T Y      TR Y  PE +      +   D++S G I+ E+LTG K +
Sbjct: 175 HADAEMTGY----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 33/238 (13%)

Query: 177 KLGEGQFGTVY--YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 232
            LGEG FG V       +   ++A+K + N   Y        EAA   I +L    E   
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-------REAARLEINVLKKIKEKDK 78

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            ++   V +        ++  CI +E +   + ++ L + NN  P        +A  +  
Sbjct: 79  ENKFLCVLMSDWFNFHGHM--CIAFE-LLGKNTFEFL-KENNFQPYPLPHVRHMAYQLCH 134

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIVKMSETSNMK-------TMY 342
           AL +LH     + H D+K  N+L   +    +         K  + ++++       T  
Sbjct: 135 ALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 343 TENLTG---TRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG--MKPIDDNNTILYY 394
            E+ T    TR Y PPE  +    +   DV+S G IL E   G  +    +N   L  
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 65/237 (27%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------ 228
           + +GEG +G V       N + +A+K +                       FE+      
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------------------FEHQTYCQR 71

Query: 229 ---EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYM-CNGSLYDRLARVNN 274
              E++ L + +H N++ +     +I+            IV + M  +      L ++  
Sbjct: 72  TLREIKILLRFRHENIIGIN----DIIRAPTIEQMKDVYIVQDLMETD------LYKLLK 121

Query: 275 TPPL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
           T  L + +  Y     +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG   ++
Sbjct: 122 TQHLSNDHICY-FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG---LA 175

Query: 334 ETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
             ++    +T  LT    TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 61/240 (25%), Positives = 94/240 (39%), Gaps = 66/240 (27%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 228
            LGEG +G V        G  +A+K +E                      F+        
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEP---------------------FDKPLFALRT 56

Query: 229 --EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYM-CNGSLYDRLARVNNT 275
             E++ L   KH N++ +     NI             I+ E M  +      L RV +T
Sbjct: 57  LREIKILKHFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTD------LHRVIST 106

Query: 276 PPL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IV 330
             L D + +Y        A+  LH  +  +IHRD+K +N+L++ N   K+ DFG    I 
Sbjct: 107 QMLSDDHIQY-FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 331 KMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           + +  ++  T     +     TR Y  PE M      ++  DV+S G IL EL    +PI
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 18/168 (10%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGVAEALHYLHSLSKPIIHRDVKS 311
            ++ +Y+  G L+  L++          + Y   I L    AL +LH L   II+RD+K 
Sbjct: 135 HLILDYINGGELFTHLSQRERFT-EHEVQIYVGEIVL----ALEHLHKLG--IIYRDIKL 187

Query: 312 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS--TKT-DV 368
            N+LLD N    L DFG+ K       +  Y     GT  YM P+ +    S   K  D 
Sbjct: 188 ENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDIVRGGDSGHDKAVDW 245

Query: 369 FSYGVILLELLTGMKP----IDDNNTILYYYLVVEQEVPVREVLDKEA 412
           +S GV++ ELLTG  P     + N+       +++ E P  + +   A
Sbjct: 246 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 63/229 (27%), Positives = 93/229 (40%), Gaps = 43/229 (18%)

Query: 177 KLGEGQFGTVY--YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 232
            LGEG FG V         G  +AVK ++N   Y        EAA   I +L   N    
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-------CEAARSEIQVLEHLNTTDP 73

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            S  + V +L       +I  CIV+E +   S YD + + N   P   +    +A  + +
Sbjct: 74  NSTFRCVQMLEWFEHHGHI--CIVFE-LLGLSTYDFI-KENGFLPFRLDHIRKMAYQICK 129

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP-------------------KLGDFGIVKMS 333
           ++++LHS    + H D+K  N+L  ++                      K+ DFG    S
Sbjct: 130 SVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG----S 183

Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
            T + +   T  L  TR Y  PE  +    S   DV+S G IL+E   G
Sbjct: 184 ATYDDEHHST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 61/241 (25%), Positives = 93/241 (38%), Gaps = 46/241 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +  V   +LK    I A+K ++        + D  +         E  V   +  
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--------EKHVFEQA-S 67

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
            H   V L        RL           V EY+  G L   + R     P +  + YS 
Sbjct: 68  NHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 117

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMY 342
            I+L    AL+YLH     II+RD+K  NVLLD     KL D+G+ K  +       T  
Sbjct: 118 EISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 170

Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +    + D ++ GV++ E++ G  P D   +        E  
Sbjct: 171 ----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226

Query: 402 V 402
           +
Sbjct: 227 L 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 31/170 (18%)

Query: 229 EVQTLSQCKHVNLLRLLGL---CNNIMNC----IVYEYM-CNGSLYDRLARVNNTPPLDS 280
           E++ L   +H N++ LL +      + +     +V  +M  +      L ++     L  
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD------LGKLMKHEKLGE 127

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           ++   +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++     
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS----- 180

Query: 341 MYTENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                +TG   TR Y  PE +    + +   D++S G I+ E++TG K +
Sbjct: 181 ----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 33/171 (19%)

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNC-----------IVYEYM-CNGSLYDRLARVNNTP 276
           E++ L   KH N++ LL    ++              +V   M  +      L  +    
Sbjct: 78  ELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGAD------LNNIVKCQ 127

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L  +    +   +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T+
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTA 183

Query: 337 NMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
           +  T Y      TR Y  PE M      +   D++S G I+ ELLTG + +
Sbjct: 184 DEMTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 52/234 (22%), Positives = 88/234 (37%), Gaps = 49/234 (20%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V   + + N    AVK + N   Y       T +A I       E   L +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-------TRSAKI-------EADILKK 87

Query: 236 CKH--------VNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            ++        V         +++  C+++E     SLY+ +   NN             
Sbjct: 88  IQNDDINNNNIVKYHGKFMYYDHM--CLIFE-PLGPSLYEII-TRNNYNGFHIEDIKLYC 143

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK-------- 339
           + + +AL+YL  +S  + H D+K  N+LLD+ +  K                        
Sbjct: 144 IEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 340 --------TMYTENLTG---TRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
                   T  ++       TR Y  PE  ++      +D++S+G +L EL TG
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 46/241 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +  V   +LK    I A++ ++        + D  +         E  V   +  
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT--------EKHVFEQA-S 110

Query: 237 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
            H   V L        RL           V EY+  G L   + R     P +  + YS 
Sbjct: 111 NHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 160

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMY 342
            I+L    AL+YLH     II+RD+K  NVLLD     KL D+G+ K  +       T  
Sbjct: 161 EISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 213

Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +    + D ++ GV++ E++ G  P D   +        E  
Sbjct: 214 ----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269

Query: 402 V 402
           +
Sbjct: 270 L 270

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 42/183 (22%)

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNC-------------------IVYEYM-CNGSLYDR 268
           E++ + +  H N++++      I+                     IV EYM  +      
Sbjct: 58  EIKIIRRLDHDNIVKVF----EILGPSGSQLTDDVGSLTELNSVYIVQEYMETD------ 107

Query: 269 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDF 327
           LA V    PL           +   L Y+HS +  ++HRD+K AN+ ++ E+ V K+GDF
Sbjct: 108 LANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDF 165

Query: 328 GIVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGM 382
           G+ ++ +       +   L+    T+ Y  P  +      TK  D+++ G I  E+LTG 
Sbjct: 166 GLARIMDPHYSHKGH---LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG- 221

Query: 383 KPI 385
           K +
Sbjct: 222 KTL 224

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 67.2 bits (163), Expect = 6e-12
 Identities = 72/474 (15%), Positives = 132/474 (27%), Gaps = 145/474 (30%)

Query: 51  LKYSAKDI-KIVERAGKRNFPERGCTDIF-----------LDEWGTSGRRRPRLSDLIMF 98
            +Y  KDI  + E A   NF    C D+            +D    S         L   
Sbjct: 14  HQYQYKDILSVFEDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70

Query: 99  LKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEE---ANNKTEYIGELIAFT 155
           L   +     ++VE +VL+       N +   +L   I+ E+   +     YI E     
Sbjct: 71  LLSKQEEMVQKFVE-EVLRI------NYK---FLMSPIKTEQRQPSMMTRMYI-EQRDRL 119

Query: 156 FCDLERATDGF-NR-KPYPRRGNKLGE---GQFGTVYYGKLKNGMEIAVKT-LENNANYS 209
           + D +       +R +PY +    L E    +   +       G+  + KT +  +    
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID------GVLGSGKTWVALDV--- 170

Query: 210 SSNSDNTEAAMIPILLFENEVQ--TLSQCKHVN--LLRLLGLCNNIMN--CIVYEYMCN- 262
              S   +         + ++    L  C      L  L  L   I        ++  N 
Sbjct: 171 -CLSYKVQCK------MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 263 ----GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL--- 315
                S+   L R      L  +K Y   L               ++  +V++A      
Sbjct: 224 KLRIHSIQAELRR------LLKSKPYENCL---------------LVLLNVQNAKAWNAF 262

Query: 316 ------L----DENFVPKLGDFGIVKMSETSNMKTMY---TENL----TGTRPY-MPPEA 357
                 L     +     L       +S   +  T+     ++L       RP  +P E 
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322

Query: 358 MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE 417
                +         +I           D   T   +          + V   +     E
Sbjct: 323 --LTTNP----RRLSII------AESIRDGLATWDNW----------KHVNCDKLTTIIE 360

Query: 418 THVETLISI----VFEKCCVFEKD---------------KRASMRDIVDLLSKS 452
           + +  L       +F++  VF                   ++ +  +V+ L K 
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY 414

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 33/222 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G K+G G FG +Y G  +  G E+A+K       +             P L  E+++ + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------------PQLHIESKIYKM 60

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +     +  +R  G   +  N +V E +  G SL D     +    L +     +A  + 
Sbjct: 61  MQGGVGIPTIRWCGAEGD-YNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL--LADQMI 115

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKM--SETSNMKTMYTEN 345
             + Y+HS  K  IHRDVK  N L+      N V  + DFG+ K      ++    Y EN
Sbjct: 116 SRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYREN 172

Query: 346 --LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKP 384
             LTGT  Y      +  + S + D+ S G +L+    G  P
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 12/102 (11%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           AL Y HS    I+HRDVK  NV++D E+   +L D+G   ++E  +    Y   +  +R 
Sbjct: 142 ALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVA-SRY 195

Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI---DDN 388
           +  PE +  +       D++S G +L  ++   +P     DN
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 33/219 (15%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G K+G G FG +Y G  ++   E+A+K       +             P LL+E+++ + 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------PQLLYESKIYRI 58

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L     +  +R  G+  +  N +V + +  G SL D     +    L +     +A  + 
Sbjct: 59  LQGGTGIPNVRWFGVEGD-YNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM--LADQMI 113

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK--MSETSNMKTMYTEN 345
             + ++H  SK  +HRD+K  N L+      N V  + DFG+ K     +++    Y EN
Sbjct: 114 NRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 346 --LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
             LTGT  Y      +  + S + D+ S G +L+  L G
Sbjct: 171 KNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 72/249 (28%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            KLG+G +G V+     + G  +AVK + +                     F+N      
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------------------AFQNSTD--- 51

Query: 235 QCKH----VNLLRLLGLCNNIMNC-------------IVYEYMCNGSLYDRLARVNNTPP 277
             +     + +L  L    NI+N              +V++YM      D L  V     
Sbjct: 52  -AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM----ETD-LHAVIRANI 105

Query: 278 L-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-------- 328
           L   +K+Y +   + + + YLHS    ++HRD+K +N+LL+     K+ DFG        
Sbjct: 106 LEPVHKQY-VVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162

Query: 329 -------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILL 376
                   + ++E +         LT    TR Y  PE +      TK  D++S G IL 
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222

Query: 377 ELLTGMKPI 385
           E+L G KPI
Sbjct: 223 EILCG-KPI 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 67/247 (27%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 228
            +G G +G VY          +A+K +                      +FE+       
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------------------MFEDLIDCKRI 72

Query: 229 --EVQTLSQCKHVNLLRLLGLC--NNIMNC----IVYEYMCNGSLYDRLARVNNTP-PL- 278
             E+  L++ K   ++RL  L   ++++      IV E        D L ++  TP  L 
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA----DSD-LKKLFKTPIFLT 127

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG---------- 328
           + + +  I   +    +++H     IIHRD+K AN LL+++   K+ DFG          
Sbjct: 128 EEHIKT-ILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 329 ------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLE 377
                 + +  E         + LT    TR Y  PE +   +  TK+ D++S G I  E
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

Query: 378 LLTGMKP 384
           LL  ++ 
Sbjct: 245 LLNMLQS 251

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 45/226 (19%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G ++GEG FG ++ G  L N  ++A+K     ++              P L  E    + 
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------------PQLRDEYRTYKL 61

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYS------ 285
           L+ C  +  +   G      N +V + +  G SL D L            +++S      
Sbjct: 62  LAGCTGIPNVYYFGQEGL-HNVLVIDLL--GPSLEDLLDL--------CGRKFSVKTVAM 110

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK-----LGDFGIVKM--SETSNM 338
            A  +   +  +H   K +++RD+K  N L+            + DFG+VK      +  
Sbjct: 111 AAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168

Query: 339 KTMYTEN--LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
              Y E   L+GT  YM     +  + S + D+ + G + +  L G
Sbjct: 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 47/227 (20%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G K+G G FG +  GK L     +A+K     +                 L  E    + 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-------------LHLEYRFYKQ 60

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYS------ 285
           L     +  +   G C    N +V E +  G SL D             ++ +S      
Sbjct: 61  LGSGDGIPQVYYFGPCGK-YNAMVLELL--GPSLEDLFDL--------CDRTFSLKTVLM 109

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL------DENFVPKLGDFGIVK--MSETSN 337
           IA+ +   + Y+HS  K +I+RDVK  N L+       +  +  + DF + K  +   + 
Sbjct: 110 IAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETK 166

Query: 338 MKTMYTEN--LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
               Y E+  LTGT  YM     +  + S + D+ + G + +  L G
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 80/256 (31%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 228
            +G G +G V           +A+K +                      +FE+       
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILR--------------------VFEDLIDCKRI 99

Query: 229 --EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYMCNGSLYDRLARVNNTP 276
             E+  L++  H +++++L    +I+            +V E        D   ++  TP
Sbjct: 100 LREIAILNRLNHDHVVKVL----DIVIPKDVEKFDELYVVLEIA----DSD-FKKLFRTP 150

Query: 277 -PL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG------ 328
             L + + +  +   +   + Y+HS    I+HRD+K AN L++++   K+ DFG      
Sbjct: 151 VYLTELHIKT-LLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207

Query: 329 ---------------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DV 368
                                T          LTG   TR Y  PE +   +  T+  DV
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267

Query: 369 FSYGVILLELLTGMKP 384
           +S G I  ELL  +K 
Sbjct: 268 WSIGCIFAELLNMIKE 283

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 50/265 (18%), Positives = 89/265 (33%), Gaps = 79/265 (29%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANY--------------SSSNSDNTEAAMI 221
           KLG G F TV+    ++    +A+K +++  +Y               +S+ ++    M+
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDS 280
             LL + ++       H+              C+V+E + +  L   + + N    PL  
Sbjct: 104 VQLLDDFKISG-VNGTHI--------------CMVFEVLGH-HLLKWIIKSNYQGLPLPC 147

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----------------DENFVPK 323
            K+  I   V + L YLH+  + IIH D+K  N+LL                   +  P 
Sbjct: 148 VKK--IIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 324 LGDFGIVKMSETSNMKTMYTENLTG--------------------------TRPYMPPEA 357
                +     T+    +                                 TR Y   E 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEV 264

Query: 358 M-HCQISTKTDVFSYGVILLELLTG 381
           +     +T  D++S   +  EL TG
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATG 289

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 39/228 (17%), Positives = 77/228 (33%), Gaps = 25/228 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTL-ENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  +G+G FG +Y   + +   +            S +    TE           ++Q  
Sbjct: 40  GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99

Query: 234 SQCKHVNLL--------RLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRY 284
            + + +  L         L          ++ +    G  L              +    
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV--L 155

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 341
            ++L + + L Y+H      +H D+K++N+LL   + + V  L D+G+        +   
Sbjct: 156 QLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEGVHKA 212

Query: 342 YTE----NLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKP 384
           Y         GT  +   +A      S + D+   G  +++ LTG  P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 38/231 (16%), Positives = 77/231 (33%), Gaps = 31/231 (13%)

Query: 175 GNKLGEGQFGTVYYGK---------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
            +       G +Y                 + ++K    +    +  +    AA    + 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 226 FENEVQTLSQCKHVNLLRLL--GLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNK 282
              ++        + +   +  G+  +    +V   +  G SL      V+    L    
Sbjct: 107 KWKKLY---STPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERS 160

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMK 339
              +A  + +AL +LH      +H +V + N+ +   D++ V  L  +G       S   
Sbjct: 161 VLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKH 217

Query: 340 TMYTEN----LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKP 384
             Y E       G   ++  +  H  C  S ++D+ S G  +L+ L G  P
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDL-HKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.1 bits (129), Expect = 3e-08
 Identities = 37/269 (13%), Positives = 76/269 (28%), Gaps = 56/269 (20%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTL----ENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           K+GEG FG V+     +   +A+K +     +  N S   +       I I    + +  
Sbjct: 27  KIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 233 LSQCKHVNLLRLLGLCNNIMNC-------------------------------IVYEYMC 261
               +    + L  +     +                                IV E+  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 262 NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV 321
            G   +++    ++         SI   +  +L    +  +   HRD+   NVLL +  +
Sbjct: 146 GGIDLEQMRTKLSSLAT----AKSILHQLTASLAVAEASLR-FEHRDLHWGNVLLKKTSL 200

Query: 322 PKLGDFG------------IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVF 369
            KL                 V + + +  +      +      M  +        + D++
Sbjct: 201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIY 260

Query: 370 SY-GVILLELLTGMKPIDDNNTILYYYLV 397
                          P   +N +  +YL 
Sbjct: 261 RLMKKENNNRWGEYHPY--SNVLWLHYLT 287

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 47/247 (19%), Positives = 81/247 (32%), Gaps = 66/247 (26%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEV- 230
           G K+G G FG +Y         + A     +E   N                L  E +  
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--------------GPLFSELKFY 87

Query: 231 QTLSQCKHVNLLRLLGLCNNI-----------------MNCIVYEYMCNG-SLYDRLARV 272
           Q +++   +         + +                    +V E +  G  L       
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS--- 142

Query: 273 NNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPK 323
                   N  +       + + + + L Y+H      +H D+K+AN+LL   + + V  
Sbjct: 143 ------GQNGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQV-Y 193

Query: 324 LGDFGIVKMSETSNMKTMYTEN----LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLE 377
           L D+G+      +     Y EN      GT  +   +A H    +S ++DV   G  +L 
Sbjct: 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDA-HKGVALSRRSDVEILGYCMLR 252

Query: 378 LLTGMKP 384
            L G  P
Sbjct: 253 WLCGKLP 259

>1d2z_A Death domain of pelle; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 PDB: 1ik7_A 1ygo_A Length = 108

 Score = 48.4 bits (115), Expect = 2e-07
 Identities = 24/108 (22%), Positives = 43/108 (39%), Gaps = 15/108 (13%)

Query: 2   TSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIV 61
           +  S +   + IR L   V  +L   L+  D W+++ + V          K     ++ +
Sbjct: 2   SHMSHLDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATAV----------KLYPDQVEQI 51

Query: 62  ERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAAR 109
               +R    R  ++ FL+ WG   +    +  L    KK +LH A R
Sbjct: 52  SSQKQRG---RSASNEFLNIWGG--QYNHTVQTLFALFKKLKLHNAMR 94

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	455
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
1d2z_B	153	Death domain of tube; six-helix bundle, linear arr	99.96
2a9i_A	113	IRAK-4, interleukin-1 receptor-associated kinase-4	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1wh4_A	127	IRAK4, interleukin-1 receptor-associated kinase 4;	99.93
3mop_K	111	IRAK-2, interleukin-1 receptor-associated kinase-l	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1d2z_A	108	Death domain of pelle; six-helix bundle, linear ar	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1wmg_A	103	Netrin receptor UNC5H2; six helix bundle, death do	99.22
3mop_A	110	Myeloid differentiation primary response protein;	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
2g7r_A	117	Mucosa-associated lymphoid tissue lymphoma transl	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
2dbf_A	100	Nuclear factor NF-kappa-B P105 subunit; apoptosis,	98.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.56
1ngr_A	85	P75 low affinity neurotrophin receptor; intracellu	98.55
2d96_A	109	Nuclear factor NF-kappa-B P100 subunit; six helix	98.46
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.31
3g5b_A	405	Netrin receptor UNC5B; ZU5, death domain, UPA, apo	98.31
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.18
2ib1_A	91	Death domain containing membrane protein nradd; ap	98.12
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.98
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.82
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.6
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.56
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.52
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.46
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.22
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.63
1wxp_A	110	THO complex subunit 1; death domain, structural ge	95.52
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.19
2yqf_A	111	Ankyrin-1; death domain, structural genomics, NPPS	94.87
2o71_A	115	Death domain-containing protein cradd; raidd, apop	94.85
2of5_A	114	Death domain-containing protein cradd; death domai	94.81
3oq9_A	86	Tumor necrosis factor receptor superfamily member;	94.62
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.33
3ezq_B	122	Protein FADD; apoptosis, DISC, FAS, membrane,recep	93.91
2of5_H	118	Leucine-rich repeat and death domain-containing pr	93.59
1fad_A	99	Protein (FADD protein); apoptosis, death domain; N	93.27
2gf5_A	191	FADD protein; death domain, death effector domain,	91.25
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.9
1ich_A	112	TNF-1, tumor necrosis factor receptor-1; death dom	89.62
4d8o_A	581	Ankyrin-2; ZU5, UPA, death domain, supramodule, pr	88.91
3ezq_A	115	Tumor necrosis factor receptor superfamily member;	88.66
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.32
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.51

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-56  Score=436.42  Aligned_cols=257  Identities=29%  Similarity=0.443  Sum_probs=201.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      +++++||+|+||+||+|+++  ..||||+++....      .     ....+.|.+|+.++++++|||||+++|++.++.
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~------~-----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  105 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDP------T-----PEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDN  105 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSC------C-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCC------C-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCe
Confidence            45688999999999999876  3699999864321      1     112567999999999999999999999998888


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+|||||+||||.++|....  .++++.+++.|+.|++.||+|||+  ++||||||||+||||++++.+||+|||+|+.
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             EEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            999999999999999997643  469999999999999999999999  8899999999999999999999999999987


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ...... ........||+.|||||++.+    .++.++|||||||+||||+||+.||.+.+...............+   
T Consensus       182 ~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p---  257 (307)
T 3omv_A          182 KSRWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP---  257 (307)
T ss_dssp             -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC---
T ss_pred             cccCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            543321 122345789999999997743    478899999999999999999999987653322222221111111   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        .... .+..++..+.+|+.+||..||++|||+.||++.|+.+.
T Consensus       258 --~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          258 --DLSK-LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             --CSTT-SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             --Cccc-ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence              0000 11234566889999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.5e-56  Score=432.64  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=205.7

Q ss_pred             CCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         175 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .++||+|+||+||+|.+.      +++.||||+++.....            ...+.|.+|+.++++++|||||+++|+|
T Consensus        31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~------------~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG------------PLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh------------HHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            478999999999999863      3678999999643221            1145699999999999999999999999


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .+ +..|+|||||++|||.++|.....             ...+++.+++.|+.|||.||+|||+  ++||||||||+||
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NI  176 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNV  176 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccce
Confidence            87 788999999999999999975321             2469999999999999999999999  8899999999999


Q ss_pred             EEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchh
Q psy5603         315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~  392 (455)
                      ||++++.+||+|||+++....... ........||+.|||||++ .+.++.++|||||||++|||+| |..||.+.....
T Consensus       177 Ll~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          177 LVYDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             EECGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             EECCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999986654331 1223456899999999965 5678999999999999999999 999999877544


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ....+......           ..+..++..+.+|+.+||..||++||+++||++.|+...
T Consensus       256 ~~~~i~~~~~~-----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          256 VVEMIRNRQVL-----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHcCCCC-----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            33333222110           112345566889999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.6e-56  Score=431.92  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=205.7

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .++++||+|+||+||+|++.      +++.||||+++....             ...+.|.+|++++++++|||||+++|
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------------~~~~~f~~E~~il~~l~HpnIV~l~g   82 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-------------NARKDFHREAELLTNLQHEHIVKFYG   82 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-------------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-------------HHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            45588999999999999874      367899999964211             11456999999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEE
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVN----------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +|.+ +..|+|||||+||||.++|...+          ....++|.+++.|+.|++.||.|||+  ++||||||||+|||
T Consensus        83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NIL  160 (299)
T 4asz_A           83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCL  160 (299)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEE
Confidence            9987 78899999999999999997642          23579999999999999999999999  88999999999999


Q ss_pred             EcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhh
Q psy5603         316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                      |++++.+||+|||+|+....... ........||+.|||||++ .+.++.++|||||||++|||+| |+.||.+.+....
T Consensus       161 l~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~  239 (299)
T 4asz_A          161 VGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  239 (299)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ECCCCcEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999987654332 2223445799999999966 4578999999999999999999 9999998765443


Q ss_pred             HHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ...+......           ..+..++..+.+|+.+||..||++|||+++|.+.|+++.
T Consensus       240 ~~~i~~~~~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          240 IECITQGRVL-----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHHHTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            3333322110           012234556889999999999999999999999998865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.6e-55  Score=432.31  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=199.2

Q ss_pred             CCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         174 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +.++||+|+||+||+|+++      +++.||||+++....             ...+.|.+|++++++++|||||+++|+
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------------~~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-------------SARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH-------------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH-------------HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3478999999999999874      368899999963211             114569999999999999999999999


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNN------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      |.+ ...|+|||||++|+|.++|.....            ..+++|.+++.|+.|++.||.|||+  ++||||||||+||
T Consensus       112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NI  189 (329)
T 4aoj_A          112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNC  189 (329)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhE
Confidence            988 788999999999999999976432            3479999999999999999999999  8899999999999


Q ss_pred             EEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchh
Q psy5603         315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~  392 (455)
                      ||++++.+||+|||+++....... ........||+.|||||++. ..++.++|||||||++|||+| |+.||.+.....
T Consensus       190 Ll~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          190 LVGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             EEETTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             EECCCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999986644332 12234568999999999664 468999999999999999999 999998876544


Q ss_pred             hHHHhhhcc-cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         393 YYYLVVEQE-VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....+.... ...            +..++..+.+|+.+||..||++|||+.||++.|+.+..
T Consensus       269 ~~~~i~~g~~~~~------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          269 AIDCITQGRELER------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHTCCCCC------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCC------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            333332211 111            12345568899999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-55  Score=421.80  Aligned_cols=246  Identities=25%  Similarity=0.410  Sum_probs=198.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      ++++.++||+|+||+||+|.++ ++..||||++......           ......|.+|+.++++++|||||++++++.
T Consensus        27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   95 (290)
T 3fpq_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-----------KSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-----------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            3456678999999999999987 4889999999754321           112466999999999999999999999764


Q ss_pred             C-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eeecCCCCCcEEEc-CCCc
Q psy5603         250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLD-ENFV  321 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~--iiH~Dikp~NILl~-~~~~  321 (455)
                      +     ...|+|||||+||+|.+++...   .++++..+..|+.||+.||+|||+  ++  ||||||||+||||+ ++|.
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~--~~~~IiHRDlKp~NILl~~~~g~  170 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGS  170 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCCCCCGGGEEESSTTSC
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCEEecccChhheeEECCCCC
Confidence            3     4579999999999999999873   469999999999999999999999  66  99999999999997 4899


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchh-hHHHhhhc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~  400 (455)
                      +||+|||+|+......     ....+||+.|||||++.+.++.++|||||||++|||+||.+||.+..... ....+...
T Consensus       171 vKl~DFGla~~~~~~~-----~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~  245 (290)
T 3fpq_A          171 VKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  245 (290)
T ss_dssp             EEECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             EEEEeCcCCEeCCCCc-----cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence            9999999998644322     33568999999999998899999999999999999999999998655322 22222211


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+  ..++        ..++..+.+||.+||..||++|||++|+++
T Consensus       246 ~~~--~~~~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 VKP--ASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCC--GGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC--CCCC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111  0111        112334788999999999999999999976

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-55  Score=433.13  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=203.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +++.++||+|+||.||+|+++ +|+.||||+++....                  +.+|+.++++++|||||++++++.+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------------------~~~E~~il~~l~HpnIV~l~~~~~~  121 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------------------RVEELVACAGLSSPRIVPLYGAVRE  121 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------------------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------------------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            455688999999999999986 489999999974321                  3479999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC-ceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG  328 (455)
                       +..|+|||||+||+|.++|...   .++++..+..|+.|++.||+|||+  ++||||||||+||||+.+| .+||+|||
T Consensus       122 ~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          122 GPWVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             CCEEEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCC
Confidence             7889999999999999999874   469999999999999999999999  8899999999999999988 69999999


Q ss_pred             cccccccCCcce--eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         329 IVKMSETSNMKT--MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +|+.........  .....++||+.|||||++.+ .++.++|||||||++|||+||.+||.+.........+.....++.
T Consensus       197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~  276 (336)
T 4g3f_A          197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR  276 (336)
T ss_dssp             TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG
T ss_pred             CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch
Confidence            998765433211  22345789999999997755 589999999999999999999999987765444444443332222


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ++         +..++..+.+||.+||..||++|||+.|+++.|.+++
T Consensus       277 ~~---------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          277 EI---------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             GS---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hc---------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            11         1234566889999999999999999999999987765

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.2e-55  Score=431.90  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=203.5

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.+.||+|+||+||+|+++ +|+.||||+++....      ..     .....|.+|+.++++++|||||++
T Consensus        20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~-----~~~~~~~~E~~il~~l~HpnIV~~   88 (350)
T 4b9d_A           20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM------SS-----KEREESRREVAVLANMKHPNIVQY   88 (350)
T ss_dssp             CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS------CH-----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC------CH-----HHHHHHHHHHHHHHHCCCCCCCcE
Confidence            444456788899999999999999986 589999999975432      11     114568999999999999999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.+ +..|+|||||+||+|.++|.... ...+++.+++.|+.||+.||.|||+  +|||||||||+||||+.+|.+|
T Consensus        89 ~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vK  165 (350)
T 4b9d_A           89 RESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQ  165 (350)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEE
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEE
Confidence            998877 88899999999999999997643 3568999999999999999999999  8999999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+|||+|+......   ......+||+.|||||++.+ .++.++|||||||++|||+||++||.+.+.......+.....
T Consensus       166 l~DFGla~~~~~~~---~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  242 (350)
T 4b9d_A          166 LGDFGIARVLNSTV---ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF  242 (350)
T ss_dssp             ECSTTEESCCCHHH---HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             EcccccceeecCCc---ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            99999998654321   12345689999999997765 588999999999999999999999998775544444433221


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.           .+..++..+.+||.+||..||++|||+.|+++
T Consensus       243 ~~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 PP-----------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC-----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10           01234456889999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.1e-55  Score=426.10  Aligned_cols=247  Identities=26%  Similarity=0.386  Sum_probs=206.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||+||+|+++ +|+.||||++.+.....          ......+.+|++++++++|||||++++++.+
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~----------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  103 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK----------ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD  103 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            466799999999999999986 58999999997542211          1125668999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+|||||+||+|.+++...   ..+++..+..++.||+.||+|||+  ++||||||||+||||+.+|.+||+|||+
T Consensus       104 ~~~~yivmEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGl  178 (311)
T 4aw0_A          104 DEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT  178 (311)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence             8889999999999999999874   469999999999999999999999  8999999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+...... ........+||+.|||||++.+ .++.++||||+||++|||+||.+||.+.+.......+......+++  
T Consensus       179 a~~~~~~~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--  255 (311)
T 4aw0_A          179 AKVLSPES-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--  255 (311)
T ss_dssp             CEECCTTT-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             ceecCCCC-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence            98765432 1223456799999999997754 5789999999999999999999999987765555555444333322  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                                .++..+++||.+||..||++||++.|++
T Consensus       256 ----------~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          256 ----------KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                      2344588999999999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-54  Score=414.52  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=190.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.++ +|+.||||++++......          .....+.+|+.++++++|||||++++++.
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS----------DMQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH----------HHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            3677799999999999999976 589999999975433211          11456899999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+||||+ +|+|.+++...   .++++.++..++.|++.||+|||+  +||+||||||+|||+++++.+||+|||
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecC
Confidence            7 8889999998 78999999873   469999999999999999999999  899999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccCC-C-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +|+......    .....+||+.|||||++.+. + +.++||||+||++|||+||++||.+.+.......+......++.
T Consensus       158 la~~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~  233 (275)
T 3hyh_A          158 LSNIMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK  233 (275)
T ss_dssp             CC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             CCeecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            998654332    12356899999999988664 3 57999999999999999999999887655444444433333222


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                  .++..+.+||.+||..||++|||++|+++
T Consensus       234 ------------~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          234 ------------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                        23445889999999999999999999987

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.8e-54  Score=424.43  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=204.6

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.++||+|+||+||+|.++ +|+.||||+++.....      .       ...+.+|+.++++++|||||+++++
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~------~-------~~~~~~Ei~il~~l~HpnIV~l~~~  139 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ------R-------RELLFNEVVIMRDYQHENVVEMYNS  139 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS------S-------GGGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh------H-------HHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            345667789999999999999987 5899999999754321      0       2347899999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ +..|+|||||+||+|.+++..    ..+++.++..|+.||+.||+|||+  +|||||||||+||||+.+|.+||+|
T Consensus       140 ~~~~~~~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~D  213 (346)
T 4fih_A          140 YLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSD  213 (346)
T ss_dssp             EEETTEEEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEec
Confidence            877 889999999999999999975    259999999999999999999999  8999999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+.......   .....+||+.|||||++.+ .++.++|||||||++|||+||.+||.+.+.......+......  
T Consensus       214 FGla~~~~~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--  288 (346)
T 4fih_A          214 FGFCAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--  288 (346)
T ss_dssp             CTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC--
T ss_pred             CcCceecCCCCC---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--
Confidence            999987654321   2346799999999997754 6899999999999999999999999887654443333321111  


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ..  .....++..+.+||.+||..||++|||+.|+++
T Consensus       289 -----~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 -----RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -----CC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 00  112345566899999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.2e-54  Score=417.43  Aligned_cols=263  Identities=23%  Similarity=0.362  Sum_probs=195.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  251 (455)
                      .++++||+|+||+||+|+++ |+.||||+++....              ....+..|+..+.+++|||||+++++|.+. 
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~--------------~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--------------RSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH--------------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--------------hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            45688999999999999986 79999999853211              012244577777889999999999988652 


Q ss_pred             ----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeeecCCCCCcEEEcCCCc
Q psy5603         252 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       252 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~------~~~iiH~Dikp~NILl~~~~~  321 (455)
                          ..|+|||||+||||.++|..    .++++..+..++.|++.||+|||+.      ..+||||||||+||||+.++.
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~  146 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCceEEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence                46999999999999999986    3589999999999999999999972      138999999999999999999


Q ss_pred             eEEeecccccccccCCcce-eeeccCCCCCCCCCcccccCC-------CCcccchHHHHHHHHHHHcCCCCCCCCcchhh
Q psy5603         322 PKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-------~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      +||+|||+|+......... .......||+.|||||++.+.       ++.++|||||||++|||+||.+||........
T Consensus       147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~  226 (303)
T 3hmm_A          147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence            9999999998765443221 223456899999999987543       56799999999999999999887754331110


Q ss_pred             HHHhhh-cccc--------hhhccchhc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         394 YYLVVE-QEVP--------VREVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~-~~~~--------~~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .+.... ....        ....+++.. ..+....+...+.+|+.+||..||++|||+.||++.|+++.+
T Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000000 0000        001111111 112233566778899999999999999999999999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.8e-53  Score=425.98  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=207.7

Q ss_pred             hcCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce
Q psy5603         163 TDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       163 t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      ...-+....|++.++||+|+||.||+|.++ +|+.||||++.....      ..       ...+.+|+.+|++++||||
T Consensus       144 ~~~~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~------~~-------~~~~~~Ei~il~~l~HpnI  210 (423)
T 4fie_A          144 VDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ------QR-------RELLFNEVVIMRDYQHENV  210 (423)
T ss_dssp             SCSSCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC------SS-------GGGHHHHHHHHHHCCCTTB
T ss_pred             CCCCChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch------hH-------HHHHHHHHHHHHhCCCCCC
Confidence            333444556788899999999999999987 489999999975322      11       2348899999999999999


Q ss_pred             eeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         242 LRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       242 v~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      |++++++.+ +..|+|||||+||+|.+++..    ..+++.++..|+.||+.||+|||+  +|||||||||+||||+.+|
T Consensus       211 V~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g  284 (423)
T 4fie_A          211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDG  284 (423)
T ss_dssp             CCEEEEEEETTEEEEEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTC
T ss_pred             CceEEEEEECCEEEEEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCC
Confidence            999998877 889999999999999999875    259999999999999999999999  8999999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||+|+......   ......+||+.|||||++.+ .++.++|||||||++|||++|.+||.+.........+..
T Consensus       285 ~vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  361 (423)
T 4fie_A          285 RVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD  361 (423)
T ss_dssp             CEEECCCTTCEECCSSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CEEEecCccceECCCCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence            99999999998765432   12346789999999997754 689999999999999999999999988765444433332


Q ss_pred             cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....       ...  ....++..+.+||.+||..||++||++.|+++
T Consensus       362 ~~~~-------~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          362 NLPP-------RLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCCC-------CCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC-------CCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2111       010  11234556889999999999999999999976

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.1e-53  Score=420.94  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=205.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc-cceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l  244 (455)
                      +++++.||+|+||+||+|.+..      ++.||||+++....      .      ...+.|.+|+.++++++| ||||++
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~------~------~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------H------SEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------h------HHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4667899999999999998753      35799999964322      1      114569999999999965 899999


Q ss_pred             cccccC--ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         245 LGLCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      +|+|.+  ...|+|||||++|+|.++|.....             ...+++..++.|+.|||.||+|||+  ++||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCcc
Confidence            998865  467999999999999999976321             3468999999999999999999999  88999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q psy5603         310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+|||+++++.+||+|||+|+....... ...+....||+.|||||++ .+.++.++|||||||+||||+| |..||.+
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987654432 2234567899999999966 5578999999999999999998 9999987


Q ss_pred             CcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................+          ..+..++..+.+++.+||..||++|||+.||++.|++++.
T Consensus       291 ~~~~~~~~~~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          291 VKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCCSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            65332222211111110          0112234558889999999999999999999999998863

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.8e-54  Score=416.33  Aligned_cols=245  Identities=24%  Similarity=0.307  Sum_probs=195.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||+||+|+..    +++.||||+++........           ...+.+|++++++++|||||+++++
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~~~   94 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-----------RVRTKMERDILVEVNHPFIVKLHYA   94 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-----------CC------CCCCCCCCTTEECEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-----------HHHHHHHHHHHHHCCCCCCCeEEEE
Confidence            567799999999999999863    3678999999754321110           1237889999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ +..|+|||||+||+|.+++...   .++++.++..++.|++.||+|||+  +||+||||||+|||++.+|.+||+|
T Consensus        95 ~~~~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~D  169 (304)
T 3ubd_A           95 FQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTD  169 (304)
T ss_dssp             EEETTEEEEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEES
T ss_pred             EEECCEEEEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecc
Confidence            877 8899999999999999999874   469999999999999999999999  8999999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+......   ......+||+.|||||++.+ .++.++|||||||++|||+||.+||.+.+.......+......++
T Consensus       170 FGla~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p  246 (304)
T 3ubd_A          170 FGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP  246 (304)
T ss_dssp             SEEEEC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cccceeccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence            99998654332   12345789999999997754 689999999999999999999999998776555555444333332


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH-----HHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM-----RDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~-----~evl~  447 (455)
                      .            .++..+.+||.+||..||++||++     +|+++
T Consensus       247 ~------------~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          247 Q------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             T------------TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C------------cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            2            234458899999999999999984     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.1e-51  Score=396.22  Aligned_cols=248  Identities=25%  Similarity=0.342  Sum_probs=183.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||+||+|+++ +|+.||||+++....            ....+.+.+|++++++++|||||++++++.+ 
T Consensus         8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   75 (299)
T 4g31_A            8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR------------ELAREKVMREVKALAKLEHPGIVRYFNAWLEK   75 (299)
T ss_dssp             EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC------------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence            45589999999999999986 589999999964321            1124568999999999999999999997754 


Q ss_pred             c------------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         251 I------------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       251 ~------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      +            ..|+|||||+||+|.+++.........++..++.|+.|++.||+|||+  +|||||||||+||||+.
T Consensus        76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECT
T ss_pred             CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECC
Confidence            2            368999999999999999876554556778899999999999999999  89999999999999999


Q ss_pred             CCceEEeecccccccccCCcce---------eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCC
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKT---------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~  388 (455)
                      +|.+||+|||+|+.........         ......+||+.|||||++.+ .++.++|||||||++|||++   ||...
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            9999999999998765432111         11234689999999997755 58999999999999999996   77643


Q ss_pred             cchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         389 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......... .....++..         .........+||.+||..||++|||+.|+++
T Consensus       231 ~~~~~~~~~-~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          231 MERVRTLTD-VRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHH-HHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cHHHHHHHH-HhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            221111111 011111111         1122334567899999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-50  Score=404.20  Aligned_cols=266  Identities=22%  Similarity=0.320  Sum_probs=202.6

Q ss_pred             CCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceee
Q psy5603         165 GFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       165 ~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      .|.....|++.+.||+|+||+||+|.++ +|+.||||+++....      .     ....+.+.+|+++|++++|||||+
T Consensus        49 ~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~------~-----~~~~~~~~~Ei~il~~l~HpnIv~  117 (398)
T 4b99_A           49 TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD------V-----VTNAKRTLRELKILKHFKHDNIIA  117 (398)
T ss_dssp             CCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc------c-----hHHHHHHHHHHHHHHhcCCCCcce
Confidence            3444456888899999999999999986 589999999964322      1     111456889999999999999999


Q ss_pred             ecccccC-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE
Q psy5603         244 LLGLCNN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       244 l~~~~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      +++++..       ...|+|||||. |+|.+++..   ..++++..+..++.||+.||.|||+  +|||||||||+|||+
T Consensus       118 l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~  191 (398)
T 4b99_A          118 IKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLV  191 (398)
T ss_dssp             EEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE
T ss_pred             EeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCcccccc
Confidence            9986532       56799999995 789999976   3479999999999999999999999  889999999999999


Q ss_pred             cCCCceEEeecccccccccCCc-ceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhh
Q psy5603         317 DENFVPKLGDFGIVKMSETSNM-KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      +.+|.+||+|||+|+....... ........+||+.|+|||++.+  .++.++||||+||++|||++|.+||.+.+....
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~  271 (398)
T 4b99_A          192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ  271 (398)
T ss_dssp             CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred             CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999999986644321 1122356799999999997654  468899999999999999999999998775443


Q ss_pred             HHHhhhc-ccchhhccch-----------hccCC---C----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         394 YYLVVEQ-EVPVREVLDK-----------EAGEW---N----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       394 ~~~~~~~-~~~~~~~~d~-----------~~~~~---~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+... ..+.......           .....   +    ...++..+.+||.+||..||++|||+.|+++
T Consensus       272 l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          272 LQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            3333221 1110000000           00000   0    0123456789999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9e-48  Score=374.83  Aligned_cols=290  Identities=36%  Similarity=0.661  Sum_probs=240.2

Q ss_pred             cceeeeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHH
Q psy5603         150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE  229 (455)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  229 (455)
                      ....|++.++..++++|+..+++..+++||+|+||.||+|.+. ++.||||++.........         .....+.+|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~~E   80 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTE---------ELKQQFDQE   80 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTT---------THHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchH---------HHHHHHHHH
Confidence            4578999999999999999999999999999999999999975 789999999754321111         124568999


Q ss_pred             HHHHhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         230 VQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       230 ~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      +.++++++||||+++++++.+ ...++||||+++|+|.+++.......++++..++.++.|++.||.|||+  +|++|||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~d  158 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRD  158 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCC
Confidence            999999999999999998877 7889999999999999999876556689999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~  388 (455)
                      |||+||+++.++.+||+|||+++....... ........||+.|+|||.+.+.++.++||||||+++|+|++|.+||...
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            999999999999999999999986654321 2223456899999999988888999999999999999999999999876


Q ss_pred             cchhhHHH----hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         389 NTILYYYL----VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       389 ~~~~~~~~----~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ........    .......+...++...... ....+..+.+++.+|+..+|++||++.+|++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             BSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC-CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             cchHHHHHHHHHhhhhhhhhhhhcccccccc-chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            53221111    1112334455555544333 3456777889999999999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-48  Score=389.89  Aligned_cols=196  Identities=27%  Similarity=0.371  Sum_probs=163.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      .|++.++||+|+||+||+|+++    +++.||||++.....               ...+.+|+++++.+ +|||||+++
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---------------~~~~~~E~~~l~~~~~h~nIv~l~   86 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---------------PIRIAAELQCLTVAGGQDNVMGVK   86 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---------------HHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---------------HHHHHHHHHHHHHhcCCCCCceEE
Confidence            4677799999999999999864    367899999864321               33478999999998 699999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-CceE
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPK  323 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-~~~k  323 (455)
                      +++.+ +..|+|||||+||+|.+++.      .+++.++..++.|++.||+|||+  +||+||||||+|||++.+ +.+|
T Consensus        87 ~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           87 YCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             EEEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEE
Confidence            98877 88899999999999999985      38999999999999999999999  899999999999999876 8999


Q ss_pred             EeecccccccccCCcc-------------------------eeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHH
Q psy5603         324 LGDFGIVKMSETSNMK-------------------------TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILL  376 (455)
Q Consensus       324 l~DFGla~~~~~~~~~-------------------------~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~  376 (455)
                      |+|||+|+........                         .......+||+.|+|||++.+  .++.++||||+||++|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            9999999865432110                         011234579999999997754  4788999999999999


Q ss_pred             HHHcCCCCCCCCc
Q psy5603         377 ELLTGMKPIDDNN  389 (455)
Q Consensus       377 elltG~~p~~~~~  389 (455)
                      ||+||++||....
T Consensus       239 ell~G~~Pf~~~~  251 (361)
T 4f9c_A          239 SLLSGRYPFYKAS  251 (361)
T ss_dssp             HHHHTCSSSSCCS
T ss_pred             HHHHCCCCCCCCC
Confidence            9999999997554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-48  Score=410.87  Aligned_cols=246  Identities=20%  Similarity=0.252  Sum_probs=195.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +|+.||||++++........       .........++.+++.++|||||++++++.+
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~-------~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-------ETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC-------HHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh-------HHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            567799999999999999987 48999999997543211111       0112223445677888899999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.++|...   ..+++..+..++.||+.||.|||+  +|||||||||+||||+.+|.+||+|||+
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccce
Confidence             8899999999999999999874   469999999999999999999999  8999999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-C-CCCcccchHHHHHHHHHHHcCCCCCCCCcch---hhHHHhhhcccch
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYYYLVVEQEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~---~~~~~~~~~~~~~  404 (455)
                      |+......     ....+||+.|||||++. + .++.++|||||||++|||++|.+||.+....   .....+......+
T Consensus       339 A~~~~~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~  413 (689)
T 3v5w_A          339 ACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL  413 (689)
T ss_dssp             CEECSSCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC
T ss_pred             eeecCCCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC
Confidence            98765432     34569999999999774 4 5789999999999999999999999865422   1111222222222


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIV  446 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl  446 (455)
                      +            ..++..+++||.+||..||++|++     +.||+
T Consensus       414 p------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          414 P------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             C------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             C------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            2            234456889999999999999998     56664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.9e-47  Score=400.87  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=204.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||||++.....      .       ....+.+|+.+|+.++|||||++++++.
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~------~-------~~~~~~~Ei~il~~l~hpnIv~l~~~~~  224 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE------S-------DKETVRKEIQTMSVLRHPTLVNLHDAFE  224 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch------h-------hHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4677799999999999999987 589999999964321      1       1345889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC--CceEEee
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~--~~~kl~D  326 (455)
                      + ...|+|||||+||+|.++|...  ...+++.++..++.||+.||.|||+  ++|+||||||+|||++.+  +.+||+|
T Consensus       225 ~~~~~~iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          225 DDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             CSSEEEEEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ECCEEEEEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEee
Confidence            7 8889999999999999999753  2469999999999999999999999  889999999999999854  8999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+.......    ....+||+.|||||++.+ .++.++|||||||++|||++|.+||.+.+.......+......+.
T Consensus       301 FG~a~~~~~~~~----~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~  376 (573)
T 3uto_A          301 FGLTAHLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  376 (573)
T ss_dssp             CSSCEECCTTSE----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             ccceeEccCCCc----eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            999987654331    234589999999997755 578899999999999999999999998775554444433222211


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..        ....++..+.+||.+||..||++||++.|+++
T Consensus       377 ~~--------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DS--------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SG--------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc--------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11        11234556889999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-46  Score=368.17  Aligned_cols=282  Identities=38%  Similarity=0.602  Sum_probs=226.0

Q ss_pred             cCcceeeeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHH
Q psy5603         148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE  227 (455)
Q Consensus       148 ~~~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (455)
                      .+.+..|++.++...+++|...      +.||+|+||.||+|.+++|+.||||++........            ...+.
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~   75 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG------------ELQFQ   75 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCST------TEEECCSSSEEEEECCSSSCCEEEEECCC-----C------------CCHHH
T ss_pred             cCccceecHHHHHHHhhccccc------eeEecCCCcEEEEEEecCCCEEEEEEeccccCchH------------HHHHH
Confidence            3456789999999999988776      99999999999999987889999999975432111            12388


Q ss_pred             HHHHHHhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCC---
Q psy5603         228 NEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSK---  302 (455)
Q Consensus       228 ~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~---  302 (455)
                      +|+.++++++||||+++++++.+ ...++||||+.+|+|.+++..... ..++++..+..++.|++.||.|||+  +   
T Consensus        76 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~  153 (326)
T 3uim_A           76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDP  153 (326)
T ss_dssp             HHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSS
T ss_pred             HHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCC
Confidence            99999999999999999999877 788999999999999999987543 4569999999999999999999999  7   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcC
Q psy5603         303 PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       303 ~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG  381 (455)
                      ||+||||||+|||++.++.+||+|||+++.......  .......||+.|+|||++ .+.++.++|||||||++|||+||
T Consensus       154 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (326)
T 3uim_A          154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG  231 (326)
T ss_dssp             CEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred             CeEeCCCchhhEEECCCCCEEeccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence            899999999999999999999999999987654332  223456799999999966 45678999999999999999999


Q ss_pred             CCCCCCCc------chhhHHHh-hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         382 MKPIDDNN------TILYYYLV-VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       382 ~~p~~~~~------~~~~~~~~-~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ..||....      ........ ...........+..............+.+++.+||..||.+||++.+|++.|+.
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            99996221      11111111 112233344444444444456677788999999999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-46  Score=369.32  Aligned_cols=280  Identities=34%  Similarity=0.572  Sum_probs=221.7

Q ss_pred             eeeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHH
Q psy5603         153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  232 (455)
Q Consensus       153 ~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  232 (455)
                      .+++.++..++++|...      +.||+|+||.||+|.+++|+.||||++.....      .       ....+.+|+.+
T Consensus        28 ~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~   88 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHK------FLIGHGVFGKVYKGVLRDGAKVALKRRTPESS------Q-------GIEEFETEIET   88 (321)
T ss_dssp             --CCSCCCCCCCCCSCC------CCSCBCSSSEEEEEECTTCCEEEEEECCSCCS------S-------HHHHHHHHHHG
T ss_pred             eecHHHHHHHHhccCcc------ceeecCCCeeEEEEEECCCCEEEEEEecccCh------H-------HHHHHHHHHHH
Confidence            45555666667777655      99999999999999988889999999864321      1       14568999999


Q ss_pred             HhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCC
Q psy5603         233 LSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       233 l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dik  310 (455)
                      +++++||||+++++++.+ ...++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+  +|++|||||
T Consensus        89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlk  166 (321)
T 2qkw_B           89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVK  166 (321)
T ss_dssp             GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCC
T ss_pred             HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCC
Confidence            999999999999999877 788999999999999999875432 3469999999999999999999999  889999999


Q ss_pred             CCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCc
Q psy5603         311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~  389 (455)
                      |+||+++.++.+||+|||+++....... ........||+.|+|||++ .+.++.++|||||||++|||+||..||....
T Consensus       167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          167 SINILLDENFVPKITDFGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             STTEEECTTCCEEECCCTTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             HHHEEECCCCCEEEeecccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            9999999999999999999986543321 1123345689999999965 5578999999999999999999999998654


Q ss_pred             chhhH----H-HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         390 TILYY----Y-LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       390 ~~~~~----~-~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .....    + ........+...+++..........+..+.+++.+||..||++||++.+|++.|+.+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            22111    1 11112223344444444334456778889999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.7e-46  Score=361.89  Aligned_cols=256  Identities=30%  Similarity=0.475  Sum_probs=197.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||+||+|++. |+.||||++.....      .     ......|.+|++++++++||||+++++++.+ 
T Consensus        39 y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF------H-----AERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC------S-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC------C-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            355689999999999999885 79999999864322      1     1114568899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~--iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      ...++||||+++|+|.+++........+++..++.++.|++.||.|||+  ++  |+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            7889999999999999999864333359999999999999999999999  77  9999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||+||..||...................   
T Consensus       185 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---  258 (309)
T 3p86_A          185 LSRLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---  258 (309)
T ss_dssp             --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC---
T ss_pred             CCccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---
Confidence            998544322   11234689999999997654 57889999999999999999999998776443332221111100   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                             ..+..++..+.+||.+||..+|.+||++.++++.|+.+++
T Consensus       259 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          259 -------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                   0112234458889999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-45  Score=362.78  Aligned_cols=244  Identities=25%  Similarity=0.399  Sum_probs=201.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||++......           ......+.+|++++++++||||+++++++.+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   85 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-----------PTSLQKLFREVRIMKILNHPNIVKLFEVIET   85 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            566799999999999999985 6899999999754321           1124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   .++++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             CCEEEEEEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence             7889999999999999999874   359999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccCC-C-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++......    ......||+.|+|||++.+. + +.++|||||||++|||+||..||.+.+.......+......++. 
T Consensus       161 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~-  235 (328)
T 3fe3_A          161 SNEFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF-  235 (328)
T ss_dssp             CGGGSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-
T ss_pred             ceecCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-
Confidence            98654432    13456899999999977553 3 47999999999999999999999987754444433333222222 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 .++..+.+|+.+||..||.+|||+.|+++
T Consensus       236 -----------~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          236 -----------YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -----------TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -----------CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       13344788999999999999999999975

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=359.96  Aligned_cols=257  Identities=26%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||.||+|.+.    .+..||||+++....      .      .....|.+|+.++++++||||+++++
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~  117 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT------E------RQRRDFLSEASIMGQFDHPNIIRLEG  117 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC------H------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC------H------HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3566799999999999999985    245699999964321      1      11456899999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...|+||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~  193 (325)
T 3kul_A          118 VVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVS  193 (325)
T ss_dssp             EECGGGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeCCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEEC
Confidence            9877 78899999999999999997543  469999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||+++................+|+.|+|||++. ..++.++|||||||++|||++ |..||................ .
T Consensus       194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~  272 (325)
T 3kul_A          194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-R  272 (325)
T ss_dssp             CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-C
T ss_pred             CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-C
Confidence            9999987655432222233456788999999764 467889999999999999999 999998776443333222211 0


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                ...+..++..+.+||.+||..||++||++.+|++.|+++++
T Consensus       273 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          273 ----------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                      00112344568889999999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-44  Score=363.15  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=205.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc--------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Ccccee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |++++.||+|+||.||+|.+.        ++..||||+++....            ......+.+|+++++++ +||||+
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~~hpnIv  150 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------------EKDLSDLVSEMEMMKMIGKHKNII  150 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB------------HHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC------------HHHHHHHHHHHHHHHHhcCCCCEe
Confidence            456789999999999999863        245799999964321            11245689999999999 899999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      ++++++.+ +..|+||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  ++|+|||
T Consensus       151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrD  228 (370)
T 2psq_A          151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRD  228 (370)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccc
Confidence            99998877 788999999999999999986431             2358999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++........ .......||+.|+|||++ ...++.++|||||||++|||+| |..||.
T Consensus       229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          229 LAARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             CCGGGEEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cchhhEEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999865443211 122345678899999966 4467899999999999999999 999998


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................           ...+..++..+.++|.+||..+|.+||++.|+++.|++++.
T Consensus       308 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          308 GIPVEELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             TCCGGGHHHHHHTTCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHhcCCC-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            7664333322221110           00112344568889999999999999999999999998863

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-44  Score=350.45  Aligned_cols=247  Identities=26%  Similarity=0.426  Sum_probs=201.4

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.++||+|+||+||+|.+. +|+.||||++......             ....+.+|+.++++++||||+++++++
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-------------KKELIINEILVMRENKNPNIVNYLDSY   86 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-------------HHHHHHHHHHHHhcCCCCCCCeEeEEE
Confidence            34566799999999999999975 5899999999754321             134588999999999999999999987


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .. +..|+||||+.||+|.+++...    .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Df  160 (297)
T 3fxz_A           87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDF  160 (297)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EECCEEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeC
Confidence            66 7889999999999999999762    58999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |++........   ......||+.|+|||++. ..++.++|||||||++|||+||..||..................   
T Consensus       161 g~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---  234 (297)
T 3fxz_A          161 GFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---  234 (297)
T ss_dssp             TTCEECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---
T ss_pred             CCceecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence            99886554321   234568999999999764 46789999999999999999999999877643333222221111   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ....+..++..+.+||.+||..||++||++.|+++
T Consensus       235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  01112345566889999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.3e-45  Score=359.97  Aligned_cols=261  Identities=25%  Similarity=0.330  Sum_probs=201.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||+||+|++. ++.||||++.....              ....+..|+.++++++||||+++++++.+.
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK--------------QSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH--------------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             chhhheecccCceEEEEEEEC-CCEEEEEEeecCch--------------HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            456689999999999999987 79999999864211              133466799999999999999999987652


Q ss_pred             -----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----------CeeecCCCCCcEEE
Q psy5603         252 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK----------PIIHRDVKSANVLL  316 (455)
Q Consensus       252 -----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~----------~iiH~Dikp~NILl  316 (455)
                           ..|+||||+++|+|.+++..    .++++..++.++.|++.||.|||+  .          +|+||||||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~--~~~~l~~~~~~~ivH~Dlkp~Nill  164 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE--DIPGLKDGHKPAISHRDIKSKNVLL  164 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC--CEEEETTEEECEEECSCCSGGGEEE
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh--hccccccccCCCEEeCCCChHhEEE
Confidence                 35999999999999999976    249999999999999999999999  7          89999999999999


Q ss_pred             cCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC------CCCcccchHHHHHHHHHHHcCCCCCCCCcc
Q psy5603         317 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~sDv~SlGvvl~elltG~~p~~~~~~  390 (455)
                      +.++.+||+|||+++....... ........||+.|+|||++.+      .++.++|||||||++|||+||..||.....
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             CCCCeEEEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            9999999999999987654332 122344689999999997754      346689999999999999999999986542


Q ss_pred             hh--hHHHhhhcccchhh--------ccchhc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         391 IL--YYYLVVEQEVPVRE--------VLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       391 ~~--~~~~~~~~~~~~~~--------~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..  ..............        ...+.. ..+.....+..+.+||.+||..||++|||+.+|++.|+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11  00000000001000        001111 122334566779999999999999999999999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=355.16  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+++++||+|+||+||+|.+. +++.||+|++....             ......|.+|++++++++||||+++++++.+
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   78 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-------------EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK   78 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-------------HHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence            456689999999999999986 48899999984321             1124568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++....  ..+++.+++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           79 DKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             CCeeEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeeccc
Confidence             78899999999999999998743  469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcce-----------eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         330 VKMSETSNMKT-----------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       330 a~~~~~~~~~~-----------~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      ++.........           .......||+.|+|||++.+ .++.++||||||+++|||++|..|+............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~  234 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL  234 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence            98654432111           01125689999999997654 5789999999999999999999998764321111000


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                           ......+..    .+..++..+.+++.+||..||++||++.++++.|+++.
T Consensus       235 -----~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          235 -----NVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             -----CHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----hhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 001111111    11123334788999999999999999999999998874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.3e-45  Score=352.08  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=196.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh--CCccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||+||+|++. ++.||||++....                ...+..|.+++..  ++||||+++++++.
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~   72 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD----------------EKSWFRETELYNTVMLRHENILGFIASDM   72 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEET-TEEEEEEEECGGG----------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred             EEEEEeeccCCCcEEEEEEEC-CEEEEEEEecccc----------------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence            456699999999999999985 7999999985321                2335566666665  79999999999753


Q ss_pred             C-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeeecCCCCCcEEE
Q psy5603         250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH--------SLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--------~~~~~iiH~Dikp~NILl  316 (455)
                      +     ...++||||+++|+|.+++..    ..+++..++.++.|++.||.|||        +  ++|+||||||+|||+
T Consensus        73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           73 TSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEETTEEEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEE
T ss_pred             cccCCCceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEE
Confidence            3     457899999999999999964    36999999999999999999999        7  889999999999999


Q ss_pred             cCCCceEEeecccccccccCCcce-eeeccCCCCCCCCCcccccCC-------CCcccchHHHHHHHHHHHcC-------
Q psy5603         317 DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTG-------  381 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-------~~~~sDv~SlGvvl~elltG-------  381 (455)
                      +.++.+||+|||+++......... .......||+.|+|||++.+.       ++.++|||||||++|||+||       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999998665443221 112345899999999977553       34689999999999999999       


Q ss_pred             ---CCCCCCCcchh----hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         382 ---MKPIDDNNTIL----YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       382 ---~~p~~~~~~~~----~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                         ..||.......    .............    .....+....++..+.+|+.+||..||++|||+.+|++.|+++
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP----NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC----CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCcchhhhhHHHhccCCCC----CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence               88886543111    0001000000000    0011222345777899999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.6e-45  Score=367.24  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=193.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|+++    ++..||||+++....      .      .....|.+|+.++++++||||++++++
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~niv~~~~~  114 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT------E------KQRRDFLGEASIMGQFDHPNIIRLEGV  114 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC------H------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC------H------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            455699999999999999875    467899999864321      1      114569999999999999999999999


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+++|+|.+++....  ..+++.+++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~D  190 (373)
T 2qol_A          115 VTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSD  190 (373)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             EeeCCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECc
Confidence            887 77899999999999999998643  469999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++................+|..|+|||++. +.++.++|||||||++|||++ |..||...........+....   
T Consensus       191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~---  267 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---  267 (373)
T ss_dssp             C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE---
T ss_pred             CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            999987654322222222345678899999664 568899999999999999998 999998776433322222110   


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                              ....+..++..+.+++.+||..+|++||++.+|++.|++++++
T Consensus       268 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 --------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             --------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                    0111123445688899999999999999999999999988753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-44  Score=345.89  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=206.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+.+++.||||++.....      .        ...+.+|++++++++||||+++++++.+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------S--------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ceeeheecCCCccEEEEEEecCCCeEEEEEeccccc------C--------HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            456689999999999999998888999999974322      1        3458899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++++|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             CceEEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEecccccc
Confidence            77899999999999999997643  468999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......||+.|+|||.+. ..++.++||||||+++|+|++ |..||.................      
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~------  225 (269)
T 4hcu_A          154 RFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------  225 (269)
T ss_dssp             GGBCCHHH--HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------
T ss_pred             cccccccc--ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc------
Confidence            86543221  1123456788899999764 568899999999999999999 9999987764433332221110      


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+...+..+.+++.+|+..+|++||++.++++.|+++.+
T Consensus       226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          226 -----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                 11112234558889999999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3e-44  Score=355.53  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=201.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +|+.||||++++....          .......+.+|+.++++++||||+++++++.+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII----------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh----------hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            355689999999999999987 4899999999754211          11124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccc
Confidence             8889999999999999999874   369999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++.  
T Consensus       152 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--  226 (337)
T 1o6l_A          152 CKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--  226 (337)
T ss_dssp             CBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             hhhcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence            98543222   12345689999999997754 5789999999999999999999999887654444443333222221  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                .++..+.+||.+||..||++||     ++.++++
T Consensus       227 ----------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          227 ----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                      2344588899999999999999     8888865

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-44  Score=350.37  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++......      .    ......|.+|+.++++++||||+++++++.
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~   81 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE------K----EETLKRFEREVHNSSQLSHQNIVSMIDVDE   81 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC------C----HHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc------c----HHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence            4667799999999999999976 4889999998643321      1    112466899999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+||||++|++|.+++...   .++++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           82 EDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCeEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCC
Confidence            7 7889999999999999999874   469999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc-chhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~  406 (455)
                      +++.......  .......||+.|+|||.+.+ .++.++||||||+++|||+||..||................. ....
T Consensus       157 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T 4eqm_A          157 IAKALSETSL--TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT  234 (294)
T ss_dssp             SSTTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH
T ss_pred             Cccccccccc--cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch
Confidence            9986543321  12345679999999996654 578899999999999999999999988764433222221111 1111


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-CHHHHHHHHHhhhc
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~~  454 (455)
                      ..        ...++..+.++|.+|+..||.+|| ++.++.+.|++++.
T Consensus       235 ~~--------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          235 DV--------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HS--------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             hc--------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            00        112445688899999999999998 99999999988764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-44  Score=343.59  Aligned_cols=252  Identities=25%  Similarity=0.414  Sum_probs=206.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.++++..||||+++....              ....+.+|++++.+++||||+++++++.+ 
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--------------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE   75 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--------------cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            456689999999999999998888999999964322              13458899999999999999999999877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           76 YPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             CceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccc
Confidence            78899999999999999997643  358999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......||+.|+|||.+.+ .++.++||||||+++|||+| |..||..................     
T Consensus       152 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----  224 (268)
T 3sxs_A          152 RYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-----  224 (268)
T ss_dssp             EECCTTCE--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----
T ss_pred             eecchhhh--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-----
Confidence            87654432  12234567788999997644 67899999999999999999 99999877644333222221111     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                            ..+..++..+.+++.+|+..+|.+||++.++++.|+++.+
T Consensus       225 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 ------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                  1112234458889999999999999999999999998865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-44  Score=359.12  Aligned_cols=253  Identities=27%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++++.||+|+||.||+|..+ +|+.||||+++..........       .....+.+|+.++++++||||+++++++.
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~   85 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG-------VCREEIEREVSILRQVLHPNIITLHDVYE   85 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS-------BCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccch-------hHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence            3567799999999999999987 489999999986543222111       11456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC----ceEE
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKL  324 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl  324 (455)
                      + ...|+||||++||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++    .+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            7 788999999999999999976   3469999999999999999999999  8899999999999998877    7999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +|||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+......
T Consensus       161 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~  236 (361)
T 2yab_A          161 IDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD  236 (361)
T ss_dssp             CCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             EecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence            9999998765432    1234689999999997754 6789999999999999999999999887654443333322211


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..    ..    ...++..+.+||.+||..||++||++.|+++
T Consensus       237 ~~~----~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          237 FDE----EF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCH----HH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCc----hh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110    00    1223456889999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.6e-45  Score=353.82  Aligned_cols=268  Identities=24%  Similarity=0.379  Sum_probs=200.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.+.||+|+||.||+|+++     +++.||||++.....             .....|.+|+.++++++||||++++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~   77 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-------------EHLRDFEREIEILKSLQHDNIVKYK   77 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-------------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-------------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            3566799999999999999842     478999999863211             1145689999999999999999999


Q ss_pred             ccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         246 GLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++..   ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~  153 (295)
T 3ugc_A           78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRV  153 (295)
T ss_dssp             EEECHHHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEE
T ss_pred             EEEecCCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeE
Confidence            98744   45799999999999999998743  358999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ||+|||+++................||..|+|||.+ ...++.++||||||+++|||+||..|+................
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  233 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ  233 (295)
T ss_dssp             EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC
T ss_pred             EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc
Confidence            999999998765443222223345677889999966 4568899999999999999999999987543211111000000


Q ss_pred             c-----chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         402 V-----PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       402 ~-----~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                      .     .....+........+..++..+.+++.+||..||++||++.++++.|+++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0     00011111111112334556788999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.9e-44  Score=355.35  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-Cc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.++||+|+||+||+|.+.. ++    +||+|.++....            ......|.+|+.++++++||||+++++
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~   84 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------------PKANKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC------------HHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            3556899999999999999753 44    358887753221            011456899999999999999999999


Q ss_pred             cccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         247 LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      ++.+...++|++|+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~D  160 (327)
T 3poz_A           85 ICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             EEESSSEEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             EEecCCeEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEcc
Confidence            998877899999999999999998743  469999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++....... ........||..|+|||.+ .+.++.++|||||||++|||+| |..||.................  
T Consensus       161 fg~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--  237 (327)
T 3poz_A          161 FGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--  237 (327)
T ss_dssp             TTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred             CcceeEccCCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC--
Confidence            999987654432 1223345678899999965 4568999999999999999999 9999987764433332222110  


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ...+..++..+.+++.+||..+|++||++.++++.|+++..
T Consensus       238 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ---------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     00112233457889999999999999999999999988764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=350.40  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=202.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++..........       .....+.+|+.++++++||||+++++++.+
T Consensus        13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A           13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG-------VSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSS-------BCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccch-------hhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            456689999999999999987 489999999976543222111       124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC----ceEEe
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl~  325 (455)
                       ...++||||+++|+|.+++..   ..++++..++.++.|++.||.|||+  ++|+||||||+|||++.++    .+||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence             788999999999999999976   3469999999999999999999999  8899999999999999887    89999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++.......    .....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.......
T Consensus       161 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  236 (326)
T 2y0a_A          161 DFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  236 (326)
T ss_dssp             CCTTCEECCTTSC----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ECCCCeECCCCCc----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence            9999987643321    23457999999999765 467899999999999999999999998766433332222211111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..   ..     ...++..+.+||.+||..||++||++.++++
T Consensus       237 ~~---~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          237 ED---EY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CH---HH-----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Cc---cc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            10   00     1123456889999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-44  Score=364.19  Aligned_cols=254  Identities=25%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++++.||+|+||.||+|.++ +++.||||+++....      .      .....|.+|++++++++||||+++++++.+ 
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP------P------DLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC------H------HHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC------H------HHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            45589999999999999987 589999999864321      1      113358899999999999999999999877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++|+|.+++....  ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s  260 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMS  260 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence            77899999999999999997643  358999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +...... .........++..|+|||.+. +.++.++|||||||++|||+| |..||................ .     
T Consensus       261 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~-----  333 (377)
T 3cbl_A          261 REEADGV-YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-R-----  333 (377)
T ss_dssp             EECTTSE-EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-C-----
T ss_pred             eecCCCc-eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence            8644321 111111224567899999664 568899999999999999999 999998776433322222111 0     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+|+.+||..||++||++.+|++.|+++.+
T Consensus       334 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          334 -----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                 01112244568889999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3e-44  Score=353.53  Aligned_cols=256  Identities=23%  Similarity=0.416  Sum_probs=201.4

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEcC-CcE----EEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLKN-GME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~----vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      ..|++.+.||+|+||.||+|.+.. ++.    ||+|.+........            ...+.+|+.++++++||||+++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~   80 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS------------FQAVTDHMLAIGSLDHAHIVRL   80 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC------------BCSCCHHHHHHHTCCCTTBCCE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH------------HHHHHHHHHHHhcCCCCCcCeE
Confidence            346777999999999999999753 443    78887754322111            2236789999999999999999


Q ss_pred             cccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         245 LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       245 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      ++++.+...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl  156 (325)
T 3kex_A           81 LGLCPGSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQV  156 (325)
T ss_dssp             EEEECBSSEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEE
T ss_pred             EEEEcCCccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEE
Confidence            99998888999999999999999997642  368999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhc-c
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ-E  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~-~  401 (455)
                      +|||+++....... ........||..|+|||.+. +.++.++|||||||++|||+| |..||............... .
T Consensus       157 ~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  235 (325)
T 3kex_A          157 ADFGVADLLPPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER  235 (325)
T ss_dssp             CSCSGGGGSCCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB
T ss_pred             CCCCcccccCcccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC
Confidence            99999987654432 12234567888999999664 578899999999999999999 99999887644333333221 1


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...+..            ++..+.+++.+||..||++||++.++++.|+++..
T Consensus       236 ~~~~~~------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 LAQPQI------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CCCCTT------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCCCCc------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111111            22236778999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.8e-44  Score=345.10  Aligned_cols=252  Identities=23%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.++++..||||+++....      .        ...+.+|++++.+++||||+++++++.+ 
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------S--------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC------C--------HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            345589999999999999998888999999974322      1        3458899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+.+++|.+++....  ..+++.+++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             CCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccccc
Confidence            78899999999999999997633  359999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......||+.|+|||.+. ..++.++||||||+++|||+| |..||...........+.....      
T Consensus       168 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------  239 (283)
T 3gen_A          168 RYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------  239 (283)
T ss_dssp             GGBCCHHH--HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------
T ss_pred             cccccccc--ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC------
Confidence            86543221  1123346788899999664 568899999999999999999 9999987764433332222110      


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+++.+||..+|.+||++.++++.|+++++
T Consensus       240 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 -----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                 11112233458889999999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=348.65  Aligned_cols=243  Identities=27%  Similarity=0.402  Sum_probs=200.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +|+.||+|+++.....          .......+.+|..+++.++||||+++++++.+
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV----------RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh----------hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            355689999999999999986 5899999999753221          11124558899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCc
Confidence             7889999999999999999873   469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.....      .....||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++.  
T Consensus       153 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--  224 (318)
T 1fot_A          153 AKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--  224 (318)
T ss_dssp             CEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             ceecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence            9865432      234689999999997654 5788999999999999999999999887654444444333322221  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                .++..+.++|.+||..||++||     ++.++++
T Consensus       225 ----------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          225 ----------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                      2334588899999999999999     8888764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-43  Score=348.25  Aligned_cols=265  Identities=24%  Similarity=0.360  Sum_probs=210.9

Q ss_pred             eeeeHHHHHHHhcCCCCCCC----CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHH
Q psy5603         152 IAFTFCDLERATDGFNRKPY----PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF  226 (455)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~----~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (455)
                      ..++++++..++......+.    +...++||+|+||.||+|.++ +|+.||||++.....      .       ....+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~------~-------~~~~~   89 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ------Q-------RRELL   89 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------C-------SHHHH
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch------h-------HHHHH
Confidence            45788888888876544332    344578999999999999987 589999999964321      1       13458


Q ss_pred             HHHHHHHhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5603         227 ENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       227 ~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~ii  305 (455)
                      .+|+.++++++||||+++++++.. ...++||||+++++|.+++..    ..+++..+..++.|++.||.|||+  +||+
T Consensus        90 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~iv  163 (321)
T 2c30_A           90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA--QGVI  163 (321)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCee
Confidence            899999999999999999998876 788999999999999998864    359999999999999999999999  8899


Q ss_pred             ecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCC
Q psy5603         306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p  384 (455)
                      ||||||+|||++.++.+||+|||+++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999886544321   1235689999999997644 578899999999999999999999


Q ss_pred             CCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      |.................+  ..       .....++..+.++|.+||..||++||++.++++
T Consensus       241 f~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          241 YFSDSPVQAMKRLRDSPPP--KL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TTTSCHHHHHHHHHHSSCC--CC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHhcCCCC--Cc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9876643332222211110  00       011234456889999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=358.16  Aligned_cols=241  Identities=26%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++ +|+.||||+++....          ........+.+|..++..+ +||||+++++++.
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~----------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI----------LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH----------HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh----------cchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            456689999999999999987 488999999975321          1111245688899999988 7999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcccc
Confidence            7 7889999999999999999874   359999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|.+||...+.......+......++..
T Consensus       170 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~  246 (353)
T 3txo_A          170 MCKEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW  246 (353)
T ss_dssp             TCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             ceeecccCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            998543322   12345689999999997644 58899999999999999999999999877655555444433332222


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                  ++..+.+||.+||..||++||++
T Consensus       247 ------------~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          247 ------------LHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ------------SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ------------CCHHHHHHHHHHhhhCHHHccCC
Confidence                        33447889999999999999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=381.46  Aligned_cols=250  Identities=21%  Similarity=0.348  Sum_probs=198.4

Q ss_pred             ccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCcee
Q psy5603         177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      .||+|+||.||+|.++   ++..||||+++.....     .       ....|.+|++++++++||||+++++++.++..
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----~-------~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  410 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----A-------DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL  410 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-----T-------THHHHHHHHHHHTTCCCTTBCCEEEEEESSSE
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-----H-------HHHHHHHHHHHHHhCCCCCEeeEEEEeccCCe
Confidence            7999999999999875   3567999999754210     1       14569999999999999999999999988889


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+.+|+|.+++...  ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       411 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999999999999753  3469999999999999999999999  88999999999999999999999999999876


Q ss_pred             ccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............+|+.|+|||++. +.++.++|||||||++|||+| |..||...........+.....         
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---------  557 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---------  557 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC---------
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            44322111122345678999999664 578999999999999999998 9999988765443333322110         


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ...+..++..+.+||.+||..+|++||++.+|++.|+.++
T Consensus       558 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          558 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              0111234556888999999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=348.46  Aligned_cols=264  Identities=22%  Similarity=0.313  Sum_probs=206.4

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+.. ++.||||+++.....            .....+.+|++++++++||||+++++++.
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL------------RPVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG------------SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc------------chHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence            46677999999999999999874 899999999643221            11455789999999999999999999875


Q ss_pred             C---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE----cCCCce
Q psy5603         250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVP  322 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl----~~~~~~  322 (455)
                      .   ...|+||||+++++|.+++........+++..++.++.|++.||.|||+  ++|+||||||+|||+    +.++.+
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEE
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceE
Confidence            5   3679999999999999999876555569999999999999999999999  889999999999999    888899


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc---------CCCCcccchHHHHHHHHHHHcCCCCCCCCcch--
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGVILLELLTGMKPIDDNNTI--  391 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~--  391 (455)
                      ||+|||+++.......    .....||+.|+|||++.         ..++.++|||||||++|||+||..||......  
T Consensus       156 kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  231 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (319)
T ss_dssp             EECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred             EEccCCCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence            9999999987654331    23457999999999763         46788999999999999999999999754321  


Q ss_pred             --hhHHHhhhccc-c-hhhc-------c--chh--ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         392 --LYYYLVVEQEV-P-VREV-------L--DKE--AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       392 --~~~~~~~~~~~-~-~~~~-------~--d~~--~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                        ........... . +...       +  ...  ........++..+.++|.+||..||++||+++|+++...+.
T Consensus       232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence              11111111110 0 0000       0  000  01122367788899999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.3e-44  Score=346.31  Aligned_cols=261  Identities=30%  Similarity=0.478  Sum_probs=195.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.++||+|+||.||+|.++  ..||||+++....      .     ......|.+|+.++++++||||+++++++.+
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP------T-----PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA   91 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC------C-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC------C-----HHHHHHHHHHHHHHHhCCCCcEEEEEeeccC
Confidence            3566799999999999999875  4699999965432      1     1124568999999999999999999998888


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+.+++|.+++...  ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             CccEEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceec
Confidence            8899999999999999999654  3469999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +....... ........||+.|+|||++.    ..++.++||||||+++|||++|..||................ ....
T Consensus       168 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~  245 (289)
T 3og7_A          168 TEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-SLSP  245 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT-SCCC
T ss_pred             cccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc-ccCc
Confidence            76543221 11234467999999999763    346789999999999999999999998765332222111111 0000


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                      ....     ....++..+.+|+.+||..+|++||++.++++.|+++.++
T Consensus       246 ~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          246 DLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             CTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             chhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            0000     0123445688999999999999999999999999998763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.7e-44  Score=347.33  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=205.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.+.      +++.||||+++....      .      .....+.+|+.++++++||||++++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~hp~iv~~~   92 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS------P------SELRDLLSEFNVLKQVNHPHVIKLY   92 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC------H------HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC------H------HHHHHHHHHHHHHhhCCCCceeeEE
Confidence            456689999999999999862      357899999864321      1      1145688999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      +++.+ ...++||||+++|+|.+++.....                     ...+++..++.++.|++.||.|||+  ++
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~  170 (314)
T 2ivs_A           93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MK  170 (314)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CC
Confidence            98877 788999999999999999987432                     1348999999999999999999999  88


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-C
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G  381 (455)
                      |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+. ..++.++|||||||++|||+| |
T Consensus       171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             CcccccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999986654332 12233456788999999664 457899999999999999999 9


Q ss_pred             CCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..||.................           ...+..++..+.+++.+||..||++||++.++++.|++++.
T Consensus       250 ~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          250 GNPYPGIPPERLFNLLKTGHR-----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             CCSSTTCCGGGHHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHhhcCCc-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999987764433332222110           00112344568889999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3e-44  Score=369.80  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++.+.||+|+||.||+|.++++..||||+++....              ....|.+|+.++++++||||+++++++.+..
T Consensus       191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  256 (454)
T 1qcf_A          191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--------------SVEAFLAEANVMKTLQHDKLVKLHAVVTKEP  256 (454)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--------------CHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--------------cHHHHHHHHHHHhhCCCCCEeeEEEEEeCCc
Confidence            45589999999999999998888999999974321              1456999999999999999999999988888


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             cEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            899999999999999997532 2358899999999999999999999  8899999999999999999999999999987


Q ss_pred             cccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ......  .......+|..|+|||++. +.++.++|||||||++|||+| |..||.+.........+.... .       
T Consensus       334 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~-------  403 (454)
T 1qcf_A          334 IEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-R-------  403 (454)
T ss_dssp             BCCHHH--HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-C-------
T ss_pred             cCCCce--eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-------
Confidence            543211  1122345778899999664 578999999999999999999 999998776443332222111 0       


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         ...+..++..+.+|+.+||..||++||++.+|++.|+++..
T Consensus       404 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence               01122345568899999999999999999999999998864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-44  Score=357.91  Aligned_cols=245  Identities=23%  Similarity=0.368  Sum_probs=196.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++........          .....+.+|+.+++.++||||+++++++.
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   79 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS----------DMHMRVEREISYLKLLRHPHIIKLYDVIT   79 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccch----------hHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3567799999999999999985 589999999964322111          11345889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+ +|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lv~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           80 TPTDIVMVIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             CSSEEEEEECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             eCCEEEEEEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEec
Confidence            7 7889999999 78999998774   359999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccCCC--CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++........    .....||+.|+|||++.+..  +.++|||||||++|+|++|..||...........+......   
T Consensus       154 ~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---  226 (336)
T 3h4j_B          154 LSNIMTDGNF----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV---  226 (336)
T ss_dssp             CTBTTTTSBT----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC---
T ss_pred             cceeccCCcc----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---
Confidence            9986544321    23458999999999876643  67999999999999999999999865422211111101111   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .+..++..+.+||.+||..||.+|||+.|+++
T Consensus       227 ---------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          227 ---------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                     11224455888999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-44  Score=352.34  Aligned_cols=257  Identities=26%  Similarity=0.448  Sum_probs=205.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.+.+      ++.||||+++....      .      .....|.+|+.++++++||||++++
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~hp~iv~~~  116 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------A------DMQADFQREAALMAEFDNPNIVKLL  116 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------H------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC------H------HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            4566899999999999999852      47899999964321      1      1245689999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      +++.+ ...|+||||+++|+|.+++.....                     ..++++.+++.++.|++.||.|||+  ++
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~  194 (343)
T 1luf_A          117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RK  194 (343)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CC
Confidence            98877 788999999999999999986431                     1579999999999999999999999  88


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-C
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G  381 (455)
                      |+||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+ .+.++.++||||||+++|||+| |
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence            999999999999999999999999999865433211 122345789999999965 4568899999999999999999 9


Q ss_pred             CCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..||...........+......           ..+..++..+.+++.+||..+|++||++.+|++.|+++..
T Consensus       274 ~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          274 LQPYYGMAHEEVIYYVRDGNIL-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCcCCCCChHHHHHHHhCCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            9999877644333322221110           0112334558889999999999999999999999999865

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.1e-44  Score=343.63  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=194.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.+..    +..||||+++....            ......+.+|+.++++++||||++++++
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~   84 (281)
T 1mp8_A           17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------------DSVREKFLQEALTMRQFDHPHIVKLIGV   84 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS------------HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC------------HHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence            4567899999999999999753    45799999864211            1124568999999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.++..++||||+++|+|.+++....  .++++..++.++.|++.||.|||+  +|++||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           85 ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             ECSSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             EccCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECcc
Confidence            88888899999999999999998643  368999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++.......  .......+|+.|+|||++. ..++.++||||||+++|||++ |..||...........+......  
T Consensus       161 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--  236 (281)
T 1mp8_A          161 GLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--  236 (281)
T ss_dssp             --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred             ccccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC--
Confidence            99987644321  1123446788999999764 567889999999999999997 99999876643332222211100  


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ..+..++..+.+++.+|+..||++||++.++++.|+++++
T Consensus       237 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          237 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                     0112344568889999999999999999999999998864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.1e-44  Score=383.70  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=200.0

Q ss_pred             CccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         176 NKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++||+|+||.||+|.+.   .++.||||+++.....           ......|.+|++++++++|||||++++++.+..
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  443 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----------PALKDELLAEANVMQQLDNPYIVRMIGICEAES  443 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-----------GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            47999999999999764   3678999999754221           112456999999999999999999999998888


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+.+|+|.+++..   ...+++..++.|+.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       444 ~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEEccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            8999999999999999986   3469999999999999999999999  8899999999999999999999999999987


Q ss_pred             cccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ...............||+.|+|||++. ..++.++|||||||++|||+| |..||.+.........+......       
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-------  591 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-------  591 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            654432222233446788999999664 478999999999999999999 99999887654433333221100       


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ..+..++..+.+||.+||..||++||++.+|++.|++++.
T Consensus       592 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          592 ----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                0112344568889999999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-43  Score=341.51  Aligned_cols=257  Identities=27%  Similarity=0.418  Sum_probs=200.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++........      .........+.+|+.++++++||||+++++++.
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE------TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC------HHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc------hhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            3566689999999999999985 588999999865432111      011112356899999999999999999999887


Q ss_pred             CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eeecCCCCCcEEEcCCCc-----e
Q psy5603         250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFV-----P  322 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~--iiH~Dikp~NILl~~~~~-----~  322 (455)
                      +.. ++||||+++|+|.+.+....  .++++..++.++.|++.||.|||+  ++  ++||||||+|||++.++.     +
T Consensus        94 ~~~-~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           94 NPP-RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             TTT-EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             CCC-eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCCCceeE
Confidence            644 79999999999999887643  479999999999999999999999  77  999999999999988776     9


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc---CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.   ..++.++|||||||++|||++|..||..............
T Consensus       169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence            99999998744321      33468999999999773   2467899999999999999999999987653322111111


Q ss_pred             cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      .......        ..+..++..+.++|.+||..||++||++.++++.|+++
T Consensus       243 ~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLRP--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCCC--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111100        11123445688999999999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-43  Score=357.92  Aligned_cols=241  Identities=23%  Similarity=0.334  Sum_probs=192.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++. ++.||||++++........          ...+.+|..++.++ +||||+++++++.
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~----------~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----------IDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH----------HHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            3455899999999999999874 7899999998654322111          23477899999887 8999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecc
Confidence            7 7889999999999999999874   359999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcc---------hhhHHHhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---------ILYYYLVV  398 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~---------~~~~~~~~  398 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|.+||.....         ......+.
T Consensus       199 la~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~  275 (396)
T 4dc2_A          199 MCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  275 (396)
T ss_dssp             TCBCCCCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred             eeeecccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence            998533222   12446789999999997654 578999999999999999999999974321         11111122


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      .....++            ..++..+.+||.+||..||++||++
T Consensus       276 ~~~~~~p------------~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          276 EKQIRIP------------RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HCCCCCC------------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ccccCCC------------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            2222222            2234558899999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-44  Score=356.32  Aligned_cols=258  Identities=23%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++++.||+|+||.||+|.+.      +++.||||+++....      .      .....+.+|++++.++ +||||+++
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------H------SEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC------H------HHHHHHHHHHHHHHhhcCCcceeee
Confidence            355699999999999999842      357899999964321      1      1145689999999999 79999999


Q ss_pred             cccccC--ceeEEEEEeccCCCHHHHHhhcCC------------------------------------------------
Q psy5603         245 LGLCNN--IMNCIVYEYMCNGSLYDRLARVNN------------------------------------------------  274 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------  274 (455)
                      ++++.+  ...++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            998766  458999999999999999986432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcc
Q psy5603         275 ---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK  339 (455)
Q Consensus       275 ---------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  339 (455)
                                     ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-
Confidence                           1228999999999999999999999  8899999999999999999999999999986544332 


Q ss_pred             eeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchhccCCCh
Q psy5603         340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE  417 (455)
Q Consensus       340 ~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  417 (455)
                      ........||+.|+|||++ ...++.++|||||||++|||+| |..||...................          ..+
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~  318 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------RAP  318 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------CCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------CCC
Confidence            1223456789999999965 4567899999999999999999 999998765332222111111100          011


Q ss_pred             hHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         418 THVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       418 ~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..++..+.+++.+||..||.+||++.+|++.|++++.
T Consensus       319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            1233458889999999999999999999999998864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-44  Score=354.23  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=199.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++ +|+.||||+++......          ......+..|..++..+ +||||+++++++.
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM----------DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh----------hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            355689999999999999987 48899999997542211          11144577899999877 9999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeECh
Confidence            7 7889999999999999999874   359999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++. 
T Consensus       164 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~-  239 (345)
T 1xjd_A          164 MCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR-  239 (345)
T ss_dssp             TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-
T ss_pred             hhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc-
Confidence            998543322   12345789999999997654 5789999999999999999999999887755444444333222221 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHH-HHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                                 .++..+.+||.+||..||++||++. +++
T Consensus       240 -----------~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          240 -----------WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                       2345588899999999999999997 553

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-43  Score=352.05  Aligned_cols=243  Identities=26%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+++ +|+.||||+++.....          .......+.+|+.++++++||||+++++++.+
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  112 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV----------KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc----------cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            455689999999999999987 5899999999653221          11124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~  187 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEccccc
Confidence             7889999999999999999874   359999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.....      .....||+.|+|||++. ..++.++|||||||++|||++|.+||...+.......+......++.  
T Consensus       188 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--  259 (350)
T 1rdq_E          188 AKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--  259 (350)
T ss_dssp             CEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             ceeccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence            9865432      23468999999999664 46789999999999999999999999887655444444333322221  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                .++..+.+||.+||..||++||+     +.++++
T Consensus       260 ----------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          260 ----------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                      23445889999999999999998     777754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-43  Score=363.45  Aligned_cols=246  Identities=28%  Similarity=0.431  Sum_probs=200.4

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC--
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ++.+.||+|+||.||+|.++ |+.||||+++....               ...|.+|+.++++++||||+++++++.+  
T Consensus       196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT---------------SHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH---------------HHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            45689999999999999987 78999999964321               3458999999999999999999998755  


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            36899999999999999998753 2457999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.....      .....+|..|+|||++ .+.++.++|||||||++|||+| |..||...........+.... .     
T Consensus       337 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~-----  404 (450)
T 1k9a_A          337 KEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-K-----  404 (450)
T ss_dssp             EECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-C-----
T ss_pred             cccccc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence            854322      1223678899999966 4568999999999999999999 999998765433322222110 0     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+||.+||..||++||++.++++.|+++..
T Consensus       405 -----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          405 -----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                 11122345568899999999999999999999999998864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=357.55  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=203.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.+.      +++.||||+++....      .      .....+.+|+.++++++||||++++
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~hpnIv~~~  140 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS------E------QDELDFLMEALIISKFNHQNIVRCI  140 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC------H------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC------h------hhHHHHHHHHHHHHhCCCCCCCeEE
Confidence            456689999999999999953      367899999863211      1      1134588999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +++.+ ...++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++
T Consensus       141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSS
T ss_pred             EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCC
Confidence            98877 778999999999999999987542    2468999999999999999999999  8899999999999999554


Q ss_pred             ---ceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHH
Q psy5603         321 ---VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       321 ---~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                         .+||+|||+++........ .......||+.|+|||++ .+.++.++|||||||++|||+| |..||..........
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~  297 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  297 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCceEEECCCcccccccccccc-ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence               5999999999854332211 112345789999999965 5578999999999999999998 999998876443333


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .+.....           ...+..++..+.+|+.+||..+|++||++.+|++.|+.+..
T Consensus       298 ~i~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          298 FVTSGGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC-----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            3322110           01112334458889999999999999999999999988754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-43  Score=348.12  Aligned_cols=256  Identities=19%  Similarity=0.214  Sum_probs=201.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|... +|+.||||++.....               ...+.+|+.+++++ +||||+++++++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~~h~~i~~~~~~~   74 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---------------APQLHLEYRFYKQLGSGDGIPQVYYFG   74 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---------------SCCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---------------hHHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence            3566799999999999999975 589999999865422               11278999999999 999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc-----e
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----P  322 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~-----~  322 (455)
                      .+ ...++||||+ +++|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.     +
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~  149 (330)
T 2izr_A           75 PCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVI  149 (330)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSE
T ss_pred             ecCCccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceE
Confidence            77 7789999999 999999998642  469999999999999999999999  88999999999999998887     9


Q ss_pred             EEeecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhH---
Q psy5603         323 KLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY---  394 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~---  394 (455)
                      ||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|..||.........   
T Consensus       150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~  229 (330)
T 2izr_A          150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY  229 (330)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred             EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence            999999998754432211    11245789999999997654 5788999999999999999999999875422211   


Q ss_pred             HHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+.......  ... ...    ..++ .+.+++..|+..+|.+||++.+|.+.|+++++
T Consensus       230 ~~i~~~~~~~--~~~-~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          230 QKIGDTKRAT--PIE-VLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHHHHHHS--CHH-HHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhhccC--CHH-HHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            1111110000  000 000    1123 58889999999999999999999999988753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=355.58  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc--------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Ccccee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |++++.||+|+||.||+|.+.        .+..||||+++....      .      .....+.+|+++++++ +||||+
T Consensus        71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hpnIv  138 (382)
T 3tt0_A           71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------E------KDLSDLISEMEMMKMIGKHKNII  138 (382)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC------H------HHHHHHHHHHHHHHHhcCCchhh
Confidence            456689999999999999863        235799999964321      1      1145688999999999 999999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      ++++++.+ +..|+||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  ++|+|||
T Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~D  216 (382)
T 3tt0_A          139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRD  216 (382)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCC
Confidence            99998877 788999999999999999987532             2459999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++........ .......||+.|+|||++. ..++.++|||||||++|||+| |..||.
T Consensus       217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          217 LAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             CCGGGEEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCcceEEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999866543211 1233456788999999664 467889999999999999999 999998


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .................           ..+..++..+.+||.+||..+|++||++.+|++.|++++
T Consensus       296 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          296 GVPVEELFKLLKEGHRM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             TCCHHHHHHHHHTTCCC-----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCC-----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            77644333332221100           011223455888999999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=350.14  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=197.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcE----EEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~----vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.++||+|+||.||+|.+.. ++.    ||+|.+......            .....+.+|+.++++++||||++++
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~~   83 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP------------KANKEILDEAYVMASVDNPHVCRLL   83 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC------------CCHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH------------HHHHHHHHHHHHHHhCCCCCeeEEE
Confidence            45667999999999999999753 444    577776532210            1145688999999999999999999


Q ss_pred             ccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         246 GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       246 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      +++.+...++|++|+.+|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           84 GICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             EEEESSSEEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEecCCceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEc
Confidence            9998877899999999999999998743  369999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||+++....... ........||+.|+|||.+ ...++.++|||||||++|||++ |..||................. 
T Consensus       160 DfG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-  237 (327)
T 3lzb_A          160 DFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-  237 (327)
T ss_dssp             CTTC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred             cCcceeEccCccc-cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            9999987644321 1122345678899999965 4467899999999999999999 9999988765443333322110 


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                ...+..++..+.+++.+||..||.+||++.++++.|+++..
T Consensus       238 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 ----------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                      01112234458889999999999999999999999998875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=345.66  Aligned_cols=251  Identities=30%  Similarity=0.484  Sum_probs=194.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.+.||+|+||.||+|.+. ++.||||++....               ....|.+|+.++++++||||+++++++.+ 
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---------------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   72 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---------------ERKAFIVELRQLSRVNHPNIVKLYGACLN-   72 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT---------------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred             eeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh---------------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            456689999999999999987 7899999985321               14568999999999999999999998875 


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCeeecCCCCCcEEEcCCCc-eEEeeccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-KPIIHRDVKSANVLLDENFV-PKLGDFGI  329 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-~~iiH~Dikp~NILl~~~~~-~kl~DFGl  329 (455)
                      ..|+||||+++|+|.+++......+.+++..++.++.|++.||.|||+.. +||+||||||+|||++.++. +||+|||+
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            47899999999999999987554456899999999999999999999853 57999999999999998886 79999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......      .....||+.|+|||++.+ .++.++||||||+++|||+||..||.....................  
T Consensus       153 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  224 (307)
T 2eva_A          153 ACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP--  224 (307)
T ss_dssp             ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC--
T ss_pred             ccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC--
Confidence            8754322      123469999999997654 6789999999999999999999999865432211111111000000  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                             ....++..+.+++.+||..||++||++.++++.|+++..
T Consensus       225 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          225 -------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             -------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             -------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                   112234558889999999999999999999999988753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.8e-44  Score=343.91  Aligned_cols=258  Identities=20%  Similarity=0.268  Sum_probs=195.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.+.||+|+||.||+|.+++|+.||||++........           ....+.+|+.++++++||||+++++++.+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-----------IPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-----------CCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc-----------cchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            3566789999999999999997789999999965432111           13458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           72 KKRLVLVFEHLD-QDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCeEEEEEEecC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence             78899999997 49999887643  468999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccc--
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP--  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~--  403 (455)
                      ++.......   ......||+.|+|||++.+  .++.++|||||||++|||+||.+||...........+..  ....  
T Consensus       147 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T 1ob3_A          147 ARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK  223 (288)
T ss_dssp             HHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccCcccc---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChh
Confidence            986543221   1234578999999997644  478999999999999999999999987764322222211  0000  


Q ss_pred             -hhh-----ccchhccC-----C--ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -VRE-----VLDKEAGE-----W--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -~~~-----~~d~~~~~-----~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .+.     ..++....     +  ....++..+.+||.+||..||++||++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             000     00000000     0  01234566889999999999999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2e-43  Score=345.57  Aligned_cols=257  Identities=21%  Similarity=0.250  Sum_probs=195.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||+||+|.+++|+.||||++......           ......+.+|++++++++||||+++++++.+ 
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-----------EGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-----------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             hHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-----------chhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            5667999999999999999988999999999644221           1113558899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+. |+|.+.+....  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  166 (311)
T 3niz_A           92 RCLTLVFEFME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLA  166 (311)
T ss_dssp             SCEEEEEECCS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEcCCC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCc
Confidence            78899999997 58888887643  469999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccch--
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV--  404 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~--  404 (455)
                      +.......   ......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+..  .....  
T Consensus       167 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  243 (311)
T 3niz_A          167 RAFGIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE  243 (311)
T ss_dssp             EETTSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred             eecCCCcc---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence            86543221   1234578999999997644  478999999999999999999999987653322222211  11000  


Q ss_pred             -hhcc------chhc---cCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 -REVL------DKEA---GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 -~~~~------d~~~---~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ....      ....   ...+    ...++..+.+||.+||..||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             0000      0000   0000    0123446788999999999999999999987

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-44  Score=352.87  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=197.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +++.||||++.......            ....+.+|+.+++.++||||+++++++.
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~hpnIv~~~~~~~   75 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------------CPENIKKEICINKMLNHENVVKFYGHRR   75 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc------------hHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4677799999999999999987 58999999996443211            0234889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           76 EGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             CSSEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEee
Confidence            7 788999999999999998875   3469999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CC-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++...... .........||+.|+|||++.+ .+ +.++|||||||++|+|++|..||...................  
T Consensus       151 ~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--  227 (323)
T 3tki_A          151 LATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--  227 (323)
T ss_dssp             TCEECEETT-EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--
T ss_pred             ccceeccCC-cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--
Confidence            998654332 1222345689999999997754 33 678999999999999999999998765332211111111000  


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ......++..+.+||.+||..||++||++.|+++
T Consensus       228 -------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          228 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                   0111234455788999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.4e-44  Score=348.46  Aligned_cols=267  Identities=23%  Similarity=0.396  Sum_probs=203.2

Q ss_pred             CcCCCccCcCCCeEEEEEEE-----cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|.+     .+++.||||+++.....            .....+.+|++++++++||||+++++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG------------NHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----------------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc------------hhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            46668999999999999984     24889999999754211            11456889999999999999999999


Q ss_pred             cccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         247 LCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       247 ~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++.+   ...++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+|
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEE
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEE
Confidence            8765   45689999999999999996543  369999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cc
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      |+|||+++................||..|+|||.+ ...++.++||||||+++|||+||..|+.............. ..
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ  246 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence            99999998766544332334456789999999966 44678899999999999999999998654321110000000 00


Q ss_pred             cc---hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         402 VP---VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       402 ~~---~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..   +...+........+..++..+.+|+.+||..||.+||++.++++.|+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            00   000011111111123445668899999999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.3e-44  Score=348.18  Aligned_cols=258  Identities=28%  Similarity=0.465  Sum_probs=205.7

Q ss_pred             CcCCCccCcCCCeEEEEEEE------cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++++.||+|+||.||+|++      .+++.||||+++....      .      .....+.+|+.+++++ +||||+++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH------L------TEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh------H------HHHHHHHHHHHHHhhcccCCCeeeE
Confidence            45668999999999999985      2367899999964321      1      1145689999999999 99999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      ++++.+ +..++||||+++|+|.+++.....               ..++++..++.++.|++.||.|||+  ++++|||
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~d  170 (313)
T 1t46_A           93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRD  170 (313)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCC
Confidence            998877 788999999999999999987532               1258999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+||+++.++.+||+|||+++........ .......||+.|+|||.+ ...++.++||||||+++|||+| |..||.
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CccceEEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999876544321 223345678899999965 5567899999999999999999 999998


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .................          ...+..++..+.+++.+||..||.+||++.++++.|++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          250 GMPVDSKFYKMIKEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             TCCSSHHHHHHHHHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchhHHHHHhccCCC----------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            76533222221111110          11112344568889999999999999999999999998874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=350.79  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=202.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++++.||+|+||.||+|.+.      ++..||||+++......            ....+.+|+.+++++ +||||+++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~~hp~iv~~  114 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS------------EREALMSELKMMTQLGSHENIVNL  114 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH------------HHHHHHHHHHHHHhhcCCCCeeeE
Confidence            356689999999999999962      35689999997432110            134588999999999 89999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNT--------------------PPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      ++++.. +..++||||+++|+|.+++......                    ..+++..++.++.|++.||.|||+  +|
T Consensus       115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~  192 (344)
T 1rjb_A          115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KS  192 (344)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CC
Confidence            998877 7889999999999999999864321                    348999999999999999999999  88


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-C
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G  381 (455)
                      |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+ .+.++.++|||||||++|||+| |
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence            99999999999999999999999999986654332 1223445788899999965 4568899999999999999998 9


Q ss_pred             CCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..||...................          ..+..++..+.+|+.+||..||.+||++.++++.|+.++.
T Consensus       272 ~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          272 VNPYPGIPVDANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCcccCCcHHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            99998765332222221111110          0112234558889999999999999999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.8e-43  Score=348.49  Aligned_cols=247  Identities=23%  Similarity=0.296  Sum_probs=189.9

Q ss_pred             CcCCCccCcCCCeEEEEEEE----cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|+.    .+|+.||||+++........         .....+.+|+.++++++||||++++++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA---------KDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------------HHHHHHHCCCTTBCCEEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhh---------hHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            45668999999999999997    35899999999754321110         013447889999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ +..|+||||++||+|.+++...   ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEe
Confidence            877 7889999999999999999873   358999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++......   .......||+.|+|||++. ..++.++|||||||++|||++|..||...........+......++
T Consensus       165 fg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p  241 (327)
T 3a62_A          165 FGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP  241 (327)
T ss_dssp             CSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             CCcccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            99987543222   1234568999999999664 4678899999999999999999999987764433333332222221


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                  ..++..+.+||.+||..||++||     ++.++++
T Consensus       242 ------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          242 ------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                        12345588999999999999999     6777764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=354.12  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=197.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. ++.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~----------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   86 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE----------RNEVRNVFKELQIMQGLEHPFLVNLWYSFQD   86 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc----------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            4566899999999999999874 7899999997533211          1124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccce
Confidence             788999999999999999986   3469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhH---HHhhhccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY---YLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~---~~~~~~~~  402 (455)
                      ++......    ......||+.|+|||++.+    .++.++|||||||++|||++|..||.........   ........
T Consensus       162 a~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  237 (384)
T 4fr4_A          162 AAMLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV  237 (384)
T ss_dssp             CEECCTTC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred             eeeccCCC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence            98654332    1345689999999997742    4788999999999999999999999865422111   11111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC-HHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~  447 (455)
                      .+            +..++..+.+||.+||..||.+||+ +.+|.+
T Consensus       238 ~~------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 TY------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CC------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CC------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11            1223455889999999999999998 666653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=349.03  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=200.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +++.||+|.+....       .       ....+.+|+.++++++||||+++++++.
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-------~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~   71 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-------T-------DQVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-------H-------HHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-------c-------cHHHHHHHHHHHHhCCCCCCCeEeEEEe
Confidence            4667799999999999999987 47899999986321       1       1345889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC--CCceEEee
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~--~~~~kl~D  326 (455)
                      + ...++||||++||+|.+++....  .++++..++.++.|++.||.|||+  +||+||||||+|||++.  ++.+||+|
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           72 SMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             ETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             cCCEEEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEE
Confidence            7 88899999999999999997532  369999999999999999999999  88999999999999987  78999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCC-CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......    .....||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+......+.
T Consensus       148 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  223 (321)
T 1tki_A          148 FGQARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD  223 (321)
T ss_dssp             CTTCEECCTTCE----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             CCCCeECCCCCc----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC
Confidence            999987654321    2345799999999977554 68899999999999999999999988765443333332221111


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .   ..     ...++..+.+||.+||..||++||++.|+++
T Consensus       224 ~---~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 E---EA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             H---HH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h---hh-----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0   00     1123456889999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.9e-44  Score=370.90  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=206.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||.||+|.++. +..||||+++....              ....|.+|+.++++++||||+++++++.+ 
T Consensus       223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--------------chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            455899999999999999875 78999999864321              14559999999999999999999999877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CcEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccc
Confidence            78899999999999999998643 3468999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......  ........+|..|+|||++. +.++.++|||||||++|||+| |..||...+...........        
T Consensus       366 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------  435 (495)
T 1opk_A          366 RLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------  435 (495)
T ss_dssp             ECCTTCC--EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------
T ss_pred             eeccCCc--eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence            8764332  11223446778899999664 568899999999999999999 99999877643332222211        


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         .....+..++..+.+||.+||..||++||++.+|++.|++++.
T Consensus       436 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          436 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence               0011122345568889999999999999999999999998864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.5e-43  Score=352.40  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=200.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++......           ......+.+|+.++++++||||+++++++.+
T Consensus        31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----------ARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            345589999999999999986 4889999999754321           0114568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---CceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~D  326 (455)
                       ...|+||||+.||+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+|
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEee
Confidence             788999999999999999976   3469999999999999999999999  889999999999999865   4599999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......    .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+.......+......++
T Consensus       175 fG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  250 (362)
T 2bdw_A          175 FGLAIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP  250 (362)
T ss_dssp             CTTCBCCTTCCS----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             cCcceEecCCcc----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            999986553321    234689999999997755 688999999999999999999999988765444333332221111


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        .....++..+.+||.+||..||++||++.++++
T Consensus       251 ~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          251 S--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             T--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0        001234556889999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-43  Score=342.79  Aligned_cols=256  Identities=22%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             CcCCC-ccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGN-KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~-~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.. .||+|+||.||+|.+.   +++.||||+++.....           ......+.+|+.++++++||||++++++
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----------PALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-----------HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34445 8999999999999653   3678999999643210           1114568999999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.....++||||+++++|.+++..   ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+||
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           87 CEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             EESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ECCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccC
Confidence            977888999999999999999987   3469999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++................||+.|+|||.+. ..++.++||||||+++|||+| |..||..................  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--  239 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--  239 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            99987654432222223345778999999764 457889999999999999999 99999887644333322221100  


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ..+..++..+.++|.+||..||++||++.+|++.|++++.
T Consensus       240 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          240 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                     0112344568899999999999999999999999998864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-43  Score=338.07  Aligned_cols=250  Identities=28%  Similarity=0.450  Sum_probs=190.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+. ++.||||+++.......         ......+.+|+++++.++||||+++++++.+ 
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDI---------SQTIENVRQEAKLFAMLKHPNIIALRGVCLKE   78 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TEEEEEEEC-------------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred             eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccH---------HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            456689999999999999986 79999999875432111         1114568899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC---eeecCCCCCcEEEcC--------C
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP---IIHRDVKSANVLLDE--------N  319 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~---iiH~Dikp~NILl~~--------~  319 (455)
                      ...++||||+++++|.+++..    .++++..++.++.|++.||.|||+  ++   ++||||||+|||++.        +
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEecccccccccC
Confidence            788999999999999998863    469999999999999999999999  77   999999999999986        7


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++......     .....||+.|+|||.+. ..++.++||||||+++|+|++|..||.............
T Consensus       153 ~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  227 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA  227 (271)
T ss_dssp             CCEEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred             cceEEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh
Confidence            889999999987654322     22457999999999664 457889999999999999999999998776443333222


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ......          ..+..++..+.+++.+|+..+|++||++.++++.|+++
T Consensus       228 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNKLAL----------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSCCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCCCCC----------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            211110          11123345688999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=359.72  Aligned_cols=249  Identities=21%  Similarity=0.281  Sum_probs=200.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||+|++.....      .     ......+.+|+.++++++||||+++++++.+
T Consensus        13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   81 (444)
T 3soa_A           13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------S-----ARDHQKLEREARICRLLKHPNIVRLHDSISE   81 (444)
T ss_dssp             EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------H-----HHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred             eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------C-----HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence            355689999999999999986 589999999975432      1     1114568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc---CCCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~D  326 (455)
                       +..|+||||+.||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++   +++.+||+|
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEcc
Confidence             7889999999999999999873   469999999999999999999999  8899999999999998   568899999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......++
T Consensus       157 FG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  233 (444)
T 3soa_A          157 FGLAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP  233 (444)
T ss_dssp             CSSCBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             CceeEEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Confidence            999976554321   1234689999999997755 589999999999999999999999988775544444333222211


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .      ..  ...++..+.+||.+||..||++||++.|+++
T Consensus       234 ~------~~--~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 S------PE--WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             T------TT--TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             c------cc--cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1      00  1234456889999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.9e-44  Score=365.73  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++.++||+|+||.||+|.++++..||||+++....              ....|.+|+.++++++||||+++++++.+..
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  252 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--------------SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP  252 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--------------CHHHHHHHHHHHHhCCCCCEeeEEEEEcCCc
Confidence            45588999999999999998778899999974321              1345899999999999999999999998888


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            899999999999999997532 2458999999999999999999999  8899999999999999999999999999986


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      .......  ......+|..|+|||.+ .+.++.++|||||||++|||+| |..||.+.........+.... .       
T Consensus       330 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~-------  399 (452)
T 1fmk_A          330 IEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-R-------  399 (452)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C-------
T ss_pred             cCCCcee--cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-------
Confidence            6533211  12334678899999965 4578999999999999999999 999998776433322222110 0       


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         ...+..++..+.+++.+||..+|++||++.+|++.|++++.
T Consensus       400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence               01112345568889999999999999999999999998864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-43  Score=347.96  Aligned_cols=260  Identities=20%  Similarity=0.296  Sum_probs=192.2

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEcC-C---cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      ..|++.+.||+|+||.||+|.++. +   ..||||+++.....           ......+.+|++++++++||||++++
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-----------SSDIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-----------------CHHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-----------HHHHHHHHHHHHHHHHCCCCceehhh
Confidence            346677999999999999999764 2   27999998643221           01145689999999999999999999


Q ss_pred             ccccC-cee------EEEEEeccCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEE
Q psy5603         246 GLCNN-IMN------CIVYEYMCNGSLYDRLARVNN---TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       246 ~~~~~-~~~------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +++.. ...      ++||||+.+|+|.+++.....   ...+++..++.++.|++.||.|||+  +||+||||||+|||
T Consensus        92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIl  169 (323)
T 3qup_A           92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCM  169 (323)
T ss_dssp             EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEE
Confidence            98765 333      899999999999999965332   2369999999999999999999999  88999999999999


Q ss_pred             EcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhh
Q psy5603         316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                      ++.++.+||+|||+++........ .......+|+.|+|||.+. ..++.++|||||||++|||++ |..||........
T Consensus       170 i~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          170 LAEDMTVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             ECTTSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EcCCCCEEEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence            999999999999999865443211 1123446788999999664 457899999999999999999 9999987765433


Q ss_pred             HHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..........           ..+..++..+.+|+.+|+..||++||++.++++.|++++.
T Consensus       249 ~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          249 YNYLIGGNRL-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHHHTTCCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            3332221100           0112234558899999999999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-43  Score=352.27  Aligned_cols=254  Identities=23%  Similarity=0.316  Sum_probs=198.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++.........        ......+.+|+.++++++||||+++++++.+
T Consensus        26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP--------GLSTEDLKREASICHMLKHPHIVELLETYSS   97 (351)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS--------SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc--------cchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            566789999999999999986 5899999999643221111        0114568999999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc---eEEe
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~---~kl~  325 (455)
                       ...|+||||++||+|.+.+.... ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEe
Confidence             78899999999999998886532 23468999999999999999999999  88999999999999986654   9999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......... +.......
T Consensus       176 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-i~~~~~~~  251 (351)
T 3c0i_A          176 GFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG-IIKGKYKM  251 (351)
T ss_dssp             CCTTCEECCTTSC---BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH-HHHTCCCC
T ss_pred             cCcceeEecCCCe---eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH-HHcCCCCC
Confidence            9999987654321   1334689999999997654 57899999999999999999999998764322211 11111111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .    ...    ...++..+.+||.+||..||++||++.++++
T Consensus       252 ~----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          252 N----PRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C----HHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C----ccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0    000    0123456889999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-43  Score=339.08  Aligned_cols=252  Identities=21%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             CccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         176 NKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ..||+|+||.||+|.+.   ++..||||+++....            ......+.+|++++++++||||+++++++.+..
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   83 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------------KADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA   83 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccc------------hhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCC
Confidence            48999999999999864   477899999975321            111456899999999999999999999997788


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++++|.+++...  ..++++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            99999999999999999753  3469999999999999999999999  8899999999999999999999999999987


Q ss_pred             cccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ...............||+.|+|||.+. ..++.++||||||+++|||+| |..||...........+......       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~-------  232 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------  232 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC-------
Confidence            654432222233456789999999764 467889999999999999999 99999876644333222221100       


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ..+..++..+.++|.+|+..+|++||++.++++.|++++.
T Consensus       233 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          233 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                0112344568889999999999999999999999998763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.3e-44  Score=364.82  Aligned_cols=250  Identities=21%  Similarity=0.272  Sum_probs=200.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||+||+|+++. ++.||||++++......          .....+.+|..++..++||||+++++++.+ 
T Consensus        77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~----------~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR----------AETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT----------TTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhH----------HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344899999999999999875 78899999975322111          112338899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+|||||+||+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            78899999999999999998632  369999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc--cc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EV  402 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~  402 (455)
                      +.......  ......+||+.|+|||++.      +.++.++|||||||++|||++|.+||...+.......+...  ..
T Consensus       223 ~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          223 LKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             EECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             hhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence            76544321  2234568999999999764      45789999999999999999999999987755444443321  11


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCC--CCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                      .++..         ...++..+.+||.+||..+|++  ||++.|+++
T Consensus       301 ~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 QFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            11111         0123455888999999888888  999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-43  Score=339.29  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=205.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.+.||+|+||.||+|.++++..||||+++....              ....+.+|++++++++||||+++++++.++
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--------------SPDAFLAEANLMKQLQHQRLVRLYAVVTQE   80 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--------------cHHHHHHHHHHHHhCCCcCcceEEEEEcCC
Confidence            456689999999999999998788999999864321              134588999999999999999999998888


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            8899999999999999987532 1258999999999999999999999  889999999999999999999999999998


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......||..|+|||.+. +.++.++||||||+++|||++ |..||.................       
T Consensus       158 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  228 (279)
T 1qpc_A          158 LIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------  228 (279)
T ss_dssp             ECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred             cccCccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-------
Confidence            7654321  1223456788999999764 567889999999999999999 9999987664332222221100       


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ...+..++..+.+++.+|+..+|++||++.++++.|++++.
T Consensus       229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence                01112344568889999999999999999999999998763

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.5e-43  Score=338.15  Aligned_cols=255  Identities=21%  Similarity=0.275  Sum_probs=202.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.+. +|+.||||++.....               ...+.+|+.+++++ +|+|++++++++
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~e~~~~~~l~~~~~i~~~~~~~   75 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---------------APQLRDEYRTYKLLAGCTGIPNVYYFG   75 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---------------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---------------cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence            3566799999999999999974 589999999864322               12278899999999 799999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc-----e
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----P  322 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~-----~  322 (455)
                      .+ ...++||||+ +++|.+++....  .++++..++.++.|++.||+|||+  +||+||||||+|||++.++.     +
T Consensus        76 ~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           76 QEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             CCCceeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeE
Confidence            77 7889999999 999999998643  369999999999999999999999  88999999999999987776     9


Q ss_pred             EEeecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhH---
Q psy5603         323 KLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY---  394 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~---  394 (455)
                      ||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|..||.........   
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            999999998765443211    12345689999999997654 5789999999999999999999999875422111   


Q ss_pred             HHhhh--cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         395 YLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       395 ~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .....  ...+.....         ..++..+.+++.+|+..+|++||++.+|++.|+++++
T Consensus       231 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          231 ERIGEKKQSTPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHHHHSCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhccCccHHHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            11111  111111110         1234568899999999999999999999999998864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.7e-44  Score=348.69  Aligned_cols=258  Identities=24%  Similarity=0.340  Sum_probs=192.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||+++.....      .    ......+.+|+.++++++||||+++++++.
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   82 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR------D----PSFYLRFRREAQNAAALNHPAIVAVYDTGE   82 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT------S----HHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC------C----HHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence            4567799999999999999975 5899999999753221      1    112456899999999999999999999875


Q ss_pred             C-c----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         250 N-I----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       250 ~-~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      . .    ..|+||||++|++|.+++...   .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           83 AETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEETTEEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEE
T ss_pred             ccCCCCcccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEE
Confidence            5 2    348999999999999999874   369999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +|||+++................||+.|+|||++.+ .++.++|||||||++|||+||..||..................
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~  237 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI  237 (311)
T ss_dssp             CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence            999999866543322223345679999999997654 6788999999999999999999999887654433332222111


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH-HHHHh
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV-DLLSK  451 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl-~~L~~  451 (455)
                      .....        ...++..+.++|.+||..||++||+..+++ ..|.+
T Consensus       238 ~~~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          238 PPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             CHHHH--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             Ccccc--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            11100        112345588899999999999999766654 44443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-43  Score=340.79  Aligned_cols=248  Identities=24%  Similarity=0.392  Sum_probs=195.4

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||.||+|..+ ++..||+|++......            .....+.+|++++++++||||+++++++.+ 
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ------------VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC------------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             eecceeccCCCeEEEEEEEccCCceEEEEEeeccccc------------hhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            44589999999999999986 4889999999754321            114568899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE---cCCCceEEee
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                      ...|+||||+++|+|.+++.... ....+++..++.++.|++.||.|||+  +||+||||||+|||+   +.++.+||+|
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence            78899999999999999886432 13579999999999999999999999  889999999999999   5568899999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++......    ......||+.|+|||++.+.++.++||||||+++|||++|..||.....................
T Consensus       171 fg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (285)
T 3is5_A          171 FGLAELFKSDE----HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV  246 (285)
T ss_dssp             CCCCCC--------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred             eecceecCCcc----cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence            99997654332    12345799999999988888999999999999999999999999887644333322221111110


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ..     ..++..+.+||.+||..||++||++.|+++
T Consensus       247 ----~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 ----EC-----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----cc-----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00     112345778999999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7e-43  Score=335.18  Aligned_cols=246  Identities=21%  Similarity=0.304  Sum_probs=201.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. +..||+|++......             ....+.+|++++++++||||+++++++.+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (277)
T 3f3z_A           11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-------------DVDRFKQEIEIMKSLDHPNIIRLYETFED   77 (277)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-------------CHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-------------hHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4566899999999999999874 678999999754321             14458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE---cCCCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                       ...|+||||+++++|.+++...   ..+++..++.++.|++.||.|||+  ++++||||||+|||+   +.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEe
Confidence             7889999999999999999873   459999999999999999999999  889999999999999   8889999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||++........    .....||+.|+|||++.+.++.++||||||+++|||++|..||...................+.
T Consensus       153 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  228 (277)
T 3f3z_A          153 FGLAARFKPGKM----MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE  228 (277)
T ss_dssp             CTTCEECCTTSC----BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             cccceeccCccc----hhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            999876544321    2345799999999988888999999999999999999999999887654433333322211111


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .   .     ...++..+.++|.+|+..||++||++.++++
T Consensus       229 ~---~-----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 K---D-----WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             H---H-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             h---h-----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   0     0123456888999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-43  Score=350.02  Aligned_cols=241  Identities=25%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|..+. |+.||||+++......          ......+.+|..++..+ +||||+++++++.
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~----------~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----------DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc----------chHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            4556899999999999999874 7889999997542211          11245588899999988 8999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..++.++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            7 8889999999999999999874   359999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++. ..++.++|||||||++|||++|.+||...+.......+......++. 
T Consensus       167 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~-  242 (353)
T 2i0e_A          167 MCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK-  242 (353)
T ss_dssp             TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-
T ss_pred             cccccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC-
Confidence            998543222   1234578999999999764 46789999999999999999999999887655444444433322221 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                 .++..+.+||.+||..||.+||+.
T Consensus       243 -----------~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          243 -----------SMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             -----------TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             -----------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence                       234558889999999999999964

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6e-44  Score=362.21  Aligned_cols=247  Identities=23%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|+++. ++.||+|++++.......          ....+.+|+.+++.++||||+++++++.+ 
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~----------~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS----------DSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTC----------CCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhH----------HHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            455899999999999999874 789999999753221111          12237899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++||+|.+++...    .+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEecccee
Confidence            7889999999999999999752    48999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccCC-----CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc--cc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE--VP  403 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--~~  403 (455)
                      +......  .......+||+.|+|||++.+.     ++.++|||||||++|||+||.+||...+.......+....  ..
T Consensus       216 ~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  293 (410)
T 3v8s_A          216 MKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  293 (410)
T ss_dssp             EECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             EeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence            8655432  1223467899999999976432     6789999999999999999999999877554444433211  11


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCC--CCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                      ++.          ...++..+.+||.+||..+|++  ||++.||++
T Consensus       294 ~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          294 FPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             CCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            110          1124456889999999988988  999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=346.00  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=197.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.+.||+|+||.||+|.++.     +..||||+++....      .      .....+.+|+.++++++||||++++
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~  112 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT------E------KQRVDFLGEAGIMGQFSHHNIIRLE  112 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC------H------HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            34566899999999999998753     23599999864321      1      1144688999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      +++.+ ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||
T Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl  188 (333)
T 1mqb_A          113 GVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKV  188 (333)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEE
T ss_pred             EEEecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEE
Confidence            98877 78899999999999999997642  469999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+++................+|+.|+|||.+. ..++.++|||||||++|||++ |..||...........+.... 
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-  267 (333)
T 1mqb_A          189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-  267 (333)
T ss_dssp             CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-
T ss_pred             CCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-
Confidence            99999987654332222223346788999999764 467889999999999999999 999998766433322222110 


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..          ..+..++..+.+++.+||..+|++||++.++++.|++++.
T Consensus       268 ~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          268 RL----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             CC----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00          0112234558889999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-43  Score=335.82  Aligned_cols=252  Identities=24%  Similarity=0.391  Sum_probs=205.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+.+++.||||++.....      .        ...+.+|++++++++||||+++++++.+ 
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------S--------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC------C--------HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            456689999999999999998888999999975322      1        2458899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEcccccc
Confidence            78899999999999999998643  368999999999999999999999  88999999999999999999999999998


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......  ........||+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.....      
T Consensus       152 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~------  223 (267)
T 3t9t_A          152 RFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------  223 (267)
T ss_dssp             GGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------
T ss_pred             ccccccc--ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc------
Confidence            8654321  11123456788999999764 567889999999999999999 9999987664333222221110      


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+++.+|+..+|++||++.++++.|+++.+
T Consensus       224 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 -----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                 01112234558889999999999999999999999998864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-43  Score=349.90  Aligned_cols=241  Identities=23%  Similarity=0.322  Sum_probs=193.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++ +++.||||+++......          ......+.+|..++.++ +||||+++++++.
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND----------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS----------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc----------hHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            355689999999999999987 48899999997643211          11145588999999988 8999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..++.++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG  155 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYG  155 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEecc
Confidence            7 8889999999999999999874   359999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcc---------hhhHHHhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---------ILYYYLVV  398 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~---------~~~~~~~~  398 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||++|..||.....         ......+.
T Consensus       156 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~  232 (345)
T 3a8x_A          156 MCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  232 (345)
T ss_dssp             GCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred             ccccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence            998543222   12345689999999997654 678999999999999999999999975321         11111111


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      .....++            ..++..+.+||.+||..||++||++
T Consensus       233 ~~~~~~p------------~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          233 EKQIRIP------------RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HCCCCCC------------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             cCCCCCC------------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            1111111            2244558889999999999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-43  Score=362.45  Aligned_cols=246  Identities=26%  Similarity=0.454  Sum_probs=201.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+++.||+|+||.||+|.++ +|+.||||+++.....          .......+.+|+.+++.++||||+++++++.
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~----------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR----------SLDVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH----------HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc----------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4567799999999999999987 5899999999753211          1112456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEecc
Confidence            7 788999999999999999976   3469999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccCC-C-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++......    .....+||+.|+|||++.+. + +.++|||||||++|||++|..||...........+.......+ 
T Consensus       162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-  236 (476)
T 2y94_A          162 LSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP-  236 (476)
T ss_dssp             SCEECCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC-
T ss_pred             chhhccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC-
Confidence            998765432    12346899999999987664 3 6799999999999999999999987764443333332221111 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 ..++..+.+||.+||..||++||++.++++
T Consensus       237 -----------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          237 -----------QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                       123345788999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.1e-44  Score=355.98  Aligned_cols=273  Identities=16%  Similarity=0.206  Sum_probs=201.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.++.      ++.||||++........  .............+..|+..++.++||||++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF--TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHH--HHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHH--HHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4566999999999999999864      37899999864321000  000000111122355677788889999999999


Q ss_pred             ccccC-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc--C
Q psy5603         246 GLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--E  318 (455)
Q Consensus       246 ~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~--~  318 (455)
                      +++..     ...|+||||+ |++|.+++...  ..++++..++.|+.|++.||.|||+  ++|+||||||+|||++  .
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEESSC
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEEecCC
Confidence            98754     3479999999 99999999874  2469999999999999999999999  8899999999999999  8


Q ss_pred             CCceEEeecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhh
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      ++.+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||+||..||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            8999999999998654432111    11134569999999997655 578999999999999999999999986432211


Q ss_pred             HH--HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         394 YY--LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~--~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..  ........+...++...   ....++..+.+++..|+..+|++||++.+|++.|+++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            11  11111222333333322   112345568889999999999999999999999998864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-43  Score=345.49  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=192.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh--CCccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++ ++.||||++....                ...+..|.+++..  ++||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           39 IQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----------------EASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             CEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             eEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----------------cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            355699999999999999987 7999999985321                1224455555554  49999999999765


Q ss_pred             C-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--------CeeecCCCCCcEEE
Q psy5603         250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK--------PIIHRDVKSANVLL  316 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~--------~iiH~Dikp~NILl  316 (455)
                      +     ...++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+  +        +|+||||||+|||+
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT--EIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHS--CBCSTTCBCCEECSCCCGGGEEE
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--hhhhhccCCCEEecccchHHEEE
Confidence            4     467999999999999999975    259999999999999999999998  6        89999999999999


Q ss_pred             cCCCceEEeecccccccccCCcce-eeeccCCCCCCCCCcccccCC-CCc------ccchHHHHHHHHHHHcC-------
Q psy5603         317 DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-IST------KTDVFSYGVILLELLTG-------  381 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~~------~sDv~SlGvvl~elltG-------  381 (455)
                      +.++.+||+|||+++......... .......||+.|+|||++.+. .+.      ++|||||||++|||+||       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999997654432211 112356899999999977553 333      48999999999999999       


Q ss_pred             ---CCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         382 ---MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         ..||.............................+....++..+.+++.+||..||.+||++.+|++.|+++.+
T Consensus       256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence               6666543211100000000000000001111223345778889999999999999999999999999998865

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.6e-43  Score=343.88  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=188.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++......            ....+.+|+.++++++||||+++++++.+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   74 (317)
T 2pmi_A            7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG------------TPSTAIREISLMKELKHENIVRLYDVIHT   74 (317)
T ss_dssp             ------------CEEEEEECSSSCCEEEEEEEECCSTTC------------SCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred             eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc------------cHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence            456699999999999999976 48999999997543210            12447899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNN---TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                       ...|+||||+. |+|.+++.....   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECc
Confidence             78899999997 699998875321   2458999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~  403 (455)
                      ||+++.......   ......||+.|+|||++.+  .++.++|||||||++|||+||..||...........+.. ...+
T Consensus       152 fg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          152 FGLARAFGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP  228 (317)
T ss_dssp             CSSCEETTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             CccceecCCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999986543221   1234578999999997754  478999999999999999999999987764332222211 0000


Q ss_pred             hhhcc---------chh------------ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VREVL---------DKE------------AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~---------d~~------------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....         ...            ........++..+.+||.+||..||++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00000         000            000011134456889999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-43  Score=354.52  Aligned_cols=245  Identities=27%  Similarity=0.351  Sum_probs=191.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHH-HhhCCccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+.+. ++.||||++++........          ...+.+|..+ ++.++||||+++++++.
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~----------~~~~~~e~~~ll~~~~hp~Iv~l~~~~~  109 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE----------EKHIMSERNVLLKNVKHPFLVGLHFSFQ  109 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-----------------------CCBCCCCCTTBCCEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH----------HHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence            3455899999999999999874 7889999998654322111          2336677776 57789999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCc
Confidence            7 8889999999999999999874   358999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++. 
T Consensus       185 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-  260 (373)
T 2r5t_A          185 LCKENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP-  260 (373)
T ss_dssp             BCGGGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS-
T ss_pred             cccccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC-
Confidence            998643322   12345789999999997654 5789999999999999999999999887755544444333222211 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                                 .++..+.+||.+||..||++||++.+.+
T Consensus       261 -----------~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          261 -----------NITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -----------SSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -----------CCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                       2344588899999999999999986433

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-43  Score=337.66  Aligned_cols=253  Identities=24%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.+.+    +..||||+++....      .      .....|.+|+.++++++||||++++++
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~i~~~~~~   81 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT------L------DNKEKFMSEAVIMKNLDHPHIVKLIGI   81 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC------H------HHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC------c------hHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3556899999999999998753    23599999864321      1      114568999999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.++..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           82 IEEEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             EcCCCCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCcc
Confidence            88888899999999999999997643  368999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhc-ccch
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ-EVPV  404 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~-~~~~  404 (455)
                      |+++.......  .......||+.|+|||.+. ..++.++||||||+++|||+| |..||............... ..+.
T Consensus       158 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (281)
T 3cc6_A          158 GLSRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK  235 (281)
T ss_dssp             CGGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred             CCCcccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC
Confidence            99986554321  1123456788999999764 567889999999999999998 99999866543322222211 1111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                  +..++..+.+++.+||..+|++||++.++++.|++++.
T Consensus       236 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          236 ------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                        12234558889999999999999999999999998763

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.3e-43  Score=336.03  Aligned_cols=244  Identities=28%  Similarity=0.446  Sum_probs=196.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. +..||||++.....          ........+.+|+.++++++||||+++++++.+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL----------EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD   80 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----------HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc----------chhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence            4566899999999999999874 67899999864321          111124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++...   .++++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccc
Confidence             7889999999999999999874   359999999999999999999999  8899999999999999999999999998


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......     .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++.  
T Consensus       156 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  228 (279)
T 3fdn_A          156 SVHAPSSR-----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--  228 (279)
T ss_dssp             ESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             cccCCccc-----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--
Confidence            86543322     234589999999997654 5688999999999999999999999877644433333222222221  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                .++..+.+||.+||..+|++||++.|+++
T Consensus       229 ----------~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          229 ----------FVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ----------TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----------cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                      23345788999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.2e-43  Score=339.12  Aligned_cols=256  Identities=28%  Similarity=0.414  Sum_probs=198.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.+.+    +..||||.++....            ......+.+|+.++++++||||++++++
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------------IGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS------------HHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC------------HHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            3556899999999999998653    23589999864221            1114568999999999999999999998


Q ss_pred             ccC--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         248 CNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       248 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      +.+  ...++||||+.+|+|.+++...  ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+
T Consensus        95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A           95 CLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             ECCSSSCCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEcCCCceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEEC
Confidence            543  6789999999999999999763  3468999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcce-eeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhccc
Q psy5603         326 DFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++......... .......||+.|+|||.+. ..++.++||||||+++|||++ |.+||.................
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  250 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred             cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence            999998654432211 2233457888999999664 467899999999999999999 6667766553332222221111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .           ..+..++..+.+++.+||..+|++||++.++++.|+++++
T Consensus       251 ~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          251 L-----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1           1112234458889999999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=342.38  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=193.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCch-------------hhhhhhhHHHHHHHHHHHhhC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDN-------------TEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++.............             ..........+.+|+++++++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            3566799999999999999986 48899999997653211100000             000011134588999999999


Q ss_pred             CccceeeecccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCc
Q psy5603         237 KHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       237 ~h~niv~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~N  313 (455)
                      +||||+++++++.+   ...|+||||+++++|.+++.    ..++++..+..++.|++.||.|||+  ++|+||||||+|
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~N  167 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSN  167 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGG
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHH
Confidence            99999999998753   57899999999999987543    3469999999999999999999999  889999999999


Q ss_pred             EEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCC----CCcccchHHHHHHHHHHHcCCCCCCCCc
Q psy5603         314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~sDv~SlGvvl~elltG~~p~~~~~  389 (455)
                      ||++.++.+||+|||+++.......   ......||+.|+|||.+.+.    .+.++|||||||++|||++|..||....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999986654321   23456899999999987553    3678999999999999999999998766


Q ss_pred             chhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         390 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......+.......+          ....++..+.+||.+||..||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHHHHCCCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHhcccCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            4333222222111111          01123455889999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-43  Score=347.99  Aligned_cols=266  Identities=26%  Similarity=0.393  Sum_probs=204.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      ++++.++||+|+||.||++.++     +++.||||+++....      .      .....+.+|++++++++||||++++
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~   99 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG------P------QHRSGWKQEIDILRTLYHEHIIKYK   99 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC------h------HHHHHHHHHHHHHHhCCCcchhhEE
Confidence            3466789999999999998753     478999999964321      1      1145689999999999999999999


Q ss_pred             ccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         246 GLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++.+   ...++||||+++|+|.+++...    .+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~  173 (318)
T 3lxp_A          100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLV  173 (318)
T ss_dssp             EEEEETTTTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCCceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCE
Confidence            98765   5678999999999999999752    48999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      ||+|||+++................||..|+|||++. ..++.++||||||+++|||+||..||..............  
T Consensus       174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  253 (318)
T 3lxp_A          174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG  253 (318)
T ss_dssp             EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred             EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence            9999999987665433223334567888999999664 4678899999999999999999999976432111110000  


Q ss_pred             --cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         400 --QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       400 --~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                        ....+...+........+..++..+.+||.+||..||++||++.++++.|+++.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence              0001111111111112223455678899999999999999999999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-43  Score=346.87  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=191.3

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      ++.+.||+|+||.||+|+++ +|+.||||+++....            ......+.+|+.++++++||||+++++++.+.
T Consensus         9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   76 (332)
T 3qd2_B            9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR------------ELAREKVMREVKALAKLEHPGIVRYFNAWLET   76 (332)
T ss_dssp             EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST------------TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred             ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc------------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence            45589999999999999987 689999999974321            01145689999999999999999999976431


Q ss_pred             ----------------------------------------------------------eeEEEEEeccCCCHHHHHhhcC
Q psy5603         252 ----------------------------------------------------------MNCIVYEYMCNGSLYDRLARVN  273 (455)
Q Consensus       252 ----------------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~  273 (455)
                                                                                ..++||||+++|+|.+++....
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  156 (332)
T 3qd2_B           77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC  156 (332)
T ss_dssp             CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred             ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence                                                                      3789999999999999998866


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcce---------eeec
Q psy5603         274 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT---------MYTE  344 (455)
Q Consensus       274 ~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~---------~~~~  344 (455)
                      .....++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.........         ....
T Consensus       157 ~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T 3qd2_B          157 SLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT  234 (332)
T ss_dssp             SGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred             CccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence            65667888899999999999999999  889999999999999999999999999998765432110         1123


Q ss_pred             cCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHH
Q psy5603         345 NLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETL  423 (455)
Q Consensus       345 ~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  423 (455)
                      ...||+.|+|||++.+ .++.++|||||||++|||++|..|+.......    ........+.         ........
T Consensus       235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~~~~  301 (332)
T 3qd2_B          235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII----TDVRNLKFPL---------LFTQKYPQ  301 (332)
T ss_dssp             SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHH----HHHHTTCCCH---------HHHHHCHH
T ss_pred             ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHH----HHhhccCCCc---------ccccCChh
Confidence            4579999999997644 67999999999999999999877653211100    0001111110         11233445


Q ss_pred             HHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         424 ISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       424 l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.+||.+||..||++||++.|+++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhh
Confidence            688999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=345.03  Aligned_cols=242  Identities=24%  Similarity=0.261  Sum_probs=188.5

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.++||+|+||+||+|.++ +|+.||||++.....      ..     .....+..|+..+.++ +||||+++++++.+
T Consensus        60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR------GP-----KDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC------SH-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc------Ch-----HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            44589999999999999987 589999999864322      11     0123355666666555 99999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||+ +++|.+++....  .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             CCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEcccee
Confidence             7889999999 789999887653  469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ++......    ......||+.|+|||++.+.++.++|||||||++|||++|..|+.......   ......  .    .
T Consensus       204 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~--~----~  270 (311)
T 3p1a_A          204 LVELGTAG----AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGY--L----P  270 (311)
T ss_dssp             CEECC----------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTC--C----C
T ss_pred             eeecccCC----CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccC--C----C
Confidence            87654332    123457999999999888889999999999999999999977765432111   111010  0    0


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...    ...++..+.++|.+|+..||++||++.|+++
T Consensus       271 ~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            000    1123456889999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.6e-43  Score=333.00  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=200.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|+++ ++.||||+++....      .     ......|.+|+.++++++||||+++++++.+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW------S-----TRKSRDFNEECPRLRIFSHPNVLPVLGACQSP   79 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC------C-----HHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred             hHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc------C-----HHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence            466689999999999999997 79999999975321      1     1114568999999999999999999998765 


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eeecCCCCCcEEEcCCCceEEee
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~--iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                        ...++||||+++|+|.+++.... ..++++..++.++.|++.||.|||+  ++  ++||||||+||+++.++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           80 PAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             TSSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTT--SSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             CCCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhc--CCCceecCCCccceEEEcCCcceeEEe
Confidence              56699999999999999998643 3469999999999999999999999  67  99999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCC-C---CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I---STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~---~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      ||++.....        ....||+.|+|||.+.+. .   +.++||||||+++|||+||..||.................
T Consensus       157 ~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  228 (271)
T 3kmu_A          157 ADVKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL  228 (271)
T ss_dssp             GGSCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC
T ss_pred             ccceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC
Confidence            998654221        234789999999977543 3   3379999999999999999999987764433222221111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..          ..+..++..+.+++.+||..||++||++.++++.|+++.+
T Consensus       229 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 RP----------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            10          0112234558899999999999999999999999998864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-43  Score=341.75  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=206.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. +..||||++.....              ....+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A           15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--------------HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--------------HHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            3556899999999999999874 78999999864221              14568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCcc
Confidence             78899999999999999998643 3569999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......  .......||+.|+|||.+. +.++.++||||||+++|+|++ |..||................      
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~------  229 (288)
T 3kfa_A          158 SRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------  229 (288)
T ss_dssp             GGTSCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------
T ss_pred             ceeccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC------
Confidence            987654332  1233456788999999664 567899999999999999999 999998776443332222110      


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ....+..++..+.+|+.+|+..||.+||++.++++.|++++.
T Consensus       230 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                 001112334568899999999999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.8e-43  Score=363.13  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=201.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.++ +++.||||++.......................+.+|+.++++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3566799999999999999987 478999999976543211111111111122456899999999999999999999988


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC---ceEEe
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~  325 (455)
                      + ...|+|||||+||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++   .+||+
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            7 7889999999999999999774   359999999999999999999999  8899999999999998776   69999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |||+++.......    .....||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.........+......+.
T Consensus       192 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          192 DFGLSSFFSKDYK----LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCTTCEECCTTSC----BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ECCCCEEcCCCCc----cccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9999987654321    234579999999998888899999999999999999999999998775444333333221111


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .   +.     ...++..+.+||.+||..||++|||+.|+++
T Consensus       268 ~---~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          268 F---ND-----WKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             H---HH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c---cc-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0   00     1123456889999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-42  Score=341.73  Aligned_cols=252  Identities=27%  Similarity=0.380  Sum_probs=202.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++..........       .....+.+|+.++++++||||+++++++.+
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG-------VSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSS-------BCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccc-------hhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            456689999999999999987 488999999986544222111       124568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC----ceEEe
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl~  325 (455)
                       ...++||||+++++|.+++..   ..++++..++.++.|++.||.|||+  +||+||||||+||+++.++    .+||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence             788999999999999999986   3468999999999999999999999  8899999999999999888    79999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++.......    .....||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.......
T Consensus       162 Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  237 (321)
T 2a2a_A          162 DFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF  237 (321)
T ss_dssp             CCTTCEECCTTCC----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             cCccceecCcccc----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence            9999986554321    23457999999999765 467889999999999999999999998766443333222211111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..    ..    ...++..+.+||.+||..||++||++.++++
T Consensus       238 ~~----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          238 DE----EF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CH----HH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Ch----hh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            10    00    0123456889999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9e-43  Score=344.12  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=203.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc--------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Ccccee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |++++.||+|+||.||+|.+.        ++..||||+++....            ......+.+|+.+++++ +||||+
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~~hp~iv  104 (334)
T 2pvf_A           37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------------EKDLSDLVSEMEMMKMIGKHKNII  104 (334)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC------------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc------------HHHHHHHHHHHHHHHHhhcCCCEe
Confidence            456689999999999999873        367899999864321            11145688999999999 899999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      ++++++.+ ...++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  ++|+|||
T Consensus       105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~D  182 (334)
T 2pvf_A          105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRD  182 (334)
T ss_dssp             CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCC
Confidence            99998877 788999999999999999986432             1248999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++....... ........||+.|+|||++ ...++.++||||||+++|||+| |..||.
T Consensus       183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          183 LAARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            999999999999999999999986654332 1223345678899999966 4467899999999999999999 999998


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .................           ..+..++..+.+++.+||..+|.+||++.++++.|++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          262 GIPVEELFKLLKEGHRM-----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             TCCHHHHHHHHHHTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHhcCCCC-----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            77643333222211100           0112234558889999999999999999999999998863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-42  Score=335.84  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=197.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      +|++.+.||+|+||.||+|.+. ++..||+|++......           ......+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-----------KSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-----------HHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence            4567788999999999999986 4788999999754321           112456899999999999999999999764


Q ss_pred             C-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eeecCCCCCcEEEc-CCCc
Q psy5603         250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLD-ENFV  321 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~--iiH~Dikp~NILl~-~~~~  321 (455)
                      .     ...|+||||+++|+|.+++...   ..+++..++.++.|++.||.|||+  ++  ++||||||+|||++ .++.
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~  170 (290)
T 1t4h_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGS  170 (290)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSC
T ss_pred             cccCCCceEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHc--CCCCEEECCCCHHHEEEECCCCC
Confidence            3     4579999999999999999874   468999999999999999999999  67  99999999999997 8899


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      +||+|||++.......     .....||+.|+|||++.+.++.++||||||+++|+|++|..||................
T Consensus       171 ~kl~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (290)
T 1t4h_A          171 VKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  245 (290)
T ss_dssp             EEECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             EEEeeCCCcccccccc-----cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc
Confidence            9999999997554332     23457999999999888889999999999999999999999998755332222211111


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ... ...        ....+..+.++|.+||..||++||++.++++
T Consensus       246 ~~~-~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 VKP-ASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCC-GGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCc-ccc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            110 000        1112234888999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=355.54  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=190.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcC--C--cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN--G--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.+.+  +  ..||||.++....      .      .....|.+|+.++++++||||+++++++
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~il~~l~hpnIv~~~~~~  159 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------I------GEVSQFLTEGIIMKDFSHPNVLSLLGIC  159 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC------S------HHHHHHHHHHTTSTTCCCTTBCCCCEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC------H------HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            456889999999999998742  2  3689999864211      0      1145699999999999999999999986


Q ss_pred             cC--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         249 NN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 ~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .+  +..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~D  235 (373)
T 3c1x_A          160 LRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVAD  235 (373)
T ss_dssp             CCCSSCCEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             EcCCCCeEEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEee
Confidence            43  57799999999999999997643  468999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcce-eeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccc
Q psy5603         327 FGIVKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      ||+++......... .......||+.|+|||.+ .+.++.++|||||||++|||+| |.+||..................
T Consensus       236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~  315 (373)
T 3c1x_A          236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL  315 (373)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC
T ss_pred             ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC
Confidence            99998654332111 112345678899999966 4567899999999999999999 78888766533322222211110


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                 ..+..++..+.+++.+||..+|++||++.++++.|++++.
T Consensus       316 -----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          316 -----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       1112344568889999999999999999999999998864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=355.50  Aligned_cols=266  Identities=21%  Similarity=0.311  Sum_probs=207.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||.||+|.++. |+.||||+++.....            .....+.+|++++++++||||+++++++.
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   77 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL------------RPVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG------------SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc------------chHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence            46777999999999999999874 899999999643221            11455789999999999999999999876


Q ss_pred             C---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE----cCCCce
Q psy5603         250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVP  322 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl----~~~~~~  322 (455)
                      +   ...|+||||+++|+|.+++........+++..++.++.|++.||.|||+  +||+||||||+|||+    +.++.+
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeE
Confidence            5   3679999999999999999875544559999999999999999999999  889999999999999    788899


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc---------CCCCcccchHHHHHHHHHHHcCCCCCCCCcc---
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGVILLELLTGMKPIDDNNT---  390 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~---  390 (455)
                      ||+|||+++.......    .....||+.|+|||++.         ..++.++|||||||++|||+||..||.....   
T Consensus       156 kL~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~  231 (396)
T 4eut_A          156 KLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (396)
T ss_dssp             EECCGGGCEECCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred             EEecCCCceEccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence            9999999986544321    23467999999999764         3467899999999999999999999975331   


Q ss_pred             -hhhHHHhhhcccc--hhhcc---------chhc--cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         391 -ILYYYLVVEQEVP--VREVL---------DKEA--GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       391 -~~~~~~~~~~~~~--~~~~~---------d~~~--~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                       .............  +....         ....  ...-...++..+.++|.+||..||++||++.++++.++++++
T Consensus       232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence             1111111111100  00000         0000  111235778889999999999999999999999999998875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.2e-43  Score=351.34  Aligned_cols=260  Identities=19%  Similarity=0.243  Sum_probs=198.9

Q ss_pred             CcCCCccCcC--CCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         172 PRRGNKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       172 ~~~~~~LG~G--~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      |++.++||+|  +||.||+|.++ +|+.||||+++.....           ......+.+|+.++++++||||+++++++
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-----------NEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-----------hHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            4566899999  99999999987 5899999999754321           11245688999999999999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccc
Confidence            77 88899999999999999998743 2469999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcc----eeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         328 GIVKMSETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       328 Gla~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      |++.........    ........||+.|+|||++.+   .++.++|||||||++|||++|..||.+.............
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            987654322111    111234589999999997754   5788999999999999999999999876533222221111


Q ss_pred             ccchhhccchh------------------------------------ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHH
Q psy5603         401 EVPVREVLDKE------------------------------------AGEWNETHVETLISIVFEKCCVFEKDKRASMRD  444 (455)
Q Consensus       401 ~~~~~~~~d~~------------------------------------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e  444 (455)
                      ..  +...+..                                    ........++..+.+||.+||..||++||++.|
T Consensus       253 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          253 TV--PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CC--CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            00  0000000                                    000012234556889999999999999999999


Q ss_pred             HHH
Q psy5603         445 IVD  447 (455)
Q Consensus       445 vl~  447 (455)
                      +++
T Consensus       331 ll~  333 (389)
T 3gni_B          331 LLN  333 (389)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=349.69  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=190.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc--cceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH--VNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.+.+++.||||++.....      .     ......+.+|+.++++++|  |||+++++++
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------D-----NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC------C-----HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc------c-----hHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            4667799999999999999988889999999975322      1     1124568999999999976  9999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...|+||| +.+++|.+++..   ..++++..+..++.|++.||.|||+  ++|+||||||+|||++ ++.+||+||
T Consensus        79 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DF  151 (343)
T 3dbq_A           79 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF  151 (343)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred             eeCCEEEEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeec
Confidence            77 78899999 568999999987   3469999999999999999999999  8899999999999997 678999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc------------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      |+++....... ........||+.|+|||++.            +.++.++|||||||++|||++|..||..........
T Consensus       152 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  230 (343)
T 3dbq_A          152 GIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  230 (343)
T ss_dssp             SSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred             ccccccCcccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH
Confidence            99986654321 11234568999999999763            457889999999999999999999998654321111


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....         +.......+...+..+.+||.+||..||++||++.++++
T Consensus       231 ~~~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          231 HAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHh---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            1110         111000011112345788999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.3e-43  Score=362.42  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=197.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.++ ++..||||++.........           ...+.+|+.++++++||||+++++++.+
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~~  107 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-----------NSKLLEEVAVLKLLDHPNIMKLYDFFED  107 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-----------THHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-----------HHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            456689999999999999987 5889999999754321111           3458899999999999999999999887


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~D  326 (455)
                       ...|+||||+++|+|.+++...   .++++..+..++.|++.||.|||+  +||+||||||+|||++.   ++.+||+|
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEE
Confidence             7889999999999999998774   459999999999999999999999  88999999999999976   45699999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++.......    .....||+.|+|||++.+.++.++|||||||++|+|++|.+||...........+......+..
T Consensus       183 fG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  258 (494)
T 3lij_A          183 FGLSAVFENQKK----MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS  258 (494)
T ss_dssp             CTTCEECBTTBC----BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred             CCCCeECCCCcc----ccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            999987654321    2346799999999988888999999999999999999999999987754444333332221110


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         +.     ...++..+.+||.+||..+|++|||+.++++
T Consensus       259 ---~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 ---PE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ---GG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---hh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence               00     1234456889999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-43  Score=355.22  Aligned_cols=248  Identities=24%  Similarity=0.303  Sum_probs=190.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC--ccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.+.+++.||||++.....      .     ......+.+|+.++++++  ||||+++++++.
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------D-----NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC------C-----HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc------c-----HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            566799999999999999988789999999975422      1     112456899999999996  599999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...|+||| +.+++|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++ ++.+||+|||
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecC
Confidence            7 78899999 5689999999873   368999999999999999999999  8899999999999995 5899999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC------------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      +++....... ........||+.|+|||++.+            .++.++|||||||++|||++|..||...........
T Consensus       200 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  278 (390)
T 2zmd_A          200 IANQMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  278 (390)
T ss_dssp             SSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             ccccccCCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH
Confidence            9986643321 112345689999999997743            578899999999999999999999986542211111


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..         ++.......+...+..+.+||.+||..||++||++.|+++
T Consensus       279 ~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          279 AI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH---------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            11         1110000001112345788999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.3e-43  Score=338.59  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=194.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-C-------cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-G-------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      |++.+.||+|+||.||+|.++. +       ..||+|++.....             .....+.+|+.++++++||||++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~   76 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-------------NYSESFFEAASMMSKLSHKHLVL   76 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-------------GGHHHHHHHHHHHHTSCCTTBCC
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-------------HHHHHHHHHHHHHHhCCCCCEeE
Confidence            4566899999999999998763 3       4699999864321             11456899999999999999999


Q ss_pred             ecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc-
Q psy5603         244 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-  321 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~-  321 (455)
                      +++++.+ ...++||||+.+|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++. 
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~  152 (289)
T 4fvq_A           77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDR  152 (289)
T ss_dssp             EEEEECCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBG
T ss_pred             EEEEEEeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcc
Confidence            9998877 78899999999999999998742  348999999999999999999999  88999999999999998887 


Q ss_pred             -------eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcC-CCCCCCCcch
Q psy5603         322 -------PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG-MKPIDDNNTI  391 (455)
Q Consensus       322 -------~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG-~~p~~~~~~~  391 (455)
                             +||+|||++......       ....||+.|+|||++.+  .++.++|||||||++|||++| .+||......
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  225 (289)
T 4fvq_A          153 KTGNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ  225 (289)
T ss_dssp             GGTBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             cccccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence                   999999998654321       23468899999997653  578899999999999999995 5555544332


Q ss_pred             hhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...... .....++...            +..+.+++.+||..||++||++.++++.|++++.
T Consensus       226 ~~~~~~-~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          226 RKLQFY-EDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHHH-HTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HHHHHh-hccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            221111 1111111111            2237788999999999999999999999998763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=348.01  Aligned_cols=244  Identities=24%  Similarity=0.356  Sum_probs=183.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. ++.||||+++....               ...+.+|+.++++++||||+++++++.+
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---------------KKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---------------HHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            4566899999999999999874 78999999974321               2347889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~D  326 (455)
                       ...++||||+++|+|.+++..   ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEcc
Confidence             788999999999999999976   3469999999999999999999999  88999999999999975   89999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchh-hHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~  404 (455)
                      ||+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|..||....... ....+.......
T Consensus       195 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~  270 (349)
T 2w4o_A          195 FGLSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF  270 (349)
T ss_dssp             CC--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC
T ss_pred             CccccccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc
Confidence            99988654322    1234679999999997654 57899999999999999999999998765332 222222111111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .   .+     ....++..+.+||.+||..||++||++.++++
T Consensus       271 ~---~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 I---SP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C---TT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C---Cc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   00     01234456889999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.4e-43  Score=337.21  Aligned_cols=258  Identities=21%  Similarity=0.253  Sum_probs=194.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.++ +++.||||+++......           .....+.+|+.++++++||||+++++++.
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   71 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-----------GVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-----------THHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-----------CcchHHHHHHHHHhcCCCCCEeeEEeEEE
Confidence            3566789999999999999986 48899999997543211           11355889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||+.+ +|.+.+...  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           72 SDKKLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            7 788999999965 666666543  3469999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-C-CCcccchHHHHHHHHHHHcCCCCCCCCc-chhhHHHhhh-cccch
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYYLVVE-QEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~-~~~~sDv~SlGvvl~elltG~~p~~~~~-~~~~~~~~~~-~~~~~  404 (455)
                      +++......   .......||+.|+|||++.+ . ++.++|||||||++|||+||..||.... .......+.. ...+.
T Consensus       147 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          147 LARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cceecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            998654322   12334688999999997644 3 6899999999999999999888865443 2221111111 00000


Q ss_pred             hhccch----------------hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDK----------------EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~----------------~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......                .........++..+.+||.+|+..||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000000                0000001234566889999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-43  Score=348.41  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=205.5

Q ss_pred             CCCcCCCccCcCCCeEEEEEEE-----cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      ..|++.+.||+|+||.||+|++     .+++.||||++.....             .....+.+|++++++++||||+++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~   89 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-------------DQQRDFQREIQILKALHSDFIVKY   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-------------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-------------HHHHHHHHHHHHHHhcCCCceeEE
Confidence            3456779999999999999984     2478999999864311             114558999999999999999999


Q ss_pred             ccccc--C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         245 LGLCN--N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       245 ~~~~~--~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++.  + ...|+||||+++++|.+++....  .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~  165 (327)
T 3lxl_A           90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAH  165 (327)
T ss_dssp             EEEEECSSSCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTE
T ss_pred             EEEEecCCCceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCC
Confidence            99764  3 66899999999999999997643  259999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||+++................||+.|+|||++. ..++.++||||||+++|+|++|..||...............
T Consensus       166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  245 (327)
T 3lxl_A          166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER  245 (327)
T ss_dssp             EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred             EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence            99999999987655443333334567889999999764 45788999999999999999999998765422111110000


Q ss_pred             cc-c---hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         401 EV-P---VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       401 ~~-~---~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .. .   +...+........+..++..+.+||.+|+..||++||++.++++.|+.++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00 0   011111111111223455668899999999999999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.3e-43  Score=342.39  Aligned_cols=257  Identities=24%  Similarity=0.401  Sum_probs=204.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.++      +++.||||++.....      .      .....+.+|+.++++++||||++++
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS------M------RERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC------H------HHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC------H------HHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            355689999999999999865      267899999864321      1      1144588999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++.+ ...++||||+++|+|.+++.....       ..++++..++.++.|++.||.|||+  +||+||||||+||+++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEEC
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEc
Confidence            98877 788999999999999999975321       2467999999999999999999999  8899999999999999


Q ss_pred             CCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHH
Q psy5603         318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++....... ........||+.|+|||.+. +.++.++||||||+++|||+| |..||..........
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             CCCeEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            999999999999886544321 11223456789999999764 467899999999999999999 899998766433332


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ........           ..+..++..+.++|.+|+..+|.+||++.++++.|++++.
T Consensus       252 ~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVMEGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHcCCcC-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            22211100           0112344558889999999999999999999999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.9e-43  Score=361.56  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=192.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +|+.||||+++.......          .....+.+|+.++++++||||+++++++.+
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTENRVLQNSRHPFLTALKYSFQT  219 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-----------------------CCCCCSCTTSCCEEEEEEE
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhh----------HHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence            456689999999999999986 488999999975422111          113457889999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+. +||+||||||+|||++.++.+||+|||+
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCC
Confidence             7889999999999999999874   3699999999999999999999961 5799999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......||+.|+|||++ ...++.++|||||||++|||++|..||...+.......+......++.  
T Consensus       296 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--  370 (446)
T 4ejn_A          296 CKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--  370 (446)
T ss_dssp             CCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             ceeccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc--
Confidence            98543322   123457899999999976 446899999999999999999999999887754444444333332222  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                .++..+.+||.+||..||++||     ++.|+++
T Consensus       371 ----------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          371 ----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                      2334588899999999999999     9999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-42  Score=342.70  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=199.8

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh--CCccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|++. |+.||||++....                ...+.+|.+++..  ++||||+++++++..
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           45 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----------------ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG----------------HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             EEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh----------------HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            45589999999999999986 8999999985321                2347788888887  799999999998766


Q ss_pred             -c----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeeecCCCCCcEEEc
Q psy5603         251 -I----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH--------SLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       251 -~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--------~~~~~iiH~Dikp~NILl~  317 (455)
                       .    ..++||||+++|+|.+++..    .++++..++.++.|++.||.|||        +  ++|+||||||+|||++
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVK  181 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEEC
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEEC
Confidence             3    67999999999999999975    25899999999999999999999        7  7899999999999999


Q ss_pred             CCCceEEeecccccccccCCcce-eeeccCCCCCCCCCcccccCC-------CCcccchHHHHHHHHHHHcC--------
Q psy5603         318 ENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTG--------  381 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-------~~~~sDv~SlGvvl~elltG--------  381 (455)
                      .++.+||+|||+++......... .......||+.|+|||++.+.       ++.++|||||||++|||+||        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998765443211 123456899999999977654       23689999999999999999        


Q ss_pred             --CCCCCCCcch---hhHHHhhhcccchhhccchhc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         382 --MKPIDDNNTI---LYYYLVVEQEVPVREVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 --~~p~~~~~~~---~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                        ..||......   ...........    ...+.. ..+....+...+.+|+.+||..||++||++.+|++.|+++.+
T Consensus       262 ~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCccccCcCcccHHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence              7788764311   10000000000    011111 122334677789999999999999999999999999999865

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-43  Score=347.42  Aligned_cols=262  Identities=24%  Similarity=0.290  Sum_probs=197.3

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.++ ++..||||++.........        ......+.+|+.++++++||||+++++++.+ 
T Consensus        29 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN--------PKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-----------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccC--------HHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            34489999999999999986 4789999999754221100        1124568999999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------TPPLDSNKRYSIALGVAEA  293 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~g  293 (455)
                      ...|+||||++||+|.+++.....                                     ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            788999999999999999852100                                     1124677888999999999


Q ss_pred             HHHHHcCCCCeeecCCCCCcEEEcCCC--ceEEeecccccccccCCcce-eeeccCCCCCCCCCccccc---CCCCcccc
Q psy5603         294 LHYLHSLSKPIIHRDVKSANVLLDENF--VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMH---CQISTKTD  367 (455)
Q Consensus       294 l~~LH~~~~~iiH~Dikp~NILl~~~~--~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~---~~~~~~sD  367 (455)
                      |.|||+  ++|+||||||+|||++.++  .+||+|||+++......... .......||+.|+|||++.   +.++.++|
T Consensus       181 l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          181 LHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999  8899999999999998776  89999999998654322111 1234567999999999764   45788999


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         368 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       368 v~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ||||||++|||++|..||.....................   +     ....++..+.+||.+|+..+|++||++.++++
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---P-----NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---G-----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---c-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999887644333333222211110   0     11224456889999999999999999999987


Q ss_pred             --HHHhh
Q psy5603         448 --LLSKS  452 (455)
Q Consensus       448 --~L~~~  452 (455)
                        +++++
T Consensus       331 hp~~~~~  337 (345)
T 3hko_A          331 HPWISQF  337 (345)
T ss_dssp             SHHHHTT
T ss_pred             ChhhccC
Confidence              44443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=335.36  Aligned_cols=255  Identities=24%  Similarity=0.392  Sum_probs=197.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      +.+++||+|+||.||+|.+.+    +..||+|++.....            ......+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   91 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE------------MQQVEAFLREGLLMRGLNHPNVLALIGIM   91 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS------------HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc------------HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            345889999999999998643    23699999864221            11145689999999999999999999988


Q ss_pred             cC--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         249 NN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 ~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .+  ...++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+  +|++||||||+|||++.++.+||+|
T Consensus        92 ~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~D  167 (298)
T 3pls_A           92 LPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVAD  167 (298)
T ss_dssp             CCSSSCCEEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECC
T ss_pred             ecCCCCcEEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCc
Confidence            65  3448999999999999999763  3468999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcce-eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcC-CCCCCCCcchhhHHHhhhcccc
Q psy5603         327 FGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      ||+++......... .......||+.|+|||.+.+ .++.++||||||+++|+|+|| .+||................ .
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~  246 (298)
T 3pls_A          168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-R  246 (298)
T ss_dssp             TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-C
T ss_pred             CCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-C
Confidence            99998654332111 22344678899999997654 678899999999999999995 45555444333222222111 0


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                ...+..++..+.+++.+|+..+|.+||++.++++.|+++++
T Consensus       247 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          247 ----------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                      00112234558889999999999999999999999998864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=355.74  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=197.9

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|+.+ +|+.||||++++....          .......+.+|..++.+++||||+++++++.+ 
T Consensus        64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~----------~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML----------KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh----------hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            44489999999999999986 5899999999743210          01113348899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++||+|.+++...+  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.+|.+||+|||++
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEeechhh
Confidence            78899999999999999998643  369999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc--------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc-
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-  401 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-  401 (455)
                      +.......  ......+||+.|+|||++.        +.++.++|||||||++|||++|..||...+.......+.... 
T Consensus       210 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          210 LKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             EECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             eeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            86654321  2234568999999999764        357899999999999999999999998877544443333211 


Q ss_pred             -cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCC---CCHHHHHH
Q psy5603         402 -VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR---ASMRDIVD  447 (455)
Q Consensus       402 -~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~R---Ps~~evl~  447 (455)
                       ..++..         ...++..+.+||.+||. +|.+|   |++.|+++
T Consensus       288 ~~~~p~~---------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 HLSLPLV---------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CcCCCcc---------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence             111100         12344568899999998 98887   68888864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.2e-43  Score=346.48  Aligned_cols=244  Identities=27%  Similarity=0.422  Sum_probs=195.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||+|... +|+.||||++.....      ..    ......+.+|++++++++||||+++++++.+
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~------~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  125 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR  125 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS------CH----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc------cc----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            344588999999999999975 589999999975322      11    1124568899999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+. |+|.+.+....  .++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       126 ~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          126 EHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CCeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence             78899999996 78888886533  469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccc----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ++.....       ....||+.|+|||++    .+.++.++|||||||++|||+||..||.................+  
T Consensus       201 a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--  271 (348)
T 1u5q_A          201 ASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--  271 (348)
T ss_dssp             CBSSSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--
T ss_pred             ceecCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--
Confidence            8765322       245799999999976    346788999999999999999999999876643322222221111  


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ......++..+.+||.+||..+|++||++.++++
T Consensus       272 --------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          272 --------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                    0111233455889999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-42  Score=360.84  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=201.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.++ +++.||||++.......           .....+.+|++++++++||||+++++++.+
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-----------KDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-----------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-----------hHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            455689999999999999986 58999999996532211           114558899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc---CCCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~D  326 (455)
                       ...|+||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++   .++.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEE
Confidence             7889999999999999999774   359999999999999999999999  8899999999999995   566899999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++......    ......||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.........+........ 
T Consensus       168 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  242 (486)
T 3mwu_A          168 FGLSTCFQQNT----KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-  242 (486)
T ss_dssp             CSCTTTBCCC--------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-
T ss_pred             CCcCeECCCCC----ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-
Confidence            99998654332    1234579999999999988899999999999999999999999988765444333332221111 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ......++..+.+||.+||..+|++|||+.++++
T Consensus       243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   0011234556889999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.1e-43  Score=362.33  Aligned_cols=249  Identities=28%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++.........          ....+.+|+.++++++||||+++++++.+
T Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT----------DKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSS----------CHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccch----------HHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            456689999999999999987 5899999999754332111          14568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE---cCCCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                       ...|+||||+.+|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||+   +.++.+||+|
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence             788999999999999999986   3469999999999999999999999  889999999999999   5678999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++.......    .....||+.|+|||++.+.++.++|||||||++|+|++|.+||...........+........ 
T Consensus       173 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  247 (484)
T 3nyv_A          173 FGLSTHFEASKK----MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-  247 (484)
T ss_dssp             TTHHHHBCCCCS----HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred             eeeeEEcccccc----cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence            999986654321    234579999999998888899999999999999999999999998775444433333221111 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ......++..+.+||.+||..+|++|||+.++++
T Consensus       248 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 -------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                   0011234566889999999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-42  Score=334.61  Aligned_cols=259  Identities=21%  Similarity=0.259  Sum_probs=198.7

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++.....               ...+.+|+.++++++|++++..+.++.
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---------------HPQLHIESKIYKMMQGGVGIPTIRWCG   74 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------------------CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---------------chHHHHHHHHHHHhcCCCCCCeeeeec
Confidence            4567799999999999999974 588999998764332               112788999999999999888887653


Q ss_pred             C--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE---cCCCceEE
Q psy5603         250 N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKL  324 (455)
Q Consensus       250 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl  324 (455)
                      .  ...++||||+ +++|.+++....  .++++..++.++.|++.||.|||+  ++|+||||||+|||+   +.++.+||
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL  149 (296)
T 4hgt_A           75 AEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred             CCCCceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEE
Confidence            3  6779999999 999999998543  369999999999999999999999  889999999999999   78999999


Q ss_pred             eecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +|||+++.........    .......||+.|+|||.+.+ .++.++|||||||++|||++|..||..............
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 4hgt_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence            9999998765443211    12245689999999997654 678899999999999999999999987542211111000


Q ss_pred             -cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         400 -QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       400 -~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                       ............     ...++..+.+++.+|+..+|++||++.+|++.|++++.
T Consensus       230 ~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          230 ISEKKMSTPIEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHHHHSCHHHH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhcccccchhhhh-----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence             000000000000     01224558899999999999999999999999998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-42  Score=339.99  Aligned_cols=258  Identities=23%  Similarity=0.347  Sum_probs=202.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++.+.||+|+||.||+|.+.      +++.||||+++....      .      .....+.+|+.++.++ +||||+++
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------H------SEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC------c------HHHHHHHHHHHHHHhcccCCCeeeE
Confidence            456699999999999999852      367899999964321      1      1135688999999999 79999999


Q ss_pred             cccccC--ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         245 LGLCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      ++++..  ...++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  +||+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccC
Confidence            998765  458999999999999999987432             1238999999999999999999999  88999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q psy5603         310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+||+++.++.+||+|||+++....... ........||+.|+|||++ ...++.++||||||+++|||+| |..||..
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999999999986544322 1223455789999999965 4567899999999999999998 9999987


Q ss_pred             CcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .................          ..+..++..+.+++.+||..+|.+||++.+|++.|++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          254 VKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCCSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHhccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            65322221111111100          0011233457889999999999999999999999998864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.3e-43  Score=368.25  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=205.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++.++||+|+||.||+|.++++..||||+++....              ....|.+|++++++++||||+++++++.+..
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  335 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--------------SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP  335 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--------------CHHHHHHHHHHHHhCCCCCEeeEEEEEeecc
Confidence            45688999999999999998778899999974321              1345899999999999999999999998888


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+.+|+|.+++.... ...+++.+++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             ceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            899999999999999997532 2358999999999999999999999  8899999999999999999999999999986


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ......  .......++..|+|||++ .+.++.++|||||||++|||+| |..||.+.........+.... ..      
T Consensus       413 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~------  483 (535)
T 2h8h_A          413 IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM------  483 (535)
T ss_dssp             CCCHHH--HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CC------
T ss_pred             cCCCce--ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC------
Confidence            543211  112234678889999965 4578999999999999999999 999998766433322222110 00      


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ..+..++..+.+||.+||..||++||++.+|++.|++++.
T Consensus       484 ----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          484 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                0112345568889999999999999999999999998864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-42  Score=337.40  Aligned_cols=258  Identities=19%  Similarity=0.258  Sum_probs=197.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++......          .......+.+|+.++++++||||+++++++.
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  104 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS----------DPVFRTRMQREARTAGRLQEPHVVPIHDFGE  104 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG----------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc----------CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            3566699999999999999986 5889999998643221          1112456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+||||+++++|.+++...   .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             eCCeEEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCc
Confidence            6 7889999999999999999874   369999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........  .......||+.|+|||.+.+ .++.++||||||+++|||+||..||............... ......
T Consensus       180 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~  256 (309)
T 2h34_A          180 IASATTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA-IPRPST  256 (309)
T ss_dssp             C------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC-CCCGGG
T ss_pred             cCcccccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC-CCCccc
Confidence            9876544321  11234579999999997644 5788999999999999999999999876643222222111 111111


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCC-CHHHHHHHHHhhhc
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~~  454 (455)
                      .        ...++..+.++|.+||..||++|| ++.++++.|++++.
T Consensus       257 ~--------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          257 V--------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             T--------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             c--------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            1        112344588899999999999999 99999999998865

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-42  Score=331.69  Aligned_cols=244  Identities=25%  Similarity=0.411  Sum_probs=199.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +++.||||++......          .......+.+|+.++++++||||+++++++.+
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE----------KEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc----------hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            456689999999999999987 4788999998643211          01124568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccc
Confidence             7889999999999999999874   358999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......     .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++   
T Consensus       161 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  232 (284)
T 2vgo_A          161 SVHAPSLR-----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP---  232 (284)
T ss_dssp             CEECSSSC-----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC---
T ss_pred             cccCcccc-----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC---
Confidence            87554322     234679999999997654 578899999999999999999999987664433332222211111   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ..++..+.++|.+||..||.+||++.++++
T Consensus       233 ---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          233 ---------PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                     123445888999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.8e-43  Score=343.60  Aligned_cols=258  Identities=27%  Similarity=0.479  Sum_probs=203.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-C-----cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++.+.||+|+||.||+|.+.. +     ..||||+++....      .      .....+.+|+.+++++ +||||+++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH------A------DEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC------h------HHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            4566899999999999999753 2     4799999964321      1      1145689999999999 89999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~  312 (455)
                      ++++.+ +..++||||+++|+|.+++.....           ..++++..++.++.|++.||.|||+  +||+||||||+
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~  193 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAAR  193 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGG
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccc
Confidence            998877 788999999999999999975321           2468999999999999999999999  88999999999


Q ss_pred             cEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcc
Q psy5603         313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      |||++.++.+||+|||+++....... ........||+.|+|||.+ .+.++.++|||||||++|||+| |..||.....
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             eEEECCCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            99999999999999999986544332 1223345678899999965 4567899999999999999999 9999987653


Q ss_pred             hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..............          ..+..++..+.+++.+||..+|.+||++.+|++.|+++..
T Consensus       273 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          273 NSKFYKLVKDGYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             SHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            32222221111110          0111234458889999999999999999999999988753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4e-42  Score=329.59  Aligned_cols=246  Identities=25%  Similarity=0.446  Sum_probs=192.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++++.||+|+||.||+|.++ +|+.||||++......          .......+.+|+.++++++||||+++++++.
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNLKLFRHPHIIKLYQVIS   81 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc----------chhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            4567799999999999999987 5899999999643211          1112456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecc
Confidence            7 7889999999999999999874   358999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccCCC--CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++.......    ......||+.|+|||.+.+..  +.++||||||+++|+|++|..||...........+......++ 
T Consensus       157 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  231 (276)
T 2h6d_A          157 LSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP-  231 (276)
T ss_dssp             GGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred             cccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc-
Confidence            988654332    123457899999999876643  5799999999999999999999987654333322222211111 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 ..++..+.++|.+||..||++||++.++++
T Consensus       232 -----------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          232 -----------EYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                       123445888999999999999999999987

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=331.79  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=179.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||++......          .......+.+|+.++++++||||+++++++.+
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY----------KAGMVQRVQNEVKIHCQLKHPSILELYNYFED   82 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh----------hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence            456689999999999999985 5899999999643211          11124568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++...  ..++++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           83 SNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence             7889999999999999999863  2469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......||+.|+|||.+.+ .++.++||||||+++|||++|..||..................     
T Consensus       159 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  230 (278)
T 3cok_A          159 ATQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-----  230 (278)
T ss_dssp             CEECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC-----
T ss_pred             eeeccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC-----
Confidence            886543221   1234579999999997654 5688999999999999999999999876532211111101100     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             .+..++..+.++|.+|+..||++||++.++++
T Consensus       231 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 -------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                   11223456888999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.9e-42  Score=333.69  Aligned_cols=255  Identities=22%  Similarity=0.299  Sum_probs=199.7

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +|+.||||++.....               ...+.+|+.++++++|+++++.+.++.
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---------------HPQLHIESKIYKMMQGGVGIPTIRWCG   74 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---------------CCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---------------hhHHHHHHHHHHHhhcCCCCCcccccc
Confidence            3566799999999999999974 589999999865322               123889999999999999888777653


Q ss_pred             C--ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE---cCCCceEE
Q psy5603         250 N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKL  324 (455)
Q Consensus       250 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl  324 (455)
                      .  ...++||||+ +++|.+++....  .++++..++.++.|++.||+|||+  ++|+||||||+|||+   +.++.+||
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl  149 (296)
T 3uzp_A           75 AEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             CCCCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEE
Confidence            3  6779999999 999999997533  369999999999999999999999  889999999999999   58899999


Q ss_pred             eecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch---hhHHH
Q psy5603         325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYYYL  396 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~---~~~~~  396 (455)
                      +|||+++.........    .......||+.|+|||.+.+ .++.++|||||||++|||++|..||......   .....
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 3uzp_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             eeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence            9999998765443211    11245689999999997654 5788999999999999999999999865421   11111


Q ss_pred             hhhc--ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         397 VVEQ--EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       397 ~~~~--~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....  ..+....         ...++..+.+++.+||..||++||++.+|++.|++++.
T Consensus       230 ~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          230 ISEKKMSTPIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHHHHSCHHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hcccccCCchHHH---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            1111  0011000         01234558889999999999999999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=349.10  Aligned_cols=248  Identities=21%  Similarity=0.310  Sum_probs=199.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||+|++.....      .       ....+.+|+.++++++||||+++++++.
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~  118 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP------L-------DKYTVKNEISIMNQLHHPKLINLHDAFE  118 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch------h-------hHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            3566799999999999999987 488999999864321      1       1345889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC--CCceEEee
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~--~~~~kl~D  326 (455)
                      + ...++||||+.||+|.+++....  ..+++..++.++.|++.||.|||+  +||+||||||+|||++.  ++.+||+|
T Consensus       119 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          119 DKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             CSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEe
Confidence            7 78899999999999999987532  368999999999999999999999  88999999999999974  57899999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......    .....||+.|+|||++.+ .++.++|||||||++|||+||..||...........+......+.
T Consensus       195 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  270 (387)
T 1kob_A          195 FGLATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD  270 (387)
T ss_dssp             CTTCEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cccceecCCCcc----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            999987654322    223479999999997654 578899999999999999999999988764433332222111111


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ......++..+.+||.+||..||++||++.++++
T Consensus       271 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 --------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    0011234556889999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=336.32  Aligned_cols=261  Identities=21%  Similarity=0.277  Sum_probs=196.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC---Cccceeeecc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~  246 (455)
                      .|++.++||+|+||+||+|.+. +++.||||+++...........        ...+.+|+.+++++   +||||+++++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~h~niv~~~~   81 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--------PISTVREVALLRRLEAFEHPNVVRLMD   81 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCC--------CHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccccc--------chhHHHHHHHHHHHhhcCCCCeEEeee
Confidence            4567799999999999999975 5889999999754432211111        23366777777666   4999999999


Q ss_pred             cccC-c-----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         247 LCNN-I-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       247 ~~~~-~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      ++.. .     ..++||||+. |+|.+++.... ...+++..++.++.|++.||+|||+  ++|+||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTS
T ss_pred             eeeccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCC
Confidence            8755 2     4689999996 69999998744 2459999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||+++......    ......||+.|+|||++ .+.++.++|||||||++|||++|.+||...........+..
T Consensus       158 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          158 TVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             CEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             CEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998654332    12346899999999966 55689999999999999999999999988764433322221


Q ss_pred             -cccchhhccc-------hhcc---CCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QEVPVREVLD-------KEAG---EWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~~d-------~~~~---~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ..........       ....   ..+    ...++..+.+||.+||..||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence             0000000000       0000   000    0134456888999999999999999999975

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.2e-42  Score=336.67  Aligned_cols=259  Identities=22%  Similarity=0.349  Sum_probs=194.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++++.||+|+||.||+|.+..    +..||||+++....      .     ......+.+|+.++++++||||+++++
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------S-----QREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------C-----HHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------c-----hhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            35667899999999999998752    45799999864322      1     111456889999999999999999999


Q ss_pred             cccC-c-----eeEEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc
Q psy5603         247 LCNN-I-----MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       247 ~~~~-~-----~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      ++.+ .     ..++||||+++|+|.+++....   ....+++..++.++.|++.||.|||+  ++|+||||||+||+++
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~  181 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLR  181 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEEC
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEc
Confidence            8765 2     3489999999999999985422   24579999999999999999999999  8899999999999999


Q ss_pred             CCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHH
Q psy5603         318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++....... ........+++.|+|||.+. ..++.++||||||+++|||++ |..||..........
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  260 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD  260 (313)
T ss_dssp             TTSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCcEEEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            999999999999886543321 11123456788999999764 457889999999999999999 999998766443333


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ........           ..+..++..+.++|.+||..+|.+||++.++++.|+++++
T Consensus       261 ~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          261 YLLHGHRL-----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HHHTTCCC-----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCC-----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            22221100           0112334568889999999999999999999999998864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-42  Score=346.43  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=185.1

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||++..+ +++.||||++......              ...+.+|+.++++++||||+++++++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~~~~~~   85 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--------------DENVQREIINHRSLRHPNIVRFKEVI   85 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--------------CHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--------------cHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34667799999999999999987 5899999999643221              23478999999999999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc--eEEe
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--PKLG  325 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~--~kl~  325 (455)
                      .+ ...|+||||+.+|+|.+++...   .++++..+..++.|++.||.|||+  +||+||||||+|||++.++.  +||+
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~  160 (361)
T 3uc3_A           86 LTPTHLAIIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKIC  160 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred             eeCCEEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEe
Confidence            77 7889999999999999999763   359999999999999999999999  88999999999999987765  9999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCc-ccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~-~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||+++......    ......||+.|+|||++.+ .++. ++|||||||++|+|++|..||...............   
T Consensus       161 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~---  233 (361)
T 3uc3_A          161 DFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR---  233 (361)
T ss_dssp             CCCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH---
T ss_pred             ecCccccccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH---
Confidence            999987433221    1234579999999997644 4544 489999999999999999999875432111111100   


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         .............++..+.+||.+||..||++|||+.|+++
T Consensus       234 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          234 ---ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ---HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ---HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence               00000000011123455888999999999999999999976

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=346.39  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=192.3

Q ss_pred             CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .+.||+|+||.||+|.+. +|+.||||+++....      .       ....+.+|++++++++||||+++++++.+ ..
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM------K-------DKEEVKNEISVMNQLDHANLIQLYDAFESKND  160 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc------c-------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            367999999999999986 589999999974321      1       14568899999999999999999998877 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE--cCCCceEEeecccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl--~~~~~~kl~DFGla  330 (455)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||+  +.++.+||+|||++
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            899999999999999987532  368999999999999999999999  889999999999999  67789999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +.......    .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......+.   .
T Consensus       237 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---~  309 (373)
T 2x4f_A          237 RRYKPREK----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE---D  309 (373)
T ss_dssp             EECCTTCB----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC---S
T ss_pred             eecCCccc----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---h
Confidence            87654321    234579999999997654 578899999999999999999999988764433333322211111   0


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..     ...++..+.+||.+||..||++||++.|+++
T Consensus       310 ~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 EE-----FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GG-----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hh-----hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00     1234456889999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.2e-43  Score=336.39  Aligned_cols=259  Identities=27%  Similarity=0.361  Sum_probs=196.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC--Cc--EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN--GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.+..  ++  .||||+++......          ......+.+|+.++++++||||++++++
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   89 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ----------PEAMDDFIREVNAMHSLDHRNLIRLYGV   89 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC----------HHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            4566899999999999998642  33  68999986542211          1124568999999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.+...++|+||+++++|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+||
T Consensus        90 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           90 VLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             EccCCceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccc
Confidence            98877899999999999999997643  358999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++................||..|+|||.+. ..++.++||||||+++|+|++ |..||....................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  245 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC
Confidence            99987655433222334557888999999764 457889999999999999999 9999987764433332222111110


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                .+..++..+.+++.+||..+|.+||++.++++.|+++..
T Consensus       246 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          246 ----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                      112344568889999999999999999999999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=341.59  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=191.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH--HHhhCCccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ--TLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|++. ++.||||++....                ...+..|.+  .+..++||||+++++.+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~   76 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN----------------RQNFINEKNIYRVPLMEHDNIARFIVGD   76 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG----------------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc----------------hhhHHHHHHHHHHHhccCcchhhheecc
Confidence            3466799999999999999885 7999999996421                122444444  45568999999999732


Q ss_pred             -----cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---------CeeecCCCCCc
Q psy5603         249 -----NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK---------PIIHRDVKSAN  313 (455)
Q Consensus       249 -----~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~---------~iiH~Dikp~N  313 (455)
                           .+ ...|+||||+++|+|.+++...    ..++..++.++.|++.||.|||+  .         +|+||||||+|
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~--~~~~~~~~~~~ivH~Dikp~N  150 (336)
T 3g2f_A           77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT--ELPRGDHYKPAISHRDLNSRN  150 (336)
T ss_dssp             EEECTTSCEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHC--CBCCGGGCBCCEECSSCSGGG
T ss_pred             cccccCCCceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHh--hhccccccccceeecccccce
Confidence                 22 4668999999999999999763    35899999999999999999999  6         89999999999


Q ss_pred             EEEcCCCceEEeecccccccccCCcc-----eeeeccCCCCCCCCCcccccC--------CCCcccchHHHHHHHHHHHc
Q psy5603         314 VLLDENFVPKLGDFGIVKMSETSNMK-----TMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~--------~~~~~sDv~SlGvvl~ellt  380 (455)
                      ||++.++.+||+|||+++........     ........||+.|+|||++.+        .++.++|||||||++|||+|
T Consensus       151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~  230 (336)
T 3g2f_A          151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM  230 (336)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence            99999999999999999866543211     111234579999999998765        34578999999999999999


Q ss_pred             CCCCCCCCcchh---hHHHhhhcccc-hh--------hccchhc-cCC-ChhHHHHHHHHHHHhhhccCcCCCCCHHHHH
Q psy5603         381 GMKPIDDNNTIL---YYYLVVEQEVP-VR--------EVLDKEA-GEW-NETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       381 G~~p~~~~~~~~---~~~~~~~~~~~-~~--------~~~d~~~-~~~-~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      |..||.......   ..........+ ..        ....+.. ..+ ....++..+.+||.+||..||++|||+.|++
T Consensus       231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l  310 (336)
T 3g2f_A          231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE  310 (336)
T ss_dssp             TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence            977765433110   00000000000 00        0000000 111 1234667799999999999999999999999


Q ss_pred             HHHHhhhc
Q psy5603         447 DLLSKSVN  454 (455)
Q Consensus       447 ~~L~~~~~  454 (455)
                      +.|+++++
T Consensus       311 ~~L~~ll~  318 (336)
T 3g2f_A          311 ERMAELMM  318 (336)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.7e-42  Score=330.28  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=198.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++..........       .....+.+|+.++++++||||+++++++.+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (283)
T 3bhy_A            7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRG-------VSREEIEREVNILREIRHPNIITLHDIFEN   79 (283)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS-------BCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccc-------hHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence            456689999999999999987 589999999986543222111       124568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC----ceEEe
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl~  325 (455)
                       ...++||||+++++|.+++...   .++++..++.++.|++.||.|||+  ++++||||||+||+++.++    .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEE
Confidence             7889999999999999999763   469999999999999999999999  8899999999999998877    89999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++.......    .....||+.|+|||.+. +.++.++||||||+++|+|++|..||...................
T Consensus       155 dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  230 (283)
T 3bhy_A          155 DFGIAHKIEAGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF  230 (283)
T ss_dssp             CCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC
T ss_pred             ecccceeccCCCc----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC
Confidence            9999886543321    23457999999999765 467889999999999999999999998776433322222211111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .    ...    ...++..+.+++.+|+..||++||++.++++
T Consensus       231 ~----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          231 D----EEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             C----HHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             c----chh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0    000    1123455888999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.4e-43  Score=335.01  Aligned_cols=247  Identities=29%  Similarity=0.427  Sum_probs=193.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.++ |+.||||+++....               ...+.+|+.++++++||||+++++++.+ 
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhH---------------HHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            456689999999999999986 79999999864321               3458899999999999999999998644 


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++.... ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeeccc
Confidence             57899999999999999997632 1248899999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++......      ....+|+.|+|||.+. ..++.++||||||+++|||+| |..||................      
T Consensus       164 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------  231 (278)
T 1byg_A          164 TKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------  231 (278)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------
T ss_pred             cccccccc------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------
Confidence            87544321      2346788999999764 467899999999999999998 999998765433222221110      


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ....+..++..+.++|.+|+..||++||++.++++.|+++..
T Consensus       232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          232 -----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                 001112344568889999999999999999999999998753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-42  Score=353.37  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=190.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||++............     ......+.+|+.++++++||||+++++++..
T Consensus       137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE-----ADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-------------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccccc-----chhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            456699999999999999986 4789999999765321111100     0112348899999999999999999999888


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---CceEEeec
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDF  327 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~DF  327 (455)
                      ...|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEEeec
Confidence            888999999999999998876   3469999999999999999999999  889999999999999754   45999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcch-hhHHHhhhccc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~  402 (455)
                      |+++......    ......||+.|+|||++.    ..++.++|||||||++|+|+||.+||...... .....+.....
T Consensus       287 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          287 GHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             STTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             ccceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            9998754322    233568999999999764    35678999999999999999999999865432 11111111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..   ....     ...++..+.+||.+||..||++||++.|+++
T Consensus       363 ~~---~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          363 NF---IPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CC---CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC---Cchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            10   0000     0123456889999999999999999999876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=337.74  Aligned_cols=258  Identities=23%  Similarity=0.356  Sum_probs=193.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||.||+|.+.. |+.||||++.....      .     ......+.+|+.++++++||||+++++++.
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   72 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED------D-----PVIKKIALREIRMLKQLKHPNLVNLLEVFR   72 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC------------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc------c-----hHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence            35667999999999999999874 89999999864321      1     112455889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+.+++|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+||+++.++.+||+|||
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           73 RKRRLHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCeEEEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            7 788999999999999998876   3459999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-ccchh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~  405 (455)
                      +++.......   ......||+.|+|||++.+  .++.++||||||+++|+|+||.+||............... ....+
T Consensus       148 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (311)
T 4agu_A          148 FARLLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP  224 (311)
T ss_dssp             TCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             CchhccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence            9986543221   1234578999999997643  5689999999999999999999999887643322222110 00000


Q ss_pred             ---------hccc----hhccCCC-----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 ---------EVLD----KEAGEWN-----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ---------~~~d----~~~~~~~-----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ....    +......     ...++..+.+||.+||..||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                     0000    0000000     0234456888999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.9e-42  Score=330.33  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=200.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +++.||+|++......           ......+.+|+.++++++||||+++++++.
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----------ARDFQKLEREARICRKLQHPNIVRLHDSIQ   75 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-----------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            3567799999999999999986 4889999999754321           111456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc---eEEe
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~---~kl~  325 (455)
                      + ...++||||+.+++|.+.+...   ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.   +||+
T Consensus        76 ~~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           76 EESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            7 7789999999999999998874   469999999999999999999999  88999999999999986655   9999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||++........    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...................
T Consensus       151 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  226 (284)
T 3kk8_A          151 DFGLAIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY  226 (284)
T ss_dssp             CCTTCEECCSSCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             eceeeEEcccCcc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC
Confidence            9999976554321    234679999999997654 57899999999999999999999998876544333332222111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.   +     ....++..+.+||.+|+..||++||++.|+++
T Consensus       227 ~~---~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 PS---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CT---T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cc---h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10   0     01223455888999999999999999999976

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.6e-42  Score=331.97  Aligned_cols=247  Identities=22%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++. ++.||+|++.......          ......+.+|+.++++++||||+++++++.
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   85 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----------PHQREKMSMEISIHRSLAHQHVVGFHGFFE   85 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC----------HHHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence            35567899999999999999874 7889999987543211          112456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||+.+++|.+++...   ..+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           86 DNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEecc
Confidence            7 7889999999999999998763   369999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++.......   ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||..................++  
T Consensus       161 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  235 (294)
T 2rku_A          161 LATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--  235 (294)
T ss_dssp             TCEECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--
T ss_pred             CceecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc--
Confidence            9886543221   1234679999999997654 578899999999999999999999987764333322222221111  


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                ..++..+.+++.+|+..||++||++.++++
T Consensus       236 ----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          236 ----------KHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----------cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                      123345888999999999999999999876

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.1e-42  Score=340.56  Aligned_cols=241  Identities=22%  Similarity=0.347  Sum_probs=174.6

Q ss_pred             CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-c
Q psy5603         175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  251 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~  251 (455)
                      ++.||+|+||.||+|.++ +++.||||++....                ...+.+|+.+++++. ||||+++++++.+ .
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----------------EANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----------------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh----------------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            378999999999999986 48999999996421                344778999999997 9999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC---ceEEeecc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFG  328 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~DFG  328 (455)
                      ..|+||||+.+|+|.+++..   ..++++..+..++.|++.||.|||+  ++|+||||||+|||++.++   .+||+|||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             EEEEEEEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            88999999999999999987   3469999999999999999999999  8899999999999997665   89999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchh-------hHHHhhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-------YYYLVVEQ  400 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~-------~~~~~~~~  400 (455)
                      +++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||.......       ....+...
T Consensus       155 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          155 FARLKPPDNQ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             TCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cceecCCCCC---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            9986543321   1234578999999997654 57889999999999999999999998654211       11111111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+.        ......++..+.+||.+||..||++||++.++++
T Consensus       232 ~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          232 DFSFE--------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCC--------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCC--------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            10000        0001234566889999999999999999998863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5e-42  Score=353.48  Aligned_cols=207  Identities=21%  Similarity=0.280  Sum_probs=156.8

Q ss_pred             CCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceee
Q psy5603         165 GFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       165 ~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      .|.....|++.+.||+|+||.||+|.++ +++.||||++.....      .     ......+.+|+.++++++||||++
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~-----~~~~~~~~~E~~~l~~l~h~niv~  116 (458)
T 3rp9_A           48 DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE------D-----LIDCKRILREIAILNRLNHDHVVK  116 (458)
T ss_dssp             SCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc------C-----HHHHHHHHHHHHHHHhCCCCCCCc
Confidence            3444566788899999999999999986 588999999964321      1     112456889999999999999999


Q ss_pred             ecccccC------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc
Q psy5603         244 LLGLCNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       244 l~~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++++..      ...|+||||+ +|+|.+++..   ...+++..+..++.||+.||.|||+  +||+||||||+||||+
T Consensus       117 l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~  190 (458)
T 3rp9_A          117 VLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVN  190 (458)
T ss_dssp             EEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEEC
T ss_pred             eEEEEecCCcccCceEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEEC
Confidence            9998732      4679999988 6899999876   3469999999999999999999999  8899999999999999


Q ss_pred             CCCceEEeecccccccccCCcce------------------------eeeccCCCCCCCCCcccc-c-CCCCcccchHHH
Q psy5603         318 ENFVPKLGDFGIVKMSETSNMKT------------------------MYTENLTGTRPYMPPEAM-H-CQISTKTDVFSY  371 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~------------------------~~~~~~~gt~~Y~aPE~~-~-~~~~~~sDv~Sl  371 (455)
                      .++.+||+|||+++.........                        ......+||+.|+|||++ . ..++.++|||||
T Consensus       191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence            99999999999998764321100                        112346789999999954 3 458999999999


Q ss_pred             HHHHHHHHc-----------CCCCCCCC
Q psy5603         372 GVILLELLT-----------GMKPIDDN  388 (455)
Q Consensus       372 Gvvl~ellt-----------G~~p~~~~  388 (455)
                      ||++|||+|           |.++|.+.
T Consensus       271 G~il~elltg~~~~~~~~~~~~p~f~g~  298 (458)
T 3rp9_A          271 GCIFAELLNMIKENVAYHADRGPLFPGS  298 (458)
T ss_dssp             HHHHHHHHTTSTTTCSSGGGCCCSCC--
T ss_pred             HHHHHHHHHhccccccccccccccCCCC
Confidence            999999999           66666554

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.7e-43  Score=344.10  Aligned_cols=256  Identities=23%  Similarity=0.291  Sum_probs=188.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.+. +++.||||+++.......           ....+.+|+.++++++||||+++++++.+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-----------VPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-------------------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc-----------cchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            456699999999999999976 588999999965432110           13347789999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE-----cCCCceEE
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKL  324 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl-----~~~~~~kl  324 (455)
                       ...|+||||+. |+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||+     +.++.+||
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             CCEEEEEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEE
Confidence             78899999996 599999987   3469999999999999999999999  889999999999999     45566999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-c
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-E  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~  401 (455)
                      +|||+++.......   ......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+... .
T Consensus       179 ~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          179 GDFGLARAFGIPIR---QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             CCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             CcCCCccccCCccc---ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999986543221   1234578999999997754  3789999999999999999999999887643332222211 0


Q ss_pred             cchhhcc-----------------chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVREVL-----------------DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~-----------------d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.....                 ...........++..+.+||.+||..||++||++.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000000                 000000001124456889999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.4e-42  Score=335.98  Aligned_cols=251  Identities=25%  Similarity=0.320  Sum_probs=190.4

Q ss_pred             CCcC-CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccc
Q psy5603         171 YPRR-GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  247 (455)
Q Consensus       171 ~~~~-~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      .|++ ++.||+|+||.||+|.+. +++.||||++.....      .       ....+.+|++++.++ +||||++++++
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~~~~h~~i~~~~~~   79 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG------H-------IRSRVFREVEMLYQCQGHRNVLELIEF   79 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS------C-------CHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc------h-------hHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            3555 478999999999999975 589999999975421      1       134588999999985 79999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc---eE
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PK  323 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~---~k  323 (455)
                      +.+ ...|+||||+++|+|.+++...   .++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +|
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~k  154 (316)
T 2ac3_A           80 FEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVK  154 (316)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEE
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceE
Confidence            877 8889999999999999999874   368999999999999999999999  88999999999999988776   99


Q ss_pred             EeecccccccccCCcc----eeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchh-
Q psy5603         324 LGDFGIVKMSETSNMK----TMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-  392 (455)
Q Consensus       324 l~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~-  392 (455)
                      |+|||+++........    ........||+.|+|||++.      +.++.++|||||||++|||++|..||....... 
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  234 (316)
T 2ac3_A          155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC  234 (316)
T ss_dssp             ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred             EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence            9999998765432111    11123456999999999764      347889999999999999999999998754211 


Q ss_pred             --------------hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         393 --------------YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       393 --------------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                    ....+......++.   ..     ...++..+.+||.+||..||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          235 GWDRGEACPACQNMLFESIQEGKYEFPD---KD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CC----CCHHHHHHHHHHHHHCCCCCCH---HH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccccchhHHHHHHHHHhccCcccCc---hh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                          00111111111100   00     0124456889999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.5e-42  Score=343.69  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=200.3

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||||+++.......     ..........+.+|+++++++ +||||+++++++..
T Consensus        97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS-----PEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCC-----HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccC-----HHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            34489999999999999986 589999999975432111     111122245688999999999 79999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.|++|.+++...   ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence             7889999999999999999863   469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +........    .....||+.|+|||++.+       .++.++|||||||++|||+||..||...........+.....
T Consensus       247 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          247 SCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CEECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ccccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            886554321    234689999999997642       467899999999999999999999987664433333222211


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   .+.     ...++..+.+||.+||..||++||++.++++
T Consensus       323 ~~~---~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          323 QFS---SPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CCC---HHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC---Ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            110   000     0123445888999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4e-42  Score=335.51  Aligned_cols=260  Identities=23%  Similarity=0.334  Sum_probs=191.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|... +|+.||||+++.....      +    ......+.+|+.++++++||||+++++++.
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  102 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM------D----AKARADCIKEIDLLKQLNHPNVIKYYASFI  102 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC------C----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc------C----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3566699999999999999975 5899999999743221      0    112456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      + ...++||||+.+++|.+++.... ....+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+||
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEec
Confidence            6 78899999999999999987522 24568999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++......   .......||+.|+|||.+. ..++.++||||||+++|+|++|..||.................... 
T Consensus       181 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  256 (310)
T 2wqm_A          181 GLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-  256 (310)
T ss_dssp             ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC-
T ss_pred             cceeeecCCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC-
Confidence            9987654322   1123457999999999664 4678899999999999999999999986542221111111111111 


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                             ......++..+.+++.+||..||++||++.+|++.|+++.
T Consensus       257 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          257 -------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             -------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                   1111234556889999999999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-42  Score=348.51  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=186.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++.....      .     ......+.+|+.++.++. ||||+++++++.
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ------N-----STDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--C------C-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc------C-----hHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            456689999999999999986 589999999864321      1     112455789999999997 999999999875


Q ss_pred             C---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .   ...|+|||||. |+|.+++..    ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecC
Confidence            3   46799999996 699998875    368999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCc------------------ceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCC
Q psy5603         327 FGIVKMSETSNM------------------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       327 FGla~~~~~~~~------------------~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~  386 (455)
                      ||+++.......                  .........||+.|+|||++.+  .++.++|||||||++|||++|.+||.
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            999986532110                  0111234689999999997644  57899999999999999999999998


Q ss_pred             CCcchhhHHHhhh-cccchhhccch----------------------hcc------------CCChhHHHHHHHHHHHhh
Q psy5603         387 DNNTILYYYLVVE-QEVPVREVLDK----------------------EAG------------EWNETHVETLISIVFEKC  431 (455)
Q Consensus       387 ~~~~~~~~~~~~~-~~~~~~~~~d~----------------------~~~------------~~~~~~~~~~l~~Li~~~  431 (455)
                      +.+.......+.. ...+..+.+..                      ...            ..+...++..+.+||.+|
T Consensus       233 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~  312 (388)
T 3oz6_A          233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL  312 (388)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence            8764332222211 11110000000                      000            000113345688999999


Q ss_pred             hccCcCCCCCHHHHHH
Q psy5603         432 CVFEKDKRASMRDIVD  447 (455)
Q Consensus       432 l~~dp~~RPs~~evl~  447 (455)
                      |..||++|||+.|+++
T Consensus       313 L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          313 LQFNPNKRISANDALK  328 (388)
T ss_dssp             CCSSGGGSCCHHHHTT
T ss_pred             hccCcccCCCHHHHhC
Confidence            9999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.1e-42  Score=331.33  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=197.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||++......     .       ....+.+|+.++++++||||+++++++.+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-----D-------CPENIKKEICINKMLNHENVVKFYGHRRE   76 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-----T-------HHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-----h-------hhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence            345689999999999999986 5899999999754321     1       13558899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++..   ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           77 GNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCC
Confidence             788999999999999998865   3469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CC-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +........ ........||+.|+|||.+.+ .+ +.++||||||+++|||++|..||...................   
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  227 (276)
T 2yex_A          152 ATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---  227 (276)
T ss_dssp             CEECEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---
T ss_pred             ccccCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---
Confidence            886543321 122345689999999997755 33 678999999999999999999998765322111111111000   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ......++..+.+||.+|+..||++||++.++++
T Consensus       228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                  0011234556888999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-42  Score=342.89  Aligned_cols=243  Identities=21%  Similarity=0.324  Sum_probs=192.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++.....      .           +.+|++++.++ +||||+++++++.
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~-----------~~~E~~~l~~~~~hp~iv~~~~~~~   86 (342)
T 2qr7_A           24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------D-----------PTEEIEILLRYGQHPNIITLKDVYD   86 (342)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------C-----------CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------C-----------hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            455689999999999999987 488999999965321      1           44688888887 7999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC----CceEE
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN----FVPKL  324 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~----~~~kl  324 (455)
                      + ...|+||||+.||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||+..+    +.+||
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           87 DGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEE
Confidence            7 7889999999999999999863   469999999999999999999999  889999999999998433    35999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcc---hhhHHHhhhc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQ  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~---~~~~~~~~~~  400 (455)
                      +|||+++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||.....   ......+...
T Consensus       162 ~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  238 (342)
T 2qr7_A          162 CDFGFAKQLRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG  238 (342)
T ss_dssp             CCCTTCEECBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred             EECCCcccCcCCCC---ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence            99999986544321   2335689999999997754 478899999999999999999999986431   1111122111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+.        ......++..+.+||.+||..||++||++.++++
T Consensus       239 ~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          239 KFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111        0011234566889999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.4e-42  Score=342.43  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=194.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-----ccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----HVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~  245 (455)
                      |++.++||+|+||.||+|.+. +++.||||+++...              .....+..|+.+++.+.     ||||++++
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--------------KYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--------------HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--------------hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            456699999999999999985 58899999986321              11344778999999886     99999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC------
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE------  318 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~------  318 (455)
                      +++.. ...|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEcccccccc
Confidence            98876 8889999999 999999998744 3469999999999999999999999  88999999999999975      


Q ss_pred             -------------------CCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHH
Q psy5603         319 -------------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLEL  378 (455)
Q Consensus       319 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~el  378 (455)
                                         ++.+||+|||+++.....      .....||+.|+|||++. ..++.++|||||||++|||
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                               889999999999864432      23468999999999664 4689999999999999999


Q ss_pred             HcCCCCCCCCcchhhHHHhhhcccchh-------------hccchh--ccCCCh-------------------hHHHHHH
Q psy5603         379 LTGMKPIDDNNTILYYYLVVEQEVPVR-------------EVLDKE--AGEWNE-------------------THVETLI  424 (455)
Q Consensus       379 ltG~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~d~~--~~~~~~-------------------~~~~~~l  424 (455)
                      +||..||.................+++             ...+..  ...|+.                   ......+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999999987764332222211101100             000000  000100                   0011457


Q ss_pred             HHHHHhhhccCcCCCCCHHHHHH
Q psy5603         425 SIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       425 ~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+||.+||..||++|||+.|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            78999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.7e-42  Score=338.21  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=200.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||++.+.. ++.||+|++.......          ......+.+|+.++++++||||+++++++.
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  111 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----------PHQREKMSMEISIHRSLAHQHVVGFHGFFE  111 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            45667999999999999999874 7889999997543211          112456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||+.+++|.+++...   ..+++.+++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          112 DNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeecc
Confidence            7 7889999999999999998763   369999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++.......   ......||+.|+|||++.+ .++.++||||||+++|||++|..||..................++. 
T Consensus       187 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  262 (335)
T 2owb_A          187 LATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK-  262 (335)
T ss_dssp             TCEECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT-
T ss_pred             CceecccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc-
Confidence            9986543321   1234679999999997644 5788999999999999999999999876643333322222222211 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 .++..+.+||.+||..||++||++.++++
T Consensus       263 -----------~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          263 -----------HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -----------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       23345788999999999999999999876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=341.06  Aligned_cols=266  Identities=24%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             CcCCCccCcCCCeEEEEEEE-----cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|.+     .+++.||||++.....      .       ....+.+|+.++++++||||+++++
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~l~h~~iv~~~~  109 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------E-------HLRDFEREIEILKSLQHDNIVKYKG  109 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS------H-------HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH------H-------HHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            45668999999999999984     2588999999864311      1       1456899999999999999999999


Q ss_pred             cccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         247 LCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       247 ~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++..   ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+|
T Consensus       110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~k  185 (326)
T 2w1i_A          110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVK  185 (326)
T ss_dssp             EECC----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEE
T ss_pred             EEEecCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEE
Confidence            7754   36799999999999999998743  368999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc-
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-  401 (455)
                      |+|||+++................+|..|+|||.+. ..++.++||||||+++|||+||..|+................ 
T Consensus       186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 2w1i_A          186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG  265 (326)
T ss_dssp             ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT
T ss_pred             EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch
Confidence            999999987655432222233456788899999664 457889999999999999999999986432111100000000 


Q ss_pred             ----cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         402 ----VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       402 ----~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ..+.+.+........+..++..+.++|.+||..||++||++.+|++.|+++.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                00011111111111123455668899999999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=344.43  Aligned_cols=248  Identities=17%  Similarity=0.109  Sum_probs=194.3

Q ss_pred             CcCCCccCcCCCeEEEEEE------EcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC---cccee
Q psy5603         172 PRRGNKLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv  242 (455)
                      |++.++||+|+||.||+|.      ..+++.||||+++...                ...+..|++++.+++   |+||+
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~iv  130 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----------------PWEFYIGTQLMERLKPSMQHMFM  130 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----------------HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----------------hhHHHHHHHHHHHhhhhhhhhhh
Confidence            4566899999999999994      3358899999986421                234777888887776   99999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVN--NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-  318 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-  318 (455)
                      .+++++.. +..|+||||+++|+|.+++....  ....+++..++.|+.|++.||+|||+  ++|+||||||+|||++. 
T Consensus       131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGG
T ss_pred             hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEeccc
Confidence            99998876 88899999999999999997532  23569999999999999999999999  88999999999999998 


Q ss_pred             ----------CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCC
Q psy5603         319 ----------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       319 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~  387 (455)
                                ++.+||+|||+++........ .......||+.|+|||++.+ .++.++|||||||++|||+||..||..
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                      899999999999765432211 22345689999999997755 579999999999999999999999965


Q ss_pred             CcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCC-CCHHHHHHHHHhhhc
Q psy5603         388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR-ASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~R-Ps~~evl~~L~~~~~  454 (455)
                      ......         .+...    ....   .....+.+++..|+..+|.+| |++.++.+.|++++.
T Consensus       288 ~~~~~~---------~~~~~----~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          288 NEGGEC---------KPEGL----FRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             EETTEE---------EECSC----CTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCCce---------eechh----cccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            432110         00001    1111   123457778889999998877 788888888887653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=345.65  Aligned_cols=259  Identities=13%  Similarity=0.108  Sum_probs=198.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC---------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN---------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      .|++.+.||+|+||.||+|.+..         ++.||||++....                  .+.+|++++++++||||
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~------------------~~~~E~~~l~~l~h~ni  104 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG------------------RLFNEQNFFQRAAKPLQ  104 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS------------------THHHHHHHHHHHCCHHH
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc------------------hHHHHHHHHHHhcccch
Confidence            35666999999999999999863         6899999986431                  28899999999999999


Q ss_pred             eee---------------ccccc--CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy5603         242 LRL---------------LGLCN--NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       242 v~l---------------~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~i  304 (455)
                      +++               ++++.  +...|+||||+ +++|.+++.... ..++++..++.++.|++.||.|||+  ++|
T Consensus       105 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~i  180 (352)
T 2jii_A          105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE--NEY  180 (352)
T ss_dssp             HHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTC
T ss_pred             hhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCc
Confidence            984               44443  36789999999 999999998642 2469999999999999999999999  889


Q ss_pred             eecCCCCCcEEEcCCC--ceEEeecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHH
Q psy5603         305 IHRDVKSANVLLDENF--VPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLE  377 (455)
Q Consensus       305 iH~Dikp~NILl~~~~--~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~e  377 (455)
                      +||||||+|||++.++  .+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++||
T Consensus       181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  260 (352)
T 2jii_A          181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK  260 (352)
T ss_dssp             BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence            9999999999999998  99999999998655432111    11234589999999997755 67889999999999999


Q ss_pred             HHcCCCCCCCCcc--hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         378 LLTGMKPIDDNNT--ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       378 lltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      |+||..||.....  ................+.+..   .....++..+.+||.+||..||++||++.+|++.|+++++
T Consensus       261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            9999999987541  111111111001111111110   0011234568889999999999999999999999998864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-42  Score=342.21  Aligned_cols=261  Identities=24%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||||+++.........        .....+.+|+.++++++||||+++++++.
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD--------GINRTALREIKLLQELSHPNIIGLLDAFG   82 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhh--------hhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence            4566799999999999999986 48999999997543211100        01234789999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+.+ +|.+++...  ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             eCCceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEecc
Confidence            7 788999999975 898888763  3468899999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-ccch-
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPV-  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~-  404 (455)
                      +++.......   ......||+.|+|||++.+  .++.++|||||||++|||++|.+||.+.........+... ..+. 
T Consensus       158 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          158 LAKSFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             GGSTTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cceeccCCcc---cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            9986543221   1234689999999997644  3688999999999999999999999887643332222211 1000 


Q ss_pred             ---------hhccchhc-cCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 ---------REVLDKEA-GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ---------~~~~d~~~-~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .+...... ...+    ...++..+.+||.+||..||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                     00000000 0000    0233466889999999999999999999976

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.1e-42  Score=337.02  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=198.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.+.      ++..||||++.....      .      .....+.+|+.++++++||||++++
T Consensus        32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~   99 (327)
T 2yfx_A           32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS------E------QDELDFLMEALIISKFNHQNIVRCI   99 (327)
T ss_dssp             CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC------H------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc------h------hhHHHHHHHHHHHhhCCCCCCCeEE
Confidence            456699999999999999842      367899999863211      1      1144688999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC--
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--  318 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~--  318 (455)
                      +++.+ ...|+||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+  +||+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~  177 (327)
T 2yfx_A          100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG  177 (327)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSS
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCC
Confidence            98877 778999999999999999987542    1458999999999999999999999  88999999999999984  


Q ss_pred             -CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHH
Q psy5603         319 -NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       319 -~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                       +..+||+|||+++....... ........||+.|+|||.+ .+.++.++||||||+++|||+| |..||..........
T Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  256 (327)
T 2yfx_A          178 PGRVAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  256 (327)
T ss_dssp             TTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CcceEEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence             45699999999876543321 1122345789999999966 4567899999999999999999 999998766433322


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .+......           ..+..++..+.++|.+||..||.+||++.++++.|+.+..
T Consensus       257 ~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          257 FVTSGGRM-----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCCC-----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            22211100           0112234568889999999999999999999999987754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=339.09  Aligned_cols=244  Identities=25%  Similarity=0.348  Sum_probs=194.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||+++...........     ......+.+|+.++++++||||+++++++.+
T Consensus        26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE-----DPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEE-----ETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccc-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            455589999999999999976 5889999999865432211000     0012337789999999999999999998877


Q ss_pred             -ceeEEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++||||+.+| +|.+++..   ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence             7889999999777 99999986   3469999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccCC-C-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++.......    .....||+.|+|||++.+. + +.++|||||||++|||++|..||.......      .....   
T Consensus       176 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~---  242 (335)
T 3dls_A          176 SAAYLERGKL----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------EAAIH---  242 (335)
T ss_dssp             TCEECCTTCC----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------TTCCC---
T ss_pred             cceECCCCCc----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------hhccC---
Confidence            9987654322    2235799999999976543 4 779999999999999999999997532210      00000   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .+..++..+.+||.+||..||++||++.++++
T Consensus       243 ---------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          243 ---------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     11123445888999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=340.30  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=190.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||.||+|.++ +++.||||+++.......            ...+.+|+.++++++||||+++++++.
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTLHDIIH   70 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------------------CCCCCCCHHHHSCCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc------------chhHHHHHHHHHhcCCCCCCeeeeEEe
Confidence            3567799999999999999987 588999999964432111            112457999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||+. |+|.+++....  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           71 TEKSLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             CSSCEEEEEECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             eCCEEEEEecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCc
Confidence            7 78899999996 69999887643  469999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-cccch-
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPV-  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~-  404 (455)
                      +++......   .......||+.|+|||++.+  .++.++|||||||++|||++|..||.+.........+.. ...+. 
T Consensus       146 ~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  222 (324)
T 3mtl_A          146 LARAKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE  222 (324)
T ss_dssp             EEECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            988654322   11234578999999997644  478899999999999999999999988764332222211 11111 


Q ss_pred             ---hhccchh------ccCC-------ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 ---REVLDKE------AGEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ---~~~~d~~------~~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         +......      ....       ....++..+.+||.+||..||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               1110000      0000       00123456789999999999999999999976

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-41  Score=351.57  Aligned_cols=256  Identities=21%  Similarity=0.243  Sum_probs=190.9

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.+.||+|+||.||+|.+. +|+.||||++.....           .......+.+|+.++++++||||++++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIISLLNV  129 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-----------SHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-----------ChHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            345677799999999999999986 488999999974321           11124568899999999999999999998


Q ss_pred             ccC-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         248 CNN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       248 ~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +..       ...|+||||+.+ +|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++
T Consensus       130 ~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~  201 (464)
T 3ttj_A          130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDC  201 (464)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTS
T ss_pred             EccCCccccCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCC
Confidence            744       356999999965 57676653     48999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||+++......    ......||+.|+|||++. ..++.++|||||||++|||++|.+||.+.+.......+..
T Consensus       202 ~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~  277 (464)
T 3ttj_A          202 TLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  277 (464)
T ss_dssp             CEEECCCCCC-----CC----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CEEEEEEEeeeecCCCc----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998654332    133468999999999664 4688999999999999999999999998764333222221


Q ss_pred             -cccchh--------------------------hccchhccC---CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QEVPVR--------------------------EVLDKEAGE---WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~--------------------------~~~d~~~~~---~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+.+                          ..+....-.   ......+..+.+||.+||..||++|||++|+++
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             111100                          000000000   001123567889999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-42  Score=342.38  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=196.1

Q ss_pred             CCCCCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         168 RKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       168 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ....|++.+.||+|+||.||+|.+.. |+.||||++.....      .     ......+.+|+.++++++||||+++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~   91 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD------D-----KMVKKIAMREIKLLKQLRHENLVNLLE   91 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS------C-----HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC------c-----hHHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            33445677899999999999999874 88999999864322      1     112455789999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...|+||||+.+++|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A           92 VCKKKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EEEETTEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EeecCCEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEE
Confidence            8877 788999999999999888765   3459999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QE  401 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~  401 (455)
                      |||+++.......   ......||+.|+|||++.+  .++.++|||||||++|+|++|.+||..............  ..
T Consensus       167 Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  243 (331)
T 4aaa_A          167 DFGFARTLAAPGE---VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN  243 (331)
T ss_dssp             CCTTC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eCCCceeecCCcc---ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            9999976543221   1234579999999997755  478899999999999999999999988764332222211  00


Q ss_pred             cc------------hhhccchhccCC-C----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VP------------VREVLDKEAGEW-N----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~------------~~~~~d~~~~~~-~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..            ......+..... +    ...++..+.+||.+||..||++||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00            000000000000 0    1134567889999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.1e-42  Score=337.01  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=198.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcE--EEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~--vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.++ ++..  ||||.++......            ....+.+|+.+++++ +||||++++++
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD------------DHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH------------HHHHHHHHHHHHHhccCCCchhhhcee
Confidence            355689999999999999976 3554  4999986432110            133488999999999 99999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCc
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~N  313 (455)
                      +.+ +..++||||+++|+|.+++....             ...++++..++.++.|++.||.|||+  +||+||||||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~N  172 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARN  172 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccce
Confidence            877 78899999999999999997643             13479999999999999999999999  889999999999


Q ss_pred             EEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHc-CCCCCCCCcch
Q psy5603         314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTI  391 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~  391 (455)
                      ||++.++.+||+|||+++......    ......+|+.|+|||.+.+ .++.++||||||+++|||+| |..||......
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~  248 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  248 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             EEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence            999999999999999987433211    1223467889999997644 57889999999999999998 99999877643


Q ss_pred             hhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .......... .          ...+..++..+.+||.+||..+|++||++.++++.|++++.
T Consensus       249 ~~~~~~~~~~-~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          249 ELYEKLPQGY-R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             HHHHHGGGTC-C----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCC-C----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            3322221110 0          01112334568899999999999999999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-41  Score=355.90  Aligned_cols=245  Identities=22%  Similarity=0.285  Sum_probs=196.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|+++ +|+.||||++.......          ......+.+|++++++++||||+++++++.
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~----------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  255 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK----------RKGYQGAMVEKKILAKVHSRFIVSLAYAFE  255 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh----------hHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3456688999999999999986 58999999997543211          112456889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      + ...|+||||++||+|.+++..... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.+|.+||+||
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeec
Confidence            7 788999999999999999976442 4569999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch----hhHHHhhhccc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~~~~  402 (455)
                      |+++.......   ......||+.|+|||++.+ .++.++|||||||++|||+||.+||......    .....+.....
T Consensus       334 Gla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~  410 (543)
T 3c4z_A          334 GLAVELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV  410 (543)
T ss_dssp             TTCEECCTTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred             ceeeeccCCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence            99987544321   1344689999999997655 5899999999999999999999999875421    11111111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      .+            +..++..+.+||.+||..||++||++
T Consensus       411 ~~------------p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 TY------------PDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CC------------CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             CC------------CcccCHHHHHHHHHhccCCHhHCCCC
Confidence            11            12344568899999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7e-42  Score=339.94  Aligned_cols=260  Identities=22%  Similarity=0.315  Sum_probs=195.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||++........           ....+.+|+.++++++||||+++++++..
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   87 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-----------FPITALREIKILQLLKHENVVNLIEICRT   87 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-----------SCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-----------chHHHHHHHHHHHhccCCCcccHhheeec
Confidence            456689999999999999985 589999999865432111           12347899999999999999999997754


Q ss_pred             ---------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         251 ---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                               +..|+||||+. |+|.+.+....  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             C--------CEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSC
T ss_pred             cccccccCCceEEEEEeccC-CCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCC
Confidence                     35789999996 58888776543  369999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcc-eeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         322 PKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +||+|||+++........ ........||+.|+|||++.+  .++.++|||||||++|||+||.+||.+.........+.
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  242 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  242 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999999999865433211 122345688999999997654  46899999999999999999999999876433332222


Q ss_pred             hc-ccchhhccch------------hccC--CChhH-----HHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 EQ-EVPVREVLDK------------EAGE--WNETH-----VETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~-~~~~~~~~d~------------~~~~--~~~~~-----~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ..........            ....  .....     .+..+.+||.+||..||++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11 0000000000            0000  00001     1345788999999999999999999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=338.70  Aligned_cols=256  Identities=21%  Similarity=0.267  Sum_probs=196.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-  249 (455)
                      |++.+.||+|+||.||++... +++.||||++.....             .....+.+|+.++++++||||+++++++. 
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-------------QDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-------------HHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-------------HHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            456689999999999999984 589999999864211             11456889999999999999999999875 


Q ss_pred             ---C-ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         250 ---N-IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       250 ---~-~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                         . ...++||||+.+|+|.+++.... ...++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl  175 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVL  175 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEE
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEE
Confidence               2 57789999999999999987632 24579999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcce------eeeccCCCCCCCCCcccccCC----CCcccchHHHHHHHHHHHcCCCCCCCCcch--h
Q psy5603         325 GDFGIVKMSETSNMKT------MYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTI--L  392 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~----~~~~sDv~SlGvvl~elltG~~p~~~~~~~--~  392 (455)
                      +|||+++.........      .......||+.|+|||++.+.    ++.++||||||+++|||++|..||......  .
T Consensus       176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  255 (317)
T 2buj_A          176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS  255 (317)
T ss_dssp             CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred             EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence            9999887543211100      001234689999999987543    588999999999999999999999642110  0


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ...... ....          ......++..+.++|.+||..||++||++.++++.|+++.
T Consensus       256 ~~~~~~-~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          256 VALAVQ-NQLS----------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHHHH-CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhHHhh-ccCC----------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            001110 1000          0011233456888999999999999999999999998874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-42  Score=341.96  Aligned_cols=258  Identities=21%  Similarity=0.340  Sum_probs=193.4

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.+.||+|+||.||+|.++ +|+.||||++.....      .     ......+.+|+.++++++||||+++
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~hpnIv~l   89 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------S-----ELFAKRAYRELRLLKHMRHENVIGL   89 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------S-----HHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc------C-----HHHHHHHHHHHHHHHhCCCcCCCCc
Confidence            333455677799999999999999986 589999999854321      1     1124568899999999999999999


Q ss_pred             cccccCc-------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc
Q psy5603         245 LGLCNNI-------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       245 ~~~~~~~-------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      ++++...       ..|+||||+ +++|.+++..    ..+++..+..++.|++.||.|||+  +||+||||||+|||++
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~  162 (367)
T 1cm8_A           90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVN  162 (367)
T ss_dssp             SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEC
T ss_pred             eeeEecCCccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEc
Confidence            9987542       359999999 8999999876    358999999999999999999999  8899999999999999


Q ss_pred             CCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|.+||.+.+......
T Consensus       163 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~  236 (367)
T 1cm8_A          163 EDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK  236 (367)
T ss_dssp             TTCCEEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCEEEEeeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999865432      234588999999997644  67899999999999999999999999876433222


Q ss_pred             Hhhh-cccchhhccc------------hh----ccCCC--hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVE-QEVPVREVLD------------KE----AGEWN--ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~-~~~~~~~~~d------------~~----~~~~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.. ...+..+.+.            ..    ...+.  ...++..+.+||.+||..||++|||+.++++
T Consensus       237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            2211 1111100000            00    00000  1234556889999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-41  Score=365.81  Aligned_cols=241  Identities=25%  Similarity=0.298  Sum_probs=199.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.++. ++.||||+++......          ......+..|..++..+ +||||+.+++++.
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~----------~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~  412 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----------DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ  412 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH----------TTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc----------HHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence            4666899999999999999874 7889999997542211          11144578899999987 7999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..+..++.||+.||.|||+  ++||||||||+||||+.+|.+||+|||
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeecc
Confidence            7 7889999999999999999874   359999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......||+.|+|||++. ..++.++|||||||++|||++|.+||...+.......+......++. 
T Consensus       488 la~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~-  563 (674)
T 3pfq_A          488 MCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK-  563 (674)
T ss_dssp             TCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT-
T ss_pred             eeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc-
Confidence            998643322   1244678999999999764 46899999999999999999999999987765555555443333322 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                 .++..+.+||.+||..||++||++
T Consensus       564 -----------~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          564 -----------SMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             -----------TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             -----------cCCHHHHHHHHHHccCCHHHCCCC
Confidence                       234558899999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=347.06  Aligned_cols=197  Identities=24%  Similarity=0.373  Sum_probs=149.7

Q ss_pred             CCccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc--c
Q psy5603         175 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC--N  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~  249 (455)
                      +++||+|+||.||+|.++   +++.||||++.....               ...+.+|+.++++++||||+++++++  .
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---------------SMSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---------------CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---------------CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            478999999999999976   478899999864321               23478999999999999999999987  3


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE----cC
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  318 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl----~~  318 (455)
                      . ...|+||||+. |+|.+++....      ....+++..++.|+.|++.||.|||+  ++|+||||||+|||+    +.
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTT
T ss_pred             CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCC
Confidence            3 67899999995 68888875321      12359999999999999999999999  889999999999999    77


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCc
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~  389 (455)
                      ++.+||+|||+++................||+.|+|||++.+  .++.++|||||||++|||+||.+||....
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            899999999999876543222222345689999999997654  47889999999999999999999997654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.5e-42  Score=357.80  Aligned_cols=248  Identities=22%  Similarity=0.280  Sum_probs=199.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|..+ +|+.||||++.......          ......+.+|+.++++++||||+++++++.
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~----------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK----------RKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh----------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            3566799999999999999986 58999999997542211          112455889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++.... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFG  331 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLG  331 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecc
Confidence            7 88899999999999999998643 3459999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch----hhHHHhhhcccc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVEQEVP  403 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~~~~~  403 (455)
                      +++.......    .....||+.|+|||++.+ .++.++|||||||++|||++|.+||......    .....+......
T Consensus       332 la~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~  407 (576)
T 2acx_A          332 LAVHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE  407 (576)
T ss_dssp             TCEECCTTCC----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC
T ss_pred             cceecccCcc----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc
Confidence            9987654321    234589999999997654 6799999999999999999999999876421    111111111111


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      ++            ..++..+.+||.+||..||.+||     ++.||++
T Consensus       408 ~p------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 YS------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CC------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CC------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            11            23445688999999999999999     6788764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=340.89  Aligned_cols=271  Identities=16%  Similarity=0.148  Sum_probs=194.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||.||+|.+.    ++..||||++........  .............+.+|+.+++.++||||+++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~--~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF--SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHH--HHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchH--HHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3556689999999999999985    467899999875422000  0000011122344778999999999999999999


Q ss_pred             cccC-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC-
Q psy5603         247 LCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-  320 (455)
Q Consensus       247 ~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~-  320 (455)
                      ++..     ...|+||||+ +++|.+++....   ++++..++.++.|++.||.|||+  ++|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccCCC
Confidence            7643     5779999999 999999987643   69999999999999999999999  8899999999999999887 


Q ss_pred             -ceEEeecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCc--chh
Q psy5603         321 -VPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN--TIL  392 (455)
Q Consensus       321 -~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~--~~~  392 (455)
                       .+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||+||..||....  ...
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             99999999998664332111    11245689999999997755 57899999999999999999999996532  111


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ...........++..+...   .+...++..+.++|.+||..||++||++.+|++.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHhhcccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111111111111111111   11113455688999999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.2e-42  Score=346.39  Aligned_cols=239  Identities=24%  Similarity=0.328  Sum_probs=183.1

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh-CCccceeeeccccc----
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCN----  249 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~----  249 (455)
                      +.||+|+||+||+|.++ +|+.||||+++..                  ..+.+|+.++.+ .+||||+++++++.    
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc------------------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            68999999999999987 4889999998521                  236788888744 58999999999764    


Q ss_pred             -CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEEe
Q psy5603         250 -NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  325 (455)
Q Consensus       250 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~  325 (455)
                       ....|+||||+.||+|.+++.... ...+++..+..|+.|++.||.|||+  ++|+||||||+|||++.   ++.+||+
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEE
Confidence             256799999999999999998643 3469999999999999999999999  88999999999999997   7899999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchh----hHHHhhhc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL----YYYLVVEQ  400 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~----~~~~~~~~  400 (455)
                      |||+++......    ......||+.|+|||++. ..++.++|||||||++|||++|..||.......    ....+...
T Consensus       207 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~  282 (400)
T 1nxk_A          207 DFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  282 (400)
T ss_dssp             CCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred             ecccccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence            999998654322    123568999999999774 468899999999999999999999998765321    11111111


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+..        .....++..+.+||.+||..||++||++.++++
T Consensus       283 ~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          283 QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111110        001234556889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-42  Score=344.39  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=193.9

Q ss_pred             CcCCCccCcCCCeEEEEEEE----cCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|+.    .+++.||||+++.........         ....+.+|+++++++ .||||+++++
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK---------TTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES---------SGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh---------HHHHHHHHHHHHHHccCCCceeEEEE
Confidence            45669999999999999998    358999999987543211000         123366799999999 6999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...++||||+++|+|.+++...   .++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~  201 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLT  201 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEES
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEe
Confidence            8776 7889999999999999999874   359999999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhh----HHHhh
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILY----YYLVV  398 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~----~~~~~  398 (455)
                      |||+++.......  .......||+.|+|||++.+   .++.++|||||||++|||+||..||........    .....
T Consensus       202 DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  279 (355)
T 1vzo_A          202 DFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  279 (355)
T ss_dssp             CSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             eCCCCeecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence            9999986543221  12334689999999997754   367899999999999999999999976542111    11111


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      .....            .+..++..+.+||.+||..||++||     ++.++++
T Consensus       280 ~~~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          280 KSEPP------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             HCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ccCCC------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            11111            1123445688899999999999999     8998875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.4e-42  Score=334.35  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=198.7

Q ss_pred             cCCCCCCCCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcccee
Q psy5603         164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL  242 (455)
Q Consensus       164 ~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  242 (455)
                      .++.....|++.+.||+|+||.||+|.++. ++.||+|++.....      .       ....+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~   79 (302)
T 2j7t_A           13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------E-------ELEDYIVEIEILATCDHPYIV   79 (302)
T ss_dssp             SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----------C-------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH------H-------HHHHHHHHHHHHhcCCCCCEe
Confidence            345555667888999999999999999874 88999999864321      1       145688999999999999999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++++.+ +..++||||+++++|.+++....  ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~  155 (302)
T 2j7t_A           80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGD  155 (302)
T ss_dssp             CEEEEEECC-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSC
T ss_pred             eeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCC
Confidence            99998876 78899999999999999987643  369999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccc------cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM------HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~------~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +||+|||++.......   .......||+.|+|||.+      ...++.++||||||+++|+|++|..||..........
T Consensus       156 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  232 (302)
T 2j7t_A          156 IRLADFGVSAKNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL  232 (302)
T ss_dssp             EEECCCHHHHHHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EEEEECCCCccccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            9999999876432211   112345799999999976      3457889999999999999999999998766433222


Q ss_pred             HhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......+         ....+..++..+.++|.+||..||++||++.++++
T Consensus       233 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          233 KIAKSDPP---------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHSCCC---------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHhccCCc---------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            22211110         01112334556889999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=338.68  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=180.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccc-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLC-  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-  248 (455)
                      |++.+.||+|+||.||+|.+. +++.||||++.....             .....+.+|+.++.++. ||||+++++++ 
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-------------EKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-------------HHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-------------HHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            456689999999999999986 589999999854311             11455889999999996 99999999876 


Q ss_pred             -------cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eeecCCCCCcEEEcC
Q psy5603         249 -------NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDE  318 (455)
Q Consensus       249 -------~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~--iiH~Dikp~NILl~~  318 (455)
                             .. ...++||||+ +|+|.+++.......++++..++.++.|++.||.|||+  ++  |+||||||+|||++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~  173 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSN  173 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECT
T ss_pred             ccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECC
Confidence                   23 4578999999 58999998764445679999999999999999999999  77  999999999999999


Q ss_pred             CCceEEeecccccccccCCcce---------eeeccCCCCCCCCCcccc----cCCCCcccchHHHHHHHHHHHcCCCCC
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKT---------MYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~Y~aPE~~----~~~~~~~sDv~SlGvvl~elltG~~p~  385 (455)
                      ++.+||+|||+++.........         .......||+.|+|||++    ...++.++|||||||++|||+||..||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            9999999999998765432111         011245699999999976    234688999999999999999999999


Q ss_pred             CCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         386 DDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..........    ....          .......+..+.+||.+||..||++||++.++++.|+++.
T Consensus       254 ~~~~~~~~~~----~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          254 EDGAKLRIVN----GKYS----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ----------------CC----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHhhc----Cccc----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7654321110    0000          0001112223778899999999999999999999998764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=326.95  Aligned_cols=251  Identities=23%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc-
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-  248 (455)
                      .|++++.||+|+||.||+|.++ +++.||||+++......         .......+.+|++++++++||||+++++++ 
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR---------IPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH---------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc---------cchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            3567799999999999999986 47899999997532110         011245689999999999999999999987 


Q ss_pred             -cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         249 -NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 -~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                       .+ ...|+||||+.++ |.+++.... ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeec
Confidence             33 5779999999876 777776643 3469999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCC---CCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      ||++......... .......||+.|+|||++.+.   .+.++||||||+++|||++|..||...........+......
T Consensus       153 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  231 (305)
T 2wtk_C          153 LGVAEALHPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA  231 (305)
T ss_dssp             CTTCEECCTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             cccccccCccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC
Confidence            9999865432211 123356799999999977542   367999999999999999999999876643333322222111


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++            ..++..+.++|.+|+..||++||++.++++
T Consensus       232 ~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          232 IP------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             CC------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CC------------CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11            123445788999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.5e-42  Score=332.43  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=196.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++.....             ....+.+|+.++++++||||+++++++.+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (304)
T 2jam_A           11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-------------RDSSLENEIAVLKKIKHENIVTLEDIYES   77 (304)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------------------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-------------chHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence            355689999999999999986 5899999999743221             02348899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE---cCCCceEEee
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                       ...|+||||+++++|.+++...   .++++..+..++.|++.||.|||+  +|++||||||+||++   +.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             CCEEEEEEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEcc
Confidence             7889999999999999999763   358999999999999999999999  889999999999999   7889999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++......     .....||+.|+|||.+.+ .++.++||||||+++|||++|..||...........+........
T Consensus       153 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (304)
T 2jam_A          153 FGLSKMEQNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE  227 (304)
T ss_dssp             CSTTCCCCCBT-----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC
T ss_pred             CCcceecCCCc-----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99987543321     223469999999997754 578899999999999999999999987764433333322211111


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        .....++..+.++|.+||..||++||++.++++
T Consensus       228 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 S--------PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             T--------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             c--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0        011234456889999999999999999999976

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.5e-42  Score=337.24  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||++...........     .......+.+|++++++++||||+++++++..
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A           12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR-----EADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccc-----cchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            355689999999999999986 478999999975432111000     01113448899999999999999999999888


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc---eEEeec
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDF  327 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~---~kl~DF  327 (455)
                      ...|+||||+++++|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.   +||+||
T Consensus        87 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           87 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             SSEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            778999999999999999876   3469999999999999999999999  88999999999999987654   999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcch-hhHHHhhhccc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~  402 (455)
                      |+++......    ......||+.|+|||++    ...++.++|||||||++|+|++|..||...... .....+.....
T Consensus       162 g~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          162 GHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             TTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             ccceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            9988654321    12345799999999975    345788999999999999999999999865532 11111111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...    +..    ...++..+.+||.+||..||++||++.++++
T Consensus       238 ~~~----~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 NFI----PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCC----HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccC----chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            100    000    1123456888999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8e-43  Score=350.50  Aligned_cols=241  Identities=16%  Similarity=0.169  Sum_probs=182.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHH---HHHhhCCccceeeecc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV---QTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||.||+|.+. +|+.||||++........          .....|.+|+   +++++++||||+++++
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~l~hpniv~~~~  143 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS----------NAIKQMKEEVLRLRLLRGIKNQKQAKVHL  143 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT----------THHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch----------HHHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence            3556699999999999999975 589999999975432111          1145688999   5566668999999984


Q ss_pred             cc-------cCc------------------eeEEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHH
Q psy5603         247 LC-------NNI------------------MNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYL  297 (455)
Q Consensus       247 ~~-------~~~------------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gl~~L  297 (455)
                      .+       .+.                  ..|+||||+ +|+|.+++.....    ..++++..++.|+.|++.||+||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  222 (377)
T 3byv_A          144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL  222 (377)
T ss_dssp             CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            33       221                  378999999 7899999986432    12344688899999999999999


Q ss_pred             HcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC------------CCCcc
Q psy5603         298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTK  365 (455)
Q Consensus       298 H~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~~~~  365 (455)
                      |+  +||+||||||+|||++.++.+||+|||+++....      ......| +.|+|||++.+            .++.+
T Consensus       223 H~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  293 (377)
T 3byv_A          223 HH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS  293 (377)
T ss_dssp             HH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred             Hh--CCeecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence            99  8899999999999999999999999999985332      1234578 99999997654            47899


Q ss_pred             cchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHH
Q psy5603         366 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI  445 (455)
Q Consensus       366 sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~ev  445 (455)
                      +|||||||++|||+||..||...........+.           ...     ..++..+.+||.+||..||++||++.++
T Consensus       294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----------~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          294 FDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----------RSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC------CCSGGGG-----------SSC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             hhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----------hhc-----cCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            999999999999999999997654221111110           000     1234458889999999999999999999


Q ss_pred             HH
Q psy5603         446 VD  447 (455)
Q Consensus       446 l~  447 (455)
                      ++
T Consensus       358 l~  359 (377)
T 3byv_A          358 ME  359 (377)
T ss_dssp             HT
T ss_pred             hh
Confidence            85

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-41  Score=328.69  Aligned_cols=256  Identities=24%  Similarity=0.322  Sum_probs=202.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||||+++........    ..........+.+|+.+++++. ||||+++++++
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS----AEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCC----HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccC----HHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3566799999999999999986 4889999999754321111    1111223566889999999995 99999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...++||||+++++|.+++...   ..+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEecc
Confidence            77 7889999999999999999873   469999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      |++........    .....||+.|+|||++.       ..++.++||||||+++|+|++|..||...............
T Consensus       169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99886543321    23457999999999763       34688999999999999999999999876644333332222


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....        ......++..+.++|.+||..||++||++.++++
T Consensus       245 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NYQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccC--------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11111        0011234566889999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.3e-42  Score=343.50  Aligned_cols=254  Identities=25%  Similarity=0.348  Sum_probs=197.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ ++..||+|+++....      .      .....+.+|+.++++++||||+++++++.+
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK------P------AIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC------H------HHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC------H------HHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            456689999999999999987 588999999975321      1      114568999999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       +..|+||||+++++|.+++...   ..+++..+..++.+++.||.|||+  + +|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECC
Confidence             7889999999999999999874   358999999999999999999998  5 79999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh---c----
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE---Q----  400 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~---~----  400 (455)
                      +++......     .....||+.|+|||++.+ .++.++|||||||++|||+||..||..............   .    
T Consensus       178 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          178 VSGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCHHHHHHC---------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCccccccc-----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            987543221     234589999999997654 578899999999999999999999987653322211100   0    


Q ss_pred             ---------------------ccchhhccc----hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 ---------------------EVPVREVLD----KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ---------------------~~~~~~~~d----~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                           .....+.++    ......+...++..+.+||.+||..||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                 000000000    01111222334567889999999999999999999976

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-41  Score=328.78  Aligned_cols=244  Identities=28%  Similarity=0.446  Sum_probs=198.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +++.||||++......     .       ....+.+|+.++++++||||+++++++.+
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   91 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-----D-------EIEDIQQEITVLSQCDSPYVTKYYGSYLK   91 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-----T-------THHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-----H-------HHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            455689999999999999976 4889999999754321     1       14568999999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++..    .++++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  165 (303)
T 3a7i_A           92 DTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGV  165 (303)
T ss_dssp             TTEEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeeccc
Confidence             788999999999999999864    369999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||..................     
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  237 (303)
T 3a7i_A          166 AGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP-----  237 (303)
T ss_dssp             CEECBTTBC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             ceecCcccc---ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC-----
Confidence            976544321   1245689999999997644 5788999999999999999999999876643332222211100     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            .....++..+.+||.+||..+|++||++.++++
T Consensus       238 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          238 ------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  001123445888999999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=326.58  Aligned_cols=245  Identities=27%  Similarity=0.349  Sum_probs=193.0

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ..||+|+||.||+|.+. +++.||||++.....      .       ....+.+|+.++++++||||+++++++.+ +..
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS------R-------YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----------------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCch------H-------HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            68999999999999985 478999999875321      1       13458899999999999999999998876 788


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CCceEEeecccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~  332 (455)
                      ++||||+++++|.+++........+++..+..++.|++.||.|||+  +|++||||||+||+++. ++.+||+|||+++.
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence            9999999999999999876555567899999999999999999999  88999999999999987 89999999999886


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .....   .......||+.|+|||++.+   .++.++||||||+++|+|++|..||................ .    ..
T Consensus       173 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~----~~  244 (295)
T 2clq_A          173 LAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-K----VH  244 (295)
T ss_dssp             SCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-C----CC
T ss_pred             cCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-c----cc
Confidence            54322   11335679999999997643   26889999999999999999999997644221111110000 0    00


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ...+..++..+.++|.+||..||++||++.++++
T Consensus       245 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          245 ----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                0011234456888999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.1e-42  Score=336.10  Aligned_cols=261  Identities=19%  Similarity=0.274  Sum_probs=198.5

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLR  243 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  243 (455)
                      |.....|++.++||+|+||.||+|.+. +++.||||+++...                ...+.+|+.++++++ ||||++
T Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~E~~~l~~l~~~~~i~~   95 (330)
T 3nsz_A           32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------------KKKIKREIKILENLRGGPNIIT   95 (330)
T ss_dssp             CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----------------HHHHHHHHHHHHHHTTSTTBCC
T ss_pred             ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----------------hHHHHHHHHHHHHcCCCCCEEE
Confidence            333345667799999999999999975 58999999986321                345889999999997 999999


Q ss_pred             ecccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         244 LLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       244 l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +++++.+   ...++||||+.+++|.+++..      +++..+..++.|++.||.|||+  +||+||||||+|||++.++
T Consensus        96 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~  167 (330)
T 3nsz_A           96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEH  167 (330)
T ss_dssp             EEEEEECTTTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTT
T ss_pred             eeeeeccCCCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCC
Confidence            9998764   567999999999999998764      8899999999999999999999  8899999999999999776


Q ss_pred             -ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH-
Q psy5603         321 -VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL-  396 (455)
Q Consensus       321 -~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~-  396 (455)
                       .+||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|..||........... 
T Consensus       168 ~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~  243 (330)
T 3nsz_A          168 RKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  243 (330)
T ss_dssp             TEEEECCCTTCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             CEEEEEeCCCceEcCCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence             899999999986544321    234579999999997643  578999999999999999999999965442111111 


Q ss_pred             hhh--cccchhhccc-----------------------hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH--HH
Q psy5603         397 VVE--QEVPVREVLD-----------------------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD--LL  449 (455)
Q Consensus       397 ~~~--~~~~~~~~~d-----------------------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~--~L  449 (455)
                      ...  ......+.++                       ..........++..+.+||.+||..||++|||++|+++  ++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            000  0000000000                       00111112235677899999999999999999999987  44


Q ss_pred             Hhhhc
Q psy5603         450 SKSVN  454 (455)
Q Consensus       450 ~~~~~  454 (455)
                      .++.+
T Consensus       324 ~~~~~  328 (330)
T 3nsz_A          324 YTVVK  328 (330)
T ss_dssp             TTCC-
T ss_pred             hhhcc
Confidence            44443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.3e-41  Score=337.05  Aligned_cols=262  Identities=21%  Similarity=0.319  Sum_probs=199.3

Q ss_pred             CCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         167 NRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       167 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      ...+.|++.+.||+|+||.||+|.+. +++.||||++.....            ......+.+|++++++++||||++++
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~   91 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH------------QTYCQRTLREIKILLRFRHENIIGIN   91 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC------------HHHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC------------cHHHHHHHHHHHHHHhcCCCCCccce
Confidence            33455777899999999999999986 578999999863211            11145688999999999999999999


Q ss_pred             ccccC------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         246 GLCNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       246 ~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      +++..      ...|+||||+. |+|.+++..    ..+++..++.++.|++.||.|||+  +||+||||||+|||++.+
T Consensus        92 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~  164 (364)
T 3qyz_A           92 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTT  164 (364)
T ss_dssp             EEECCSSTTTCCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTT
T ss_pred             eEEecCCccccceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCC
Confidence            97754      35799999996 699999875    359999999999999999999999  889999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +.+||+|||+++................||+.|+|||++ .+ .++.++|||||||++|||++|.+||.+.........+
T Consensus       165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  244 (364)
T 3qyz_A          165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  244 (364)
T ss_dssp             CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred             CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            999999999998765433222223456899999999965 33 4789999999999999999999999887643332222


Q ss_pred             hh-cccchhhcc----c--------hhc--cCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VE-QEVPVREVL----D--------KEA--GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~-~~~~~~~~~----d--------~~~--~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ...+..+.+    +        ...  ...+    ...++..+.+||.+||..||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11 000000000    0        000  0000    0123456889999999999999999999976

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.6e-42  Score=328.18  Aligned_cols=242  Identities=23%  Similarity=0.378  Sum_probs=195.8

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.+. +++.||||+++...                 ..+.+|++++++++||||+++++++.. 
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B           14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----------------EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----------------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----------------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            44589999999999999987 58999999996432                 126789999999999999999997642 


Q ss_pred             ----------------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         251 ----------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       251 ----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                                      ...++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Ni  153 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNI  153 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHE
Confidence                            44689999999999999997643 3469999999999999999999999  8899999999999


Q ss_pred             EEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhh
Q psy5603         315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      |++.++.+||+|||+++.......    .....||+.|+|||.+.+ .++.++||||||+++|||++|..|+....... 
T Consensus       154 l~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-  228 (284)
T 2a19_B          154 FLVDTKQVKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF-  228 (284)
T ss_dssp             EEEETTEEEECCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH-
T ss_pred             EEcCCCCEEECcchhheecccccc----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHH-
Confidence            999999999999999886654321    234579999999997644 57899999999999999999998875321110 


Q ss_pred             HHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                       ...  ....+.            ..++..+.++|.+|+..||.+||++.++++.|..+.+
T Consensus       229 -~~~--~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          229 -TDL--RDGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -HHH--HTTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -HHh--hccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence             000  111111            1233457889999999999999999999999988754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=328.53  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=194.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++. |+.||||++.....               ...+.+|+.++++++||||+++++++.
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~~~~~   94 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---------------LQEIIKEISIMQQCDSPHVVKYYGSYF   94 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---------------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---------------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            34566899999999999999874 89999999975321               244889999999999999999999876


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||+.+++|.+++...  ...+++..++.++.|++.||.|||+  .|++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A           95 KNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             eCCEEEEEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecc
Confidence            6 7889999999999999999743  3469999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||..................  ..
T Consensus       171 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~  245 (314)
T 3com_A          171 VAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP--TF  245 (314)
T ss_dssp             TCEECBTTBS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CC
T ss_pred             cchhhhhhcc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc--cc
Confidence            9876543321   1234579999999997644 5788999999999999999999999876543322222111100  00


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ..+..++..+.+||.+||..||++||++.++++
T Consensus       246 -------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 -------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                   012234456889999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.8e-42  Score=334.44  Aligned_cols=255  Identities=26%  Similarity=0.412  Sum_probs=194.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+++  .||||+++........           ...+.+|+.++++++||||+++++++.+ 
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQ-----------LKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCC-----------CCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHH-----------HHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            4566999999999999999863  5999999754322111           1236789999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+|||++ ++.+||+|||++
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             CceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCCc
Confidence            78899999999999999997632  368999999999999999999999  8899999999999998 689999999998


Q ss_pred             cccccCCcc--eeeeccCCCCCCCCCcccccC----------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         331 KMSETSNMK--TMYTENLTGTRPYMPPEAMHC----------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       331 ~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~----------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +........  ........||+.|+|||++.+          .++.++||||||+++|||++|..||.............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            765322111  111234568999999997643          36789999999999999999999998776443332222


Q ss_pred             hcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....+  ...        ...++..+.+++.+||..+|++||++.++++.|+++.+
T Consensus       257 ~~~~~--~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          257 TGMKP--NLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             TTCCC--CCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             cCCCC--CCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            21111  000        01123347889999999999999999999999998764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.3e-41  Score=343.39  Aligned_cols=206  Identities=24%  Similarity=0.296  Sum_probs=165.6

Q ss_pred             cCCCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcccee
Q psy5603         164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL  242 (455)
Q Consensus       164 ~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  242 (455)
                      .+|.....|++.+.||+|+||.||+|.++ +++.||||+++....      .     ......+.+|+.++++++||||+
T Consensus        20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~nIv   88 (432)
T 3n9x_A           20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE------D-----LIDCKRILREITILNRLKSDYII   88 (432)
T ss_dssp             GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT------S-----HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc------C-----hHHHHHHHHHHHHHHHcCCCCcc
Confidence            45666667888899999999999999986 478999999964321      1     11245689999999999999999


Q ss_pred             eecccccC------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE
Q psy5603         243 RLLGLCNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       243 ~l~~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      ++++++..      ...|+||||+. |+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||+
T Consensus        89 ~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl  162 (432)
T 3n9x_A           89 RLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLL  162 (432)
T ss_dssp             CEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred             eEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEE
Confidence            99997754      35799999985 699999986   3469999999999999999999999  889999999999999


Q ss_pred             cCCCceEEeecccccccccCCcce-------------------eeeccCCCCCCCCCcccc--cCCCCcccchHHHHHHH
Q psy5603         317 DENFVPKLGDFGIVKMSETSNMKT-------------------MYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVIL  375 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~-------------------~~~~~~~gt~~Y~aPE~~--~~~~~~~sDv~SlGvvl  375 (455)
                      +.++.+||+|||+++.........                   .......||+.|+|||++  ...++.++|||||||++
T Consensus       163 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il  242 (432)
T 3n9x_A          163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF  242 (432)
T ss_dssp             CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence            999999999999998764432110                   112456899999999964  33589999999999999


Q ss_pred             HHHHcCCCCCC
Q psy5603         376 LELLTGMKPID  386 (455)
Q Consensus       376 ~elltG~~p~~  386 (455)
                      |||++|..||.
T Consensus       243 ~ell~g~~p~~  253 (432)
T 3n9x_A          243 AELLNMLQSHI  253 (432)
T ss_dssp             HHHHTTCTTTC
T ss_pred             HHHHhcccccc
Confidence            99998555443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.9e-42  Score=327.67  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=197.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-  249 (455)
                      |++.+.||+|+||.||+|.++ +++.||+|++.....      .     ......+.+|+.++++++||||+++++++. 
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------T-----EAEKQMLVSEVNLLRELKHPNIVRYYDRIID   76 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC------C-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC------C-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence            456689999999999999986 589999999975422      1     112456899999999999999999999763 


Q ss_pred             -C-ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCC-----eeecCCCCCcEEEcCCCc
Q psy5603         250 -N-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKP-----IIHRDVKSANVLLDENFV  321 (455)
Q Consensus       250 -~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~-----iiH~Dikp~NILl~~~~~  321 (455)
                       . ...++||||+++++|.+++..... ..++++..++.++.|++.||.|||+  .+     ++||||||+||+++.++.
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~~  154 (279)
T 2w5a_A           77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQN  154 (279)
T ss_dssp             GGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSSC
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCCC
Confidence             2 678999999999999999976332 3469999999999999999999999  77     999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||+++.......   ......||+.|+|||.+.+ .++.++||||||+++|+|+||..||...........+...
T Consensus       155 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~  231 (279)
T 2w5a_A          155 VKLGDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG  231 (279)
T ss_dssp             EEECCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EEEecCchheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc
Confidence            99999999886543221   1233578999999997644 5788999999999999999999999877643332222221


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                      ...  .         .+..++..+.++|.+||..+|++||++.+|++.+
T Consensus       232 ~~~--~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          232 KFR--R---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCC--C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ccc--c---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            110  0         0112345688899999999999999999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.8e-42  Score=333.04  Aligned_cols=260  Identities=22%  Similarity=0.329  Sum_probs=182.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++......            .....+.+|+.++++++||||+++++++.
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ------------TSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------------CCCCCCCTTBCCEEEEEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc------------hhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            4567799999999999999875 4789999998643211            01344889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      . ...++||||+++++|.+++...     .....+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+|
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEE
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEE
Confidence            6 7889999999999999998742     123469999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcc--eeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         324 LGDFGIVKMSETSNMK--TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       324 l~DFGla~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      |+|||++.........  ........||+.|+|||++.+  .++.++||||||+++|||++|..||..............
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            9999998765433211  112234679999999997743  578999999999999999999999987664332222211


Q ss_pred             cc-cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QE-VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~-~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ........   .......++..+.++|.+||..||.+||++.++++
T Consensus       242 ~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 NDPPSLETGVQ---DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCCccccccc---cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11 11110000   00011223456888999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.1e-41  Score=345.48  Aligned_cols=259  Identities=21%  Similarity=0.244  Sum_probs=198.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc-cc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG-LC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~  248 (455)
                      .|++.++||+|+||.||+|.+. +++.||||++.....               ...+.+|+++++.++|++.+..+. ++
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------~~~~~~E~~il~~L~~~~~i~~i~~~~   72 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------HPQLLYESKIYRILQGGTGIPNVRWFG   72 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---------------SCCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---------------cHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            3567799999999999999975 589999999865432               112788999999998865555444 44


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE---cCCCceEE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKL  324 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl  324 (455)
                      .+ ...|+||||+ +++|.+++....  ..+++..++.|+.||+.||.|||+  ++|+||||||+||||   +.++.+||
T Consensus        73 ~~~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL  147 (483)
T 3sv0_A           73 VEGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYI  147 (483)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEE
T ss_pred             eeCCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEE
Confidence            44 7779999999 999999998543  369999999999999999999999  889999999999999   68899999


Q ss_pred             eecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|..||..............
T Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (483)
T 3sv0_A          148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (483)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred             EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence            9999998765443211    11235789999999996654 678899999999999999999999987653211111110


Q ss_pred             -cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         400 -QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       400 -~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                       ........+.....     .++..+.+||..||..+|++||++.+|++.|++++.
T Consensus       228 i~~~~~~~~~~~l~~-----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          228 ISEKKVATSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HHHHHHHSCHHHHHT-----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HhhccccccHHHHhc-----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence             11111111111111     224558889999999999999999999999998853

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-41  Score=343.14  Aligned_cols=253  Identities=22%  Similarity=0.284  Sum_probs=191.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +|+.||||++.....                 ...+|+++++.++||||+++++++.
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----------------~~~~E~~il~~l~hpnIv~l~~~~~   70 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----------------YKNRELDIMKVLDHVNIIKLVDYFY   70 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----------------SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----------------hHHHHHHHHHHcCCCCccchhheee
Confidence            3567799999999999999985 589999999864321                 1337999999999999999999762


Q ss_pred             C---------------------------------------ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHH
Q psy5603         250 N---------------------------------------IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALG  289 (455)
Q Consensus       250 ~---------------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~  289 (455)
                      .                                       ...++||||++ |+|.+.+... .....+++..+..++.|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q  149 (383)
T 3eb0_A           71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ  149 (383)
T ss_dssp             EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred             ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence            2                                       34789999997 6887777542 12457999999999999


Q ss_pred             HHHHHHHHHcCCCCeeecCCCCCcEEEc-CCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCccc
Q psy5603         290 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKT  366 (455)
Q Consensus       290 i~~gl~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~s  366 (455)
                      ++.||.|||+  +||+||||||+|||++ .++.+||+|||+++.......    .....||+.|+|||++.+  .++.++
T Consensus       150 i~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          150 LFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcch
Confidence            9999999999  8899999999999998 689999999999986544321    234578999999997644  478999


Q ss_pred             chHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccchhhcc---------------chhccCCChhHHHHHHHHHHH
Q psy5603         367 DVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPVREVL---------------DKEAGEWNETHVETLISIVFE  429 (455)
Q Consensus       367 Dv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~~~~~---------------d~~~~~~~~~~~~~~l~~Li~  429 (455)
                      |||||||++|||++|.+||.+.........+..  .........               ........+..++..+.+||.
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  303 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE  303 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence            999999999999999999998764332222211  111110000               000000011234556889999


Q ss_pred             hhhccCcCCCCCHHHHHH
Q psy5603         430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||++|||+.|+++
T Consensus       304 ~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          304 QILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHCCSSGGGSCCHHHHHT
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999974

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-41  Score=347.19  Aligned_cols=252  Identities=23%  Similarity=0.313  Sum_probs=188.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++.....                 .+.+|++++++++||||+++++++..
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------------~~~~E~~il~~l~hpniv~l~~~~~~  118 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------FKNRELQIMRKLDHCNIVRLRYFFYS  118 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----------------SCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----------------hHHHHHHHHHHcCCCCccceeeEEec
Confidence            456689999999999999986 489999999864321                 13469999999999999999987632


Q ss_pred             -------ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC-Cc
Q psy5603         251 -------IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FV  321 (455)
Q Consensus       251 -------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~-~~  321 (455)
                             ...++||||+++ +|.+.+... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.+ +.
T Consensus       119 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~  195 (420)
T 1j1b_A          119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAV  195 (420)
T ss_dssp             EETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTE
T ss_pred             cCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCe
Confidence                   246799999975 666665431 124579999999999999999999999  889999999999999955 67


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|++||.+.........+..
T Consensus       196 ~kl~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~  271 (420)
T 1j1b_A          196 LKLCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK  271 (420)
T ss_dssp             EEECCCTTCEECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEeccchhhhhcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            89999999986543321    234578999999997644  578999999999999999999999988763322222111


Q ss_pred             --cccchh----------hccchhcc--CC---ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 --QEVPVR----------EVLDKEAG--EW---NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 --~~~~~~----------~~~d~~~~--~~---~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ......          ++.-+...  .|   ....++..+.+||.+||..||++||++.|+++
T Consensus       272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              110000          00000000  01   01123466889999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-41  Score=344.44  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=189.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+..+..||+|++......                 ..+|+++++.++||||+++++++.. 
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----------------~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----------------KNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----------------CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----------------HHHHHHHHHhCCCCCcceEEEEEEec
Confidence            4566899999999999999987777999998643210                 2369999999999999999997733 


Q ss_pred             ------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc-CCCceE
Q psy5603         251 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPK  323 (455)
Q Consensus       251 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~-~~~~~k  323 (455)
                            ...|+||||++++.+............+++..+..++.|++.||.|||+  +||+||||||+|||++ .++.+|
T Consensus       105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEE
Confidence                  2378999999765444433322224579999999999999999999999  8899999999999999 799999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      |+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|.+||.+.+.......+..  
T Consensus       183 L~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~  258 (394)
T 4e7w_A          183 LIDFGSAKILIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL  258 (394)
T ss_dssp             ECCCTTCEECCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EeeCCCcccccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999987543321    234578999999997644  478999999999999999999999998764322222211  


Q ss_pred             cccchh-------hccchhc---cCC-----ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QEVPVR-------EVLDKEA---GEW-----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~-------~~~d~~~---~~~-----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......       .+.....   ...     ....++..+.+||.+||..||++||++.|+++
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            110000       0000000   000     01124456889999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3e-41  Score=325.84  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.++ +++.||||++........           ....+.+|+.++++++||||+++++++.+ 
T Consensus        25 ~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (287)
T 2wei_A           25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----------DTSTILREVELLKKLDHPNIMKLFEILEDS   93 (287)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-----------CHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-----------HHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence            45589999999999999986 588999999975432111           14558899999999999999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---CceEEeec
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDF  327 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~DF  327 (455)
                      ...++|+||+++++|.+++...   ..+++..++.++.|++.||.|||+  +|++||||||+||+++.+   +.+||+||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Df  168 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDF  168 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred             CeEEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEecc
Confidence            7889999999999999998764   359999999999999999999999  889999999999999754   47999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      |+++.......    .....||+.|+|||.+.+.++.++||||||+++|+|++|..||...........+........  
T Consensus       169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  242 (287)
T 2wei_A          169 GLSTCFQQNTK----MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD--  242 (287)
T ss_dssp             TGGGTBCCCSS----CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             CcceeecCCCc----cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            99886543321    123468899999998888899999999999999999999999988764433333222211110  


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH--HHHhh
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD--LLSKS  452 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~--~L~~~  452 (455)
                      . +     ....++..+.++|.+||..+|++||++.++++  ++++.
T Consensus       243 ~-~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          243 L-P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             S-G-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             c-h-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            0 0     01223456888999999999999999999987  45443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.9e-42  Score=330.54  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=181.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||+++....      .     ......+..+...++.++||||+++++++.+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   77 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN------S-----QEQKRLLMDLDISMRTVDCPFTVTFYGALFR   77 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C------H-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC------c-----HHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence            456689999999999999985 589999999964321      1     1112334555566888999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCCcEEEcCCCceEEeec
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                       +..++||||+. |+|.+++... ....++++..++.++.|++.||.|||+  + |++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeec
Confidence             78899999996 5888877542 124579999999999999999999999  7 8999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccc-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+++.......    .....||+.|+|||.+     ...++.++||||||+++|||+||..||.................
T Consensus       155 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          155 GISGYLVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             CCccccccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            99886544321    2334799999999975     23578899999999999999999999986442221111111110


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ....+...++..+.+++.+|+..||++||++.++++
T Consensus       231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ---------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                     011112234456889999999999999999999976

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.6e-41  Score=336.39  Aligned_cols=255  Identities=22%  Similarity=0.264  Sum_probs=188.0

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|.+. +++.||||++.....      .     ......+.+|+.++++++||||+++++++
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~   93 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------N-----QTHAKRAYRELVLMKCVNHKNIIGLLNVF   93 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC------C-----hHHHHHHHHHHHHHHhcCCCCccceEEee
Confidence            34566799999999999999986 488999999974321      1     11245688999999999999999999987


Q ss_pred             cC-c------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         249 NN-I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .. .      ..|+||||+. |+|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~  165 (371)
T 2xrw_A           94 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  165 (371)
T ss_dssp             CSCCSTTTCCEEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSC
T ss_pred             ccccccccccceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCC
Confidence            55 2      6799999996 578888863     48999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+.......+...
T Consensus       166 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  241 (371)
T 2xrw_A          166 LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  241 (371)
T ss_dssp             EEECCCCC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred             EEEEEeeccccccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999998654322    1234589999999996644 5789999999999999999999999887643333222211


Q ss_pred             -ccchhhc--------------------------cchhccC---CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 -EVPVREV--------------------------LDKEAGE---WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 -~~~~~~~--------------------------~d~~~~~---~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ..+.++.                          +......   ......+..+.+||.+||..||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence             1110000                          0000000   001234667899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.4e-41  Score=322.70  Aligned_cols=241  Identities=18%  Similarity=0.257  Sum_probs=190.4

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.+. +++.||||+++......    .       ....+.+|+..+.++ +||||+++++++.+
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~-------~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A           14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS----V-------DEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS----H-------HHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             hhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc----H-------HHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            45589999999999999987 58999999997542210    1       145588999999999 99999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC---------
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---------  319 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~---------  319 (455)
                       +..++||||+++++|.+++..... ..++++..++.++.|++.||.|||+  ++|+||||||+|||++.+         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccc
Confidence             888999999999999999976422 2568999999999999999999999  889999999999999844         


Q ss_pred             ----------CceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCC--CCcccchHHHHHHHHHHHcCCCCCCC
Q psy5603         320 ----------FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       320 ----------~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~sDv~SlGvvl~elltG~~p~~~  387 (455)
                                ..+||+|||++.......       ...||+.|+|||.+.+.  ++.++|||||||++|+|++|.+|+..
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             cccccccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                      489999999988654322       23699999999977554  45799999999999999999988755


Q ss_pred             CcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....   ......  ...         .+..++..+.++|.+||..||++||++.++++
T Consensus       234 ~~~~~---~~~~~~--~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          234 GDQWH---EIRQGR--LPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SHHHH---HHHTTC--CCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhHHH---HHHcCC--CCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            43211   111110  000         01123455888999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.8e-41  Score=334.08  Aligned_cols=275  Identities=17%  Similarity=0.238  Sum_probs=197.5

Q ss_pred             HHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhh
Q psy5603         156 FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  235 (455)
Q Consensus       156 ~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  235 (455)
                      ..++....++|.      +.+.||+|+||.||+|.+.+|+.||||++..........  ...........+.+|+.++++
T Consensus        14 ~~~~~~~~~~y~------~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           14 IAELHAMQSPYT------VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV--NILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHTTCSCE------EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCE--EGGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhccceE------EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchh--hhhhhhhHHHHHHHHHHHHHh
Confidence            445666666654      459999999999999998889999999997654322111  001112224678999999999


Q ss_pred             CCccceeeeccccc-----C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         236 CKHVNLLRLLGLCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       236 l~h~niv~l~~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      ++||||+++++++.     . ...|+||||+. |+|.+.+...  ..++++..+..++.|++.||.|||+  +||+||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dl  160 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDL  160 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCC
Confidence            99999999999772     2 36799999996 7888888753  3469999999999999999999999  88999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCC
Q psy5603         310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~  387 (455)
                      ||+|||++.++.+||+|||+++......    ......||+.|+|||++.  ..++.++|||||||++|+|++|..||..
T Consensus       161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          161 HPGNILLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             CGGGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ChHHEEEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999997544322    123457899999999764  3578999999999999999999999988


Q ss_pred             CcchhhHHHhhh--cccchh-----------hccchhccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         388 NNTILYYYLVVE--QEVPVR-----------EVLDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       388 ~~~~~~~~~~~~--~~~~~~-----------~~~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........+..  ......           ..+.......+       ...++..+.+||.+||..||++||++.|+++
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            764332222211  111110           11111110000       1123455889999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.2e-41  Score=360.75  Aligned_cols=253  Identities=28%  Similarity=0.418  Sum_probs=201.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++++.||+|+||.||+|.+..    +..||||+++....      .      .....|.+|+.++++++||||++++++
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS------D------SVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC------H------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC------H------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4567889999999999999752    45799999864221      1      124568999999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.++..|+||||+++|+|.+++....  .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       460 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          460 ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             EecCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEec
Confidence            98888899999999999999998642  368999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcc-cch
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQE-VPV  404 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~-~~~  404 (455)
                      |+++.......  .......||+.|+|||++. ..++.++|||||||++|||++ |..||.+.........+.... .+.
T Consensus       536 G~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~  613 (656)
T 2j0j_A          536 GLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM  613 (656)
T ss_dssp             CCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC
T ss_pred             CCCeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99987644321  1123456788999999664 468899999999999999997 999998776443333222211 111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                  +..++..+.++|.+||..||++||++.++++.|+++++
T Consensus       614 ------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          614 ------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                        12334568889999999999999999999999998864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.6e-41  Score=332.92  Aligned_cols=246  Identities=23%  Similarity=0.298  Sum_probs=194.0

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++ +++.||||+++......           .....+.+|+.++.++ .||||+++++++.+ ..
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-----------DCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-----------ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-----------HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            67999999999999987 48999999997543211           1145588999999999 46999999998877 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEEeeccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGI  329 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGl  329 (455)
                      .++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            899999999999999886532 3569999999999999999999999  88999999999999987   78999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......    ......||+.|+|||++. ..++.++|||||||++|||++|..||...........+.........  
T Consensus       181 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  254 (327)
T 3lm5_A          181 SRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE--  254 (327)
T ss_dssp             CEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             ccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence            98664332    123468999999999765 46789999999999999999999999887654433333222111110  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            .....++..+.+||.+||..||++||++.++++
T Consensus       255 ------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          255 ------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                  111234456889999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.4e-41  Score=334.21  Aligned_cols=254  Identities=23%  Similarity=0.265  Sum_probs=180.0

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||||++......              ...+.++++.++.++||||+++++++.. 
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--------------RNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCTTC--------------CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--------------cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            34489999999999999986 4889999998643221              1236678888999999999999998743 


Q ss_pred             c-------eeEEEEEeccCCCHHHHHh-hcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCeeecCCCCCcEEEcC-C
Q psy5603         251 I-------MNCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYSIALGVAEALHYLH--SLSKPIIHRDVKSANVLLDE-N  319 (455)
Q Consensus       251 ~-------~~~lV~e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~~~iiH~Dikp~NILl~~-~  319 (455)
                      .       ..++||||+.+ +|.+.+. .......+++..+..++.|++.||.|||  +  +||+||||||+|||++. +
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS--VNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT--TCCBCSCCCGGGEEEETTT
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC--CCeecCcCCHHHEEEeCCC
Confidence            2       26899999975 5554443 2233567899999999999999999999  7  88999999999999997 8


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +.+||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||+||..||...+.......+
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            9999999999986654321    234578999999997643  3789999999999999999999999987643332222


Q ss_pred             hh-cccchhhccc---h----------hccC------CChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VE-QEVPVREVLD---K----------EAGE------WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~-~~~~~~~~~d---~----------~~~~------~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ...+..+.+.   +          ....      ......+..+.+||.+||..||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            21 1111000000   0          0000      001124567889999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.8e-41  Score=338.17  Aligned_cols=254  Identities=26%  Similarity=0.361  Sum_probs=178.6

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|.+. +|+.||||++.....      .     ......+.+|+.++++++||||+++++++
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------S-----IIHAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc------C-----HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            44667799999999999999975 589999999864321      1     11245688999999999999999999976


Q ss_pred             cC-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..       ...|+|++++ +++|.+++..    ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~  170 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCE  170 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCC
T ss_pred             ecCCccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCC
Confidence            43       4568999998 8999998875    369999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|.+||.+.+.......+..
T Consensus       171 ~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  244 (367)
T 2fst_X          171 LKILDFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  244 (367)
T ss_dssp             EEECC---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEEeecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999865432      234589999999997644  578899999999999999999999988764322222211


Q ss_pred             -cccchhhccch-----------hcc---CCCh----hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QEVPVREVLDK-----------EAG---EWNE----THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~~d~-----------~~~---~~~~----~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+..+.+..           ...   ....    ..++..+.+||.+||..||++||++.++++
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             11110000000           000   0000    123456889999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-41  Score=330.33  Aligned_cols=248  Identities=24%  Similarity=0.294  Sum_probs=188.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC--ccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.+++++.||||++.....      .     ......+.+|+.++++++  ||||+++++++.
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------D-----NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC------C-----HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc------c-----ccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            455689999999999999988889999999965322      1     112456899999999997  499999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||| +.+++|.+++...   .++++..+..++.|++.||.|||+  ++|+||||||+|||+++ +.+||+|||
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeecc
Confidence            7 78899999 6689999999873   468999999999999999999999  88999999999999965 899999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC------------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      +++....... ........||+.|+|||.+.+            .++.++||||||+++|||++|..||...........
T Consensus       172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (313)
T 3cek_A          172 IANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  250 (313)
T ss_dssp             SSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             ccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence            9986543321 112234579999999997653            567899999999999999999999986543221111


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....         .......+...+..+.++|.+||..||++||++.++++
T Consensus       251 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          251 AIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            1111         10000001112345888999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.1e-41  Score=335.24  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||||++.....      .     ......+.+|+.++++++||||+++++++.
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  111 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------S-----EIFAKRAYRELLLLKHMQHENVIGLLDVFT  111 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc------c-----hhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence            4566689999999999999986 489999999964321      1     112456889999999999999999999876


Q ss_pred             C-cee------EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-IMN------CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-~~~------~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      . ...      |+||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+
T Consensus       112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~  183 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL  183 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCE
T ss_pred             ccCCcccceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCE
Confidence            6 333      99999996 788887643     49999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|+|+||..||.+.+.......+.. 
T Consensus       184 kL~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  257 (371)
T 4exu_A          184 KILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  257 (371)
T ss_dssp             EECSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEEecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            99999998854332      234678999999997654  678899999999999999999999988764332222211 


Q ss_pred             cccchhhccch-----------hccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QEVPVREVLDK-----------EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~-----------~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+..+....           ......       ...++..+.+||.+||..||++||++.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            11110000000           000000       0123556889999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=328.51  Aligned_cols=262  Identities=20%  Similarity=0.289  Sum_probs=191.1

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      +.....|++.+.||+|+||.||+|.++. ++.||||++.....             .....+.+|+.++++++||||+++
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~   73 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-------------QSVKHALREIKIIRRLDHDNIVKV   73 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-------------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-------------HHHHHHHHHHHHHHhcCCCCeeEE
Confidence            3344557778999999999999999874 89999999864311             114568899999999999999999


Q ss_pred             ccccc--------------C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         245 LGLCN--------------N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~--------------~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      ++++.              + ...|+||||+. |+|.+++..    .++++..++.++.|++.||.|||+  +||+||||
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl  146 (320)
T 2i6l_A           74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDL  146 (320)
T ss_dssp             EEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCC
T ss_pred             EEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCC
Confidence            98752              2 56789999997 699999864    468999999999999999999999  88999999


Q ss_pred             CCCcEEEc-CCCceEEeecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCC
Q psy5603         310 KSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       310 kp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~  386 (455)
                      ||+|||++ +++.+||+|||+++................||..|+|||.+.  ..++.++|||||||++|||+||..||.
T Consensus       147 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  226 (320)
T 2i6l_A          147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA  226 (320)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence            99999997 567999999999986543322222233457899999999653  467889999999999999999999998


Q ss_pred             CCcchhhHHHhhhcccc------------hhhccchhcc--CCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         387 DNNTILYYYLVVEQEVP------------VREVLDKEAG--EWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~------------~~~~~d~~~~--~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..........+......            +...+.....  ..+    ...++..+.+||.+||..||++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            87643322222111000            0000000000  000    0124566889999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-41  Score=340.87  Aligned_cols=252  Identities=11%  Similarity=0.055  Sum_probs=175.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC--Cccceeeecc-c
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC--KHVNLLRLLG-L  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~-~  247 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||+++.....      .    ......+.+|+.+++.+  +||||++++. +
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~  133 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN------S----RSELERLHEATFAAARLLGESPEEARDRRRL  133 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT------H----HHHHHHHHHHHHHHHHHHC----------CB
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc------c----ccHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence            456689999999999999986 5899999999764321      1    11245577785444444  6999888553 2


Q ss_pred             ------ccC------------------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHH
Q psy5603         248 ------CNN------------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR------YSIALGVAEALHYL  297 (455)
Q Consensus       248 ------~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~gl~~L  297 (455)
                            +..                  ...|+||||+. |+|.+++.....  .+++..+      ..++.|++.||.||
T Consensus       134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence                  111                  33699999998 899999986432  3455566      78889999999999


Q ss_pred             HcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHH
Q psy5603         298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVI  374 (455)
Q Consensus       298 H~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvv  374 (455)
                      |+  ++|+||||||+|||++.++.+||+|||+++.....      .....||+.|+|||++.+   .++.++|||||||+
T Consensus       211 H~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i  282 (371)
T 3q60_A          211 QS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS  282 (371)
T ss_dssp             HH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred             HH--CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence            99  88999999999999999999999999999865421      113467799999997754   57899999999999


Q ss_pred             HHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         375 LLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       375 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +|||+||..||...........   ....................++..+.+||.+||..||++||++.++++
T Consensus       283 l~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          283 IYRVWCLFLPFGLVTPGIKGSW---KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHSSCSTTBCCTTCTTCC---CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHhCCCCCCCcCcccccch---hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999987642211000   000000000001100111234566889999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=332.75  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=190.6

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||++.....      .        ...+.+|+.+++++ +||||+++++++.
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~--------~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------E--------EEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------T--------THHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------c--------HHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            456699999999999999985 589999999864321      1        23488999999999 8999999999774


Q ss_pred             C-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCE
Confidence            3       56799999999999999998643 3468999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHH
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      ||+|||++.......   .......||+.|+|||++.      +.++.++|||||||++|+|+||..||...........
T Consensus       169 kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  245 (326)
T ss_dssp             EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             EEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            999999987654321   1123457999999999764      3578899999999999999999999987664332222


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......  ..        .....++..+.+||.+||..||.+||++.++++
T Consensus       246 ~~~~~~--~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 IPRNPA--PR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHSCC--CC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhcCcc--cc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            211111  11        111223456889999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.5e-40  Score=324.79  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=194.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc--CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC---Cccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~  245 (455)
                      .|++.+.||+|+||.||+|.+.  +|+.||||+++........           ...+.+|+.+++.+   +||||++++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----------PLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----------BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-----------CchhhHHHHHHHhhhccCCCCeEeee
Confidence            3566799999999999999983  5789999999755432111           11256777776665   899999999


Q ss_pred             cccc-----C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         246 GLCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       246 ~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      +++.     . ...++||||+. |+|.+++.... ...+++..++.++.|++.||.|||+  +||+||||||+||+++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~  156 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSS  156 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCC
Confidence            9875     3 67799999997 69999998744 2458999999999999999999999  889999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++......    ......||+.|+|||++. +.++.++|||||||++|||+||..||...........+.
T Consensus       157 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  232 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCEEEecCcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            999999999987654322    123467999999999664 467899999999999999999999998876433222221


Q ss_pred             h--cccchhhc----------cch-hcc--CCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 E--QEVPVREV----------LDK-EAG--EWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~--~~~~~~~~----------~d~-~~~--~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  ........          +.. ...  ......++..+.+||.+||..||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1  00000000          000 000  0001234566889999999999999999999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-40  Score=326.53  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEE-c-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc------ee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKL-K-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN------LL  242 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv  242 (455)
                      .|++.+.||+|+||.||+|.+ + +++.||||+++...              .....+.+|+.+++.++|+|      ++
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~~~i~   80 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--------------RYCEAARSEIQVLEHLNTTDPNSTFRCV   80 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--------------HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--------------chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence            466779999999999999987 3 47899999986321              11345788999999887765      89


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---  318 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---  318 (455)
                      ++++++.+ +..|+||||+ +++|.+++.... ..++++..+..++.|++.||.|||+  +||+||||||+|||++.   
T Consensus        81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~  156 (339)
T 1z57_A           81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDY  156 (339)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCE
T ss_pred             eeecccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEecccc
Confidence            99998776 8889999999 999999998743 3468999999999999999999999  88999999999999987   


Q ss_pred             ----------------CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcC
Q psy5603         319 ----------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       319 ----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG  381 (455)
                                      ++.+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  230 (339)
T 1z57_A          157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG  230 (339)
T ss_dssp             EEEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence                            678999999998864332      234589999999997644 679999999999999999999


Q ss_pred             CCCCCCCcchhhHHHhhhcccchhh----------ccchhc----------------------cCCChhHHHHHHHHHHH
Q psy5603         382 MKPIDDNNTILYYYLVVEQEVPVRE----------VLDKEA----------------------GEWNETHVETLISIVFE  429 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~----------~~d~~~----------------------~~~~~~~~~~~l~~Li~  429 (455)
                      ..||...+.............+++.          ......                      ........+..+.+||.
T Consensus       231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            9999877643222221110000000          000000                      01112345677889999


Q ss_pred             hhhccCcCCCCCHHHHHH
Q psy5603         430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||++||++.|+++
T Consensus       311 ~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          311 KMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhCcCcccccCHHHHhc
Confidence            999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-40  Score=339.43  Aligned_cols=253  Identities=21%  Similarity=0.308  Sum_probs=193.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC------Cccceee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC------KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~  243 (455)
                      .|++.+.||+|+||.||+|.+.. ++.||||+++....              ....+.+|+.+++.+      .|+||++
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--------------~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--------------FHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--------------hHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            35677999999999999999864 88999999963211              134467788887776      5779999


Q ss_pred             ecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc-
Q psy5603         244 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-  321 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~-  321 (455)
                      +++++.. ...|+||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++. 
T Consensus       164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~  239 (429)
T 3kvw_A          164 MLENFTFRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRS  239 (429)
T ss_dssp             EEEEEEETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSC
T ss_pred             EEeecccCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCc
Confidence            9998876 88899999995 79999988744 3459999999999999999999999  88999999999999999987 


Q ss_pred             -eEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         322 -PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 -~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                       +||+|||+++.....      .....||+.|+|||++. ..++.++|||||||++|||+||.+||...+.......+..
T Consensus       240 ~vkL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~  313 (429)
T 3kvw_A          240 GIKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE  313 (429)
T ss_dssp             CEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ceEEeecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence             999999998754332      23458999999999664 4689999999999999999999999988764322222111


Q ss_pred             -cccchhh----------ccchh---------------------------------ccCCC---hhHHHHHHHHHHHhhh
Q psy5603         400 -QEVPVRE----------VLDKE---------------------------------AGEWN---ETHVETLISIVFEKCC  432 (455)
Q Consensus       400 -~~~~~~~----------~~d~~---------------------------------~~~~~---~~~~~~~l~~Li~~~l  432 (455)
                       ...+...          +++..                                 ...|.   ....+..+.+||.+||
T Consensus       314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L  393 (429)
T 3kvw_A          314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL  393 (429)
T ss_dssp             HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred             HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence             1111100          00000                                 00000   0112456889999999


Q ss_pred             ccCcCCCCCHHHHHH
Q psy5603         433 VFEKDKRASMRDIVD  447 (455)
Q Consensus       433 ~~dp~~RPs~~evl~  447 (455)
                      ..||++|||+.|+++
T Consensus       394 ~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          394 EWDPAVRMTPGQALR  408 (429)
T ss_dssp             CSSTTTSCCHHHHHT
T ss_pred             CCChhhCCCHHHHhC
Confidence            999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.6e-40  Score=328.40  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=194.5

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.+.||+|+||.||+|.++ +|+.||||++.....            ......+.+|+.++++++||||++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~   77 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK------------PLFALRTLREIKILKHFKHENIITIFNI   77 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS------------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc------------chHHHHHHHHHHHHHhCcCCCcCCeeee
Confidence            345677799999999999999987 588999999953211            1114457899999999999999999987


Q ss_pred             ccC------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         248 CNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +..      ...|+||||+. |+|.+++..    ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~  150 (353)
T 2b9h_A           78 QRPDSFENFNEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCD  150 (353)
T ss_dssp             CCCSCSTTCCCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCC
T ss_pred             ecccccCccceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCc
Confidence            643      56799999996 699998876    359999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcce-------eeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcchh
Q psy5603         322 PKLGDFGIVKMSETSNMKT-------MYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL  392 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~  392 (455)
                      +||+|||+++.........       .......||+.|+|||++.  ..++.++|||||||++|||++|.+||.+.+...
T Consensus       151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  230 (353)
T 2b9h_A          151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH  230 (353)
T ss_dssp             EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999998664332111       0123457899999999653  457889999999999999999999998876322


Q ss_pred             hHHHhhh--cccc------------hhhccchhc--cCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         393 YYYLVVE--QEVP------------VREVLDKEA--GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       393 ~~~~~~~--~~~~------------~~~~~d~~~--~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......  ....            ..+.+....  ....    ...++..+.+||.+||..||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            2211111  0000            000000000  0000    0134556889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-40  Score=333.50  Aligned_cols=253  Identities=24%  Similarity=0.259  Sum_probs=192.7

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC--------ccce
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--------HVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~ni  241 (455)
                      .|++.++||+|+||.||+|.+. +++.||||+++...              .....+.+|+.++++++        |+||
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--------------HYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--------------cchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            4567799999999999999976 47899999996321              11455889999999885        7889


Q ss_pred             eeeccccc----C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCCcEE
Q psy5603         242 LRLLGLCN----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVL  315 (455)
Q Consensus       242 v~l~~~~~----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~-~iiH~Dikp~NIL  315 (455)
                      +++++++.    + ...|+||||+ +++|.+.+.... ...+++..++.++.|++.||.|||+  + ||+||||||+|||
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIl  179 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENIL  179 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEE
T ss_pred             eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHee
Confidence            99999775    3 6789999999 777777776533 2469999999999999999999999  7 8999999999999


Q ss_pred             EcCCC-------------------------------------------------ceEEeecccccccccCCcceeeeccC
Q psy5603         316 LDENF-------------------------------------------------VPKLGDFGIVKMSETSNMKTMYTENL  346 (455)
Q Consensus       316 l~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~  346 (455)
                      ++.++                                                 .+||+|||+++.....      ....
T Consensus       180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~  253 (397)
T 1wak_A          180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTED  253 (397)
T ss_dssp             ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSC
T ss_pred             EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccC
Confidence            99775                                                 8999999999865432      2245


Q ss_pred             CCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhh------HHHhhh--cccch---------hhcc
Q psy5603         347 TGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILY------YYLVVE--QEVPV---------REVL  408 (455)
Q Consensus       347 ~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~------~~~~~~--~~~~~---------~~~~  408 (455)
                      .||+.|+|||++.+ .++.++|||||||++|||+||..||........      ......  ...+.         ..++
T Consensus       254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            79999999996644 589999999999999999999999986542110      000000  11000         0000


Q ss_pred             chh--------c-----------cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKE--------A-----------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~--------~-----------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...        .           ........+..+.+||.+||..||++||++.|+++
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000        0           00113456677889999999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.8e-41  Score=331.97  Aligned_cols=269  Identities=22%  Similarity=0.262  Sum_probs=200.2

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCC----chhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS----DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||.||+|.+ +|+.||||++...........    ............+.+|+.++++++||||+++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            356679999999999999999 789999999975432111000    000000011256999999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDR------LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++.+ +..++||||+++|+|.++      +.... ..++++..++.++.|++.||.|||+ .+|++||||||+||+++.+
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECTT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcCC
Confidence            8877 788999999999999998      44321 4579999999999999999999997 2579999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCC--CCc-ccchHHHHHHHHHHHcCCCCCCCCcc-hhhHH
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--IST-KTDVFSYGVILLELLTGMKPIDDNNT-ILYYY  395 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~-~sDv~SlGvvl~elltG~~p~~~~~~-~~~~~  395 (455)
                      +.+||+|||+++.....     ......||+.|+|||++.+.  ++. ++||||||+++|||++|..||..... .....
T Consensus       189 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             SCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            99999999999865433     23456899999999977654  445 99999999999999999999987664 22222


Q ss_pred             Hhhhcccchhhccch-------hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         396 LVVEQEVPVREVLDK-------EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~-------~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........+.....       .........++..+.+||.+||..||.+||++.++++
T Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222221111110000       0000011334566889999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=328.11  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=190.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.+.||+|+||.||+|.++ +|+.||||++.....      .     ......+.+|+.++++++||||+++++++.
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------S-----EIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc------c-----hHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            3556689999999999999986 589999999964321      1     112456889999999999999999999876


Q ss_pred             C-c------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         250 N-I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      . .      ..|+||||+. ++|.+++..     .+++..+..++.|++.||.|||+  +||+||||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~  165 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL  165 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCE
T ss_pred             cccccccceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcE
Confidence            5 3      2499999996 688877643     48999999999999999999999  889999999999999999999


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|..||.+.+.......+.. 
T Consensus       166 kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~  239 (353)
T 3coi_A          166 KILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  239 (353)
T ss_dssp             EECSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred             EEeecccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999998764322      234578999999997644  578899999999999999999999987763322222111 


Q ss_pred             cccchhhc------------cc---hhc-cCC--ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QEVPVREV------------LD---KEA-GEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~------------~d---~~~-~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+..+.            +.   ... ..+  ....++..+.+||.+|+..||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000000            00   000 000  01234567889999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.1e-40  Score=319.00  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=184.1

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc--
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN--  249 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--  249 (455)
                      ++.+.||+|+||.||+|.+. +++.||||++....              .....+.+|+.++++++||||+++++++.  
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   74 (303)
T 1zy4_A            9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--------------EKLSTILSEVMLLASLNHQYVVRYYAAWLER   74 (303)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             hhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--------------HHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence            45589999999999999986 58999999985321              11456889999999999999999998653  


Q ss_pred             ------------CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc
Q psy5603         250 ------------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       250 ------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                                  ....|+||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+|||++
T Consensus        75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFID  150 (303)
T ss_dssp             CCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEC
T ss_pred             cchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEc
Confidence                        256789999999999999998633  467889999999999999999999  8899999999999999


Q ss_pred             CCCceEEeecccccccccCCc-----------ceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCC
Q psy5603         318 ENFVPKLGDFGIVKMSETSNM-----------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p  384 (455)
                      .++.+||+|||+++.......           .........||+.|+|||++.+  .++.++|||||||++|||++   |
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p  227 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P  227 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence            999999999999876543210           0111234579999999997754  57899999999999999998   5


Q ss_pred             CCCCcch-hhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         385 IDDNNTI-LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       385 ~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      |...... ............++..        .....+..+.++|.+|+..||++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          228 FSTGMERVNILKKLRSVSIEFPPD--------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CSSHHHHHHHHHHHHSTTCCCCTT--------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCchhHHHHHHhccccccccCcc--------ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            5432211 1111111111111111        11233455788999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-40  Score=337.63  Aligned_cols=250  Identities=21%  Similarity=0.279  Sum_probs=182.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      |...+.||+|+||+||.+...+|+.||||++....                ...+.+|+.++.++ +||||+++++++.+
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----------------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   80 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----------------CDIALMEIKLLTESDDHPNVIRYYCSETT   80 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----------------HHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            44568899999999987666678999999986421                23477899999876 89999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCC----CCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC------
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPP----LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN------  319 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~----l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~------  319 (455)
                       ...|+||||+. |+|.+++........    .++..++.++.|++.||.|||+  ++|+||||||+|||++.+      
T Consensus        81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSC
T ss_pred             CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccc
Confidence             78899999995 799999986432111    1333467899999999999999  889999999999999754      


Q ss_pred             -------CceEEeecccccccccCCcc-eeeeccCCCCCCCCCccccc--------CCCCcccchHHHHHHHHHHHc-CC
Q psy5603         320 -------FVPKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLT-GM  382 (455)
Q Consensus       320 -------~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~--------~~~~~~sDv~SlGvvl~ellt-G~  382 (455)
                             +.+||+|||+++........ ........||+.|+|||++.        ..++.++|||||||++|||+| |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   48999999999876543211 11223568999999999764        347889999999999999999 99


Q ss_pred             CCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .||........  .+.........     ........++..+.+||.+||..||++||++.+|++
T Consensus       238 ~Pf~~~~~~~~--~i~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          238 HPFGDKYSRES--NIIRGIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CTTCSTTTHHH--HHHHTCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCchhhHH--HHhcCCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            99976543221  11111111111     112223456778999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-39  Score=323.13  Aligned_cols=253  Identities=21%  Similarity=0.306  Sum_probs=192.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-C-cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc------ee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-G-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN------LL  242 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv  242 (455)
                      .|++.+.||+|+||.||+|.+.. + +.||||+++...              .....+.+|+.++++++|++      ++
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~~~~~~~~~   85 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--------------KYREAARLEINVLKKIKEKDKENKFLCV   85 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--------------cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence            45667999999999999999863 4 689999986321              11345788999999998776      88


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEE-----
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----  316 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl-----  316 (455)
                      .+++++.. +..|+||||+ +++|.+.+.... ..++++..++.++.|++.||.|||+  +||+||||||+|||+     
T Consensus        86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~  161 (355)
T 2eu9_A           86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEF  161 (355)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCE
T ss_pred             EeeeeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccc
Confidence            88887766 8889999999 778888777643 2469999999999999999999999  889999999999999     


Q ss_pred             --------------cCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcC
Q psy5603         317 --------------DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       317 --------------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG  381 (455)
                                    +.++.+||+|||+++.....      .....||+.|+|||++ ...++.++|||||||++|||+||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                          67889999999999864332      2345899999999966 44679999999999999999999


Q ss_pred             CCCCCCCcchhhHHHhhhcccchhh-c---------cchh----------------------ccCCChhHHHHHHHHHHH
Q psy5603         382 MKPIDDNNTILYYYLVVEQEVPVRE-V---------LDKE----------------------AGEWNETHVETLISIVFE  429 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~-~---------~d~~----------------------~~~~~~~~~~~~l~~Li~  429 (455)
                      ..||..................++. .         ....                      .........+..+.+||.
T Consensus       236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            9999877633222221110000000 0         0000                      001112334567889999


Q ss_pred             hhhccCcCCCCCHHHHHH
Q psy5603         430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||++||++.|+++
T Consensus       316 ~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhcCChhhCcCHHHHhc
Confidence            999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-39  Score=327.72  Aligned_cols=199  Identities=26%  Similarity=0.305  Sum_probs=163.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-cc-----ceee
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HV-----NLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~  243 (455)
                      .|++.+.||+|+||+||+|.+. +++.||||+++....              ....+..|+.++..++ |+     +|++
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA--------------FLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH--------------HHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH--------------HHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            3566789999999999999986 478999999963211              1345777888887774 44     4899


Q ss_pred             ecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc--CCC
Q psy5603         244 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENF  320 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~--~~~  320 (455)
                      +++++.. ...|+||||+. |+|.+++.... ...+++..+..++.|++.||.|||+...||+||||||+|||++  .++
T Consensus       121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             EEEEEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred             eeeeeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence            9997766 88899999995 69999998743 2458999999999999999999995336899999999999994  578


Q ss_pred             ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcch
Q psy5603         321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      .+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|||+||.+||...+..
T Consensus       199 ~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             CEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            8999999999865432      234689999999996654 6899999999999999999999999987643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.2e-40  Score=322.10  Aligned_cols=251  Identities=24%  Similarity=0.308  Sum_probs=172.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHH-HHhhCCccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++....      ..      ....+..|+. +++.++||||+++++++.
T Consensus        24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~------~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD------EK------EQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC------HH------HHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC------ch------HHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            456699999999999999986 589999999974321      10      1233555665 677889999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCCcEEEcCCCceEEe
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      + +..++||||+. |+|.+++...  .....+++..+..++.|++.||.|||+  . |++||||||+|||++.++.+||+
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A           92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEc
Confidence            6 78899999997 5888877631  113579999999999999999999999  7 89999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccc-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      |||+++.......    .....||+.|+|||++     ...++.++|||||||++|||++|..||............. .
T Consensus       169 Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~  243 (327)
T 3aln_A          169 DFGISGQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-V  243 (327)
T ss_dssp             CCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-C
T ss_pred             cCCCceecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-h
Confidence            9999876543321    2234799999999976     2357889999999999999999999998654211100000 0


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......     ........++..+.+||.+||..||++||++.++++
T Consensus       244 ~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          244 KGDPPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CSCCCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000000     001011234456888999999999999999999965

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=321.26  Aligned_cols=241  Identities=27%  Similarity=0.420  Sum_probs=187.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC----Cccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC----KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|.+. +++.||||+++...........       ....+.+|+.++.++    +||||+++++
T Consensus        33 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLS-------DSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC---------------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             eEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccch-------hhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            456699999999999999875 4889999999754332111000       122366789999888    8999999999


Q ss_pred             cccC-ceeEEEEEe-ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc-CCCceE
Q psy5603         247 LCNN-IMNCIVYEY-MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPK  323 (455)
Q Consensus       247 ~~~~-~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~-~~~~~k  323 (455)
                      ++.+ +..++|+|| +.+++|.+++...   .++++..++.++.|++.||.|||+  ++|+||||||+||+++ .++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCeEE
Confidence            8876 788999999 7899999999873   359999999999999999999999  8899999999999999 899999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC-CC-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcc
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      |+|||+++......     .....||..|+|||++.+ .+ +.++||||||+++|||++|..||......      ....
T Consensus       181 l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~  249 (312)
T 2iwi_A          181 LIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------LEAE  249 (312)
T ss_dssp             ECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHTC
T ss_pred             EEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------hhhc
Confidence            99999988765432     234579999999997643 34 45899999999999999999999754211      1111


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.            ..++..+.++|.+||..+|++||++.++++
T Consensus       250 ~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 LHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CCCC------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCCc------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111            123445788999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-40  Score=335.02  Aligned_cols=244  Identities=21%  Similarity=0.333  Sum_probs=180.6

Q ss_pred             CCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-c
Q psy5603         174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  251 (455)
                      +.+.||+|+||+||.....+|+.||||++.....                ..+.+|+++++++ +||||+++++++.+ .
T Consensus        28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----------------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----------------SFADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----------------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----------------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            3478999999996654445689999999864221                1156899999999 89999999998877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-----CCceEEee
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGD  326 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-----~~~~kl~D  326 (455)
                      ..|+||||+. |+|.+++.....  .+.+..++.++.|++.||.|||+  ++|+||||||+|||++.     ...+||+|
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EEEEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            8899999995 699999986442  34555677899999999999999  88999999999999943     34688999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ||+++................||+.|+|||++.    ..++.++|||||||++|||+| |..||.............  .
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~--~  244 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG--A  244 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT--C
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc--c
Confidence            999987654322222234568999999999775    346779999999999999999 999997554322221111  1


Q ss_pred             cchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....       ...+....+..+.+||.+||..||++||++.+|++
T Consensus       245 ~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          245 CSLD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1110       01112345566889999999999999999999984

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.9e-40  Score=323.53  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=192.4

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC--ccceeeeccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGL  247 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  247 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++............       ....+.+|+.++++++  |+||++++++
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP-------NGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECT-------TCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhh-------hhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3567799999999999999975 5889999999765432110000       0123678999999996  5999999998


Q ss_pred             ccC-ceeEEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc-CCCceEE
Q psy5603         248 CNN-IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKL  324 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl  324 (455)
                      +.+ ...++|+|++.+ ++|.+++...   ..+++..++.++.|++.||.|||+  ++|+||||||+|||++ +++.+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCEEE
Confidence            877 788999999976 8999999873   469999999999999999999999  8899999999999999 7899999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC-CC-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+++......     .....||+.|+|||++.+ .. +.++||||||+++|||+||..||......      .....
T Consensus       192 ~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~  260 (320)
T 3a99_A          192 IDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQV  260 (320)
T ss_dssp             CCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHCCC
T ss_pred             eeCcccccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------hcccc
Confidence            9999988665332     234579999999997643 33 67899999999999999999999754211      01111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..            ...++..+.+||.+||..||++||++.++++
T Consensus       261 ~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 FF------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11            1123445888999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.2e-40  Score=326.70  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=190.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-----------c
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----------H  238 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h  238 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++....              .....+.+|+.++++++           |
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~   85 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--------------VYTEAAEDEIKLLQRVNDADNTKEDSMGA   85 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--------------cchhhhhHHHHHHHHhhcccccchhcccc
Confidence            4567799999999999999985 58999999986321              11345788999988876           8


Q ss_pred             cceeeecccccC-c----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCC
Q psy5603         239 VNLLRLLGLCNN-I----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSA  312 (455)
Q Consensus       239 ~niv~l~~~~~~-~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~-~iiH~Dikp~  312 (455)
                      |||+++++++.. .    ..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+  + ||+||||||+
T Consensus        86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~  161 (373)
T 1q8y_A           86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPE  161 (373)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGG
T ss_pred             chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChH
Confidence            999999998764 2    678999999 999999998644 2459999999999999999999999  7 8999999999


Q ss_pred             cEEEc------CCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCC
Q psy5603         313 NVLLD------ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       313 NILl~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~  385 (455)
                      |||++      ..+.+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|||+||..||
T Consensus       162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          162 NVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             GEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             HeEEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            99994      4458999999999865432      224579999999997644 5789999999999999999999999


Q ss_pred             CCCcchh-------hHHHhhh-cccch---------hhccch-------------------hccCCChhHHHHHHHHHHH
Q psy5603         386 DDNNTIL-------YYYLVVE-QEVPV---------REVLDK-------------------EAGEWNETHVETLISIVFE  429 (455)
Q Consensus       386 ~~~~~~~-------~~~~~~~-~~~~~---------~~~~d~-------------------~~~~~~~~~~~~~l~~Li~  429 (455)
                      .......       ....... ...+.         ..++..                   ......+..++..+.+||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence            8654111       0000000 10000         000000                   0001123466778999999


Q ss_pred             hhhccCcCCCCCHHHHHH
Q psy5603         430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||++||++.|+++
T Consensus       316 ~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          316 PMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GGGCSSTTTCBCHHHHHT
T ss_pred             HHhccCccccCCHHHHhh
Confidence            999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-39  Score=322.47  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=164.8

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHH-HHHhhCCccceeeecccccC---
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QTLSQCKHVNLLRLLGLCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~---  250 (455)
                      +.||+|+||.||+|.++ +|+.||||++....                 . ..+|+ ..+..+.||||+++++++..   
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~-~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----------------K-ARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----------------H-HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----------------H-HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            56999999999999987 58999999986321                 1 22333 33566799999999997753   


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEEe
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~  325 (455)
                        ...++||||+.||+|.+++.... ..++++.+++.++.|++.||.|||+  +||+||||||+|||++.   ++.+||+
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEe
Confidence              34789999999999999998643 3469999999999999999999999  88999999999999976   4569999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++......     .....||+.|+|||++. ..++.++|||||||++|+|++|..||.............. ....
T Consensus       174 Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~  247 (336)
T 3fhr_A          174 DFGFAKETTQNA-----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-RIRL  247 (336)
T ss_dssp             CCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             ccccceeccccc-----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-hhhc
Confidence            999998654322     23457899999999764 4578899999999999999999999976653221110000 0000


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   .........++..+.+||.+||..||++||++.++++
T Consensus       248 ~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          248 GQY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000   0000011234556889999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=315.77  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=174.2

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||||++.....      ..     .....+..+..+++.++||||+++++++.+ 
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN------KE-----ENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEETTSC------HH-----HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cccceeeecCCeeEEEEEEecCCeEEEEEEeccccc------ch-----HHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            44588999999999999986 589999999975422      11     112334455567888899999999998877 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      ...++||||+ ++.+..+....  ..++++..+..++.|++.||.|||+  + |++||||||+||+++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence            7889999999 56666655543  2468999999999999999999998  5 899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcch-hhHHHhhhccc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~  402 (455)
                      +........    .....||+.|+|||.+.      ..++.++|||||||++|||++|..||...... ...........
T Consensus       172 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (318)
T 2dyl_A          172 SGRLVDDKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP  247 (318)
T ss_dssp             C------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC
T ss_pred             chhccCCcc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC
Confidence            876543221    23457999999999763      35788999999999999999999999875422 11111111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..   +.      ....++..+.++|.+||..||.+||++.++++
T Consensus       248 ~~---~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 PL---LP------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC---CC------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC---CC------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            10   00      01123445888999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.6e-39  Score=341.12  Aligned_cols=265  Identities=21%  Similarity=0.304  Sum_probs=199.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-  249 (455)
                      |++.++||+|+||.||+|.+. +|+.||||+++....      .      .....+.+|+.++++++||||+++++++. 
T Consensus        16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~------~------~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~   83 (676)
T 3qa8_A           16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS------P------KNRERWCLEIQIMKKLNHPNVVSAREVPDG   83 (676)
T ss_dssp             -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC------H------HHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC------H------HHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence            566799999999999999985 488999999864321      1      11456899999999999999999998753 


Q ss_pred             ------CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc--
Q psy5603         250 ------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--  321 (455)
Q Consensus       250 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~--  321 (455)
                            +...|+||||++||+|.+++.......++++..++.++.|++.||.|||+  .||+||||||+||+++.++.  
T Consensus        84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSC
T ss_pred             cccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCce
Confidence                  35668999999999999999876655679999999999999999999999  88999999999999997664  


Q ss_pred             -eEEeecccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         322 -PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 -~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                       +||+|||+++.......    .....||+.|+|||++. +.++.++|||||||++|||++|..||........+.....
T Consensus       162 ~vKL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~  237 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGEL----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR  237 (676)
T ss_dssp             EEEECSCCCCCBTTSCCC----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC
T ss_pred             eEEEcccccccccccccc----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh
Confidence             99999999987654321    23468999999999765 4678999999999999999999999987542211110000


Q ss_pred             ----cccchhhc------cchhc--cCCChhHHHHHHHHHHHhhhccCcCCCCCHHH-----HHHHHHhhhc
Q psy5603         400 ----QEVPVREV------LDKEA--GEWNETHVETLISIVFEKCCVFEKDKRASMRD-----IVDLLSKSVN  454 (455)
Q Consensus       400 ----~~~~~~~~------~d~~~--~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e-----vl~~L~~~~~  454 (455)
                          ........      +....  .......++..+.++|.+|+..||++||++.+     +++.++++++
T Consensus       238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                00000000      00000  01112456788999999999999999999988     5566666553

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-39  Score=348.25  Aligned_cols=238  Identities=20%  Similarity=0.257  Sum_probs=189.5

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc--CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.+.  +|+.||||++.....      .      .....|.+|++++++++||||+++++++
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~  148 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD------A------EAQAMAMAERQFLAEVVHPSIVQIFNFV  148 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC------H------HHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC------H------HHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence            4677799999999999999986  479999999864211      1      1145688999999999999999999988


Q ss_pred             cC-ce-----eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCce
Q psy5603         249 NN-IM-----NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       249 ~~-~~-----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .. ..     .|+||||++|++|.+++..     ++++.+++.|+.|++.||.|||+  +||+||||||+|||++.+ .+
T Consensus       149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~  220 (681)
T 2pzi_A          149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QL  220 (681)
T ss_dssp             EEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CE
T ss_pred             eecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cE
Confidence            66 33     5999999999999987653     69999999999999999999999  889999999999999985 89


Q ss_pred             EEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      ||+|||+++.....       ....||+.|+|||++.+..+.++|||||||++|+|++|.+||......           
T Consensus       221 kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------  282 (681)
T 2pzi_A          221 KLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------  282 (681)
T ss_dssp             EECCCTTCEETTCC-------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------
T ss_pred             EEEecccchhcccC-------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc-----------
Confidence            99999998865432       345799999999988777789999999999999999999988753210           


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC-HHHHHHHHHhhh
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVDLLSKSV  453 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~~L~~~~  453 (455)
                      .+.       ...+....+..+.++|.+||..||++||+ ++++...|..++
T Consensus       283 ~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 GLP-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             SCC-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ccc-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            000       01111223456888999999999999995 666666666543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3e-38  Score=305.42  Aligned_cols=228  Identities=14%  Similarity=0.055  Sum_probs=179.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+.. ++.||||+++......          ......|.+|+.++.+++||||+++++++.
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP----------DDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC----------HHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            35666899999999999999874 8999999997543211          112456899999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+||||+.|++|.+++..    . ....++..|+.|++.||.|||+  +||+||||||+|||++.+|.+||+++|
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc
Confidence            7 788999999999999999854    1 3556788999999999999999  889999999999999999999998543


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHH---Hhhhcccchh
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY---LVVEQEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~---~~~~~~~~~~  405 (455)
                                             |++      .++.++|||||||++|||+||..||..........   ..........
T Consensus       175 -----------------------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T 3uqc_A          175 -----------------------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP  225 (286)
T ss_dssp             -----------------------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred             -----------------------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence                                   333      36789999999999999999999998765321110   0000100000


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ...        ...++..+.++|.+||..||++| |+.++++.|+++.
T Consensus       226 ~~~--------~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          226 ADI--------DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HHH--------CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hhc--------ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            000        01244558899999999999999 9999999998864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-37  Score=302.28  Aligned_cols=220  Identities=25%  Similarity=0.343  Sum_probs=171.7

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH-hhCCccceeeeccccc----
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-SQCKHVNLLRLLGLCN----  249 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~----  249 (455)
                      +.||+|+||.||+|.++ +++.||||+++..                  ..+.+|+.++ +..+||||+++++++.    
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc------------------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            67999999999999985 5889999998531                  2367889888 5569999999999764    


Q ss_pred             -CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEEe
Q psy5603         250 -NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  325 (455)
Q Consensus       250 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~  325 (455)
                       +...++||||+++|+|.+++.... ..++++..++.++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence             356799999999999999998743 3469999999999999999999999  88999999999999998   7899999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |||++.....                        ..++.++|||||||++|||+||..||.............       
T Consensus       163 Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-------  211 (299)
T 3m2w_A          163 DFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------  211 (299)
T ss_dssp             CCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-------
T ss_pred             cccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-------
Confidence            9998764321                        346789999999999999999999997654321110000       


Q ss_pred             hccchhccCCCh---hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNE---THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~---~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.......+.   ..++..+.+||.+|+..||++||++.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000001111   234566889999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-38  Score=321.38  Aligned_cols=239  Identities=17%  Similarity=0.195  Sum_probs=174.6

Q ss_pred             cCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc-cceeeec-----
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLL-----  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~-----  245 (455)
                      ..+++||+|+||.||+|.+. +|+.||||+++.......          .....|.+|+.+++.++| .|...+.     
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~----------~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~  150 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS----------NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  150 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC--------------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH----------HHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence            34588999999999999976 589999999874332111          114558999999999977 2221111     


Q ss_pred             ----------------ccccC------ceeEEEEEeccCCCHHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHc
Q psy5603         246 ----------------GLCNN------IMNCIVYEYMCNGSLYDRLARV----NNTPPLDSNKRYSIALGVAEALHYLHS  299 (455)
Q Consensus       246 ----------------~~~~~------~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~gl~~LH~  299 (455)
                                      .+...      ...+++|+++ +++|.+++...    ....++++..++.++.|++.||.|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  229 (413)
T 3dzo_A          151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  229 (413)
T ss_dssp             CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                            11111      1245666655 79999988521    123468889999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc----------cC-CCCcccch
Q psy5603         300 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM----------HC-QISTKTDV  368 (455)
Q Consensus       300 ~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~-~~~~~sDv  368 (455)
                        ++|+||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++          .+ .++.++||
T Consensus       230 --~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          230 --YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             --TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             --CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence              88999999999999999999999999998764332      334578 999999976          22 36779999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       369 ~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      |||||++|||+||..||............          +..    +  ..++..+.+||.+||..||++||++.++++
T Consensus       301 wSlGvil~elltg~~Pf~~~~~~~~~~~~----------~~~----~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          301 WTLGLAIYWIWCADLPNTDDAALGGSEWI----------FRS----C--KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHHHHHSSCCCCTTGGGSCSGGG----------GSS----C--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhhHHHH----------Hhh----c--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999999999999876532211111          110    0  022355889999999999999999877743

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5e-38  Score=310.35  Aligned_cols=243  Identities=16%  Similarity=0.142  Sum_probs=179.6

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC---------------
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---------------  237 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------------  237 (455)
                      ++.+.||+|+||+||+|++ +|+.||||+++..........     .......+.+|+.+++.++               
T Consensus        23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGS-----HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTB-----CCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccc-----cchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            4558999999999999998 479999999986543211000     0111455888999988886               


Q ss_pred             -----------ccceeeeccccc--------------CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH
Q psy5603         238 -----------HVNLLRLLGLCN--------------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE  292 (455)
Q Consensus       238 -----------h~niv~l~~~~~--------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~  292 (455)
                                 ||||+++++++.              ....|+||||+.+|++.+.+..    ..+++..+..++.|++.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence                       555555555443              4788999999999987776643    35899999999999999


Q ss_pred             HHHHHH-cCCCCeeecCCCCCcEEEcCCC--------------------ceEEeecccccccccCCcceeeeccCCCCCC
Q psy5603         293 ALHYLH-SLSKPIIHRDVKSANVLLDENF--------------------VPKLGDFGIVKMSETSNMKTMYTENLTGTRP  351 (455)
Q Consensus       293 gl~~LH-~~~~~iiH~Dikp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~  351 (455)
                      ||.||| +  ++|+||||||+|||++.++                    .+||+|||+++.....        ...||+.
T Consensus       173 aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCC
T ss_pred             HHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeec
Confidence            999999 8  7899999999999999887                    9999999999865432        2379999


Q ss_pred             CCCcccccCCCCcccchHHHHHH-HHHHHcCCCCCCCCcc--hhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHH
Q psy5603         352 YMPPEAMHCQISTKTDVFSYGVI-LLELLTGMKPIDDNNT--ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVF  428 (455)
Q Consensus       352 Y~aPE~~~~~~~~~sDv~SlGvv-l~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li  428 (455)
                      |+|||++.+..+.++||||||++ .+++++|..||.....  .......  .....    ...........++..+.+||
T Consensus       243 y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          243 SMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML--KQMTF----KTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             TTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH--HTCCC----SSCCCSHHHHHHHHHHHHHH
T ss_pred             ccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh--hhhcc----CcccchhhhhhcCHHHHHHH
Confidence            99999988877889999998777 7788999999853210  0000000  00000    00001111346778899999


Q ss_pred             HhhhccCcCCCCCHHHHH
Q psy5603         429 EKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       429 ~~~l~~dp~~RPs~~evl  446 (455)
                      .+||..|     |+.|++
T Consensus       317 ~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          317 RTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHGGGSS-----SHHHHH
T ss_pred             HHHhccC-----CHHHHH
Confidence            9999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=7e-33  Score=292.04  Aligned_cols=195  Identities=19%  Similarity=0.105  Sum_probs=134.1

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC-ce
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      ...+.|++|.+..++.. .|+.||+|++...........   +......+.|.+|+++|+++ .|+||+++++++.+ ..
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~  316 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTA---EESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS  316 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCH---HHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchh---hhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence            34678888877765533 488999999986654332221   12333466799999999999 79999999999988 88


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .||||||++|++|.++|..   ..+++..   .|+.||+.||+|+|+  +|||||||||+||||+++|.+||+|||+|+.
T Consensus       317 ~yLVMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCee
Confidence            9999999999999999987   3457664   488999999999999  8999999999999999999999999999986


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCC
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p  384 (455)
                      .....   ......+||+.|+|||++.+....++|+||+|++++++.++..+
T Consensus       389 ~~~~~---~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDC---SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC------CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             CCCCC---ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            55432   12345689999999999988888999999999998877665443

>1d2z_B Death domain of tube; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2

Probab=99.96  E-value=7.8e-31  Score=217.70  Aligned_cols=122  Identities=34%  Similarity=0.602  Sum_probs=108.6

Q ss_pred             cCCCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCC---------------CCCCCCcchHHHHHHHHhcccC
Q psy5603           4 ESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCD---------------PLKPLKYSAKDIKIVERAGKRN   68 (455)
Q Consensus         4 ~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~---------------~~~~~~~~~~~~~~~e~~~~~~   68 (455)
                      .+.+|++||||+||++++++||++||+++.|++||+.|+++-+               .++++||++.||+.||+.++| 
T Consensus         2 ~~~~t~~teIR~Lp~~~~~~La~iLD~~d~WkkLm~~Ipk~l~~~~~~~~~~~~~~~~~~~~~kY~~~~i~~ie~~~~r-   80 (153)
T 1d2z_B            2 SSKYSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGFKYTAQDVFQIDEAANR-   80 (153)
T ss_dssp             CCSCCTTSBGGGSCHHHHHHHHHHHHGGGHHHHHHHHCBSSCCHHHHHSTTCCCHHHHGGGCBSSCHHHHHHHHHHHHH-
T ss_pred             CCcccCcceeeeCCHHHHHHHHHHcCccchHHHHHHhccccccccccccccccccccccccccCcCHHHHHHHHHHHhh-
Confidence            4789999999999999999999999999999999999999511               135889999999999999987 


Q ss_pred             CC--CCCchHHHHHhhhcCCC--CCCCHHHHHHHHHhccccccccccccccccC--CCCCCCCch
Q psy5603          69 FP--ERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTE  127 (455)
Q Consensus        69 ~~--~~s~t~~ll~~w~~~~~--~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~  127 (455)
                       +  |+|||++||++|||+|+  +||||++|+++|.+++|++||+++.++.++.  |++|..++.
T Consensus        81 -~~~~~Spt~~lLdeWGTsG~~~~rpTV~~L~~LL~kaeL~~AAd~va~d~l~e~~p~RP~~gpa  144 (153)
T 1d2z_B           81 -LPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVALDFLNESTPARPVDGPG  144 (153)
T ss_dssp             -SCTTCCHHHHHHHHHHTCSSSTTSCBHHHHHHHHHHTTCHHHHHHHHHHTTCCCCCCCCSSSTT
T ss_pred             -ccCCCCHHHHHHHHhccCCcccCCCcHHHHHHHHHHhhHHHHHHHHHHHHhcCCCCCCCCCCCC
Confidence             5  99999999999999998  8999999999999999999999999998876  444444443

>2a9i_A IRAK-4, interleukin-1 receptor-associated kinase-4; hexahelical bundle, transferase; 1.70A {Mus musculus} PDB: 3mop_G

Probab=99.95  E-value=1.3e-28  Score=200.18  Aligned_cols=107  Identities=21%  Similarity=0.318  Sum_probs=99.8

Q ss_pred             ccCCCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhh
Q psy5603           3 SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEW   82 (455)
Q Consensus         3 ~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w   82 (455)
                      |+.++|++||||+||++++++||++||++++|++||+.|++++|   ++||++.||+.||...+   +|+|||++||++|
T Consensus         1 ~~~~~~~~~~I~~Lp~~~r~~L~~~LD~~~~W~~La~~i~~~~~---~~ky~~~~i~~~e~~~~---~~~SPT~~LL~~W   74 (113)
T 2a9i_A            1 MNKPLTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSG---DDRYNQFHIRRFEALLQ---TGLSPTCELLFDW   74 (113)
T ss_dssp             --CCCCTTSBGGGCCHHHHHHHHHHHSGGGHHHHHHHHCBCTTS---SBSSCHHHHHHHHHTTT---TTCCHHHHHHHHH
T ss_pred             CCCCCCCCCchhhCCHHHHHHHHHHhCCcccHHHHHHHHcCccc---cCCCCHHHHHHHHHhhc---cCCCHHHHHHHHH
Confidence            46789999999999999999999999999999999999999877   89999999999999965   6999999999999


Q ss_pred             hcCCCCCCCHHHHHHHHHhccccccccccccccccC
Q psy5603          83 GTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK  118 (455)
Q Consensus        83 ~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~  118 (455)
                      |++   ||||++|+++|.+.++++|++++.++++++
T Consensus        75 g~~---~~TV~~Ll~lL~~~~l~~Aa~~L~~~~~~~  107 (113)
T 2a9i_A           75 GTT---NCTVGDLVDLLVQIELFAPATLLLPDAVPQ  107 (113)
T ss_dssp             GGG---TCBHHHHHHHHHHTTCHHHHHHHCGGGSCC
T ss_pred             ccC---CCcHHHHHHHHHHcccHHHHHHhchhhccc
Confidence            997   999999999999999999999999888755

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.3e-28  Score=257.96  Aligned_cols=191  Identities=16%  Similarity=0.166  Sum_probs=145.9

Q ss_pred             CCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-cee
Q psy5603         175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  253 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      .+.||+|+||.||+|... ++.+|+|+.......     ..........+.|.+|++++++++||||+++..++.+ ...
T Consensus       341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~-----~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  414 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYR-----DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK  414 (540)
T ss_dssp             -------CCEEEEEEECS-SCEEEEEEECCCTTS-----CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred             CCEEeeCCCEEEEEEEEC-CCeEEEEEEeccccc-----chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence            468999999999999665 789999987543211     1111222335668999999999999999965554444 677


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||++|++|.+++..           +..++.|++.||.|||+  ++|+||||||+|||++.  .+||+|||+++..
T Consensus       415 ~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            999999999999999874           56899999999999999  88999999999999999  9999999999876


Q ss_pred             ccCCcce----eeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCC
Q psy5603         334 ETSNMKT----MYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       334 ~~~~~~~----~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~  386 (455)
                      .......    .......||+.|+|||++.+   .++..+|+||..+-.++-..++.+|.
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            5432111    01235689999999998754   46778999999999999888877764

>1wh4_A IRAK4, interleukin-1 receptor-associated kinase 4; death domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: a.77.1.2

Probab=99.93  E-value=1.1e-26  Score=192.51  Aligned_cols=108  Identities=21%  Similarity=0.327  Sum_probs=101.6

Q ss_pred             CccCCCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHh
Q psy5603           2 TSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDE   81 (455)
Q Consensus         2 ~~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~   81 (455)
                      +|+.++++++|||+||++++++||++||++++|++||..|.+++|   ++||++.|||.||...+   +|+|||++||++
T Consensus         7 ~~~~~~~~~~~i~~Lp~~vr~~L~~~LD~~~~Wr~LA~~i~~~~~---~~ry~~~ei~~ie~~~~---~~~SPT~~LL~~   80 (127)
T 1wh4_A            7 GMNKPLTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSG---DDRYNQFHIRRFEALLQ---TGKSPTCELLFD   80 (127)
T ss_dssp             CCCCCCCTTSBGGGSCHHHHHHHHHHHSSTTHHHHHHHHCBCTTC---CBSSCHHHHHHHHHHHT---TTSCHHHHHHHH
T ss_pred             CCCCCCCCCchhhhCCHHHHHHHHHHhCCcccHHHHHHHHccccc---cCCcCHHHHHHHHHhhc---cCCCHHHHHHHH
Confidence            467889999999999999999999999999999999999998777   78999999999999866   699999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHhccccccccccccccccC
Q psy5603          82 WGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK  118 (455)
Q Consensus        82 w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~  118 (455)
                      ||++   |+||++|+++|.+.++++|++++.++.++.
T Consensus        81 Wg~~---~~TV~~Ll~lL~~~~~~~Aa~~L~~~~l~~  114 (127)
T 1wh4_A           81 WGTT---NCTVGDLVDLLVQIELFAPATLLLPDAVPQ  114 (127)
T ss_dssp             HHHH---CCBHHHHHHHHHHTTCHHHHHHHCTTSSSS
T ss_pred             Hhcc---CCcHHHHHHHHHHcccHHHHHHHHHhhhcC
Confidence            9997   899999999999999999999999988866

>3mop_K IRAK-2, interleukin-1 receptor-associated kinase-like 2; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens}

Probab=99.93  E-value=2.9e-26  Score=183.75  Aligned_cols=93  Identities=17%  Similarity=0.191  Sum_probs=83.2

Q ss_pred             CceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCC
Q psy5603          10 DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRR   89 (455)
Q Consensus        10 ~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~   89 (455)
                      +||||+||++++++||++||++++|+.++.+++.        .|+++|||+||+.+++  ||+|||+|||++||++   |
T Consensus         1 ~~yIy~LP~~v~~~Lc~iLD~~~~W~~~~~a~~i--------~~d~~~iR~~e~~~~~--~G~SpT~eLL~~Wg~~---N   67 (111)
T 3mop_K            1 ACYIYQLPSWVLDDLCRNMDALSEWDWMEFASYV--------ITDLTQLRKIKSMEWV--QGVSITRELLWWWGMR---Q   67 (111)
T ss_dssp             CCBGGGSCHHHHHHHTTTTTTSCHHHHHHHHTTT--------TCCHHHHHHHHHGGGS--TTCCHHHHHHHHHHTT---T
T ss_pred             CcchhhCCHHHHHHHHHHcCCCCcHHHHHHHHHh--------hccHHHHHHHHHHHhh--cCCCcHHHHHHHHHhc---C
Confidence            5899999999999999999999999877666542        2479999999999876  8999999999999987   9


Q ss_pred             CCHHHHHHHHHhcccccccccccccc
Q psy5603          90 PRLSDLIMFLKKAELHQAARYVEVDV  115 (455)
Q Consensus        90 ~~~~~l~~~l~~~~l~~~~~~~~~~~  115 (455)
                      +||+||+++|.++++++|++++.+..
T Consensus        68 ~TV~eL~~lL~~l~l~rA~~li~~~~   93 (111)
T 3mop_K           68 ATVQQLVDLLCRLELYRAAQIILNWK   93 (111)
T ss_dssp             CBSHHHHHTTTTTSCHHHHTTTTSCC
T ss_pred             CcHHHHHHHHHHcccHhHHHHHhccC
Confidence            99999999999999999999886543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.6e-25  Score=215.70  Aligned_cols=159  Identities=17%  Similarity=0.115  Sum_probs=120.1

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhh----hh-hhhHHHHHHHHHHHhhCCccceee
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTE----AA-MIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      ..+|.+++.||+|+||.||+|.+.+|+.||||+++..............    .+ ......+.+|++++++++  | ++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            3456677999999999999999976899999999754321111000000    00 012456899999999999  5 77


Q ss_pred             ecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         244 LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       244 l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      +.+++..+..|+||||++||+|.+ +..         .....++.|++.||.|||+  +||+||||||+|||++ ++.+|
T Consensus       166 v~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          166 VPKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             SCCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE-TTEEE
T ss_pred             cCeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHHEEEE-CCcEE
Confidence            777666677899999999999988 421         2244799999999999999  8899999999999999 99999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCccccc
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH  359 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  359 (455)
                      |+|||+++.                +..|+|||.+.
T Consensus       233 l~DFG~a~~----------------~~~~~a~e~l~  252 (282)
T 1zar_A          233 IIDFPQSVE----------------VGEEGWREILE  252 (282)
T ss_dssp             ECCCTTCEE----------------TTSTTHHHHHH
T ss_pred             EEECCCCeE----------------CCCCCHHHHHH
Confidence            999998763                23467888764

>1d2z_A Death domain of pelle; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 PDB: 1ik7_A 1ygo_A

Probab=99.90  E-value=1.3e-24  Score=174.45  Aligned_cols=96  Identities=25%  Similarity=0.424  Sum_probs=85.0

Q ss_pred             cCCCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhh-
Q psy5603           4 ESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEW-   82 (455)
Q Consensus         4 ~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w-   82 (455)
                      ++.+++++|||.||++++++||++|||++.|+++|..++         +|+. +|+.||++++   +|+|||++||++| 
T Consensus         4 ~~~~~~~~~i~~Lp~~vr~~L~~~LD~~~~W~~la~~~m---------~~~~-ev~~ir~~~~---~~~SPT~~LL~~W~   70 (108)
T 1d2z_A            4 MSHLDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATAVK---------LYPD-QVEQISSQKQ---RGRSASNEFLNIWG   70 (108)
T ss_dssp             ---CCCCCBGGGSCHHHHHHHHHHHHHHTCHHHHHHHTT---------CCHH-HHHHHHHHHH---TTCCHHHHHHHHHH
T ss_pred             cccCCCCChHHhCCHHHHHHHHHHhCCcchHHHHHHHHc---------CCch-HHHHHHHHHh---hCCChHHHHHHHhc
Confidence            366889999999999999999999999999999999877         5666 8888888877   5999999999999 


Q ss_pred             hcCCCCCCCHHHHHHHHHhcccccccccccccc
Q psy5603          83 GTSGRRRPRLSDLIMFLKKAELHQAARYVEVDV  115 (455)
Q Consensus        83 ~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~  115 (455)
                      |++   |+||++|+++|.+.++++|++++.+.+
T Consensus        71 g~~---n~TV~~L~~lL~k~~l~~a~~~L~~~V  100 (108)
T 1d2z_A           71 GQY---NHTVQTLFALFKKLKLHNAMRLIKDYV  100 (108)
T ss_dssp             HHH---CCBHHHHHHHHHHTTCHHHHHHTGGGS
T ss_pred             CCC---CCcHHHHHHHHHHcchHHHHHHHHHHh
Confidence            886   999999999999999999999876543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=2.3e-21  Score=184.01  Aligned_cols=150  Identities=17%  Similarity=0.208  Sum_probs=107.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEE-cCCcE--EEEEEeecccCcCCCCCc-----------hhhhhhhhHHHHHHHHHHHhhC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKL-KNGME--IAVKTLENNANYSSSNSD-----------NTEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~--vAvK~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      +|++.+.||+|+||.||+|.+ .+|+.  ||||+++...........           ...........+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            345668999999999999998 56888  999998654211000000           0000112234688999999999


Q ss_pred             Cccce--eeecccccCceeEEEEEeccC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCeeecC
Q psy5603         237 KHVNL--LRLLGLCNNIMNCIVYEYMCN-G----SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH-SLSKPIIHRD  308 (455)
Q Consensus       237 ~h~ni--v~l~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH-~~~~~iiH~D  308 (455)
                      .|+++  ..++.   ....++||||+.+ |    +|.+....      .++..+..++.|++.||.||| +  .||+|||
T Consensus       128 ~~~~i~~p~~~~---~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~--~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYT---YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE--AELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEE---EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT--SCEECSS
T ss_pred             HhCCCCCCeEEE---cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH--CCEEeCC
Confidence            88864  22332   2466899999942 4    77765432      234567889999999999999 8  7899999


Q ss_pred             CCCCcEEEcCCCceEEeeccccccc
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=3.8e-19  Score=176.61  Aligned_cols=153  Identities=14%  Similarity=0.091  Sum_probs=101.3

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCch--------h-hhhhhhHHHHHHHHHHHhhCCcc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDN--------T-EAAMIPILLFENEVQTLSQCKHV  239 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~--------~-~~~~~~~~~~~~E~~~l~~l~h~  239 (455)
                      .-+|+++..||+|+||.||+|...+|+.||||+++............        . ....+.......|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34578889999999999999999889999999987542211100000        0 00001111123455555555333


Q ss_pred             ceeeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         240 NLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       240 niv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++. ....+.....++||||+.|++|.++..       .  .....++.|++.+|.+||+  .|||||||||.|||++++
T Consensus       174 gv~-vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          174 GFP-VPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAK--HGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             TCS-CCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEEEE
T ss_pred             CCC-CCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeCC
Confidence            321 111111234479999999988865321       1  2345688999999999999  889999999999999887


Q ss_pred             C----------ceEEeeccccccc
Q psy5603         320 F----------VPKLGDFGIVKMS  333 (455)
Q Consensus       320 ~----------~~kl~DFGla~~~  333 (455)
                      |          .+.|+||+-+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            7          3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=9.4e-12  Score=117.45  Aligned_cols=136  Identities=13%  Similarity=0.080  Sum_probs=103.1

Q ss_pred             CCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-ce
Q psy5603         175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      ...+|.|+++.||++... ++.+++|+........             ...+.+|+.+++.+. +.++.++++++.+ +.
T Consensus        19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-------------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-------------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-------------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            366888899999999865 6899999986432111             112788999998884 5677778887766 78


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-------------------------------  301 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-------------------------------  301 (455)
                      .|+||||++|.+|.+.+.        +......++.+++.+|..||+..                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             eEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            899999999999987531        11223467889999999999820                               


Q ss_pred             --------------------------CCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         302 --------------------------KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 --------------------------~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                                ..++|||++|.|||+++++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                      3489999999999998766677999997653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.3e-11  Score=115.81  Aligned_cols=127  Identities=17%  Similarity=0.136  Sum_probs=92.4

Q ss_pred             CcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce--eeecccccC-ceeEE
Q psy5603         179 GEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGLCNN-IMNCI  255 (455)
Q Consensus       179 G~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-~~~~l  255 (455)
                      +.|..+.||++...+|..+++|......                ...+.+|+.+++.+.+.++  .+++++..+ +..++
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT----------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc----------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            4566699999987667889999975321                1127789999988865454  447776655 66799


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------
Q psy5603         256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS----------------------------------  301 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~----------------------------------  301 (455)
                      ||||++|.+|.  ...      .+   ...++.+++..|..||+..                                  
T Consensus        93 v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           93 LLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            99999998884  211      12   2256777788888888631                                  


Q ss_pred             ----------------------CCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         302 ----------------------KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ----------------------~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                            ..++|||++|.|||+++++.+.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  1299999999999998877777999997653

>1wmg_A Netrin receptor UNC5H2; six helix bundle, death domain, apoptosis, structural genomi NPPSFA; 2.10A {Mus musculus} SCOP: a.77.1.2

Probab=99.22  E-value=9.4e-12  Score=99.72  Aligned_cols=83  Identities=12%  Similarity=0.211  Sum_probs=72.6

Q ss_pred             eeecCHHHHHHhhhhcCC----cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCC
Q psy5603          13 IRHLKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        13 i~~l~~~~~~~l~~~ld~----~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      +++||+.++++||.+||+    .++|+.||..+          .|+. +|+.|+       ++.|||..||+.|.+++..
T Consensus         9 ~~~Lp~~~r~~L~~lLD~~~~~g~dWr~LA~~L----------g~~~-~i~~~~-------~~~SPt~~LL~~W~~~~~~   70 (103)
T 1wmg_A            9 AFKIPLSIRQKICSSLDAPNSRGNDWRLLAQKL----------SMDR-YLNYFA-------TKASPTGVILDLWEARQQD   70 (103)
T ss_dssp             CCCCCHHHHHHHHHHHHCGGGTTSSHHHHHHHT----------TCGG-GHHHHH-------TSSCHHHHHHHHHHHHCCS
T ss_pred             cccCCHHHHHHHHHHhCcCCCCccCHHHHHHHc----------CChH-HHHHHH-------cCCCHHHHHHHHHHHhcCC
Confidence            789999999999999998    45799999963          4556 899998       5789999999999987656


Q ss_pred             CCCHHHHHHHHHhcccccccccccc
Q psy5603          89 RPRLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                      ++||++|+.+|...+...|++.+..
T Consensus        71 ~~tv~~L~~~L~~mgR~Da~~~L~~   95 (103)
T 1wmg_A           71 DGDLNSLASALEEMGKSEMLVAMAT   95 (103)
T ss_dssp             TTTHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCcHHHHHHHHHHcCCHHHHHHHHc
Confidence            8999999999999999999987654

>3mop_A Myeloid differentiation primary response protein; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens}

Probab=99.17  E-value=3.2e-11  Score=97.19  Aligned_cols=82  Identities=21%  Similarity=0.369  Sum_probs=70.4

Q ss_pred             ceeeecCHHHHHHhhhhcCCcc----hHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCC
Q psy5603          11 IEIRHLKQYVVHELGIILNERD----DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~----~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      .+++.|+++++++||.+|||.+    +|+.+|..          ..|+..+|+.||       +.+|||..||..|.++ 
T Consensus         2 ~pl~~L~~~~R~kL~~~LDp~~~~g~dWr~LA~~----------Lg~~~~~I~~fe-------~~~sPT~~lL~~W~~r-   63 (110)
T 3mop_A            2 LPLAALNMRVRRRLSLFLNVRTQVAADWTALAEE----------MDFEYLEIRQLE-------TQADPTGRLLDAWQGR-   63 (110)
T ss_dssp             CCGGGSCHHHHHHHHHHHTSCCSSSCCHHHHHTT----------TTCCHHHHHHHT-------SSSSHHHHHHHHHHSS-
T ss_pred             CChhhCCHHHHHHHHHHcCCCCCccccHHHHHHH----------cCCCHHHHHHHh-------CCCCcHHHHHHHHhcC-
Confidence            3678999999999999999976    99999984          478888999998       4689999999999876 


Q ss_pred             CCCCCHHHHHHHHHhcccccccccc
Q psy5603          87 RRRPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                       .++||++|+.+|...+..-++..+
T Consensus        64 -~~aTVg~L~~~L~~i~R~Dv~~~l   87 (110)
T 3mop_A           64 -PGASVGRLLELLTKLGRDDVLLEL   87 (110)
T ss_dssp             -SSCSHHHHHHHHHHHTCHHHHTTS
T ss_pred             -CCCcHHHHHHHHHHcCCHHHHHHH
Confidence             589999999999988776655443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=1.5e-10  Score=114.51  Aligned_cols=140  Identities=15%  Similarity=0.276  Sum_probs=104.0

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEee--cccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC--ccceeeecccccCc
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLE--NNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  251 (455)
                      +.|+.|.++.||+.... +..+++|+..  .......            ...+.+|+.+++.+.  +..+.+++.++.+.
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~------------~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPS------------AHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCc------------HHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            67899999999999876 4688899875  3221100            123778999998886  34577778777653


Q ss_pred             ----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------
Q psy5603         252 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL---------------------------  300 (455)
Q Consensus       252 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---------------------------  300 (455)
                          ..++||||++|.++.+..     ...++..++..++.+++..|..||+.                           
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence                478999999998875411     23478888999999999999999972                           


Q ss_pred             -----------------------------CCCeeecCCCCCcEEEcCCCc--eEEeeccccccc
Q psy5603         301 -----------------------------SKPIIHRDVKSANVLLDENFV--PKLGDFGIVKMS  333 (455)
Q Consensus       301 -----------------------------~~~iiH~Dikp~NILl~~~~~--~kl~DFGla~~~  333 (455)
                                                   ...++|||+++.|||++.++.  +.|+||+.+...
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                         145999999999999997753  689999988754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=5.5e-10  Score=107.86  Aligned_cols=180  Identities=20%  Similarity=0.154  Sum_probs=120.6

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccc--eeeecccccC--
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVN--LLRLLGLCNN--  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~--  250 (455)
                      +.++.|....||+..    ..+++|+....               .....+.+|..+++.+. +..  +.+++.+...  
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~---------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~   86 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS---------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE   86 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH---------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc---------------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC
Confidence            568999999999863    56899986422               01345888999998873 322  2334443322  


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS---------------------------  301 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---------------------------  301 (455)
                        ...|+||++++|.+|.+....     .++..++..++.+++..+..||+..                           
T Consensus        87 ~~~~~~~vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (304)
T 3sg8_A           87 TYQMSFAGFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL  161 (304)
T ss_dssp             SCSCSCEEEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcceEEEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence              245899999999998764432     3677888888889998888888621                           


Q ss_pred             -----------------------------CCeeecCCCCCcEEEcC--CCceEEeecccccccccCCcceeeeccCCCCC
Q psy5603         302 -----------------------------KPIIHRDVKSANVLLDE--NFVPKLGDFGIVKMSETSNMKTMYTENLTGTR  350 (455)
Q Consensus       302 -----------------------------~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~  350 (455)
                                                   ..++|||++|.||++++  ...+.|+||+.+.........       ....
T Consensus       162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-------~~~~  234 (304)
T 3sg8_A          162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-------ISLM  234 (304)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-------HTTC
T ss_pred             cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-------HHHH
Confidence                                         24799999999999998  567889999988754321100       0000


Q ss_pred             CC---CCccccc------C---------CCCcccchHHHHHHHHHHHcCCCCCC
Q psy5603         351 PY---MPPEAMH------C---------QISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       351 ~Y---~aPE~~~------~---------~~~~~sDv~SlGvvl~elltG~~p~~  386 (455)
                      .+   ..|+...      +         ......+.|++|.++|.+.+|..+|.
T Consensus       235 ~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          235 EDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             hhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11   1222110      1         11223689999999999999987764

>2g7r_A Mucosa-associated lymphoid tissue lymphoma transl protein 1; death domain, chromosomal translocation, hydrolase; 2.70A {Homo sapiens}

Probab=98.99  E-value=5.3e-10  Score=88.12  Aligned_cols=97  Identities=15%  Similarity=0.276  Sum_probs=74.5

Q ss_pred             CCCceeeecCHHHHHHhhhhcCCc---chHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhc
Q psy5603           8 TEDIEIRHLKQYVVHELGIILNER---DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGT   84 (455)
Q Consensus         8 ~~~~~i~~l~~~~~~~l~~~ld~~---~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~   84 (455)
                      .++.-|..|+-.++++||++||..   .+|+++|..+--+  .  -.|++..++..+---+-.  ++.||+..||+-|+.
T Consensus        16 ~~~~~l~~L~e~~L~~Lc~lLD~~~~~kGWrkLAe~l~~~--~--~fr~S~~~l~~cslkvle--~~gSPSr~LL~~~~~   89 (117)
T 2g7r_A           16 PRGSTLNRLREPLLRRLSELLDQAPEGRGWRRLAELAGSR--G--RLRLSCLDLEQCSLKVLE--PEGSPSLCLLKLMGE   89 (117)
T ss_dssp             ----CGGGSCHHHHHHHHHHHTCC----CHHHHHHHCC----------CCHHHHHHHHGGGGS--TTCCHHHHHHHHHHH
T ss_pred             CCCCChhhCCHHHHHHHHHHHcCCCcCCCHHHHHHHhccc--c--ccccChHHhhhhhhhhhc--cCCChHHHHHHHHHH
Confidence            345778899999999999999986   7999999998744  2  226677666666522222  899999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcccccccccccc
Q psy5603          85 SGRRRPRLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        85 ~~~~~~~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                      +   ++|+.+|+++|......+|.+++.+
T Consensus        90 ~---g~Tl~~L~~~Lq~mg~~EAi~~L~~  115 (117)
T 2g7r_A           90 K---GCTVTELSDFLQAMEHTEVLQLLSP  115 (117)
T ss_dssp             T---TCCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred             c---CCcHHHHHHHHHHhccHHHHHHhcC
Confidence            8   8999999999999999999988754

>2dbf_A Nuclear factor NF-kappa-B P105 subunit; apoptosis, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.73  E-value=1.2e-08  Score=80.50  Aligned_cols=84  Identities=12%  Similarity=0.214  Sum_probs=69.3

Q ss_pred             CceeeecCHHHHHHhhhhcCC---cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCC
Q psy5603          10 DIEIRHLKQYVVHELGIILNE---RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus        10 ~~~i~~l~~~~~~~l~~~ld~---~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      .--+..||..++++||.+||+   ..+|+.+|..+--+          - -|+.||       +..|||..||+.|... 
T Consensus         6 ~~~l~~L~~~~r~kL~~lLd~~~~~~dWr~LAe~Lg~~----------~-li~~f~-------~~~SPt~~LL~~we~~-   66 (100)
T 2dbf_A            6 SGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLG----------I-LNNAFR-------LSPAPSKTLMDNYEVS-   66 (100)
T ss_dssp             CCSCTTSCHHHHHHHHHHHTSCCTTSSHHHHHHHHTCG----------G-GHHHHH-------HSSCHHHHHHHHHHHT-
T ss_pred             cchhhhCCHHHHHHHHHHhCCCCCCCCHHHHHHHHCcH----------H-HHHHHh-------cCCChHHHHHHHHHhC-
Confidence            344678999999999999995   56999999987632          2 377777       4669999999999886 


Q ss_pred             CCCCCHHHHHHHHHhccccccccccccc
Q psy5603          87 RRRPRLSDLIMFLKKAELHQAARYVEVD  114 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l~~~~~~~~~~  114 (455)
                        ++||++|+++|.......|+.++.+.
T Consensus        67 --~~tv~~L~~~L~~mgr~dav~~L~~~   92 (100)
T 2dbf_A           67 --GGTVRELVEALRQMGYTEAIEVIQAA   92 (100)
T ss_dssp             --CCCHHHHHHHHHHHTCSHHHHHHHHH
T ss_pred             --CCCHHHHHHHHHHhCcHHHHHHHHHH
Confidence              88999999999999988888766543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.56  E-value=3.5e-07  Score=88.26  Aligned_cols=134  Identities=18%  Similarity=0.169  Sum_probs=91.5

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcc---ceeeeccccc--C
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV---NLLRLLGLCN--N  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~--~  250 (455)
                      ..++.|....||+.    |..++||+....               .....+.+|..++..+.+.   .+.+.+.++.  +
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~---------------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~   85 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKSQ---------------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD   85 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESSH---------------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCCc---------------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC
Confidence            56889999999988    577899985311               0134588999999998652   2344455442  3


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------------------------------  300 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~------------------------------  300 (455)
                      +..++||++++|.+|.+....     .++..++..++.+++..|..||+.                              
T Consensus        86 g~~~~v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           86 GNPFVGYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             SCEEEEEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             CceEEEEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            567899999999988763221     234555555555555555555542                              


Q ss_pred             ----------------------------CCCeeecCCCCCcEEEcC---CCc-eEEeeccccccc
Q psy5603         301 ----------------------------SKPIIHRDVKSANVLLDE---NFV-PKLGDFGIVKMS  333 (455)
Q Consensus       301 ----------------------------~~~iiH~Dikp~NILl~~---~~~-~kl~DFGla~~~  333 (455)
                                                  ...++|||++|.|||++.   ++. ..|+||+.+...
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                        124699999999999987   455 489999987654

>1ngr_A P75 low affinity neurotrophin receptor; intracellular domain, death domain; NMR {Rattus norvegicus} SCOP: a.77.1.2

Probab=98.55  E-value=6.4e-08  Score=74.39  Aligned_cols=78  Identities=19%  Similarity=0.360  Sum_probs=66.5

Q ss_pred             eecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHH
Q psy5603          14 RHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLS   93 (455)
Q Consensus        14 ~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~   93 (455)
                      .+||+..++++|..|| ..+|+.+|...          .|+..+|+.|+.       ..|||..+|..|..+  ..+||+
T Consensus         5 ~~lp~~~r~~l~~lL~-g~dW~~LA~~L----------g~~~~~I~~~~~-------~~~pt~~lL~~W~~r--~~atv~   64 (85)
T 1ngr_A            5 SSLPLTKREEVEKLLN-GDTWRHLAGEL----------GYQPEHIDSFTH-------EACPVRALLASWGAQ--DSATLD   64 (85)
T ss_dssp             TTSCSTTTHHHHHHSC-TTHHHHHHHHT----------TCCHHHHHHHHH-------SSCHHHHHHHHGGGS--TTCBHH
T ss_pred             hhCCHHHHHHHHHHhC-cCCHHHHHHHc----------CCCHHHHHHHHc-------CCCHHHHHHHHHHhC--CCCCHH
Confidence            4799999999999999 99999999973          566789999983       458999999999986  359999


Q ss_pred             HHHHHHHhcccccccccc
Q psy5603          94 DLIMFLKKAELHQAARYV  111 (455)
Q Consensus        94 ~l~~~l~~~~l~~~~~~~  111 (455)
                      .|+..|.+.+...++..+
T Consensus        65 ~L~~aL~~igR~Dv~~~L   82 (85)
T 1ngr_A           65 ALLAALRRIQRADIVESL   82 (85)
T ss_dssp             HHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHcCcHHHHHHH
Confidence            999999988877666544

>2d96_A Nuclear factor NF-kappa-B P100 subunit; six helix bundle, processing, proteasome, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.46  E-value=3.8e-07  Score=72.55  Aligned_cols=83  Identities=12%  Similarity=0.181  Sum_probs=68.3

Q ss_pred             ceeeecCHHHHHHhhhhcC---CcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCC
Q psy5603          11 IEIRHLKQYVVHELGIILN---ERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld---~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      --+..|+..++++||.+||   +..+|++||...--           ...+..|+       +.-|||.-||+-|...  
T Consensus         7 ~~~~~L~~~~~~kLc~lLD~p~~~~~Wr~LA~~L~~-----------~~l~~~f~-------~~~SPt~~LL~l~E~~--   66 (109)
T 2d96_A            7 GPGLSLGDTALQNLEQLLDGPEAQGSWAELAERLGL-----------RSLVDTYR-------QTTSPSGSLLRSYELA--   66 (109)
T ss_dssp             SSSCSCCHHHHHHHHHHHSSSSCSSCHHHHHHHHTC-----------HHHHHHHH-------TSSCHHHHHHHHHHHT--
T ss_pred             cchhhCCHHHHHHHHHHcCCCCCCCCHHHHHHHhCh-----------hHHHHHHh-------CCCChHHHHHHHHHhc--
Confidence            3457899999999999999   45699999998652           23444554       4679999999999976  


Q ss_pred             CCCCHHHHHHHHHhccccccccccccc
Q psy5603          88 RRPRLSDLIMFLKKAELHQAARYVEVD  114 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~~~~  114 (455)
                       +++|.+|+++|.......|++++.+.
T Consensus        67 -ggtl~~L~~aL~~MG~~eav~~L~~~   92 (109)
T 2d96_A           67 -GGDLAGLLEALSDMGLEEGVRLLRGP   92 (109)
T ss_dssp             -TCCHHHHHHHHHHHTCHHHHHHHHCC
T ss_pred             -CCCHHHHHHHHHHhccHHHHHHhccc
Confidence             78999999999999999999887653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=1.2e-06  Score=82.51  Aligned_cols=133  Identities=20%  Similarity=0.171  Sum_probs=92.0

Q ss_pred             ccCcCCCe-EEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-ce
Q psy5603         177 KLGEGQFG-TVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  252 (455)
Q Consensus       177 ~LG~G~fg-~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      .+..|..| .||+..... +..+++|+-....                ...+.+|...|+.+. +--+.++++++.+ +.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~----------------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~   94 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV----------------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD   94 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH----------------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC----------------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCe
Confidence            34445444 689887653 5779999865321                234778888888774 3235566777666 77


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-------------------------------  301 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-------------------------------  301 (455)
                      .++||++++|.++.+.....       ......++.+++..|..||+..                               
T Consensus        95 ~~lvme~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (272)
T 4gkh_A           95 AWLLTTAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF  167 (272)
T ss_dssp             EEEEEECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred             EEEEEEeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence            89999999999987765431       1223446666777777777510                               


Q ss_pred             -------------------------CCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         302 -------------------------KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 -------------------------~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                               ..++|||+++.|||+++++.+-|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                     0279999999999999887778999997654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=1.7e-06  Score=86.35  Aligned_cols=80  Identities=18%  Similarity=0.148  Sum_probs=48.3

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccC-cCCCCCchhhhhhhhHHHHHHHHHHHhhCCc--ccee-eecccccC
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNAN-YSSSNSDNTEAAMIPILLFENEVQTLSQCKH--VNLL-RLLGLCNN  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~  250 (455)
                      +.||.|.++.||++... +++.|+||....... ....       .......+..|.++++.+..  +..+ +++.+ ..
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~-------~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~  107 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-------WPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT  107 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC--------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC-------CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cC
Confidence            57999999999999754 368899998753221 0000       00112336678888877632  3333 44443 33


Q ss_pred             ceeEEEEEeccCC
Q psy5603         251 IMNCIVYEYMCNG  263 (455)
Q Consensus       251 ~~~~lV~e~~~~g  263 (455)
                      ...++|||+++|.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            4568999999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.31  E-value=1.5e-06  Score=85.40  Aligned_cols=81  Identities=5%  Similarity=0.015  Sum_probs=51.6

Q ss_pred             Ccc-CcCCCeEEEEEEEc-------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc---cceeee
Q psy5603         176 NKL-GEGQFGTVYYGKLK-------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH---VNLLRL  244 (455)
Q Consensus       176 ~~L-G~G~fg~Vy~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l  244 (455)
                      +.| +.|....+|+....       ++..+++|............          ...+.+|+.+++.+..   ..+.++
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----------~~~~~~E~~~l~~L~~~~~vpvP~v   95 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----------TYRLDHQFEVIRLVGELTDVPVPRV   95 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----------CCCHHHHHHHHHHHHHHCCSCCCCE
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----------hhHHHHHHHHHHHHhhcCCCCCCcE
Confidence            457 88999999998764       25788999865432000000          0126678888877742   245566


Q ss_pred             cccccCc----eeEEEEEeccCCCHH
Q psy5603         245 LGLCNNI----MNCIVYEYMCNGSLY  266 (455)
Q Consensus       245 ~~~~~~~----~~~lV~e~~~~gsL~  266 (455)
                      +.++.+.    ..++||||++|.++.
T Consensus        96 ~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           96 RWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             EEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             EEEccCCCccCCceEEEEecCCCChh
Confidence            7666543    468999999887653

>3g5b_A Netrin receptor UNC5B; ZU5, death domain, UPA, apoptosis, developmental protein, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; 2.00A {Rattus norvegicus}

Probab=98.31  E-value=3.4e-07  Score=90.33  Aligned_cols=83  Identities=13%  Similarity=0.238  Sum_probs=69.2

Q ss_pred             eeeecCHHHHHHhhhhcCC----cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCC
Q psy5603          12 EIRHLKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        12 ~i~~l~~~~~~~l~~~ld~----~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      +-.+||+.++++||..||+    .++|+.||..+-=+       +    .|..|+       ++.|||..||+.|..++.
T Consensus       314 ~~f~Lp~~~r~~L~~lLd~~~~~g~DWr~LA~~Lgl~-------~----~i~~f~-------~~~sPT~~LL~~We~~~~  375 (405)
T 3g5b_A          314 YAFKIPLSIRQKICNSLDAPNSRGNDWRLLAQKLSMD-------R----YLNYFA-------TKASPTGVILDLWEARQQ  375 (405)
T ss_dssp             TTCSSCHHHHHHHHHHHSSCCTTSTTHHHHHHHTTCC-------T----TTHHHH-------TSSCHHHHHHHHHHHHHT
T ss_pred             ccccCCHHHHHHHHHHhCCCCCCCCCHHHHHHHcCcH-------H----HHHHHh-------cCCCcHHHHHHHHHhhCC
Confidence            4568999999999999997    46999999987632       2    266666       589999999999987766


Q ss_pred             CCCCHHHHHHHHHhccccccccccc
Q psy5603          88 RRPRLSDLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~~  112 (455)
                      .++||++|.++|.+.....++..+.
T Consensus       376 ~~~tl~~L~~~L~emgR~D~~~~l~  400 (405)
T 3g5b_A          376 DDGDLNSLASALEEMGKSEMLVAMT  400 (405)
T ss_dssp             TTCCHHHHHHHHHHTTCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCHHHHHhhc
Confidence            6889999999999999888877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.18  E-value=5.3e-06  Score=80.56  Aligned_cols=31  Identities=29%  Similarity=0.309  Sum_probs=27.7

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++|||+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            6799999999999998888999999997653

>2ib1_A Death domain containing membrane protein nradd; apoptosis, NOGO, FADD; NMR {Mus musculus}

Probab=98.12  E-value=2.3e-06  Score=66.44  Aligned_cols=79  Identities=15%  Similarity=0.238  Sum_probs=66.2

Q ss_pred             CHHHHHHhhhhcCCcc---hHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHH
Q psy5603          17 KQYVVHELGIILNERD---DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLS   93 (455)
Q Consensus        17 ~~~~~~~l~~~ld~~~---~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~   93 (455)
                      |..-++++|.+||++.   +|+.||...          .|+..+|+.|+       ..-+||..+|..|-++...++||+
T Consensus         1 p~~~r~~v~~ll~~~~~G~dW~~LA~~L----------g~~~~~I~~i~-------~~~~~~~~lL~~W~~r~g~~ATv~   63 (91)
T 2ib1_A            1 PQQQQEEVQRLLMMGEPAKGWQELAGHL----------GYQAEAVETMA-------CDQMPAYTLLRNWAAQEGNRATLR   63 (91)
T ss_dssp             CCHHHHTTHHHHTTTCCSSTHHHHHHHH----------TCCHHHHHHHT-------TSSCHHHHHHHHTTSSSSSTTSTT
T ss_pred             ChHHHHHHHHHhcCCCCCccHHHHHHHc----------CCCHHHHHHHH-------hcCcHHHHHHHHHHhccCCCCcHH
Confidence            5567899999999854   999999873          57788999998       356889999999988766689999


Q ss_pred             HHHHHHHhccccccccccc
Q psy5603          94 DLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        94 ~l~~~l~~~~l~~~~~~~~  112 (455)
                      .|+..|.+.....++..+.
T Consensus        64 ~L~~aL~~i~R~Di~~~L~   82 (91)
T 2ib1_A           64 VLEDALAAIGREDVVQVLS   82 (91)
T ss_dssp             HHHHHHHTTTCHHHHHHHT
T ss_pred             HHHHHHHHcCHHHHHHHHh
Confidence            9999999998877776654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.98  E-value=1.9e-05  Score=75.20  Aligned_cols=74  Identities=19%  Similarity=0.176  Sum_probs=51.3

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcc---ceeeecccccCce
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV---NLLRLLGLCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~  252 (455)
                      ..+|.|..+.||+.+..+|+.|+||+........             ...|..|...|+.+...   -+.+++++   +.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-------------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~   84 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-------------DGLFRAEALGLDWLGRSFGSPVPQVAGW---DD   84 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-------------TTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-------------hhHHHHHHHHHHHHHhhCCCCcceEEec---cC
Confidence            5689999999999999889999999865332100             12378899988887432   22333332   34


Q ss_pred             eEEEEEeccCCCH
Q psy5603         253 NCIVYEYMCNGSL  265 (455)
Q Consensus       253 ~~lV~e~~~~gsL  265 (455)
                      .++||||+.++..
T Consensus        85 ~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 RTLAMEWVDERPP   97 (288)
T ss_dssp             TEEEEECCCCCCC
T ss_pred             ceEEEEeecccCC
Confidence            4789999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.82  E-value=0.00015  Score=65.42  Aligned_cols=103  Identities=17%  Similarity=0.136  Sum_probs=69.4

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceee
Q psy5603         263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY  342 (455)
Q Consensus       263 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  342 (455)
                      -||.+.|...+.  |+++.++|.++.|.+.+|.-+-.. +.-..+=+.|..|+|..+|.+.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            489999988754  899999999999999998876210 1112333457999999999887664 1110           


Q ss_pred             eccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCC
Q psy5603         343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       343 ~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p  384 (455)
                          .....+.|||......+.+.=|||||++||..+--..|
T Consensus        98 ----~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence                11234678987755667788999999999999974444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=0.0002  Score=71.88  Aligned_cols=77  Identities=13%  Similarity=0.105  Sum_probs=46.2

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCC----CCcccchHHHHHHHHH
Q psy5603         302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLE  377 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~sDv~SlGvvl~e  377 (455)
                      ..++|||++|.|||++.++ ++|+||+.+...............  -...|++|+.....    .....++.+....+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            6799999999999999877 999999988765422100000000  01235555533211    1223455677777777


Q ss_pred             HHcC
Q psy5603         378 LLTG  381 (455)
Q Consensus       378 lltG  381 (455)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7665

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=0.00018  Score=69.28  Aligned_cols=162  Identities=12%  Similarity=0.054  Sum_probs=86.6

Q ss_pred             eeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH
Q psy5603         154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      ++..++......|..... ...+.|+.|....+|+....+| .+++|.......               ...+..|+.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~-~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---------------~~~l~~e~~~l   69 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSL-TSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---------------KNDLPFFLGLM   69 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCE-EEEEEECC---EEEEEEEESSC-CEEEEEECC------------------CCHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCcc-eEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---------------HHHHHHHHHHH
Confidence            455666666655543110 1124578888899999987654 788998864210               01144566666


Q ss_pred             hhCCccc--eeeecccc-------cCceeEEEEEeccCCCHH--------------HHHhhcCC--CCC----C---CHH
Q psy5603         234 SQCKHVN--LLRLLGLC-------NNIMNCIVYEYMCNGSLY--------------DRLARVNN--TPP----L---DSN  281 (455)
Q Consensus       234 ~~l~h~n--iv~l~~~~-------~~~~~~lV~e~~~~gsL~--------------~~l~~~~~--~~~----l---~~~  281 (455)
                      ..+...+  +.+++...       .++..++|++|++|.++.              ..++....  ..+    .   .|.
T Consensus        70 ~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~  149 (322)
T 2ppq_A           70 QHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWK  149 (322)
T ss_dssp             HHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHH
T ss_pred             HHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHH
Confidence            6553222  22233211       124568999999886531              11222111  001    1   122


Q ss_pred             HHHH------------HHHHHHHHHHHHHc-----CCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         282 KRYS------------IALGVAEALHYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       282 ~~~~------------i~~~i~~gl~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ....            +...+...+..++.     ...+++|+|+++.|||+++++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          150 VLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            2110            01113444555542     124699999999999999876668999997654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.60  E-value=0.00052  Score=66.10  Aligned_cols=135  Identities=15%  Similarity=0.160  Sum_probs=87.0

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC---ccceeeecccccC-c
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGLCNN-I  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~-~  251 (455)
                      ..|+.|....+|+.... +..+++|+.....                ...|..|...|+.+.   ...+.+++.++.. +
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~----------------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g  104 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERSY----------------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQG  104 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGGG----------------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCccc----------------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence            56899999999999864 6789999875320                344788988888774   2456677776655 6


Q ss_pred             eeEEEEEeccCCCHH--------H---HHhhcCCCC-------------------CCCHHHHH---HHH-----------
Q psy5603         252 MNCIVYEYMCNGSLY--------D---RLARVNNTP-------------------PLDSNKRY---SIA-----------  287 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~--------~---~l~~~~~~~-------------------~l~~~~~~---~i~-----------  287 (455)
                      ..++||||++|.++.        .   .|+.....+                   .-+|....   ++.           
T Consensus       105 ~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~  184 (312)
T 3jr1_A          105 HSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGL  184 (312)
T ss_dssp             EEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTC
T ss_pred             ceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            789999999988652        1   223321100                   12454321   111           


Q ss_pred             -----HHHHHH-HHHHH--cCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         288 -----LGVAEA-LHYLH--SLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       288 -----~~i~~g-l~~LH--~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                           ..++.. ...|.  .....++|+|+.+.|++++.++ +.|.||.
T Consensus       185 ~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          185 IFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             ChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                 111111 22342  2235699999999999999887 8899974

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.56  E-value=0.00034  Score=67.76  Aligned_cols=33  Identities=24%  Similarity=0.275  Sum_probs=28.4

Q ss_pred             CCeeecCCCCCcEEEcCC----CceEEeecccccccc
Q psy5603         302 KPIIHRDVKSANVLLDEN----FVPKLGDFGIVKMSE  334 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~~~  334 (455)
                      ..++|||+.+.|||++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            569999999999999874    689999999887654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.52  E-value=0.00022  Score=68.06  Aligned_cols=70  Identities=10%  Similarity=0.116  Sum_probs=42.8

Q ss_pred             CccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcccee-eecccccCceeE
Q psy5603         176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL-RLLGLCNNIMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~  254 (455)
                      +.|+.|....+|+.     ..+++|+.......   ..+           ..+|+.+++.+...++. +++++.. ...+
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~-----------r~~E~~~l~~l~~~g~~P~~~~~~~-~~~~   83 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YIN-----------RANEAVAAREAAKAGVSPEVLHVDP-ATGV   83 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC-------CCC-----------HHHHHHHHHHHHHTTSSCCEEEECT-TTCC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccc---eeC-----------HHHHHHHHHHHHHcCCCCceEEEEC-CCCE
Confidence            67999999999998     46888987543210   001           34577777666433333 4444433 3347


Q ss_pred             EEEEec-cCCCH
Q psy5603         255 IVYEYM-CNGSL  265 (455)
Q Consensus       255 lV~e~~-~~gsL  265 (455)
                      +|++|+ +|.+|
T Consensus        84 ~v~e~i~~g~~l   95 (301)
T 3dxq_A           84 MVTRYIAGAQTM   95 (301)
T ss_dssp             EEEECCTTCEEC
T ss_pred             EEEeecCCCccC
Confidence            899999 65554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.46  E-value=0.0016  Score=62.60  Aligned_cols=162  Identities=12%  Similarity=0.035  Sum_probs=85.9

Q ss_pred             eeHHHHHHHhcCCCCCCCCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHH
Q psy5603         154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      ++..++..+...+..... .....|+ |....||+....+|+.+++|.......      .        ...+..|..++
T Consensus        11 l~~~~i~~~l~~~g~~~~-~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~--------~~~~~~E~~~~   74 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVD-SGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------T--------ADQILEEHQFA   74 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCC-SCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------C--------HHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCCC-ceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC------C--------HHHHHHHHHHH
Confidence            444455554444422111 0113566 888899998876677899999863211      0        22355677776


Q ss_pred             hhCCccc--eeeeccc-----c-cCceeEEEEEeccCCCHH-----H------H---HhhcCC------CCCCCHHHH--
Q psy5603         234 SQCKHVN--LLRLLGL-----C-NNIMNCIVYEYMCNGSLY-----D------R---LARVNN------TPPLDSNKR--  283 (455)
Q Consensus       234 ~~l~h~n--iv~l~~~-----~-~~~~~~lV~e~~~~gsL~-----~------~---l~~~~~------~~~l~~~~~--  283 (455)
                      ..+....  +.+++..     . .++..++||++++|.++.     .      .   ++....      .+.+++...  
T Consensus        75 ~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~  154 (328)
T 1zyl_A           75 LQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLI  154 (328)
T ss_dssp             HHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTH
T ss_pred             HHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHh
Confidence            6663222  3333332     0 124557899999875432     1      1   111100      112222211  


Q ss_pred             --------------------HHHHHHHHHHHHHHHc--CCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         284 --------------------YSIALGVAEALHYLHS--LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       284 --------------------~~i~~~i~~gl~~LH~--~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                                          ...+..++..+.-+-.  ....++|||+++.|||++ + .+.|+||+.+...
T Consensus       155 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          155 EPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                                0111122222222111  124589999999999999 4 8999999877644

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.22  E-value=0.00079  Score=67.85  Aligned_cols=72  Identities=14%  Similarity=0.211  Sum_probs=47.3

Q ss_pred             CccCcCCCeEEEEEEEcC--------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce-eeecc
Q psy5603         176 NKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~  246 (455)
                      ..|+.|....||++...+        +..+++|+.... .      .        ...+.+|..++..+...++ .++++
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~------~--------~~~li~E~~~l~~L~~~g~~P~l~~  143 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E------T--------ESHLVAESVIFTLLSERHLGPKLYG  143 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C------C--------HHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C------c--------HHHHHHHHHHHHHHHhCCCCCcEEE
Confidence            568899999999998752        478999987321 0      0        0124468888887754444 44566


Q ss_pred             cccCceeEEEEEeccCCCH
Q psy5603         247 LCNNIMNCIVYEYMCNGSL  265 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL  265 (455)
                      .+.+   .+|++|++|.+|
T Consensus       144 ~~~~---g~v~e~l~G~~l  159 (429)
T 1nw1_A          144 IFSG---GRLEEYIPSRPL  159 (429)
T ss_dssp             EETT---EEEECCCCEEEC
T ss_pred             EeCC---CEEEEEeCCccc
Confidence            5544   389999986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.07  E-value=0.0027  Score=64.46  Aligned_cols=73  Identities=12%  Similarity=0.068  Sum_probs=46.4

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce-eeecccccCcee
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLGLCNNIMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~  253 (455)
                      ..|+.|-...+|+....+ +..+++|+......   ...+           -.+|..++..+...++ .++++++.+   
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~id-----------R~~E~~vl~~L~~~gl~P~ll~~~~~---  176 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIIN-----------REREKKISCILYNKNIAKKIYVFFTN---  176 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSC-----------HHHHHHHHHHHTTSSSBCCEEEEETT---
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcC-----------HHHHHHHHHHHHhcCCCCCEEEEeCC---
Confidence            568889999999998864 47888998743211   0000           2478888888865455 346665543   


Q ss_pred             EEEEEeccCCCH
Q psy5603         254 CIVYEYMCNGSL  265 (455)
Q Consensus       254 ~lV~e~~~~gsL  265 (455)
                      .+||+|++|.+|
T Consensus       177 G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEECCCSEEC
T ss_pred             eEEEEeeCCccC
Confidence            359999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.76  E-value=0.014  Score=56.48  Aligned_cols=32  Identities=19%  Similarity=0.248  Sum_probs=28.1

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ..++|+|+.+.||++++++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46999999999999998888999999877654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.66  E-value=0.0029  Score=62.10  Aligned_cols=31  Identities=19%  Similarity=0.306  Sum_probs=25.2

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ..++|+|+++.|||+++++ +.|+||..+...
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g  242 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGFN  242 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCCC
Confidence            3599999999999998665 899999876543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.63  E-value=0.0065  Score=59.99  Aligned_cols=140  Identities=14%  Similarity=0.109  Sum_probs=81.1

Q ss_pred             CccCcCCCeEEEEEEEc--------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce-eeecc
Q psy5603         176 NKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~  246 (455)
                      +.|..|-...+|+....        +++.|++|+.-...       ..       .....+|..+++.+.-.++ .++++
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-------~~-------~~~~~rE~~vl~~L~~~gv~P~ll~  121 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-------QG-------VDSLVLESVMFAILAERSLGPQLYG  121 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----------CC-------HHHHHHHHHHHHHHHHTTSSCCEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-------ch-------HHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            56788888899999864        24789999853211       00       2235588888877743333 44566


Q ss_pred             cccCceeEEEEEeccCCCHH--------------HHH---hhcCC--CCCC--CHHHHHHHHHHHHH-------------
Q psy5603         247 LCNNIMNCIVYEYMCNGSLY--------------DRL---ARVNN--TPPL--DSNKRYSIALGVAE-------------  292 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~--------------~~l---~~~~~--~~~l--~~~~~~~i~~~i~~-------------  292 (455)
                      ++.++   +||||++|.+|.              +.|   +...-  ..+.  -+.++..+..++..             
T Consensus       122 ~~~~g---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~  198 (379)
T 3feg_A          122 VFPEG---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE  198 (379)
T ss_dssp             EETTE---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred             EcCCc---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence            65553   899999876543              111   11110  1122  24555555544322             


Q ss_pred             ------HHHHH----HcC--CCCeeecCCCCCcEEEcCC----CceEEeecccccc
Q psy5603         293 ------ALHYL----HSL--SKPIIHRDVKSANVLLDEN----FVPKLGDFGIVKM  332 (455)
Q Consensus       293 ------gl~~L----H~~--~~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~  332 (455)
                            .+..|    ...  ...++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                  22333    221  2359999999999999876    7899999987654

>1wxp_A THO complex subunit 1; death domain, structural genomics, nuclear matrix, riken structural genomics/proteomics initiative, RSGI, transport protein; NMR {Homo sapiens}

Probab=95.52  E-value=0.011  Score=47.37  Aligned_cols=84  Identities=17%  Similarity=0.253  Sum_probs=64.1

Q ss_pred             cCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHH
Q psy5603          16 LKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDL   95 (455)
Q Consensus        16 l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l   95 (455)
                      +--..+..+++.|-  .+|++||-.+          .|+..+|+.||.. .+  .=+....++|..|-.++...+|+..|
T Consensus        16 ~~~~~~~~ia~~lg--~~Wk~LAr~L----------g~~~~~I~~ie~~-~~--~~~eq~~~mL~~W~~r~G~~AT~~~L   80 (110)
T 1wxp_A           16 VTGEQIEVFANKLG--EQWKILAPYL----------EMKDSEIRQIECD-SE--DMKMRAKQLLVAWQDQEGVHATPENL   80 (110)
T ss_dssp             CCHHHHHHHHHHHT--TTHHHHTTTT----------TCCHHHHHHHHHH-CS--SHHHHHHHHHHHHHHHHGGGCCHHHH
T ss_pred             cHHHHHHHHHHHHh--hhHHHHHHHh----------CCCHHHHHHHHHc-CC--CHHHHHHHHHHHHHHhhCcCcHHHHH
Confidence            34567778888884  7899999863          5678899999933 21  22356789999997665558999999


Q ss_pred             HHHHHhccccccccccccc
Q psy5603          96 IMFLKKAELHQAARYVEVD  114 (455)
Q Consensus        96 ~~~l~~~~l~~~~~~~~~~  114 (455)
                      +..|.+..+...++.+...
T Consensus        81 ~~AL~~~~~~dvae~l~~~   99 (110)
T 1wxp_A           81 INALNKSGLSDLAESLTND   99 (110)
T ss_dssp             HHHHHHTTCHHHHHHHHCC
T ss_pred             HHHHHHcCcHHHHHHHHHH
Confidence            9999999998888766443

>2yqf_A Ankyrin-1; death domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2yvi_A

Probab=94.87  E-value=0.038  Score=44.25  Aligned_cols=81  Identities=12%  Similarity=0.207  Sum_probs=60.8

Q ss_pred             HHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHH
Q psy5603          19 YVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMF   98 (455)
Q Consensus        19 ~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~   98 (455)
                      ..+..+|+.|-  .+|++||...          .|+..+|+.|+....+  .=+....++|..|-..+...+|+..|+..
T Consensus        19 ~~~~~ia~~lg--~~Wk~LAr~L----------g~s~~~I~~I~~~~p~--~~~eq~~~mL~~W~~~~g~~AT~~~L~~a   84 (111)
T 2yqf_A           19 MKMAVISEHLG--LSWAELAREL----------QFSVEDINRIRVENPN--SLLEQSVALLNLWVIREGQNANMENLYTA   84 (111)
T ss_dssp             HHHHHHHHHHT--TTHHHHHHHT----------TCCHHHHHHHHHHSCS--CHHHHHHHHHHHHHHHHTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHh--hhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHhhCCCchHHHHHHH
Confidence            35566777774  6999999874          5678899999954321  11334889999997665568999999999


Q ss_pred             HHhcccccccccccc
Q psy5603          99 LKKAELHQAARYVEV  113 (455)
Q Consensus        99 l~~~~l~~~~~~~~~  113 (455)
                      |.+..+...++.+..
T Consensus        85 L~~i~r~diae~l~~   99 (111)
T 2yqf_A           85 LQSIDRGEIVNMLEG   99 (111)
T ss_dssp             HHHTTCCHHHHHHSC
T ss_pred             HHHcCcHHHHHHHHH
Confidence            999998877765543

>2o71_A Death domain-containing protein cradd; raidd, apoptosis; 2.00A {Homo sapiens}

Probab=94.85  E-value=0.025  Score=45.53  Aligned_cols=85  Identities=14%  Similarity=0.137  Sum_probs=63.7

Q ss_pred             CCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcC
Q psy5603           6 IITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTS   85 (455)
Q Consensus         6 ~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~   85 (455)
                      .+.+..|.+.++-..+..||+.|-  .+|++||-..          .++..+|..|+....+  .=+....++|..|-.+
T Consensus        12 ~~~~~~~~~~~t~~~l~~Ia~~LG--~~Wk~LAR~L----------Glse~dId~I~~~~p~--dl~eq~~qmL~~W~~r   77 (115)
T 2o71_A           12 GIPSHILNSSPSDRQINQLAQRLG--PEWEPMVLSL----------GLSQTDIYRCKANHPH--NVQSQVVEAFIRWRQR   77 (115)
T ss_dssp             ----CGGGSCCCHHHHHHHHHHCC--TTHHHHHHHT----------TCCHHHHHHHHHHCTT--CHHHHHHHHHHHHHHH
T ss_pred             CCCchhccCCCCHHHHHHHHHHHh--hhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHH
Confidence            344556778888889999999984  8999999863          5678899999965432  1234577899999765


Q ss_pred             CCCCCCHHHHHHHHHhccc
Q psy5603          86 GRRRPRLSDLIMFLKKAEL  104 (455)
Q Consensus        86 ~~~~~~~~~l~~~l~~~~l  104 (455)
                      +...+|+..|+..|.+..+
T Consensus        78 ~G~~AT~~~L~~AL~~~~l   96 (115)
T 2o71_A           78 FGKQATFQSLHNGLRAVEV   96 (115)
T ss_dssp             HGGGCCHHHHHHHHHHTTC
T ss_pred             HCcCcHHHHHHHHHHHcCC
Confidence            5457999999999998775

>2of5_A Death domain-containing protein cradd; death domain complex, apoptosis; 3.20A {Homo sapiens}

Probab=94.81  E-value=0.025  Score=45.54  Aligned_cols=85  Identities=15%  Similarity=0.146  Sum_probs=63.2

Q ss_pred             CCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcC
Q psy5603           6 IITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTS   85 (455)
Q Consensus         6 ~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~   85 (455)
                      .+.+..|.+.++-..+..||+.|-  .+|++||-.          ..++..+|..|+....+  .=+....++|..|-.+
T Consensus        12 ~~~~~~~~~~~t~~~l~~Ia~~lG--~~Wk~LAR~----------LGlse~dId~I~~~~p~--~l~eq~~qmL~~W~~r   77 (114)
T 2of5_A           12 GIPSHILNSSPSDRQINQLAQRLG--PEWEPMVLS----------LGLSQTDIYRCKANHPH--NVQSQVVEAFIRWRQR   77 (114)
T ss_dssp             ----CCTTSCCCHHHHHHHHHTCC--STHHHHHHT----------TTCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHH
T ss_pred             CCCchhhcCCCCHHHHHHHHHHHh--hhHHHHHHH----------cCCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHH
Confidence            344556778888888999999984  899999985          35678899999965432  1234577899999765


Q ss_pred             CCCCCCHHHHHHHHHhccc
Q psy5603          86 GRRRPRLSDLIMFLKKAEL  104 (455)
Q Consensus        86 ~~~~~~~~~l~~~l~~~~l  104 (455)
                      +...+|+..|+..|.+..+
T Consensus        78 ~G~~AT~~~L~~AL~~~~l   96 (114)
T 2of5_A           78 FGKQATFQSLHNGLRAVEV   96 (114)
T ss_dssp             HGGGCCHHHHHHHHHHTTC
T ss_pred             HCcCcHHHHHHHHHHHcCC
Confidence            5457999999999988765

>3oq9_A Tumor necrosis factor receptor superfamily member; apoptosis, DISC, FAS; 6.80A {Mus musculus}

Probab=94.62  E-value=0.046  Score=41.44  Aligned_cols=75  Identities=19%  Similarity=0.099  Sum_probs=58.7

Q ss_pred             hhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q psy5603          24 LGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAE  103 (455)
Q Consensus        24 l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~~  103 (455)
                      +++.| +-.+|++||-.          ...+..+|..++....|  ...-...++|..|-...+..+++..|+..|.+..
T Consensus         6 ia~~~-~~~~wK~~~R~----------LGlse~~Id~I~~~~~~--d~~Eq~~qmL~~W~~~~g~~a~~~~Li~~Lr~~~   72 (86)
T 3oq9_A            6 IAEDM-TIQEAKKFARE----------NNIKEGKIDEIMHDSIQ--DTAEQKVQLLLCWYQSHGKSDAYQDLIKGLKKAE   72 (86)
T ss_dssp             HHHHS-CHHHHHHHHHT----------TTSCHHHHHHHHHTCTT--CCTTHHHHHHHHHHHHSCSSSHHHHHHHHHHHTT
T ss_pred             HHHHc-CHHHHHHHHHH----------cCCCHhHHHHHHHhCCC--ChHHHHHHHHHHHHHHhCcchHHHHHHHHHHHcc
Confidence            34444 35689999875          24567899999977655  4567789999999987777899999999999999


Q ss_pred             cccccccc
Q psy5603         104 LHQAARYV  111 (455)
Q Consensus       104 l~~~~~~~  111 (455)
                      +..+++.+
T Consensus        73 l~~~Ad~I   80 (86)
T 3oq9_A           73 CRRTLDKF   80 (86)
T ss_dssp             CSSHHHHH
T ss_pred             chhHHHHH
Confidence            88777654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.33  E-value=0.15  Score=50.98  Aligned_cols=140  Identities=14%  Similarity=0.181  Sum_probs=82.1

Q ss_pred             CccCcCCCeEEEEEEEcC--------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccce-eeecc
Q psy5603         176 NKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~  246 (455)
                      +.|..|-...+|+....+        +..|++++......   ...+           -.+|..+++.+...++ .++++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~id-----------R~~E~~~l~~L~~~gi~P~l~~  141 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYD-----------SKVELDVFRYLSNINIAPNIIA  141 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCC-----------HHHHHHHHHHHHHTTSSCCEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcC-----------HHHHHHHHHHHHhcCCCCCEEE
Confidence            567888899999998753        47899998643221   1111           3467777777643333 33444


Q ss_pred             cccCceeEEEEEeccCCCHHH--------------HH---hhc-------C---CCCCCCHHHHHHHHHHH---------
Q psy5603         247 LCNNIMNCIVYEYMCNGSLYD--------------RL---ARV-------N---NTPPLDSNKRYSIALGV---------  290 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~--------------~l---~~~-------~---~~~~l~~~~~~~i~~~i---------  290 (455)
                      .+.   .++||+|++|.+|..              .|   +..       .   ...+.-+.++..+..++         
T Consensus       142 ~~~---~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~  218 (424)
T 3mes_A          142 DFP---EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNF  218 (424)
T ss_dssp             EET---TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC-
T ss_pred             EcC---CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccch
Confidence            332   368999999866421              11   110       0   11222355444443322         


Q ss_pred             ----------HHHHHHHH--------------------cC--CCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         291 ----------AEALHYLH--------------------SL--SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       291 ----------~~gl~~LH--------------------~~--~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                                ...+..|.                    ..  ...++|+|+.+.||+ +.++.+.|+||..+...
T Consensus       219 ~~~~~~~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          219 QIDKELYSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             hhccccHHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence                      12223332                    11  135899999999999 88889999999877643

>3ezq_B Protein FADD; apoptosis, DISC, FAS, membrane,receptor, transmembrane; 2.73A {Homo sapiens} PDB: 1e3y_A 1e41_A 3oq9_H

Probab=93.91  E-value=0.071  Score=43.36  Aligned_cols=76  Identities=17%  Similarity=0.279  Sum_probs=56.3

Q ss_pred             HHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHHh
Q psy5603          22 HELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKK  101 (455)
Q Consensus        22 ~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~  101 (455)
                      ..+++.|-  .+|++||-.+          .++..+|..|+....+  .=+....++|..|-.+...++|+..|+..|.+
T Consensus        10 ~~Ia~~lG--~~Wk~LAR~L----------Glse~dId~Ie~~~p~--dl~eq~~~mL~~W~~r~G~~ATv~~L~~AL~~   75 (122)
T 3ezq_B           10 NVICDNVG--KDWRRLARQL----------KVSDTKIDSIEDRYPR--NLTERVRESLRIWKNTEKENATVAHLVGALRS   75 (122)
T ss_dssp             HHHHTTCC--TTHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHHCTTTCCHHHHHHHHHH
T ss_pred             HHHHHhhh--hhHHHHHHHh----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHhhCCCchHHHHHHHHHH
Confidence            34555554  8999999753          5678899999865421  01245778999998766679999999999999


Q ss_pred             cccccccccc
Q psy5603         102 AELHQAARYV  111 (455)
Q Consensus       102 ~~l~~~~~~~  111 (455)
                      ..+...++.+
T Consensus        76 i~~~diAe~I   85 (122)
T 3ezq_B           76 CQMNLVADLV   85 (122)
T ss_dssp             TTCHHHHHHH
T ss_pred             CCCHHHHHHH
Confidence            9887777654

>2of5_H Leucine-rich repeat and death domain-containing protein; death domain complex, apoptosis; 3.20A {Homo sapiens}

Probab=93.59  E-value=0.15  Score=41.14  Aligned_cols=82  Identities=15%  Similarity=0.192  Sum_probs=63.2

Q ss_pred             ecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCC-CCchHHHHHhhhcCC-CCCCCH
Q psy5603          15 HLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPE-RGCTDIFLDEWGTSG-RRRPRL   92 (455)
Q Consensus        15 ~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~-~s~t~~ll~~w~~~~-~~~~~~   92 (455)
                      .|.-..+..+|+.|-  .+|++||...          .++..+|+.|+....   .+ +.+..++|..|-.+. ...+|+
T Consensus        10 ~lt~~~l~~ia~~lg--~dWk~LAr~L----------g~s~~~I~~I~~~~~---~~l~eq~~~mL~~W~~~~g~~~Atv   74 (118)
T 2of5_H           10 FLTQSNLLSVAGRLG--LDWPAVALHL----------GVSYREVQRIRHEFR---DDLDEQIRHMLFSWAERQAGQPGAV   74 (118)
T ss_dssp             CCCHHHHHHHHHTCC--TTHHHHHHHT----------TCCHHHHHHHHHHTT---TCHHHHHHHHHHHHHHTTSSCSSHH
T ss_pred             CCCHHHHHHHHHHHh--hHHHHHHHHc----------CCCHHHHHHHHHHCC---CCHHHHHHHHHHHHHhccCCCCcHH
Confidence            355567788888885  5899999873          567889999996542   12 468899999997665 347999


Q ss_pred             HHHHHHHHhcccccccccc
Q psy5603          93 SDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        93 ~~l~~~l~~~~l~~~~~~~  111 (455)
                      ..|+..|.+..+...++.+
T Consensus        75 ~~L~~aL~~~~r~diae~l   93 (118)
T 2of5_H           75 GLLVQALEQSDRQDVAEEV   93 (118)
T ss_dssp             HHHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHHcCcHHHHHHH
Confidence            9999999998887666543

>1fad_A Protein (FADD protein); apoptosis, death domain; NMR {Mus musculus} SCOP: a.77.1.2

Probab=93.27  E-value=0.037  Score=43.28  Aligned_cols=78  Identities=18%  Similarity=0.264  Sum_probs=57.5

Q ss_pred             HHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHH
Q psy5603          20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      ....+++.|  ..+|++||-..          .++..+|+.|+....+  .=+....++|..|-......+|+..|+..|
T Consensus        16 ~~~~ia~~l--g~~Wk~Lar~L----------g~~~~~I~~I~~~~~~--d~~eq~~~mL~~W~~~~g~~At~~~L~~AL   81 (99)
T 1fad_A           16 AFDIVCDNV--GRDWKRLAREL----------KVSEAKMDGIEEKYPR--SLSERVRESLKVWKNAEKKNASVAGLVKAL   81 (99)
T ss_dssp             HHHHHHHHH--HHHHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHHHGGGGSHHHHHHHH
T ss_pred             HHHHHHHHH--hhhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHhccCCCCcHHHHHHHH
Confidence            345566666  48999999863          5678899999965432  224568889999976544589999999999


Q ss_pred             Hhcccccccccc
Q psy5603         100 KKAELHQAARYV  111 (455)
Q Consensus       100 ~~~~l~~~~~~~  111 (455)
                      .+..+...++.+
T Consensus        82 ~~~~~~~iae~i   93 (99)
T 1fad_A           82 RTCRLNLVADLV   93 (99)
T ss_dssp             HHHTCHHHHHHH
T ss_pred             HHCCcHHHHHHH
Confidence            998876666543

>2gf5_A FADD protein; death domain, death effector domain, apoptosis, death- inducing signaling complex; NMR {Homo sapiens} SCOP: a.77.1.2 a.77.1.4

Probab=91.25  E-value=0.27  Score=43.28  Aligned_cols=77  Identities=16%  Similarity=0.261  Sum_probs=57.8

Q ss_pred             HHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHH
Q psy5603          20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      ....+++.+-  .+|++||-..          .++..+|..|+....+  .=+....++|..|-.++...+|+..|+..|
T Consensus       100 ~~~~ia~~lg--~~Wk~Lar~L----------gl~~~~I~~I~~~~~~--d~~eq~~~mL~~W~~r~g~~At~~~L~~AL  165 (191)
T 2gf5_A          100 AFNVICDNVG--KDWRRLARQL----------KVSDTKIDSIEDRYPR--NLTERVRESLRIWKNTEKENATVAHLVGAL  165 (191)
T ss_dssp             HHHHHHHSCC--TTHHHHHHHT----------TCCHHHHHHHHHHSSS--CSHHHHHHHHHHHHHHTTTTCCHHHHHHHH
T ss_pred             HHHHHHHccc--hhHHHHHHHc----------CCCHHHHHHHHHhCCC--CHHHHHHHHHHHHHHhhCCCcHHHHHHHHH
Confidence            3445555553  8999999863          5678899999965432  234568899999987666789999999999


Q ss_pred             Hhccccccccc
Q psy5603         100 KKAELHQAARY  110 (455)
Q Consensus       100 ~~~~l~~~~~~  110 (455)
                      ....+...++.
T Consensus       166 ~~~~~~diae~  176 (191)
T 2gf5_A          166 RSCQMNLVADL  176 (191)
T ss_dssp             HHHTCHHHHHH
T ss_pred             HHcCcHHHHHH
Confidence            99887666653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.90  E-value=0.41  Score=42.96  Aligned_cols=83  Identities=8%  Similarity=-0.038  Sum_probs=59.5

Q ss_pred             CccceeeecccccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCeeecCCCCCcEE
Q psy5603         237 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH-YLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       237 ~h~niv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~-~LH~~~~~iiH~Dikp~NIL  315 (455)
                      .||++ +.---..++...+.|+.-+++-=...+..      ++...+++++..++.... ++++    -+|--++|+||+
T Consensus        48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEE
T ss_pred             cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEE
Confidence            67777 33222333565666665544422334443      788999999999998887 6665    678899999999


Q ss_pred             EcCCCceEEeecccc
Q psy5603         316 LDENFVPKLGDFGIV  330 (455)
Q Consensus       316 l~~~~~~kl~DFGla  330 (455)
                      ++.++.|+|...|+-
T Consensus       117 f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          117 FNRALEPFFLHVGVK  131 (219)
T ss_dssp             ECTTCCEEESCCEET
T ss_pred             EeCCCcEEEEEcCCc
Confidence            999999999988863

>1ich_A TNF-1, tumor necrosis factor receptor-1; death domain, apoptosis; NMR {Homo sapiens} SCOP: a.77.1.2

Probab=89.62  E-value=0.19  Score=39.92  Aligned_cols=82  Identities=18%  Similarity=0.201  Sum_probs=58.0

Q ss_pred             CHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCch---HHHHHhhhcCC-CCCCCH
Q psy5603          17 KQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCT---DIFLDEWGTSG-RRRPRL   92 (455)
Q Consensus        17 ~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t---~~ll~~w~~~~-~~~~~~   92 (455)
                      .+.++..+++.+- ...||+||-..-          .+..+|..+|...     ++...   -++|..|-... +..+||
T Consensus        12 ~~~~l~~i~d~v~-~~~WK~~aRkLG----------Lse~~Id~Ie~~~-----~r~l~Eq~yqmLr~W~~~~G~~~Atv   75 (112)
T 1ich_A           12 DPATLYAVVENVP-PLRWKEFVKRLG----------LSDHEIDRLELQN-----GRCLREAQYSMLATWRRRTPRREATL   75 (112)
T ss_dssp             -CHHHHHHHHHSC-STTHHHHHHHHT----------CCHHHHHHHHHHC-----CSCHHHHHHHHHHHHHHHSCCSSCHH
T ss_pred             chHHHHHHHHhCC-HHHHHHHHHHcC----------CCHHHHHHHHHHC-----cCChHHHHHHHHHHHHHhcCCCCCcH
Confidence            3455555666554 468999997643          3467999998553     33332   24899998665 468899


Q ss_pred             HHHHHHHHhccccccccccccc
Q psy5603          93 SDLIMFLKKAELHQAARYVEVD  114 (455)
Q Consensus        93 ~~l~~~l~~~~l~~~~~~~~~~  114 (455)
                      ..|+..|.+..+..+++.+...
T Consensus        76 ~~L~~aLr~~~l~~~ae~Ie~~   97 (112)
T 1ich_A           76 ELLGRVLRDMDLLGCLEDIEEA   97 (112)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccHHHHHHHHHH
Confidence            9999999999998888766543

>4d8o_A Ankyrin-2; ZU5, UPA, death domain, supramodule, protein binding; 2.20A {Homo sapiens}

Probab=88.91  E-value=0.23  Score=50.87  Aligned_cols=78  Identities=12%  Similarity=0.215  Sum_probs=57.1

Q ss_pred             HHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHH
Q psy5603          20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      -+..+|+.|.  .+|++||..          ..++..+|+.|+.....  .-.+++.++|..|-.++..++|++.|+..|
T Consensus       500 ~L~~Ia~~LG--~DWk~LAr~----------LG~s~~dId~I~~~~p~--dl~eQ~~~mL~~W~~r~G~~ATv~~L~~AL  565 (581)
T 4d8o_A          500 RLAYIADHLG--FSWTELARE----------LDFTEEQIHQIRIENPN--SLQDQSHALLKYWLERDGKHATDTNLVECL  565 (581)
T ss_dssp             HHHHHHHHHT--THHHHHHHH----------TTCCHHHHHHHHHHSTT--CHHHHHHHHHHHHHHHHGGGCCHHHHHHHH
T ss_pred             HHHHHHHhcc--cCHHHHHHH----------cCCCHHHHHHHHhhCCC--CHHHHHHHHHHHHHhCcCCCchHHHHHHHH
Confidence            4445666665  689999975          35778999999865321  124579999999987765689999999999


Q ss_pred             Hhcccccccccc
Q psy5603         100 KKAELHQAARYV  111 (455)
Q Consensus       100 ~~~~l~~~~~~~  111 (455)
                      .+......++.+
T Consensus       566 r~igR~DIae~L  577 (581)
T 4d8o_A          566 TKINRMDIVHLM  577 (581)
T ss_dssp             HHTTCHHHHC--
T ss_pred             HHcChHHHHHHh
Confidence            988776655543

>3ezq_A Tumor necrosis factor receptor superfamily member; apoptosis, DISC, FAS, membrane,receptor, transmembrane; 2.73A {Homo sapiens} SCOP: a.77.1.2 PDB: 1ddf_A

Probab=88.66  E-value=0.13  Score=41.08  Aligned_cols=78  Identities=17%  Similarity=0.151  Sum_probs=58.4

Q ss_pred             HhhhhcCC--cchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy5603          23 ELGIILNE--RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLK  100 (455)
Q Consensus        23 ~l~~~ld~--~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~  100 (455)
                      -|..|.|-  -..|++||-..          +.+..+|..|+.-..+  ...-...++|..|-......+++..|+..|.
T Consensus        10 ~i~~Iae~m~~~~wK~laR~L----------Glse~~Id~I~~d~~~--d~~Eq~~qlLr~W~~~~G~~aa~~~Li~aLr   77 (115)
T 3ezq_A           10 YITTIAGVMTLSQVKGFVRKN----------GVNEAKIDEIKNDNVQ--DTAEQKVQLLRNWHQLHGKKEAYDTLIKDLK   77 (115)
T ss_dssp             HHHHHHHTSCHHHHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHTTSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCHHHHHHHHHHc----------CCCHhhHHHHHHcCCC--ChHHHHHHHHHHHHHHhCcccHHHHHHHHHH
Confidence            34444443  57899998763          4567889988866543  3445578899999988777889999999999


Q ss_pred             hccccccccccc
Q psy5603         101 KAELHQAARYVE  112 (455)
Q Consensus       101 ~~~l~~~~~~~~  112 (455)
                      +..+..+|+.+.
T Consensus        78 ~~~l~~~Ad~Iq   89 (115)
T 3ezq_A           78 KANLCTLAEKIQ   89 (115)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HccchhHHHHHH
Confidence            999988887553

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.32  E-value=0.062  Score=54.42  Aligned_cols=62  Identities=5%  Similarity=-0.029  Sum_probs=17.2

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEE------EEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAV------KTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAv------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .+.++||   ||.||+|.++. ..+|||      |..+.....           ......|.+|..+++.+.|||+++.+
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-----------~e~~~~~~rea~l~~~~~H~niv~~h  210 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-----------EKRLTSLVRRATLKENEQIPKYEKIH  210 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC----------------------------------------------CBCC
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccccc-----------ccccccccccccccccccccccCCCc
Confidence            3447787   99999999874 367888      766432211           11134588899999999999999987


Q ss_pred             ccc
Q psy5603         246 GLC  248 (455)
Q Consensus       246 ~~~  248 (455)
                      +|.
T Consensus       211 ~f~  213 (463)
T 3cxl_A          211 NFK  213 (463)
T ss_dssp             CEE
T ss_pred             ceE
Confidence            643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.51  E-value=0.4  Score=42.89  Aligned_cols=114  Identities=11%  Similarity=0.126  Sum_probs=76.4

Q ss_pred             CccceeeecccccC-ceeEEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         237 KHVNLLRLLGLCNN-IMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       237 ~h~niv~l~~~~~~-~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .||++++. .+..+ +...+.|+.-+.+ ++.. +.      .++...+++++..|+....++++    =+|--++|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceE
Confidence            67888876 33333 4444545543322 3322 33      37889999999999999977765    57889999999


Q ss_pred             EEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCC
Q psy5603         315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~  386 (455)
                      +++.++.|+|.-.|+-...                    +|.    ..+...=.-.+=+++..+++++..|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l--------------------~P~----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV--------------------DPL----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTB--------------------SCC----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCC--------------------CCC----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999988853221                    121    11112223456788889999988875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	455
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-50
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-48
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-38
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-27
d1d2zb_	150	a.77.1.2 (B:) Tube death domain {Drosophila melano	3e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d1wh4a_	127	a.77.1.2 (A:) Interleukin-1 receptor-associated ki	6e-17
d1d2za_	102	a.77.1.2 (A:) Pelle death domain {Drosophila melan	2e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 79/281 (28%), Positives = 132/281 (46%), Gaps = 28/281 (9%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L    N ++      +A       F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKML----NVTAPTPQQLQA-------FKNEVGVLR 59

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGM 117

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH  +K IIHRD+KS N+ L E+   K+GDFG+  +    +    +   L+G+  +M 
Sbjct: 118 DYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMA 174

Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +  Q     S ++DV+++G++L EL+TG  P  + N       +V      R  L  
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSP 229

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           +  +      + +  ++  +C   ++D+R     I+  +  
Sbjct: 230 DLSKVRSNCPKAMKRLM-AECLKKKRDERPLFPQILASIEL 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 35/284 (12%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           + +   ++G G F TVY G      +E+A   L++     S               F+ E
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-----------FKEE 58

Query: 230 VQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            + L   +H N++R      + +       +V E M +G+L   L R      +      
Sbjct: 59  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLR 115

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYT 343
           S    + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S  K +  
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-- 173

Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
               GT  +M PE    +     DV+++G+ +LE+ T   P  +       Y  V   V 
Sbjct: 174 ---IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
                      +++  +  +  I+ E C    KD+R S++D+++
Sbjct: 231 --------PASFDKVAIPEVKEII-EGCIRQNKDERYSIKDLLN 265

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 1e-52
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 30/278 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +   +LG GQFG V+ G      ++AVK+L+  +    +              F  E   
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------------FLAEANL 61

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + Q +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAE 120

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +  +    E       +
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKW 176

Query: 353 MPP-EAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
             P    +   + K+DV+S+G++L E++T  +      T       +E+   +       
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------- 229

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                +   E L  ++   C     + R +   +  +L
Sbjct: 230 --VRPDNCPEELYQLM-RLCWKERPEDRPTFDYLRSVL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-51
 Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 35/276 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K +   +A+K L      +       E           EV+  
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQ------LRREVEIQ 60

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELAN 117

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T+      GT  Y
Sbjct: 118 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL-----CGTLDY 170

Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           +PPE +  +    K D++S GV+  E L G  P + N     Y  +   E    + + + 
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 230

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
           A +            +  +       +R  +R++++
Sbjct: 231 ARD------------LISRLLKHNPSQRPMLREVLE 254

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-51
 Identities = 65/306 (21%), Positives = 113/306 (36%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G+FG V+ GK + G E+AVK   +    S                 E E+    
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTV 52

Query: 235 QCKHVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +   N          +V +Y  +GSL+D L R      +       +AL 
Sbjct: 53  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALS 108

Query: 290 VAEALHYLHSL------SKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMY 342
            A  L +LH           I HRD+KS N+L+ +N    + D G+       ++   + 
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 343 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY 395
             +  GT+ YM PE +       H +   + D+++ G++  E+         +      Y
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 396 LVVEQEVPVREVLDKEAGE----------WNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             +    P  E + K   E          W       +++ +  +C       R +   I
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 446 VDLLSK 451
              LS+
Sbjct: 289 KKTLSQ 294

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-50
 Identities = 59/281 (20%), Positives = 114/281 (40%), Gaps = 36/281 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             ++G GQFG V+ G   N  ++A+KT+   A                   F  E + + 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--------------FIEEAEVMM 55

Query: 235 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +  H  L++L G+C      C+V+E+M +G L D            +     + L V E 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL      +IHRD+ + N L+ EN V K+ DFG+ +     + +   +        + 
Sbjct: 114 MAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWA 169

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVREVLDK 410
            PE     + S+K+DV+S+GV++ E+ +  K    + +N+ +   +     +    +   
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
              +            +   C     + R +   ++  L++
Sbjct: 230 HVYQ------------IMNHCWKERPEDRPAFSRLLRQLAE 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-50
 Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 30/278 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           R   KLG+G FG V+ G       +A+KTL+       +              F  E Q 
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--------------FLQEAQV 65

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + + +H  L++L  + +     IV EYM  GSL D   +      L   +   +A  +A 
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIAS 124

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +       +       +
Sbjct: 125 GMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQGAKFPIKW 180

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
             PE A++ + + K+DV+S+G++L EL T  +              VE+   +       
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------- 233

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                    E+L  ++  +C   E ++R +   +   L
Sbjct: 234 --PCPPECPESLHDLM-CQCWRKEPEERPTFEYLQAFL 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 3e-50
 Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 38/282 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +    +G+G+FG V  G  + G ++AVK ++N+A   +               F  E   
Sbjct: 10  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASV 53

Query: 233 LSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           ++Q +H NL++LLG+         IV EYM  GSL D L R      L  +     +L V
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDV 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            EA+ YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++              
Sbjct: 113 CEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPV 164

Query: 351 PYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            +  PE     + STK+DV+S+G++L E+ +  +       +      VE+   +     
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----- 219

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               +  +     +  ++ + C   +   R S   + + L  
Sbjct: 220 ----DAPDGCPPAVYEVM-KNCWHLDAAMRPSFLQLREQLEH 256

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-50
 Identities = 67/284 (23%), Positives = 108/284 (38%), Gaps = 34/284 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                +G G +G     + K +G  +  K L    +Y S      +          +EV 
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQM-------LVSEVN 55

Query: 232 TLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIA 287
            L + KH N++R         N    IV EY   G L   + +       LD      + 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 288 LGVAEALHYLHSLSK---PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++       T + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAK 172

Query: 345 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              GT  YM PE M+    + K+D++S G +L EL   M P    +       + E +  
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
                          + + L  I+  +    +   R S+ +I++
Sbjct: 233 ----------RIPYRYSDELNEII-TRMLNLKDYHRPSVEEILE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-49
 Identities = 70/322 (21%), Positives = 120/322 (37%), Gaps = 62/322 (19%)

Query: 159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 217
           +E   D F       + ++LG G  G V+    K +G+ +A K +      +  N     
Sbjct: 1   MELKDDDF------EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---- 50

Query: 218 AAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTP 276
                      E+Q L +C    ++   G   ++    I  E+M  GSL   L +     
Sbjct: 51  --------IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 99

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            +       +++ V + L YL      I+HRDVK +N+L++     KL DFG+      S
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

Query: 337 NMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT----- 390
              +       GTR YM PE       S ++D++S G+ L+E+  G  PI   +      
Sbjct: 159 MANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

Query: 391 -----------------------ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIV 427
                                  +  Y +     + + E+LD    E        + S+ 
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273

Query: 428 F----EKCCVFEKDKRASMRDI 445
           F     KC +    +RA ++ +
Sbjct: 274 FQDFVNKCLIKNPAERADLKQL 295

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 3e-49
 Identities = 57/278 (20%), Positives = 106/278 (38%), Gaps = 32/278 (11%)

Query: 177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G  +     +++A+K L+     + +                 E Q +
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE------------MMREAQIM 63

Query: 234 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++RL+G+C      +V E    G L+  L  V     +  +    +   V+  
Sbjct: 64  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMG 121

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  +HRD+ + NVLL      K+ DFG+ K     +              + 
Sbjct: 122 MKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
            PE     + S+++DV+SYGV + E L+ G KP            + + +          
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------- 231

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
             E        L +++   C +++ + R     +   +
Sbjct: 232 --ECPPECPPELYALM-SDCWIYKWEDRPDFLTVEQRM 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 32/279 (11%)

Query: 176 NKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
            +LG G FGTV  G  +       +AVK L+N AN  +   +              E   
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-----------LLAEANV 61

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + Q  +  ++R++G+C      +V E    G L   L +      +       +   V+ 
Sbjct: 62  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSM 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL       +HRD+ + NVLL      K+ DFG+ K             +      +
Sbjct: 119 GMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
             PE   + + S+K+DV+S+GV++ E  + G KP           ++ + E         
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------- 229

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                       +  ++   C  ++ + R     +   L
Sbjct: 230 ---GCPAGCPREMYDLM-NLCWTYDVENRPGFAAVELRL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (420), Expect = 2e-48
 Identities = 72/314 (22%), Positives = 124/314 (39%), Gaps = 39/314 (12%)

Query: 154 FTFCDLERATDGFNRKPYPRR---GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNA 206
           FTF D   A   F ++           +G G+FG V  G LK      + +A+KTL++  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 265
                              F +E   + Q  H N++ L G+        I+ E+M NGSL
Sbjct: 67  TEKQRRD------------FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114

Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
                   N       +   +  G+A  + YL       +HRD+ + N+L++ N V K+ 
Sbjct: 115 DSF--LRQNDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVS 170

Query: 326 DFGIVKMSETSNMKTMYTENLT--GTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-G 381
           DFG+ +  E       YT  L       +  PEA  + + ++ +DV+SYG+++ E+++ G
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
            +P  D         + +                       L  ++   C   +++ R  
Sbjct: 231 ERPYWDMTNQDVINAIEQDYRL----------PPPMDCPSALHQLM-LDCWQKDRNHRPK 279

Query: 442 MRDIVDLLSKSVNN 455
              IV+ L K + N
Sbjct: 280 FGQIVNTLDKMIRN 293

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 5e-48
 Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 38/277 (13%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G G FG VY+ + ++N   +A+K +  +   S+    +             EV+ L 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQ 70

Query: 235 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +H N ++  G         +V EY    +            PL   +  ++  G  + 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQG 127

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS    +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M
Sbjct: 128 LAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTPYWM 178

Query: 354 PPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P      
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----A 233

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            ++G W+E +    +      C       R +   ++
Sbjct: 234 LQSGHWSE-YFRNFVD----SCLQKIPQDRPTSEVLL 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 6e-48
 Identities = 62/278 (22%), Positives = 118/278 (42%), Gaps = 34/278 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V YGK +   ++A+K ++  +                   F  E + + 
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--------------FIEEAKVMM 54

Query: 235 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
              H  L++L G+C       I+ EYM NG L + L          + +   +   V EA
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEA 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL   SK  +HRD+ + N L+++  V K+ DFG+ +        +  +        + 
Sbjct: 113 MEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWS 168

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           PPE  M+ + S+K+D++++GV++ E+ + G  P +          + +     R      
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----- 223

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                    E + +I+   C   + D+R + + ++  +
Sbjct: 224 -----HLASEKVYTIM-YSCWHEKADERPTFKILLSNI 255

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 3e-47
 Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 37/281 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               +LG+G FG VY  + K   +  A K ++  +     +             +  E+ 
Sbjct: 15  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-------------YMVEID 61

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L+ C H N+++LL       N  I+ E+   G++   +  +    PL  ++   +    
Sbjct: 62  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQT 119

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   +  +  +     +  GT 
Sbjct: 120 LDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD---SFIGTP 174

Query: 351 PYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            +M PE + C+         K DV+S G+ L+E+     P  + N +     + + E P 
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                + +  + +      +     KC     D R +   +
Sbjct: 235 LAQPSRWSSNFKD-----FLK----KCLEKNVDARWTTSQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 72/283 (25%), Positives = 120/283 (42%), Gaps = 30/283 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           R   KLG+G FG V  G+        + +AVK L+ +        D+          F  
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIR 60

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           EV  +    H NL+RL G+       +V E    GSL DRL +      L +  RY  A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 118

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            VAE + YL   SK  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+   
Sbjct: 119 QVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 349 TRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE 406
              +  PE       S  +D + +GV L E+ T G +P    N     + + ++   +  
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-- 234

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                     E   + + +++  +C   + + R +   + D L
Sbjct: 235 -------PRPEDCPQDIYNVM-VQCWAHKPEDRPTFVALRDFL 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 34/276 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R  K+G+G  GTVY    +  G E+A++ +      +       E       L  NE+ 
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQM------NLQQQPKKE-------LIINEIL 69

Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            + + K+ N++  L          +V EY+  GSL D +        +D  +  ++    
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            +AL +LHS    +IHRD+KS N+LL  +   KL DFG          +      + GT 
Sbjct: 126 LQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTP 180

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+     P     +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-----E 235

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            +  E         ++    +C   + +KR S +++
Sbjct: 236 LQNPEKLSAIFRDFLN----RCLDMDVEKRGSAKEL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (403), Expect = 6e-46
 Identities = 67/305 (21%), Positives = 120/305 (39%), Gaps = 52/305 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
              +GEG FG V+  +            +AVK L+  A+                  F+ 
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD------------FQR 65

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVN-------------- 273
           E   +++  + N+++LLG+C      C+++EYM  G L + L  ++              
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 274 -------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                    PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+ D
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIAD 183

Query: 327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPID 386
           FG+ +   +++       +    R   P    + + +T++DV++YGV+L E+ +      
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
                        +EV +  V D       E     L +++   C       R S   I 
Sbjct: 244 YGMA--------HEEV-IYYVRDGNILACPENCPLELYNLM-RLCWSKLPADRPSFCSIH 293

Query: 447 DLLSK 451
            +L +
Sbjct: 294 RILQR 298

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (400), Expect = 1e-45
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 30/279 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +KLG GQ+G VY G  K   + +AVKTL+ +                    F  E   +
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------------FLKEAAVM 67

Query: 234 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + KH NL++LLG+C       I+ E+M  G+L D L    N   + +     +A  ++ 
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISS 126

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++                 +  
Sbjct: 127 AMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWT 183

Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            P    + + S K+DV+++GV+L E+ T          +   Y ++E++           
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------- 234

Query: 413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            E  E   E +  ++   C  +    R S  +I      
Sbjct: 235 MERPEGCPEKVYELM-RACWQWNPSDRPSFAEIHQAFET 272

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 1e-45
 Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 31/277 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LGEG +G V     +     +AVK ++          D  E         + E+ 
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-----MKRAVDCPEN-------IKKEIC 55

Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
                 H N+++  G      +  +  EY   G L+DR+        +           +
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQL 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YLH     I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT 
Sbjct: 113 MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTL 169

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
           PY+ PE +  +   +   DV+S G++L  +L G  P D  +     Y   +++       
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            K            L+     K  V     R ++ DI
Sbjct: 230 KKIDSAPLA-----LLH----KILVENPSARITIPDI 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 65/286 (22%), Positives = 118/286 (41%), Gaps = 33/286 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
            R   +G G+FG VY G LK       + +A+KTL+                      F 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD------------FL 57

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E   + Q  H N++RL G+ +      I+ EYM NG+L                +   +
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGM 115

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             G+A  + YL +     +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T   
Sbjct: 116 LRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 347 TGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
                +  PEA+   + ++ +DV+S+G+++ E++T  +      +             ++
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMK 224

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            + D             +  ++  +C   E+ +R    DIV +L K
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLM-MQCWQQERARRPKFADIVSILDK 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-44
 Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 38/287 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G FG VY+G L +     +  AVK+L    +    +             F  E 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ------------FLTEG 79

Query: 231 QTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +    H N+L LLG+C  +     +V  YM +G L +     N T            L
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGL 137

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 347
            VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ + M +             
Sbjct: 138 QVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPV 404
               +M  E     + +TK+DV+S+GV+L EL+T   P   D N   +  YL+  + +  
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            E       E            V  KC   + + R S  ++V  +S 
Sbjct: 256 PEYCPDPLYE------------VMLKCWHPKAEMRPSFSELVSRISA 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-44
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 35/283 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +N  + S                F  E 
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 59

Query: 231 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G+       I+ E    G L            LD       A  +
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQL 117

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL   SK  +HRD+ + NVL+  N   KLGDFG+ +  E S              
Sbjct: 118 STALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK--ASKGKLPI 173

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M PE+++ +  ++ +DV+ +GV + E+L  G+KP            +   E       
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----- 228

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                        TL S++  KC  ++  +R    ++   LS 
Sbjct: 229 -----PMPPNCPPTLYSLM-TKCWAYDPSRRPRFTELKAQLST 265

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-44
 Identities = 64/278 (23%), Positives = 107/278 (38%), Gaps = 31/278 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + G  LGEG F TV   + L    E A+K LE       +                 E  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----------VTRERD 60

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +S+  H   ++L     +         Y  NG L   + ++      D          +
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEI 117

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+    + +        GT 
Sbjct: 118 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTA 174

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            Y+ PE +  +     +D+++ G I+ +L+ G+ P    N  L +  +++ E    E   
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF 234

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
            +A +        L+     K  V +  KR    ++  
Sbjct: 235 PKARD--------LVE----KLLVLDATKRLGCEEMEG 260

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  152 bits (386), Expect = 9e-44
 Identities = 64/283 (22%), Positives = 102/283 (36%), Gaps = 31/283 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG G    V          E AVK ++     S S  +  E           EV 
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE----ATLKEVD 61

Query: 232 TLSQCK-HVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
            L +   H N+++L           +V++ M  G L+D L        L   +   I   
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRA 118

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           + E +  LH     I+HRD+K  N+LLD++   KL DFG     +             GT
Sbjct: 119 LLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV----CGT 172

Query: 350 RPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
             Y+ PE + C           + D++S GVI+  LL G  P      +L   +++    
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                   +  +     V+ L+S    +  V +  KR +  + 
Sbjct: 233 QFGSPEWDDYSD----TVKDLVS----RFLVVQPQKRYTAEEA 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 46/303 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LG G FG V              M +AVK L+ +A+ +   +              +
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA------------LMS 75

Query: 229 EVQTLSQCK-HVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLAR--------------- 271
           E++ LS    H+N++ LLG C       ++ EY C G L + L R               
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
             +  +   +        +   P    +C  + ++DV+SYG+ L EL +           
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP- 252

Query: 392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                        + + +       E     +  I+ + C   +  KR + + IV L+ K
Sbjct: 253 -------VDSKFYKMIKEGFRMLSPEHAPAEMYDIM-KTCWDADPLKRPTFKQIVQLIEK 304

Query: 452 SVN 454
            ++
Sbjct: 305 QIS 307

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 71/296 (23%), Positives = 124/296 (41%), Gaps = 47/296 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            + +GEG FG V   ++K     M+ A+K ++  A+                  F  E++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELE 62

Query: 232 TLSQC-KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR-------------VNNTP 276
            L +   H N++ LLG C +     +  EY  +G+L D L +              +   
Sbjct: 63  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E  
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 337 NMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY 395
             KTM          +M  E++ +   +T +DV+SYGV+L E+++         T    Y
Sbjct: 181 VKKTMG----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             + Q   +         E      + +  ++  +C   +  +R S   I+  L++
Sbjct: 237 EKLPQGYRL---------EKPLNCDDEVYDLM-RQCWREKPYERPSFAQILVSLNR 282

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 7e-43
 Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 55/305 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LG G FG V              +++AVK L+  A+ S   +              +
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA------------LMS 89

Query: 229 EVQTLSQC-KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRL----------------- 269
           E++ ++Q   H N++ LLG C       +++EY C G L + L                 
Sbjct: 90  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149

Query: 270 ---ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                  +   L        A  VA+ + +L    K  +HRD+ + NVL+    V K+ D
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICD 207

Query: 327 FGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKP 384
           FG+ +   + +   +   N      +M PE       + K+DV+SYG++L E+ + G+ P
Sbjct: 208 FGLARDIMSDSNYVVRG-NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266

Query: 385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRD 444
                    +Y +++    +         +      E +  I+ + C  F+  KR S  +
Sbjct: 267 YPGIPVDANFYKLIQNGFKM---------DQPFYATEEIYIIM-QSCWAFDSRKRPSFPN 316

Query: 445 IVDLL 449
           +   L
Sbjct: 317 LTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-42
 Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 35/286 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LG G FGTVY G          + +A+K L    +  ++                
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------IL 59

Query: 228 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   + ++ RLLG+C      ++ + M  G L D      +   + S    +  
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWC 117

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+   +  K  + E   
Sbjct: 118 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEGGK 174

Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 405
               +M  E  +H   + ++DV+SYGV + EL+T G KP D         ++ + E    
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 232

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                            +  I+  KC + + D R   R+++   SK
Sbjct: 233 --------PQPPICTIDVYMIM-VKCWMIDADSRPKFRELIIEFSK 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  150 bits (381), Expect = 2e-42
 Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 34/276 (12%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V+       G   A K +       + +  + E           E+QT+
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFV------MTPHESDKET-------VRKEIQTM 77

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H  L+ L     +     ++YE+M  G L++++A  +N   +  ++       V +
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCK 135

Query: 293 ALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            L ++H      +H D+K  N++     +   KL DFG+    +      + T    GT 
Sbjct: 136 GLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTA 189

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            +  PE    + +   TD++S GV+   LL+G+ P    N       V   +  + +   
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
               E            +  K  + + + R ++   
Sbjct: 250 SGISED-------GKDFI-RKLLLADPNTRMTIHQA 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-42
 Identities = 53/275 (19%), Positives = 103/275 (37%), Gaps = 33/275 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G+FG V+      +      K ++                     L + E+  L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--------------LVKKEISIL 55

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +  +H N+L L     ++    +++E++    +++R+    +   L+  +  S    V E
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCE 113

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           AL +LHS    I H D++  N++     +   K+ +FG  +  +  +   +     T   
Sbjct: 114 ALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPE 168

Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
            Y P    H  +ST TD++S G ++  LL+G+ P            ++  E    E   K
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           E            +     +  V E+  R +  + 
Sbjct: 229 EISI----EAMDFVD----RLLVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (379), Expect = 6e-42
 Identities = 51/278 (18%), Positives = 99/278 (35%), Gaps = 34/278 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               +LG G FG V+       G     K +      ++    +           +NE+ 
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYT-------VKNEIS 78

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            ++Q  H  L+ L     +     ++ E++  G L+DR+A       +   +  +     
Sbjct: 79  IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQA 136

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTG 348
            E L ++H     I+H D+K  N++ +       K+ DFG+        +  + T     
Sbjct: 137 CEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT----A 190

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV 407
           T  +  PE +  + +   TD+++ GV+   LL+G+ P    + +     V   +    E 
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250

Query: 408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                        +  I          E  KR ++ D 
Sbjct: 251 AFSSVSP----EAKDFIK----NLLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  145 bits (367), Expect = 5e-41
 Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 31/290 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
             G  LG G    V+  + L+   ++AVK L  +     S            L F  E Q
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF----------YLRFRREAQ 59

Query: 232 TLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D +       P+   +   +
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV 116

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 117 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ +   Y  V ++    
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR-ASMRDIVDLLSKSVN 454
               +            L ++V  K      + R  +  ++   L +  N
Sbjct: 235 SARHEGLSAD-------LDAVV-LKALAKNPENRYQTAAEMRADLVRVHN 276

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-39
 Identities = 65/294 (22%), Positives = 123/294 (41%), Gaps = 40/294 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LG+G FG VY G  K          +A+KT+    N ++S  +  E        F N
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIE--------FLN 72

Query: 229 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRL-------ARVNNTPPLDS 280
           E   + +    +++RLLG+ +      ++ E M  G L   L       A      P   
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +         
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 189

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
                      +M PE++     +T +DV+S+GV+L E+ T  +      +         
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------- 240

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV 453
            E  +R V++    +  +   + L  ++   C  +    R S  +I+  + + +
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELM-RMCWQYNPKMRPSFLEIISSIKEEM 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 1e-38
 Identities = 59/277 (21%), Positives = 103/277 (37%), Gaps = 35/277 (12%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG G F  V   +  +    +A+K +   A      S             ENE+  L
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS------------MENEIAVL 61

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + KH N++ L  +  +  +  ++ + +  G L+DR+                +   V +
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLD 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           A+ YLH     I+HRD+K  N+L    DE+    + DFG+ KM +  ++ +       GT
Sbjct: 119 AVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC----GT 172

Query: 350 RPYMPP-EAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
             Y+ P        S   D +S GVI   LL G  P  D N    +  +++ E       
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             +  +            +       + +KR +    
Sbjct: 233 WDDISDS-------AKDFI-RHLMEKDPEKRFTCEQA 261

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-38
 Identities = 58/280 (20%), Positives = 100/280 (35%), Gaps = 41/280 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + G  LG G FG+VY G  + + + +A+K +E +         N             EV 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT-------RVPMEVV 59

Query: 232 TLSQCK--HVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L +       ++RLL       +  ++ E             +     L      S   
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFW 117

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLT 347
            V EA+ + H+    ++HRD+K  N+L+D N    KL DFG   + + +           
Sbjct: 118 QVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-----D 170

Query: 348 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           GTR Y PPE +           V+S G++L +++ G  P + +  I+   +   Q V   
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS-- 228

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                               ++   C       R +  +I
Sbjct: 229 ---------------SECQHLI-RWCLALRPSDRPTFEEI 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  139 bits (352), Expect = 2e-38
 Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 22/242 (9%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +    LG G FG V+  + + NG   A+K L+          ++            +E  
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH----------TNDERL 56

Query: 232 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            LS   H  ++R+ G   +     +      G     L R +   P    K Y  A  V 
Sbjct: 57  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVC 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            AL YLHS  K II+RD+K  N+LLD+N   K+ DFG  K              L GT  
Sbjct: 115 LALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY------TLCGTPD 166

Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           Y+ PE +  +  +   D +S+G+++ E+L G  P  D+NT+  Y  ++  E+      ++
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

Query: 411 EA 412
           + 
Sbjct: 227 DV 228

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-38
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 49/301 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V   +             ++AVK L+++A     +              
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD------------L 65

Query: 227 ENEVQTLSQC-KHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL-------------AR 271
            +E++ +    KH N++ LLG C  +    ++ EY   G+L + L               
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNT 390
                +     T N      +M PEA+  +  + ++DV+S+GV+L E+ T          
Sbjct: 184 DIHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           +         E   + + +    +        L  ++   C      +R + + +V+ L 
Sbjct: 243 V---------EELFKLLKEGHRMDKPSNCTNELYMMM-RDCWHAVPSQRPTFKQLVEDLD 292

Query: 451 K 451
           +
Sbjct: 293 R 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 7e-38
 Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 34/276 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V+  + K      A+K L+ +      + +              E + L
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----------TMVEKRVL 56

Query: 234 S-QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           S   +H  L  +        N   V EY+  G L   +         D ++    A  + 
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEII 113

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             L +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + KT       GT  
Sbjct: 114 LGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPD 168

Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           Y+ PE +  Q  +   D +S+GV+L E+L G  P    +    ++ +          L+K
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           EA        + L+     K  V E +KR  +R  +
Sbjct: 229 EA--------KDLLV----KLFVREPEKRLGVRGDI 252

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 3e-37
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 36/290 (12%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           + LGEGQF TVY  + KN    +A+K ++      + +  N             E++ L 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT--------ALREIKLLQ 55

Query: 235 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +  H N++ LL    +  N  +V+++M            +N+  L  +   +  L   + 
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQG 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLH     I+HRD+K  N+LLDEN V KL DFG+ K   + N    +      TR Y 
Sbjct: 113 LEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ---VVTRWYR 167

Query: 354 PPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREVLDK 410
            PE            D+++ G IL ELL  +  +  ++ +     + E    P  E    
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227

Query: 411 EAGEWNETHVETLISIVF---------------EKCCVFEKDKRASMRDI 445
                +    ++   I                 +   +F    R +    
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 8e-37
 Identities = 52/287 (18%), Positives = 110/287 (38%), Gaps = 28/287 (9%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
              + +GEG +G V       N + +A+K +    + +                   E++
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR------------TLREIK 58

Query: 232 TLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            L + +H N++ +  +        + +  +  ++    LY  L        L ++     
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYF 114

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              +   L Y+HS    ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +    
Sbjct: 115 LYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 347 TGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
             TR Y  PE M      +   D++S G IL E+L+        + +     ++      
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            +  +      N      L+S+  +    + +    +    +DLL K
Sbjct: 233 SQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  136 bits (342), Expect = 1e-36
 Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 21/227 (9%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G G FG VY  +    G   A+K L              +      L     +  +
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERIMLSLV 61

Query: 234 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S      ++ +    +       + + M  G L+  L++       D       A  +  
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---MRFYAAEIIL 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L ++H+  + +++RD+K AN+LLDE+   ++ D G+                  GT  Y
Sbjct: 119 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGY 171

Query: 353 MPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
           M PE +       +  D FS G +L +LL G  P   + T   + + 
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 5e-36
 Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 31/280 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
             G +LG GQF  V   + K  G++ A K ++     SS    + E         E EV 
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-------IEREVS 65

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L + +H N++ L  +  N  +  ++ E +  G L+D    +     L   +       +
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQI 122

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENL 346
              ++YLHS    I H D+K  N++L +  VP    K+ DFG+    +  N         
Sbjct: 123 LNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 177

Query: 347 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  ++ PE ++ + +  + D++S GVI   LL+G  P   +        V        
Sbjct: 178 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +       E+           +  +  V +  KR +++D 
Sbjct: 237 D-------EYFSNTSALAKDFI-RRLLVKDPKKRMTIQDS 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  131 bits (331), Expect = 8e-36
 Identities = 52/292 (17%), Positives = 99/292 (33%), Gaps = 37/292 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
               K+GEG +G VY  +   G   A+K +          S               E+  
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST-----------TIREISI 53

Query: 233 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           L + KH N+++L  + +     ++     +  L   L        L+S    S  L +  
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLN 111

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  +      T  Y
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE---IVTLWY 166

Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE----------Q 400
             P+ +    + ST  D++S G I  E++ G       +       +             
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 401 EVPVREVLDKEAGEWNETHVETLISIV-------FEKCCVFEKDKRASMRDI 445
            V      D     +     E+ +  +         K    + ++R + +  
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-35
 Identities = 62/286 (21%), Positives = 103/286 (36%), Gaps = 40/286 (13%)

Query: 171 YPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           Y      LG G  G V      +   + A+K L++                        E
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------------------ARRE 54

Query: 230 VQTLSQ-CKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           V+   +  +  +++R++ +  N+        IV E +  G L+ R+            + 
Sbjct: 55  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREA 113

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 340
             I   + EA+ YLHS    I HRDVK  N+L      N + KL DFG  K + + N  T
Sbjct: 114 SEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
                   T  Y+ PE +  +      D++S GVI+  LL G  P   N+ +     +  
Sbjct: 172 TPCY----TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +    +              V+ LI          E  +R ++ + 
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLI----RNLLKTEPTQRMTITEF 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 61/300 (20%), Positives = 104/300 (34%), Gaps = 47/300 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LG G FG V                +AVK L+  A +S   +              +
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA------------LMS 65

Query: 229 EVQTLSQCKH-VNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTP--------- 276
           E++ L    H +N++ LLG C        ++ E+   G+L   L    N           
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 277 ----PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
                L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+ DFG+ + 
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 333 SETSNMKTMYTENLTGTRPYMP-PEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
                       +      +M          + ++DV+S+GV+L E+ +          I
Sbjct: 184 IYKDPDYVRKG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
              +    +E       D    E  +             C   E  +R +  ++V+ L  
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGN 293

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 4e-35
 Identities = 59/301 (19%), Positives = 103/301 (34%), Gaps = 51/301 (16%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                +G G FG VY  KL  +G  +A+K +  +  +                    E+Q
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----------------KNRELQ 65

Query: 232 TLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            + +  H N++RL           + +   +V +Y+                 L      
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 343
                +  +L Y+H  S  I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 126 LYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 344 ENLTGTRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q 400
            +    R Y  PE        ++  DV+S G +L ELL G      ++ +     +++  
Sbjct: 184 CS----RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

Query: 401 EVPVREVLDKEAGEWNETHVETLISIVF----------------EKCCVFEKDKRASMRD 444
             P RE + +    + E     + +  +                 +   +    R +  +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 445 I 445
            
Sbjct: 300 A 300

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 6e-35
 Identities = 55/297 (18%), Positives = 106/297 (35%), Gaps = 40/297 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
               ++GEG +G V+  +     G  +A+K +              E   +  +     +
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--------RVQTGEEGMPLSTIREVAVL 61

Query: 231 QTLSQCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           + L   +H N++RL  +C            +V+E++               P + +    
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT--TYLDKVPEPGVPTETIK 119

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++       T    
Sbjct: 120 DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-- 175

Query: 345 NLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE---- 399
               T  Y  PE +     +T  D++S G I  E+         ++ +     +++    
Sbjct: 176 --VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 400 ---------QEVPVREVLDKEAGEWNE--THVETLISIVFEKCCVFEKDKRASMRDI 445
                      +P +    K A    +  T ++ L   +  KC  F   KR S    
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 1e-34
 Identities = 51/290 (17%), Positives = 88/290 (30%), Gaps = 35/290 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R G K+G G FG +Y G  +  G E+A+K       +                    E +
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---------------LHIESK 54

Query: 232 TLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
                +    +  +  C      N +V E +              +          +A  
Sbjct: 55  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQ 111

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKM----SETSNMKTMY 342
           +   + Y+HS +   IHRDVK  N L     +  +  + DFG+ K         ++    
Sbjct: 112 MISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 343 TENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
            +NLTGT  Y      +  + S + D+ S G +L+    G  P                 
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                   +   +   +   T +      C     D +     +  L   
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFRN 275

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 35/283 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG+G FG V   + K  G   A+K L      +             +     E +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----------VAHTVTESR 57

Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L   +H  L  L      +   C V EY   G L+  L+R          +       +
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEI 114

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K   +            GT 
Sbjct: 115 VSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTP 169

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            Y+ PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L 
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS 229

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASM--RDIVDLLS 450
            EA        ++L++         +  +R      D  +++ 
Sbjct: 230 PEA--------KSLLA----GLLKKDPKQRLGGGPSDAKEVME 260

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 9e-34
 Identities = 58/292 (19%), Positives = 107/292 (36%), Gaps = 30/292 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            +  K+G+G FG V+  +  K G ++A+K +                          E++
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-----------ALREIK 61

Query: 232 TLSQCKHVNLLRLLGLC---------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L   KH N++ L+ +C               +V+++  +          N       ++
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSE 118

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTM 341
              +   +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +  
Sbjct: 119 IKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176

Query: 342 YTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              N   T  Y PPE +  +       D++  G I+ E+ T    +  N       L+ +
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               +   +      +       L+     K     K         +DL+ K
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD-PYALDLIDK 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 49/292 (16%), Positives = 94/292 (32%), Gaps = 37/292 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + G ++GEG FG ++ G  L N  ++A+K     ++               +       +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------------LRDEYRTYK 55

Query: 232 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            L+ C  +  +   G    + N +V + +                          A  + 
Sbjct: 56  LLAGCTGIPNVYYFG-QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQML 111

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDFGIVKM----SETSNMKTMY 342
             +  +H   K +++RD+K  N L+            + DFG+VK         ++    
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTG--MKPIDDNNTILYYYLVVE 399
            +NL+GT  YM       +  S + D+ + G + +  L G          T    Y  + 
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           ++     + +  AG   E                   D       +  L SK
Sbjct: 230 EKKQSTPLRELCAGFPEE------FYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 54/293 (18%), Positives = 106/293 (36%), Gaps = 37/293 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           ++  K+GEG +G VY  + K  G  +A+K +  +       S               E+ 
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST-----------AIREIS 53

Query: 232 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            L +  H N+++LL + +      +     +  L   +   +    +      S    + 
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM-DASALTGIPLPLIKSYLFQLL 112

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + L + HS    ++HRD+K  N+L++     KL DFG+ +          +      T  
Sbjct: 113 QGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE---VVTLW 167

Query: 352 YMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL- 408
           Y  PE +      ST  D++S G I  E++T       ++ I   + +        EV+ 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 409 ---------DKEAGEWNETHVETLISIVFE-------KCCVFEKDKRASMRDI 445
                         +W       ++  + E       +   ++ +KR S +  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 6e-31
 Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 24/243 (9%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R   LG G FG V   K  ++G   A+K L+          ++            NE +
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH----------TLNEKR 93

Query: 232 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L       L++L     +  N  +V EY+  G ++  L R+              A  +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQI 150

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
                YLHS    +I+RD+K  N+L+D+    ++ DFG  K  +             GT 
Sbjct: 151 VLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------GTP 202

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
             + PE +  +  +   D ++ GV++ E+  G  P   +  I  Y  +V  +V       
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262

Query: 410 KEA 412
            + 
Sbjct: 263 SDL 265

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (287), Expect = 1e-29
 Identities = 54/295 (18%), Positives = 108/295 (36%), Gaps = 41/295 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            +  K+GEG +GTV+  K +     +A+K +  + +     S               E+ 
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-----------ALREIC 53

Query: 232 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L + KH N++RL  +  ++    +V+E+          +   +  P       S    +
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP---EIVKSFLFQL 110

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            + L + HS  + ++HRD+K  N+L++ N   KL +FG+ +                 T 
Sbjct: 111 LKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE---VVTL 165

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-------- 400
            Y PP+ +      ST  D++S G I  EL    +P+   N +      + +        
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225

Query: 401 ------EVPVREVLDKEAGEWNETHVETLISIVF----EKCCVFEKDKRASMRDI 445
                 ++P  +         +  +V   ++       +        +R S  + 
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-28
 Identities = 58/280 (20%), Positives = 96/280 (34%), Gaps = 33/280 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
                LG G +G V+  +       G   A+K L+       + +               
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE---------HTRT 77

Query: 229 EVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           E Q L   +    L  L           ++ +Y+  G L+  L   +       ++    
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIY 134

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              +  AL +LH     II+RD+K  N+LLD N    L DFG+ K       +T    + 
Sbjct: 135 VGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDF 190

Query: 347 TGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
            GT  YM P+ +           D +S GV++ ELLTG  P   +        +  + + 
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR 443
                 +E         + LI     +  + +  KR    
Sbjct: 251 SEPPYPQEMSA----LAKDLIQ----RLLMKDPKKRLGCG 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-27
 Identities = 59/321 (18%), Positives = 123/321 (38%), Gaps = 55/321 (17%)

Query: 154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSN 212
           F   ++ +      R  Y R    +G G +G V      + G ++A+K L          
Sbjct: 4   FYRQEVTKTAWEV-RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61

Query: 213 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSL 265
                           E++ L   +H N++ LL +        +     +V  +M  G+ 
Sbjct: 62  KR-----------AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTD 108

Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
             +L +      L  ++   +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ 
Sbjct: 109 LGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKIL 163

Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMK 383
           DFG+ + ++ S M          TR Y  PE +    + +   D++S G I+ E++TG  
Sbjct: 164 DFGLARQAD-SEMTGY-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 384 P-IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISI---------------- 426
                ++      ++     P  E + +   +  + +++ L  +                
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 277

Query: 427 --VFEKCCVFEKDKRASMRDI 445
             + EK  V + ++R +  + 
Sbjct: 278 VNLLEKMLVLDAEQRVTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (274), Expect = 2e-27
 Identities = 55/292 (18%), Positives = 109/292 (37%), Gaps = 41/292 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +   KLG G++  V+    + N  ++ VK L+                       + E++
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----------------IKREIK 81

Query: 232 TLSQCK-HVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            L   +   N++ L  +  + ++    +V+E++ N               L         
Sbjct: 82  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYM 135

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             + +AL Y H  S  I+HRDVK  NV++D E+   +L D+G+ +         +     
Sbjct: 136 YEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---- 189

Query: 347 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI---DDNNTILYYYLVVEQE 401
             +R +  PE +  +       D++S G +L  ++   +P     DN   L     V   
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM--RDIVDLLSK 451
             + + +DK   E +    + L     ++   F   +   +   + +D L K
Sbjct: 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

>d1d2zb_ a.77.1.2 (B:) Tube death domain {Drosophila melanogaster [TaxId: 7227]} Length = 150

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tube death domain
species: Drosophila melanogaster [TaxId: 7227]

 Score =  101 bits (252), Expect = 3e-26
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 17/134 (12%)

Query: 5   SIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPL------------- 51
           S  + + E+R ++   ++ L  IL+E   W+K+MSI+    D                  
Sbjct: 3   SKYSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKK 62

Query: 52  --KYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQA 107
             KY+A+D+  ++ A  R  P++  + + +DEW TSG+   RP +  L+  L +AEL  A
Sbjct: 63  GFKYTAQDVFQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSA 122

Query: 108 ARYVEVDVLKKPES 121
           A +V +D L +   
Sbjct: 123 ADFVALDFLNESTP 136

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 4e-26
 Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 34/288 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +  + +G G +G+V      K G+ +AVK L                ++I       E++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPFQSIIHAKRTYRELR 69

Query: 232 TLSQCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            L   KH N++ LL +           +  +  ++    L +    +     L  +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQF 125

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++      +    
Sbjct: 126 LIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--- 180

Query: 346 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              TR Y  PE M      +   D++S G I+ ELLTG       + I    L++     
Sbjct: 181 ---TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               L K+    +E+    + S+       F      +    VDLL K
Sbjct: 238 PGAELLKKI--SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 8e-25
 Identities = 52/261 (19%), Positives = 90/261 (34%), Gaps = 32/261 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +    +G G  G V           +A+K L       +                  E+ 
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-----------AKRAYRELV 68

Query: 232 TLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            +    H N++ LL +              +V E M           +      D  +  
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMS 122

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y  
Sbjct: 123 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV- 179

Query: 345 NLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
               TR Y  PE  +        D++S G I+ E++         + I  +  V+EQ   
Sbjct: 180 ---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 404 VREVLDKEAGEWNETHVETLI 424
                 K+       +VE   
Sbjct: 237 PCPEFMKKLQPTVRNYVENRP 257

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (250), Expect = 4e-24
 Identities = 49/249 (19%), Positives = 90/249 (36%), Gaps = 36/249 (14%)

Query: 164 DGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIP 222
           + +    Y     KLG G F TV+  K + N   +A+K +  +  Y+ +           
Sbjct: 8   EPYKDARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA----------- 55

Query: 223 ILLFENEVQTLSQCKHVNLLRLLGLC----------------NNIMNCIVYEYMCNGSLY 266
               E+E++ L +    +  +   +                 N +   +V+E +    L 
Sbjct: 56  ---AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA 112

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                 +   PL   K+  I+  +   L Y+H     IIH D+K  NVL++    P+   
Sbjct: 113 LIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLI 169

Query: 327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +     +     +  N   TR Y  PE +         D++S   ++ EL+TG    
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229

Query: 386 DDNNTILYY 394
           + +    Y 
Sbjct: 230 EPDEGHSYT 238

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.8 bits (201), Expect = 1e-18
 Identities = 29/179 (16%), Positives = 56/179 (31%), Gaps = 13/179 (7%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +GEG+   V+    +   E  VK  +      +S     E      L F       +
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVG---HTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 235 QCKHVNLLRLLGLCNNIMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +   L +L GL       +   Y     ++   L        +       +   + E 
Sbjct: 62  RNEFRALQKLQGL------AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           +   +   + I+H D+   NVL+ E     + DF           + +   ++     Y
Sbjct: 116 VAKFY--HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITY 171

>d1wh4a_ a.77.1.2 (A:) Interleukin-1 receptor-associated kinase 4, IRAK4 {Mouse (Mus musculus) [TaxId: 10090]} Length = 127

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Interleukin-1 receptor-associated kinase 4, IRAK4
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 74.6 bits (183), Expect = 6e-17
 Identities = 24/117 (20%), Positives = 48/117 (41%), Gaps = 9/117 (7%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +     P    +Y+   I+  E   +
Sbjct: 12  LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAI---KKPSGDDRYNQFHIRRFEALLQ 68

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPG 123
                +  T   L +WGT+      + DL+  L + EL   A  +  D + +     
Sbjct: 69  TG---KSPTCELLFDWGTTN---CTVGDLVDLLVQIELFAPATLLLPDAVPQTVKSL 119

>d1d2za_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]} Length = 102

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

 Score = 44.2 bits (104), Expect = 2e-06
 Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 15/106 (14%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +   + IR L   V  +L   L+  D W+++ +           +K     ++ +    +
Sbjct: 1   LDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATA----------VKLYPDQVEQISSQKQ 50

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVE 112
           R    R  ++ FL+ WG   +    +  L    KK +LH A R ++
Sbjct: 51  RG---RSASNEFLNIWGG--QYNHTVQTLFALFKKLKLHNAMRLIK 91

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	455
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1d2zb_	150	Tube death domain {Drosophila melanogaster [TaxId:	99.96
d1wh4a_	127	Interleukin-1 receptor-associated kinase 4, IRAK4	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1d2za_	102	Pelle death domain {Drosophila melanogaster [TaxId	99.65
d1wmga_	90	Netrin receptor UNC5B {Mouse (Mus musculus) [TaxId	98.96
d1ngra_	85	p75 low affinity neurotrophin receptor {Rat (Rattu	98.72
d1ik7a_	52	Pelle death domain {Drosophila melanogaster [TaxId	98.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.39
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.98
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.85
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.16
d1icha_	87	Tumor necrosis factor receptor-1 death domain {Hum	93.81
d2gf5a1	103	FADD (Mort1) {Human (Homo sapiens) [TaxId: 9606]}	93.8
d1ddfa_	127	Fas {Human (Homo sapiens) [TaxId: 9606]}	90.59
d1fada_	95	FADD (Mort1) {Mouse (Mus musculus) [TaxId: 10090]}	89.31

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=418.26  Aligned_cols=260  Identities=30%  Similarity=0.493  Sum_probs=203.3

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|+++++||+|+||+||+|+++  ..||||+++......    .       ..+.|.+|+.++++++|||||++++++.+
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~   75 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP----Q-------QLQAFKNEVGVLRKTRHVNILLFMGYSTA   75 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT----T-------HHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH----H-------HHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence            4567799999999999999875  469999996543211    1       14669999999999999999999999988


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|||||+||+|.+++....  .++++..++.|+.|++.||+|||+  ++||||||||+||||+.++.+||+|||+|
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             cEEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccce
Confidence            88999999999999999997643  369999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccccC----CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +....... ........||+.|+|||++.+    .++.++|||||||++|||+||..||.+.................+.
T Consensus       152 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~  230 (276)
T d1uwha_         152 TVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD  230 (276)
T ss_dssp             CC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred             eeccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence            87654321 122345789999999997743    3688999999999999999999999876543222222111111110


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      . ..     ....++..+.+|+.+||..||++|||+++|++.|+.+..
T Consensus       231 ~-~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         231 L-SK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             G-GG-----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c-hh-----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            0 00     112344568899999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-55  Score=422.10  Aligned_cols=277  Identities=25%  Similarity=0.393  Sum_probs=210.2

Q ss_pred             eeeeHHHHHHHhcCCCCC---CCCcCCCccCcCCCeEEEEEEEcC-C---cEEEEEEeecccCcCCCCCchhhhhhhhHH
Q psy5603         152 IAFTFCDLERATDGFNRK---PYPRRGNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPIL  224 (455)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~---~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~  224 (455)
                      ..++|+|+.+++.+|+..   ..|+++++||+|+||+||+|.++. +   ..||||++.....      .      ...+
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~   72 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT------E------KQRR   72 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC------H------HHHH
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC------H------HHHH
Confidence            346778888888888643   335677899999999999999863 2   3589998864322      1      1145


Q ss_pred             HHHHHHHHHhhCCccceeeecccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         225 LFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       225 ~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      .|.+|++++++++|||||+++|++.+ +..++|||||++|+|.+++....  ..+++.+++.++.|++.||.|||+  ++
T Consensus        73 ~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~--~~  148 (299)
T d1jpaa_          73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLAD--MN  148 (299)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhh--CC
Confidence            69999999999999999999999877 78899999999999999887643  469999999999999999999999  88


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccccCCccee--eeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt  380 (455)
                      |+||||||+||||+.++.+||+|||+++..........  ......||+.|+|||.+ .+.++.++|||||||++|||+|
T Consensus       149 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t  228 (299)
T d1jpaa_         149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS  228 (299)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence            99999999999999999999999999987654332211  12235689999999966 4568999999999999999998


Q ss_pred             -CCCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhcC
Q psy5603         381 -GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       381 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                       |.+||.+.........+.... .          ...+..++..+.+|+.+||..||++||++.||++.|++++.|
T Consensus       229 ~g~~Pf~~~~~~~~~~~i~~~~-~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         229 YGERPYWDMTNQDVINAIEQDY-R----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             TSCCTTTTCCHHHHHHHHHTTC-C----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC-C----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence             899998876543333332211 1          111223455688999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=404.12  Aligned_cols=244  Identities=28%  Similarity=0.441  Sum_probs=203.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||+||+|+++ +|+.||||++.......          ......+.+|++++++++|||||++++++.+
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   77 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK----------AGVEHQLRREVEIQSHLRHPNILRLYGYFHD   77 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC----------hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence            466789999999999999986 58899999996432211          1124568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||++|+|.+++...   .++++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~ivmEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          78 ATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             CCEEEEEEeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccce
Confidence             7889999999999999999874   469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+......     .....||+.|+|||++.+ .++.++|||||||++|||+||++||.+.+.......+......+++  
T Consensus       153 a~~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--  225 (263)
T d2j4za1         153 SVHAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--  225 (263)
T ss_dssp             CSCCCCCC-----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--
T ss_pred             eeecCCCc-----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence            98654432     234689999999998766 4789999999999999999999999887654444444333322222  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                .++..+.+||.+||..||++|||++|+++
T Consensus       226 ----------~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         226 ----------FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                      23455889999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=404.36  Aligned_cols=252  Identities=24%  Similarity=0.403  Sum_probs=195.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||+||+|.+++++.||||+++....      .        ...|.+|++++++++|||||+++|+|.+ 
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------S--------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   72 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------c--------HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence            355689999999999999998888999999864321      1        3458999999999999999999999876 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||++
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             CceEEEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchh
Confidence            7889999999999999998764  3468999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........  ......||+.|+|||++. +.++.++|||||||++|||+| |.+||...........+.....      
T Consensus       149 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------  220 (263)
T d1sm2a_         149 RFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------  220 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------
T ss_pred             eeccCCCce--eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------
Confidence            876543321  223467999999999765 468999999999999999999 5666665544333333222111      


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+|+.+||..||++|||+++|++.|+++..
T Consensus       221 -----~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 -----LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                 11112234558889999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=407.70  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||.||+|.+++++.||||+++....              ..+.|.+|++++++++|||||+++|++.++
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--------------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   80 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--------------SPDAFLAEANLMKQLQHQRLVRLYAVVTQE   80 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--------------CHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence            356688999999999999998888999999964321              134599999999999999999999999888


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|.+++.... ..++++..++.|+.||+.||+|||+  ++|+||||||+||||++++.+||+|||+|+
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceE
Confidence            8899999999999999876533 2459999999999999999999999  889999999999999999999999999998


Q ss_pred             ccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHcC-CCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......  ........||+.|+|||++. +.++.++|||||||++|||+|| .+|+...........+.....       
T Consensus       158 ~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-------  228 (272)
T d1qpca_         158 LIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------  228 (272)
T ss_dssp             ECSSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred             EccCCc--cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-------
Confidence            765432  22234568999999999664 5689999999999999999995 455554443332222221110       


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          ...+..++..+.+|+.+||..||++|||+++|++.|++++
T Consensus       229 ----~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence                1112234456889999999999999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=406.94  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=201.6

Q ss_pred             CccCcCCCeEEEEEEEcC---CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCce
Q psy5603         176 NKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++||+|+||+||+|.+++   ++.||||+++.....           ......|.+|++++++++|||||+++|+|.++.
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~   81 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----------PALKDELLAEANVMQQLDNPYIVRMIGICEAES   81 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-----------HHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC
Confidence            469999999999998753   467999999643221           111456999999999999999999999998878


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ..++++..++.|+.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~lvmE~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhh
Confidence            8999999999999999987   3469999999999999999999999  8899999999999999999999999999987


Q ss_pred             cccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccch
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ...............||+.|+|||.+ .+.++.++|||||||++|||+| |.+||.+.........+.....        
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~--------  228 (277)
T d1xbba_         157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------  228 (277)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------
T ss_pred             ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            65544333334456899999999966 5568899999999999999998 9999988764433333322110        


Q ss_pred             hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                         ...+..++..+.+|+.+||..||++|||+++|.+.|+...
T Consensus       229 ---~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         229 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence               0111234556889999999999999999999999888764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=409.52  Aligned_cols=249  Identities=23%  Similarity=0.337  Sum_probs=199.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|+++ +|+.||||+++......            ..+.+.+|++++++++|||||++++++.+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------------~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~   74 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------------CPENIKKEICINKMLNHENVVKFYGHRRE   74 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch------------HHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            567799999999999999986 58999999997543211            12348899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++..   ..++++..+..++.|++.||+|||+  +||+||||||+|||+++++.+||+|||+
T Consensus        75 ~~~~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          75 GNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             CceeEEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchh
Confidence             788999999999999999875   3469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CC-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      |+....... .......+||+.|+|||++.+ .+ +.++|||||||++|||+||++||...................   
T Consensus       150 a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---  225 (271)
T d1nvra_         150 ATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---  225 (271)
T ss_dssp             CEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---
T ss_pred             heeeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---
Confidence            987654432 222345789999999997755 44 568999999999999999999998765332222221111111   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..+...++..+.+||.+||..||++|||++|+++
T Consensus       226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  1112234556788999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-53  Score=404.18  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=204.7

Q ss_pred             ccCcCCCeEEEEEEEc---CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCcee
Q psy5603         177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      +||+|+||.||+|.++   ++..||||+++....      .      .....|.+|++++++++|||||+++|++.++..
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~------~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~   83 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------K------ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL   83 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------H------HHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcC------H------HHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeE
Confidence            4999999999999875   255799999964321      1      114569999999999999999999999988888


Q ss_pred             EEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+|||||++|+|.+++....  .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999999986533  469999999999999999999999  89999999999999999999999999999977


Q ss_pred             ccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccchh
Q psy5603         334 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............||+.|+|||++ .+.++.++|||||||++|||+| |..||.+.........+.....         
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---------  230 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---------  230 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            6544333334456799999999966 4568999999999999999998 9999988764433333322111         


Q ss_pred             ccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ...+..++..+.+||.+||..+|++||++.+|.+.|+.+.
T Consensus       231 --~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         231 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              0112234556889999999999999999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=400.22  Aligned_cols=246  Identities=25%  Similarity=0.407  Sum_probs=197.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      ++++..+||+|+||+||+|.++ +++.||+|++......           ......|.+|++++++++|||||++++++.
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   78 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-----------KSERQRFKEEAEMLKGLQHPNIVRFYDSWE   78 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-----------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            4466678999999999999986 4789999999754321           111456899999999999999999999764


Q ss_pred             C-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eeecCCCCCcEEEc-CCCc
Q psy5603         250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLD-ENFV  321 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~--iiH~Dikp~NILl~-~~~~  321 (455)
                      +     ...|+||||+++|+|.+++...   .++++..+..++.|++.||+|||+  ++  |+||||||+|||++ +++.
T Consensus        79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~--~~~~IiHrDiKp~NILl~~~~~~  153 (270)
T d1t4ha_          79 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGS  153 (270)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSC
T ss_pred             eccccCCEEEEEEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHH--CCCCEEeCCcChhhceeeCCCCC
Confidence            2     4578999999999999999874   469999999999999999999999  56  99999999999996 5899


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHHHHHHcCCCCCCCCcchh-hHHHhhhc
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~  400 (455)
                      +||+|||+++......     .....||+.|+|||++.+.++.++|||||||++|||+||+.||.+..... ....+...
T Consensus       154 ~Kl~DFGla~~~~~~~-----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~  228 (270)
T d1t4ha_         154 VKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  228 (270)
T ss_dssp             EEECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             EEEeecCcceeccCCc-----cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence            9999999998644322     23568999999999998899999999999999999999999998655322 22222211


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+ . .+        ...++..+.+||.+||..||++|||++|+++
T Consensus       229 ~~~-~-~~--------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 VKP-A-SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCC-G-GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC-c-cc--------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111 0 01        1112334788999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=400.05  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=203.5

Q ss_pred             CCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.++||+|+||+||+|.++ +|+.||||+++.....             ..+.+.+|+.++++++|||||+++++
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~E~~il~~l~HpnIv~~~~~   85 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-------------KKELIINEILVMRENKNPNIVNYLDS   85 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-------------HHHHHHHHHHHHHhCCCCCEeeEeEE
Confidence            345778899999999999999975 5899999999754221             13458999999999999999999998


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...|+|||||+||+|.+++..    .++++.++..++.|++.||+|||+  +||+||||||+|||++.+|.+||+|
T Consensus        86 ~~~~~~~~ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~D  159 (293)
T d1yhwa1          86 YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTD  159 (293)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeecc
Confidence            877 888999999999999998765    259999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+.......   ......||+.|+|||++.+ .++.++|||||||++|||+||.+||.+.+.......+....... 
T Consensus       160 FG~a~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-  235 (293)
T d1yhwa1         160 FGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-  235 (293)
T ss_dssp             CTTCEECCSTTC---CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-
T ss_pred             chhheeeccccc---cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-
Confidence            999987644321   2345689999999997755 57899999999999999999999998776443333322211110 


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ...+..++..+.+||.+||..||++|||+.|+++
T Consensus       236 --------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             --------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0112334566899999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-52  Score=404.67  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=204.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||+||+|.++. |+.||||+++....      .        .+.|.+|++++++++|||||++++++.+ 
T Consensus        20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------E--------VEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------h--------HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            455889999999999999874 88999999864321      1        3459999999999999999999998887 


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++|||||++|+|.+++.... ...+++..++.|+.|++.||+|||+  ++|+||||||+||||++++.+||+|||++
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             CeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccce
Confidence            78899999999999999997643 3579999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCC-CCcchhhHHHhhhcccchhhcc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPID-DNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........  ......||+.|+|||++ .+.++.++|||||||++|||++|..|+. ..+.......+... ..     
T Consensus       163 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~-----  234 (287)
T d1opja_         163 RLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR-----  234 (287)
T ss_dssp             TTCCSSSSE--EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC-----
T ss_pred             eecCCCCce--eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CC-----
Confidence            876544322  23345689999999965 5678999999999999999999666654 44333222222111 11     


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+|+.+||..||++|||+++|++.|+.++.
T Consensus       235 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         235 -----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 11122345568899999999999999999999999998765

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=407.25  Aligned_cols=253  Identities=24%  Similarity=0.392  Sum_probs=205.3

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      .++..+|++.+.||+|+||+||+|+++ +|+.||||+++....      ..       .+.|.+|++++++++|||||++
T Consensus         8 ~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~-------~~~~~~E~~il~~l~HpnIv~l   74 (288)
T d2jfla1           8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE------EE-------LEDYMVEIDILASCDHPNIVKL   74 (288)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS------GG-------GGGTHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH------HH-------HHHHHHHHHHHHhCCCCCCCeE
Confidence            344456788899999999999999986 588999999975322      11       3458899999999999999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.+ +..|+|||||+||+|.+++....  .++++.++..++.|++.||.|||+  +||+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~K  150 (288)
T d2jfla1          75 LDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIK  150 (288)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEeeCCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEE
Confidence            998876 88899999999999999987643  369999999999999999999999  8899999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCccccc------CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      |+|||+|+......   .......||+.|+|||++.      ..++.++|||||||++|||+||.+||.+.+.......+
T Consensus       151 l~DFG~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i  227 (288)
T d2jfla1         151 LADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI  227 (288)
T ss_dssp             ECCCTTCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred             EEechhhhccCCCc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            99999987543321   1234568999999999763      24688999999999999999999999887654443333


Q ss_pred             hhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....+.         ...+..++..+.+||.+||..||++|||+.|+++
T Consensus       228 ~~~~~~~---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         228 AKSEPPT---------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHSCCCC---------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HcCCCCC---------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3222111         0112334566889999999999999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-52  Score=391.61  Aligned_cols=249  Identities=23%  Similarity=0.416  Sum_probs=206.6

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-c
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.++||+|+||+||+|++++++.||||+++....      .        ...|.+|+.++++++||||++++|+|.+ .
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------~--------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~   72 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------S--------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   72 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------C--------HHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence            55699999999999999998888999999975422      1        3458999999999999999999999877 7


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|.+++....  ..+++..+..++.|+++||.|||+  +||+||||||+|||++.++.+||+|||+++
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             ceEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhe
Confidence            8899999999999999977643  368999999999999999999999  899999999999999999999999999998


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchhhccc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......||+.|+|||.+ .+.++.++|||||||++|||+| |+.||...........+.....       
T Consensus       149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~-------  219 (258)
T d1k2pa_         149 YVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------  219 (258)
T ss_dssp             BCSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-------
T ss_pred             eccCCCce--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC-------
Confidence            66543322  23346799999999966 4578999999999999999998 8999988775544443332111       


Q ss_pred             hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                          ...+..++..+.+||.+||..||++|||+.++++.|.++
T Consensus       220 ----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 ----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                111123345688999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=405.45  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=201.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||+||+|.++ +|+.||||+++......          ......+.+|++++++++||||+++++++.+
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   79 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK----------ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD   79 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC----------HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence            567799999999999999986 58999999997532211          1124568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++...   .++++..+..++.|++.||+|||+  +|||||||||+|||+++++.+||+|||+
T Consensus        80 ~~~~~ivmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~  154 (288)
T d1uu3a_          80 DEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT  154 (288)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEeccccc
Confidence             7889999999999999998874   469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+....... ........||+.|+|||++.+ .++.++|||||||++|||+||..||...+.......+......++.  
T Consensus       155 a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--  231 (288)
T d1uu3a_         155 AKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--  231 (288)
T ss_dssp             CEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--
T ss_pred             ceecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--
Confidence            987654321 122345689999999997754 5788999999999999999999999987755554444433332222  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                .++..+.+||.+||..||++|||++|+++
T Consensus       232 ----------~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         232 ----------KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----------TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----------cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                      23445889999999999999999998643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=398.81  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=190.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|+++ +|+.||||+++....      .+     ...+.|.+|++++++++|||||++++++.+
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TE-----AEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS------CH-----HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC------CH-----HHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            456689999999999999986 588999999965432      11     114568999999999999999999997753


Q ss_pred             ---ceeEEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC---CCeeecCCCCCcEEEcCCCceE
Q psy5603         251 ---IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---~~iiH~Dikp~NILl~~~~~~k  323 (455)
                         ...|+|||||+||+|.+++.... ...++++..++.++.|++.||+|||+.+   .+||||||||+|||++.++.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence               45789999999999999986532 2457999999999999999999999821   2499999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+|||+++......   .......||+.|+|||++.+ .++.++|||||||++|||+||++||...+.......+.....
T Consensus       155 l~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~  231 (269)
T d2java1         155 LGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF  231 (269)
T ss_dssp             ECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             EeeccceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998765432   12345789999999997754 679999999999999999999999988765443333322211


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  .         .+..++..+.+||.+||..||++|||+.|+++
T Consensus       232 ~--~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 R--R---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             C--C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C--C---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1  0         01224456889999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-52  Score=397.27  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=193.9

Q ss_pred             cCCCccCcCCCeEEEEEEEcCC-----cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +++++||+|+||.||+|.++++     ..||||+++....      .      .....|.+|++++++++|||||+++|+
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~------~------~~~~~~~~E~~il~~l~H~nIv~~~g~   77 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT------E------KQRVDFLGEAGIMGQFSHHNIIRLEGV   77 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC------h------HHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence            4558899999999999997642     3699999864321      1      114468999999999999999999999


Q ss_pred             ccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+.+|+|.+.+....  ..+++.++..++.|++.||+|||+  ++|+||||||+||||+.++.+||+|
T Consensus        78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~D  153 (283)
T d1mqba_          78 ISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSD  153 (283)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             EecCCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcc
Confidence            877 78899999999999999887643  479999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCC-CCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP-IDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++................||+.|+|||++ .+.++.++|||||||++|||+||..| +...........+.... . 
T Consensus       154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~-  231 (283)
T d1mqba_         154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-R-  231 (283)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-C-
T ss_pred             cchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-C-
Confidence            99998765443223333456789999999966 45689999999999999999996555 44444333222222111 1 


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ...+..++..+.+|+.+||..+|++||++.||++.|+++++
T Consensus       232 ---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         232 ---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                     11122344568899999999999999999999999998764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-52  Score=402.16  Aligned_cols=244  Identities=26%  Similarity=0.390  Sum_probs=198.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||+||+|++. +|+.||||+++....      ..    ....+.|.+|++++++++|||||++++++.+
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS------CH----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc------cC----HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            455589999999999999976 588999999975432      11    1124568999999999999999999998876


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||.+|+|..++..   ..++++.+++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CCEEEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeeccc
Confidence             788999999999999877665   3469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc----CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+....       .....||+.|+|||++.    +.++.++|||||||++|||++|..||.+.........+.....+. 
T Consensus       162 a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-  233 (309)
T d1u5ra_         162 ASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-  233 (309)
T ss_dssp             CBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-
T ss_pred             ccccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-
Confidence            986432       23458999999999764    347889999999999999999999998776443333332221110 


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .....++..+.+||.+||..||++|||++|+++
T Consensus       234 ---------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                     111234456899999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=402.83  Aligned_cols=255  Identities=26%  Similarity=0.443  Sum_probs=201.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-C-----cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      +++++.||+|+||+||+|++.. +     ..||||++.......            ....|.+|+.++.++ +|||||++
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS------------EREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH------------HHHHHHHHHHHHHHhcCCCcEeEE
Confidence            3566899999999999999753 2     369999986443211            134588999999998 89999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN--------------------TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      ++++.+ +..|+|||||+||+|.++|.....                    ..++++..++.++.|++.||+|||+  ++
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~  184 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KS  184 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CC
Confidence            999887 888999999999999999976432                    2468999999999999999999999  88


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-C
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G  381 (455)
                      ||||||||+|||++.++.+||+|||+|+........ .......||+.|+|||++ .+.++.++|||||||++|||+| |
T Consensus       185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             eeeccCchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence            999999999999999999999999999876554322 223456789999999965 5678999999999999999998 8


Q ss_pred             CCCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHh
Q psy5603         382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .+||.+.........+......+          ..+..++..+.+||.+||..||++|||++||++.|..
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            99998765433222222221111          1122344568899999999999999999999999964

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=406.71  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=197.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.++ +|+.||||+++....    .        .....+.+|+.++++++|||||++++++.+
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----P--------AIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----T--------THHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----H--------HHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            455689999999999999986 589999999975421    0        114568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++.+.   ..+++..+..++.|++.||.|||+. ++|+||||||+|||++.+|.+||+|||+
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGl  151 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  151 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCC
Confidence             8889999999999999999874   3599999999999999999999971 3799999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh---cc----
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE---QE----  401 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~---~~----  401 (455)
                      |+......     ....+||+.|+|||++.+ .++.++|||||||++|||+||+.||...+..........   ..    
T Consensus       152 a~~~~~~~-----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  226 (322)
T d1s9ja_         152 SGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  226 (322)
T ss_dssp             CHHHHHHT-----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred             ccccCCCc-----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence            98654322     235689999999997654 689999999999999999999999987653221111000   00    


Q ss_pred             ---------------------cchhhccch----hccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         402 ---------------------VPVREVLDK----EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ---------------------~~~~~~~d~----~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                           ....+..+.    .....+....+..+.+||.+||..||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                 000000000    0011112234556889999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-51  Score=400.47  Aligned_cols=248  Identities=24%  Similarity=0.340  Sum_probs=188.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|+++ +|+.||||++........            ...+.+|+.++++++|||||++++++.
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------------~~~~~~Ei~il~~l~HpnIv~l~~~~~   77 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK------------EGSMENEIAVLHKIKHPNIVALDDIYE   77 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH------------HHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4677799999999999999986 588999999975432111            234789999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc---CCCceEEe
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~  325 (455)
                      + +..|+|||||+||+|.+++..   ..++++..+..++.|++.||+|||+  ++|+||||||+|||+.   +++.+||+
T Consensus        78 ~~~~~~lvmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          78 SGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             ECCEEEEEEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEe
Confidence            7 788999999999999999986   3469999999999999999999999  8899999999999994   57899999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++......    ......||+.|+|||++.+ .++.++|||||||++|||+||.+||.+.........+......+
T Consensus       153 DFG~a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~  228 (307)
T d1a06a_         153 DFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF  228 (307)
T ss_dssp             CC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC
T ss_pred             ccceeEEccCCC----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC
Confidence            999998654332    1234689999999997755 57999999999999999999999998876554444443322221


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...        ....++..+.+||.+||..||++|||++|+++
T Consensus       229 ~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DSP--------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CTT--------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCc--------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111        11234456889999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=395.56  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=198.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      +++++.||+|+||+||+|.+++++.||||+++....      .        ...|.+|+.++++++|||||+++|++.++
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~--------~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   84 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------S--------PEAFLQEAQVMKKLRHEKLVQLYAVVSEE   84 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------C--------HHHHHHHHHHHHhcccCCEeEEEEEEecC
Confidence            466789999999999999998888899999964322      1        34599999999999999999999999888


Q ss_pred             eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|..++.... ...+++.+++.|+.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             CeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhh
Confidence            8899999999999999887543 2469999999999999999999999  889999999999999999999999999998


Q ss_pred             ccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCC-CcchhhHHHhhhc-ccchhhcc
Q psy5603         332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQ-EVPVREVL  408 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~-~~~~~~~~~~~~~-~~~~~~~~  408 (455)
                      .......  .......||+.|+|||++ .+.++.++|||||||++|||+||..|+.. .........+... ..+.    
T Consensus       162 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~----  235 (285)
T d1fmka3         162 LIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC----  235 (285)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----
T ss_pred             hccCCCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence            7654332  123346799999999965 56789999999999999999996555544 3332222222111 1111    


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              +..++..+.+||.+||..||++||++++|++.|++.+.
T Consensus       236 --------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         236 --------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                    12344568899999999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=393.42  Aligned_cols=254  Identities=25%  Similarity=0.363  Sum_probs=206.6

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+|++++.||+|+||+||+|.++ +|+.||||+++..........       ...+.|.+|+.++++++|||||++++++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG-------VSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS-------BCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhh-------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            35778899999999999999986 589999999976543222211       1256699999999999999999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC----ceE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPK  323 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~----~~k  323 (455)
                      .+ ...|+|||||+||+|.+++...   .++++..++.++.|++.||+|||+  ++|+||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EECCEEEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceE
Confidence            77 8889999999999999999874   369999999999999999999999  8899999999999998776    599


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|||+||..||.+.+.......+.....
T Consensus       158 l~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~  233 (293)
T d1jksa_         158 IIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY  233 (293)
T ss_dssp             ECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred             ecchhhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence            99999998765432    1335689999999997755 578999999999999999999999998775544443333222


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......        ...++..+.+||.+||..||++|||++|+++
T Consensus       234 ~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 EFEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCchh--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211110        1123456889999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-51  Score=398.37  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=202.1

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC-Cc----EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.++||+|+||+||+|.+.. |+    .||||+++.....            ...+.|.+|++++++++|||||+++|
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~HpnIv~l~g   78 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP------------KANKEILDEAYVMASVDNPHVCRLLG   78 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----------------CTHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH------------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            5667999999999999999753 43    5889988643210            11456999999999999999999999


Q ss_pred             cccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         247 LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +|.++..+++++|+.+|+|.+.+...  ...+++..++.++.||+.||+|||+  ++||||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          79 ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             EEESSSEEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             EEecCCeeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeec
Confidence            99998889999999999999988764  3479999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccch
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++....... ........||+.|+|||++ .+.++.++|||||||++|||+| |.+||.+.........+...... 
T Consensus       155 FGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-  232 (317)
T d1xkka_         155 FGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-  232 (317)
T ss_dssp             CSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-
T ss_pred             cccceecccccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            999997654432 2223446799999999965 5578999999999999999999 89999877654433333221110 


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                ..+..++..+.+|+.+||..||++|||+.||++.|+++.+
T Consensus       233 ----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         233 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                      1112344558889999999999999999999999988754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=390.80  Aligned_cols=254  Identities=27%  Similarity=0.401  Sum_probs=197.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++++.||+|+||.||+|.+..    +..||||+++....            ......|.+|++++++++|||||++++
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~------------~~~~~~~~~E~~~l~~l~HpnIv~l~~   75 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------------DSVREKFLQEALTMRQFDHPHIVKLIG   75 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS------------HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC------------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            35677999999999999998753    35689998853221            112456999999999999999999999


Q ss_pred             cccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         247 LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      ++.++..|+||||+++|+|.+++....  .++++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|
T Consensus        76 ~~~~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          76 VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             EECSSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEecCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEcc
Confidence            998888999999999999999887643  468999999999999999999999  8899999999999999999999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcc-cc
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQE-VP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~-~~  403 (455)
                      ||+++.......  .......||+.|+|||.+ .+.++.++|||||||++|||+| |.+||...+.......+.... .+
T Consensus       152 fG~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~  229 (273)
T d1mp8a_         152 FGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP  229 (273)
T ss_dssp             ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred             chhheeccCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            999987554321  223456789999999976 4578889999999999999998 899998877544443333221 11


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      +            +..++..+.+||.+||..||++|||+.||++.|++++.
T Consensus       230 ~------------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         230 M------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1            12345568899999999999999999999999998864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-50  Score=393.21  Aligned_cols=243  Identities=27%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|+++ +|+.||||+++.....          .......+.+|+.++++++|||||++++++.+
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~----------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   75 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV----------RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   75 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc----------CHHHHHHHHHHHHHHHhccCcChhheeeeEee
Confidence            466799999999999999986 5899999999753221          11125668999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||.||+|..++..   ...+++..+..++.|++.||+|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        76 ~~~~~ivmE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~  150 (316)
T d1fota_          76 AQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGF  150 (316)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CCeeeeEeeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCcc
Confidence             888999999999999999987   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+.....      .....||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.+.......+......++.  
T Consensus       151 a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--  222 (316)
T d1fota_         151 AKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--  222 (316)
T ss_dssp             CEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             ceEeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--
Confidence            9876432      234689999999998765 4789999999999999999999999987755554444433333222  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                .++..+.++|.+||..||.+||     +++++++
T Consensus       223 ----------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         223 ----------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                      2334588899999999999996     8888875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-50  Score=388.43  Aligned_cols=261  Identities=24%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.+. +|+.||||+++.....      +    ......|.+|++++++++||||+++++++.
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~----~~~~~~~~~E~~~l~~~~hpniv~~~~~~~   77 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR------D----PSFYLRFRREAQNAAALNHPAIVAVYDTGE   77 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT------C----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc------C----HHHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence            3677799999999999999985 5899999999754321      1    112456999999999999999999999775


Q ss_pred             C-----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEE
Q psy5603         250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      .     ...|+||||++||+|.+++...   .++++.+++.++.|++.||+|||+  +||+||||||+|||++.++..+|
T Consensus        78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l  152 (277)
T d1o6ya_          78 AETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV  152 (277)
T ss_dssp             EECSSSEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEE
T ss_pred             eccCCCceEEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCcccccee
Confidence            4     2478999999999999998874   469999999999999999999999  88999999999999999999999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +|||.+.................||+.|+|||++.+ .++.++|||||||++|||+||.+||.+.+..............
T Consensus       153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~  232 (277)
T d1o6ya_         153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI  232 (277)
T ss_dssp             CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC
Confidence            999998765544333333456789999999997755 5789999999999999999999999887654443333322211


Q ss_pred             hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCC-CHHHHHHHHHhhhc
Q psy5603         404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~~  454 (455)
                      .....        ...++..+.+||.+||..||++|| +++++++.|.++.+
T Consensus       233 ~~~~~--------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         233 PPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CGGGT--------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CCchh--------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            11111        122445688999999999999999 89999999998865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=396.42  Aligned_cols=246  Identities=22%  Similarity=0.346  Sum_probs=204.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +|+.||||++++.....          ......+.+|+.++++++||||+++++++.+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~----------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA----------KDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC----------HHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            456689999999999999986 58999999997543211          1125668899999999999999999998887


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++...   ..+++..+..++.|++.||+|||+  +|||||||||+|||++++|.+||+|||+
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ccccccceeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeeccc
Confidence             7889999999999999999874   358999999999999999999999  8999999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+.......   .....+||+.|+|||++.+ .++.++|||||||++|||+||.+||.+.+.......+......++.  
T Consensus       152 a~~~~~~~~---~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--  226 (337)
T d1o6la_         152 CKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--  226 (337)
T ss_dssp             CBCSCCTTC---CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             ccccccCCc---ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--
Confidence            986543321   2345789999999997754 6899999999999999999999999988765555554444333332  


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                .++..+.+||.+||..||++||+     +.|+++
T Consensus       227 ----------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         227 ----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                      23445889999999999999995     677764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=389.97  Aligned_cols=257  Identities=27%  Similarity=0.371  Sum_probs=197.4

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC--C--cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN--G--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|+++.  +  ..||||+++......          ....+.|.+|+.++++++|||||+++|+
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~----------~~~~~~~~~Ei~~l~~l~H~nIv~~~g~   79 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ----------PEAMDDFIREVNAMHSLDHRNLIRLYGV   79 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC----------HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4566889999999999998752  2  368999986543211          1124569999999999999999999999


Q ss_pred             ccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.+...++||||+++|+|.+++....  .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          80 VLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             EeecchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccc
Confidence            98888899999999999999887643  369999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCccccc-CCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhcccchh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++................||..|+|||.+. ..++.++|||||||++|||+| |.+||.+.+.......+......++
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  235 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            99998765543334445567888999999664 457889999999999999998 8999988775544333332221111


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhh
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                                .+..++..+.+||.+||..||++|||+.+|.+.|+++
T Consensus       236 ----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 ----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      1123345688999999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=386.75  Aligned_cols=244  Identities=29%  Similarity=0.452  Sum_probs=194.2

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC--
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ++++.||+|+||.||+|.++ |+.||||+++....               .+.|.+|++++++++||||++++|+|.+  
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK   73 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----------------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH---------------HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence            45688999999999999997 78999999964321               3458999999999999999999998854  


Q ss_pred             ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q psy5603         251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||+++|+|.++|.... ..++++..++.|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          74 GGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             CcEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccc
Confidence            56799999999999999997532 2358999999999999999999999  88999999999999999999999999999


Q ss_pred             cccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCCCCcchhhHHHhhhc-ccchhhc
Q psy5603         331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ-EVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~-~~~~~~~  407 (455)
                      +.....      .....+|..|+|||.+ .+.++.++|||||||++|||+| |.+||...........+... ..++   
T Consensus       151 ~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~---  221 (262)
T d1byga_         151 KEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---  221 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---
T ss_pred             eecCCC------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            864432      2234789999999965 5678999999999999999998 78888876644433333221 1111   


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                               +..++..+.+||.+||..||++|||+.+|++.|+++.
T Consensus       222 ---------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         222 ---------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                     1123345889999999999999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.3e-50  Score=398.33  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=201.9

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++.....      .       ..+.+.+|+.++++++|||||++++++.+
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~------~-------~~~~~~~E~~il~~l~HpnIv~~~~~~~~   94 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE------S-------DKETVRKEIQTMSVLRHPTLVNLHDAFED   94 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH------H-------HHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch------h-------hHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            566799999999999999986 589999999964321      1       14568899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc--CCCceEEeec
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDF  327 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~--~~~~~kl~DF  327 (455)
                       +..|+|||||+||+|.+++...  ..++++..+..|+.||+.||.|||+  +|||||||||+|||++  .++.+||+||
T Consensus        95 ~~~~~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2          95 DNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             TTEEEEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeec
Confidence             8899999999999999999653  3469999999999999999999999  8999999999999995  4689999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhh
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++.......    .....||+.|+|||++.+ .++.++|||||||++|||+||..||.+.+.......+......+..
T Consensus       171 G~a~~~~~~~~----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  246 (350)
T d1koaa2         171 GLTAHLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD  246 (350)
T ss_dssp             TTCEECCTTSC----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC
T ss_pred             chheecccccc----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            99987654332    234689999999997755 5788999999999999999999999877654444333332222111


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        ....++..+.+||.+||..||++|||++|+++
T Consensus       247 ~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         247 S--------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             G--------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             c--------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1        11234456889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-50  Score=389.81  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeec
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      +++.+.||+|+||+||+|+++      +++.||||+++....      .      .....|.+|++++++++||||++++
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~------~------~~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------A------DMQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------H------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC------h------HHHHHHHHHHHHHHhcCCCCcccce
Confidence            355689999999999999975      247899999864321      1      1145699999999999999999999


Q ss_pred             ccccC-ceeEEEEEeccCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5603         246 GLCNN-IMNCIVYEYMCNGSLYDRLARVN---------------------NTPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~  303 (455)
                      +++.+ ...++||||+++|+|.+++....                     ....+++..++.|+.|++.||+|||+  ++
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~  160 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RK  160 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CC
Confidence            98877 78899999999999999996532                     12358999999999999999999999  88


Q ss_pred             eeecCCCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCC
Q psy5603         304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~  382 (455)
                      +|||||||+|||+|.++.+||+|||+++....... ........||+.|+|||.+ ...++.++|||||||++|||++|.
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            99999999999999999999999999986544322 2223456789999999965 457899999999999999999985


Q ss_pred             -CCCCCCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         383 -KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       383 -~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                       +||...........+......  .         .+..++..+.+|+.+||..+|++|||+.||+++|+++.+
T Consensus       240 ~~p~~~~~~~e~~~~v~~~~~~--~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         240 LQPYYGMAHEEVIYYVRDGNIL--A---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCC--C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCC--C---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             678776654433333222111  0         012234458889999999999999999999999999863

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.3e-50  Score=382.86  Aligned_cols=256  Identities=24%  Similarity=0.340  Sum_probs=207.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||+||+|+.+ +|+.||||+++.........    +........+.+|+.++++++ ||||+++++++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~   79 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA----EEVQELREATLKEVDILRKVSGHPNIIQLKDTY   79 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCH----HHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhH----HHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence            3577899999999999999985 58999999998654422211    112223566899999999997 99999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeec
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ +..|+|||||+||+|.+++...   .++++.++..++.||+.||+|||+  +||+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          80 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccc
Confidence            87 8889999999999999999873   469999999999999999999999  88999999999999999999999999


Q ss_pred             ccccccccCCcceeeeccCCCCCCCCCcccccC-------CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc
Q psy5603         328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      |+++.......    .....||+.|+|||.+.+       .++.++||||+||++|||+||+.||.+.........+...
T Consensus       155 G~a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         155 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             hheeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            99987654321    234689999999997632       3578999999999999999999999987755444444333


Q ss_pred             ccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+.        ......++..+.+||.+||..||++||+++||++
T Consensus       231 ~~~~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         231 NYQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            22111        1112235566899999999999999999999976

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.5e-50  Score=396.52  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=202.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||||+++....      .       ....+.+|++++++++|||||++++++.
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~-------~~~~~~~Ei~il~~l~HpnIv~~~~~~~   96 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP------L-------DKYTVKNEISIMNQLHHPKLINLHDAFE   96 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch------h-------HHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3567799999999999999986 589999999864321      1       1345889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc--CCCceEEee
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~--~~~~~kl~D  326 (455)
                      + ...|+|||||+||+|.+++...  ..++++.+++.|+.||+.||.|||+  +||+||||||+||||+  .++.+||+|
T Consensus        97 ~~~~~~ivmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_          97 DKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             CSSEEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             ECCEEEEEEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEee
Confidence            7 8889999999999999987653  3469999999999999999999999  8999999999999998  678999999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+.......    .....||+.|+|||++.+ .++.++|||||||++|||+||.+||.+.........+......++
T Consensus       173 FGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  248 (352)
T d1koba_         173 FGLATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD  248 (352)
T ss_dssp             CTTCEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cccceecCCCCc----eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            999987654432    234589999999997755 579999999999999999999999988765444433333222211


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..        ....++..+.+||.+||..||++|||+.|+++
T Consensus       249 ~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         249 ED--------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SS--------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cc--------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11        11234456889999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=386.13  Aligned_cols=258  Identities=23%  Similarity=0.333  Sum_probs=193.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |+++++||+|+||.||+|++..      ++.||||+++....      .      .....+.+|+.++.++ +|+||+.+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~------~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------H------SEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------c------HHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            5667999999999999999742      46899999864322      1      1145578888888777 68999999


Q ss_pred             cccccC--ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5603         245 LGLCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Di  309 (455)
                      ++++.+  ...++|||||++|+|.+++.....             ...+++.+++.++.|++.||+|||+  ++||||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDl  160 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  160 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcC
Confidence            997754  567999999999999999975421             2458999999999999999999999  88999999


Q ss_pred             CCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcC-CCCCCC
Q psy5603         310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG-MKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG-~~p~~~  387 (455)
                      ||+||||++++.+||+|||+|+....... ........||+.|+|||++ .+.++.++|||||||++|||+|| .+||..
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceeECCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999986554332 2223456899999999966 45689999999999999999996 567876


Q ss_pred             CcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .................          ..+..++..+.+|+.+||..||++|||++||++.|++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCCSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            55332222221111111          0112234458889999999999999999999999998863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-49  Score=389.79  Aligned_cols=243  Identities=26%  Similarity=0.355  Sum_probs=202.0

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++......          ......+.+|++++++++|||||++++++.+
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  112 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK----------LKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC----------HHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence            466689999999999999986 58999999996432211          1124568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.||+|.+++...   ..+++..+..++.||+.||.|||+  ++||||||||+|||++.+|.+||+|||+
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~  187 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ccccccccccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeecee
Confidence             7889999999999999999874   359999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhcc
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+.....      .....||+.|+|||++.+ .++.++|||||||++|||+||.+||.+.+.......+......++   
T Consensus       188 a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---  258 (350)
T d1rdqe_         188 AKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP---  258 (350)
T ss_dssp             CEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             eeecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC---
Confidence            9876432      234689999999997755 578999999999999999999999988775554444443332222   


Q ss_pred             chhccCCChhHHHHHHHHHHHhhhccCcCCCC-----CHHHHHH
Q psy5603         409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               ..++..+.+||.+||..||.+|+     +++++++
T Consensus       259 ---------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 ---------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                     12344588999999999999994     8888875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=382.60  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=198.1

Q ss_pred             CccCcCCCeEEEEEEEcC----CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-
Q psy5603         176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++||+|+||+||+|++.+    ...||||+++....      .      .....|.+|++++++++||||++++|++.+ 
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~------~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~  100 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------I------GEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  100 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCC------H------HHHHHHHHHHHHHHTCCCTTBCCCCEEEEET
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC------H------HHHHHHHHHHHHHHhCCCCCEeEEeEEEEec
Confidence            679999999999999753    23589999863221      1      114669999999999999999999998754 


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|||||++|+|.+++...  ...+++..++.++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+
T Consensus       101 ~~~~~lv~E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~  176 (311)
T d1r0pa_         101 EGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL  176 (311)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred             CCceEEEEEEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccc
Confidence             5789999999999999998764  3467899999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcce-eeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCc-chhhHHHhhhcccchhh
Q psy5603         330 VKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~  406 (455)
                      ++......... .......||+.|+|||.+ .+.++.++||||||+++|||+||..||.... .......+......   
T Consensus       177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~---  253 (311)
T d1r0pa_         177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---  253 (311)
T ss_dssp             GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC---
T ss_pred             hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            98765443222 223346799999999965 5678999999999999999999777776543 22221111111110   


Q ss_pred             ccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              ..+..++..+.+|+.+||..||++||++.||++.|++++.
T Consensus       254 --------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         254 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                    1112334568899999999999999999999999998864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-49  Score=393.15  Aligned_cols=247  Identities=20%  Similarity=0.239  Sum_probs=194.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+++ +|+.||||++........       ...........|+.+++.++|||||++++++.+
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~   78 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-------QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT   78 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-------TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-------hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence            566799999999999999986 589999999964321100       001112223445778888899999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+|||||+||+|.+++...   ..+++..+..++.||+.||.|||+  +|||||||||+|||++.+|.+||+|||+
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeece
Confidence             7889999999999999999874   468999999999999999999999  8999999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCccccc-C-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh---cccch
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE---QEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~---~~~~~  404 (455)
                      |+......     .....||+.|+|||++. + .++.++|||||||++|||+||+.||..............   ....+
T Consensus       154 a~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  228 (364)
T d1omwa3         154 ACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL  228 (364)
T ss_dssp             CEECSSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCC
T ss_pred             eeecCCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence            98665432     33468999999999764 4 478999999999999999999999987653222221111   11111


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                  +..++..+.+||.+||..||++||+     ++|+++
T Consensus       229 ------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         229 ------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                        1224455889999999999999999     577754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=380.48  Aligned_cols=256  Identities=28%  Similarity=0.419  Sum_probs=201.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcC--------CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Ccccee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |++++.||+|+||.||+|+...        +..||||+++....      .      .....+.+|+..+.++ +|||||
T Consensus        15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~------~------~~~~~~~~e~~~l~~~~~HpnIv   82 (299)
T d1fgka_          15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------E------KDLSDLISEMEMMKMIGKHKNII   82 (299)
T ss_dssp             EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC------H------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC------h------HHHHHHHHHHHHHHHhcCCCeEE
Confidence            4667899999999999998642        24799999965322      1      1145688999999888 899999


Q ss_pred             eecccccC-ceeEEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         243 RLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      +++++|.+ ...++|||||++|+|.+++.....             ...+++.+++.++.|++.||+|||+  ++|||||
T Consensus        83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrD  160 (299)
T d1fgka_          83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRD  160 (299)
T ss_dssp             CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeee
Confidence            99998887 778999999999999999975431             2458999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++........ .......||+.|+|||.+ .+.++.++||||||||+|||+| |.+||.
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ecccceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            9999999999999999999999876554322 224456899999999955 5678999999999999999998 799998


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..........+.... .+          ..+..++..+.+||.+||..||++|||+.||++.|++++
T Consensus       240 ~~~~~~~~~~i~~~~-~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         240 GVPVEELFKLLKEGH-RM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             TCCHHHHHHHHHTTC-CC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHcCC-CC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            776544333332211 11          011223455889999999999999999999999999886

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=383.26  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=199.0

Q ss_pred             cCCCccCcCCCeEEEEEEEcC-Cc--EEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeeecccc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      ++++.||+|+||.||+|++++ |.  .||||+++......            ..+.|.+|+++++++ +|||||+++|++
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD------------DHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH------------HHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            455899999999999999864 43  57888875432211            134589999999998 799999999988


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARV-------------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .+ +..++||||++||+|.++|...             .....+++.++..++.||+.||.|||+  ++|+||||||+||
T Consensus        81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NI  158 (309)
T d1fvra_          81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNI  158 (309)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred             ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceE
Confidence            77 7889999999999999999753             124579999999999999999999999  8899999999999


Q ss_pred             EEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCC-CCCCCCcchh
Q psy5603         315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGM-KPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~-~p~~~~~~~~  392 (455)
                      |++.++.+||+|||+++......    ......||..|+|||.+ .+.++.++|||||||++|||++|. +||...+...
T Consensus       159 L~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~  234 (309)
T d1fvra_         159 LVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  234 (309)
T ss_dssp             EECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEcCCCceEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999998544322    12345799999999966 556889999999999999999965 5677666444


Q ss_pred             hHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....+.... .          ...+..++..+.+||.+||..||++||||.||++.|+++++
T Consensus       235 ~~~~i~~~~-~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         235 LYEKLPQGY-R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHGGGTC-C----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcC-C----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            333332211 0          01112344568899999999999999999999999998874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=383.19  Aligned_cols=257  Identities=23%  Similarity=0.254  Sum_probs=192.9

Q ss_pred             CCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC-ce
Q psy5603         175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .++||+|+||+||+|.++ +|+.||||+++........        ......+.+|+.++++++|||||++++++.+ +.
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~   74 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK--------DGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   74 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhh--------HHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence            478999999999999986 4899999999754321111        0113458899999999999999999998877 88


Q ss_pred             eEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+.++++..+...   ...+++..+..++.||+.||+|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~ivmE~~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          75 ISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             CEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eeehhhhhcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccc
Confidence            8999999988877665543   3468999999999999999999999  8899999999999999999999999999986


Q ss_pred             cccCCcceeeeccCCCCCCCCCccccc-C-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccch---h
Q psy5603         333 SETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV---R  405 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~---~  405 (455)
                      ......   ......||+.|+|||++. + .++.++|||||||++|||+||.+||.+.........+..  .....   .
T Consensus       150 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         150 FGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  226 (299)
T ss_dssp             TTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             cCCCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            554321   123468999999999664 3 468899999999999999999999988764433332221  00000   0


Q ss_pred             hccc------h-hccCCCh----hHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLD------K-EAGEWNE----THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d------~-~~~~~~~----~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....      . .....+.    ..++..+.+||.+||..||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000      0 0000000    123456889999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=385.03  Aligned_cols=258  Identities=28%  Similarity=0.462  Sum_probs=205.7

Q ss_pred             CcCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-Cccceeee
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      ++++++||+|+||.||+|++.      +++.||||+++....      .      .....|.+|+.+++++ +|||||++
T Consensus        25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~------~------~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH------L------TEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC------H------HHHHHHHHHHHHHHhccCCCCEEEE
Confidence            355689999999999999863      357899999974322      1      1145689999999999 69999999


Q ss_pred             cccccC-ceeEEEEEeccCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecC
Q psy5603         245 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~D  308 (455)
                      +++|.+ ...++|||||++|+|.+++.....               ...+++..+..++.||+.||+|||+  ++++|||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrD  170 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRD  170 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecc
Confidence            999887 778999999999999999976431               2368999999999999999999999  8899999


Q ss_pred             CCCCcEEEcCCCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHc-CCCCCC
Q psy5603         309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++....... ........||+.|+|||.+ .+.++.++|||||||++|||+| |.+||.
T Consensus       171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         171 LAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             cccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            999999999999999999999997665432 2334557899999999965 4567999999999999999999 666666


Q ss_pred             CCcchhhHHHhhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................          ....+..++..+.+||.+||..||++|||+++|++.|++++.
T Consensus       250 ~~~~~~~~~~~i~~~~----------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         250 GMPVDSKFYKMIKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             TCCSSHHHHHHHHHTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCC----------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            6554332222221111          111122344568899999999999999999999999998764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=384.01  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHh-hCCccceeeeccccc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS-QCKHVNLLRLLGLCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~  249 (455)
                      |++++.||+|+||+||+|+++ +|+.||||++++.....          ......+..|..++. .++|||||++++++.
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~----------~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~   73 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM----------DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   73 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC----------hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc
Confidence            567799999999999999986 58999999997532211          111345677777765 689999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+|||||+||+|.+++...   ..+++.++..++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||
T Consensus        74 ~~~~~yivmEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          74 TKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCceeEEEeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccc
Confidence            7 7889999999999999999874   458999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchhhc
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++.......   ......||+.|+|||++.+ .++.++|||||||++|||+||..||.+.+.......+......++. 
T Consensus       149 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~-  224 (320)
T d1xjda_         149 MCKENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR-  224 (320)
T ss_dssp             TCBCCCCTTC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-
T ss_pred             hhhhcccccc---cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-
Confidence            9986544321   2345689999999996654 6899999999999999999999999987765554444433333222 


Q ss_pred             cchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHH-HHH
Q psy5603         408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                                 .++..+.+||.+||..||++||++. +++
T Consensus       225 -----------~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         225 -----------WLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             -----------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----------cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                       2345588999999999999999985 664

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=383.18  Aligned_cols=263  Identities=23%  Similarity=0.364  Sum_probs=196.1

Q ss_pred             cCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccCc-
Q psy5603         173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  251 (455)
                      .+.++||+|+||.||+|+++ |+.||||+++....              ....+..|+..+.+++|||||+++++|.+. 
T Consensus         6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~--------------~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--------------RSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH--------------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--------------hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            34578999999999999986 79999999853211              012234466666788999999999988652 


Q ss_pred             ----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeeecCCCCCcEEEcCCCc
Q psy5603         252 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       252 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~------~~~iiH~Dikp~NILl~~~~~  321 (455)
                          ..|+|||||++|+|.++|.+.    +++|.+++.++.|++.||.|||+.      .+||+||||||+||||+.++.
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             CcceEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence                568999999999999999862    589999999999999999999973      258999999999999999999


Q ss_pred             eEEeecccccccccCCcce-eeeccCCCCCCCCCcccccCC-------CCcccchHHHHHHHHHHHcCCCCCCCCcchhh
Q psy5603         322 PKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-------~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      +||+|||+++......... .......||+.|+|||++.+.       ++.++|||||||++|||+||..||........
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            9999999998765543222 233467899999999987543       46789999999999999999988754331110


Q ss_pred             HHHhhh-cccc--------hhhccchhc-cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         394 YYLVVE-QEVP--------VREVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~-~~~~--------~~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...... ....        .....++.. ..+........+.+|+.+||..||++|||+.||++.|+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000000 0000        001111111 222334566778899999999999999999999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=383.49  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=202.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++++.||+|+||+||+|.++ +|+.||||+++....       +       ...+.+|++++++++|||||++++++.
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-------~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~   71 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-------D-------QVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-------H-------HHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-------c-------HHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4678899999999999999986 588999999964321       1       345889999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC--CCceEEee
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~--~~~~kl~D  326 (455)
                      + ...|+|||||+||+|.+++....  .++++.++..|+.||+.||+|||+  +||+||||||+|||++.  .+.+||+|
T Consensus        72 ~~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~D  147 (321)
T d1tkia_          72 SMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             ETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcc
Confidence            6 88999999999999999997632  369999999999999999999999  89999999999999985  45899999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccchh
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......    .....||+.|+|||.+.+ .++.++|||||||++|+|++|.+||...+.......+......+.
T Consensus       148 FG~~~~~~~~~~----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~  223 (321)
T d1tkia_         148 FGQARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD  223 (321)
T ss_dssp             CTTCEECCTTCE----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             cchhhccccCCc----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            999987644321    234578999999996644 578899999999999999999999998775554444443322221


Q ss_pred             hccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...        ...++..+.+||.+||..||++|||+.|+++
T Consensus       224 ~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEA--------FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110        0123455889999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=377.94  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             cCCCccCcCCCeEEEEEEEc------CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      +++++||+|+||+||+|.++      +++.||||+++....      .      .....|.+|+.++++++|||||++++
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~------~------~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS------M------RERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC------H------HHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC------h------HHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            45688999999999999874      257899999863321      1      11456899999999999999999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVN-------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ++.. ...++||||+++|+|.+++....       ....+++..+..++.|+++||.|||+  ++|+||||||+|||+++
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECT
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecC
Confidence            8876 78899999999999999986432       23467999999999999999999999  88999999999999999


Q ss_pred             CCceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcC-CCCCCCCcchhhHHH
Q psy5603         319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG-~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++...... .........||+.|+|||.+ .+.++.++|||||||++|||+|| .+||.+.+.......
T Consensus       169 ~~~~Kl~DFGla~~~~~~~-~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~  247 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  247 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CceEEEeecccceeccCCc-ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999998765443 22334556799999999965 45678899999999999999998 577877664443333


Q ss_pred             hhhcccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +......           ..+..++..+.++|.+||..+|++|||+.+|++.|++.+
T Consensus       248 i~~~~~~-----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         248 VMEGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHhCCCC-----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            3221110           011234456889999999999999999999999998865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=384.28  Aligned_cols=243  Identities=25%  Similarity=0.333  Sum_probs=190.2

Q ss_pred             CccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC-CccceeeecccccC---
Q psy5603         176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  250 (455)
                      +.||+|+||+||+|.++ +++.||||+++..                  ..+.+|+.++.++ +|||||++++++.+   
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc------------------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            46999999999999985 5899999998631                  2377899987655 89999999997643   


Q ss_pred             --ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC---CCceEEe
Q psy5603         251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~  325 (455)
                        ...|+|||||+||+|.+++.... ..++++.++..|+.|++.||.|||+  +||+||||||+|||++.   ++.+||+
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHH--cCCcccccccccccccccccccccccc
Confidence              56799999999999999998643 3469999999999999999999999  88999999999999975   5679999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhcccch
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+|+.......    .....||+.|+|||++.+ .++.++|||||||++|+|+||.+||.+.+........... ...
T Consensus       157 DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~-i~~  231 (335)
T d2ozaa1         157 DFGFAKETTSHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-IRM  231 (335)
T ss_dssp             CCTTCEECCCCCC----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C-CCS
T ss_pred             ccceeeeccCCCc----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH-Hhc
Confidence            9999987654332    235689999999998765 5889999999999999999999999866532211111100 000


Q ss_pred             hhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   .........++..+.+||.+||..||++|||+.|+++
T Consensus       232 ~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 GQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000   0001112345667899999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=371.83  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=193.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC--ccceeeeccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGL  247 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  247 (455)
                      .|++++.||+|+||+||+|++. +|+.||||+++...........       ...++.+|+.++++++  |||||+++++
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~-------~~~~~~~E~~il~~l~~~h~nIv~~~~~   77 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP-------NGTRVPMEVVLLKKVSSGFSGVIRLLDW   77 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT-------TCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh-------HHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence            4678899999999999999986 5899999999765432111000       0223668999999986  8999999998


Q ss_pred             ccC-ceeEEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-CCceEE
Q psy5603         248 CNN-IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKL  324 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl  324 (455)
                      +.+ ...++||||+.+ +++.+++...   ..+++..+..++.|++.||+|||+  +||+||||||+|||++. ++.+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          78 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEE
T ss_pred             EeeCCeEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEE
Confidence            877 788999999976 5888888763   469999999999999999999999  88999999999999985 479999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCcccccC-CC-CcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+|+......     .....||+.|+|||++.+ .+ +.++|||||||++|||+||..||.....      +.....
T Consensus       153 ~DFG~a~~~~~~~-----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~~  221 (273)
T d1xwsa_         153 IDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQV  221 (273)
T ss_dssp             CCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC
T ss_pred             Cccccceeccccc-----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhccc
Confidence            9999998654332     235689999999997744 33 5678999999999999999999976431      111111


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .++            ..++..+.+||.+||..||++|||++|+++
T Consensus       222 ~~~------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 FFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111            123455889999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=371.26  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=194.5

Q ss_pred             CcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.+. +|+.||||+++......           .....+.+|++++++++|||||++++++.+
T Consensus         4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-----------GVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC------------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh-----------HHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            456699999999999999985 58999999996543211           113458899999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.+ ++.+++.... ...+++..+..++.|++.||+|||+  +|||||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~iv~e~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          73 ENKLYLVFEFLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             ccceeEEEeecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCc
Confidence             788999999965 5555554332 3469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-ccc---
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVP---  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~---  403 (455)
                      |+.......   ......||+.|+|||.+..  ..+.++|||||||++|+|++|+.||.+.+.......+... ..+   
T Consensus       149 a~~~~~~~~---~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  225 (298)
T d1gz8a_         149 ARAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV  225 (298)
T ss_dssp             HHHHCCCSB---CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ceeccCCcc---cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            987654321   2334589999999996533  3578999999999999999999999877643333222210 000   


Q ss_pred             -hhhc--cc---hhccCCC-------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         404 -VREV--LD---KEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -~~~~--~d---~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ....  ..   .....+.       ...++..+.+||.+||..||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             0000  00   0000000       0123456889999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.3e-48  Score=369.83  Aligned_cols=258  Identities=19%  Similarity=0.210  Sum_probs=195.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.++||+|+||+||+|++++|+.||||+++......           .....+.+|+.++++++||||+++++++.+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-----------GIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-----------CCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-----------HHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            456779999999999999999889999999996543211           113568999999999999999999998877


Q ss_pred             -ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q psy5603         251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..+++++|+.++.+..+...   ...+++..+..++.|++.||+|||+  .+||||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCceeEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEeccccc
Confidence             888999999977766666554   3469999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--cccch-
Q psy5603         330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV-  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~-  404 (455)
                      +........   ......||+.|+|||.+.+  .++.++|||||||++|||++|++||.+.+.......+..  ..... 
T Consensus       147 a~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~  223 (286)
T d1ob3a_         147 ARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK  223 (286)
T ss_dssp             HHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ceecccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence            987654321   1234579999999996643  468999999999999999999999987764332222211  10000 


Q ss_pred             --------hhcc------chhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         405 --------REVL------DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 --------~~~~------d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ....      ...........++..+.+||.+||..||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0000      000000111234566889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=365.28  Aligned_cols=258  Identities=23%  Similarity=0.316  Sum_probs=192.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-C-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhC---Cccceeeec
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-N-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~  245 (455)
                      .|++.++||+|+||+||+|.+. + ++.||||+++........           ...+.+|+.+++.+   +||||++++
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~E~~~l~~l~~~~HpnIv~~~   76 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----------PLSTIREVAVLRHLETFEHPNVVRLF   76 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----------BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-----------HHHHHHHHHHHHHHhhcCCCCcceee
Confidence            4677799999999999999984 4 567999999765432111           11255677766555   899999999


Q ss_pred             cccc-----C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         246 GLCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       246 ~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      +++.     . ...+++|||+.++++.......  ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.+
T Consensus        77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~  152 (305)
T d1blxa_          77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSS  152 (305)
T ss_dssp             EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTT
T ss_pred             eeecccccccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCC
Confidence            9763     2 4678999999887775544432  3568999999999999999999999  889999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++......    ......||+.|+|||++ ...++.++||||+||++|||+||++||.+.+.......+.
T Consensus       153 ~~~kl~dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  228 (305)
T d1blxa_         153 GQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  228 (305)
T ss_dssp             CCEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCeeecchhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999999999987654332    23456899999999966 4568999999999999999999999998876433322221


Q ss_pred             h-cccchhh------------ccchhcc--CCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         399 E-QEVPVRE------------VLDKEAG--EWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~-~~~~~~~------------~~d~~~~--~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      . ...+...            .......  ......++..+.+||.+||..||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1 0000000            0000000  0011234567889999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=368.66  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=197.2

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |...+.|++.++||+|+||+||+|.++ +|+.||||+++....      .      ...+.+.+|+++|++++||||+++
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~------~~~~~~~~Ei~il~~l~hp~iv~~   71 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH------Q------TYCQRTLREIKILLRFRHENIIGI   71 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC------H------HHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC------h------HHHHHHHHHHHHHHHcCCCCCCcE
Confidence            445566888899999999999999975 689999999964221      1      114568899999999999999999


Q ss_pred             cccccCc-----eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCC
Q psy5603         245 LGLCNNI-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       245 ~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++++...     ..+++++|+.+|+|.+++..    ..+++..+..++.|++.||+|||+  +|||||||||+|||++.+
T Consensus        72 ~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~  145 (345)
T d1pmea_          72 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTT  145 (345)
T ss_dssp             CEEECCSSTTTCCCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTT
T ss_pred             EEEEeeccccccceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCC
Confidence            9977542     33566677889999999975    259999999999999999999999  899999999999999999


Q ss_pred             CceEEeecccccccccCCcceeeeccCCCCCCCCCccccc-C-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +.+||+|||+++................||+.|+|||++. + .++.++||||+||++|||++|+.||............
T Consensus       146 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~  225 (345)
T d1pmea_         146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  225 (345)
T ss_dssp             CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence            9999999999987655433333345578999999999763 3 4678999999999999999999999877633222221


Q ss_pred             hh--cccchh-----------hccc--hhccCCC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VE--QEVPVR-----------EVLD--KEAGEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~--~~~~~~-----------~~~d--~~~~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..  ......           ....  +.....+    ...++..+.+||.+||..||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11  000000           0000  0000000    0123345788999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=371.58  Aligned_cols=256  Identities=21%  Similarity=0.277  Sum_probs=191.1

Q ss_pred             CCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccccC--
Q psy5603         174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ..++||+|+||+||+|+++ +|+.||||+++....                 .+.+|++++++++||||+++++++..  
T Consensus        24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----------------~~~~Ei~il~~l~h~niv~~~~~~~~~~   86 (350)
T d1q5ka_          24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------FKNRELQIMRKLDHCNIVRLRYFFYSSG   86 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----------------SCCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----------------HHHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence            3478999999999999986 589999999975421                 13479999999999999999997632  


Q ss_pred             -----ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC-ceEE
Q psy5603         251 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKL  324 (455)
Q Consensus       251 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl  324 (455)
                           .+.|+|||||+++.+...........++++.++..++.|++.||+|||+  +||+||||||+|||++.++ .+||
T Consensus        87 ~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          87 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             -CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEE
T ss_pred             ccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeE
Confidence                 3468999999766544444333335579999999999999999999999  8999999999999999775 8999


Q ss_pred             eecccccccccCCcceeeeccCCCCCCCCCccccc--CCCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh--c
Q psy5603         325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--Q  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~  400 (455)
                      +|||+++.......    .....||+.|+|||.+.  ..++.++||||+||++|||++|.+||...........+..  .
T Consensus       165 ~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g  240 (350)
T d1q5ka_         165 CDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG  240 (350)
T ss_dssp             CCCTTCEECCTTSC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ecccchhhccCCcc----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999987654332    23458999999999553  3578999999999999999999999987764332222211  0


Q ss_pred             ccc---------------hhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH--HHHhh
Q psy5603         401 EVP---------------VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD--LLSKS  452 (455)
Q Consensus       401 ~~~---------------~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~--~L~~~  452 (455)
                      ...               +................+..+.+||.+||..||++|||+.|+++  +|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            000               00000000000111234556889999999999999999999985  34443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=360.47  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=190.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|+++ +|+.||||++.......           ....++.+|++++++++||||+++++++.
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-----------GFPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-----------SSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----------HHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            3566789999999999999986 58999999986543211           11345889999999999999999998763


Q ss_pred             C---------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         250 N---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       250 ~---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .         ...|+||||+.++.+......   ...++...+..++.|++.||.|||+  +||+||||||+|||++.++
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~  154 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDG  154 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTS
T ss_pred             cccccccccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCC
Confidence            3         356899999987766544333   3468999999999999999999999  8899999999999999999


Q ss_pred             ceEEeecccccccccCCcce-eeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHh
Q psy5603         321 VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      .+||+|||+++......... .......||+.|+|||++.+  .+++++|||||||++|||++|++||.+.+.......+
T Consensus       155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i  234 (318)
T d3blha1         155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI  234 (318)
T ss_dssp             CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence            99999999997665432211 22234579999999997643  4789999999999999999999999877643333222


Q ss_pred             hhcccch-hhc------------cchhcc-CCC------hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         398 VEQEVPV-REV------------LDKEAG-EWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~-~~~------------~d~~~~-~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....... .+.            +..... ...      .......+.+||.+||..||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            2100000 000            000000 000      0112345678999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-45  Score=353.83  Aligned_cols=258  Identities=21%  Similarity=0.259  Sum_probs=193.9

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc-
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-  248 (455)
                      .|++++.||+|+||.||+|++. +|+.||||++.....               ...+..|++++++++|+|++..+..+ 
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------~~~~~~E~~i~~~l~~~~~i~~~~~~~   72 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---------------HPQLHIESKIYKMMQGGVGIPTIRWCG   72 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---------------SCCHHHHHHHHHHSTTSTTCCCEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---------------CHHHHHHHHHHHHccCCCcccEEEEEE
Confidence            4677899999999999999986 488999999875322               11277899999999988877766644 


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEc---CCCceEE
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKL  324 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl  324 (455)
                      .+ ...++||||+ +++|.+.+....  ..+++..+..++.|++.||+|||+  +|||||||||+|||++   .+..+||
T Consensus        73 ~~~~~~~ivme~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl  147 (299)
T d1ckia_          73 AEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYI  147 (299)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             ecCCEEEEEEEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeee
Confidence            33 6778899998 677777666533  469999999999999999999999  8899999999999985   4567999


Q ss_pred             eecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +|||+|+.........    .......||+.|+|||.+.+ .++.++|||||||++|||+||..||..............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            9999998765433211    12345789999999997755 579999999999999999999999987653222211111


Q ss_pred             -cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhh
Q psy5603         400 -QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       400 -~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                       ............     ...++..+.+++.+|+..+|++||++.++.+.|++++
T Consensus       228 ~~~~~~~~~~~~~-----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         228 ISEKKMSTPIEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHHHHHSCHHHH-----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhcccCCCChhHh-----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             000000000000     1123455888999999999999999999999888764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=362.18  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=189.9

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.++||+|+||+||+|.++ +|+.||||+++....      .     ....+.+.+|+++|++++|||||++++++
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~-----~~~~~~~~~Ei~il~~l~hpniv~l~~~~   86 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------S-----ELFAKRAYRELRLLKHMRHENVIGLLDVF   86 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------S-----HHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc------C-----hHHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence            45777899999999999999986 589999999964321      1     11245688999999999999999999987


Q ss_pred             cC-c------eeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         249 NN-I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .. +      ..|+||||+ +++|...+..    .++++..++.++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~  159 (346)
T d1cm8a_          87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCE  159 (346)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCC
T ss_pred             ccCccccccceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccc
Confidence            54 2      469999999 6778777654    359999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +||+|||+|+.....      .....||+.|+|||++.+  .++.++||||+||++|||++|.+||.+.+..........
T Consensus       160 ~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  233 (346)
T d1cm8a_         160 LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  233 (346)
T ss_dssp             EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence            999999999865432      234689999999997643  468899999999999999999999988763322222111


Q ss_pred             -cccchhhc---------------cch-hccCC--ChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 -QEVPVREV---------------LDK-EAGEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~---------------~d~-~~~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ......+.               +.. ....+  ....++..+.+||.+||..||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             00000000               000 00000  01233456788999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-44  Score=347.33  Aligned_cols=255  Identities=21%  Similarity=0.291  Sum_probs=199.0

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc-cceeeecccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGLC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~  248 (455)
                      .|+++++||+|+||+||+|++. +|+.||||++.....               ...+.+|+++++.+.| +|++.+++++
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------~~~~~~e~~~~~~l~~~~~i~~~~~~~   70 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---------------APQLRDEYRTYKLLAGCTGIPNVYYFG   70 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---------------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---------------cHHHHHHHHHHHHhcCCCCCCEEEEEe
Confidence            3677899999999999999986 588999999864322               1126788999999965 8999999987


Q ss_pred             cC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcC-----CCce
Q psy5603         249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVP  322 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~-----~~~~  322 (455)
                      .+ ...++||||+ +++|.+++....  ..++...+..++.|++.||+|||+  +||+||||||+|||++.     ++.+
T Consensus        71 ~~~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~v  145 (293)
T d1csna_          71 QEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMI  145 (293)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             ecCCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCce
Confidence            76 7889999998 899999887643  369999999999999999999999  88999999999999974     5789


Q ss_pred             EEeecccccccccCCcce----eeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchh---hH
Q psy5603         323 KLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL---YY  394 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~---~~  394 (455)
                      ||+|||+|+.........    .......||+.|+|||++.+ .++.++|||||||++|||+||..||.+.....   ..
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~  225 (293)
T d1csna_         146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  225 (293)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence            999999998765432111    22345789999999997655 58899999999999999999999998654221   11


Q ss_pred             HHhhh--cccchhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHHHHHhhhc
Q psy5603         395 YLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       395 ~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+..  ...+..+..         ..++..+.+++..|+..+|++||+++.+.+.|+++++
T Consensus       226 ~~i~~~~~~~~~~~l~---------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         226 ERIGEKKQSTPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHHHHHHHHSCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhccCCCChHHhc---------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            11111  111111110         1133457888999999999999999999999888753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-45  Score=358.66  Aligned_cols=261  Identities=19%  Similarity=0.275  Sum_probs=198.1

Q ss_pred             CCCCCCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceee
Q psy5603         166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLR  243 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  243 (455)
                      |.....|++.++||+|+||+||+|+++ +|+.||||+++...                ...+.+|+++++++. ||||++
T Consensus        31 ~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------------~~~~~~Ei~il~~l~~hpnIv~   94 (328)
T d3bqca1          31 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------------KKKIKREIKILENLRGGPNIIT   94 (328)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----------------HHHHHHHHHHHHHHTTSTTBCC
T ss_pred             CCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----------------HHHHHHHHHHHHhccCCCCCcE
Confidence            333445678899999999999999986 58999999986321                345889999999995 999999


Q ss_pred             ecccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCC
Q psy5603         244 LLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       244 l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +++++..   ...++|||||.+++|.+..      ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~  166 (328)
T d3bqca1          95 LADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEH  166 (328)
T ss_dssp             EEEEEECTTTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTT
T ss_pred             EEEEEEecCCCceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCC
Confidence            9997743   5689999999999997653      259999999999999999999999  8899999999999998654


Q ss_pred             -ceEEeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhh-HHH
Q psy5603         321 -VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILY-YYL  396 (455)
Q Consensus       321 -~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~-~~~  396 (455)
                       .+||+|||+|+.......    .....||+.|+|||.+.+  .++.++||||+||++|||++|..||........ ...
T Consensus       167 ~~vkl~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~  242 (328)
T d3bqca1         167 RKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  242 (328)
T ss_dssp             TEEEECCGGGCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             CeeeecccccceeccCCCc----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence             699999999987654321    345689999999996544  468999999999999999999999986652211 111


Q ss_pred             hhh--c---------------ccchhhccc--------hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH--HH
Q psy5603         397 VVE--Q---------------EVPVREVLD--------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD--LL  449 (455)
Q Consensus       397 ~~~--~---------------~~~~~~~~d--------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~--~L  449 (455)
                      +..  .               .........        ..........++..+.+||.+||..||++|||++|+++  ++
T Consensus       243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            000  0               000000000        00111122345667889999999999999999999987  55


Q ss_pred             Hhhhc
Q psy5603         450 SKSVN  454 (455)
Q Consensus       450 ~~~~~  454 (455)
                      .++.+
T Consensus       323 ~~v~~  327 (328)
T d3bqca1         323 YTVVK  327 (328)
T ss_dssp             TTSCC
T ss_pred             CCCCC
Confidence            55443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-45  Score=349.61  Aligned_cols=263  Identities=21%  Similarity=0.215  Sum_probs=200.6

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|++. +|+.||||+++.....           .....++.+|+.+++.++||||+++++++.
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-----------~~~~~~~~~E~~il~~l~h~niv~~~~~~~   71 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-----------EGVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-----------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-----------hHHHHHHHHHHHHHHhcCcCCEEeeccccc
Confidence            4677799999999999999986 5889999999754321           011566899999999999999999999887


Q ss_pred             C-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q psy5603         250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++|++++.+++|..++..   ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          72 SDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CSSEEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             cccceeEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecc
Confidence            7 788999999999999888776   3468999999999999999999999  889999999999999999999999999


Q ss_pred             cccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcc-hhhHHHhhh-cccch
Q psy5603         329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVE-QEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~-~~~~~~~~~-~~~~~  404 (455)
                      .++.......   ......+++.|+|||.+.+  .++.++|||||||++|||++|..||...+. ......+.. .....
T Consensus       147 ~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         147 LARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhcccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence            9987654321   1233467888999996644  368899999999999999999999755442 222222111 00000


Q ss_pred             ----------hhccc------hhccCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH--HHHhh
Q psy5603         405 ----------REVLD------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD--LLSKS  452 (455)
Q Consensus       405 ----------~~~~d------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~--~L~~~  452 (455)
                                .....      ...........+..+.+||.+||..||++|||++|+++  +|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                      00000      00001112234566889999999999999999999986  44443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=358.74  Aligned_cols=252  Identities=22%  Similarity=0.273  Sum_probs=195.2

Q ss_pred             CcCCCccCcCCCeEEEEEEEc----CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCc-cceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~  246 (455)
                      |++.+.||+|+||+||+|...    +|+.||||+++.........         ....+.+|++++++++| |||+++++
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~---------~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK---------TTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES---------SGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH---------HHHHHHHHHHHHHhccCCCeEEEeee
Confidence            456689999999999999862    37899999987543211111         13347889999999977 89999999


Q ss_pred             cccC-ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEe
Q psy5603         247 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...++||||+.+|+|.+++....   .+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEES
T ss_pred             eeccCCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEe
Confidence            8876 88899999999999999998744   57889999999999999999999  889999999999999999999999


Q ss_pred             ecccccccccCCcceeeeccCCCCCCCCCcccccC---CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhccc
Q psy5603         326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++.......  .......||+.|+|||.+.+   .++.++|||||||+||||+||..||...........+.....
T Consensus       172 DFG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~  249 (322)
T d1vzoa_         172 DFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  249 (322)
T ss_dssp             CSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             eccchhhhccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence            9999986544322  12345689999999997643   367799999999999999999999987653322222211100


Q ss_pred             chhhccchhccCCChhHHHHHHHHHHHhhhccCcCCCCC-----HHHHHH
Q psy5603         403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      ..        ....+..++..+.+||.+||..||++||+     ++|+++
T Consensus       250 ~~--------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         250 KS--------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cC--------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            00        00011234566889999999999999995     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=356.66  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=192.1

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeeccccc
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+. +|+.||||+++....      .     ......+.+|++++++++|||||++++++.
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~-----~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------S-----IIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc------C-----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4677899999999999999975 589999999964321      1     111456889999999999999999999763


Q ss_pred             ------CceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceE
Q psy5603         250 ------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                            +...+++++|+.||+|.+++..    .++++..+..++.|++.||+|||+  +||+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred             eccccccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCcccccccccccc
Confidence                  2345777888899999999864    359999999999999999999999  8999999999999999999999


Q ss_pred             EeecccccccccCCcceeeeccCCCCCCCCCcccccC--CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhhc-
Q psy5603         324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-  400 (455)
                      ++|||++......      .....||+.|+|||.+.+  .++.++|||||||++|+|++|.+||.+.+.......+... 
T Consensus       162 l~dfg~a~~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~  235 (348)
T d2gfsa1         162 ILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  235 (348)
T ss_dssp             ECCC----CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccccchhcccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998754332      234578999999996543  3578999999999999999999999887644333332221 


Q ss_pred             ccchhhcc-----------chhccC---CC----hhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         401 EVPVREVL-----------DKEAGE---WN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~-----------d~~~~~---~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....+..           ......   ..    ...++..+.+||.+||..||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00000000           000000   00    0123456889999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=353.11  Aligned_cols=255  Identities=21%  Similarity=0.256  Sum_probs=185.6

Q ss_pred             CCCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccceeeecccc
Q psy5603         170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.++||+|+||+||+|.++ +|+.||||+++....      .     ......+.+|+.++++++|||||++++++
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~-----~~~~~~~~~Ei~il~~l~hpnIv~~~~~f   85 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------N-----QTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc------C-----HHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence            34677799999999999999987 589999999975432      1     11145688999999999999999999976


Q ss_pred             cC-------ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCc
Q psy5603         249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..       ...|+|||||.++ +.+.+..     .+++..++.++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~  157 (355)
T d2b1pa1          86 TPQKTLEEFQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  157 (355)
T ss_dssp             CSCCSTTTCCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCC
T ss_pred             ecccccccCceeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccc
Confidence            32       5779999999655 4454432     58999999999999999999999  88999999999999999999


Q ss_pred             eEEeecccccccccCCcceeeeccCCCCCCCCCcccccC-CCCcccchHHHHHHHHHHHcCCCCCCCCcchhhHHHhhh-
Q psy5603         322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +|++|||+++......    ......||+.|+|||++.+ .+++++||||+||++|||++|++||.+.+.......+.. 
T Consensus       158 ~kl~df~~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~  233 (355)
T d2b1pa1         158 LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_dssp             EEECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             eeeechhhhhcccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999987654432    2345689999999997654 678999999999999999999999987663322222111 


Q ss_pred             cccc--------------------------hhhccchhc---cCCChhHHHHHHHHHHHhhhccCcCCCCCHHHHHH
Q psy5603         400 QEVP--------------------------VREVLDKEA---GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~--------------------------~~~~~d~~~---~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+                          .........   ........+..+.+||.+|+..||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000                          011111111   00112345677899999999999999999999975

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-38  Score=316.15  Aligned_cols=256  Identities=23%  Similarity=0.262  Sum_probs=184.8

Q ss_pred             CCcCCCccCcCCCeEEEEEEEc-CCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-----------c
Q psy5603         171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----------H  238 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h  238 (455)
                      .|++.++||+|+||+||+|+++ +|+.||||+++....              ....+.+|+.++++++           |
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--------------~~~~~~~Ei~~l~~l~~~~~~~~~~~~~   79 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------------YTEAAEDEIKLLQRVNDADNTKEDSMGA   79 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--------------chHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence            3788899999999999999986 589999999964311              1344778888888775           5


Q ss_pred             cceeeecccccC---ceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEE
Q psy5603         239 VNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       239 ~niv~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +||+++++++..   ...++++.++..+..............+++..+..++.|++.||.|||+. .||+||||||+|||
T Consensus        80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIl  158 (362)
T d1q8ya_          80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVL  158 (362)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEE
T ss_pred             CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHee
Confidence            788999887643   45567777776665544444444456799999999999999999999962 57999999999999


Q ss_pred             EcCCC------ceEEeecccccccccCCcceeeeccCCCCCCCCCcccc-cCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q psy5603         316 LDENF------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       316 l~~~~------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~sDv~SlGvvl~elltG~~p~~~~  388 (455)
                      ++.++      .+|++|||.+......      .....||+.|+|||++ ...++.++|+||+||+++||++|+.||...
T Consensus       159 l~~~~~~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         159 MEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeccCcccccceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            98665      4999999998754432      2346899999999965 456889999999999999999999999765


Q ss_pred             cchhh-------HHHh-hhcccc---------hhhccc---------h----------hccCCChhHHHHHHHHHHHhhh
Q psy5603         389 NTILY-------YYLV-VEQEVP---------VREVLD---------K----------EAGEWNETHVETLISIVFEKCC  432 (455)
Q Consensus       389 ~~~~~-------~~~~-~~~~~~---------~~~~~d---------~----------~~~~~~~~~~~~~l~~Li~~~l  432 (455)
                      .....       .... .....+         .....+         .          ..........+..+.+||.+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL  312 (362)
T d1q8ya_         233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  312 (362)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence            42100       0000 000000         000000         0          0011123456778999999999


Q ss_pred             ccCcCCCCCHHHHHH
Q psy5603         433 VFEKDKRASMRDIVD  447 (455)
Q Consensus       433 ~~dp~~RPs~~evl~  447 (455)
                      ..||++|||++|+++
T Consensus       313 ~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         313 QLDPRKRADAGGLVN  327 (362)
T ss_dssp             CSSTTTCBCHHHHHT
T ss_pred             CCChhHCcCHHHHhc
Confidence            999999999999986

>d1d2zb_ a.77.1.2 (B:) Tube death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tube death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=99.96  E-value=2.1e-30  Score=209.72  Aligned_cols=126  Identities=34%  Similarity=0.594  Sum_probs=110.1

Q ss_pred             ccCCCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCC---------------CCCCCcchHHHHHHHHhccc
Q psy5603           3 SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDP---------------LKPLKYSAKDIKIVERAGKR   67 (455)
Q Consensus         3 ~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~---------------~~~~~~~~~~~~~~e~~~~~   67 (455)
                      |.+.+|++||||+|++..+++|+++||++++|++||+.|+++.+.               +.++||++.|+++||..++|
T Consensus         1 ~~~~~t~sTeiRkl~~~~~~~La~iLD~~~~WkkLm~~Ipk~~d~~~~~~~~~~~~~~~~n~~~kY~~~hi~~ie~~a~~   80 (150)
T d1d2zb_           1 LSSKYSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGFKYTAQDVFQIDEAANR   80 (150)
T ss_dssp             CCCSCCTTSBGGGSCHHHHHHHHHHHHGGGHHHHHHHHCBSSCCHHHHHSTTCCCHHHHGGGCBSSCHHHHHHHHHHHHH
T ss_pred             CCCcccCcceeecCCHHHHHHHHHHcCccchHHHHHHHcCCCccccccccccccccccccCCCccccHHHHHHHHHHHhh
Confidence            457899999999999999999999999999999999999999321               34789999999999988763


Q ss_pred             CCCCCCchHHHHHhhhcCCC--CCCCHHHHHHHHHhccccccccccccccccC--CCCCCCCchh
Q psy5603          68 NFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTEA  128 (455)
Q Consensus        68 ~~~~~s~t~~ll~~w~~~~~--~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~  128 (455)
                      --+|+|||++||++|||+|+  .||||++|+++|.+.++++|++++..+.++.  |..|..++.+
T Consensus        81 ~~~~~S~t~~lL~eWgTSGk~~~rpTvg~Ll~LLvk~el~~AAd~va~d~L~~~pp~rP~~gpaA  145 (150)
T d1d2zb_          81 LPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVALDFLNESTPARPVDGPGA  145 (150)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSSTTSCBHHHHHHHHHHTTCHHHHHHHHHHTTCCCCCCCCSSSTTS
T ss_pred             ccCCCChHHHHHHHhcccCcccCCCCHHHHHHHHHHcchHHHHHHHHHHhccCCCCCCCCCCCCC
Confidence            33799999999999999998  4999999999999999999999999888876  4455555443

>d1wh4a_ a.77.1.2 (A:) Interleukin-1 receptor-associated kinase 4, IRAK4 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Interleukin-1 receptor-associated kinase 4, IRAK4
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=1.7e-27  Score=196.82  Aligned_cols=108  Identities=21%  Similarity=0.327  Sum_probs=100.6

Q ss_pred             CccCCCCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHh
Q psy5603           2 TSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDE   81 (455)
Q Consensus         2 ~~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~   81 (455)
                      +|..+++++||||+||++++++||++||++++|++||+.|..+.+   ..+|++.||++||++.+   +|+|||++||++
T Consensus         7 g~~~~~~~~~~I~~Lp~~~~~~L~~~LD~~~~W~~LA~~i~~~~~---~~~ys~~~i~~~e~~~~---~~~Spt~~LL~~   80 (127)
T d1wh4a_           7 GMNKPLTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSG---DDRYNQFHIRRFEALLQ---TGKSPTCELLFD   80 (127)
T ss_dssp             CCCCCCCTTSBGGGSCHHHHHHHHHHHSSTTHHHHHHHHCBCTTC---CBSSCHHHHHHHHHHHT---TTSCHHHHHHHH
T ss_pred             CCCCCCCCCccHhhCCHHHHHHHHHhcCCcccHHHHHHHhccccc---ccccCHHHHHHHHHHhc---CCCCHHHHHHHH
Confidence            477899999999999999999999999999999999999998755   57999999999998877   599999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHhccccccccccccccccC
Q psy5603          82 WGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK  118 (455)
Q Consensus        82 w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~  118 (455)
                      ||++   |+||++|+++|.+.++++|++++.+++.+.
T Consensus        81 Wg~~---~~TV~~L~~~L~~~~~~~A~~~l~~~~~~~  114 (127)
T d1wh4a_          81 WGTT---NCTVGDLVDLLVQIELFAPATLLLPDAVPQ  114 (127)
T ss_dssp             HHHH---CCBHHHHHHHHHHTTCHHHHHHHCTTSSSS
T ss_pred             HHHc---CCcHHHHHHHHHHcCCHHHHHHHccccccc
Confidence            9998   899999999999999999999998877655

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.2e-26  Score=208.22  Aligned_cols=183  Identities=16%  Similarity=0.138  Sum_probs=124.8

Q ss_pred             CcCCCccCcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCc-----hhhhhhhhHHHHHHHHHHHhhCCccceeeecc
Q psy5603         172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD-----NTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      +.++++||+|+||+||+|.+.+|+.||||+++...........     ...........+..|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            3467899999999999999888999999998654321111000     00111222345667899999999999988776


Q ss_pred             cccCceeEEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCcEEEcCCCceEEee
Q psy5603         247 LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.   ..++||||+.+..+.+          ++......++.|++.|++|||+  +||+||||||+|||+++++ ++|+|
T Consensus        82 ~~---~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~~-~~liD  145 (191)
T d1zara2          82 WE---GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEEG-IWIID  145 (191)
T ss_dssp             EE---TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETTE-EEECC
T ss_pred             ec---CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCCC-EEEEE
Confidence            53   3489999998765532          3444567899999999999999  8899999999999999764 89999


Q ss_pred             cccccccccCCcceeeeccCCCCCCCCCcccccCCCCcccchHHHHHHH
Q psy5603         327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVIL  375 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~sDv~SlGvvl  375 (455)
                      ||+|+.................     -.+.+...++.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~~l~rd~~~-----~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREILERDVRN-----IITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHHHHHHHHH-----HHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHHHHHHH-----HHHHHcCCCCCcccHHHHHHHH
Confidence            9998765433211100000000     0123445678899999985443

>d1d2za_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=99.65  E-value=2.7e-17  Score=130.71  Aligned_cols=92  Identities=23%  Similarity=0.420  Sum_probs=82.6

Q ss_pred             CCCCceeeecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCC
Q psy5603           7 ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus         7 ~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      ++++++||.||+.++++||.+||+.++|+.||..+.          |+..+|+.||...+   +++|||++||+.|+++ 
T Consensus         1 l~~~~~i~~Lp~~~r~~L~~~Ld~~~~Wr~LA~~Lg----------~~~~~I~~i~~~~~---~~~Spt~~lL~~W~~~-   66 (102)
T d1d2za_           1 LDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATAVK----------LYPDQVEQISSQKQ---RGRSASNEFLNIWGGQ-   66 (102)
T ss_dssp             CCCCCBGGGSCHHHHHHHHHHHHHHTCHHHHHHHTT----------CCHHHHHHHHHHHH---TTCCHHHHHHHHHHHH-
T ss_pred             CCCcchhhhCCHHHHHHHHHHcCCcccHHHHHHHhC----------CCHHHHHHHHhccc---CCCChHHHHHHHHHhc-
Confidence            578899999999999999999999999999999874          44789999998877   4899999999999974 


Q ss_pred             CCCCCHHHHHHHHHhcccccccccccc
Q psy5603          87 RRRPRLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                       .++||++|+++|.+.++..|++.+..
T Consensus        67 -~~~Tv~~L~~~L~~~~~~da~~~i~~   92 (102)
T d1d2za_          67 -YNHTVQTLFALFKKLKLHNAMRLIKD   92 (102)
T ss_dssp             -HCCBHHHHHHHHHHTTCHHHHHHTGG
T ss_pred             -CCCcHHHHHHHHHHcChHHHHHHHHH
Confidence             37999999999999999999987653

>d1wmga_ a.77.1.2 (A:) Netrin receptor UNC5B {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Netrin receptor UNC5B
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.96  E-value=2.5e-10  Score=87.45  Aligned_cols=82  Identities=12%  Similarity=0.222  Sum_probs=68.4

Q ss_pred             eeeecCHHHHHHhhhhcCCc----chHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCC
Q psy5603          12 EIRHLKQYVVHELGIILNER----DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        12 ~i~~l~~~~~~~l~~~ld~~----~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      |.++||+.++++||..||+.    .+|+.||..+-          ++ .+|+.|+       ...|||..+|..|.+++.
T Consensus         1 ~~~~Lp~~~r~~L~~~LD~~~~~g~dWr~LA~~Lg----------~~-~~i~~~~-------~~~sPt~~lL~~w~~~~~   62 (90)
T d1wmga_           1 YAFKIPLSIRQKICSSLDAPNSRGNDWRLLAQKLS----------MD-RYLNYFA-------TKASPTGVILDLWEARQQ   62 (90)
T ss_dssp             CCCCCCHHHHHHHHHHHHCGGGTTSSHHHHHHHTT----------CG-GGHHHHH-------TSSCHHHHHHHHHHHHCC
T ss_pred             CcccCCHHHHHHHHHHhCCCCCCCccHHHHHHHhC----------Cc-HHHHHHH-------hCCCchhhHHHHHHHHhC
Confidence            68999999999999999984    45999999864          22 2677776       478999999999987766


Q ss_pred             CCCCHHHHHHHHHhcccccccccc
Q psy5603          88 RRPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      .++||++|++.|...+..-++..+
T Consensus        63 ~~~tv~~L~~~L~~i~R~Dvv~~L   86 (90)
T d1wmga_          63 DDGDLNSLASALEEMGKSEMLVAM   86 (90)
T ss_dssp             STTTHHHHHHHHHHTTCHHHHHHH
T ss_pred             CCCcHHHHHHHHHHcCcHHHHHHH
Confidence            688999999999998877776654

>d1ngra_ a.77.1.2 (A:) p75 low affinity neurotrophin receptor {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: p75 low affinity neurotrophin receptor
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.72  E-value=4.8e-09  Score=79.06  Aligned_cols=78  Identities=19%  Similarity=0.355  Sum_probs=65.7

Q ss_pred             eecCHHHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHH
Q psy5603          14 RHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLS   93 (455)
Q Consensus        14 ~~l~~~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~   93 (455)
                      .+||+.++.+||..||. .+|+.||..+          .|+..+|+.|+       ...|||..+|..|..+.  ++||+
T Consensus         5 ~~lp~~~r~~l~~~Ldg-~dWr~LA~~L----------Gl~~~~I~~i~-------~~~spt~~lL~~W~~~~--~~tl~   64 (85)
T d1ngra_           5 SSLPLTKREEVEKLLNG-DTWRHLAGEL----------GYQPEHIDSFT-------HEACPVRALLASWGAQD--SATLD   64 (85)
T ss_dssp             TTSCSTTTHHHHHHSCT-THHHHHHHHT----------TCCHHHHHHHH-------HSSCHHHHHHHHGGGST--TCBHH
T ss_pred             hhCCHHHHHHHHHHcCC-CCHHHHHHHc----------CCCHHHHHHHH-------cCCChHHHHHHHHHHcC--CCcHH
Confidence            36899999999999995 5699999874          45578999998       35689999999999773  68999


Q ss_pred             HHHHHHHhcccccccccc
Q psy5603          94 DLIMFLKKAELHQAARYV  111 (455)
Q Consensus        94 ~l~~~l~~~~l~~~~~~~  111 (455)
                      .|+..|......-+++.+
T Consensus        65 ~L~~~L~~~~r~Dv~~~l   82 (85)
T d1ngra_          65 ALLAALRRIQRADIVESL   82 (85)
T ss_dssp             HHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHcCcHHHHHHH
Confidence            999999998887777654

>d1ik7a_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=98.66  E-value=4.5e-10  Score=72.68  Aligned_cols=40  Identities=30%  Similarity=0.596  Sum_probs=36.6

Q ss_pred             CCCchHHHHHhhhcCCCCCCCHHHHHHHHHhccccccccccc
Q psy5603          71 ERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        71 ~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~  112 (455)
                      |+|||+|||..||.+  +|+||.+|+.+|.+.++++||.++-
T Consensus         2 g~SPt~elL~~Wg~q--~NHTi~eLF~ll~~mk~~~aM~iiK   41 (52)
T d1ik7a_           2 GRSASNEFLNIWGGQ--YNHTVQTLFALFKKLKLHNAMRLIK   41 (52)
T ss_dssp             THHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHHhCCc--ccccHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999984  3889999999999999999998653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.39  E-value=1.1e-06  Score=80.10  Aligned_cols=132  Identities=13%  Similarity=0.070  Sum_probs=85.0

Q ss_pred             CcCCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-ccceeeecccccC-ceeEEE
Q psy5603         179 GEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IMNCIV  256 (455)
Q Consensus       179 G~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lV  256 (455)
                      +.|+.+.||+.... ++.++||+........             ...+.+|...+..+. +--+.+++.+..+ +..++|
T Consensus        23 ~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~-------------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          23 EGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-------------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             CCCSSSEEEEEECS-SCEEEEEEECGGGTTS-------------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             CCCCCCcEEEEEeC-CCeEEEEEcCCCcccc-------------hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            33445789998765 5778889875433211             112567877776653 3224455665544 778999


Q ss_pred             EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q psy5603         257 YEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-----------------------------------  301 (455)
Q Consensus       257 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-----------------------------------  301 (455)
                      |++++|.++.+....     ..   ....++.+++..+..||+..                                   
T Consensus        89 ~~~l~G~~~~~~~~~-----~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          89 MSEADGVLCSEEYED-----EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHTTT-----CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEecccccccccccc-----cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999888654321     01   12234555555566666410                                   


Q ss_pred             ----------------------CCeeecCCCCCcEEEcCCCceEEeecccccc
Q psy5603         302 ----------------------KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ----------------------~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                            ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  1379999999999999877777999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.98  E-value=7.7e-06  Score=73.80  Aligned_cols=72  Identities=15%  Similarity=0.025  Sum_probs=47.1

Q ss_pred             cCcCC-CeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcc--ceeeecccccC-cee
Q psy5603         178 LGEGQ-FGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV--NLLRLLGLCNN-IMN  253 (455)
Q Consensus       178 LG~G~-fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~-~~~  253 (455)
                      +..|. -+.||+...+++..+++|.......                ..+..|...++.+...  .+.+++.+..+ +..
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----------------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~   81 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----------------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   81 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----------------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----------------hHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence            44444 3679999887777788998643221                1156677777665332  24455666555 677


Q ss_pred             EEEEEeccCCCH
Q psy5603         254 CIVYEYMCNGSL  265 (455)
Q Consensus       254 ~lV~e~~~~gsL  265 (455)
                      ++||++++|.++
T Consensus        82 ~~v~~~i~G~~~   93 (255)
T d1nd4a_          82 WLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEECCSSEET
T ss_pred             EEEEEeeecccc
Confidence            899999987765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.95  E-value=1.3e-05  Score=77.71  Aligned_cols=83  Identities=16%  Similarity=0.103  Sum_probs=47.9

Q ss_pred             CccCcCCCeEEEEEEEcC-CcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCC-c-c-ceeeecccccCc
Q psy5603         176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-H-V-NLLRLLGLCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~  251 (455)
                      +.||.|....||+....+ ++.|+||.-..........      +.....+...|...++.+. + | .+.+++.+.. .
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~------~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES------WPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-E  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CC------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-T
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCC------CCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-C
Confidence            468999999999998654 6789999764322111100      0111223456777776552 2 3 3444555433 4


Q ss_pred             eeEEEEEeccCCCH
Q psy5603         252 MNCIVYEYMCNGSL  265 (455)
Q Consensus       252 ~~~lV~e~~~~gsL  265 (455)
                      ..++|||++.+..+
T Consensus       105 ~~~lvmE~L~~~~~  118 (392)
T d2pula1         105 MAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTEEEECCCTTSEE
T ss_pred             CCEEEEeccCCccc
Confidence            55789999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.50  E-value=0.00057  Score=63.78  Aligned_cols=137  Identities=15%  Similarity=0.116  Sum_probs=75.7

Q ss_pred             CCCeEEEEEEEcCCcEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCccc-----eeeecc---cccCce
Q psy5603         181 GQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-----LLRLLG---LCNNIM  252 (455)
Q Consensus       181 G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l~~---~~~~~~  252 (455)
                      |.--.||+++.++|..|++|+.+....              ...++..|...+..+...+     .+..-+   +..++.
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~--------------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~   98 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERW--------------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF   98 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTS--------------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCCC--------------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeE
Confidence            334589999998899999999864321              1334666777776664222     222222   112356


Q ss_pred             eEEEEEeccCCCHH----HH----------Hhhc--C----CCCCCCHH----------------------HHHHHHHHH
Q psy5603         253 NCIVYEYMCNGSLY----DR----------LARV--N----NTPPLDSN----------------------KRYSIALGV  290 (455)
Q Consensus       253 ~~lV~e~~~~gsL~----~~----------l~~~--~----~~~~l~~~----------------------~~~~i~~~i  290 (455)
                      .+.+++++.|..+.    +.          ++..  .    ....++..                      .....+..+
T Consensus        99 ~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (325)
T d1zyla1          99 YFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDEL  178 (325)
T ss_dssp             EEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHH
T ss_pred             EEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHH
Confidence            68899998764331    11          1110  0    01112211                      112223333


Q ss_pred             HHHHHHHH--cCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q psy5603         291 AEALHYLH--SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       291 ~~gl~~LH--~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ...+.-.-  ....++||+|+.+.|||++++  ..++||+-+...
T Consensus       179 ~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         179 IAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             HHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             HHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcccC
Confidence            33333221  113468999999999999743  458999987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.85  E-value=0.0015  Score=60.25  Aligned_cols=31  Identities=26%  Similarity=0.274  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEeeccccc
Q psy5603         301 SKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       301 ~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||+|+.++||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3579999999999999998877899999765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.16  E-value=0.0074  Score=57.47  Aligned_cols=72  Identities=14%  Similarity=0.199  Sum_probs=45.7

Q ss_pred             CccCcCCCeEEEEEEEcCC--------cEEEEEEeecccCcCCCCCchhhhhhhhHHHHHHHHHHHhhCCcccee-eecc
Q psy5603         176 NKLGEGQFGTVYYGKLKNG--------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL-RLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~  246 (455)
                      +.|+.|-.=.+|++...++        ..|.+++.- ...      .        .....+|..+++.+.-.++. ++++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~------~--------~idr~~E~~i~~~ls~~gl~Pkll~  112 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE------T--------ESHLVAESVIFTLLSERHLGPKLYG  112 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC------C--------HHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc------h--------hhHHHHHHHHHHHHHhCCCCCeEEE
Confidence            5688999999999987532        456666542 111      0        11244688888777544444 5677


Q ss_pred             cccCceeEEEEEeccCCCH
Q psy5603         247 LCNNIMNCIVYEYMCNGSL  265 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL  265 (455)
                      ++.+   .+|++|++|.+|
T Consensus       113 ~~~~---g~I~efi~g~~l  128 (395)
T d1nw1a_         113 IFSG---GRLEEYIPSRPL  128 (395)
T ss_dssp             EETT---EEEECCCCEEEC
T ss_pred             EcCC---ceEEEEeccccC
Confidence            6654   578999987544

>d1icha_ a.77.1.2 (A:) Tumor necrosis factor receptor-1 death domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tumor necrosis factor receptor-1 death domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.81  E-value=0.033  Score=40.57  Aligned_cols=80  Identities=19%  Similarity=0.214  Sum_probs=57.8

Q ss_pred             HHHHHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcC-CCCCCCHHHHHH
Q psy5603          19 YVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTS-GRRRPRLSDLIM   97 (455)
Q Consensus        19 ~~~~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~-~~~~~~~~~l~~   97 (455)
                      ..+..+++-+.+. .|++||...          .++..+|..|+.....  .-+....++|..|-.+ |...+|+..|+.
T Consensus         2 ~~l~~va~~v~~~-~Wk~lar~L----------Gls~~~i~~I~~~~~~--~~~eq~~~mL~~W~~~~g~~~at~~~L~~   68 (87)
T d1icha_           2 ATLYAVVENVPPL-RWKEFVKRL----------GLSDHEIDRLELQNGR--CLREAQYSMLATWRRRTPRREATLELLGR   68 (87)
T ss_dssp             HHHHHHHHHSCST-THHHHHHHH----------TCCHHHHHHHHHHCCS--CHHHHHHHHHHHHHHHSCCSSCHHHHHHH
T ss_pred             hHHHHHHHHCChH-HHHHHHHHh----------CcCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHhhCCCchHHHHHHH
Confidence            3456677777654 699999874          4567899999866532  2235688899999643 344689999999


Q ss_pred             HHHhcccccccccc
Q psy5603          98 FLKKAELHQAARYV  111 (455)
Q Consensus        98 ~l~~~~l~~~~~~~  111 (455)
                      .|.+..+...++.+
T Consensus        69 aL~~~~~~~~Ae~i   82 (87)
T d1icha_          69 VLRDMDLLGCLEDI   82 (87)
T ss_dssp             HHHHTTCHHHHHHH
T ss_pred             HHHHCCCHHHHHHH
Confidence            99999887766543

>d2gf5a1 a.77.1.2 (A:89-191) FADD (Mort1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: FADD (Mort1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.80  E-value=0.044  Score=41.21  Aligned_cols=76  Identities=17%  Similarity=0.279  Sum_probs=55.6

Q ss_pred             HHhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHHh
Q psy5603          22 HELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKK  101 (455)
Q Consensus        22 ~~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~  101 (455)
                      .-+++.|-  .+|++||...          .++..+|..|+.....  .-+....++|..|-.....++|+..|+..|..
T Consensus        14 ~~ia~~lg--~~W~~La~~L----------gl~~~~I~~I~~~~~~--~~~e~~~~mL~~W~~~~g~~at~~~L~~aL~~   79 (103)
T d2gf5a1          14 NVICDNVG--KDWRRLARQL----------KVSDTKIDSIEDRYPR--NLTERVRESLRIWKNTEKENATVAHLVGALRS   79 (103)
T ss_dssp             HHHHHSCC--TTHHHHHHHT----------TCCHHHHHHHHHHSSS--CSHHHHHHHHHHHHHHTTTTCCHHHHHHHHHH
T ss_pred             HHHHHHHH--HhHHHHHHHc----------CCCHHHHHHHHHHcCC--CHHHHHHHHHHHHHHHcCCCcHHHHHHHHHHH
Confidence            34666663  6899999874          3457899999865432  12345778999998766668999999999998


Q ss_pred             cccccccccc
Q psy5603         102 AELHQAARYV  111 (455)
Q Consensus       102 ~~l~~~~~~~  111 (455)
                      ..+...++.+
T Consensus        80 ~~~~dlad~i   89 (103)
T d2gf5a1          80 CQMNLVADLV   89 (103)
T ss_dssp             HTCHHHHHHH
T ss_pred             CCcHHHHHHH
Confidence            8876666543

>d1ddfa_ a.77.1.2 (A:) Fas {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Fas
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.59  E-value=0.16  Score=39.67  Aligned_cols=68  Identities=18%  Similarity=0.176  Sum_probs=53.2

Q ss_pred             chHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHHhcccccccccc
Q psy5603          32 DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        32 ~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      .+|++||...          ..+..+|..|+....+  .-+....++|..|-.+....+|+..|+..|.+..+...++-+
T Consensus        27 ~dwk~lar~L----------Gls~~~I~~I~~~~~~--d~~eq~~qmL~~W~~~~G~~at~~~L~~aL~~~~~~dlAeki   94 (127)
T d1ddfa_          27 SQVKGFVRKN----------GVNEAKIDEIKNDNVQ--DTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKI   94 (127)
T ss_dssp             HHHHHHHHTT----------TSCHHHHHHHHHTTTT--CCSSHHHHHHHHHHHHSCSSSHHHHHHHHHHHTTCSSHHHHH
T ss_pred             HHHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHHhCchhHHHHHHHHHHHcCcHHHHHHH
Confidence            5799999764          4557899999977543  346678889999987767799999999999998887766543

>d1fada_ a.77.1.2 (A:) FADD (Mort1) {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: FADD (Mort1)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=89.31  E-value=0.062  Score=39.67  Aligned_cols=75  Identities=19%  Similarity=0.271  Sum_probs=53.1

Q ss_pred             HhhhhcCCcchHHHHHHhhhcCCCCCCCCCcchHHHHHHHHhcccCCCCCCchHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q psy5603          23 ELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKA  102 (455)
Q Consensus        23 ~l~~~ld~~~~w~~~~~~i~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~  102 (455)
                      .+++.|  ..+|++||...          .++..+|..|+.....  .-+....++|..|-.+...++|+..|+..|.+.
T Consensus        15 ~ia~~l--g~~Wk~Lar~L----------gls~~~I~~I~~~~~~--~~~e~~~~mL~~W~~~~g~~at~~~L~~aL~~~   80 (95)
T d1fada_          15 IVCDNV--GRDWKRLAREL----------KVSEAKMDGIEEKYPR--SLSERVRESLKVWKNAEKKNASVAGLVKALRTC   80 (95)
T ss_dssp             HHHHHH--HHHHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHHHGGGGSHHHHHHHHHHH
T ss_pred             HHHHHH--HHhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHc
Confidence            344555  36999999753          4567899999865431  113457789999965544588999999999998


Q ss_pred             ccccccccc
Q psy5603         103 ELHQAARYV  111 (455)
Q Consensus       103 ~l~~~~~~~  111 (455)
                      .+...++.+
T Consensus        81 ~~~d~ae~i   89 (95)
T d1fada_          81 RLNLVADLV   89 (95)
T ss_dssp             TCHHHHHHH
T ss_pred             CcHHHHHHH
Confidence            877666543